PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, YM; Shin, HT; Seo, YH; Byun, HO; Yoon, SH; Lee, IK; Hyun, DH; Chung, HY; Yoon, G				Kim, You-Mie; Shin, Hyun-Taek; Seo, Yong-Hak; Byun, Hae-Ok; Yoon, Soo-Han; Lee, In-Kyu; Hyun, Dong-Hoon; Chung, Hae-Young; Yoon, Gyesoon			Sterol Regulatory Element-binding Protein (SREBP)-1-mediated Lipogenesis Is Involved in Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; ATP CITRATE LYASE; TRANSCRIPTION FACTOR; HUMAN FIBROBLASTS; OXIDATIVE STRESS; MITOCHONDRIAL MASS; LIPID-SYNTHESIS; GROWTH; DNA; INHIBITORS	Increased cell mass is one of the characteristics of senescent cells, but this event has not been clearly defined. When subcellular organellar mass was estimated with organelle-specific fluorescence dyes, we observed that most membranous organelles progressively increase in mass during cell senescence. This increase was accompanied by an increase in membrane lipids and augmented expression of lipogenic enzymes, such as fatty acid synthase (FAS), ATP citrate lyase, and acetyl-CoA carboxylase. The mature form of sterol regulatory element-binding protein (SREBP)-1 was also elevated. Increased expression of these lipogenic effectors was further observed in the liver tissues of aging Fischer 344 rats. Ectopic expression of mature form of SREBP-1 in both Chang cells and primary young human diploid fibroblasts was enough to induce senescence. Blocking lipogenesis with FAS inhibitors (cerulenin and C75) and via siRNA-mediated silencing of SREBP-1 and ATP citrate lyase significantly attenuated H2O2-induced senescence. Finally, old human diploid fibroblasts were effectively reversed to young-like cells by challenging with FAS inhibitors. Our results suggest that enhanced lipogenesis is not only a common event, but also critically involved in senescence via SREBP-1 induction, thereby contributing to the increase in organelle mass (as a part of cell mass), a novel indicator of senescence.	[Yoon, Gyesoon] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea; [Yoon, Soo-Han] Ajou Univ, Dept Neurosurg, Sch Med, Suwon 443721, South Korea; [Kim, You-Mie; Shin, Hyun-Taek; Seo, Yong-Hak; Byun, Hae-Ok; Yoon, Soo-Han; Yoon, Gyesoon] Ajou Univ, Dept Mol Sci & Technol, Grad Sch, Suwon 443721, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea; [Hyun, Dong-Hoon] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Chung, Hae-Young] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Ajou University; Ajou University; Ajou University; Kyungpook National University; Ewha Womans University; Pusan National University	Yoon, G (corresponding author), Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea.	ypeace@ajou.ac.kr	Lee, In-Kyu/AAR-6374-2021		Korean government [R13-2003-019-01007-0]	Korean government(Korean Government)	This work was supported by Korean Science and Engineering Foundation Grant R13-2003-019-01007-0 funded by the Korean government.	Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42; Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379; CRISTOFA.VJ, 1969, MED EXP, V19, P313; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; GREENBERG SB, 1977, IN VITRO CELL DEV B, V13, P297; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4; Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009; Nakakuki M, 2007, FEBS J, V274, P4440, DOI 10.1111/j.1742-4658.2007.05973.x; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pizer ES, 1998, CANCER RES, V58, P4611; Porstmann T, 2009, BIOCHEM SOC T, V37, P278, DOI 10.1042/BST0370278; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004; Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wei YH, 2001, ANN NY ACAD SCI, V928, P97; Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	43	60	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29069	29077		10.1074/jbc.M110.120386	http://dx.doi.org/10.1074/jbc.M110.120386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615871	Green Published, hybrid			2022-12-27	WOS:000281740100008
J	Zhang, C; Browne, A; Child, D; Tanzi, RE				Zhang, Can; Browne, Andrew; Child, Daniel; Tanzi, Rudolph E.			Curcumin Decreases Amyloid-beta Peptide Levels by Attenuating the Maturation of Amyloid-beta Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; SECRETASE CLEAVAGE; TRANSGENIC MOUSE; APP METABOLISM; GENERATION; HYPOTHESIS; EXPRESSION; OLIGOMERS; PATHOLOGY	Alzheimer disease (AD) is a devastating neurodegenerative disease with no cure. The pathogenesis of AD is believed to be driven primarily by amyloid-beta (A beta), the principal component of senile plaques. A beta is an similar to 4-kDa peptide generated via cleavage of the amyloid-beta precursor protein (APP). Curcumin is a compound in the widely used culinary spice, turmeric, which possesses potent and broad biological activities, including anti-inflammatory and antioxidant activities, chemopreventative effects, and effects on protein trafficking. Recent in vivo studies indicate that curcumin is able to reduce A beta-related pathology in transgenic AD mouse models via unknown molecular mechanisms. Here, we investigated the effects of curcumin on A beta levels and APP processing in various cell lines and mouse primary cortical neurons. We show for the first time that curcumin potently lowers A beta levels by attenuating the maturation of APP in the secretory pathway. These data provide a mechanism of action for the ability of curcumin to attenuate amyloid-beta pathology.	[Tanzi, Rudolph E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,MassGen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,MassGen Inst Neurodegenerat Dis, Dept Neurol,Genet & Aging Res Unit, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Child, Daniel/0000-0002-4309-0144	Cure Alzheimer's Fund; Massachusetts General Hospital; Harvard NeuroDiscovery Center; Massachusetts Alzheimer's Disease Research Center	Cure Alzheimer's Fund; Massachusetts General Hospital(General Electric); Harvard NeuroDiscovery Center; Massachusetts Alzheimer's Disease Research Center	This work was supported by the Cure Alzheimer's Fund, the Funds for Medical Discovery from Massachusetts General Hospital, and a Neurodegenerative Disease Pilot Study Grant from the Harvard NeuroDiscovery Center and Massachusetts Alzheimer's Disease Research Center.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Antczak C, 2009, COMB CHEM HIGH T SCR, V12, P258, DOI 10.2174/138620709787581729; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Calabrese V, 2003, AMINO ACIDS, V25, P437, DOI 10.1007/s00726-003-0048-2; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2007, J NEUROCHEM, V102, P619, DOI 10.1111/j.1471-4159.2007.04587.x; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Kelloff GJ, 1997, PROG CLIN BIOL RES, V396, P159; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimmyo Y, 2008, NEUROREPORT, V19, P1329, DOI 10.1097/WNR.0b013e32830b8ae1; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Thomas P, 2009, MUTAT RES-FUND MOL M, V661, P25, DOI 10.1016/j.mrfmmm.2008.10.016; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; ZHANG C, J BIOL CHEM, V285, P8515; ZHANG C, CURR ALZHEIMER RES, V7, P21; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang Can, 2007, Discov Med, V7, P113	39	137	144	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28472	28480		10.1074/jbc.M110.133520	http://dx.doi.org/10.1074/jbc.M110.133520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622013	Green Published, hybrid			2022-12-27	WOS:000281594000010
J	Du, JX; McConnell, BB; Yang, VW				Du, James X.; McConnell, Beth B.; Yang, Vincent W.			A Small Ubiquitin-related Modifier-interacting Motif Functions as the Transcriptional Activation Domain of Kruppel-like Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; SUMO-BINDING MOTIF; SUBNUCLEAR LOCALIZATION; TRANSACTIVATION DOMAIN; GENE-EXPRESSION; NUCLEAR-BODIES; P53 ACTIVITY; FACTOR KLF4; PROTEIN; ALPHA	The zinc finger transcription factor, Kruppel-like factor 4 (KLF4), regulates numerous biological processes, including proliferation, differentiation, and embryonic stem cell self-renewal. Although the DNA sequence to which KLF4 binds is established, the mechanism by which KLF4 controls transcription is not well defined. Small ubiquitin-related modifier (SUMO) is an important regulator of transcription. Here we show that KLF4 is both SUMOylated at a single lysine residue and physically interacts with SUMO-1 in a region that matches an acidic and hydrophobic residue-rich SUMO-interacting motif (SIM) consensus. The SIM in KLF4 is required for transactivation of target promoters in a SUMO-1-dependent manner. Mutation of either the acidic or hydrophobic residues in the SIM significantly impairs the ability of KLF4 to interact with SUMO-1, activate transcription, and inhibit cell proliferation. Our study provides direct evidence that SIM in KLF4 functions as a transcriptional activation domain. A survey of transcription factor sequences reveals that established transactivation domains of many transcription factors contain sequences highly related to SIM. These results, therefore, illustrate a novel mechanism by which SUMO interaction modulates the activity of transcription factors.	[Du, James X.; McConnell, Beth B.; Yang, Vincent W.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu			National Institutes of Health [DK52230, DK64399, DK76742, DK77381, CA84197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, K01DK076742, R03DK089131, R01DK052230, F32DK077381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52230, DK64399, DK76742, DK77381, and CA84197.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Breiding DE, 1996, VIROLOGY, V221, P34, DOI 10.1006/viro.1996.0350; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Defossez PA, 1997, NUCLEIC ACIDS RES, V25, P4455, DOI 10.1093/nar/25.22.4455; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; Hagos EG, 2009, ONCOGENE, V28, P1197, DOI 10.1038/onc.2008.465; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim DH, 2009, BMB REP, V42, P411, DOI 10.5483/BMBRep.2009.42.7.411; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; OHARE P, 1992, BIOCHEMISTRY-US, V31, P4150, DOI 10.1021/bi00131a035; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pountney DL, 2003, EXP NEUROL, V184, P436, DOI 10.1016/j.expneurol.2003.07.004; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SEIPEL K, 1994, BIOL CHEM H-S, V375, P463, DOI 10.1515/bchm3.1994.375.7.463; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Subang MC, 2009, SCIENCE, V326, P238, DOI 10.1126/science.1181038; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; VANHOY M, 1993, CELL, V72, P587, DOI 10.1016/0092-8674(93)90077-4; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang DM, 2002, ONCOGENE, V21, P1611, DOI 10.1038/sj.onc.1205236; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; XIAO H, 1994, MOL CELL BIOL, V14, P7507, DOI 10.1128/MCB.14.11.7507; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	83	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28298	28308		10.1074/jbc.M110.101717	http://dx.doi.org/10.1074/jbc.M110.101717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584900	Green Published, hybrid			2022-12-27	WOS:000281404100072
J	Gao, ZB; Zhang, TZ; Wu, M; Xiong, QJ; Sun, HY; Zhang, YA; Zu, LS; Wang, W; Li, M				Gao, Zhaobing; Zhang, Tangzhi; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Zhang, Yinan; Zu, Liansuo; Wang, Wei; Li, Min			Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KCNQ2/KCNQ3 K+ CHANNELS; I-KS; ANTICONVULSANT RETIGABINE; ION CHANNELS; ACTIVATION; ICA-27243; BINDING; ASSAY; N-(6-CHLORO-PYRIDIN-3-YL)-3,4-DIFLUORO-BENZAMIDE; SENSITIVITY	Kv7 channels, especially Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3), are key determinants for membrane excitability in the brain. Some chemical modulators of KCNQ channels are in development for use as anti-epileptic drugs, such as retigabine (D-23129, N-(2-amino-4-(4-fluorobenzylamino)-phenyl)), which was recently approved for clinical use. In addition, several other compounds were also reported to potentiate activity of the Kv7 channels. It is therefore of interest to investigate compound-channel interactions, so that more insights may be gained to aid future development of therapeutics. We have conducted a screen of 20,000 compounds for KCNQ2 potentiators using rubidium flux combined with atomic absorption spectrometry. Here, we report the characterization of a series of new structures that display isoform specificity and induce a marked reduction of deactivation distinct from that of retigabine. Furthermore, KCNQ2(W236L), a previously reported mutation that abolishes sensitivity to retigabine, remains fully sensitive to these compounds. This result, together with mutagenesis and other studies, suggests that the reported compounds confer a unique mode of action and involve new molecular determinants on the channel protein, consistent with the idea of recognizing a new site on channel protein.	[Zhang, Tangzhi; Zhang, Yinan; Zu, Liansuo; Wang, Wei] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Gao, Zhaobing; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Li, Min] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Zhaobing; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD 21205 USA	University of New Mexico; Johns Hopkins University; Johns Hopkins University	Wang, W (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	wwang@unm.edu; minli@jhmi.edu	Wu, Meng/F-3958-2010	Wu, Meng/0000-0003-2222-0736	National Institutes of Health [GM078579, MH084691]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078579 and MH084691 (to M. L.). This work was also supported by a postdoctoral fellowship award from the American Heart Association (to Z. G.).	Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Brown DA, 2008, J PHYSIOL-LONDON, V586, P1781, DOI 10.1113/jphysiol.2008.153007; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Padilla K, 2009, NEUROSCI LETT, V465, P138, DOI 10.1016/j.neulet.2009.08.071; RAE JL, 1990, CURR EYE RES, V9, P847, DOI 10.3109/02713689008999557; Redrobe JP, 2009, BEHAV BRAIN RES, V198, P481, DOI 10.1016/j.bbr.2008.12.027; Roeloffs R, 2008, J PHARMACOL EXP THER, V326, P818, DOI 10.1124/jpet.108.137794; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Sun HY, 2004, P NATL ACAD SCI USA, V101, P16964, DOI 10.1073/pnas.0404178101; Surti Toral S, 2005, Curr Opin Investig Drugs, V6, P704; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Terstappen GC, 1999, ANAL BIOCHEM, V272, P149, DOI 10.1006/abio.1999.4179; TOPLISS JG, 1977, J MED CHEM, V20, P463, DOI 10.1021/jm00214a001; TOPLISS JG, 1972, J MED CHEM, V15, P1006, DOI 10.1021/jm00280a002; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wickenden AD, 2008, MOL PHARMACOL, V73, P977, DOI 10.1124/mol.107.043216; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu J, 2001, DRUG DISCOV TODAY, V6, P1278, DOI 10.1016/S1359-6446(01)02095-5	43	46	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28322	28332		10.1074/jbc.M110.116392	http://dx.doi.org/10.1074/jbc.M110.116392			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584905	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000281404100074
J	Jastrebova, N; Vanwildemeersch, M; Lindahl, U; Spillmann, D				Jastrebova, Nadja; Vanwildemeersch, Maarten; Lindahl, Ulf; Spillmann, Dorothe			Heparan Sulfate Domain Organization and Sulfation Modulate FGF-induced Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CRYSTAL-STRUCTURE; BASIC FGF; BINDING; SEQUENCE; OLIGOSACCHARIDES; IDENTIFICATION; CHONDROITIN; DEPOLYMERIZATION; GROWTH-FACTOR-1	Heparan sulfates (HSs) modulate various developmental and homeostatic processes by binding to protein ligands. We have evaluated the structural characteristics of porcine HS in cellular signaling induced by basic fibroblast growth factor (FGF2), using CHO745 cells devoid of endogenous glycosaminoglycans as target. Markedly enhanced stimulation of cell signaling, measured as phosphorylation of ERK1/2 and protein kinase B, was only observed with the shortest HS chains isolated from liver, whereas the longer chains from either liver or intestine essentially prolonged duration of signals induced by FGF2 in the absence of polysaccharide. Structural analysis showed that contiguous sulfated domains were most abundant in the shortest HS chains and were more heavily sulfated in HS from liver than in HS from intestine. Moreover, the shortest chains from either source entered into ternary complexes with FGF2 and FGF receptor-1c more efficiently than the corresponding longer chains. In addition to authentic HSs, decasaccharide libraries generated by chemo-enzymatic modification of heparin were probed for effect on FGF2 signaling. Only the most highly sulfated decamers, previously found most efficient in ternary complex formation (Jastrebova, N., Vanwildemeersch, M., Rapraeger, A. C., Gimenez-Gallego, G., Lindahl, U., and Spillmann, D. (2006) J. Biol. Chem. 281, 26884-26892), promoted FGF2 cellular signaling as efficiently as short HS chains from liver. Together these results suggest that the effects of HS on FGF2 signaling are determined by both the structure of the highly sulfated domains and by the organization/availability of such domains within the HS chain. These findings underpin the need for regulation of HS biosynthesis in relation to control of growth factor-induced signaling pathways.	[Spillmann, Dorothe] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Spillmann, D (corresponding author), Uppsala Univ, BMC, Dept Med Biochem & Microbiol, POB 582, SE-75123 Uppsala, Sweden.	Dorothe.Spillmann@imbim.uu.se			Swedish Research Council [150223]; Swedish Cancer Society; Swedish Foundation for Strategic Research [A303: 156e]; Polysackaridforskning AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Polysackaridforskning AB	This work was supported by Swedish Research Council Grant 150223, Swedish Cancer Society, Swedish Foundation for Strategic Research Grant A303: 156e, and Polysackaridforskning AB.	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Kariya Y, 2000, J BIOL CHEM, V275, P25949, DOI 10.1074/jbc.M004140200; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; LINKER A, 1973, CARBOHYD RES, V29, P41, DOI 10.1016/S0008-6215(00)82069-8; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Ornitz DM, 2001, GENOME BIOL, V2; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; REILAND J, 1993, J CELL SCI, V105, P1085; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	65	55	54	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26842	26851		10.1074/jbc.M109.093542	http://dx.doi.org/10.1074/jbc.M109.093542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576609	Green Published, hybrid			2022-12-27	WOS:000281172700015
J	Kuhn, FJP; Witschas, K; Kuhn, C; Luckhoff, A				Kuehn, Frank J. P.; Witschas, Katja; Kuehn, Cornelia; Lueckhoff, Andreas			Contribution of the S5-Pore-S6 Domain to the Gating Characteristics of the Cation Channels TRPM2 and TRPM8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR TRPM8; INTRACELLULAR CALCIUM; VOLTAGE SENSOR; MENTHOL; ACTIVATION; ICILIN; DESENSITIZATION; SELECTIVITY; MECHANISM; STIMULI	The closely related cation channels TRPM2 and TRPM8 show completely different requirements for stimulation and are regulated by Ca2+ in an opposite manner. TRPM8 is basically gated in a voltage-dependent process enhanced by cold temperatures and cooling compounds such as menthol and icilin. The putative S4 voltage sensor of TRPM8 is closely similar to that of TRPM2, which, however, is mostly devoid of voltage sensitivity. To gain insight into principal interactions of critical channel domains during the gating process, we created chimeras in which the entire S5-pore-S6 domains were reciprocally exchanged. The chimera M2-M8P (i.e. TRPM2 with the pore of TRPM8) responded to ADP-ribose and hydrogen peroxide and was regulated by extracellular and intracellular Ca2+ as was wild-type TRPM2. Single-channel recordings revealed the characteristic pattern of TRPM2 with extremely long open times. Only at far-negative membrane potentials (-120 to -140 mV) did differences become apparent because currents were reduced by hyperpolarization in M2-M8P but not in TRPM2. The reciprocal chimera, M8-M2P, showed currents after stimulation with high concentrations of menthol and icilin, but these currents were only slightly larger than in controls. The transfer of the NUDT9 domain to the C terminus of TRPM8 produced a channel sensitive to cold, menthol, or icilin but insensitive to ADPribose or hydrogen peroxide. We conclude that the gating processes in TRPM2 and TRPM8 differ in their requirements for specific structures within the pore. Moreover, the regulation by extracellular and intracellular Ca2+ and the single-channel properties in TRPM2 are not determined by the S5-pore-S6 region.	[Kuehn, Frank J. P.; Witschas, Katja; Kuehn, Cornelia; Lueckhoff, Andreas] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany	RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018; Witschas, Katja/AAJ-3431-2020	Witschas, Katja/0000-0002-0960-683X	Deutsche Forschungsgemeinschaft [DFG KU 2271/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG KU 2271/11.	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; Kuhn FJP, 2009, J BIOL CHEM, V284, P4102, DOI 10.1074/jbc.M806651200; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862	30	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26806	26814		10.1074/jbc.M110.109975	http://dx.doi.org/10.1074/jbc.M110.109975			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20587417	Green Published, hybrid			2022-12-27	WOS:000281172700011
J	Wang, B; Ardura, JA; Romero, G; Yang, YM; Hall, RA; Friedman, PA				Wang, Bin; Ardura, Juan A.; Romero, Guillermo; Yang, Yanmei; Hall, Randy A.; Friedman, Peter A.			Na/H Exchanger Regulatory Factors Control Parathyroid Hormone Receptor Signaling by Facilitating Differential Activation of G alpha Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; OSTEOBLAST-LIKE CELLS; OPOSSUM KIDNEY-CELLS; SMOOTH-MUSCLE-CELLS; (PTH)/PTH-RELATED PEPTIDE; PHOSPHOLIPASE-C; CYCLIC-AMP; KINASE-C; CA2+-DEPENDENT INHIBITION; PHOSPHATE-TRANSPORT	The Na/H exchanger regulatory factors, NHERF1 and NHERF2, are adapter proteins involved in targeting and assembly of protein complexes. The parathyroid hormone receptor (PTHR) interacts with both NHERF1 and NHERF2. The NHERF proteins toggle PTHR signaling from predominantly activation of adenylyl cyclase in the absence of NHERF to principally stimulation of phospholipase C when the NHERF proteins are expressed. We hypothesized that this signaling switch occurs at the level of the G protein. We measured G protein activation by [S-35]GTP gamma S binding and G alpha subtype-specific immunoprecipitation using three different cellular models of PTHR signaling. These studies revealed that PTHR interactions with NHERF1 enhance receptor-mediated stimulation of G alpha(q) but have no effect on stimulation of G alpha(i) or G alpha(s). In contrast, PTHR associations with NHERF2 enhance receptor-mediated stimulation of both G alpha(q) and G alpha(i) but decrease stimulation of G alpha(s). Consistent with these functional data, NHERF2 formed cellular complexes with both G alpha(q) and G alpha(i), whereas NHERF1 was found to interact only with G alpha(q). These findings demonstrate that NHERF interactions regulate PTHR signaling at the level of G proteins and that NHERF1 and NHERF2 exhibit isotype-specific effects on G protein activation.	[Wang, Bin; Ardura, Juan A.; Romero, Guillermo; Yang, Yanmei; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, Pittsburgh, PA 15261 USA; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, W-1340 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan/L-8139-2014; Ardura, Juan Antonio/F-3378-2017	Ardura, Juan/0000-0002-8881-4775; Ardura, Juan Antonio/0000-0002-2827-3364; Hall, Randy/0000-0002-8318-8728; Wang, Bin/0000-0002-5396-6111	National Institutes of Health [R01DK69998, R01NS055179]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK69998 (to P. A. F.) and R01NS055179 (to R. A. H.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; ATKINSON MJ, 1987, J BONE MINER RES, V2, P303; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; HRUSKA KA, 1987, J CLIN INVEST, V79, P230, DOI 10.1172/JCI112788; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; KLINGER M, 1990, KIDNEY INT, V37, P1543, DOI 10.1038/ki.1990.147; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maeda S, 1996, ENDOCRINOLOGY, V137, P3154, DOI 10.1210/en.137.8.3154; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; ORLOFF JJ, 1995, ENDOCRINOLOGY, V136, P3016, DOI 10.1210/en.136.7.3016; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; RAMPE D, 1991, AM J PHYSIOL, V261, pH1945, DOI 10.1152/ajpheart.1991.261.6.H1945; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; SCHLUTER KD, 1995, BIOCHEM J, V310, P439, DOI 10.1042/bj3100439; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; WHITFIELD JF, 1971, J CELL PHYSIOL, V78, P355, DOI 10.1002/jcp.1040780305; WHITFIELD JF, 1992, J CELL PHYSIOL, V150, P299, DOI 10.1002/jcp.1041500212; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; WU SX, 1993, ENDOCRINOLOGY, V133, P2437, DOI 10.1210/en.133.6.2437; YAMAMOTO I, 1988, ENDOCRINOLOGY, V122, P1208, DOI 10.1210/endo-122-4-1208	53	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26976	26986		10.1074/jbc.M110.147785	http://dx.doi.org/10.1074/jbc.M110.147785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562104	hybrid, Green Published			2022-12-27	WOS:000281172700029
J	Chen, ZJ; Norris, JY; Finck, BN				Chen, Zhouji; Norris, Jin Y.; Finck, Brian N.			Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha (PGC-1 alpha) Stimulates VLDL Assembly through Activation of Cell Death-inducing DFFA-like Effector B (CideB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; FATTY-ACID OXIDATION; TRIGLYCERIDE TRANSFER PROTEIN; NUCLEAR FACTOR 4-ALPHA; APO-B; HEPATIC GLUCONEOGENESIS; HEPG2 CELLS; FAMILIAL HYPOBETALIPOPROTEINEMIA; APOLIPOPROTEIN-B; GENE-EXPRESSION	Abnormalities in very low density lipoprotein (VLDL) assembly and secretion impact intrahepatic lipid homeostasis, plasma lipoprotein profile, and energy metabolism of distal peripheral tissues. We have evaluated the role of the transcriptional coactivator, the peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), in VLDL assembly and secretion. PGC-1 alpha overexpression in HepG2 cells led to diminished rates of triglyceride (TG) synthesis but strongly stimulated VLDL-TG secretion, markedly increasing the efficiency of secretion of newly synthesized TG. PGC-1 alpha overexpression increased the rate of secretion of apoB100 and promoted secretion of larger, less dense VLDL particles. PGC-1 alpha overexpression in intact mouse liver also stimulated rates of VLDL TG secretion and attenuated hepatic TG accumulation resulting from high fat diet feeding. To determine the molecular mechanisms mediating the effect of PGC-1 alpha on VLDL assembly, we evaluated the expression of several candidate mediators known to be involved in VLDL assembly or hepatic lipid homeostasis. Cell death-inducing DFFA-like effector B (CideB) expression was greatly induced by PGC-1 alpha, and siRNA against CideB reversed the effects of PGC-1 alpha on the secretion of TG and VLDL-sized particles by HepG2 cells, indicating that CideB is a critical mediator of stimulatory effects of PGC-1 alpha on VLDL secretion. Collectively, these data suggest that PGC-1 alpha plays an important role in partitioning cytoplasmic TG toward the VLDL secretory compartments and promoting VLDL secretion via transcriptional induction of CideB.	[Chen, Zhouji; Norris, Jin Y.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Chen, ZJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Geriatr & Nutr Sci, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	zchen23@wustl.edu		Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK078187, R01 HL73939]; Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center at Washington University School of Medicine [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK052574, R01DK078187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Nutrition Obesity Research Center at Washington University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078187 (to B. N. F.) and R01 HL73939 (to Z. C.). This work was also supported by the core services of the Digestive Diseases Research Core Center Grant P30 DK52574 and the Nutrition Obesity Research Center Grant P30 DK56341 at Washington University School of Medicine.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1711; Chen ZJ, 2008, J LIPID RES, V49, P2013, DOI 10.1194/jlr.M800240-JLR200; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Chen ZJ, 2004, J LIPID RES, V45, P155, DOI 10.1194/jlr.M300275-JLR200; Chen ZJ, 2002, J BIOL CHEM, V277, P14135, DOI 10.1074/jbc.M200617200; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; DIXON JL, 1993, J LIPID RES, V34, P167; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; GIBBONS GF, 1994, J LIPID RES, V35, P1801; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Hamilton R L, 1972, Adv Exp Med Biol, V26, P7; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li XH, 1997, J LIPID RES, V38, P1277; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin XB, 2005, AM J PHYSIOL-GASTR L, V289, pG146, DOI 10.1152/ajpgi.00309.2004; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Neuzil J, 1998, J LIPID RES, V39, P354; Oberkofler H, 2004, BIOCHEM J, V381, P357, DOI 10.1042/BJ20040173; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; SNIDERMAN AD, 1993, ARTERIOSCLER THROMB, V13, P629, DOI 10.1161/01.ATV.13.5.629; Swift LL, 2001, J LIPID RES, V42, P218; THRIFT RN, 1986, J LIPID RES, V27, P236; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wu XJ, 1996, J LIPID RES, V37, P1198; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; YANG LY, 1995, J LIPID RES, V36, P125; YAO ZM, 1993, ARTERIOSCLER THROMB, V13, P1476, DOI 10.1161/01.ATV.13.10.1476; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	58	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25996	26004		10.1074/jbc.M110.141598	http://dx.doi.org/10.1074/jbc.M110.141598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551328	hybrid, Green Published			2022-12-27	WOS:000280921000014
J	Gasser, A; Cheng, XY; Gilmore, ES; Tyrrell, L; Waxman, SG; Dib-Hajj, SD				Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.			Two Nedd4-binding Motifs Underlie Modulation of Sodium Channel Na(v)1.6 by p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; CURRENT-DENSITY; AXONAL INJURY; C-TERMINUS; SCN8A; NEURONS; NEDD4; COLOCALIZATION; DETERMINANTS; ACTIVATION	Sodium channel Na(v)1.6 is essential for neuronal excitability in central and peripheral nervous systems. Loss-of-function mutations in Nav1.6 underlie motor disorders, with homozygous-null mutations causing juvenile lethality. Phosphorylation of Na(v)1.6 by the stress-induced p38 MAPK at a Pro-Gly-Ser(553)-Pro motif in its intracellular loop L1 reduces Na(v)1.6 current density in a dorsal root ganglion-derived cell line, without changing its gating properties. Phosphorylated Pro-Gly-Ser(553)-Pro motif is a putative binding site to Nedd4 ubiquitin ligases, and we hypothesized that Nedd4-like ubiquitin ligases may contribute to channel ubiquitination and internalization. We report here that p38 activation in hippocampal neurons from wild-type mice, but not from Scn8a(medtg) mice that lack Na(v)1.6, reduces tetrodotoxin-S sodium currents, suggesting isoform-specific modulation of Na(v)1.6 by p38 in these neurons. Pharmacological block of endocytosis completely abolishes p38-mediated Na(v)1.6 current reduction, supporting our hypothesis that channel internalization underlies current reduction. We also report that the ubiquitin ligase Nedd4-2 interacts with Na(v)1.6 via a Pro-Ser-Tyr(1945) motif in the C terminus of the channel and reduces Na(v)1.6 current density, and we show that this regulation requires both the Pro-Gly-Ser-Pro motif in L1 and the Pro-Ser-Tyr motif in the C terminus. Similarly, both motifs are necessary for p38-mediated reduction of Na(v)1.6 current, whereas abrogating binding of the ubiquitin ligase Nedd4-2 to the Pro-Ser-Tyr motif results in stress-mediated increase in Na(v)1.6 current density. Thus, phosphorylation of the Pro-Gly-Ser-Pro motif within L1 of Na(v)1.6 is necessary for stress-induced current modulation, with positive or negative regulation depending upon the availability of the C-terminal Pro-Ser-Tyr motif to bind Nedd4-2.	[Dib-Hajj, Sulayman D.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Yale Univ, Ctr Neurosci & Regenerat Res, Sch Med, New Haven, CT 06510 USA; [Gasser, Andreas; Cheng, Xiaoyang; Gilmore, Elaine S.; Tyrrell, Lynda; Waxman, Stephen G.; Dib-Hajj, Sulayman D.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA; [Gilmore, Elaine S.] Yale Univ, Dept Dermatol, Sch Med, New Haven, CT 06511 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Dib-Hajj, SD (corresponding author), Vet Affairs Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res 127A, Bldg 34,950 Campbell Ave, West Haven, CT 06516 USA.	sulayman.dib-hajj@yale.edu	Cheng, Xiaoyang/M-1257-2017; Cheng, Xiaoyang/N-9970-2019; Waxman, Stephen/Z-2507-2019; Cheng, Xiaoyang/A-1729-2012	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Waxman, Stephen/0000-0001-5718-7177; Cheng, Xiaoyang/0000-0003-1446-2815	National Multiple Sclerosis Society; Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007016] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Multiple Sclerosis Society and the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs. The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Cummins TR, 2005, FEBS LETT, V579, P2166, DOI 10.1016/j.febslet.2005.03.009; Dargent B, 1996, NEUROSCIENCE, V73, P209, DOI 10.1016/0306-4522(95)00608-7; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Garcia KD, 1998, J NEUROSCI, V18, P5234, DOI 10.1523/JNEUROSCI.18-14-05234.1998; Garrido JJ, 2003, BIOL CELL, V95, P437, DOI 10.1016/S0248-4900(03)00091-1; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Hedstrom KL, 2006, J NEUROCHEM, V98, P1345, DOI 10.1111/j.1471-4159.2006.04001.x; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Liu CJ, 2005, MOL CELL NEUROSCI, V28, P636, DOI 10.1016/j.mcn.2004.11.007; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Meisler MH, 2001, NEUROSCIENTIST, V7, P136, DOI 10.1177/107385840100700208; Paillart C, 1996, J CELL BIOL, V134, P499, DOI 10.1083/jcb.134.2.499; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Schaller KL, 2000, J COMP NEUROL, V420, P84; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wittmack EK, 2005, J NEUROSCI, V25, P6621, DOI 10.1523/JNEUROSCI.0541-05.2005; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084	48	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26149	26161		10.1074/jbc.M109.098681	http://dx.doi.org/10.1074/jbc.M109.098681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20530479	Green Published, hybrid			2022-12-27	WOS:000280921000032
J	Wakabayashi, S; Nakamura, TY; Kobayashi, S; Hisamitsu, T				Wakabayashi, Shigeo; Nakamura, Tomoe Y.; Kobayashi, Soushi; Hisamitsu, Takashi			Novel Phorbol Ester-binding Motif Mediates Hormonal Activation of Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTRACELLULAR PH REGULATION; GROWTH-FACTOR; MOLECULAR PHYSIOLOGY; HOMOLOGOUS PROTEIN-1; ESSENTIAL COFACTOR; ISOFORM-1 NHE1; PHOSPHORYLATION; ALPHA; FIBROBLASTS	Protein kinase C (PKC) is considered crucial for hormonal Na+/H+ exchanger (NHE1) activation because phorbol esters (PEs) strongly activate NHE1. However, here we report that rather than PKC, direct binding of PEs/diacylglycerol to the NHE1 lipid-interacting domain (LID) and the subsequent tighter association of LID with the plasma membrane mainly underlies NHE1 activation. We show that (i) PEs directly interact with the LID of NHE1 in vitro, (ii) like PKC, green fluorescent protein (GFP)-labeled LID translocates to the plasma membrane in response to PEs and receptor agonists, (iii) LID mutations markedly inhibit these interactions and PE/receptor agonist-induced NHE1 activation, and (iv) PKC inhibitors ineffectively block NHE1 activation, except staurosporin, which itself inhibits NHE1 via LID. Thus, we propose a PKC-independent mechanism of NHE1 regulation via a PE-binding motif previously unrecognized.	[Wakabayashi, Shigeo; Nakamura, Tomoe Y.; Kobayashi, Soushi; Hisamitsu, Takashi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Physiol, Osaka 5658565, Japan	National Cerebral & Cardiovascular Center - Japan	Wakabayashi, S (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Physiol, Fujishirodai 5-7-1, Osaka 5658565, Japan.	wak@ri.ncvc.go.jp			National Institute of Biomedical Innovation (NIBIO) [18077015, 19390080]; Ministry of Health, Labour, and Welfare of Japan [20C-3, 21A-13, nano-006]; Grants-in-Aid for Scientific Research [21590248] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas 18077015 and Grants-in-Aid for Scientific Research (B) 19390080, a grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO), research grants for Cardiovascular Diseases (20C-3 and 21A-13), and a grant (nano-006) for Research on Advanced Medical Technology from the Ministry of Health, Labour, and Welfare of Japan.	Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BESTERMAN JM, 1984, J CELL BIOL, V99, P340, DOI 10.1083/jcb.99.1.340; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GRINSTEIN S, 1985, J CELL BIOL, V101, P269, DOI 10.1083/jcb.101.1.269; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; Liu FM, 2001, AM J PHYSIOL-RENAL, V280, pF415, DOI 10.1152/ajprenal.2001.280.3.F415; Maly K, 2002, FEBS LETT, V521, P205, DOI 10.1016/S0014-5793(02)02867-3; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; MOOLENAAR WH, 1984, NATURE, V312, P371, DOI 10.1038/312371a0; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PARIS S, 1984, J BIOL CHEM, V259, P989; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; SARDET C, 1991, J BIOL CHEM, V266, P19166; Slater SJ, 1998, J BIOL CHEM, V273, P23160, DOI 10.1074/jbc.273.36.23160; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	54	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26652	26661		10.1074/jbc.M110.130120	http://dx.doi.org/10.1074/jbc.M110.130120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551318	Green Published, hybrid			2022-12-27	WOS:000280921000080
J	Adamczyk, P; Zenkert, C; Balasubramanian, PG; Yamada, S; Murakoshi, S; Sugahara, K; Hwang, JS; Gojobori, T; Holstein, TW; Ozbek, S				Adamczyk, Patrizia; Zenkert, Claudia; Balasubramanian, Prakash G.; Yamada, Shuhei; Murakoshi, Saori; Sugahara, Kazuyuki; Hwang, Jung Shan; Gojobori, Takashi; Holstein, Thomas W.; Ozbek, Suat			A Non-sulfated Chondroitin Stabilizes Membrane Tubulation in Cnidarian Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; CENTRAL-NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS; CELL-DIVISION; HYDRA; PROTEOGLYCANS; NEMATOCYSTS; SULFATE; DIFFERENTIATION; IDENTIFICATION	Membrane tubulation is generally associated with rearrangements of the cytoskeleton and other cytoplasmic factors. Little is known about the contribution of extracellular matrix components to this process. Here, we demonstrate an essential role of proteoglycans in the tubulation of the cnidarian nematocyst vesicle. The morphogenesis of this extrusive organelle takes place inside a giant post-Golgi vesicle, which topologically represents extracellular space. This process includes the formation of a complex collagenous capsule structure that elongates into a long tubule, which invaginates after its completion. We show that a non-sulfated chondroitin appears as a scaffold in early morphogenesis of all nematocyst types in Hydra and Nematostella. It accompanies the tubulation of the vesicle membrane forming a provisional tubule structure, which after invagination matures by collagen incorporation. Inhibition of chondroitin synthesis by beta-xylosides arrests nematocyst morphogenesis at different stages of tubule outgrowth resulting in retention of tubule material and a depletion of mature capsules in the tentacles of hydra. Our data suggest a conserved role of proteoglycans in the stabilization of a membrane protrusion as an essential step in organelle morphogenesis.	[Yamada, Shuhei; Murakoshi, Saori; Sugahara, Kazuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Holstein, Thomas W.; Ozbek, Suat] Univ Heidelberg, Dept Mol Evolut & Genom, Inst Zool, D-69120 Heidelberg, Germany; [Hwang, Jung Shan; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Hwang, Jung Shan; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan	Hokkaido University; Ruprecht Karls University Heidelberg; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sugahara, K (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci,Kita Ku, Nishi 11 Choume,Kita 21-Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp; soezbek@zoo.uni-heidelberg.de	Hwang, Jung Shan/AAJ-3014-2020; Özbek, Suat/D-3701-2014	Hwang, Jung Shan/0000-0002-0908-2036; Holstein, Thomas/0000-0003-0480-4674; Ozbek, Suat/0000-0003-2569-3942	German Science Foundation (Deutsche Forschungsgemeinschaft); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [20390019]	German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the German Science Foundation (Deutsche Forschungsgemeinschaft) (to S. O. and T. W. H.) and in part by Grants-in-aid for Scientific Research (B) (20390019) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.).	Adamczyk P, 2008, J MOL BIOL, V376, P1008, DOI 10.1016/j.jmb.2007.10.090; Bosch TCG, 2010, DEV GROWTH DIFFER, V52, P15, DOI 10.1111/j.1440-169X.2009.01143.x; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P69, DOI 10.1083/jcb.5.1.69; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P79, DOI 10.1083/jcb.5.1.79; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; DAVID CN, 1974, J CELL SCI, V16, P359; Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; HOLSTEIN T, 1981, J ULTRA MOL STRUCT R, V75, P276, DOI 10.1016/S0022-5320(81)80085-8; HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KARAMANOS NK, 1988, BIOCHIM BIOPHYS ACTA, V966, P36, DOI 10.1016/0304-4165(88)90126-2; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; LOOMIS WF, 1953, SCIENCE, V117, P565, DOI 10.1126/science.117.3047.565; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nakagawa H, 2007, GLYCOBIOLOGY, V17, P157, DOI 10.1093/glycob/cwl058; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Rich F., 1969, Revue Suisse de Zoologie, V76, P779; RODRIGUEZ ML, 1988, EUR J BIOCHEM, V177, P117, DOI 10.1111/j.1432-1033.1988.tb14351.x; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; SKAER RJ, 1973, J CELL SCI, V13, P371; SLAUTTERBACK DB, 1959, J BIOPHYS BIOCHEM CY, V5, P441, DOI 10.1083/jcb.5.3.441; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Technau U, 1996, DEV BIOL, V177, P599, DOI 10.1006/dbio.1996.0189; Watanabe H, 2009, SEMIN CELL DEV BIOL, V20, P1114, DOI 10.1016/j.semcdb.2009.09.008; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Yamada S, 1999, BIOCHEMISTRY-US, V38, P838, DOI 10.1021/bi981889n; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	38	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25613	25623		10.1074/jbc.M110.107904	http://dx.doi.org/10.1074/jbc.M110.107904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538610	Green Published, hybrid			2022-12-27	WOS:000280682400055
J	Duke, AM; Hopkins, PM; Calaghan, SC; Halsall, JP; Steele, DS				Duke, Adrian M.; Hopkins, Philip M.; Calaghan, Sarah C.; Halsall, Jane P.; Steele, Derek S.			Store-operated Ca2+ Entry in Malignant Hyperthermia-susceptible Human Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED CALCIUM-ENTRY; SARCOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RYANODINE RECEPTOR; FIBERS; STIM1; ACTIVATION; DEPLETION; RELEASE; RYR1	In malignant hyperthermia (MH), mutations in RyR1 underlie direct activation of the channel by volatile anesthetics, leading to muscle contracture and a life-threatening increase in core body temperature. The aim of the present study was to establish whether the associated depletion of sarcoplasmic reticulum (SR) Ca2+ triggers sarcolemmal Ca2+ influx via store-operated Ca2+ entry (SOCE). Samples of vastus medialis muscle were obtained from patients undergoing assessment for MH susceptibility using the in vitro contracture test. Single fibers were mechanically skinned, and confocal microscopy was used to detect changes in [Ca2+] either within the resealed t-system ([Ca2+](t-sys)) or within the cytosol. In normal fibers, halothane (0.5 mM) failed to initiate SR Ca2+ release or Ca-t-sys(2+) depletion. However, in MH-susceptible (MHS) fibers, halothane induced both SR Ca2+ release and Ca-t-sys(2+) depletion, consistent with SOCE. In some MHS fibers, halothane-induced SR Ca2+ release took the form of a propagated wave, which was temporally coupled to a wave of Ca(t-sys)(2+)depletion. SOCE was potently inhibited by "extracellular" application of a STIM1 antibody trapped within the t-system but not when the antibody was denatured by heating. In conclusion, (i) in human MHS muscle, SR Ca2+ depletion induced by a level of volatile anesthetic within the clinical range is sufficient to induce SOCE, which is tightly coupled to SR Ca2+ release; (ii) sarcolemmal STIM1 has an important role in regulating SOCE; and (iii) sustained SOCE from an effectively infinite extracellular Ca2+ pool may contribute to the maintained rise in cytosolic [Ca2+] that underlies MH.	Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Hopkins, Philip M.; Halsall, Jane P.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Saint James's University Hospital; University of Leeds		d.steele@leeds.ac.uk	Hopkins, Philip/ABE-5970-2020	Hopkins, Philip/0000-0002-8127-1739; Calaghan, Sarah/0000-0002-9145-2576; Steele, Derek/0000-0002-1339-784X	Medical Research Council; MRC [G0601243] Funding Source: UKRI; Medical Research Council [G0601243] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a grant from the Medical Research Council.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Allard B, 2006, J PHYSIOL-LONDON, V575, P69, DOI 10.1113/jphysiol.2006.112367; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; BRUM G, 1988, J PHYSIOL-LONDON, V398, P441, DOI 10.1113/jphysiol.1988.sp017052; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; DAVIES DN, 1972, BRIT J ANAESTH, V44, P548, DOI 10.1093/bja/44.6.548; Duke AM, 1998, PFLUG ARCH EUR J PHY, V436, P104, DOI 10.1007/s004240050610; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Edwards JN, 2010, CELL CALCIUM, V47, P458, DOI 10.1016/j.ceca.2010.04.001; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hopkins PM, 2000, BRIT J ANAESTH, V85, P118, DOI 10.1093/bja/85.1.118; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Kabbara AA, 2001, J PHYSIOL-LONDON, V534, P87, DOI 10.1111/j.1469-7793.2001.00087.x; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Launikonis BS, 2009, J PHYSIOL-LONDON, V587, P2299, DOI 10.1113/jphysiol.2009.168682; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Launikonis BS, 2003, P NATL ACAD SCI USA, V100, P2941, DOI 10.1073/pnas.0536227100; Launikonis BS, 2002, CELL BIOL INT, V26, P921, DOI 10.1006/cbir.2002.0942; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; LYNCH GS, 1995, J MUSCLE RES CELL M, V16, P65, DOI 10.1007/BF00125311; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Posterino GS, 2003, J PHYSIOL-LONDON, V551, P219, DOI 10.1113/jphysiol.2003.040022; REICHELT S, 2001, MICROSC ANAL, V86, P9; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Steele DS, 2007, ARCH BIOCHEM BIOPHYS, V458, P57, DOI 10.1016/j.abb.2006.03.001; Steele DS, 2003, ACTA PHYSIOL SCAND, V179, P39, DOI 10.1046/j.1365-201X.2003.01169.x; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; WESTERBLAD H, 1992, J PHYSIOL-LONDON, V453, P413, DOI 10.1113/jphysiol.1992.sp019236; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; ZIMINA OA, 2008, DOKL AKAD NAUK, V420, P214	45	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25645	25653		10.1074/jbc.M110.104976	http://dx.doi.org/10.1074/jbc.M110.104976			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566647	Green Published, hybrid			2022-12-27	WOS:000280682400058
J	Feng, H; Guo, L; Song, ZQ; Gao, HQ; Wang, D; Fu, WS; Han, JY; Li, ZY; Huang, B; Li, XA				Feng, Hong; Guo, Ling; Song, Zhiqing; Gao, Haiqing; Wang, Dan; Fu, Weisi; Han, Jingyan; Li, Zhenyu; Huang, Bin; Li, Xiang-An			Caveolin-1 Protects against Sepsis by Modulating Inflammatory Response, Alleviating Bacterial Burden, and Suppressing Thymocyte Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MURINE MACROPHAGES; CARDIAC MYOCYTES; CECAL LIGATION; UNITED-STATES; LIVER-INJURY; CELL-DEATH; MICE; INNATE; SALMONELLA	Sepsis is a leading cause of death, which is characterized by uncontrolled inflammatory response. In this study, we report that caveolin-1, a major component of caveolae, is a critical survival factor of sepsis. We induced sepsis using a well established sepsis animal model, cecal ligation and puncture (CLP). CLP induced 67% fatality in caveolin-1 null mice, but only 27% fatality in wild type littermates (p = 0.015). Further studies revealed that mice deficient in caveolin-1 exhibited marked increase in tumor necrosis factor-alpha and interleukin-6 production 20 h following CLP treatment, indicating uncontrolled inflammatory responses in the absence of caveolin-1. Caveolin-1 null mice also had a significant increase in bacteria number recovered from liver and spleen, indicating elevated bacterial burdens. In addition, caveolin-1 null mice had a 2-fold increase in thymocyte apoptosis compared with wild type littermates, indicating caveolin-1 as a critical modulator of thymocyte apoptosis during sepsis. In conclusion, our findings demonstrate that caveolin-1 is a critical protective modulator of sepsis in mice. Caveolin-1 exerts its protective function likely through its roles in modulating inflammatory response, alleviating bacterial burdens, and suppressing thymocyte apoptosis.	[Feng, Hong; Guo, Ling; Song, Zhiqing; Wang, Dan; Fu, Weisi; Li, Xiang-An] Univ Kentucky, Sch Med, Dept Pediat, Lexington, KY 40536 USA; [Feng, Hong; Gao, Haiqing] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250012, Peoples R China; [Song, Zhiqing] Taian Cent Hosp, Dept Internal Med, Tai An 271000, Shandong, Peoples R China; [Han, Jingyan; Li, Zhenyu] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Huang, Bin] Univ Kentucky, Sch Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; Shandong University; University of Kentucky; University of Kentucky	Li, XA (corresponding author), Univ Kentucky, Sch Med, Dept Pediat, Biomed Biol Sci Res Bldg B365,741 S Limestone St, Lexington, KY 40536 USA.	xli2@email.uky.edu			National Institutes of Health [R01GM085231, 3R01GM085231-02S1]; American Heart Association [0530241N]; Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085231 and 3R01GM085231-02S1. This work was also supported by the American Heart Association (0530241N) and the Children's Miracle Network (to X.-A.L.).	AYALA A, 1992, CIRC SHOCK, V36, P191; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; da Silva F, 2009, APOPTOSIS, V14, P509, DOI 10.1007/s10495-009-0320-3; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Gadjeva M, 2010, J IMMUNOL, V184, P296, DOI 10.4049/jimmunol.0900604; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Ko YG, 1999, J IMMUNOL, V162, P7217; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lalor D, 2004, CELL IMMUNOL, V230, P10, DOI 10.1016/j.cellimm.2004.08.003; Lei MG, 2005, INFECT IMMUN, V73, P8136, DOI 10.1128/IAI.73.12.8136-8143.2005; Li JW, 2005, CELL CYCLE, V4, P1599, DOI 10.4161/cc.4.11.2117; Li XA, 2005, TRENDS CARDIOVAS MED, V15, P92, DOI 10.1016/j.tcm.2005.04.001; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Razani B, 2001, J BIOL CHEM, V276, P38121; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhao J, 2009, TRENDS IMMUNOL, V30, P8, DOI 10.1016/j.it.2008.10.003; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123	41	46	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25154	25160		10.1074/jbc.M110.116897	http://dx.doi.org/10.1074/jbc.M110.116897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534584	Green Published, hybrid			2022-12-27	WOS:000280682400007
J	Meng, S; Luo, M; Sun, H; Yu, X; Shen, ML; Zhang, QC; Zhou, RD; Ju, XF; Tao, W; Liu, D; Deng, HK; Lu, ZG				Meng, Sha; Luo, Min; Sun, He; Yu, Xin; Shen, Meili; Zhang, Quancang; Zhou, Rudan; Ju, Xiaofang; Tao, Wei; Liu, Di; Deng, Hongkui; Lu, Zhigang			Identification and Characterization of Bmi-1-responding Element within the Human p16 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; HEMATOPOIETIC STEM-CELLS; BMI-1 EXPRESSION; P-GLYCOPROTEIN; NEUROBLASTOMA-CELLS; TELOMERASE ACTIVITY; H2A UBIQUITYLATION; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; INK4A/ARF LOCUS	Bmi-1, the first functionally identified polycomb gene family member, plays critical roles in cell cycle regulation, cell immortalization, and cell senescence. Bmi-1 is involved in the development and progression of carcinomas and is a potent target for cancer therapy. One important pathway regulated by Bmi-1 is that involving two cyclin-dependent kinase inhibitors, p16(Ink4a) and p19(Arf), as Bmi-1 represses the INK4a locus on which they are encoded. A close correlation between the up-regulation of Bmi-1 and down-regulation of p16 has been demonstrated in various tumors; however, how Bmi-1 regulates p16 expression is not clear. In this study, we revealed that Bmi-1 regulates the expression of p16 by binding directly to the Bmi-1-responding element (BRE) within the p16 promoter. The BRE resided at bp -821 to -732 upstream of the p16 ATG codon. BRE alone was sufficient to allow Bmi-1-mediated regulation of the CMV promoter. Bmi-1 typically functions by forming a complex with Ring2; however, regulation of p16 was independent of Ring2. Chromatin immunoprecipitation sequencing of Bmi-1-precipitated chromatin DNA revealed that 1536 genes were targeted by Bmi-1, including genes involved in tissue-specific differentiation, cell cycle, and apoptosis. By analyzing the binding sequences of these genes, we found two highly conserved Bmi-1-binding motifs, which were required for Bmi-1-mediated p16 promoter regulation. Taken together, our results revealed the molecular mechanism of Bmi-1-mediated regulation of the p16 gene, thus providing further insights into the functions of Bmi-1 as well as a sensitive high-throughput platform with which to screen Bmi-1-targeted small molecules for cancer therapy.	[Liu, Di] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China; [Deng, Hongkui; Lu, Zhigang] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China; [Shen, Meili; Tao, Wei; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yu, Xin] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Peking University; University Town of Shenzhen; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Liu, D (corresponding author), Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China.	liud@im.ac.cn; hongkui_deng@pku.edu.cn; luzg@szpku.edu.cn	Liu, Di/G-6135-2014; Liu, Di/ABD-2729-2021	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726; Lu, Zhigang/0000-0002-2880-7848	National Natural Science Foundation of China [30700411, 90919031, 30800640]; Shenzhen Bureau of Science Technology, and Information [SZKJ-2006018, SZKJ-2007012]; Ministry of Education [705001]; Ministry of Science and Technology [2010CB530303]; Shenzhen Key Laboratory Advancement Scheme [SZKJ-2006018, SZKJ-2007012]; Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology, and Information; Ministry of Education; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shenzhen Key Laboratory Advancement Scheme; Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information	This work was supported by National Natural Science Foundation of China Grant 30700411, Shenzhen Bureau of Science Technology, and Information Grants (SZKJ-2006018, SZKJ-2007012), Shenzhen Key Laboratory Advancement Scheme, and Shenzhen Nanshan Shenzhen Bureau of Science Technology and Information Grants (to Z. L.); Ministry of Education Grant 705001 and National Natural Science Foundation of China (90919031) (to H. D.); and the National Natural Science Foundation of China (30800640) and "Program 973" (2010CB530303) of the Ministry of Science and Technology (to D. L.).	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Bartkova J, 1996, CANCER RES, V56, P5475; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chumsri S, 2008, CURR OPIN MOL THER, V10, P323; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dimri GP, 2002, CANCER RES, V62, P4736; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Grinstein E, 2007, CELL SIGNAL, V19, P2428, DOI 10.1016/j.cellsig.2007.06.021; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Hara E, 1996, MOL CELL BIOL, V16, P859; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; JIN XM, 1995, CANCER RES, V55, P3250; Johnstone RW, 1999, BLOOD, V93, P1075, DOI 10.1182/blood.V93.3.1075.403k35_1075_1085; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Wang Q, 2009, J CELL BIOCHEM, V106, P16, DOI 10.1002/jcb.21969; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang F., 2008, Experimental Oncology, V30, P70; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	52	46	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33219	33229		10.1074/jbc.M110.133686	http://dx.doi.org/10.1074/jbc.M110.133686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20551323	Green Published, hybrid			2022-12-27	WOS:000283048200059
J	Brier, S; Pflieger, D; Le Mignon, M; Bally, I; Gaboriaud, C; Arlaud, GJ; Daniel, R				Brier, Sebastien; Pflieger, Delphine; Le Mignon, Maxime; Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.; Daniel, Regis			Mapping Surface Accessibility of the C1r/C1s Tetramer by Chemical Modification and Mass Spectrometry Provides New Insights into Assembly of the Human C1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST COMPONENT; PROTEASE C1R; CATALYTIC DOMAIN; HYDROGEN/DEUTERIUM-EXCHANGE; NEUTRON-SCATTERING; CRYSTAL-STRUCTURE; SERINE PROTEASES; FUNCTIONAL-MODEL; LECTIN PATHWAYS; SUB-COMPONENTS	C1, the complex that triggers the classic pathway of complement, is a 790-kDa assembly resulting from association of a recognition protein C1q with a Ca2+-dependent tetramer comprising two copies of the proteases C1r and C1s. Early structural investigations have shown that the extended C1s-C1r-C1r-C1s tetramer folds into a compact conformation in C1. Recent site-directed mutagenesis studies have identified the C1q-binding sites in C1r and C1s and led to a three-dimensional model of the C1 complex (Bally, I., Rossi, V., Lunardi, T., Thielens, N. M., Gaboriaud, C., and Arlaud, G. J. (2009) J. Biol. Chem. 284, 19340-19348). In this study, we have used a mass spectrometry-based strategy involving a label-free semi-quantitative analysis of protein samples to gain new structural insights into C1 assembly. Using a stable chemical modification, we have compared the accessibility of the lysine residues in the isolated tetramer and in C1. The labeling data account for 51 of the 73 lysine residues of C1r and C1s. They strongly support the hypothesis that both C1s CUB1-EGF-CUB2 interaction domains, which are distant in the free tetramer, associate with each other in the C1 complex. This analysis also provides the first experimental evidence that, in the proenzyme form of C1, the C1s serine protease domain is partly positioned inside the C1q cone and yields precise information about its orientation in the complex. These results provide further structural insights into the architecture of the C1 complex, allowing significant improvement of our current C1 model.	[Brier, Sebastien; Pflieger, Delphine; Le Mignon, Maxime; Daniel, Regis] Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, CNRS, UMR 8587, F-91025 Evry, France; [Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.] CEA CNRS UJF, Inst Biol Struct JP Ebel, Lab Enzymol Mol, UMR 5075, F-38027 Grenoble, France; [Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.] CEA CNRS UJF, Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Prot, UMR 5075, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Brier, S (corresponding author), Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, CNRS, UMR 8587, Blvd Francois Mitterrand, F-91025 Evry, France.	sebastien.brier@novartis.com; regis.daniel@univ-evry.fr	Daniel, Regis/S-7890-2016; Brier, Sebastien/L-7787-2019; Pflieger, Delphine/ABD-1496-2021; Brier, Sébastien/E-8558-2019	Daniel, Regis/0000-0003-0725-5439; Brier, Sebastien/0000-0003-1758-8237; 	CNRS; Genopole-France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Genopole-France	This work was supported by CNRS and by Genopole-France.	ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61; ARLAUD GJ, 1987, IMMUNOL TODAY, V8, P106, DOI 10.1016/0167-5699(87)90860-7; ARLAUD GJ, 1986, BIOCHEMISTRY-US, V25, P5177, DOI 10.1021/bi00366a029; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bally I, 2008, MOL IMMUNOL, V45, P4097, DOI 10.1016/j.molimm.2008.08.008; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; BOYD J, 1983, P NATL ACAD SCI-BIOL, V80, P3769, DOI 10.1073/pnas.80.12.3769; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Cutalo JM, 2006, BIOCHEMISTRY-US, V45, P15458, DOI 10.1021/bi061392a; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Gabant G, 2008, J MASS SPECTROM, V43, P360, DOI 10.1002/jms.1328; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; ILLY C, 1993, J PROTEIN CHEM, V12, P771, DOI 10.1007/BF01024936; Janecki DJ, 2005, ANAL CHEM, V77, P7274, DOI 10.1021/ac050891z; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; PERKINS SJ, 1984, J MOL BIOL, V179, P547, DOI 10.1016/0022-2836(84)90079-2; Pflieger D, 2006, PROTEOMICS, V6, P5868, DOI 10.1002/pmic.200402040; Pflieger D, 2010, MOL CELL PROTEOMICS, V9, P593, DOI 10.1074/mcp.M900350-MCP200; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Scholten A, 2006, J AM SOC MASS SPECTR, V17, P983, DOI 10.1016/j.jasms.2006.03.005; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; STRANG CJ, 1982, P NATL ACAD SCI-BIOL, V79, P586, DOI 10.1073/pnas.79.2.586; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Tissot B, 2005, BIOCHEMISTRY-US, V44, P2602, DOI 10.1021/bi047802h; TSCHOPP J, 1980, P NATL ACAD SCI-BIOL, V77, P7014, DOI 10.1073/pnas.77.12.7014; VILLIERS CL, 1985, P NATL ACAD SCI USA, V82, P4477, DOI 10.1073/pnas.82.13.4477; WEISS V, 1986, J MOL BIOL, V189, P573, DOI 10.1016/0022-2836(86)90325-6; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yan XG, 2002, PROTEIN SCI, V11, P2113, DOI 10.1110/ps.0204402; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2500	44	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32251	32263		10.1074/jbc.M110.149112	http://dx.doi.org/10.1074/jbc.M110.149112			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20592021	Green Published, hybrid			2022-12-27	WOS:000282683000038
J	Lee, SB; Kwon, IS; Park, J; Lee, KH; Ahn, Y; Lee, C; Kim, J; Choi, SY; Cho, SW; Ahn, JY				Lee, Sang Bae; Kwon, Il-Sun; Park, Jihye; Lee, Kyung-Hoon; Ahn, Younghee; Lee, Cheolju; Kim, Joon; Choi, Soo Young; Cho, Sung-Woo; Ahn, Jee-Yin			Ribosomal Protein S3, a New Substrate of Akt, Serves as a Signal Mediator between Neuronal Apoptosis and DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC NEURONS; CELL-DEATH; GENOTOXIC STRESS; SURVIVAL; DAMAGE; PHOSPHORYLATION; PATHWAY; TRANSLOCATION; EXPRESSION; ACTIVATION	RPS3, a conserved, eukaryotic ribosomal protein of the 40 S subunit, is required for ribosome biogenesis. Because ribosomal proteins are abundant and ubiquitous, they may have additional extraribosomal functions. Here, we show that human RPS3 is a physiological target of Akt kinase and a novel mediator of neuronal apoptosis. NGF stimulation resulted in phosphorylation of threonine 70 of RPS3 by Akt, and this phosphorylation was required for Akt binding to RPS3. RPS3 induced neuronal apoptosis, up-regulating proapoptotic proteins Dp5/Hrk and Bim by binding to E2F1 and acting synergistically with it. Akt-dependent phosphorylation of RPS3 inhibited its proapoptotic function and perturbed its interaction with E2F1. These events coincided with nuclear translocation and accumulation of RPS3, where it functions as an endonuclease. Nuclear accumulation of RPS3 results in an increase in DNA repair activity to some extent, thereby sustaining neuronal survival. Abolishment of Akt-mediated RPS3 phosphorylation through mutagenesis accelerated apoptotic cell death and severely compromised nuclear translocation of RPS3. Thus, our findings define an extraribosomal role of RPS3 as a molecular switch that accommodates apoptotic induction to DNA repair through Akt-mediated phosphorylation.	[Lee, Sang Bae; Kwon, Il-Sun; Park, Jihye; Ahn, Jee-Yin] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Lee, Kyung-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Anat, Suwon 440746, South Korea; [Kwon, Il-Sun; Lee, Kyung-Hoon; Ahn, Jee-Yin] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Ctr Mol Med, Suwon 440746, South Korea; [Ahn, Younghee; Lee, Cheolju] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon 200702, South Korea; [Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon 200702, South Korea; [Cho, Sung-Woo] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung; Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Korea University; Hallym University; Hallym University; University of Ulsan	Ahn, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	jyahn@med.skku.ac.kr		LEE, SANG BAE/0000-0002-4031-8051	Ministry of Education, Science and Technology, Republic of Korea [NI-1:22-2009-00-010-00]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant NI-1:22-2009-00-010-00 from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, Republic of Korea (to J.-Y. A.).	AHMED NN, 1993, ONCOGENE, V8, P1957; Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bavelloni A, 1999, J CELL SCI, V112, P631; Besirli CG, 2003, CELL DEATH DIFFER, V10, P1045, DOI 10.1038/sj.cdd.4401259; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; GRABOWSKI DT, 1991, NUCLEIC ACIDS RES, V19, P4297, DOI 10.1093/nar/19.15.4297; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Tan JH, 2003, CANCER RES, V63, P7663; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	35	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29457	29468		10.1074/jbc.M110.131367	http://dx.doi.org/10.1074/jbc.M110.131367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605787	Green Published, hybrid			2022-12-27	WOS:000281740100048
J	Chang, YP; Tsai, CC; Huang, WC; Wang, CY; Chen, CL; Lin, YS; Kai, JI; Hsieh, CY; Cheng, YL; Choi, PC; Chen, SH; Chang, SP; Liu, HS; Lin, CF				Chang, Yu-Ping; Tsai, Cheng-Chieh; Huang, Wei-Ching; Wang, Chi-Yun; Chen, Chia-Ling; Lin, Yee-Shin; Kai, Jui-In; Hsieh, Chia-Yuan; Cheng, Yi-Lin; Choi, Pui-Ching; Chen, Shun-Hua; Chang, Shih-Ping; Liu, Hsiao-Sheng; Lin, Chiou-Feng			Autophagy Facilitates IFN-gamma-induced Jak2-STAT1 Activation and Cellular Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-GAMMA; DENDRITIC CELLS; PHOSPHATASE 2; STAT1; MACROPHAGES; SURVIVAL; CANCER; ROLES; BCG	Autophagy is regulated for IFN-gamma-mediated antimicrobial efficacy; however, its molecular effects for IFN-gamma signaling are largely unknown. Here, we show that autophagy facilitates IFN-gamma-activated Jak2-STAT1. IFN-gamma induces autophagy in wild-type but not in autophagy protein 5 (Atg5(-/-))-deficient mouse embryonic fibroblasts (MEFs), and, autophagy-dependently, IFN-gamma induces IFN regulatory factor 1 and cellular inflammatory responses. Pharmacologically inhibiting autophagy using 3-methyladenine, a known inhibitor of class III phosphatidylinositol 3-kinase, confirms these effects. Either Atg5(-/-) or Atg7(-/-) MEFs are, independent of changes in IFN-gamma receptor expression, resistant to IFN-gamma-activated Jak2-STAT1, which suggests that autophagy is important for IFN-gamma signal transduction. Lentivirus-based short hairpin RNA for Atg5 knockdown confirmed the importance of autophagy for IFN-gamma-activated STAT1. Without autophagy, reactive oxygen species increase and cause SHP2 (Src homology-2 domain-containing phosphatase 2)-regulated STAT1 inactivation. Inhibiting SHP2 reversed both cellular inflammation and the IFN-gamma-induced activation of STAT1 in Atg5(-/-) MEFs. Our study provides evidence that there is a link between autophagy and both IFN-gamma signaling and cellular inflammation and that autophagy, because it inhibits the expression of reactive oxygen species and SHP2, is pivotal for Jak2-STAT1 activation.	[Kai, Jui-In; Hsieh, Chia-Yuan; Cheng, Yi-Lin; Choi, Pui-Ching; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan; [Tsai, Cheng-Chieh; Huang, Wei-Ching; Wang, Chi-Yun; Lin, Yee-Shin; Chen, Shun-Hua; Liu, Hsiao-Sheng; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Chang, Yu-Ping; Chen, Chia-Ling; Lin, Yee-Shin; Chen, Shun-Hua; Chang, Shih-Ping; Liu, Hsiao-Sheng; Lin, Chiou-Feng] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Cheng, Yi-Lin] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Coll Med, Tainan 701, Taiwan; [Tsai, Cheng-Chieh] Chung Hwa Univ Med Technol, Dept Nursing, Tainan 717, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; National Cheng Kung University	Lin, CF (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan.	cflin@mail.ncku.edu.tw		Liu, Hsiao-Sheng/0000-0003-0576-7203; Wang, Chi-Yun/0000-0003-0317-5378	National Health Research Institutes, Taiwan [NHRI-EX99-9917NC]; National Science Council, Taiwan [NSC 96-2320-B-006-018-MY3]; National Cheng Kung University, Taiwan [C020]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University, Taiwan	This work was supported by Grants NHRI-EX99-9917NC and NSC 96-2320-B-006-018-MY3 from the National Health Research Institutes and the National Science Council, respectively, Taiwan, and Landmark Project C020 of National Cheng Kung University, Taiwan.	Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee L, 2006, GENE CHROMOSOME CANC, V45, P933, DOI 10.1002/gcc.20357; Lehtonen A, 1997, J IMMUNOL, V159, P794; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Park SJ, 2009, FREE RADICAL BIO MED, V46, P1694, DOI 10.1016/j.freeradbiomed.2009.03.026; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416	30	70	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28715	28722		10.1074/jbc.M110.133355	http://dx.doi.org/10.1074/jbc.M110.133355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592027	Green Published, hybrid			2022-12-27	WOS:000281594000037
J	Hoshino, A; Iimura, T; Ueha, S; Hanada, S; Maruoka, Y; Mayahara, M; Suzuki, K; Imai, T; Ito, M; Manome, Y; Yasuhara, M; Kirino, T; Yamaguchi, A; Matsushima, K; Yamamoto, K				Hoshino, Akiyoshi; Iimura, Tadahiro; Ueha, Satoshi; Hanada, Sanshiro; Maruoka, Yutaka; Mayahara, Mitsuori; Suzuki, Keiko; Imai, Toshio; Ito, Masako; Manome, Yoshinobu; Yasuhara, Masato; Kirino, Takaaki; Yamaguchi, Akira; Matsushima, Kouji; Yamamoto, Kenji			Deficiency of Chemokine Receptor CCR1 Causes Osteopenia Due to Impaired Functions of Osteoclasts and Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; BIOCHEMICAL MARKERS; OSTEOLYTIC LESIONS; MULTIPLE-MYELOMA; BONE-FORMATION; CELLS; EXPRESSION; ACTIVATOR; RANKL; DIFFERENTIATION	Chemokines are characterized by the homing activity of leukocytes to targeted inflammation sites. Recent research indicates that chemokines play more divergent roles in various phases of pathogenesis as well as immune reactions. The chemokine receptor, CCR1, and its ligands are thought to be involved in inflammatory bone destruction, but their physiological roles in the bone metabolism in vivo have not yet been elucidated. In the present study, we investigated the roles of CCR1 in bone metabolism using CCR1-deficient mice. Ccr1(-/-) mice have fewer and thinner trabecular bones and low mineral bone density in cancellous bones. The lack of CCR1 affects the differentiation and function of osteoblasts. Runx2, Atf4, Osteopontin, and Osteonectin were significantly up-regulated in Ccr1(-/-) mice despite sustained expression of Osterix and reduced expression of Osteocalcin, suggesting a lower potential for differentiation into mature osteoblasts. In addition, mineralized nodule formation was markedly disrupted in cultured osteoblastic cells isolated from Ccr1(-/-) mice. Osteoclastogenesis induced from cultured Ccr1(-/-) bone marrow cells yielded fewer and smaller osteoclasts due to the abrogated cell-fusion. Ccr1(-/-) osteoclasts exerted no osteolytic activity concomitant with reduced expressions of Rank and its downstream targets, implying that the defective osteoclastogenesis is involved in the bone phenotype in Ccr1(-/-) mice. The co-culture of wild-type osteoclast precursors with Ccr1(-/-) osteoblasts failed to facilitate osteoclastogenesis. This finding is most likely due to a reduction in Rankl expression. These observations suggest that the axis of CCR1 and its ligands are likely to be involved in crosstalk between osteoclasts and osteoblasts by modulating the RANK-RANKL-mediated interaction.	[Yamamoto, Kenji] Int Med Ctr Japan, Int Clin Res Ctr, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; [Hoshino, Akiyoshi; Manome, Yoshinobu] Tokyo Med & Dent Univ, Dept Pharmacokinet & Pharmacodynam Hosp Pharm, Tokyo 1138519, Japan; [Iimura, Tadahiro; Yamaguchi, Akira] Tokyo Med & Dent Univ, Dept Oral Pathol, Global Ctr Excellence, Tokyo 1138519, Japan; [Hoshino, Akiyoshi; Manome, Yoshinobu] Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Res Ctr Med Sci,Sch Med, Tokyo 1058461, Japan; [Maruoka, Yutaka] Toyama Natl Hosp, Int Med Ctr Japan, Dept Dent & Oral Surg, Tokyo 1628655, Japan; [Mayahara, Mitsuori] Showa Univ, Dept Oral Histol, Sch Dent, Tokyo 1428555, Japan; [Suzuki, Keiko] Showa Univ, Dept Pharmacol, Sch Dent, Tokyo 1428555, Japan; [Imai, Toshio] Kan Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Ito, Masako] Nagasaki Univ, Dept Radiol, Sch Med, Nagasaki 8528501, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Jikei University; National Center for Global Health & Medicine - Japan; Showa University; Showa University; KAN Research Institute; Nagasaki University	Yamamoto, K (corresponding author), Int Med Ctr Japan, Int Clin Res Ctr, Res Inst, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.	backen@ri.ncgm.go.jp	Hanada, Sanshiro/I-6525-2013; YAMAMOTO, Kenji/I-1758-2013; Iimura, Tadahiro/P-3550-2018	Hanada, Sanshiro/0000-0003-2933-3522; Iimura, Tadahiro/0000-0002-1431-0689; Manome, Yoshinobu/0000-0002-8755-8976; Ueha, Satoshi/0000-0002-3871-9921	Ministry of Health, Labor and Welfare [H19-nano-012, H21-nanchi-097, H22-nanchi-ippan157]; Japan Society for the Promotion of Science [21659426]; Japan Foundation of Cardiovascular Research; Naito Foundation; Japanese Ministry of Education; Global Center of Excellence Program; International Research Center for Molecular Science in Tooth and Bone Diseases; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Solution Oriented Research for Science and Technology; Japan Science and Technology Corp	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation of Cardiovascular Research; Naito Foundation(Naito Memorial Foundation); Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Research Center for Molecular Science in Tooth and Bone Diseases; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Solution Oriented Research for Science and Technology; Japan Science and Technology Corp(Japan Science & Technology Agency (JST))	This work was supported in part by Grant H19-nano-012 from the Ministry of Health, Labor and Welfare (to K. Y.) and by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists (2007-2009) (to A. H.).; Supported by grants from the Japan Foundation of Cardiovascular Research (2006) and from the Naito Foundation (2005).; Supported by a grant from the Japanese Ministry of Education, Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases.; Supported by The Takeda Science Foundation, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21659426).; Supported by Grants H21-nanchi-097 and H22-nanchi-ippan157 from the Ministry of Health, Labor and Welfare. Supported by Solution Oriented Research for Science and Technology and by Japan Science and Technology Corp.	Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Anders HJ, 2003, J IMMUNOL, V170, P5658, DOI 10.4049/jimmunol.170.11.5658; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Chintalacharuvu SR, 2005, IMMUNOL LETT, V100, P202, DOI 10.1016/j.imlet.2005.03.012; Choi SJ, 2000, BLOOD, V96, P671; Coates PTH, 2004, KIDNEY INT, V66, P1907, DOI 10.1111/j.1523-1755.2004.00965.x; DELMAS PD, 1993, J BONE MINER RES, V8, pS549; Doi M, 2002, BIOCHEM BIOPH RES CO, V290, P381, DOI 10.1006/bbrc.2001.6196; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Furuichi K, 2008, J IMMUNOL, V181, P8670, DOI 10.4049/jimmunol.181.12.8670; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lean JM, 2002, J CELL BIOCHEM, V87, P386, DOI 10.1002/jcb.10319; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Menu E, 2006, CLIN EXP METASTAS, V23, P291, DOI 10.1007/s10585-006-9038-6; Murphy PM, 2000, PHARMACOL REV, V52, P145; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Okamatsu Y, 2004, J IMMUNOL, V173, P2084, DOI 10.4049/jimmunol.173.3.2084; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; Saitoh Y, 2007, BIOCHEM BIOPH RES CO, V364, P417, DOI 10.1016/j.bbrc.2007.09.137; Sakai N, 2006, J LEUKOCYTE BIOL, V79, P555, DOI 10.1189/jlb.0305127; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schneider DL, 1997, ARCH INTERN MED, V157, P1241, DOI 10.1001/archinte.157.11.1241; Shang XZ, 2000, AM J PATHOL, V157, P2055, DOI 10.1016/S0002-9440(10)64844-4; Takahashi M, 1997, J ENDOCRINOL INVEST, V20, P112, DOI 10.1007/BF03346887; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Vallet S, 2007, BLOOD, V110, P3744, DOI 10.1182/blood-2007-05-093294; Votta BJ, 2000, J CELL PHYSIOL, V183, P196, DOI 10.1002/(SICI)1097-4652(200005)183:2<196::AID-JCP6>3.3.CO;2-#; WILSON MJ, 1991, BIOL REPROD, V44, P776, DOI 10.1095/biolreprod44.5.776; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	46	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28826	28837		10.1074/jbc.M109.099424	http://dx.doi.org/10.1074/jbc.M109.099424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20571024	Green Published, hybrid			2022-12-27	WOS:000281594000048
J	Oh, KJ; Singh, P; Lee, K; Foss, K; Lee, S; Park, M; Lee, S; Aluvila, S; Park, M; Singh, P; Kim, RS; Symersky, J; Walters, DE				Oh, Kyoung Joon; Singh, Pawan; Lee, Kyungro; Foss, Kelly; Lee, Shinyoub; Park, Minji; Lee, Steffi; Aluvila, Sreevidya; Park, Matthew; Singh, Puja; Kim, Ryung-Suk; Symersky, Jindrich; Walters, D. Eric			Conformational Changes in BAK, a Pore-forming Proapoptotic Bcl-2 Family Member, upon Membrane Insertion and Direct Evidence for the Existence of BH3-BH3 Contact Interface in BAK Homo-oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; LABELED SIDE-CHAINS; CYTOCHROME-C; T4 LYSOZYME; LIPID-BILAYERS; X-RAY; PROTEIN-STRUCTURE; DIPHTHERIA-TOXIN; BH3 DOMAIN; CELL-DEATH	During apoptosis, the pro-apoptotic Bcl-2 family proteins BAK and BAX form large oligomeric pores in the mitochondrial outer membrane. Apoptotic factors, including cytochrome c, are released through these pores from the mitochondrial intermembrane space into the cytoplasm where they initiate the cascade of events leading to cell death. To better understand this pivotal step toward apoptosis, a method was developed to induce membrane permeabilization by BAK in the membrane without using the full-length protein. Using a soluble form of BAK with a hexahistidine tag at the C terminus and a liposomal system containing the Ni2+-nitrilotriacetic acid lipid analog that can bind hexahistidine-tagged proteins, BAK oligomers were formed in the presence of the activator protein p7/p15Bid. In this system, we determined the conformational changes in BAK upon membrane insertion by applying the site-directed spin labeling method of EPR to 13 different amino acid locations. Upon membrane insertion, the BH3 domains were reorganized, and the alpha 5-alpha 6 helical hairpin structure was partially exposed to the membrane environment. The monomer-monomer interface in the oligomeric structure was also mapped by measuring the distance-dependent spin-spin interactions for each residue location. Spin labels attached in the BH3 domain were juxtaposed within 5-10 angstrom distance in the oligomeric form in the membrane. These results are consistent with the current hypothesis that BAK or BAX forms homodimers, and these homodimers assemble into a higher order oligomeric pore. Detailed analyses of the data provide new insights into the structure of the BAX or BAK homodimer.	[Oh, Kyoung Joon; Singh, Pawan; Lee, Kyungro; Foss, Kelly; Lee, Shinyoub; Park, Minji; Lee, Steffi; Aluvila, Sreevidya; Park, Matthew; Singh, Puja; Symersky, Jindrich; Walters, D. Eric] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Kim, Ryung-Suk] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Yeshiva University; Albert Einstein College of Medicine	Oh, KJ (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kyoung.oh@rosalindfranklin.edu	Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522; OH, KYOUNG JOON/0000-0002-4729-9674	American Heart Association [0835026G]; Rosalind Franklin University of Medicine and Science	American Heart Association(American Heart Association); Rosalind Franklin University of Medicine and Science	This work was supported in part by the Scientist Development Grant from the American Heart Association (0835026G) and the Start-up fund from the Rosalind Franklin University of Medicine and Science.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Barnes JP, 1999, BIOPHYS J, V76, P3298, DOI 10.1016/S0006-3495(99)77482-5; Billeter S.R., 1996, GROMOS96 MANUAL USER; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Culmsee C, 2007, EMBO REP, V8, P129, DOI 10.1038/sj.embor.7400892; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L, PYMOL MOL GRAPHICS S; DeSensi SC, 2008, BIOPHYS J, V94, P3798, DOI 10.1529/biophysj.107.125419; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; FEIX JB, 1998, BIO MAGN RE, V14, P251; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1994, MEMBRANE PROTEIN STR, P244; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P229; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P1; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Mchaourab HS, 1999, BIOCHEMISTRY-US, V38, P2947, DOI 10.1021/bi9826310; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; Oh KJ, 2000, METH MOL B, V145, P147; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tristram-Nagle S, 2004, CHEM PHYS LIPIDS, V127, P3, DOI 10.1016/j.chemphyslip.2003.09.002; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	76	72	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28924	28937		10.1074/jbc.M110.135293	http://dx.doi.org/10.1074/jbc.M110.135293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605789	Green Published, hybrid			2022-12-27	WOS:000281594000057
J	Samuel, CE				Samuel, Charles E.			Thematic Minireview Series: Toward a Structural Basis for Understanding Influenza Virus-Host Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			NIAID NIH HHS [AI-20611, R01 AI012520, R01 AI012520-34, AI-12520, R01 AI020611, R37 AI012520, R01 AI020611-25] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012520, R01AI012520, R01AI020611] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOIVIN S, 2010, J BIOL CHEM IN PRESS, V285; GAMBLIN SJ, 2010, J BIOL CHEM IN PRESS, V285; HALLER O, 2010, J BIOL CHEM IN PRESS, V285; Knipe DM, 2007, FIELDS VIROLOGY; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Samuel CE, 2006, J BIOL CHEM, V281, P8305, DOI 10.1074/jbc.R500032200	6	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28399	28401		10.1074/jbc.R110.149625	http://dx.doi.org/10.1074/jbc.R110.149625			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20538603	Green Published, hybrid			2022-12-27	WOS:000281594000001
J	Schliep, M; Crossett, B; Willows, RD; Chen, M				Schliep, Martin; Crossett, Ben; Willows, Robert D.; Chen, Min			O-18 Labeling of Chlorophyll d in Acaryochloris marina Reveals That Chlorophyll a and Molecular Oxygen Are Precursors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC PROKARYOTE; RHODOBACTER-SPHAEROIDES; PHOTOSYSTEM-II; BIOSYNTHESIS; BACTERIOCHLOROPHYLL; DERIVATION; PATHWAYS; 3-ACETYL; ORIGIN; IDENTIFICATION	The cyanobacterium Acaryochloris marina was cultured in the presence of either H-2 O-18 or O-18(2), and the newly synthesized chlorophylls (Chl a and Chl d) were isolated using high performance liquid chromatography and analyzed by mass spectroscopy. In the presence of H-2 O-18, newly synthesized Chl a and d, both incorporated up to four isotopic O-18 atoms. Time course H-2 O-18 labeling experiments showed incorporation of isotopic O-18 atoms originating from H-2 O-18 into Chl a, with over 90% of Chl a O-18-labeled at 48 h. The incorporation of isotopic O-18 atoms into Chl d upon incubation in H-2 O-18 was slower compared with Chl a with similar to 50% O-18-labeled Chl d at 115 h. The rapid turnover of newly synthesized Chl a suggested that Chl a is the direct biosynthetic precursor of Chl d. In the presence of O-18(2) gas, one isotopic O-18 atom was incorporated into Chl a with approximately the same kinetic incorporation rate observed in the H-2 O-18 labeling experiment, reaching over 90% labeling intensity at 48 h. The incorporation of two isotopic O-18 atoms derived from molecular oxygen (O-18(2)) was observed in the extracted Chl d, and the percentage of double isotopic O-18-labeled Chl d increased in parallel with the decrease of non-isotopic-labeled Chl d. This clearly indicated that the oxygen atom in the C3(1)-formyl group of Chl d is derived from dioxygen via an oxygenase-type reaction mechanism.	Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Crossett, Ben] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Macquarie University	Chen, M (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Willows, Robert/C-1537-2010; Crossett, Ben/G-2316-2011	Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Australian Research Council [DP0665169, DP0986581]	Australian Research Council(Australian Research Council)	This work was supported, in whole or in part, by Australian Research Council Grants DP0665169 and DP0986581. The mass spectrometry was facilitated by access to the Sydney University Proteome Research Unit, established under the Australian Government's Major National Research Facilities program and supported by the University of Sydney.	Akiyama M, 2002, PHOTOSYNTH RES, V74, P97, DOI 10.1023/A:1020915506409; Akiyama M, 2001, ANAL SCI, V17, P205, DOI 10.2116/analsci.17.205; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Blankenship RE, 1998, TRENDS BIOCHEM SCI, V23, P94, DOI 10.1016/S0968-0004(98)01186-4; Chen M, 2005, PHOTOCH PHOTOBIO SCI, V4, P1060, DOI 10.1039/b507057k; Chen M, 2002, FEBS LETT, V514, P149, DOI 10.1016/S0014-5793(02)02315-3; Gloag RS, 2007, BBA-BIOENERGETICS, V1767, P127, DOI 10.1016/j.bbabio.2006.11.014; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; HAYAISHI O, 1974, MOL MECHANISMS OXYGE, P1; Hu Q, 1998, P NATL ACAD SCI USA, V95, P13319, DOI 10.1073/pnas.95.22.13319; Kuhl Michael, 2007, V11, P101; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Mimuro M, 2004, FEBS LETT, V556, P95, DOI 10.1016/S0014-5793(03)01383-8; Mimuro M, 2000, BBA-BIOENERGETICS, V1456, P27, DOI 10.1016/S0005-2728(99)00095-X; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Porra RJ, 1998, EUR J BIOCHEM, V257, P185, DOI 10.1046/j.1432-1327.1998.2570185.x; PORRA RJ, 1993, FEBS LETT, V323, P31, DOI 10.1016/0014-5793(93)81442-3; Porra RJ, 2000, PHOTOSYNTH RES, V66, P159, DOI 10.1023/A:1010631505071; PORRA RJ, 1995, FEBS LETT, V371, P21, DOI 10.1016/0014-5793(95)00854-3; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Razeghifard MR, 2005, BIOCHEMISTRY-US, V44, P11178, DOI 10.1021/bi048314c; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Schiller H, 1997, FEBS LETT, V410, P433, DOI 10.1016/S0014-5793(97)00620-0; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	33	49	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28450	28456		10.1074/jbc.M110.146753	http://dx.doi.org/10.1074/jbc.M110.146753			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610399	hybrid, Green Published			2022-12-27	WOS:000281594000008
J	Hanelt, I; Wunnicke, D; Muller-Trimbusch, M; Vor der Bruggen, M; Kraus, I; Bakker, EP; Steinhoff, HJ				Haenelt, Inga; Wunnicke, Dorith; Mueller-Trimbusch, Meike; Vor der Brueggen, Marc; Kraus, Inga; Bakker, Evert P.; Steinhoff, Heinz-Juergen			Membrane Region M-2C2 in Subunit KtrB of the K+ Uptake System KtrAB from Vibrio alginolyticus Forms a Flexible Gate Controlling K+ Flux AN ELECTRON PARAMAGNETIC RESONANCE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; ESCHERICHIA-COLI K-12; FULL-LENGTH KCSA; POTASSIUM-TRANSPORT; DISTANCE MEASUREMENTS; CRYSTAL-STRUCTURE; GLYCINE RESIDUES; KDPFABC COMPLEX; HIGH-AFFINITY; ION CHANNEL	Transmembrane stretch M-2C from the bacterial K+-translocating protein KtrB is unusually long. In its middle part, termed M-2C2, it contains several small and polar amino acids. This region is flanked by the two alpha-helices M-2C1 and M-2C3 and may form a flexible gate at the cytoplasmic side of the membrane controlling K+ translocation. In this study, we provide experimental evidence for this notion by using continuous wave and pulse EPR measurements of single and double spin-labeled cysteine variants of KtrB. Most of the spin-labeled residues in M-2C2 were shown to be immobile, pointing to a compact structure. However, the high polarity revealed for the microenvironment of residue positions 317, 318, and 327 indicated the existence of a water-accessible cavity. Upon the addition of K+ ions, M2C2 residue Thr-318R1 (R1 indicates the bound spin label) moved with respect to M-2B residue Asp-222R1 and M2C3 residue Val-331R1 but not with respect to M2C1 residue Met-311R1. Based on distances determined between spin-labeled residues of double-labeled variants of KtrB in the presence and absence of K+ ions, structural models of the open and closed conformations were developed.	[Bakker, Evert P.] Univ Osnabruck, Dept Microbiol, D-49076 Osnabruck, Germany; [Wunnicke, Dorith; Mueller-Trimbusch, Meike; Steinhoff, Heinz-Juergen] Univ Osnabruck, Dept Phys, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Hanelt, I (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	i.haenelt@rug.nl	Steinhoff, Heinz-Juergen/H-3791-2014; Hänelt, Inga/N-2982-2016	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft [SFB431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB431 (projects P6 and P18).	Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DRIESSEN AJM, 1993, METHOD ENZYMOL, V221, P394, DOI 10.1016/0076-6879(93)21032-4; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P475; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, J MAGN RESON, V169, P1, DOI 10.1016/j.jmr.2004.03.024; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kato N, 2007, CHANNELS, V1, P161, DOI 10.4161/chan.4374; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Savitsky A, 2004, J PHYS CHEM B, V108, P9541, DOI 10.1021/jp036397l; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; STUMPE S, 1996, HDB BIOL PHYS, V2, P473; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; van der Laan M, 2002, J BACTERIOL, V184, P5491, DOI 10.1128/JB.184.19.5491-5494.2002; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	50	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28210	28219		10.1074/jbc.M110.139311	http://dx.doi.org/10.1074/jbc.M110.139311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573964	Green Published, hybrid			2022-12-27	WOS:000281404100064
J	Komaba, S; Coluccio, LM				Komaba, Shigeru; Coluccio, Lynne M.			Localization of Myosin 1b to Actin Protrusions Requires Phosphoinositide Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; RAT-LIVER; MECHANICAL TRANSDUCTION; ATPASE SITE; MYO1C; IDENTIFICATION; MICROVILLUS; ADAPTATION; MOTOR	Myosin 1b (Myo1b), a class I myosin, is a widely expressed, single-headed, actin-associated molecular motor. Transient kinetic and single-molecule studies indicate that it is kinetically slow and responds to tension. Localization and subcellular fractionation studies indicate that Myo1b associates with the plasma membrane and certain subcellular organelles such as endosomes and lysosomes. Whether Myo1b directly associates with membranes is unknown. We demonstrate here that full-length rat Myo1b binds specifically and with high affinity to phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidylinositol 3,4,5-triphosphate (PIP3), two phosphoinositides that play important roles in cell signaling. Binding is not Ca2+-dependent and does not involve the calmodulin-binding IQ region in the neck domain of Myo1b. Furthermore, the binding site is contained entirely within the C-terminal tail region, which contains a putative pleckstrin homology domain. Single mutations in the putative pleckstrin homology domain abolish binding of the tail domain of Myo1b to PIP2 and PIP3 in vitro. These same mutations alter the distribution of Myc-tagged Myo1b at membrane protrusions in HeLa cells where PIP2 localizes. In addition, we found that motor activity is required for Myo1b localization in filopodia. These results suggest that binding of Myo1b to phosphoinositides plays an important role in vivo by regulating localization to actin-enriched membrane projections.	[Komaba, Shigeru; Coluccio, Lynne M.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Coluccio, LM (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	coluccio@bbri.org			National Institutes of Health [DC08793-01, DC08793-01S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008793, R55DC008793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC08793-01 and DC08793-01S1 (to L. M. C.).	Balish MF, 1999, ARCH BIOCHEM BIOPHYS, V370, P285, DOI 10.1006/abbi.1999.1409; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gillespie PG, 2004, PHILOS T ROY SOC B, V359, P1945, DOI 10.1098/rstb.2004.1564; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McDonough AA, 2009, AM J PHYSIOL-CELL PH, V297, pC1331, DOI 10.1152/ajpcell.00423.2009; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RUPPERT C, 1993, J CELL BIOL, V120, P1393, DOI 10.1083/jcb.120.6.1393; RUPPERT C, 1995, J CELL SCI, V108, P3775; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Sharma VP, 2008, J LEUKOCYTE BIOL, V84, P440, DOI 10.1189/jlb.0907636; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Takamoto N, 2006, ARCH BIOCHEM BIOPHYS, V456, P194, DOI 10.1016/j.abb.2006.09.026; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wagner MC, 2005, AM J PHYSIOL-CELL PH, V289, pC120, DOI 10.1152/ajpcell.00569.2003; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; WILLIAMS R, 1994, CELL MOTIL CYTOSKEL, V27, P41, DOI 10.1002/cm.970270105; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	57	49	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27686	27693		10.1074/jbc.M109.087270	http://dx.doi.org/10.1074/jbc.M109.087270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610386	Green Published, hybrid			2022-12-27	WOS:000281404100024
J	Talsky, KB; Collins, K				Talsky, Kristin Benjamin; Collins, Kathleen			Initiation by a Eukaryotic RNA-dependent RNA Polymerase Requires Looping of the Template End and Is Influenced by the Template-tailing Activity of an Associated Uridyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS	A conserved family of eukaryotic RNA-dependent RNA polymerases (RDRs) initiates or amplifies the production of small RNAs to provide sequence specificity for gene regulation by Argonaute/Piwi proteins. RDR-dependent silencing processes affect the genotype-phenotype relationship in many eukaryotes, but the principles that underlie the specificity of RDR template selection and product synthesis are largely unknown. Here, we characterize the initiation specificity of the Tetrahymena RDR, Rdr1, as a heterologously expressed single subunit and in the context of its biologically assembled multisubunit complexes (RDRCs). Truncation analysis of recombinant Rdr1 revealed domain requirements different from those of the only other similarly characterized RDR, suggesting that there are subfamilies of the RDR enzyme with distinct structural requirements for activity. We demonstrate an apparently obligate Rdr1 mechanism of initiation in which the template end is looped to provide the hydroxyl group priming the synthesis of dsRNA. RDRC subunits with poly(U) polymerase activity can act on the template end prior to looping to increase the duplex length of product, thus impacting the small RNA sequences generated by the RDRC-coupled Dicer. Overall, our findings give new perspective on mechanisms of RDR initiation and demonstrate that non-RDR subunits of an RDRC can affect the specificity of product synthesis.	[Talsky, Kristin Benjamin; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54198 (to K. C.).; Supported by a National Science Foundation predoctoral fellowship.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lee SR, 2009, RNA, V15, P1363, DOI 10.1261/rna.1630309; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	21	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27614	27623		10.1074/jbc.M110.142273	http://dx.doi.org/10.1074/jbc.M110.142273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20622019	hybrid, Green Published			2022-12-27	WOS:000281404100017
J	Park, KH; Kurokawa, K; Zheng, L; Jung, DJ; Tateishi, K; Jin, JO; Ha, NC; Kang, HJ; Matsushita, M; Kwak, JY; Takahashi, K; Lee, BL				Park, Keun-Hwa; Kurokawa, Kenji; Zheng, Lili; Jung, Dong-Jun; Tateishi, Koichiro; Jin, Jun-O; Ha, Nam-Chul; Kang, Hee Jung; Matsushita, Misao; Kwak, Jong-Young; Takahashi, Kazue; Lee, Bok Luel			Human Serum Mannose-binding Lectin Senses Wall Teichoic Acid Glycopolymer of Staphylococcus aureus, Which Is Restricted in Infancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; SERINE-PROTEASE; COMPLEMENT ACTIVATION; INNATE IMMUNITY; ASSOCIATION; INFECTION; RESISTANCE; PATHWAY; GENE	Innate immunity is the first line of host defense against invading pathogens, and it is recognized by a variety of pattern recognition molecules, including mannose-binding lectin (MBL). MBL binds to mannose and N-acetylglucosamine residues present on the glycopolymers of microorganisms. Human serum MBL functions as an opsonin and activates the lectin complement pathway. However, which glycopolymer of microorganism is recognized by MBL is still uncertain. Here, we show that wall teichoic acid of Staphylococcus aureus, a bacterial cell surface glycopolymer containing N-acetylglucosamine residue, is a functional ligand of MBL. Whereas serum MBL in adults did not bind to wall teichoic acid because of an inhibitory effect of anti-wall teichoic acid antibodies, MBL in infants who had not yet fully developed their adaptive immunity could bind to S. aureus wall teichoic acid and then induced complement C4 deposition. Our data explain the molecular reasons of why MBL-deficient infants are susceptible to S. aureus infection.	[Park, Keun-Hwa; Kurokawa, Kenji; Zheng, Lili; Jung, Dong-Jun; Ha, Nam-Chul; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Tateishi, Koichiro; Matsushita, Misao] Tokai Univ, Dept Appl Biochem, Kanagawa 2591292, Japan; [Jin, Jun-O; Kwak, Jong-Young] Dong A Univ, Dept Biochem, Pusan 602714, South Korea; [Kang, Hee Jung] Hallym Univ, Coll Med, Dept Lab Med, Anyang Si 431070, South Korea; [Takahashi, Kazue] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Programs Dev Immunol, Boston, MA 02114 USA	Pusan National University; Tokai University; Dong A University; Hallym University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	National Research Foundation of Korea [M10400000028-04J0000-02, 2009-032-2000, 2008-8057-6001, BK21]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Programs M10400000028-04J0000-02, 2009-032-2000, 2008-8057-6001, and BK21 of the National Research Foundation of Korea.	Archer GL, 2001, NEW ENGL J MED, V344, P55, DOI 10.1056/NEJM200101043440110; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Fattom AI, 2004, VACCINE, V22, P880, DOI 10.1016/j.vaccine.2003.11.034; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jo EJ, 2004, J IMMUNOL, V173, P6433, DOI 10.4049/jimmunol.173.10.6433; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kang HJ, 2007, IMMUNOLOGY, V122, P335, DOI 10.1111/j.1365-2567.2007.02644.x; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weisman LE, 2007, ARCH PEDIATRIE, V14, pS31, DOI 10.1016/S0929-693X(07)80008-X; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157	47	50	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27167	27175		10.1074/jbc.M110.141309	http://dx.doi.org/10.1074/jbc.M110.141309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592033	Green Published, hybrid			2022-12-27	WOS:000281172700047
J	Vinogradov, E; King, JD; Pathak, AK; Harvill, ET; Preston, A				Vinogradov, Evgeny; King, Jerry D.; Pathak, Ashutosh K.; Harvill, Eric T.; Preston, Andrew			Antigenic Variation among Bordetella BORDETELLA BRONCHISEPTICA STRAIN MO149 EXPRESSES A NOVEL O CHAIN THAT IS POORLY IMMUNOGENIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGENS; RESPIRATORY-TRACT INFECTION; BORDETELLA-BRONCHISEPTICA; GENE-CLUSTER; PERTUSSIS; POLYSACCHARIDE; PARAPERTUSSIS; BIOSYNTHESIS; BINDING; CHAIN	The O chain polysaccharide (O PS) of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharide is a homopolymer of 2,3-diacetamido-2,3-dideoxygalacturonic acid (GalNAc3NAcA) in which some of the sugars are present as uronamides. The terminal residue contains several unusual modifications. To date, two types of modification have been characterized, and a survey of numerous strains demonstrated that each contained one of these two modification types. Host antibody responses against the O PS are directed against the terminal residue modifications, and there is little cross-reactivity between the two types. This suggests that Bordetella O PS modifications represent a means of antigenic variation. Here we report the characterization of the O PS of B. bronchiseptica strain MO149. It consists of a novel two-sugar repeating unit and a novel terminal residue modification, with the structure Me-4-alpha-L-Ga1NAc3NAcA-(4-beta-D-G1cNAc3NAcA-4-alpha-L-Ga1NAc3NAcA-) (5-6)-, which we propose be defined as the B. bronchiseptica O3 PS. We show that the O3 PS is very poorly immunogenic and that the MO149 strain contains a novel wbm (O PS biosynthesis) locus. Thus, there is greater diversity among Bordetella O PSs than previously recognized, which is likely to be a result of selection pressure from host immunity. We also determine experimentally, for the first time, the absolute configuration of the diacetimido-uronic acid sugars in Bordetella O PS.	[Preston, Andrew] Univ Bristol, Dept Vet Clin Sci, Langford BS40 5DU, North Somerset, England; CNR, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [King, Jerry D.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Pathak, Ashutosh K.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	University of Bristol; National Research Council Canada; University of Guelph; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Preston, A (corresponding author), Univ Bristol, Dept Vet Clin Sci, Langford BS40 5DU, North Somerset, England.	a.preston@bristol.ac.uk		Preston, Andrew/0000-0002-1489-280X; Harvill, Eric/0000-0001-8893-2133; Vinogradov, Evgeny/0000-0002-5364-1376	National Institutes of Health [GM083113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083113 (to E. T. H.).	Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Buboltz AM, 2009, INFECT IMMUN, V77, P3249, DOI 10.1128/IAI.01448-08; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; Merino S, 2000, INFECT IMMUN, V68, P2435, DOI 10.1128/IAI.68.5.2435-2440.2000; PEPPLER MS, 1984, INFECT IMMUN, V43, P224, DOI 10.1128/IAI.43.1.224-232.1984; Pilione MR, 2004, INFECT IMMUN, V72, P2837, DOI 10.1128/IAI.72.5.2837-2842.2004; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Preston A, 1996, J BACTERIOL, V178, P396, DOI 10.1128/jb.178.2.396-402.1996; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Vinogradov E, 2002, CARBOHYD RES, V337, P961; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; Vinogradov E, 2008, CARBOHYD RES, V343, P3079, DOI 10.1016/j.carres.2008.09.015; Vinogradov E, 2007, CARBOHYD RES, V342, P638, DOI 10.1016/j.carres.2006.10.025; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Zhang XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006989; Zhang XQ, 2009, INFECT IMMUN, V77, P5050, DOI 10.1128/IAI.00667-09	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26869	26877		10.1074/jbc.M110.115121	http://dx.doi.org/10.1074/jbc.M110.115121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592026	hybrid, Green Published			2022-12-27	WOS:000281172700018
J	Cardi, D; Pozza, A; Arnou, B; Marchal, E; Clausen, JD; Andersen, JP; Krishna, S; Moller, JV; le Maire, M; Jaxel, C				Cardi, Delphine; Pozza, Alexandre; Arnou, Bertrand; Marchal, Estelle; Clausen, Johannes D.; Andersen, Jens Peter; Krishna, Sanjeev; Moller, Jesper V.; le Maire, Marc; Jaxel, Christine			Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; FALCIPARUM MALARIA PARASITES; ANTIMALARIAL-DRUG-RESISTANCE; PLASMODIUM-FALCIPARUM; IN-VITRO; ADENOSINE-TRIPHOSPHATASE; TRANSMEMBRANE SEGMENTS; INORGANIC-PHOSPHATE; MEMBRANE-PROTEIN; S769N MUTATION	The antimalarial drugs artemisinins have been described as inhibiting Ca2+-ATPase activity of PfATP6 (Plasmodium falciparum ATP6) after expression in Xenopus oocytes. Mutation of an amino acid residue in mammalian SERCA1 (Glu(255)) to the equivalent one predicted in PfATP6 (Leu) was reported to induce sensitivity to artemisinin in the oocyte system. However, in the present experiments, we found that artemisinin did not inhibit mammalian SERCA1a E255L either when expressed in COS cells or after purification of the mutant expressed in Saccharomyces cerevisiae. Moreover, we found that PfATP6 after expression and purification from S. cerevisiae was insensitive to artemisinin and significantly less sensitive to thapsigargin and 2,5-di(tert-butyl)-1,4-benzo-hydroquinone than rabbit SERCA1 but retained higher sensitivity to cyclopiazonic acid, another type of SERCA1 inhibitor. Although mammalian SERCA and purified PfATP6 appear to have different pharmacological profiles, their insensitivity to artemisinins suggests that the mechanism of action of this class of drugs on the calcium metabolism in the intact cell is complex and cannot be ascribed to direct inhibition of PfATP6. Furthermore, the successful purification of PfATP6 affords the opportunity to develop new antimalarials by screening for inhibitors against PfATP6.	[Cardi, Delphine; Pozza, Alexandre; Marchal, Estelle; le Maire, Marc; Jaxel, Christine] Univ Paris Sud, Lab Rech Associe 17V, F-91191 Gif Sur Yvette, France; [Krishna, Sanjeev] St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London SW17 0RE, England; [Arnou, Bertrand; Clausen, Johannes D.; Andersen, Jens Peter; Moller, Jesper V.] Univ Aarhus, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Cardi, Delphine; Pozza, Alexandre; Marchal, Estelle; le Maire, Marc; Jaxel, Christine] Commissariat Energie Atom, Inst Biol & Technol Saclay, SB2SM, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; St Georges University London; Aarhus University; Danmarks Grundforskningsfond; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	le Maire, M (corresponding author), CEA Saclay, CNRS, URA 2096, IBiTec S,SB2SM,LPM, F-91191 Gif Sur Yvette, France.	marc.lemaire@cea.fr; christine.jaxel@.cea.fr	Hua, QX/HGE-3640-2022	Andersen, Jens Peter/0000-0003-0654-4300; Marchal, Estelle/0000-0003-4121-311X; JAXEL, CHRISTINE/0000-0002-1387-4458; Krishna, Sanjeev/0000-0003-0066-0634	Danish Medical Research Council; Danish Natural Science Research Council (Center for Structural Biology); Aarhus University Research Foundation; Novo-Nordic Foundation (Denmark); Commissariat a l'Energie Atomique (Saclay, France); CNRS; DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France); European Communities [018834]; Wellcome Trust [074395/Z/04/Z]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council (Center for Structural Biology)(Danish Natural Science Research Council); Aarhus University Research Foundation; Novo-Nordic Foundation (Denmark)(Novo Nordisk Foundation); Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France); European Communities(European Commission); Wellcome Trust(Wellcome Trust)	This work was supported by the Danish Medical Research Council, the Danish Natural Science Research Council (Center for Structural Biology, the Dansync program), the Aarhus University Research Foundation, the Novo-Nordic Foundation (Denmark), the Commissariat a l'Energie Atomique (Saclay, France), CNRS, and the DIM Maladies Infectieuses, Parasitaires et Nosocomiales Emergentes/Ile de France (France).; Supported by Commission of the European Communities ANTIMAL Grant 018834 and Wellcome Trust Grant 074395/Z/04/Z.	ASAWAMAHASAKDA W, 1994, ANTIMICROB AGENTS CH, V38, P1854, DOI 10.1128/AAC.38.8.1854; AVERY MA, 1993, J MED CHEM, V36, P4264, DOI 10.1021/jm00078a017; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; CENTENO F, 1994, FEBS LETT, V354, P117, DOI 10.1016/0014-5793(94)01104-4; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2003, BIOCHEMISTRY-US, V42, P2585, DOI 10.1021/bi0271897; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; Ferreira ID, 2008, TROP MED INT HEALTH, V13, P199, DOI 10.1111/j.1365-3156.2007.01991.x; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Garah FBE, 2009, CHEMMEDCHEM, V4, P1469, DOI 10.1002/cmdc.200900200; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; GU HM, 1984, T ROY SOC TROP MED H, V78, P265, DOI 10.1016/0035-9203(84)90296-7; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haynes RK, 2006, ANGEW CHEM INT EDIT, V45, P2082, DOI 10.1002/anie.200503071; Hedfalk K, 2008, PROTEIN EXPRES PURIF, V59, P69, DOI 10.1016/j.pep.2008.01.004; Hoppe HC, 2004, ANTIMICROB AGENTS CH, V48, P2370, DOI 10.1128/AAC.48.7.2370-2378.2004; Ittarat Wanida, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P744; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KIMURA M, 1993, J CELL SCI, V104, P1129; Kombila M, 1997, AM J TROP MED HYG, V57, P643, DOI 10.4269/ajtmh.1997.57.643; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Krishna S, 2008, TRENDS PHARMACOL SCI, V29, P520, DOI 10.1016/j.tips.2008.07.004; KUMAR N, 1990, PARASITOL RES, V76, P214, DOI 10.1007/BF00930817; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; LUND S, 1989, J BIOL CHEM, V264, P4907; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2007, ANTIMICROB AGENTS CH, V51, P3816, DOI 10.1128/AAC.00582-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; O'Neill PM, 2005, EXPERT OPIN INV DRUG, V14, P1117, DOI 10.1517/13543784.14.9.1117; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Soulie S, 1998, J BIOCHEM-TOKYO, V124, P417, DOI 10.1093/oxfordjournals.jbchem.a022128; Stockwin LH, 2009, INT J CANCER, V125, P1266, DOI 10.1002/ijc.24496; Tan W, 2006, ARCH BIOCHEM BIOPHYS, V452, P119, DOI 10.1016/j.abb.2006.06.017; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toovey S, 2008, BASIC CLIN PHARMACOL, V103, P209, DOI 10.1111/j.1742-7843.2008.00256.x; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Varotti FD, 2008, ANTIMICROB AGENTS CH, V52, P3868, DOI 10.1128/AAC.00510-08; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Witting PK, 2001, J BIOL CHEM, V276, P3991, DOI 10.1074/jbc.M005758200; Woodrow CJ, 2005, POSTGRAD MED J, V81, P71, DOI 10.1136/pgmj.2004.028399; Zhang GQ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-122; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	74	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26406	26416		10.1074/jbc.M109.090340	http://dx.doi.org/10.1074/jbc.M109.090340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20530490	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000280921000059
J	Nakatsumi, H; Yonehara, S				Nakatsumi, Hirokazu; Yonehara, Shin			Identification of Functional Regions Defining Different Activity in Caspase-3 and Caspase-7 within Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; KEY MEDIATORS; ACTIVATION; APOPTOSIS; SUBSTRATE; MECHANISMS; CLEAVAGE; SPECIFICITIES; PROCASPASE-7; INHIBITION	Caspases are central to apoptosis, and the principal executioner caspases, caspase-3 and -7, were reported to be similar in activity, primary structure, and three-dimensional structure. Here, we identified different activity in caspase-3 and -7 within cells and examined the relationship between their structure and function using human cells expressing almost equal amounts of exogenous caspase-3, caspase-7, and/or chimeric constructs after down-regulation of endogenous caspase-3 and -7 expression. Caspase-3 (produced in human cells) showed much stronger cleaving activity than caspase-7 against a low molecular weight substrate in vitro dependent on four specific amino acid regions. Within cells, however, an additional three regions were required for caspase-3 to exert much stronger protease activity than caspase-7 against cellular substrates. Three of the former four regions and the latter three regions were shown to form two different three-dimensional structures that were located at the interface of the homodimer of procaspase-7 on opposite sides. In addition, procaspase-3 and -7 revealed specific homodimer-forming activity within cells dependent on five amino acid regions, which were included in the regions critical to the cleaving activity within cells. Thus, human caspase-3 and -7 exhibit differences in protease activity, specific homodimer-forming activity, and three-dimensional structural features, all of which are closely interrelated.	[Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Dept Anim Dev & Physiol,Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Dept Anim Dev & Physiol,Sakyo Ku, SCRB Bldg G,Konoe Cho, Kyoto 6068501, Japan.	yonehara@lif.kyoto-u.ac.jp	Nakatsumi, Hirokazu/AFQ-3000-2022	Nakatsumi, Hirokazu/0000-0003-0944-6319				Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Gyobu H, 2004, CANCER RES, V64, P1490, DOI 10.1158/0008-5472.CAN-03-2780; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Morita A, 2000, BIOCHEM BIOPH RES CO, V278, P627, DOI 10.1006/bbrc.2000.3860; Piana S, 2003, BIOCHEMISTRY-US, V42, P8720, DOI 10.1021/bi034032l; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Tahara-Hanaoka S, 2002, EXP HEMATOL, V30, P11, DOI 10.1016/S0301-472X(01)00761-5; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	28	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25418	25425		10.1074/jbc.M110.126573	http://dx.doi.org/10.1074/jbc.M110.126573			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566630	Green Published, hybrid			2022-12-27	WOS:000280682400035
J	Osman, D; Waldron, KJ; Denton, H; Taylor, CM; Grant, AJ; Mastroeni, P; Robinson, NJ; Cavet, JS				Osman, Deenah; Waldron, Kevin J.; Denton, Harriet; Taylor, Clare M.; Grant, Andrew J.; Mastroeni, Pietro; Robinson, Nigel J.; Cavet, Jennifer S.			Copper Homeostasis in Salmonella Is Atypical and Copper-CueP Is a Major Periplasmic Metal Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH PHAGOCYTE OXIDASE; ANTIMICROBIAL ACTIONS; SUPEROXIDE-DISMUTASE; ATPASE REDUCE; ENTERICA; TYPHIMURIUM; INFECTION; PROTEIN; GENE; PROLIFERATION	Salmonella enterica sv. typhimurium (S. enterica sv. Typhimurium) has two metal-transporting P-1-type ATPases whose actions largely overlap with respect to growth in elevated copper. Mutants lacking both ATPases over-accumulate copper relative to wild-type or either single mutant. Such duplication of ATPases is unusual in bacterial copper tolerance. Both ATPases are under the control of MerR family metal-responsive transcriptional activators. Analyses of periplasmic copper complexes identified copper-CueP as one of the predominant metal pools. Expression of cueP was recently shown to be controlled by the same metal-responsive activator as one of the P1-type ATPase genes (copA), and copper-CueP is a further atypical feature of copper homeostasis in S. enterica sv. Typhimurium. Elevated copper is detected by a reporter construct driven by the promoter of copA in wild-type S. enterica sv. Typhimurium during infection of macrophages. Double mutants missing both ATPases also show reduced survival inside cultured macrophages. It is hypothesized that elevated copper within macrophages may have selected for specialized copper-resistance systems in pathogenic microorganism such as S. enterica sv. Typhimurium.	[Cavet, Jennifer S.] Univ Manchester, Manchester M13 9PT, Lancs, England; [Waldron, Kevin J.; Robinson, Nigel J.] Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Grant, Andrew J.; Mastroeni, Pietro] Univ Cambridge, Cambridge CB3 0ES, England	University of Manchester; Newcastle University - UK; University of Cambridge	Cavet, JS (corresponding author), Univ Manchester, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	Jennifer.s.cavet@manchester.ac.uk	Robinson, Nigel J/J-6363-2012; Waldron, Kevin John/HHM-8983-2022; Waldron, Kevin/J-2368-2016; Osman, Deenah/AAB-4516-2020	Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin John/0000-0002-5577-7357; Waldron, Kevin/0000-0002-5577-7357; Osman, Deenah/0000-0002-0251-9231; Cavet, Jennifer/0000-0001-5913-7157; Mastroeni, Pietro/0000-0003-3838-4962	Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee [BB/G010765/1]; Biotechnology and Biological Sciences Research Council [BB/G010765/1] Funding Source: researchfish; Medical Research Council [G0801161] Funding Source: researchfish; BBSRC [BB/G010765/1] Funding Source: UKRI; MRC [G0801161] Funding Source: UKRI	Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Biotechnology and Biological Science Research Council (BBSRC) Agri-food Committee (BB/G010765/1) and BBSRC studentship (to D.O.).	Aarestrup FM, 2004, VET MICROBIOL, V100, P83, DOI 10.1016/j.vetmic.2004.01.013; Achard MES, 2010, INFECT IMMUN, V78, P2312, DOI 10.1128/IAI.01208-09; Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; Huang ZXL, 2000, J NUTR, V130, P1536, DOI 10.1093/jn/130.6.1536; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kim JS, 2002, FEMS MICROBIOL LETT, V210, P99, DOI 10.1111/j.1574-6968.2002.tb11166.x; Lim SY, 2002, MOL CELLS, V14, P177; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Percival SS, 1998, AM J CLIN NUTR, V67, p1064S, DOI 10.1093/ajcn/67.5.1064S; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Sambrook J., 2001, MOL CLONING LAB MANU; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Segal AW, 1997, ANN NY ACAD SCI, V832, P215, DOI 10.1111/j.1749-6632.1997.tb46249.x; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; Stoyanov JV, 2003, J BIOL CHEM, V278, P1407, DOI 10.1074/jbc.C200580200; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor CM, 2009, MICROB PATHOGENESIS, V46, P114, DOI 10.1016/j.micpath.2008.11.001; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201	46	122	123	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25259	25268		10.1074/jbc.M110.145953	http://dx.doi.org/10.1074/jbc.M110.145953			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534583	Green Published, hybrid			2022-12-27	WOS:000280682400019
J	Murthy, S; Ryan, A; He, C; Mallampalli, RK; Carter, AB				Murthy, Shubha; Ryan, Alan; He, Chao; Mallampalli, Rama K.; Carter, A. Brent			Rac1-mediated Mitochondrial H2O2 Generation Regulates MMP-9 Gene Expression in Macrophages via Inhibition of SP-1 and AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MATRIX METALLOPROTEINASES; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION; SP1 PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TISSUE INHIBITOR; BINDING-PROTEIN; IV COLLAGENASE	Aberrant matrix deposition is a hallmark of pulmonary fibrosis and is characterized by an imbalance between matrix deposition and degradation. We have previously shown that mice harboring a conditional deletion of the GTP-binding protein, Rac1, in macrophages are protected from asbestos-induced pulmonary fibrosis. To investigate the contribution of aberrant matrix degradation, we addressed the role of Rac1 in regulating expression of macrophage-specific MMP-9 (matrix metalloproteinase-9). We found that MMP-9 gene transcription was significantly greater in Rac1 null macrophages. Deletion and mutational analysis of the MMP-9 promoter revealed that both SP-1 and AP-1 are essential for MMP-9 transcription. Overexpression of constitutive active Rac1 (V12) revealed that H2O2 was derived from the mitochondria. Rac1-induced H2O2 generation down-regulated MMP-9 gene transcription, whereas catalase overexpression in WT cells enhanced MMP-9 expression. SP-1 interacted directly with both c-Jun and c-Fos, and H2O2 decreased this binding, suggesting that SP-1 and AP-1 function cooperatively to regulate MMP-9 transcription. Rac1-mediated H2O2 inhibited the ERK MAPK, which was essential for activation of SP-1 and AP-1. ERK activation and MMP-9 expression were recovered by overexpressing catalase or transfecting siRNA for the mitochondrial iron-sulfur protein, Rieske. These observations were recapitulated in vivo. MMP-9 mRNA was higher in alveolar macrophages isolated from Rac1 null mice and wild type mice given catalase. Rac1 regulates MMP-9 transcription via mitochondrial H2O2 generation, providing a potential mechanism by which Rac1 null mice fail to develop pulmonary fibrosis.	[Murthy, Shubha; Ryan, Alan; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, C33 GH, Iowa City, IA 52242 USA.				National Institutes of Health [HL068135, HL081784, HL097376, ES015981, ES014871]; Department of Veterans Affairs, Office of Research and Development; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081784, R01HL068135, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014871, R01ES015981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068135, HL081784, and HL097376 (to R. K. M.) and ES015981 and ES014871 (to A. B. C.). This work was also supported by a grant from the Department of Veterans Affairs, Office of Research and Development (to R. K. M.).	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Binker MG, 2009, BIOCHEM BIOPH RES CO, V386, P124, DOI 10.1016/j.bbrc.2009.05.136; Binker MG, 2009, BIOCHEM BIOPH RES CO, V379, P445, DOI 10.1016/j.bbrc.2008.12.080; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Carter AB, 2001, J BIOL CHEM, V276, P33826, DOI 10.1074/jbc.M100209200; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; De Minicis S, 2007, ARCH BIOCHEM BIOPHYS, V462, P266, DOI 10.1016/j.abb.2007.04.016; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Monick MM, 1999, J BIOL CHEM, V274, P18075, DOI 10.1074/jbc.274.25.18075; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Ozaki M, 2000, J BIOL CHEM, V275, P35377, DOI 10.1074/jbc.M005287200; Ozaki M, 2000, FASEB J, V14, P418, DOI 10.1096/fasebj.14.2.418; PANUS PC, 1993, FREE RADICAL BIO MED, V14, P217, DOI 10.1016/0891-5849(93)90013-K; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Poitevin S, 2008, J THROMB HAEMOST, V6, P1586, DOI 10.1111/j.1538-7836.2008.03051.x; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; SATO H, 1993, J BIOL CHEM, V268, P23460; SETH A, 1992, J BIOL CHEM, V267, P24796; SHAPIRO SD, 1993, BIOCHEMISTRY-US, V32, P4286, DOI 10.1021/bi00067a018; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tephly LA, 2008, AM J RESP CELL MOL, V39, P113, DOI 10.1165/rcmb.2007-0356OC; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Woo CH, 2002, J BIOL CHEM, V277, P8572, DOI 10.1074/jbc.M104766200; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yang JQ, 2002, MOL CARCINOGEN, V33, P206, DOI 10.1002/mc.10037; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	57	65	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25062	25073		10.1074/jbc.M109.099655	http://dx.doi.org/10.1074/jbc.M109.099655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529870	Green Published, hybrid			2022-12-27	WOS:000280542100079
J	Swayne, LA; Sorbara, CD; Bennett, SAL				Swayne, Leigh Anne; Sorbara, Catherine D.; Bennett, Steffany A. L.			Pannexin 2 Is Expressed by Postnatal Hippocampal Neural Progenitors and Modulates Neuronal Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; PROTEIN; HEMICHANNELS; RECEPTORS; CHANNELS; FAMILY; PALMITOYLATION; RELEASE; BORN	The pannexins (Panx1, -2, and -3) are a mammalian family of putative single membrane channels discovered through homology to invertebrate gap junction-forming proteins, the innexins. Because connexin gap junction proteins are known regulators of neural stem and progenitor cell proliferation, migration, and specification, we asked whether pannexins, specifically Panx2, play a similar role in the postnatal hippocampus. We show that Panx2 protein is differentially expressed by multipotential progenitor cells and mature neurons. Both in vivo and in vitro, Type I and IIa stem-like neural progenitor cells express an S-palmitoylated Panx2 species localizing to Golgi and endoplasmic reticulum membranes. Protein expression is down-regulated during neurogenesis in neuronally committed Type IIb and III progenitor cells and immature neurons. Panx2 is re-expressed by neurons following maturation. Protein expressed by mature neurons is not palmitoylated and localizes to the plasma membrane. To assess the impact of Panx2 on neuronal differentiation, we used short hairpin RNA to suppress Panx2 expression in Neuro2a cells. Knockdown significantly accelerated the rate of neuronal differentiation. Neuritic extension and the expression of antigenic markers of mature neurons occurred earlier in stable lines expressing Panx2 short hairpin RNA than in controls. Together, these findings describe an endogenous post-translational regulation of Panx2, specific to early neural progenitor cells, and demonstrate that this expression plays a role in modulating the timing of their commitment to a neuronal lineage.	[Swayne, Leigh Anne] Univ Ottawa, Neural Regenerat Lab, Ottawa, ON K1M 1E5, Canada; Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON K1M 1E5, Canada	University of Ottawa; University of Ottawa	Swayne, LA (corresponding author), Univ Ottawa, Neural Regenerat Lab, 451 Smyth Rd, Ottawa, ON K1M 1E5, Canada.	lswayne@uottawa.ca			Canadian Institutes of Health Research (CIHR) [MOP-62826]; Heart and Stroke Foundation Centre; Genome Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation Centre; Genome Canada(Genome Canada)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-62826, the Heart and Stroke Foundation Centre for Stroke Recovery, and Genome Canada operating support (to S.A.L.B.).	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Hogg RC, 2004, EUR J NEUROSCI, V19, P2410, DOI 10.1111/j.0953-816X.2004.03346.x; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Imbeault S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-13; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Li GN, 2010, CURR OPIN NEUROBIOL, V20, P126, DOI 10.1016/j.conb.2009.12.008; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lin JHC, 2007, DEV BIOL, V302, P356, DOI 10.1016/j.ydbio.2006.09.017; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Melanson-Drapeau L, 2003, J NEUROSCI, V23, P1759; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; Tole S, 1997, DEVELOPMENT, V124, P4959; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Wegner F, 2008, J NEUROCHEM, V107, P1056, DOI 10.1111/j.1471-4159.2008.05688.x; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028	49	78	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24977	24986		10.1074/jbc.M110.130054	http://dx.doi.org/10.1074/jbc.M110.130054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529862	hybrid, Green Published			2022-12-27	WOS:000280542100070
J	Meissner, M; Hrgovic, I; Doll, M; Naidenow, J; Reichenbach, G; Hailemariam-Jahn, T; Michailidou, D; Gille, J; Kaufmann, R				Meissner, Markus; Hrgovic, Igor; Doll, Monika; Naidenow, Julia; Reichenbach, Gabi; Hailemariam-Jahn, Tsige; Michailidou, Despina; Gille, Jens; Kaufmann, Roland			Peroxisome Proliferator-activated Receptor delta Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA/DELTA PPAR-BETA/DELTA; NF-KAPPA-B; EPITHELIAL-CELLS; GENE-EXPRESSION; LIGAND ACTIVATION; PROTEIN-KINASE; MESSENGER-RNA; GROWTH-FACTOR; ALPHA; INTERLEUKIN-8	Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are implicated in the regulation of lipid and glucose homeostasis. PPAR agonists have been shown to control inflammatory processes, in part by inhibiting distinct proinflammatory genes (e.g. Il-1 beta and IFN-gamma). IL-8 is a member of the proinflammatory chemokine family that is important for various functions, such as mediating the adhesion of eosinophilic granulocytes onto endothelial cells. The influence of PPAR delta activators on the expression of IL-8 in noninduced quiescent endothelial cells is unclear. Therefore, we explored the influence of PPAR delta activators on the expression of IL-8 in nonstimulated endothelial cells. PPAR delta agonists induce IL-8 expression in human umbilical vein endothelial cells. This induction is demonstrated at the level of both protein and mRNA expression. Transcriptional activation studies using IL-8 reporter gene constructs and DNA binding assays revealed that PPAR delta agonists mediated their effects via an NF kappa B binding site. It is well known that IL-8 is also regulated by mRNA stability. To provide further evidence for this concept, we performed mRNA stability assays and found that PPAR delta agonists induce the mRNA stability of IL-8. In addition, we showed that PPAR delta agonists induce the phosphorylation of ERK1/2 and p38, which are known to be involved in the increase of mRNA stability. The inhibition of these MAPK signaling pathways resulted in a significant suppression of the induced IL-8 expression and the reduced mRNA stability. Therefore, our data provide the first evidence that PAR delta induces IL-8 expression in nonstimulated endothelial cells via transcriptional as well as posttranscriptional mechanisms.	[Meissner, Markus; Hrgovic, Igor; Doll, Monika; Naidenow, Julia; Reichenbach, Gabi; Hailemariam-Jahn, Tsige; Michailidou, Despina; Gille, Jens; Kaufmann, Roland] Goethe Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Meissner, M (corresponding author), Klinikum JW Goethe Univ, Zentrum Dermatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	markus.meissner@kgu.de	Meissner, Markus/AAP-8179-2020; Meissner, Markus/F-9125-2014	Meissner, Markus/0000-0002-5630-587X	Wilhelm Sander Stiftung	Wilhelm Sander Stiftung	This work was supported by the Wilhelm Sander Stiftung (M.M.).	Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Chen WZ, 2000, EXP LUNG RES, V26, P13, DOI 10.1080/019021400269934; Clifton DR, 2005, INT J MED MICROBIOL, V295, P267, DOI 10.1016/j.ijmm.2005.05.006; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Gross B, 2007, BEST PRACT RES CL EN, V21, P687, DOI 10.1016/j.beem.2007.09.004; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Hansen MK, 2008, CURR OPIN INVEST DR, V9, P247; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kim DJ, 2006, CARCINOGENESIS, V27, P1105, DOI 10.1093/carcin/bgi346; Lee JW, 2008, J IMMUNOL, V181, P6536, DOI 10.4049/jimmunol.181.9.6536; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Liang YJ, 2010, INT J CARDIOL, V143, P361, DOI 10.1016/j.ijcard.2009.03.100; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; Meissner M, 2009, CANCER RES, V69, P1976, DOI 10.1158/0008-5472.CAN-08-3150; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040; Ren SY, 2005, BIOCHEM BIOPH RES CO, V338, P1818, DOI 10.1016/j.bbrc.2005.10.158; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Rochelson B, 2007, J REPROD IMMUNOL, V73, P101, DOI 10.1016/j.jri.2006.06.004; Rodriguez-Calvo R, 2008, DIABETES, V57, P2149, DOI 10.2337/db08-0176; Seedorf U, 2007, BBA-MOL CELL BIOL L, V1771, P1125, DOI 10.1016/j.bbalip.2007.04.017; Subramaniam D, 2008, GASTROENTEROLOGY, V134, P1070, DOI 10.1053/j.gastro.2008.01.040; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Torra IP, 2001, CURR OPIN LIPIDOL, V12, P245, DOI 10.1097/00041433-200106000-00002; Wang NP, 2008, PPAR RES, V2008, DOI 10.1155/2008/164163; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	37	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33797	33804		10.1074/jbc.M110.137943	http://dx.doi.org/10.1074/jbc.M110.137943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20592029	Green Published, hybrid			2022-12-27	WOS:000283354000026
J	Fujii, T; Ueda, T; Nagata, S; Fukunaga, R				Fujii, Toshihiro; Ueda, Takeshi; Nagata, Shigekazu; Fukunaga, Rikiro			Essential Role of p400/mDomino Chromatin-remodeling ATPase in Bone Marrow Hematopoiesis and Cell-cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE VARIANT EXCHANGE; C-MYC; ACETYLTRANSFERASE COMPLEX; CHROMOSOME STABILITY; DNA; TIP60; PROTEIN; ACETYLATION; TARGET; GENES	p400/mDomino is an ATP-dependent chromatin-remodeling protein that catalyzes the deposition of histone variant H2A.Z into nucleosomes to regulate gene expression. We previously showed that p400/mDomino is essential for embryonic development and primitive hematopoiesis. Here we generated a conditional knock-out mouse for the p400/mDomino gene and investigated the role of p400/mDomino in adult bone marrow hematopoiesis and in the cell-cycle progression of embryonic fibroblasts. The Mx1-Cre-mediated deletion of p400/mDomino resulted in an acute loss of nucleated cells in the bone marrow, including committed myeloid and erythroid cells as well as hematopoietic progenitor and stem cells. A hematopoietic colony assay revealed a drastic reduction in colony-forming activity after the deletion of p400/mDomino. Moreover, the loss of p400/mDomino in mouse embryonic fibroblasts (MEFs) resulted in strong growth inhibition. Cell-cycle analysis revealed that the mDomino-deficient MEFs exhibited a pleiotropic cellcycle defect at the S and G2/M phases, and polyploid and multinucleated cells with micronuclei emerged. DNA microarray analysis revealed that the p400/mDomino deletion from MEFs caused the impaired expression of many cell-cycle-regulatory genes, including G2/M-specific genes targeted by the transcription factors FoxM1 and c-Myc. These results indicate that p400/mDomino plays a key role in cellular proliferation by controlling the expression of cell-cycle-regulatory genes.	[Fujii, Toshihiro; Nagata, Shigekazu; Fukunaga, Rikiro] Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Fujii, Toshihiro; Ueda, Takeshi; Nagata, Shigekazu; Fukunaga, Rikiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nagata, Shigekazu; Fukunaga, Rikiro] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Fukunaga, R (corresponding author), Kyoto Univ, Dept Med Chem, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan.	rfukunaga@mfour.med.kyoto-u.ac.jp	Fukunaga, Rikiro/CAG-2891-2022; Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Ueda, Takeshi/0000-0001-9823-6764	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Iida S, 2005, J LEUKOCYTE BIOL, V78, P481, DOI 10.1189/jlb.0904515; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ogawa H, 2003, GENES CELLS, V8, P325, DOI 10.1046/j.1365-2443.2003.00636.x; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2007, GENES CELLS, V12, P581, DOI 10.1111/j.1365-2443.2007.01080.x; VAN ATTIKUM H, 2005, NAT REV MOL CELL BIO, V6, P757; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937	44	21	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30214	30223		10.1074/jbc.M110.104513	http://dx.doi.org/10.1074/jbc.M110.104513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20610385	Green Published, hybrid			2022-12-27	WOS:000281984300058
J	Soriani, M; Petit, P; Grifantini, R; Petracca, R; Gancitano, G; Frigimelica, E; Nardelli, F; Garcia, C; Spinelli, S; Scarabelli, G; Fiorucci, S; Affentranger, R; Ferrer-Navarro, M; Zacharias, M; Colombo, G; Vuillard, L; Daura, X; Grandi, G				Soriani, Marco; Petit, Pierre; Grifantini, Renata; Petracca, Roberto; Gancitano, Giovanni; Frigimelica, Elisabetta; Nardelli, Filomena; Garcia, Christel; Spinelli, Silvia; Scarabelli, Guido; Fiorucci, Sebastien; Affentranger, Roman; Ferrer-Navarro, Mario; Zacharias, Martin; Colombo, Giorgio; Vuillard, Laurent; Daura, Xavier; Grandi, Guido			Exploiting Antigenic Diversity for Vaccine Design THE CHLAMYDIA ArtJ PARADIGM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTION SITES; PROTEINS; IDENTIFICATION; SIMULATIONS; PNEUMONIAE; CANDIDATES; ENERGETICS; STABILITY; EXTENSION; BINDING	Wepresent an interdisciplinary approach that, by incorporating a range of experimental and computational techniques, allows the identification and characterization of functional/ immunogenic domains. This approach has been applied to ArtJ, an arginine-binding protein whose orthologs in Chlamydiae trachomatis (CT ArtJ) and pneumoniae (CPn ArtJ) are shown to have different immunogenic properties despite a high sequence similarity (60% identity). We have solved the crystallographic structures of CT ArtJ and CPn ArtJ, which are found to display a type II transporter fold organized in two alpha-beta domains with the arginine-binding region at their interface. Although ArtJ is considered to belong to the periplasm, we found that both domains contain regions exposed on the bacterial surface. Moreover, we show that recombinant ArtJ binds to epithelial cells in vitro, suggesting a role for ArtJ in host-cell adhesion during Chlamydia infection. Experimental epitope mapping and computational analysis of physicochemical determinants of antibody recognition revealed that immunogenic epitopes reside mainly in the terminal (D1) domain of both CPn and CT ArtJ, whereas the surface properties of the respective binding-prone regions appear sufficiently different to assume divergent immunogenic behavior. Neutralization assays revealed that sera raised against CPn ArtJ D1 partially reduce both CPn and CT infectivity in vitro, suggesting that functional antibodies directed against this domain may potentially impair chlamydial infectivity. These findings suggest that the approach presented here, combining functional and structure-based analyses of evolutionary-related antigens can be a valuable tool for the identification of cross-species immunogenic epitopes for vaccine development.	[Soriani, Marco; Grifantini, Renata; Petracca, Roberto; Gancitano, Giovanni; Frigimelica, Elisabetta; Nardelli, Filomena; Grandi, Guido] Novartis Vaccines, I-53100 Siena, Italy; [Petit, Pierre; Garcia, Christel; Vuillard, Laurent] Univ Aix Marseille 1, BioXtal Struct Biol Unit, F-13288 Marseille 09, France; [Spinelli, Silvia] Univ Aix Marseille 1, AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Spinelli, Silvia] Univ Aix Marseille 2, AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Petit, Pierre; Garcia, Christel; Vuillard, Laurent] Univ Aix Marseille 2, BioXtal Struct Biol Unit, F-13288 Marseille 09, France; [Fiorucci, Sebastien; Zacharias, Martin] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Affentranger, Roman; Ferrer-Navarro, Mario; Daura, Xavier] Univ Autonoma Barcelona, IBB, Bellaterra 08193, Spain; [Daura, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain	Novartis; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Jacobs University; Autonomous University of Barcelona; ICREA	Grandi, G (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	guido.grandi@novartis.com	Colombo, Giorgio/A-2730-2012; Fiorucci, Sebastien/A-2060-2010; Daura, Xavier/C-9275-2009; Renata, Grifantini/AAB-9969-2022; Fiorucci, Stefano/I-1251-2012	Colombo, Giorgio/0000-0002-1318-668X; Fiorucci, Sebastien/0000-0003-2245-0478; Daura, Xavier/0000-0001-9235-6730; Renata, Grifantini/0000-0003-0024-3355; Grandi, Guido/0000-0001-9724-2185; SORIANI, Marco/0000-0002-9752-5844; Ferrer-Navarro, Mario/0000-0001-9990-914X	European Union [LSHB-CT-2006-037325]; ICREA Funding Source: Custom	European Union(European Commission); ICREA(ICREA)	This work was supported by Sixth Research Framework Programme of the European Union Ref. LSHB-CT-2006-037325, BacAbs.	Affentranger R, 2006, J CHEM THEORY COMPUT, V2, P217, DOI 10.1021/ct050250b; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Fiorucci S, 2010, BIOPHYS J, V98, P1921, DOI 10.1016/j.bpj.2009.12.4332; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; GOURLAY LJ, 2009, HUM VACCIN, V5, P1; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2005, Journal of Structural and Functional Genomics, V6, P89, DOI 10.1007/s10969-005-3084-1; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-9-RESEARCH0033; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meoni E, 2009, INFECT IMMUN, V77, P4168, DOI 10.1128/IAI.00344-09; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Morra G, 2008, PROTEINS, V72, P660, DOI 10.1002/prot.21963; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarabelli G, 2010, BIOPHYS J, V98, P1966, DOI 10.1016/j.bpj.2010.01.014; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tiana G, 2004, PROTEIN SCI, V13, P113, DOI 10.1110/ps.03223804; Vahedi-Faridi A, 2008, J MOL BIOL, V375, P448, DOI 10.1016/j.jmb.2007.10.049; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	32	34	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30126	30138		10.1074/jbc.M110.118513	http://dx.doi.org/10.1074/jbc.M110.118513			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20592031	Green Published, hybrid			2022-12-27	WOS:000281984300050
J	Riemer, AB; Keskin, DB; Zhang, GL; Handley, M; Anderson, KS; Brusic, V; Reinhold, B; Reinherz, EL				Riemer, Angelika B.; Keskin, Derin B.; Zhang, Guanglan; Handley, Maris; Anderson, Karen S.; Brusic, Vladimir; Reinhold, Bruce; Reinherz, Ellis L.			A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2(+) Epithelial Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HLA CLASS-I; CERVICAL INTRAEPITHELIAL NEOPLASIA; MAJOR HISTOCOMPATIBILITY COMPLEX; TYPE-16 E6; HIGH-GRADE; IMMUNE-RESPONSES; CTL EPITOPES; E5 PROTEIN; ANTIGEN PRESENTATION; BINDING PREDICTION	Human Papillomavirus 16 (HPV-16) has been identified as the causative agent of 50% of cervical cancers and many other HPV-associated tumors. The transforming potential/tumor maintenance capacity of this high risk HPV is mediated by two viral oncoproteins, E6 and E7, making them attractive targets for therapeutic vaccines. Of 21 E6 and E7 peptides computed to bind HLA-A*0201, 10 were confirmed through TAP-deficient T2 cell HLA stabilization assay. Those scoring positive were investigated to ascertain which were naturally processed and presented by surface HLA molecules for CTL recognition. Because IFN gamma ELISpot frequencies from healthy HPV-exposed blood donors against HLA-A*0201-binding peptides were unable to identify specificities for tumor targeting, their physical presence among peptides eluted from HPV-16-transformed epithelial tumor HLA-A*0201 immunoprecipitates was analyzed by MS3 Poisson detection mass spectrometry. Only one epitope (E7(11-19)) highly conserved among HPV-16 strains was detected. This 9-mer serves to direct cytolysis by T cell lines, whereas a related 10-mer (E7(11-20)), previously used as a vaccine candidate, was neither detected by MS3 on HPV-transformed tumor cells nor effectively recognized by 9-mer specific CTL. These data underscore the importance of precisely defining CTL epitopes on tumor cells and offer a paradigm for T cell-based vaccine design.	[Riemer, Angelika B.; Keskin, Derin B.; Handley, Maris; Reinhold, Bruce; Reinherz, Ellis L.] Harvard Univ, Sch Med, Immunobiol Lab, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; [Riemer, Angelika B.; Zhang, Guanglan; Handley, Maris; Anderson, Karen S.; Brusic, Vladimir; Reinhold, Bruce; Reinherz, Ellis L.] Harvard Univ, Sch Med, Canc Vaccine Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Reinherz, EL (corresponding author), Harvard Univ, Sch Med, Immunobiol Lab, Dana Farber Canc Inst,Dept Med Oncol, HIM 419,4 Blackfan Circle, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu	Brusic, Vladimir/B-1478-2008	Brusic, Vladimir/0000-0003-0523-5266; Anderson, Karen/0000-0002-3870-5730; Riemer, Angelika/0000-0002-5865-0714	Erwin Schrodinger Fellowship	Erwin Schrodinger Fellowship	Supported by an Erwin Schrodinger Fellowship of the Austrian Science Fund. Present address: Dept. of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.	[Anonymous], [No title captured]; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; Ashrafi GH, 2006, INT J CANCER, V119, P2105, DOI 10.1002/ijc.22089; BENACERRAF B, 1992, NOBEL LECT PHYSL MED, P597; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BOURGAULT VI, 2004, CANCER RES, V64, P8761; Brady CS, 2000, TISSUE ANTIGENS, V55, P401, DOI 10.1034/j.1399-0039.2000.550502.x; Brusic V, 2005, EXPERT REV VACCINES, V4, P407, DOI 10.1586/14760584.4.3.407; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Cento V, 2009, J MED VIROL, V81, P1627, DOI 10.1002/jmv.21552; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Davy CE, 2006, VIROLOGY, V349, P230, DOI 10.1016/j.virol.2006.02.024; DE GROOT AS, 2004, METHODS, V34, P425; Derkay CS, 2005, ANN OTO RHINOL LARYN, V114, P730, DOI 10.1177/000348940511400913; Devaraj K, 2003, CRIT REV ORAL BIOL M, V14, P345, DOI 10.1177/154411130301400505; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Einstein MH, 2007, GYNECOL ONCOL, V106, P453, DOI 10.1016/j.ygyno.2007.04.038; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Fiander AN, 2006, INT J GYNECOL CANCER, V16, P1075, DOI 10.1111/j.1525-1438.2006.00598.x; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Gallagher KME, 2007, J GEN VIROL, V88, P1470, DOI 10.1099/vir.0.82558-0; Gao Su-qing, 2009, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V26, P228, DOI 10.3760/cma.j.issn.1003-9406.2009.02.025; Garcia-Hernandez E, 2006, CANCER GENE THER, V13, P592, DOI 10.1038/sj.cgt.7700937; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Hallez S, 2004, CANCER IMMUNOL IMMUN, V53, P642, DOI 10.1007/s00262-004-0501-4; Hara M, 2005, INT J ONCOL, V27, P1371; HAUSEN HZ, 1977, CURR TOP MICROBIOL, P1; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002; Kadish AS, 1997, J NATL CANCER I, V89, P1285, DOI 10.1093/jnci/89.17.1285; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; KAST WM, 1994, J IMMUNOL, V152, P3904; KAST WM, 1993, J IMMUNOTHER, V14, P115, DOI 10.1097/00002371-199308000-00006; Kather A, 2003, INT J CANCER, V104, P345, DOI 10.1002/ijc.10940; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lee JH, 2004, P NATL ACAD SCI USA, V101, P2094, DOI 10.1073/pnas.0308615100; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Leggatt GR, 2007, CURR OPIN IMMUNOL, V19, P232, DOI 10.1016/j.coi.2007.01.004; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; McIntosh PB, 2008, J VIROL, V82, P8196, DOI 10.1128/JVI.00509-08; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Muderspach L, 2000, CLIN CANCER RES, V6, P3406; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nakagawa M, 2004, CLIN DIAGN LAB IMMUN, V11, P889, DOI 10.1128/CDLI.11.5.889-896.2004; Nakagawa M, 2007, J VIROL, V81, P1412, DOI 10.1128/JVI.01768-06; O'Brien PM, 2002, VIRUS RES, V88, P103, DOI 10.1016/S0168-1702(02)00123-5; Oerke S, 2005, INT J CANCER, V114, P766, DOI 10.1002/ijc.20794; Palefsky JM, 2006, AIDS, V20, P1151, DOI 10.1097/01.aids.0000226955.02719.26; PARKIN J, 1906, ANN ROY BOT GARD, V3, P11; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Peng SW, 2007, CLIN CANCER RES, V13, P2479, DOI 10.1158/1078-0432.CCR-06-2916; Piersma SJ, 2008, INT J CANCER, V122, P486, DOI 10.1002/ijc.23162; Printz Carrie, 2009, Cancer, V115, P5130, DOI 10.1002/cncr.24728; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Ramqvist T, 2007, EXPERT OPIN BIOL TH, V7, P997, DOI 10.1517/14712598.7.7.997; RESSING ME, 1995, J IMMUNOL, V154, P5934; Ressing ME, 2000, J IMMUNOTHER, V23, P255, DOI 10.1097/00002371-200003000-00010; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Roden RBS, 2004, HUM PATHOL, V35, P971, DOI 10.1016/j.humpath.2004.04.007; Rudolf MP, 2001, CLIN CANCER RES, V7, p788S; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sarkar AK, 2005, GYNECOL ONCOL, V99, pS251, DOI 10.1016/j.ygyno.2005.07.099; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; Steller MA, 1998, CLIN CANCER RES, V4, P2103; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; VAN DEN HENDE M, 2008, INT J CANCER, V123, P146; VAN DER BURG SH, 2001, INT J CANCER, V91, P612; VAN DRIEL WJ, 1999, EUR J CANCER, V35, P946; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; Villada IB, 2000, EUR J IMMUNOL, V30, P2281, DOI 10.1002/1521-4141(2000)30:8<2281::AID-IMMU2281>3.0.CO;2-N; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; Warrino DE, 2004, CLIN CANCER RES, V10, P3301, DOI 10.1158/1078-0432.CCR-03-0498; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Zhang BY, 2003, VIROLOGY, V310, P100, DOI 10.1016/S0042-6822(03)00103-X; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	94	53	59	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29608	29622		10.1074/jbc.M110.126722	http://dx.doi.org/10.1074/jbc.M110.126722			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615877	Green Published, hybrid			2022-12-27	WOS:000281740100062
J	Harrington, JM; Widener, J; Stephens, N; Johnson, T; Francia, M; Capewell, P; Macleod, A; Hajduk, SL				Harrington, John M.; Widener, Justin; Stephens, Natalie; Johnson, Thomas; Francia, Maria; Capewell, Paul; Macleod, Annette; Hajduk, Stephen L.			The Plasma Membrane of Bloodstream-form African Trypanosomes Confers Susceptibility and Specificity to Killing by Hydrophobic Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; VARIANT SURFACE GLYCOPROTEIN; HAPTOGLOBIN-RELATED PROTEIN; HUMAN-SERUM; LYTIC FACTOR; BRUCEI; ENDOCYTOSIS; CAPACITY; ANCHOR; ROLES	Trypanosoma brucei is the causative agent of both a veterinary wasting disease and human African trypanosomiasis, or sleeping sickness. The cell membrane of the developmental stage found within the mammalian host, the bloodstream form (BSF), is highly dynamic, exhibiting rapid rates of endocytosis and lateral flow of glycosylphosphatidylinositol-anchored proteins. Here, we show that the cell membrane of these organisms is a target for killing by small hydrophobic peptides that increase the rigidity of lipid bilayers. Specifically, we have derived trypanocidal peptides that are based upon the hydrophobic N-terminal signal sequences of human apolipoproteins. These peptides selectively partitioned into the plasma membrane of BSF trypanosomes, resulting in an increase in the rigidity of the bilayer, dramatic changes in cell motility, and subsequent cell death. No killing of the developmental stage found within the insect midgut, the procyclic form, was observed. Additionally, the peptides exhibited no toxicity toward mammalian cell lines and did not induce hemolysis. Studies with model liposomes indicated that bilayer fluidity dictates the susceptibility of membranes to manipulation by hydrophobic peptides. We suggest that the composition of the BSF trypanosome cell membrane confers a high degree of fluidity and unique susceptibility to killing by hydrophobic peptides and is therefore a target for the development of trypanocidal drugs.	[Harrington, John M.; Widener, Justin; Stephens, Natalie; Johnson, Thomas; Francia, Maria; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Capewell, Paul; Macleod, Annette] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow Biomed Res Ctr, Fac Vet Med, Glasgow G12 8TA, Lanark, Scotland	University System of Georgia; University of Georgia; University of Glasgow	Hajduk, SL (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, B129 Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Capewell, Paul/R-1935-2017	Capewell, Paul/0000-0002-8803-5034; Francia, Maria/0000-0001-9664-9573	National Institutes of Health [AI039033]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039033 (to S.L.H.).; Supported by a National Research Service Award from NIAID.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Cantor RS, 1998, TOXICOL LETT, V101, P451, DOI 10.1016/S0378-4274(98)00220-3; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Kamaraju K, 2008, BIOCHEMISTRY-US, V47, P10540, DOI 10.1021/bi801092g; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Lanteri CA, 2006, MOL PHARMACOL, V70, P1585, DOI 10.1124/mol.106.024653; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; Morgan GW, 2001, J CELL SCI, V114, P2605; Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129	34	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28659	28666		10.1074/jbc.M110.151886	http://dx.doi.org/10.1074/jbc.M110.151886			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615879	Green Published, hybrid			2022-12-27	WOS:000281594000030
J	Ding, WX; Ni, HM; Li, M; Liao, Y; Chen, XY; Stolz, DB; Dorn, GW; Yin, XM				Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Stolz, Donna B.; Dorn, Gerald W., II; Yin, Xiao-Ming			Nix Is Critical to Two Distinct Phases of Mitophagy, Reactive Oxygen Species-mediated Autophagy Induction and Parkin-Ubiquitin-p62-mediated Mitochondrial Priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ORGANELLE DEGRADATION; SELECTIVE AUTOPHAGY; SPERM MITOCHONDRIA; CELL-DEATH; MATURATION; BNIP3; CLEARANCE; UBIQUITIN; PROTEIN	Damaged mitochondria can be eliminated by autophagy, i.e. mitophagy, which is important for cellular homeostasis and cell survival. Despite the fact that a number of factors have been found to be important for mitophagy in mammalian cells, their individual roles in the process had not been clearly defined. Parkin is a ubiquitin-protein isopeptide ligase able to translocate to the mitochondria that are to be removed. We showed here in a chemical hypoxia model of mitophagy induced by an uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP) that Parkin translocation resulted in mitochondrial ubiquitination and p62 recruitment to the mitochondria. Small inhibitory RNA-mediated knockdown of p62 significantly diminished mitochondrial recognition by the autophagy machinery and the subsequent elimination. Thus Parkin, ubiquitin, and p62 function in preparing mitochondria for mitophagy, here referred to as mitochondrial priming. However, these molecules were not required for the induction of autophagy machinery. Neither Parkin nor p62 seemed to affect autophagy induction by CCCP. Instead, we found that Nix was required for the autophagy induction. Nix promoted CCCP-induced mitochondrial depolarization and reactive oxygen species generation, which inhibited mTOR signaling and activated autophagy. Nix also contributed to mitochondrial priming by controlling the mitochondrial translocation of Parkin, although reactive oxygen species generation was not involved in this step. Deletion of the C-terminal membrane targeting sequence but not mutations in the BH3 domain disabled Nix for these functions. Our work thus distinguished the molecular events responsible for the different phases of mitophagy and placed Nix upstream of the events.	[Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Yin, Xiao-Ming] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Ding, Wen-Xing; Ni, Hong-Min] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Yin, XM (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Chen, Xiaoyun/K-4786-2019; Li, Min/B-1281-2011		National Institutes of Health [R01 CA83817, R01 CA111456, R21-AA017421, P20 RR021940, P20 RR016475]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA83817 and R01 CA111456 (to X.-M. Y.) and R21-AA017421, P20 RR021940, and P20 RR016475 (to W.-X. D.).	Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	40	442	454	3	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27879	27890		10.1074/jbc.M110.119537	http://dx.doi.org/10.1074/jbc.M110.119537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573959	Green Published, hybrid			2022-12-27	WOS:000281404100043
J	Kim, TH; Sebastian, S; Pinkham, JT; Ross, RA; Blalock, LT; Kasper, DL				Kim, Tae-Hyun; Sebastian, Shite; Pinkham, Jessica T.; Ross, Robin A.; Blalock, LeeAnn T.; Kasper, Dennis L.			Characterization of the O-antigen Polymerase (Wzy) of Francisella tularensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; CHAIN-LENGTH; GENE-CLUSTER; FUNCTIONAL-CHARACTERIZATION; CAPSULAR POLYSACCHARIDES	The O-antigen polymerase of Gram-negative bacteria has been difficult to characterize. Herein we report the biochemical and functional characterization of the protein product (Wzy) of the gene annotated as the putative O-antigen polymerase, which is located in the O-antigen biosynthetic locus of Francisella tularensis. In silico analysis (homology searching, hydropathy plotting, and codon usage assessment) strongly suggested that Wzy is an O-antigen polymerase whose function is to catalyze the addition of newly synthesized O-antigen repeating units to a glycolipid consisting of lipid A, inner core polysaccharide, and one repeating unit of the O-polysaccharide (O-PS). To characterize the function of the Wzy protein, a non-polar deletion mutant of wzy was generated by allelic replacement, and the banding pattern of O-PS was observed by immunoblot analysis of whole-cell lysates obtained by SDS-PAGE and stained with an O-PS-specific monoclonal antibody. These immunoblot analyses showed that O-PS of the wzy mutant expresses only one repeating unit of O-antigen. Further biochemical characterization of the subcellular fractions of the wzy mutant demonstrated that (as is characteristic of O-antigen polymerase mutants) the low molecular weight O-antigen accumulates in the periplasm of the mutant. Site-directed mutagenesis based on protein homology and topology, which was carried out to locate a catalytic residue of the protein, showed that modification of specific residues (Gly(176), Asp(177), Gly(323), and Tyr(324)) leads to a loss of O-PS polymerization. Topology models indicate that these amino acids most likely lie in close proximity on the bacterial surface.	[Kim, Tae-Hyun; Sebastian, Shite; Pinkham, Jessica T.; Blalock, LeeAnn T.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Kim, Tae-Hyun; Sebastian, Shite; Ross, Robin A.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kasper, DL (corresponding author), 200 Longwood Ave, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu			National Institutes of Health New England Regional Center of Excellence [R01-AI47484]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	National Institutes of Health New England Regional Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health New England Regional Center of Excellence Grant R01-AI47484.	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; Baron G S, 1995, Methods Mol Biol, V47, P149; BATCHELOR RA, 1992, J BACTERIOL, V174, P5228, DOI 10.1128/JB.174.16.5228-5236.1992; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; FORSMAN M, 1990, APPL ENVIRON MICROB, V56, P949, DOI 10.1128/AEM.56.4.949-955.1990; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Francis E, 1925, J AMER MED ASSOC, V84, P1243, DOI 10.1001/jama.1925.02660430001001; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; KNIREL YA, 1985, EUR J BIOCHEM, V150, P541, DOI 10.1111/j.1432-1033.1985.tb09055.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lauriano CM, 2003, FEMS MICROBIOL LETT, V229, P195, DOI 10.1016/S0378-1097(03)00820-6; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; MILNE JJ, 1995, BIOCHEM J, V311, P1015, DOI 10.1042/bj3111015; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; MORONA R, 1994, J BACTERIOL, V176, P733, DOI 10.1128/jb.176.3.733-747.1994; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; OSBORN MJ, 1972, J BIOL CHEM, V247, P3973; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Sambrook J., 2002, MOL CLONING LAB MANU; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wong DKH, 1999, MICROBIOL-UK, V145, P2443, DOI 10.1099/00221287-145-9-2443; YAO ZJ, 1994, J BACTERIOL, V176, P4133, DOI 10.1128/JB.176.13.4133-4143.1994	60	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27839	27849		10.1074/jbc.M110.143859	http://dx.doi.org/10.1074/jbc.M110.143859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605777	hybrid, Green Published			2022-12-27	WOS:000281404100039
J	Lucana, DOD; Roscher, M; Honigmann, A; Schwarz, J				Lucana, Dario Ortiz de Orue; Roscher, Mareike; Honigmann, Alf; Schwarz, Julia			Iron-mediated Oxidation Induces Conformational Changes within the Redox-sensing Protein HbpS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING CHARACTERISTICS; RESONANCE ENERGY-TRANSFER; CATALASE-PEROXIDASE CPEB; STREPTOMYCES-RETICULI; CIRCULAR-DICHROISM; OXYGEN RADICALS; HEME; DITYROSINE; STRESS; FLUORESCENCE	HbpS is an extracellular oligomeric protein, which has been shown to act in concert with the two-component system SenS-SenR during the sensing of redox stress. HbpS can bind and degrade heme under oxidative stress conditions, leading to a free iron ion. The liberated iron is subsequently coordinated on the protein surface. Furthermore, HbpS has been shown to modulate the phosphorylation state of the sensor kinase SenS as, in the absence of oxidative stress conditions, HbpS inhibits SenS autophosphorylation whereas the presence of heme or iron ions and redox-stressing agents enhances it. Using HbpS wild type and mutants as well as different biochemical and biophysical approaches, we show that iron-mediated oxidative stress induces both secondary structure and overall intrinsic conformational changes within HbpS. We demonstrate in addition that HbpS is oxidatively modified, leading to the generation of highly reactive carbonyl groups and tyrosine-tyrosine bonds. Further examination of the crystal structure and subsequent mutational analyses allowed the identification of the tyrosine residue participating in dityrosine formation, which occurs between two monomers within the octomeric assembly. Therefore, it is proposed that oxidative modifications causing structural and conformational changes are responsible for the control of SenS and hence of the HbpS-SenS-SenR signaling cascade.	Univ Osnabruck, Fac Biol Chem, Dept Appl Genet Microorganisms, D-49069 Osnabruck, Germany; [Honigmann, Alf] Univ Osnabruck, Fac Biol Chem, Dept Biophys, D-49069 Osnabruck, Germany	University Osnabruck; University Osnabruck	Lucana, DOD (corresponding author), Barbarastr 13, D-49069 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	; Honigmann, Alf/C-4832-2017	Schwarz, Julia/0000-0002-7227-6730; Honigmann, Alf/0000-0003-0475-3790	Deutsche Forschungsgemeinschaft (DFG) [OR 224/1-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Grant OR 224/1-3 from the Deutsche Forschungsgemeinschaft (DFG).	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DiMarco T, 2007, MASS SPECTROM REV, V26, P108, DOI 10.1002/mas.20109; Ding F, 2003, PROTEINS, V53, P220, DOI 10.1002/prot.10468; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; Hagelueken G., 2009, ANGEW CHEM INT EDIT, V121, P2948, DOI DOI 10.1002/ange.200805758; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hopwood D.A., 1985, GENETIC MANIPULATION; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KIM K, 1985, J BIOL CHEM, V260, P5394; KUNGL AJ, 1994, BIOPHYS J, V67, P309, DOI 10.1016/S0006-3495(94)80482-5; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2005, MICROBIOL-SGM, V151, P3603, DOI 10.1099/mic.0.28298-0; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Nishimura C, 2000, J MOL BIOL, V299, P1133, DOI 10.1006/jmbi.2000.3804; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Rintala H, 2001, MOL CELL PROBE, V15, P337, DOI 10.1006/mcpr.2001.0379; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sambrook J., 2006, CONDENSED PROTOCOLS; Sambrook J, 1989, MOL CLONING LABORATO; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SREEREMA N, 2000, ANAL BIOCHEM, V287, P52; SREEREMA N, 2003, SCIENCE, V12, P384; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Steinhoff HJ, 2004, BIOL CHEM, V385, P913, DOI 10.1515/BC.2004.119; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; VILLAREJO M, 1972, J BIOL CHEM, V247, P2212; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Zou P, 2008, ACTA CRYSTALLOGR E, V64, pO2215, DOI 10.1107/S160053680803465X	49	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28086	28096		10.1074/jbc.M110.127506	http://dx.doi.org/10.1074/jbc.M110.127506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20571030	Green Published, hybrid			2022-12-27	WOS:000288742300007
J	Mandapathil, M; Szczepanski, MJ; Szajnik, M; Ren, J; Jackson, EK; Johnson, JT; Gorelik, E; Lang, S; Whiteside, TL				Mandapathil, Magis; Szczepanski, Miroslaw J.; Szajnik, Marta; Ren, Jin; Jackson, Edwin K.; Johnson, Jonas T.; Gorelik, Elieser; Lang, Stephan; Whiteside, Theresa L.			Adenosine and Prostaglandin E-2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PERIPHERAL-BLOOD; TYPE-1 CELLS; EXPRESSION; RECEPTORS; CANCER; HEAD; NECK; CYCLOOXYGENASE-2; CARCINOMA	Adaptive regulatory T cells (Tr1) are induced in the periphery upon encountering cognate antigens. In cancer, their frequency is increased; however, Tr1-mediated suppression mechanisms are not yet defined. Here, we evaluate the simultaneous involvement of ectonucleotidases (CD39/CD73) and cyclooxygenase 2 (COX-2) in Tr1-mediated suppression. Human Tr1 cells were generated from peripheral blood mononuclear cell-derived, sorted CD4(+)CD25(-) T cells and incubated with autologous immature dendritic cells, irradiated COX-2(+) or COX-2(-) tumor cells, and IL-2, IL-10, and IL-15 (each at 10-15 IU/ml) for 10 days as described (Bergmann, C., Strauss, L., Zeidler, R., Lang, S., and Whiteside, T. L. (2007) Cancer Immunol. Immunother. 56, 1429-1442). Tr1 were phenotyped by multicolor flow cytometry, and suppression of proliferating responder cells was assessed in carboxyfluorescein diacetate succinimidyl ester-based assays. ATP hydrolysis was measured using a luciferase detection assay, and levels of adenosine or prostaglandin E-2 (PGE(2)) in cell supernatants were analyzed by mass spectrometry or ELISA, respectively. Intracellular cAMP levels were measured by enzyme immunoassay. The COX-2(+) tumor induced a greater number of Tr1 than COX-2(-) tumor (p < 0.05). Tr1 induced by COX-2(+) tumor were more suppressive, hydrolyzed more exogenous ATP (p < 0.05), and produced higher levels of adenosine and PGE(2) (p < 0.05) than Tr1 induced by COX-2(-) tumor. Inhibitors of ectonucleotidase activity, A(2A) and EP2 receptor antagonists, or an inhibitor of the PKA type I decreased Tr1-mediated suppression (p < 0.05), whereas rolipram, a PDE4 inhibitor, increased the intracellular cAMP level in responder cells and their susceptibility to Tr1-mediated suppression. Tr1 present in tumors or the peripheral blood of head and neck squamous cell carcinoma patients co-expressed COX-2, CD39, and CD73. A concomitant inhibition of PGE(2) and adenosine via the common intracellular cAMP pathway might be a novel approach for improving results of immune therapies for cancer.	[Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Ren, Jin; Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15219 USA; [Johnson, Jonas T.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Mandapathil, Magis; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45127 Essen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavilion 5117 Ctr Ave,Suite 1-27, Pittsburgh, PA 15213 USA.	whitesidetl@upmc.edu	Mandapathil, Magis/AFL-3260-2022	Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [PO1 CA109688]; Philip Morris International; Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program; United States Department of Defense IDEA [W81XWH-06-1-0498]; Hillman Foundation; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris International; Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program; United States Department of Defense IDEA(United States Department of Defense); Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA109688 (to T. L. W.). This work was also supported by Philip Morris International and the Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program (to M. M.) and by United States Department of Defense IDEA Award W81XWH-06-1-0498 and Hillman Foundation grants (to E. G.).	Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Bergmann C, 2007, CANCER IMMUNOL IMMUN, V56, P1429, DOI 10.1007/s00262-007-0280-9; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Czystowska M, 2010, J MOL MED, V88, P577, DOI 10.1007/s00109-010-0602-9; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Denkert Carsten, 2004, Clin Breast Cancer, V4, P428, DOI 10.3816/CBC.2004.n.006; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Duarte MMF, 2007, FEBS J, V274, P2707, DOI 10.1111/j.1742-4658.2007.05805.x; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harris Randall E, 2007, Subcell Biochem, V42, P93; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HEO DS, 1989, CANCER RES, V49, P5167; JOHNSON KW, 1988, P NATL ACAD SCI USA, V85, P6072, DOI 10.1073/pnas.85.16.6072; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Mahic M, 2006, J IMMUNOL, V177, P246, DOI 10.4049/jimmunol.177.1.246; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Marra LE, 2004, J IMMUNOL, V172, P1028, DOI 10.4049/jimmunol.172.2.1028; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mrena J, 2005, CLIN CANCER RES, V11, P7362, DOI 10.1158/1078-0432.CCR-05-0764; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Schaefer U, 2007, J PHARMACOL EXP THER, V322, P1269, DOI 10.1124/jpet.107.125328; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Su YY, 2008, CANCER IMMUNOL IMMUN, V57, P1611, DOI 10.1007/s00262-008-0494-5; TAKAYAMA H, 1989, J PHARM SCI, V78, P8, DOI 10.1002/jps.2600780104; Torgersen KM, 1997, J BIOL CHEM, V272, P5495, DOI 10.1074/jbc.272.9.5495; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wolf AM, 2003, CLIN CANCER RES, V9, P606	44	117	128	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27571	27580		10.1074/jbc.M110.127100	http://dx.doi.org/10.1074/jbc.M110.127100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558731	hybrid, Green Published			2022-12-27	WOS:000281404100012
J	Melillo, AA; Bakshi, CS; Melendez, JA				Melillo, Amanda A.; Bakshi, Chandra Shekhar; Melendez, J. Andres			Francisella tularensis Antioxidants Harness Reactive Oxygen Species to Restrict Macrophage Signaling and Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; FACTOR-KAPPA-B; REVERSIBLE OXIDATION; REDOX REGULATION; IMMUNE-RESPONSE; DOWN-REGULATION; IFN-GAMMA; TNF-ALPHA; INACTIVATION; VIRULENCE	Francisella tularensis is the etiologic agent of the highly infectious animal and human disease tularemia. Its extreme infectivity and virulence are associated with its ability to evade immune detection, which we now link to its robust reactive oxygen species-scavenging capacity. Infection of primary human monocyte-derived macrophages with virulent F. tularensis SchuS4 prevented proinflammatory cytokine production in the presence or absence of IFN-gamma compared with infection with the attenuated live vaccine strain. SchuS4 infection also blocked signals required for macrophage cytokine production, including Akt phosphorylation, I kappa B alpha degradation, and NF-kappa B nuclear localization and activation. Concomitant with SchuS4-mediated suppression of Akt phosphorylation was an increase in the levels of the Akt antagonist PTEN. Moreover, SchuS4 prevented the H2O2-dependent oxidative inactivation of PTEN compared with a virulent live vaccine strain. Mutation of catalase (katG) sensitized F. tularensis to H2O2 and enhanced PTEN oxidation, Akt phosphorylation, NF-kappa B activation, and inflammatory cytokine production. Together, these findings suggest a novel role for bacterial antioxidants in restricting macrophage activation through their ability to preserve phosphatases that temper kinase signaling and proinflammatory cytokine production.	[Melillo, Amanda A.; Bakshi, Chandra Shekhar; Melendez, J. Andres] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Melendez, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Mail Code 151,47 New Scotland Ave, Albany, NY 12208 USA.	melenda@mail.amc.edu		Melendez, Juan/0000-0001-8021-3097	National Institutes of Health [2P01AI056320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P01AI056320.	ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Claiborne A, 1985, CRC HDB METHODS OXYG, P283; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Flaherty DM, 2006, J BIOL CHEM, V281, P5058, DOI 10.1074/jbc.M508997200; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hrstka R, 2007, FOLIA MICROBIOL, V52, P631, DOI 10.1007/BF02932193; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	39	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27553	27560		10.1074/jbc.M110.144394	http://dx.doi.org/10.1074/jbc.M110.144394			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558723	Green Published, hybrid			2022-12-27	WOS:000281404100010
J	Cho, SJ; Chen, XB				Cho, Seong Jun; Chen, Xinbin			Myosin VI Is Differentially Regulated by DNA Damage in p53-and Cell Type-dependent Manners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; MOTOR PROPERTIES; PROSTATE-CANCER; IN-VIVO; P53; MIGRATION; INVASION; GOLGI; PHOSPHORYLATION; TRANSCRIPTION	Myosin VI is an unconventional motor protein and functions in a variety of intracellular processes such as cell migration, vesicular trafficking, and homeostasis of the Golgi complex. Previously, we found that myosin VI is up-regulated in RKO, LS174T, and H1299 cells by DNA damage in a p53-dependent manner and mediates the pro-survival function of p53. Here, we showed that the levels of myosin VI protein were markedly inhibited in MCF7 and LNCaP cells by topoisomerase I-II inhibitors. However, the levels of myosin VI transcript were decreased only by topoisomerase I inhibitors. We also found that the levels of myosin VI protein were markedly inhibited in MCF7 cells by wild-type p53 but not tumor-derived mutant p53. Surprisingly, we found that the level of myosin VI transcript was slightly increased instead of decreased in MCF7 cells by p53, suggesting that a mechanism other than transcriptional repression is involved. Additionally, we found that on the myosin VI promoter, the level of acetylated histone H3 was markedly decreased, whereas that of p53 and acetylated histone H4 was slightly increased in MCF7 cells upon treatment with topoisomerase I-II inhibitors. Finally, we showed that overexpression of myosin VI enhances, whereas knockdown of myosin VI decreases, DNA damage-induced stabilization of p53, and consequently, knockdown of myosin VI de-sensitizes MCF7 cells to DNA damage-induced apoptosis. Taken together, as a mediator of the p53 pro-survival pathway and a marker of malignancy in some tumors, differential regulation of myosin VI in various tumor cells by topoisomerase inhibitors dictates whether knockdown of myosin VI inhibits, rather than enhances, the susceptibility of tumor cells to some therapeutic agents, which might be explored for designing a proper therapeutic strategy.	[Cho, Seong Jun; Chen, Xinbin] Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Canc Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Canc Ctr, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health [CA121137, CA076069]; NATIONAL CANCER INSTITUTE [R01CA121137, R29CA076069, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121137 and CA076069.	Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CUMMINGS J, 1993, ANN ONCOL, V4, P533, DOI 10.1093/oxfordjournals.annonc.a058584; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Gadea G, 2004, J CELL SCI, V117, P6355, DOI 10.1242/jcs.01566; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hodge T, 2000, J CELL SCI, V113, P3353; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Morris CA, 2003, J BIOL CHEM, V278, P23324, DOI 10.1074/jbc.M208957200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; Rene B, 2007, BIOCHIMIE, V89, P508, DOI 10.1016/j.biochi.2007.02.011; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Tamaki K, 2008, NEUROSCI LETT, V433, P183, DOI 10.1016/j.neulet.2007.12.062; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zhu JH, 1998, CANCER RES, V58, P5061	42	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27159	27166		10.1074/jbc.M110.142117	http://dx.doi.org/10.1074/jbc.M110.142117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576604	Green Published, hybrid			2022-12-27	WOS:000281172700046
J	Pastrana-Mena, R; Dinglasan, RR; Franke-Fayard, B; Vega-Rodriguez, J; Fuentes-Caraballo, M; Baerga-Ortiz, A; Coppens, I; Jacobs-Lorena, M; Janse, CJ; Serrano, AE				Pastrana-Mena, Rebecca; Dinglasan, Rhoel R.; Franke-Fayard, Blandine; Vega-Rodriguez, Joel; Fuentes-Caraballo, Mariela; Baerga-Ortiz, Abel; Coppens, Isabelle; Jacobs-Lorena, Marcelo; Janse, Chris J.; Serrano, Adelfa E.			Glutathione Reductase-null Malaria Parasites Have Normal Blood Stage Growth but Arrest during Development in the Mosquito	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT PLASMODIUM-FALCIPARUM; HIGH-EFFICIENCY TRANSFECTION; METHYLENE-BLUE; INFECTED ERYTHROCYTES; IN-VIVO; THIOREDOXIN SYSTEM; OXIDATIVE STRESS; INTRACELLULAR GLUTATHIONE; DIHYDROFOLATE-REDUCTASE; DISULFIDE REDUCTASES	Malaria parasites contain a complete glutathione (GSH) redox system, and several enzymes of this system are considered potential targets for antimalarial drugs. Through generation of a gamma-glutamylcysteine synthetase (gamma-GCS)-null mutant of the rodent parasite Plasmodium berghei, we previously showed that de novo GSH synthesis is not critical for blood stage multiplication but is essential for oocyst development. In this study, phenotype analyses of mutant parasites lacking expression of glutathione reductase (GR) confirmed that GSH metabolism is critical for the mosquito oocyst stage. Similar to what was found for gamma-GCS, GR is not essential for blood stage growth. GR-null parasites showed the same sensitivity to methylene blue and eosin B as wild type parasites, demonstrating that these compounds target molecules other than GR in Plasmodium. Attempts to generate parasites lacking both GR and gamma-GCS by simultaneous disruption of gr and gamma-gcs were unsuccessful. This demonstrates that the maintenance of total GSH levels required for blood stage survival is dependent on either de novo GSH synthesis or glutathione disulfide (GSSG) reduction by Plasmodium GR. Our studies provide new insights into the role of the GSH system in malaria parasites with implications for the development of drugs targeting GSH metabolism.	[Pastrana-Mena, Rebecca; Vega-Rodriguez, Joel; Fuentes-Caraballo, Mariela; Serrano, Adelfa E.] Univ Puerto Rico, Sch Med, Dept Microbiol, San Juan, PR 00936 USA; [Baerga-Ortiz, Abel] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Dinglasan, Rhoel R.; Coppens, Isabelle; Jacobs-Lorena, Marcelo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ Med Ctr, Ctr Infect Dis, Dept Parasitol, Leiden Malaria Res Grp, NL-2333 ZA Leiden, Netherlands	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Leiden University; Leiden University Medical Center (LUMC)	Serrano, AE (corresponding author), Univ Puerto Rico, Sch Med, Dept Microbiol, POB 365067, San Juan, PR 00936 USA.	adelfa.serrano@upr.edu		, Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205; Dinglasan, Rhoel/0000-0001-6563-1506; Dinglasan, Rhoel/0000-0001-5433-8179	National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS) [GM08224]; National Center for Research Resources Research Centers in Minority Institutions [G12RR03051]; MBRS/Research Initiative for Scientific Enhancement [R25GM061838]; National Institutes of Health [9 T37 MD001477-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [T37MD001477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MBRS/Research Initiative for Scientific Enhancement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS) Grant GM08224 and National Center for Research Resources Research Centers in Minority Institutions Grant G12RR03051.; Supported in part by MBRS/Research Initiative for Scientific Enhancement Grant R25GM061838.; Supported in part by National Institutes of Health MHIRT Award 9 T37 MD001477-05.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Arora K, 2005, PARASITOL RES, V97, P521, DOI 10.1007/s00436-005-1478-4; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Atreya CE, 2003, J BIOL CHEM, V278, P14092, DOI 10.1074/jbc.M212690200; Ayi K, 1998, FEBS LETT, V424, P257, DOI 10.1016/S0014-5793(98)00185-9; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; Birago C, 1999, MOL BIOCHEM PARASIT, V99, P33, DOI 10.1016/S0166-6851(98)00179-0; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; ELFERINK RPJO, 1990, AM J PHYSIOL, V258, pG699, DOI 10.1152/ajpgi.1990.258.5.G699; ENEA V, 1984, P NATL ACAD SCI-BIOL, V81, P7520, DOI 10.1073/pnas.81.23.7520; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Friebolin W, 2008, J MED CHEM, V51, P1260, DOI 10.1021/jm7009292; Gallo V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007303; Garavito G, 2007, PARASITE, V14, P135, DOI 10.1051/parasite/2007142135; Gilberger TW, 2000, MOL BIOCHEM PARASIT, V107, P169, DOI 10.1016/S0166-6851(00)00188-2; Grellier P, 2001, ARCH BIOCHEM BIOPHYS, V393, P199, DOI 10.1006/abbi.2001.2487; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Janse CJ, 2003, MOL MICROBIOL, V50, P1539, DOI 10.1046/j.1365-2958.2003.03820.x; JANSE CJ, 1994, INT J PARASITOL, V24, P589, DOI 10.1016/0020-7519(94)90150-3; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; KELNER MJ, 1985, J BIOL CHEM, V260, P5168; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; KRAUTHSIEGEL RL, 1989, BIOCHEM SOC T, V17, P315, DOI 10.1042/bst0170315; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Massimine KM, 2006, ANTIMICROB AGENTS CH, V50, P3132, DOI 10.1128/AAC.00621-06; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Meierjohann S, 2002, BIOCHEM J, V363, P833, DOI 10.1042/0264-6021:3630833; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Muller S, 2001, PROTOPLASMA, V217, P43, DOI 10.1007/BF01289412; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; Ponzi M, 2009, CELL MICROBIOL, V11, P1272, DOI 10.1111/j.1462-5822.2009.01331.x; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Rodrigues JR, 2009, PARASITOL RES, V104, P1491, DOI 10.1007/s00436-009-1355-7; Rodriguez JF, 1998, PEDIATR INFECT DIS J, V17, P236, DOI 10.1097/00006454-199803000-00012; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P32; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; SINDEN RE, 1997, MOL BIOL INSECT DIS, P261; SINDEN RE, 1978, RODENT MALARIA, P1; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Srinivasan P, 2008, CELL MICROBIOL, V10, P1304, DOI 10.1111/j.1462-5822.2008.01127.x; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Taraschi TF, 2001, INT J PARASITOL, V31, P1381, DOI 10.1016/S0020-7519(01)00256-9; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Wiser MF, 1996, MOL BIOCHEM PARASIT, V83, P25, DOI 10.1016/S0166-6851(96)02743-0; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; WORTHINGTON DJ, 1974, EUR J BIOCHEM, V48, P167, DOI 10.1111/j.1432-1033.1974.tb03754.x; Zhang JM, 1999, MOL BIOCHEM PARASIT, V99, P129, DOI 10.1016/S0166-6851(99)00008-0; Zuluaga L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-47	81	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27045	27056		10.1074/jbc.M110.122275	http://dx.doi.org/10.1074/jbc.M110.122275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573956	hybrid, Green Published			2022-12-27	WOS:000281172700036
J	Saharia, A; Teasley, DC; Duxin, JP; Dao, B; Chiappinelli, KB; Stewart, SA				Saharia, Abhishek; Teasley, Daniel C.; Duxin, Julien P.; Dao, Benjamin; Chiappinelli, Katherine B.; Stewart, Sheila A.			FEN1 Ensures Telomere Stability by Facilitating Replication Fork Re-initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; DNA-REPLICATION; FLAP ENDONUCLEASE-1; WERNER-SYNDROME; WRN HELICASE; HOMOLOGOUS RECOMBINATION; SUBSTRATE-BINDING; FRAGILE SITES; BLM HELICASE; G4 DNA	Telomeres are terminal repetitive DNA sequences whose stability requires the coordinated actions of telomere-binding proteins and the DNA replication and repair machinery. Recently, we demonstrated that the DNA replication and repair protein Flap endonuclease 1 (FEN1) is required for replication of lagging strand telomeres. Here, we demonstrate for the first time that FEN1 is required for efficient re-initiation of stalled replication forks. At the telomere, we find that FEN1 depletion results in replicative stress as evidenced by fragile telomere expression and sister telomere loss. We show that FEN1 participation in Okazaki fragment processing is not required for efficient telomere replication. Instead we find that FEN1 gap endonuclease activity, which processes DNA structures resembling stalled replication forks, and the FEN1 interaction with the RecQ helicases are vital for telomere stability. Finally, we find that FEN1 depletion neither impacts cell cycle progression nor in vitro DNAreplication through non-telomeric sequences. Our finding that FEN1 is required for efficient replication fork re-initiation strongly suggests that the fragile telomere expression and sister telomere losses observed upon FEN1 depletion are the direct result of replication fork collapse. Together, these findings suggest that other nucleases compensate for FEN1 loss throughout the genome during DNA replication but fail to do so at the telomere. We propose that FEN1 maintains stable telomeres by facilitating replication through the G-rich lagging strand telomere, thereby ensuring high fidelity telomere replication.	[Saharia, Abhishek; Teasley, Daniel C.; Duxin, Julien P.; Dao, Benjamin; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Chiappinelli, Katherine B.] Washington Univ, Sch Med, Dept Surg, Div Endocrine & Oncol Surg, St Louis, MO 63110 USA; [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	sheila.stewart@wustl.edu		Stewart, Sheila/0000-0002-2260-9576	Children's Discovery Institute; Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant [T32 GM007067-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Children's Discovery Institute (to S. A. S.) and Cellular, Biochemical, and Molecular Sciences Predoctoral Training Grant T32 GM007067-35 (to D. C. T.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Brush GS, 1995, METHOD ENZYMOL, V262, P522; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Moreau S, 2001, GENETICS, V159, P1423; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Stucki M, 2001, PROG NUCLEIC ACID RE, V65, P261; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Undarmaa B, 2004, BIOCHEM BIOPH RES CO, V315, P51, DOI 10.1016/j.bbrc.2004.01.014; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wu L, 2002, MUTAT RES-FUND MOL M, V509, P35, DOI 10.1016/S0027-5107(02)00225-7; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	61	50	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27057	27066		10.1074/jbc.M110.112276	http://dx.doi.org/10.1074/jbc.M110.112276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551483	Green Published, hybrid			2022-12-27	WOS:000281172700037
J	Winarski, KL; Sheng, N; Chen, JX; Kleyman, TR; Sheng, SH				Winarski, Katie L.; Sheng, Nan; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu			Extracellular Allosteric Regulatory Subdomain within the gamma Subunit of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELF-INHIBITION; HISTIDINE-RESIDUES; ENAC; ACTIVATION; SITES; FURIN; SELECTIVITY; TRANSPORT; PROTEASES	The activity of the epithelial Na+ channel (ENaC) is modulated by Na+ self-inhibition, a down-regulation of the open probability of ENaC by extracellular Na+. A His residue within the extracellular domain of gamma ENaC (gamma His(239)) was found to have a critical role in Na+ self-inhibition. We investigated the functional roles of residues in the vicinity of this His by mutagenesis and analyses of Na+ self-inhibition responses in Xenopus oocytes. Significant changes in the speed and magnitude of Na+ self-inhibition were observed in 16 of the 47 mutants analyzed. These 16 mutants were distributed within a 22-residue tract. We further characterized this scanned region by examining the accessibility of introduced Cys residues to the sulfhydryl reagent MTSET. External MTSET irreversibly increased or decreased currents in 13 of 47 mutants. The distribution patterns of the residues where substitutions significantly altered Na+ self-inhibition or/and conferred sensitivity to MTSET were consistent with the existence of two helices within this region. In addition, single channel recordings of the gamma H239F mutant showed that, in the absence of Na+ self-inhibition and with an increased open probability, ENaCs still undergo transitions between open and closed states. We conclude that gamma His(239) functions within an extracellular allosteric regulatory subdomain of the gamma subunit that has an important role in conferring the response of the channel to external Na+.	[Winarski, Katie L.; Sheng, Nan; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 DK054354, R01 ES014701, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK054354, R01 ES014701, and P30 DK079307.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	39	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26088	26096		10.1074/jbc.M110.149963	http://dx.doi.org/10.1074/jbc.M110.149963			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20587418	Green Published, hybrid			2022-12-27	WOS:000280921000025
J	Keutgens, A; Zhang, X; Shostak, K; Robert, I; Olivier, S; Vanderplasschen, A; Chapelle, JP; Viatour, P; Merville, MP; Bex, F; Gothot, A; Chariot, A				Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Vanderplasschen, Alain; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Bex, Francoise; Gothot, Andre; Chariot, Alain			BCL-3 Degradation Involves Its Polyubiquitination through a FBW7-independent Pathway and Its Binding to the Proteasome Subunit PSMB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FBW7 UBIQUITIN LIGASE; ANAPLASTIC LARGE-CELL; CYCLIN-E DEGRADATION; PROTOONCOGENE BCL-3; ONCOPROTEIN BCL-3; TUMOR-SUPPRESSOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The oncogenic protein BCL-3 activates or represses gene transcription through binding with the NF-kappa B proteins p50 and p52 and is degraded through a phospho-and GSK3-dependent pathway. However, the mechanisms underlying its degradation remain poorly understood. Yeast two-hybrid analysis led to the identification of the proteasome subunit PSMB1 as a BCL-3-associated protein. The binding of BCL-3 to PSMB1 is required for its degradation through the proteasome. Indeed, PSMB1-depleted cells are defective in degrading polyubiquitinated BCL-3. The N-terminal part of BCL-3 includes lysines 13 and 26 required for the Lys(48)-linked polyubiquitination of BCL-3. Moreover, the E3 ligase FBW7, known to polyubiquitinate a variety of substrates phosphorylated by GSK3, is dispensable for BCL-3 degradation. Thus, our data defined a unique motif of BCL-3 that is needed for its recruitment to the proteasome and identified PSMB1 as a key protein required for the proteasome-mediated degradation of a nuclear and oncogenic I kappa B protein.	[Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Gothot, Andre; Chariot, Alain] Univ Liege, Fac Vet Med, Interdisciplinary Cluster Appl Genoprote GIGA Res, B-4000 Liege, Belgium; [Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Chariot, Alain] Univ Liege, Fac Vet Med, Unit Med Chem, B-4000 Liege, Belgium; [Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Chariot, Alain] Univ Liege, Fac Vet Med, GIGA Signal Transduct, B-4000 Liege, Belgium; [Vanderplasschen, Alain] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, B-4000 Liege, Belgium; [Bex, Francoise] Univ Brussels, Inst Microbiol Res JM Wiame, B-1070 Brussels, Belgium; [Bex, Francoise] Univ Brussels, Microbiol Lab, B-1070 Brussels, Belgium; [Gothot, Andre] Univ Liege, Dept Med Hematol, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Chariot, A (corresponding author), Univ Liege, GIGA R, Med Chem Lab, Tour GIGA, 2 B34, B-4000 Liege, Belgium.	Alain.chariot@ulg.ac.be		Chariot, Alain/0000-0002-1691-4347	Fonds de la Recherche Scientifique (FNRS); TELEVIE; Belgian Federation Against Cancer; University of Liege [04/09-323]; Federal Ministry of Science; Centre Anti-Cancereux; Leon Fredericq Foundation (ULg); King Baudouin Foundation (Brussels, Belgium)	Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Belgian Federation Against Cancer; University of Liege(University of Liege); Federal Ministry of Science; Centre Anti-Cancereux; Leon Fredericq Foundation (ULg); King Baudouin Foundation (Brussels, Belgium)	This work was supported by grants from the Fonds de la Recherche Scientifique (FNRS), TELEVIE, the Belgian Federation Against Cancer, the Concerted Research Action Program (04/09-323, University of Liege), the Inter-University Attraction Pole 6/12 (Federal Ministry of Science), the Centre Anti-Cancereux, the Leon Fredericq Foundation (ULg), and the King Baudouin Foundation (Brussels, Belgium).	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Arsura M, 2000, MOL CELL BIOL, V20, P5381, DOI 10.1128/MCB.20.15.5381-5391.2000; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brenne AT, 2009, EUR J HAEMATOL, V82, P354, DOI 10.1111/j.1600-0609.2009.01225.x; Canoz O, 2004, MODERN PATHOL, V17, P911, DOI 10.1038/modpathol.3800140; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hanson JL, 2003, J BIOL CHEM, V278, P34910, DOI 10.1074/jbc.M304189200; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; Minella AC, 2005, P NATL ACAD SCI USA, V102, P9649, DOI 10.1073/pnas.0503677102; Nishikori M, 2003, BLOOD, V101, P2789, DOI 10.1182/blood-2002-08-2464; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; O'Neil BH, 2007, ONCOLOGY-BASEL, V72, P97, DOI 10.1159/000111116; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Ong ST, 1998, ONCOGENE, V16, P2333, DOI 10.1038/sj.onc.1201771; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	32	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25831	25840		10.1074/jbc.M110.112128	http://dx.doi.org/10.1074/jbc.M110.112128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558726	Green Published, hybrid			2022-12-27	WOS:000280682400075
J	Scholz, R; Sidler, CL; Thali, RF; Winssinger, N; Cheung, PCF; Neumann, D				Scholz, Roland; Sidler, Corinne L.; Thali, Ramon F.; Winssinger, Nicolas; Cheung, Peter C. F.; Neumann, Dietbert			Autoactivation of Transforming Growth Factor beta-activated Kinase 1 Is a Sequential Bimolecular Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IL-1 SIGNALING PATHWAY; RESORCYLIC ACID LACTONES; PROTEIN-KINASE; TAK1 MAPKKK; TAK1-BINDING PROTEIN-1; TRANSDUCTION PATHWAY; STRUCTURAL BASIS; IN-VITRO; PHOSPHORYLATION	Transforming growth factor-beta-activated kinase 1 (TAK1), an MAP3K, is a key player in processing a multitude of inflammatory stimuli. TAK1 autoactivation involves the interplay with TAK1-binding proteins (TAB), e. g. TAB1 and TAB2, and phosphorylation of several activation segment residues. However, the TAK1 autoactivation is not yet fully understood on the molecular level due to the static nature of available x-ray structural data and the complexity of cellular systems applied for investigation. Here, we established a bacterial expression system to generate recombinant mammalian TAK1 complexes. Co-expression of TAK1 and TAB1, but not TAB2, resulted in a functional and active TAK1-TAB1 complex capable of directly activating full-length heterotrimeric mammalian AMP-activated protein kinase (AMPK) in vitro. TAK1-dependent AMPK activation was mediated via hydrophobic residues of the AMPK kinase domain alpha G-helix as observed in vitro and in transfected cell culture. Co-immunoprecipitation of differently epitope-tagged TAK1 from transfected cells and mutation of hydrophobic alpha G-helix residues in TAK1 point to an intermolecular mechanism of TAB1-induced TAK1 autoactivation, as TAK1 autophosphorylation of the activation segment was impaired in these mutants. TAB1 phosphorylation was enhanced in a subset of these mutants, indicating a critical role of alpha G-helix residues in this process. Analyses of phosphorylation site mutants of the activation segment indicate that autophosphorylation of Ser-192 precedes TAB1 phosphorylation and is followed by sequential phosphorylation of Thr-178, Thr-187, and finally Thr-184. Finally, we present a model for the chronological order of events governing TAB1-induced TAK1 autoactivation.	[Winssinger, Nicolas; Neumann, Dietbert] ETH, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Winssinger, Nicolas] Univ Strasbourg, CNRS, Inst Sci & Ingn Supramol, UMR7006, F-67000 Strasbourg, France; [Cheung, Peter C. F.] Nanyang Technol Univ, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Winssinger, N (corresponding author), ETH, Dept Biol, Inst Cell Biol, Schafmattstr 18,HPMD23, CH-8093 Zurich, Switzerland.	dietbert.neumann@cell.biol.ethz.ch	Scholz, Roland W./AAH-8385-2020; Cheung, Peter/A-2213-2011; Winssinger, Nicolas/B-6710-2017	Scholz, Roland W./0000-0003-2506-3254; Neumann, Dietbert/0000-0002-4316-684X; Winssinger, Nicolas/0000-0003-1636-7766	Swiss National Science Foundation [3100A0-114137]; European Union [LSHM-CT-2004-005272, 36/05-3, 32/05-3]; Agence National de la Recherche; Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC) [07/1/22/19/523]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR))	This work was supported in part by the Swiss National Science Foundation Grant 3100A0-114137, the European Union FP6 Contract LSHM-CT-2004-005272 (EXGENESIS), and Graduate Training Fellowships ETHIIRA 36/05-3 and 32/05-3 (for R. S. and R. F. T.).; Recipient of funding from the Agence National de la Recherche.; Supported by Agency for Science, Technology, and Research (A*STAR) Biomedical Research Council (BMRC) Grant 07/1/22/19/523.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; Dakas PY, 2009, CHEM-EUR J, V15, P11490, DOI 10.1002/chem.200901373; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; Eisenberg D., 1982, FARADAY S CHEM SOC, V17, P109, DOI DOI 10.1039/FS9821700109; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Huang JH, 2003, BIOCHEM BIOPH RES CO, V303, P532, DOI 10.1016/S0006-291X(03)00387-5; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jogireddy R, 2009, CHEM-EUR J, V15, P11498, DOI 10.1002/chem.200901375; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2003, BIOCHEM SOC T, V31, P169, DOI 10.1042/bst0310169; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2009, J BIOL CHEM, V284, P27425, DOI 10.1074/jbc.M109.047670; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tu Z, 2003, CELL SIGNAL, V15, P65, DOI 10.1016/S0898-6568(02)00056-6; Tuerk RD, 2009, ANAL BIOCHEM, V390, P141, DOI 10.1016/j.ab.2009.04.015; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200	61	65	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25753	25766		10.1074/jbc.M109.093468	http://dx.doi.org/10.1074/jbc.M109.093468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538596	Green Published, hybrid			2022-12-27	WOS:000280682400068
J	Wang, YY; Brittain, JM; Jarecki, BW; Park, KD; Wilson, SM; Wang, B; Hale, R; Meroueh, SO; Cummins, TR; Khanna, R				Wang, Yuying; Brittain, Joel M.; Jarecki, Brian W.; Park, Ki Duk; Wilson, Sarah M.; Wang, Bo; Hale, Rachel; Meroueh, Samy O.; Cummins, Theodore R.; Khanna, Rajesh			In Silico Docking and Electrophysiological Characterization of Lacosamide Binding Sites on Collapsin Response Mediator Protein-2 Identifies a Pocket Important in Modulating Sodium Channel Slow Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; NEURONS; MECHANISMS; CURRENTS; FAMILY; AXONS	The anti-epileptic drug (R)-lacosamide ((2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide (LCM)) modulates voltage-gated sodium channels (VGSCs) by preferentially interacting with slow inactivated sodium channels, but the observation that LCM binds to collapsin response mediator protein 2 (CRMP-2) suggests additional mechanisms of action for LCM. We postulated that CRMP-2 levels affects the actions of LCM on VGSCs. CRMP-2 labeling by LCM analogs was competitively displaced by excess LCM in rat brain lysates. Manipulation of CRMP-2 levels in the neuronal model system CAD cells affected slow inactivation of VGSCs without any effects on other voltage-dependent properties. In silico docking was performed to identify putative binding sites in CRMP-2 that may modulate the effects of LCM on VGSCs. These studies identified five cavities in CRMP-2 that can accommodate LCM. CRMP-2 alanine mutants of key residues within these cavities were functionally similar to wildtype CRMP-2 as assessed by similar levels of enhancement in dendritic complexity of cortical neurons. Next, we examined the effects of expression of wild-type and mutant CRMP-2 constructs on voltage-sensitive properties of VGSCs in CAD cells: 1) steady-state voltage-dependent activation and fast-inactivation properties were not affected by LCM, 2) CRMP-2 single alanine mutants reduced the LCM-mediated effects on the ability of endogenous Na+ channels to transition to a slow inactivated state, and 3) a quintuplicate CRMP-2 alanine mutant further decreased this slow inactivated fraction. Collectively, these results identify key CRMP-2 residues that can coordinate LCM binding thus making it more effective on its primary clinical target.	[Wang, Yuying; Jarecki, Brian W.; Hale, Rachel; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Dept Chem, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wang, Bo; Meroueh, Samy O.] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Brittain, Joel M.; Wilson, Sarah M.; Wang, Bo; Meroueh, Samy O.; Cummins, Theodore R.; Khanna, Rajesh] Indiana Univ, Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Park, Ki Duk] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of North Carolina; University of North Carolina Chapel Hill	Khanna, R (corresponding author), 950 W Walnut St,R2,Rm 478, Indianapolis, IN 46202 USA.	khanna5@iupui.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health [CA135380, NS053422]; Indiana State Dept. of Health [A70-9-079138]; Spinal Cord and Brain Injury Fund [2286501]; NATIONAL CANCER INSTITUTE [R01CA135380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Dept. of Health; Spinal Cord and Brain Injury Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135380 (to S.O.M.) and NS053422 (to T. R. C.). This work was also supported by a grant from the Indiana State Dept. of Health (A70-9-079138, to R. K.), Spinal Cord and Brain Injury Fund (2286501, to R. K.).	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bartolomei F, 1997, J NEUROCYTOL, V26, P667, DOI 10.1023/A:1018549928277; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Castaneda-Castellanos DR, 2000, BRAIN RES, V866, P281, DOI 10.1016/S0006-8993(00)02297-6; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Charych EI, 2006, J NEUROSCI, V26, P10164, DOI 10.1523/JNEUROSCI.2379-06.2006; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Choi D, 1996, J MED CHEM, V39, P1907, DOI 10.1021/jm9508705; Curia G, 2009, CNS DRUGS, V23, P555, DOI 10.2165/00023210-200923070-00002; Czech T, 2004, NEUROCHEM RES, V29, P2189, DOI 10.1007/s11064-004-7025-3; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Errington AC, 2006, NEUROPHARMACOLOGY, V50, P1016, DOI 10.1016/j.neuropharm.2006.02.002; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harris JA, 2009, ANN PHARMACOTHER, V43, P1809, DOI 10.1345/aph.1M303; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Klein JP, 2004, BRAIN RES, V1000, P102, DOI 10.1016/j.brainres.2003.11.051; Mechaly I, 2005, NEUROSCIENCE, V130, P389, DOI 10.1016/j.neuroscience.2004.09.034; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Park KD, 2009, J MED CHEM, V52, P6897, DOI 10.1021/jm9012054; Perucca E, 2008, NAT REV DRUG DISCOV, V7, P973, DOI 10.1038/nrd2764; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Ryu MJ, 2008, J NEUROCHEM, V104, P1260, DOI 10.1111/j.1471-4159.2007.05100.x; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tilz C, 2009, EPILEPSIA, V50, P35; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Wang H, 2000, J NEUROPHYSIOL, V84, P2888, DOI 10.1152/jn.2000.84.6.2888; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang Yuying, 2010, Commun Integr Biol, V3, P172; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3	50	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25296	25307		10.1074/jbc.M110.128801	http://dx.doi.org/10.1074/jbc.M110.128801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538611	Green Published, hybrid			2022-12-27	WOS:000280682400022
J	Yu, FX; Chai, TF; He, HP; Hagen, T; Luo, Y				Yu, Fa-Xing; Chai, Tin Fan; He, Hongpeng; Hagen, Thilo; Luo, Yan			Thioredoxin-interacting Protein (Txnip) Gene Expression SENSING OXIDATIVE PHOSPHORYLATION STATUS AND GLYCOLYTIC RATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-CONTAINING MOLECULES; CARBOHYDRATE RESPONSE ELEMENT; BETA-CELL APOPTOSIS; GLUCOSE; ACTIVATION; STIMULATION; KINASE; GROWTH; VDUP1; 6-PHOSPHOFRUCTO-2-KINASE	Thioredoxin-interacting protein (Txnip) has important functions in regulating cellular metabolism including glucose utilization; the expression of the Txnip gene is sensitive to the availability of glucose and other fuels. Here, we show that Txnip expression is down-regulated at the transcriptional level by diverse inhibitors of mitochondrial oxidative phosphorylation (OXPHOS). The effect of these OXPHOS inhibitors is mediated by earlier identified carbohydrate-response elements (ChoREs) on the Txnip promoter and the ChoRE-associated transcription factors Max-like protein X (MLX) and MondoA (or carbohydrate-response element-binding protein (ChREBP)) involved in glucose-induced Txnip expression, suggesting that inhibited oxidative phosphorylation compromises glucose-induced effects on Txnip expression. We also show that the OXPHOS inhibitors repress the Txnip transcription most likely by inducing the glycolytic rate, and increased glycolytic flux decreases the levels of glycolytic intermediates important for the function of MLX and MondoA (or ChREBP). Our findings suggest that the Txnip expression is tightly correlated with glycolytic flux, which is regulated by oxidative phosphorylation status. The identified link between the Txnip expression and glycolytic activity implies a mechanism by which the cellular glucose uptake/homeostasis is regulated in response to various metabolic cues, oxidative phosphorylation status, and other physiological signals, and this may facilitate our efforts toward understanding metabolism in normal or cancer cells.	[Chai, Tin Fan; Hagen, Thilo; Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Yu, Fa-Xing; He, Hongpeng; Luo, Yan] Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hagen, T (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	thilo_hagen@nuhs.edu.sg; yluo@imcb.a-star.edu.sg		Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Agency for Science, Technology and Research (A*STAR), Singapore.	APARICIO O, 2005, CURRENT PROTOCOLS MO; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Fan X, 2003, J BIOL CHEM, V278, P10232, DOI 10.1074/jbc.M209911200; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; LANKS KW, 1986, J CELL PHYSIOL, V126, P319, DOI 10.1002/jcp.1041260224; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shaked M, 2009, DIABETOLOGIA, V52, P636, DOI 10.1007/s00125-009-1274-2; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397; Yu FX, 2009, MOL ENDOCRINOL, V23, P932, DOI 10.1210/me.2008-0383; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	36	56	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25822	25830		10.1074/jbc.M110.108290	http://dx.doi.org/10.1074/jbc.M110.108290			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558747	Green Published, hybrid			2022-12-27	WOS:000280682400074
J	Oot, RA; Wilkens, S				Oot, Rebecca A.; Wilkens, Stephan			Domain Characterization and Interaction of the Yeast Vacuolar ATPase Subunit C with the Peripheral Stator Stalk Subunits E and G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILUS H+-ATPASE/SYNTHASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; THERMUS-THERMOPHILUS; ELECTRON-MICROSCOPY; A(1)A(0)-ATP SYNTHASE; CRYSTAL-STRUCTURE; CROSS-LINKING; PROTON PUMP; G VMA10P	The proton pumping activity of the eukaryotic vacuolar ATPase (V-ATPase) is regulated by a unique mechanism that involves reversible enzyme dissociation. In yeast, under conditions of nutrient depletion, the soluble catalytic V-1 sector disengages from the membrane integral V-o, and at the same time, both functional units are silenced. Notably, during enzyme dissociation, a single V-1 subunit, C, is released into the cytosol. The affinities of the other V-1 and V-o subunits for subunit Care therefore of particular interest. The C subunit crystal structure shows that the subunit is elongated and dumbbell-shaped with two globular domains (C-head and C-foot) separated by a flexible helical neck region (Drory, O., Frolow, F., and Nelson, N. (2004) EMBO Rep. 5, 1148-1152). We have recently shown that subunit C is bound in the V-1-V-o interface where the subunit is in contact with two of the three peripheral stators (subunit EG heterodimers): one via C-head and one via C-foot (Zhang, Z., Zheng, Y., Mazon, H., Milgrom, E., Kitagawa, N., Kish-Trier, E., Heck, A. J., Kane, P. M., and Wilkens, S. (2008) J. Biol. Chem. 283, 3598335995). In vitro, however, subunit C binds only one EG heterodimer (Fethiere, J., Venzke, D., Madden, D. R., and Bottcher, B. (2005) Biochemistry 44, 15906-15914), implying that EG has different affinities for the two domains of the C subunit. To determine which subunit C domain binds EG with high affinity, we have generated C-head and C-foot and characterized their interaction with subunit EG heterodimer. Our findings indicate that the high affinity site for EGC interaction is C-head. In addition, we provide evidence that the EGC(head) interaction greatly stabilizes EG heterodimer. The vacuolar	[Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM58600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58600.	Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FOURY F, 1990, J BIOL CHEM, V265, P18554; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LAU WC, P NATL ACAD SCI US, V107, P1367; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nicholls D., 2002, BIOENERGETICS, V3; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	54	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24654	24664		10.1074/jbc.M110.136960	http://dx.doi.org/10.1074/jbc.M110.136960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529855	Green Published, hybrid			2022-12-27	WOS:000280542100038
J	Shin, DH; Cho, MH; Kim, TL; Yoo, J; Kim, JI; Han, YJ; Song, PS; Jeon, JS; Bhoo, SH; Hahn, TR				Shin, Dong Ho; Cho, Man-Ho; Kim, Tae-Lim; Yoo, Jihye; Kim, Jeong-Il; Han, Yun-Jeong; Song, Pill-Soon; Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong			A Small GTPase Activator Protein Interacts with Cytoplasmic Phytochromes in Regulating Root Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED POSITIVE PHOTOTROPISM; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ROP GTPASE; LIGHT; GROWTH; PLANTS; ELONGATION; AUXIN	Phytochromes enable plants to sense light information and regulate developmental responses. Phytochromes interact with partner proteins to transmit light signals to downstream components for plant development. PIRF1 (phytochrome-interacting ROP guanine-nucleotide exchange factor (RopGEF 1)) functions as a light-signaling switch regulating root development through the activation of ROPs (Rho-like GTPase of plant) in the cytoplasm. In vitro pulldown and yeast two-hybrid assays confirmed the interaction between PIRF1 and phytochromes. PIRF1 interacted with the N-terminal domain of phytochromes through its conserved PRONE (plant-specific ROP nucleotide exchanger) region. PIRF1 also interacted with ROPs and activated them in a phytochrome-dependent manner. The Pr form of phytochrome A enhanced the RopGEF activity of PIRF1, whereas the Pfr form inhibited it. A bimolecular fluorescence complementation analysis demonstrated that PIRF1 was localized in the cytoplasm and bound to the phytochromes in darkness but not in light. PIRF1 loss of function mutants (pirf1) of Arabidopsis thaliana showed a longer root phenotype in the dark. In addition, both PIRF1 overexpression mutants (PIRF1-OX) and phytochrome-null mutants (phyA-211 and phyB-9) showed retarded root elongation and irregular root hair formation, suggesting that PIRF1 is a negative regulator of phytochrome-mediated primary root development. We propose that phytochrome and ROP signaling are interconnected through PIRF1 in regulating the root growth and development in Arabidopsis.	[Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Jeon, Jong-Seong; Bhoo, Seong Hee; Hahn, Tae-Ryong] Kyung Hee Univ, Plant Metab Res Ctr, Yongin 446701, South Korea; [Kim, Jeong-Il; Han, Yun-Jeong] Chonnam Natl Univ, Kumho Life Sci Lab, Kwangju 500757, South Korea; [Kim, Jeong-Il; Han, Yun-Jeong] Chonnam Natl Univ, Dept Biotechnol, Kwangju 500757, South Korea; [Song, Pill-Soon] Jeju Natl Univ, Fac Biotechnol, Cheju 690756, South Korea	Kyung Hee University; Kyung Hee University; Chonnam National University; Chonnam National University; Jeju National University		shbhoo@khu.ac.kr; trhahn@khu.ac.kr	Jeon, Jong-Seong/AAJ-2161-2020	Jeon, Jong-Seong/0000-0001-6221-4993	MOST/KOSEF from the Plant Metabolism Research Center, Kyung Hee University [R11-2000-081]; Plant Diversity Research Center [PF06302-02]; Biogreen21 Program [20080401034014]; KOSEF/NCRC [R15-2003-012-01003-0]; Rural Development Administration, Republic of Korea [200901FHT010407539]; Korean Ministry of Education, Science, and Technology [R33-2008-000-10168-0]	MOST/KOSEF from the Plant Metabolism Research Center, Kyung Hee University; Plant Diversity Research Center; Biogreen21 Program(Rural Development Administration (RDA), Republic of Korea); KOSEF/NCRC(Korea Science and Engineering Foundation); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the SRC program of MOST/KOSEF R11-2000-081 from the Plant Metabolism Research Center, Kyung Hee University. This work was also supported by the Plant Diversity Research Center of the 21st Century Frontier Research Program PF06302-02 (to J.-I. K.), in part by Biogreen21 Program Grant 20080401034014 and KOSEF/NCRC Grant R15-2003-012-01003-0 (to P.-S. S.), by Grant 200901FHT010407539 from the Biogreen 21 Program, Rural Development Administration, Republic of Korea (to S. H. B.), and by Grant R33-2008-000-10168-0 from the World Class University program of the Korean Ministry of Education, Science, and Technology (to J.-S.J.).	Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; De Simone S, 2000, J PLANT RES, V113, P63, DOI 10.1007/PL00013917; Fankhauser C, 2008, TRENDS PLANT SCI, V13, P596, DOI 10.1016/j.tplants.2008.08.007; Galen C, 2007, NEW PHYTOL, V173, P91, DOI 10.1111/j.1469-8137.2006.01893.x; Gu Y, 2006, PLANT CELL, V18, P366, DOI 10.1105/tpc.105.036434; Hemm MR, 2004, PLANT J, V38, P765, DOI 10.1111/j.1365-313X.2004.02089.x; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Kang JG, 2001, CELL, V105, P625, DOI 10.1016/S0092-8674(01)00370-1; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Kevei E, 2007, J EXP BOT, V58, P3113, DOI 10.1093/jxb/erm145; Kim JI, 2005, LIGHT SENSING IN PLANTS, P57, DOI 10.1007/4-431-27092-2_6; Kim JI, 2002, BIOCHEM BIOPH RES CO, V298, P457, DOI 10.1016/S0006-291X(02)02494-4; Kiss JZ, 2002, PLANT CELL PHYSIOL, V43, P35, DOI 10.1093/pcp/pcf017; Kiss JZ, 2003, PLANT PHYSIOL, V131, P1411, DOI 10.1104/pp.013847; Kost B, 2008, TRENDS CELL BIOL, V18, P119, DOI 10.1016/j.tcb.2008.01.003; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; Matsushita T, 2003, NATURE, V424, P571, DOI 10.1038/nature01837; Montgomery BL, 2008, PLANT SIGNAL BEHAV, V3, P1053, DOI 10.4161/psb.3.12.6857; Nagatani A, 2005, LIGHT SENSING IN PLANTS, P69, DOI 10.1007/4-431-27092-2_7; Neff MM, 2000, GENE DEV, V14, P257; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Phee BK, 2008, BIOCHEM J, V415, P247, DOI 10.1042/BJ20071555; Phee BK, 2006, PROTEOMICS, V6, P3671, DOI 10.1002/pmic.200500222; Pratt Lee H., 1994, P163; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Reed JW, 1999, CURR OPIN PLANT BIOL, V2, P393, DOI 10.1016/S1369-5266(99)00011-4; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; Ruppel NJ, 2001, PLANTA, V212, P424, DOI 10.1007/s004250000410; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Schultheiss H, 2005, PLANT PHYSIOL, V139, P353, DOI 10.1104/pp.105.066613; Shen Y, 2005, J BIOL CHEM, V280, P5740, DOI 10.1074/jbc.M408965200; Shin DH, 2009, PLANT BIOTECHNOL REP, V3, P183, DOI 10.1007/s11816-009-0090-y; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; SOMERS DE, 1995, PLANT J, V7, P413, DOI 10.1046/j.1365-313X.1995.7030413.x; Sun Q, 2005, J EXP BOT, V56, P191, DOI 10.1093/jxb/eri019; Tao LZ, 2005, PLANT CELL, V17, P2369, DOI 10.1105/tpc.105.032987; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Tian Q, 2003, PLANT J, V36, P643, DOI 10.1046/j.1365-313X.2003.01909.x; WANG H, 2002, ARABIDOPSIS BOOK; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	61	18	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32151	32159		10.1074/jbc.M110.133710	http://dx.doi.org/10.1074/jbc.M110.133710			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20551316	Green Published, hybrid			2022-12-27	WOS:000282683000028
J	Oda, Y; Yoshimura, Y; Ohnishi, H; Tadokoro, M; Katsube, Y; Sasao, M; Kubo, Y; Hattori, K; Saito, S; Horimoto, K; Yuba, S; Ohgushi, H				Oda, Yasuaki; Yoshimura, Yasuhide; Ohnishi, Hiroe; Tadokoro, Mika; Katsube, Yoshihiro; Sasao, Mari; Kubo, Yoko; Hattori, Koji; Saito, Shigeru; Horimoto, Katsuhisa; Yuba, Shunsuke; Ohgushi, Hajime			Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-THERAPY; HUMAN FIBROBLASTS; IN-VITRO; GENERATION; MOUSE; PTIP; EFFICIENCY; CHROMATIN; LIVER	The expression of four transcription factors (OCT3/4, SOX2, KLF4, and MYC) can reprogram mouse as well as human somatic cells to induced pluripotent stem (iPS) cells. We generated iPS cells from mesenchymal stromal cells (MSCs) derived from human third molars (wisdom teeth) by retroviral transduction of OCT3/4, SOX2, and KLF4 without MYC, which is considered as oncogene. Interestingly, some of the clonally expanded MSCs could be used for iPS cell generation with 30-100-fold higher efficiency when compared with that of other clonally expanded MSCs and human dermal fibroblasts. Global gene expression profiles demonstrated some up-regulated genes regarding DNA repair/histone conformational change in the efficient clones, suggesting that the processes of chromatin remodeling have important roles in the cascade of iPS cells generation. The generated iPS cells resembled human embryonic stem (ES) cells in many aspects, including morphology, ES marker expression, global gene expression, epigenetic states, and the ability to differentiate into the three germ layers in vitro and in vivo. Because human third molars are discarded as clinical waste, our data indicate that clonally expanded MSCs derived from human third molars are a valuable cell source for the generation of iPS cells.	[Kubo, Yoko; Hattori, Koji; Yuba, Shunsuke; Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tissue Engn Res Grp, Hyogo 6610974, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Biol Network Team, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Ohgushi, H (corresponding author), 3-11-46 Nakouji, Amagasaki, Hyogo 6610974, Japan.	hajime-ohgushi@aist.go.jp	Saito, Shigeru/B-2785-2012	Saito, Shigeru/0000-0002-8708-9102; Yoshimura, Yasuhide/0000-0002-9121-8667; Ohnishi, Hiroe/0000-0003-3437-680X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the project for realization of regenerative medicine of the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Ikeda E, 2008, DIFFERENTIATION, V76, P495, DOI 10.1111/j.1432-0436.2007.00245.x; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murata K, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-4; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	52	94	101	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29270	29278		10.1074/jbc.M109.055889	http://dx.doi.org/10.1074/jbc.M109.055889			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595386	Green Published, hybrid			2022-12-27	WOS:000281740100029
J	Ding, JZ; Zhang, Z; Roberts, GJ; Falcone, M; Miao, YW; Shao, YL; Zhang, XJC; Andrews, DW; Lin, JL				Ding, Jingzhen; Zhang, Zhi; Roberts, G. Jane; Falcone, Mina; Miao, Yiwei; Shao, Yuanlong; Zhang, Xuejun C.; Andrews, David W.; Lin, Jialing			Bcl-2 and Bax Interact via the BH1-3 Groove-BH3 Motif Interface and a Novel Interface Involving the BH4 Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; FAMILY PROTEINS; NONIONIC DETERGENTS; ALPHA-HELIX; CELL-DEATH; APOPTOSIS; DIMERIZATION; ACTIVATION; DOMAIN; OLIGOMERIZATION	The interaction of Bcl-2 family proteins at the mitochondrial outer membrane controls membrane permeability and thereby the apoptotic program. The anti-apoptotic protein Bcl-2 binds to the pro-apoptotic protein Bax to prevent Bax homo-oligomerization required for membrane permeabilization. Here, we used site-specific photocross-linking to map the surfaces of Bax and Bcl-2 that interact in the hetero-complex formed in a Triton X-100 micelle as a membrane surrogate. Heterodimer-specific photoadducts were detected from multiple sites in Bax and Bcl-2. Many of the interaction sites are located in the Bcl-2 homology 3 (BH3) region of Bax and the BH1-3 groove of Bcl-2 that likely form the BH3-BH1-3 groove interface. However, other interaction sites form a second interface that includes helix 6 of Bax and the BH4 region of Bcl-2. Loss-of-function mutations in the BH3 region of Bax and the BH1 region of Bcl-2 disrupted the BH3-BH1-3 interface, as expected. Surprisingly the second interface was also disrupted by these mutations. Similarly, a loss-of-function mutation in the BH4 region of Bcl-2 that forms part of the second interface also disrupted both interfaces. As expected, both kinds of mutation abolished Bcl-2-mediated inhibition of Bax oligomerization in detergent micelles. Therefore, Bcl-2 binds Bax through two interdependent interfaces to inhibit the pro-apoptotic oligomerization of Bax.	[Lin, Jialing] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA; [Roberts, G. Jane; Falcone, Mina; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Miao, Yiwei; Shao, Yuanlong] Texas A&M Univ, Dept Mol & Cellular Med, Syst Hlth Sci Ctr, College Stn, TX 77843 USA; [Zhang, Xuejun C.] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935,POB, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	ding, Jingzhen/B-5427-2015	Andrews, David/0000-0002-9266-7157	National Institutes of Health [GM062964]; Canadian Institutes of Health [FRN 12517]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062964 (to J. L.). This work was also supported by Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A.).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Feng Y, 2008, J BIOCHEM, V143, P243, DOI 10.1093/jb/mvm216; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottilie S, 1997, J BIOL CHEM, V272, P16955, DOI 10.1074/jbc.272.27.16955; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Peng J, 2009, APOPTOSIS, V14, P1145, DOI 10.1007/s10495-009-0389-8; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha HB, 1997, J BIOL CHEM, V272, P31482, DOI 10.1074/jbc.272.50.31482; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	61	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28749	28763		10.1074/jbc.M110.148361	http://dx.doi.org/10.1074/jbc.M110.148361			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20584903	hybrid, Green Published			2022-12-27	WOS:000281594000041
J	Sen, A; O'Malley, K; Wang, Z; Raj, GV; DeFranco, DB; Hammes, SR				Sen, Aritro; O'Malley, Katherine; Wang, Zhou; Raj, Ganesh V.; DeFranco, Donald B.; Hammes, Stephen R.			Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EXTRANUCLEAR STEROID-RECEPTORS; FOCAL ADHESION KINASE; PLASMA-MEMBRANE; SERTOLI-CELLS; C-SRC; EPITHELIAL MORPHOGENESIS; LNCAP CELLS; STEM-CELLS; CROSS-TALK	Although transcriptional effects of androgens have been extensively studied, mechanisms regulating transcription-independent (nongenomic) androgen actions are poorly understood. Previously, we have shown that paxillin, a multidomain adaptor protein, is a critical regulator of testosterone-induced MAPK-signaling during Xenopus oocyte maturation. Here we examine the nongenomic effects of dihydrotestosterone (DHT) in prostate cancer cells, focusing on how paxillin mediates Erk signaling and downstream physiologic actions. We show that in LnCAP cells DHT functions as a growth factor that indirectly activates the EGF-receptor (EGFR) via androgen receptor binding and matrix metalloproteinase-mediated release of EGFR ligands. Interestingly, siRNA-mediated knockdown of paxillin expression in androgen-dependent LnCAP cells as well as in androgen-independent PC3 cells abrogates DHT- and/or EGF-induced Erk signaling. Furthermore, EGFR-induced Erk activation requires Src-mediated phosphorylation of paxillin on tyrosines 31/118. In contrast, paxillin is not required for PKC-induced Erk signaling. However, Erk-mediated phosphorylation of paxillin on serines 83/126/130 is still needed for both EGFR and PKC-mediated cellular proliferation. Thus, paxillin serves as a specific upstream regulator of Erk in response to receptor-tyrosine kinase signaling but as a general regulator of downstream Erk actions regardless of agonist. Importantly, Erk-mediated serine phosphorylation of paxillin is also required for DHT-induced prostate-specific antigen mRNA expression in LnCAP cells as well as EGF-induced cyclin D1 mRNA expression in PC3 cells, suggesting that paxillin may regulate prostate cancer proliferation by serving as a liaison between extra-nuclear kinase signaling and intra-nuclear transcriptional signals. Thus, paxillin may prove to be a novel diagnostic or therapeutic target in prostate cancer.	[Sen, Aritro; Hammes, Stephen R.] Univ Rochester, Med Ctr, Div Endocrinol, Dept Med, Rochester, NY 14642 USA; [O'Malley, Katherine; Wang, Zhou] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA; [Wang, Zhou; DeFranco, Donald B.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15232 USA; [Wang, Zhou; DeFranco, Donald B.] Univ Pittsburgh, Dept Biol Chem, Pittsburgh, PA 15232 USA; [Raj, Ganesh V.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75310 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hammes, SR (corresponding author), Univ Rochester, Div Endocrinol & Metab, Sch Med & Dent, 601 Elmwood Ave, Rochester, NY 14642 USA.	Stephen_Hammes@urmc.rochester.edu		Sen, Aritro/0000-0001-8038-3715	National Institutes of Health [DK59913]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059913, R01DK078394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK59913 (to S. R. H.).	Arnold JT, 2005, AM J PHYSIOL-ENDOC M, V288, pE573, DOI 10.1152/ajpendo.00454.2004; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dobkin-Bekman M, 2009, MOL ENDOCRINOL, V23, P1850, DOI 10.1210/me.2008-0260; Evaul K, 2008, J BIOL CHEM, V283, P27525, DOI 10.1074/jbc.M803867200; Festuccia C, 2009, PROSTATE, V69, P1529, DOI 10.1002/pros.20995; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Franco OE, 2003, PROSTATE, V56, P319, DOI 10.1002/pros.10258; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; IWATA KK, 2004, P AM ASSOC CANC RES, V9, P142; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Kasai M, 2003, CANCER RES, V63, P4927; Ku H, 2000, J BIOL CHEM, V275, P11333, DOI 10.1074/jbc.275.15.11333; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li Z, 2007, J BIOL CHEM, V282, P3428, DOI 10.1074/jbc.C600277200; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Nishiyama T, 2007, J UROLOGY, V178, P1282, DOI 10.1016/j.juro.2007.05.138; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Qi WQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-142; Rasar M, 2006, J BIOL CHEM, V281, P39455, DOI 10.1074/jbc.M608959200; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Suzuki H, 2003, ENDOCR-RELAT CANCER, V10, P209, DOI 10.1677/erc.0.0100209; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Woodrow MA, 2003, EXP CELL RES, V287, P325, DOI 10.1016/S0014-4827(03)00122-8; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Zhang L, 2009, CANCER LETT, V285, P58, DOI 10.1016/j.canlet.2009.04.041; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	62	72	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28787	28795		10.1074/jbc.M110.134064	http://dx.doi.org/10.1074/jbc.M110.134064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628053	Green Published, hybrid			2022-12-27	WOS:000281594000044
J	Zhang, Y; Liang, J; Li, YY; Xuan, CH; Wang, F; Wang, DD; Shi, L; Zhang, D; Shang, YF				Zhang, Yu; Liang, Jing; Li, Yanyan; Xuan, Chenghao; Wang, Feng; Wang, Dandan; Shi, Lei; Zhang, Di; Shang, Yongfeng			CCCTC-binding Factor Acts Upstream of FOXA1 and Demarcates the Genomic Response to Estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; ENHANCER-BLOCKING ACTIVITY; BETA-GLOBIN LOCUS; BREAST-CANCER; PROTEIN CTCF; ENDOMETRIAL CARCINOGENESIS; CHROMOSOME CONFORMATION; GENE; METHYLATION; INSULATORS	Transcription activation by estrogen receptor (ER) is rapid and dynamic. How the prompt and precise ER response is established and maintained is still not fully understood. Here, we report that two boundary elements surrounding the well defined ER alpha target TFF1 locus are occupied by the CCCTC-binding factor (CTCF). These elements are separated by 40 kb but cluster in the nuclear space depending on CTCF but independent of estrogen and transcription. In contrast, in estrogen non-responsive breast cancer cells, the spatial proximity of these two elements is lost and the entire locus instead displays a polycomb repressive complex 2-controlled heterochromatin characteristic. We showed that CTCF acts upstream of the "pioneer" factor FOXA1 in determining the genomic response to estrogen. We propose that the CTCF-bound boundary elements demarcate active versus inactive regions, building a framework of adjacent chromosome territory that predisposes ER alpha-regulated transcription.	[Zhang, Yu; Liang, Jing; Li, Yanyan; Xuan, Chenghao; Wang, Feng; Wang, Dandan; Shi, Lei; Zhang, Di; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Zhang, Di/AAD-6936-2021; Zhang, Di/AAE-2027-2021		National Natural Science Foundation of China [30830032, 30921062]; Ministry of Science and Technology of China [2005CB522404, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China Grants 30830032 and 30921062 (to Y. S.) and 973 Program Grants 2005CB522404 and 2007CB914503 (to Y. S.) from the Ministry of Science and Technology of China.	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chambon P, 2004, NAT MED, V10, P1027, DOI 10.1038/nm1004-1027; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; O'Malley BW, 2005, MOL ENDOCRINOL, V19, P1402, DOI 10.1210/me.2004-0480; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	43	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28604	28613		10.1074/jbc.M110.149658	http://dx.doi.org/10.1074/jbc.M110.149658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610384	hybrid, Green Published			2022-12-27	WOS:000281594000024
J	Kang, N; Jun, AH; Bhutia, YD; Kannan, N; Unadkat, JD; Govindarajan, R				Kang, Nayoung; Jun, Ah Hyun; Bhutia, Yangzom Doma; Kannan, Natarajan; Unadkat, Jashvant D.; Govindarajan, Rajgopal			Human Equilibrative Nucleoside Transporter-3 (hENT3) Spectrum Disorder Mutations Impair Nucleoside Transport, Protein Localization, and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ESCHERICHIA-COLI; GENE; MITOCHONDRIA; DELTA-F508; GLYCINE; PACKING; RESCUE; FAMILY; CELLS	Accumulating evidence reveals that sole mutations in hENT3 cause a spectrum of human genetic disorders. Among these include H syndrome, characterized by scleroderma, hyperpigmentation, hypertrichosis, hepatomegaly, cardiac abnormalities and musculoskeletal deformities, pigmented hypertrichotic dermatosis with insulin-dependent diabetes syndrome, characterized by autoantibody-negative diabetes mellitus and skin deformities, familial Rosai-Dorfman disease, characterized by short stature, familial histiocytosis and sinus histiocytosis with massive lymphadenopathy (SHML), characterized by severe tissue infiltration of immune cells and swollen lymph nodes. hENT3 spectrum disorders share a common mutation and share overlapping clinical manifestations that display many intriguing resemblances to mitochondrial and lysosomal disorders. Although earlier studies identify hENT3 as a mitochondrial and a lysosomal nucleoside transporter, the precise connections between hENT3 and the pathophysiology of these disorders remain unresolved. In this study, we performed functional and biochemical characterization of these mutations in hENT3. We report severe reductions/losses of hENT3 nucleoside transport functions of hENT3 syndrome mutants. In addition to transport alterations, we provide evidence for possible loss of hENT3 functions in all H and pigmented hypertrichotic dermatosis with insulin-dependent diabetes syndromes due to either mis-trafficking or altered stability of mutant hENT3 proteins.	[Kang, Nayoung; Jun, Ah Hyun; Bhutia, Yangzom Doma; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Unadkat, Jashvant D.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Washington; University of Washington Seattle	Govindarajan, R (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Rm 234 A,RC Wilson Pharm Bldg, Athens, GA 30602 USA.	rgovinda@rx.uga.edu		Unadkat, Jashvant/0000-0002-4820-8455	NCI, National Institutes of Health [5 P50-CA128613-SPORE]; Department of Pharmaceutical and Biomedical Sciences (University of Georgia); NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Pharmaceutical and Biomedical Sciences (University of Georgia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported, in whole or in part, by NCI, National Institutes of Health Award 5 P50-CA128613-SPORE in Head-and-Neck Cancer (to R. G.). This work was also supported by the Department of Pharmaceutical and Biomedical Sciences (University of Georgia).	Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Flanagan SA, 2007, LEUKEMIA LYMPHOMA, V48, P1816, DOI 10.1080/10428190701528491; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Thomson M, 1998, BBA-MOL CELL RES, V1403, P211, DOI 10.1016/S0167-4889(98)00069-X; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	27	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28343	28352		10.1074/jbc.M110.109199	http://dx.doi.org/10.1074/jbc.M110.109199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595384	Green Published, hybrid			2022-12-27	WOS:000281404100076
J	Singleton, WCJ; McInnes, KT; Cater, MA; Winnall, WR; McKirdy, R; Yu, Y; Taylor, PE; Ke, BX; Richardson, DR; Mercer, JFB; La Fontaine, S				Singleton, William C. J.; McInnes, Kelly T.; Cater, Michael A.; Winnall, Wendy R.; McKirdy, Ross; Yu, Yu; Taylor, Philip E.; Ke, Bi-Xia; Richardson, Des R.; Mercer, Julian F. B.; La Fontaine, Sharon			Role of Glutaredoxin1 and Glutathione in Regulating the Activity of the Copper-transporting P-type ATPases, ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN WILSON PROTEIN; S-GLUTATHIONYLATION; MENKES; TRAFFICKING; EXPRESSION; MECHANISM; BINDING; THIOLTRANSFERASE; INTERPLAY; DOMAINS	The copper-transporting P-type ATPases (Cu-ATPases), ATP7A and ATP7B, are essential for the regulation of intracellular copper homeostasis. In this report we describe new roles for glutathione (GSH) and glutaredoxin1 (GRX1) in Cu homeostasis through their regulation of Cu-ATPase activity. GRX1 is a thiol oxidoreductase that catalyzes the reversible reduction of GSH-mixed disulfides to their respective sulfhydryls (deglutathionylation). Here, we demonstrated that glutathionylation of the Cu-ATPases and their interaction with GRX1 were affected by alterations in Cu levels. The data support our hypothesis that the Cu-ATPases serve as substrates for Cu-dependent GRX1-mediated deglutathionylation. This in turn liberates the Cu-ATPase cysteinyl thiol groups for Cu binding and transport. GSH depletion experiments led to reversible inhibition of the Cu-ATPases that correlated with effects on intracellular Cu levels and GRX1 activity. Finally, knockdown of GRX1 expression resulted in an increase in intracellular Cu accumulation. Together, these data directly implicate GSH and GRX1 with important new roles in redox regulation of the Cu-ATPases, through modulation of Cu binding by the Cu-ATPase cysteine motifs.	[Singleton, William C. J.; McInnes, Kelly T.; McKirdy, Ross; Taylor, Philip E.; Ke, Bi-Xia; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Singleton, William C. J.; McInnes, Kelly T.; McKirdy, Ross; Taylor, Philip E.; Ke, Bi-Xia; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Cater, Michael A.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Winnall, Wendy R.] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3168, Australia; [Yu, Yu; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Deakin University; Deakin University; Monash University; University of Sydney	La Fontaine, S (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	Yu, Yu/AAD-7947-2019; La Fontaine, Sharon/G-7113-2018; Mercer, Julian/R-8583-2019	Yu, Yu/0000-0002-0209-0586; La Fontaine, Sharon/0000-0002-9948-074X; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	Deakin University; National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; University of Sydney Faculty of Medicine; Cancer Institute of New South Wales	Deakin University; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney Faculty of Medicine(University of Sydney); Cancer Institute of New South Wales	This work was supported by grants from Deakin University and the National Health and Medical Research Council of Australia (NHMRC) (to S. L. and J. F. B. M.), a NHMRC biomedical research fellowship (to M. A. C.), a NHMRC senior principal research fellowship and grants from the NHMRC and the Australian Research Council (to D. R. R.), and a University of Sydney Faculty of Medicine postgraduate scholarship and Cancer Institute of New South Wales research scholarship (to Y. Y.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; [Anonymous], 1995, METABOLIC BASIS INHE; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Chen HHW, 2008, MOL PHARMACOL, V74, P697, DOI 10.1124/mol.108.047969; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Craythorn RG, 2009, MOL HUM REPROD, V15, P757, DOI 10.1093/molehr/gap058; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; FREEDMAN JH, 1989, BIOCHEM BIOPH RES CO, V164, P134, DOI 10.1016/0006-291X(89)91693-8; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Miras R, 2008, J BIOL INORG CHEM, V13, P195, DOI 10.1007/s00775-007-0310-2; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Raghavachari N, 2001, INVEST OPHTH VIS SCI, V42, P1002; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shelton MD, 2008, MOL CELLS, V25, P332; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; TERADA T, 1994, BIOCHEM MOL BIOL INT, V32, P239; van den Berghe PVE, 2010, J BIOL INORG CHEM, V15, P37, DOI 10.1007/s00775-009-0592-7; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	52	56	57	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27111	27121		10.1074/jbc.M110.154468	http://dx.doi.org/10.1074/jbc.M110.154468			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566629	hybrid, Green Published			2022-12-27	WOS:000281172700042
J	Spain, MM; Caruso, JA; Swaminathan, A; Pile, LA				Spain, Marla M.; Caruso, Joseph A.; Swaminathan, Aishwarya; Pile, Lori A.			Drosophila SIN3 Isoforms Interact with Distinct Proteins and Have Unique Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; CELLULAR SENESCENCE; STRUCTURAL BASIS; COREPRESSOR; FAMILY; YEAST; COMPONENT; IDENTIFICATION	The SIN3 corepressor serves as a scaffold for the assembly of histone deacetylase (HDAC) complexes. SIN3 and its associated HDAC have been shown to have critical roles in both development and the regulation of cell cycle progression. Although multiple SIN3 isoforms have been reported in simple to complex eukaryotic organisms, the mechanisms by which such isoforms regulate specific biological processes are still largely uncharacterized. To gain insight into how SIN3 isoform-specific function contributes to the growth and development of a metazoan organism, we have affinity-purified two SIN3 isoform-specific complexes, SIN3 187 and 220, from Drosophila S2 cells and embryos. We have identified a number of proteins common to the complexes, including the HDAC RPD3, as well as orthologs of several proteins known to have roles in regulating cell proliferation in other organisms. We additionally identified factors, including the histone demethylase little imaginal discs and histone-interacting protein p55, that exhibited a preferential interaction with the largest SIN3 isoform. Our experiments indicate that the isoforms are associated with distinct HDAC activity and are recruited to unique and shared sites along polytene chromosome arms. Furthermore, although expression of SIN3 220 can substitute for genetic loss of other isoforms, expression of SIN3 187 does not support Drosophila viability. Together our findings suggest that SIN3 isoforms serve distinct roles in transcriptional regulation by partnering with different histone-modifying enzymes.	[Spain, Marla M.; Swaminathan, Aishwarya; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Caruso, Joseph A.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	loripile@wayne.edu	Swaminathan, Aishwarya/I-4242-2019; Caruso, Joseph A./U-8429-2019	Swaminathan, Aishwarya/0000-0001-9082-502X; Caruso, Joseph A./0000-0003-2900-3996	American Cancer Society; Wayne State University; NIEHS, National Institutes of Health [P30-ES006639]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Wayne State University; NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a research scholar grant from the American Cancer Society (to L. A. P.) and graduate enhancement research support from Wayne State University (to M. M. S. and A. S.). The Proteomics Core Facility of the Institute of Environmental Health Sciences at Wayne State University is supported by NIEHS, National Institutes of Health, Grant P30-ES006639.	Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dang VD, 1999, MOL CELL BIOL, V19, P2351; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Ge Z, 2010, FASEB J, V24, P579, DOI 10.1096/fj.09-140087; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Matyash A, 2009, J BIOL CHEM, V284, P3012, DOI 10.1074/jbc.M806163200; McCallum SA, 2006, BIOCHEMISTRY-US, V45, P11974, DOI 10.1021/bi060687l; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Neufeld TP, 1998, GENETICS, V148, P277; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Nourani A, 2003, J BIOL CHEM, V278, P19171, DOI 10.1074/jbc.C300036200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Sambrook J., 2001, MOL CLONING LAB MANU; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vermaak D, 1999, MOL CELL BIOL, V19, P5847; Viiri KM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-149; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; WANG HM, 1993, MOL CELL BIOL, V13, P1805, DOI 10.1128/MCB.13.3.1805; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Zhang W, 2007, EMBO REP, V8, P952, DOI 10.1038/sj.embor.7401049; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao C, 2003, J BIOL CHEM, V278, P43901, DOI 10.1074/jbc.M302714200	69	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27457	27467		10.1074/jbc.M110.130245	http://dx.doi.org/10.1074/jbc.M110.130245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566628	Green Published, hybrid			2022-12-27	WOS:000281172700075
J	Wiley, M; Sweeney, KR; Chan, DA; Brown, KM; McMurtrey, C; Howard, EW; Giaccia, AJ; Blader, IJ				Wiley, Mandi; Sweeney, Kristin R.; Chan, Denise A.; Brown, Kevin M.; McMurtrey, Curtis; Howard, Eric W.; Giaccia, Amato J.; Blader, Ira J.			Toxoplasma gondii Activates Hypoxia-inducible Factor (HIF) by Stabilizing the HIF-1 alpha Subunit via Type I Activin-like Receptor Kinase Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NF-KAPPA-B; GENE-EXPRESSION; MURINE MACROPHAGES; HUMAN FIBROBLASTS; DOWN-REGULATION; IMMUNE EVASION; PROTEIN-KINASE; MESSENGER-RNA; PROLYL	Toxoplasma gondii is an intracellular protozoan parasite that can cause devastating disease in fetuses and immune-compromised individuals. We previously reported that the alpha subunit of the host cell transcription factor, hypoxia-inducible factor-1 (HIF-1), is up-regulated by infection and necessary for Toxoplasma growth. Under basal conditions, HIF-1 alpha is constitutively expressed but rapidly targeted for proteasomal degradation after two proline residues are hydroxylated by a family of prolyl hydroxylases (PHDs). The PHDs are alpha-ketoglutarate-dependent dioxygenases that have low K-m values for oxygen, making them important cellular oxygen sensors. Thus, when oxygen levels decrease, HIF-1 alpha is not hydroxylated, and HIF-1 is activated. How Toxoplasma activates HIF-1 under normoxic conditions remains unknown. Here, we report that Toxoplasma infection increases HIF-1 alpha stability by preventing HIF-1 alpha prolyl hydroxylation. Infection significantly decreases PHD2 abundance, which is the key prolyl hydroxylase for regulating HIF-1 alpha. The effects of Toxoplasma on HIF-1 alpha abundance and prolyl hydroxylase activity require activin-like receptor kinase signaling. Finally, parasite growth is severely diminished when signaling from this family of receptors is inhibited. Together, these data indicate that PHD2 is a key host cell factor for T. gondii growth and represent a novel mechanism by which a microbial pathogen subverts host cell signaling and transcription to establish its replicative niche.	[Wiley, Mandi; Sweeney, Kristin R.; Brown, Kevin M.; McMurtrey, Curtis; Blader, Ira J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Howard, Eric W.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Chan, Denise A.; Giaccia, Amato J.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Chan, Denise A.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; Stanford University	Blader, IJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1019,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.				National Institutes of Health [AI069986]; American Cancer Society [MBC-114461]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI069986. This work was also supported by American Cancer Society Grant MBC-114461 (to I. J. B.).	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arrais-Silva WW, 2005, EXP MOL PATHOL, V78, P49, DOI 10.1016/j.yexmp.2004.09.002; Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; COPPENS I, 2001, EXPERT REV MOL MED, P1; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Goebel S, 1999, MED MICROBIOL IMMUN, V187, P221, DOI 10.1007/s004300050096; HALONEN SK, 1994, J EUKARYOT MICROBIOL, V41, P65, DOI 10.1111/j.1550-7408.1994.tb05936.x; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUNTER CA, 1993, INFECT IMMUN, V61, P4038, DOI 10.1128/IAI.61.10.4038-4044.1993; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2006, J IMMUNOL, V177, P2584, DOI 10.4049/jimmunol.177.4.2584; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Lee SK, 2005, J DERMATOL SCI, V40, P95, DOI 10.1016/j.jdermsci.2005.06.008; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Luder CGK, 1998, CLIN EXP IMMUNOL, V112, P308; Mason NJ, 2004, INFECT IMMUN, V72, P5662, DOI 10.1128/IAI.72.10.5662-5667.2004; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Nakamura M, 2009, VIROLOGY, V387, P442, DOI 10.1016/j.virol.2009.02.036; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nash PB, 1998, J IMMUNOL, V160, P1824; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Payne TM, 2003, J CELL SCI, V116, P4345, DOI 10.1242/jcs.00756; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sinai AP, 1997, J CELL SCI, V110, P2117; Sodhi A, 2000, CANCER RES, V60, P4873; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; SWEENEY KR, 2010, EUKARYOT CELL; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	90	46	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26852	26860		10.1074/jbc.M110.147041	http://dx.doi.org/10.1074/jbc.M110.147041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20581113	hybrid, Green Published			2022-12-27	WOS:000281172700016
J	Bennett, JC; Roggero, CM; Mancifesta, FE; Mayorga, LS				Castillo Bennett, Jimena; Roggero, Carlos M.; Mancifesta, Franco E.; Mayorga, Luis S.			Calcineurin-mediated Dephosphorylation of Synaptotagmin VI Is Necessary for Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; DEPENDENT PROTEIN PHOSPHATASE; LYTIC GRANULE EXOCYTOSIS; PANCREATIC ALPHA-CELLS; MEMBRANE-FUSION; HUMAN SPERMATOZOA; HUMAN SPERM; INHIBITS EXOCYTOSIS; SNARE COMPLEX; CALCIUM	Regulated secretion is a fundamental process underlying the function of many cell types. In particular, acrosomal exocytosis in mammalian sperm is essential for egg fertilization. In general, exocytosis is initiated by a cytosolic calcium increase. In this report we show that calcium affects several factors during human sperm acrosomal exocytosis. By using an antibody that specifically recognizes synaptotagmin VI phosphorylated at the polybasic region of the C2B domain, we showed that a calcium-dependent dephosphorylation of this protein occurred at early stages of the acrosomal exocytosis in streptolysin O-permeabilized sperm. We identified the phosphatase as calcineurin and showed that the activity of this enzyme is absolutely required during the early steps of the secretory process. When added to sperm, an inhibitor-insensitive, catalytically active domain of calcineurin was able to rescue the effect of the specific calcineurin inhibitor cyclosporin A. This same domain dephosphorylated recombinant synaptotagmin VI C2B domain, validating this protein as a new substrate for calcineurin. When sperm were treated with catalytically active calcineurin before stimulation, exocytosis was inhibited, an effect that was rescued by the phosphomimetic synaptotagmin VI C2B-T418E,T419E mutant domain. These observations indicate that synaptotagmin must be dephosphorylated at a specific window of time and suggest that phosphorylated synaptotagmin has an active role at early stages of the acrosomal exocytosis.	[Castillo Bennett, Jimena; Roggero, Carlos M.; Mancifesta, Franco E.; Mayorga, Luis S.] Univ Nacl Cuyo, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Mayorga, LS (corresponding author), Casilla Correo 56, RA-5500 Mendoza, Argentina.	lmayorga@fcm.uncu.edu.ar	Roggero, Carlos/AAX-4354-2020	Mayorga, Luis S/0000-0002-5995-0671; Castillo Bennett, Jimena/0000-0001-8651-7083	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina)	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Universidad Nacional de Cuyo, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Agencia Nacional de Promocion Cienti\fica y Tecnologica (Argentina).	Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Ashizawa K, 2004, REPRODUCTION, V128, P783, DOI 10.1530/rep.1.00327; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; Brachya G, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S4; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Grybko MJ, 2007, J BIOL CHEM, V282, P18009, DOI 10.1074/jbc.M702222200; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hoy M, 2001, J BIOL CHEM, V276, P924, DOI 10.1074/jbc.M007562200; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Kee Y, 1996, J NEUROSCI, V16, P1975; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Liu P, 2005, BIOCHIMIE, V87, P215, DOI 10.1016/j.biochi.2004.10.009; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; MOMAYEZI M, 1987, J CELL BIOL, V105, P181, DOI 10.1083/jcb.105.1.181; MORIYA M, 1995, CELL TISSUE RES, V281, P273, DOI 10.1007/s004410050424; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; Pores-Fernando AT, 2009, CELL IMMUNOL, V254, P105, DOI 10.1016/j.cellimm.2008.07.004; Raufman JP, 1997, BBA-MOL CELL RES, V1357, P73, DOI 10.1016/S0167-4889(97)00023-2; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Yanagimachi R., 1994, P189; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200	52	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26269	26278		10.1074/jbc.M109.095752	http://dx.doi.org/10.1074/jbc.M109.095752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551332	hybrid, Green Published			2022-12-27	WOS:000280921000044
J	Emery, AC; Pshenichkin, S; Takoudjou, GR; Grajkowska, E; Wolfe, BB; Wroblewski, JT				Emery, Andrew C.; Pshenichkin, Sergey; Takoudjou, Guy Rodrigue; Grajkowska, Ewa; Wolfe, Barry B.; Wroblewski, Jarda T.			The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, beta-Arrestin-1-dependent ERK Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ELEMENT-BINDING PROTEIN; GLUTAMATE-RECEPTOR-1 INTERNALIZATION; DEPENDENCE RECEPTOR; REGULATED KINASES; ACTIVATION; AGONIST; CELLS; ANTAGONIST; PATHWAYS	Metabotropic glutamate receptor 1 (mGlu1) is a G protein-coupled receptor that enhances the hydrolysis of membrane phosphoinositides. In addition to its role in synaptic transmission and plasticity, mGlu1 has been shown to be involved in neuroprotection and neurodegeneration. In this capacity, we have reported previously that in neuronal cells, mGlu1a exhibits the properties of a dependence receptor, inducing apoptosis in the absence of glutamate, while promoting neuronal survival in its presence (Pshenichkin, S., Dolinska, M., Klauzinska, M., Luchenko, V., Grajkowska, E., and Wroblewski, J. T. (2008) Neuropharmacology 55, 500-508). Here, using CHO cells expressing mGlu1a receptors, we show that the protective effect of glutamate does not rely on the classical mGlu1 signal transduction. Instead, mGlu1a protective signaling is mediated by a novel, G protein-independent, pathway which involves the activation of the MAPK pathway and a sustained phosphorylation of ERK, which is distinct from the G protein-mediated transient ERK phosphorylation. Moreover, the sustained phosphorylation of ERK and protective signaling through mGlu1a receptors require expression of beta-arrestin-1, suggesting a possible role for receptor internalization in this process. Our data reveal the existence of a novel, noncanonical signaling pathway associated with mGlu1a receptors, which mediates glutamate-induced protective signaling.	[Wroblewski, Jarda T.] Georgetown Univ, Dept Pharmacol, Med Ctr, Washington, DC 20057 USA; [Emery, Andrew C.; Pshenichkin, Sergey; Wolfe, Barry B.; Wroblewski, Jarda T.] Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC 20057 USA	Georgetown University; Georgetown University	Wroblewski, JT (corresponding author), Georgetown Univ, Dept Pharmacol, Med Ctr, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	wroblewj@georgetown.edu		Emery, Andrew/0000-0002-6760-2570	National Institutes of Health [NS37436]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037436, T32NS041218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS37436.	ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; BLEAKMAN D, 1992, MOL PHARMACOL, V42, P192; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Broca C, 2009, J BIOL CHEM, V284, P4332, DOI 10.1074/jbc.M807595200; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; BRUNO V, 1994, EUR J PHARMACOL, V256, P109, DOI 10.1016/0014-2999(94)90624-6; CHAO MV, 2003, SCI STKE, pPE38; Choe ES, 2001, MOL BRAIN RES, V94, P75, DOI 10.1016/S0169-328X(01)00217-0; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diviani D, 1996, J BIOL CHEM, V271, P5049; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Lavreysen H, 2004, NEUROPHARMACOLOGY, V47, P961, DOI 10.1016/j.neuropharm.2004.08.007; Litschig S, 1999, MOL PHARMACOL, V55, P453; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mundell SJ, 2002, MOL PHARMACOL, V61, P1114, DOI 10.1124/mol.61.5.1114; Mundell SJ, 2001, J NEUROCHEM, V78, P546, DOI 10.1046/j.1471-4159.2001.00421.x; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; PIN JP, 1995, NEUROPHARMACOLOGY, V1, P1; Pshenichkin S, 2008, NEUROPHARMACOLOGY, V55, P500, DOI 10.1016/j.neuropharm.2008.06.039; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheffler DJ, 2008, NEUROPHARMACOLOGY, V55, P419, DOI 10.1016/j.neuropharm.2008.06.047; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; SILIPRANDI R, 1992, EUR J PHARMACOL, V219, P173, DOI 10.1016/0014-2999(92)90598-X; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533	49	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26041	26048		10.1074/jbc.M110.139899	http://dx.doi.org/10.1074/jbc.M110.139899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566651	Green Published, hybrid			2022-12-27	WOS:000280921000019
J	McAllister-Lucas, LM; Jin, XH; Gu, SF; Siu, K; McDonnell, S; Ruland, J; Delekta, PC; Van Beek, M; Lucas, PC				McAllister-Lucas, Linda M.; Jin, Xiaohong; Gu, Shufang; Siu, Katy; McDonnell, Scott; Ruland, Juergen; Delekta, Phillip C.; Van Beek, Matthew; Lucas, Peter C.			The CARMA3-Bcl10-MALT1 Signalosome Promotes Angiotensin II-dependent Vascular Inflammation and Atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; MALT1; ATHEROSCLEROSIS; LYMPHOCYTES; CARMA1; PATHOGENESIS; SYSTEM; BCL10	The CARMA1, Bcl10, and MALT1 proteins together constitute a signaling complex (CBM signalosome) that mediates antigen-dependent activation of NF-kappa B in lymphocytes, thereby representing a cornerstone of the adaptive immune response. Although CARMA1 is restricted to cells of the immune system, the analogous CARMA3 protein has a much wider expression pattern. Emerging evidence suggests that CARMA3 can substitute for CARMA1 in non-immune cells to assemble a CARMA3-Bcl10-MALT1 signalosome and mediate G protein-coupled receptor activation of NF-kappa B. Here we show that one G protein-coupled receptor, the type 1 receptor for angiotensin II, utilizes this mechanism for activation of NF-kappa B in endothelial and vascular smooth muscle cells, thereby inducing pro-inflammatory signals within the vasculature, a key factor in atherogenesis. Further, we demonstrate that Bcl10-deficient mice are protected from developing angiotensin-dependent atherosclerosis and aortic aneurysms. By uncovering a novel vascular role for the CBM signalosome, these findings illustrate that CBM-dependent signaling has functions outside the realm of adaptive immunity and impacts pathobiology more broadly than previously known.	[Jin, Xiaohong; Siu, Katy; McDonnell, Scott; Delekta, Phillip C.; Van Beek, Matthew; Lucas, Peter C.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [McAllister-Lucas, Linda M.; Gu, Shufang] Univ Michigan, Dept Pediat & Communicable Dis, Sch Med, Ann Arbor, MI 48109 USA; [Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, D-85764 Neuherberg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lucas, PC (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 3510 MSRB 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu	Nuñez, Gabriel/A-7160-2014; Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597; Lucas, Peter/0000-0003-4880-7172	National Institutes of Health [R01-HL082914, R01-DK079973]; Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School; Nathan Shock Center [AG013283]; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School; Nathan Shock Center; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL082914 and R01-DK079973 (to P. C. L.). This work was also supported by a grant from the Anatomic Pathology Division of the Pathology Department at The University of Michigan Medical School, a grant from the Nathan Shock Center (National Institutes of Health Grant AG013283), and the Shirley K. Schlafer Foundation.	Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Boisvert WA, 2004, TRENDS CARDIOVAS MED, V14, P161, DOI 10.1016/j.tcm.2004.02.006; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Fukuda D, 2008, PHARMACOL THERAPEUT, V118, P268, DOI 10.1016/j.pharmthera.2008.02.007; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li XC, 2008, CURR OPIN NEPHROL HY, V17, P37, DOI 10.1097/MNH.0b013e3282f2903c; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Sagaert X, 2007, LEUKEMIA, V21, P389, DOI 10.1038/sj.leu.2404517; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; WEGENER E, 2007, SCI STKE, pPE21; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	24	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25880	25884		10.1074/jbc.C110.109421	http://dx.doi.org/10.1074/jbc.C110.109421			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20605784	hybrid, Green Published			2022-12-27	WOS:000280921000002
J	Bitew, T; Sveen, CE; Heyne, B; Zaremberg, V				Bitew, Teshager; Sveen, Christopher E.; Heyne, Belinda; Zaremberg, Vanina			Vitamin E Prevents Lipid Raft Modifications Induced by an Anti-cancer Lysophospholipid and Abolishes a Yap1-mediated Stress Response in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BUDDING YEAST; NUCLEAR-LOCALIZATION; TRANSCRIPTION FACTOR; MASS-SPECTROMETRY; APOPTOSIS; CELLS	We have previously established that the anti-cancer lysophospholipid edelfosine (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, Et-18-OCH3) induces cell death in yeast by selective modification of lipid raft composition at the plasma membrane. In this study we determined that alpha-tocopherol protects cells from the edelfosine cytotoxic effect, preventing the internalization of sterols and the plasma membrane proton pump ATPase, Pma1p. Two non-mutually exclusive hypotheses were considered to explain the protective effect of alpha-tocopherol: (i) its classical antioxidant activity is necessary to break progression of lipid peroxidation, despite the fact Saccharomyces cerevisiae does not possess polyunsaturated fatty acids and (ii) due to its complementary cone shape, insertion of alpha-tocopherol could correct membrane curvature stress imposed by edelfosine (inverted cone shape). We then developed tools to distinguish between these two hypotheses and dissect the structural requirements that confer alpha-tocopherol its protective effect. Our results indicated its lipophilic nature and the H donating hydroxyl group from the chromanol ring are both required to counteract the cytotoxic effect of edelfosine, suggesting edelfosine induces oxidation of membrane components. To further support this finding and learn more about the early cellular response to edelfosine we investigated the role that known oxidative stress signaling pathways play in modulating sensitivity to the lipid drug. Our results indicate the transcription factors Yap1 and Skn7 as well as the major peroxiredoxin, Tsa1, mediate a response to edelfosine. Interestingly, the pathway differed from the one triggered by hydrogen peroxide and its activation (measured as Yap1 translocation to the nucleus) was abolished by co-treatment of the cells with alpha-tocopherol.	[Bitew, Teshager; Sveen, Christopher E.; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Sveen, Christopher E.; Heyne, Belinda] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Zaremberg, V (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca		Heyne, Belinda/0000-0003-1655-6719	National Sciences and Engineering Research Council (NSERC)	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the National Sciences and Engineering Research Council (NSERC) (to B. H. and V. Z.) and a University Faculty Award from NSERC (to V. Z.).	Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bocking T, 2000, EUR J BIOCHEM, V267, P1607, DOI 10.1046/j.1432-1327.2000.01179.x; Busto JV, 2007, BBA-BIOMEMBRANES, V1768, P1855, DOI 10.1016/j.bbamem.2007.04.025; Busto Jon V, 2008, J Chem Biol, V1, P89, DOI 10.1007/s12154-008-0009-z; Cipak A, 2008, BBA-MOL CELL BIOL L, V1781, P283, DOI 10.1016/j.bbalip.2008.03.010; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Neuzil H, 2002, BIOCHEM BIOPH RES CO, V293, P1309, DOI 10.1016/S0006-291X(02)00358-3; Neuzil J, 2005, BIOCHEM BIOPH RES CO, V327, P1024, DOI 10.1016/j.bbrc.2004.12.115; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Sambrook J., 2001, MOL CLONING LAB MANU; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; Vrablic AS, 2001, FASEB J, V15, P1739, DOI 10.1096/fj.00-0300com; Wagner BA, 1998, CANCER RES, V58, P2809; WAGNER BA, 1992, CANCER RES, V52, P6045; Wagner BA, 1996, ARCH BIOCHEM BIOPHYS, V334, P261, DOI 10.1006/abbi.1996.0454; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhang H, 2007, ACTA PHARMACOL SIN, V28, P888, DOI 10.1111/j.1745-7254.2007.00568.x	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25731	25742		10.1074/jbc.M110.122200	http://dx.doi.org/10.1074/jbc.M110.122200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538604	hybrid, Green Published			2022-12-27	WOS:000280682400066
J	Chen, JS; Hsu, YM; Chen, CC; Chen, LL; Lee, CC; Huang, TS				Chen, Jinn-Shiun; Hsu, Yuan-Ming; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing			Secreted Heat Shock Protein 90 alpha Induces Colorectal Cancer Cell Invasion through CD91/LRP-1 and NF-kappa B-mediated Integrin alpha(V) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90; HSP90-ALPHA; RECEPTOR; HEAT-SHOCK-PROTEIN-90; INDUCTION; MIGRATION; CHAPERONE; EXOSOMES; MOTILITY; SURFACE	HCT-8 colon cancer cells secreted heat shock protein 90 alpha (HSP90 alpha) and had increased invasiveness upon serum starvation. The concentrated conditioned medium of serum-starved HCT-8 cells was able to stimulate the migration and invasion of non-serum-starved cells, which could be prevented by treatment with an anti-HSP90 alpha antibody. Recombinant HSP90 alpha (rHSP90 alpha) also enhanced HCT-8 cell migration and invasion, suggesting a stimulatory role of secreted HSP90 alpha in cancer malignancy. HSP90 alpha binding to CD91 alpha and Neu was evidenced by the proximity ligation assay, and rHSP90 alpha-induced HCT-8 cell invasion could be suppressed by the addition of anti-CD91 alpha or anti-Neu antibodies. Via CD91 alpha and Neu, rHSP90 alpha selectively induced integrin alpha(V) expression, and knockdown of integrin alpha(V) efficiently blocked rHSP90 alpha-induced HCT-8 cell invasion. rHSP90 alpha induced the activities of ERK, PI3K/Akt, and NF-kappa B p65, but only NF-kappa B activation was involved in HSP90 alpha induced integrin alpha(V) expression. Additionally, we investigated the serum levels of HSP90 alpha and the expression status of tumor integrin alpha(V) mRNA in colorectal cancer patients. Serum HSP90 alpha levels of colorectal cancer patients were significantly higher than those of normal volunteers (p < 0.001). Patients with higher serum HSP90 alpha levels significantly exhibited elevated levels of integrin alpha(V) mRNA in tumor tissues as compared with adjacent non-tumor tissues (p < 0.001). Furthermore, tumor integrin alpha(V) overexpression was significantly correlated with TNM (Tumor, Node, Metastasis) staging (p = 0.001).	[Chen, Jinn-Shiun] Chang Gung Univ, Chang Gung Mem Hosp, Div Colorectal Surg, Tao Yuan 333, Taiwan; [Hsu, Yuan-Ming; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli 350, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010	Huang, Tze-Sing/0000-0001-8736-4330; 	National Health Research Institutes [CA-097-PP-13, CA-098-PP-10]; Chang Gung Memorial Hospital [CMRPG361691]; Department of Health, Taiwan, Republic of China [DOH99-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Taiwan, Republic of China	This work was supported by Grants CA-097-PP-13 and CA-098-PP-10 from the National Health Research Institutes, Grant CMRPG361691 from Chang Gung Memorial Hospital, and Grant DOH99-TD-C-111-004 from the Department of Health, Taiwan, Republic of China.	Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; De Filippo A, 2008, J IMMUNOL, V181, P6525, DOI 10.4049/jimmunol.181.9.6525; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Max R, 1997, INT J CANCER, V71, P320, DOI 10.1002/(SICI)1097-0215(19970502)71:3<320::AID-IJC2>3.3.CO;2-3; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xu A, 2007, J CANC MOL, V3, P107; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	23	85	96	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25458	25466		10.1074/jbc.M110.139345	http://dx.doi.org/10.1074/jbc.M110.139345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558745	Green Published, hybrid			2022-12-27	WOS:000280682400039
J	Misumi, S; Inoue, M; Dochi, T; Kishimoto, N; Hasegawa, N; Takamune, N; Shoji, S				Misumi, Shogo; Inoue, Mutsumi; Dochi, Takeo; Kishimoto, Naoki; Hasegawa, Naomi; Takamune, Nobutoki; Shoji, Shozo			Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; CYCLE-DEPENDENT PHOSPHORYLATION; FLIGHT MASS-SPECTROMETRY; HIV-1 CAPSID PROTEIN; INTRACELLULAR TRAFFICKING; IN-VITRO; CELL; INFECTION; DOMAIN; GENE	The process by which the human immunodeficiency virus type 1 (HIV-1) conical core dissociates is called uncoating, but not much is known about this process. Here, we show that the uncoating process requires the interaction of the capsid (CA) protein with the peptidyl-prolyl isomerase Pin1 that specifically recognizes the phosphorylated serine/threonine residue followed by proline. We found that the HIV-1 core is composed of some isoforms of the CA protein with different isoelectric points, and one isoform is preferentially phosphorylated in the Ser(16)-Pro(17) motif. The mutant virus S16A/P17A shows a severely attenuated HIV-1 replication and an impaired reverse transcription. The S16A/P17A change increased the amount of particulate CA cores in the cytosol of target cells and correlated with the restriction of HIV-1 infection. Glutathione S-transferase pulldown assays demonstrated a direct interaction between Pin1 and the HIV-1 core via the Ser(16)-Pro(17) motif. Suppression of Pin1 expression by RNA interference in a target cell results in an attenuated HIV-1 replication and increases the amount of particulate CA cores in the cytosol of target cells. Furthermore, heat-inactivated, inhibitor-treated, or W34A/K63A Pin1 causes an attenuated in vitro uncoating of the HIV-1 core. The Pin1-dependent uncoating is inhibited by antisera raised against a CA peptide phosphorylated at Ser(16) or treatment of the HIV-1 core with alkaline phosphatase. These findings provide insights into this obscure uncoating process in the HIV-1 life cycle and a new cellular target for HIV-1 drug development.	[Misumi, Shogo; Shoji, Shozo] Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Shoji, Shozo] Kumamoto Hlth Sci Univ, Kumamoto 8615598, Japan	Kumamoto University; Kumamoto Health Science University	Misumi, S (corresponding author), Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	misumi@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science [217212]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Health Science Research Grant from the Ministry of Health, Labour, and Welfare of Japan.; Recipient of Japan Society for the Promotion of Science for Young Scientists Research Fellowship 217212.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Auewarakul P, 2005, VIROLOGY, V337, P93, DOI 10.1016/j.virol.2005.02.028; Dvorin JD, 2003, CURR TOP MICROBIOL, V281, P179; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Fuchigami T, 2002, BIOCHEM BIOPH RES CO, V293, P1107, DOI 10.1016/S0006-291X(02)00329-7; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Kawano Y, 1997, J VIROL, V71, P8456, DOI 10.1128/JVI.71.11.8456-8466.1997; LAURENT AG, 1989, J VIROL, V63, P4074, DOI 10.1128/JVI.63.9.4074-4078.1989; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; Misumi S, 2002, J VIROL, V76, P10000, DOI 10.1128/JVI.76.19.10000-10008.2002; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; VERONESE FD, 1988, J VIROL, V62, P795, DOI 10.1128/JVI.62.3.795-801.1988; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	30	50	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25185	25195		10.1074/jbc.M110.114256	http://dx.doi.org/10.1074/jbc.M110.114256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529865	Green Published, hybrid			2022-12-27	WOS:000280682400011
J	Pecheur, EI; Diaz, O; Molle, J; Icard, V; Bonnafous, P; Lambert, O; Andre, P				Pecheur, Eve-Isabelle; Diaz, Olivier; Molle, Jennifer; Icard, Vinca; Bonnafous, Pierre; Lambert, Olivier; Andre, Patrice			Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MEMBRANE-FUSION; CRYOELECTRON MICROSCOPY; PLASMA-LIPOPROTEINS; APOLIPOPROTEIN-B; PARTICLES; ASSOCIATION; DETERMINANTS; REPLICATION; RESISTANCE	The density of hepatitis C virus (HCV) particles circulating in the blood of chronically infected patients and of cell-culture produced HCV is heterogeneous. Specific infectivity and fusion of low density particles are higher than those of high density particles. We recently characterized hybrid particles produced by Caco-2 colon or Huh-7.5 liver cells transduced with HCV E1 and E2 envelope glycoproteins. Caco-2-derived particles, called empty lipo-viral particles (eLVP), are composed of triglyceride-rich lipoproteins positive for apolipoproteins B (i.e. apoB100 and apoB48) and contain HCV E1 and E2. Here we aimed at characterizing the morphology and in vitro fusion properties of eLVP using electron microscopy and fluorescence spectroscopy. They displayed the aspect of beta-lipoproteins, and immunogold labeling confirmed the presence of apoB and HCV E1 and E2 at their surface. These particles are able to fuse with lipid bilayers (liposomes) in a fusion process leading to the coalescence of internal contents of triglyceride-rich lipoproteins particles and liposomes. Fusion was pH-dependent and could be inhibited by either Z-fFG, a peptide known to inhibit viral fusion, or by monoclonal antibodies directed against HCV E2 or the apolipoprotein moiety of the hybrid particle. Interestingly, particles derived from Huh-7.5 cells failed to display equivalent efficient fusion. Optimal fusion activity is, thus, observed when HCV envelope proteins are associated to apoB-positive hybrid particles. Our results, therefore, point to a crucial role of the E1 and E2 proteins in HCV fusion with a subtle interplay with the apolipoprotein part of eLVP.	[Pecheur, Eve-Isabelle; Molle, Jennifer] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, Lyon BioSci Gerland IFR128,UMR 5086, F-69007 Lyon, France; [Bonnafous, Pierre; Lambert, Olivier] Univ Bordeaux 1, CNRS, Inst Europeen Chim & Biol, UMR 5248, F-33405 Talence, France; [Diaz, Olivier; Andre, Patrice] INSERM, Lyon BioSci Gerland IFR128, U851, F-69007 Lyon, France; [Icard, Vinca; Andre, Patrice] Hosp Civils Lyon, Lab Virol Nord, F-69004 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Pecheur, EI (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, Lyon BioSci Gerland IFR128,UMR 5086, F-69007 Lyon, France.	patrice.andre@inserm.fr; patrice.andre@inserm.fr	André, Patrice/M-8139-2014; Bonnafous, Pierre/M-7845-2014; diaz, olivier/M-8112-2014	André, Patrice/0000-0002-5834-7395; diaz, olivier/0000-0002-3451-9914; Pecheur, Eve/0000-0002-8613-862X; Lambert, Olivier/0000-0002-5651-8082	CNRS; INSERM; Agence Nationale de Recherche contre le SIDA et les hepatites virales	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de Recherche contre le SIDA et les hepatites virales(French National Research Agency (ANR))	This work was supported by the CNRS, INSERM, and the Agence Nationale de Recherche contre le SIDA et les hepatites virales (to E.-I. P. and P. A.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; BONNAFOUS P, 2010, J GEN VIROL IN PRESS; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; DENTINO AR, 1995, BBA-BIOMEMBRANES, V1235, P213, DOI 10.1016/0005-2736(95)80007-3; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; FORTE T, 1971, J CLIN INVEST, V50, P1141, DOI 10.1172/JCI106586; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; KELSEY DR, 1990, J BIOL CHEM, V265, P12178; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2001, FIELDS VIROLOGY, V1, P991; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murphy D, 2007, HEPATOLOGY, V46, p623A; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Owens JA, 2009, J AM ACAD CHILD PSY, V48, P99, DOI [10.1097/CHI.0b013e3181930639, 10.1097/CHI.0b013e181930639]; PAWLOTSKY JM, 2010, GASTROENTEROLOGY, V138; Pumeechockchai W, 2002, J MED VIROL, V68, P335, DOI 10.1002/jmv.10208; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Segrest JP, 2001, J LIPID RES, V42, P1346; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SMITH LC, 1978, ANNU REV BIOCHEM, V47, P751, DOI 10.1146/annurev.bi.47.070178.003535; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; THEOLIS R, 1984, ARTERIOSCLEROSIS, V4, P498, DOI 10.1161/01.ATV.4.5.498; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; VANANTWERPEN R, 1994, J LIPID RES, V35, P2223; vanAntwerpen R, 1997, J LIPID RES, V38, P659; WILSCHUT J, 1979, NATURE, V281, P690, DOI 10.1038/281690a0; WILSCHUT J, 1980, BIOCHEMISTRY-US, V19, P6011, DOI 10.1021/bi00567a011; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25802	25811		10.1074/jbc.M110.131664	http://dx.doi.org/10.1074/jbc.M110.131664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551330	hybrid, Green Published			2022-12-27	WOS:000280682400072
J	Baluchamy, S; Ravichandran, P; Periyakaruppan, A; Ramesh, V; Hall, JC; Zhang, Y; Jejelowo, O; Gridley, DS; Wu, HL; Ramesh, GT				Baluchamy, Sudhakar; Ravichandran, Prabakaran; Periyakaruppan, Adaikkappan; Ramesh, Vani; Hall, Joseph C.; Zhang, Ye; Jejelowo, Olufisayo; Gridley, Daila S.; Wu, Honglu; Ramesh, Govindarajan T.			Induction of Cell Death through Alteration of Oxidants and Antioxidants in Lung Epithelial Cells Exposed to High Energy Protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; CARBON NANOTUBES; REACTIVE OXYGEN; APOPTOSIS; CANCER; DAMAGE	Radiation affects several cellular and molecular processes, including double strand breakage and modifications of sugar moieties and bases. In outer space, protons are the primary radiation source that poses a range of potential health risks to astronauts. On the other hand, the use of proton irradiation for tumor radiation therapy is increasing, as it largely spares healthy tissues while killing tumor tissues. Although radiation-related research has been conducted extensively, the molecular toxicology and cellular mechanisms affected by proton irradiation remain poorly understood. Therefore, in this study, we irradiated rat lung epithelial cells with different doses of protons and investigated their effects on cell proliferation and death. Our data show an inhibition of cell proliferation in proton-irradiated cells with a significant dose-dependent activation and repression of reactive oxygen species and antioxidants glutathione and superoxide dismutase, respectively, compared with control cells. In addition, the activities of apoptosis-related genes such as caspase-3 and -8 were induced in a dose-dependent manner with corresponding increased levels of DNA fragmentation in proton-irradiated cells compared with control cells. Together, our results show that proton irradiation alters oxidant and antioxidant levels in cells to activate the apoptotic pathway for cell death.	[Baluchamy, Sudhakar; Ravichandran, Prabakaran; Ramesh, Vani; Hall, Joseph C.; Ramesh, Govindarajan T.] Norfolk State Univ, Mol Toxicol Lab, Ctr Biotechnol & Biomed Sci, Dept Biol, Norfolk, VA 23504 USA; [Periyakaruppan, Adaikkappan; Jejelowo, Olufisayo] Texas So Univ, Dept Biol, Houston, TX 77004 USA; [Zhang, Ye; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Radiat Biophys Lab, Houston, TX 77058 USA; [Zhang, Ye; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Human Adaptat & Countermeasures Div, Houston, TX 77058 USA; [Gridley, Daila S.] Loma Linda Univ, Med Ctr, Dept Radiat Med, Loma Linda, CA 92354 USA	Norfolk State University; Texas Southern University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Loma Linda University	Ramesh, GT (corresponding author), Norfolk State Univ, Mol Toxicol Lab, Ctr Biotechnol & Biomed Sci, Dept Biol, Norfolk, VA 23504 USA.	gtramesh@nsu.edu	Gridley, Daila S/P-7711-2015; Periyakaruppan, Adaikkappan/B-7398-2013	Periyakaruppan, Adaikkappan/0000-0002-0395-6564	NIH [1P20MD001822-1]; NASA [NNX08BA47A, NCC-1-02038]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, by NIH (1P20MD001822-1) and NASA Grants NNX08BA47A and NCC-1-02038.	BALUCHAMY S, 2010, IN VITRO CELL DEV, DOI DOI 10.1007/S-11626-010-9330-2; Baluchamy S, 2010, MOL CELL BIOCHEM, V341, P207, DOI 10.1007/s11010-010-0451-4; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1; Dominguez-Rodriguez JR, 2001, ANTICANCER RES, V21, P1869; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; NCRP, 1989, 98 NCRP; Periyakaruppan A, 2007, ARCH TOXICOL, V81, P389, DOI 10.1007/s00204-006-0167-0; Ravichandran P, 2009, J BIOCHEM MOL TOXIC, V23, P333, DOI 10.1002/jbt.20296; Schimmerling Walter, 2003, Gravit Space Biol Bull, V16, P5; Sharma CS, 2007, J NANOSCI NANOTECHNO, V7, P2466, DOI 10.1166/jnn.2007.431; Stein TP, 2000, AM J PHYSIOL-ENDOC M, V278, pE375, DOI 10.1152/ajpendo.2000.278.3.E375; Wise KC, 2005, IN VITRO CELL DEV-AN, V41, P118; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; WOOD DH, 1991, RADIAT RES, V126, P132, DOI 10.2307/3577811; Zhao YF, 2001, ANTIOXID REDOX SIGN, V3, P375, DOI 10.1089/15230860152409022	20	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24769	24774		10.1074/jbc.M110.138099	http://dx.doi.org/10.1074/jbc.M110.138099			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538614	Green Published, hybrid			2022-12-27	WOS:000280542100049
J	Wang, L; Barylko, B; Byers, C; Ross, JA; Jameson, DM; Albanesi, JP				Wang, Lei; Barylko, Barbara; Byers, Christopher; Ross, Justin A.; Jameson, David M.; Albanesi, Joseph P.			Dynamin 2 Mutants Linked to Centronuclear Myopathies Form Abnormally Stable Polymers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTPASE ACTIVITY; ACTIVATION; MUTATIONS	Mutations in the dynamin 2 gene have been identified in patients with autosomal dominant forms of centronuclear myopathy (CNM). Dynamin 2 is a ubiquitously expressed similar to 100kDa GTPase that assembles around the necks of vesiculating membranes and promotes their constriction and scission. It has also been implicated in regulation of the actin and microtubule cytoskeletons. At present, the cellular functions of dynamin 2 that are affected by CNM-linked mutations are not well defined, and the effects of these mutations on the physical and enzymatic properties of dynamin have been not examined. Here, we report the expression, purification, and characterization of four CNM-associated dynamin mutants. All four mutants display higher than wild-type GTPase activities, and more importantly, the mutants form high order oligomers that are significantly more resistant than wild-type dynamin 2 to disassembly by guanine nucleotides or high ionic strength. These observations suggest that the corresponding wild-type residues serve to prevent excessive or prolonged dynamin assembly on cellular membranes or inappropriate self-assembly in the cytoplasm. To our knowledge, this report contains the first identification of point mutations that enhance the stability of dynamin polymers without impairing their ability to bind and/or hydrolyze GTP. We envision that the formation of abnormally large and stable complexes of these dynamin mutants in vivo contributes to their role in CNM pathogenesis.	[Wang, Lei; Barylko, Barbara; Byers, Christopher; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Ross, Justin A.; Jameson, David M.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Hawaii System	Albanesi, JP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	joseph.albanesi@utsouthwestern.edu			National Institutes of Health [R01 GM076665]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076665.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eccleston JF, 2002, EUR BIOPHYS J BIOPHY, V31, P275, DOI 10.1007/s00249-002-0226-2; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Jungbluth H, 2010, NEUROMUSCULAR DISORD, V20, P49, DOI 10.1016/j.nmd.2009.10.005; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Scaife R, 1998, BIOCHEMISTRY-US, V37, P17673, DOI 10.1021/bi981180g; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yang ZY, 2001, J BIOL CHEM, V276, P4251, DOI 10.1074/jbc.M006371200	36	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22751	22755		10.1074/jbc.C110.130013	http://dx.doi.org/10.1074/jbc.C110.130013			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20529869	Green Published, hybrid			2022-12-27	WOS:000279999900006
J	Okuyama, T; Inoue, H; Ookuma, S; Satoh, T; Kano, K; Honjoh, S; Hisamoto, N; Matsumoto, K; Nishida, E				Okuyama, Tetsuya; Inoue, Hideki; Ookuma, Sadatsugu; Satoh, Takayuki; Kano, Kei; Honjoh, Sakiko; Hisamoto, Naoki; Matsumoto, Kunihiro; Nishida, Eisuke			The ERK-MAPK Pathway Regulates Longevity through SKN-1 and Insulin-like Signaling in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; C-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; KINASE; CELLS; DAF-2; MITOGEN; PROTEIN; ACTIVATION	It has not been determined yet whether the ERK-MAPK pathway regulates longevity of metazoans. Here, we show that the Caenorhabditis elegans ERK cascade promotes longevity through the two longevity-promoting transcription factors, SKN-1 and DAF-16. We find that RNAi of three genes, which constitute the ERK cascade (lin-45/RAF1, mek-2/MEK1/2, and mpk-1/ERK1/2), results in reduction of life span. Moreover, RNAi of lip-1, the gene encoding a MAPK phosphatase that inactivates MPK-1, increases life span. Epistasis analyses show that the ERK (MPK-1) cascade-mediated life span extension requires SKN-1, whose function is mediated, at least partly, through DAF-2/DAF-16 insulin-like signaling. MPK-1 phosphorylates SKN-1 on the key sites that are required for SKN-1 nuclear accumulation. Our results also show that one mechanism by which SKN-1 regulates insulin-like signaling is through the regulation of expression of insulin-like peptides. Our findings thus identify a novel ERK-MAPK-mediated signaling pathway that promotes longevity.	[Nishida, Eisuke] Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Hisamoto, Naoki; Matsumoto, Kunihiro] Nagoya Univ, Dept Mol Biol, Grad Sch Sci, Inst Adv Res,Chikusa Ku, Nagoya, Aichi 4648602, Japan	Kyoto University; Nagoya University	Nishida, E (corresponding author), Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	nishida@lif.kyoto-u.ac.jp		Inoue, Hideki/0000-0002-4301-1936	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institutes of Health NCRR; Grants-in-Aid for Scientific Research [21227004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E.N.).; C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health NCRR. We thank members of the Nishida laboratory for technical comments and helpful discussions.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BRENNER S, 1974, GENETICS, V77, P71; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Gems D, 1998, GENETICS, V150, P129; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Lackner MR, 1998, GENETICS, V150, P103; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; Lee MH, 2006, EMBO J, V25, P88, DOI 10.1038/sj.emboj.7600901; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Manning Gerard, 2005, WormBook, P1; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sundaram Meera V, 2006, WormBook, P1; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	38	64	74	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30274	30281		10.1074/jbc.M110.146274	http://dx.doi.org/10.1074/jbc.M110.146274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624915	hybrid, Green Published			2022-12-27	WOS:000281984300063
J	Winther, AML; Liu, HZ; Sonntag, Y; Olesen, C; le Maire, M; Soehoel, H; Olsen, CE; Christensen, SB; Nissen, P; Moller, JV				Winther, Anne-Marie L.; Liu, Huizhen; Sonntag, Yonathan; Olesen, Claus; le Maire, Marc; Soehoel, Helmer; Olsen, Carl-Erik; Christensen, S. Brogger; Nissen, Poul; Moller, Jesper V.			Critical Roles of Hydrophobicity and Orientation of Side Chains for Inactivation of Sarcoplasmic Reticulum Ca2+-ATPase with Thapsigargin and Thapsigargin Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ TRANSPORT ATPASE; CRYSTAL-STRUCTURE; CALCIUM-PUMP; KINETIC CHARACTERIZATION; CYCLOPIAZONIC ACID; INHIBITION; BINDING; CRYSTALLOGRAPHY; PERTURBATION; TOOL	Thapsigargin (Tg), a specific inhibitor of sarco/endoplasmic Ca2+-ATPases (SERCA), binds with high affinity to the E2 conformation of these ATPases. SERCA inhibition leads to elevated calcium levels in the cytoplasm, which in turn induces apoptosis. We present x-ray crystallographic and intrinsic fluorescence data to show how Tg and chemical analogs of the compound with modified or removed side chains bind to isolated SERCA 1a membranes. This occurs by uptake via the membrane lipid followed by insertion into a resident intramembranous binding site with few adaptative changes. Our binding data indicate that a balanced hydrophobicity and accurate positioning of the side chains, provided by the central guaianolide ring structure, defines a pharmacophore of Tg that governs both high affinity and access to the protein-binding site. Tg analogs substituted with long linkers at O-8 extend from the binding site between transmembrane segments to the putative N-terminal Ca2+ entry pathway. The long chain analogs provide a rational basis for the localization of the linker, the presence of which is necessary for enabling prostate-specific antigen to cleave peptide-conjugated prodrugs targeting SERCA of cancer cells (Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, S. B., and Isaacs, J. T. (2003) J. Natl. Cancer Inst. 95, 990-1000). Our study demonstrates the usefulness of a simple in vitro system to test and direct development toward the formulation of new Tg derivatives with improved properties for SERCA targeting. Finally, we propose that the Tg binding pocket may be a regulatory site that, for example, is sensitive to cholesterol.	[Winther, Anne-Marie L.; Sonntag, Yonathan; Olesen, Claus; Nissen, Poul; Moller, Jesper V.] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Winther, Anne-Marie L.; Sonntag, Yonathan; Nissen, Poul] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liu, Huizhen; Soehoel, Helmer; Christensen, S. Brogger] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen O, Denmark; [Olesen, Claus; Moller, Jesper V.] Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; [le Maire, Marc] Univ Paris Sud, SB2SM, Inst Biol & Technol Saclay, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France; [le Maire, Marc] Univ Paris Sud, Lab Rech Associe 17V, F-91191 Gif Sur Yvette, France; [le Maire, Marc] CNRS, URA 2096, F-91191 Gif Sur Yvette, France; [Olsen, Carl-Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, DK-1780 Frederiksberg C, Denmark	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen; Aarhus University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Moller, JV (corresponding author), Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk	Sonntag, Yonathan/GRF-4277-2022; Nissen, Poul/D-5774-2014; Olsen, Carl E/H-3031-2014; Christensen, Søren Brøgger/H-4526-2019	Sonntag, Yonathan/0000-0002-8063-0285; Olsen, Carl E/0000-0002-2275-0596; Christensen, Søren Brøgger/0000-0002-5773-6874; Nissen, Poul/0000-0003-0948-6628; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989	Danish Medical Research Foundation; Danish Natural Science Foundation; Danish Cancer Society; Lundbeck Foundation; Aarhus University Research Foundation; Novo Nordisk Foundation; Carlsberg Foundation; Danish Research Council for Technical Sciences and Production; Faculty of Health Science, Aarhus University; Danish Research Council for Health Sciences; Commissariat a l'Energie Atomique; CNRS; ANR France	Danish Medical Research Foundation; Danish Natural Science Foundation(Danish Natural Science Research Council); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Danish Research Council for Technical Sciences and Production; Faculty of Health Science, Aarhus University; Danish Research Council for Health Sciences; Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR France(French National Research Agency (ANR))	This work was supported in part by the Danish Medical Research Foundation, the Danish Natural Science Foundation (through the Dansync Program), the Danish Cancer Society, the Lundbeck Foundation, the Aarhus University Research Foundation, the Novo Nordisk Foundation, and the Carlsberg Foundation.; Recipient of a Ph.D. stipend through the Lundbeck Foundation and a postdoctoral fellowship from the Danish Research Council for Technical Sciences and Production.; Recipient of a Ph.D. stipend from the Faculty of Health Science, Aarhus University, and a postdoctoral fellowship from the Danish Research Council for Health Sciences.; Supported by Commissariat a l'Energie Atomique, CNRS, and ANR France.; Supported by a Hallas-Moller stipend from the Novo Nordisk Foundation.	ANDERSEN A, 1994, ACTA CHEM SCAND, V48, P340, DOI 10.3891/acta.chem.scand.48-0340; ANDERSEN JP, 1983, EUR J BIOCHEM, V134, P205, DOI 10.1111/j.1432-1033.1983.tb07552.x; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; CHRISTENSEN SB, 1985, J LABELLED COMPD RAD, V22, P71; Ciulli A, 2007, CURR OPIN BIOTECH, V18, P489, DOI 10.1016/j.copbio.2007.09.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEFORESTA B, 1992, EUR J BIOCHEM, V209, P1023, DOI 10.1111/j.1432-1033.1992.tb17378.x; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jakobsen CM, 2001, J MED CHEM, V44, P4696, DOI 10.1021/jm010985a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Paula S, 2004, PROTEINS, V56, P595, DOI 10.1002/prot.20105; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Seekoe T, 2001, J BIOL CHEM, V276, P46737, DOI 10.1074/jbc.M106320200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SILVIUS Jr, 1984, BIOCHEMISTRY-US, V23, P538, DOI 10.1021/bi00298a022; SIMMONDS AC, 1982, BIOCHIM BIOPHYS ACTA, V693, P398, DOI 10.1016/0005-2736(82)90447-3; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Sohoel H, 2005, J MED CHEM, V48, P7005, DOI 10.1021/jm058036v; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; WICTOME M, 1994, BIOCHEM BIOPH RES CO, V199, P916, DOI 10.1006/bbrc.1994.1316; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542	47	77	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28883	28892		10.1074/jbc.M110.136242	http://dx.doi.org/10.1074/jbc.M110.136242			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20551329	Green Published, hybrid			2022-12-27	WOS:000281594000053
J	Fujihara, C; Yamada, S; Ozaki, N; Takeshita, N; Kawaki, H; Takano-Yamamoto, T; Murakami, S				Fujihara, Chiharu; Yamada, Satoru; Ozaki, Nobuhiro; Takeshita, Nobuo; Kawaki, Harumi; Takano-Yamamoto, Teruko; Murakami, Shinya			Role of Mechanical Stress-induced Glutamate Signaling-associated Molecules in Cytodifferentiation of Periodontal Ligament Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; TOOTH MOVEMENT; STEM-CELLS; IN-VITRO; RECEPTOR; BONE; RAT; NEURONS; ACTIVATION; PATHWAY	In this study, we analyzed the effects of tensile mechanical stress on the gene expression profile of in vitro-maintained human periodontal ligament (PDL) cells. A DNA chip analysis identified 17 up-regulated genes in human PDL cells under the mechanical stress, including HOMER1 (homer homolog 1) and GRIN3A (glutamate receptor ionotropic N-methyl-D-aspartate 3A), which are related to glutamate signaling. RT-PCR and real-time PCR analyses revealed that human PDL cells constitutively expressed glutamate signaling-associated genes and that mechanical stress increased the expression of these mRNAs, leading to release of glutamate from human PDL cells and intracellular glutamate signal transduction. Interestingly, exogenous glutamate increased them RNAs of cytodifferentiation and mineralization-related genes as well as the ALP (alkaline phosphatase) activities during the cytodifferentiation of the PDL cells. On the other hand, the glutamate signaling inhibitors riluzole and (+)-MK801 maleate suppressed the alkaline phosphatase activities and mineralized nodule formation during the cytodifferentiation and mineralization. Riluzole inhibited the mechanical stress-induced glutamate signaling-associated gene expressions in human PDL cells. Moreover, in situ hybridization analyses showed up-regulation of glutamate signaling-associated gene expressions at tension sites in the PDL under orthodontic tooth movement in a mouse model. The present data demonstrate that the glutamate signaling induced by mechanical stress positively regulates the cytodifferentiation and mineralization of PDL cells.	[Fujihara, Chiharu; Yamada, Satoru; Ozaki, Nobuhiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, Suita, Osaka 5650871, Japan; [Takeshita, Nobuo; Kawaki, Harumi; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Orthodont & Dentofacial Orthoped,Aoba Ku, Sendai, Miyagi 9808578, Japan	Osaka University; Tohoku University	Murakami, S (corresponding author), Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ipshinya@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X; Kawaki, Harumi/0000-0002-5528-7016	Japan Society for the Promotion of Science [20390529, 20390530]; Ministry of Health, Labor, and Welfare [H21-001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-aid 20390529 and 20390530 from the Japan Society for the Promotion of Science and Research Grant H21-001 from the Ministry of Health, Labor, and Welfare.	Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; COHN S. A., 1965, ARCH ORAL BIOL, V10, P909, DOI 10.1016/0003-9969(65)90084-1; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; de Araujo RMS, 2007, J PERIODONTAL RES, V42, P15, DOI 10.1111/j.1600-0765.2006.00906.x; Domon S, 2001, EUR J ORTHODONT, V23, P339, DOI 10.1093/ejo/23.4.339; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Harris SL, 2004, MOL CELL NEUROSCI, V25, P275, DOI 10.1016/j.mcn.2003.10.018; Henneman S, 2008, ARCH ORAL BIOL, V53, P161, DOI 10.1016/j.archoralbio.2007.08.010; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Iemata M, 2007, J CELL PHYSIOL, V213, P721, DOI 10.1002/jcp.21145; Kanda T, 2007, J CELL BIOCHEM, V101, P1329, DOI 10.1002/jcb.21306; Kaneko S, 2001, J PERIODONTAL RES, V36, P9, DOI 10.1034/j.1600-0765.2001.00607.x; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lai DM, 2008, NEUROCHEM INT, V52, P470, DOI 10.1016/j.neuint.2007.08.010; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao LM, 2003, J NEUROCHEM, V84, P233, DOI 10.1046/j.1471-4159.2003.01256.x; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Moriyama Y, 2004, J BIOCHEM, V135, P155, DOI 10.1093/jb/mvh018; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; Patton AJ, 1998, BONE, V22, P645, DOI 10.1016/S8756-3282(98)00061-1; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401; PICHE JE, 1989, J DENT RES, V68, P761, DOI 10.1177/00220345890680050201; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Sakai Y, 2009, J DENT RES, V88, P345, DOI 10.1177/0022034509334649; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; TAKANOYAMAMOTO T, 1994, J HISTOCHEM CYTOCHEM, V42, P885, DOI 10.1177/42.7.8014472; TORII K, 1980, BIOCHIM BIOPHYS ACTA, V627, P313; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Yamaguchi N, 2002, ARCH ORAL BIOL, V47, P465, DOI 10.1016/S0003-9969(02)00022-5	43	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28286	28297		10.1074/jbc.M109.097303	http://dx.doi.org/10.1074/jbc.M109.097303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576613	Green Published, hybrid			2022-12-27	WOS:000281404100071
J	Gauthier, K; Billon, C; Bissler, M; Beylot, M; Lobaccaro, JM; Vanacker, JM; Samarut, J				Gauthier, Karine; Billon, Cyrielle; Bissler, Marie; Beylot, Michel; Lobaccaro, Jean-Marc; Vanacker, Jean-Marc; Samarut, Jacques			Thyroid Hormone Receptor beta (TR beta) and Liver X Receptor (LXR) Regulate Carbohydrate-response Element-binding Protein (ChREBP) Expression in a Tissue-selective Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LIPOGENIC ENZYMES; DEUTERATED WATER; OB/OB MICE; GLUCOSE; ALPHA; INSULIN; RAT; CHOLESTEROL; DEFICIENCY	Thyroid hormone (TR) and liver X (LXR) receptors are transcription factors involved in lipogenesis. Both receptors recognize the same consensus DNA-response element in vitro. It was previously shown that their signaling pathways interact in the control of cholesterol elimination in the liver. In the present study, carbohydrate-response element-binding protein (ChREBP), a major transcription factor controlling the activation of glucose-induced lipogenesis in liver, is characterized as a direct target of thyroid hormones (TH) in liver and white adipose tissue (WAT), the two main lipogenic tissues in mice. Using genetic and molecular approaches, ChREBP is shown to be specifically regulated by TR beta but not by TR alpha in vivo, even in WAT where both TR isoforms are expressed. However, this isotype specificity is not found in vitro. This TR beta specific regulation correlates with the loss of TH-induced lipogenesis in TR beta(-/-) mice. Fasting/refeeding experiments show that TR beta is not required for the activation of ChREBP expression particularly marked in WAT following refeeding. However, TH can stimulate ChREBP expression in WAT even under fasting conditions, suggesting completely independent pathways. Because ChREBP has been described as an LXR target, the interaction of LXR and TR beta in ChREBP regulation was assayed both in vitro and in vivo. Each receptor recognizes a different response element on the ChREBP promoter, located only 8 bp apart. There is a cross-talk between LXR and TR beta signaling on the ChREBP promoter in liver but not in WAT where LXR does not regulate ChREBP expression. The molecular basis for this cross-talk has been determined in in vitro systems.	[Gauthier, Karine] Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,IGFL,UMR5242, F-69364 Lyon 07, France; [Beylot, Michel] Univ Lyon 1, Fac Rockefeller, INSERM, ERI 22 EA4173, F-69373 Lyon, France; [Lobaccaro, Jean-Marc] Clermont Univ, CNRS, UMR 6247, Ctr Rech Nutr Humaine Auvergne, F-63177 Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS)	Gauthier, K (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,IGFL,UMR5242, 46 Allee Italie, F-69364 Lyon 07, France.	kgauthie@ens-lyon.fr	LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Samarut, Jacques/AAD-2587-2019	Lobaccaro, Jean-Marc/0000-0001-9890-2392; 	SIGNATOR [ANR-06-BLAN-0232-01]; Crescendo [LSHM-CT-2005-018652]; Cascade [FOOD-CT2004-506319]; Fondation pour la Recherche Medicale [INE2000407031/1]; Fondation BNP-Paribas	SIGNATOR; Crescendo(European Commission); Cascade(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation BNP-Paribas	This work was supported by SIGNATOR Grant ANR-06-BLAN-0232-01, Crescendo Contract LSHM-CT-2005-018652, Cascade, Contract FOOD-CT2004-506319, the Fondation pour la Recherche Medicale Grant INE2000407031/1, and the Fondation BNP-Paribas.	Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Boelen A, 2006, J ENDOCRINOL, V190, P537, DOI 10.1677/joe.1.06872; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; CORREZE C, 1982, EUR J BIOCHEM, V122, P387, DOI 10.1111/j.1432-1033.1982.tb05893.x; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Diraison F, 1996, METABOLISM, V45, P817, DOI 10.1016/S0026-0495(96)90152-3; Flamant F, 2007, MOL ENDOCRINOL, V21, P321, DOI 10.1210/me.2006-0035; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Hashimoto K, 2007, ENDOCRINOLOGY, V148, P4667, DOI 10.1210/en.2007-0150; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MARIASH CN, 1980, J CLIN INVEST, V65, P1126, DOI 10.1172/JCI109766; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Winter H, 2006, J CELL SCI, V119, P2975, DOI 10.1242/jcs.03013	34	50	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28156	28163		10.1074/jbc.M110.146241	http://dx.doi.org/10.1074/jbc.M110.146241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615868	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000281404100058
J	Biondi, MJ; Beilhartz, GL; McCormick, S; Gotte, M				Biondi, Mia J.; Beilhartz, Greg L.; McCormick, Suzanne; Gotte, Matthias			N348I in HIV-1 Reverse Transcriptase Can Counteract the Nevirapine-mediated Bias toward RNase H Cleavage during Plus-strand Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NONNUCLEOSIDE INHIBITORS; CONNECTION DOMAIN; DRUG-RESISTANCE; DNA-SYNTHESIS; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; CONFERS ZIDOVUDINE; PRIMER UNBLOCKING; KINETIC ANALYSES; DUAL RESISTANCE	Drug resistance-associated mutations in HIV-1 reverse transcriptase (RT) can affect the balance between polymerase and ribonuclease H (RNase H) activities of the enzyme. We have recently demonstrated that the N348I mutation in the connection domain causes selective dissociation from RNase H-competent complexes, whereas the functional integrity of the polymerase-competent complex remains largely unaffected. N348I has been associated with resistance to the non-nucleoside RT inhibitor (NNRTI), nevirapine; however, a possible mechanism that links changes in RNase H activity to changes in NNRTI susceptibility remains to be established. To address this problem, we consider recent findings suggesting that NNRTIs may affect the orientation of RT on its nucleic acid substrate and increase RNase H activity. Here we demonstrate that RNase H-mediated primer removal is indeed more efficient in the presence of NNRTIs; however, the N348I mutant enzyme is able to counteract this effect. Efavirenz, a tight binding inhibitor, restricts the influence of the mutation. These findings provide strong evidence to suggest that N348I can thwart the inhibitory effects of nevirapine during initiation of (+)-strand DNA synthesis, which provides a novel mechanism for resistance. The data are in agreement with clinical data, which demonstrate a stronger effect of N348I on susceptibility to nevirapine as compared with efavirenz.	[Biondi, Mia J.; Beilhartz, Greg L.; McCormick, Suzanne; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research (CIHR).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Archer RH, 2000, J VIROL, V74, P8390, DOI 10.1128/JVI.74.18.8390-8401.2000; Archer RH, 2001, BIOCHEMISTRY-US, V40, P4087, DOI 10.1021/bi002328a; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arion D, 2000, J BIOL CHEM, V275, P9251, DOI 10.1074/jbc.275.13.9251; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Brehm JH, 2008, BIOCHEMISTRY-US, V47, P14020, DOI 10.1021/bi8014778; Coffin J, 1997, RETROVIRUSES; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Delviks-Frankenberry KA, 2007, J VIROL, V81, P6837, DOI 10.1128/JVI.02820-06; DING JP, 1995, NAT STRUCT BIOL, V2, P407, DOI 10.1038/nsb0595-407; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gerondelis P, 1999, J VIROL, V73, P5803, DOI 10.1128/JVI.73.7.5803-5813.1999; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Gotte M, 2000, J VIROL, V74, P3579, DOI 10.1128/JVI.74.8.3579-3585.2000; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Hang JQ, 2007, BIOCHEM BIOPH RES CO, V352, P341, DOI 10.1016/j.bbrc.2006.11.018; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Radzio J, 2008, MOL PHARMACOL, V73, P601, DOI 10.1124/mol.107.038596; Ren J, 2001, J MOL BIOL, V312, P795, DOI 10.1006/jmbi.2001.4988; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; SMERDON SJ, 1994, P NATL ACAD SCI USA, V91, P3911, DOI 10.1073/pnas.91.9.3911; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wang J, 2006, VIROLOGY, V348, P462, DOI 10.1016/j.virol.2006.01.014; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zelina S, 2008, ANTIMICROB AGENTS CH, V52, P157, DOI 10.1128/AAC.00904-07	51	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26966	26975		10.1074/jbc.M110.105775	http://dx.doi.org/10.1074/jbc.M110.105775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20530477	Green Published, hybrid			2022-12-27	WOS:000281172700028
J	Fieni, F; Parkar, A; Misgeld, T; Kerschensteiner, M; Lichtman, JW; Pasinelli, P; Trotti, D				Fieni, Francesca; Parkar, Anjum; Misgeld, Thomas; Kerschensteiner, Martin; Lichtman, Jeff W.; Pasinelli, Piera; Trotti, Davide			Voltage-dependent Inwardly Rectifying Potassium Conductance in the Outer Membrane of Neuronal Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX VOLUME; CHANNEL; PERMEABILITY; TRANSPORT; VDAC	Potassium fluxes integrate mitochondria into cellular activities, controlling their volume homeostasis and structural integrity in many pathophysiological mechanisms. The outer mitochondrial membrane (OMM) is thought to play a passive role in this process because K+ is believed to equilibrate freely between the cytosol and mitochondrial intermembrane space. By patch clamping mitochondria isolated from the central nervous systems of adult mitoCFP transgenic mice, we discovered the existence of I-OMMKi, a novel voltage-dependent inwardly rectifying K+ conductance located in the OMM. I-OMMKi is regulated by osmolarity, potentiated by cAMP, and activated at physiological negative potentials, allowing K+ to enter the mitochondrial intermembrane space in a controlled regulated fashion. The identification of I-OMMKi in the OMM supports the notion that a membrane potential could exist across this membrane in vivo and suggests that the OMM possesses regulated pathways for K+ uptake.	[Fieni, Francesca; Parkar, Anjum; Pasinelli, Piera; Trotti, Davide] Thomas Jefferson Univ, Dept Neurosci, Weinberg Unit ALS Res, Philadelphia, PA 19107 USA; [Fieni, Francesca; Parkar, Anjum; Pasinelli, Piera; Trotti, Davide] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Misgeld, Thomas; Kerschensteiner, Martin; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Jefferson University; Jefferson University; Harvard University	Trotti, D (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Weinberg Unit ALS Res, 900 Walnut St, Philadelphia, PA 19107 USA.	davide.trotti@jefferson.edu		Trotti, Davide/0000-0001-6338-6404; Pasinelli, Piera/0000-0002-3385-2707	National Institutes of Health [RO1-NS064488, RO1-NS044942, RO1-NS051488]; ALS Association; Muscular Dystrophy Association; Christopher and Dana Reeve Foundation; Dana Foundation; Deutsche Forschungsgemeinschaft; Farber Family Foundation; Paralyzed Veterans of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051488, R01NS064488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Muscular Dystrophy Association(Muscular Dystrophy Association); Christopher and Dana Reeve Foundation; Dana Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Farber Family Foundation; Paralyzed Veterans of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS064488 and RO1-NS044942 (to D. T.) and RO1-NS051488 (to P. P.). This work was also supported by the ALS Association (to P. P.) and the Muscular Dystrophy Association (to D. T.). The generation of the mitoCFP mice was supported by grants from the Christopher and Dana Reeve Foundation, the Dana Foundation, and the Deutsche Forschungsgemeinschaft. The Weinberg Unit for ALS Research is sponsored by the Farber Family Foundation.; Supported in part by a Paralyzed Veterans of America fellowship.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Bednarczyk P, 2008, BBA-BIOENERGETICS, V1777, P540, DOI 10.1016/j.bbabio.2008.04.018; Bednarczyk P, 2009, ACTA BIOCHIM POL, V56, P385; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Devin A, 1997, J BIOENERG BIOMEMBR, V29, P579, DOI 10.1023/A:1022435102552; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; HORN R, 1980, J GEN PHYSIOL, V75, P297, DOI 10.1085/jgp.75.3.297; HORN R, 1980, P NATL ACAD SCI-BIOL, V77, P6930, DOI 10.1073/pnas.77.11.6930; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Korge P, 2005, AM J PHYSIOL-HEART C, V289, pH66, DOI 10.1152/ajpheart.01296.2004; Lemeshko VV, 2002, BIOPHYS J, V82, P684, DOI 10.1016/S0006-3495(02)75431-3; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Mannella CA, 2008, J BIOENERG BIOMEMBR, V40, P149, DOI 10.1007/s10863-008-9143-0; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; MORAN O, 1992, EUR BIOPHYS J BIOPHY, V20, P311, DOI 10.1007/BF00196590; MORAN O, 1992, J BIOENERG BIOMEMBR, V24, P91, DOI 10.1007/BF00769535; Nowikovsky K, 2009, BBA-BIOENERGETICS, V1787, P345, DOI 10.1016/j.bbabio.2008.10.006; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; WUNDER UR, 1991, J MEMBRANE BIOL, V123, P83, DOI 10.1007/BF01993966; ZIZI M, 1994, J BIOL CHEM, V269, P1614	33	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27411	27417		10.1074/jbc.M110.131243	http://dx.doi.org/10.1074/jbc.M110.131243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551319	Green Published, hybrid			2022-12-27	WOS:000281172700070
J	Teste, MA; Francois, JM; Parrou, JL				Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc			Characterization of a New Multigene Family Encoding Isomaltases in the Yeast Saccharomyces cerevisiae, the IMA Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-INDUCED INACTIVATION; MAL GENE-EXPRESSION; ALPHA-GLUCOSIDASE; CATABOLITE INACTIVATION; SUBSTRATE-SPECIFICITY; HEXOSE TRANSPORTERS; REGULATORY ELEMENTS; MALTOSE PERMEASE; FINGER PROTEINS; SHUTTLE VECTORS	It has been known for a long time that the yeast Saccharomyces cerevisiae can assimilate alpha-methylglucopyranoside and isomaltose. We here report the identification of 5 genes (YGR287c, YIL172c, YJL216c, YJL221c and YOL157c), which, similar to the SUCx, MALx, or HXTx multigene families, are located in the subtelomeric regions of different chromosomes. They share high nucleotide sequence identities between themselves (66-100%) and with the MALx2 genes (63-74%). Comparison of their amino acid sequences underlined a substitution of threonine by valine in region II, one of the four highly conserved regions of the alpha -glucosidase family. This change was previously shown to be sufficient to discriminate alpha-1,4-to alpha-1,6glucosidase activity in YGR287c (Yamamoto, K., Nakayama, A., Yamamoto, Y., and Tabata, S. (2004) Eur. J. Biochem. 271, 34143420). We showed that each of these five genes encodes a protein with alpha-glucosidase activity on isomaltose, and we therefore renamed these genes IMA1 to IMA5 for IsoMAltase. Our results also illustrated that sequence polymorphisms among this family led to interesting variability of gene expression patterns and of catalytic efficiencies on different substrates, which altogether should account for the absence of functional redundancy for growth on isomaltose. Indeed, deletion studies revealed that IMA1/YGR287c encodes the major isomaltase and that growth on isomaltose required the presence of AGT1, which encodes an alpha-glucoside transporter. Expressions of IMA1 and IMA5/YJL216c were strongly induced by maltose, isomaltose, and alpha-methylglucopyranoside, in accordance with their regulation by the Malx3p-transcription system. The physiological relevance of this IMAx multigene family in S. cerevisiae is discussed.	[Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] CNRS, UMR5504, F-31400 Toulouse, France; [Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] INRA, Ingn Syst Biol & Procedes UMR792, F-31400 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Parrou, JL (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	jean-luc.parrou@insa-toulouse.fr	parrou, jean-luc/A-6874-2015	Teste, Marie Ange/0000-0001-9173-9190	ANR Blanc [05-2-42128]	ANR Blanc(French National Research Agency (ANR))	This work was supported by ANR Blanc 05-2-42128 and Genopole Toulouse associated with transport, cleavage, or regulatory function. (to J. M. F.).	Alberti A, 2003, YEAST, V20, P1085, DOI 10.1002/yea.1025; Allosio-Ouarnier N, 2000, J I BREWING, V106, P45, DOI 10.1002/j.2050-0416.2000.tb00039.x; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; BRUNELLI JP, 1993, YEAST, V9, P1299, DOI 10.1002/yea.320091203; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; CARLSON M, 1983, MOL CELL BIOL, V3, P351, DOI 10.1128/MCB.3.3.351; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHANG YS, 1988, CURR GENET, V14, P201, DOI 10.1007/BF00376740; CHARRON MJ, 1989, GENETICS, V122, P307; CHENG Q, 1991, J BACTERIOL, V173, P1817, DOI 10.1128/jb.173.5.1817-1820.1991; Codon AC, 1998, APPL MICROBIOL BIOT, V49, P154, DOI 10.1007/s002530051152; DALE CJ, 1991, J I BREWING, V97, P187, DOI 10.1002/j.2050-0416.1991.tb01065.x; Day RE, 2002, YEAST, V19, P1015, DOI 10.1002/yea.894; Despons L, 2006, TRENDS GENET, V22, P10, DOI 10.1016/j.tig.2005.10.001; DUBIN RA, 1985, J BACTERIOL, V164, P605, DOI 10.1128/JB.164.2.605-610.1985; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gibson AW, 1997, GENETICS, V146, P1287; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; HAWTHORNE D. C., 1958, Heredity, V12, P273, DOI 10.1038/hdy.1958.29; He S, 2009, FEBS J, V276, P5432, DOI 10.1111/j.1742-4658.2009.07227.x; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Hu Z, 2000, GENETICS, V154, P121; HUTSON DH, 1965, BIOCHEM J, V94, P783, DOI 10.1042/bj0940783; Jiang H, 2000, J BACTERIOL, V182, P647, DOI 10.1128/JB.182.3.647-654.2000; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KHAN NA, 1967, BIOCHIM BIOPHYS ACTA, V146, P173, DOI 10.1016/0005-2744(67)90084-8; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Lucero Pilar, 2002, FEMS Yeast Research, V1, P307, DOI 10.1016/S1567-1356(01)00045-9; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996; Naumoff DG, 2010, DOKL BIOCHEM BIOPHYS, V432, P114, DOI 10.1134/S1607672910030051; NAUMOV GI, 1985, DOKLADY AKAD NAUKS S, V279, P1496; NEEDLEMAN R, 1991, MOL MICROBIOL, V5, P2079, DOI 10.1111/j.1365-2958.1991.tb02136.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Rintala E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-53; SIRENKO OI, 1995, CURR GENET, V27, P509, DOI 10.1007/BF00314440; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; TAMAKI H, 1978, MOL GEN GENET, V164, P205, DOI 10.1007/BF00267385; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; TENBERGE AM, 1972, MOL GEN GENET, V115, P80, DOI 10.1007/BF00272220; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Vidgren V, 2005, APPL ENVIRON MICROB, V71, P7846, DOI 10.1128/AEM.71.12.7846-7857.2005; WACH A, 1994, YEAST, V10, P1808; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Yamamoto K, 2004, EUR J BIOCHEM, V271, P3414, DOI 10.1111/j.1432-1033.2004.04276.x; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193	67	42	54	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26815	26824		10.1074/jbc.M110.145946	http://dx.doi.org/10.1074/jbc.M110.145946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562106	Green Published, hybrid			2022-12-27	WOS:000281172700012
J	Kashiwaya, Y; Pawlosky, R; Markis, W; King, MT; Bergman, C; Srivastava, S; Murray, A; Clarke, K; Veech, RL				Kashiwaya, Yoshihiro; Pawlosky, Robert; Markis, William; King, M. Todd; Bergman, Christian; Srivastava, Shireesh; Murray, Andrew; Clarke, Kieran; Veech, Richard L.			A Ketone Ester Diet Increases Brain Malonyl-CoA and Uncoupling Proteins 4 and 5 while Decreasing Food Intake in the Normal Wistar Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-BETA-HYDROXYBUTYRATE; KETOGENIC DIET; ENERGY; INSULIN; BODIES; METABOLISM; EXPRESSION; D,L-3-HYDROXYBUTYRATE; LOCALIZATION; GLUTAMINASE	Three groups of male Wistar rats were pair fed NIH-31 diets for 14 days to which were added 30% of calories as corn starch, palm oil, or R-3-hydroxybutyrate-R-1,3-butanediol monoester (3HB-BD ester). On the 14th day, animal brains were removed by freeze-blowing, and brain metabolites measured. Animals fed the ketone ester diet had elevated mean blood ketone bodies of 3.5 mM and lowered plasma glucose, insulin, and leptin. Despite the decreased plasma leptin, feeding the ketone ester diet ad lib decreased voluntary food intake 2-fold for 6 days while brain malonyl-CoA was increased by about 25% in ketone-fed group but not in the palm oil fed group. Unlike the acute effects of ketone body metabolism in the perfused working heart, there was no increased reduction in brain free mitochondrial [NAD(+)]/[NADH] ratio nor in the free energy of ATP hydrolysis, which was compatible with the observed 1.5-fold increase in brain uncoupling proteins 4 and 5. Feeding ketone ester or palm oil supplemented diets decreased brain L-glutamate by 15-20% and GABA by about 34% supporting the view that fatty acids as well as ketone bodies can be metabolized by the brain.	[Veech, Richard L.] NIAAA, Lab Metab Control, NIH, DHHS, Rockville, MD 20852 USA; [Murray, Andrew] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Cambridge; University of Oxford	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, DHHS, 5625 Fishers Lane,Rm 2S28, Rockville, MD 20852 USA.	rveech@mail.nih.gov	Bergman, Carl/N-1444-2017; Bergman, Carl/AGH-0291-2022; Murray, Andrew/B-3130-2010; Bergman, Christian/D-8680-2012; Bergman, Christian/N-1444-2017	Bergman, Carl/0000-0003-0367-9031; Murray, Andrew/0000-0002-0929-9315; Bergman, Christian/0000-0002-5426-8593; Markis, William/0000-0002-1157-3627	Defense Advanced Research Projects Administration, United States Dept. of Defense; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000112, ZIAAA000113, ZIAAA000110] Funding Source: NIH RePORTER	Defense Advanced Research Projects Administration, United States Dept. of Defense; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by the Defense Advanced Research Projects Administration, United States Dept. of Defense.	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; AMIEL SA, 1991, CLIN SCI, V81, P189, DOI 10.1042/cs0810189; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; BENZINGER T, 1959, BIOCHEM J, V71, P400, DOI 10.1042/bj0710400; BERL S, 1984, GLUTAMINE METABOLISM; Bisschop PH, 2001, AM J CLIN NUTR, V73, P554; CARPENTER RG, 1983, PHYSIOL BEHAV, V30, P57, DOI 10.1016/0031-9384(83)90038-0; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Conklin H. W., 1922, J AM OSTEOPATH ASSOC, V26, P11; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.0.CO;2-E; Cullingford TE, 2002, EPILEPSY RES, V49, P99, DOI 10.1016/S0920-1211(02)00011-6; DAVIS RJ, 1981, BIOCHEM J, V196, P133, DOI 10.1042/bj1960133; Erecinska M, 1996, J NEUROCHEM, V67, P2325; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; GUYNN RW, 1972, J BIOL CHEM, V247, P7325; HAWKINS RA, 1973, BIOCHEM J, V134, P1001, DOI 10.1042/bj1341001; HOGSTAD S, 1988, NEUROCHEM RES, V13, P383, DOI 10.1007/BF00972489; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Johnstone AM, 2008, AM J CLIN NUTR, V87, P44, DOI 10.1093/ajcn/87.1.44; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KOPPELMAN R, 1958, J BIOL CHEM, V230, P73; Krebs H. A., 1969, ENERGY LEVEL METABOL, P329; KREBS HA, 1953, BIOCHEM J, V54, P82, DOI 10.1042/bj0540082; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; LANGHANS W, 1983, PHYSIOL BEHAV, V31, P483, DOI 10.1016/0031-9384(83)90070-7; LUST WD, 1973, SCIENCE, V181, P280, DOI 10.1126/science.181.4096.280; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Mehlman MA., 1972, ENERGY METABOLISM RE, P171; MILLER AL, 1973, J NEUROCHEM, V20, P1393, DOI 10.1111/j.1471-4159.1973.tb00251.x; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Pawlosky RJ, 2010, ALCOHOL CLIN EXP RES, V34, P375, DOI 10.1111/j.1530-0277.2009.01099.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rossi R, 2000, J VET MED A, V47, P9, DOI 10.1046/j.1439-0442.2000.00255.x; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Veech RL, 2001, IUBMB LIFE, V51, P241; VEECH RL, 1973, J NEUROCHEM, V20, P183, DOI 10.1111/j.1471-4159.1973.tb12115.x; VELOSO D, 1973, J BIOL CHEM, V248, P4811; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Woods JW, 2003, BRAIN RES, V975, P10, DOI 10.1016/S0006-8993(03)02515-0; Yudkoff M, 1997, J NEUROCHEM, V69, P682; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722	58	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25950	25956		10.1074/jbc.M110.138198	http://dx.doi.org/10.1074/jbc.M110.138198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529850	Green Published, hybrid			2022-12-27	WOS:000280921000009
J	Chiang, BY; Chen, TC; Pai, CH; Chou, CC; Chen, HH; Ko, TP; Hsu, WH; Chang, CY; Wu, WF; Wang, AHJ; Lin, CH				Chiang, Bing-Yu; Chen, Tzu-Chieh; Pai, Chien-Hua; Chou, Chi-Chi; Chen, Hsuan-He; Ko, Tzu-Ping; Hsu, Wen-Hung; Chang, Chun-Yang; Wu, Whei-Fen; Wang, Andrew H. -J.; Lin, Chun-Hung			Protein S-Thiolation by Glutathionylspermidine (Gsp) THE ROLE OF ESCHERICHIA COLI Gsp SYNTHETASE/AMIDASE IN REDOX REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE SULFENIC ACID; CRITHIDIA-FASCICULATA; GLUTATHIONYLATION; TRYPANOTHIONE; INTERMEDIATE; ENZYME; METABOLISM; SPERMIDINE; MECHANISM; BACTERIA	Certain bacteria synthesize glutathionylspermidine (Gsp), from GSH and spermidine. Escherichia coli Gsp synthetase/amidase (GspSA) catalyzes both the synthesis and hydrolysis of Gsp. Prior to the work reported herein, the physiological role(s) of Gsp or how the two opposing GspSA activities are regulated had not been elucidated. We report that Gsp-modified proteins from E. coli contain mixed disulfides of Gsp and protein thiols, representing a new type of post-translational modification formerly undocumented. The level of these proteins is increased by oxidative stress. We attribute the accumulation of such proteins to the selective inactivation of GspSA amidase activity. X-ray crystallography and a chemical modification study indicated that the catalytic cysteine thiol of the GspSA amidase domain is transiently inactivated by H2O2 oxidation to sulfenic acid, which is stabilized by a very short hydrogen bond with a water molecule. We propose a set of reactions that explains how the levels of Gsp and Gsp S-thiolated proteins are modulated in response to oxidative stress. The hypersensitivities of GspSA and GspSA/glutaredoxin null mutants to H2O2 support the idea that GspSA and glutaredoxin act synergistically to regulate the redox environment of E. coli.	[Chen, Hsuan-He; Chang, Chun-Yang; Wu, Whei-Fen] Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan; [Wu, Whei-Fen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan; [Chiang, Bing-Yu; Chen, Tzu-Chieh; Hsu, Wen-Hung; Wang, Andrew H. -J.; Lin, Chun-Hung] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chiang, Bing-Yu; Chen, Tzu-Chieh; Pai, Chien-Hua; Ko, Tzu-Ping; Hsu, Wen-Hung; Wang, Andrew H. -J.; Lin, Chun-Hung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wang, Andrew H. -J.; Lin, Chun-Hung] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chou, Chi-Chi] Acad Sinica, Natl Res Program Genome Med Core Facil Prote Res, Taipei 11529, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Wu, WF (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan.	whifinwu@ntu.edu.tw; ahjwang@gate.sinica.edu.tw; chunhung@gate.sinica.edu.tw	Chou, Chi-Chi/X-6053-2019; Pai, Chien-Hua/C-2477-2011; Lin, Chun-Hung/AAM-9711-2021; Wu, Whei-Fen/AAS-6031-2021; Pai, Chien-Hua/ABG-2711-2020	Chou, Chi-Chi/0000-0002-7862-7757; Lin, Chun-Hung/0000-0002-6795-8825; Pai, Chien-Hua/0000-0003-2254-5928; WU, WHI-FIN/0000-0002-9526-6287	National Science Council of Taiwan [NSC97-2628-M-001-016-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant NSC97-2628-M-001-016-MY3.	Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Chu F, 2001, CARCINOGENESIS, V22, P1221, DOI 10.1093/carcin/22.8.1221; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Katz BA, 2001, J MOL BIOL, V307, P1451, DOI 10.1006/jmbi.2001.4516; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; KrauthSiegel RL, 1996, MOL BIOCHEM PARASIT, V80, P203, DOI 10.1016/0166-6851(96)02689-8; Lin CH, 1997, BIOCHEMISTRY-US, V36, P14930, DOI 10.1021/bi9714464; Lountos GT, 2006, BIOCHEMISTRY-US, V45, P9648, DOI 10.1021/bi060692p; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Potamitou A, 2002, J BIOL CHEM, V277, P17775, DOI 10.1074/jbc.M201306200; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; SHIM H, 1988, J GEN MICROBIOL, V134, P807; SMITH K, 1995, BIOCHEM J, V312, P465, DOI 10.1042/bj3120465; TABOR H, 1975, J BIOL CHEM, V250, P2648; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004	31	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25345	25353		10.1074/jbc.M110.133363	http://dx.doi.org/10.1074/jbc.M110.133363			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530482	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000280682400027
J	Hwang, DS; Zeng, HB; Masic, A; Harrington, MJ; Israelachvili, JN; Waite, JH				Hwang, Dong Soo; Zeng, Hongbo; Masic, Admir; Harrington, Matthew J.; Israelachvili, Jacob N.; Waite, J. Herbert			Protein- and Metal-dependent Interactions of a Prominent Protein in Mussel Adhesive Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NUCLEAR-MAGNETIC-RESONANCE; MYTILUS-EDULIS; CROSS-LINKING; BYSSAL THREADS; FOOT PROTEINS; BLUE MUSSEL; SURFACES; DOPA; CALIFORNIANUS	The adhesive plaques of Mytilus byssus are investigated increasingly to determine the molecular requirements for wet adhesion. Mfp-2 is the most abundant protein in the plaques, but little is known about its function. Analysis of Mfp-2 films using the surface forces apparatus detected no interaction between films or between a film and bare mica; however, addition of Ca2+ and Fe3+ induced significant reversible bridging (work of adhesion W-ad approximate to 0.3 mJ/m(2) to 2.2 mJ/m(2)) between two films at 0.35 M salinity. The strongest observed Fe3+-mediated bridging approaches the adhesion of oriented avidin-biotin complexes. Raman microscopy of plaque sections supports the co-localization of Mfp-2 and iron, which interact by forming bis- or tris-DOPA-iron complexes. Mfp-2 adhered strongly to Mfp-5, a DOPA-rich interfacial adhesive protein, but not to another interfacial protein, Mfp-3, which may in fact displace Mfp-2 from mica. In the presence of metal ions or Mfp-5, Mfp-2 adhesion was fully reversible. These results suggest that plaque cohesiveness depends on Mfp-2 complexation of metal ions, particularly Fe3+ and also by Mfp-2 interaction with Mfp-5 at the plaque-substratum interface.	[Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Zeng, Hongbo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada; [Masic, Admir; Harrington, Matthew J.] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Alberta; Max Planck Society; University of California System; University of California Santa Barbara	Waite, JH (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	waite@lifesci.ucsb.edu	Zeng, Hongbo/C-8491-2011; Hwang, Dong Soo/C-7291-2011	Zeng, Hongbo/0000-0002-1432-5979; Hwang, Dong Soo/0000-0002-2487-2255; Masic, Admir/0000-0002-1207-4926	National Institutes of Health [R01 DE018468]; National Science Foundation Materials Research Science and Engineering Center [DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Materials Research Science and Engineering Center(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grant R01 DE018468 and National Science Foundation Materials Research Science and Engineering Center Grant DMR05-20415.	Anderson KE, 2000, J EXP BIOL, V203, P3065; [Anonymous], 1992, INTERMOLECULAR SURFA; AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Fant C, 2002, BIOMACROMOLECULES, V3, P732, DOI 10.1021/bm025506j; Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; ISRAELACHVILI J, 1987, P NATL ACAD SCI USA, V84, P4722, DOI 10.1073/pnas.84.14.4722; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1990, J MATER RES, V5, P2223, DOI 10.1557/JMR.1990.2223; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NJUS D, 1978, BIOCHEMISTRY-US, V17, P4337, DOI 10.1021/bi00613a035; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Rand MD, 1997, PROTEIN SCI, V6, P2059; Robinson MW, 2001, PARASITOLOGY, V123, P509, DOI 10.1017/S0031182001008630; RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413; Sagert J, 2009, J EXP BIOL, V212, P2224, DOI 10.1242/jeb.029686; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Suci PA, 2001, COLLOID SURFACE B, V22, P159, DOI 10.1016/S0927-7765(01)00149-7; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1995, METHOD ENZYMOL, V258, P1; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Wang JJ, 2008, ADV MATER, V20, P3872, DOI 10.1002/adma.200801140; Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002; Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107; Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	40	184	189	7	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25850	25858		10.1074/jbc.M110.133157	http://dx.doi.org/10.1074/jbc.M110.133157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566644	Green Published, hybrid			2022-12-27	WOS:000280682400077
J	Okamoto, S; Van Petegem, F; Patrauchan, MA; Eltis, LD				Okamoto, Sachi; Van Petegem, Filip; Patrauchan, Marianna A.; Eltis, Lindsay D.			AnhE, a Metallochaperone Involved in the Maturation of a Cobalt-dependent Nitrile Hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING; ESCHERICHIA-COLI; CARBONIC-ANHYDRASE; RHODOCOCCUS-ERYTHROPOLIS; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; PROTEIN; IRON; INSIGHTS; ISCA	Acetonitrile hydratase (ANHase) of Rhodococcus jostii RHA1 is a cobalt-containing enzyme with no significant sequence identity with characterized nitrile hydratases. The ANHase structural genes anhA and anhB are separated by anhE, predicted to encode an 11.1-kDa polypeptide. An anhE deletion mutant did not grow on acetonitrile but grew on acetamide, the ANHase reaction product. Growth on acetonitrile was restored by providing anhE in trans. AnhA could be used to assemble ANHase in vitro, provided the growth medium was supplemented with 50 mu M CoCl2. Ten- to 100-fold less CoCl2 sufficed when anhE was co-expressed with anhA. Moreover, AnhA contained more cobalt when produced in cells containing AnhE. Chromatographic analyses revealed that AnhE existed as a monomer-dimer equilibrium (100 mM phosphate, pH 7.0, 25 degrees C). Divalent metal ions including Co2+, Cu2+, Zn2+, and Ni2+ stabilized the dimer. Isothermal titration calorimetry studies demonstrated that AnhE binds two half-equivalents of Co2+ with K-d of 0.12 +/- 0.06 nM and 110 +/- 35 nM, respectively. By contrast, AnhE bound only one half-equivalent of Zn2+ (K-d = 11 +/- 2 nM) and Ni2+ (K-d = 49 +/- 17 nM) and did not detectably bind Cu2+. Substitution of the sole histidine residue did not affect Co2+ binding. Holo-AnhE had a weak absorption band at 490 nm (epsilon = 9.7 +/- 0.1 M-1 cm(-1)), consistent with hexacoordinate cobalt. The data support a model in which AnhE acts as a dimeric metallochaperone to deliver cobalt to ANHase. This study provides insight into the maturation of NHases and metallochaperone function.	Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015; Van Petegem, Filip/M-6061-2016	Eltis, Lindsay D/0000-0002-6774-8158; Van Petegem, Filip/0000-0003-2728-8537	Genome Canada; Natural Sciences and Engineering Research Council (NSERC) of Canada	Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Genome Canada and a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to L.D.E.).	Adrait A, 1999, BIOCHEMISTRY-US, V38, P6248, DOI 10.1021/bi9823232; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; BERTINI I, 1982, STRUCT BOND, V48, P45; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Brennan BA, 1996, BIOCHEMISTRY-US, V35, P10068, DOI 10.1021/bi960163t; Colpas GJ, 1998, J BIOL INORG CHEM, V3, P150, DOI 10.1007/s007750050216; Colpas GJ, 1999, BIOCHEMISTRY-US, V38, P4078, DOI 10.1021/bi982435t; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; DiTusa CA, 2001, BIOCHEMISTRY-US, V40, P5338, DOI 10.1021/bi001731e; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gray HB, 2003, P NATL ACAD SCI USA, V100, P3563, DOI 10.1073/pnas.0730378100; Hashimoto K, 2008, J BIOL CHEM, V283, P36617, DOI 10.1074/jbc.M806577200; Hashimoto Y, 2002, J INORG BIOCHEM, V91, P70, DOI 10.1016/S0162-0134(02)00373-2; Kalscheuer R, 1999, APPL MICROBIOL BIOT, V52, P508, DOI 10.1007/s002530051553; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lu J, 2003, FEBS LETT, V553, P391, DOI 10.1016/S0014-5793(03)01070-6; MARCUS Y, 1994, J SOLUTION CHEM, V23, P831, DOI 10.1007/BF00972677; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Miura T, 1998, BBA-PROTEIN STRUCT M, V1384, P171, DOI 10.1016/S0167-4838(98)00015-6; NAGASAWA T, 1991, EUR J BIOCHEM, V196, P581, DOI 10.1111/j.1432-1033.1991.tb15853.x; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Okamoto S, 2007, MOL MICROBIOL, V65, P828, DOI 10.1111/j.1365-2958.2007.05834.x; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shearer J, 2001, J AM CHEM SOC, V123, P463, DOI 10.1021/ja002642s; TU CK, 1985, BIOCHEMISTRY-US, V24, P5881, DOI 10.1021/bi00342a029; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	41	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25126	25133		10.1074/jbc.M110.109223	http://dx.doi.org/10.1074/jbc.M110.109223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558748	Green Published, hybrid			2022-12-27	WOS:000280682400004
J	Artegiani, B; Labbaye, C; Sferra, A; Quaranta, MT; Torreri, P; Macchia, G; Ceccarini, M; Petrucci, TC; Macioce, P				Artegiani, Benedetta; Labbaye, Catherine; Sferra, Antonella; Quaranta, Maria Teresa; Torreri, Paola; Macchia, Gianfranco; Ceccarini, Marina; Petrucci, Tamara C.; Macioce, Pompeo			The Interaction with HMG20a/b Proteins Suggests a Potential Role for beta-Dystrobrevin in Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; KINESIN HEAVY-CHAIN; ALPHA-DYSTROBREVIN; GENOMIC ORGANIZATION; NUCLEAR-MATRIX; SYNAPSIN-I; EXPRESSION; DP71; GENE	alpha and beta dystrobrevins are cytoplasmic components of the dystrophin-associated protein complex that are thought to play a role as scaffold proteins in signal transduction and intracellular transport. In the search of new insights into the functions of beta-dystrobrevin, the isoform restricted to non-muscle tissues, we performed a two-hybrid screen of a mouse cDNA library to look for interacting proteins. Amongthe positive clones, one encodes iBRAF/ HMG20a, a high mobility group (HMG)-domain protein that activates REST (RE-1 silencing transcription factor)-responsive genes, playing a key role in the initiation of neuronal differentiation. We characterized the beta-dystrobrevin-iBRAF interaction by in vitro and in vivo association assays, localized the binding region of one protein to the other, and assessed the kinetics of the interaction as one of high affinity. We also found that beta-dystrobrevin directly binds to BRAF35/HMG20b, a close homologue of iBRAF and a member of a co-repressor complex required for the repression of neural specific genes in neuronal progenitors. In vitro assays indicated that beta-dystrobrevin binds to RE-1 and represses the promoter activity of synapsin I, a REST-responsive gene that is a marker for neuronal differentiation. Altogether, our data demonstrate a direct interaction of beta-dystrobrevin with the HMG20 proteins iBRAF and BRAF35 and suggest that beta-dystrobrevin may be involved in regulating chromatin dynamics, possibly playing a role in neuronal differentiation.	[Macchia, Gianfranco; Petrucci, Tamara C.; Macioce, Pompeo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Labbaye, Catherine; Quaranta, Maria Teresa] Ist Super Sanita, Dept Haematol Oncol & Mol Med, I-00161 Rome, Italy; [Torreri, Paola; Ceccarini, Marina] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Macioce, P (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	pompeo.macioce@iss.it	CECCARINI, MARINA/A-6637-2015; TORRERI, PAOLA/A-6656-2015; Macioce, Pompeo/H-2142-2016; Labbaye, Catherine/J-9930-2016; Quaranta, Maria Teresa/AAC-2134-2019; Sferra, Antonella/J-2774-2018	CECCARINI, MARINA/0000-0002-7021-4499; TORRERI, PAOLA/0000-0002-0488-956X; Macioce, Pompeo/0000-0002-1829-9448; Quaranta, Maria Teresa/0000-0002-5886-507X; Labbaye, Catherine/0000-0003-1255-4396; Sferra, Antonella/0000-0001-8701-3696	Italy-USA Collaborative Programme [7DR1]	Italy-USA Collaborative Programme	This work was supported in part by the Italy-USA Collaborative Programme (Grant Rare Diseases, 7DR1).	Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Ambrose HJ, 1997, GENOMICS, V39, P359, DOI 10.1006/geno.1996.4515; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Benson MA, 2004, TRENDS NEUROSCI, V27, P516, DOI 10.1016/j.tins.2004.06.004; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Ceccarini M, 2005, J MOL BIOL, V354, P872, DOI 10.1016/j.jmb.2005.09.069; Ceccarini M, 2002, NEUROMUSCULAR DISORD, V12, P36, DOI 10.1016/S0960-8966(01)00230-9; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hsiao JC, 2006, J VIROL, V80, P7714, DOI 10.1128/JVI.00207-06; JUNG D, 1993, NEUROMUSCULAR DISORD, V3, P515, DOI 10.1016/0960-8966(93)90107-U; JUNGLING S, 1994, EUR J BIOCHEM, V226, P925, DOI 10.1111/j.1432-1033.1994.00925.x; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Loh NY, 2001, MOL CELL BIOL, V21, P7442, DOI 10.1128/MCB.21.21.7442-7448.2001; Loh NY, 1998, MAMM GENOME, V9, P857, DOI 10.1007/s003359900883; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; Marquez FG, 2003, NEUROSCIENCE, V118, P957, DOI 10.1016/S0306-4522(03)00063-0; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Rees MLJ, 2007, NEUROMUSCULAR DISORD, V17, P123, DOI 10.1016/j.nmd.2006.11.003; Rodriguez-Munoz R, 2008, BIOCHEM BIOPH RES CO, V375, P303, DOI 10.1016/j.bbrc.2008.07.135; Russo K, 2000, BIOCHEM BIOPH RES CO, V274, P93, DOI 10.1006/bbrc.2000.3103; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312	44	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24740	24750		10.1074/jbc.M109.090654	http://dx.doi.org/10.1074/jbc.M109.090654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530487	Green Published, hybrid			2022-12-27	WOS:000280542100046
J	Borompokas, N; Papachatzaki, MM; Kanavouras, K; Mastorodemos, V; Zaganas, I; Spanaki, C; Plaitakis, A				Borompokas, Nikolas; Papachatzaki, Maria-Martha; Kanavouras, Konstantinos; Mastorodemos, Vasileios; Zaganas, Ioannis; Spanaki, Cleanthe; Plaitakis, Andreas			Estrogen Modification of Human Glutamate Dehydrogenases Is Linked to Enzyme Activation State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; BASAL ACTIVITY; GLUD2; GENE; MECHANISMS; NEURONS; DIETHYLSTILBESTROL; MITOCHONDRIA; ASTROCYTES; MUTATIONS	Mammalian glutamate dehydrogenase (GDH) is a housekeeping enzyme central to the metabolism of glutamate. Its activity is potently inhibited by GTP (IC50 = 0.1-0.3 mu M) and thought to be controlled by the need of the cell in ATP. Estrogens are also known to inhibit mammalian GDH, but at relatively high concentrations. Because, in addition to this housekeeping human (h) GDH1, humans have acquired via a duplication event an hGDH2 isoform expressed in human cortical astrocytes, we tested here the interaction of estrogens with the two human isoenzymes. The results showed that, under base-line conditions, diethylstilbestrol potently inhibited hGDH2 (IC50 = 0.08 +/- 0.01 mu M) and with similar to 18-fold lower affinity hGDH1 (IC50 = 1.67 +/- 0.06 mu M; p < 0.001). Similarly, 17 beta-estradiol showed a similar to 18-fold higher affinity for hGDH2 (IC50 = 1.53 +/- 0.24 mu M) than for hGDH1 (IC50 = 26.94 +/- 1.07 mu M; p < 0.001). Also, estriol and progesterone were more potent inhibitors of hGDH2 than hGDH1. Structure/function analyses revealed that the evolutionary R443S substitution, which confers low basal activity, was largely responsible for sensitivity of hGDH2 to estrogens. Inhibition of both human GDHs by estrogens was inversely related to their state of activation induced by ADP, with the slope of this correlation being steeper for hGDH2 than for hGDH1. Also, the study of hGDH1 and hGDH2 mutants displaying different states of activation revealed that the affinity of estrogen for these enzymes correlated inversely (R = 0.99; p = 0.0001) with basal catalytic activity. Because astrocytes are known to synthesize estrogens, these hormones, by interacting potently with hGDH2 in its closed state, may contribute to regulation of glutamate metabolism in brain.	[Borompokas, Nikolas; Papachatzaki, Maria-Martha; Kanavouras, Konstantinos; Mastorodemos, Vasileios; Zaganas, Ioannis; Spanaki, Cleanthe; Plaitakis, Andreas] Univ Crete, Neurol Lab, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece	University of Crete	Plaitakis, A (corresponding author), Univ Crete, Neurol Lab, Sch Hlth Sci, Fac Med, Iraklion 71003, Crete, Greece.	plaitakis@yahoo.com	Zaganas, Ioannis/AAE-5441-2020; MASTORODIMOS, VASILEIOS/AAK-7838-2021	Zaganas, Ioannis/0000-0002-0774-5772	European Community; Ministry of Development/General Secretariat for Research and Technology [PENED 2003/03ED576]; Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN	European Community(European Commission); Ministry of Development/General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN	This work was supported by European Community and the Ministry of Development/General Secretariat for Research and Technology Contract Grant PENED 2003/03ED576 and by Association for the Advancement of Research and Treatment of Neurologic Disorders of Crete EY ZHN.	Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Ba F, 2004, NEUROCHEM INT, V45, P31, DOI 10.1016/j.neuint.2003.12.013; Bao XD, 2009, J NEUROSCI, V29, P13929, DOI 10.1523/JNEUROSCI.4413-09.2009; Blutstein T, 2006, J NEUROENDOCRINOL, V18, P692, DOI 10.1111/j.1365-2826.2006.01466.x; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; HAUKKAMAA M, 1977, CLIN ENDOCRINOL, V7, P111, DOI 10.1111/j.1365-2265.1977.tb01302.x; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; Hill RA, 2009, MOL CELL NEUROSCI, V41, P1, DOI 10.1016/j.mcn.2008.12.009; KALLOS J, 1971, P NATL ACAD SCI USA, V68, P916, DOI 10.1073/pnas.68.5.916; Kanavouras K, 2007, J NEUROSCI RES, V85, P1101, DOI 10.1002/jnr.21197; Kanavouras K, 2009, J NEUROCHEM, V109, P167, DOI 10.1111/j.1471-4159.2009.05914.x; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; MCENERY MW, 1986, J BIOL CHEM, V261, P1745; MCENERY MW, 1989, J BIOL CHEM, V264, P12029; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Plaitakis A, 2010, EUR J HUM GENET, V18, P336, DOI 10.1038/ejhg.2009.179; PONS M, 1978, EUR J BIOCHEM, V84, P257, DOI 10.1111/j.1432-1033.1978.tb12164.x; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; SMITH EL, 1979, P AM PHILOS SOC, V123, P73; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Spanaki C, 2010, J BIOL CHEM, V285, P16748, DOI 10.1074/jbc.M109.092999; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; WARREN JC, 1964, BIOCHEM J, V93, P409, DOI 10.1042/bj0930409; YIELDING KL, 1960, P NATL ACAD SCI USA, V46, P1483, DOI 10.1073/pnas.46.11.1483; Zaganas I, 2002, J BIOL CHEM, V277, P46552, DOI 10.1074/jbc.M208596200; Zaganas I, 2002, J BIOL CHEM, V277, P26422, DOI 10.1074/jbc.M200022200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	38	16	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31380	31387		10.1074/jbc.M110.146084	http://dx.doi.org/10.1074/jbc.M110.146084			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20628048	hybrid, Green Published			2022-12-27	WOS:000282764600032
J	Garcia-Mata, C; Wang, JW; Gajdanowicz, P; Gonzalez, W; Hills, A; Donald, N; Riedelsberger, J; Amtmann, A; Dreyer, I; Blatt, MR				Garcia-Mata, Carlos; Wang, Jianwen; Gajdanowicz, Pawel; Gonzalez, Wendy; Hills, Adrian; Donald, Naomi; Riedelsberger, Janin; Amtmann, Anna; Dreyer, Ingo; Blatt, Michael R.			A Minimal Cysteine Motif Required to Activate the SKOR K+ Channel of Arabidopsis by the Reactive Oxygen Species H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; VOLTAGE SENSOR; SODIUM INFLUX; XYLEM; IDENTIFICATION; NITROSYLATION; ACCUMULATION; RESPONSES; STRESS; EFFLUX	Reactive oxygen species (ROS) are essential for development and stress signaling in plants. They contribute to plant defense against pathogens, regulate stomatal transpiration, and influence nutrient uptake and partitioning. Although both Ca2+ and K+ channels of plants are known to be affected, virtually nothing is known of the targets for ROS at a molecular level. Here we report that a single cysteine (Cys) residue within the Kv-like SKOR K+ channel of Arabidopsis thaliana is essential for channel sensitivity to the ROS H2O2. We show that H2O2 rapidly enhanced current amplitude and activation kinetics of heterologously expressed SKOR, and the effects were reversed by the reducing agent dithiothreitol (DTT). Both H2O2 and DTT were active at the outer face of the membrane and current enhancement was strongly dependent on membrane depolarization, consistent with a H2O2-sensitive site on the SKOR protein that is exposed to the outside when the channel is in the open conformation. Cys substitutions identified a single residue, Cys(168) located within the S3 alpha-helix of the voltage sensor complex, to be essential for sensitivity to H2O2. The same Cys residue was a primary determinant for current block by covalent Cys S-methioylation with aqueous methanethiosulfonates. These, and additional data identify Cys168 as a critical target for H2O2, and implicate ROS-mediated control of the K+ channel in regulating mineral nutrient partitioning within the plant.	[Amtmann, Anna; Blatt, Michael R.] Univ Glasgow, Fac Biomed & Life Sci Plant Sci, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland; [Wang, Jianwen] Soochow Univ, Sch Pharmaceut Sci, Suzhou 215123, Peoples R China; [Gajdanowicz, Pawel; Riedelsberger, Janin; Dreyer, Ingo] Univ Potsdam, Inst Biochem & Biol, Heisenberg Grp BPMPB, D-14476 Golm, Germany; [Gonzalez, Wendy] Univ Talca, Ctr Bioinformat & Simulac Mol, Talca, Chile	University of Glasgow; Soochow University - China; University of Potsdam; Universidad de Talca	Blatt, MR (corresponding author), Univ Glasgow, Fac Biomed & Life Sci Plant Sci, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland.	m.blatt@bio.gla.ac.uk	García-Mata, Carlos/AAF-9251-2019; Wang, Jian Wen/AAE-4412-2020; Wang, Jian Wen/B-3254-2009; Dreyer, Ingo/N-4747-2014	García-Mata, Carlos/0000-0003-4243-0554; Wang, Jian Wen/0000-0002-3095-7394; Wang, Jian Wen/0000-0002-3095-7394; Dreyer, Ingo/0000-0002-2781-0359; Gajdanowicz, Pawel/0000-0003-3075-5992; Riedelsberger, Janin/0000-0002-4687-7495; Blatt, Michael R/0000-0003-1361-4645; Gonzalez, Wendy/0000-0002-7535-6883; Amtmann, Anna/0000-0001-8533-121X	National Science Foundation of China [30772731]; Heisenberg Fellowship; Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas; Max Planck Research School; Biotechnology and Biological Sciences Research Council [BB/D001528/1]; John Simon Guggenheim Memorial Fellowship; BBSRC [BB/H009817/1, BB/D006775/1, BB/F001673/1, BB/F001630/1, BB/D001528/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C500595/1, BB/F001673/1, BB/F001630/1, P12750, BB/D006775/1, BB/H009817/1] Funding Source: researchfish	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heisenberg Fellowship(German Research Foundation (DFG)); Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas(Deutscher Akademischer Austausch Dienst (DAAD)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Max Planck Research School(Max Planck Society); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Simon Guggenheim Memorial Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Science Foundation of China Grant 30772731 (to J. W.), a Heisenberg Fellowship (to I. D.), Deutsche Akademische Austausch Dienst/Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant "NiaPoc" (to I. D. and W. G.), a Max Planck Research School "Primary Metabolism and Plant Growth" studentship (to J. R.), Biotechnology and Biological Sciences Research Council Grant BB/D001528/1, and a John Simon Guggenheim Memorial Fellowship (to M. R. B.).	AMTMANN A, 2007, PLANT SOLUTE TRANSPO, P99; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Coelho SM, 2002, PLANT CELL, V14, P2369, DOI 10.1105/tpc.003285; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Dreyer I, 2009, TRENDS PLANT SCI, V14, P383, DOI 10.1016/j.tplants.2009.04.001; Essah PA, 2003, PLANT PHYSIOL, V133, P307, DOI 10.1104/pp.103.022178; FOHR KJ, 1993, METHOD ENZYMOL, V221, P149, DOI 10.1016/0076-6879(93)21014-Y; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gajdanowicz P, 2009, NEW PHYTOL, V182, P380, DOI 10.1111/j.1469-8137.2008.02749.x; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson I, 2006, PLANT J, V46, P269, DOI [10.1111/j.1365-313X.2006.02690.x, 10.1111/j.1365-313X.2006.02690.X]; Kaddour R, 2009, CR BIOL, V332, P784, DOI 10.1016/j.crvi.2009.05.003; Kohler B, 2003, PLANT PHYSIOL, V131, P385, DOI 10.1104/pp.016014; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Maathuis FJM, 2006, J EXP BOT, V57, P1137, DOI 10.1093/jxb/erj001; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilot G, 2003, PLANT MOL BIOL, V51, P773, DOI 10.1023/A:1022597102282; Riedelsberger J, 2010, MOL PLANT, V3, P236, DOI 10.1093/mp/ssp096; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Sokolovski S, 2004, PLANT PHYSIOL, V136, P4275, DOI 10.1104/pp.104.050344; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tang XZ, 2004, PHYS PLASMAS, V11, P171, DOI 10.1063/1.1630574; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wang B, 2006, J EXP BOT, V57, P1161, DOI 10.1093/jxb/erj116; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue T, 2002, J BIOL CHEM, V277, P46233, DOI 10.1074/jbc.M204915200	46	94	97	0	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29286	29294		10.1074/jbc.M110.141176	http://dx.doi.org/10.1074/jbc.M110.141176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605786	Green Published, hybrid			2022-12-27	WOS:000281740100031
J	Ji, YR; Kim, MO; Kim, SH; Yu, DH; Shin, MJ; Kim, HJ; Yuh, HS; Bae, KB; Kim, JY; Park, HD; Lee, SG; Hyun, BH; Ryoo, ZY				Ji, Young Rae; Kim, Myoung Ok; Kim, Sung Hyun; Yu, Dong Hun; Shin, Mi Jung; Kim, Hei Jung; Yuh, Hyung Soo; Bae, Ki Beom; Kim, Jae Young; Park, Hum Dai; Lee, Sang Gyu; Hyun, Byung Hwa; Ryoo, Zae Young			Effects of Regulator of G Protein Signaling 19 (RGS19) on Heart Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN FUNCTION; WNT/BETA-CATENIN; NEGATIVE REGULATOR; PROGENITOR CELLS; STEM-CELL; PATHWAY; DIFFERENTIATION; MORPHOGENESIS; HYPERTROPHY; EXPRESSION	Wnt/Wg genes play a critical role in the development of various organisms. For example, the Wnt/beta-catenin signal promotes heart formation and cardiomyocyte differentiation in mice. Previous studies have shown that RGS19 ((r) under bar egulator of (G) under bar protein (s) under bar ignaling (19) under bar), which has G alpha subunits with GTPase activity, inhibits the Wnt/beta-catenin signal through inactivation of G alpha(o). In the present study, the effects of RGS19 on mouse cardiac development were observed. In P19 teratocarcinoma cells with RGS19 overexpression, RGS19 inhibited cardiomyocyte differentiation by blocking the Wnt signal. Additionally, several genes targeted by Wnt were down-regulated. For the in vivo study, we generated RGS19-overexpressing transgenic (RGS19 TG) mice. In these transgenic mice, septal defects and thin-walled ventricles were observed during the embryonic phase of development, and the expression of cardiogenesis-related genes, BMP4 and Mef2C, was reduced significantly. RGS19 TG mice showed increased expression levels of brain natriuretic peptide and beta-MHC, which are markers of heart failure, increase of cell proliferation, and electrocardiogram analysis shows abnormal ventricle repolarization. These data provide in vitro and in vivo evidence that RGS19 influenced cardiac development and had negative effects on heart function.	[Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, Taegu 702701, South Korea; [Kim, Jae Young] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Brain Korea Project 21,IHBR, Taegu 702701, South Korea; [Hyun, Byung Hwa] Korea Res Inst Biosci & Biotechnol, Dis Model Res Ctr, Daegeon 305806, South Korea; [Park, Hum Dai] Daegu Univ, Dept Biotechnol, Sch Engn, Gyeongsang 712714, Gyeongbuk, South Korea	Kyungpook National University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Daegu University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, 1370 Sankyuk Dong, Taegu 702701, South Korea.	jaewoong64@hanmail.net	RYOO, ZAEYOUNG/AAQ-1573-2020; Ji, Youngrae/AAK-9724-2021; Ji, Youngrae/AAK-9711-2021	Ji, Youngrae/0000-0002-8825-9783; 	National Research Foundation of Korea [NRF2009-0088343]; Korean government [2009-0063409]; Korea Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Korea Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Grant NRF2009-0088343 from the National Research Foundation of Korea, SRC Program of Korea Science and Engineering Foundation (KOSEF) Grant 2009-0063409 (funded by the Korean government), and the Regional Care Research Program from the Korea Ministry of Education, Science, and Technology.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Braz JC, 2009, EUR J HEART FAIL, V11, P739, DOI 10.1093/eurjhf/hfp094; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; HOGAN B, 1986, MANIPULATING MOUSE E; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Howes AL, 2006, J MOL CELL CARDIOL, V40, P597, DOI 10.1016/j.yjmcc.2005.12.003; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Korol O, 2008, DEV BIOL, V324, P131, DOI 10.1016/j.ydbio.2008.09.012; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Qu JX, 2007, J MOL CELL CARDIOL, V43, P319, DOI 10.1016/j.yjmcc.2007.06.006; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104	44	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28627	28634		10.1074/jbc.M109.073718	http://dx.doi.org/10.1074/jbc.M109.073718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20562099	hybrid, Green Published			2022-12-27	WOS:000281594000026
J	Singh, N; Thangaraju, M; Prasad, PD; Martin, PM; Lambert, NA; Boettger, T; Offermanns, S; Ganapathy, V				Singh, Nagendra; Thangaraju, Muthusamy; Prasad, Puttur D.; Martin, Pamela M.; Lambert, Nevin A.; Boettger, Thomas; Offermanns, Stefan; Ganapathy, Vadivel			Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; NICOTINIC-ACID; COLON-CANCER; SLC5A8; RELEVANCE; RECEPTOR; GENE; DIFFERENTIATION; IDENTIFICATION; ACTIVATION	Mammalian colon harbors trillions of bacteria, yet there is no undue inflammatory response by the host against these bacteria under normal conditions. The bacterial fermentation products acetate, propionate, and butyrate are believed, at least in part, to be responsible for these immunosuppressive effects. Dendritic cells play an essential role in presentation of antigens to T lymphocytes and initiation of adaptive immune responses. Here we report that butyrate and propionate block the generation of dendritic cells from bone marrow stem cells, without affecting the generation of granulocytes. This effect is dependent on the Na+-coupled monocarboxylate transporter Slc5a8, which transports butyrate and propionate into cells, and on the ability of these two bacterial metabolites to inhibit histone deacetylases. Acetate, which is also a substrate for Slc5a8 but not an inhibitor of histone deacetylases, does not affect dendritic cell development, indicating the essential role of histone deacetylase inhibition in the process. The blockade of dendritic cell development by butyrate and propionate is associated with decreased expression of the transcription factors PU.1 and RelB. Butyrate also elicits its biologic effects through its ability to activate the G-protein-coupled receptor Gpr109a, but this mechanism is not involved in butyrate-induced blockade of dendritic cell development. The participation of Slc5a8 and the non-involvement of Gpr109a in butyrate effects have been substantiated using bone marrow cells obtained from Slc5a8(-/-) and Gpr109a(-/-) mice. These findings uncover an important mechanism underlying the anti-inflammatory functions of the bacterial fermentation products butyrate and propionate.	[Singh, Nagendra; Thangaraju, Muthusamy; Prasad, Puttur D.; Martin, Pamela M.; Ganapathy, Vadivel] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Lambert, Nevin A.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Boettger, Thomas] Max Planck Inst Herz & Lundgenforsch, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Offermanns, Stefan] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Max Planck Society; Ruprecht Karls University Heidelberg	Ganapathy, V (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	vganapat@mail.mcg.edu	Boettger, Thomas/E-3406-2012; Offermanns, Stefan/L-3313-2017	Boettger, Thomas/0000-0003-4280-8449; Offermanns, Stefan/0000-0001-8676-6805				Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dehm SM, 2004, MOL CELL BIOL, V24, P2296, DOI 10.1128/MCB.24.6.2296-2307.2004; Dong XY, 2005, P NATL ACAD SCI USA, V102, P16007, DOI 10.1073/pnas.0506516102; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Frank H, 2008, J BIOL CHEM, V283, P24729, DOI 10.1074/jbc.M802681200; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gopal E, 2005, BIOCHEM J, V388, P309, DOI 10.1042/BJ20041916; Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1; Gupta N, 2006, LIFE SCI, V78, P2419, DOI 10.1016/j.lfs.2005.10.028; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaisho T, 2003, CURR MOL MED, V3, P759, DOI 10.2174/1566524033479366; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koski GK, 2001, CRIT REV IMMUNOL, V21, P179; Kostyniuk CL, 2002, ONCOGENE, V21, P6340, DOI 10.1038/sj.onc.1205787; Laribee RN, 2005, BBA-GENE STRUCT EXPR, V1730, P226, DOI 10.1016/j.bbaexp.2005.08.003; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Onai N, 2008, IMMUNITY, V28, P490, DOI 10.1016/j.immuni.2008.03.006; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thangaraju M, 2008, J GASTROINTEST SURG, V12, P1773, DOI 10.1007/s11605-008-0573-0; Thangaraju M, 2006, CANCER RES, V66, P11560, DOI 10.1158/0008-5472.CAN-06-1950; Thangaraju M, 2009, CANCER, V115, P4655, DOI 10.1002/cncr.24532; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Trifilo MJ, 2006, J INFECT DIS, V194, pS3, DOI 10.1086/505355; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	51	161	166	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27601	27608		10.1074/jbc.M110.102947	http://dx.doi.org/10.1074/jbc.M110.102947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601425	Green Published, hybrid			2022-12-27	WOS:000281404100015
J	Vaidyanathan, R; Taffet, SM; Vikstrom, KL; Anumonwo, JMB				Vaidyanathan, Ravi; Taffet, Steven M.; Vikstrom, Karen L.; Anumonwo, Justus M. B.			Regulation of Cardiac Inward Rectifier Potassium Current (I-K1) by Synapse-associated Protein-97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; RECTIFYING K+ CHANNELS; GUINEA-PIG; ANCHORING PROTEIN; SINGLE-CHANNEL; RECEPTOR INTERNALIZATION; CHOLINERGIC MODULATION; SAP97; KIR2.1; PSD-95	Synapse-associated protein-97 (SAP97) is a membrane-associated guanylate kinase scaffolding protein expressed in cardiomyocytes. SAP97 has been shown to associate and modulate voltage-gated potassium (Kv) channel function. In contrast to Kv channels, little information is available on interactions involving SAP97 and inward rectifier potassium (Kir2. x) channels that underlie the classical inward rectifier current, I-K1. To investigate the functional effects of silencing SAP97 on I-K1 in adult rat ventricular myocytes, SAP97 was silenced using an adenoviral short hairpin RNA vector. Western blot analysis showed that SAP97 was silenced by similar to 85% on day 3 post-infection. Immunostaining showed that Kir2.1 and Kir2.2 co-localize with SAP97. Co-immunoprecipitation (co-IP) results demonstrated that Kir2. x channels associate with SAP97. Voltage clamp experiments showed that silencing SAP97 reduced I-K1 whole cell density by similar to 55%. I-K1 density at -100 mV was -1.45 +/- 0.15 pA/picofarads (n = 6) in SAP97-silenced cells as compared with -3.03 +/- 0.37 pA/picofarads (n = 5) in control cells. Unitary conductance properties of IK1 were unaffected by SAP97 silencing. The major mechanism for the reduction of I-K1 density appears to be a decrease in Kir2. x channel abundance. Furthermore, SAP97 silencing impaired IK1 regulation by beta(1)-adrenergic receptor (beta(1)-AR) stimulation. In control, isoproterenol reduced I-K1 amplitude by similar to 75%, an effect that was blunted following SAP97 silencing. Our co-IP data show that beta(1)-AR associates with SAP97 and Kir2.1 and also that Kir2.1 co-IPs with protein kinase A and beta(1)-AR. SAP97 immunolocalizes with protein kinase A and beta(1)-AR in the cardiac myocytes. Our results suggest that in cardiac myocytes SAP97 regulates surface expression of channels underlying I-K1, as well as assembles a signaling complex involved in beta(1)-AR regulation of I-K1.	[Anumonwo, Justus M. B.] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48108 USA; [Vaidyanathan, Ravi] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Taffet, Steven M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Anumonwo, JMB (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, 5025 Venture Dr, Ann Arbor, MI 48108 USA.	anumonwo@umich.edu			National Institutes of Health, NIGMS [1R01-GM-076608]; NIH [PO1HL039707, PO1HL087226]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707, P01HL087226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076608] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-GM-076608 from the NIGMS and Grants PO1HL039707 and PO1HL087226 from NIH.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Godreau D, 2002, CARDIOVASC RES, V56, P433, DOI 10.1016/S0008-6363(02)00602-8; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; Horackova M, 1997, EXP CELL RES, V237, P158, DOI 10.1006/excr.1997.3775; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; JOSEPHSON IR, 1986, J MEMBRANE BIOL, V94, P19, DOI 10.1007/BF01901010; JOSEPHSON IR, 1988, MOL CELL BIOCHEM, V80, P21; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Koumi S, 1995, J CLIN INVEST, V96, P2870, DOI 10.1172/JCI118358; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P647, DOI 10.1113/jphysiol.1995.sp020841; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Liu GX, 2004, J PHYSIOL-LONDON, V556, P401, DOI 10.1113/jphysiol.2003.059303; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Luu T, 2006, J BIOL CHEM, V281, P35699, DOI 10.1074/jbc.M605590200; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Munoz V, 2007, HEART RHYTHM, V4, P487, DOI 10.1016/j.hrthm.2006.12.033; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rinne A, 2006, J MUSCLE RES CELL M, V27, P413, DOI 10.1007/s10974-006-9087-0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Veldkamp MW, 1999, CARDIOVASC RES, V42, P424, DOI 10.1016/S0008-6363(99)00046-2; Vikstrom KL, 2009, AM J PHYSIOL-HEART C, V297, pH1387, DOI 10.1152/ajpheart.00638.2008; WAHLER GM, 1992, AM J PHYSIOL, V262, pC1266, DOI 10.1152/ajpcell.1992.262.5.C1266; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200	43	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28000	28009		10.1074/jbc.M110.110858	http://dx.doi.org/10.1074/jbc.M110.110858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20530486	Green Published, hybrid			2022-12-27	WOS:000281404100053
J	Chen, VP; Xie, HQ; Chan, WKB; Leung, KW; Chan, GKL; Choi, RCY; Bon, S; Massoulie, J; Tsim, KWK				Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Bon, Suzanne; Massoulie, Jean; Tsim, Karl W. K.			The PRiMA-linked Cholinesterase Tetramers Are Assembled from Homodimers HYBRID MOLECULES COMPOSED OF ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE DIMERS ARE UP-REGULATED DURING DEVELOPMENT OF CHICKEN BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH-MEMBRANE-ANCHOR; TERMINAL T-PEPTIDE; SYNAPTIC ACETYLCHOLINESTERASE; MUSCLE ACETYLCHOLINESTERASE; QUATERNARY ASSOCIATIONS; CHICKEN BRAIN; COLLAGEN TAIL; FORMS; DEGRADATION; EXPRESSION	Acetylcholinesterase (AChE) is anchored onto cell membranes by the transmembrane protein PRiMA (proline-rich membrane anchor) as a tetrameric globular form that is prominently expressed in vertebrate brain. In parallel, the PRiMA-linked tetrameric butyrylcholinesterase (BChE) is also found in the brain. A single type of AChE-BChE hybrid tetramer was formed in cell cultures by co-transfection of cDNAs encoding AChE(T) and BChE(T) with proline-rich attachment domain-containing proteins, PRiMA I, PRiMA II, or a fragment of ColQ having a C-terminal GPI addition signal (Q(N-GPI)). Using AChE and BChE mutants, we showed that AChE-BChE hybrids linked with PRiMA or Q(N-GPI) always consist of AChE(T) and BChE(T) homodimers. The dimer formation of AChE(T) and BChE(T) depends on the catalytic domains, and the assembly of tetramers with a proline-rich attachment domain-containing protein requires the presence of C-terminal "t-peptides" in cholinesterase subunits. Our results indicate that PRiMA-or ColQ-linked cholinesterase tetramers are assembled from AChE(T) or BChE(T) homodimers. Moreover, the PRiMA-linked AChE-BChE hybrids occur naturally in chicken brain, and their expression increases during development, suggesting that they might play a role in cholinergic neurotransmission.	[Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Bon, Suzanne; Massoulie, Jean] Ecole Normale Super, CNRS, Inst Biol, UMR 8197, F-75005 Paris, France	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [N_HKUST629/07, 662407, 662608, 660409, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]; Centre National de la Recherche Scientifique; Ecole Normale Superieure; Association Francaise contre les Myopathies; French Ministry of Foreign Affairs	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Foreign Affairs	This work was supported by Research Grants Council of Hong Kong Grants N_HKUST629/07, 662407, 662608, 660409, and F-HK21/06T and Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.) and grants from Centre National de la Recherche Scientifique, Ecole Normale Superieure, Association Francaise contre les Myopathies, and French Ministry of Foreign Affairs (to J. M.).	ANSELMET A, 1994, J NEUROCHEM, V62, P2158; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 2004, EUR J BIOCHEM, V271, P33, DOI 10.1046/j.1432-1033.2003.03892.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1988, J NEUROCHEM, V51, P786, DOI 10.1111/j.1471-4159.1988.tb01813.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi RCY, 1996, NEUROSCI LETT, V217, P165, DOI 10.1016/0304-3940(96)13102-5; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; Garcia-Ayllon MS, 2001, NEUROSCIENCE, V107, P199, DOI 10.1016/S0306-4522(01)00355-4; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; KARNOVSKY MJ, 1964, HISTOCHEM CYTOCHEM, V12, P219; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; LEE SL, 1982, J BIOL CHEM, V257, P12282; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; LI Y, 1991, J BIOL CHEM, V266, P23083; Liang D, 2009, FEBS J, V276, P94, DOI 10.1111/j.1742-4658.2008.06756.x; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Perrier NA, 2003, EUR J NEUROSCI, V18, P1837, DOI 10.1046/j.1460-9568.2003.02914.x; RANDALL WR, 1987, EUR J BIOCHEM, V164, P95, DOI 10.1111/j.1432-1033.1987.tb10998.x; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TSIM KWK, 1988, EMBO J, V7, P2451, DOI 10.1002/j.1460-2075.1988.tb03091.x; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27265	27278		10.1074/jbc.M110.113647	http://dx.doi.org/10.1074/jbc.M110.113647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566626	Green Published, hybrid			2022-12-27	WOS:000281172700057
J	Leenders, JJ; Wijnen, WJ; Hiller, M; van der Made, I; Lentink, V; van Leeuwen, REW; Herias, V; Pokharel, S; Heymans, S; de Windt, LJ; Hoydal, MA; Pinto, YM; Creemers, EE				Leenders, Joost J.; Wijnen, Wino J.; Hiller, Monika; van der Made, Ingeborg; Lentink, Viola; van Leeuwen, Rick E. W.; Herias, Veronica; Pokharel, Saraswati; Heymans, Stephane; de Windt, Leon J.; Hoydal, Morten A.; Pinto, Yigal M.; Creemers, Esther E.			Regulation of Cardiac Gene Expression by KLF15, a Repressor of Myocardin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; PRESSURE-OVERLOAD; DISEASE GENE; CELL-GROWTH; PROTEIN; P38; HYPERTROPHY; FAMILY; PROMOTER; MYOCYTES	Pathological forms of left ventricular hypertrophy (LVH) often progress to heart failure. Specific transcription factors have been identified that activate the gene program to induce pathological forms of LVH. It is likely that apart from activating transcriptional inducers of LVH, constitutive transcriptional repressors need to be removed during the development of cardiac hypertrophy. Here, we report that the constitutive presence of Kruppel-like factor 15 (KLF15) is lost in pathological hypertrophy and that this loss precedes progression toward heart failure. We show that transforming growth factor-beta-mediated activation of p38 MAPK is necessary and sufficient to decrease KLF15 expression. We further show that KLF15 robustly inhibits myocardin, a potent transcriptional activator. Loss of KLF15 during pathological LVH relieves the inhibitory effects on myocardin and stimulates the expression of serum response factor target genes, such as atrial natriuretic factor. This uncovers a novel mechanism where activated p38 MAPK decreases KLF15, an important constitutive transcriptional repressor whose removal seems a vital step to allow the induction of pathological LVH.	[Leenders, Joost J.; Wijnen, Wino J.; Hiller, Monika; van der Made, Ingeborg; Pinto, Yigal M.; Creemers, Esther E.] Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lentink, Viola; van Leeuwen, Rick E. W.; Herias, Veronica; Heymans, Stephane; de Windt, Leon J.] Univ Maastricht, Cardiovasc Res Inst, NL-6229 ER Maastricht, Netherlands; [Pokharel, Saraswati] Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40292 USA; [Hoydal, Morten A.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, NO-7491 Trondheim, Norway	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Louisville; Norwegian University of Science & Technology (NTNU)	Creemers, EE (corresponding author), Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	de Windt, Leon/AAO-6395-2020; Høydal, Morten A/K-2806-2012; Wijnen, Wino/P-4774-2015	de Windt, Leon/0000-0002-7793-2856; Høydal, Morten A/0000-0003-1804-2578; Wijnen, Wino/0000-0002-3513-3618; Creemers, Esther/0000-0002-9001-3854; Heymans, Stephane/0000-0001-9477-7803	Netherlands Heart Foundation [2003T302, 2007B077]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by Netherlands Heart Foundation Grants 2003T302 (to Y. M. P.) and 2007B077 (to E. E. C.).	Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	34	47	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27449	27456		10.1074/jbc.M110.107292	http://dx.doi.org/10.1074/jbc.M110.107292			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566642	Green Published, hybrid			2022-12-27	WOS:000281172700074
J	Manchinelly, SAS; Miller, JA; Su, L; Miyake, T; Palmer, L; Mikawa, M; Parsons, SJ				Manchinelly, Sergio A. Sanchez; Miller, Joyce Agati; Su, Ling; Miyake, Tsuyoshi; Palmer, Lisa; Mikawa, Masahito; Parsons, Sarah J.			Mitotic Down-regulation of p190RhoGAP Is Required for the Successful Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; RHO GTPASE; EXCHANGE FACTOR; HUMAN ECT2; P190; ACTIVATION; PROTEIN; PHOSPHORYLATION; DEGRADATION; LOCALIZATION	p190RhoGAP-A (p190) is a GTPase-activating protein known to regulate actin cytoskeleton dynamics by decreasing RhoGTP levels through activation of Rho intrinsic GTPase activity. We have previously shown that p190 protein levels are cell cycle-regulated, decreasing in mitosis, and that this decrease is mediated by the ubiquitin-proteasome pathway. In addition, overexpression of p190 results in decreased RhoGTP levels at the cleavage furrow during cytokinesis, p190 and the RhoGEF Ect2 play opposing roles in cytokinesis, and sustained levels of p190 in mitosis are associated with cytokinesis failure, all findings that suggest but do not directly demonstrate that completion of cytokinesis is dependent on reduced levels of p190. Here we report, using an RNAi reconstitution approach with a degradation- resistant mutant, that decreased p190 levels are required for successful cytokinesis. We also show that the multinucleation phenotype is dependent on p190 RhoGAP activity, determine that the N-terminal GBDS1 region is necessary and sufficient for p190 mitotic ubiquitination and degradation, and identify four N-terminal residues as necessary for the degradation of p190 in mitosis. Our data indicate that in addition to activation of RhoGEF(s), reduction of RhoGAP (p190) is a critical mechanism by which increased RhoGTP levels are achieved in late mitosis, thereby ensuring proper cell division.	[Parsons, Sarah J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Parsons, Sarah J.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Palmer, Lisa] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Parsons, SJ (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	sap@virginia.edu			National Institutes of Health, NCI [R01CA039438]; NCI [CA039438-20S1, T32 CA009109]; NATIONAL CANCER INSTITUTE [T32CA009109, R01CA039438] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA039438 (to S. J. P.), supplemental Grant CA039438-20S1 (to S. A. S. M.), and Cancer Training Grant T32 CA009109 (to the University of Virginia Cancer Center), all from the NCI.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Fincham VJ, 1999, J CELL SCI, V112, P947; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Haskell MD, 2001, J CELL SCI, V114, P1699; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kim JH, 2008, BIOCHEM BIOPH RES CO, V366, P1036, DOI 10.1016/j.bbrc.2007.12.070; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mikawa M, 2008, CELL CYCLE, V7, P2003, DOI 10.4161/cc.7.13.6128; Miller AL, 2008, BIOCHEM SOC T, V36, P378, DOI 10.1042/BST0360378; Moasser MM, 1999, CANCER RES, V59, P6145; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Nishimura Y, 1998, FEBS LETT, V441, P121, DOI 10.1016/S0014-5793(98)01531-2; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Su L, 2003, J CELL BIOL, V163, P571, DOI 10.1083/jcb.200308007; TAKAISHI K, 1995, ONCOGENE, V11, P39; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Welbourn S, 2009, J GEN VIROL, V90, P1071, DOI 10.1099/vir.0.009944-0; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	43	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26923	26932		10.1074/jbc.M110.103804	http://dx.doi.org/10.1074/jbc.M110.103804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20534586	Green Published, hybrid			2022-12-27	WOS:000281172700024
J	Masuda, T; Esumi, N				Masuda, Tomohiro; Esumi, Noriko			SOX9, through Interaction with Microphthalmia-associated Transcription Factor (MITF) and OTX2, Regulates BEST1 Expression in the Retinal Pigment Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; MYELIN PROTEIN ZERO; CAMPOMELIC DYSPLASIA; CRE RECOMBINASE; EYE DEVELOPMENT; VMD2 PROMOTER; NEURAL CREST; IN-VIVO; GENE	BEST1 is highly and preferentially expressed in the retinal pigment epithelium (RPE) and causes Best macular dystrophy when mutated. We previously demonstrated that the human BEST1 upstream region -154 to +38 bp is sufficient to direct expression in the RPE of transgenic mice, and microphthalmia-associated transcription factor (MITF) and OTX2 regulate this BEST1 promoter. However, a number of questions remained. Here, we show that yeast one-hybrid screen with bait corresponding to BEST1 -120 to -88 bp identified the SOX-E factors, SOX8, SOX9, and SOX10. A paired SOX site was found in this bait, and mutation of either of the paired sites significantly decreased BEST1 promoter activity in RPE primary cultures. Among the SOX-E genes, SOX9 is highly and preferentially expressed in the RPE, and chromatin immunoprecipitation with fresh RPE cells revealed binding of SOX9, but not SOX10, to the BEST1 region where the paired SOX site is located. BEST1 promoter activity was increased by SOX9 overexpression and decreased by siRNA-mediated SOX9 knockdown. Importantly, SOX9 physically interacted with MITF and OTX2 and orchestrated synergistic activation of the BEST1 promoter with the paired SOX site playing essential roles. A combination of the expression patterns of SOX9, MITF, and OTX2 yielded tissue distribution remarkably similar to that of BEST1. Lastly, the BEST1 promoter was also active in Sertoli cells of the testis in transgenic mice where SOX9 is highly expressed. These results define SOX9 as a key regulator of BEST1 expression and demonstrate for the first time its functional role in the RPE.	[Esumi, Noriko] Johns Hopkins Univ, Sch Med, Guerrieri Ctr Genet Engn & Mol Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Esumi, N (corresponding author), Johns Hopkins Univ, Sch Med, Guerrieri Ctr Genet Engn & Mol Ophthalmol, Wilmer Eye Inst, Smith Bldg,Rm 3041,400 N Broadway, Baltimore, MD 21287 USA.	nesumi1@jhmi.edu			National Institutes of Health [EY015410, EY016398, EY001765]; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY016398, R03EY015410, P30EY001765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY015410, EY016398, and EY001765. This work was also supported in part by unrestricted funds from Research to Prevent Blindness, Inc. and generous gifts from Mr. and Mrs. Robert and Clarice Smith and the Guerrieri Family Foundation.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; BOK D, 1993, J CELL SCI, P189; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bridgewater LC, 2003, NUCLEIC ACIDS RES, V31, P1541, DOI 10.1093/nar/gkg230; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Chen SM, 2000, METHOD ENZYMOL, V316, P590; Davidson AE, 2009, AM J HUM GENET, V85, P581, DOI 10.1016/j.ajhg.2009.09.015; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Goding CR, 2000, GENE DEV, V14, P1712; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Ida H, 2004, MOL VIS, V10, P439; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jiao ZX, 2004, PIGM CELL RES, V17, P352, DOI 10.1111/j.1600-0749.2004.00154.x; Kachi S, 2006, GENE THER, V13, P798, DOI 10.1038/sj.gt.3302700; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; Koopman P, 2005, TRENDS GENET, V21, P367, DOI 10.1016/j.tig.2005.05.006; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THUMANN G, 2001, RETINA, V3, P104; Ueki Y, 2009, VISION RES, V49, P615, DOI 10.1016/j.visres.2009.01.012; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Wistow G, 2002, MOL VIS, V8, P205; Yardley J, 2004, INVEST OPHTH VIS SCI, V45, P3683, DOI 10.1167/iovs.04-0550; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583	80	37	39	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26933	26944		10.1074/jbc.M110.130294	http://dx.doi.org/10.1074/jbc.M110.130294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20530484	Green Published, hybrid			2022-12-27	WOS:000281172700025
J	Hawkins, BJ; Levin, MD; Doonan, PJ; Petrenko, NB; Davis, CW; Patel, VV; Madesh, M				Hawkins, Brian J.; Levin, Mark D.; Doonan, Patrick J.; Petrenko, Nataliya B.; Davis, Christiana W.; Patel, Vickas V.; Madesh, Muniswamy			Mitochondrial Complex II Prevents Hypoxic but Not Calcium- and Proapoptotic Bcl-2 Protein-induced Mitochondrial Membrane Potential Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C; RESPIRATORY-CHAIN; CELL-DEATH; SUCCINATE-DEHYDROGENASE; INNER MEMBRANE; CAROTID-BODY; APOPTOSIS; OXYGEN; SUPEROXIDE	Mitochondrial membrane potential loss has severe bioenergetic consequences and contributes to many human diseases including myocardial infarction, stroke, cancer, and neurodegeneration. However, despite its prominence and importance in cellular energy production, the basic mechanism whereby the mitochondrial membrane potential is established remains unclear. Our studies elucidate that complex II-driven electron flow is the primary means by which the mitochondrial membrane is polarized under hypoxic conditions and that lack of the complex II substrate succinate resulted in reversible membrane potential loss that could be restored rapidly by succinate supplementation. Inhibition of mitochondrial complex I and F0F1-ATP synthase induced mitochondrial depolarization that was independent of the mitochondrial permeability transition pore, Bcl-2 (B-cell lymphoma 2) family proteins, or high amplitude swelling and could not be reversed by succinate. Importantly, succinate metabolism under hypoxic conditions restores membrane potential and ATP levels. Furthermore, a reliance on complex II-mediated electron flow allows cells from mitochondrial disease patients devoid of a functional complex I to maintain a mitochondrial membrane potential that conveys both a mitochondrial structure and the ability to sequester agonist-induced calcium similar to that of normal cells. This finding is important as it sets the stage for complex II functional preservation as an attractive therapy to maintain mitochondrial function during hypoxia.	[Hawkins, Brian J.; Doonan, Patrick J.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Levin, Mark D.; Petrenko, Nataliya B.; Patel, Vickas V.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Davis, Christiana W.] Univ Penn, Inst Environm Med, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania	Hawkins, BJ (corresponding author), 815 Mercer St,Rm N 134 SLU, Seattle, WA 98108 USA.	bhawkins@u.washington.edu; madeshm@temple.edu	Levin, Mark David/AAE-1013-2021	Levin, Mark David/0000-0002-2241-9828	American Heart Association [0530087N]; National Institutes of Health [HL086699, 1S10RR022511, HL074108, K99HL094536]; Pennsylvania Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022511] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699, K08HL074108, K99HL094536, R00HL094536] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 0530087N, National Institutes of Health Grants HL086699 and 1S10RR022511 and Pennsylvania Department of Health (to M. M.) and National Institutes of Health Grant HL074108 (to V. V. P.).; Supported by National Institutes of Health Grant K99HL094536. To whom correspondence may be addressed: 815 Mercer St., Rm. N-134 SLU, Seattle, WA 98108. Tel.: 206-543-6140; E-mail: bhawkins@u.washington.edu.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bernardi P., 2007, V45, P481; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Csordas G, 2002, EMBO J, V21, P2198, DOI 10.1093/emboj/21.9.2198; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; HALESTRAP AP, 1982, BIOCHEM J, V204, P49, DOI 10.1042/bj2040049; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; KAUPPINEN RA, 1986, J NEUROCHEM, V47, P1864, DOI 10.1111/j.1471-4159.1986.tb13100.x; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saulle E, 2004, MOL CELL NEUROSCI, V25, P9, DOI 10.1016/j.mcn.2003.09.013; Storz P., 2006, SCI STKE, V2006, pre3, DOI DOI 10.1126/STKE.3322006RE3; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wyatt CN, 2004, J PHYSIOL-LONDON, V556, P175, DOI 10.1113/jphysiol.2003.058131; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	57	30	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26494	26505		10.1074/jbc.M110.143164	http://dx.doi.org/10.1074/jbc.M110.143164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566649	Green Published, hybrid			2022-12-27	WOS:000280921000067
J	Jincho, Y; Araki, R; Hoki, Y; Tamura, C; Nakamura, M; Ando, S; Kasama, Y; Abe, M				Jincho, Yuko; Araki, Ryoko; Hoki, Yuko; Tamura, Chihiro; Nakamura, Miki; Ando, Shunsuke; Kasama, Yasuji; Abe, Masumi			Generation of Genome Integration-free Induced Pluripotent Stem Cells from Fibroblasts of C57BL/6 Mice without c-Myc Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE; INDUCTION	Although the induction of genome integration-free induced pluripotent stem cells (iPSCs) has been reported, c-Myc was still required for the efficient generation of these cells. Herein, we report mouse strain-dependent differences in the c-Myc dependence for iPSC generation and the successful generation of genome integration-free iPSCs without c-Myc transduction using C57BL/6 mouse embryonic fibroblasts. We performed 49 independent experiments and obtained a total of 24 iPSC clones, including 18 genome integration-free iPSC clones. These iPSCs were indistinguishable from embryonic stem cells and from iPSCs generated using other methods. Furthermore, the generation of three-factor iPSCs free of virus vectors revealed the contribution of c-Myc to the genomic integration of external genes. C57BL/6 is an inbred mouse strain with substantial advantages for use in genetic and molecular biological studies due to its use in the whole mouse genome sequencing project. Thus, the present series of C57BL/6 iPSCs generated by various procedures will serve as a valuable resource for future genetic studies of iPSC generation.	[Jincho, Yuko; Araki, Ryoko; Hoki, Yuko; Tamura, Chihiro; Nakamura, Miki; Ando, Shunsuke; Kasama, Yasuji; Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan; [Araki, Ryoko; Nakamura, Miki] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan	National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST)	Abe, M (corresponding author), Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan.	abemasum@nirs.go.jp		Abe, Masumi/0000-0003-1550-2006	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a research grant from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST).	Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	25	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26384	26389		10.1074/jbc.M110.115915	http://dx.doi.org/10.1074/jbc.M110.115915			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554535	hybrid, Green Published			2022-12-27	WOS:000280921000057
J	Ling, L; Dombrowski, C; Foong, KM; Haupt, LM; Stein, GS; Nurcombe, V; van Wijnen, AJ; Cool, SM				Ling, Ling; Dombrowski, Christian; Foong, Kin Mun; Haupt, Larisa M.; Stein, Gary S.; Nurcombe, Victor; van Wijnen, Andre J.; Cool, Simon M.			Synergism between Wnt3a and Heparin Enhances Osteogenesis via a Phosphoinositide 3-Kinase/Akt/RUNX2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; ALKALINE-PHOSPHATASE EXPRESSION; FRIZZLED-RELATED PROTEIN-1; TRANSCRIPTION FACTOR RUNX2; RECEPTOR-RELATED PROTEIN-5; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; PHOSPHATIDYLINOSITOL 3-KINASE; SULFATE PROTEOGLYCANS; BIOLOGICAL-ACTIVITIES	A new strategy has emerged to improve healing of bone defects using exogenous glycosaminoglycans by increasing the effectiveness of bone-anabolic growth factors. Wnt ligands play an important role in bone formation. However, their functional interactions with heparan sulfate/heparin have only been investigated in non-osseous tissues. Our study now shows that the osteogenic activity of Wnt3a is cooperatively stimulated through physical interactions with exogenous heparin. N-Sulfation and to a lesser extent O-sulfation of heparin contribute to the physical binding and optimal co-stimulation of Wnt3a. Wnt3a-heparin signaling synergistically increases osteoblast differentiation with minimal effects on cell proliferation. Thus, heparin selectively reduces the effective dose of Wnt3a needed to elicit osteogenic, but not mitogenic responses. Mechanistically, Wnt3a-heparin signaling strongly activates the phosphoinositide 3-kinase/Akt pathway and requires the bone-related transcription factor RUNX2 to stimulate alkaline phosphatase activity, which parallels canonical beta-catenin signaling. Collectively, our findings establish the osteo-inductive potential of a heparin-mediated Wnt3a-phosphoinositide 3-kinase/Akt-RUNX2 signaling network and suggest that heparan sulfate supplementation may selectively reduce the therapeutic doses of peptide factors required to promote bone formation.	[Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Ctr Canc, Sch Med, Worcester, MA 01655 USA; [Cool, Simon M.] Inst Med Biol, Singapore 138648, Singapore; [Nurcombe, Victor; Cool, Simon M.] Natl Univ Singapore, Dept Orthopaed Surg, Yong Loo Lin Sch Med, Singapore 119074, Singapore	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	van Wijnen, AJ (corresponding author), Univ Massachusetts, Dept Cell Biol, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.	andre.vanwijnen@umassmed.edu; simon.cool@imb.a-star.edu.sg	Cool, Simon McKenzie/AAG-4346-2021; Cool, Simon/W-1257-2018; van Wijnen, Andre J./AAG-3578-2019; Haupt, Larisa M/C-6066-2017	Cool, Simon/0000-0001-8543-3056; van Wijnen, Andre J./0000-0002-4458-0946; Haupt, Larisa M/0000-0002-7735-8110	Singapore Agency for Science Technology and Research (A*STAR); Biomedical Research Council of Singapore; Institute of Medical Biology, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	Singapore Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the Singapore Agency for Science Technology and Research (A*STAR), the Biomedical Research Council of Singapore, and the Institute of Medical Biology, Singapore.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ambrosetti D, 2008, MOL CELL BIOL, V28, P4759, DOI 10.1128/MCB.01849-07; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; Jackson RA, 2007, J CELL PHYSIOL, V210, P38, DOI 10.1002/jcp.20813; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kumarasuriyar A, 2009, J CELL PHYSIOL, V218, P501, DOI 10.1002/jcp.21620; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Ling L, 2006, J CELL PHYSIOL, V209, P811, DOI 10.1002/jcp.20760; Mahtouk K, 2004, BLOOD, V103, P1829, DOI 10.1182/blood-2003-05-1510; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Mehta VB, 2005, J IMMUNOL, V175, P1911, DOI 10.4049/jimmunol.175.3.1911; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sobel M, 2001, J VASC SURG, V33, P587, DOI 10.1067/mva.2001.112696; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Teplyuk NM, 2009, J CELL BIOCHEM, V107, P144, DOI 10.1002/jcb.22108; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	59	64	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26233	26244		10.1074/jbc.M110.122069	http://dx.doi.org/10.1074/jbc.M110.122069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547765	Green Published, hybrid			2022-12-27	WOS:000280921000040
J	Malivert, L; Ropars, V; Nunez, M; Drevet, P; Miron, S; Faure, G; Guerois, R; Mornon, JP; Revy, P; Charbonnier, JB; Callebaut, I; de Villartay, JP				Malivert, Laurent; Ropars, Virginie; Nunez, Marcela; Drevet, Pascal; Miron, Simona; Faure, Guilhem; Guerois, Raphael; Mornon, Jean-Paul; Revy, Patrick; Charbonnier, Jean-Baptiste; Callebaut, Isabelle; de Villartay, Jean-Pierre			Delineation of the Xrcc4-interacting Region in the Globular Head Domain of Cernunnos/XLF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; DNA-LIGASE-IV; END-JOINING FACTOR; CRYSTAL-STRUCTURE; HUMAN XLF; REPAIR PROTEIN; XRCC4; COMPLEX; XLF/CERNUNNOS; RECOMBINATION	In mammals, the majority of DNA double-strand breaks are processed by the nonhomologous end-joining (NHEJ) pathway, composed of seven factors: Ku70, Ku80, DNA-PKcs, Artemis, Xrcc4 (X4), DNA-ligase IV (L4), and Cernunnos/XLF. Cernunnos is part of the ligation complex, constituted by X4 and L4. To improve our knowledge on the structure and function of Cernunnos, we performed a systematic mutagenesis study on positions selected from an analysis of the recent three-dimensional structures of this factor. Ten of 27 screened mutants were nonfunctional in several DNA repair assays. Outside amino acids critical for the expression and stability of Cernunnos, we identified three amino acids (Arg(64), Leu(65), and Leu(115)) essential for the interaction with X4 and the proper function of Cernunnos. Docking the crystal structures of the two factors further validated this probable interaction surface of Cernunnos with X4.	[Revy, Patrick; de Villartay, Jean-Pierre] Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; [Ropars, Virginie; Nunez, Marcela; Drevet, Pascal; Faure, Guilhem; Guerois, Raphael; Charbonnier, Jean-Baptiste] CEA, Inst Biol & Technol Saclay, CNRS, Unites Rech Associees 2096,Lab Biol Struct & Radi, F-91191 Gif Sur Yvette, France; [Miron, Simona] Inst Curie, INSERM 759, Integrat Imaging Unit, F-91405 Orsay, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 06, CNRS, UMR7590, Dept Biol Struct,IMPMC, F-75005 Paris, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 07, F-75005 Paris, France; [Revy, Patrick; de Villartay, Jean-Pierre] Univ Paris 05, Fac Med Rene Descartes, F-75005 Paris, France; [de Villartay, Jean-Pierre] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Villartay, JP (corresponding author), Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, 149 Rue Sevres, F-75015 Paris, France.	jean-pierre.de-villartay@inserm.fr	Revy, Patrick/H-8137-2017; de Villartay, jean pierre/H-9353-2017; Charbonnier, Jean-Baptiste/A-3868-2009; Miron, Simona/M-9223-2018; , raph/AAF-4380-2019	de Villartay, jean pierre/0000-0001-5987-0463; Charbonnier, Jean-Baptiste/0000-0002-5219-1983; Revy, Patrick/0000-0003-0758-8022; Ropars, Virginie/0000-0002-3372-6030; Malivert, Laurent/0000-0002-0944-6573; Faure, Guilhem/0000-0001-9537-2277	INSERM; Ligue National contre le Cancer (Equipe labellisee LA LIGUE); Institut National du Cancer a/Canceropole Ile-de-France; Agence Nationale pour la Recherche [ANR'06]; Commissariat a l'Energie Atomique [LRC-CEA 40V]; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue National contre le Cancer (Equipe labellisee LA LIGUE); Institut National du Cancer a/Canceropole Ile-de-France; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by institutional grants from INSERM as well as grants from the Ligue National contre le Cancer (Equipe labellisee LA LIGUE), the Institut National du Cancer a/Canceropole Ile-de-France, Agence Nationale pour la Recherche (ANR'06), and Commissariat a l'Energie Atomique (LRC-CEA 40V).; Supported by the Association pour la Recherche sur le Cancer and by ANR'06.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callebaut I, 2006, J BIOL CHEM, V281, P13857, DOI 10.1074/jbc.C500473200; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Malivert L, 2009, MOL CELL BIOL, V29, P1116, DOI 10.1128/MCB.01521-08; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Recuero-Checa MA, 2009, DNA REPAIR, V8, P1380, DOI 10.1016/j.dnarep.2009.09.007; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P11876, DOI 10.1021/bi001013s; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137	29	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26475	26483		10.1074/jbc.M110.138156	http://dx.doi.org/10.1074/jbc.M110.138156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558749	hybrid, Green Published			2022-12-27	WOS:000280921000065
J	Altenhofer, S; Witte, I; Teiber, JF; Wilgenbus, P; Pautz, A; Li, H; Daiber, A; Witan, H; Clement, AM; Forstermann, U; Horke, S				Altenhoefer, Sebastian; Witte, Ines; Teiber, John F.; Wilgenbus, Petra; Pautz, Andrea; Li, Huige; Daiber, Andreas; Witan, Heidrun; Clement, Albrecht M.; Foerstermann, Ulrich; Horke, Sven			One Enzyme, Two Functions PON2 PREVENTS MITOCHONDRIAL SUPEROXIDE FORMATION AND APOPTOSIS INDEPENDENT FROM ITS LACTONASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; PARAOXONASE-2; PON1; ATHEROSCLEROSIS; MITOCHONDRIA; ANTIOXIDANT	The human enzyme paraoxonase-2 (PON2) has two functions, an enzymatic lactonase activity and the reduction of intracellular oxidative stress. As a lactonase, it dominantly hydrolyzes bacterial signaling molecule 3OC12 and may contribute to the defense against pathogenic Pseudomonas aeruginosa. By its anti-oxidative effect, PON2 reduces cellular oxidative damage and influences redox signaling, which promotes cell survival. This may be appreciated but also deleterious given that high PON2 levels reduce atherosclerosis but may stabilize tumor cells. Here we addressed the unknown mechanisms and linkage of PON2 enzymatic and anti-oxidative function. We demonstrate that PON2 indirectly but specifically reduced superoxide release from the inner mitochondrial membrane, irrespective whether resulting from complex I or complex III of the electron transportchain. PON2 left O-2((center dot) over bar) dismutase activities and cytochrome c expression unaltered, and it did not oxidize O2((center dot) over bar) but rather prevented its formation, which implies that PON2 acts by modulating quinones. To analyze linkage to hydrolytic activity, we introduced several point mutations and show that residues His(114) and His(133) are essential for PON2 activity. Further, we mapped its glycosylation sites and provide evidence that glycosylation, but not a native polymorphism Ser/Cys(311), was critical to its activity. Importantly, none of these mutations altered the anti-oxidative/anti-apoptotic function of PON2, demonstrating unrelated activities of the same protein. Collectively, our study provides detailed mechanistic insight into the functions of PON2, which is important for its role in innate immunity, atherosclerosis, and cancer.	[Foerstermann, Ulrich; Horke, Sven] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, D-55131 Mainz, Germany; [Teiber, John F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA; [Daiber, Andreas] Johannes Gutenberg Univ Mainz, Dept Internal Med 2, D-55101 Mainz, Germany; [Witan, Heidrun; Clement, Albrecht M.] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Horke, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	horke@uni-mainz.de	Li, Huige/M-2662-2013	Li, Huige/0000-0003-3458-7391	German Research Foundation (Deutsche Forschungsgemeinschaft) [HO3925/4-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from intramural sources and the German Research Foundation (Deutsche Forschungsgemeinschaft; Grant HO3925/4-1) (to S. H.).	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Horke S, 2008, BIOCHEM J, V416, P395, DOI 10.1042/BJ20080775; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Linnane AW, 2007, MITOCHONDRION, V7, P1, DOI 10.1016/j.mito.2006.11.009; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Orrenius S, 2005, NAT CHEM BIOL, V1, P188, DOI 10.1038/nchembio0905-188; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Shiner M, 2004, FREE RADICAL BIO MED, V37, P2052, DOI 10.1016/j.freeradbiomed.2004.09.003; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Teiber JF, 2007, ARCH BIOCHEM BIOPHYS, V461, P24, DOI 10.1016/j.abb.2007.02.015; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	34	110	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24398	24403		10.1074/jbc.M110.118604	http://dx.doi.org/10.1074/jbc.M110.118604			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530481	hybrid, Green Published			2022-12-27	WOS:000280542100011
J	Watashi, K; Yeung, ML; Starost, MF; Hosmane, RS; Jeang, KT				Watashi, Koichi; Yeung, Man Lung; Starost, Matthew F.; Hosmane, Ramachandra S.; Jeang, Kuan-Teh			Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN TRBP; RNA-INTERFERENCE; EXPRESSION; GENE; DICER; HIV-1; KINASE; CELLS; LOCALIZATION; DEREGULATION	MicroRNAs (miRNAs) act in post-transcriptional gene silencing and are proposed to function in a wide spectrum of pathologies, including cancers and viral diseases. Currently, to our knowledge, no detailed mechanistic characterization of small molecules that interrupt miRNA pathways have been reported. In screening a small chemical library, we identified compounds that suppress RNA interference activity in cultured cells. Two compounds were characterized; one impaired Dicer activity while the other blocked small RNA-loading into an Argonaute 2 (AGO2) complex. We developed a cell-based model of miRNA-dependent tumorigenesis, and using this model, we observed that treatment of cells with either of the two compounds effectively neutralized tumor growth. These findings indicate that miRNA pathway-suppressing small molecules could potentially reverse tumorigenesis.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Hosmane, Ramachandra S.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore	Jeang, KT (corresponding author), 9000 Rockville Pike,Bldg 4,Rm 303A, Bethesda, MD 20892 USA.	kjeang@niaid.nih.gov	Jeang, Kuan-Teh/A-2424-2008; Yeung, Man Lung/E-9903-2010	Yeung, Man Lung/0000-0002-6117-7884	National Institutes of Health [1R01 GM087738-01A1]; NIAID; NIH; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 GM087738-01A1 (to R. S. H.) and by intramural funds from NIAID, NIH and the Intramural AIDS Targeted Antiviral Program from the office of the Director, NIH (to K.-T. J.).; A recipient of a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bouzar AB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koesters R, 1999, GENOMICS, V61, P210, DOI 10.1006/geno.1999.5951; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Leung AKL, 2006, COLD SPRING HARB SYM, V71, P29, DOI 10.1101/sqb.2006.71.049; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033	52	93	95	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24707	24716		10.1074/jbc.M109.062976	http://dx.doi.org/10.1074/jbc.M109.062976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529860	Green Published, hybrid			2022-12-27	WOS:000280542100043
J	Luo, JY; Tang, M; Huang, JY; He, BC; Gao, JL; Chen, LA; Zuo, GW; Zhang, WL; Luo, Q; Shi, QO; Zhang, BQ; Bi, Y; Luo, XJ; Jiang, W; Su, YX; Shen, JK; Kim, SH; Huang, EY; Gao, YH; Zhou, JZ; Yang, K; Luu, HH; Pan, XC; Haydon, RC; Deng, ZL; He, TC				Luo, Jinyong; Tang, Min; Huang, Jiayi; He, Bai-Cheng; Gao, Jian-Li; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Jiang, Wei; Su, Yuxi; Shen, Jikun; Kim, Stephanie H.; Huang, Enyi; Gao, Yanhong; Zhou, Jian-Zhong; Yang, Ke; Luu, Hue H.; Pan, Xiaochuan; Haydon, Rex C.; Deng, Zhong-Liang; He, Tong-Chuan			TGF beta/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; GROWTH-FACTOR; KINASE RECEPTOR; BMP; GENE; EXPRESSION; SMAD6; GENERATION; INDUCTION	Mesenchymal stem cells (MSCs) are bone marrow stromal cells that can differentiate into multiple lineages. We previously demonstrated that BMP9 is one of the most potent BMPs to induce osteogenic differentiation of MSCs. BMP9 is one of the least studied BMPs. Whereas ALK1, ALK5, and/or endoglin have recently been reported as potential BMP9 type I receptors in endothelial cells, little is known about type I receptor involvement in BMP9-induced osteogenic differentiation in MSCs. Here, we conduct a comprehensive analysis of the functional role of seven type I receptors in BMP9-induced osteogenic signaling in MSCs. We have found that most of the seven type I receptors are expressed in MSCs. However, using dominant-negative mutants for the seven type I receptors, we demonstrate that only ALK1 and ALK2 mutants effectively inhibit BMP9-induced osteogenic differentiation in vitro and ectopic ossification in MSC implantation assays. Protein fragment complementation assays demonstrate that ALK1 and ALK2 directly interact with BMP9. Likewise, RNAi silencing of ALK1 and ALK2 expression inhibits BMP9-induced BMPR-Smad activity and osteogenic differentiation in MSCs both in vitro and in vivo. Therefore, our results strongly suggest that ALK1 and ALK2 may play an important role in mediating BMP9-induced osteogenic differentiation. These findings should further aid us in understanding the molecular mechanism through which BMP9 regulates osteogenic differentiation of MSCs.	[Luo, Jinyong; Huang, Jiayi; He, Bai-Cheng; Gao, Jian-Li; Chen, Liang; Zuo, Guo-Wei; Zhang, Wenli; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Jiang, Wei; Su, Yuxi; Shen, Jikun; Kim, Stephanie H.; Huang, Enyi; Gao, Yanhong; Zhou, Jian-Zhong; Yang, Ke; Luu, Hue H.; Haydon, Rex C.; Deng, Zhong-Liang; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Pan, Xiaochuan] Univ Chicago, Med Ctr, Dept Radiol, Chicago, IL 60637 USA; [Luo, Jinyong; Tang, Min; Huang, Jiayi; He, Bai-Cheng; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Bi, Yang; Luo, Xiaoji; Su, Yuxi; Zhou, Jian-Zhong; Deng, Zhong-Liang; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chinese Minist Educ, Key Lab Diagnost Med Designated, Chongqing 400016, Peoples R China; [Zhang, Wenli] Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610065, Sichuan, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing 400044, Peoples R China; [Gao, Yanhong] Jiatong Univ, Xinhua Hosp Shanghai, Dept Geriatr, Shanghai 200092, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing 400030, Peoples R China	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Sichuan University; Chongqing University; Army Medical University	He, TC (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, 5841 S Maryland Ave,MC3079, Chicago, IL 60637 USA.	tche@surgery.bsd.uchicago.edu	GAO, JianLi/J-4997-2017	GAO, JianLi/0000-0002-5977-0021; tang, min/0000-0001-5633-0816; Zhang, Wenli/0000-0002-4989-7950	National Institutes of Health [CA106569, AT004418, AR50142, AR054381]; Brinson Foundation; Orthopaedic Research and Education Foundation; Ministry of Science and Technology of China [2007AA2z400]; Natural Science Foundation of China [30901530, 30800658, 30772211]; Chongqing Science and Technology Commission [2008BB5396, 2009BB5060]; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brinson Foundation; Orthopaedic Research and Education Foundation; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Research Grants CA106569, AT004418, AR50142, and AR054381 (to T.-C. H., R. C. H., and H. H. L.) from the National Institutes of Health. This work was also supported by The Brinson Foundation (to T.-C. H.), the Orthopaedic Research and Education Foundation (to R. C. H. and H. H. L.), the 863 Program of Ministry of Science and Technology of China (2007AA2z400, to T.-C. H. and Z.-L. D.), the Natural Science Foundation of China (30901530, to X. L., 30800658, to J.L., and 30772211, to Z.-L. D.), and the Natural Science Foundation Project of Chongqing Science and Technology Commission 2008BB5396 (to L. C. and M. T.) and 2009BB5060 (to J.L.).	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Massague J, 1996, CANCER SURV, V27, P41; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Roelen BAJ, 1997, DEV DYNAM, V209, P418, DOI 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; VAN DINTHER M, 2010, J BONE MINER RES, V25, P1208; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zhou L, 2002, BIOTECHNIQUES, V33, P1126, DOI 10.2144/02335dd07	50	147	170	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29588	29598		10.1074/jbc.M110.130518	http://dx.doi.org/10.1074/jbc.M110.130518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628059	hybrid, Green Published			2022-12-27	WOS:000281740100060
J	Park, N; Skern, T; Gustin, KE				Park, Nogi; Skern, Tim; Gustin, Kurt E.			Specific Cleavage of the Nuclear Pore Complex Protein Nup62 by a Viral Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLIOVIRUS-INFECTED CELLS; 2A PROTEINASE; NUCLEOCYTOPLASMIC TRANSPORT; SUBSTRATE RECOGNITION; REPEAT REGIONS; IN-VITRO; IMPORT; RHINOVIRUS; NUCLEOPORINS; SITE	Previous work has shown that several nucleoporins, including Nup62 are degraded in cells infected with human rhinovirus (HRV) and poliovirus (PV) and that this contributes to the disruption of certain nuclear transport pathways. In this study, the mechanisms underlying proteolysis of Nup62 have been investigated. Analysis of Nup62 in lysates from HRV-infected cells revealed that Nup62 was cleaved at multiple sites during viral infection. The addition of purified HRV2 2A protease (2A(pro)) to uninfected HeLa whole cell lysates resulted in the cleavage of Nup62, suggesting that 2A(pro) is a major contributor to Nup62 processing. The ability of purified 2A(pro) to cleave bacterially expressed and purified Nup62 demonstrated that 2A(pro) directly cleaves Nup62 in vitro. Site-directed mutagenesis of putative cleavage sites in Nup62 identified six different positions that are cleaved by 2A(pro) in vitro. This analysis revealed that 2A(pro) cleavage sites were located between amino acids 103 and 298 in Nup62 and suggested that the N-terminal FG-rich region of Nup62 was released from the nuclear pore complex in infected cells. Analysis of HRV- and PV-infected cells using domain-specific antibodies confirmed that this was indeed the case. These results are consistent with a model whereby PV and HRV disrupt nucleo-cytoplasmic trafficking by selectively removing FG repeat domains from a subset of nuclear pore complex proteins.	[Park, Nogi; Gustin, Kurt E.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Skern, Tim] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	University of Arizona; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Gustin, KE (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, 425 N 5th St, Phoenix, AZ 85004 USA.	kgustin@arizoan.edu	Skern, Tim/AAC-1732-2022; Gustin, Kurt/A-5003-2016	Skern, Tim/0000-0001-8865-5500; Gustin, Kurt/0000-0002-1824-9002	National Institutes of Health [AI059467, AI064432]; National Institutes of Health/NCRR COBRE [P20 RR15587]; INBRE [P20 RR016454]; Austrian Science Fund [P20889]; American Cancer Society [RSG 109705]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015587, P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI064432, R56AI059467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); INBRE; Austrian Science Fund(Austrian Science Fund (FWF)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059467 and AI064432 and by National Institutes of Health/NCRR COBRE Grant P20 RR15587 and INBRE Grant P20 RR016454 (to K. E. G.). This work was also supported by Austrian Science Fund Grant P20889 (to T. S.) and by American Cancer Society Grant RSG 109705 (to K. E. G.).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Gradi A, 2004, J VIROL, V78, P3271, DOI 10.1128/JVI.78.7.3271-3278.2004; Gradi A, 2003, J VIROL, V77, P5026, DOI 10.1128/JVI.77.8.5026-5029.2003; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LIEBIG HD, 1993, BIOCHEMISTRY-US, V32, P7581, DOI 10.1021/bi00080a033; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MOLLA A, 1993, J VIROL, V67, P4688, DOI 10.1128/JVI.67.8.4688-4695.1993; Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200; OLSON MOJ, 1981, EXP CELL RES, V135, P259, DOI 10.1016/0014-4827(81)90161-0; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SKERN T, 1994, METHOD ENZYMOL, V244, P583; Skern Tim, 2002, P199; SOMMERGRUBER W, 1992, J BIOL CHEM, V267, P22639; Sousa C, 2006, FEBS LETT, V580, P5713, DOI 10.1016/j.febslet.2006.09.023; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	48	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28796	28805		10.1074/jbc.M110.143404	http://dx.doi.org/10.1074/jbc.M110.143404			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622012	hybrid, Green Published			2022-12-27	WOS:000281594000045
J	Marchese, FP; Aubareda, A; Tudor, C; Saklatvala, J; Clark, AR; Dean, JLE				Marchese, Francesco P.; Aubareda, Anna; Tudor, Corina; Saklatvala, Jeremy; Clark, Andrew R.; Dean, Jonathan L. E.			MAPKAP Kinase 2 Blocks Tristetraprolin-directed mRNA Decay by Inhibiting CAF1 Deadenylase Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENTS; POLY(A) BINDING-PROTEIN; P38 SIGNALING CASCADE; GENE-EXPRESSION; STABILITY; ALPHA; LOCALIZATION; TTP; CYCLOOXYGENASE-2	Tristetraprolin (TTP) directs its target AU-rich element (ARE)-containing mRNAs for degradation by promoting removal of the poly(A) tail. The p38 MAPK pathway regulates mRNA stability via the downstream kinase MAPK-activated protein kinase 2 (MAPKAP kinase 2 or MK2), which phosphorylates and prevents the mRNA-destabilizing function of TTP. We show that deadenylation of endogenous ARE-containing tumor necrosis factor mRNA is inhibited by p38 MAPK. To investigate whether phosphorylation of TTP by MK2 regulates TTP-directed deadenylation of ARE-containing mRNAs, we used a cell-free assay that reconstitutes the mechanism in vitro. We find that phosphorylation of Ser-52 and Ser-178 of TTP by MK2 results in inhibition of TTP-directed deadenylation of ARE-containing RNA. The use of 14-3-3 protein antagonists showed that regulation of TTP-directed deadenylation by MK2 is independent of 14-3-3 binding to TTP. To investigate the mechanism whereby TTP promotes deadenylation, it was necessary to identify the deadenylases involved. The carbon catabolite repressor protein (CCR)4.CCR4-associated factor (CAF)1 complex was identified as the major source of deadenylase activity in HeLa cells responsible for TTP-directed deadenylation. CAF1a and CAF1b were found to interact with TTP in an RNA-independent fashion. We find that MK2 phosphorylation reduces the ability of TTP to promote deadenylation by inhibiting the recruitment of CAF1 deadenylase in a mechanism that does not involve sequestration of TTP by 14-3-3. Cyclooxygenase-2 mRNA stability is increased in CAF1-depleted cells in which it is no longer p38 MAPK/MK2-regulated.	[Marchese, Francesco P.; Aubareda, Anna; Tudor, Corina; Saklatvala, Jeremy; Clark, Andrew R.; Dean, Jonathan L. E.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, London W6 8LH, England	Imperial College London; University of Oxford	Dean, JLE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, 65 Aspenlea Rd, London W6 8LH, England.	jonathan.dean@imperial.ac.uk	Marchese, Francesco P/AAA-6473-2021; Clark, Andrew/AAN-4043-2021	Marchese, Francesco P/0000-0002-6028-117X; Dean, Jonathan/0000-0002-0703-2756; Clark, Andy/0000-0003-4996-8322	Arthritis Research UK; MRC [G8623776] Funding Source: UKRI; Medical Research Council [G8623776] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are most grateful to J. Steitz, S. Hoshino, A. Virtanen, and M. Brook for provision of reagents. We also acknowledge Arthritis Research UK for support.	Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark AR, 2009, ARTHRITIS RHEUM-US, V60, P3513, DOI 10.1002/art.24919; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Korner CG, 1997, J BIOL CHEM, V272, P10448; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	44	118	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27590	27600		10.1074/jbc.M110.136473	http://dx.doi.org/10.1074/jbc.M110.136473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595389	Green Published, hybrid			2022-12-27	WOS:000281404100014
J	Patel, HH; Hamuro, LL; Chun, BJ; Kawaraguchi, Y; Quick, A; Rebolledo, B; Pennypacker, J; Thurston, J; Rodriguez-Pinto, N; Self, C; Olson, G; Insel, PA; Giles, WR; Taylor, SS; Roth, DM				Patel, Hemal H.; Hamuro, Lora L.; Chun, Byeong Jo; Kawaraguchi, Yoshitaka; Quick, Alexander; Rebolledo, Brian; Pennypacker, Juniper; Thurston, Jackie; Rodriguez-Pinto, Natalia; Self, Christopher; Olson, Gary; Insel, Paul A.; Giles, Wayne R.; Taylor, Susan S.; Roth, David M.			Disruption of Protein Kinase A Localization Using a Trans-activator of Transcription (TAT)-conjugated A-kinase-anchoring Peptide Reduces Cardiac Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; SIGNALING COMPLEX; HEART; PKA; BINDING; PHOSPHORYLATION; RECEPTOR; COMPARTMENTATION; SPECIFICITY; CHANNELS	Localization of protein kinase A (PKA) via A-kinase-anchoring proteins (AKAPs) is important for cAMP responsiveness in many cellular systems, and evidence suggests that AKAPs play an important role in cardiac signaling. To test the importance of AKAP-mediated targeting of PKA on cardiac function, we designed a cell-permeable peptide, which we termed trans-activator of transcription (TAT)-AKAD for TAT-conjugated A-kinase-anchoring disruptor, using the PKA binding region of AKAP10 and tested the effects of this peptide in isolated cardiac myocytes and in Langendorff-perfused mouse hearts. We initially validated TAT-AKAD as a PKA localization inhibitor in cardiac myocytes by the use of confocal microscopy and cellular fractionation to show that treatment with the peptide disrupts type I and type II PKA regulatory subunits. Knockdown of PKA activity was demonstrated by decrease in phosphorylation of phospholamban and troponin I after beta-adrenergic stimulation in isolated myocytes. Treatment with TAT-AKAD reduced myocyte shortening and rates of contraction and relaxation. Injection of TAT-AKAD (1 mu M), but not scrambled control peptide, into the coronary circulation of isolated perfused hearts rapidly (<1 min) and reversibly decreased heart rate and peak left ventricular developed pressure. TAT-AKAD also had a pronounced effect on developed pressure (-dP/dt), consistent with a delayed relaxation of the heart. The effects of TAT-AKAD on heart rate and contractility persisted in hearts pretreated with isoproterenol. Disruption of PKA localization with TAT-AKAD thus had negative effects on chronotropy, inotropy, and lusitropy, thereby indicating a key role for AKAP-targeted PKA in control of heart rate and contractile function.	[Patel, Hemal H.; Chun, Byeong Jo; Kawaraguchi, Yoshitaka; Quick, Alexander; Roth, David M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Pennypacker, Juniper; Taylor, Susan S.] Univ Calif San Diego, Dept Chem Biochem, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hamuro, Lora L.; Rodriguez-Pinto, Natalia; Self, Christopher; Olson, Gary] Provid Pharmaceut, N Brunswick, NJ 08902 USA; [Thurston, Jackie; Giles, Wayne R.] Univ Calgary, Calgary, AB, Canada; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92093 USA; [Rebolledo, Brian; Roth, David M.] Dept Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Calgary; Howard Hughes Medical Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Hamuro, LL (corresponding author), Merck Res Labs, Preclin Drug Metab, 770 Sumneytown Pike,POB 4, West Point, PA 19486 USA.	lora_hamuro@merck.com	Patel, Hemal/C-7325-2019	Patel, Hemal/0000-0001-6722-9625; jeon, byeongjo/0000-0002-5240-4213	United States Public Health Service, National Institutes of Health [HL081400, HL066941, HL091071, DK054441, HL079788]; American Heart Association [060039N]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R43HL079788, R01HL081400, P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081400 (to D. M. R.), HL066941 (to P. A. I. and D. M. R.), HL091071 (to H. H. P.), DK054441 (to S. S. T.) and HL079788 (to L. L. H.) from the United States Public Health Service. This work was also supported by Scientist Development Grant 060039N (to H. H. P.) from the American Heart Association and a Veterans Affairs Merit grant (to D. M. R.) from the Department of Veterans Affairs.	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Burns LL, 2003, BIOCHEMISTRY-US, V42, P5754, DOI 10.1021/bi0265729; CADD GG, 1990, J BIOL CHEM, V265, P19502; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; Clark D., 1996, GUIDE CARE USE LAB A; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Futaki S, 2003, J MOL RECOGNIT, V16, P260, DOI 10.1002/jmr.635; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Guy CA, 1997, METHOD ENZYMOL, V289, P67; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Krall J, 1999, J MOL CELL CARDIOL, V31, P971, DOI 10.1006/jmcc.1999.0926; Landeen LK, 2008, AM J PHYSIOL-HEART C, V294, pH736, DOI 10.1152/ajpheart.00316.2007; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Neumann SA, 2009, PSYCHOPHYSIOLOGY, V46, P466, DOI 10.1111/j.1469-8986.2009.00802.x; Reinitz CA, 1997, ARCH BIOCHEM BIOPHYS, V348, P391, DOI 10.1006/abbi.1997.0401; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Roth DM, 2004, AM J PHYSIOL-HEART C, V287, pH172, DOI 10.1152/ajpheart.01009.2003; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SKALHEGG BS, 1994, SCIENCE, V263, P84, DOI 10.1126/science.8272870; Soughayer JS, 2004, BIOCHEMISTRY-US, V43, P8528, DOI 10.1021/bi036296d; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Vinogradova TM, 2009, J MOL CELL CARDIOL, V47, P456, DOI 10.1016/j.yjmcc.2009.06.014; Waggoner Jason R, 2005, Heart Fail Clin, V1, P207, DOI 10.1016/j.hfc.2005.03.008; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056	49	39	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27632	27640		10.1074/jbc.M110.146589	http://dx.doi.org/10.1074/jbc.M110.146589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581396	Green Published, hybrid			2022-12-27	WOS:000281404100019
J	Aluvila, S; Kotaria, R; Sun, JK; Mayor, JA; Walters, DE; Harrison, DHT; Kaplan, RS				Aluvila, Sreevidya; Kotaria, Rusudan; Sun, Jiakang; Mayor, June A.; Walters, D. Eric; Harrison, David H. T.; Kaplan, Ronald S.			The Yeast Mitochondrial Citrate Transport Protein MOLECULAR DETERMINANTS OF ITS SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; TRANSMEMBRANE DOMAIN-III; FATTY-ACID SYNTHESIS; TRANSLOCATION PATHWAY; SECONDARY STRUCTURE; EXCHANGE REACTIONS; MEMBRANE-PROTEINS; LIKELY COMPRISE; TRICARBOXYLATE; IDENTIFICATION	The objective of this study was to identify the role of individual amino acid residues in determining the substrate specificity of the yeast mitochondrial citrate transport protein (CTP). Previously, we showed that the CTP contains at least two substrate-binding sites. In this study, utilizing the overexpressed, single-Cys CTP-binding site variants that were functionally reconstituted in liposomes, we examined CTP specificity from both its external and internal surfaces. Upon mutation of residues comprising the more external site, the CTP becomes less selective for citrate with numerous external anions able to effectively inhibit [C-14] citrate/citrate exchange. Thus, the site 1 variants assume the binding characteristics of a nonspecific anion carrier. Comparison of [C-14] citrate uptake in the presence of various internal anions versus water revealed that, with the exception of the R189C mutant, the other site 1 variants showed substantial uniport activity relative to exchange. Upon mutation of residues comprising site 2, we observed two types of effects. The K37C mutant displayed a markedly enhanced selectivity for external citrate. In contrast, the other site 2 mutants displayed varying degrees of relaxed selectivity for external citrate. Examination of internal substrates revealed that, in contrast to the control transporter, the R181C variant exclusively functioned as a uniporter. This study provides the first functional information on the role of specific binding site residues in determining mitochondrial transporter substrate selectivity. We interpret our findings in the context of our homology-modeled CTP as it cycles between the outward-facing, occluded, and inward-facing states.	[Aluvila, Sreevidya; Kotaria, Rusudan; Sun, Jiakang; Mayor, June A.; Walters, D. Eric; Kaplan, Ronald S.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, N Chicago, IL 60064 USA; [Harrison, David H. T.] Rosalind Franklin Univ Med & Sci, Dept Pharmaceut Sci, Coll Pharm, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Kaplan, RS (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	ronald.kaplan@rosalindfranklin.edu	Mayor, June/AAP-1544-2021; Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522; KAPLAN, RONALD/0000-0001-9164-0297	National Institutes of Health [GM-054642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-054642 (to R. S. K.).	Aluvila S, 2010, MOL PHARMACOL, V77, P26, DOI 10.1124/mol.109.058750; BRUNENGR.H, 1973, FEBS LETT, V36, P130, DOI 10.1016/0014-5793(73)80353-9; BUCHANAN BB, 1976, P NATL ACAD SCI USA, V73, P2280, DOI 10.1073/pnas.73.7.2280; CONOVER TE, 1987, TRENDS BIOCHEM SCI, V12, P88, DOI 10.1016/0968-0004(87)90042-9; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; Eriks LR, 2003, ANAL BIOCHEM, V323, P234, DOI 10.1016/j.ab.2003.09.002; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KAPLAN RS, 1989, ANION CARRIERS OF MITOCHONDRIAL MEMBRANES, P59; KAPLAN RS, 1990, ARCH BIOCHEM BIOPHYS, V280, P181, DOI 10.1016/0003-9861(90)90534-6; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1982, CANCER RES, V42, P4399; KAPLAN RS, 1990, J BIOL CHEM, V265, P13379; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; Ma CL, 2006, BBA-BIOENERGETICS, V1757, P1271, DOI 10.1016/j.bbabio.2006.06.011; Ma CL, 2005, J BIOL CHEM, V280, P2331, DOI 10.1074/jbc.M411474200; Ma CL, 2004, J BIOL CHEM, V279, P1533, DOI 10.1074/jbc.M310866200; Mayor JA, 2010, J BIOENERG BIOMEMBR, V42, P99, DOI 10.1007/s10863-010-9280-0; PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x; PALMIERI F, 1977, STRUCTURE FUNCTION E, P251; Pebay-Peyroula E, 2004, CURR OPIN STRUC BIOL, V14, P420, DOI 10.1016/j.sbi.2004.06.009; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; ROBINSON BH, 1971, J BIOL CHEM, V246, P5280; ROBINSON BH, 1971, EUR J BIOCHEM, V20, P65, DOI 10.1111/j.1432-1033.1971.tb01363.x; Rudnick G., 2002, TRANSMEMBRANE TRANSP, P125; VANWINKLE LJ, 1999, BIOMEMBRANE TRANSPOR, P90; Walters DE, 2004, BIOPHYS J, V87, P907, DOI 10.1529/biophysj.104.042127; WATSON JA, 1970, J BIOL CHEM, V245, P5993; Xu Y, 2000, J BIOL CHEM, V275, P7117, DOI 10.1074/jbc.275.10.7117; XU Y, 1995, BIOCHEM BIOPH RES CO, V207, P783, DOI 10.1006/bbrc.1995.1255	39	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27314	27326		10.1074/jbc.M110.137364	http://dx.doi.org/10.1074/jbc.M110.137364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551333	Green Published, hybrid			2022-12-27	WOS:000281172700061
J	Kim, Y; Park, H; Park, D; Lee, YS; Choe, J; Hahn, JH; Lee, H; Kim, YM; Jeoung, D				Kim, Youngmi; Park, Hyunmi; Park, Deokbum; Lee, Yun-Sil; Choe, Jongseon; Hahn, Jang-Hee; Lee, Hansoo; Kim, Young-Myeong; Jeoung, Dooil			Cancer/Testis Antigen CAGE Exerts Negative Regulation on p53 Expression through HDAC2 and Confers Resistance to Anti-cancer Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; DOWN-REGULATION; TUMOR-GROWTH; P53-MEDIATED APOPTOSIS; GENE; CELASTROL; TRANSCRIPTION; CELLS; DNMT1; HYPOMETHYLATION	The role of the cancer/testis antigen CAGE in drug resistance was investigated. The drug-resistant human melanoma Malme3M (Malme3M(R)) and the human hepatic cancer cell line SNU387 (SNU387(R)) showed in vivo drug resistance and CAGE induction. Induction of CAGE resulted from decreased expression and thereby displacement of DNA methyltransferase 1(DNMT1) from CAGE promoter sequences. Various drugs induce expression of CAGE by decreasing expression of DNMT1, and hypomethylation of CAGE was correlated with the increased expression of CAGE. Down-regulation of CAGE in these cell lines decreased invasion and enhanced drug sensitivity resulting from increased apoptosis. Down-regulation of CAGE also led to decreased anchorage-independent growth. Down-regulation of CAGE led to increased expression of p53, suggesting that CAGE may act as a negative regulator of p53. Down-regulation of p53 enhanced resistance to drugs and prevented drugs from exerting apoptotic effects. In SNU387R cells, CAGE induced the interaction between histone deacetylase 2 (HDAC2) and Snail, which exerted a negative effect on p53 expression. Chromatin immunoprecipitation assay showed that CAGE, through interaction with HDAC2, exerted a negative effect on p53 expression in Malme3MR cells. These results suggest that CAGE confers drug resistance by regulating expression of p53 through HDAC2. Taken together, these results show the potential value of CAGE as a target for the development of cancer therapeutics.	[Kim, Youngmi; Park, Hyunmi; Park, Deokbum; Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Coll Nat Sci, Sch Biol Sci, Chunchon 200701, South Korea; [Lee, Yun-Sil] Korea Inst Radiol & Med Sci, Div Radiat Biol, Lab Radiat Effect, Seoul 139706, South Korea; [Choe, Jongseon; Hahn, Jang-Hee; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Chunchon 200701, South Korea	Kangwon National University; Korea Institute of Radiological & Medical Sciences; Kangwon National University	Jeoung, D (corresponding author), Kangwon Natl Univ, Coll Nat Sci, Sch Biol Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Korea Research Foundation [C1001478-01-01, C1006272-01-01, 2009-0063908]; Ministry of Science & Technology in Korea [FG06-2-23]; National Research Foundation [C00016]; Korean Government (MEST)	Korea Research Foundation(National Research Foundation of Korea); Ministry of Science & Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Research Foundation; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Research Foundation (C1001478-01-01, C1006272-01-01, and 2009-0063908) and by a grant (FG06-2-23) from the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea. This work was also supported by a grant from the National Research Foundation (C00016, to Y. K.) and by the Korea Research Foundation Grant funded by the Korean Government (MEST) (The Regional Research Universities Program/Medical & Bio-Materials Research Center).	Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Bheda A, 2008, ONCOGENE, V27, P4315, DOI 10.1038/onc.2008.65; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Iwata T, 2005, CLIN CANCER RES, V11, P3949, DOI 10.1158/1078-0432.CCR-04-1702; James SR, 2006, ONCOGENE, V25, P6975, DOI 10.1038/sj.onc.1209678; Karim R, 2009, CLIN CANCER RES, V15, P6341, DOI 10.1158/1078-0432.CCR-09-1652; Kim EH, 2007, CANCER RES, V67, P6333, DOI 10.1158/0008-5472.CAN-06-4344; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kunze E, 2007, INT J MOL MED, V20, P557; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lee TS, 2006, ANN NY ACAD SCI, V1091, P218, DOI 10.1196/annals.1378.068; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mishra MV, 2008, MOL CANCER RES, V6, P243, DOI 10.1158/1541-7786.MCR-07-0373; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Muscella A, 2009, BRIT J PHARMACOL, V156, P751, DOI 10.1111/j.1476-5381.2008.00049.x; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Park S, 2003, BBA-GENE STRUCT EXPR, V1625, P173, DOI 10.1016/S0167-4781(02)00620-6; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Rotem-Dai N, 2009, EXP CELL RES, V315, P2616, DOI 10.1016/j.yexcr.2009.06.004; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Shim H, 2006, MOL CELLS, V21, P367; Song JH, 2009, INT J CANCER, V125, P1074, DOI 10.1002/ijc.24386; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang JM, 2003, MOL CANCER RES, V1, P420	50	43	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25957	25968		10.1074/jbc.M109.095950	http://dx.doi.org/10.1074/jbc.M109.095950			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20534591	Green Published, hybrid			2022-12-27	WOS:000280921000010
J	Palou, G; Palou, R; Guerra-Moreno, A; Duch, A; Travesa, A; Quintana, DG				Palou, Gloria; Palou, Roger; Guerra-Moreno, Angel; Duch, Alba; Travesa, Anna; Quintana, David G.			Cyclin Regulation by the S Phase Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; STALLED REPLICATION FORKS; DNA-DAMAGE CHECKPOINT; CELL-CYCLE; BUDDING YEAST; PROTEIN-KINASE; DISTINCT MECHANISMS; SWI6 PROTEIN; G1 PHASE; TRANSCRIPTION	In eukaryotic cells a surveillance mechanism, the S phase checkpoint, detects and responds to DNA damage and replication stress, protecting DNA replication and arresting cell cycle progression. We show here that the S phase cyclins Clb5 and Clb6 are regulated in response to genotoxic stress in the budding yeast Saccharomyces cerevisiae. Clb5 and Clb6 are responsible for the activation of the specific Cdc28 cyclin-dependent kinase activity that drives the onset and progression of the S phase. Intriguingly, Clb5 and Clb6 are regulated by different mechanisms. Thus, the presence of Clb6, which is eliminated early in an unperturbed S phase, is stabilized when replication is compromised by replication stress or DNA damage. Such stabilization depends on the checkpoint kinases Mec1 and Rad53. The stabilization of Clb6 levels is a dynamic process that requires continued de novo protein synthesis, because the cyclin remains subject to degradation. It also requires the activity of the G(1) transcription factor Mlu1 cell cycle box-binding factor (MBF) in the S phase, whereas Dun1, the checkpoint kinase characteristically responsible for the transcriptional response to genotoxic stress, is dispensable in this case. On the other hand, two subpopulations of endogenous Clb5 can be distinguished according to turnover in an unperturbed S phase. In the presence of replication stress, the unstable Clb5 pool is stabilized, and such stabilization requires neither MBF transcriptional activity nor de novo protein synthesis.	[Quintana, David G.] Univ Autonoma Barcelona, Sch Med, Biophys Unit, Dept Biochem & Mol Biol, Bellaterra 08193, Catalonia, Spain; Univ Autonoma Barcelona, Ctr Biophys Studies, Bellaterra 08193, Catalonia, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Quintana, DG (corresponding author), Univ Autonoma Barcelona, Sch Med, Biophys Unit, Dept Biochem & Mol Biol, Bellaterra 08193, Catalonia, Spain.	davidg.quintana@uab.cat	Duch, Alba/AGI-1035-2022; Angel, Guerra-Moreno/AAF-7135-2021; Quintana, David G/M-5628-2018; Guerra-Moreno, Angel/K-6258-2015	Duch, Alba/0000-0001-6041-1360; Angel, Guerra-Moreno/0000-0003-2321-1129; Guerra-Moreno, Angel/0000-0003-2321-1129; Quintana, David G./0000-0002-4909-6686	Ministerio de Ciencia e Innovacion [BFU2008-03778]; Ministerio de Educacion y Ciencia [BFU2006-06833]; Generalitat de Catalunya; Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by Grant BFU2008-03778 from the Ministerio de Ciencia e Innovacion and Grant BFU2006-06833 from the Ministerio de Educacion y Ciencia (to D. G. Q.), a Formacio d'Investigadors fellowship from the Generalitat de Catalunya (to G. P.), and Formacion de Personal Investigador fellowships from the Ministerio de Educacion y Ciencia (to A. D. and A. T.).	Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BASCO RD, 1995, MOL CELL BIOL, V15, P5030; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Germain D, 1997, J CELL SCI, V110, P1813; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jackson LP, 2006, MOL CELL BIOL, V26, P2456, DOI 10.1128/MCB.26.6.2456-2466.2006; Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; KUHNE C, 1993, EMBO J, V12, P3437, DOI 10.1002/j.1460-2075.1993.tb06018.x; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pati D, 1997, MOL CELL BIOL, V17, P3037, DOI 10.1128/MCB.17.6.3037; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sari F, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703744200; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sidorova JM, 2003, MOL CELL BIOL, V23, P3405, DOI 10.1128/MCB.23.10.3405-3416.2003; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; SIKORSKI RS, 1989, GENETICS, V122, P19; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	73	12	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26431	26440		10.1074/jbc.M110.138669	http://dx.doi.org/10.1074/jbc.M110.138669			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538605	hybrid, Green Published			2022-12-27	WOS:000280921000061
J	Tolg, C; Hamilton, SR; Morningstar, L; Zhang, J; Zhang, S; Esguerra, KV; Telmer, PG; Luyt, LG; Harrison, R; McCarthy, JB; Turley, EA				Tolg, Cornelia; Hamilton, Sara R.; Morningstar, Lyndsey; Zhang, Jing; Zhang, S.; Esguerra, Kenneth V.; Telmer, Patrick G.; Luyt, Len G.; Harrison, Rene; McCarthy, James B.; Turley, Eva A.			RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN-BINDING PROTEIN; SIGNAL-REGULATED KINASE; MEDIATED MOTILITY RHAMM; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; MAP KINASE; INTRACELLULAR HYALURONAN; FUNCTIONAL PROTEOMICS; CELL-PROLIFERATION; MULTIPLE-MYELOMA	An oncogenic form of RHAMM (receptor for hyaluronan-mediated motility, mouse, amino acids 163-794 termed RHAMM(Delta 163)) is a cell surface hyaluronan receptor and mitotic spindle protein that is highly expressed in aggressive human cancers. Its regulation of mitotic spindle integrity is thought to contribute to tumor progression, but the molecular mechanisms underlying this function have not previously been defined. Here, we report that intracellular RHAMM(Delta 163) modifies the stability of interphase and mitotic spindle microtubules through ERK1/2 activity. RHAMM(-/-) mouse embryonic fibroblasts exhibit strongly acetylated interphase microtubules, multi-pole mitotic spindles, aberrant chromosome segregation, and inappropriate cytokinesis during mitosis. These defects are rescued by either expression of RHAMM or mutant active MEK1. Mutational analyses show that RHAMM(Delta 163) binds to alpha- and beta-tubulin protein via a carboxyl-terminal leucine zipper, but in vitro analyses indicate this interaction does not directly contribute to tubulin polymerization/stability. Co-immunoprecipitation and pulldown assays reveal complexes of RHAMM(Delta 163), ERK1/2-MEK1, and alpha- and beta-tubulin and demonstrate direct binding of RHAMM(Delta 163) to ERK1 via a D-site motif. In vitro kinase analyses, expression of mutant RHAMM(Delta 163) defective in ERK1 binding in mouse embryonic fibroblasts, and blocking MEK1 activity collectively confirm that the effect of RHAMM(Delta 163) on interphase and mitotic spindle microtubules is mediated by ERK1/2 activity. Our results suggest a model wherein intracellular RHAMM(Delta 163) functions as an adaptor protein to control microtubule polymerization during interphase and mitosis as a result of localizing ERK1/2-MEK1 complexes to their tubulin-associated substrates.	[Esguerra, Kenneth V.; Luyt, Len G.; Turley, Eva A.] Univ Western Ontario, London Reg Canc Program, Dept Oncol & Chem, London, ON N6A 4L6, Canada; [Telmer, Patrick G.] Univ Western Ontario, London Reg Canc Program, Dept Oncol & Biochem, London, ON N6A 4L6, Canada; London Hlth Sci Ctr, London, ON N6A 4L6, Canada; [Harrison, Rene] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [McCarthy, James B.] Univ Minnesota, Mason Comprehens Canc Ctr, Tumor Biol & Res Program, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; University of Toronto; University Toronto Scarborough; University of Minnesota System; University of Minnesota Twin Cities	Turley, EA (corresponding author), Univ Western Ontario, London Reg Canc Program, Dept Oncol & Chem, London, ON N6A 4L6, Canada.	eva.turley@lhsc.on.ca	Luyt, Leonard/B-3543-2015	Luyt, Leonard/0000-0002-0941-4731; Hamilton, Sara/0000-0001-6062-2037	NCI [5R0119092]; Cancer Research Society, Montreal, Canada; Canadian Breast Cancer Society; London Regional Cancer Program	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Society, Montreal, Canada; Canadian Breast Cancer Society; London Regional Cancer Program	This work was supported, in whole or in part, by National Institutes of Health Grant 5R0119092 from NCI (to J. B. M. and E. A. T.). This work was also supported by a grant from the Cancer Research Society, Montreal, Canada (to E. A. T.), and by the Canadian Breast Cancer Society (partial salary to E. A. T.).; Supported by a Translational Breast Cancer Studentship from the London Regional Cancer Program.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Alberti C, 2009, EUR REV MED PHARMACO, V13, P13; Arce CA, 2008, FEBS J, V275, P4664, DOI 10.1111/j.1742-4658.2008.06615.x; Assmann V, 1999, J CELL SCI, V112, P3943; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bedard PL, 2010, NAT REV CLIN ONCOL, V7, P22, DOI 10.1038/nrclinonc.2009.186; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Crasta K, 2008, CELL CYCLE, V7, P2960, DOI 10.4161/cc.7.19.6783; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; Fang ZY, 2010, TRAFFIC, V11, P782, DOI 10.1111/j.1600-0854.2010.01062.x; Giannopoulos K, 2006, LEUKEMIA LYMPHOMA, V47, P2028, DOI 10.1080/10428190600709721; Greiner J, 2008, CLIN CANCER RES, V14, P7161, DOI 10.1158/1078-0432.CCR-08-1102; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Harrison RE, 2001, NEOPLASIA, V3, P385, DOI 10.1038/sj.neo.7900180; Holmfeldt P, 2009, CELL MOL LIFE SCI, V66, P3263, DOI 10.1007/s00018-009-0084-5; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kalmyrzaev B, 2008, CANCER EPIDEM BIOMAR, V17, P3618, DOI 10.1158/1055-9965.EPI-08-0216; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kotwaliwale C, 2006, CELL, V127, P1105, DOI 10.1016/j.cell.2006.11.032; Lefloch R, 2009, CELL CYCLE, V8, P705, DOI 10.4161/cc.8.5.7734; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lynn BD, 2001, J COMP NEUROL, V439, P315, DOI 10.1002/cne.1353; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Matkovic K, 2009, INT J HEMATOL, V89, P159, DOI 10.1007/s12185-008-0248-3; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Roberts EC, 2006, PROTEOMICS, V6, P4541, DOI 10.1002/pmic.200600365; Schmitt M, 2008, BLOOD, V111, P1357, DOI 10.1182/blood-2007-07-099366; Schwartz J, 2009, AM J HEALTH-SYST PH, V66, pS3, DOI 10.2146/ajhp090438; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Sturgill TW, 2008, BIOCHEM BIOPH RES CO, V371, P1, DOI 10.1016/j.bbrc.2008.04.002; Tillement V, 2009, BIOL CELL, V101, P1, DOI 10.1042/BC20070162; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Xia F, 2008, MOL CELL BIOL, V28, P5299, DOI 10.1128/MCB.02039-07; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Ziebell MR, 2004, J COMPUT AID MOL DES, V18, P597, DOI 10.1007/s10822-004-5433-8	62	65	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26461	26474		10.1074/jbc.M110.121491	http://dx.doi.org/10.1074/jbc.M110.121491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558733	Green Published, hybrid			2022-12-27	WOS:000280921000064
J	Mizrahi, A; Berdichevsky, Y; Casey, PJ; Pick, E				Mizrahi, Ariel; Berdichevsky, Yevgeny; Casey, Patrick J.; Pick, Edgar			A Prenylated p47(phox)-p67(phox)-Rac1 Chimera Is a Quintessential NADPH Oxidase Activator MEMBRANE ASSOCIATION AND FUNCTIONAL CAPACITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; DEPENDENT SUPEROXIDE-PRODUCTION; SODIUM DODECYL-SULFATE; SRC HOMOLOGY-3 DOMAINS; SH3 DOMAIN; PHAGOCYTE MEMBRANES; MOLECULAR-BASIS; RAC; P67(PHOX); P47(PHOX)	The superoxide-generating NADPH oxidase complex of resting phagocytes includes cytochrome b(559), a membrane-associated heterodimer composed of two subunits (Nox2 and p22(phox)), and four cytosolic proteins (p47(phox), p67(phox), Rac, and p40(phox)). Upon stimulation, the cytosolic components translocate to the membrane, as the result of a series of interactions among the cytosolic components and among the cytosolic components and cytochrome b(559) and its phospholipid environment. Wedescribed the construction of a tripartite chimera (trimera) consisting of strategic domains of p47(phox), p67(phox), and Rac1, in which interactions among cytosolic components were replaced by fusion (Berdichevsky, Y., Mizrahi, A., Ugolev, Y., Molshanski-Mor, S., and Pick, E. (2007) J. Biol. Chem. 282, 22122-22139). We now fused green fluorescent protein (GFP) to the N terminus of the trimera and found the following. 1) The GFP-p47(phox)-p67(phox)-Rac1 trimera activates the oxidase in amphiphile-dependent and -independent (anionic phospholipid-enriched membrane) cell-free systems. 2) Geranylgeranylation of the GFP-trimera makes it a potent oxidase activator in unmodified (native) membranes and in the absence of amphiphile. 3) Prenylated GFP-trimera binds spontaneously to native membranes (as assessed by gel filtration and in-line fluorometry), forming a tight complex capable of NADPH-dependent, activator-independent superoxide production at rates similar to those measured in canonical cell-free systems. 4) Prenylation of the GFP-trimera supersedes completely the dependence of oxidase activation on the p47(phox) phox homology domain and, partially, on the Rac1 polybasic domain, but the requirement for Trp(193) in p47(phox) persists. Prenylated GFP-p47(phox)-p67(phox)-Rac1 trimera acts as a quintessential single molecule oxidase activator of potential use in high throughput screening of inhibitors.	[Mizrahi, Ariel; Berdichevsky, Yevgeny; Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Julius Friedrich Cohnheim Lab Phagocyte Res, IL-69978 Tel Aviv, Israel; [Casey, Patrick J.] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore	Tel Aviv University; Sackler Faculty of Medicine; National University of Singapore	Pick, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Julius Friedrich Cohnheim Lab Phagocyte Res, IL-69978 Tel Aviv, Israel.	epick@post.tau.ac.il	; Pick, Edgar/B-1795-2008	Casey, Patrick/0000-0002-7366-9309; Pick, Edgar/0000-0003-4625-3233; Berdichevsky, Yevgeny/0000-0002-5038-6816	National Institutes of Health [GM46372]; Israel Science Foundation [19/05, 49/09]; David and Natalie Roberts Chair in Immunopharmacology; Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research; Ela Kodesz Institute of Host Defense against Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); David and Natalie Roberts Chair in Immunopharmacology; Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research; Ela Kodesz Institute of Host Defense against Infectious Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46372 (to P.J.C.). This work was also supported by Israel Science Foundation Grants 19/05 and 49/09, the David and Natalie Roberts Chair in Immunopharmacology, the Julius Friedrich Cohnheim-Minerva Center for Phagocyte Research, and the Ela Kodesz Institute of Host Defense against Infectious Diseases (to E.P.).	Alloul N, 2001, BIOCHEMISTRY-US, V40, P14557, DOI 10.1021/bi0117347; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; CASEY PJ, 1991, P NATL ACAD SCI USA, V88, P8631, DOI 10.1073/pnas.88.19.8631; DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Ebisu K, 2001, J BIOL CHEM, V276, P24498, DOI 10.1074/jbc.M101122200; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HARPER AM, 1984, BIOCHEM J, V219, P519, DOI 10.1042/bj2190519; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Marcoux J, 2009, FEBS LETT, V583, P835, DOI 10.1016/j.febslet.2009.01.046; Miyano K, 2001, BIOCHEMISTRY-US, V40, P14089, DOI 10.1021/bi010882u; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Morozov I, 1998, J BIOL CHEM, V273, P15435, DOI 10.1074/jbc.273.25.15435; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; PICK E, 1987, J BIOL CHEM, V262, P16476; Pick E, 2010, J LEUKOCYTE BIOL, V87, P537, DOI 10.1189/jlb.1109710; Sambrook J., 2001, MOL CLONING LAB MANU; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; Sigal N, 2003, INFLAMMATION, V27, P147, DOI 10.1023/A:1023869828688; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Taylor RA, 2007, BIOCHEMISTRY-US, V46, P14291, DOI 10.1021/bi701626p; Toporik A, 1998, BIOCHEMISTRY-US, V37, P7147, DOI 10.1021/bi9800404; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; ZHANG FL, 1994, J BIOL CHEM, V269, P23465	47	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25485	25499		10.1074/jbc.M110.113779	http://dx.doi.org/10.1074/jbc.M110.113779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529851	hybrid, Green Published			2022-12-27	WOS:000280682400042
J	Sanchez, J; Talamillo, A; Lopitz-Otsoa, F; Perez, C; Hjerpe, R; Sutherland, JD; Herboso, L; Rodriguez, MS; Barrio, R				Sanchez, Jonatan; Talamillo, Ana; Lopitz-Otsoa, Fernando; Perez, Coralia; Hjerpe, Roland; Sutherland, James D.; Herboso, Leire; Rodriguez, Manuel S.; Barrio, Rosa			Sumoylation Modulates the Activity of Spalt-like Proteins during Wing Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; GENE-COMPLEX; OKIHIRO-SYNDROME; MUTATIONS; SALL1; UBC9; MORPHOGENESIS; MELANOGASTER; EXPRESSION; ENCODES	The Spalt-like family of zinc finger transcription factors is conserved throughout evolution and is involved in fundamental processes during development and during embryonic stem cell maintenance. Although human SALL1 is modified by SUMO-1 in vitro, it is not known whether this post-translational modification plays a role in regulating the activity of this family of transcription factors. Here, we show that the Drosophila Spalt transcription factors are modified by sumoylation. This modification influences their nuclear localization and capacity to induce vein formation through the regulation of target genes during wing development. Furthermore, spalt genes interact genetically with the sumoylation machinery to repress vein formation in intervein regions and to attain the wing final size. Our results suggest a new level of regulation of Sall activity in vivo during animal development through post-translational modification by sumoylation. The evolutionary conservation of this family of transcription factors suggests a functional role for sumoylation in vertebrate Sall members.	[Sutherland, James D.; Herboso, Leire; Rodriguez, Manuel S.; Barrio, Rosa] CIC bioGUNE, Derio 48160, Bizkaia, Spain; [Rodriguez, Manuel S.] CIC bioGUNE CIBERehd, Leioa 48940, Spain; [Rodriguez, Manuel S.] Univ Basque Country, Leioa 48940, Spain	CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Basque Country	Barrio, R (corresponding author), CIC bioGUNE, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain.	rbarrio@cicbiogune.es	Sutherland, James D/K-2686-2014; Barrio, Rosa/F-8712-2011; Lopitz-Otsoa, Fernando/A-1966-2017; Talamillo, Ana/AAA-4633-2019; RODRIGUEZ, Manuel S./D-5439-2018	Sutherland, James D/0000-0003-3229-793X; Barrio, Rosa/0000-0002-9663-0669; Lopitz-Otsoa, Fernando/0000-0001-8452-6939; Talamillo, Ana/0000-0003-3089-7675; Perez Fernandez, Coralia/0000-0002-1195-2563	Spanish Ministerio de Ciencia e Innovacion [BFU2008-01884, CSD2007-008-25120]; Departments of Education and Industry of the Basque Government [PI2009-16]; Etortek Research Programs; Bizkaia County	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Departments of Education and Industry of the Basque Government; Etortek Research Programs; Bizkaia County	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2008-01884 and CSD2007-008-25120, Departments of Education and Industry of the Basque Government Grant PI2009-16 and Etortek Research Programs 2008/2009, and the Bizkaia County.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Apionishev S, 2001, GENES CELLS, V6, P215, DOI 10.1046/j.1365-2443.2001.00413.x; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; Barrio R, 1996, DEV GENES EVOL, V206, P315, DOI 10.1007/s004270050058; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bohren KM, 2007, PROTEIN EXPRES PURIF, V54, P289, DOI 10.1016/j.pep.2007.03.013; de Celis JF, 1999, DEVELOPMENT, V126, P2653; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lunde K, 1998, DEVELOPMENT, V125, P4145; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Netzer C, 2002, BIOCHEM BIOPH RES CO, V296, P870, DOI 10.1016/S0006-291X(02)02003-X; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Takanaka Y, 2005, MECH DEVELOP, V122, P1130, DOI 10.1016/j.mod.2005.05.004; Talamillo A, 2008, BIOCHEM SOC T, V36, P868, DOI 10.1042/BST0360868; Talamillo A, 2008, DEVELOPMENT, V135, P1659, DOI 10.1242/dev.020685; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25841	25849		10.1074/jbc.M110.124024	http://dx.doi.org/10.1074/jbc.M110.124024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562097	Green Published, hybrid			2022-12-27	WOS:000280682400076
J	Wilkie, S; Burbridge, SE; Chiapero-Stanke, L; Pereira, ACP; Cleary, S; van der Stegen, SJC; Spicer, JF; Davies, DM; Maher, J				Wilkie, Scott; Burbridge, Sophie E.; Chiapero-Stanke, Laura; Pereira, Ana C. P.; Cleary, Siobhan; van der Stegen, Sjoukje J. C.; Spicer, James F.; Davies, David M.; Maher, John			Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; PROSTATE-CANCER; TUMOR REJECTION; GENE-THERAPY; PHASE-I; GROWTH; CYTOKINE; IL-4; PROLIFERATION; INHIBITION	Polyclonal T-cells can be directed against cancer using transmembrane fusion molecules known as chimeric antigen receptors (CARs). Although preclinical studies have provided encouragement, pioneering clinical trials using CAR-based immunotherapy have been disappointing. Key obstacles are the need for robust expansion ex vivo followed by sustained survival of infused T-cells in patients. To address this, we have developed a system to achieve selective proliferation of CAR(+) T-cells using IL-4, a cytokine with several pathophysiologic and therapeutic links to cancer. A chimeric cytokine receptor (4 alpha beta) was engineered by fusion of the IL-4 receptor alpha (IL-4R alpha) ectodomain to the beta(c) subunit, used by IL-2 and IL-15. Addition of IL-4 to T-cells that express 4 alpha beta resulted in STAT3/STAT5/ERK phosphorylation and exponential proliferation, mimicking the actions of IL-2. Using receptor-selective IL-4 muteins, partnering of 4 alpha beta with gamma(c) was implicated in signal delivery. Next, human T-cells were engineered to co-express 4 alpha beta with a CAR specific for tumor-associated MUC1. These T-cells exhibited an unprecedented capacity to elicit repeated destruction of MUC1-expressing tumor cultures and expanded through several logs in vitro. Despite prolonged culture in IL-4, T-cells retained specificity for target antigen, type 1 polarity, and cytokine dependence. Similar findings were observed using CARs directed against two additional tumor-associated targets, demonstrating generality of application. Furthermore, this system allows rapid ex vivo expansion and enrichment of engineered T-cells from small blood volumes, under GMP-compliant conditions. Together, these findings provide proof of principle for the development of IL-4-enhanced T-cell immunotherapy of cancer.	[van der Stegen, Sjoukje J. C.; Spicer, James F.; Davies, David M.; Maher, John] Kings Coll London, Sch Med, Div Canc Studies, Res Oncol Sect, London SE1 9RT, England; [Maher, John] Barnet & Chase Farm Natl Hlth Serv Trust, Dept Immunol, Barnet EN5 3DJ, Herts, England; [Maher, John] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, Dept Allergy & Immunol, London SE1 9RT, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Maher, J (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Res Oncol Sect, 3rd Floor Bermondsey Wing,Guys Hosp Campus,St Tho, London SE1 9RT, England.	john.maher@kcl.ac.uk		Maher, John/0000-0001-8275-8488; Papa, Sophie/0000-0002-9063-7675; Spicer, James/0000-0003-3732-8491	Breast Cancer Campaign Project [2006NovPR18]; Association for International Cancer Research Project [08-0419]; Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London); Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; St. Thomas' National Health Service Foundation Trust; King's College Hospital National Health Service Foundation Trust; Worldwide Cancer Research [08-0419] Funding Source: researchfish	Breast Cancer Campaign Project; Association for International Cancer Research Project; Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London); Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; St. Thomas' National Health Service Foundation Trust; King's College Hospital National Health Service Foundation Trust; Worldwide Cancer Research	This work was supported by Breast Cancer Campaign Project Grant 2006NovPR18, Association for International Cancer Research Project Grant 08-0419, Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London) and by Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust.	Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Chavez ARD, 2009, ANN NY ACAD SCI, V1182, P14, DOI 10.1111/j.1749-6632.2009.05160.x; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eguchi J, 2005, GENE THER, V12, P733, DOI 10.1038/sj.gt.3302401; Finney HM, 1998, J IMMUNOL, V161, P2791; Gasser S, 2000, J IMMUNOL, V164, P5659, DOI 10.4049/jimmunol.164.11.5659; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gooch JL, 2002, NEOPLASIA, V4, P324, DOI 10.1038/sj.neo.7900248; Haynes NM, 2002, J IMMUNOL, V169, P5780, DOI 10.4049/jimmunol.169.10.5780; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; HURFORD RK, 1995, NAT GENET, V10, P430, DOI 10.1038/ng0895-430; IZUHARA K, 1993, BIOCHEM BIOPH RES CO, V190, P992, DOI 10.1006/bbrc.1993.1147; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kurtz DM, 2007, LEUKEMIA LYMPHOMA, V48, P1290, DOI 10.1080/10428190701355028; Lee SO, 2008, PROSTATE, V68, P85, DOI 10.1002/pros.20691; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Lo ASY, 2008, MOL IMMUNOL, V45, P1276, DOI 10.1016/j.molimm.2007.09.010; de Oliveira MVM, 2009, HEAD NECK-J SCI SPEC, V31, P1439, DOI 10.1002/hed.21121; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Majhail NS, 2004, INVEST NEW DRUG, V22, P421, DOI 10.1023/B:DRUG.0000036684.67675.fe; MITCHELL LC, 1989, J IMMUNOL, V142, P1548; Olver S, 2007, TISSUE ANTIGENS, V69, P293, DOI 10.1111/j.1399-0039.2007.00831.x; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Post DE, 2007, CANCER RES, V67, P6872, DOI 10.1158/0008-5472.CAN-06-3244; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; SATYAM A, 2010, UROL ONCOL IN PRESS; Schuler T, 2003, J EXP MED, V198, P1487, DOI 10.1084/jem.20030849; Shanafelt AB, 1998, P NATL ACAD SCI USA, V95, P9454, DOI 10.1073/pnas.95.16.9454; Srivannaboon K, 2001, BLOOD, V97, P752, DOI 10.1182/blood.V97.3.752; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TOI M, 1992, CANCER RES, V52, P275; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Volpert OV, 1998, J EXP MED, V188, P1039, DOI 10.1084/jem.188.6.1039; Vukmanovic-Stejic M, 2000, BLOOD, V95, P231; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Zhang S, 2009, EUR J IMMUNOL, V39, P1252, DOI 10.1002/eji.200839152	50	125	151	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25538	25544		10.1074/jbc.M110.127951	http://dx.doi.org/10.1074/jbc.M110.127951			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562098	hybrid, Green Published			2022-12-27	WOS:000280682400048
J	Larson, Y; Liu, JY; Stevens, PD; Li, X; Li, J; Evers, BM; Gao, TY				Larson, Yan; Liu, Jianyu; Stevens, Payton D.; Li, Xin; Li, Jing; Evers, B. Mark; Gao, Tianyan			Tuberous Sclerosis Complex 2 (TSC2) Regulates Cell Migration and Polarity through Activation of CDC42 and RAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR GENE-PRODUCT; FOCAL ADHESION; RHO; MTOR; GROWTH; AKT; GTPASES; CYTOSKELETON; PROTRUSION; INTERPLAY	The phosphatidylinositol 3-kinase (PI3K)/AKT pathway plays important roles in regulating cell motility. TSC2, a downstream target of AKT, is a central player in negatively controlling cell proliferation and protein translation through suppressing the activity of mTOR (mammalian target of rapamycin). However, the function of TSC2 in regulating cell migration remains unclear. Here, we show that TSC2 plays a critical role in the control of cell spreading, polarity, and migration. TSC2-deficient fibroblast cells were impaired in their ability to spread and alter actin cytoskeleton upon stimulation with insulin-like growth factor-1. Using scratch-induced polarization assay, we demonstrate that TSC2((-/-)) fibroblast cells polarized poorly toward the wound compared with wild-type cells. Similarly, knockdown of TSC2 expression in colon cancer cells resulted in a marked decrease in cell motility. Functionally, the activation of CDC42-and RAC1-GTPase was largely reduced in TSC2 knock-out fibroblast and TSC2 knockdown cancer cells. Furthermore, overexpression of an activating p110 alpha mutant or short term rapamycin treatment rescued the cell polarization defect in TSC2((-/-)) fibroblast cells. Concurrently, the activation of CDC42 and RAC1 increased. The defect in cell migration and CDC42 and RAC1 activation was reversed by reintroducing TSC2 back into TSC2((-/-)) fibroblast cells. Taken together, we identified a novel role of TSC2 in controlling cell polarity and migration by regulating CDC42 and RAC1 activation.	[Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Larson, Yan] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Liu, Jianyu; Stevens, Payton D.; Li, Xin; Li, Jing; Evers, B. Mark; Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Li, Jing; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01CA133429, R01CA104748]; American Cancer Society Research Scholar [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA104748, R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA133429 (to T. G.). This work was also supported by American Cancer Society Research Scholar Grant RSG0822001TBE (to T.G.) and NIH Grant R01CA104748(to B. M. E.).	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955	29	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24987	24998		10.1074/jbc.M109.096917	http://dx.doi.org/10.1074/jbc.M109.096917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530489	Green Published, hybrid			2022-12-27	WOS:000280542100071
J	O'Brien, SK; Cao, H; Nathans, R; Ali, A; Rana, TM				O'Brien, Siobhan K.; Cao, Hong; Nathans, Robin; Ali, Akbar; Rana, Tariq M.			P-TEFb Kinase Complex Phosphorylates Histone H1 to Regulate Expression of Cellular and HIV-1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; VIRUS TYPE-1 REPLICATION; TRANSCRIPTIONAL ELONGATION; CHROMATIN-STRUCTURE; LIVING CELLS; 7SK SNRNA; IN-VIVO; RECRUITMENT; BINDING	Transcription of HIV-1 genes depends on the RNA polymerase II kinase and elongation factor positive transcription elongation factor b (P-TEFb), the complex of cyclin T1 and CDK9. Recent evidence suggests that regulation of transcription by P-TEFb involves chromatin binding and modifying factors. To determine how P-TEFb may connect chromatin remodeling to transcription, we investigated the relationship between P-TEFb and histone H1. We identify histone H1 as a substrate for P-TEFb involved in cellular and HIV-1 transcription. We show that P-TEFb interacts with H1 and that P-TEFb inhibition by RNAi, flavopiridol, or dominant negative CDK9 expression correlates with loss of phosphorylation and mobility of H1 in vivo. Importantly, P-TEFb directs H1 phosphorylation in response to wild-type HIV-1 infection, but not Tat-mutant HIV-1 infection. Our results show that P-TEFb phosphorylates histone H1 at a specific C-terminal phosphorylation site. Expression of a mutant H1.1 that cannot be phosphorylated by P-TEFb also disrupts Tat transactivation in an HIV reporter cell line as well as transcription of the c-fos and hsp70 genes in HeLa cells. We identify histone H1 as a novel P-TEFb substrate, and our results suggest new roles for P-TEFb in both cellular and HIV-1 transcription.	Univ Massachusetts, Dept Mol Pharmacol & Biochem, Sch Med, Worcester, MA 01605 USA; [Rana, Tariq M.] Sanford Burnham Med Res Inst, Program RNA Biol, La Jolla, CA 92037 USA	University of Massachusetts System; University of Massachusetts Worcester; Sanford Burnham Prebys Medical Discovery Institute	Rana, TM (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	trana@sanfordburnham.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants from the National Institutes of Health.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bhattacharjee RN, 2006, VIROLOGY, V346, P1, DOI 10.1016/j.virol.2005.12.034; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Garriga J, 1996, BIOCHEM J, V320, P983, DOI 10.1042/bj3200983; Gondeau C, 2005, J BIOL CHEM, V280, P13793, DOI 10.1074/jbc.M413690200; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lis JT, 2000, GENE DEV, V14, P792; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Romanowicz L, 2010, INT J EXP PATHOL, V91, P1, DOI 10.1111/j.1365-2613.2009.00675.x; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Verhoef K, 2001, J VIROL, V75, P979, DOI 10.1128/JVI.75.2.979-987.2001; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Xie A, 2007, MOL CELL, V27, P178, DOI 10.1016/j.molcel.2007.07.005; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	43	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29713	29720		10.1074/jbc.M110.125997	http://dx.doi.org/10.1074/jbc.M110.125997			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20551309	hybrid, Green Published			2022-12-27	WOS:000281984300006
J	Schmitt, P; Wilmes, M; Pugniere, M; Aumelas, A; Bachere, E; Sahl, HG; Schneider, T; Destoumieux-Garzon, D				Schmitt, Paulina; Wilmes, Miriam; Pugniere, Martine; Aumelas, Andre; Bachere, Evelyne; Sahl, Hans-Georg; Schneider, Tanja; Destoumieux-Garzon, Delphine			Insight into Invertebrate Defensin Mechanism of Action OYSTER DEFENSINS INHIBIT PEPTIDOGLYCAN BIOSYNTHESIS BY BINDING TO LIPID II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; CRASSOSTREA-GIGAS; MAMMALIAN DEFENSINS; ANTIBIOTIC-ACTIVITY; ESCHERICHIA-COLI; INSECT DEFENSIN; GENE-REGULATION; BACTERIA; BETA-DEFENSIN-3	Three oyster defensin variants (Cg-Defh1, Cg-Defh2, and Cg-Defm) were produced as recombinant peptides and characterized in terms of activities and mechanism of action. In agreement with their spectrum of activity almost specifically directed against Gram-positive bacteria, oyster defensins were shown here to be specific inhibitors of a bacterial biosynthesis pathway rather than mere membrane-active agents. Indeed, at lethal concentrations, the three defensins did not compromise Staphylococcus aureus membrane integrity but inhibited the cell wall biosynthesis as indicated by the accumulation of the UDP-N-acetylmuramyl-pentapeptide cell wall precursor. In addition, a combination of antagonization assays, thin layer chromatography, and surface plasmon resonance measurements showed that oyster defensins bind almost irreversibly to the lipid II peptidoglycan precursor, thereby inhibiting the cell wall biosynthesis. To our knowledge, this is the first detailed analysis of the mechanism of action of antibacterial defensins produced by invertebrates. Interestingly, the three defensins, which were chosen as representative of the oyster defensin molecular diversity, bound differentially to lipid II. This correlated with their differential antibacterial activities. From our experimental data and the analysis of oyster defensin sequence diversity, we propose that oyster defensin activity results from selective forces that have conserved residues involved in lipid II binding and diversified residues at the surface of oyster defensins that could improve electrostatic interactions with the bacterial membranes.	[Schmitt, Paulina; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, CNRS, UMR 5119, Lab Ecosyst Lagunaires, F-34095 Montpellier, France; [Schmitt, Paulina; Bachere, Evelyne; Destoumieux-Garzon, Delphine] Univ Montpellier 2, IFREMER, UMR 5119, Lab Ecosyst Lagunaires,IRD, F-34095 Montpellier, France; [Wilmes, Miriam; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53105 Bonn, Germany; [Aumelas, Andre] CNRS, UMR 5048, INSERM, U554, F-34090 Montpellier, France; [Aumelas, Andre] Univ Montpellier I, Ctr Biochim Struct, F-34090 Montpellier, France; [Aumelas, Andre] Univ Montpellier 2, Ctr Biochim Struct, F-34090 Montpellier, France; [Pugniere, Martine] Ctr Etud Agents Pathogenes & Biotechnol Sante, CNRS, UMR 5236, Inst Biol, F-34965 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bonn; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Destoumieux-Garzon, D (corresponding author), Univ Montpellier 2, CNRS, UMR 5119, Lab Ecosyst Lagunaires, Pl Eugene Bataillon,CC80, F-34095 Montpellier, France.	Delphine.Destoumieux.Garzon@ifremer.fr	Bachere, Evelyne/O-6117-2014; PUGNIERE, Martine/AAD-4315-2020; Destoumieux-Garzón, Delphine/O-3328-2014; Pugniere, Martine/T-1355-2017; Schneider, Tanja/L-8049-2013	PUGNIERE, Martine/0000-0002-2049-2909; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Pugniere, Martine/0000-0002-2049-2909; Schneider, Tanja/0000-0001-7269-4716; Schmitt, Paulina/0000-0001-6598-837X	Ifremer; CNRS; Languedoc-Roussillon region; Federal Ministry of Education and Research; Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica; University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement)	Ifremer; CNRS(Centre National de la Recherche Scientifique (CNRS)); Languedoc-Roussillon region(Region Occitanie); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica; University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement)	This work was supported in part by Ifremer, CNRS, the Languedoc-Roussillon region ("Chercheur(se) d'Avenir" program, REVAResp project), and the German Federal Ministry of Education and Research (Skinstaph project and the BONFOR program of the Medical Faculty, University of Bonn).; Supported by a graduate scholarship from Program Becas Chile-Comision Nacional de Investigacion Cientifica y Tecnologica and a traveling grant from University of Montpellier 2 (Systemes Integres en Biologie, Agronomie, Geosciences, Hydrosciences, Environnement).	Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; DAI D, 1988, J BACTERIOL, V170, P2197, DOI 10.1128/jb.170.5.2197-2201.1988; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Timothy DA, 2006, BBA-BIOMEMBRANES, V1758, P1285, DOI 10.1016/j.bbamem.2006.03.016; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hetru C, 1997, Methods Mol Biol, V78, P35; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; KOHLRAUSCH U, 1991, FEMS MICROBIOL LETT, V78, P253; Lamberty M, 1999, J BIOL CHEM, V274, P9320, DOI 10.1074/jbc.274.14.9320; LEEUW ED, 2010, FEBS LETT, V584, P1543; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nakajima Y, 2003, BBA-GEN SUBJECTS, V1624, P125, DOI 10.1016/j.bbagen.2003.10.004; Otvos L, 2000, J PEPT SCI, V6, P497; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Saulnier D, 2000, DIS AQUAT ORGAN, V40, P109, DOI 10.3354/dao040109; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sugiarto H, 2007, FEMS MICROBIOL LETT, V270, P195, DOI 10.1111/j.1574-6968.2007.00642.x; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Yang Y, 2009, BIOPOLYMERS, V91, P207, DOI 10.1002/bip.21119; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	45	103	107	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29208	29216		10.1074/jbc.M110.143388	http://dx.doi.org/10.1074/jbc.M110.143388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605792	hybrid, Green Published			2022-12-27	WOS:000281740100021
J	Alves, CS; Melo, MN; Franquelim, HG; Ferre, R; Planas, M; Feliu, L; Bardaji, E; Kowalczyk, W; Andreu, D; Santos, NC; Fernandes, MX; Castanho, MARB				Alves, Carla S.; Melo, Manuel N.; Franquelim, Henri G.; Ferre, Rafael; Planas, Marta; Feliu, Lidia; Bardaji, Eduard; Kowalczyk, Wioleta; Andreu, David; Santos, Nuno C.; Fernandes, Miguel X.; Castanho, Miguel A. R. B.			Escherichia coli Cell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; MEMBRANE; BACTERIA	The potential of antimicrobial peptides (AMPs) as an alternative to conventional therapies is well recognized. Insights into the biological and biophysical properties of AMPs are thus key to understanding their mode of action. In this study, the mechanisms adopted by two AMPs in disrupting the Gram-negative Escherichia coli bacterial envelope were explored. BP100 is a short cecropin A-melittin hybrid peptide known to inhibit the growth of phytopathogenic Gram-negative bacteria. pepR, on the other hand, is a novel AMP derived from the dengue virus capsid protein. Both BP100 and pepR were found to inhibit the growth of E. coli at micromolar concentrations. Zeta potential measurements of E. coli incubated with increasing peptide concentrations allowed for the establishment of a correlation between the minimal inhibitory concentration (MIC) of each AMP and membrane surface charge neutralization. While a neutralization-mediated killing mechanism adopted by either AMP is not necessarily implied, the hypothesis that surface neutralization occurs close to MIC values was confirmed. Atomic force microscopy (AFM) was then employed to visualize the structural effect of the interaction of each AMP with the E. coli cell envelope. At their MICs, BP100 and pepR progressively destroyed the bacterial envelope, with extensive damage already occurring 2 h after peptide addition to the bacteria. A similar effect was observed for each AMP in the concentration-dependent studies. At peptide concentrations below MIC values, only minor disruptions of the bacterial surface occurred.	[Castanho, Miguel A. R. B.] Univ Lisbon, Unidade Bioquim Fis, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal; [Fernandes, Miguel X.] Univ Madeira, Ctr Quim Madeira, P-9000390 Funchal, Portugal; [Ferre, Rafael; Planas, Marta; Feliu, Lidia; Bardaji, Eduard] Univ Girona, Lab Innovacio Proc & Prod Sintesi Organ, Dept Quim, Girona 17071, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, E-08003 Barcelona, Spain	Universidade de Lisboa; Universidade da Madeira; Universitat de Girona; Pompeu Fabra University	Castanho, MARB (corresponding author), Univ Lisbon, Unidade Bioquim Fis, Inst Mol Med, Fac Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.	macastanho@fm.ul.pt	Andreu, David/I-4359-2014; Feliu, Lidia/H-8285-2015; Planas, Marta/E-4145-2015; BARDAJI, EDUARD/I-1211-2015; Fernandes, Miguel Xavier/A-4373-2013; Kowalczyk, Wioleta/F-5904-2014; Santos, Nuno/N-7248-2013; Franquelim, Henri/P-4985-2017; Fernandes, Miguel Xavier/AAP-6504-2020	Andreu, David/0000-0002-6317-6666; Feliu, Lidia/0000-0001-9792-6106; Planas, Marta/0000-0003-4988-4970; BARDAJI, EDUARD/0000-0001-6281-3646; Fernandes, Miguel Xavier/0000-0002-1840-616X; Santos, Nuno/0000-0002-0580-0475; Franquelim, Henri/0000-0001-6229-4276; Fernandes, Miguel Xavier/0000-0002-1840-616X; Alves, Carla Sophia/0000-0002-8891-5234; Melo, Manuel Nuno/0000-0001-6567-0513; Kowalczyk, Wioleta/0000-0001-5180-594X; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0003-1034-3552; FCCN, Bogus/0000-0001-6282-8004	Fundacao para Ciencia e Tecnologia, Portugal [SFRH/BD/24547/2005, SFRH/BD/24778/2005, SFRH/BD/39039/2007, PTDC/QUI/69937/2006, REEQ/140/BIO/2005]	Fundacao para Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para Ciencia e Tecnologia, Portugal (Fellowships SFRH/BD/24547/2005, SFRH/BD/24778/2005, and SFRH/BD/39039/2007, to C. S. A., M. N. M., and H. G. F., respectively, and Projects PTDC/QUI/69937/2006 and REEQ/140/BIO/2005).	Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Colville K, 2010, LANGMUIR, V26, P2639, DOI 10.1021/la902826n; Conte M, 2007, WORLD J MICROB BIOT, V23, P1679, DOI 10.1007/s11274-007-9415-6; da Silva A, 2005, WORLD J MICROB BIOT, V21, P1103, DOI 10.1007/s11274-005-0077-y; den Hertog AL, 2004, BIOCHEM J, V379, P665, DOI 10.1042/BJ20031785; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Ferre R, 2006, APPL ENVIRON MICROB, V72, P3302, DOI 10.1128/AEM.72.5.3302-3308.2006; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Huang HW, 2009, BIOPHYS J, V96, P3263, DOI 10.1016/j.bpj.2009.01.030; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Oren Z, 1998, BIOPOLYMERS, V47, P451; Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	36	176	177	0	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27536	27544		10.1074/jbc.M110.130955	http://dx.doi.org/10.1074/jbc.M110.130955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566635	hybrid, Green Published			2022-12-27	WOS:000281404100008
J	Jeon, YJ; Lee, KY; Cho, YY; Pugliese, A; Kim, HG; Jeong, CH; Bode, AM; Dong, Z				Jeon, Young Jin; Lee, Kun Yeong; Cho, Yong-Yeon; Pugliese, Angelo; Kim, Hong Gyum; Jeong, Chul-Ho; Bode, Ann M.; Dong, Zigang			Role of NEK6 in Tumor Promoter-induced Transformation in JB6 C141 Mouse Skin Epidermal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIMA-RELATED KINASE-6; ASPERGILLUS-NIDULANS; CANCER DEVELOPMENT; STAT3 ACTIVATION; FAMILY KINASES; PROTEIN-KINASE; PHOSPHORYLATION; SUBSTRATE; GENE	NEK6 (NIMA-related kinase 6) is a homologue of the Aspergillus nidulans protein NIMA (never in mitosis, gene A). We demonstrate that overexpression of NEK6 induces anchorage-independent transformation of JB6 Cl41 mouse epidermal cells. Tissue arrays and Western immunoblot analysis show that NEK6 is overexpressed in malignant tissues and several cancer cell lines. Our data also show that NEK6 interacts with STAT3, an oncogenic transcription factor, and phosphorylates STAT3 on Ser(727), which is important for transcriptional activation. Additional studies using NEK6 mutants suggested that the phosphorylation on both Ser(206) and Thr(210) of NEK6 is critical for STAT3 phosphorylation and anchorage-independent transformation of mouse epidermal cells. Notably, knockdown of NEK6 decreased colony formation and STAT3 Ser(727) phosphorylation. Based on our findings, the most likely mechanism that can account for this biological effect involves the activation of STAT3 through the phosphorylation on Ser(727). Because of the critical role that STAT3 plays in mediating oncogenesis, the stimulatory effects of NEK6 on STAT3 and cell transformation suggest that this family of serine/threonine kinases might represent a novel chemotherapeutic target.	[Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Jeon, Young Jin] Chosun Univ, Coll Med, Kwangju 501709, South Korea	University of Minnesota System; Chosun University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA077646, R37CA081064, CA111536, CA120388, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA111536, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, R37CA081064, CA111536, CA120388, and ES016548. This work was also supported by the Hormel Foundation.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Lee EJ, 2007, BIOCHEM BIOPH RES CO, V358, P783, DOI 10.1016/j.bbrc.2007.04.203; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	26	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28126	28133		10.1074/jbc.M110.137190	http://dx.doi.org/10.1074/jbc.M110.137190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20595392	Green Published, hybrid			2022-12-27	WOS:000288742300011
J	Meng, JM; Drolet, JR; Monks, BG; Golenbock, DT				Meng, Jianmin; Drolet, Joshua R.; Monks, Brian G.; Golenbock, Douglas T.			MD-2 Residues Tyrosine 42, Arginine 69, Aspartic Acid 122, and Leucine 125 Provide Species Specificity for Lipid IVA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TLR4-MD-2 COMPLEX; CUTTING EDGE; LIPOPOLYSACCHARIDE; RECEPTOR; TLR4; ENDOTOXIN; MICE; LPS; RESPONSIVENESS; ACTIVATION	Lipopolysaccharide (LPS) activates the innate immune response through the Toll-like receptor 4 (TLR4).MD-2 complex. A synthetic lipid A precursor, lipid IVA, induces an innate immune response in mice but not in humans. Both TLR4 and MD-2 are required for the agonist activity of lipid IVA in mice, with TLR4 interacting through specific surface charges at the dimerization interface. In this study, we used site-directed mutagenesis to identify the MD-2 residues that determine lipid IVA species specificity. A single mutation of murine MD-2 at the hydrophobic pocket entrance, E122K, substantially reduced the response to lipid IVA. Combining the murine MD-2 E122K with the murine TLR4 K367E/S386K/R434Q mutations completely abolished the response to lipid IVA, effectively converting the murine cellular response to a human-like response. In human cells, however, simultaneous mutations of K122E, K125L, Y41F, and R69G on human MD-2 were required to promote a response to lipid IVA. Combining the human MD-2 quadruple mutations with the human TLR4 E369K/Q436R mutations completely converted the human MD-2/human TLR4 receptor to a murine-like receptor. Because MD-2 residues 122 and 125 reside at the dimerization interface near the pocket entrance, surface charge differences here directly affect receptor dimerization. In comparison, residues 42 and 69 reside at the MD-2/TLR4 interaction surface opposite the dimerization interface. Surface charge differences there likely affect the binding angle and/or rigidity between MD-2 and TLR4, exerting an indirect influence on receptor dimerization and activation. Thus, surface charge differences at the two MD-2/TLR4 interfaces determine the species-specific activation of lipid IVA.	[Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St,LRB 208, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015	Monks, Brian/0000-0003-4008-3093	National Institutes of Health [GM54060, U19 AI084048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060, R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54060 (to D. T. G.) and U19 AI084048 (to J. M. and D. T. G.).	Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	22	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27935	27943		10.1074/jbc.M110.134668	http://dx.doi.org/10.1074/jbc.M110.134668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592019	Green Published, hybrid			2022-12-27	WOS:000281404100048
J	Ravasio, A; Olmeda, B; Bertocchi, C; Haller, T; Perez-Gil, J				Ravasio, Andrea; Olmeda, Barbara; Bertocchi, Cristina; Haller, Thomas; Perez-Gil, Jesus			Lamellar Bodies Form Solid Three-dimensional Films at the Respiratory Air-Liquid Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT MEMBRANES; II CELLS; LUNG SURFACTANT; IN-VITRO; SECRETION; PROTEINS; CHOLESTEROL; COEXISTENCE; ADSORPTION; EXOCYTOSIS	Pulmonary surfactant is essential for lung function. It is assembled, stored and secreted as particulate entities (lamellar body-like particles; LBPs). LBPs disintegrate when they contact an air-liquid interface, leading to an instantaneous spreading of material and a decline in surface tension. Here, we demonstrate that the film formed by the adsorbed material spontaneously segregate into distinct ordered and disordered lipid phase regions under unprecedented near-physiological conditions and, unlike natural surfactant purified from bronchoalveolar lavages, dynamically reorganized into highly viscous multilayer domains with complex three-dimensional topographies. Multilayer domains, in coexistence with liquid phases, showed a progressive stiffening and finally solidification, probably driven by a self-driven disassembly of LBPs from a sub-surface compartment. We conclude that surface film formation from LBPs is a highly dynamic and complex process, leading to a more elaborated scenario than that observed and predicted by models using reconstituted, lavaged, or fractionated preparations.	[Ravasio, Andrea; Haller, Thomas] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Bertocchi, Cristina] Innsbruck Med Univ, Dept Internal Med 1, A-6020 Innsbruck, Austria; [Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Bioquim, E-28040 Madrid, Spain	Medical University of Innsbruck; Medical University of Innsbruck; Complutense University of Madrid	Haller, T (corresponding author), Innsbruck Med Univ, Dept Physiol & Med Phys, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	Thomas.Haller@i-med.ac.at; jpg@bbm1.ucm.es	Haller, Thomas/H-9036-2015; Bertocchi, Cristina/GSJ-6994-2022; Perez-Gil, Jesus/H-3102-2019; Ravasio, Andrea/G-6167-2011; Ravasio, Andrea/H-6722-2012; Olmeda, Bárbara/H-1440-2015	Haller, Thomas/0000-0001-9147-4081; Bertocchi, Cristina/0000-0003-0907-1318; Perez-Gil, Jesus/0000-0003-3587-7147; Ravasio, Andrea/0000-0001-7835-5133; Olmeda, Bárbara/0000-0001-6004-1603	Austrian FWF [P17501, P 20472]; Spanish Ministry of Science [BIO2009-09694, CSD2007-00010]; Community of Madrid [S2009MAT-1507]; European Commission [RTN-512229]; Austrian Science Fund (FWF) [P 20472] Funding Source: researchfish	Austrian FWF(Austrian Science Fund (FWF)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Community of Madrid(Comunidad de Madrid); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian FWF (P17501, P 20472), by Grants from Spanish Ministry of Science (BIO2009-09694, CSD2007-00010), and the Community of Madrid (S2009MAT-1507), and Marie Curie Network Pulmonet (RTN-512229) from the European Commission.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; BANGHAM AD, 1979, BIOCHIM BIOPHYS ACTA, V573, P552, DOI 10.1016/0005-2760(79)90229-7; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Bertocchi C, 2005, BIOPHYS J, V89, P1353, DOI 10.1529/biophysj.104.053132; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Dahim M, 2002, BIOPHYS J, V83, P1511, DOI 10.1016/S0006-3495(02)73921-0; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Discher BM, 1996, BIOPHYS J, V71, P2583, DOI 10.1016/S0006-3495(96)79450-X; Fisher AB, 2010, AM J PHYSIOL-LUNG C, V299, pL51, DOI 10.1152/ajplung.00066.2010; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; Haller T, 2004, AM J PHYSIOL-LUNG C, V286, pL1009, DOI 10.1152/ajplung.00342.2003; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Kashchiev D, 2001, EUR BIOPHYS J BIOPHY, V30, P34, DOI 10.1007/s002490000120; Larsson M, 2006, CHEM PHYS LIPIDS, V144, P137, DOI 10.1016/j.chemphyslip.2006.08.006; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Ravasio A, 2008, J LIPID RES, V49, P2479, DOI 10.1194/jlr.D800029-JLR200; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Sato Shigeru, 2001, Medical Electron Microscopy, V34, P142, DOI 10.1007/s007950170008; Schurch S, 2001, COMP BIOCHEM PHYS A, V129, P195, DOI 10.1016/S1095-6433(01)00316-6; SCHURCH S, 1995, BIOL NEONATE, V67, P61; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Veldhuizen RAW, 1999, EXP LUNG RES, V25, P127, DOI 10.1080/019021499270349; Wemhoner A, 2006, J BIOMOL SCREEN, V11, P286, DOI 10.1177/1087057105285284; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; WILLIAMS MC, 1977, J CELL BIOL, V72, P260, DOI 10.1083/jcb.72.2.260; Yan WF, 2007, J APPL PHYSIOL, V102, P1739, DOI 10.1152/japplphysiol.00948.2006; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	36	28	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28174	28182		10.1074/jbc.M110.106518	http://dx.doi.org/10.1074/jbc.M110.106518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558742	Green Published, hybrid			2022-12-27	WOS:000281404100060
J	Peng, Y; Veneziano, SE; Gillispie, GD; Broderick, JB				Peng, Yi; Veneziano, Susan E.; Gillispie, Gregory D.; Broderick, Joan B.			Pyruvate Formate-lyase, Evidence for an Open Conformation Favored in the Presence of Its Activating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PYRUVATE; LINEAR EXTRAPOLATION METHOD; UNIQUE IRON SITE; S-ADENOSYLMETHIONINE; PROTEIN SUPERFAMILY; ALPHA-CHYMOTRYPSIN; RADICAL-SAM; MECHANISM; CLUSTER; 4FE-4S	Pyruvate formate-lyase-activating enzyme (PFL-AE) activates pyruvate formate-lyase (PFL) by generating a catalytically essential radical on Gly-734 of PFL. Crystal structures of unactivated PFL reveal that Gly-734 is buried 8 angstrom from the surface of the protein in what we refer to here as the closed conformation of PFL. We provide here the first experimental evidence for an alternate open conformation of PFL in which: (i) the glycyl radical is significantly less stable; (ii) the activated enzyme exhibits lower catalytic activity; (iii) the glycyl radical undergoes less H/D exchange with solvent; and (iv) the T-m of the protein is decreased. The evidence suggests that in the open conformation of PFL, the Gly-734 residue is located not in its buried position in the enzyme active site but rather in a more solvent-exposed location. Further, we find that the presence of the PFL-AE increases the proportion of PFL in the open conformation; this observation supports the idea that PFL-AE accesses Gly-734 for direct hydrogen atom abstraction by binding to the Gly-734 loop in the open conformation, thereby shifting the closed 7 open equilibrium of PFL to the right. Together, our results lead to a model in which PFL can exist in either a closed conformation, with Gly-734 buried in the active site of PFL and harboring a stable glycyl radical, or an open conformation, with Gly-734 more solvent-exposed and accessible to the PFL-AE active site. The equilibrium between these two conformations of PFL is modulated by the interaction with PFL-AE.	[Peng, Yi; Veneziano, Susan E.; Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peng, Yi; Veneziano, Susan E.; Broderick, Joan B.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA; [Gillispie, Gregory D.] Fluorescence Innovat, Bozeman, MT 59718 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Broderick, JB (corresponding author), Montana State Univ, Dept Chem & Biochem, 103 CBB, Bozeman, MT 59717 USA.	jbroderick@chemistry.montana.edu		Broderick, Joan/0000-0001-7057-9124	National Institutes of Health [GM54608]; Montana Board of Research and Commercialization Technology [08-48]; NASA Astrobiology Institute [NAI05-19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM054608, R29GM054608, R01GM054608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Board of Research and Commercialization Technology; NASA Astrobiology Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54608 (to J.B.B.). This work was also supported by Montana Board of Research and Commercialization Technology Grant 08-48 (to G. D. G.). The Astrobiology Biogeocatalysis Research Center is supported by the NASA Astrobiology Institute Grant NAI05-19.	AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Baker SN, 2004, CHEM COMMUN, P940, DOI 10.1039/b401304m; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Beinert H, 1978, Methods Enzymol, V54, P435; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 1997, J AM CHEM SOC, V119, P7396, DOI 10.1021/ja9711425; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KNAPPE J, 1974, EUR J BIOCHEM, V50, P253, DOI 10.1111/j.1432-1033.1974.tb03894.x; KNAPPE J, 1976, BIOCHEM BIOPH RES CO, V71, P1110, DOI 10.1016/0006-291X(76)90768-3; KNAPPE J, 1993, BIOCHEM SOC T, V21, P731, DOI 10.1042/bst0210731; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Krebs C, 2000, J AM CHEM SOC, V122, P12497, DOI 10.1021/ja003335p; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Lehtio L, 2002, ACTA CRYSTALLOGR D, V58, P2209, DOI 10.1107/S0907444902016402; Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024; Pace CN, 2000, PROTEINS, P1; PARAST CV, 1995, BIOCHEMISTRY-US, V34, P2393, DOI 10.1021/bi00008a001; PARAST CV, 1995, J AM CHEM SOC, V117, P10601, DOI 10.1021/ja00147a034; PLAGA W, 1988, EUR J BIOCHEM, V178, P445, DOI 10.1111/j.1432-1033.1988.tb14468.x; Plaga W, 2000, FEBS LETT, V466, P45, DOI 10.1016/S0014-5793(99)01752-4; RODEL W, 1988, EUR J BIOCHEM, V177, P153, DOI 10.1111/j.1432-1033.1988.tb14356.x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s	40	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27224	27231		10.1074/jbc.M109.096875	http://dx.doi.org/10.1074/jbc.M109.096875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571026	hybrid, Green Published			2022-12-27	WOS:000281172700053
J	Iharada, M; Miyaji, T; Fujimoto, T; Hiasa, M; Anzai, N; Omote, H; Moriyama, Y				Iharada, Masafumi; Miyaji, Takaaki; Fujimoto, Takahiro; Hiasa, Miki; Anzai, Naohiko; Omote, Hiroshi; Moriyama, Yoshinori			Type 1 Sodium-dependent Phosphate Transporter (SLC17A1 Protein) Is a Cl--dependent Urate Exporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; URIC-ACID; CHLORIDE CONDUCTANCE; SYNAPTIC VESICLES; ANION TRANSPORT; APICAL MEMBRANE; XENOPUS OOCYTES; ORGANIC CATION; IDENTIFICATION; EXPRESSION	SLC17A1 protein (NPT1) is the first identified member of the SLC17 phosphate transporter family and mediates the transmembrane cotransport of Na+/P-i in oocytes. Although this protein is believed to be a renal polyspecific anion exporter, its transport properties are not well characterized. Here, we show that proteoliposomes containing purified SLC17A1 transport various organic anions such as p-aminohippuric acid and acetylsalicylic acid (aspirin) in an inside positive membrane potential (Delta psi)-dependent manner. We found that NPT1 also transported urate. The uptake characteristics were similar to that of SLC17 members in its Cl- dependence and inhibitor sensitivity. When arginine 138, an essential amino acid residue for members of the SLC17 family such as the vesicular glutamate transporter, was specifically mutated to alanine, the resulting mutant protein was inactive in Delta psi-dependent anion transport. Heterologously expressed and purified human NPT1 carrying the single nucleotide polymorphism mutation that is associated with increased risk of gout in humans exhibited 32% lower urate transport activity compared with the wild type protein. These results strongly suggested that NPT1 is a Cl--dependent polyspecific anion exporter involved in urate excretion under physiological conditions.	[Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Miyaji, Takaaki; Moriyama, Yoshinori] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Anzai, Naohiko] Kyorin Univ, Dept Pharmacol, Sch Med, Tokyo 1818611, Japan	Okayama University; Okayama University; Kyorin University	Moriyama, Y (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	OMOTE, Hiroshi/B-1635-2011; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458; Miyaji, Takaaki/0000-0002-7257-7621	Japanese Ministry of Education, Science, Sports, and Culture; Ajinomoto 3ARP; Brain Science Foundation; Salt Science Foundation	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto 3ARP; Brain Science Foundation; Salt Science Foundation	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Science, Sports, and Culture (to H.O. and Y.M.), the Ajinomoto 3ARP, the Brain Science Foundation, and the Salt Science Foundation (to Y.M.).	Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Inui K, 2000, KIDNEY INT, V58, P944, DOI 10.1046/j.1523-1755.2000.00251.x; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Koepsell H, 2004, TRENDS PHARMACOL SCI, V25, P375, DOI 10.1016/j.tips.2004.05.005; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Urano W, 2010, ANN RHEUM DIS, V69, P1232, DOI 10.1136/ard.2008.106856; Ushijima H, 2008, BIOCHEM BIOPH RES CO, V374, P325, DOI 10.1016/j.bbrc.2008.07.034; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003	28	84	91	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26107	26113		10.1074/jbc.M110.122721	http://dx.doi.org/10.1074/jbc.M110.122721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566650	Green Published, hybrid			2022-12-27	WOS:000280921000027
J	Xiao, D; Powolny, AA; Moura, MB; Kelley, EE; Bommareddy, A; Kim, SH; Hahm, ER; Normolle, D; Van Houten, B; Singh, SV				Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Kelley, Eric E.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Normolle, Daniel; Van Houten, Bennett; Singh, Shivendra V.			Phenethyl Isothiocyanate Inhibits Oxidative Phosphorylation to Trigger Reactive Oxygen Species-mediated Death of Human Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MITOCHONDRIAL-MEMBRANE; PHENYLETHYL ISOTHIOCYANATE; SUPEROXIDE; CARCINOGENESIS; DEGRADATION; ACTIVATION; GENERATION; VEGETABLES; INDUCTION	Phenethyl isothiocyanate (PEITC), a constituent of edible cruciferous vegetables such as watercress, not only affords significant protection against chemically induced cancer in experimental rodents but also inhibits growth of human cancer cells by causing apoptotic and autophagic cell death. However, the underlying mechanism of PEITC-induced cell death is not fully understood. Using LNCaP and PC-3 human prostate cancer cells as a model, we demonstrate that the PEITC-induced cell death is initiated by production of reactive oxygen species (ROS) resulting from inhibition of oxidative phosphorylation (OXPHOS). Exposure of LNCaP and PC-3 cells to pharmacologic concentrations of PEITC resulted in ROS production, which correlated with inhibition of complex III activity, suppression of OXPHOS, and ATP depletion. These effects were not observed in a representative normal human prostate epithelial cell line (PrEC). The ROS production by PEITC treatment was not influenced by cyclosporin A. The Rho-0 variants of LNCaP and PC-3 cells were more resistant to PEITC-mediated ROS generation, apoptotic DNA fragmentation, and collapse of mitochondrial membrane potential compared with respective wild-type cells. The PEITC treatment resulted in activation of Bax in wild-type LNCaP and PC-3 cells, but not in their respective Rho-0 variants. Furthermore, RNA interference of Bax and Bak conferred significant protection against PEITC-induced apoptosis. The Rho-0 variants of LNCaP and PC-3 cells also resisted PEITC-mediated autophagy. In conclusion, the present study provides novel insight into the molecular circuitry of PEITC-induced cell death involving ROS production due to inhibition of complex III and OXPHOS.	[Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Kelley, Eric E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Normolle, Daniel] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15213 USA; [Normolle, Daniel] Univ Pittsburgh, Biostat Facil, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), 2-32A Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu	Van Houten, Bennett/K-2284-2019	Normolle, Daniel/0000-0001-8675-5014	National Cancer Institute [CA101753, CA115498, CA129347]; NATIONAL CANCER INSTITUTE [R01CA129347, R01CA101753, R01CA115498] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, USPHS Grants CA101753, CA115498, and CA129347 awarded by the National Cancer Institute.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BERNARDES CF, 1994, BBA-BIOENERGETICS, V1188, P93, DOI 10.1016/0005-2728(94)90026-4; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN H, 1999, APPL MIXED MODELS ME, P33; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; Kim YA, 2007, MOL CANCER THER, V6, P1599, DOI 10.1158/1535-7163.MCT-06-0754; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; MORSE MA, 1989, CANCER RES, V49, P549; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Pereira MA, 1995, ANTICANCER RES, V15, P1953; STONER GD, 1991, CANCER RES, V51, P2063; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, MOL CANCER THER, V3, P567; Xiao D, 2002, CANCER RES, V62, P3615; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yang YM, 2002, CANCER RES, V62, P2; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	48	134	136	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26558	26569		10.1074/jbc.M109.063255	http://dx.doi.org/10.1074/jbc.M109.063255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20571029	hybrid, Green Published			2022-12-27	WOS:000280921000072
J	Chamoux, E; Bisson, M; Payet, MD; Roux, S				Chamoux, Estelle; Bisson, Martine; Payet, Marcel Daniel; Roux, Sophie			TRPV-5 Mediates a Receptor Activator of NF-kappa B (RANK) Ligand-induced Increase in Cytosolic Ca2+ in Human Osteoclasts and Down-regulates Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; RAT OSTEOCLASTS; RESORBING ACTIVITY; KINASE-ACTIVITY; ACID-SECRETION; CALCIUM; CHANNELS; ORGANIZATION; CALCITONIN; CELL	Most of the signaling effectors located downstream of receptor activator of NF-kappa B (RANK) activation are calcium-sensitive. However, the early signaling events that lead to the mobilization of intracellular calcium in human osteoclasts are still poorly understood. The Ca2+-sensitive fluorescent probe Fura2 was used to detect changes in the intracellular concentration of Ca2+ ([Ca2+](i)) in a model of human osteoclasts. Stimulating these cells with receptor activator of NF-kappa B ligand (RANKL) induced a rapid and significant increase in [Ca2+](i). Adding extracellular Ca2+ chelators, depleting intracellular stores, and the use of a phospholipase C inhibitor all indicated that the Ca2+ was of extracellular origin, suggesting the involvement of a Ca2+ channel. We showed that none of the classical Ca2+ channels (L-, T-, or R-type) were involved in the RANKL-induced Ca2+ spike. However, the effect of high doses of Gd3+ did suggest that TRP family channels were present in human osteoclasts. The TRPV-5 channel was expressed in osteoclasts and was mainly located in the cellular area in contact with the bone surface. Furthermore, the RNA inactivation of TRPV-5 channel completely inhibited the RANKL-induced increase in [Ca2+](i), which was accompanied in the long term by marked activation of bone resorption. Overall, our results show that RANKL induced a significant increase in [Ca2+](i) of extracellular origin, probably as a result of the opening of TRPV-5 calcium channels on the surface of human osteoclasts. Our findings suggest that TRPV-5 contributes to maintaining the homeostasis of the human skeleton via a negative feedback loop in RANKL-induced bone resorption.	[Chamoux, Estelle; Bisson, Martine; Roux, Sophie] Univ Sherbrooke, Fac Med, Div Rheumatol, Sherbrooke, PQ J1H 5N4, Canada; [Payet, Marcel Daniel] Univ Sherbrooke, Fac Med, Div Physiol & Biophys, Sherbrooke, PQ J1H 5N4, Canada; [Chamoux, Estelle] Bishops Univ, Div Nat Sci & Math, Sherbrooke, PQ J1M 1Z7, Canada	University of Sherbrooke; University of Sherbrooke; Bishops University	Roux, S (corresponding author), 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	sophie.roux@usherbrooke.ca			Canadian Institutes of Health Research; Bishop's University Senate Research Committee; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bishop's University Senate Research Committee; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research and from Bishop's University Senate Research Committee grants and from the Fonds de la Recherche en Sante du Quebec (to S. R.).	Bennett BD, 2001, ENDOCRINOLOGY, V142, P1968, DOI 10.1210/en.142.5.1968; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Kajiya H, 2003, AM J PHYSIOL-CELL PH, V285, pC457, DOI 10.1152/ajpcell.00033.2003; Kajiya H, 2000, J CELL PHYSIOL, V183, P83, DOI 10.1002/(SICI)1097-4652(200004)183:1<83::AID-JCP10>3.0.CO;2-W; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Mangashetti LS, 2005, J IMMUNOL, V175, P917, DOI 10.4049/jimmunol.175.2.917; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Micelli S, 2006, FRONT BIOSCI-LANDMRK, V11, P2035, DOI 10.2741/1945; Michou L, 2010, BONE, V46, P598, DOI 10.1016/j.bone.2009.11.012; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; MIYAUCHI A, 1993, OSTEOPOROS INT S1, V3, P132; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; RADDING W, 1994, J CELL PHYSIOL, V160, P17, DOI 10.1002/jcp.1041600104; Roux S, 2005, BIOCHEM BIOPH RES CO, V333, P42, DOI 10.1016/j.bbrc.2005.05.092; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Supanchart C, 2008, ARCH BIOCHEM BIOPHYS, V473, P161, DOI 10.1016/j.abb.2008.03.029; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teti A, 1990, Boll Soc Ital Biol Sper, V66, P1; Tousova K, 2005, MOL CELL NEUROSCI, V30, P207, DOI 10.1016/j.mcn.2005.07.004; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Tsuzuki T, 2000, JPN J PHYSIOL, V50, P67, DOI 10.2170/jjphysiol.50.67; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; VANEPPSFUNG C, 1994, BIOCHEM BIOPH RES CO, V204, P565, DOI 10.1006/bbrc.1994.2496; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	34	41	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25354	25362		10.1074/jbc.M109.075234	http://dx.doi.org/10.1074/jbc.M109.075234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547482	Green Published, hybrid			2022-12-27	WOS:000280682400028
J	Goupil, E; Tassy, D; Bourguet, C; Quiniou, C; Wisehart, V; Petrin, D; Le Gouill, C; Devost, D; Zingg, HH; Bouvier, M; Saragovi, HU; Chemtob, S; Lubell, WD; Claing, A; Hebert, TE; Laporte, SA				Goupil, Eugenie; Tassy, Danae; Bourguet, Carine; Quiniou, Christiane; Wisehart, Veronica; Petrin, Darlaine; Le Gouill, Christian; Devost, Dominic; Zingg, Hans H.; Bouvier, Michel; Saragovi, Horacio Uri; Chemtob, Sylvain; Lubell, William D.; Claing, Audrey; Hebert, Terence E.; Laporte, Stephane A.			A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2 alpha-mediated Rho/ROCK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; PROTEIN-COUPLED RECEPTOR; BOVINE LUTEAL CELLS; AMINO-ACIDS; F RECEPTOR; RHO-KINASE; MUSCARINIC RECEPTORS; PRETERM LABOR; MICE LACKING; ACTIVATION	The prostaglandin F2 alpha (PGF2 alpha) receptor (FP) is a key regulator of parturition and a target for pharmacological management of preterm labor. However, an incomplete understanding of signaling pathways regulating myometrial contraction hinders the development of improved therapeutics. Here we used a peptidomimetic inhibitor of parturition in mice, PDC113.824, whose structure was based on the NH2-terminal region of the second extracellular loop of FP receptor, to gain mechanistic insight underlying FP receptor-mediated cell responses in the context of parturition. We show that PDC113.824 not only delayed normal parturition in mice but also that it inhibited both PGF2 alpha- and lipopolysaccharide-induced preterm labor. PDC113.824 inhibited PGF2 alpha-mediated, G alpha(12)-dependent activation of the Rho/ROCK signaling pathways, actin remodeling, and contraction of human myometrial cells likely by acting as a non-competitive, allosteric modulator of PGF2 alpha binding. In contrast to its negative allosteric modulating effects on Rho/ROCK signaling, PDC113.824 acted as a positive allosteric modulator on PGF2 alpha-mediated protein kinase C and ERK1/2 signaling. This bias in receptor-dependent signaling was explained by an increase in FP receptor coupling to G alpha(q), at the expense of coupling to G alpha(12). Our findings regarding the allosteric and biased nature of PDC113.824 offer new mechanistic insights into FP receptor signaling relevant to parturition and suggest novel therapeutic opportunities for the development of new tocolytic drugs.	[Goupil, Eugenie; Petrin, Darlaine; Devost, Dominic; Zingg, Hans H.; Saragovi, Horacio Uri; Chemtob, Sylvain; Hebert, Terence E.; Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Goupil, Eugenie; Wisehart, Veronica; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 1A1, Canada; [Tassy, Danae; Claing, Audrey] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Bourguet, Carine; Lubell, William D.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Le Gouill, Christian; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Quiniou, Christiane; Chemtob, Sylvain] CHU St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hebert, TE (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	terence.hebert@mcgill.ca; stephane.laporte@mcgill.ca	Zingg, Hans/GPS-9984-2022; Bouvier, Michel/H-2758-2014; Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Bouvier, Michel/0000-0003-1128-0100; Laporte, Stephane/0000-0002-0633-543X; Lubell, William/0000-0002-3080-2712; Goupil, Eugenie/0000-0001-5554-8717	Canadian Institutes of Health (CIHR) Research Team [CTP 79848]; CIHR [MOP-36279, PRG-82673, MOP-74603]	Canadian Institutes of Health (CIHR) Research Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health (CIHR) Research Team Grant in GPCR Allosteric Regulation (CTiGAR, CTP 79848, to H. U. S., W. D. L., S. C., A. C., T. E. H., S. A. L., and M. B.) and CIHR Grants MOP-36279 (to T. E. H.) and PRG-82673 and MOP-74603 (to S. A. L.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Birdsall NJM, 1999, MOL PHARMACOL, V55, P778; Birdsall NJM, 1996, PROG BRAIN RES, V109, P147; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bourguet CB, 2009, ADV EXP MED BIOL, V611, P271, DOI 10.1007/978-0-387-73657-0_122; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen DB, 2001, ENDOCRINOLOGY, V142, P887, DOI 10.1210/en.142.2.887; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Cluzeau J, 2005, BIOPOLYMERS, V80, P98, DOI 10.1002/bip.20213; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P3728, DOI 10.1073/pnas.84.11.3728; de Asua LJ, 1997, ADV EXP MED BIOL, V400, P531; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Hanessian S, 1997, TETRAHEDRON, V53, P12789, DOI 10.1016/S0040-4020(97)00476-6; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; ITO S, 1994, BIOCHEM BIOPH RES CO, V200, P756, DOI 10.1006/bbrc.1994.1515; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joseph KS, 1998, NEW ENGL J MED, V339, P1434, DOI 10.1056/NEJM199811123392004; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lanzafame A, 2004, J PHARMACOL EXP THER, V308, P830, DOI 10.1124/jpet.103.060590; Lartey J, 2007, BIOL REPROD, V76, P971, DOI 10.1095/biolreprod.106.058982; Lartey J, 2009, REPRODUCTION, V138, P407, DOI 10.1530/REP-09-0160; Lombart HG, 1996, J ORG CHEM, V61, P9437, DOI 10.1021/jo961872f; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; Makino S, 2007, SEMIN REPROD MED, V25, P60, DOI 10.1055/s-2006-956776; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ohmichi M, 1997, ENDOCRINOLOGY, V138, P3103, DOI 10.1210/en.138.8.3103; Olson DM, 2003, PLACENTA, V24, pS47, DOI 10.1053/plac.2002.0938; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Phillippe M, 1997, AM J PHYSIOL-ENDOC M, V273, pE665, DOI 10.1152/ajpendo.1997.273.4.E665; Pierce KL, 1997, J BIOL CHEM, V272, P883, DOI 10.1074/jbc.272.2.883; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Podlech J., 2002, ORG SYNTH, V79, P154; Pryde Peter G, 2004, Expert Opin Drug Saf, V3, P639, DOI 10.1517/14740338.3.6.639; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schaafsma D, 2004, BRIT J PHARMACOL, V143, P477, DOI 10.1038/sj.bjp.0705903; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; SPETH RC, 2000, ANGIOTENSIN PROTOCOL, P275; Sugimoto Y, 1998, ADV EXP MED BIOL, V449, P317; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tahara M, 2005, AM J OBSTET GYNECOL, V192, P903, DOI 10.1016/j.ajog.2004.09.016; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Tateyama M, 2006, P NATL ACAD SCI USA, V103, P1124, DOI 10.1073/pnas.0505925103; Thornton S, 2001, EXP PHYSIOL, V86, P297, DOI 10.1113/eph8602186; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Vauquelin G, 2002, TRENDS PHARMACOL SCI, V23, P514, DOI 10.1016/S0165-6147(02)02081-3	59	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25624	25636		10.1074/jbc.M110.115196	http://dx.doi.org/10.1074/jbc.M110.115196			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551320	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000280682400056
J	Hasegawa, H; Kido, S; Tomomura, M; Fujimoto, K; Ohi, M; Kiyomura, M; Kanegae, H; Inaba, A; Sakagami, H; Tomomura, A				Hasegawa, Hiroya; Kido, Seisui; Tomomura, Mineko; Fujimoto, Kengo; Ohi, Michi; Kiyomura, Masaru; Kanegae, Haruhide; Inaba, Akemi; Sakagami, Hiroshi; Tomomura, Akito			Serum Calcium-decreasing Factor, Caldecrin, Inhibits Osteoclast Differentiation by Suppression of NFATc1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BONE HOMEOSTASIS; GENE-EXPRESSION; ESTROGEN DEFICIENCY; MOLECULAR-CLONING; CA2+ OSCILLATION; T-CELLS; ACTIVATION; RECEPTOR; RANKL	Caldecrin/chymotrypsin C is a novel secretory-type serine protease that was originally isolated as a serum calcium-decreasing factor from the pancreas. Previously, we reported that caldecrin suppressed the bone-resorbing activity of rabbit mature osteoclasts (Tomomura, A., Yamada, H., Fujimoto, K., Inaba, A., and Katoh, S. (2001) FEBS Lett. 508, 454-458). Here, we investigated the effects of caldecrin on mouse osteoclast differentiation induced by macrophage-colony stimulating factor and the receptor activator of NF-kappa B ligand (RANKL) from the monocyte/macrophage cell lineage of bone marrow cells. Wildtype and protease-deficient mutant caldecrin dose-dependently inhibited RANKL-stimulated tartrate-resistant acid phosphatase-positive osteoclast formation from bone marrow cells. Caldecrin did not affect macrophage colony formation from monocyte/macrophage lineage cells or osteoclast progenitor generation in cultures of bone marrow cells. Caldecrin inhibited accumulation of the RANKL-stimulated nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) mRNA in bone marrow cells, which is a key transcription factor for the differentiation of osteoclasts. Caldecrin also suppressed RANKL-induced differentiation of the RAW264.7 monocyte/macrophage cell line into osteoclasts. Caldecrin reduced the transcriptional activity of NFATc1 in RAW264.7 cells, whereas those of NF-kappa B and c-Fos, which are also transcription factors involved in osteoclast differentiation, were unaffected. Caldecrin inhibited RANKL-stimulated nuclear translocation of NFATc1 and the activity of the calcium/calmodulin-dependent phosphatase, calcineurin. Caldecrin inhibited phospholipase C gamma 1-mediated Ca2+ oscillation evoked by RANKL stimulation. RANKL-stimulated phosphorylation of spleen tyrosine kinase (Syk) was also attenuated by caldecrin. Taken together, these results indicate that caldecrin inhibits osteoclastogenesis, without its protease activity, by preventing a phospholipase C gamma 1-mediated Ca2+ oscillation-calcineurin-NFATc1 pathway.	[Tomomura, Mineko; Fujimoto, Kengo; Inaba, Akemi; Tomomura, Akito] Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, Sakado, Saitama 3500283, Japan; [Kido, Seisui; Kiyomura, Masaru; Kanegae, Haruhide] Meikai Univ, Sch Dent, Dept Human Dev & Fostering, Div Orthodont, Sakado, Saitama 3500283, Japan; Meikai Univ, Sch Dent, Grad Sch Dent, Dept Orthodont, Sakado, Saitama 3500283, Japan; [Tomomura, Mineko; Sakagami, Hiroshi] Meikai Univ, Sch Dent, Meikai Pharmacomed Lab, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University; Meikai University; Meikai University	Tomomura, M (corresponding author), Meikai Univ, Sch Dent, Dept Oral Biol & Tissue Engn, Div Biochem, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.	mineko-t@dent.meikai.ac.jp; atomomu@dent.meikai.ac.jp		Sakagami, Hiroshi/0000-0001-8001-2121	Ministry of Education, Culture, Sports, Science, and Technology of JAPAN [C14571773, C16591864]	Ministry of Education, Culture, Sports, Science, and Technology of JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C14571773 (to M. K.) and C16591864 (to A. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of JAPAN.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CHAMBERS TJ, 1984, J CELL SCI, V66, P383; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DE KP, 1998, SCIENCE, V279, P227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; HARRIS ML, 1992, PHARMACOL THERAPEUT, V53, P375, DOI 10.1016/0163-7258(92)90057-7; Hayashi S, 1997, J CELL PHYSIOL, V170, P241, DOI 10.1002/(SICI)1097-4652(199703)170:3<241::AID-JCP4>3.0.CO;2-O; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Raeder EMB, 1999, J IMMUNOL, V163, P6785; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; SZILYAGI L, 1998, HDB PROTEOLYTIC ENZY, P38; TAKAHASHI N, 2005, PRINCIPLES BONE BIOL, P109; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; TOMOMURA A, 1993, FEBS LETT, V335, P213, DOI 10.1016/0014-5793(93)80732-A; Tomomura A, 2001, FEBS LETT, V508, P454, DOI 10.1016/S0014-5793(01)03107-6; Tomomura A, 1996, FEBS LETT, V386, P26, DOI 10.1016/0014-5793(96)00377-8; Tomomura A, 1995, J BIOL CHEM, V270, P30315, DOI 10.1074/jbc.270.51.30315; TOMOMURA A, 1992, FEBS LETT, V301, P277, DOI 10.1016/0014-5793(92)80256-G; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; XU LX, 1995, J CELL PHYSIOL, V165, P624, DOI 10.1002/jcp.1041650321; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yoshino-Yasuda I, 1998, J BIOCHEM, V123, P546; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	53	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25448	25457		10.1074/jbc.M109.068742	http://dx.doi.org/10.1074/jbc.M109.068742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547767	hybrid, Green Published			2022-12-27	WOS:000280682400038
J	Schmidt, F; Treiber, N; Zocher, G; Bjelic, S; Steinmetz, MO; Kalbacher, H; Stehle, T; Dodt, G				Schmidt, Friederike; Treiber, Nora; Zocher, Georg; Bjelic, Sasa; Steinmetz, Michel O.; Kalbacher, Hubert; Stehle, Thilo; Dodt, Gabriele			Insights into Peroxisome Function from the Structure of PEX3 in Complex with a Soluble Fragment of PEX19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; ZELLWEGER-SYNDROME; IMPORT RECEPTOR; BIOGENESIS; COMPLEMENTATION; IDENTIFICATION; CHAPERONE; ABSENCE; CLONING	The human peroxins PEX3 and PEX19 play a central role in peroxisomal membrane biogenesis. The membrane-anchored PEX3 serves as the receptor for cytosolic PEX19, which in turn recognizes newly synthesized peroxisomal membrane proteins. After delivering these proteins to the peroxisomal membrane, PEX19 is recycled to the cytosol. The molecular mechanisms underlying these processes are not well understood. Here, we report the crystal structure of the cytosolic domain of PEX3 in complex with a PEX19-derived peptide. PEX3 adopts a novel fold that is best described as a large helical bundle. A hydrophobic groove at the membrane-distal end of PEX3 engages the PEX19 peptide with nanomolar affinity. Mutagenesis experiments identify phenylalanine 29 in PEX19 as critical for this interaction. Because key PEX3 residues involved in complex formation are highly conserved across species, the observed binding mechanism is of general biological relevance.	[Stehle, Thilo; Dodt, Gabriele] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Treiber, Nora] Univ Freiburg, Inst Organ Chem & Biochem, D-79106 Freiburg, Germany; [Bjelic, Sasa; Steinmetz, Michel O.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; University of Freiburg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de; gabriele.dodt@uni-tuebingen.de	Steinmetz, Michel O/AAA-3349-2022; Bjelic, Sasa/N-1348-2019; Bjelic, Sasa/G-6849-2011	Steinmetz, Michel O/0000-0001-6157-3687; Bjelic, Sasa/0000-0002-9805-3201; Bjelic, Sasa/0000-0002-9805-3201	Deutsche Forschungsgemeinschaft [Do492/2, SFB685]; BESSY (Berlin, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BESSY (Berlin, Germany)	This work was supported by Deutsche Forschungsgemeinschaft Grants Do492/2 (to G. D.) and SFB685 (to H. K.).; We thank the beamline staff of BESSY (Berlin, Germany) for support during data collection. The structure determination of PEX3 was initiated in the laboratory of Prof. Dr. Georg E. Schulz (University of Freiburg, Germany). ITC measurements of PEX3 with full-length PEX19 were carried out by Dr. Carsten Kintscher at the Max-Planck Institute for Developmental Biology in Tubingen, Germany.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huybrechts SJ, 2009, TRAFFIC, V10, P1722, DOI 10.1111/j.1600-0854.2009.00970.x; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kammerer S, 1998, FEBS LETT, V429, P53, DOI 10.1016/S0014-5793(98)00557-2; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Muntau AC, 2000, AM J HUM GENET, V67, P967, DOI 10.1086/303071; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2008, J BIOL CHEM, V283, P6136, DOI 10.1074/jbc.M706139200; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Toro A, 2007, BIOL RES, V40, P231, DOI 10.4067/S0716-97602007000200014; Toro AA, 2009, J CELL BIOCHEM, V107, P1083, DOI 10.1002/jcb.22210; TREIBER N, 2008, THESIS ALBERTLUDWIGS; Voorn-Brouwer T, 2001, J CELL SCI, V114, P2199; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424	55	43	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25410	25417		10.1074/jbc.M110.138503	http://dx.doi.org/10.1074/jbc.M110.138503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554521	Green Published, hybrid			2022-12-27	WOS:000280682400034
J	Abella, JV; Parachoniak, CA; Sangwan, V; Park, M				Abella, Jasmine V.; Parachoniak, Christine A.; Sangwan, Veena; Park, Morag			Dorsal Ruffle Microdomains Potentiate Met Receptor Tyrosine Kinase Signaling and Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MORPHOGENESIS DOWNSTREAM; EPIDERMAL-GROWTH-FACTOR; JUXTAMEMBRANE DOMAIN; PLASMA-MEMBRANE; BINDING-SITE; C-MET; MACROPINOCYTOSIS; PROTEIN; MUTATIONS; ENDOCYTOSIS	Dorsal ruffles are apical protrusions induced in response to many growth factors, yet their function is poorly understood. Here we report that downstream from the hepatocyte growth factor (HGF) receptor tyrosine kinase (RTK), Met, dorsal ruffles function as both a localized signaling microdomain as well as a platform from which the Met RTK internalizes and traffics to a degradative compartment. In response to HGF, colonies of epithelial Madin-Darby canine kidney cells form dorsal ruffles for up to 20 min. Met is transcytosed from the basolateral membrane on Rab4 endosomes, to the apical surface where Met, as well as a Met substrate and scaffold protein, Gab1, localize to the dorsal ruffle membrane. This results in activation of downstream signaling proteins, as evidenced by localization of phospho-ERK1/2 to dorsal ruffles. As dorsal ruffles collapse, Met is internalized into EEA1- and Rab5-positive endosomes and is targeted for degradation through delivery to an Hrs-positive sorting compartment. Enhancing HGF-dependent dorsal ruffle formation, through overexpression of Gab1 or activated Pak1 kinase, promotes more efficient degradation of the Met RTK. Conversely, the ablation of dorsal ruffle formation, by pre-treatment with SITS (4-acetamido-4'-isothiocyabatostilbene-2',2disulfonicacid) or expression of a Gab1 mutant, impairs Met degradation. Taken together, these data support a function for dorsal ruffles as a biologically relevant signaling microenvironment and a mechanism for Met receptor internalization and degradation.	McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Abella, Jasmine V.; Parachoniak, Christine A.; Sangwan, Veena; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), Room 511,1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	morag.park@mcgill.ca			United States Department of Defense Breast Cancer [DAMD17-99-1-9284]; Canadian Institutes of Health Research Canada Graduate Scholarship (CGS); Canadian Cancer Society Research Institute	United States Department of Defense Breast Cancer(United States Department of Defense); Canadian Institutes of Health Research Canada Graduate Scholarship (CGS)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by United States Department of Defense Breast Cancer Research Initiative Fellowship DAMD17-99-1-9284 (to J.V.A.), a Canadian Institutes of Health Research Canada Graduate Scholarship (CGS) Doctoral Award (to C.A.P.), and an operating grant from the Canadian Cancer Society Research Institute (to M.P.).	Abella JV, 2010, J CELL SCI, V123, P1306, DOI 10.1242/jcs.062570; Abella JV, 2009, AM J PHYSIOL-ENDOC M, V296, pE973, DOI 10.1152/ajpendo.90857.2008; Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Araki N, 2000, J CELL SCI, V113, P3329; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; CREPALDI T, 1994, J CELL BIOL, V125, P313, DOI 10.1083/jcb.125.2.313; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Frigault MM, 2008, J CELL PHYSIOL, V214, P694, DOI 10.1002/jcp.21264; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gibson A, 1998, J CELL BIOL, V143, P81, DOI 10.1083/jcb.143.1.81; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Grassart A, 2008, EMBO REP, V9, P356, DOI 10.1038/embor.2008.28; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lamorte L, 2002, J BIOL CHEM, V277, P37904, DOI 10.1074/jbc.M201743200; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Mohrmann K, 2002, J BIOL CHEM, V277, P10474, DOI 10.1074/jbc.M111237200; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wu RF, 2003, J BIOL CHEM, V278, P36830, DOI 10.1074/jbc.M302251200; Yamazaki T, 2002, J CELL SCI, V115, P1791	55	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24956	24967		10.1074/jbc.M110.127985	http://dx.doi.org/10.1074/jbc.M110.127985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529867	Green Published, hybrid			2022-12-27	WOS:000280542100068
J	Vaarmann, A; Gandhi, S; Abramov, AY				Vaarmann, Annika; Gandhi, Sonia; Abramov, Andrey Y.			Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; INTRACELLULAR CALCIUM; NEURONS; RELEASE; INHIBITION; METABOLISM; ACTIVATION; RECEPTORS; CHANNELS; CELLS	Dopamine is a neurotransmitter that plays a major role in a variety of brain functions, as well as in disorders such as Parkinson disease and schizophrenia. In cultured astrocytes, we have found that dopamine induces sporadic cytoplasmic calcium ([Ca2+](c)) signals. Importantly, we show that the dopamine-induced calcium signaling is receptor-independent in midbrain, cortical, and hippocampal astrocytes. We demonstrate that the calcium signal is initiated by the metabolism of dopamine by monoamine oxidase, which produces reactive oxygen species and induces lipid peroxidation. This stimulates the activation of phospholipase C and subsequent release of calcium from the endoplasmic reticulum via the inositol 1,4,5-trisphosphate receptor mechanism. These findings have major implications on the function of astrocytes that are exposed to dopamine and may contribute to understanding the physiological role of dopamine.	[Vaarmann, Annika; Gandhi, Sonia; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Vaarmann, Annika/AAH-7289-2021; Abramov, Andrey/AAC-6712-2019	Abramov, Andrey Y/0000-0002-7646-7235; Vaarmann, Annika/0000-0003-0296-8325; Abramov, Andrey/0000-0002-7646-7235	Parkinson&apos;s UK [F-0806] Funding Source: Medline; Parkinson&quot;s UK [F-0806] Funding Source: researchfish	Parkinson&apos;s UK(Parkinson&apos;s UK); Parkinson&quot;s UK(Parkinson&apos;s UK)		Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Abramov AY, 2003, J NEUROSCI, V23, P5088; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Cantuti-Castelvetri I, 1999, FREE RADICAL BIO MED, V27, P1393, DOI 10.1016/S0891-5849(99)00188-4; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Gonzalez A, 2006, NEUROCHEM RES, V31, P741, DOI 10.1007/s11064-006-9078-y; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hidalgo C, 2000, BIOL RES, V33, P113; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; LIN CW, 1995, MOL PHARMACOL, V47, P131; Liu J, 2009, CELL MOL NEUROBIOL, V29, P317, DOI 10.1007/s10571-008-9323-9; Matyash M, 2001, FASEB J, V15, P84, DOI 10.1096/fj.01-0380fje; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NEMEROFF CB, 1988, ANN NY ACAD SCI, V537, P273, DOI 10.1111/j.1749-6632.1988.tb42113.x; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Peuchen S, 1996, NEUROSCIENCE, V71, P871, DOI 10.1016/0306-4522(95)00515-3; Sulzer D, 2007, NEURON, V55, P8, DOI 10.1016/j.neuron.2007.06.023; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Tang TS, 2004, J BIOL CHEM, V279, P42082, DOI 10.1074/jbc.M407389200; Teschemacher AG, 2005, ADV DRUG DELIVER REV, V57, P79, DOI 10.1016/j.addr.2004.05.004; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009	27	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25018	25023		10.1074/jbc.M110.111450	http://dx.doi.org/10.1074/jbc.M110.111450			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20547771	Green Published, hybrid			2022-12-27	WOS:000280542100074
J	Patterson, ST; Reithmeier, RAF				Patterson, Sian T.; Reithmeier, Reinhart A. F.			Cell Surface Rescue of Kidney Anion Exchanger 1 Mutants by Disruption of Chaperone Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; N-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; MEMBRANE GLYCOPROTEIN; ERYTHROCYTE-MEMBRANE; ASIAN OVALOCYTOSIS; TRANSPORT PROTEIN; CYSTIC-FIBROSIS; IMPAIRED TRAFFICKING; MOLECULAR CHAPERONES	Mutations in the human kidney anion exchanger 1 (kAE1) membrane glycoprotein cause impaired urine acidification resulting in distal renal tubular acidosis (dRTA). Dominant and recessive dRTA kAE1 mutants exhibit distinct trafficking defects with retention in the endoplasmic reticulum (ER), Golgi, or mislocalization to the apical membrane in polarized epithelial cells. We examined the interaction of kAE1 with the quality control system responsible for the folding of membrane glycoproteins and the retention and degradation of misfolded mutants. Using small molecule inhibitors to disrupt chaperone interactions, two functional, dominant kAE1 mutants (R589H and R901stop), retained in the ER and targeted to the proteasome for degradation by ubiquitination, were rescued to the basolateral membrane of Madin-Darby canine kidney cells. In contrast, the Golgi-localized, recessive G701D and the severely misfolded, ER-retained dominant Southeast Asian ovalocytosis (SAO) mutants were not rescued. These results show that functional dRTA mutants are retained in the ER due to their interaction with molecular chaperones, particularly calnexin, and that disruption of these interactions can promote their escape from the ER and cell surface rescue.	[Patterson, Sian T.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, MSB5216,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca			Canadian Institutes of Health Research [MOP102493]; Faculty of Medicine, University of Toronto; NIH [P540-GM67082, P30-DK79307]; CIHR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine, University of Toronto(University of Toronto); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (MOP102493) from the Canadian Institutes of Health Research and funding from the Faculty of Medicine, University of Toronto. Development of reagents supplied by Jeff Brodsky (University of Pittsburgh) was supported by NIH Center Grants (P540-GM67082 and P30-DK79307).; Recipient of a studentship award from the CIHR Strategic Training Program in Membrane Proteins in Health and Disease.	Batlle D, 2001, ANNU REV MED, V52, P471, DOI 10.1146/annurev.med.52.1.471; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; CASEY JR, 1992, J BIOL CHEM, V267, P11940; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; Demaurex N., 2003, CALRETICULIN, P134; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Kameh H, 1998, BIOCHEM CELL BIOL, V76, P823, DOI 10.1139/bcb-76-5-823; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kittanakom S, 2008, BIOCHEM J, V410, P271, DOI 10.1042/BJ20070615; KOLLERTJONS A, 1993, AM J PHYSIOL, V265, pF813, DOI 10.1152/ajprenal.1993.265.6.F813; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; PIMPLIKAR SW, 1986, J BIOL CHEM, V261, P9770; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, BIOCHEM J, V368, P895, DOI 10.1042/BJ20020574; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Rodriguez-Soriano J, 2000, PEDIATR NEPHROL, V14, P1121, DOI 10.1007/s004670000407; Rungroj N, 2004, J BIOL CHEM, V279, P13833, DOI 10.1074/jbc.M400188200; SAMPSON HM, 2008, WILEY ENCY CHEM BIOL, P1; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; SCHOFIELD AE, 1992, NATURE, V355, P836, DOI 10.1038/355836a0; TAM LY, 1994, J BIOL CHEM, V269, P32542; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; TANNER MJA, 1988, BIOCHEM J, V256, P703, DOI 10.1042/bj2560703; Tanphaichitr VS, 1998, J CLIN INVEST, V102, P2173, DOI 10.1172/JCI4836; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wang Y, 2007, MOL MEMBR BIOL, V24, P65, DOI 10.1080/09687860600945263; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	53	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33423	33434		10.1074/jbc.M110.144261	http://dx.doi.org/10.1074/jbc.M110.144261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20628050	hybrid, Green Published			2022-12-27	WOS:000283048200077
J	Khorosjutina, O; Wanrooij, PH; Walfridsson, J; Szilagyi, Z; Zhu, XF; Baraznenok, V; Ekwall, K; Gustafsson, CM				Khorosjutina, Olga; Wanrooij, Paulina H.; Walfridsson, Julian; Szilagyi, Zsolt; Zhu, Xuefeng; Baraznenok, Vera; Ekwall, Karl; Gustafsson, Claes M.			A Chromatin-remodeling Protein Is a Component of Fission Yeast Mediator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHD1; SUBUNITS; CHROMODOMAINS; EXPRESSION; ACTIVATOR; COMPLEX; DOMAIN; GENES; SAGA	The multiprotein Mediator complex is an important regulator of RNA polymerase II-dependent genes in eukaryotic cells. In contrast to the situation in many other eukaryotes, the conserved Med15 protein is not a stable component of Mediator isolated from fission yeast. We here demonstrate that Med15 exists in a protein complex together with Hrp1, a CHD1 ATP-dependent chromatin-remodeling protein. The Med15-Hrp1 subcomplex is not a component of the core Mediator complex but can interact with the L-Mediator conformation. Deletion of med15(+) and hrp1(+) causes very similar effects on global steady-state levels of mRNA, and genome-wide analyses demonstrate that Med15 associates with a distinct subset of Hrp1-bound gene promoters. Our findings therefore indicate that Mediator may directly influence histone density at regulated promoters.	[Wanrooij, Paulina H.; Szilagyi, Zsolt; Zhu, Xuefeng; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; Karolinska Inst, Div Metab Dis, SE-14186 Stockholm, Sweden; [Walfridsson, Julian; Ekwall, Karl] Karolinska Inst, Dept Biosci & Med Nutr, SE-14186 Stockholm, Sweden; [Walfridsson, Julian; Ekwall, Karl] Univ Coll Sodertorn, Dept Life Sci, SE-14157 Huddinge, Sweden; [Gustafsson, Claes M.] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Sodertorn University; Max Planck Society	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se	Wanrooij, Paulina/R-1509-2019; Wanrooij, Paulina/C-6002-2012	Wanrooij, Paulina/0000-0002-8607-7564; Wanrooij, Paulina/0000-0002-8607-7564; Gustafsson, Claes/0000-0003-3531-8468; Ekwall, Karl/0000-0002-3029-4041	Swedish Cancer Society; Swedish Research Council; European Union (EU); "The Epigenome" Network of Excellence (NoE) network; EU Marie Curie Early Stage Training Center; Goran Gustafsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union (EU)(CGIAREuropean Commission); "The Epigenome" Network of Excellence (NoE) network; EU Marie Curie Early Stage Training Center; Goran Gustafsson Foundation	This work was supported by grants from Swedish Cancer Society (to K.E. and C.M.G.), Swedish Research Council (to K.E. and C.M.G.), the European Union (EU) "The Epigenome" Network of Excellence (NoE) network (to K.E.), the EU Marie Curie Early Stage Training Center "Mitomed-Train" (to P.H.W.), and the Goran Gustafsson Foundation (to C.M.G.).	Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lemieux K, 2008, BIOCHEM BIOPH RES CO, V369, P1103, DOI 10.1016/j.bbrc.2008.02.144; Linder T, 2008, NUCLEIC ACIDS RES, V36, P2489, DOI 10.1093/nar/gkn070; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Okuda M, 2007, J MOL BIOL, V365, P1047, DOI 10.1016/j.jmb.2006.10.039; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; SUZUKI Y, 1988, MOL CELL BIOL, V8, P4991, DOI 10.1128/MCB.8.11.4991; Tanaka N, 1998, BIOCHEM BIOPH RES CO, V245, P246, DOI 10.1006/bbrc.1998.8406; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xue YT, 2004, YEAST, V21, P25, DOI 10.1002/yea.1053; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	36	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29729	29737		10.1074/jbc.M110.153858	http://dx.doi.org/10.1074/jbc.M110.153858			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20622008	Green Published, hybrid			2022-12-27	WOS:000281984300008
J	Hao, Q; Yin, P; Yan, CY; Yuan, XQ; Li, WQ; Zhang, ZP; Liu, L; Wang, JW; Yan, NE				Hao, Qi; Yin, Ping; Yan, Chuangye; Yuan, Xiaoqiu; Li, Wenqi; Zhang, Zhiping; Liu, Lei; Wang, Jiawei; Yan, Nieng			Functional Mechanism of the Abscisic Acid Agonist Pyrabactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Pyrabactin is a synthetic abscisic acid (ABA) agonist that selectively inhibits seed germination. The use of pyrabactin was pivotal in the identification of the PYR1/PYL/RCAR family (PYL) of proteins as the ABA receptor. Although they both act through PYL proteins, pyrabactin and ABA share no apparent chemical or structural similarity. It remains unclear how pyrabactin functions as an ABA agonist. Here, we report the crystal structure of pyrabactin in complex with PYL1 at 2.4 angstrom resolution. Structural and biochemical analyses revealed that recognition of pyrabactin by the pocket residues precedes the closure of switch loop CL2. Structural comparison between pyrabactin- and ABA-bound PYL1 reveals a general principle in the arrangements of function groups of the two distinct ligands. The study provides a framework for the development of novel ABA agonists that may have applicable potentials in agriculture.	[Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Hao, Qi; Yin, Ping; Yuan, Xiaoqiu; Li, Wenqi; Yan, Nieng] Tsinghua Univ, Sch Med, Struct Biol Ctr, Beijing 100084, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Zhiping; Liu, Lei] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Rm C329,Med Sci Bldg, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918802]; Tsinghua University; Yuyuan Foundation; National Science Foundation of China [20932006]; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Foundation	This work was supported by Ministry of Science and Technology Grant 2009CB918802, Tsinghua University 985 Phase II funds, the Yuyuan Foundation, National Science Foundation of China Grant 20932006, and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEDOROFF NV, 2002, SCI STKE, pRE10; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; LESLIE AG, 1992, JOINT CCP4ESF EAMCB, V26; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Schroeder JI, 2006, CELL, V126, P1023, DOI 10.1016/j.cell.2006.09.001; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	18	39	47	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28946	28952		10.1074/jbc.M110.149005	http://dx.doi.org/10.1074/jbc.M110.149005			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20554531	Green Published, hybrid			2022-12-27	WOS:000281594000059
J	Georgieva, ER; Ramlall, TF; Borbat, PP; Freed, JH; Eliezer, D				Georgieva, Elka R.; Ramlall, Trudy F.; Borbat, Peter P.; Freed, Jack H.; Eliezer, David			The Lipid-binding Domain of Wild Type and Mutant alpha-Synuclein COMPACTNESS AND INTERCONVERSION BETWEEN THE BROKEN AND EXTENDED HELIX FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIR DISTANCE DISTRIBUTIONS; PARKINSONS-DISEASE; MEMBRANE INTERACTIONS; RESIDUAL STRUCTURE; PROTEIN; DYNAMICS; ESR; VESICLES; EPR; NMR	alpha-Synuclein (alpha S) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three alpha S point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of alpha S is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Upon binding to vesicles, alpha S undergoes a structural reorganization from a dynamic and disordered ensemble to a conformation consisting of a long extended helix. In the presence of small spheroidal detergent micelles, however, this extended helix conformation can convert into a broken helix state, in which a region near the middle of the helix unwinds to form a linker between the two resulting separated helices. Membrane-bound conformations of alpha S likely mediate the function of the protein, but may also play a role in the aggregation and toxicity of the protein. Here we have undertaken a study of the effects of the three known PD-linked mutations on the detergent-and membrane-bound conformations of alpha S, as well as factors that govern the transition of the protein between the extended helix and broken helix states. Using pulsed dipolar ESR measurements of distances up to 8.7 nm, we show that all three PD-linked alpha S mutants retain the ability to transition from the broken helix to the extended helix conformation. In addition, we find that the ratio of protein to detergent, rather than just the absolute detergent concentration, determines whether the protein adopts the broken or extended helix conformation.	[Georgieva, Elka R.; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Ramlall, Trudy F.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Ramlall, Trudy F.; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Freed, JH (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jhf3@cornell.edu; dae2005@med.cornell.edu	Borbat, Petr P/A-8658-2014; Georgieva, Elka R./AAA-6785-2021; borbat, peter/B-1616-2016	Georgieva, Elka R./0000-0001-9980-5260	National Institutes of Health, NIA [AG019391, AG025440]; National Institutes of Health, NCRR [P41-RR016242]; National Institutes of Health, NIBIB [EB03150]; Irma T. Hirschl Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR016292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025440, R01AG019391, R37AG019391] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Irma T. Hirschl Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG019391 and AG025440 (to D. E.) from the NIA and NCRR P41-RR016242 and NIBIB EB03150 (to J. H. F.), the Irma T. Hirschl Foundation, and a gift from Herbert and Ann Siegel (to D. E.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bhatnagar J, 2007, METHOD ENZYMOL, V423, P117, DOI 10.1016/S0076-6879(07)23004-6; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Boettcher JM, 2008, BIOCHEMISTRY-US, V47, P12357, DOI 10.1021/bi801450t; Borbat P.P., 2007, EPR NEWSLETTER, V17, P21; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Borbat PP, 2007, METHOD ENZYMOL, V423, P52, DOI 10.1016/S0076-6879(07)23003-4; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer D, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P575, DOI 10.1016/B978-0-12-374028-1.00042-7; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Madine J, 2006, BIOCHEMISTRY-US, V45, P5783, DOI 10.1021/bi052151q; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; RAO IV, 1987, J COLLOID INTERF SCI, V119, P211, DOI 10.1016/0021-9797(87)90261-X; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Upadhyay AK, 2008, BIOCHEMISTRY-US, V47, P1554, DOI 10.1021/bi7021377; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	77	104	104	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28261	28274		10.1074/jbc.M110.157214	http://dx.doi.org/10.1074/jbc.M110.157214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592036	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000281404100069
J	Mezo, AR; Sridhar, V; Badger, J; Sakorafas, P; Nienaber, V				Mezo, Adam R.; Sridhar, Vandana; Badger, John; Sakorafas, Paul; Nienaber, Vicki			X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERFACES; IMMUNOGLOBULIN-G; 2.8 ANGSTROM; BINDING; IGG; MECHANISM; HORMONE	The neonatal Fc receptor, FcRn, is responsible for the long half-life of IgG molecules in vivo and is a potential therapeutic target for the treatment of autoimmune diseases. A family of peptides comprising the consensus motif GHFGGXY, where X is preferably a hydrophobic amino acid, was shown previously to inhibit the human IgG: human FcRn protein-protein interaction (Mezo, A. R., McDonnell, K. A., Tan Hehir, C. A., Low, S. C., Palombella, V. J., Stattel, J. M., Kamphaus, G. D., Fraley, C., Zhang, Y., Dumont, J. A., and Bitonti, A. J. (2008) Proc. Natl. Acad. Sci. U.S.A., 105, 2337-2342). Herein, the x-ray crystal structure of a representative monomeric peptide in complex with human FcRn was solved to 2.6 angstrom resolution. The structure shows that the peptide binds to human FcRn at the same general binding site as does the Fc domain of IgG. The data correlate well with structure-activity relationship data relating to how the peptide family binds to human FcRn. In addition, the x-ray crystal structure of a representative dimeric peptide in complex with human FcRn shows how the bivalent ligand can bridge two FcRn molecules, which may be relevant to the mechanism by which the dimeric peptides inhibit FcRn and increase IgG catabolism in vivo. Modeling of the peptide: FcRn structure as compared with available structural data on Fc and FcRn suggest that the His-6 and Phe-7 (peptide) partially mimic the interaction of His-310 and Ile-253 (Fc) in binding to FcRn, but using a different backbone topology.	[Mezo, Adam R.; Sakorafas, Paul] Biogen Idec Inc, Syntonix Subsidiary, Waltham, MA 02451 USA; [Sridhar, Vandana; Badger, John; Nienaber, Vicki] Zenobia Therapeut, La Jolla, CA 92037 USA	Biogen	Mezo, AR (corresponding author), 9 4th Ave, Waltham, MA 02451 USA.	adam.mezo@biogenidec.com						Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Collaborative Computational Project, 1994, ACTA CRYST D, V50, P760; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; GASTINEL LN, 2005, Patent No. 5623053; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu Z, 1997, J EXP MED, V186, P777, DOI 10.1084/jem.186.5.777; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Low SC, 2009, AAPS J, V11, P432, DOI 10.1208/s12248-009-9120-5; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonnell KA, 2010, J MED CHEM, V53, P1587, DOI 10.1021/jm901128z; Mezo AR, 2008, BIOORGAN MED CHEM, V16, P6394, DOI 10.1016/j.bmc.2008.05.004; Mezo AR, 2008, P NATL ACAD SCI USA, V105, P2337, DOI 10.1073/pnas.0708960105; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; *RIG AM CORP, 2008, MIFIT 8 MAN; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	33	33	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27694	27701		10.1074/jbc.M110.120667	http://dx.doi.org/10.1074/jbc.M110.120667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592032	Green Published, hybrid			2022-12-27	WOS:000281404100025
J	Mizutani, T; Yazawa, T; Ju, YF; Imamichi, Y; Uesaka, M; Inaoka, Y; Matsuura, K; Kamiki, Y; Oki, M; Umezawa, A; Miyamoto, K				Mizutani, Tetsuya; Yazawa, Takashi; Ju, Yunfeng; Imamichi, Yoshitaka; Uesaka, Miki; Inaoka, Yoshihiko; Matsuura, Kaoru; Kamiki, Yasue; Oki, Masaya; Umezawa, Akihiro; Miyamoto, Kaoru			Identification of a Novel Distal Control Region Upstream of the Human Steroidogenic Acute Regulatory Protein (StAR) Gene That Participates in SF-1-dependent Chromatin Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; ELEMENT-BINDING-PROTEIN; LIPOID ADRENAL-HYPERPLASIA; OVARIAN GRANULOSA-CELLS; MESENCHYMAL STEM-CELLS; FACTOR-I; NUCLEAR RECEPTOR; TRANSCRIPTIONAL REGULATION; PROMOTER ACTIVITY; HISTONE MODIFICATIONS	StAR (steroidogenic acute regulatory protein) mediates the transport of cholesterol from the outer to the inner mitochondrial membrane, the process of which is the rate-limiting step for steroidogenesis. Transcriptional regulation of the proximal promoter of the human StAR gene has been well characterized, where as analysis of its distal control region has not. Recently, we found that SF-1 (steroidogenic factor 1) induced the differentiation of mesenchymal stem cells (MSCs) into steroidogenic cells with the concomitant strong induction of StAR expression. Here, we show, using differentiated MSCs, that StAR expression is regulated by a novel distal control region. Using electrophoretic mobility shift (EMSA) and chromatin immunoprecipitation (ChIP) assays, we identified novel SF-1 binding sites between 3,000 and 3,400 bp upstream of StAR. A luciferase reporter assay revealed that the region worked as a strong regulator to exert maximal transcription of StAR. ChIP analysis of histone H3 revealed that upon SF-1 expression, nucleosome eviction took place at the SF-1 binding sites, not only in the promoter but also in the distal SF-1 binding sites. Chromosome conformation capture analysis revealed that the region upstream of StAR formed a chromatin loop both in the differentiated MSCs and in KGN cells, a human granulosa cell tumor cell line, where SF-1 is endogenously expressed. Finally, SF-1 knockdown resulted in disrupted formation of this chromatin loop in KGN cells. These results indicate that the novel distal control region participate in StAR activation through SF-1 dependent alterations of chromatin structure, including histone eviction and chromatin loop formation.	[Mizutani, Tetsuya; Yazawa, Takashi; Ju, Yunfeng; Imamichi, Yoshitaka; Uesaka, Miki; Inaoka, Yoshihiko; Matsuura, Kaoru; Kamiki, Yasue; Miyamoto, Kaoru] Univ Fukui, Fac Med Sci, Dept Biochem, Eiheiji, Fukui 9101193, Japan; [Mizutani, Tetsuya; Yazawa, Takashi; Oki, Masaya; Miyamoto, Kaoru] Univ Fukui, Org Life Sci Adv Programs, Translat Res Ctr, Eiheiji, Fukui 9101193, Japan; [Oki, Masaya] Univ Fukui, Fac Engn, Dept Appl Chem & Biotechnol, Eiheiji, Fukui 9101193, Japan; [Oki, Masaya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	University of Fukui; University of Fukui; University of Fukui; Japan Science & Technology Agency (JST); National Center for Child Health & Development - Japan	Miyamoto, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Biochem, Eiheiji, Fukui 9101193, Japan.	kmiyamot@u-fukui.ac.jp	Yazawa, Takashi/AEZ-6785-2022	Yazawa, Takashi/0000-0003-4526-6585	Health and Labor Sciences Research; Ministry of Education, Culture, Sports, Science and Culture; Yamaguchi Endocrine Research Foundation; Japan Science and Technology Agency	Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi Endocrine Research Foundation; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from Health and Labor Sciences Research; a grant from the Ministry of Education, Culture, Sports, Science and Culture; the Yamaguchi Endocrine Research Foundation; and the Precursory Research for Embryonic Science and Technology program from the Japan Science and Technology Agency.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; AEsoy R, 2002, ENDOCRINOLOGY, V143, P295, DOI 10.1210/en.143.1.295; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; Chen WY, 2005, MOL CELL BIOL, V25, P10442, DOI 10.1128/MCB.25.23.10442-10453.2005; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Christenson LK, 1999, J BIOL CHEM, V274, P26591, DOI 10.1074/jbc.274.37.26591; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; LaVoie HA, 1999, ENDOCRINOLOGY, V140, P146, DOI 10.1210/en.140.1.146; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; LUO XR, 1995, ENDOCR RES, V21, P517, DOI 10.3109/07435809509030469; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; Mizutani T, 2000, J BIOL CHEM, V275, P22512, DOI 10.1074/jbc.M001631200; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rusovici R, 2005, BIOL REPROD, V72, P862, DOI 10.1095/biolreprod.104.034298; Rust W, 1998, J MOL ENDOCRINOL, V21, P189, DOI 10.1677/jme.0.0210189; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Sandhoff TW, 1998, ENDOCRINOLOGY, V139, P4820, DOI 10.1210/en.139.12.4820; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P1525, DOI 10.1210/en.142.4.1525; Shimizu T, 2009, MOL CELL BIOCHEM, V328, P41, DOI 10.1007/s11010-009-0072-y; Silverman E, 1999, J BIOL CHEM, V274, P17987, DOI 10.1074/jbc.274.25.17987; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wooton-Kee CR, 2000, ENDOCRINOLOGY, V141, P1345, DOI 10.1210/en.141.4.1345; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Yazawa T, 2003, ENDOCRINOLOGY, V144, P1920, DOI 10.1210/en.2002-221070; Yazawa T, 2006, ENDOCRINOLOGY, V147, P4104, DOI 10.1210/en.2006-0162; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Yazawa T, 2009, ENDOCRINOLOGY, V150, P3885, DOI 10.1210/en.2008-1310; Yoshino M, 2002, BIOL REPROD, V66, P1813, DOI 10.1095/biolreprod66.6.1813; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200	64	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28240	28251		10.1074/jbc.M110.129510	http://dx.doi.org/10.1074/jbc.M110.129510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601698	Green Published, hybrid			2022-12-27	WOS:000281404100067
J	Rooijakkers, SHM; Rasmussen, SL; McGillivray, SM; Bartnikas, TB; Mason, AB; Friedlander, AM; Nizet, V				Rooijakkers, Suzan H. M.; Rasmussen, Suzanne L.; McGillivray, Shauna M.; Bartnikas, Thomas B.; Mason, Anne B.; Friedlander, Arthur M.; Nizet, Victor			Human Transferrin Confers Serum Resistance against Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INNATE IMMUNITY; LETHAL TOXIN; IRON; BACTERIAL; LACTOFERRIN; MICE; ACQUISITION; COMPLEMENT; VIRULENCE	The innate immune system in humans consists of both cellular and humoral components that collaborate to eradicate invading bacteria from the body. Here, we discover that the Gram-positive bacterium Bacillus anthracis, the causative agent of anthrax, does not grow in human serum. Fractionation of serum by gel filtration chromatography led to the identification of human transferrin as the inhibiting factor. Purified transferrin blocks growth of both the fully virulent encapsulated B. anthracis Ames and the non-encapsulated Sterne strain. Growth inhibition was also observed in serum of wild-type mice but not of hypotransferrinemic mice that only have similar to 1% circulating transferrin levels. We were able to definitely assign the bacteriostatic activity of transferrin to its iron-binding function: neither iron-saturated transferrin nor a recombinant transferrin mutant unable to bind iron could inhibit growth of B. anthracis. Additional iron could restore bacterial growth in human serum. The observation that other important Gram-positive pathogens are not inhibited by transferrin suggests they have evolved effective mechanisms to circumvent serum iron deprivation. These findings provide a better understanding of human host defense mechanisms against anthrax and provide a mechanistic basis for the antimicrobial activity of human transferrin.	[Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Rasmussen, Suzanne L.; Friedlander, Arthur M.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Bartnikas, Thomas B.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mason, Anne B.] Univ Vermont, Dept Biochem, Coll Med, Burlington, VT 05405 USA; [Nizet, Victor] Rady Childrens Hosp, San Diego, CA 92123 USA	Utrecht University; Utrecht University Medical Center; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; University of Vermont; Rady Childrens Hospital San Diego	Rooijakkers, SHM (corresponding author), Univ Med Ctr Utrecht, G04-614, NL-3584 CX Utrecht, Netherlands.	s.h.m.rooijakkers@umcutrecht.nl	Nizet, Victor/AAF-3190-2019; Mason, Anne B/A-6754-2008; McGillivray, Shauna/AAN-3074-2021	McGillivray, Shauna/0000-0002-8863-1522; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, DK084122-01, DK21739]; European Organization of Molecular Biology (EMBO); NIGMS [GM068524]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK084122, R01DK021739, R56DK021739, K99DK084122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Organization of Molecular Biology (EMBO)(European Molecular Biology Organization (EMBO)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grants AI077780 (to V. N.), DK084122-01 (to T. B. B.), and DK21739 (to A. B. M.). This work was also supported by the European Organization of Molecular Biology (EMBO) (to S. H. M. R.).; Supported by an IRACDA postdoctoral fellowship from NIGMS (GM068524) and a Biomedical Research Fellowship from The Hartwell Foundation.	Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Aguilera O, 2003, FEBS LETT, V548, P5, DOI 10.1016/S0014-5793(03)00719-1; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; BEZKOROVAINY A, 1982, ADV EXP MED BIOL, V135, P139; Bischof TS, 2007, J INFECT DIS, V195, P888, DOI 10.1086/511824; BULLEN JJ, 1974, INFECT IMMUN, V10, P443, DOI 10.1128/IAI.10.3.443-450.1974; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cornelissen CN, 2003, FRONT BIOSCI-LANDMRK, V8, pD836, DOI 10.2741/1076; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Harvill ET, 2005, INFECT IMMUN, V73, P4420, DOI 10.1128/IAI.73.7.4420-4422.2005; Jeffrey PD, 1998, BIOCHEMISTRY-US, V37, P13978, DOI 10.1021/bi9812064; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Lisanby MW, 2008, J IMMUNOL, V181, P4989, DOI 10.4049/jimmunol.181.7.4989; Mason AB, 2004, PROTEIN EXPRES PURIF, V36, P318, DOI 10.1016/j.pep.2004.04.013; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; McGillivray SM, 2009, J INNATE IMMUN, V1, P494, DOI 10.1159/000225955; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; ORAM JD, 1968, BIOCHIM BIOPHYS ACTA, V170, P351, DOI 10.1016/0304-4165(68)90015-9; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; ROSSING N, 1981, CLIN PHYSIOL, V1, P275, DOI 10.1111/j.1475-097X.1981.tb00896.x; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; VALENTI P, 1982, ANTIMICROB AGENTS CH, V21, P840, DOI 10.1128/AAC.21.5.840; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Wally J, 2007, BIOMETALS, V20, P249, DOI 10.1007/s10534-006-9062-7; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WILLIAMS J, 1980, BIOCHEM J, V185, P483, DOI 10.1042/bj1850483	42	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27609	27613		10.1074/jbc.M110.154930	http://dx.doi.org/10.1074/jbc.M110.154930			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615872	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000281404100016
J	Pinheiro, AS; Proell, M; Eibl, C; Page, R; Schwarzenbacher, R; Peti, W				Pinheiro, Anderson S.; Proell, Martina; Eibl, Clarissa; Page, Rebecca; Schwarzenbacher, Robert; Peti, Wolfgang			Three-dimensional Structure of the NLRP7 Pyrin Domain INSIGHT INTO PYRIN-PYRIN-MEDIATED EFFECTOR DOMAIN SIGNALING IN INNATE IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; NF-KAPPA-B; REPRODUCTIVE WASTAGE; HYDATIDIFORM MOLES; PROTEIN; DEATH; MUTATIONS; APOPTOSIS; DYNAMICS; NALP7	The innate immune system provides an initial line of defense against infection. Nucleotide-binding domain-and leucine-rich repeat-containing protein (NLR or (NOD-like)) receptors play a critical role in the innate immune response by surveying the cytoplasm for traces of intracellular invaders and endogenous stress signals. NLRs themselves are multi-domain proteins. Their N-terminal effector domains (typically a pyrin or caspase activation and recruitment domain) are responsible for driving downstream signaling and initiating the formation of inflammasomes, multi-component complexes necessary for cytokine activation. However, the currently available structures of NLR effector domains have not yet revealed the mechanism of their differential modes of interaction. Here, we report the structure and dynamics of the N-terminal pyrin domain of NLRP7 (NLRP7 PYD) obtained by NMR spectroscopy. The NLRP7 PYD adopts a six-alpha-helix bundle death domain fold. A comparison of conformational and dynamics features of the NLRP7 PYD with other PYDs showed distinct differences for helix alpha 3 and loop alpha 2-alpha 3, which, in NLRP7, is stabilized by a strong hydrophobic cluster. Moreover, the NLRP7 and NLRP1 PYDs have different electrostatic surfaces. This is significant, because death domain signaling is driven by electrostatic contacts and stabilized by hydrophobic interactions. Thus, these results provide new insights into NLRP signaling and provide a first molecular understanding of inflammasome formation.	[Pinheiro, Anderson S.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Proell, Martina; Eibl, Clarissa; Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Brown University; Brown University; Salzburg University	Peti, W (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	wolfgang_peti@brown.edu	Peti, Wolfgang/L-3492-2014; Pinheiro, Anderson/AAL-5299-2021; Pinheiro, Anderson S/B-6350-2014	Pinheiro, Anderson/0000-0001-5118-6931; Eibl, Clarissa/0000-0001-8248-5133	National Institutes of Health [R01NS056128, S10-RR017269]; European Union [MCEXT-033534]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS056128 (to W. P.) and S10-RR017269. This work was also supported by the European Union Grant MCEXT-033534 (to R. S.).	Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deveault C, 2009, HUM MOL GENET, V18, P888, DOI 10.1093/hmg/ddn418; Djuric U, 2006, HUM GENET, V120, P390, DOI 10.1007/s00439-006-0192-3; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Espejo F, 2006, BIOCHEM BIOPH RES CO, V340, P860, DOI 10.1016/j.bbrc.2005.12.087; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kinoshita T, 2006, INT IMMUNOL, V18, P1701, DOI 10.1093/intimm/dxl104; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lich JD, 2007, MICROBES INFECT, V9, P672, DOI 10.1016/j.micinf.2007.01.018; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Ohno S, 2008, ANTICANCER RES, V28, P2493; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; PALMER AG, 1992, J AM CHEM SOC, V114, P9059, DOI 10.1021/ja00049a043; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pelupessy P, 2003, J MAGN RESON, V161, P258, DOI 10.1016/S1090-7807(02)00190-8; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pinheiro AD, 2009, BIOMOL NMR ASSIGN, V3, P207, DOI 10.1007/s12104-009-9176-2; Puechberty J, 2009, CLIN GENET, V75, P298, DOI 10.1111/j.1399-0004.2008.01098.x; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Slim R, 2007, CLIN GENET, V71, P25, DOI 10.1111/j.1399-0004.2006.00697.x; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Staub E, 2001, TRENDS BIOCHEM SCI, V26, P83, DOI 10.1016/S0968-0004(00)01717-5; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang CY, 2003, MAGN RESON CHEM, V41, P866, DOI 10.1002/mrc.1262; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Yeretssian G, 2008, CYTOKINE, V43, P380, DOI 10.1016/j.cyto.2008.07.015; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	63	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27402	27410		10.1074/jbc.M110.113191	http://dx.doi.org/10.1074/jbc.M110.113191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20547486	hybrid, Green Published			2022-12-27	WOS:000281172700069
J	Chen, X; Lu, L; Qi, Z; Lu, H; Wang, J; Yu, XX; Chen, YH; Jiang, SB				Chen, Xi; Lu, Lu; Qi, Zhi; Lu, Hong; Wang, Ji; Yu, Xiaoxia; Chen, Yinghua; Jiang, Shibo			Novel Recombinant Engineered gp41 N-terminal Heptad Repeat Trimers and Their Potential as Anti-HIV-1 Therapeutics or Microbicides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INHIBITORS TARGETING GP41; HIV-1 TRANSMEMBRANE GLYCOPROTEIN; D-PEPTIDE INHIBITORS; FUSION INHIBITOR; COILED-COIL; ENTRY INHIBITORS; CORE STRUCTURE; ENFUVIRTIDE RESISTANCE; ENVELOPE GLYCOPROTEINS	Peptides derived from N-terminal heptad repeat (NHR) of the HIV-1 gp41 are generally poor inhibitors of HIV-1 entry, because they tend to aggregate and do not form a trimeric coiled-coil. In this study, we have fused portions of gp41 NHR, e. g. N36 or N28, to the T4 fibritin trimerization domain, Foldon (Fd), thus constructing novel NHR trimers, designated N36Fd or N28Fd, which could be expressed in Escherichia coli cells. The purified N36Fd and N28Fd exhibited SDS-resistant trimeric coiled-coil conformation with improved alpha-helicity compared with the corresponding N-peptides. They could interact with a C-peptide (e.g. C34) to form stable six-helix bundle and possessed potent anti-HIV-1 activity against a broad spectrum of HIV-1 strains. N28Fd was effective against T20-resistant HIV-1 variants and more resistant to proteinase K compared with T20 (enfuvirtide), a C-peptide-based HIV fusion inhibitor. Therefore, N28Fd trimer has great potentials for further development as an affordable therapeutic or microbicide for treatment and prevention of HIV-1 infection.	[Chen, Xi; Wang, Ji; Chen, Yinghua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chen, Xi; Lu, Lu; Qi, Zhi; Lu, Hong; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Yu, Xiaoxia] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; New York Blood Center; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, YH (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chenyh@mail.tsinghua.edu.cn; sjiang@nybloodcenter.org	Lu, Lu/K-7070-2014; chen, ying/HHS-8254-2022; lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135	National Institutes of Health [AI046221]; China Scholarship Council [973-2006CB504203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S.J.). This work was also supported by Grant 973-2006CB504203 (to Y.C.) and a scholarship from the China Scholarship Council (to X.C.).	Antonelli G, 1999, EUR CYTOKINE NETW, V10, P413; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Cai LF, 2007, ANTIMICROB AGENTS CH, V51, P2388, DOI 10.1128/AAC.00150-07; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Hanley JP, 1998, LEUKEMIA LYMPHOMA, V29, P257, DOI 10.3109/10428199809068563; Harrison PF, 2003, CLIN INFECT DIS, V36, P1290, DOI 10.1086/374834; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Holguin A, 2007, AIDS RES HUM RETROV, V23, P1067, DOI 10.1089/aid.2006.0256; Huang JH, 2007, BIOCHEM J, V403, P565, DOI 10.1042/BJ20061275; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jacobs A, 2004, PROTEIN SCI, V13, P2811, DOI 10.1110/ps.04916704; Jenabian MA, 2009, J ANTIMICROB CHEMOTH, V64, P1192, DOI 10.1093/jac/dkp380; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Laue T, 2001, CURR OPIN STRUC BIOL, V11, P579, DOI 10.1016/S0959-440X(00)00250-5; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2004, CURR PHARM DESIGN, V10, P1827, DOI 10.2174/1381612043384466; Liu SW, 2003, J BIOMOL SCREEN, V8, P685, DOI 10.1177/1087057103259155; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Veazey RS, 2008, P NATL ACAD SCI USA, V105, P10531, DOI 10.1073/pnas.0802666105; Walmsley S, 2003, J INFECT DIS, V188, P1827, DOI 10.1086/379810; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu Y, 2007, J ORG CHEM, V72, P6700, DOI 10.1021/jo070836l; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yap ML, 2010, J MOL BIOL, V395, P349, DOI 10.1016/j.jmb.2009.10.071; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	64	47	55	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25506	25515		10.1074/jbc.M110.101170	http://dx.doi.org/10.1074/jbc.M110.101170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538590	hybrid, Green Published			2022-12-27	WOS:000280682400044
J	Deng, XY; Lee, J; Michael, AJ; Tomchick, DR; Goldsmith, EJ; Phillips, MA				Deng, Xiaoyi; Lee, Jeongmi; Michael, Anthony J.; Tomchick, Diana R.; Goldsmith, Elizabeth J.; Phillips, Margaret A.			Evolution of Substrate Specificity within a Diverse Family of beta/alpha-Barrel-fold Basic Amino Acid Decarboxylases X-RAY STRUCTURE DETERMINATION OF ENZYMES WITH SPECIFICITY FOR L-ARGININE AND CARBOXYNORSPERMIDINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC ORNITHINE DECARBOXYLASES; MULTIPLE PROTEIN-SEQUENCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DIAMINOPIMELATE DECARBOXYLASE; TRYPANOSOMA-BRUCEI; STRUCTURE ALIGNMENTS; VIBRIO-CHOLERAE; BINDING; CRYSTALLIZATION	Pyridoxal 5'-phosphate (PLP)-dependent basic amino acid decarboxylases from the beta/alpha-barrel-fold class (group IV) exist in most organisms and catalyze the decarboxylation of diverse substrates, essential for polyamine and lysine biosynthesis. Herein we describe the first x-ray structure determination of bacterial biosynthetic arginine decarboxylase (ADC) and carboxynorspermidine decarboxylase (CANSDC) to 2.3- and 2.0-angstrom resolution, solved as product complexes with agmatine and norspermidine. Despite low overall sequence identity, the monomeric and dimeric structures are similar to other enzymes in the family, with the active sites formed between the beta/alpha-barrel domain of one subunit and the beta-barrel of the other. ADC contains both a unique interdomain insertion (4-helical bundle) and a C-terminal extension (3-helical bundle) and it packs as a tetramer in the asymmetric unit with the insertions forming part of the dimer and tetramer interfaces. Analytical ultracentrifugation studies confirmed that the ADC solution structure is a tetramer. Specificity for different basic amino acids appears to arise primarily from changes in the position of, and amino acid replacements in, a helix in the beta-barrel domain we refer to as the "specificity helix." Additionally, in CANSDC a key acidic residue that interacts with the distal amino group of other substrates is replaced by Leu(314), which interacts with the aliphatic portion of norspermidine. Neither product, agmatine in ADC nor norspermidine in CANSDC, form a Schiff base to pyridoxal 5'-phosphate, suggesting that the product complexes may promote product release by slowing the back reaction. These studies provide insight into the structural basis for the evolution of novel function within a common structural-fold.	[Deng, Xiaoyi; Michael, Anthony J.; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Tomchick, Diana R.; Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lee, Jeongmi] Sungkyunkwan Univ, Coll Pharm, Suwon 440747, Gyeonggi Do, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sungkyunkwan University (SKKU)	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Lee, Jeongmi/AAJ-7720-2020; Tomchick, Diana/HGV-2018-2022; Deng, Xiaoyi/E-4394-2011	Lee, Jeongmi/0000-0002-9948-7554; Tomchick, Diana/0000-0002-7529-4643	National Institutes of Health [R01AI34432, R37AI34432]; Welch Foundation [I-1257]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034432, R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI34432 and R37AI34432 (to M. A. P.) and Welch Foundation Grant I-1257 (to M. A. P.).; We thank Bruce Pearson of the Institute of Food Research, Norwich, for the C. jejuni CANSDC clone. The structures described in this report were derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fries D.S., 2003, BURGERS MED CHEM DRU, P1033; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Liu XY, 2009, ACTA CRYSTALLOGR F, V65, P282, DOI 10.1107/S1744309109003856; MOMANY C, 1995, PROTEIN SCI, V4, P849; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osterman AL, 1997, BIOCHEMISTRY-US, V36, P4558, DOI 10.1021/bi962916h; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; OSTERMAN AL, 1995, J BIOL CHEM, V270, P11797, DOI 10.1074/jbc.270.20.11797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Patel CN, 2004, ACTA CRYSTALLOGR D, V60, P2396, DOI 10.1107/S0907444904027180; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Poole AM, 2006, CURR OPIN STRUC BIOL, V16, P508, DOI 10.1016/j.sbi.2006.06.013; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; RODRIGUEZ BR, 1994, ACTA CRYSTALLOGR D, V50, P175, DOI 10.1107/S0907444993009989; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Song JP, 2010, MOL BIOL REP, V37, P1823, DOI 10.1007/s11033-009-9617-0; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Weyand Simone, 2009, Journal of Structural and Functional Genomics, V10, P209, DOI 10.1007/s10969-009-9065-z; YAMAMOTO S, 1994, MICROBIOL-UK, V140, P3117, DOI 10.1099/13500872-140-11-3117	51	22	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25708	25719		10.1074/jbc.M110.121137	http://dx.doi.org/10.1074/jbc.M110.121137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534592	Green Published, hybrid			2022-12-27	WOS:000280682400064
J	Chen, QA; Pinon, DI; Miller, LJ; Dong, MQ				Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing			Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor A REGION CRITICAL FOR BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOAFFINITY CROSS-LINKING; PROTEIN-COUPLED-RECEPTOR; 1ST EXTRACELLULAR LOOP; CORTICOTROPIN-RELEASING-FACTOR; PARATHYROID-HORMONE PTH; CALCITONIN RECEPTOR; SECRETIN RECEPTOR; AGONIST-BINDING; MOLECULAR RECOGNITION; DIRECT IDENTIFICATION	Understanding the molecular basis of natural ligand binding and activation of the glucagon-like peptide 1 (GLP1) receptor may facilitate the development of agonist drugs useful for the management of type 2 diabetes mellitus. We previously reported molecular approximations between carboxyl-terminal residues 24 and 35 within GLP1 and its receptor. In this work, we have focused on the amino-terminal region of GLP1, known to be critical for receptor activation. We developed two high-affinity, full agonist photolabile GLP1 probes having sites of covalent attachment in positions 6 and 12 of the 30-residue peptide (GLP1(7-36)). Both probes bound to the receptor specifically and covalently labeled single distinct sites. Chemical and protease cleavage of the labeled receptor identified the juxtamembrane region of its amino-terminal domain as the region of covalent attachment of the position 12 probe, whereas the region of labeling by the position 6 probe was localized to the first extracellular loop. Radiochemical sequencing identified receptor residue Tyr(145), adjacent to the first transmembrane segment, as the site of labeling by the position 12 probe, and receptor residue Tyr(205), within the first extracellular loop, as the site of labeling by the position 6 probe. These data provide support for a common mechanism for natural ligand binding and activation of family B G protein-coupled receptors. This region of interaction of peptide amino-terminal domains with the receptor may provide a pocket that can be targeted by small molecule agonists.	[Chen, Quan; Pinon, Delia I.; Miller, Laurence J.; Dong, Maoqing] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Dong, MQ (corresponding author), 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	dongmq@mayo.edu			National Institutes of Health [DK46577]; American Diabetes Association [1-08-RA-42]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577 and American Diabetes Association Grant 1-08-RA-42.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Behar V, 1999, ENDOCRINOLOGY, V140, P4251, DOI 10.1210/en.140.9.4251; Beinborn M, 2005, REGUL PEPTIDES, V130, P1, DOI 10.1016/j.regpep.2005.05.001; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Ceraudo E, 2008, J MOL NEUROSCI, V36, P245, DOI 10.1007/s12031-008-9073-7; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Drucker DJ, 2005, NAT CLIN PRACT ENDOC, V1, P22, DOI 10.1038/ncpendmet0017; Du K, 1997, BIOCHEM BIOPH RES CO, V230, P289, DOI 10.1006/bbrc.1996.5949; Estall JL, 2006, CURR PHARM DESIGN, V12, P1731, DOI 10.2174/138161206776873671; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Piserchio A, 2000, BIOCHEMISTRY-US, V39, P8153, DOI 10.1021/bi000196f; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; Tokuyama Y, 2004, DIABETES RES CLIN PR, V66, P63, DOI 10.1016/j.diabres.2004.02.004; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	60	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24508	24518		10.1074/jbc.M110.135749	http://dx.doi.org/10.1074/jbc.M110.135749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529866	Green Published, hybrid			2022-12-27	WOS:000280542100023
J	Singh, K; Gitti, RK; Diouf, A; Zhou, H; Gowda, DC; Miura, K; Ostazeski, SA; Fairhurst, RM; Garboczi, DN; Long, CA				Singh, Kavita; Gitti, Rossitza K.; Diouf, Ababacar; Zhou, Hong; Gowda, D. Channe; Miura, Kazutoyo; Ostazeski, Stanley A.; Fairhurst, Rick M.; Garboczi, David N.; Long, Carole A.			Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x Is Identified as a Minimal Chondroitin Sulfate A-binding Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION-BLOCKING ANTIBODIES; PREGNANCY-ASSOCIATED MALARIA; VARIANT SURFACE-ANTIGENS; N-TERMINAL DOMAIN; INFECTED ERYTHROCYTES; PARASITE ADHESION; PLACENTAL MALARIA; VAR GENE; RECEPTOR; NMR	Molecular interactions between the VAR2CSA protein, expressed on the surface of Plasmodium falciparum-infected erythrocytes, and placental chondroitin sulfate A (CSA) are primarily responsible for pregnancy-associated malaria (PAM). Interrupting these interactions may prevent or ameliorate the severity of PAM. Several of the Duffy binding-like (DBL) domains of VAR2CSA, including the DBL3x domain, have been shown to bind CSA in vitro, but a more detailed understanding of how DBL domains bind CSA is needed. In this study, we demonstrate that subdomain 3 (S3), one of the three subdomains of VAR2CSA DBL3x by itself, is the major contributor toward CSA binding. NMR spectroscopy and flow cytometry analyses show that S3 and the intact DBL3x domain bind CSA similarly. Mutations within the S3 portion of DBL3x markedly affect CSA binding. Both recombinant molecules, S3 and DBL3x, are recognized by antibodies in the plasma of previously pregnant women living in malaria-endemic regions of Mali, but much less so by plasma from men of the same regions. As the S3 sequence is highly conserved in all known VAR2CSA proteins expressed by different parasite isolates obtained from various malaria endemic areas of the world, the identification of S3 as an independent CSA-binding region provides a compelling molecular basis for designing interventions against PAM.	[Garboczi, David N.] NIAID, Struct Biol Sect, Res Technol Branch, NIH, Rockville, MD 20852 USA; [Gitti, Rossitza K.; Ostazeski, Stanley A.] Edgewood Chem Biol Ctr, Forens Analyt Branch, Aberdeen Proving Ground, MD 21010 USA; [Diouf, Ababacar; Zhou, Hong; Miura, Kazutoyo; Fairhurst, Rick M.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health		ksingh@niaid.nih.gov; clong@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432; Gowda, Channe/0000-0002-6860-5108	NIAID, National Institutes of Health [AI45086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045086, R01AI045086, ZIAAI001000, ZICAI001051, ZIAAI001020] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grant AI45086 from NIAID, National Institutes of Health and the Division of Intramural Research of the NIAID, National Institutes of Health.	Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; CLORE GM, 1982, EUR J BIOCHEM, V128, P113; Cosman M, 2005, METH MOL B, V300, P141; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; GLAUDEMANS CPJ, 1990, BIOCHEMISTRY-US, V29, P10906, DOI 10.1021/bi00501a007; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SCHERF T, 1993, BIOPHYS J, V64, P754, DOI 10.1016/S0006-3495(93)81436-X; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SODEOKA M, 1993, BIOORG MED CHEM LETT, V3, P1089, DOI 10.1016/S0960-894X(00)80293-0; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; TOIDA T, 1993, ANAL SCI, V9, P53, DOI 10.2116/analsci.9.53; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	39	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24855	24862		10.1074/jbc.M110.118612	http://dx.doi.org/10.1074/jbc.M110.118612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529864	Green Published, hybrid			2022-12-27	WOS:000280542100058
J	Dautant, A; Velours, J; Giraud, MF				Dautant, Alain; Velours, Jean; Giraud, Marie-France			Crystal Structure of the Mg center dot ADP-inhibited State of the Yeast F(1)c(10)-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-SYNTHASE; ROTOR RING; MOLECULAR ARCHITECTURE; BOVINE F-1-ATPASE; CATALYTIC SITES; NA+-ATPASE; SUBUNIT-C; RESOLUTION; MECHANISM; F1-ATPASE	The F(1)c(10) subcomplex of the yeast F1F0-ATP synthase includes the membrane rotor part c(10)-ring linked to a catalytic head, (alpha beta)(3), by a central stalk, gamma delta epsilon. The Saccharomyces cerevisiae yF(1)c(10).ADP subcomplex was crystallized in the presence of Mg center dot ADP, dicyclohexylcarbodiimide (DCCD), and azide. The structure was solved by molecular replacement using a high resolution model of the yeast F-1 and a bacterial c-ring model with 10 copies of the c-subunit. The structure refined to 3.43-angstrom resolution displays new features compared with the original yF(1)c(10) and with the yF1 inhibited by adenylyl imidodiphosphate (AMP-PNP) (yF(1)(I-III)). An ADP molecule was bound in both beta(DP) and beta(TP) catalytic sites. The alpha(DP)-beta(DP) pair is slightly open and resembles the novel conformation identified in yF(1), whereas the alpha(TP)-beta(TP) pair is very closed and resembles more a DP pair. yF(1)c(10) ADP provides a model of a new Mg center dot ADP-inhibited state of the yeast F-1. As for the original yF(1) and yF(1)c(10) structures, the foot of the central stalk is rotated by similar to 40 degrees with respect to bovine structures. The assembly of the F-1 central stalk with the F(0)c-ring rotor is mainly provided by electrostatic interactions. On the rotor ring, the essential cGlu(59) carboxylate group is surrounded by hydrophobic residues and is not involved in hydrogen bonding.	[Dautant, Alain; Velours, Jean; Giraud, Marie-France] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Dautant, A (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	A.Dautant@ibgc.cnrs.fr; Marie-France.Giraud@ibgc.cnrs.fr			Region Aquitaine; Agence Nationale de la Recherche [ANR-06-PCVI-0016]; European Synchrotron Radiation Facility; Synchrotron SOLEIL	Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Synchrotron Radiation Facility; Synchrotron SOLEIL	This work was supported by the Region Aquitaine, the Agence Nationale de la Recherche (ANR-06-PCVI-0016), the European Synchrotron Radiation Facility, and the synchrotron SOLEIL.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BOYER PD, 1988, TRENDS BIOCHEM SCI, V13, P5, DOI 10.1016/0968-0004(88)90005-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; DIPIETRO A, 1986, BIOCHIM BIOPHYS ACTA, V851, P283, DOI 10.1016/0005-2728(86)90136-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Karmali AM, 2009, ACTA CRYSTALLOGR D, V65, P121, DOI 10.1107/S0907444908040006; Kiselyova OI, 2005, J CRYST GROWTH, V275, pE1447, DOI 10.1016/j.jcrysgro.2004.11.234; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oberfeld B, 2006, BIOCHEMISTRY-US, V45, P1841, DOI 10.1021/bi052304+; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schouppe C, 1999, J BIOENERG BIOMEMBR, V31, P105, DOI 10.1023/A:1005495626823; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Talbot JC, 2009, J BIOENERG BIOMEMBR, V41, P349, DOI 10.1007/s10863-009-9235-5; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; VON BALLMOOS C, 2007, BIOCHEMISTRY-US, V46, P11800; VON BALLMOOS C, 2007, J BIOENERG BIOMEMBR, V39, P441; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1	49	66	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29502	29510		10.1074/jbc.M110.124529	http://dx.doi.org/10.1074/jbc.M110.124529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610387	hybrid, Green Published			2022-12-27	WOS:000281740100052
J	Pradhan, S; Alrehani, N; Patel, V; Khatlani, T; Vijayan, KV				Pradhan, Subhashree; Alrehani, Nawaf; Patel, Vimal; Khatlani, Tanvir; Vijayan, K. Vinod			Cross-talk between Serine/Threonine Protein Phosphatase 2A and Protein Tyrosine Phosphatase 1B Regulates Src Activation and Adhesion of Integrin alpha(IIb)beta(3) to Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGENS; MIDDLE-T; PHOSPHORYLATION; KINASE; POLYMORPHISM; REVEALS; FAMILY; CELLS; PTP1B	Integrin alpha(IIb)beta(3) signaling mediated by kinases and phosphatases participate in hemostasis and thrombosis, in part, by supporting stable platelet adhesion. Our previous studies indicate that the genetic manipulation of PP2Ac alpha (alpha isoform of the catalytic subunit of protein phosphatase 2A) negatively regulate the adhesion of human embryonal kidney 293 cells expressing alpha(IIb)beta(3) to fibrinogen. Here, we demonstrated that small interference RNA (siRNA) mediated knockdown of PP2Ac alpha in 293 alpha(IIb)beta(3) cells led to the dephosphorylation of Src Tyr-529, phosphorylation of Src Tyr-418 and an increased Src kinase activity. Conversely, overexpression of PP2Ac alpha decreased the basal Src activity. Pharmacological inhibition of PP2Ac in human platelets or PP2Ac alpha knockdown in primary murine megakaryocytes resulted in Src activation. PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells did not alter the serine (Ser) phosphorylation of Src but enhanced the Ser-50 phosphorylation of protein tyrosine phosphatase 1B (PTP-1B) with a concomitant increase in the PTP-1B activity. Src activation in the PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells was abolished by siRNA mediated knockdown of PTP-1B. Pharmacological inhibition of Src or knockdown of Src, PTP-1B blocked the enhanced activation of extracellular signal-regulated kinase (ERK1/2) and the increased adhesiveness of PP2Ac alpha-depleted 293 alpha(IIb)beta(3) cells to fibrinogen, respectively. Thus, inactivation of PP2Ac alpha promotes hyperphosphorylation of PTP-1B Ser-50, elevates PTP-1B activity, which dephosphorylates Src Tyr-529 to activate Src and its downstream ERK1/2 signaling pathways that regulate alpha(IIb)beta(3) adhesion. Moreover, these studies extend the notion that a cross-talk between Ser/Thr and Tyr phosphatases can fine-tune alpha(IIb)beta(3) outside-in signaling.	[Vijayan, K. Vinod] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Vijayan, KV (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,BCM 286,N1319, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu			National Institutes of Health [HL081613, T32HL072754]; American Heart Association [GRNT2260224]; Fondren Foundation; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondren Foundation; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grant HL081613 from the National Institutes of Health. This work was also supported by the American Heart Association (GRNT2260224) and the Fondren Foundation.; <SUP>1</SUP>Supported by Grant T32HL072754 from the National Institutes of Health.; <SUP>2</SUP>Supported by the Mary R. Gibson Foundation.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Artcanuthurry Valerie, 1996, Seminars in Thrombosis and Hemostasis, V22, P317, DOI 10.1055/s-2007-999026; BRAUTIGAN DL, 1993, MOL CELL BIOCHEM, V128, P121; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; CHACKALAPARAMPIL I, 1994, ONCOGENE, V9, P1947; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MOYERS JS, 1993, MOL CELL BIOL, V13, P2391, DOI 10.1128/MCB.13.4.2391; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Rita M, 2003, INT J CANCER, V103, P38, DOI 10.1002/ijc.10772; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Vijayan KV, 2003, J BIOL CHEM, V278, P3860, DOI 10.1074/jbc.M208680200; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Weiser D. C., 2003, CURR PROTOC PROTEIN; Yokoyama N, 2001, FEBS LETT, V505, P460, DOI 10.1016/S0014-5793(01)02874-5; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	30	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29059	29068		10.1074/jbc.M109.085167	http://dx.doi.org/10.1074/jbc.M109.085167			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615878	hybrid, Green Published			2022-12-27	WOS:000281740100007
J	Blacklock, BJ; Scheffler, BE; Shepard, MR; Jayasuriya, N; Minto, RE				Blacklock, Brenda J.; Scheffler, Brian E.; Shepard, Michael R.; Jayasuriya, Naomi; Minto, Robert E.			Functional Diversity in Fungal Fatty Acid Synthesis THE FIRST ACETYLENASE FROM THE PACIFIC GOLDEN CHANTERELLE, CANTHARELLUS FORMOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; CREPENYNATE PATHWAY; NATURAL ACETYLENES; HISTIDINE-RESIDUES; ARABIDOPSIS FAD2; DESATURASE GENE; POLYACETYLENES; IDENTIFICATION; BASIDIOMYCETE	Acetylenic specialized metabolites containing one or more carbon-carbon triple bonds are widespread, being found in fungi, vascular and lower plants, marine sponges and algae, and insects. Plants, moss, and most recently, insects, have been shown to employ an energetically difficult, sequential dehydrogenation mechanism for acetylenic bond formation. Here, we describe the cloning and heterologous expression in yeast of a linoleoyl 12-desaturase (acetylenase) and a bifunctional desaturase with Delta(12)-/Delta(14)-regiospecificity from the Pacific golden chanterelle. The acetylenase gene, which is the first identified from a fungus, is phylogenetically distinct from known plant and fungal desaturases. Together, the bifunctional desaturase and the acetylenase provide the enzymatic activities required to drive oleate through linoleate to crepenynate and the conjugated enyne (14Z)-dehydrocrepenynate, the branchpoint precursors to a major class of acetylenic natural products.	Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Scheffler, Brian E.] Jamie Whitten Delta States Res Ctr, Genom & Bioinformat Res Unit, Stoneville, MS 38776 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Minto, RE (corresponding author), 402 N Blackford St,LD 326, Indianapolis, IN 46202 USA.	rminto@iupui.edu	Jayasuriya, Niranjali/H-2351-2014	Scheffler, Brian/0000-0003-1968-8952; Minto, Robert/0000-0001-7070-6832	National Institutes of Health [R15 GM06493-02]; American Cancer Society, Ohio Division; Miami University (Ohio); School of Science, Indiana University-Purdue University Indianapolis; National Science Foundation [CHE 0619254, DBI 0821661]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society, Ohio Division(American Cancer Society); Miami University (Ohio); School of Science, Indiana University-Purdue University Indianapolis; National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 GM06493-02. This work was also supported by a grant from the American Cancer Society, Ohio Division and startup support from Miami University (Ohio) and the School of Science, Indiana University-Purdue University Indianapolis.; NMR and MS data were collected using instruments acquired through the support of National Science Foundation Grants CHE 0619254 and DBI 0821661. We acknowledge John Dyer and Ed Cahoon for helpful discussions. Plasmids for Delta 12 and Myc-tagged Delta 15 desaturases were appreciated gifts from Ed Cahoon, Ralph Dewey, and John Dyer. C. alpina seed oil was provided by Richard Adlof (United States Department of Agriculture, Peoria, IL). We greatly appreciate the efforts of many undergraduate researchers and Errol Huffman, who earlier tested necessary but unfruitful approaches to the isolation of a fungal acetylenase.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; AVELANGEMACHEREL MH, 1995, FEBS LETT, V361, P111, DOI 10.1016/0014-5793(95)00163-4; Badami RC, 1980, PROG LIPID RES, V19, P119; BARLEY GC, 1987, J CHEM RES-S, P232; Beckmann C, 2002, ANGEW CHEM INT EDIT, V41, P2298, DOI 10.1002/1521-3773(20020703)41:13&lt;2298::AID-ANIE2298&gt;3.0.CO;2-G; Bohlmann F., 1973, NATURALLY OCCURRING; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; BULOCK JD, 1955, J CHEM SOC, P4270, DOI 10.1039/jr9550004270; Cahoon EB, 2004, J BIOL CHEM, V279, P12495, DOI 10.1074/jbc.M314329200; Cahoon EB, 2003, PLANT J, V34, P671, DOI 10.1046/j.1365-313X.2003.01757.x; Carlsson AS, 2004, EUR J BIOCHEM, V271, P2991, DOI 10.1111/j.1432-1033.2004.04231.x; CELMER WD, 1952, J AM CHEM SOC, V74, P1870, DOI 10.1021/ja01127a529; Christie WW, 1998, CHEM PHYS LIPIDS, V94, P35, DOI 10.1016/S0009-3084(98)00016-4; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; FARRELL IW, 1987, J CHEM RES-S, P234; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; FORD GL, 1985, J CHROMATOGR, V346, P431, DOI 10.1016/S0021-9673(00)90536-3; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Hiroi Masaru, 1992, Transactions of the Mycological Society of Japan, V33, P517; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaworski J, 2003, CURR OPIN PLANT BIOL, V6, P178, DOI 10.1016/S1369-5266(03)00013-X; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Minto RE, 2009, APPL ENVIRON MICROB, V75, P1156, DOI 10.1128/AEM.02049-08; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; PANG Z, 1991, J ORG CHEM, V56, P1233, DOI 10.1021/jo00003a054; Parish CA, 2004, J NAT PROD, V67, P1900, DOI 10.1021/np0497853; Redhead SA, 1997, MYCOTAXON, V65, P285; Reed DW, 2003, J AM CHEM SOC, V125, P10635, DOI 10.1021/ja036489o; Rosa LH, 2006, WORLD J MICROB BIOT, V22, P539, DOI 10.1007/s11274-005-9002-7; ROST B, 1995, PROTEIN SCI, V4, P521; Sakai H, 2005, MOL GENET GENOMICS, V273, P336, DOI 10.1007/s00438-005-1138-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Serra M, 2007, P NATL ACAD SCI USA, V104, P16444, DOI 10.1073/pnas.0705385104; Shanklin J, 2003, FEBS LETT, V545, P188, DOI 10.1016/S0014-5793(03)00529-5; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Singh SP, 2005, CURR OPIN PLANT BIOL, V8, P197, DOI 10.1016/j.pbi.2005.01.012; Sperling P, 2000, EUR J BIOCHEM, V267, P3801, DOI 10.1046/j.1432-1327.2000.01418.x; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; Vance DE, 2008, N COMP BIOC, P1; Watanabe K, 2004, BIOSCI BIOTECH BIOCH, V68, P721, DOI 10.1271/bbb.68.721; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031	51	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28442	28449		10.1074/jbc.M110.151498	http://dx.doi.org/10.1074/jbc.M110.151498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20606235	hybrid, Green Published			2022-12-27	WOS:000281594000007
J	Christian, BE; Spremulli, LL				Christian, Brooke E.; Spremulli, Linda L.			Preferential Selection of the 5 '-Terminal Start Codon on Leaderless mRNAs by Mammalian Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; PUNCTUATION MODEL; PURIFICATION; TRANSCRIPTS	Mammalian mitochondrial mRNAs are basically leaderless, having few or no untranslated nucleotides prior to the 5'-start codon. We demonstrate here that mammalian mitochondrial 55 S ribosomes preferentially form initiation complexes at a 5'-terminal AUG codon over an internal AUG. The preferential use of the 5'-start codon is also seen on mitochondrial 28 S small subunits, which suggests that mitochondrial translation initiation on leaderless mRNAs does not require the large ribosomal subunit. The selection of the 5'-AUG is dependent on the presence of fMet-tRNA and is enhanced by the presence of the mitochondrial initiation factor IF2(mt). In prokaryotes, IF3 is believed to antagonize initiation on leaderless mRNAs. However, IF3(mt) stimulates initiation complex formation on leaderless mRNAs when tested with 55 S ribosomes. The addition of even a few nucleotides 5' to the AUG codon significantly reduces the efficiency of initiation, highlighting the importance of the leaderless or nearly leaderless nature of mitochondrial mRNAs. In addition, very few initiation complexes could form on a hybrid mRNA construct consisting of tRNA(Met) attached at the 5'-end of a mitochondrial protein-coding sequence. This observation demonstrates that post-transcriptional processing	[Christian, Brooke E.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	linda_spremulli@unc.edu	Christian, Brooke Elizabeth/ABA-8019-2021	Christian, Brooke/0000-0002-1495-5639	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhargava K, 2005, NUCLEIC ACIDS RES, V33, P7011, DOI 10.1093/nar/gki1007; Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Christian BE, 2009, BIOCHEMISTRY-US, V48, P3269, DOI 10.1021/bi8023493; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Gaur R, 2008, MOL CELL, V29, P180, DOI 10.1016/j.molcel.2007.11.021; Grasso DG, 2007, METHOD ENZYMOL, V430, P59, DOI 10.1016/S0076-6879(07)30004-9; GRAVES MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P192, DOI 10.1016/0003-9861(83)90516-7; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LIAO HX, 1989, J BIOL CHEM, V264, P7518; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Ringquist S, 1998, METH MOL B, V77, P283; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Tedin K, 1999, MOL MICROBIOL, V31, P67, DOI 10.1046/j.1365-2958.1999.01147.x; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200	27	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28379	28386		10.1074/jbc.M110.149054	http://dx.doi.org/10.1074/jbc.M110.149054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610392	hybrid, Green Published			2022-12-27	WOS:000281404100080
J	Drechsel, DA; Patel, M				Drechsel, Derek A.; Patel, Manisha			Respiration-dependent H2O2 Removal in Brain Mitochondria via the Thioredoxin/Peroxiredoxin System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; OXIDATIVE STRESS; MAMMALIAN PEROXIREDOXIN; PARKINSONS-DISEASE; THIOREDOXIN; EXPRESSION; CATALASE; NEURODEGENERATION; GLUTATHIONE; INHIBITION	Mitochondrial reactive oxygen species (ROS) play an important role in both physiological cell signaling processes and numerous pathological states, including neurodegenerative disorders such as Parkinson disease. While mitochondria are considered the major cellular source of ROS, their role in ROS removal remains largely unknown. Using polarographic methods for real-time detection of steady-state H2O2 levels, we were able to quantitatively measure the contributions of potential systems toward H2O2 removal by brain mitochondria. Isolated rat brain mitochondria showed significant rates of exogenous H2O2 removal (9-12 nmol/min/mg of protein) in the presence of substrates, indicating a respiration-dependent process. Glutathione systems showed only minimal contributions: 25% decrease with glutathione reductase inhibition and no effect by glutathione peroxidase inhibition. In contrast, inhibitors of thioredoxin reductase, including auranofin and 1-chloro-2,4-dini-trobenzene, attenuated H2O2 removal rates in mitochondria by 80%. Furthermore, a 50% decrease in H2O2 removal was observed following oxidation of peroxiredoxin. Differential oxidation of glutathione or thioredoxin proteins by copper (II) or arsenite, respectively, provided further support for the thioredoxin/peroxiredoxin system as the major contributor to mitochondrial H2O2 removal. Inhibition of the thioredoxin system exacerbated mitochondrial H2O2 production by the redox cycling agent, paraquat. Additionally, decreases in H2O2 removal were observed in intact dopaminergic neurons with thioredoxin reductase inhibition, implicating this mechanism in whole cell systems. Therefore, in addition to their recognized role in ROS production, mitochondria also remove ROS. These findings implicate respiration- and thioredoxin-dependent ROS removal as a potentially important mitochondrial function that may contribute to physiological and pathological processes in the brain.	[Drechsel, Derek A.; Patel, Manisha] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Patel, M (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Res Bldg 2,12700 E 19th Ave,Mailstop C238-P15,POB, Aurora, CO 80045 USA.	manisha.patel@ucdenver.edu			National Institutes of Health [RO1NS04748, RO1NS039587]; NINDS [1F31NS061438]; American Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039587, R01NS045748, F31NS061438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS04748 and RO1NS039587 (to M. P.) and 1F31NS061438 (to D. A. D.) from NINDS. This work was also supported by an American Foundation for Pharmaceutical Education pre-doctoral fellowship (to D. A. D.).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912; Brown KK, 2008, FREE RADICAL BIO MED, V45, P494, DOI 10.1016/j.freeradbiomed.2008.04.030; Castello PR, 2008, J PHARMACOL EXP THER, V324, P970, DOI 10.1124/jpet.107.132134; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chinta SJ, 2009, FREE RADICAL BIO MED, V46, P939, DOI 10.1016/j.freeradbiomed.2009.01.010; Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2; Gitler C, 2002, BIOCHEM BIOPH RES CO, V290, P624, DOI 10.1006/bbrc.2001.6214; GUIDOT DM, 1995, J CLIN INVEST, V96, P1131, DOI 10.1172/JCI118100; Halliwell B, 2004, CURR MED CHEM, V11, P1085, DOI 10.2174/0929867043365404; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; Hill KE, 1997, BIOCHEM BIOPH RES CO, V234, P293, DOI 10.1006/bbrc.1997.6618; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P167, DOI 10.1016/0926-6593(66)90058-0; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; RADI R, 1991, J BIOL CHEM, V266, P22028; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rogers Kara E., 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P454; Rybnikova E, 2000, EUR J NEUROSCI, V12, P1669, DOI 10.1046/j.1460-9568.2000.00059.x; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Wendel A, 1981, Methods Enzymol, V77, P325; Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200	46	147	154	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27850	27858		10.1074/jbc.M110.101196	http://dx.doi.org/10.1074/jbc.M110.101196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558743	Green Published, hybrid			2022-12-27	WOS:000281404100040
J	Pierroz, DD; Bonnet, N; Baldock, PA; Ominsky, MS; Stolina, M; Kostenuik, PJ; Ferrari, SL				Pierroz, Dominique D.; Bonnet, Nicolas; Baldock, Paul A.; Ominsky, Michael S.; Stolina, Marina; Kostenuik, Paul J.; Ferrari, Serge L.			Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone? A STUDY OF INTERMITTENT PARATHYROID HORMONE WITH DENOSUMAB OR ALENDRONATE IN KNOCK-IN MICE EXPRESSING HUMANIZED RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMENOPAUSAL WOMEN; CORTICAL POROSITY; OSTEOPROTEGERIN; TERIPARATIDE; OSTEOPOROSIS; DENSITY; RESORPTION; INCREASES; TURNOVER; RECEPTOR	PTH stimulates osteoblastic cells to form new bone and to produce osteoblast-osteoclast coupling factors such as RANKL. Whether osteoclasts or their activity are needed for PTH anabolism remains uncertain. We treated ovariectomized huRANKL knock-in mice with a human RANKL inhibitor denosumab (DMAb), alendronate (Aln), or vehicle for 4 weeks, followed by co-treatment with intermittent PTH for 4 weeks. Loss of bone mass and microarchitecture was prevented by Aln and further significantly improved by DMAb. PTH improved bone mass, microstructure, and strength, and was additive to Aln but not to DMAb. Aln inhibited biochemical and histomorphometrical indices of bone turnover, -i.e. osteocalcin and bone formation rate (BFR) on cancellous bone surfaces-, and Dmab inhibited them further. However Aln increased whereas Dmab suppressed osteoclast number and surfaces. PTH significantly increased osteocalcin and bone formation indices, in the absence or presence of either antiresorptive, although BFR remained lower in presence of Dmab. To further evaluate PTH effects in the complete absence of osteoclasts, high dose PTH was administered to RANK(-/-) mice. PTH increased osteocalcin similarly in RANK(-/-) and WT mice. It also increased BMD in RANK(-/-) mice, although less than in WT. These results further indicate that osteoclasts are not strictly required for PTH anabolism, which presumably still occurs via stimulation of modeling-based bone formation. However the magnitude of PTH anabolic effects on the skeleton, in particular its additive effects with antiresorptives, depends on the extent of the remodeling space, as determined by the number and activity of osteoclasts on bone surfaces.	[Ferrari, Serge L.] Univ Hosp Geneva, HUGs, Dept Rehabil & Geriatr, Serv Bone Dis, CH-1211 Geneva 14, Switzerland; [Pierroz, Dominique D.; Bonnet, Nicolas; Ferrari, Serge L.] Fac Med, CH-1211 Geneva 14, Switzerland; [Baldock, Paul A.] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Program, Sydney, NSW 2010, Australia; [Ominsky, Michael S.; Stolina, Marina; Kostenuik, Paul J.] Amgen Inc, Metab Disorders Res, Thousand Oaks, CA 91320 USA	University of Geneva; University of Geneva; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Amgen	Ferrari, SL (corresponding author), Univ Hosp Geneva, HUGs, Dept Rehabil & Geriatr, Serv Bone Dis, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	Serge.Ferrari@unige.ch	Ferrari, Serge/ABD-2730-2020; Baldock, Paul/B-3840-2012	Ferrari, Serge/0000-0002-1372-4417; Bonnet, Nicolas/0000-0001-9832-5767	Amgen Inc.	Amgen Inc.(Amgen)	This work was supported by Amgen Inc.	Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI 10.1359/JBMR.080324; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/JBMR.0809010, 10.1359/jbmr.080901]; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chavassieux P, 2008, J BONE MINER RES, V23, P1076, DOI 10.1359/JBMR.080231; Cosman F, 2008, CALCIFIED TISSUE INT, V82, pS59; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Cosman F, 2008, CURR OPIN ENDOCRINOL, V15, P495, DOI 10.1097/MED.0b013e32831a46d6; Dempster DW, 1999, J CLIN ENDOCR METAB, V84, P1562, DOI 10.1210/jc.84.5.1562; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Finkelstein JS, 2006, J CLIN ENDOCR METAB, V91, P2882, DOI 10.1210/jc.2006-0190; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fox J, 2007, BONE, V41, P321, DOI 10.1016/j.bone.2007.04.197; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; HODSMAN AB, 1993, BONE, V14, P523, DOI 10.1016/8756-3282(93)90190-L; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Johnston S, 2007, ENDOCRINOLOGY, V148, P4466, DOI 10.1210/en.2007-0229; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Kostenuik PJ, 2001, ENDOCRINOLOGY, V142, P4295, DOI 10.1210/en.142.10.4295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; Martin TJ, 2006, ANN NY ACAD SCI, V1068, P458, DOI 10.1196/annals.1346.043; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Ominsky MS, 2007, J BONE MINER RES, V22, pS88; Ominsky MS, 2008, J BONE MINER RES, V23, pS61; Ominsky MS, 2009, J BONE MINER RES, V24, P1234, DOI [10.1359/JBMR.090215, 10.1359/jbmr.090215]; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Samadfam R, 2007, J BONE MINER RES, V22, P55, DOI 10.1359/JBMR.060915; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Takahashi H., 1964, H FORD HOSP MED B, V12, P359; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	47	71	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28164	28173		10.1074/jbc.M110.101964	http://dx.doi.org/10.1074/jbc.M110.101964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558734	Green Published, hybrid			2022-12-27	WOS:000281404100059
J	Schwarzer, S; Nobles, M; Tinker, A				Schwarzer, Sarah; Nobles, Muriel; Tinker, Andrew			Do Caveolae Have a Role in the Fidelity and Dynamics of Receptor Activation of G-protein-gated Inwardly Rectifying Potassium Channels?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; RAT ATRIAL MYOCYTES; GIRK CHANNELS; K+-CHANNEL; MUSCARINIC RECEPTOR; DESENSITIZATION; IDENTIFICATION; EXPRESSION; MEMBRANE; AGONIST	In atrial and nodal cardiac myocytes, M2 muscarinic receptors activate inhibitory G-proteins (G(i/o)), which in turn stimulate G-protein-gated inwardly rectifying K+ channels through direct binding of the G beta gamma subunit. Despite also releasing G beta gamma, G(s)-coupled receptors such as the beta-adrenergic receptor are not able to prominently activate this current. An appealing hypothesis would be if components were sequestered in membrane domains such as caveolae/rafts. Using biochemical fractionation followed by Western blotting and/or radioligand binding experiments, we examined the distribution of the components in stable HEK293 and HL-1 cells, which natively express the transduction cascade. The channel, M2 muscarinic, and A1 adenosine receptors were located in noncaveolar/nonraft fractions. G(i)alpha(1/2) was enriched in both caveolar/raft and noncaveolar/nonraft fractions. In contrast, G(s)alpha was only enriched in caveolar/raft fractions. We constructed YFP-tagged caveolin-2 (YFP-Cav2) and chimeras with the M2 (M2-YFP-Cav2) and A1 (A1-YFP-Cav2) receptors. Analysis of gradient fractions showed that these receptor chimeras were now localized to caveolae-enriched fractions. Microscopy showed that M2-YFP and A1-YFP had a diffuse homogenous membrane signal. YFP-Cav2, M2-YFP-Cav2, and A1-YFP-Cav2 revealed a more punctuate pattern. Finally, we looked at the consequences for signaling. Activation via M2-YFP-Cav2 or A1-YFP-Cav2 revealed substantially slower kinetics compared with M2-YFP or A1-YFP and was reversed by the addition of methyl-beta-cyclodextrin. Thus the localization of the channel signal transduction cascade in non-cholesterol rich domains substantially enhances the speed of signaling. The presence of G(s)alpha solely in caveolae may account for signaling selectivity between G(i/o) and G(s)-coupled receptors.	[Schwarzer, Sarah; Nobles, Muriel; Tinker, Andrew] UCL, BHF Labs, Dept Med, Rayne Inst, London WC1E 6JJ, England	University of London; King's College London; University College London	Tinker, A (corresponding author), UCL, BHF Labs, Dept Med, Rayne Inst, 5 Univ St, London WC1E 6JJ, England.	a.tinker@ucl.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Bender K, 2004, J PHYSIOL-LONDON, V561, P471, DOI 10.1113/jphysiol.2004.072462; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen CY, 2006, B MATH BIOL, V68, P863, DOI 10.1007/s11538-005-9058-4; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; Delling M, 2002, J NEUROSCI, V22, P7154; Drici MD, 2000, BRIT J PHARMACOL, V131, P569, DOI 10.1038/sj.bjp.0703611; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Fialka I, 1997, ELECTROPHORESIS, V18, P2582, DOI 10.1002/elps.1150181414; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuzhikandathil EV, 2000, J GEN PHYSIOL, V115, P697, DOI 10.1085/jgp.115.6.697; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaney JL, 2004, AM J PHYSIOL-CELL PH, V287, pC182, DOI 10.1152/ajpcell.00540.2003; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mercier I, 2009, LAB INVEST, V89, P614, DOI 10.1038/labinvest.2009.23; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rimoldi V, 2003, ONCOGENE, V22, P6054, DOI 10.1038/sj.onc.1206612; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Wellner-Kienitz MC, 2001, J BIOL CHEM, V276, P37347, DOI 10.1074/jbc.M106234200; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Yamada M, 1998, PHARMACOL REV, V50, P723; Yamanushi TT, 2007, AM J PHYSIOL-HEART C, V292, pH1737, DOI 10.1152/ajpheart.01287.2005; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	56	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27817	27826		10.1074/jbc.M110.103598	http://dx.doi.org/10.1074/jbc.M110.103598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20562107	Green Published, hybrid			2022-12-27	WOS:000281404100037
J	Snow, JW; Kim, J; Currie, CR; Xu, JA; Orkin, SH				Snow, Jonathan W.; Kim, Jonghwan; Currie, Caroline R.; Xu, Jian; Orkin, Stuart H.			Sumoylation Regulates Interaction of FOG1 with C-terminal-binding Protein (CTBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; SUMO MODIFICATION; MAMMALIAN-CELLS; FINGER PROTEIN; REPRESSION; HEMATOPOIESIS; ACTIVATION; GENE; LINEAGE	Erythropoietic and megakaryocytic programs are specified from multipotential progenitors by the transcription factor GATA1. FOG1, a GATA1-interaction partner, is critical for GATA1 function in several contexts by bringing multiple complexes into association with GATA1 to facilitate activation or repression of target genes. To further elucidate regulation of these associations by cellular and extracellular cues, we examined FOG1 for post-translational modifications. We found that FOG1 is SUMOylated and phosphorylated in erythroid cells in a differentiation-dependent manner. Removal of the SUMOylation sites in FOG1 does not impair nuclear localization, protein stability, or chromatin occupancy. However, SUMOylation of FOG1 modulates interactions with C-terminal binding protein family members, specifically promoting CTBP1 binding. Phosphorylation of FOG1 modulates SUMOylation and, therefore, indirectly regulates the CTBP interaction. Post-translational modification of FOG1 may contribute to control of co-occupancy by CTBP family members, the NuRD complex, and GATA1 at differentially regulated genes.	[Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Snow, Jonathan W.; Kim, Jonghwan; Currie, Caroline R.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Snow, Jonathan W.; Kim, Jonghwan; Xu, Jian; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kim, Jonghwan; Xu, Jian; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [HL32259]; Leukemia and Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL32259 (to S. H. O.).; Supported in part by a Leukemia and Lymphoma Society Fellowship.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chretien S, 1996, EMBO J, V15, P4174, DOI 10.1002/j.1460-2075.1996.tb00792.x; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fernandez-Lloris R, 2006, FEBS LETT, V580, P1215, DOI 10.1016/j.febslet.2006.01.031; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang H, 2009, MOL CELL BIOL, V29, P4103, DOI 10.1128/MCB.00090-09; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; KIM J, 2005, CURR PROTOC MOL BIOL, pCH21; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ORKIN SH, 1992, BLOOD, V80, P575; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Snow JW, 2009, J BIOL CHEM, V284, P29310, DOI 10.1074/jbc.M109.043497; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vyas P, 1999, BLOOD, V93, P2867; Vyas P, 2007, CURR OPIN PEDIATR, V19, P9, DOI 10.1097/MOP.0b013e328013e7b2; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhao LJ, 2008, ONCOGENE, V27, P5214, DOI 10.1038/onc.2008.162; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	63	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28064	28075		10.1074/jbc.M109.096909	http://dx.doi.org/10.1074/jbc.M109.096909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20587419	Green Published, hybrid			2022-12-27	WOS:000288742300005
J	Kogai, T; Liu, YY; Richter, LL; Mody, K; Kagechika, H; Brent, GA				Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Kagechika, Hiroyuki; Brent, Gregory A.			Retinoic Acid Induces Expression of the Thyroid Hormone Transporter, Monocarboxylate Transporter 8 (Mct8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PLASMINOGEN-ACTIVATOR GENE; BREAST-CANCER CELLS; SODIUM/IODIDE SYMPORTER; INDUCED TRANSCRIPTION; RETINOBENZOIC ACIDS; BINDING PROTEINS; RECEPTOR-ALPHA; START SITES; DIFFERENTIATION	Retinoic acid (RA) and thyroid hormone are critical for differentiation and organogenesis in the embryo. Mct8 (monocarboxylate transporter 8), expressed predominantly in the brain and placenta, mediates thyroid hormone uptake from the circulation and is required for normal neural development. RA induces differentiation of F9 mouse teratocarcinoma cells toward neurons as well as extraembryonal endoderm. We hypothesized that Mct8 is functionally expressed in F9 cells and induced by RA. All-trans-RA (tRA) and other RA receptor (RAR) agonists dramatically (>300-fold) induced Mct8. tRA treatment significantly increased uptake of triiodothyronine and thyroxine (4.1- and 4.3-fold, respectively), which was abolished by a selective Mct8 inhibitor, bromosulfophthalein. Sequence inspection of the Mct8 promoter region and 5'-rapid amplification of cDNA ends PCR analysis in F9 cells identified 11 transcription start sites and a proximal Sp1 site but no TATA box. tRA significantly enhanced Mct8 promoter activity through a consensus RA-responsive element located 6.6 kilobases upstream of the coding region. A chromatin immunoprecipitation assay demonstrated binding of RAR and retinoid X receptor to the RA response element. The promotion of thyroid hormone uptake through the transcriptional up-regulation of Mct8 by RAR is likely to be important for extraembryonic endoderm development and neural differentiation. This finding demonstrates cross-talk between RA signaling and thyroid hormone signaling in early development at the level of the thyroid hormone transporter.	[Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; [Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Medical & Dental University (TMDU)	Kogai, T (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Bldg 114,Rm 230,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	tkogai@ucla.edu; gbrent@ucla.edu		Kagechika, Hiroyuki/0000-0002-6747-1013	Veterans Affairs; National Institutes of Health [RO1 CA089364]; NATIONAL CANCER INSTITUTE [R01CA089364] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Veterans Affairs Merit Review Funds. This work was also supported by National Institutes of Health Grant RO1 CA089364 (to G. A. B.).	BANKER DE, 1991, MOL CELL BIOL, V11, P5079, DOI 10.1128/MCB.11.10.5079; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Bulens F, 1997, J BIOL CHEM, V272, P663; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Flajollet S, 2006, J BIOL CHEM, V281, P20338, DOI 10.1074/jbc.M603023200; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Furlow JD, 2006, TRENDS ENDOCRIN MET, V17, P38, DOI 10.1016/j.tem.2006.01.007; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hagenbuch B, 2007, BEST PRACT RES CL EN, V21, P209, DOI 10.1016/j.beem.2007.03.004; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Han YH, 2009, J BIOL CHEM, V284, P18503, DOI 10.1074/jbc.M109.007708; Horie S, 2001, J BIOL CHEM, V276, P2440, DOI 10.1074/jbc.M004942200; Jansen J, 2005, THYROID, V15, P757, DOI 10.1089/thy.2005.15.757; Johansson S, 1997, ANAT EMBRYOL, V195, P483, DOI 10.1007/s004290050067; KAGECHIKA H, 1989, J MED CHEM, V32, P834, DOI 10.1021/jm00124a016; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Kogai T, 2004, CANCER RES, V64, P415, DOI 10.1158/0008-5472.CAN-03-2285; Kogai T, 2008, J CLIN ENDOCR METAB, V93, P1884, DOI 10.1210/jc.2007-1627; Komiya S, 2005, GENES CELLS, V10, P1065, DOI 10.1111/j.1365-2443.2005.00899.x; KRAFT JC, 1994, J CRAN GENET DEV BIO, V14, P75; KUFF EL, 1980, DEV BIOL, V77, P103, DOI 10.1016/0012-1606(80)90459-5; LEE LR, 1994, MOL ENDOCRINOL, V8, P746, DOI 10.1210/me.8.6.746; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LIU Y, 1994, MOL CELL ENDOCRINOL, V103, P149; Liu YY, 2002, ENDOCRINOLOGY, V143, P2664, DOI 10.1210/en.143.7.2664; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MARUYAMA K, 1994, GENE, V138, P171; Merchiers P, 1999, FEBS LETT, V456, P149, DOI 10.1016/S0014-5793(99)00942-4; Santos NC, 2010, ENDOCRINOLOGY, V151, P2361, DOI 10.1210/en.2009-1338; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Sugiura M, 2007, BIOCHEM BIOPH RES CO, V360, P741, DOI 10.1016/j.bbrc.2007.06.109; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Teng S, 2008, MOL PHARMACEUT, V5, P67, DOI 10.1021/mp700102q; van der Deure WM, 2007, BEST PRACT RES CL EN, V21, P339, DOI 10.1016/j.beem.2007.03.006; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	51	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27279	27288		10.1074/jbc.M110.123158	http://dx.doi.org/10.1074/jbc.M110.123158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573951	hybrid, Green Published			2022-12-27	WOS:000281172700058
J	Qian, SB; Zhang, XQ; Sun, J; Bennink, JR; Yewdell, JW; Patterson, C				Qian, Shu-Bing; Zhang, Xingqian; Sun, Jun; Bennink, Jack R.; Yewdell, Jonathan W.; Patterson, Cam			mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; LIFE-SPAN; TRANSLATIONAL CONTROL; HYDROGEN-PEROXIDE; BINDING PARTNER; TOR; RAPAMYCIN; STRESS; RAPTOR; CHIP	Balanced protein synthesis and degradation are crucial for proper cellular function. Protein synthesis is tightly coupled to energy status and nutrient levels by the mammalian target of rapamycin complex 1 (mTORC1). Quality of newly synthesized polypeptides is maintained by the molecular chaperone and ubiquitin-proteasome systems. Little is known about how cells integrate information about the quantity and quality of translational products simultaneously. We demonstrate that cells distinguish moderate reductions in protein quality from severe protein misfolding using molecular chaperones to differentially regulate mTORC1 signaling. Moderate reduction of chaperone availability enhances mTORC1 signaling, whereas stress-induced complete depletion of chaperoning capacity suppresses mTORC1 signaling. Molecular chaperones regulate mTORC1 assembly in coordination with nutrient availability. This mechanism enables mTORC1 to rapidly detect and respond to environmental cues while also sensing intracellular protein misfolding. The tight linkage between protein quality and quantity control provides a plausible mechanism coupling protein misfolding with metabolic dyshomeostasis.	[Qian, Shu-Bing; Zhang, Xingqian; Sun, Jun] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill	Qian, SB (corresponding author), Cornell Univ, Div Nutr Sci, 301 Biotech, Ithaca, NY 14853 USA.	sq38@cornell.edu; cpatters@med.unc.edu	yewdell, jyewdell@nih.gov jonathan/A-1702-2012		National Institutes of Health through NIAID; National Institutes of Health [GM61728, AG024282, DK056350]; Cornell Startup Research Funds; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Startup Research Funds; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through NIAID (to J. R. B. and J. W. Y.) and National Institutes of Health Grants GM61728, AG024282, and DK056350 (to C. P.). This work was also supported by Cornell Startup Research Funds and the Ellison Medical Foundation (to S. B. Q.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Ding M, 2002, MOL CELL BIOCHEM, V234, P81, DOI 10.1023/A:1015901232124; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang CS, 2002, CANCER RES, V62, P5689; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JURIVICH DA, 1991, J CELL PHYSIOL, V148, P252, DOI 10.1002/jcp.1041480210; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kraiss LW, 2001, J SURG RES, V97, P20, DOI 10.1006/jsre.2001.6091; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lin RZ, 1997, J BIOL CHEM, V272, P31196, DOI 10.1074/jbc.272.49.31196; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Ohji G, 2006, J BIOCHEM, V139, P129, DOI 10.1093/jb/mvj008; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	49	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27385	27395		10.1074/jbc.M110.120295	http://dx.doi.org/10.1074/jbc.M110.120295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605781	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000281172700067
J	Xu, GM; Wang, JA; Wang, LQ; Tian, XY; Yang, HH; Fan, KQ; Yang, KQ; Tan, HR				Xu, Gangming; Wang, Juan; Wang, Linqi; Tian, Xiuyun; Yang, Haihua; Fan, Keqiang; Yang, Keqian; Tan, Huarong			"Pseudo" gamma-Butyrolactone Receptors Respond to Antibiotic Signals to Coordinate Antibiotic Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); COMPLETE GENOME SEQUENCE; VENEZUELAE ISP5230; GENE-CLUSTER; SECONDARY METABOLISM; BINDING-PROTEIN; PATHWAY; REGULATOR; CHLORAMPHENICOL; IDENTIFICATION	In actinomycetes, the onset of secondary metabolite biosynthesis is often triggered by the quorum-sensing signal gamma-butyrolactones (GBLs) via specific binding to their cognate receptors. However, the presence of multiple putative GBL receptor homologues in the genome suggests the existence of an alternative regulatory mechanism. Here, in the model streptomycete Streptomyces coelicolor, ScbR2 (SCO6286, a homologue of GBL receptor) is shown not to bind the endogenous GBL molecule SCB1, hence designated "pseudo" GBL receptor. Intriguingly, it could bind the endogenous antibiotics actinorhodin and undecylprodigiosin as ligands, leading to the derepression of KasO, an activator of a cryptic type I polyketide synthase gene cluster. Likewise, JadR2 is also a putative GBL receptor homologue in Streptomyces venezuelae, the producer of chloramphenicol and cryptic antibiotic jadomycin. It is shown to coordinate their biosynthesis via direct repression of JadR1, which activates jadomycin biosynthesis while repressing chloramphenicol biosynthesis directly. Like ScbR2, JadR2 could also bind these two disparate antibiotics, and the interactions lead to the derepression of jadR1. The antibiotic responding activities of these pseudo GBL receptors were further demonstrated in vivo using the lux reporter system. Overall, these results suggest that pseudo GBL receptors play a novel role to coordinate antibiotic biosynthesis by binding and responding to antibiotics signals. Such an antibiotic-mediated regulatory mechanism could be a general strategy to coordinate antibiotic biosynthesis in the producing bacteria.	[Xu, Gangming; Wang, Juan; Wang, Linqi; Tian, Xiuyun; Yang, Haihua; Fan, Keqiang; Yang, Keqian; Tan, Huarong] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Yang, KQ (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.	yangkq@im.ac.cn; tanhr@im.ac.cn	Wang, Linqi/K-6256-2016; Fan, Keqiang/E-5366-2012	Wang, Linqi/0000-0002-5243-341X; Fan, Keqiang/0000-0003-2420-1889; Tian, Xiuyun/0000-0001-8557-633X; Xu, Gangming/0000-0003-2894-7805	Ministry of Science and Technology of China [2009CB118905]; National Natural Science Foundation of China [31030242, 30870041]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB118905 and National Natural Science Foundation of China Grants 31030242 and 30870041.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Bunet R, 2008, J BACTERIOL, V190, P3293, DOI 10.1128/JB.01989-07; Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; Healy FG, 2009, J BACTERIOL, V191, P4786, DOI 10.1128/JB.00437-09; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jiang H, 2006, RES MICROBIOL, V157, P666, DOI 10.1016/j.resmic.2006.02.004; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Nishida H, 2007, ENVIRON MICROBIOL, V9, P1986, DOI 10.1111/j.1462-2920.2007.01314.x; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Piraee M, 2004, MICROBIOL-SGM, V150, P85, DOI 10.1099/mic.0.26319-0; RAMOS JL, 2005, MICROBIOL MOL BIOL R, V326, P356; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; STRAUCH E, 1991, MOL MICROBIOL, V5, P289, DOI 10.1111/j.1365-2958.1991.tb02109.x; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Takano E, 2006, CURR OPIN MICROBIOL, V9, P287, DOI 10.1016/j.mib.2006.04.003; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang SL, 2008, J BACTERIOL, V190, P4061, DOI 10.1128/JB.01954-07; Wohlert SE, 2001, J NAT PROD, V64, P1077, DOI 10.1021/np010067f; YANG KQ, 1995, J BACTERIOL, V177, P6111, DOI 10.1128/jb.177.21.6111-6117.1995; Yang YH, 2005, APPL ENVIRON MICROB, V71, P5050, DOI 10.1128/AEM.71.9.5050-5055.2005; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	40	99	106	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27440	27448		10.1074/jbc.M110.143081	http://dx.doi.org/10.1074/jbc.M110.143081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562102	Green Published, hybrid			2022-12-27	WOS:000281172700073
J	Amadi, ST; Koteiche, HA; Mishra, S; Mchaourab, HS				Amadi, Sepan T.; Koteiche, Hanane A.; Mishra, Sanjay; Mchaourab, Hassane S.			Structure, Dynamics, and Substrate-induced Conformational Changes of the Multidrug Transporter EmrE in Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON BINDING-SITE; LABELED SIDE-CHAINS; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; T4 LYSOZYME; TOPOLOGY; DOMAIN; MODEL; MSBA; MOTION	EmrE, a member of the small multidrug transporters superfamily, extrudes positively charged hydrophobic compounds out of Escherichia coli cytoplasm in exchange for inward movement of protons down their electrochemical gradient. Although its transport mechanism has been thoroughly characterized, the structural basis of energy coupling and the conformational cycle mediating transport have yet to be elucidated. In this study, EmrE structure in liposomes and the substrate-induced conformational changes were investigated by systematic spin labeling and EPR analysis. Spin label mobilities and accessibilities describe a highly dynamic ligand-free (apo) conformation. Dipolar coupling between spin labels across the dimer reveals at least two spin label populations arising from different packing interfaces of the EmrE dimer. One population is consistent with antiparallel arrangement of the monomers, although the EPR parameters suggest deviations from the crystal structure of substrate-bound EmrE. Resolving these discrepancies requires an unusual disposition of TM3 relative to the membrane-water interface and a kink in its backbone that enables bending of its C-terminal part. Binding of the substrate tetraphenylphosphonium changes the environment of spin labels and their proximity in three transmembrane helices. The underlying conformational transition involves repacking of TM1, tilting of TM2, and changes in the backbone configurations of TM3 and the adjacent loop connecting it to TM4. A dynamic apo conformation is necessary for the polyspecificity of EmrE allowing the binding of structurally diverse substrates. The flexibility of TM3 may play a critical role in movement of substrates across the membrane.	[Amadi, Sepan T.; Koteiche, Hanane A.; Mishra, Sanjay; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), 2215 Garland Ave,741 Light Hall, Nashville, TN 37232 USA.	Hassane.mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	NIGMS, National Institutes of Health [GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077659 from the NIGMS.	Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Edwards RA, 1998, BIOCHEM CELL BIOL, V76, P791, DOI 10.1139/bcb-76-5-791; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Gottschalk KE, 2004, BIOPHYS J, V86, P3335, DOI 10.1529/biophysj.103.034546; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Koteiche HA, 2002, FEBS LETT, V519, P16, DOI 10.1016/S0014-5793(02)02688-1; Mchaourab HS, 2008, BIOCHEMISTRY-US, V47, P7980, DOI 10.1021/bi800628d; Mchaourab HS, 1999, BIOCHEMISTRY-US, V38, P2947, DOI 10.1021/bi9826310; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Schuldiner S, 1997, J EXP BIOL, V200, P335; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	42	42	43	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26710	26718		10.1074/jbc.M110.132621	http://dx.doi.org/10.1074/jbc.M110.132621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551331	Green Published, hybrid			2022-12-27	WOS:000280921000085
J	He, Y; Wortmann, A; Burke, LJ; Reid, JC; Adams, MN; Abdul-Jabbar, I; Quigley, JP; Leduc, R; Kirchhofer, D; Hooper, JD				He, Yaowu; Wortmann, Andreas; Burke, Les J.; Reid, Janet C.; Adams, Mark N.; Abdul-Jabbar, Ibtissam; Quigley, James P.; Leduc, Richard; Kirchhofer, Daniel; Hooper, John D.			Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKC delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; PROSTATE-CANCER; TUMOR-CELLS; SUBSTRATE TRASK; MATRIPTASE; EXPRESSION; HEPSIN; IDENTIFICATION; GROWTH; INHIBITORS	CUB-domain-containing protein 1 (CDCP1) is an integral membrane glycoprotein with potential as a marker and therapeutic target for a number of cancers. Here we examine mechanisms regulating cellular processing of CDCP1. By analyzing cell lines exclusively passaged non-enzymatically and through use of a panel of protease inhibitors, we demonstrate that full-length 135 kDa CDCP1 is post-translationally processed in a range of cell lines by a mechanism involving serine protease activity, generating a C-terminal 70-kDa fragment. Immunopurification and N-terminal sequencing of this cell-retained fragment and detailed mutagenesis, show that proteolytic processing of CDCP1 occurs at two sites, Arg-368 and Lys-369. We show that the serine protease matriptase is an efficient, but not essential, cellular processor of CDCP1 at Arg-368. Importantly, we also demonstrate that proteolysis induces tyrosine phosphorylation of 70-kDa CDCP1 and recruitment of Src and PKC delta to this fragment. In addition, Western blot and mass spectroscopy analyses show that an N-terminal 65-kDa CDCP1 ectodomain is shed intact from the cell surface. These data provide new insights into mechanisms regulating CDCP1 and suggest that the biological role of this protein and, potentially, its function in cancer, may be mediated by both 70-kDa cell retained and 65-kDa shed fragments, as well as the full-length 135-kDa protein.	[He, Yaowu; Wortmann, Andreas; Burke, Les J.; Reid, Janet C.; Adams, Mark N.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Abdul-Jabbar, Ibtissam] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Queensland University of Technology (QUT); University of Queensland; Scripps Research Institute; University of Sherbrooke; Roche Holding; Genentech	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.	jhooper@mmri.mater.org.au	Hooper, John/C-1481-2016; Reid, Janet/AAI-6631-2021; Hooper, John/B-4153-2011; Wortmann, Dr Andreas/D-2074-2012; Adams, Mark/AAE-1209-2021	Hooper, John/0000-0003-1054-8486; Reid, Janet/0000-0002-4512-3026; Adams, Mark/0000-0003-1906-5018; HE, Yaowu/0000-0002-7828-263X; Burke, Lez/0000-0002-2932-6843	National Health and Medical Research Council of Australia [339732]; Canadian Institutes of Health Research (CIHR); Cancer & Bowel Research Trust; Australian Government National Collaborative Research Infrastructure Strategy (NCRIS); NATIONAL CANCER INSTITUTE [R01CA129484, R01CA105412] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer & Bowel Research Trust; Australian Government National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (Fellowship 339732 to J.D.H.), by a Canadian Institutes of Health Research (CIHR) grant (to R.L.), and by funding supplied by the Cancer & Bowel Research Trust (scholarship to A.W.).; We thank Dr. Georgina Giannikopoulos and Dr. Bernie McInerney for performing N-terminal sequencing, which was facilitated by access to the Australian Proteome Analysis Facility which is supported under the Australian Government National Collaborative Research Infrastructure Strategy (NCRIS). We also thank Carina Walpole and Dr. Sally-Anne Stephenson (Queensland University of Technology) for providing breast cancer cell lines, and James Broadbent for assistance with mass spectroscopy analysis.	Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Cowan FM, 2002, CELL BIOL TOXICOL, V18, P175, DOI 10.1023/A:1015511720481; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; HULTSCH T, 1988, AGENTS ACTIONS, V23, P198, DOI 10.1007/BF02142539; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kunitz M, 1936, J GEN PHYSIOL, V19, P991, DOI 10.1085/jgp.19.6.991; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; SMITH RA, 1988, BIOCHEMISTRY-US, V27, P6568, DOI 10.1021/bi00417a056; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; TAKAHASHI K, 1976, J BIOCHEM-TOKYO, V80, P497, DOI 10.1093/oxfordjournals.jbchem.a131304; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Umezawa H, 1976, Methods Enzymol, V45, P678; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Zhukov A, 1997, BBA-PROTEIN STRUCT M, V1337, P85, DOI 10.1016/S0167-4838(96)00152-5	50	54	54	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26162	26173		10.1074/jbc.M109.096453	http://dx.doi.org/10.1074/jbc.M109.096453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551327	Green Published, hybrid			2022-12-27	WOS:000280921000033
J	Nagy, S; Rock, RS				Nagy, Stanislav; Rock, Ronald S.			Structured Post-IQ Domain Governs Selectivity of Myosin X for Fascin-Actin Bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE STEP-SIZE; PROCESSIVE MYOSIN; SINGLE-MOLECULE; OPTICAL TRAPS; LEVER-ARM; MOTOR; VI; BINDING; MODEL; NUCLEOTIDE	Without guidance cues, cytoskeletal motors would traffic components to the wrong destination with disastrous consequences for the cell. Recently, we identified a motor protein, myosin X, that identifies bundled actin filaments for transport. These bundles direct myosin X to a unique destination, the tips of cellular filopodia. Because the structural and kinetic features that drive bundle selection are unknown, we employed a domain-swapping approach with the nonselective myosin V to identify the selectivity module of myosin X. We found a surprising role of the myosin X tail region (post-IQ) in supporting long runs on bundles. Moreover, the myosin X head is adapted for initiating processive runs on bundles. We found that the tail is structured and biases the orientation of the two myosin X heads because a targeted insertion that introduces flexibility in the tail abolishes selectivity. Together, these results suggest how myosin motors may manage to read cellular addresses.	[Nagy, Stanislav; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rock, RS (corresponding author), 929 E 57th St,GCIS W240, Chicago, IL 60637 USA.	rrock@uchicago.edu	Nagy, Stanislav/T-5247-2017; Nagy, Stanislav/GXW-2342-2022		National Institutes of Health [GM078450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM078450 (to R. S. R.).	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mehta AD, 1998, METHOD ENZYMOL, V298, P436, DOI 10.1016/S0076-6879(98)98039-9; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; RICCA BL, 2010, BIOPHYS J IN PRESS; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Visscher K, 1996, IEEE J SEL TOP QUANT, V2, P1066, DOI 10.1109/2944.577338; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wuhr M, 2008, CURR BIOL, V18, pR912, DOI 10.1016/j.cub.2008.08.043; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	37	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26608	26617		10.1074/jbc.M110.104661	http://dx.doi.org/10.1074/jbc.M110.104661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538587	Green Published, hybrid			2022-12-27	WOS:000280921000076
J	Zhu, Y; Kim, YM; Li, SB; Zhuang, YA				Zhu, Yi; Kim, Young-Mi; Li, Shibo; Zhuang, Yuan			Generation and Analysis of Partially Haploid Cells with Cre-mediated Chromosome Deletion in the Lymphoid System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MITOTIC RECOMBINATION; MOUSE BONE-MARROW; MOSAIC ANALYSIS; DOUBLE MARKERS; MICE; E2A; REARRANGEMENTS; CONSORTIUM; TRANSPOSON; PROTEINS	The fast accumulation of mutant mouse strains in recent years has provided an invaluable resource for phenotype-based genetic screens. However, study of lymphoid phenotypes can be obscured or impractical if homozygous mutations cause early embryonic defects. To aid phenotype screening of germ line mutations in the lymphoid system, we developed a method to induce loss of heterozygosity (LOH) in developing lymphocytes through chromosome deletion. Chromosome deletion was triggered by Cre/loxP-mediated inverse sister chromatid recombination in the G(2)/M phase of the cell cycle, leading to the generation of daughter cells missing part of or the entire recombinant chromosome. We show that the resulting cells were viable and capable of additional rounds of cell division, thus providing raw materials for subsequent phenotypic assessment. We used the recombination system to induce LOH at the E2A locus in developing B cells. A significant loss of pro-B and pre-B cells was observed when the wild-type allele was removed by chromosome deletion from the E2A heterozygous mice, a result consistent with the required role for E2A in B cell development. We also demonstrated the effectiveness of Cre-mediated chromosome deletion in the LOH assay for HEB function in T cell development. Thus, the Cre-mediated chromosome deletion provides a new and effective method for genome-wide assessment of germ line mutations in the lymphoid system.	[Zhu, Yi; Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Zhu, Yi; Zhuang, Yuan] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Kim, Young-Mi; Li, Shibo] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73014 USA	Duke University; Fudan University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhuang, YA (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	yzhuang@duke.edu		zhuang, yuan/0000-0002-2964-3654	National Basic Research Program of China [2006CB806700]; National Hi-tech Research and Development Program of China [2007AA022101]; Stewart Trust; Duke University Medical Center Bridge; National Institutes of Health [AG034457, CA72433, GM059638]; NATIONAL CANCER INSTITUTE [R01CA072433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034457] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Stewart Trust; Duke University Medical Center Bridge; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Basic Research Program of China Grant 2006CB806700 and National Hi-tech Research and Development Program of China Grant 2007AA022101 (to Fudan University) and by the Stewart Trust Fund, the Duke University Medical Center Bridge Fund, and National Institutes of Health Grants AG034457, CA72433, and GM059638 (to Y. Z.).	BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Collins FS, 2007, CELL, V129, P235, DOI 10.1016/j.cell.2007.04.007; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Gregoire D, 2008, P NATL ACAD SCI USA, V105, P14492, DOI 10.1073/pnas.0807484105; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Otsuji T, 2008, J MOL BIOL, V378, P328, DOI 10.1016/j.jmb.2008.01.065; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Sun L, 2008, P NATL ACAD SCI USA, V105, P4237, DOI 10.1073/pnas.0800798105; Sun LV, 2008, NUCLEIC ACIDS RES, V36, pD729, DOI 10.1093/nar/gkm790; Tada M, 2009, CHROMOSOME RES, V17, P443, DOI 10.1007/s10577-009-9035-0; Wang W, 2007, P NATL ACAD SCI USA, V104, P4501, DOI 10.1073/pnas.0607953104; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	31	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26005	26012		10.1074/jbc.M110.139196	http://dx.doi.org/10.1074/jbc.M110.139196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551312	Green Published, hybrid			2022-12-27	WOS:000280921000015
J	Lachmann, P; Huang, YF; Reimann, J; Flock, U; Adelroth, P				Lachmann, Peter; Huang, Yafei; Reimann, Joachim; Flock, Ulrika; Adelroth, Pia			Substrate Control of Internal Electron Transfer in Bacterial Nitric-oxide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; HEME-COPPER OXIDASE; PARACOCCUS-DENITRIFICANS; PROTON-TRANSFER; ACTIVE-SITE; SPECTROSCOPIC CHARACTERIZATION; DINUCLEAR CENTER; CARBON-MONOXIDE; NO REDUCTION; PATHWAY	Nitric-oxide reductase (NOR) from Paracoccus denitrificans catalyzes the reduction of nitric oxide (NO) to nitrous oxide (N2O) (2NO + 2H(+) + 2e(-) -> N2O + H2O) by a poorly understood mechanism. NOR contains two low spin hemes c and b, one high spin heme b(3), and a non-heme iron Fe-B. Here, we have studied the reaction between fully reduced NOR and NO using the "flow-flash" technique. Fully (four-electron) reduced NOR is capable of two turnovers with NO. Initial binding of NO to reduced heme b(3) occurs with a time constant of similar to 1 mu s at 1.5 mM NO, in agreement with earlier studies. This reaction is [NO]-dependent, ruling out an obligatory binding of NO to FeB before ligation to heme b(3). Oxidation of hemes b and c occurs in a biphasic reaction with rate constants of 50 s(-1) and 3 s(-1) at 1.5 mM NO and pH 7.5. Interestingly, this oxidation is accelerated as [NO] is lowered; the rate constants are 120 s(-1) and 12 s(-1) at 75 mu M NO. Protons are taken up from solution concomitantly with oxidation of the low spin hemes, leading to an acceleration at low pH. This effect is, however, counteracted by a larger degree of substrate inhibition at low pH. Our data thus show that substrate inhibition in NOR, previously observed during multiple turnovers, already occurs during a single oxidative cycle. Thus, NO must bind to its inhibitory site before electrons redistribute to the active site. The further implications of our data for the mechanism of NO reduction by NOR are discussed.	[Lachmann, Peter; Huang, Yafei; Reimann, Joachim; Flock, Ulrika; Adelroth, Pia] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Adelroth, P (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	piaa@dbb.su.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council.	ARMOR JN, 1974, J CHEM ENG DATA, V19, P82, DOI 10.1021/je60060a013; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P240, DOI 10.1016/j.bbabio.2006.04.008; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Brzezinski P, 1998, J BIOENERG BIOMEMBR, V30, P99, DOI 10.1023/A:1020567729941; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Field SJ, 2002, J BIOL CHEM, V277, P20146, DOI 10.1074/jbc.M112202200; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; Hendriks J, 1998, BIOCHEMISTRY-US, V37, P13102, DOI 10.1021/bi980943x; Hendriks JHM, 2001, BIOCHEMISTRY-US, V40, P13361, DOI 10.1021/bi011428t; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Huang YF, 2008, P NATL ACAD SCI USA, V105, P20257, DOI 10.1073/pnas.0805429106; Kumita H, 2004, J BIOL CHEM, V279, P55247, DOI 10.1074/jbc.M409996200; Moenne-Loccoz P, 2000, J AM CHEM SOC, V122, P9344, DOI 10.1021/ja0016295; Moenne-Loccoz P, 1998, J AM CHEM SOC, V120, P5147, DOI 10.1021/ja973671e; Moenne-Loccoz P, 2007, NAT PROD REP, V24, P610, DOI 10.1039/B604194A; Namslauer A, 2002, BIOCHEMISTRY-US, V41, P10369, DOI 10.1021/bi025976y; Pinakoulaki E, 2002, J BIOL CHEM, V277, P23407, DOI 10.1074/jbc.M201913200; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Sakurai T, 2005, BIOCHEM BIOPH RES CO, V333, P483, DOI 10.1016/j.bbrc.2005.05.149; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; Stubauer G, 1998, BIOCHEM BIOPH RES CO, V245, P459, DOI 10.1006/bbrc.1998.8457; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Watmough NJ, 2009, BIOCHEM SOC T, V37, P392, DOI 10.1042/BST0370392; Watmough NJ, 1998, J BIOENERG BIOMEMBR, V30, P55, DOI 10.1023/A:1020507511285; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	34	30	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25531	25537		10.1074/jbc.M110.123984	http://dx.doi.org/10.1074/jbc.M110.123984			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547487	Green Published, hybrid			2022-12-27	WOS:000280682400047
J	Choi, EJ; Kim, DH; Kim, JG; Kim, DY; Kim, JD; Seol, OJ; Jeong, CS; Park, JW; Choi, MY; Kang, SG; Costa, ME; Ojeda, SR; Lee, BJ				Choi, Eun Jung; Kim, Dong Hee; Kim, Jae Geun; Kim, Dong Yeol; Kim, Jung Dae; Seol, Ok Ju; Jeong, Choon Soo; Park, Jeong Woo; Choi, Min Young; Kang, Sung Goo; Costa, Maria E.; Ojeda, Sergio R.; Lee, Byung Ju			Estrogen-dependent Transcription of the NEL-like 2 (NELL2) Gene and Its Role in Protection from Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEXUALLY DIMORPHIC NUCLEUS; FACTOR RECEPTOR GENE; EGF-LIKE REPEATS; PROMOTER REGION; PREOPTIC AREA; RAT-BRAIN; IN-VITRO; MEDIATED NEUROPROTECTION; RESPONSE ELEMENTS; MAMMALIAN-CELLS	NELL2 (neural tissue-specific epidermal growth factor-like repeat domain-containing protein) is a secreted glycoprotein that is predominantly expressed in neural tissues. We reported previously that NELL2 mRNA abundance in brain is increased by estrogen (E2) treatment and that NELL2 is involved in the E2-dependent organization of a sexually dimorphic nucleus in the preoptic area. In this study we cloned the mouse NELL2 promoter and found it to contain two half-E2 response elements. Electrophoretic mobility shift assays and promoter assays showed that E2 and its receptors (ER alpha and ER beta) stimulated NELL2 transcription by binding to the two half-E2 response elements. Hippocampal neuroprogenitor HiB5 cells expressing recombinant NELL2 showed increased cell survival under cell death-inducing conditions. Blockade of endogenous synthesis of NELL2 in HiB5 cells abolished the cell survival effect of E2 and resulted in a decrease in phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2). These data suggest that the NELL2 gene is trans-activated by E2 and contributes to mediating the survival promoting effects of E2 via intracellular signaling pathway of ERK.	[Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Choi, Min Young] Gyeongsang Natl Univ, Dept Life Sci & Appl Life Sci, Jinju 660701, South Korea; [Kang, Sung Goo] Inje Univ, Sch Biotechnol & Biomed Sci, Kimhae 621749, South Korea; [Costa, Maria E.; Ojeda, Sergio R.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	University of Ulsan; Gyeongsang National University; Inje University; Oregon Health & Science University; Oregon National Primate Research Center	Lee, BJ (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	bjlee@ulsan.ac.kr		Kim, Jung Dae/0000-0002-4750-6856	National Institutes of Health [HD25123]; Eunice Kennedy Shriver NICHD [U54 HD18185]; Brain Research Center of 21st Century Frontier Research Program [2009K001268];  [RR000163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, R01HD025123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000163, P51RR000163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Brain Research Center of 21st Century Frontier Research Program; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant HD25123, by the Eunice Kennedy Shriver NICHD through cooperative agreement U54 HD18185 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, and by Grant RR000163 for the operation of the Oregon National Primate Research Center 9to M. E. C. and S. R. O.). This work was also supported by the Brain Research Center of 21st Century Frontier Research Program Research Grant 2009K001268.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARAI Y, 1994, HORM BEHAV, V28, P313, DOI 10.1006/hbeh.1994.1027; BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; BISHOP J, 1994, MOL CELL NEUROSCI, V5, P303, DOI 10.1006/mcne.1994.1036; BROOKS AR, 1991, J BIOL CHEM, V266, P7848; Choi EJ, 2001, MOL BRAIN RES, V97, P115, DOI 10.1016/S0169-328X(01)00302-3; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Ediger TR, 2002, MOL ENDOCRINOL, V16, P1828, DOI 10.1210/me.2001-0290; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gorski R A, 1985, J Anim Sci, V61 Suppl 3, P38; Green PS, 1997, J NEUROSCI, V17, P511; Ha CM, 2008, NEUROENDOCRINOLOGY, V88, P199, DOI 10.1159/000139579; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jeong JK, 2008, MOL CELLS, V26, P186; Jeong JK, 2008, J NEUROCHEM, V106, P1604, DOI 10.1111/j.1471-4159.2008.05505.x; Kim H, 2002, J NEUROCHEM, V83, P1389, DOI 10.1046/j.1471-4159.2002.01245.x; Kim MS, 2002, J BIOL CHEM, V277, P36863, DOI 10.1074/jbc.M206443200; KLINGE CM, 1992, CANCER RES, V52, P1073; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753; LANS MS, 1994, J BIOL CHEM, V269, P14170; Li C, 2001, ENDOCRINOLOGY, V142, P1546, DOI 10.1210/en.142.4.1546; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MCCUBREY JA, 2010, BIOCHIM BIOPHYS ACTA, V1773, P1263; Mize AL, 2003, ENDOCRINOLOGY, V144, P306, DOI 10.1210/en.2002-220698; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Oyasu M, 2000, MOL BRAIN RES, V76, P151, DOI 10.1016/S0169-328X(99)00342-3; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Rabadan-Diehl C, 2000, J NEUROENDOCRINOL, V12, P437; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; RHEES RW, 1990, DEV BRAIN RES, V52, P17, DOI 10.1016/0165-3806(90)90217-M; RISHI AK, 1995, CANCER RES, V55, P4999; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Voigtlander T, 1999, HYPERTENSION, V33, P303, DOI 10.1161/01.HYP.33.1.303; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628	49	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25074	25084		10.1074/jbc.M110.100545	http://dx.doi.org/10.1074/jbc.M110.100545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538601	Green Published, hybrid			2022-12-27	WOS:000280542100080
J	Schmitt, MW; Venkatesan, RN; Pillaire, MJ; Hoffmann, JS; Sidorova, JM; Loeb, LA				Schmitt, Michael W.; Venkatesan, Ranga N.; Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien; Sidorova, Julia M.; Loeb, Lawrence A.			Active Site Mutations in Mammalian DNA Polymerase delta Alter Accuracy and Replication Fork Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI; AMINO-ACID; MISMATCH REPAIR; CANCER GENOME; FIDELITY; MUTATOR; MICE; EXONUCLEASE; PROCESSIVITY	DNA polymerase delta (pol delta) is one of the two main replicative polymerases in eukaryotes; it synthesizes the lagging DNA strand and also functions in DNA repair. In previous work, we demonstrated that heterozygous expression of the pol delta L604G variant in mice results in normal life span and no apparent phenotype, whereas a different substitution at the same position, L604K, is associated with shortened life span and accelerated carcinogenesis. Here, we report in vitro analysis of the homologous mutations at position Leu-606 in human pol delta. Four-subunit human pol delta variants that harbor or lack 3' -> 5'-exonucleolytic proofreading activity were purified from Escherichia coli. The pol delta L606G and L606K holoenzymes retain catalytic activity and processivity similar to that of wild type pol delta. pol delta L606G is highly error prone, incorporating single noncomplementary nucleotides at a high frequency during DNA synthesis, whereas pol delta L606K is extremely accurate, with a higher fidelity of single nucleotide incorporation by the active site than that of wild type pol delta. However, pol delta L606K is impaired in the bypass of DNA adducts, and the homologous variant in mouse embryonic fibroblasts results in a decreased rate of replication fork progression in vivo. These results indicate that different substitutions at a single active site residue in a eukaryotic polymerase can either increase or decrease the accuracy of synthesis relative to wild type and suggest that enhanced fidelity of base selection by a polymerase active site can result in impaired lesion bypass and delayed replication fork progression.	[Loeb, Lawrence A.] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; [Venkatesan, Ranga N.; Sidorova, Julia M.; Loeb, Lawrence A.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien] CNRS, Inst Pharmacol & Struct Biol, Genet Instabil & Canc Grp, F-31077 Toulouse, France; [Pillaire, Marie-Jeanne; Hoffmann, Jean-Sebastien] Univ Toulouse, F-31077 Toulouse, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Loeb, LA (corresponding author), Univ Washington, Sch Med, Dept Biochem, Box 357705, Seattle, WA 98195 USA.	laloeb@u.washington.edu	Hoffmann, Jean-Sebastien/O-9183-2014; Pillaire, Marie-Jeanne/P-1579-2014	Hoffmann, Jean-Sebastien/0000-0003-2222-354X; Pillaire, Marie-Jeanne/0000-0001-6866-7416; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [R01 CA102029, R01 CA115802, P01 CA077852, F30 AG030314, T32 GM007266]; NATIONAL CANCER INSTITUTE [R01CA102029, P01CA077852, R01CA115802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA102029, R01 CA115802, and P01 CA077852 (to L. A. L.) and F30 AG030314 and T32 GM007266 (to M. W. S.).	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Bielas JH, 2007, TRENDS GENET, V23, P154, DOI 10.1016/j.tig.2007.02.009; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Creighton S, 1995, METHOD ENZYMOL, V262, P232; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Floyd RA, 1995, THE OXYGEN PARADOX, P89; Fox EJ, 2009, CANCER RES, V69, P4948, DOI 10.1158/0008-5472.CAN-09-1231; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; LOEB LA, 1974, CANCER RES, V34, P2311; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Loh E, 2010, P NATL ACAD SCI USA, V107, P1154, DOI 10.1073/pnas.0912451107; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; MAKI H, 1985, J BIOL CHEM, V260, P2987; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Pillaire MJ, 2007, CELL CYCLE, V6, P471, DOI 10.4161/cc.6.4.3857; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Shinkai A, 2001, J BIOL CHEM, V276, P46759, DOI 10.1074/jbc.M104780200; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3	54	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32264	32272		10.1074/jbc.M110.147017	http://dx.doi.org/10.1074/jbc.M110.147017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20628184	Green Published, hybrid			2022-12-27	WOS:000282683000039
J	Sokolov, A; Radhakrishnan, A				Sokolov, Anna; Radhakrishnan, Arun			Accessibility of Cholesterol in Endoplasmic Reticulum Membranes and Activation of SREBP-2 Switch Abruptly at a Common Cholesterol Threshold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; CONDENSED COMPLEXES; BINDING; CYTOLYSIN; PORE; MECHANISM; INSERTION; PHOSPHOLIPIDS; METABOLISM; TRANSPORT	Recent studies have shown that cooperative interactions in endoplasmic reticulum (ER) membranes between Scap, cholesterol, and Insig result in switch-like control over activation of SREBP-2 transcription factors. This allows cells to rapidly adjust rates of cholesterol synthesis and uptake in response to even slight deviations from physiological set-point levels, thereby ensuring cholesterol homeostasis. In the present study we directly probe for the accessibility of cholesterol in purified ER membranes. Using a soluble cholesterol-binding bacterial toxin, perfringolysin O, we show that cholesterol accessibility increases abruptly at similar to 5 mol% ERcholesterol, the same concentration at which SREBP-2 activation is halted. This switch-like change in cholesterol accessibility is observed not only in purified ER membranes but also in liposomes made from ER lipid extracts. The accessibility of cholesterol in membranes is related to its chemical activity. Complex formation between cholesterol and some ER phospholipids can result in sharp changes in cholesterol chemical activity and its accessibility to perfringolysin O or membrane sensors like Scap. The control of the availability of the cholesterol ligand to participate in cooperative Scap/cholesterol/Insig interactions further sharpens the sensitive switch that exerts precise control over cholesterol levels in cell membranes.	[Sokolov, Anna; Radhakrishnan, Arun] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Radhakrishnan, A (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	arun314@yahoo.com	Radhakrishnan, Arun/Q-7437-2019	Radhakrishnan, Arun/0000-0002-7266-7336				Anderson TG, 2001, BIOPHYS J, V81, P2774, DOI 10.1016/S0006-3495(01)75920-6; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; McConnell H, 2006, P NATL ACAD SCI USA, V103, P1184, DOI 10.1073/pnas.0510514103; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; REY P, 1977, J AM CHEM SOC, V99, P1637, DOI 10.1021/ja00447a059; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; VAN MEER G, 2008, NAT REV MOL CELL BIO, V9, P112; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; Zitzer A, 2003, FEBS LETT, V553, P229, DOI 10.1016/S0014-5793(03)01023-8	29	68	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29480	29490		10.1074/jbc.M110.148254	http://dx.doi.org/10.1074/jbc.M110.148254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20573965	Green Published, hybrid			2022-12-27	WOS:000281740100050
J	Kleene, R; Cassens, C; Bahring, R; Theis, T; Xiao, MF; Dityatev, A; Schafer-Nielsen, C; Doring, F; Wischmeyer, E; Schachner, M				Kleene, Ralf; Cassens, Claas; Baehring, Robert; Theis, Thomas; Xiao, Mei-Fang; Dityatev, Alexander; Schafer-Nielsen, Claus; Doering, Frank; Wischmeyer, Erhard; Schachner, Melitta			Functional Consequences of the Interactions among the Neural Cell Adhesion Molecule NCAM, the Receptor Tyrosine Kinase TrkB, and the Inwardly Rectifying K+ Channel KIR3.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; PROTEIN-KINASE; BRAIN; ASSOCIATION; HIPPOCAMPUS; EXPRESSION; DEPENDENCE	Cell adhesion molecules and neurotrophin receptors are crucial for the development and the function of the nervous system. Among downstream effectors of neurotrophin receptors and recognition molecules are ion channels. Here, we provide evidence that G protein-coupled inwardly rectifying K+ channel Kir3.3 directly binds to the neural cell adhesion molecule (NCAM) and neurotrophin receptor TrkB. We identified the binding sites for NCAM and TrkB at the C-terminal intracellular domain of Kir3.3. The interaction between NCAM, TrkB, and Kir3.3 was supported by immunocytochemical co-localization of Kir3.3, NCAM, and/or TrkB at the surface of hippocampal neurons. Co-expression of TrkB and Kir3.1/3.3 in Xenopus oocytes increased the K+ currents evoked by Kir3.1/3.3 channels. This current enhancement was reduced by the concomitant co-expression with NCAM. Both surface fluorescence measurements of microinjected oocytes and cell surface biotinylation of transfected CHO cells indicated that the cell membrane localization of Kir3.3 is regulated by TrkB and NCAM. Furthermore, the level of Kir3.3, but not of Kir3.2, at the plasma membranes was reduced in TrkB-deficient mice, supporting the notion that TrkB regulates the cell surface expression of Kir3.3. The premature expression of developmentally late appearing Kir3.1/3.3 in hippocampal neurons led to a reduction of NCAM-induced neurite outgrowth. Our observations indicate a decisive role for the neuronal K+ channel in regulating NCAM-dependent neurite outgrowth and attribute a physiologically meaningful role to the functional interplay of Kir3.3, NCAM, and TrkB in ontogeny.	[Kleene, Ralf; Cassens, Claas; Theis, Thomas; Xiao, Mei-Fang; Dityatev, Alexander; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, D-20246 Hamburg, Germany; [Schafer-Nielsen, Claus] Schafer N ApS, DK-2100 Copenhagen, Denmark; [Doering, Frank; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Martinistr 85, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008; Bähring, Robert/F-7146-2010; Theis, Thomas/I-4247-2019	Dityatev, Alexander/0000-0002-0472-0553; Theis, Thomas/0000-0001-5555-8501; Bahring, Robert/0000-0002-0406-5958; Doring, Frank/0000-0003-1017-1498	Deutsche Forschungsgemeinschaft [SCHA185/17-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA185/17-4.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Beuten J, 2007, BIOL PSYCHIAT, V61, P48, DOI 10.1016/j.biopsych.2006.02.023; Brennaman LH, 2010, ADV EXP MED BIOL, V663, P299, DOI 10.1007/978-1-4419-1170-4_19; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Delling M, 2002, J NEUROSCI, V22, P7154; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1983, P NATL ACAD SCI-BIOL, V80, P4384, DOI 10.1073/pnas.80.14.4384; Grosse G, 2003, MOL CELL NEUROSCI, V24, P709, DOI 10.1016/S1044-7431(03)00234-3; Ippolito DL, 2002, J BIOL CHEM, V277, P32692, DOI 10.1074/jbc.M204407200; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Iwasaki Y, 1997, BIOCHEMISTRY-US, V36, P2694, DOI 10.1021/bi962057x; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Karschin C, 1996, J NEUROSCI, V16, P3559; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kozell LB, 2009, J NEUROSCI, V29, P11662, DOI 10.1523/JNEUROSCI.1413-09.2009; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Rogalski SL, 2000, J BIOL CHEM, V275, P25082, DOI 10.1074/jbc.M000183200; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; TANNAHILL L, 1995, EUR J NEUROSCI, V7, P1424, DOI 10.1111/j.1460-9568.1995.tb01136.x; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Xu K, 2007, PHARMACOGENOMICS J, V7, P368, DOI 10.1038/sj.tpj.6500430	37	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28968	28979		10.1074/jbc.M110.114876	http://dx.doi.org/10.1074/jbc.M110.114876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610389	hybrid, Green Published			2022-12-27	WOS:000281594000062
J	Duderstadt, KE; Mott, ML; Crisona, NJ; Chuang, K; Yang, H; Berger, JM				Duderstadt, Karl E.; Mott, Melissa L.; Crisona, Nancy J.; Chuang, Kevin; Yang, Haw; Berger, James M.			Origin Remodeling and Opening in Bacteria Rely on Distinct Assembly States of the DnaA Initiator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; REPLICATION-ORIGIN; RECOGNITION COMPLEX; BINDING DOMAIN; T-ANTIGEN; IN-VITRO; MUTATIONAL ANALYSIS; STRUCTURAL BASIS; PROTEIN DNAA; AMINO-ACIDS	The initiation of DNA replication requires the melting of chromosomal origins to provide a template for replisomal polymerases. In bacteria, the DnaA initiator plays a key role in this process, forming a large nucleoprotein complex that opens DNA through a complex and poorly understood mechanism. Using structure-guided mutagenesis, biochemical, and genetic approaches, we establish an unexpected link between the duplex DNA-binding domain of DnaA and the ability of the protein to both self-assemble and engage single-stranded DNA in an ATP-dependent manner. Intersubunit cross-talk between this domain and the DnaA ATPase region regulates this link and is required for both origin unwinding in vitro and initiator function in vivo. These findings indicate that DnaA utilizes at least two different oligomeric conformations for engaging single- and double-stranded DNA, and that these states play distinct roles in controlling the progression of initiation.	[Mott, Melissa L.; Crisona, Nancy J.; Chuang, Kevin; Berger, James M.] Univ Calif Berkeley, Calif Inst Quantitat Biol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Yang, Haw] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Princeton University	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Dept Mol & Cell Biol, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Duderstadt, Karl/0000-0002-1279-7841	National Institutes of Health Molecular Biophysics [T32 GM008295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM071747, T32GM008295, R01GM071747] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health Molecular Biophysics Training Grant T32 GM008295.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Alexandrov AI, 2002, J BIOL CHEM, V277, P44886, DOI 10.1074/jbc.M207022200; ASAI T, 1990, EMBO J, V9, P4065, DOI 10.1002/j.1460-2075.1990.tb07628.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Crisona NJ, 2006, J BIOL CHEM, V281, P18927, DOI 10.1074/jbc.M603068200; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Grimwade JE, 2007, MOL MICROBIOL, V66, P428, DOI 10.1111/j.1365-2958.2007.05930.x; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kornberg A., 1992, DNA REPLICATION; KOWALSKI D, 1984, NUCLEIC ACIDS RES, V12, P7071, DOI 10.1093/nar/12.18.7071; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Langer U, 1996, MOL MICROBIOL, V21, P301, DOI 10.1046/j.1365-2958.1996.6481362.x; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Li ZY, 1999, PROTEIN EXPRES PURIF, V17, P41, DOI 10.1006/prep.1999.1094; Marians KJ, 2008, NAT STRUCT MOL BIOL, V15, P125, DOI 10.1038/nsmb0208-125; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Meinke G, 2007, PLOS BIOL, V5, P144, DOI 10.1371/journal.pbio.0050023; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; Schuck S, 2007, J VIROL, V81, P3293, DOI 10.1128/JVI.02432-06; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SIMMONS DT, 1993, J VIROL, V67, P4227, DOI 10.1128/JVI.67.7.4227-4236.1993; Simmons LA, 2003, MOL MICROBIOL, V49, P849, DOI 10.1046/j.1365-2958.2003.03603.x; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stenlund A, 2003, NAT REV MOL CELL BIO, V4, P777, DOI 10.1038/nrm1226; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; WEBER K, 1969, J BIOL CHEM, V244, P4406; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086	63	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28229	28239		10.1074/jbc.M110.147975	http://dx.doi.org/10.1074/jbc.M110.147975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595381	hybrid, Green Published			2022-12-27	WOS:000281404100066
J	Wei, B; Gao, JM; Huang, XP; Jin, JP				Wei, Bin; Gao, Jimin; Huang, Xu-Pei; Jin, J. -P.			Mutual Rescues between Two Dominant Negative Mutations in Cardiac Troponin I and Cardiac Troponin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL TRUNCATION; FUNCTIONAL ADAPTATION; THIN-FILAMENTS; CARDIOMYOPATHY; DOMAIN	Troponin T (TnT) and troponin I (TnI) are two evolutionarily and functionally linked subunits of the troponin complex that regulates striated muscle contraction. We previously reported a single amino acid substitution in the highly conserved TnT-binding helix of cardiac TnI (cTnI) in wild turkey hearts in concurrence with an abnormally spliced myopathic cardiac TnT (cTnT) (Biesiadecki, B. J., Schneider, K. L., Yu, Z. B., Chong, S. M., and Jin, J. P. (2004) J. Biol. Chem. 279, 13825-13832). To investigate the functional effect of this cTnI mutation and its potential value in compensating for the cTnT abnormality, we developed transgenic mice expressing the mutant cTnI (K118C) in the heart with or without the deletion of the endogenous cTnI gene to mimic the homozygote and heterozygote of wild turkeys. Double and triple transgenic mice were created by crossing the cTnI-K118C lines with transgenic mice overexpressing the myopathic cTnT (exon 7 deletion). Functional studies of ex vivo working hearts found that cTnI-K118C alone had a dominantly negative effect on diastolic function and blunted the inotropic responses of cardiac muscle to beta-adrenergic stimuli without abolishing the protein kinase A-dependent phosphorylation of cTnI. When co-expressed with the cTnT mutation, cTnI-K118C corrected the significant depression of systolic function caused by cTnT exon 7 deletion, and the co-existence of exon 7-deleted cTnT minimized the diastolic abnormality of cTnI-K118C. Characterization of this naturally selected pair of mutually rescuing mutations demonstrated that TnI-TnT interaction is a critical link in the Ca2+ signaling and beta-adrenergic regulation in cardiac muscle, suggesting a potential target for the treatment of troponin cardiomyopathies and heart failure.	[Wei, Bin; Gao, Jimin; Jin, J. -P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Wei, Bin; Gao, Jimin; Jin, J. -P.] Northwestern Univ, ENH Res Inst, Evanston, IL 60201 USA; [Huang, Xu-Pei] Florida Atlantic Univ, Sch Biomed Sci, Boca Raton, FL 33431 USA	Wayne State University; Northwestern University; State University System of Florida; Florida Atlantic University	Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	jjin@med.wayne.edu	Wei, Bin/M-2017-2014; Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL-078773, AR-048816]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-078773 and AR-048816.	Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Biesiadecki BJ, 2004, J BIOL CHEM, V279, P13825, DOI 10.1074/jbc.M314225200; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P50275, DOI 10.1074/jbc.M206369200; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P18459, DOI 10.1074/jbc.M200788200; Boussouf SE, 2007, ADV EXP MED BIOL, V592, P99; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Feng HZ, 2009, ARCH BIOCHEM BIOPHYS, V487, P36, DOI 10.1016/j.abb.2009.05.001; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Huang XP, 1999, CIRC RES, V84, P1; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Jin JP, 1996, BIOCHEM BIOPH RES CO, V225, P883, DOI 10.1006/bbrc.1996.1267; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Zhang ZL, 2006, BIOCHEMISTRY-US, V45, P11681, DOI 10.1021/bi060273s	27	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27806	27816		10.1074/jbc.M110.137844	http://dx.doi.org/10.1074/jbc.M110.137844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20551314	hybrid, Green Published			2022-12-27	WOS:000281404100036
J	Yeh, LK; Liu, CY; Kao, WWY; Huang, CJ; Hu, FR; Chien, CL; Wang, IJ				Yeh, Lung-Kun; Liu, Chia-Yang; Kao, Winston W. -Y.; Huang, Chang-Jen; Hu, Fung-Rong; Chien, Chung-Liang; Wang, I-Jong			Knockdown of Zebrafish Lumican Gene (zlum) Causes Scleral Thinning and Increased Size of Scleral Coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; TREE SHREW SCLERA; HIGH MYOPIA; CHROMOSOMAL LOCALIZATION; EYE ENLARGEMENT; EXPRESSION; PIRENZEPINE; RECEPTORS; ATROPINE	The lumican gene (lum), which encodes one of the major keratan sulfate proteoglycans (KSPGs) in the vertebrate cornea and sclera, has been linked to axial myopia in humans. In this study, we chose zebrafish (Danio rerio) as an animal model to elucidate the role of lumican in the development of axial myopia. The zebrafish lumican gene (zlum) spans similar to 4.6 kb of the zebrafish genome. Like human (hLUM) and mouse (mlum), zlum consists of three exons, two introns, and a TATA box-less promoter at the 5'-flanking region of the transcription initiation site. Sequence analysis of the cDNA predicts that zLum encodes 344 amino acids. zLum shares 51% amino acid sequence identity with human lumican. Similar to hLUM and mlum, zlum mRNA is expressed in the eye and many other tissues, such as brain, muscle, and liver as well. Transgenic zebrafish harboring an enhanced GFP reporter gene construct downstream of a 1.7-kb zlum 5'-flanking region displayed enhanced GFP expression in the cornea and sclera, as well as throughout the body. Downregulation of zlum expression by antisense zlum morpholinos manifested ocular enlargement resembling axial myopia due to disruption of the collagen fibril arrangement in the sclera and resulted in scleral thinning. Administration of muscarinic receptor antagonists, e. g. atropine and pirenzepine, effectively subdued the ocular enlargement caused by morpholinos in in vivo zebrafish larvae assays. The observation suggests that zebrafish can be used as an in vivo model for screening compounds in treating myopia.	[Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 100, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linko, Dept Ophthalmol, Tao Yuan 333, Taiwan; [Liu, Chia-Yang; Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Cell Biol Neurosci & Anat, Cincinnati, OH 45267 USA; [Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan	National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Chien, CL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Sec 1,Jen Ai Rd, Taipei 100, Taiwan.	chien@ntu.edu.tw; ijong@ms8.hinet.net		Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; HU, FUNG-RONG/0000-0002-2102-5317	National Institutes of Health, NEI [EY12486, EY011845]; National Science Council [923112B002004, 933112B002031, 943112B002007, 932314B002090, 942314B002043, 952314B002149MY3, 972314B182A059, 982314B182A029MY3, 983112B002040]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY011845, R01EY012486] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Council(Ministry of Science and Technology, Taiwan); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY12486 from NEI (to C.-Y.L.) and EY011845 (to W. W.Y.K.). This work was also supported in part by National Science Council Grants 923112B002004, 933112B002031, 943112B002007, 932314B002090, 942314B002043, 952314B002149MY3, 972314B182A059, 982314B182A029MY3, and 983112B002040, Research to Prevent Blindness, and Ohio Lions Eye Research Foundation.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; Barathi VA, 2009, MOL VIS, V15, P1277; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Chou AC, 1997, J OCUL PHARMACOL TH, V13, P61, DOI 10.1089/jop.1997.13.61; CONRAD GW, 2000, CARBOHYDRATES CHEM 2, V4, P717; Cottriall CL, 1996, INVEST OPHTH VIS SCI, V37, P1368; Cottriall CL, 1999, OPHTHAL PHYSL OPT, V19, P327, DOI 10.1016/S0275-5408(98)00079-9; Deere M, 1996, GENOMICS, V38, P399, DOI 10.1006/geno.1996.0643; FISHER LW, 1991, J BIOL CHEM, V266, P14371; FUNDERBURGH JL, 1991, BIOCHEM SOC T, V19, P871, DOI 10.1042/bst0190871; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Iozzo RV, 1999, PROG NUCLEIC ACID RE, V62, P19; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Johnson J, 2006, MOL VIS, V12, P1057; Kao WWY, 2006, CORNEA, V25, pS7, DOI 10.1097/01.ico.0000247207.55520.a4; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; LIU CY, 1994, J BIOL CHEM, V269, P24627; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; LIU O, 2007, MOL VIS, V13, P1234; Luft WA, 2003, INVEST OPHTH VIS SCI, V44, P1330, DOI 10.1167/iovs.02-0796; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Morel L, 2004, PLOS BIOL, V2, P1061, DOI 10.1371/journal.pbio.0020241; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paluru PC, 2004, MOL VIS, V10, P917; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; PULKKINEN L, 1992, CYTOGENET CELL GENET, V60, P107, DOI 10.1159/000133314; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Raouf A, 2002, MATRIX BIOL, V21, P361, DOI 10.1016/S0945-053X(02)00027-6; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P2094, DOI 10.1167/iovs.02-1059; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; SCHWARTZ M, 1990, CLIN GENET, V38, P281; Shih YF, 2001, ACTA OPHTHALMOL SCAN, V79, P233, DOI 10.1034/j.1600-0420.2001.790304.x; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; STONE RA, 1991, EXP EYE RES, V52, P755, DOI 10.1016/0014-4835(91)90027-C; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tan DTH, 2005, OPHTHALMOLOGY, V112, P84, DOI 10.1016/j.ophtha.2004.06.038; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Wang IJ, 2006, MOL VIS, V12, P852; Westerfield M, 1995, ZEBRAFISH BOOK; Williams FE, 2004, COMP BIOCHEM PHYS C, V137, P349, DOI 10.1016/j.cca.2004.03.002; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; Yeh LK, 2008, J BIOL CHEM, V283, P506, DOI 10.1074/jbc.M707656200; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111	61	31	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28141	28155		10.1074/jbc.M109.043679	http://dx.doi.org/10.1074/jbc.M109.043679			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20551313	Green Published, hybrid			2022-12-27	WOS:000281404100057
J	Burch, ML; Ballinger, ML; Yang, SNY; Getachew, R; Itman, C; Loveland, K; Osman, N; Little, PJ				Burch, Micah L.; Ballinger, Mandy L.; Yang, Sundy N. Y.; Getachew, Robel; Itman, Catherine; Loveland, Kate; Osman, Narin; Little, Peter J.			Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor beta Type I Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ATHEROSCLEROSIS; SMAD; GROWTH-FACTOR-BETA-1; ANTAGONIST; BIGLYCAN; DISEASE; PAR-1; CELLS	Growth factors modify the structure of the glycosaminoglycan (GAG) chains on biglycan leading to enhanced LDL binding. G-protein receptor-coupled agonists such as thrombin, signal changes the structure of proteoglycans produced by vascular smooth muscle cells (VSMCs). One component of classical G-protein- coupled receptor (GPCR) signaling invokes transactivation of protein tyrosine kinase receptors such as the epidermal growth factor receptor. Serine/threonine receptor growth factors such as transforming growth factor-(TGF)-beta are potent activators of proteoglycan synthesis. We have used the model of proteoglycan synthesis to demonstrate that the signaling paradigm of GPCR signaling can be extended to include the transactivation of serine/threonine receptor, specifically the TGF-beta type I receptor (T beta RI) also known as activin-like kinase (ALK) V. Thrombin stimulated elongation of GAG chains and increased proteoglycan core protein expression and these responses were blocked by the T beta RI antagonist, SB431542 and T beta RI siRNA knockdown, as well as several protease-activated receptor (PAR)-1 antagonists. The canonical downstream response to TGF-beta is increased C-terminal phosphorylation of the transcription factor Smad2 generating phospho-Smad2C (phosphorylation of Smad2 C-terminal region). Thrombin stimulated increased phospho-Smad2C levels, and the response was blocked by SB431542 and JNJ5177094. The proteolytically inactive thrombin mimetic thrombin-receptor activating peptide also stimulated an increase in cytosolic phospho-Smad2C. Signaling pathways for growth factor regulated proteoglycan synthesis represent therapeutic targets for the prevention of atherosclerosis, but the novel finding of a GPCR-mediated transactivation of a serine/threonine growth factor receptor almost certainly has implications well beyond the synthesis of proteoglycans.	[Burch, Micah L.; Ballinger, Mandy L.; Yang, Sundy N. Y.; Getachew, Robel; Osman, Narin; Little, Peter J.] BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Med, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Immunol, Melbourne, Vic 3004, Australia; [Itman, Catherine; Loveland, Kate] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Itman, Catherine; Loveland, Kate] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University	Little, PJ (corresponding author), BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia.	peter.little@bakeridi.edu.au	Little, Peter J./F-9865-2015; Loveland, Kate L/X-4404-2019	Little, Peter J./0000-0002-0335-3835; Loveland, Kate L/0000-0002-5750-8046; yang, sundy/0000-0003-2418-1611; Ballinger, Mandy/0000-0002-9706-0514	National Health and Medical Research Council of Australia [268928, 472611, 418934]; Diabetes Australia Research Trust; National Heart Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by National Health and Medical Research Council of Australia Project Grants 268928 and 472611, Development Grant 418934 (to P. J. L.) and Fellowship (to P .J. L.); project grants from the Diabetes Australia Research Trust (to P. J. L. and N. O.); and a grant-in-aid from the National Heart Foundation of Australia (to P. J. L.).	Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; Coughlin SR, 1999, THROMB HAEMOSTASIS, V82, P353; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dabbagh K, 1998, THROMB HAEMOSTASIS, V79, P405; Dadlani H, 2008, J BIOL CHEM, V283, P7844, DOI 10.1074/jbc.M703125200; Damiano BP, 2003, CARDIOVASC DRUG REV, V21, P313; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Harris H, 2004, CYTOKINE, V25, P85, DOI 10.1016/j.cyto.2003.10.002; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Ivey ME, 2008, THROMB RES, V123, P288, DOI 10.1016/j.thromres.2008.04.019; JANSSENS WJ, 1982, BLOOD VESSELS, V19, P126; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Lefkowitz RJ, 2007, BBA-BIOMEMBRANES, V1768, P748, DOI 10.1016/j.bbamem.2006.11.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Little PJ, 2008, CURR OPIN LIPIDOL, V19, P448, DOI 10.1097/MOL.0b013e32830dd7c4; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Maryanoff Bruce E., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P13, DOI 10.2174/1568016033356724; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; NEYLON CB, 1992, J BIOL CHEM, V267, P7295; Nigro J, 2002, ATHEROSCLEROSIS, V162, P119, DOI 10.1016/S0021-9150(01)00704-3; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069	36	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26798	26805		10.1074/jbc.M109.092767	http://dx.doi.org/10.1074/jbc.M109.092767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571025	hybrid, Green Published			2022-12-27	WOS:000281172700010
J	Haeusler, RA; Han, S; Accili, D				Haeusler, Rebecca A.; Han, Seongah; Accili, Domenico			Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; FATTY-ACID SYNTHESIS; FORKHEAD PROTEIN FOXO1; INSULIN-RESISTANCE; DEPENDENT REGULATION; DIABETES-MELLITUS; VLDL PRODUCTION; PPAR-ALPHA; MICE; LIVER	Patients with diabetes suffer disproportionately from impaired lipid metabolism and cardiovascular disease, but the relevant roles of insulin resistance and hyperglycemia in these processes are unclear. Transcription factor FoxO1 is regulated dually by insulin and nutrients. In this study, we addressed the hypothesis that, in addition to its established role to regulate hepatic glucose production, FoxO1 controls aspects of lipid metabolism in the diabetic liver. Mice with a liver-specific deletion of FoxO1 (L-FoxO1) and their control littermates were rendered hyperglycemic by streptozotocin administration. Subsequently, we monitored serum lipids, liver VLDL secretion, and hepatic expression of genes related to lipid metabolism. Hepatic FoxO1 ablation resulted in increased VLDL secretion, increased cholesterol, and increased plasma free fatty acids, three hallmarks of the diabetic state. L-FoxO1 mice expressed increased levels of SREBP-2 and FGF21 without affecting lipogenic genes. We propose that FoxO1 fine tunes lipolysis through its actions on FGF21 and that hepatic FoxO1 ablation increases availability of substrates for hepatic triglyceride and cholesterol synthesis and VLDL secretion. The implications of these findings are that FoxO1 protects against excessive hepatic lipid production during hyperglycemia and that its inhibition by intensive insulin treatment may exacerbate paradoxically the lipid abnormalities of diabetes.	[Haeusler, Rebecca A.; Han, Seongah; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Haeusler, Rebecca/0000-0002-6973-9845	National Institutes of Health (Columbia Diabetes & Endocrinology Research Center) [P01HL87123, T32DK07328, P30DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health (Columbia Diabetes & Endocrinology Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01HL87123, T32DK07328, and P30DK63608 (Columbia Diabetes & Endocrinology Research Center).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Annuzzi G, 2004, ARTERIOSCL THROM VAS, V24, P2397, DOI 10.1161/01.ATV.0000146267.71816.30; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; REAVEN EP, 1974, J CLIN INVEST, V54, P1167, DOI 10.1172/JCI107860; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sobel BE, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.07.002; Takahashi T, 2003, METABOLISM, V52, P1354, DOI 10.1016/S0026-0495(03)00202-6; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	47	58	61	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26861	26868		10.1074/jbc.M110.134023	http://dx.doi.org/10.1074/jbc.M110.134023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573950	hybrid, Green Published			2022-12-27	WOS:000281172700017
J	Kovacs, JM; Hannan, JP; Eisenmesser, EZ; Holers, VM				Kovacs, James M.; Hannan, Jonathan P.; Eisenmesser, Elan Z.; Holers, V. Michael			Biophysical Investigations of Complement Receptor 2 (CD21 and CR2)-Ligand Interactions Reveal Amino Acid Contacts Unique to Each Receptor-Ligand Pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; HUMAN LYMPHOCYTES-B; C3D RECEPTOR; BINDING-SITE; GP350/220 BINDING; ANTIGEN RECEPTOR; EBV/C3D RECEPTOR; NMR-SPECTROSCOPY; FRAGMENT C3D; IFN-ALPHA	Human complement receptor type 2 (CR2 and CD21) is a cell membrane receptor, with 15 or 16 extracellular short consensus repeats (SCRs), that promotes B lymphocyte responses and bridges innate and acquired immunity. The most distally located SCRs, SCR1-2, mediate the interaction of CR2 with its four known ligands (C3d, EBV gp350, IFN alpha, and CD23). To ascertain specific interacting residues on CR2, we utilized NMR studies wherein gp350 and IFN alpha were titrated into N-15-labeled SCR1-2, and chemical shift changes indicative of specific intermolecular interactions were identified. With backbone assignments made, the chemical shift changes were mapped onto the crystal structure of SCR1-2. With regard to gp350, the binding region of CR2 is primarily focused on SCR1 and the inter-SCR linker, specifically residues Asn(11), Arg(13), Ala(22), Arg(28), Ser(32), Arg(36), Lys(41), Lys(57), Tyr(64), Lys(67), Tyr(68), Arg(83), Gly(84), and Arg(89). With regard to IFN alpha, the binding is similar to the CR2-C3d interaction with specific residues being Arg(13), Tyr(16), Arg(28), Ser(42), Lys(48), Lys(50), Tyr(68), Arg(83), Gly(84), and Arg(89). We also report thermodynamic properties of each ligand-receptor pair determined using isothermal titration calorimetry. The CR2-C3d interaction was characterized as a two-mode binding interaction with K-d values of 0.13 and 160 mu M, whereas the CR2-gp350 and CR2-IFN alpha interactions were characterized as single site binding events with affinities of 0.014 and 0.035 mu M, respectively. The compilation of chemical binding maps suggests specific residues on CR2 that are uniquely important in each of these three binding interactions.	[Kovacs, James M.; Holers, V. Michael] Univ Colorado, Denver Sch Med, Dept Med & Immunol, Aurora, CO 80045 USA; [Eisenmesser, Elan Z.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hannan, Jonathan P.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Edinburgh	Holers, VM (corresponding author), 1775 Aurora Ct,M20-3102E Mail Stop B115, Aurora, CO 80045 USA.	michael.holers@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341	National Institutes of Health [R0-1 CA053615]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 CA053615 (to V. M. H.). This work was also supported by an American Heart Association predoctoral fellowship (to J. M. K.) and assisted by the University of Colorado Denver-Rocky Mountain Regional 900 MHz Facility.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; AHEARN JM, 1988, P NATL ACAD SCI USA, V85, P9307, DOI 10.1073/pnas.85.23.9307; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; BOHNSACK JF, 1988, J IMMUNOL, V141, P2569; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; CARTER RH, 1989, J IMMUNOL, V143, P1755; COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELCAYRE AX, 1993, J VIROL, V67, P2918, DOI 10.1128/JVI.67.5.2918-2921.1993; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; HADDAD RS, 1989, J VIROL, V63, P4998, DOI 10.1128/JVI.63.12.4998-5005.1989; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HOLERS VM, 1995, PRINCIPLES PRACTICES, P363; IIDA K, 1983, J EXP MED, V158, P1021, DOI 10.1084/jem.158.4.1021; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Takahashi K, 1997, J IMMUNOL, V159, P1557; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Tolnay M, 1998, CLIN IMMUNOL IMMUNOP, V88, P123, DOI 10.1006/clin.1998.4552; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047; WEIS JJ, 1986, P NATL ACAD SCI USA, V83, P5639, DOI 10.1073/pnas.83.15.5639; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Young KA, 2008, J VIROL, V82, P11217, DOI 10.1128/JVI.01673-08; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200; Zhang L, 2007, J MOL BIOL, V369, P567, DOI 10.1016/j.jmb.2007.02.101; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	60	10	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27251	27258		10.1074/jbc.M110.106617	http://dx.doi.org/10.1074/jbc.M110.106617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558730	hybrid, Green Published			2022-12-27	WOS:000281172700056
J	de Castro, RO; Zhang, J; Jamur, MC; Oliver, C; Siraganian, RP				de Castro, Rodrigo O.; Zhang, Juan; Jamur, Maria C.; Oliver, Constance; Siraganian, Reuben P.			Tyrosines in the Carboxyl Terminus Regulate Syk Kinase Activity and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; CELL ANTIGEN RECEPTOR; PHOSPHOTYROSINE-BINDING DOMAIN; BASOPHILIC LEUKEMIA-CELLS; ACTIVATION LOOP TYROSINES; PROTEIN-COUPLED RECEPTOR; MAST-CELLS; SIGNAL-TRANSDUCTION; IMMUNOGLOBULIN-E	The Syk tyrosine kinase family plays an essential role in immunoreceptor tyrosine-based activation motif (ITAM) signaling. The binding of Syk to tyrosine-phosphorylated ITAM subunits of immunoreceptors, such as Fc epsilon RI on mast cells, results in a conformational change, with an increase of enzymatic activity of Syk. This conformational change exposes the COOH-terminal tail of Syk, which has three conserved Tyr residues (Tyr-623, Tyr-624, and Tyr-625 of rat Syk). To understand the role of these residues in signaling, wild-type and mutant Syk with these three Tyr mutated to Phe was expressed in Syk-deficient mast cells. There was decreased Fc epsilon RI-induced degranulation, nuclear factor for T cell activation and NF kappa B activation with the mutated Syk together with reduced phosphorylation of MAP kinases p38 and p42/44 ERK. In non-stimulated cells, the mutated Syk was more tyrosine phosphorylated predominantly as a result of autophosphorylation. In vitro, there was reduced binding of mutated Syk to phosphorylated ITAM due to this increased phosphorylation. This mutated Syk from non-stimulated cells had significantly reduced kinase activity toward an exogenous substrate, whereas its autophosphorylation capacity was not affected. However, the kinase activity and the autophosphorylation capacity of this mutated Syk were dramatically decreased when the protein was dephosphorylated before the in vitro kinase reaction. Furthermore, mutation of these tyrosines in the COOH-terminal region of Syk transforms it to an enzyme, similar to its homolog ZAP-70, which depends on other tyrosine kinases for optimal activation. In testing Syk mutated singly at each one of the tyrosines, Tyr-624 but especially Tyr-625 had the major role in these reactions. Therefore, these results indicate that these tyrosines in the tail region play a critical role in regulating the kinase activity and function of Syk.	[Siraganian, Reuben P.] Natl Inst Dent & Craniofacial Res, Receptors & Signal Transduct Sect, NIH, Bethesda, MD 20892 USA; [de Castro, Rodrigo O.; Jamur, Maria C.; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049900 Sao Paulo, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidade de Sao Paulo	Siraganian, RP (corresponding author), Natl Inst Dent & Craniofacial Res, Receptors & Signal Transduct Sect, NIH, Bldg 49,Rm 1A16,NIDCR, Bethesda, MD 20892 USA.	rs53x@nih.gov	Jamur, Maria Celia/L-5520-2016	Jamur, Maria Celia/0000-0001-7065-8543	NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIDCR.	Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; Chen T, 1996, J BIOL CHEM, V271, P25308, DOI 10.1074/jbc.271.41.25308; Cho SH, 2004, J ALLERGY CLIN IMMUN, V114, P1085, DOI 10.1016/j.jaci.2004.07.035; Costello PS, 1996, ONCOGENE, V13, P2595; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grodzki ACG, 2009, MOL IMMUNOL, V46, P2539, DOI 10.1016/j.molimm.2009.05.013; Hamawy MM, 1997, BIOCHEM BIOPH RES CO, V239, P670, DOI 10.1006/bbrc.1997.7532; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Hsueh Robert C, 2002, BMC Immunol, V3, P16, DOI 10.1186/1471-2172-3-16; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Klemm S, 2006, IMMUNOBIOLOGY, V211, P815, DOI 10.1016/j.imbio.2006.07.001; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Latour S, 1998, EMBO J, V17, P2584, DOI 10.1093/emboj/17.9.2584; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; SHIUE L, 1995, MOL CELL BIOL, V15, P272, DOI 10.1128/MCB.15.1.272; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAYLOR JA, 1995, MOL CELL BIOL, V15, P4149; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; Wu JN, 2004, J IMMUNOL, V172, P6768, DOI 10.4049/jimmunol.172.11.6768; Yamashita T, 1998, J BIOCHEM, V123, P1199; YANAGI S, 1995, CELL SIGNAL, V7, P185, DOI 10.1016/0898-6568(94)00088-S; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang J, 2007, J BIOL CHEM, V282, P37669, DOI 10.1074/jbc.M705168200; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	65	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26674	26684		10.1074/jbc.M110.134262	http://dx.doi.org/10.1074/jbc.M110.134262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554527	hybrid, Green Published			2022-12-27	WOS:000280921000082
J	Meshki, J; Caino, MC; von Burstin, VA; Griner, E; Kazanietz, MG				Meshki, John; Caino, M. Cecilia; von Burstin, Vivian A.; Griner, Erin; Kazanietz, Marcelo G.			Regulation of Prostate Cancer Cell Survival by Protein Kinase C epsilon Involves Bad Phosphorylation and Modulation of the TNF alpha/JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER-INDUCED APOPTOSIS; EPIDERMAL-GROWTH-FACTOR; PKC-EPSILON; MOLECULAR-MECHANISMS; MEDIATED APOPTOSIS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; DOWN-REGULATION; GLIOMA-CELLS; DELTA-PKC	Protein kinase C epsilon (PKC epsilon), a diacyglycerol- and phorbol ester-responsive serine-threonine kinase, has been implicated in mitogenic and survival control, and it is markedly overexpressed in human tumors, including in prostate cancer. Although prostate cancer cells undergo apoptosis in response to phorbol ester stimulation via PKC delta-mediated release of death factors, the involvement of PKC epsilon in this response is not known. PKC epsilon depletion by RNAi or expression of a dominant negative kinase-dead PKC epsilon mutant potentiated the apoptotic response of PMA and sensitized LNCaP cells to the death receptor ligand TNF alpha. On the other hand, overexpression of PKC epsilon by adenoviral means protected LNCaP cells against apoptotic stimuli. Interestingly, PKC epsilon RNAi depletion significantly enhanced the release of TNF alpha in response to PMA and greatly potentiated JNK activation by this cytokine. Further mechanistic analysis revealed that PMA fails to promote phosphorylation of Bad in Ser(112) in PKC epsilon-depleted LNCaP cells, whereas PKC epsilon overexpression greatly enhanced Bad phosphorylation. This effect was independent of Akt, ERK, or p90Rsk, well established kinases for Ser(112) in Bad. Moreover, expression of a S112A-Bad mutant potentiated PMA-induced apoptosis. Finally, we found that upon activation PKC epsilon accumulated in mitochondrial fractions in LNCaP cells and that Bad was a substrate of PKC epsilon in vitro. Our results established that PKC epsilon modulates survival in prostate cancer cells via multiple pathways.	[Meshki, John; Caino, M. Cecilia; von Burstin, Vivian A.; Griner, Erin; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazanietz, MG (corresponding author), 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Caino, M. Cecilia/0000-0001-8294-8070	National Institutes of Health [R01-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; BLUMBERG PM, 1988, CANCER RES, V48, P1; BORNER C, 1995, J BIOL CHEM, V270, P78, DOI 10.1074/jbc.270.1.78; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cacace AM, 1998, J CELL PHYSIOL, V175, P314, DOI 10.1002/(SICI)1097-4652(199806)175:3<314::AID-JCP9>3.0.CO;2-R; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAY ML, 1994, CELL GROWTH DIFFER, V5, P735; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garzotto M, 1999, CANCER RES, V59, P5194; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Ikezoe T, 2004, BRIT J CANCER, V90, P2017, DOI 10.1038/sj.bjc.6601834; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Koren R, 2004, ONCOL REP, V11, P321; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mukherjee S, 2009, J ENVIRON PATHOL TOX, V28, P269, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.30; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Powell CT, 2006, INT J CANCER, V118, P1572, DOI 10.1002/ijc.21511; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shinohara H, 2001, BIOCHEM BIOPH RES CO, V284, P1162, DOI 10.1006/bbrc.2001.5104; Shiroshita N, 2001, J PHARMACOL EXP THER, V297, P868; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Wu DQ, 2002, CANCER RES, V62, P2423; Xiao LQ, 2008, METHOD ENZYMOL, V446, P123, DOI 10.1016/S0076-6879(08)01607-8; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yin LH, 2005, J BIOL CHEM, V280, P5533, DOI 10.1074/jbc.M405266200; Yu R, 2000, CANCER RES, V60, P2384; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	48	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26033	26040		10.1074/jbc.M110.128371	http://dx.doi.org/10.1074/jbc.M110.128371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566643	Green Published, hybrid			2022-12-27	WOS:000280921000018
J	Boyd, M; Hansen, M; Jensen, TGK; Perearnau, A; Olsen, AK; Bram, LL; Bak, M; Tommerup, N; Olsen, J; Troelsen, JT				Boyd, Mette; Hansen, Morten; Jensen, Tine G. K.; Perearnau, Anna; Olsen, Anders K.; Bram, Lotte L.; Bak, Mads; Tommerup, Niels; Olsen, Jorgen; Troelsen, Jesper T.			Genome-wide Analysis of CDX2 Binding in Intestinal Epithelial Cells (Caco-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTORS; CAUDAL-RELATED HOMEOBOX; GENE-EXPRESSION; BETA-CATENIN; DIFFERENTIAL EXPRESSION; PROTEINS; ACTIVATION; BOX; HEPATOCYTE-NUCLEAR-FACTOR-4-ALPHA; PHOSPHORYLATION	The CDX2 transcription factor is known to play a crucial role in inhibiting proliferation, promoting differentiation and the expression of intestinal specific genes in intestinal cells. The overall effect of CDX2 in intestinal cells has previously been investigated in conditional knock-out mice, revealing a critical role of CDX2 in the formation of the normal intestinal identity. The identification of direct targets of transcription factors is a key problem in the study of gene regulatory networks. The ChIP-seq technique combines chromatin immunoprecipitation (ChIP) with next generation sequencing resulting in a high throughput experimental method of identifying direct targets of specific transcription factors. The method was applied to CDX2, leading to the identification of the direct binding of CDX2 to several known and novel target genes in the intestinal cell. Examination of the transcript levels of selected genes verified the regulatory role of CDX2 binding. The results place CDX2 as a key node in a transcription factor network controlling the proliferation and differentiation of intestinal cells.	[Bak, Mads; Tommerup, Niels; Troelsen, Jesper T.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Troelsen, JT (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, Bldg 6-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	troelsen@sund.ku.dk	Troelsen, Jesper Thorvald T/B-6264-2013; Olsen, Jørgen/K-5355-2019; Tommerup, Niels/T-8776-2017	Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Olsen, Jørgen/0000-0003-1974-6446; Tommerup, Niels/0000-0003-2304-0112; Perearnau, Anna/0000-0002-7925-2942; Bak, Mads/0000-0003-2762-1002	Novo Nordisk Foundation; Lundbeck Foundation; Danish Research Council; Lundbeck Foundation [R13-2007-1172] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Novo Nordisk Foundation, the Lundbeck Foundation, and the Danish Research Council.	Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Balakrishnan A, 2008, SURGERY, V144, P168, DOI 10.1016/j.surg.2008.03.010; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fang RX, 2006, GENE EXPR PATTERNS, V6, P426, DOI 10.1016/j.modgep.2005.09.003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gautier-Stein A, 2003, NUCLEIC ACIDS RES, V31, P5238, DOI 10.1093/nar/gkg747; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hadari YR, 2000, J CELL SCI, V113, P2385; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; JAMES R, 1991, J BIOL CHEM, V266, P3246; Jedlicka P, 2009, AM J PATHOL, V174, P1280, DOI 10.2353/ajpath.2009.080409; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Krasinski SD, 2001, AM J PHYSIOL-GASTR L, V281, pG69, DOI 10.1152/ajpgi.2001.281.1.G69; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Lottaz D, 1999, CANCER RES, V59, P1127; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; Okochi H, 1999, J CLIN GASTROENTEROL, V29, P63, DOI 10.1097/00004836-199907000-00016; OKUDA T, 1995, GENOMICS, V29, P623, DOI 10.1006/geno.1995.9957; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sauvaget D, 2002, J BIOL CHEM, V277, P34540, DOI 10.1074/jbc.M206074200; Schjoldager KTBG, 2008, AM J PHYSIOL-GASTR L, V294, pG1335, DOI 10.1152/ajpgi.00265.2007; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimizu T, 2006, DEVELOPMENT, V133, P4709, DOI 10.1242/dev.02660; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Troelsen JT, 2003, GENE, V305, P101, DOI 10.1016/S0378-1119(02)01232-5; Valente AJ, 2008, FREE RADICAL BIO MED, V44, P430, DOI 10.1016/j.freeradbiomed.2007.10.035; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang LY, 2004, AM J PHYSIOL-GASTR L, V287, pG943, DOI 10.1152/ajpgi.00121.2004; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310	62	60	61	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25115	25125		10.1074/jbc.M109.089516	http://dx.doi.org/10.1074/jbc.M109.089516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551321	hybrid, Green Published			2022-12-27	WOS:000280682400003
J	Yamasaki-Mann, M; Demuro, A; Parker, I				Yamasaki-Mann, Michiko; Demuro, Angelo; Parker, Ian			Modulation of Endoplasmic Reticulum Ca2+ Store Filling by Cyclic ADP-ribose Promotes Inositol Trisphosphate (IP3)-evoked Ca2+ Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; 1,4,5-TRISPHOSPHATE RECEPTOR; CYTOSOLIC CA2+; LUMINAL CA2+; CALCIUM STORES; IP3 RECEPTORS; RELEASE; CHANNEL; ACTIVATION; SINGLE	In addition to its well established function in activating Ca2+ release from the endoplasmic reticulum (ER) through ryanodine receptors (RyR), the second messenger cyclic ADP-ribose (cADPR) also accelerates the activity of SERCA pumps, which sequester Ca2+ into the ER. Here, we demonstrate a potential physiological role for cADPR in modulating cellular Ca2+ signals via changes in ER Ca2+ store content, by imaging Ca2+ liberation through inositol trisphosphate receptors (IP3R) in Xenopus oocytes, which lack RyR. Oocytes were injected with the non-metabolizable analog 3-deaza-cADPR, and cytosolic [Ca2+] was transiently elevated by applying voltage-clamp pulses to induce Ca2+ influx through expressed plasmalemmal nicotinic channels. We observed a subsequent potentiation of global Ca2+ signals evoked by strong photorelease of IP3, and increased numbers of local Ca2+ puffs evoked by weaker photorelease. These effects were not evident with cADPR alone or following cytosolic Ca2+ elevation alone, indicating that they did not arise through direct actions of cADPR or Ca2+ on the IP3R, but likely resulted from enhanced ER store filling. Moreover, the appearance of a new population of puffs with longer latencies, prolonged durations, and attenuated amplitudes suggests that luminal ER Ca2+ may modulate IP3R function, in addition to simply determining the size of the available store and the electrochemical driving force for release.	[Yamasaki-Mann, Michiko; Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Parker, Ian] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Yamasaki-Mann, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 635 Charles Young Dr S, Los Angeles, CA 90095 USA.	michikomann@ucla.edu			National Institutes of Health [GM48071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048071, R37GM048071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM48071 (to I. P.) from the National Institutes of Health.	Albrecht MA, 2002, J GEN PHYSIOL, V119, P211, DOI 10.1085/jgp.119.3.211; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERS DM, 1995, AM J PHYSIOL-CELL PH, V268, pC271, DOI 10.1152/ajpcell.1995.268.1.C271; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Bruzzone S, 2003, J CELL BIOL, V163, P837, DOI 10.1083/jcb.200307016; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Ching LL, 2000, CIRC RES, V87, P201, DOI 10.1161/01.RES.87.3.201; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Friel D, 2004, BIOL RES, V37, P665, DOI 10.4067/s0716-97602004000400024; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; HIROSE K, 1994, NATURE, V372, P791; HORNE JH, 1995, BIOCHEMISTRY-US, V34, P12738, DOI 10.1021/bi00039a033; Lukyanenko V, 2001, CIRC RES, V89, P614, DOI 10.1161/hh1901.098066; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MISSIAEN L, 1992, J BIOL CHEM, V267, P22961; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MORGAN AJ, 2002, CYCLIC ADP RIBOSE NA; OLDERSHAW KA, 1993, BIOCHEM J, V292, P631, DOI 10.1042/bj2920631; Olson ML, 2010, J BIOL CHEM, V285, P2040, DOI 10.1074/jbc.M109.027094; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1993, J BIOL CHEM, V268, P25206; Patterson M, 2007, J GEN PHYSIOL, V129, P29, DOI 10.1085/jgp.200609660; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pozzo-Miller LD, 2000, J PHYSIOL-LONDON, V525, P53, DOI 10.1111/j.1469-7793.2000.t01-1-00053.x; Rose HJ, 2006, BIOPHYS J, V91, P4024, DOI 10.1529/biophysj.106.088872; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Swatton JE, 2002, J BIOL CHEM, V277, P17571, DOI 10.1074/jbc.M200524200; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Yano K, 2004, BIOCHEM J, V383, P353, DOI 10.1042/BJ20040629; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	45	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25053	25061		10.1074/jbc.M109.095257	http://dx.doi.org/10.1074/jbc.M109.095257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538594	hybrid, Green Published			2022-12-27	WOS:000280542100078
J	Coley, W; Van Duyne, R; Carpio, L; Guendel, I; Kehn-Hall, K; Chevalier, S; Narayanan, A; Luu, T; Lee, N; Klase, Z; Kashanchi, F				Coley, William; Van Duyne, Rachel; Carpio, Lawrence; Guendel, Irene; Kehn-Hall, Kylene; Chevalier, Sebastien; Narayanan, Aarthi; Luu, Truong; Lee, Norman; Klase, Zachary; Kashanchi, Fatah			Absence of DICER in Monocytes and Its Regulation by HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; STEM-CELLS; SILENCING PATHWAY; HUMAN MACROPHAGES; GENE-EXPRESSION; TAR ELEMENT; INFECTION; RNA	MicroRNAs (miRNAs) are a class of small RNA molecules that function to control gene expression and restrict viral replication in host cells. The production of miRNAs is believed to be dependent upon the DICER enzyme. Available evidence suggests that in T lymphocytes, HIV-1 can both suppress and co-opt the host's miRNA pathway for its own benefit. In this study, we examined the state of miRNA production in monocytes and macrophages as well as the consequences of viral infection upon the production of miRNA. Monocytes in general express low amounts of miRNA-related proteins, and DICER in particular could not be detected until after monocytes were differentiated into macrophages. In the case where HIV-1 was present prior to differentiation, the expression of DICER was suppressed. MicroRNA chip results for RNA isolated from transfected and treated cells indicated that a drop in miRNA production coincided with DICER protein suppression in macrophages. We found that the expression of DICER in monocytes is restricted by miR-106a, but HIV-1 suppressed DICER expression via the viral gene Vpr. Additionally, analysis of miRNA expression in monocytes and macrophages revealed evidence that some miRNAs can be processed by both DICER and PIWIL4. Results presented here have implications for both the pathology of viral infections in macrophages and the biogenesis of miRNAs. First, HIV-1 suppresses the expression and function of DICER in macrophages via a previously unknown mechanism. Second, the presence of miRNAs in monocytes lacking DICER indicates that some miRNAs can be generated by proteins other than DICER.	[Coley, William; Van Duyne, Rachel; Carpio, Lawrence; Guendel, Irene; Kehn-Hall, Kylene; Narayanan, Aarthi; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Klase, Zachary] NIAID, Bethesda, MD 20892 USA; [Chevalier, Sebastien] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Luu, Truong; Lee, Norman] George Washington Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20037 USA	George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodefense & Infect Dis, Dept Mol & Microbiol, Discovery Hall,Rm 306,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Van Duyne, Rachel/ABI-2429-2020; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/I-7365-2019	Van Duyne, Rachel/0000-0003-2914-6874; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health [AI078859, AI074410, AI043894]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043894, R21AI074410, R21AI078859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078859, AI074410, and AI043894.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Gillim-Ross L, 2005, VIRAL IMMUNOL, V18, P190, DOI 10.1089/vim.2005.18.190; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Liou LY, 2004, INT J BIOCHEM CELL B, V36, P1767, DOI 10.1016/j.biocel.2004.02.018; Liu YP, 2009, NUCLEIC ACIDS RES, V37, P6194, DOI 10.1093/nar/gkp644; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; OKADA Y, 1995, IMMUNOPHARMACOLOGY, V30, P27, DOI 10.1016/0162-3109(95)98646-K; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Provost P, 2006, VIRUS RES, V121, P107, DOI 10.1016/j.virusres.2006.06.015; Ruiz ME, 1998, J IMMUNOL, V161, P4169; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; STANLEY SK, 1992, J IMMUNOL, V149, P689; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; SUZAN M, 1991, J IMMUNOL, V146, P377; Suzuki K, 2008, J BIOL CHEM, V283, P23353, DOI 10.1074/jbc.M709651200; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zhu T, 2002, J ANTIMICROB CHEMOTH, V50, P309, DOI 10.1093/jac/dkf143; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	56	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31930	31943		10.1074/jbc.M110.101709	http://dx.doi.org/10.1074/jbc.M110.101709			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20584909	hybrid, Green Published			2022-12-27	WOS:000282683000006
J	Gabilly, ST; Dreyfuss, BW; Karamoko, M; Corvest, V; Kropat, J; Page, MD; Merchant, SS; Hamel, PP				Gabilly, Stephane T.; Dreyfuss, Beth Welty; Karamoko, Mohamed; Corvest, Vincent; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.; Hamel, Patrice P.			CCS5, a Thioredoxin-like Protein Involved in the Assembly of Plastid c-Type Cytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE OXIDOREDUCTASES; BACILLUS-SUBTILIS RESA; CHLAMYDOMONAS-REINHARDTII; SYSTEM-II; NUCLEAR TRANSFORMATION; XANTHOPHYLL CYCLE; ESCHERICHIA-COLI; B(6)F COMPLEX; BIOGENESIS; HEME	The c-type cytochromes are metalloproteins with a heme molecule covalently linked to the sulfhydryls of a CXXCH hemebinding site. In plastids, at least six assembly factors are required for heme attachment to the apo-forms of cytochrome f and cytochrome c(6) in the thylakoid lumen. CCS5, controlling plastid cytochrome c assembly, was identified through insertional mutagenesis in the unicellular green alga Chlamydomonas reinhardtii. The complementing gene encodes a protein with similarity to Arabidopsis thaliana HCF164, which is a thylakoid membrane-anchored protein with a lumen-facing thioredoxin-like domain. HCF164 is required for cytochrome b(6)f biogenesis, but its activity and site of action in the assembly process has so far remained undeciphered. We show that CCS5 is a component of a trans-thylakoid redox pathway and operates by reducing the CXXCH heme-binding site of apocytochrome c prior to the heme ligation reaction. The proposal is based on the following findings: 1) the ccs5 mutant is rescued by exogenous thiols; 2) CCS5 interacts with apocytochrome f and c6 in a yeast two-hybrid assay; and 3) recombinant CCS5 is able to reduce a disulfide in the CXXCH heme-binding site of apocytochrome f.	[Hamel, Patrice P.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Hamel, Patrice P.] Ohio State Univ, Dept Mol Cellular Biochem, Columbus, OH 43210 USA; [Gabilly, Stephane T.; Hamel, Patrice P.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Dreyfuss, Beth Welty; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dreyfuss, Beth Welty; Kropat, Janette; Page, M. Dudley; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), POB 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu; hamel.16@osu.edu			National Institutes of Health [GM48350]; Muscular Dystrophy Association [4727]; National Science Foundation [MCB-0920062]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2004-35318-14953]; Div Of Molecular and Cellular Bioscience [0920062] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Foundation(National Science Foundation (NSF)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48350. This work was also supported by Muscular Dystrophy Association Grant 4727, National Science Foundation Grant MCB-0920062 (to P.P.H.), and National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2004-35318-14953 (to S.S.M.).	Bardischewsky F, 2001, J BACTERIOL, V183, P257, DOI 10.1128/JB.183.1.257-263.2001; Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; BENNOUN P, 1980, GENETICS, V95, P39; Bialek W, 2008, BIOCHEMISTRY-US, V47, P5515, DOI 10.1021/bi701973g; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BONNARD G, 2010, ANTIOXID RE IN PRESS; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; COLLIER JL, 1995, J BACTERIOL, V177, P3269, DOI 10.1128/jb.177.11.3269-3276.1995; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Dreyfuss BW, 2003, J BIOL CHEM, V278, P2604, DOI 10.1074/jbc.M208652200; DREYFUSS BW, 1999, P 1 INT C PHOT, V4, P3139; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Feissner RE, 2005, J BACTERIOL, V187, P3941, DOI 10.1128/JB.187.12.3941-3949.2005; FENTON JM, 1990, PHOTOSYNTH RES, V26, P59, DOI 10.1007/BF00048977; Ferguson SJ, 2008, BBA-BIOENERGETICS, V1777, P980, DOI 10.1016/j.bbabio.2008.03.020; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; GUMPEL NJ, 1994, CURR GENET, V26, P438, DOI 10.1007/BF00309931; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Hamel PP, 2003, J BIOL CHEM, V278, P2593, DOI 10.1074/jbc.M208651200; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOWE G, 1995, MOL GEN GENET, V246, P156, DOI 10.1007/BF00294678; HOWE G, 1993, P NATL ACAD SCI USA, V90, P1862, DOI 10.1073/pnas.90.5.1862; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; James P, 1996, GENETICS, V144, P1425; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kuras R, 2007, P NATL ACAD SCI USA, V104, P9906, DOI 10.1073/pnas.0702340104; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Lyska D, 2007, PLANT CELL PHYSIOL, V48, P1737, DOI 10.1093/pcp/pcm146; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Moller M, 2006, ANTIOXID REDOX SIGN, V8, P823, DOI 10.1089/ars.2006.8.823; MOTOHASHI K, 2010, ANTIOXID RE IN PRESS; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Ortenberg R, 2003, ANTIOXID REDOX SIGN, V5, P403, DOI 10.1089/152308603768295140; Page MLD, 2004, J BIOL CHEM, V279, P32474, DOI 10.1074/jbc.M404285200; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Quinlan GJ, 1998, NATO ADV SCI I A-LIF, V297, P263; ROCHAIX JD, 2009, ORGANELLAR METABOLIC, V2, P819; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Shimogawara K, 1998, GENETICS, V148, P1821; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Xie ZY, 1998, GENETICS, V148, P681; [No title captured]	65	24	24	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29738	29749		10.1074/jbc.M109.099069	http://dx.doi.org/10.1074/jbc.M109.099069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20628047	hybrid, Green Published			2022-12-27	WOS:000281984300009
J	Gilbert, WV				Gilbert, Wendy V.			Alternative Ways to Think about Cellular Internal Ribosome Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CAP-INDEPENDENT TRANSLATION; IRES-MEDIATED TRANSLATION; MESSENGER-RNA; DEPENDENT TRANSLATION; SACCHAROMYCES-CEREVISIAE; C-MYC; YEAST; INITIATION; EIF4G; IDENTIFICATION	Internal ribosome entry sites (IRESs) are specialized mRNA elements that allow recruitment of eukaryotic ribosomes to naturally uncapped mRNAs or to capped mRNAs under conditions in which cap-dependent translation is inhibited. Putative cellular IRESs have been proposed to play crucial roles in stress responses, development, apoptosis, cell cycle control, and neuronal function. However, most of the evidence for cellular IRES activity rests on bicistronic reporter assays, the reliability of which has been questioned. Here, the mechanisms underlying cap-independent translation of cellular mRNAs and the contributions of such translation to cellular protein synthesis are discussed. I suggest that the division of cellular mRNAs into mutually exclusive categories of "cap-dependent" and "IRES-dependent" should be reconsidered and that the implications of cellular IRES activity need to be incorporated into our models of cap-dependent initiation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gilbert, WV (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wgilbert@mit.edu		/0000-0003-2807-9657	National Institutes of Health [5R00GM081399-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM081399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R00GM081399-03. This is the fifth article in the Thematic Minireview Series on Protein Synthesis. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Allam H, 2010, J BIOL CHEM, V285, P5713, DOI 10.1074/jbc.M109.029462; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Elango N, 2006, J CELL BIOCHEM, V99, P1108, DOI 10.1002/jcb.20909; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Huang BL, 2007, J CELL COMMUN SIGNAL, V1, P17, DOI 10.1007/s12079-007-0003-1; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; KOZAK M, 1988, MOL CELL BIOL, V8, P2737, DOI 10.1128/MCB.8.7.2737; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Reineke LC, 2008, J BIOL CHEM, V283, P19011, DOI 10.1074/jbc.M803109200; Reineke LC, 2009, RNA, V15, P2264, DOI 10.1261/rna.1722809; Saffran HA, 2009, RNA, V15, P1980, DOI 10.1261/rna.1557809; SAGLIOCCO FA, 1993, J BIOL CHEM, V268, P26522; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; VON DEN DRIESCH P, 2002, J AM ACAD DERMATOL, V46, P531; Wang ZP, 2005, NUCLEIC ACIDS RES, V33, P2248, DOI 10.1093/nar/gki523; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200	41	83	84	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29033	29038		10.1074/jbc.R110.150532	http://dx.doi.org/10.1074/jbc.R110.150532			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20576611	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000281740100002
J	Akin, BL; Chen, ZH; Jones, LR				Akin, Brandy L.; Chen, Zhenhui; Jones, Larry R.			Superinhibitory Phospholamban Mutants Compete with Ca2+ for Binding to SERCA2a by Stabilizing a Unique Nucleotide-dependent Conformational State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CROSS-LINKING; ATP-BINDING; FUNCTIONAL INTERACTIONS; ENERGY-TRANSFER; SF21 CELLS; CA2+-ATPASE; INHIBITION; THAPSIGARGIN	Three cross-linkable phospholamban (PLB) mutants of increasing inhibitory strength (N30C-PLB < N27A,N30C,L37A-PLB (PLB3) < N27A,N30C,L37A,V49G-PLB (PLB4)) were used to determine whether PLB decreases the Ca2+ affinity of SERCA2a by competing for Ca2+ binding. The functional effects of N30C-PLB, PLB3, and PLB4 on Ca2+-ATPase activity and E1 similar to P formation were correlated with their binding interactions with SERCA2a measured by chemical cross-linking. Successively higher Ca2+ concentrations were required to both activate the enzyme co-expressed with N30C-PLB, PLB3, and PLB4 and to dissociate N30C-PLB, PLB3, and PLB4 from SERCA2a, suggesting competition between PLB and Ca2+ for binding to SERCA2a. This was confirmed with the Ca2+ pump mutant, D351A, which is catalytically inactive but retains strong Ca2+ binding. Increasingly higher Ca2+ concentrations were also required to dissociate N30C-PLB, PLB3, and PLB4 from D351A, demonstrating directly that PLB antagonizes Ca2+ binding. Finally, the specific conformation of E2 (Ca2+-free state of SERCA2a) that binds PLB was investigated using the Ca2+-pump inhibitors thapsigargin and vanadate. Crosslinking assays conducted in the absence of Ca2+ showed that PLB bound preferentially to E2 with bound nucleotide, forming a remarkably stable complex that is highly resistant to both thapsigargin and vanadate. In the presence of ATP, N30C-PLB had an affinity for SERCA2a approaching that of vanadate (micromolar), whereas PLB3 and PLB4 had much higher affinities, severalfold greater than even thapsigargin (nanomolar or higher). We conclude that PLB decreases Ca2+ binding to SERCA2a by stabilizing a unique E2.ATP state that is unable to bind thapsigargin or vanadate.	Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Jones, LR (corresponding author), 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DEJESUS F, 1993, FEBS LETT, V332, P229, DOI 10.1016/0014-5793(93)80638-B; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; INESI G, 1984, J BIOL CHEM, V259, P996; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1978, J BIOL CHEM, V253, P1643; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P230, DOI 10.1016/0005-2736(79)90105-6; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mahaney JE, 2000, BIOPHYS J, V78, P1306, DOI 10.1016/S0006-3495(00)76686-0; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; PICK U, 1982, J BIOL CHEM, V257, P6111; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344, DOI 10.1152/ajpheart.1991.261.4.H1344; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Waggoner JR, 2007, BIOCHEMISTRY-US, V46, P1999, DOI 10.1021/bi061365k; WATANABE T, 1981, BIOCHEMISTRY-US, V20, P6617, DOI 10.1021/bi00526a015; WICTOME M, 1992, BIOCHEM J, V283, P525, DOI 10.1042/bj2830525; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28540	28552		10.1074/jbc.M110.151779	http://dx.doi.org/10.1074/jbc.M110.151779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622261	Green Published, hybrid			2022-12-27	WOS:000281594000018
J	Golubkov, VS; Cieplak, P; Chekanov, AV; Ratnikov, BI; Aleshin, AE; Golubkova, NV; Postnova, TI; Radichev, IA; Rozanov, DV; Zhu, WH; Motamedchaboki, K; Strongin, AY				Golubkov, Vladislav S.; Cieplak, Piotr; Chekanov, Alexei V.; Ratnikov, Boris I.; Aleshin, Alexander E.; Golubkova, Natalya V.; Postnova, Tatiana I.; Radichev, Ilian A.; Rozanov, Dmitri V.; Zhu, Wenhong; Motamedchaboki, Khatereh; Strongin, Alex Y.			Internal Cleavages of the Autoinhibitory Prodomain Are Required for Membrane Type 1 Matrix Metalloproteinase Activation, although Furin Cleavage Alone Generates Inactive Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CELL-MIGRATION; 1-MATRIX METALLOPROTEINASE; INTRACELLULAR ACTIVATION; PROPROTEIN CONVERTASES; TISSUE INHIBITOR; CYSTEINE SWITCH; IV COLLAGENASE; MT1-MMP; SURFACE	The functional activity of invasion-promoting membrane type 1 matrix metalloproteinase (MT1-MMP) is elevated in cancer. This elevated activity promotes cancer cell migration, invasion, and metastasis. MT1-MMP is synthesized as a zymogen, the latency of which is maintained by its prodomain. Excision by furin was considered sufficient for the prodomain release and MT1-MMP activation. We determined, however, that the full-length intact prodomain released by furin alone is a potent autoinhibitor of MT1-MMP. Additional MMP cleavages within the prodomain sequence are required to release the MT1-MMP enzyme activity. Using mutagenesis of the prodomain sequence and mass spectrometry analysis of the prodomain fragments, we demonstrated that the intradomain cleavage of the PGD down arrow L-50 site initiates the MT1-MMP activation, whereas the (RRKR111)-R-108 down arrow Y-112 cleavage by furin completes the removal and the degradation of the autoinhibitory prodomain and the liberation of the functional activity of the emerging enzyme of MT1-MMP.	[Golubkov, Vladislav S.; Cieplak, Piotr; Chekanov, Alexei V.; Ratnikov, Boris I.; Aleshin, Alexander E.; Golubkova, Natalya V.; Postnova, Tatiana I.; Radichev, Ilian A.; Rozanov, Dmitri V.; Zhu, Wenhong; Motamedchaboki, Khatereh; Strongin, Alex Y.] La Jolla Canc Res Fdn, Canc Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), La Jolla Canc Res Fdn, Canc Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@burnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; FOTOUHI N, 1994, J BIOL CHEM, V269, P30227; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; HANGLOW AC, 1993, AGENTS ACTIONS, V39, P148; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Li W, 2004, CANCER RES, V64, P8657, DOI 10.1158/0008-5472.CAN-04-3019; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; MAST AE, 1991, J BIOL CHEM, V266, P15810; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368	41	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27726	27736		10.1074/jbc.M110.135442	http://dx.doi.org/10.1074/jbc.M110.135442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605791	hybrid, Green Published			2022-12-27	WOS:000281404100028
J	Lu, LD; Sun, Q; Fan, XY; Zhong, Y; Yao, YF; Zhao, GP				Lu, Liang-dong; Sun, Qing; Fan, Xiao-yong; Zhong, Yi; Yao, Yu-feng; Zhao, Guo-Ping			Mycobacterial MazG Is a Novel NTP Pyrophosphohydrolase Involved in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TUBERCULOSIS H37RV; SURVIVAL; PROTEIN; MACROPHAGES; ADAPTATION; REGULATOR	MazG nucleoside triphosphate pyrophosphohydrolase (NTP-PPase, EC 3.6.1.8) from the avirulent Mycobacterium tuberculosis H37Ra contains a spontaneous mutation on a highly conserved residue, resulting in an A219E substitution (MtMazG[A219E]). In this work, we show that mycobacterial MazG from either the virulent M. tuberculosis H37Rv (MtMazG) or the fast-growing Mycobacterium smegmatis (MsMazG) is a potent NTP-PPase capable of hydrolyzing all canonical (d) NTPs, as well as the mutagenic dUTP and 8-oxo-7,8-dihydro-2'-dGTP. However, this hydrolysis activity is diminished by the MtMazG[A219E] mutation. Moreover, deletion of mazG in M. smegmatis rendered the mycobacteria defective in response to oxidative stress. Importantly, expression of the wildtype MtMazG, but not the A219E mutant, restored cell viability under oxidative stress. Intriguingly, under oxidative stress, both the mazG-null and MtMazG[A219E]-expressing M. smegmatis strains failed to elevate relA, while retaining their ability to up-regulate sigE, suggesting a specific role for the MazGNTP-PPase activity in oxidative stress-triggered, transcriptional activation of relA. The MtMazG is a homotetramer with each subunit containing a single MazG core domain flanked by two regions, both of which are essential for NTP-PPase activity. Taken together, these results demonstrate that the mycobacterial MazG is a potent NTP-PPase and that this activity is required to maintain the full capacity of the mycobacteria to respond to oxidative stress. Our work implicates a role for the MazG activity in the virulence of M. tuberculosis.	[Lu, Liang-dong; Sun, Qing; Yao, Yu-feng] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China; [Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Fan, Xiao-yong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhong, Yi; Zhao, Guo-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Yao, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China.	yfyao@sjtu.edu.cn; gpzhao@sibs.ac.cn	sun, qingshen/U-9700-2018; Lyu, Liangdong/C-6557-2014	sun, qingshen/0000-0001-7282-4330; Lyu, Liangdong/0000-0001-6391-6030; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [30830002, 30970077]; Science and Technology Commission of Shanghai Municipality [09QA1403600]; State Key Development Programs for Basic Research of China (973 Program) [2009CB522605]; Shanghai Institutions of Higher Learning	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); State Key Development Programs for Basic Research of China (973 Program)(National Basic Research Program of China); Shanghai Institutions of Higher Learning	This work was supported by grants from the National Natural Science Foundation of China (No. 30830002 and No. 30970077), Shanghai Rising-Star Program, Science and Technology Commission of Shanghai Municipality (No. 09QA1403600), the State Key Development Programs for Basic Research of China (973 Program No. 2009CB522605), and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; He XY, 2003, MICROBES INFECT, V5, P851, DOI 10.1016/S1286-4579(03)00179-5; Hu YM, 2004, FEMS MICROBIOL LETT, V237, P415, DOI 10.1016/j.femsle.2004.07.005; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Lari N, 1999, MICROB PATHOGENESIS, V26, P281, DOI 10.1006/mpat.1998.0270; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; MACKANESS GB, 1954, AM REV TUBERC PULM, V69, P479; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Payandeh J, 2006, J BIOL CHEM, V281, P6070, DOI 10.1074/jbc.M509377200; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Sambrook J, 1989, MOL CLONING LABORATO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STREEKEN W, 1946, AM REV TUBERC, V54, P62; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Tassotto ML, 2002, J BIOL CHEM, V277, P15807, DOI 10.1074/jbc.M200965200; Walker J M, 1994, Methods Mol Biol, V32, P5; Wu BL, 2007, J MOL BIOL, V367, P1405, DOI 10.1016/j.jmb.2007.01.057; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zhang JJ, 2003, J BIOL CHEM, V278, P21408, DOI 10.1074/jbc.M213294200; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	42	37	51	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28076	28085		10.1074/jbc.M109.088872	http://dx.doi.org/10.1074/jbc.M109.088872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20529853	hybrid, Green Published			2022-12-27	WOS:000288742300006
J	Papareddy, P; Kalle, M; Kasetty, G; Morgelin, M; Rydengard, V; Albiger, B; Lundqvist, K; Malmsten, M; Schmidtchen, A				Papareddy, Praveen; Kalle, Martina; Kasetty, Gopinath; Morgelin, Matthias; Rydengard, Victoria; Albiger, Barbara; Lundqvist, Katarina; Malmsten, Martin; Schmidtchen, Artur			C-terminal Peptides of Tissue Factor Pathway Inhibitor Are Novel Host Defense Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL ANTIMICROBIAL PEPTIDES; HEPARIN-BINDING; INNATE IMMUNITY; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL PEPTIDES; COMPLEMENT-SYSTEM; ESCHERICHIA-COLI; PROTEIN; POLYPEPTIDES; DOMAIN	Tissue factor pathway inhibitor (TFPI) inhibits tissue factor-induced coagulation, but may, via its C terminus, also modulate cell surface, heparin, and lipopolysaccharide interactions as well as participate in growth inhibition. Here we show that C-terminal TFPI peptide sequences are antimicrobial against the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungi Candida albicans and Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen for the "classic" human antimicrobial peptide LL-37. The killing of E. coli, but not P. aeruginosa, by the C-terminal peptide GGLIKTKRKRKKQRVKIAYEEIFVKNM (GGL27), was enhanced in human plasma and largely abolished in heat-inactivated plasma, a phenomenon linked to generation of antimicrobial C3a and activation of the classic pathway of complement activation. Furthermore, GGL27 displayed anti-endotoxic effects in vitro and in vivo in a mouse model of LPS shock. Importantly, TFPI was found to be expressed in the basal layers of normal epidermis, and was markedly up-regulated in acute skin wounds as well as wound edges of chronic leg ulcers. Furthermore, C-terminal fragments of TFPI were associated with bacteria present in human chronic leg ulcers. These findings suggest a new role for TFPI in cutaneous defense against infections.	[Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Biomed Ctr, Div Dermatol & Venereol, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden	Lund University; Lund University; Uppsala University	Schmidtchen, A (corresponding author), Lund Univ, Dept Clin Sci, Biomed Ctr, Div Dermatol & Venereol, Tornavagen 10, SE-22184 Lund, Sweden.	artur.schmidtchen@med.lu.se	Schmidtchen, Artur/F-9507-2015	Papareddy, Praveen/0000-0002-3872-478X	Swedish Research Council [521-2009-3378, 7480, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen, Crafoord, Osterlund, and Kock Foundations; Marianne and Marcus Wallenberg Foundation; XImmune AB; The Swedish Government Funds for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen, Crafoord, Osterlund, and Kock Foundations; Marianne and Marcus Wallenberg Foundation; XImmune AB; The Swedish Government Funds for Clinical Research	This work was supported by grants from the Swedish Research Council (projects 521-2009-3378, 7480, and 621-2003-4022), the Royal Physiographic Society in Lund, the Welander-Finsen, Crafoord, Osterlund, and Kock Foundations, the Marianne and Marcus Wallenberg Foundation, XImmune AB, and The Swedish Government Funds for Clinical Research.	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; Cunningham AC, 2002, BIOCHEM J, V367, P451, DOI 10.1042/BJ20020696; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Ettelaie C, 1999, FEBS LETT, V463, P341, DOI 10.1016/S0014-5793(99)01663-4; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hembrough TA, 2004, BLOOD, V103, P3374, DOI 10.1182/blood-2003-07-2234; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li A, 1998, THROMB HAEMOSTASIS, V80, P423, DOI 10.1055/s-0037-1615224; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lundqvist K, 2004, THROMB HAEMOSTASIS, V92, P281, DOI 10.1160/TH03-12-0732; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Maroney SA, 2010, THROMB RES, V125, pS52, DOI 10.1016/j.thromres.2010.01.038; Meyer-Hoffert U, 2008, FASEB J, V22, P2427, DOI 10.1096/fj.07-103440; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; PAPAREDDY P, PLOS PATHOG, V6; Park CT, 1997, BLOOD, V89, P4268, DOI 10.1182/blood.V89.12.4268; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Schirm S, 2009, J INFECT DIS, V199, P1807, DOI 10.1086/599097; Schmidtchen A, 2001, ACTA DERM-VENEREOL, V81, P406; Sjogren H, 2005, BIOPHYS CHEM, V116, P11, DOI 10.1016/j.bpc.2005.01.007; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Yamamoto N, 2010, PEPTIDES, V31, P794, DOI 10.1016/j.peptides.2010.01.006; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	50	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28387	28398		10.1074/jbc.M110.127019	http://dx.doi.org/10.1074/jbc.M110.127019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592020	Green Published, hybrid			2022-12-27	WOS:000281404100081
J	Pereira, JH; Ralston, CY; Douglas, NR; Meyer, D; Knee, KM; Goulet, DR; King, JA; Frydman, J; Adams, PD				Pereira, Jose H.; Ralston, Corie Y.; Douglas, Nicholai R.; Meyer, Daniel; Knee, Kelly M.; Goulet, Daniel R.; King, Jonathan A.; Frydman, Judith; Adams, Paul D.			Crystal Structures of a Group II Chaperonin Reveal the Open and Closed States Associated with the Protein Folding Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT KINETIC-ANALYSIS; EUKARYOTIC CHAPERONIN; ARCHAEAL CHAPERONIN; ATP-BINDING; IN-VIVO; GROEL; MECHANISM; REFINEMENT; COMPLEX; CONFORMATION	Chaperonins are large protein complexes consisting of two stacked multisubunit rings, which open and close in an ATP-dependent manner to create a protected environment for protein folding. Here, we describe the first crystal structure of a group II chaperonin in an open conformation. We have obtained structures of the archaeal chaperonin from Methanococcus maripaludis in both a peptide acceptor (open) state and a protein folding (closed) state. In contrast with group I chaperonins, in which the equatorial domains share a similar conformation between the open and closed states and the largest motions occurs at the intermediate and apical domains, the three domains of the archaeal chaperonin subunit reorient as a single rigid body. The large rotation observed from the open state to the closed state results in a 65% decrease of the folding chamber volume and creates a highly hydrophilic surface inside the cage. These results suggest a completely distinct closing mechanism in the group II chaperonins as compared with the group I chaperonins.	[Pereira, Jose H.; Ralston, Corie Y.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Douglas, Nicholai R.; Meyer, Daniel; Frydman, Judith] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Meyer, Daniel; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Knee, Kelly M.; Goulet, Daniel R.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Adams, PD (corresponding author), 1 Cyclotron Rd, Berkeley, CA 94720 USA.	pdadams@lbl.gov	Adams, Paul David/A-1977-2013; Meyer, Daniel/B-7324-2014	Adams, Paul David/0000-0001-9333-8219; Meyer, Daniel/0000-0001-8948-052X; , judith/0000-0003-2302-6943	Nanomedicine Development Center [2PN2EY016525]; NIGMS, National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER	Nanomedicine Development Center; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was performed as part of the Center for Protein Folding Machinery and National Institutes of Health Roadmap-supported Nanomedicine Development Center (Grant 2PN2EY016525). The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dobrzynski JK, 1996, BIOCHEMISTRY-US, V35, P15870, DOI 10.1021/bi961114j; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GUAGLIARDI A, 1994, PROTEIN SCI, V3, P1436, DOI 10.1002/pro.5560030910; Gutsche I, 2000, CURR BIOL, V10, P405, DOI 10.1016/S0960-9822(00)00421-8; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Roseman AM, 2001, J STRUCT BIOL, V135, P115, DOI 10.1006/jsbi.2001.4374; Saibil HR, 2002, ADV PROTEIN CHEM, V59, P45; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sewell BT, 2004, NAT STRUCT MOL BIOL, V11, P1128, DOI 10.1038/nsmb844; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taubes G, 1996, SCIENCE, V271, P1493, DOI 10.1126/science.271.5255.1493; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	58	55	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27958	27966		10.1074/jbc.M110.125344	http://dx.doi.org/10.1074/jbc.M110.125344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573955	hybrid, Green Published			2022-12-27	WOS:000281404100050
J	Chen, YL; Eriksson, S; Chang, ZF				Chen, Yen-Ling; Eriksson, Staffan; Chang, Zee-Fen			Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE R2; MOUSE ERYTHROLEUKEMIA-CELLS; COLON-CANCER CELLS; GENE-EXPRESSION; CYCLE CHECKPOINT; MAMMALIAN-CELLS; P53 STATUS; AGENTS; RECOVERY; PATHWAY	Cellular supply of dNTPs is essential in the DNA replication and repair processes. Here we investigated the regulation of thymidine kinase 1 (TK1) in response to DNA damage and found that genotoxic insults in tumor cells cause up-regulation and nuclear localization of TK1. During recovery from DNA damage, TK1 accumulates in p53-null cells due to a lack of mitotic proteolysis as these cells are arrested in the G(2) phase by checkpoint activation. We show that in p53-proficient cells, p21 expression in response to DNA damage prohibits G(1)/S progression, resulting in a smaller G(2) fraction and less TK1 accumulation. Thus, the p53 status of tumor cells affects the level of TK1 after DNA damage through differential cell cycle control. Furthermore, it was shown that in HCT-116 p53(-/-) cells, TK1 is dispensable for cell proliferation but crucial for dTTP supply during recovery from DNA damage, leading to better survival. Depletion of TK1 decreases the efficiency of DNA repair during recovery from DNA damage and generates more cell death. Altogether, our data suggest that more dTTP synthesis via TK1 take place after genotoxic insults in tumor cells, improving DNA repair during G(2) arrest.	[Chang, Zee-Fen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chen, Yen-Ling; Chang, Zee-Fen] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Eriksson, Staffan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden	National Yang Ming Chiao Tung University; National Taiwan University; Swedish University of Agricultural Sciences	Chang, ZF (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sec 2,Linong St, Taipei 112, Taiwan.	ZFCHANG@ym.edu.tw			National Health Research Institute [NHRI-EX99-9701B]; National Health Research Institute and National Science Council, Taiwan [NSC99-3112-B-010-021]; Ministry of Education, Taiwan; Swedish Research Council	National Health Research Institute(National Health Research Institutes - Taiwan); National Health Research Institute and National Science Council, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by Grants NHRI-EX99-9701B and NSC99-3112-B-010-021 from National Health Research Institute and National Science Council, Taiwan, respectively, and a grant from Aim for the Top University plan in National Yang-Ming University supported by the Ministry of Education, Taiwan.; Supported by grants from the Swedish Research Council.	ALNABULSI I, 1994, CANCER RES, V54, P5614; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; BOOTHMAN DA, 1994, INT J RADIAT ONCOL, V30, P391, DOI 10.1016/0360-3016(94)90019-1; Brockenbrough JS, 2009, J HISTOCHEM CYTOCHEM, V57, P1087, DOI 10.1369/jhc.2009.952804; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; CHANG ZF, 1994, J BIOL CHEM, V269, P21249; Chang ZF, 1999, J CELL BIOCHEM, V75, P300, DOI 10.1002/(SICI)1097-4644(19991101)75:2<300::AID-JCB12>3.0.CO;2-Z; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; ECKSTEIN H, 1974, Z NATURFORSCH C, VC 29, P272; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; GOULIAN M, 1980, J BIOL CHEM, V255, P630; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hu CM, 2008, CANCER RES, V68, P2831, DOI 10.1158/0008-5472.CAN-07-3069; HUANG SH, 1994, DNA CELL BIOL, V13, P461, DOI 10.1089/dna.1994.13.461; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Longley DB, 2002, CANCER RES, V62, P2644; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; MCKENNA PG, 1981, CELL BIOL INT REP, V5, P555, DOI 10.1016/S0309-1651(81)80006-9; MCKENNA PG, 1988, MUTAT RES, V200, P231, DOI 10.1016/0027-5107(88)90087-5; MCKENNA PG, 1985, SOMAT CELL MOLEC GEN, V11, P239, DOI 10.1007/BF01534680; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; NAVALGUND LG, 1980, J BIOL CHEM, V255, P7386; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROEHL HH, 1990, MOL CELL BIOL, V10, P3834, DOI 10.1128/MCB.10.7.3834; Sarkaria JN, 1999, CANCER RES, V59, P4375; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wakazono Y, 1996, MUTAT RES-DNA REPAIR, V362, P119, DOI 10.1016/0921-8777(95)00042-9; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	56	57	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27327	27335		10.1074/jbc.M110.137042	http://dx.doi.org/10.1074/jbc.M110.137042			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20554529	hybrid, Green Published			2022-12-27	WOS:000281172700062
J	Tejero, J; Hannibal, L; Mustovich, A; Stuehr, DJ				Tejero, Jesus; Hannibal, Luciana; Mustovich, Anthony; Stuehr, Dennis J.			Surface Charges and Regulation of FMN to Heme Electron Transfer in Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL EQUILIBRIUM; REDUCTASE DOMAIN; TETRAHYDROBIOPTERIN; CALMODULIN; CATALYSIS; BINDING; FLAVIN; SUBSTRATE; PTERIN; BRAIN	The nitric-oxide synthases (NOS, EC 1.14.13.39) are modular enzymes containing attached flavoprotein and heme (NOSoxy) domains. To generate nitric oxide (NO), the NOS FMN subdomain must interact with the NOSoxy domain to deliver electrons to the heme for O-2 activation during catalysis. The molecular basis and how the interaction is regulated is unclear. We explored the role of eight positively charged residues that create an electropositive patch on NOSoxy in enabling the electron transfer by incorporating mutations that neutralized or reversed their individual charges. Stopped-flow and steady-state experiments revealed that individual charges at Lys(423), Lys(620), and Lys(660) were the most important in enabling heme reduction in nNOS. Charge reversal was more disruptive than neutralization in all cases, and the effects on heme reduction were not due to a weakening in the thermodynamic driving force for heme reduction. Mutant NO synthesis activities displayed a complex pattern that could be simulated by a global model for NOS catalysis. This analysis revealed that the mutations impact the NO synthesis activity only through their effects on heme reduction rates. We conclude that heme reduction and NO synthesis in nNOS is enabled by electrostatic interactions involving Lys(423), Lys(620), and Lys(660), which form a triad of positive charges on the NOSoxy surface. A simulated docking study reveals how electrostatic interactions of this triad can enable an FMN-NOSoxy interaction that is productive for electron transfer.	[Tejero, Jesus; Hannibal, Luciana; Mustovich, Anthony; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Hannibal, Luciana/AAY-7689-2021; Tejero, Jesus/G-3953-2017	Hannibal, Luciana/0000-0002-0911-5758; Tejero, Jesus/0000-0003-3245-9978	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [0625632B]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D.J.S.). This work was also supported by American Heart Association Postdoctoral Fellowship 0625632B (to J.T.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Feng CJ, 2008, FEBS LETT, V582, P2768, DOI 10.1016/j.febslet.2008.07.005; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Gorren ACF, 2002, BIOCHEMISTRY-US, V41, P7819, DOI 10.1021/bi025675o; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Kang SA, 2005, P NATL ACAD SCI USA, V102, P15465, DOI 10.1073/pnas.0505176102; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Medina M, 2008, PROTEINS, V72, P848, DOI 10.1002/prot.21979; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Salerno JC, 2008, FEBS LETT, V582, P1395, DOI 10.1016/j.febslet.2008.03.051; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Yadav J, 2004, CHEM LETT, V33, P752, DOI 10.1246/cl.2004.752; Yumoto T, 2000, J INORG BIOCHEM, V82, P163, DOI 10.1016/S0162-0134(00)00142-2	60	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27232	27240		10.1074/jbc.M110.138842	http://dx.doi.org/10.1074/jbc.M110.138842			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592038	Green Published, hybrid			2022-12-27	WOS:000281172700054
J	Chen, C; Sun, QH; Narayanan, B; Nuss, DL; Herzberg, O				Chen, Chen; Sun, Qihong; Narayanan, Buvaneswari; Nuss, Donald L.; Herzberg, Osnat			Structure of Oxalacetate Acetylhydrolase, a Virulence Factor of the Chestnut Blight Fungus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-METHYLISOCITRATE LYASE PRPB; PETAL DEATH PROTEIN; CRYSTAL-STRUCTURE; OXALATE PRODUCTION; ISOCITRATE LYASE; OXALIC-ACID; CRYPHONECTRIA-PARASITICA; ENZYME SUPERFAMILY; ESCHERICHIA-COLI; CATALYSIS	Oxalacetate acetylhydrolase (OAH), a member of the phosphoenolpyruvate mutase/isocitrate lyase superfamily, catalyzes the hydrolysis of oxalacetate to oxalic acid and acetate. This study shows that knock-out of the oah gene in Cryphonectria parasitica, the chestnut blight fungus, reduces the ability of the fungus to form cankers on chestnut trees, suggesting that OAH plays a key role in virulence. OAH was produced in Escherichia coli and purified, and its catalytic rates were determined. Oxalacetate is the main OAH substrate, but the enzyme also acts as a lyase of (2R, 3S)-dimethyl malate with similar to 1000-fold lower efficacy. The crystal structure of OAH was determined alone, in complex with a mechanism-based inhibitor, 3,3-difluorooxalacetate (DFOA), and in complex with the reaction product, oxalate, to a resolution limit of 1.30, 1.55, and 1.65 angstrom, respectively. OAH assembles into a dimer of dimers with each subunit exhibiting an (alpha/beta)(8) barrel fold and each pair swapping the 8th alpha-helix. An active site "gating loop" exhibits conformational disorder in the ligand-free structure. To obtain the structures of the OAH center dot ligand complexes, the ligand-free OAH crystals were soaked briefly with DFOA or oxalacetate. DFOA binding leads to ordering of the gating loop in a conformation that sequesters the ligand from the solvent. DFOA binds in a gem-diol form analogous to the oxalacetate intermediate/transition state. Oxalate binds in a planar conformation, but the gating loop is largely disordered. Comparison between the OAH structure and that of the closely related enzyme, 2,3-dimethylmalate lyase, suggests potential determinants of substrate preference.	[Herzberg, Osnat] Univ Maryland, W M Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, Rockville, MD 20850 USA; [Sun, Qihong; Nuss, Donald L.] Univ Maryland, Ctr Biosyst Res, Inst Biotechnol, Rockville, MD 20850 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Herzberg, O (corresponding author), Univ Maryland, W M Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu			National Institutes of Health [P01-GM057890, GM55981]; National Science Foundation [MCB9813271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057890, R01GM055981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-GM057890 (to O. H.) and GM55981 (to D. N.). This work was also supported by National Science Foundation Grant MCB9813271 (to O. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANAGNOSTAKIS SL, 1982, SCIENCE, V215, P466, DOI 10.1126/science.215.4532.466; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Britton KL, 2000, STRUCTURE, V8, P349, DOI 10.1016/S0969-2126(00)00117-9; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chaudhuri BN, 2003, STRUCTURE, V11, P753, DOI 10.1016/S0969-2126(03)00106-0; Chen CCH, 2006, BIOCHEMISTRY-US, V45, P11491, DOI 10.1021/bi061208l; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; DeLano W.L, PYMOL MOL GRAPHICS S; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; EMLY M, 1981, J AM CHEM SOC, V103, P628, DOI 10.1021/ja00393a022; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; HAVIR EA, 1983, PHYSIOL PLANT PATHOL, V23, P369, DOI 10.1016/0048-4059(83)90021-8; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HILLMAN BI, 1990, PHYTOPATHOLOGY, V80, P950, DOI 10.1094/Phyto-80-950; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; Joosten HJ, 2008, PROTEINS, V70, P157, DOI 10.1002/prot.21622; Jordan CR, 1996, HOLZFORSCHUNG, V50, P312, DOI 10.1515/hfsg.1996.50.4.312; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kirkland BH, 2005, J MED ENTOMOL, V42, P346, DOI 10.1603/0022-2585(2005)042[0346:OAAAFA]2.0.CO;2; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Liu SJ, 2004, BIOCHEMISTRY-US, V43, P4447, DOI 10.1021/bi036255h; Liu SJ, 2005, BIOCHEMISTRY-US, V44, P2949, DOI 10.1021/bi0479712; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P16365, DOI 10.1021/bi051776l; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Nakagawa Y., 1999, J Infect Chemother, V5, P97, DOI 10.1007/s101560050016; Narayanan B, 2009, J MOL BIOL, V386, P486, DOI 10.1016/j.jmb.2008.12.037; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; POLLACK SJ, 1992, EUR J BIOCHEM, V209, P735, DOI 10.1111/j.1432-1033.1992.tb17342.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Simanshu DK, 2003, BIOCHEM BIOPH RES CO, V311, P193, DOI 10.1016/j.bbrc.2003.09.193; SWAIN AL, 1989, J BIOL CHEM, V264, P16620; Teplyakov A, 2005, BIOCHEMISTRY-US, V44, P16377, DOI 10.1021/bi051779y; von Delft F, 2003, STRUCTURE, V11, P985, DOI 10.1016/S0969-2126(03)00158-8; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Welch AJ, 2007, PLANT SCI, V172, P488, DOI 10.1016/j.plantsci.2006.10.015; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	52	35	36	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26685	26696		10.1074/jbc.M110.117804	http://dx.doi.org/10.1074/jbc.M110.117804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558740	hybrid, Green Published			2022-12-27	WOS:000280921000083
J	Dettmer, U; Kuhn, PH; Abou-Ajram, C; Lichtenthaler, SF; Kruger, M; Kremmer, E; Haass, C; Haffner, C				Dettmer, Ulf; Kuhn, Peer-Hendrik; Abou-Ajram, Claudia; Lichtenthaler, Stefan F.; Krueger, Marcus; Kremmer, Elisabeth; Haass, Christian; Haffner, Christof			Transmembrane Protein 147 (TMEM147) Is a Novel Component of the Nicalin-NOMO Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEX; INTRAMEMBRANE PROTEOLYSIS; SIGNALING PATHWAY; BETA-APP; NICASTRIN; PRESENILIN; APH-1; NOTCH; ENDOPROTEOLYSIS; EXPRESSION	Nicastrin and its relative Nicalin (Nicastrin-like protein) are both members of larger protein complexes, namely gamma-secretase and the Nicalin-NOMO (Nodal modulator) complex. The gamma-secretase complex, which contains Presenilin, APH-1, and PEN-2 in addition to Nicastrin, catalyzes the proteolytic cleavage of the transmembrane domain of various proteins including the beta-amyloid precursor protein and Notch. Nicalin and its binding partner NOMO form a complex that was shown to modulate Nodal signaling in developing zebrafish embryos. Because its experimentally determined native size (200-220 kDa) could not be satisfyingly explained by the molecular masses of Nicalin (60 kDa) and NOMO(130 kDa), we searched in affinity-purified complex preparations for additional components in the low molecular mass range. A similar to 22-kDa protein was isolated and identified by mass spectrometry as transmembrane protein 147 (TMEM147), a novel, highly conserved membrane protein with a putative topology similar to APH-1. Like Nicalin and NOMO, it localizes to the endoplasmic reticulum and is expressed during early zebrafish development. Overexpression and knockdown experiments in cultured cells demonstrate a close relationship between the three proteins and suggest that they are components of the same complex. We present evidence that, similar to gamma-secretase, its assembly is hierarchical starting with the formation of a Nicalin-NOMO intermediate. Nicalin appears to represent the limiting factor regulating the assembly rate by stabilizing the other two components. We conclude that TMEM147 is a novel core component of the Nicalin-NOMO complex, further emphasizing its similarity with gamma-secretase.	[Haass, Christian; Haffner, Christof] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian; Haffner, Christof] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Krueger, Marcus] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Max Planck Society; Helmholtz Association	Haffner, C (corresponding author), Univ Munich, Inst Stroke & Dementia Res, Klinikum Grosshadern, Max Lebsche Pl 30, D-81377 Munich, Germany.	chaffner@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016; Haffner, Christof/AAG-6676-2020	Lichtenthaler, Stefan F/0000-0003-2211-2575; Kuhn, Peer-Hendrik/0000-0001-7891-5102; Dettmer, Ulf/0000-0001-6676-0107	Deutsche Forschungsgemeinschaft [596]; Bundesministerium fur Bildung und Forschung (BMBF); Centre for Integrated Protein Science Munich; Ludwig-Maximilians-University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Centre for Integrated Protein Science Munich; Ludwig-Maximilians-University	This work was supported by the Deutsche Forschungsgemeinschaft (Leibniz Award to C. Haass, Sonderforschungsbereich 596 to C. Haass and S. F. L.), the Bundesministerium fur Bildung und Forschung (BMBF) through the competence network "Degenerative dementias" (to S. F. L. and C. Haass), the Centre for Integrated Protein Science Munich, a Ph. D. scholarship of the "Stiftung Stipendien-Fonds des Verbandes der chemischen Industrie" (to U. D.), and a "Forschungsprofessur" of the Ludwig-Maximilians-University (to C. Haass).	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Haffner C, 2007, J BIOL CHEM, V282, P10632, DOI 10.1074/jbc.M611033200; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; THISSE C, 1993, DEVELOPMENT, V119, P1203; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	35	28	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26174	26181		10.1074/jbc.M110.132548	http://dx.doi.org/10.1074/jbc.M110.132548			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538592	Green Published, hybrid			2022-12-27	WOS:000280921000034
J	Boyd, JM; Clark, DD; Kofoed, MA; Ensign, SA				Boyd, Jeffrey M.; Clark, Daniel D.; Kofoed, Melissa A.; Ensign, Scott A.			Mechanism of Inhibition of Aliphatic Epoxide Carboxylation by the Coenzyme M Analog 2-Bromoethanesulfonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE OXIDOREDUCTASE; STRUCTURAL BASIS; ACTIVE-SITE; M REDUCTASE; METHANOGENESIS; DEHYDROGENASE; ENZYMES; PATHWAY; GROWTH; FAMILY	The bacterial metabolism of epoxypropane formed from propylene oxidation uses the atypical cofactor coenzyme M (CoM, 2-mercaptoethanesulfonate) as the nucleophile for epoxide ring opening and as a carrier of intermediates that undergo dehydrogenation, reductive cleavage, and carboxylation to form acetoacetate in a three-step metabolic pathway. 2-Ketopropyl-CoM carboxylase/oxidoreductase (2-KPCC), the terminal enzyme of this pathway, is the only known member of the disulfide oxidoreductase family of enzymes that is a carboxylase. In the present work, the CoM analog 2-bromoethanesulfonate (BES) is shown to be a reversible inhibitor of 2-KPCC and hydroxypropyl-CoM dehydrogenase but not of epoxyalkane: CoM transferase. Further investigations revealed that BES is a time-dependent inactivator of dithiothreitol-reduced 2-KPCC, where the redox active cysteines are in the free thiol forms. BES did not inactivate air-oxidized 2-KPCC, where the redox active cysteine pair is in the disulfide form. The inactivation of 2-KPCC exhibited saturation kinetics, and CoM slowed the rate of inactivation. Mass spectral analysis demonstrated that BES inactivation of reduced 2-KPCC occurs with covalent modification of the interchange thiol (Cys(82)) by a group with a molecular mass identical to that of ethylsulfonate. The flavin thiol Cys(87) was not alkylated by BES under reducing conditions, and no amino acid residues were modified by BES in the oxidized enzyme. The UV-visible spectrum of BES-modifed 2-KPCC showed the characteristic charge transfer absorbance expected with alkylation at Cys(82). These results identify BES as a reactive CoM analog that specifically alkylates the interchange thiol that facilitates thioether bond cleavage and enolacetone formation during catalysis.	[Boyd, Jeffrey M.; Kofoed, Melissa A.; Ensign, Scott A.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Clark, Daniel D.] Calif State Univ Chico, Dept Chem, Chico, CA 95929 USA	Utah System of Higher Education; Utah State University; California State University System; California State University Chico	Ensign, SA (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	scott.ensign@usu.edu		Boyd, Jeffrey/0000-0001-7721-3926	National Institutes of Health [GM51805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051805, R01GM051805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51805.	Aliverti A, 1999, METH MOL B, V131, P9; Allen JR, 1999, P NATL ACAD SCI USA, V96, P8432, DOI 10.1073/pnas.96.15.8432; Allen JR, 1997, J BACTERIOL, V179, P3110, DOI 10.1128/jb.179.10.3110-3115.1997; Boyd JM, 2006, J BACTERIOL, V188, P8062, DOI 10.1128/JB.00947-06; Cleland W W, 1979, Methods Enzymol, V63, P103; Copeland R. A., 2000, ENZYMES, V2nd; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ensign SA, 2003, ANNU REV BIOCHEM, V72, P55, DOI 10.1146/annurev.biochem.72.121801.161820; Ensign SA, 2001, BIOCHEMISTRY-US, V40, P5845, DOI 10.1021/bi015523d; FOX BS, 1983, BIOCHEMISTRY-US, V22, P4082, DOI 10.1021/bi00286a014; Goenrich M, 2004, J BIOL INORG CHEM, V9, P691, DOI 10.1007/s00775-004-0552-1; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Hinderberger D, 2006, ANGEW CHEM INT EDIT, V45, P3602, DOI 10.1002/anie.200600366; Krishnakumar AM, 2006, BIOCHEMISTRY-US, V45, P8831, DOI 10.1021/bi0603569; Kruger K, 1999, APPL MICROBIOL BIOT, V52, P666, DOI 10.1007/s002530051576; Kunz RC, 2008, BIOCHEMISTRY-US, V47, P2661, DOI 10.1021/bi701942w; Kunz RC, 2006, J BIOL CHEM, V281, P34663, DOI 10.1074/jbc.M606715200; Nocek B, 2002, BIOCHEMISTRY-US, V41, P12907, DOI 10.1021/bi026580p; Pai EF, 1991, CURR OPIN STRUC BIOL, V1, P796, DOI 10.1016/0959-440X(91)90181-R; Pandey AS, 2006, BIOCHEMISTRY-US, V45, P113, DOI 10.1021/bi051518o; SPARLING R, 1987, CAN J MICROBIOL, V33, P1132, DOI 10.1139/m87-199; TAYLOR CD, 1974, J BACTERIOL, V120, P974, DOI 10.1128/JB.120.2.974-975.1974; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; WOLFE RS, 1991, ANNU REV MICROBIOL, V45, P1, DOI 10.1146/annurev.mi.45.100191.000245; ZINDER SH, 1984, APPL ENVIRON MICROB, V47, P1343, DOI 10.1128/AEM.47.6.1343-1345.1984	25	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25232	25242		10.1074/jbc.M110.144410	http://dx.doi.org/10.1074/jbc.M110.144410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551308	Green Published, hybrid			2022-12-27	WOS:000280682400016
J	Kamitani, S; Kitadokoro, K; Miyazawa, M; Toshima, H; Fukui, A; Abe, H; Miyake, M; Horiguchi, Y				Kamitani, Shigeki; Kitadokoro, Kengo; Miyazawa, Masayuki; Toshima, Hirono; Fukui, Aya; Abe, Hiroyuki; Miyake, Masami; Horiguchi, Yasuhiko			Characterization of the Membrane-targeting C1 Domain in Pasteurella multocida Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POTENT MITOGEN; PROTEIN; ACTIVATION; IDENTIFICATION; LOCALIZATION; CLEAVAGE; FRAGMENT; DEPENDS	Pasteurella multocida toxin (PMT) is a virulence factor responsible for the pathogenesis of some forms of pasteurellosis. The toxin activates G(q)- and G(12/13)-dependent pathways through the deamidation of a glutamine residue in the alpha-subunit of heterotrimeric GTPases. We recently reported the crystal structure of the C terminus (residues 575-1285) of PMT (C-PMT), which is composed of three domains (C1, C2, and C3), and that the C1 domain is involved in the localization of C-PMT to the plasma membrane, and the C3 domain possesses a cysteine protease-like catalytic triad. In this study, we analyzed the membrane-targeting function of the C1 domain in detail. The C1 domain consists of seven helices of which the first four (residues 590670), showing structural similarity to the N terminus of Clostridium difficile toxin B, were found to be involved in the recruitment of C-PMT to the plasma membrane. C-PMT lacking these helices (C-PMT Delta C1(4H)) neither localized to the plasma membrane nor stimulated the G(q/12/13)-dependent signaling pathways. When the membrane-targeting property was complemented by a peptide tag with an N-myristoylation motif, C-PMT Delta C1(4H) recovered the PMT activity. Direct binding between the C1 domain and liposomes containing phospholipids was evidenced by surface plasmon resonance analyses. These results indicate that the C1 domain of C-PMT functions as a targeting signal for the plasma membrane.	[Miyake, Masami; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Kyoto 6068585, Japan; [Miyake, Masami] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Environm Sci, Osaka 5998531, Japan	Osaka University; Kyoto Institute of Technology; Osaka Metropolitan University		skami@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Kamitani, Shigeki/0000-0002-1268-4652	Ministry of Education, Culture, Science, and Technology of Japan	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Science, and Technology of Japan.	Baldwin MR, 2004, MOL MICROBIOL, V54, P239, DOI 10.1111/j.1365-2958.2004.04264.x; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Busch C, 2001, INFECT IMMUN, V69, P3628, DOI 10.1128/IAI.69.6.3628-3634.2001; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Essler M, 1998, J IMMUNOL, V161, P5640; FALBO V, 1993, INFECT IMMUN, V61, P4909, DOI 10.1128/IAI.61.11.4909-4914.1993; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Hanajima-Ozawa M, 2007, INFECT IMMUN, V75, P565, DOI 10.1128/IAI.01479-06; HIGGINS TE, 1992, P NATL ACAD SCI USA, V89, P4240, DOI 10.1073/pnas.89.10.4240; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Lacerda HM, 1996, J BIOL CHEM, V271, P439, DOI 10.1074/jbc.271.1.439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Miyazawa M, 2006, ACTA CRYSTALLOGR F, V62, P906, DOI 10.1107/S1744309106030375; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MURPHY AC, 1992, J BIOL CHEM, V267, P25296; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2004, J BIOL CHEM, V279, P34150, DOI 10.1074/jbc.M405353200; Orth JHC, 2003, BIOCHEMISTRY-US, V42, P4971, DOI 10.1021/bi0272959; Orth JHC, 2008, J BIOL CHEM, V283, P23288, DOI 10.1074/jbc.M803435200; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; OSWALD E, 1994, P NATL ACAD SCI USA, V91, P3814, DOI 10.1073/pnas.91.9.3814; Pullinger GD, 2001, INFECT IMMUN, V69, P7839, DOI 10.1128/IAI.69.12.7839-7850.2001; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Ward PN, 1998, INFECT IMMUN, V66, P5636, DOI 10.1128/IAI.66.12.5636-5642.1998; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	35	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25467	25475		10.1074/jbc.M110.102285	http://dx.doi.org/10.1074/jbc.M110.102285			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534589	Green Published, hybrid			2022-12-27	WOS:000280682400040
J	Shibagaki, N; Grossman, AR				Shibagaki, Nakako; Grossman, Arthur R.			Binding of Cysteine Synthase to the STAS Domain of Sulfate Transporter and Its Regulatory Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SERINE ACETYLTRANSFERASE; O-ACETYLSERINE SULFHYDRYLASE; ARABIDOPSIS-THALIANA; NITRATE TRANSPORTER; GENE FAMILY; SULFUR NUTRITION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; SALMONELLA-TYPHIMURIUM; BIOCHEMICAL-ANALYSIS	The sulfate ion (SO42-) is transported into plant root cells by SO42- transporters and then mostly reduced to sulfide (S2-). The S2- is then bonded to O-acetylserine through the activity of cysteine synthase (O-acetylserine (thiol) lyase or OASTL) to form cysteine, the first organic molecule of the SO42- assimilation pathway. Here, we show that a root plasma membrane SO42- transporter of Arabidopsis, SULTR1;2, physically interacts with OASTL. The interaction was initially demonstrated using a yeast two-hybrid system and corroborated by both in vivo and in vitro binding assays. The domain of SULTR1;2 shown to be important for association with OASTL is called the STAS domain. This domain is at the C terminus of the transporter and extends from the plasma membrane into the cytoplasm. The functional relevance of the OASTL-STAS interaction was investigated using yeast mutant cells devoid of endogenous SO42- uptake activity but co-expressing SULTR1;2 and OASTL. The analysis of SO42- transport in these cells suggests that the binding of OASTL to the STAS domain in this heterologous system negatively impacts transporter activity. In contrast, the activity of purified OASTL measured in vitro was enhanced by co-incubation with the STAS domain of SULTR1;2 but not with the analogous domain of the SO42- transporter isoform SULTR1;1, even though the SULTR1;1 STAS peptide also interacts with OASTL based on the yeast two-hybrid system and in vitro binding assays. These observations suggest a regulatory model in which interactions between SULTR1;2 and OASTL coordinate internalization of SO42- with the energetic/metabolic state of plant root cells.	[Shibagaki, Nakako; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Shibagaki, N (corresponding author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	nshibagaki@mls.eng.osaka-u.ac.jp			National Science Foundation [MCB0235878, MCB-0824469]; Carnegie Institution for Science	National Science Foundation(National Science Foundation (NSF)); Carnegie Institution for Science	This work was supported by National Science Foundation Grants MCB0235878 and MCB-0824469 (to A. R. G.) and by The Carnegie Institution for Science.	Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Blaszczyk A, 1999, PLANT J, V20, P237, DOI 10.1046/j.1365-313x.1999.00596.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burke D, 2000, METHODS YEAST GENETI, P103; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Cherest H, 1997, GENETICS, V145, P627; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gotor C, 1997, PLANT J, V11, P347, DOI 10.1046/j.1365-313X.1997.11020347.x; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Hell R, 2002, AMINO ACIDS, V22, P245, DOI 10.1007/s007260200012; HESSE H, 1995, PLANT PHYSIOL, V108, P851, DOI 10.1104/pp.108.2.851; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Ho MS, 2003, J BIOL CHEM, V278, P20898, DOI 10.1074/jbc.M302305200; Hopkins L, 2005, PLANT PHYSIOL, V138, P433, DOI 10.1104/pp.104.057521; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jost R, 2000, GENE, V253, P237, DOI 10.1016/S0378-1119(00)00261-4; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18816, DOI 10.1073/pnas.0604711103; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Martin Y, 2008, PLANT MOL BIOL, V68, P215, DOI 10.1007/s11103-008-9363-z; Maruyama-Nakashita A, 2004, J EXP BOT, V55, P1843, DOI 10.1093/jxb/erh175; Maruyama-Nakashita A, 2004, PLANT CELL PHYSIOL, V45, P340, DOI 10.1093/pcp/pch029; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mulet JM, 2004, YEAST, V21, P303, DOI 10.1002/yea.1076; Nakae H, 2007, CHINA FOUNDRY, V4, P34; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Noji M, 2002, AMINO ACIDS, V22, P231, DOI 10.1007/s007260200011; Rouached H, 2008, PLANT PHYSIOL, V147, P897, DOI 10.1104/pp.108.118612; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Shibagaki N, 2002, PLANT J, V29, P475, DOI 10.1046/j.0960-7412.2001.01232.x; Shibagaki N, 2004, J BIOL CHEM, V279, P30791, DOI 10.1074/jbc.M403248200; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; SORENSEN MA, 1991, J BACTERIOL, V173, P5244, DOI 10.1128/jb.173.16.5244-5246.1991; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Warrilow AGS, 1998, J EXP BOT, V49, P1625, DOI 10.1093/jexbot/49.327.1625; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Yoshimoto N, 2007, PLANT PHYSIOL, V145, P378, DOI 10.1104/pp.107.105742; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	51	41	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25094	25102		10.1074/jbc.M110.126888	http://dx.doi.org/10.1074/jbc.M110.126888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529854	Green Published, hybrid			2022-12-27	WOS:000280542100082
J	Cho, HH; Cahill, CM; Vanderburg, CR; Scherzer, CR; Wang, B; Huang, XD; Rogers, JT				Cho, Hyun-Hee; Cahill, Catherine M.; Vanderburg, Charles R.; Scherzer, Clemens R.; Wang, Bin; Huang, Xudong; Rogers, Jack T.			Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSIVE-ELEMENT; RNA-BINDING; NEURODEGENERATIVE DISEASE; PHOSPHOMIMETIC MUTATION; 5'-UNTRANSLATED REGION; TARGETED DELETION; ALPHA-SYNUCLEIN; BRAIN IRON; FERRITIN	Iron influx increases the translation of the Alzheimer amyloid precursor protein (APP) via an iron-responsive element (IRE) RNA stem loop in its 5'-untranslated region. Equal modulated interaction of the iron regulatory proteins (IRP1 and IRP2) with canonical IREs controls iron-dependent translation of the ferritin subunits. However, our immunoprecipitation RT-PCR and RNA binding experiments demonstrated that IRP1, but not IRP2, selectively bound the APP IRE in human neural cells. This selective IRP1 interaction pattern was evident in human brain and blood tissue from normal and Alzheimer disease patients. We computer-predicted an optimal novel RNA stem loop structure for the human, rhesus monkey, and mouse APP IREs with reference to the canonical ferritin IREs but also the IREs encoded by erythroid heme biosynthetic aminolevulinate synthase and Hif-2 alpha mRNAs, which preferentially bind IRP1. Selective 2'-hydroxyl acylation analyzed by primer extension analysis was consistent with a 13-base single-stranded terminal loop and a conserved GC-rich stem. Biotinylated RNA probes deleted of the conserved CAGA motif in the terminal loop did not bind to IRP1 relative to wild type probes and could no longer base pair to form a predicted AGA triloop. An AGU pseudo-triloop is key for IRP1 binding to the canonical ferritin IREs. RNA probes encoding the APP IRE stem loop exhibited the same high affinity binding to rhIRP1 as occurs for the H-ferritin IRE (35pM). Intracellular iron chelation increased binding of IRP1 to the APP IRE, decreasing intracellular APP expression in SH-SY5Y cells. Functionally, shRNA knockdown of IRP1 caused increased expression of neural APP consistent with IRP1-APP IRE-driven translation.	[Cahill, Catherine M.; Rogers, Jack T.] Harvard Univ, Massachusetts Gen Hosp, Neurochem Lab, Dept Psychiat Neurosci,Sch Med, Charlestown, MA 02129 USA; [Vanderburg, Charles R.] Massachusetts Gen Hosp, Harvard NeuroDiscovery Ctr, Boston, MA 02129 USA; [Wang, Bin] Marshall Univ, Dept Chem, Huntington, WV 25755 USA; [Scherzer, Clemens R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Huang, Xudong] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Marshall University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cahill, CM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Neurochem Lab, Dept Psychiat Neurosci,Sch Med, Bldg 149,Rm 2510,13th St, Charlestown, MA 02129 USA.	ccahill@helix.mgh.harvard.edu; jrogers@partners.org	Huang, Xudong/D-9711-2018; Vanderburg, Charles/C-4516-2013	Huang, Xudong/0000-0002-4811-1901; Rogers, Jack/0000-0003-1262-8578; Scherzer, Clemens/0000-0002-0567-9193; Vanderburg, Charles/0000-0001-8979-5054	National Institutes of Health [AG20181]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant AG20181 (to J. T. R.). This work was also supported by a Zenith award from the Alzheimer's Association (to J. T. R.).	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; Avramovich-Tirosh Y, 2007, J NEUROCHEM, V100, P490, DOI 10.1111/j.1471-4159.2006.04258.x; Bandyopadhyay S, 2006, J NEURAL TRANSM-SUPP, P237; Bartzokis G, 2004, ANN NY ACAD SCI, V1012, P224, DOI 10.1196/annals.1306.019; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; Chen GH, 2007, CARCINOGENESIS, V28, P785, DOI 10.1093/carcin/bgl210; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; CONNOR JR, 1995, J NEUROCHEM, V65, P717; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Fillebeen C, 2005, BIOCHEM J, V388, P143, DOI 10.1042/BJ20041623; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; Fischer P, 1997, LIFE SCI, V60, P2273, DOI 10.1016/S0024-3205(97)00282-8; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2006, NAT GENET, V38, P967, DOI 10.1038/ng0906-967; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Janssen S, 2010, BIOINFORMATICS, V26, P632, DOI 10.1093/bioinformatics/btq014; Jefferies WA, 2001, J ALZHEIMERS DIS, V3, P339, DOI 10.3233/JAD-2001-3309; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Khan MA, 2009, J BIOL CHEM, V284, P30122, DOI 10.1074/jbc.M109.041061; Kim DK, 2001, NEUROPSYCHOPHARMACOL, V25, P84, DOI 10.1016/S0893-133X(00)00230-X; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Leibold EA, 2001, HISTOCHEM CELL BIOL, V115, P195; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Lin E, 2001, J BIOL CHEM, V276, P27685, DOI 10.1074/jbc.M100941200; Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/j.jsb.2005.12.011; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Morse LJ, 2004, J MOL NEUROSCI, V24, P129, DOI 10.1385/JMN:24:1:129; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pinero DJ, 2000, CELL MOL BIOL, V46, P761; Pitula JS, 2004, P NATL ACAD SCI USA, V101, P10907, DOI 10.1073/pnas.0404308101; Reznichenko L, 2006, J NEUROCHEM, V97, P527, DOI 10.1111/j.1471-4159.2006.03770.x; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROGERS J, 2002, Patent No. 2002034766; Rogers JT, 2008, BIOCHEM SOC T, V36, P1282, DOI 10.1042/BST0361282; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MA, 1997, J NEUROSCI, V17, P2653; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Squitti R, 2003, NEUROLOGY, V60, P2013, DOI 10.1212/01.WNL.0000068013.27968.29; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; TANZI RE, 1991, NATURE, V350, P564, DOI 10.1038/350564a0; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Westmark CJ, 2005, J NEUROPATH EXP NEUR, V64, P1037, DOI 10.1097/01.jnen.0000189835.71574.e1; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wolfe MS, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0506-72; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	91	113	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31217	31232		10.1074/jbc.M110.149161	http://dx.doi.org/10.1074/jbc.M110.149161			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20558735	Green Published, hybrid			2022-12-27	WOS:000282764600016
J	Horita, S; Ishibashi, J; Nagata, K; Miyakawa, T; Yamakawa, M; Tanokura, M				Horita, Shoichiro; Ishibashi, Jun; Nagata, Koji; Miyakawa, Takuya; Yamakawa, Minoru; Tanokura, Masaru			Isolation, cDNA Cloning, and Structure-based Functional Characterization of Oryctin, a Hemolymph Protein from the Coconut Rhinoceros Beetle, Oryctes rhinoceros, as a Novel Serine Protease Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVOMUCOID 3RD DOMAIN; KAZAL-TYPE INHIBITOR; CHEMICAL-SHIFT; ELASTASE; SEQUENCE; CRYSTAL; COMPLEX	We isolated oryctin, a 66-residue peptide, from the hemolymph of the coconut rhinoceros beetle Oryctes rhinoceros and cloned its cDNA. Oryctin is dissimilar to any other known peptides in amino acid sequence, and its function has been unknown. To reveal that function, we determined the solution structure of recombinant C-13, N-15-labeled oryctin by heteronuclear NMR spectroscopy. Oryctin exhibits a fold similar to that of Kazal-type serine protease inhibitors but has a unique additional C-terminal alpha-helix. We performed protease inhibition assays of oryctin against several bacterial and eukaryotic proteases. Oryctin does inhibit the following serine proteases: alpha-chymotrypsin, endopeptidase K, subtilisin Carlsberg, and leukocyte elastase, with K-i values of 3.9 x 10(-10) (M), 6.2 x 10(-10) (M), 1.4 x 10(-9) (M), and 1.2 x 10(-8) (M), respectively. Although the target molecule of oryctin in the beetle hemolymph remains obscure, our results showed that oryctin is a novel single domain Kazal-type inhibitor and could play a key role in protecting against bacterial infections.	[Horita, Shoichiro; Nagata, Koji; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishibashi, Jun; Yamakawa, Minoru] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Yamakawa, Minoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; University of Tsukuba	Tanokura, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480	Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Enhancement of Center of Excellence, Special Coordination Funds for Promoting Science and Technology, Science and Technology Agency, Japan; and by the National Project on Protein Structural and Functional Analyses, the Targeted Proteins Research Program, and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; EGUCHI M, 1994, J BIOCHEM-TOKYO, V115, P881, DOI 10.1093/oxfordjournals.jbchem.a124434; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; FUJINAGA M, 1987, J MOL BIOL, V195, P397, DOI 10.1016/0022-2836(87)90659-0; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ishibashi J, 1999, EUR J BIOCHEM, V266, P616, DOI 10.1046/j.1432-1327.1999.00906.x; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Lauber T, 2003, J MOL BIOL, V328, P205, DOI 10.1016/S0022-2836(03)00245-6; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tomie T, 2003, BIOCHEM BIOPH RES CO, V307, P261, DOI 10.1016/S0006-291X(03)01162-8; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang J, 1998, EUR J BIOCHEM, V255, P734, DOI 10.1046/j.1432-1327.1998.2550734.x	17	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30150	30158		10.1074/jbc.M110.124735	http://dx.doi.org/10.1074/jbc.M110.124735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630859	Green Published, hybrid			2022-12-27	WOS:000281984300052
J	Joo, HJ; Kim, KY; Yim, YH; Jin, YX; Kim, H; Kim, MY; Paik, YK				Joo, Hyoe-Jin; Kim, Kwang-Youl; Yim, Yong-Hyeon; Jin, You-Xun; Kim, Heekyeong; Kim, Mun-Young; Paik, Young-Ki			Contribution of the Peroxisomal acox Gene to the Dynamic Balance of Daumone Production in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUER PHEROMONE COMPONENT; BIOGENESIS DISORDERS; BETA-OXIDATION; TEMPERATURE; BIOSYNTHESIS; OXIDASE	Dauer pheromones or daumones, which are signaling molecules that interrupt development and reproduction (dauer larvae) during unfavorable growth conditions, are essential for cellular homeostasis in Caenorhabditis elegans. According to earlier studies, dauer larva formation in strain N2 is enhanced by a temperature increase, suggesting the involvement of a temperature-dependent component in dauer pheromone biosynthesis or sensing. Several naturally occurring daumone analogs (e. g. daumones 1-3) have been identified, and these molecules are predicted to be synthesized in different physiological settings in this nematode. To elucidate the molecular regulatory system that may influence the dynamic balance of specific daumone production in response to sudden temperature changes, we characterized the peroxisomal acox gene encoding acyl-CoA oxidase, which is predicted to catalyze the first reaction during biosynthesis of the fatty acid component of daumones. Using acox-1(ok2257) mutants and a new, robust analytical method, we quantified the three most abundant daumones in worm bodies and showed that acox likely contributes to the dynamic production of various quantities of three different daumones in response to temperature increase, changes that are critical in C. elegans for coping with the natural environmental changes it faces.	[Paik, Young-Ki] Yonsei Univ, World Class Univ Program, Dept Biomed Sci,Dept Biochem, Yonsei Proteome Res Ctr,Coll Life Sci & Biotechno, Seoul 120749, South Korea; [Yim, Yong-Hyeon; Jin, You-Xun] Korea Res Inst Stand & Sci, Taejon 305340, South Korea	Yonsei University; Korea Research Institute of Standards & Science (KRISS)	Paik, YK (corresponding author), Yonsei Univ, World Class Univ Program, Dept Biomed Sci,Dept Biochem, Yonsei Proteome Res Ctr,Coll Life Sci & Biotechno, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		kim, kwangyoul/0000-0001-8667-3369	Ministry of Health and Welfare of Republic of Korea [A030003]; World Class University through National Research Foundation of Korea [R31-2008-000-10086-0]	Ministry of Health and Welfare of Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); World Class University through National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by Korea Health 21 R & DProject Ministry of Health and Welfare of Republic of Korea Grant A030003 (to Y.-K. P.) and by World Class University Program Grant R31-2008-000-10086-0 through the National Research Foundation of Korea.	Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, ORG LETT, V11, P3100, DOI 10.1021/ol901011c; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gurvitz A, 2000, YEAST, V17, P188, DOI 10.1002/1097-0061(20000930)17:3<188::AID-YEA27>3.0.CO;2-E; Imamura A, 2001, J MED GENET, V38, P871, DOI 10.1136/jmg.38.12.871; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sambrook J., 1989, MOL CLONING, pA1; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016	22	50	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29319	29325		10.1074/jbc.M110.122663	http://dx.doi.org/10.1074/jbc.M110.122663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610393	hybrid, Green Published			2022-12-27	WOS:000281740100034
J	Skipwith, CG; Cao, WJ; Zheng, XL				Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long			Factor VIII and Platelets Synergistically Accelerate Cleavage of von Willebrand Factor by ADAMTS13 under Fluid Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-CLEAVING PROTEASE; GLYCOPROTEIN IB; ENDOTHELIAL-CELLS; BINDING; ULTRALARGE; SURFACE; CONFORMATION; DEFICIENCY; MUTATIONS; THROMBIN	Previous studies have demonstrated that factor VIII (FVIII) or platelets alone increase cleavage of von Willebrand factor (VWF) by ADAMTS13 under mechanically induced shear stresses. We show in this study that the combination of FVIII and platelets at the physiological concentrations is more effective than either one alone. In the absence of FVIII, lyophilized platelets increase the formation of cleavage product by 2-3-fold. However, in the presence of physiological concentration of FVIII (1 nM), the formation of VWF cleavage product increases dramatically as a function of increasing platelets with the maximal rate enhancement of similar to 8-fold. Conversely, in the presence of a physiological concentration of lyophilized platelets (150 x 10(3)/mu l), the half-maximal concentration of FVIII required to accelerate VWF proteolysis by ADAMTS13 reduces by similar to 10-fold (to similar to 0.3 nM) compared with that in the absence of platelets (similar to 3.0 nM). Further studies using the FVIII derivative that lacks an acidic region (a3), an antiplatelet glycoprotein 1b alpha IgG, and a purified recombinant VWF-A1 domain or glycoprotein 1b alpha-stripped platelets demonstrate that the synergistic rate-enhancing effect of FVIII and platelets depends on their specific binding interactions with VWF. Our findings suggest that FVIII and platelets are cofactors that regulate proteolysis of multimeric VWF by ADAMTS13 under physiological conditions.	[Skipwith, Christopher G.; Zheng, X. Long] Childrens Hosp Philadelphia, Biochem & Mol Biophys Grad Program, Philadelphia, PA 19104 USA; [Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Skipwith, Christopher G.; Cao, Wenjing; Zheng, X. Long] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Zheng, XL (corresponding author), 816G Abramson Res Ctr, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zheng@email.chop.edu	Zheng, X. Long/ABD-7362-2021	Zheng, X. Long/0000-0003-1680-5295	National Institutes of Health [R01HL079027, P01 HL074124]; National Aeronautics and Space Administration (NASA); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081588, P01HL074124, R01HL079027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL079027 and P01 HL074124-Project 3 (to X. L. Z.). This work was also supported by a National Aeronautics and Space Administration (NASA)-Harriett G. Jenkins Predoctoral fellowship project (to C. G. S.), an American Heart Association postdoctoral fellowship (to W. C.).	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; BUDDE U, 1993, BLOOD, V82, P1749; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Castaman G, 2003, HAEMATOLOGICA, V88, P94; COLLER BS, 1983, BLOOD, V61, P99; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Furlan M, 1997, BLOOD, V89, P3097, DOI 10.1182/blood.V89.9.3097; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Jin SY, 2009, J THROMB HAEMOST, V7, P1749, DOI 10.1111/j.1538-7836.2009.03570.x; Kinlough-Rathbone RL, 2000, THROMB RES, V99, P165, DOI 10.1016/S0049-3848(00)00240-1; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Laje P, 2009, BLOOD, V113, P2172, DOI 10.1182/blood-2008-08-173021; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liu LB, 1997, J BIOL CHEM, V272, P1997, DOI 10.1074/jbc.272.3.1997; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; OZEKI M, 2009, THROMB RES, V125, P17; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; SADLER JE, 1991, J BIOL CHEM, V266, P22777; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; Weeterings C, 2008, BLOOD, V112, P3227, DOI 10.1182/blood-2008-02-139113; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; YEO E, 1993, BLOOD, V82, pA612; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035; Zheng XL, 2002, CURR OPIN HEMATOL, V9, P389, DOI 10.1097/00062752-200209000-00001	48	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28596	28603		10.1074/jbc.M110.131227	http://dx.doi.org/10.1074/jbc.M110.131227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605782	Green Published, hybrid			2022-12-27	WOS:000281594000023
J	Ballottari, M; Girardon, J; Betterle, N; Morosinotto, T; Bassi, R				Ballottari, Matteo; Girardon, Julien; Betterle, Nico; Morosinotto, Tomas; Bassi, Roberto			Identification of the Chromophores Involved in Aggregation-dependent Energy Quenching of the Monomeric Photosystem II Antenna Protein Lhcb5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING-COMPLEX; TIME-RESOLVED FLUORESCENCE; PIGMENT-PIGMENT INTERACTIONS; A/B BINDING-PROTEINS; FAR-RED FLUORESCENCE; HIGHER-PLANT ANTENNA; CHLOROPHYLL FLUORESCENCE; MUTATION ANALYSIS; IN-VITRO; ELECTRON CRYSTALLOGRAPHY	Non-photochemical quenching (NPQ) of excess absorbed light energy is a fundamental process that regulates photosynthetic light harvesting in higher plants. Among several proposed NPQ mechanisms, aggregation-dependent quenching (ADQ) and charge transfer quenching have received the most attention. In vitro spectroscopic features of both mechanisms correlate with very similar signals detected in more intact systems and in vivo, where full NPQ can be observed. A major difference between the models is the proposed quenching site, which is predominantly the major trimeric light-harvesting complex II in ADQ and exclusively monomeric Lhcb proteins in charge transfer quenching. Here, we studied ADQ in both monomeric and trimeric Lhcb proteins, investigating the activities of each antenna subunit and their dependence on zeaxanthin, a major modulator of NPQ in vivo. We found that monomeric Lhcb proteins undergo stronger quenching than light-harvesting complex II during aggregation and that this is enhanced by binding to zeaxanthin, as occurs during NPQ in vivo. Finally, the analysis of Lhcb5 mutants showed that chlorophyll 612 and 613, in close contact with lutein bound at site L1, are important facilitators of ADQ.	[Ballottari, Matteo; Girardon, Julien; Betterle, Nico; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy	University of Verona; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, Ca Vignal 1,Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Morosinotto, Tomas/AAC-3188-2019; Ballottari, Matteo/N-1916-2019; Betterle, Nico/AAE-1004-2021	Morosinotto, Tomas/0000-0002-0803-7591; Ballottari, Matteo/0000-0001-8410-3397; Betterle, Nico/0000-0002-7556-6696; bassi, roberto/0000-0002-4140-8446	Italian Ministry of Research [20073YHRLE]; EU [238017]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	This work was supported by Italian Ministry of Research Special Fund for Basic Research Grant PRIN 20073YHRLE and by EU project 238017 HARVEST.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BARZDA V, 1994, BIOCHEMISTRY-US, V33, P10837, DOI 10.1021/bi00201a034; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; BASSI R, 1991, J PHOTOCH PHOTOBIO B, V9, P335, DOI 10.1016/1011-1344(91)80170-M; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; BETTERLE N, 2010, ARCH BIOCH IN PRESS; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Calhoun TR, 2009, J PHYS CHEM B, V113, P16291, DOI 10.1021/jp908300c; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; DAINESE P, 1991, J BIOL CHEM, V266, P8136; DAINESE P, 1992, RES PHOTOSYNTHESIS, V1, P13; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; HORTON P, 1988, BIOCHIM BIOPHYS ACTA, V932, P107, DOI 10.1016/0005-2728(88)90144-2; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Jahns P, 2001, J BIOL CHEM, V276, P22154, DOI 10.1074/jbc.M102147200; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Passarini F, 2009, J BIOL CHEM, V284, P29536, DOI 10.1074/jbc.M109.036376; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rogl H, 1999, BIOCHEMISTRY-US, V38, P16214, DOI 10.1021/bi990739p; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2009, PHOTOSYNTH RES, V99, P173, DOI 10.1007/s11120-008-9387-x; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1994, PHOTOSYNTH RES, V40, P181, DOI 10.1007/BF00019335; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Wentworth M, 2004, BIOCHEMISTRY-US, V43, P501, DOI 10.1021/bi034975i; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wentworth M, 2001, BIOCHEMISTRY-US, V40, P9902, DOI 10.1021/bi0103718	92	30	31	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28309	28321		10.1074/jbc.M110.124115	http://dx.doi.org/10.1074/jbc.M110.124115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584907	hybrid, Green Published			2022-12-27	WOS:000281404100073
J	Okazaki, Y; Ohshima, N; Yoshizawa, I; Kamei, Y; Mariggio, S; Okamoto, K; Maeda, M; Nogusa, Y; Fujioka, Y; Izumi, T; Ogawa, Y; Shiro, Y; Wada, M; Kato, N; Corda, D; Yanaka, N				Okazaki, Yuri; Ohshima, Noriyasu; Yoshizawa, Ikumi; Kamei, Yasutomi; Mariggio, Stefania; Okamoto, Keiko; Maeda, Masahiro; Nogusa, Yoshihito; Fujioka, Yuichiro; Izumi, Takashi; Ogawa, Yoshihiro; Shiro, Yoshitsugu; Wada, Masanobu; Kato, Norihisa; Corda, Daniela; Yanaka, Noriyuki			A Novel Glycerophosphodiester Phosphodiesterase, GDE5, Controls Skeletal Muscle Development via a Non-enzymatic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALPHA-DEFENSINS; PROTEIN; METABOLISM; ENZYME; GLPQ; GENE; DIFFERENTIATION; EXPRESSION; CHOLINE	Mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) have been identified recently and shown to be implicated in several physiological functions. This study isolated a novel GP-PDE, GDE5, and showed that GDE5 selectively hydrolyzes glycerophosphocholine (GroPCho) and controls skeletal muscle development. We show that GDE5 expression was reduced in atrophied skeletal muscles in mice and that decreasing GDE5 abundance promoted myoblastic differentiation, suggesting that decreased GDE5 expression has a counter-regulatory effect on the progression of skeletal muscle atrophy. Forced expression of full-length GDE5 in cultured myoblasts suppressed myogenic differentiation. Unexpectedly, a truncated GDE5 construct (GDE5 Delta C471), which contained a GP-PDE sequence identified in other GP-PDEs but lacked GroPCho phosphodiesterase activity, showed a similar inhibitory effect. Furthermore, transgenic mice specifically expressing GDE5 Delta C471 in skeletal muscle showed less skeletal muscle mass, especially type II fiber-rich muscle. These results indicate that GDE5 negatively regulates skeletal muscle development even without GroPCho phosphodiesterase activity, providing novel insight into the biological significance of mammalian GP-PDE function in a non-enzymatic mechanism.	[Okazaki, Yuri; Yoshizawa, Ikumi; Okamoto, Keiko; Maeda, Masahiro; Nogusa, Yoshihito; Fujioka, Yuichiro; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Ohshima, Noriyasu; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, Gunma 3718511, Japan; [Kamei, Yasutomi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Med & Metab, Med Res Inst, Tokyo 1138510, Japan; [Mariggio, Stefania; Corda, Daniela] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; [Mariggio, Stefania; Corda, Daniela] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Hongo 6795148, Japan; [Wada, Masanobu] Hiroshima Univ, Dept Human Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan	Hiroshima University; Gunma University; Tokyo Medical & Dental University (TMDU); Consorzio Mario Negri Sud; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); RIKEN; Hiroshima University	Yanaka, N (corresponding author), Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	yanaka@hiroshima-u.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015; Yanaka, Noriyuki/P-9096-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Telethon Italia	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Telethon Italia(Fondazione Telethon)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by Telethon Italia.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Bachmann AS, 2006, GENE, V371, P144, DOI 10.1016/j.gene.2005.11.023; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; BURT CT, 1976, BIOCHEMISTRY-US, V15, P4850, DOI 10.1021/bi00667a015; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Fan X, 2001, MOL MICROBIOL, V41, P1029, DOI 10.1046/j.1365-2958.2001.02571.x; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Han WH, 2009, FEBS J, V276, P6603, DOI 10.1111/j.1742-4658.2009.07370.x; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang H, 2007, J NEUROSCI, V27, P5948, DOI 10.1523/JNEUROSCI.0621-07.2007; KATES M, 1972, LABORATORY TECHNIQUE, V3, P347; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Sprott H, 2000, RHEUMATOLOGY, V39, P1121, DOI 10.1093/rheumatology/39.10.1121; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Turchanowa L, 2000, EUR J CLIN INVEST, V30, P72; van der Rest B, 2004, BIOCHEM J, V379, P601, DOI 10.1042/BJ20031489; van der Rest B, 2002, PLANT PHYSIOL, V130, P244, DOI 10.1104/pp.003392; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27652	27663		10.1074/jbc.M110.106708	http://dx.doi.org/10.1074/jbc.M110.106708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576599	Green Published, hybrid			2022-12-27	WOS:000281404100021
J	Ruan, L; Osawa, M; Hosoda, N; Imai, S; Machiyama, A; Katada, T; Hoshino, S; Shimada, I				Ruan, Lin; Osawa, Masanori; Hosoda, Nao; Imai, Shunsuke; Machiyama, Asako; Katada, Toshiaki; Hoshino, Shin-ichi; Shimada, Ichio			Quantitative Characterization of Tob Interactions Provides the Thermodynamic Basis for Translation Termination-coupled Deadenylase Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A)-BINDING PROTEIN; ANTIPROLIFERATIVE ACTIVITY; STRUCTURAL BASIS; TOB/BTG1 FAMILY; MEMBER; RECOGNITION; DOMAIN; YEAST; PABC; TURNOVER	Translation termination-coupled deadenylation is the first and often the rate-limiting step of eukaryotic mRNA decay in which two deadenylases, Ccr4-Caf1 and Pan2, play key roles. One of the deadenylases, Caf1, associates with Tob, which recruits Caf1 to the poly(A) tail through interactions with a cytoplasmic poly(A)-binding protein 1 (PABPC1). We previously proposed that the competition between Tob and eRF3 (a translation termination factor that interacts with PABPC1) is responsible for the regulation of deadenylase activity. However, the molecular mechanism of the regulation should be addressed by investigating the binding affinity and the cellular levels of these proteins. In this work, we characterized the human Tob interactions with Caf1 and a C-terminal domain of PABPC1 (PABC). Nuclear magnetic resonance (NMR) and Western blot analyses revealed that Tob consists of a structured N-terminal BTG-Tob domain and an unstructured C-terminal region with two conserved PAM2 (PABPC1-interacting motif 2) motifs. The BTG-TOB domain associates with Caf1, whereas the C-terminal PAM2 motif binds to PABC, with a K-d value of 20 mu M. Furthermore, we demonstrated that the levels of eRF3 and Tob in HeLa cells are 4-5 mu M and less than 0.2 mu M, respectively. On the basis of these results, we propose a thermodynamic mechanism for the translation termination-coupled deadenylation mediated by the Tob-Caf1 complex.	[Ruan, Lin; Osawa, Masanori; Imai, Shunsuke; Machiyama, Asako; Shimada, Ichio] Univ Tokyo, Dept Phys Chem, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Katada, Toshiaki] Univ Tokyo, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Hosoda, Nao; Hoshino, Shin-ichi] Nagoya City Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Osawa, Masanori/GRS-5726-2022	Hoshino, Shinichi/0000-0001-6135-7896; Osawa, Masanori/0000-0002-1285-4316; Imai, Shunsuke/0000-0001-9346-2359	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for scientific research on priority areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from the Takeda Science Foundation (to M. O.).	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Goddard T.D., 2004, SPARKY 3; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805	26	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27624	27631		10.1074/jbc.M110.138867	http://dx.doi.org/10.1074/jbc.M110.138867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595394	Green Published, hybrid			2022-12-27	WOS:000281404100018
J	Jeelani, G; Husain, A; Sato, D; Ali, V; Suematsu, M; Soga, T; Nozaki, T				Jeelani, Ghulam; Husain, Afzal; Sato, Dan; Ali, Vahab; Suematsu, Makoto; Soga, Tomoyoshi; Nozaki, Tomoyoshi			Two Atypical L-Cysteine-regulated NADPH-dependent Oxidoreductases Involved in Redox Maintenance, L-Cystine and Iron Reduction, and Metronidazole Activation in the Enteric Protozoan Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE SYNTHASE; ESCHERICHIA-COLI; NAD(P)H-FLAVIN OXIDOREDUCTASE; HYPERTHERMOPHILIC ARCHAEON; HYDROGEN-PEROXIDE; GIARDIA-LAMBLIA; SMALL-SUBUNIT; FERREDOXIN; CLONING; COMPLEX	We discovered novel catalytic activities of two atypical NADPH-dependent oxidoreductases (EhNO1/2) from the enteric protozoan parasite Entamoeba histolytica. EhNO1/2 were previously annotated as the small subunit of glutamate synthase (glutamine: 2-oxoglutarate amidotransferase) based on similarity to authentic bacterial homologs. As E. histolytica lacks the large subunit of glutamate synthase, EhNO1/2 were presumed to play an unknown role other than glutamine/glutamate conversion. Transcriptomic and quantitative reverse PCR analyses revealed that supplementation or deprivation of extracellular L-cysteine caused dramatic up- or down-regulation, respectively, of EhNO2, but not EhNO1 expression. Biochemical analysis showed that these FAD-and 2[4Fe-4S]-containing enzymes do not act as glutamate synthases, a conclusion which was supported by phylogenetic analyses. Rather, they catalyze the NADPH-dependent reduction of oxygen to hydrogen peroxide and L-cystine to L-cysteine and also function as ferric and ferredoxin-NADP(+) reductases. EhNO1/2 showed notable differences in substrate specificity and catalytic efficiency; EhNO1 had lower K-m and higher k(cat)/K-m values for ferric ion and ferredoxin than EhNO2, whereas EhNO2 preferred L-cystine as a substrate. In accordance with these properties, only EhNO1 was observed to physically interact with intrinsic ferredoxin. Interestingly, EhNO1/2 also reduced metronidazole, and E. histolytica transformants overexpressing either of these proteins were more sensitive to metronidazole, suggesting that EhNO1/2 are targets of this anti-amebic drug. To date, this is the first report to demonstrate that small subunit-like proteins of glutamate synthase could play an important role in redox maintenance, L-cysteine/L-cystine homeostasis, iron reduction, and the activation of metronidazole.	[Jeelani, Ghulam; Husain, Afzal; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Jeelani, Ghulam] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Dan; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Biochem, Patna 800007, Bihar, India; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan	National Institute of Infectious Diseases (NIID); Keio University; Keio University; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Keio University	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Soga, Tomoyoshi/B-8105-2014; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; HUSAIN, AFZAL/0000-0002-6627-5520	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18GS0314, 18050006, 18073001]; Ministry of Health, Labour, and Welfare of Japan [H20-Shinkosaiko-016]; Japan Health Sciences Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation	This work was supported by Grants-in-aid for Scientific Research 18GS0314, 18050006, and 18073001 (to T. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour, and Welfare of Japan (H20-Shinkosaiko-016), and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (to T. N.).	Andersson JO, 2002, EUKARYOT CELL, V1, P304, DOI 10.1128/EC.1.2.304-310.2002; [Anonymous], 1997, Epidemiol Bull, V18, P13; BAND RN, 1979, J PROTOZOOL, V26, P282, DOI 10.1111/j.1550-7408.1979.tb02781.x; Barchini E, 1996, ARCH MICROBIOL, V166, P51, DOI 10.1007/s002030050354; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchhaus I, 1997, BIOCHEM J, V326, P785, DOI 10.1042/bj3260785; CHEN JS, 1979, ANAL BIOCHEM, V93, P216, DOI 10.1016/S0003-2697(79)80140-2; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Deane SM, 1996, GENE, V177, P261, DOI 10.1016/0378-1119(96)00282-X; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FOUST GP, 1969, J BIOL CHEM, V244, P964; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; GILLIN FD, 1981, EXP PARASITOL, V51, P382, DOI 10.1016/0014-4894(81)90125-9; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; GILLIN FD, 1980, J PROTOZOOL, V27, P474, DOI 10.1111/j.1550-7408.1980.tb05402.x; GOLDMAN P, 1986, BIOCHEM PHARMACOL, V35, P43, DOI 10.1016/0006-2952(86)90553-8; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Hoffman JS, 2001, CURR OPIN GASTROEN, V17, P30, DOI 10.1097/00001574-200101000-00006; ICHIKAWA Y, 1980, FLAVINS FLAVOPROTEIN, P677; INOUYE S, 1994, FEBS LETT, V347, P163, DOI 10.1016/0014-5793(94)00528-1; JABLONSKI E, 1978, BIOCHEMISTRY-US, V17, P672, DOI 10.1021/bi00597a018; Jongsareejit B, 1997, MOL GEN GENET, V254, P635, DOI 10.1007/s004380050461; KERSCHER L, 1982, TRENDS BIOCHEM SCI, V7, P371, DOI 10.1016/0968-0004(82)90118-9; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; Leao-Helder AN, 2004, FEBS LETT, V577, P491, DOI 10.1016/j.febslet.2004.10.055; Leitsch D, 2007, PLOS BIOL, V5, P1820, DOI 10.1371/journal.pbio.0050211; LESUISSE E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P253, DOI 10.1016/0167-4838(90)90213-Y; LO HS, 1980, MOL BIOCHEM PARASIT, V2, P23, DOI 10.1016/0166-6851(80)90045-6; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LUDLUM DB, 1988, CARCINOGENESIS, V9, P593, DOI 10.1093/carcin/9.4.593; Maralikova B, 2010, CELL MICROBIOL, V12, P331, DOI 10.1111/j.1462-5822.2009.01397.x; Morandi P, 2000, BIOCHEMISTRY-US, V39, P727, DOI 10.1021/bi9920329; MORENO SNJ, 1985, ENVIRON HEALTH PERSP, V64, P199, DOI 10.2307/3430010; MULLER M, 1986, BIOCHEM PHARMACOL, V35, P37, DOI 10.1016/0006-2952(86)90552-6; MULLER M, 1983, SURGERY, V93, P165; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Olson JW, 2000, BIOCHEMISTRY-US, V39, P16213, DOI 10.1021/bi001744s; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; PELANDA R, 1993, J BIOL CHEM, V268, P3099; RATTI S, 1985, J BACTERIOL, V163, P724, DOI 10.1128/JB.163.2.724-729.1985; REEVES RE, 1984, ADV PARASIT, V23, P105, DOI 10.1016/S0065-308X(08)60286-9; Rosenbaum K, 1998, BIOCHEMISTRY-US, V37, P17598, DOI 10.1021/bi9815997; Sambrook J., 2001, MOL CLONING LAB MANU; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Srivastava M, 2001, J BIOL CHEM, V276, P15481, DOI 10.1074/jbc.M006920200; Stutz HE, 2004, BBA-GENE STRUCT EXPR, V1676, P71, DOI 10.1016/j.bbaexp.2003.11.001; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Toth A, 2008, FEMS MICROBIOL LETT, V282, P8, DOI 10.1111/j.1574-6968.2008.01085.x; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Vanoni MA, 1998, BIOCHEMISTRY-US, V37, P1828, DOI 10.1021/bi972342w; Vanoni MA, 1999, CELL MOL LIFE SCI, V55, P617, DOI 10.1007/s000180050319; WEINBACH EC, 1974, EXP PARASITOL, V35, P232, DOI 10.1016/0014-4894(74)90027-7; WEST SB, 1982, CHEM-BIOL INTERACT, V41, P265, DOI 10.1016/0009-2797(82)90105-3; WHO Model List of Essential Medicines, 2007, WHO MOD LIST ESS MED; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1984, J BIOL CHEM, V259, P6153	71	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26889	26899		10.1074/jbc.M110.106310	http://dx.doi.org/10.1074/jbc.M110.106310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592025	Green Published, hybrid			2022-12-27	WOS:000281172700020
J	Leonard, R; Wopfner, N; Pabst, M; Stadlmann, J; Petersen, BO; Duus, JO; Himly, M; Radauer, C; Gadermaier, G; Razzazi-Fazeli, E; Ferreira, F; Altmann, F				Leonard, Renaud; Wopfner, Nicole; Pabst, Martin; Stadlmann, Johannes; Petersen, Bent O.; Duus, Jens O.; Himly, Martin; Radauer, Christian; Gadermaier, Gabriele; Razzazi-Fazeli, Ebrahim; Ferreira, Fatima; Altmann, Friedrich			A New Allergen from Ragweed (Ambrosia artemisiifolia) with Homology to Art v 1 from Mugwort	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLLEN ALLERGENS; AMINO-ACIDS; O-GLYCANS; HYPERSENSITIVITY; GLYCOSYLATION; SENSITIZATION; PROTEINS; RESIDUES; BIOLOGY; BINDING	Art v 1, the major pollen allergen of the composite plant mugwort (Artemisia vulgaris) has been identified recently as a thionin-like protein with a bulky arabinogalactan-protein moiety. A close relative of mugwort, ragweed (Ambrosia artemisiifolia) is an important allergen source in North America, and, since 1990, ragweed has become a growing health concern in Europe as well. Weed pollen-sensitized patients demonstrated IgE reactivity to a ragweed pollen protein of apparently 29-31 kDa. This reaction could be inhibited by the mugwort allergen Art v 1. The purified ragweed pollen protein consisted of a 57-amino acid-long defensin-like domain with high homology to Art v 1 and a C-terminal proline-rich domain. This part contained hydroxyproline-linked arabinogalactan chains with one galactose and 5 to 20 and more alpha-arabinofuranosyl residues with some beta-arabinoses in terminal positions as revealed by high field NMR. The ragweed protein contained only small amounts of the single hydroxyproline-linked beta-arabinosyl residues, which form an important IgE binding determinant in Art v 1. cDNA clones for this protein were obtained from ragweed flowers. Immunological characterization revealed that the recombinant ragweed protein reacted with >30% of the weed pollen allergic patients. Therefore, this protein from ragweed pollen constitutes a novel important ragweed allergen and has been designated Amb a 4.	[Leonard, Renaud; Pabst, Martin; Stadlmann, Johannes; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci BOKU, Dept Chem, A-1190 Vienna, Austria; [Wopfner, Nicole; Himly, Martin; Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, Dept Mol Biol, A-5020 Salzburg, Austria; [Petersen, Bent O.; Duus, Jens O.] Carlsberg Lab, DK-2500 Valby, Denmark; [Radauer, Christian] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, Core Facil Res, VetOMICS, A-1220 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Salzburg University; Medical University of Vienna; University of Veterinary Medicine Vienna	Altmann, F (corresponding author), Univ Nat Resources & Appl Life Sci BOKU, Dept Chem, A-1190 Vienna, Austria.	friedrich.altmann@boku.ac.at	Ferreira, Fatima/AAB-4321-2019; Duus, Jens Øllgaard/N-4279-2013; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/E-4889-2011; Pabst, Martin/GOH-1766-2022; Radauer, Christian/AAN-6260-2021; Stadlmann, Johannes/AAC-3157-2021; Himly, Martin/D-1568-2015	Ferreira, Fatima/0000-0003-0989-2335; Duus, Jens Øllgaard/0000-0003-3625-1250; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Pabst, Martin/0000-0001-9897-0723; Radauer, Christian/0000-0001-9920-4449; Stadlmann, Johannes/0000-0001-5693-6690; Leonard, Renaud/0000-0001-5023-1032; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301; Himly, Martin/0000-0001-5416-085X; Altmann, Friedrich/0000-0002-0112-7877	Austrian Science Fund [S8802, P19172]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund (S8802 and P19172).	ALTMANN F, 1992, ANAL BIOCHEM, V204, P215, DOI 10.1016/0003-2697(92)90164-3; Altmann F, 2000, J GEN VIROL, V81, P1111, DOI 10.1099/0022-1317-81-4-1111; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Gupta N, 1996, J ALLERGY CLIN IMMUN, V98, P903, DOI 10.1016/S0091-6749(96)80006-6; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Himly M, 2003, J ALLERGY CLIN IMMUN, V111, P882, DOI 10.1067/mai.2003.163; Hirschwehr R, 1998, J ALLERGY CLIN IMMUN, V101, P196, DOI 10.1016/S0091-6749(98)70384-7; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; KJAER M, 1994, METHODS ENZYMOL, V239, P288; LAMPORT DTA, 1969, BIOCHEMISTRY-US, V8, P1155, DOI 10.1021/bi00831a049; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; MUTSCHLECHNER S, 2003, 22 C EUR AC ALL CLIN; Oberhuber C, 2008, INT ARCH ALLERGY IMM, V145, P94, DOI 10.1159/000108134; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; ROEBBER M, 1991, Journal of Allergy and Clinical Immunology, V87, P324, DOI 10.1016/0091-6749(91)92021-R; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; SUBIZA J, 1989, J ALLERGY CLIN IMMUN, V84, P353, DOI 10.1016/0091-6749(89)90420-X; TAPUHI Y, 1981, ANAL BIOCHEM, V115, P123, DOI 10.1016/0003-2697(81)90534-0; Winder J S, 1993, Methods Mol Biol, V16, P313, DOI 10.1385/0-89603-234-5:313; Wopfner N, 2008, ALLERGY, V63, P872, DOI 10.1111/j.1398-9995.2008.01635.x; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188	30	57	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27192	27200		10.1074/jbc.M110.127118	http://dx.doi.org/10.1074/jbc.M110.127118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576600	hybrid, Green Published			2022-12-27	WOS:000281172700050
J	Bawa-Khalfe, T; Cheng, J; Lin, SH; Ittmann, MM; Yeh, ETH				Bawa-Khalfe, Tasneem; Cheng, Jinke; Lin, Sue-Hwa; Ittmann, Michael M.; Yeh, Edward T. H.			SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ANDROGEN RECEPTOR EXPRESSION; SUMO-SPECIFIC PROTEASE-1; DEPENDENT TRANSCRIPTION; UP-REGULATION; CANCER; ANGIOGENESIS; DESUMOYLATION; INCREASES; GROWTH	SUMOylation has been shown to modulate DNA replication/repair, cell cycle progression, signal transduction, and the hypoxic response. SUMO (small ubiquitin-like modifier)-specific proteases regulate SUMOylation, but how changes in the expression of these proteases contribute to physiological and/or pathophysiological events remains undefined. Here, we show that SENP1 (sentrin/SUMO-specific protease 1) is highly expressed in human prostate cancer specimens and correlates with hypoxia-inducing factor 1 alpha (HIF1 alpha) expression. Mechanistic studies in a mouse model indicate that androgen-driven expression of murine SENP1 leads to HIF1 alpha stabilization, enhanced vascular endothelial growth factor production, and angiogenesis. Further pathological assessment of the mouse indicates that SENP1 overexpression induces transformation of the normal prostate gland and gradually facilitates the onset of high-grade prostatic intraepithelial neoplasia. Consistent with cell culture studies, SENP1 enhances prostate epithelial cell proliferation via modulating the androgen receptor and cyclin D-1. These results demonstrate that deSUMOylation plays a critical role in prostate pathogenesis through induction of HIF1 alpha-dependent angiogenesis and enhanced cell proliferation.	[Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Unit 449, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Ittmann, Michael M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Biochem, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China; [Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Mol & Cell Biol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ, Shanghai 200025, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute; Baylor College of Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Unit 449, 1515 Holcombe Blvd, Houston, TX 77030 USA.	etyeh@mdanderson.org			National Institutes of Health [CA139520, P50CA058204]; NCI [CA111479]; United States Department of Defense [PC040121, PC060932]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [F32CA110620, P50CA058204, R01CA111479, R01CA139520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense(United States Department of Defense); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was also supported, in whole or in part, by National Institutes of Health Grants CA139520 (to E.T.H.Y.), P50CA058204 (to the Baylor Prostate Cancer SPORE, M. M. I.), and CA111479 (to S.-H. L.) from NCI. This work was also supported by United States Department of Defense Grants PC040121 (to E.T.H.Y.) and PC060932 (to J.C.) and the Prostate Cancer Development Award from The University of Texas MD Anderson Cancer Center (to E.T.H.Y.).	Alqawi O, 2007, FREE RADICAL RES, V41, P788, DOI 10.1080/10715760701361531; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Bawa-Khalfe T, 2010, SUBCELL BIOCHEM, V54, P170, DOI 10.1007/978-1-4419-6676-6_14; Chan Norman, 2007, Future Oncol, V3, P329, DOI 10.2217/14796694.3.3.329; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Dai JL, 1996, MOL ENDOCRINOL, V10, P1582, DOI 10.1210/me.10.12.1582; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghafar MA, 2003, PROSTATE, V54, P58, DOI 10.1002/pros.10162; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huss WJ, 2001, CANCER RES, V61, P2736; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Knudsen KE, 1999, CANCER RES, V59, P2297; Leav I, 1996, PROSTATE, V29, P137, DOI 10.1002/1097-0045(199609)29:3<137::AID-PROS2990290302>3.0.CO;2-Z; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Lekas A, 2006, ANTICANCER RES, V26, P2989; Mazzucchelli R, 2000, PROSTATE, V45, P72; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Montironi R, 2002, ANN NY ACAD SCI, V963, P169; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Pallares J, 2006, HISTOL HISTOPATHOL, V21, P857, DOI 10.14670/HH-21.857; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sweat SD, 1999, J UROLOGY, V161, P1229, DOI 10.1016/S0022-5347(01)61644-6; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009	34	85	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25859	25866		10.1074/jbc.M110.134874	http://dx.doi.org/10.1074/jbc.M110.134874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551310	Green Published, hybrid			2022-12-27	WOS:000280682400078
J	Sanchez-Cenizo, L; Formentini, L; Aldea, M; Ortega, AD; Garcia-Huerta, P; Sanchez-Arago, M; Cuezva, JM				Sanchez-Cenizo, Laura; Formentini, Laura; Aldea, Marcos; Ortega, Alvaro D.; Garcia-Huerta, Paula; Sanchez-Arago, Maria; Cuezva, Jose M.			Up-regulation of the ATPase Inhibitory Factor 1 (IF1) of the Mitochondrial H+-ATP Synthase in Human Tumors Mediates the Metabolic Shift of Cancer Cells to a Warburg Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-F1-ATPASE MESSENGER-RNA; BIOENERGETIC SIGNATURE; F1FO-ATPASE INHIBITOR; DOWN-REGULATION; PROTEIN; PROGRESSION; MECHANISM; PHOSPHORYLATION; TRANSLATION; CARCINOMAS	The H+-ATP synthase is a reversible engine of mitochondria that synthesizes or hydrolyzes ATP upon changes in cell physiology. ATP synthase dysfunction is involved in the onset and progression of diverse human pathologies. During ischemia, the ATP hydrolytic activity of the enzyme is inhibited by the ATPase inhibitory factor 1 (IF1). The expression of IF1 in human tissues and its participation in the development of human pathology are unknown. Here, we have developed monoclonal antibodies against human IF1 and determined its expression in paired normal and tumor biopsies of human carcinomas. We show that the relative mitochondrial content of IF1 increases significantly in carcinomas, suggesting the participation of IF1 in oncogenesis. The expression of IF1 varies significantly in cancer cell lines. To investigate the functional activity of IF1 in cancer, we have manipulated its cellular content. Overexpression of IF1 or of its pH-insensitive H49K mutant in cells that express low levels of IF1 triggers the up-regulation of aerobic glycolysis and the inhibition of oxidative phosphorylation with concurrent mitochondrial hyperpolarization. Treatment of the cells with the H+-ATP synthase inhibitor oligomycin mimicked the effects of IF1 overexpression. Conversely, small interfering RNA-mediated silencing of IF1 in cells that express high levels of IF1 promotes the down-regulation of aerobic glycolysis and the increase in oxidative phosphorylation. Overall, these findings support that the mitochondrial content of IF1 controls the activity of oxidative phosphorylation mediating the shift of cancer cells to an enhanced aerobic glycolysis, thus supporting an oncogenic role for the de-regulated expression of IF1 in cancer.	[Sanchez-Cenizo, Laura; Formentini, Laura; Aldea, Marcos; Ortega, Alvaro D.; Garcia-Huerta, Paula; Sanchez-Arago, Maria; Cuezva, Jose M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,ISCIII, Consejo Super Invest Cient,Ctr Invest Biomed Red, E-28049 Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III	Cuezva, JM (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol,ISCIII, Consejo Super Invest Cient,Ctr Invest Biomed Red, E-28049 Madrid, Spain.	jmcuezva@cbm.uam.es	Cuezva, Jose M/F-8381-2011; Cuezva, Jose M/AAR-5392-2020; Aldea, Marcos/H-8154-2015; Ortega, Alvaro Dario/K-5394-2018	Aldea, Marcos/0000-0003-2146-2733; Ortega, Alvaro Dario/0000-0003-0691-7154; Cuezva Marcos, Jose Manuel/0000-0003-1118-248X; Formentini, Laura/0000-0001-5641-821X	Ministerio de Educacion y Ciencia [BFU2007-65253]; Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid, Spain [S-GEN-0269]	Ministerio de Educacion y Ciencia(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid, Spain	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2007-65253 and the Centro de Investigacion Biomedica en Red de Enfermedades Raras and Comunidad de Madrid Grant S-GEN-0269, Spain.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; de Heredia ML, 2000, J BIOL CHEM, V275, P7430, DOI 10.1074/jbc.275.10.7430; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Li RJ, 2010, ANN ONCOL, V21, P1506, DOI 10.1093/annonc/mdp569; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; ORTEGA AD, 2010, J CELL SCI IN PRESS; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Shin YK, 2005, CANCER RES, V65, P3162, DOI 10.1158/0008-5472.CAN-04-3300; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	39	153	159	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25308	25313		10.1074/jbc.M110.146480	http://dx.doi.org/10.1074/jbc.M110.146480			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538613	Green Published, hybrid			2022-12-27	WOS:000280682400023
J	Tardif, S; Wilson, MD; Wagner, R; Hunt, P; Gertsenstein, M; Nagy, A; Lobe, C; Koop, BF; Hardy, DM				Tardif, Steve; Wilson, Michael D.; Wagner, Rebecca; Hunt, Peter; Gertsenstein, Marina; Nagy, Andras; Lobe, Corrinne; Koop, Ben F.; Hardy, Daniel M.			Zonadhesin Is Essential for Species Specificity of Sperm Adhesion to the Egg Zona Pellucida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; ZP3-BINDING PROTEIN; MEMBRANE-PROTEIN; BINDING-ACTIVITY; IN-VITRO; FERTILIZATION; IDENTIFICATION; CAPACITATION	Interaction of rapidly evolving molecules imparts species specificity to sperm-egg recognition in marine invertebrates, but it is unclear whether comparable interactions occur during fertilization in any vertebrate species. In mammals, the sperm acrosomal protein zonadhesin is a rapidly evolving molecule with species-specific binding activity for the egg zona pellucida (ZP). Here we show using null mice produced by targeted disruption of Zan that zonadhesin confers species specificity to sperm-ZP adhesion. Sperm capacitation selectively exposed a partial von Willebrand D domain of mouse zonadhesin on the surface of living, motile cells. Antibodies to the exposed domain inhibited adhesion of wild-type spermatozoa to the mouse ZP but did not inhibit adhesion of spermatozoa lacking zonadhesin. Zan(-/-) males were fertile, and their spermatozoa readily fertilized mouse eggs in vitro. Remarkably, however, loss of zonadhesin increased adhesion of mouse spermatozoa to pig, cow, and rabbit ZP but not mouse ZP. We conclude that zonadhesin mediates species-specific ZP adhesion, and Zan(-/-) males are fertile because their spermatozoa retain adhesion capability that is not species-specific. Mammalian sperm-ZP adhesion is therefore molecularly robust, and species-specific egg recognition by a protein in the sperm acrosome is conserved between invertebrates and vertebrates, even though the adhesion molecules themselves are unrelated.	[Hardy, Daniel M.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; [Wilson, Michael D.; Wagner, Rebecca; Hunt, Peter; Koop, Ben F.] Univ Victoria, Ctr Biomed Res, Dept Biol, Victoria, BC V8P 5C2, Canada; [Gertsenstein, Marina; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Lobe, Corrinne] Sunnybrook Hlth Sci Ctr, Mol & Cellular Biol Div, Toronto, ON M4N 3M5, Canada	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Victoria; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Hardy, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Stop 6540,3601 4th St, Lubbock, TX 79430 USA.	Daniel.Hardy@ttuhsc.edu	Hardy, Daniel/AAP-5823-2020; Wilson, Michael D/K-6294-2014; Koop, Ben F./A-8151-2008; Nagy, Andras/G-6465-2013	Hardy, Daniel/0000-0002-7297-3093; Wilson, Michael D/0000-0002-4015-3066; Koop, Ben F./0000-0003-0045-5200; Nagy, Andras/0000-0003-4311-0413	National Institutes of Health [HD35166]; Texas Department of Agriculture; Lalor Foundation; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Michael Smith Foundation; "Le Fonds quebecois de la recherche sur la nature et les technologies"; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD035166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Department of Agriculture; Lalor Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation(Michael Smith Foundation for Health Research); "Le Fonds quebecois de la recherche sur la nature et les technologies"(FQRNT); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported, in whole or in part, by grants from the National Institutes of Health (Grant HD35166) and the Texas Department of Agriculture (to D.M.H.), by postdoctoral fellowships from "Le Fonds quebecois de la recherche sur la nature et les technologies" and the Lalor Foundation (to S.T.), by Canadian Institutes for Health Research and Natural Sciences and Engineering Research Council grants (to B.F.K.), and by a Michael Smith Foundation for Health Research trainee award (to M.D.W.).	Baba D, 2002, J BIOL CHEM, V277, P30310, DOI 10.1074/jbc.M204596200; BABA T, 1994, J BIOL CHEM, V269, P31845; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BI M, 2002, FERTILIZATION, P153; BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; FRASER LR, 1993, METHOD ENZYMOL, V225, P239; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Gasper J, 2006, AM J HUM GENET, V79, P820, DOI 10.1086/508473; Gerton G L., 2002, FERTILIZATION, P265; Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333; HARDY DM, 1991, BIOCHEM J, V275, P759, DOI 10.1042/bj2750759; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HARDY DM, 1994, J BIOL CHEM, V269, P19000; Herlyn H, 2008, INT J DEV BIOL, V52, P781, DOI 10.1387/ijdb.082626hh; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Honda A, 2002, HUM REPROD UPDATE, V8, P405, DOI 10.1093/humupd/8.5.405; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; Kim E, 2008, INT J DEV BIOL, V52, P677, DOI 10.1387/ijdb.072528ek; Lu QX, 1997, DEVELOPMENT, V124, P4121; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Nagy A., 2003, MANIPULATING MOUSE E; Olson GE, 2004, BIOL REPROD, V71, P1128, DOI 10.1095/biolreprod.104.029975; ORAND MG, 1988, GAMETE RES, V19, P315, DOI 10.1002/mrd.1120190402; Shur BD, 2006, MOL CELL ENDOCRINOL, V250, P137, DOI 10.1016/j.mce.2005.12.037; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tardif S, 1999, MOL REPROD DEV, V54, P292, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;292::AID-MRD10&gt;3.0.CO;2-F; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Tardif S, 2010, BIOL REPROD, V82, P413, DOI 10.1095/biolreprod.109.077891; VACQUIER VD, 1990, P NATL ACAD SCI USA, V87, P5792, DOI 10.1073/pnas.87.15.5792; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wilson MD, 2001, NUCLEIC ACIDS RES, V29, P1352, DOI 10.1093/nar/29.6.1352; Yanagimachi R., 1994, P189	37	58	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24863	24870		10.1074/jbc.M110.123125	http://dx.doi.org/10.1074/jbc.M110.123125			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529856	Green Published, hybrid			2022-12-27	WOS:000280542100059
J	Kim, D; Song, J; Ra, J; Jin, EJ				Kim, Dongkyun; Song, Jinsoo; Ra, Jongbum; Jin, Eun-Jung			MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting mdm2	DEVELOPMENTAL BIOLOGY			English	Meeting Abstract	69th Annual Meeting of the Society-for-Developmental-Biology/Japanese-Society-of-Developmental-Biologists	AUG 05-09, 2010	Albuquerque, NM	Soc Dev Biol, Japanese Soc Dev Biologists					[Kim, Dongkyun; Song, Jinsoo; Jin, Eun-Jung] Wonkwang Univ, Dept Biol Sci, Iksan 570749, Chunbuk, South Korea; [Ra, Jongbum] Jinju Natl Univ, Dept Interior Mat Engn, Jinju 660758, Kyongnam, South Korea	Wonkwang University									0	7	7	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606			DEV BIOL	Dev. Biol.	AUG 1	2010	344	1				211	476	476		10.1016/j.ydbio.2010.05.252	http://dx.doi.org/10.1016/j.ydbio.2010.05.252			1	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Developmental Biology	632LO	20576614	Bronze			2022-12-27	WOS:000280426400243
J	Wang, ZH; Yeats, T; Han, H; Jetter, R				Wang, Zhonghua; Yeats, Trevor; Han, Hong; Jetter, Reinhard			Cloning and Characterization of Oxidosqualene Cyclases from Kalanchoe daigremontiana ENZYMES CATALYZING UP TO 10 REARRANGEMENT STEPS YIELDING FRIEDELIN AND OTHER TRITERPENOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYRIN SYNTHASE; CYCLOARTENOL SYNTHASE; LANOSTEROL SYNTHASE; LUPEOL SYNTHASE; ACTIVE-SITE; BIOSYNTHESIS; TRITERPENE; CYCLIZATION; 2,3-OXIDOSQUALENE; MECHANISM	The first committed step in triterpenoid biosynthesis is the cyclization of oxidosqualene to polycyclic alcohols or ketones C30H50O. It is catalyzed by single oxidosqualene cyclase (OSC) enzymes that can carry out varying numbers of carbocation rearrangements and, thus, generate triterpenoids with diverse carbon skeletons. OSCs from diverse plant species have been cloned and characterized, the large majority of them catalyzing relatively few rearrangement steps. It was recently predicted that special OSCs must exist that can form friedelin, the pentacyclic triterpenoid whose formation involves the maximum possible number of rearrangement steps. The goal of the present study, therefore, was to clone a friedelin synthase from Kalanchoe daigremontiana, a plant species known to accumulate this triterpenoid in its leaf surface waxes. Five OSC cDNAs were isolated, encoding proteins with 761-779 amino acids and sharing between 57.4 and 94.3% nucleotide sequence identity. Heterologous expression in yeast and GC-MS analyses showed that one of the OSCs generated the steroid cycloartenol together with minor side products, whereas the other four enzymes produced mixtures of pentacyclic triterpenoids dominated by lupeol (93%), taraxerol (60%), glutinol (66%), and friedelin (71%), respectively. The cycloartenol synthase was found expressed in all leaf tissues, whereas the lupeol, taraxerol, glutinol, and friedelin synthases were expressed only in the epidermis layers lining the upper and lower surfaces of the leaf blade. It is concluded that the function of these enzymes is to form respective triterpenoid aglycones destined to coat the leaf exterior, probably as defense compounds against pathogens or herbivores.	[Jetter, Reinhard] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Jetter, R (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	jetter@interchange.ubc.ca		Han, Hong/0000-0001-8977-9679	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canada Research Chairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Special Research Opportunity Grant, by the Canada Foundation for Innovation, and by the Canada Research Chairs Program.	Abe I, 1996, J AM CHEM SOC, V118, P9180, DOI 10.1021/ja961643a; ABE I, 1995, LIPIDS, V30, P231, DOI 10.1007/BF02537826; ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; Cattel L, 1998, CRIT REV BIOCHEM MOL, V33, P353, DOI 10.1080/10409239891204378; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; Corey EJ, 1997, J AM CHEM SOC, V119, P1289, DOI 10.1021/ja963228o; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guhling O, 2006, ARCH BIOCHEM BIOPHYS, V448, P60, DOI 10.1016/j.abb.2005.12.013; Hart EA, 1999, J AM CHEM SOC, V121, P9887, DOI 10.1021/ja992589b; Hayashi H, 2001, EUR J BIOCHEM, V268, P6311, DOI 10.1046/j.0014-2956.2001.02588.x; Herrera JBR, 2000, J AM CHEM SOC, V122, P6765, DOI 10.1021/ja0013226; Kurti L, 2008, J AM CHEM SOC, V130, P9031, DOI 10.1021/ja800980h; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Kushiro T, 2000, J AM CHEM SOC, V122, P6816, DOI 10.1021/ja0010709; Lodeiro S, 2005, J AM CHEM SOC, V127, P14132, DOI 10.1021/ja053791j; Lodeiro S, 2007, J AM CHEM SOC, V129, P11213, DOI 10.1021/ja073133u; Markstadter C, 2000, CHEMOECOLOGY, V10, P33, DOI 10.1007/s000490050005; Morikubo N, 2006, J AM CHEM SOC, V128, P13184, DOI 10.1021/ja063358p; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; PORALLA K, 1994, TRENDS BIOCHEM SCI, V19, P157, DOI 10.1016/0968-0004(94)90276-3; Segura MJR, 2003, NAT PROD REP, V20, P304, DOI 10.1039/b008338k; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VAN MAARSEVEEN C, 2009, PHYTOCHEMISTRY, V70, P899; VAN MAARSEVEEN C, 2009, PLANT CELL ENVIRON, V32, P73; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014	27	53	63	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29703	29712		10.1074/jbc.M109.098871	http://dx.doi.org/10.1074/jbc.M109.098871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20610397	hybrid, Green Published			2022-12-27	WOS:000281984300005
J	Tanno, B; Sesti, F; Cesi, V; Bossi, G; Ferrari-Amorotti, G; Bussolari, R; Tirindelli, D; Calabretta, B; Raschella, G				Tanno, Barbara; Sesti, Fabiola; Cesi, Vincenzo; Bossi, Gianluca; Ferrari-Amorotti, Giovanna; Bussolari, Rita; Tirindelli, Donatella; Calabretta, Bruno; Raschella, Giuseppe			Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-METASTASIS; BREAST-CANCER; ANTISENSE OLIGODEOXYNUCLEOTIDES; DOWN-REGULATION; NEURAL CREST; SNAIL GENES; B-MYB; NEUROBLASTOMA; CARCINOMA	In metastatic cancer cells, the process of invasion is regulated by several transcription factors that induce changes required for migration and resistance to apoptosis. Slug (SNAI2, Snail2) is involved in epithelial mesenchymal transition in physiological and in pathological contexts. We show here that in embryonic kidney, colon carcinoma, chronic myeloid leukemia-blast crisis, and in neuroblastoma cells, expression of Slug is transcriptionally regulated by c-Myb via Myb binding sites in the 5'-flanking region and in the first intron of the slug gene. In embryonic kidney and neuroblastoma cells, c-Myb induced vimentin, fibronectin, and N-cadherin expression and membrane ruffling via actin polymerization consistent with the acquisition of a mesenchymal-like phenotype. Furthermore, down-regulation of endogenous c-Myb levels in colon carcinoma cells led to increased expression of E-cadherin and reduced levels of vimentin. Some of these changes are predominantly Slug-dependent as Slug silencing via RNA interference (RNAi) reverts the cells to a quasi-parental condition. Changes in gene expression and morphology induced by c-Myb-activated Slug correlated with increased ability to migrate (embryonic kidney) and to invade through a Matrigel membrane (embryonic kidney, colon carcinoma, neuroblastoma). c-Myb-dependent Slug expression was also essential for the homing of chronic myeloid leukemia K562 cells to the bone marrow. In summary, we show here that the proto-oncogene c-Myb controls Slug transcription in tumor cells of different origin. Such a regulatory pathway contributes to the acquisition of invasive properties that are important for the metastatic process.	[Tanno, Barbara; Sesti, Fabiola; Cesi, Vincenzo; Tirindelli, Donatella; Raschella, Giuseppe] Italian Natl Agcy New Technol Energy & Sustainabl, Lab Radiat Biol & Biomed, Res Ctr Casaccia, I-00123 Rome, Italy; [Bossi, Gianluca] Regina Elena Inst Canc Res, Dept Expt Oncol, I-00158 Rome, Italy; [Ferrari-Amorotti, Giovanna; Calabretta, Bruno] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Bussolari, Rita] Univ Modena, Dept Hematol Oncol, I-41100 Modena, Italy; [Calabretta, Bruno] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Jefferson University	Raschella, G (corresponding author), ENEA Res Ctr Casaccia, Lab Radiat Biol & Biomed, Via Anguillarese 301, I-00123 Rome, Italy.	giuseppe.raschella@enea.it	Bossi, Gianluca/B-9394-2017; Bossi, Gianluca/ABH-6846-2020	Bossi, Gianluca/0000-0002-2947-1063; Bossi, Gianluca/0000-0002-2947-1063; Sesti, Fabiola/0000-0003-4142-1760	Fondazione Italiana per la Lotta al Neuroblastoma; National Institutes of Health [RO1 CA95111]; Associazione Italiana per la Ricerca sul Cancro [8804]; NATIONAL CANCER INSTITUTE [R01CA095111] Funding Source: NIH RePORTER	Fondazione Italiana per la Lotta al Neuroblastoma; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Fondazione Italiana per la Lotta al Neuroblastoma (to G. R.). This work was also supported by National Institutes of Health Grant RO1 CA95111 (NCI; to B. C.) and Associazione Italiana per la Ricerca sul Cancro IG Grant 8804 (to G. B.).	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Berge T, 2007, BLOOD CELL MOL DIS, V39, P278, DOI 10.1016/j.bcmd.2007.05.007; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boutet A, 2007, CELL CYCLE, V6, P638, DOI 10.4161/cc.6.6.4022; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Civenni G, 2009, SEMIN CANCER BIOL, V19, P68, DOI 10.1016/j.semcancer.2008.11.003; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; DRESSLER GR, 2002, MOUSE DEV PATTERNING, P395; DREWINKO B, 1978, J NATL CANCER I, V61, P75, DOI 10.1093/jnci/61.1.75; ESS KC, 1995, MOL CELL BIOL, V15, P5707; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUERIN M, 1990, ONCOGENE, V5, P131; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Karafiat V, 2005, CELL MOL LIFE SCI, V62, P2516, DOI 10.1007/s00018-005-5297-7; Kauraniemi P, 2000, CANCER RES, V60, P5323; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; MELANI C, 1991, CANCER RES, V51, P2897; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ramsay RG, 2003, EXPERT OPIN THER TAR, V7, P235; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Raschella G, 1999, CANCER RES, V59, P3365; RASCHELLA G, 1992, CANCER RES, V52, P4221; RATAJCZAK MZ, 1992, P NATL ACAD SCI USA, V89, P11823, DOI 10.1073/pnas.89.24.11823; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Syed M, 2008, CLIN EXP METASTAS, V25, P787, DOI 10.1007/s10585-008-9192-0; Tanno B, 2002, J BIOL CHEM, V277, P23172, DOI 10.1074/jbc.M200141200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson MA, 1998, CANCER RES, V58, P5168; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	43	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29434	29445		10.1074/jbc.M109.089045	http://dx.doi.org/10.1074/jbc.M109.089045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622260	Green Published, hybrid			2022-12-27	WOS:000281740100046
J	Veale, EL; Rees, KA; Mathie, A; Trapp, S				Veale, Emma L.; Rees, Kathryn A.; Mathie, Alistair; Trapp, Stefan			Dominant Negative Effects of a Non-conducting TREK1 Splice Variant Expressed in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND POTASSIUM CHANNEL; DOMAIN K+ CHANNEL; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; K-2P CHANNELS; TASK-1; SUBUNIT; LOCALIZATION; TRANSPORT; CLONING	Two-pore domain potassium (K-2P) channels modulate neuronal excitability throughout the entire CNS. The stretch-activated channel TREK1 (K(2P)2.1) is expressed widely in brain and has been linked to depression, neuroprotection, pain perception, and epilepsy. Little, however, is known about the regulation of TREK1 expression on the transcriptional and translational level or about its trafficking to the plasma membrane. Here we have used PCR techniques to identify a splice variant of TREK1 expressed in the brain, which encodes a heavily truncated TREK1 protein retaining a single transmembrane domain. Functional expression of this splice variant TREK1 Delta Ex4 in tsA201 cells in the presence or absence of wild type TREK1 revealed that TREK1 Delta Ex4 has no channel activity itself but reduced TREK1 whole cell current amplitude. Confocal analysis of the expression of fluorescently tagged TREK1 variants revealed that TREK1 Delta Ex4 is translated, but it is retained in the intracellular compartment. Additionally, TREK1 Delta Ex4 reduced the level of TREK1 expression in the plasma membrane. Long and short forms of TREK1 derived from alternative translation initiation are differentially affected by TREK1 Delta Ex4, with the short form (lacking the first 41 amino acids at its N terminus) unaffected. This differential regulatory role of TREK1 Delta Ex4 will alter the functional profile of TREK1 current in neurons where they are expressed. These results indicate that the N-terminal domain and first transmembrane domain of TREK1 are likely to be important for channel dimerization and trafficking to the plasma membrane.	[Trapp, Stefan] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, London SW7 2AZ, England; [Trapp, Stefan] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England; Univ Greenwich Medway, Medway Sch Pharm, Chatham ME4 4TB, Kent, England	Imperial College London; Imperial College London; University of Greenwich; University of Kent; University of Greenwich	Trapp, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Sect, S Kensington Campus, London SW7 2AZ, England.	s.trapp@imperial.ac.uk	Veale, Emma/AAA-5022-2022; Mathie, Alistair/K-7198-2019; Trapp, Stefan/D-9240-2011	Veale, Emma/0000-0002-6778-9929; Mathie, Alistair/0000-0001-6094-2890; Trapp, Stefan/0000-0003-0665-4948	Medical Research Council [G0600928, G0200370]; MRC [G0200370, G0600928] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (Ref. G0600928 (to S. T.) and Ref. G0200370 (to E. L. V. and A. M.)).	Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Chapman CG, 2000, MOL BRAIN RES, V82, P74; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Franks NP, 1999, NAT NEUROSCI, V2, P395, DOI 10.1038/8054; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Karschin C, 2001, MOL CELL NEUROSCI, V18, P632, DOI 10.1006/mcne.2001.1045; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Sandoz G, 2008, J NEUROSCI, V28, P8545, DOI 10.1523/JNEUROSCI.1962-08.2008; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Zanzouri M, 2006, BIOCHEM BIOPH RES CO, V348, P1350, DOI 10.1016/j.bbrc.2006.07.194; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	55	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29295	29304		10.1074/jbc.M110.108423	http://dx.doi.org/10.1074/jbc.M110.108423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605797	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000281740100032
J	Boivin, S; Cusack, S; Ruigrok, RWH; Hart, DJ				Boivin, Stephane; Cusack, Stephen; Ruigrok, Rob W. H.; Hart, Darren J.			Influenza A Virus Polymerase: Structural Insights into Replication and Host Adaptation Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SINGLE AMINO-ACID; CAP-BINDING-PROTEIN; RNA-POLYMERASE; PA SUBUNIT; HUMAN TRANSMISSIBILITY; INHIBITORY-ACTIVITY; CRYSTAL-STRUCTURE; VIRAL POLYMERASE; NUCLEAR IMPORT; PB2 PROTEINS	The heterotrimeric RNA-dependent RNA polymerase of influenza viruses catalyzes RNA replication and transcription activities in infected cell nuclei. The nucleotide polymerization activity is common to both replication and transcription processes, with an additional cap-snatching function being employed during transcription to steal short 5'-capped RNA primers from host mRNAs. Cap-binding, endonuclease, and polymerase activities have long been studied biochemically, but structural studies on the polymerase and its subunits have been hindered by difficulties in producing sufficient quantities of material. Recently, because of heightened effort and advances in expression and crystallization technologies, a series of high resolution structures of individual domains have been determined. These shed light on intrinsic activities of the polymerase, including cap snatching, subunit association, and nucleocytoplasmic transport, and open up the possibility of structure-guided development of new polymerase inhibitors. Furthermore, the activity of influenza polymerase is highly host- and cell type-specific, being dependent on the identity of a few key amino acid positions in the different subunits, especially in the C-terminal region of PB2. New structures demonstrate the surface exposure of these residues, consistent with ideas that they might modulate interactions with host- specific factors that enhance or restrict activity. Recent proteomic and genome-wide interactome and RNA interference screens have suggested the identities of some of these potential regulators of polymerase function.	[Boivin, Stephane; Cusack, Stephen; Ruigrok, Rob W. H.; Hart, Darren J.] UJF EMBL CNRS, UMI3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Boivin, Stephane; Cusack, Stephen; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL)	Hart, DJ (corresponding author), UJF EMBL CNRS, UMI3265, Unit Virus Host Cell Interact, 6 Rue Jules Horowitz, F-38042 Grenoble 9, France.	hart@embl.fr	Boivin, Stephane/K-4018-2012; Hart, Darren/C-4858-2015	Boivin, Stephane/0000-0003-1460-326X; Hart, Darren/0000-0002-3502-2002; Cusack, Stephen/0000-0002-9324-0796	European Union [SP5B-CT-2007-044263]; Agence Nationale de Research [ANR-06-MIME-014-02]; FINOVI Foundation	European Union(European Commission); Agence Nationale de Research(French National Research Agency (ANR)); FINOVI Foundation	This work was supported by European Union FLUPOL Contract SP5B-CT-2007-044263, Agence Nationale de Research FLU INTERPOL Contract ANR-06-MIME-014-02, and the FINOVI Foundation. This is the second article in the Thematic Minireview Series on Influenza Virus. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Angelini A, 2009, FEBS J, V276, P816, DOI 10.1111/j.1742-4658.2008.06826.x; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BLAAS D, 1982, NUCLEIC ACIDS RES, V10, P4803; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Enserink M, 2007, SCIENCE, V315, P923; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Huarte M, 2003, J VIROL, V77, P6007, DOI 10.1128/JVI.77.10.6007-6013.2003; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Iwatsuki-Horimoto K, 2004, J VIROL, V78, P10149, DOI 10.1128/JVI.78.18.10149-10155.2004; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2010, VIRUSES-BASEL, V2, P566, DOI 10.3390/v2020566; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Poole EL, 2007, FEBS LETT, V581, P5300, DOI 10.1016/j.febslet.2007.10.025; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Skehel J, 2009, BIOLOGICALS, V37, P177, DOI 10.1016/j.biologicals.2009.02.012; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	89	148	158	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28411	28417		10.1074/jbc.R110.117531	http://dx.doi.org/10.1074/jbc.R110.117531			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20538599	hybrid, Green Published			2022-12-27	WOS:000281594000003
J	Meyer, NH; Tripsianes, K; Vincendeau, M; Madl, T; Kateb, F; Brack-Werner, R; Sattler, M				Meyer, N. Helge; Tripsianes, Konstantinos; Vincendeau, Michelle; Madl, Tobias; Kateb, Fatiha; Brack-Werner, Ruth; Sattler, Michael			Structural Basis for Homodimerization of the Src-associated during Mitosis, 68-kDa Protein (Sam68) Qua1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; KH-DOMAIN; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; SPLICE VARIANT; CD44; RELAXATION	Sam68 (Src-associated during mitosis, 68 kDa) is a prototypical member of the STAR (signal transducer and activator of RNA) family of RNA-binding proteins. STAR proteins bind mRNA targets and modulate cellular processes such as cell cycle regulation and tissue development in response to extracellular signals. Sam68 has been shown to modulate alternative splicing of the pre-mRNAs of CD44 and Bcl-xL, which are linked to tumor progression and apoptosis. Sam68 and other STAR proteins recognize bipartite RNA sequences and are thought to function as homodimers. However, the structural and functional roles of the self-association are not known. Here, we present the solution structure of the Sam68 Qua1 homodimerization domain. Each monomer consists of two antiparallel alpha-helices connected by a short loop. The two subunits are arranged perpendicular to each other in an unusual four-helix topology. Mutational analysis of Sam68 in vitro and in a cell-based assay revealed that the Qua1 domain and residues within the dimerization interface are essential for alternative splicing of a CD44 minigene. Together, our results indicate that the Qua1 homodimerization domain is required for regulation of alternative splicing by Sam68.	[Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Meyer, N. Helge; Tripsianes, Konstantinos; Madl, Tobias; Kateb, Fatiha; Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci CiPSM, D-85747 Garching, Germany; [Vincendeau, Michelle; Brack-Werner, Ruth] Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Brack-Werner, Ruth/M-4615-2014; Madl, Tobias/B-1682-2012; Tripsianes, Konstantinos/I-8382-2014; Vincendeau, Michelle/AAD-4320-2022	Sattler, Michael/0000-0002-1594-0527; Brack-Werner, Ruth/0000-0002-8651-9318; Madl, Tobias/0000-0002-9725-5231; Tripsianes, Konstantinos/0000-0003-0948-813X; 	Deutsche Forschungsgemeinschaft; Alexander von Humboldt foundation; EMBO fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); EMBO fellowship(European Molecular Biology Organization (EMBO))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft and grants from the Alexander von Humboldt foundation (to K. T. and F. K.) and an EMBO fellowship (to T. M.).	ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goddard T. D, 2007, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guitard E, 1998, BIOCHEM BIOPH RES CO, V245, P562, DOI 10.1006/bbrc.1998.8374; Hadian K, 2009, J BIOL CHEM, V284, P33384, DOI 10.1074/jbc.M109.021659; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Itoh M, 2002, NUCLEIC ACIDS RES, V30, P5452, DOI 10.1093/nar/gkf673; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li JL, 2002, J VIROL, V76, P4526, DOI 10.1128/JVI.76.9.4526-4535.2002; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Najib S, 2005, CELL MOL LIFE SCI, V62, P36, DOI 10.1007/s00018-004-4309-3; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Pillay I, 1996, CELL GROWTH DIFFER, V7, P1487; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Zorn AM, 1997, GENE DEV, V11, P2176, DOI 10.1101/gad.11.17.2176	53	30	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28893	28901		10.1074/jbc.M110.126185	http://dx.doi.org/10.1074/jbc.M110.126185			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610388	Green Published, hybrid			2022-12-27	WOS:000281594000054
J	Vonk, WIM; Wijmenga, C; Berger, R; van de Sluis, B; Klomp, LWJ				Vonk, Willianne I. M.; Wijmenga, Cisca; Berger, Ruud; van de Sluis, Bart; Klomp, Leo W. J.			Cu,Zn Superoxide Dismutase Maturation and Activity Are Regulated by COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COPPER CHAPERONE CCS; AMYOTROPHIC-LATERAL-SCLEROSIS; EPITHELIAL SODIUM-CHANNEL; WILSON-DISEASE PROTEIN; COMMD1-DEPENDENT UBIQUITINATION; DIRECTLY INTERACTS; ACTIVATION; MURR1; METAL	The maturation and activation of the anti-oxidant Cu, Zn superoxide dismutase (SOD1) are highly regulated processes that require several post-translational modifications. The maturation of SOD1 is initiated by incorporation of zinc and copper ions followed by disulfide oxidation leading to the formation of enzymatically active homodimers. Our present data indicate that homodimer formation is a regulated final step in SOD1 maturation and implicate the recently characterized copper homeostasis protein COMMD1 in this process. COMMD1 interacts with SOD1, and this interaction requires CCS-mediated copper incorporation into SOD1. COMMD1 does not regulate disulfide oxidation of SOD1 but reduces the level of SOD1 homodimers. RNAi-mediated knockdown of COMMD1 expression results in a significant induction of SOD1 activity and a consequent decrease in superoxide anion concentrations, whereas overexpression of COMMD1 exerts exactly the opposite effects. Here, we identify COMMD1 as a novel protein regulating SOD1 activation and associate COMMD1 function with the production of free radicals.	Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; Netherlands Metabol Ctr, NL-3584 EA Utrecht, Netherlands; [Vonk, Willianne I. M.; Wijmenga, Cisca; van de Sluis, Bart] Univ Med Ctr Utrecht, Complex Genet Sect, NL-3584 EA Utrecht, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Vonk, WIM (corresponding author), Dept Metab & Endocrine Dis, POB 85090, NL-3508 AB Utrecht, Netherlands.	w.i.m.vonk@umcutrecht.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Vonk, Willianne/0000-0002-5906-3933	Netherlands Organization for Scientific Research NWO [40-00812-98-03106]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research NWO Grant 40-00812-98-03106.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; GALIAZZO F, 1991, EUR J BIOCHEM, V196, P545, DOI 10.1111/j.1432-1033.1991.tb15848.x; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Leitch JM, 2009, J BIOL CHEM, V284, P24679, DOI 10.1074/jbc.R109.040410; Lian M, 2009, J BIOL CHEM, V284, P17998, DOI 10.1074/jbc.M809752200; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Stasser JP, 2007, BIOCHEMISTRY-US, V46, P11845, DOI 10.1021/bi700566h; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332	43	33	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28991	29000		10.1074/jbc.M110.101477	http://dx.doi.org/10.1074/jbc.M110.101477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595380	Green Published, hybrid			2022-12-27	WOS:000281594000064
J	Yang, ZT; Philips, JD; Doty, RT; Giraudi, P; Ostrow, JD; Tiribelli, C; Smith, A; Abkowitz, JL				Yang, Zhantao; Philips, John D.; Doty, Raymond T.; Giraudi, Pablo; Ostrow, J. Donald; Tiribelli, Claudio; Smith, Ann; Abkowitz, Janis L.			Kinetics and Specificity of Feline Leukemia Virus Subgroup C Receptor (FLVCR) Export Function and Its Dependence on Hemopexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOSE PERMEASE; HEME-HEMOPEXIN; ESCHERICHIA-COLI; IRON HOMEOSTASIS; TRANSPORTER; EXPRESSION; BILIRUBIN; BINDING; MECHANISM; PROTEIN	The feline leukemia virus subgroup C receptor (FLVCR) is a heme export protein that is required for proerythroblast survival and facilitates macrophage heme iron recycling. However, its mechanism of heme export and substrate specificity are uncharacterized. Using [Fe-55]heme and the fluorescent heme analog zinc mesoporphyrin, we investigated whether export by FLVCR depends on the availability and avidity of extracellular heme-binding proteins. Export was 100-fold more efficient when the medium contained hemopexin (K-d < 1 pM) compared with albumin (K-d = 5 nM) at the same concentration and was not detectable when the medium lacked heme-binding proteins. Besides heme, FLVCR could export other cyclic planar porphyrins, such as protoporphyrin IX and coproporphyrin. However, FLVCR has a narrow substrate range because unconjugated bilirubin, the primary breakdown product of heme, was not transported. As neither protoporphyrin IX nor coproporphyrin export improved with extracellular hemopexin (versus albumin), our observations further suggest that hemopexin, an abundant protein with a serum concentration (6.7-25 mu M) equivalent to that of the iron transport protein transferrin (22-31 mu M), by accepting heme from FLVCR and targeting it to the liver, might regulate macrophage heme export and heme iron recycling in vivo. Final studies show that hemopexin directly interacts with FLVCR, which also helps explain why FLVCR, in contrast to some major facilitator superfamily members, does not function as a bidirectional gradient-dependent transporter. Together, these data argue that hemopexin has a role in assuring systemic iron balance during homeostasis in addition to its established role as a scavenger during internal bleeding or hemolysis.	[Yang, Zhantao; Doty, Raymond T.; Abkowitz, Janis L.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Ostrow, J. Donald] Univ Washington, Dept Med, Div Gastroenterol Hepatol, Seattle, WA 98195 USA; [Philips, John D.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84132 USA; [Giraudi, Pablo; Tiribelli, Claudio] Univ Trieste, Ctr Studi Fegato, I-34127 Trieste, Italy; [Giraudi, Pablo; Tiribelli, Claudio] Univ Trieste, Dept Clin Anesthesiol Surg Anat Pathol Dermatol H, I-34127 Trieste, Italy; [Smith, Ann] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Trieste; University of Trieste; University of Missouri System; University of Missouri Kansas City	Abkowitz, JL (corresponding author), Univ Washington, Dept Med, Div Hematol, POB 357710,1959 NE Pacific St, Seattle, WA 98195 USA.	janabk@u.washington.edu	Tiribelli, Claudio/A-4716-2014	Tiribelli, Claudio/0000-0001-6596-7595; Doty, Raymond/0000-0002-9312-8622	National Institutes of Health [R01 HL31823, R01 DK020503, P30 DK072437, DK085146]; Telethon [GGP05062]; University of Missouri-Kansas City; Ministry of Foreign Affairs, Rome, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020503, P30DK072437, R01DK085146, R56DK085146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); University of Missouri-Kansas City; Ministry of Foreign Affairs, Rome, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL31823, R01 DK020503, P30 DK072437, and DK085146. This work was also supported by Telethon Grant GGP05062 and the University of Missouri-Kansas City Research Incentive Funds.; Ph.D. student sponsored by a fellowship from the Ministry of Foreign Affairs, Rome, Italy.	Abkowitz JL, 1998, STEM CELLS, V16, P288, DOI 10.1002/stem.160288; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, MOL MEMBR BIOL, V21, P227, DOI 10.1080/09687680410001716862; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Bayon JE, 2001, J LAB CLIN MED, V138, P313, DOI 10.1067/mlc.2001.118746; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Calligaris S, 2006, FEBS LETT, V580, P1355, DOI 10.1016/j.febslet.2006.01.056; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Duvigneau JC, 2008, LAB INVEST, V88, P70, DOI 10.1038/labinvest.3700691; Eskew JD, 1999, J BIOL CHEM, V274, P638, DOI 10.1074/jbc.274.2.638; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; FLETCHER J, 1968, NATURE, V218, P1211, DOI 10.1038/2181211a0; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P229, DOI 10.1189/jlb.1208742; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; MORGAN WT, 1980, BIOCHIM BIOPHYS ACTA, V624, P271, DOI 10.1016/0005-2795(80)90246-9; MORRIS CM, 1993, NEUROSCI LETT, V149, P141, DOI 10.1016/0304-3940(93)90756-B; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ostrow JD, 2007, TRANSL RES, V149, P37, DOI 10.1016/j.trsl.2006.07.006; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; SEERY VL, 1973, J BIOL CHEM, V248, P3796; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; SMITH A, 1984, J BIOL CHEM, V259, P2049; Smith K. M., 1975, PORPHYRINS METALLOPO; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 1996, BIOCHEM BIOPH RES CO, V218, P694, DOI 10.1006/bbrc.1996.0124; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zukor H, 2009, J NEUROCHEM, V109, P776, DOI 10.1111/j.1471-4159.2009.06007.x	63	66	70	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28874	28882		10.1074/jbc.M110.119131	http://dx.doi.org/10.1074/jbc.M110.119131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610401	Green Published, hybrid			2022-12-27	WOS:000281594000052
J	Chi, CN; Bach, A; Gottschalk, M; Kristensen, AS; Stromgaard, K; Jemth, P				Chi, Celestine N.; Bach, Anders; Gottschalk, Marie; Kristensen, Anders S.; Stromgaard, Kristian; Jemth, Per			Deciphering the Kinetic Binding Mechanism of Dimeric Ligands Using a Potent Plasma-stable Dimeric Inhibitor of Postsynaptic Density Protein-95 as an Example	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM PDZ DOMAINS; DESIGN; AFFINITY	Dimeric ligands can be potent inhibitors of protein-protein or enzyme-substrate interactions. They have increased affinity and specificity toward their targets due to their ability to bind two binding sites simultaneously and are therefore attractive in drug design. However, few studies have addressed the kinetic mechanism of interaction of such bivalent ligands. We have investigated the binding interaction of a recently identified potent plasma-stable dimeric pentapeptide and PDZ1-2 of postsynaptic density protein-95 (PSD-95) using protein engineering in combination with fluorescence polarization, isothermal titration calorimetry, and stopped-flow fluorimetry. We demonstrate that binding occurs via a two-step process, where an initial binding to either one of the two PDZ domains is followed by an intramolecular step, which produces the bidentate complex. We have determined all rate constants involved in the binding reaction and found evidence for a conformational transition of the complex. Our data demonstrate the importance of a slow dissociation for a successful dimeric ligand but also highlight the possibility of optimizing the intramolecular association rate. The results may therefore aid the design of dimeric inhibitors in general.	[Bach, Anders; Gottschalk, Marie; Kristensen, Anders S.; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Chi, Celestine N.; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Copenhagen; Uppsala University	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Med Chem, Univ Pk 2, DK-2100 Copenhagen, Denmark.	krst@farma.ku.dk; Per.Jemth@imbim.uu.se	Kristensen, Anders Skov/B-4414-2009	Kristensen, Anders Skov/0000-0001-8955-6790; Bach, Anders/0000-0003-4305-9910; Stromgaard, Kristian/0000-0003-2206-4737	Swedish Research Council; Carl Trygger Foundation; O. E. and Edla Johansson Foundation; Lundbeck Foundation; Danish Council for Independent Research, Technology and Production Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; O. E. and Edla Johansson Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF))	This work was supported by grants from the Swedish Research Council, the Carl Trygger Foundation and the O. E. and Edla Johansson Foundation (to P.J.), the Lundbeck Foundation (to K. S.), and the Danish Council for Independent Research, Technology and Production Sciences (to A. B.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Clemons PA, 1999, CURR OPIN CHEM BIOL, V3, P112, DOI 10.1016/S1367-5931(99)80020-9; Corson TW, 2008, ACS CHEM BIOL, V3, P677, DOI 10.1021/cb8001792; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HOPFNER KP, 1993, BIOCHEMISTRY-US, V32, P2947, DOI 10.1021/bi00063a004; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Paduch M, 2007, CHEMBIOCHEM, V8, P443, DOI 10.1002/cbic.200600389; SZEWCZUK Z, 1993, BIOCHEMISTRY-US, V32, P3396, DOI 10.1021/bi00064a025; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Zhou HX, 2003, J MOL BIOL, V329, P1, DOI 10.1016/S0022-2836(03)00372-3; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P15069, DOI 10.1021/bi015795g	27	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28252	28260		10.1074/jbc.M110.124040	http://dx.doi.org/10.1074/jbc.M110.124040			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576616	hybrid, Green Published			2022-12-27	WOS:000281404100068
J	Fernandez-Leiro, R; Pereira-Rodriguez, A; Cerdan, ME; Becerra, M; Sanz-Aparicio, J				Fernandez-Leiro, Rafael; Pereira-Rodriguez, Angel; Esperanza Cerdan, M.; Becerra, Manuel; Sanz-Aparicio, Juliana			Structural Analysis of Saccharomyces cerevisiae alpha-Galactosidase and Its Complexes with Natural Substrates Reveals New Insights into Substrate Specificity of GH27 Glycosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIMA-RELATED KINASE-6; STAT3 ACTIVATION; FAMILY KINASES; PROTEIN-KINASE; NEK6; TRANSFORMATION; PROMOTION; GENE	alpha-Galactosidases catalyze the hydrolysis of terminal alpha-1,6-galactosyl units from galacto-oligosaccharides and polymeric galactomannans. The crystal structures of tetrameric Saccharomyces cerevisiae alpha-galactosidase and its complexes with the substrates melibiose and raffinose have been determined to 1.95, 2.40, and 2.70 angstrom resolution. The monomer folds into a catalytic (alpha/beta) 8 barrel and a C-terminal beta-sandwich domain with unassigned function. This pattern is conserved with other family 27 glycosidases, but this enzyme presents a unique 45-residue insertion in the beta-sandwich domain that folds over the barrel protecting it from the solvent and likely explaining its high stability. The structure of the complexes and the mutational analysis show that oligomerization is a key factor in substrate binding, as the substrates are located in a deep cavity making direct interactions with the adjacent subunit. Furthermore, docking analysis suggests that the supplementary domain could be involved in binding sugar units distal from the scissile bond, therefore ascribing a role in fine-tuning substrate specificity to this domain. It may also have a role in promoting association with the polymeric substrate because of the ordered arrangement that the four domains present in one face of the tetramer. Our analysis extends to other family 27 glycosidases, where some traits regarding specificity and oligomerization can be formulated on the basis of their sequence and the structures available. These results improve our knowledge on the activity of this important family of enzymes and give a deeper insight into the structural features that rule modularity and protein-carbohydrate interactions.	[Fernandez-Leiro, Rafael; Sanz-Aparicio, Juliana] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, E-28006 Madrid, Spain; [Fernandez-Leiro, Rafael; Pereira-Rodriguez, Angel; Esperanza Cerdan, M.; Becerra, Manuel] Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna 15071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidade da Coruna	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	Fernandez-Leiro, Rafael/L-6095-2017; Becerra, Manuel/N-6358-2019; Becerra, Manuel/E-2878-2017; Sanz-Aparicio, Julia/F-6201-2013; CERDAN, MARIA ESPERANZA/D-5644-2013	Fernandez-Leiro, Rafael/0000-0002-7941-0357; Becerra, Manuel/0000-0003-0913-9749; Becerra, Manuel/0000-0003-0913-9749; Sanz-Aparicio, Julia/0000-0002-6849-8621; CERDAN, MARIA ESPERANZA/0000-0001-8540-1417	Xunta de Galicia [07TAL010103PR]; FEDER; Direccion General de Investigacion [BIO2007-67708-C04-04]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); FEDER(European Commission); Direccion General de Investigacion(Spanish Government)	Research performed at the Universidade da Coruna was supported by Grant 07TAL010103PR from Xunta de Galicia co-financed by FEDER (CEE). General support during 2008-2010 was provided by Xunta de Galicia. Research performed at the Consejo Superior de Investigaciones Cientificas was supported by Grant BIO2007-67708-C04-04 from the Direccion General de Investigacion. This work is a product of the project "Factoria de Cristalizacion" from the program Consolider-Ingenio 2010.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Lee EJ, 2007, BIOCHEM BIOPH RES CO, V358, P783, DOI 10.1016/j.bbrc.2007.04.203; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	26	32	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28020	28033		10.1074/jbc.M110.144584	http://dx.doi.org/10.1074/jbc.M110.144584			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592022	Green Published, hybrid			2022-12-27	WOS:000281404100055
J	Giladi, M; Boyman, L; Mikhasenko, H; Hiller, R; Khananshvili, D				Giladi, Moshe; Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel			Essential Role of the CBD1-CBD2 Linker in Slow Dissociation of Ca2+ from the Regulatory Two-domain Tandem of NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; CA2+-BINDING DOMAIN; DYNAMIC PROPERTIES; BINDING PROPERTIES; CRYSTAL-STRUCTURES; STEADY-STATE; SENSOR; MODULATION	In NCX proteins CBD1 and CBD2 domains are connected through a short linker (3 or 4 amino acids) forming a regulatory tandem (CBD12). Only three of the six CBD12 Ca2+-binding sites contribute to NCX regulation. Two of them are located on CBD1 (K-d = similar to 0.2 mu M), and one is on CBD2 (K-d = similar to 5 mu M). Here we analyze how the intrinsic properties of individual regulatory sites are affected by linker-dependent interactions in CBD12 (AD splice variant). The three sites of CBD12 and CBD1 + CBD2 have comparable K-d values but differ dramatically in their Ca2+ dissociation kinetics. CBD12 exhibits multiphasic kinetics for the dissociation of three Ca2+ ions (k(r) = 280 s(-1), k(f) = 7 s(-1), and k(s) = 0.4 s(-1)), whereas the dissociation of two Ca2+ ions from CBD1(k(f) = 16 s(-1)) and one Ca2+ ion from CBD2 (k(r) = 125 s(-1)) is monophasic. Insertion of seven alanines into the linker (CBD12-7Ala) abolishes slow dissociation of Ca2+, whereas the kinetic and equilibrium properties of three Ca2+ sites of CBD12-7Ala and CBD1 + CBD2 are similar. Therefore, the linker-dependent interactions in CBD12 decelerate the Ca2+ on/off kinetics at a specific CBD1 site by 50-80-fold, thereby representing Ca2+ "occlusion" at CBD12. Notably, the kinetic and equilibrium properties of the remaining two sites of CBD12 are "linker-independent," so their intrinsic properties are preserved in CBD12. In conclusion, the dynamic properties of three sites are specifically modified, conserved, diversified, and integrated by the linker in CBD12, thereby generating a wide range dynamic sensor.	[Giladi, Moshe; Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Giladi, Moshe/0000-0002-8589-6920; Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [2010-3-6266]; USA-Israeli Binational Research Grant [2009334]; Israel Science Foundation [23/10]	Israeli Ministry of Health; USA-Israeli Binational Research Grant; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israeli Ministry of Health Grant 2010-3-6266, USA-Israeli Binational Research Grant 2009334, and Israel Science Foundation Grant 23/10.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Baazov D, 1999, BIOCHEMISTRY-US, V38, P1435, DOI 10.1021/bi981429u; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 2007, P NATL ACAD SCI USA, V104, P18349, DOI 10.1073/pnas.0709008104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2008, BIOCHEMISTRY-US, V47, P6602, DOI 10.1021/bi8004279; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chaptal Vincent, 2007, Channels (Austin), V1, P397; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kargacin GJ, 2003, J THEOR BIOL, V221, P245, DOI 10.1006/jtbi.2003.3187; KHANANSHVILI D, 1995, BIOCHEMISTRY-US, V34, P10290, DOI 10.1021/bi00032a024; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; Khananshvili D, 1996, BIOCHEMISTRY-US, V35, P15933, DOI 10.1021/bi961099i; KHANANSHVILI D, 1988, BIOCHEMISTRY-US, V27, P8290, DOI 10.1021/bi00421a045; KHANANSHVILI D, 1998, ADV MOL CEL A&B, V23, P311; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897; Sher AA, 2008, PROG BIOPHYS MOL BIO, V96, P377, DOI 10.1016/j.pbiomolbio.2007.07.018; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	51	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28117	28125		10.1074/jbc.M110.127001	http://dx.doi.org/10.1074/jbc.M110.127001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20587421	Green Published, hybrid			2022-12-27	WOS:000288742300010
J	Haque, ME; Elmore, KB; Tripathy, A; Koc, H; Koc, EC; Spremulli, LL				Haque, Md. Emdadul; Elmore, Kevin B.; Tripathy, Ashutosh; Koc, Hasan; Koc, Emine C.; Spremulli, Linda L.			Properties of the C-terminal Tail of Human Mitochondrial Inner Membrane Protein Oxa1L and Its Interactions with Mammalian Mitochondrial Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING COILED COILS; TRANSLATIONAL INITIATION-FACTOR-3; CIRCULAR-DICHROISM; COMPLEX; INSERTION; EXPORT; YEAST; IDENTIFICATION; EXTENSIONS; MACHINERY	In humans the mitochondrial inner membrane protein Oxa1L is involved in the biogenesis of membrane proteins and facilitates the insertion of both mitochondrial- and nuclear-encoded proteins from the mitochondrial matrix into the inner membrane. The C-terminal similar to 100-amino acid tail of Oxa1L (Oxa1L-CTT) binds to mitochondrial ribosomes and plays a role in the co-translational insertion of mitochondria-synthesized proteins into the inner membrane. Contrary to suggestions made for yeast Oxa1p, our results indicate that the C-terminal tail of human Oxa1L does not form a coiled-coil helical structure in solution. The Oxa1L-CTT exists primarily as a monomer in solution but forms dimers and tetramers at high salt concentrations. The binding of Oxa1L-CTT to mitochondrial ribosomes is an enthalpy-driven process with a K-d of 0.3-0.8 mu M and a stoichiometry of 2. Oxa1L-CTT cross-links to mammalian mitochondrial homologs of the bacterial ribosomal proteins L13, L20, and L28 and to mammalian mitochondrial specific ribosomal proteins MRPL48, MRPL49, and MRPL51. Oxa1L-CTT does not cross-link to proteins decorating the conventional exit tunnel of the bacterial large ribosomal subunit (L22, L23, L24, and L29).	[Haque, Md. Emdadul; Elmore, Kevin B.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Koc, Hasan; Koc, Emine C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Spremulli, LL (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	Linda_spremulli@unc.edu		Elmore, Kevin/0000-0001-6740-9159	National Institutes of Health [GM 32734, GM071034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734, R01GM071034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 32734 (to L.L.S.) and GM071034 (to E.C.K.).	BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bhargava K, 2005, NUCLEIC ACIDS RES, V33, P7011, DOI 10.1093/nar/gki1007; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canaves JM, 1998, J BIOL CHEM, V273, P34214, DOI 10.1074/jbc.273.51.34214; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; EMDADUL HM, 2008, MITOCHONDRION, V8, P254; FRERE V, 1995, J BIOL CHEM, V270, P17502, DOI 10.1074/jbc.270.29.17502; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; Grasso DG, 2007, METHOD ENZYMOL, V430, P59, DOI 10.1016/S0076-6879(07)30004-9; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Haque ME, 2008, NUCLEIC ACIDS RES, V36, P589, DOI 10.1093/nar/gkm1072; Haque ME, 2008, J MOL BIOL, V384, P929, DOI 10.1016/j.jmb.2008.09.077; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; KITAKAWA M, 1991, BIOCHIMIE, V73, P813, DOI 10.1016/0300-9084(91)90061-5; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miller JL, 2009, J PROTEOME RES, V8, P4789, DOI 10.1021/pr9004844; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	45	35	42	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28353	28362		10.1074/jbc.M110.148262	http://dx.doi.org/10.1074/jbc.M110.148262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601428	Green Published, hybrid			2022-12-27	WOS:000281404100077
J	Huang, BL; Brugger, SM; Lyons, KM				Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.			Stage-specific Control of Connective Tissue Growth Factor (CTGF/CCN2) Expression in Chondrocytes by Sox9 and beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CHONDROCYTES; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; CELL-GROWTH; C-MAF; TRANSCRIPTION; DIFFERENTIATION; CHONDROGENESIS; PROTEIN; PROLIFERATION	CCN2/connective tissue growth factor is highly expressed in hypertrophic chondrocytes and is required for chondrogenesis. However, the transcriptional mechanisms controlling its expression in cartilage are largely unknown. The activity of the Ccn2 promoter was, therefore, investigated in osteochondro-progenitor cells and hypertrophic chondrocytes to ascertain these mechanisms. Sox9 and T-cell factor (TCF). lymphoid enhancer factor (LEF) factors contain HMG domains and bind to related consensus sites. TCF.LEF factors are normally repressive but when bound to DNA in a complex with beta-catenin become activators of gene expression. In silico analysis of the Ccn2 proximal promoter identified multiple consensus TCF.LEF elements, one of which was also a consensus binding site for Sox9. Using luciferase reporter constructs, the TCF.LEF.Sox9 site was found to be involved in stage-specific expression of Ccn2. Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP analysis revealed that Sox9 represses Ccn2 expression by binding to the consensus TCF.LEF.Sox9 site. On the other hand, the same assays showed that in hypertrophic chondrocytes, TCF.LEF .beta-catenin complexes occupy the consensus TCF.LEF.Sox9 site and activate Ccn2 expression. Furthermore, transgenic mice in which lacZ expression is driven under the control of the proximal Ccn2 promoter revealed that the proximal Ccn2 promoter responded to Wnt signaling in cartilage. Hence, we propose that differential occupancy of the TCF.LEF.Sox9 site by Sox9 versus beta-catenin restricts high levels of Ccn2 expression to hypertrophic chondrocytes.	[Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.] Univ Calif Los Angeles, Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.] Orthoped Hosp, Los Angeles, CA 90095 USA; [Huang, Bau-Lin] Univ Calif Los Angeles, Sch Dent, Dept Oral Biol, Los Angeles, CA 90095 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lyons, KM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	klyons@mednet.ucla.edu	Huang, Bau-Lin/K-8317-2019; Huang, Bau-Lin/S-4133-2019	Huang, Bau-Lin/0000-0003-3747-6697	National Institutes of Health [AR052686]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR052686.	Akiyama H, 1996, J BONE MINER RES, V11, P22; Akiyama H, 1999, J CELL PHYSIOL, V181, P169, DOI 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brown AJ, 2008, BONE, V43, P689, DOI 10.1016/j.bone.2008.05.022; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Eguchi T, 2002, BIOCHEM BIOPH RES CO, V295, P445, DOI 10.1016/S0006-291X(02)00700-3; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Oka M, 2007, J HISTOCHEM CYTOCHEM, V55, P1245, DOI 10.1369/jhc.7A7263.2007; Omoteyama K, 2006, BIOCHEM BIOPH RES CO, V339, P1089, DOI 10.1016/j.bbrc.2005.11.119; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pateder DB, 2001, J CELL PHYSIOL, V188, P343, DOI 10.1002/jcp.1118; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; SCHREIBER E, 1989, SOMAT CELL MOLEC GEN, V15, P591, DOI 10.1007/BF01534920; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798	56	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27702	27712		10.1074/jbc.M110.108498	http://dx.doi.org/10.1074/jbc.M110.108498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20571031	Green Published, hybrid			2022-12-27	WOS:000281404100026
J	Lakshmipathy, SK; Gupta, R; Pinkert, S; Etchells, SA; Hartl, FU				Lakshmipathy, Sathish Kumar; Gupta, Rashmi; Pinkert, Stefan; Etchells, Stephanie Anne; Hartl, F. Ulrich			Versatility of Trigger Factor Interactions with Ribosome-Nascent Chain Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI RIBOSOME; TRANSLATING RIBOSOMES; POLYPEPTIDE-CHAINS; IN-VIVO; CHAPERONE; BINDING; MEMBRANE; SEQUENCE	Trigger factor (TF) is the first molecular chaperone that interacts with nascent chains emerging from bacterial ribosomes. TF is a modular protein, consisting of an N-terminal ribosome binding domain, a PPIase domain, and a C-terminal domain, all of which participate in polypeptide binding. To directly monitor the interactions of TF with nascent polypeptide chains, TF variants were site-specifically labeled with an environmentally sensitive NBD fluorophore. We found a marked increase in TF-NBD fluorescence during translation of firefly luciferase (Luc) chains, which expose substantial regions of hydrophobicity, but not with nascent chains lacking extensive hydrophobic segments. TF remained associated with Luc nascent chains for 111 +/- 7 s, much longer than it remained bound to the ribosomes (t(1/2) similar to 10-14 s). Thus, multiple TF molecules can bind per nascent chain during translation. The Escherichia coli cytosolic proteome was classified into predicted weak and strong interactors for TF, based on the occurrence of continuous hydrophobic segments in the primary sequence. The residence time of TF on the nascent chain generally correlated with the presence of hydrophobic regions and the capacity of nascent chains to bury hydrophobicity. Interestingly, TF bound the signal sequence of a secretory protein, pOmpA, but not the hydrophobic signal anchor sequence of the inner membrane protein FtsQ. On the other hand, proteins lacking linear hydrophobic segments also recruited TF, suggesting that TF can recognize hydrophobic surface features discontinuous in sequence. Moreover, TF retained significant affinity for the folded domain of the positively charged, ribosomal protein S7, indicative of an alternative mode of TF action. Thus, unlike other chaperones, TF appears to employ multiple mechanisms to interact with a wide range of substrate proteins.	[Lakshmipathy, Sathish Kumar; Gupta, Rashmi; Pinkert, Stefan; Etchells, Stephanie Anne; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Pinkert, Stefan/A-5534-2009; Hartl, F. Ulrich/Y-8206-2019					Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; DeLano W.L, PYMOL MOL GRAPHICS S; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier T, 2005, CURR OPIN STRUC BIOL, V15, P204, DOI 10.1016/j.sbi.2005.03.005; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Michel G, 2003, J BIOL CHEM, V278, P19463, DOI 10.1074/jbc.M300794200; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schulze-Gahmen U, 2005, ACTA CRYSTALLOGR D, V61, P1343, DOI [10.1107/S090744490502264X, 10.1107/S09074490502264X]; Shi Y, 2007, PROTEIN SCI, V16, P1165, DOI 10.1110/ps.062623707; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x	51	33	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27911	27923		10.1074/jbc.M110.134163	http://dx.doi.org/10.1074/jbc.M110.134163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595383	Green Published, hybrid			2022-12-27	WOS:000281404100046
J	Levy-Adam, F; Feld, S; Cohen-Kaplan, V; Shteingauz, A; Gross, M; Arvatz, G; Naroditsky, I; Ilan, N; Doweck, I; Vlodavsky, I				Levy-Adam, Flonia; Feld, Sari; Cohen-Kaplan, Victoria; Shteingauz, Anna; Gross, Miriam; Arvatz, Gil; Naroditsky, Inna; Ilan, Neta; Doweck, Ilana; Vlodavsky, Israel			Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEPARANASE; EXTRACELLULAR-MATRIX; ENZYMATIC-ACTIVITY; CANCER METASTASIS; TUMOR PROGRESSION; PATIENT SURVIVAL; CELLULAR UPTAKE; NECK-CANCER; EXPRESSION; PROTEOGLYCANS	Heparanase activity is highly implicated in cell dissemination associated with tumor metastasis, angiogenesis, and inflammation. Heparanase expression is induced in many hematological and solid tumors, associated with poor prognosis. Heparanase homolog, termed heparanase 2 (Hpa2), was cloned based on sequence homology. Detailed characterization of Hpa2 at the biochemical, cellular, and clinical levels has not been so far reported, and its role in normal physiology and pathological disorders is obscure. We provide evidence that unlike heparanase, Hpa2 is not subjected to proteolytic processing and exhibits no enzymatic activity typical of heparanase. Notably, the full-length Hpa2c protein inhibits heparanase enzymatic activity, likely due to its high affinity to heparin and heparan sulfate and its ability to associate physically with heparanase. Hpa2 expression was markedly elevated in head and neck carcinoma patients, correlating with prolonged time to disease recurrence (follow-up to failure; p = 0.006) and inversely correlating with tumor cell dissemination to regional lymph nodes (N-stage; p = 0.03). Hpa2 appears to restrain tumor metastasis, likely by attenuating heparanase enzymatic activity, conferring a favorable outcome of head and neck cancer patients.	[Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Naroditsky, Inna] Dept Pathol, IL-31096 Haifa, Israel; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34362 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	Vlodavsk@cc.huji.ac.il		Doweck, Ilana/0000-0002-1065-0299	National Institutes of Health (NCI) [RO1-CA106456]; Israel Science Foundation [549/06]; Israel Cancer Research Fund; DKFZ-MOST; Rappaport Family Institute; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; DKFZ-MOST; Rappaport Family Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-CA106456 (NCI). This work was also supported by grants from the Israel Science Foundation (549/06), the Israel Cancer Research Fund, the DKFZ-MOST cooperation program in cancer research, and the Rappaport Family Institute Fund.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Bar-Sela G, 2006, HISTOPATHOLOGY, V49, P188, DOI 10.1111/j.1365-2559.2006.02469.x; Ben-Izhak O, 2006, NEOPLASIA, V8, P879, DOI 10.1593/neo.06382; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Casu B, 2004, J MED CHEM, V47, P838, DOI 10.1021/jm030893g; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; de Moura JP, 2009, INT J GYNECOL CANCER, V19, P1494, DOI 10.1111/IGC.0b013e3181a834a2; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Fairweather JK, 2008, BIOORGAN MED CHEM, V16, P699, DOI 10.1016/j.bmc.2007.10.044; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2007, FASEB J, V21, P3986, DOI 10.1096/fj.07-8866com; Goldshmidt O, 2002, EXP CELL RES, V281, P50, DOI 10.1006/excr.2002.5651; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; LIDER O, 1995, P NATL ACAD SCI USA, V92, P5037, DOI 10.1073/pnas.92.11.5037; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Nadav L, 2002, J CELL SCI, V115, P2179; Nagler R, 2007, CANCER-AM CANCER SOC, V110, P2732, DOI 10.1002/cncr.23095; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Peretti T, 2008, EUR J GASTROEN HEPAT, V20, P756, DOI 10.1097/MEG.0b013e3282fc2649; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Simizu S, 2004, J BIOL CHEM, V279, P2697, DOI 10.1074/jbc.M300541200; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Temkin V, 2004, J ALLERGY CLIN IMMUN, V113, P703, DOI 10.1016/j.jaci.2003.11.038; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; VLODAVSKY I, 1983, CANCER RES, V43, P2704; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; WEICHSELBAUM RR, 1989, HEAD NECK-J SCI SPEC, V11, P437, DOI 10.1002/hed.2880110510; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	51	92	95	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28010	28019		10.1074/jbc.M110.116384	http://dx.doi.org/10.1074/jbc.M110.116384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576607	Green Published, hybrid			2022-12-27	WOS:000281404100054
J	Pinta, E; Duda, KA; Hanuszkiewicz, A; Salminen, TA; Bengoechea, JA; Hyytiainen, H; Lindner, B; Radziejewska-Lebrecht, J; Holst, O; Skurnik, M				Pinta, Elise; Duda, Katarzyna Anna; Hanuszkiewicz, Anna; Salminen, Tiina A.; Antonio Bengoechea, Jose; Hyytiainen, Heidi; Lindner, Buko; Radziejewska-Lebrecht, Joanna; Holst, Otto; Skurnik, Mikael			Characterization of the Six Glycosyltransferases Involved in the Biosynthesis of Yersinia enterocolitica Serotype O:3 Lipopolysaccharide Outer Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O166; TAIL-LIKE BACTERIOCIN; PATHOGENIC YERSINIAE; BIOLOGICAL ROLE; SIDE-CHAIN; ANTIGEN; O-3; PHAGE; POLYSACCHARIDE; VIRULENCE	Yersinia enterocolitica (Ye) is a Gram-negative bacterium; Ye serotype O:3 expresses lipopolysaccharide (LPS) with a hexasaccharide branch known as the outer core (OC). The OC is important for the resistance of the bacterium to cationic antimicrobial peptides and also functions as a receptor for bacteriophage phi R1-37 and enterocoliticin. The biosynthesis of the OC hexasaccharide is directed by the OC gene cluster that contains nine genes (wzx, wbcKLMNOPQ, and gne). In this study, we inactivated the six OC genes predicted to encode glycosyltransferases (GTase) one by one by nonpolar mutations to assign functions to their gene products. The mutants expressed no OC or truncated OC oligosaccharides of different lengths. The truncated OC oligosaccharides revealed that the minimum structural requirements for the interactions of OC with bacteriophage phi R1-37, enterocoliticin, and OC-specific monoclonal antibody 2B5 were different. Furthermore, using chemical and structural analyses of the mutant LPSs, we could assign specific functions to all six GTases and also revealed the exact order in which the transferases build the hexasaccharide. Comparative modeling of the catalytic sites of glucosyltransferases WbcK and WbcL followed by site-directed mutagenesis allowed us to identify Asp-182 and Glu-181, respectively, as catalytic base residues of these two GTases. In general, conclusive evidence for specific GTase functions have been rare due to difficulties in accessibility of the appropriate donors and acceptors; however, in this work we were able to utilize the structural analysis of LPS to get direct experimental evidence for five different GTase specificities.	[Pinta, Elise; Hyytiainen, Heidi; Skurnik, Mikael] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Pinta, Elise] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Duda, Katarzyna Anna; Radziejewska-Lebrecht, Joanna] Univ Silesia, Dept Microbiol, PL-40032 Katowice, Poland; [Duda, Katarzyna Anna; Hanuszkiewicz, Anna; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Salminen, Tiina A.] Abo Akad Univ, Dept Biochem & Pharm, FIN-20520 Turku, Finland; [Antonio Bengoechea, Jose] Fdn Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola 07110, Spain; [Antonio Bengoechea, Jose] CSIC, Bunyola 07110, Spain; [Skurnik, Mikael] Univ Helsinki, Cent Hosp, Diagnost Lab, FIN-00029 Helsinki, Finland	University of Helsinki; University of Turku; University of Silesia in Katowice; Forschungszentrum Borstel; Forschungszentrum Borstel; Abo Akademi University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Helsinki; Helsinki University Central Hospital	Skurnik, M (corresponding author), Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Bacteriol & Immunol, POB 21, FIN-00014 Helsinki, Finland.	mikael.skurnik@helsinki.fi	Salminen, Tiina A./AAM-5443-2021; Skurnik, Mikael/I-8477-2019; Salminen, Tiina A/G-7492-2019; Duda, Katarzyna/M-5274-2018; Lindner, Buko/G-9731-2014	Salminen, Tiina A./0000-0002-4135-8020; Skurnik, Mikael/0000-0001-8791-9260; Salminen, Tiina A/0000-0002-4135-8020; Duda, Katarzyna/0000-0001-7701-3262; Bengoechea, Jose/0000-0002-9677-8751; Hyytiainen, Heidi/0000-0002-3109-9600	Tor, Joe, and Pentti Borgs Memorial Fund; Sigrid Juselius Foundation; Fondo de Investigacion Sanitaria [PI03/0881]; Consejo Superior Investigaciones Cientificas Proyecto Intramural [200820I174]; Academy of Finland [114075, 104361, 50441]; Glycoscience Graduate School	Tor, Joe, and Pentti Borgs Memorial Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Consejo Superior Investigaciones Cientificas Proyecto Intramural; Academy of Finland(Academy of Finland); Glycoscience Graduate School	This work was supported by Tor, Joe, and Pentti Borgs Memorial Fund and Sigrid Juselius Foundation (to T. A. S.), Fondo de Investigacion Sanitaria Grant PI03/0881, Consejo Superior Investigaciones Cientificas Proyecto Intramural 200820I174 (to J. A. B.), Academy of Finland Projects 114075, 104361, and 50441 (to M. S.), and Glycoscience Graduate School funds (to E. P.).	ALHENDY A, 1992, INFECT IMMUN, V60, P870, DOI 10.1128/IAI.60.3.870-875.1992; Ali T, 2007, CARBOHYD RES, V342, P274, DOI 10.1016/j.carres.2006.11.023; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; APPLEYARD RK, 1954, GENETICS, V39, P440; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DeLano W.L, PYMOL MOL GRAPHICS S; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Edwards KJ, 2005, J BACTERIOL, V187, P2939, DOI 10.1128/JB.187.9.2939-2947.2005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holst O., 2007, COMPREHENSIVE GLYCOS, P123, DOI DOI 10.1016/B978-044451967-2/00004-0; JANN K, 1965, BIOCHEM Z, V342, P1; Johnson MS, 1996, METHOD ENZYMOL, V266, P575; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Kiljunen S, 2005, MICROBIOL-SGM, V151, P4093, DOI 10.1099/mic.0.28265-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liu B, 2010, MICROBIOL-SGM, V156, P1642, DOI 10.1099/mic.0.037325-0; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; MULLERLOENNIES S, 1994, EUR J BIOCHEM, V224, P751, DOI 10.1111/j.1432-1033.1994.t01-1-00751.x; Oertelt C, 2001, EUR J BIOCHEM, V268, P554, DOI 10.1046/j.1432-1327.2001.01891.x; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; PEKKOLAHEINO K, 1987, ACTA PATH MICRO IM C, V95, P27; Pinta E, 2009, CHEM-EUR J, V15, P9747, DOI 10.1002/chem.200901255; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Radziejewska-Lebrecht J, 1998, ACTA BIOCHIM POL, V45, P1011, DOI 10.18388/abp.1998_4358; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sirisena DM, 2003, J APPL MICROBIOL, V94, P686, DOI 10.1046/j.1365-2672.2003.01897.x; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Skurnik M, 2003, ADV EXP MED BIOL, V529, P187; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SKURNIK M, 1995, MOL MICROBIOL, V17, P575, DOI 10.1111/j.1365-2958.1995.mmi_17030575.x; SKURNIK M, 1984, J APPL BACTERIOL, V56, P355, DOI 10.1111/j.1365-2672.1984.tb01362.x; Skurnik M, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P23; Skurnik M., 2004, YERSINIA MOL CELLULA, P215; Skurnik M, 2007, J BACTERIOL, V189, P7244, DOI 10.1128/JB.00605-07; Strauch E, 2003, ADV EXP MED BIOL, V529, P249; Strauch E, 2001, APPL ENVIRON MICROB, V67, P5634, DOI 10.1128/AEM.67.12.5634-5642.2001; Yang JH, 2009, J BACTERIOL, V191, P1891, DOI 10.1128/JB.01532-08; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang LJ, 1995, CONTRIB TO MICROBIOL, V13, P310; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994	54	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28333	28342		10.1074/jbc.M110.111336	http://dx.doi.org/10.1074/jbc.M110.111336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595390	Green Published, hybrid			2022-12-27	WOS:000281404100075
J	Zhou, QOL; Jiang, ZY; Mabardy, AS; Del Campo, CM; Lambright, DG; Holik, J; Fogarty, KE; Straubhaar, J; Nicoloro, S; Chawla, A; Czech, MP				Zhou, Qiong L.; Jiang, Zhen Y.; Mabardy, Allan S.; Del Campo, Claudia M.; Lambright, David G.; Holik, John; Fogarty, Kevin E.; Straubhaar, Juerg; Nicoloro, Sarah; Chawla, Anil; Czech, Michael P.			A Novel Pleckstrin Homology Domain-containing Protein Enhances Insulin-stimulated Akt Phosphorylation and GLUT4 Translocation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; MITOCHONDRIAL BIOGENESIS; BINDING POCKET; AGC KINASES; ACTIVATION; IDENTIFICATION; MECHANISM; LL5-BETA; PDK1	Protein kinase B/Akt protein kinases control an array of diverse functions, including cell growth, survival, proliferation, and metabolism. We report here the identification of pleckstrin homology-like domain family B member 1 (PHLDB1) as an insulin-responsive protein that enhances Akt activation. PHLDB1 contains a pleckstrin homology domain, which we show binds phosphatidylinositol PI(3,4)P-2, PI(3,5)P-2, and PI(3,4,5)P-3, as well as a Forkhead-associated domain and coiled coil regions. PHLDB1 expression is increased during adipocyte differentiation, and it is abundant in many mouse tissues. Both endogenous and HA- or GFP-tagged PHLDB1 displayed a cytoplasmic disposition in unstimulated cultured adipocytes but translocated to the plasma membrane in response to insulin. Depletion of PHLDB1 by siRNA inhibited insulin stimulation of Akt phosphorylation but not tyrosine phosphorylation of IRS-1. RNAi-based silencing of PHLDB1 in cultured adipocytes also attenuated insulin-stimulated deoxyglucose transport and Myc-GLUT4-EGFP translocation to the plasma membrane, whereas knockdown of the PHLDB1 isoform PHLDB2 failed to attenuate insulin-stimulated deoxyglucose transport. Furthermore, adenovirus-mediated expression of PHLDB1 in adipocytes enhanced insulin-stimulated Akt and p70 S6 kinase phosphorylation, as well as GLUT4 translocation. These results indicate that PHLDB1 is a novel modulator of Akt protein kinase activation by insulin.	[Jiang, Zhen Y.] Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Zhou, Qiong L.; Mabardy, Allan S.; Del Campo, Claudia M.; Lambright, David G.; Fogarty, Kevin E.; Straubhaar, Juerg; Nicoloro, Sarah; Chawla, Anil; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Holik, John] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiang, ZY (corresponding author), Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA.	zjiang@sanfordburnham.org; Michael.Czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	National Institutes of Health [DK060564]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK060564 (to M. P. C.). This work was also supported by an American Diabetes Association Junior Faculty Award (to Z. Y. J.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Buser CA, 1998, METH MOL B, V84, P267; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARRISON SA, 1990, J BIOL CHEM, V265, P20106; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Katoh M, 2003, INT J ONCOL, V23, P1477; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Murray JT, 2004, BIOCHEM J, V384, P489, DOI 10.1042/BJ20041058; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003	43	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27581	27589		10.1074/jbc.M110.146886	http://dx.doi.org/10.1074/jbc.M110.146886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20587420	Green Published, hybrid			2022-12-27	WOS:000281404100013
J	Ishimaru, D; Zuraw, L; Ramalingam, S; Sengupta, TK; Bandyopadhyay, S; Reuben, A; Fernandes, DJ; Spicer, EK				Ishimaru, Daniella; Zuraw, Lisa; Ramalingam, Sivakumar; Sengupta, Tapas K.; Bandyopadhyay, Sumita; Reuben, Adrian; Fernandes, Daniel J.; Spicer, Eleanor K.			Mechanism of Regulation of bcl-2 mRNA by Nucleolin and A plus U-rich Element-binding Factor 1 (AUF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; HELA CYTOPLASMIC EXTRACTS; DOMAINS DETERMINE; PROTEIN-BINDING; LEUKEMIA-CELLS; IDENTIFICATION; TURNOVER; STABILIZATION; COMPLEX; DESTABILIZATION	The antiapoptotic Bcl-2 protein is overexpressed in a variety of cancers, particularly leukemias. In some cell types this is the result of enhanced stability of bcl-2 mRNA, which is controlled by elements in its 3'-untranslated region. Nucleolin is one of the proteins that binds to bcl-2 mRNA, thereby increasing its half-life. Here, we examined the site on the bcl-2 3'-untranslated region that is bound by nucleolin as well as the protein binding domains important for bcl-2 mRNA recognition. RNase foot-printing and RNA fragment binding assays demonstrated that nucleolin binds to a 40-nucleotide region at the 5' end of the 136-nucleotide bcl-2 AU-rich element (ARE(bcl-2)). The first two RNA binding domains of nucleolin were sufficient for high affinity binding to ARE(bcl-2). In RNA decay assays, ARE(bcl-2) transcripts were protected from exosomal decay by the addition of nucleolin. AUF1 has been shown to recruit the exosome to mRNAs. When MV-4-11 cell extracts were immunodepleted of AUF1, the rate of decay of ARE(bcl-2) transcripts was reduced, indicating that nucleolin and AUF1 have opposing roles in bcl-2 mRNA turnover. When the function of nucleolin in MV-4-11 cells was impaired by treatment with the nucleolin-targeting aptamer AS1411, association of AUF1 with bcl-2 mRNA was increased. This suggests that the degradation of bcl-2 mRNA induced by AS1411 results from both interference with nucleolin protection of bcl-2 mRNA and recruitment of the exosome by AUF1. Based on our findings, we propose a model that illustrates the opposing roles of nucleolin and AUF1 in regulating bcl-2 mRNA stability.	[Ishimaru, Daniella; Ramalingam, Sivakumar; Sengupta, Tapas K.; Bandyopadhyay, Sumita; Fernandes, Daniel J.; Spicer, Eleanor K.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Reuben, Adrian] Med Univ S Carolina, Dept Med, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA; [Zuraw, Lisa] The Citadel, Dept Chem, Charleston, SC 29409 USA	Medical University of South Carolina; Medical University of South Carolina	Spicer, EK (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, POB 250509, Charleston, SC 29425 USA.	spicer@musc.edu	Sengupta, Tapas K/P-7126-2014; Ogunwobi, Olorunseun/F-3172-2010		National Institutes of Health [CA 87553, CA 109254]; Antisoma Research Limited, UK; NATIONAL CANCER INSTITUTE [R01CA087553, R01CA109254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antisoma Research Limited, UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants CA 87553 (to E. K. S.) and CA 109254 (to D. J. F.) from the National Institutes of Health and an unrestricted grant from Antisoma Research Limited, UK (to D. J. F.).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Bandyopadhyay S, 2003, BIOCHEM PHARMACOL, V66, P1151, DOI 10.1016/S0006-2952(03)00453-2; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; David PS, 2007, RNA, V13, P1453, DOI 10.1261/rna.501707; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Finger LD, 2003, NUCLEIC ACIDS RES, V31, P6461, DOI 10.1093/nar/gkg866; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 2001, J BIOL CHEM, V276, P14338, DOI 10.1074/jbc.M011120200; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Singh K, 2004, J IMMUNOL, V173, P976, DOI 10.4049/jimmunol.173.2.976; Sokoloski KJ, 2008, METHOD ENZYMOL, V448, P139, DOI 10.1016/S0076-6879(08)02608-6; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; ZAIDI SHE, 1995, J BIOL CHEM, V270, P17292, DOI 10.1074/jbc.270.29.17292; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	77	81	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27182	27191		10.1074/jbc.M109.098830	http://dx.doi.org/10.1074/jbc.M109.098830			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571027	hybrid, Green Published			2022-12-27	WOS:000281172700049
J	Cao, G; Lee, KP; van der Wijst, J; de Graaf, M; van der Kemp, A; Bindels, RJM; Hoenderop, JGJ				Cao, Gang; Lee, Kyu Pil; van der Wijst, Jenny; de Graaf, Mark; van der Kemp, AnneMiete; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Methionine Sulfoxide Reductase B1 (MsrB1) Recovers TRPM6 Channel Activity during Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVITY; FUNCTIONAL EXPRESSION; RESIDUES; ACTIVATION; MODULATION; MAGNESIUM; DOMAIN; CA2+; AUTOPHOSPHORYLATION; HYPOMAGNESEMIA	Mg2+ is an essential ion for many cellular processes, including protein synthesis, nucleic acid stability, and numerous enzymatic reactions. Mg2+ homeostasis in mammals depends on the equilibrium between intestinal absorption, renal excretion, and exchange with bone. The transient receptor potential melastatin type 6 (TRPM6) is an epithelial Mg2+ channel, which is abundantly expressed in the luminal membrane of the renal and intestinal cells. It functions as the gatekeeper of transepithelial Mg2+ transport. Remarkably, TRPM6 combines a Mg2+-permeable channel with an alpha-kinase domain. Here, by the Ras recruitment system, we identified methionine sulfoxide reductase B1 (MsrB1) as an interacting protein of the TRPM6 alpha-kinase domain. Importantly, MsrB1 and TRPM6 are both present in the renal Mg2+-transporting distal convoluted tubules. MsrB1 has no effect on TRPM6 channel activity in the normoxic conditions. However, hydrogen peroxide (H2O2) decreased TRPM6 channel activity. Co-expression of MsrB1 with TRPM6 attenuated the inhibitory effect of H2O2 (TRPM6, 67 +/- 5% of control; TRPM6 + MsrB1, 81 +/- 5% of control). Cell surface biotinylation assays showed that H2O2 treatment does not affect the expression of TRPM6 at the plasma membrane. Next, mutation of Met(1755) to Ala in TRPM6 reduced the inhibitory effect of H2O2 on TRPM6 channel activity (TRPM6 M1755A: 84 +/- 10% of control), thereby mimicking the action of MsrB1. Thus, these data suggest that MsrB1 recovers TRPM6 channel activity by reducing the oxidation of Met(1755) and could, thereby, function as a modulator of TRPM6 during oxidative stress.	[Cao, Gang; Lee, Kyu Pil; van der Wijst, Jenny; de Graaf, Mark; van der Kemp, AnneMiete; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, 286 Physiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; van der Wijst, Jenny/D-9726-2016; van der Wijst, Jenny/T-1620-2019	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; van der Wijst, Jenny/0000-0002-1547-516X; van der Wijst, Jenny/0000-0002-1547-516X; lee, kyu pil/0000-0002-7192-4791	Netherlands Organization for Scientific Research (ZonMw) [9120.6110, 9120.8026]; European Science Foundation; Dutch Kidney Foundation [C03.6017]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission); Dutch Kidney Foundation	This work was supported by the Netherlands Organization for Scientific Research (ZonMw Grants 9120.6110, 9120.8026), a European Young Investigator award from the European Science Foundation, and the Dutch Kidney Foundation (Grant C03.6017).	Aronheim A, 2001, METHODS, V24, P29, DOI 10.1006/meth.2001.1153; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, FEBS LETT, V582, P2993, DOI 10.1016/j.febslet.2008.07.043; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Eckers A, 2009, REDOX REP, V14, P141, DOI 10.1179/135100009X392610; Eisfeld J., 2007, V179, P237; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Grimellec C L, 1975, Pflugers Arch, V354, P117, DOI 10.1007/BF00579943; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Hansel A, 2003, REDOX REP, V8, P384, DOI 10.1179/135100003225003429; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Jung S, 2002, FEBS LETT, V527, P91, DOI 10.1016/S0014-5793(02)03171-X; Kohchi C, 2009, ANTICANCER RES, V29, P817; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kuschel L, 1999, FEBS LETT, V456, P17, DOI 10.1016/S0014-5793(99)00917-5; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; MADSEN KM, 1988, J ELECTRON MICR TECH, V9, P187, DOI 10.1002/jemt.1060090206; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Nabuchi Y, 1995, PHARMACEUT RES, V12, P2049, DOI 10.1023/A:1016281031373; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Rempe DA, 2009, NAT NEUROSCI, V12, P1215, DOI 10.1038/nn1009-1215; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	57	61	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26081	26087		10.1074/jbc.M110.103655	http://dx.doi.org/10.1074/jbc.M110.103655			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20584906	hybrid, Green Published			2022-12-27	WOS:000280921000024
J	Fu, ZJ; Runquist, JA; Montgomery, C; Miziorko, HM; Kim, JJP				Fu, Zhuji; Runquist, Jennifer A.; Montgomery, Christa; Miziorko, Henry M.; Kim, Jung-Ja P.			Functional Insights into Human HMG-CoA Lyase from Structures of Acyl-CoA-containing Ternary Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEVALONII 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; COENZYME-A; CRYSTAL-STRUCTURE; ACETYL-COENZYME; MALATE SYNTHASE; ENZYME; MECHANISM; SUBSTRATE; DEHYDROGENASE; CATALYSIS	HMG-CoA lyase (HMGCL) is crucial to ketogenesis, and inherited human mutations are potentially lethal. Detailed understanding of the HMGCL reaction mechanism and the molecular basis for correlating human mutations with enzyme deficiency have been limited by the lack of structural information for enzyme liganded to an acyl-CoA substrate or inhibitor. Crystal structures of ternary complexes of WT HMGCL with the competitive inhibitor 3-hydroxyglutaryl-CoA and of the catalytically deficient HMGCL R41M mutant with substrate HMG-CoA have been determined to 2.4 and 2.2 angstrom, respectively. Comparison of these beta/alpha-barrel structures with those of unliganded HMGCL and R41M reveals substantial differences for Mg2+ coordination and positioning of the flexible loop containing the conserved HMGCL "signature" sequence. In the R41M-Mg2+-substrate ternary complex, loop residue Cys(266) (implicated in active-site function by mechanistic and mutagenesis observations) is more closely juxtaposed to the catalytic site than in the case of unliganded enzyme or the WT enzyme-Mg2+-3-hydroxyglutaryl-CoA inhibitor complex. In both ternary complexes, the S-stereoisomer of substrate or inhibitor is specifically bound, in accord with the observed Mg2+ liganding of both C3 hydroxyl and C5 carboxyl oxygens. In addition to His(233) and His(235) imidazoles, other Mg2+ ligands are the Asp(42) carboxyl oxygen and an ordered water molecule. This water, positioned between Asp(42) and the C3 hydroxyl of bound substrate/inhibitor, may function as a proton shuttle. The observed interaction of Arg(41) with the acyl-CoA C1 carbonyl oxygen explains the effects of Arg(41) mutation on reaction product enolization and explains why human Arg(41) mutations cause drastic enzyme deficiency.	[Montgomery, Christa; Miziorko, Henry M.] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Missouri System; University of Missouri Kansas City; Medical College of Wisconsin	Miziorko, HM (corresponding author), Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	miziorkoh@umkc.edu; jjkim@mcw.edu			National Institutes of Health [GM29076, DK21491, RR07707]; United Stated Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; Office of Biological and Environmental Research [DE-AC02-06CH11357]; Marion Merrell Dow Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021491, R01DK021491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Stated Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marion Merrell Dow Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM29076 (to J.-J. P. K.) and DK21491 (to H. M. M.). Use of the Advanced Photon Source was supported by the United Stated Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38, and Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. Use of BioCARS Sector 14 was supported by National Center for Research Resources Grant RR07707 from the National Institutes of Health.; Supported in part by Marion Merrell Dow Foundation endowment funds (to H. M. M.).	Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carrasco P, 2007, MOL GENET METAB, V91, P120, DOI 10.1016/j.ymgme.2007.03.007; Casals N, 2003, J BIOL CHEM, V278, P29016, DOI 10.1074/jbc.M304276200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouhar F, 2006, J BIOL CHEM, V281, P7533, DOI 10.1074/jbc.M507996200; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; HANSON KR, 1975, ACCOUNTS CHEM RES, V8, P1, DOI 10.1021/ar50085a001; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; KRAMER PR, 1983, BIOCHEMISTRY-US, V22, P2353, DOI 10.1021/bi00279a008; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; MESSNER B, 1975, EUR J BIOCHEM, V53, P255, DOI 10.1111/j.1432-1033.1975.tb04064.x; NARASIMHAN C, 1995, BIOCHEMISTRY-US, V34, P9930, DOI 10.1021/bi00031a015; NARASIMHAN C, 1994, ARCH BIOCHEM BIOPHYS, V312, P467, DOI 10.1006/abbi.1994.1333; Pie J, 2007, MOL GENET METAB, V92, P198, DOI 10.1016/j.ymgme.2007.06.020; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBERTS JR, 1995, J BIOL CHEM, V270, P17311, DOI 10.1074/jbc.270.29.17311; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROUSSEL A, 1999, TURBO FRODO; SIDDIQI MA, 1967, J BACTERIOL, V93, P207, DOI 10.1128/JB.93.1.207-214.1967; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; Tuinstra RL, 2004, BIOCHEMISTRY-US, V43, P5287, DOI 10.1021/bi0499765; Tuinstra RL, 2003, J BIOL CHEM, V278, P37092, DOI 10.1074/jbc.M304472200; Tuinstra RL, 2002, ARCH BIOCHEM BIOPHYS, V408, P286, DOI 10.1016/S0003-9861(02)00584-2; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057	36	16	16	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26341	26349		10.1074/jbc.M110.139931	http://dx.doi.org/10.1074/jbc.M110.139931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558737	Green Published, hybrid			2022-12-27	WOS:000280921000052
J	Gahring, LC; Rogers, SW				Gahring, Lorise C.; Rogers, Scott W.			Nicotinic Receptor Subunit alpha 5 Modifies Assembly, Up-regulation, and Response to Pro-inflammatory Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; BINDING-SITES; RAT-BRAIN; CHOLINERGIC-RECEPTOR; HIPPOCAMPAL-NEURONS; IN-VIVO; BETA 4; EXPRESSION; CELLS; PHARMACOLOGY	In the mammalian brain high affinity nicotine-binding sites are composed of at least the alpha 4 and beta 2 subunits. Additional nicotinic acetylcholine receptor subunits that are often co-expressed with alpha 4 + beta 2 include alpha 5. The introduction of alpha 5 into 293 cells expressing alpha 4 + beta 2 strongly favors assembly of alpha 4 + alpha 5 + beta 2 receptors, increases constitutive ligand binding density as measured using [H-3] epibatidine, but reduces the magnitude of up-regulation in response to chronic nicotine. In contrast, when beta 4 is substituted for beta 2, alpha 5 interferes with the assembly of these receptors, demonstrating an important role for the beta subunit in this process. When cells co-express alpha 4 + alpha 5 + beta 2 + beta 4, over 50% of the subunit associations include all four subunits, but they fail to be detected using [H-3] epibatidine binding. However, complexes of alpha 4 + alpha 5 + beta 2 do preferentially emerge from these subunit mixtures, and these mixtures bind ligand. In previous studies of alpha 4 + beta 2 + beta 4 co-expression by 293 cells, the inflammatory cytokines IL-1 beta and TNF alpha influenced the outcome of receptor assembly (Gahring, L. C., Days, E. L., Kaasch, T., Gonzalez de Mendoza, M., Owen, L., Persiyanov, K., and Rogers, S. W. (2005) J. Neuroimmunol. 166, 88-101). When alpha 5 is included in this subunit mixture, and cells are exposed to either inflammatory cytokine, subunit association is no longer altered. These findings suggest that alpha 5 is an influential modulator of alpha 4 + beta 2 nicotinic acetylcholine receptor assembly and stabilizes their expression in response to fluctuations in external conditions.	[Rogers, Scott W.] Univ Utah, Sch Med 2C132, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Univ Utah, Sch Med 2C132, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, 30 North,1900 East, Salt Lake City, UT 84132 USA.	scott.rogers@hsc.utah.edu			National Institutes of Health [AG017517, AG029838, DA025057]; Veterans Affairs; NATIONAL INSTITUTE ON AGING [R01AG017517, R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG017517 (to S. W. R.), AG029838 (to L. C. G.), and DA025057 (to L. C. G. and S. W. R.). This work was also supported by a Veterans Affairs-Merit award (to L. C. G.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 1996, J PHARMACOL EXP THER, V279, P1491; ANAND R, 1991, J BIOL CHEM, V266, P11192; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bruschweiler-Li L, 2010, NEUROSCIENCE, V166, P864, DOI 10.1016/j.neuroscience.2010.01.026; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Cauley K, 1996, J NEUROBIOL, V30, P303, DOI 10.1002/(SICI)1097-4695(199606)30:2<303::AID-NEU11>3.0.CO;2-K; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; DINELEYMILLER K, 1992, MOL BRAIN RES, V16, P339, DOI 10.1016/0169-328X(92)90244-6; Flores CM, 1996, J NEUROSCI, V16, P7892; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2005, NEUROBIOL AGING, V26, P973, DOI 10.1016/j.neurobiolaging.2004.07.005; Gahring LC, 2004, J COMP NEUROL, V468, P322, DOI 10.1002/cne.10942; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; MARKS MJ, 1985, J PHARMACOL EXP THER, V235, P619; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; O'Hara BF, 1999, MOL BRAIN RES, V66, P71, DOI 10.1016/S0169-328X(99)00004-2; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; PAULSON HL, 1991, J CELL BIOL, V113, P1371, DOI 10.1083/jcb.113.6.1371; Picciotto M R, 1999, Nicotine Tob Res, V1 Suppl 2, pS121; Rogers SW, 1998, J NEUROSCI, V18, P4825; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Wang DW, 2009, CHIN J TRAUMATOL, V12, P355, DOI 10.3760/cma.j.issn.1008-1275.2009.06.007; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Zoli M, 2002, J NEUROSCI, V22, P8785	48	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26049	26057		10.1074/jbc.M110.105346	http://dx.doi.org/10.1074/jbc.M110.105346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566638	Green Published, hybrid			2022-12-27	WOS:000280921000020
J	Inoue, E; Yamashita, A; Inoue, H; Sekiguchi, M; Shiratori, A; Yamamoto, Y; Tadokoro, T; Ishimi, Y; Yamauchi, J				Inoue, Erina; Yamashita, Aoi; Inoue, Hirofumi; Sekiguchi, Mariko; Shiratori, Asuka; Yamamoto, Yuji; Tadokoro, Tadahiro; Ishimi, Yoshiko; Yamauchi, Jun			Identification of Glucose Transporter 4 Knockdown-dependent Transcriptional Activation Element on the Retinol Binding Protein 4 Gene Promoter and Requirement of the 20 S Proteasome Subunit for Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; VITAMIN-A; NUCLEAR-LOCALIZATION; 3T3-L1 ADIPOCYTES; DIABETIC SUBJECTS; CELLULAR UPTAKE; HUMAN HOMOLOG; IN-VITRO; EXPRESSION; RECEPTOR	Retinol binding protein 4 (RBP4) is the transport protein that carries retinol in blood. RBP4 was described recently as a new adipokine that reduced insulin sensitivity. Mice lacking glucose transporter 4 (GLUT4) in adipocytes have enhanced Rbp4 gene expression; however, the molecular mechanism is unknown. We found a G4KA (GLUT4 knockdown-dependent transcriptional activation) element located similar to 1.3 kb upstream of the Rbp4 promoter. Mutations within the G4KA sequence significantly reduced expression of the Rbp4 promoter-reporter construct in G4KD-L1 (GLUT4 knockdown 3T3-L1) adipocyte cells. In a yeast one-hybrid screen of a G4KD-L1 cell cDNA library, using the G4KA element as bait, we identified subunits of the 20 S proteasome, PSMB1 and PSMA4, as binding partners. In chromatin immunoprecipitation assays, both subunits bound to the G4KA element; however, only PSMB1 was tightly bound in the GLUT4 knockdown model. PSMB1 RNA interference, but not PSMA4, significantly inhibited Rbp4 transcription. Nuclear transportation of PSMB1 was increased in G4KD-L1 cells. These results provide evidence for an exclusive proteasome subunit-related mechanism for transcriptional activation of RBP4 within a GLUT4 knockdown model.	[Yamauchi, Jun] Natl Inst Hlth & Nutr, Food Funct & Labeling Program, Nutr Epidemiol Program, Shinjyuku Ku, Tokyo 1628636, Japan; [Inoue, Hirofumi; Shiratori, Asuka; Yamamoto, Yuji; Tadokoro, Tadahiro] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo 1568502, Japan	National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture	Yamauchi, J (corresponding author), Natl Inst Hlth & Nutr, Food Funct & Labeling Program, Nutr Epidemiol Program, Shinjyuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	junyama@nih.go.jp			Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare (to J.Y.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to J.Y.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; BLOMHOFF R, 1991, PHYSIOL REV, V71, P951, DOI 10.1152/physrev.1991.71.4.951; Catlow K, 2007, J BIOL CHEM, V282, P17069, DOI 10.1074/jbc.M611421200; Chang TL, 2009, METABOLISM, V58, P1643, DOI 10.1016/j.metabol.2009.05.020; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; COLANTUONI V, 1987, EMBO J, V6, P631, DOI 10.1002/j.1460-2075.1987.tb04801.x; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; DONOFRIO C, 1985, EMBO J, V4, P1981, DOI 10.1002/j.1460-2075.1985.tb03881.x; Gottlicher M, 1996, STEROIDS, V61, P257, DOI 10.1016/0039-128X(96)00032-3; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HAGIWARA M, 2009, BIOCHEM BIOPH RES CO, V389, P171; Hammarstedt A, 2008, J INTERN MED, V263, P440, DOI 10.1111/j.1365-2796.2007.01914.x; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; Inoue E, 2006, BIOCHEM BIOPH RES CO, V351, P793, DOI 10.1016/j.bbrc.2006.10.124; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakamura A, 2006, NEUROSCI LETT, V406, P43, DOI 10.1016/j.neulet.2006.07.050; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; NORUM KR, 1992, AM J CLIN NUTR, V56, P735, DOI 10.1093/ajcn/56.4.735; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; VOM BE, 1996, EMBO J, V15, P110; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	44	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25545	25553		10.1074/jbc.M109.079152	http://dx.doi.org/10.1074/jbc.M109.079152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530491	Green Published, hybrid			2022-12-27	WOS:000280682400049
J	Nili, M; Shinde, U; Rotwein, P				Nili, Mahta; Shinde, Ujwal; Rotwein, Peter			Soluble Repulsive Guidance Molecule c/Hemojuvelin Is a Broad Spectrum Bone Morphogenetic Protein (BMP) Antagonist and Inhibits both BMP2-and BMP6-mediated Signaling and Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPCIDIN EXPRESSION; IRON-METABOLISM; TGF-BETA; JUVENILE HEMOCHROMATOSIS; HEMOJUVELIN; FAMILY; RECEPTORS; OVERLOAD; NEOGENIN; COMPLEX	Inactivating mutations in hemojuvelin/repulsive guidance molecule c (HJV/RGMc) cause juvenile hemochromatosis (JH), a rapidly progressive iron overload disorder in which expression of hepcidin, a key liver-derived iron-regulatory hormone, is severely diminished. Several growth factors in the bone morphogenetic protein (BMP) family, including BMP2 and BMP6, can stimulate production of hepcidin, a biological effect that may be modified by RGMc. Here we demonstrate that soluble RGMc proteins are potent BMP inhibitors. Wefind that 50- and 40-kDa RGMc isoforms, when added to cells as highly purified IgG Fc fusion proteins, are able to block the acute effects of both BMP2 and BMP6 at the levels of Smad induction and gene activation, and thus represent a potentially unique class of broad-spectrum BMP antagonists. Whole transcript microarray analysis revealed that BMP2 and BMP6 each stimulated expression of a nearly identical cohort of similar to 40 mRNAs in Hep3B cells and demonstrated that 40-kDa RGMc was an effective inhibitor of both growth factors, although its potency was less than that of the known BMP2-selective antagonist, Noggin. We additionally show that JH-linked RGMc mutant proteins that retain the ability to bind BMPs are also able to function as BMP inhibitors, and like the wild type soluble RGMc species, can block BMP-activated hepcidin gene expression. The latter results raise the question of whether disease severity in JH will vary depending on the ability of a given mutant RGMc protein to interact with BMPs.	[Nili, Mahta; Shinde, Ujwal; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), 3181 SW Sam Jackson Pk Rd,Mail Code L224, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK042748, F31 HL095271, WSF 0746589]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL095271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants R01 DK042748 (to P. R.), F31 HL095271 (to M. N.), and WSF 0746589 (to U. S.).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; ASCHAFFENBURG R, 1979, J MOL BIOL, V135, P1033, DOI 10.1016/0022-2836(79)90528-X; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kuninger D, 2004, GENOMICS, V84, P876, DOI 10.1016/j.ygeno.2004.07.013; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	48	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24783	24792		10.1074/jbc.M110.130286	http://dx.doi.org/10.1074/jbc.M110.130286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530805	Green Published, hybrid			2022-12-27	WOS:000280542100051
J	Chen, JK; Liu, J; Han, QK; Qin, DJ; Xu, JY; Chen, Y; Yang, JQ; Song, H; Yang, DS; Peng, MX; He, WZ; Li, RH; Wang, H; Gan, Y; Ding, K; Zeng, LW; Lai, LX; Esteban, MA; Pei, DQ				Chen, Jiekai; Liu, Jing; Han, Qingkai; Qin, Dajiang; Xu, Jianyong; Chen, You; Yang, Jiaqi; Song, Hong; Yang, Dongshan; Peng, Meixiu; He, Wenzhi; Li, Ronghui; Wang, Hao; Gan, Yi; Ding, Ke; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing			Towards an Optimized Culture Medium for the Generation of Mouse Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC FIBROBLASTS; INDUCTION; PROMOTE	Generation of induced pluripotent stem cells from somatic cells using defined factors has potential relevant applications in regenerative medicine and biology. However, this promising technology remains inefficient and time consuming. We have devised a serum free culture medium termed iSF1 that facilitates the generation of mouse induced pluripotent stem cells. This optimization of the culture medium is sensitive to the presence of Myc in the reprogramming factors. Moreover, we could reprogram meningeal cells using only two factors Oct4/Klf4. Therefore, iSF1 represents a basal medium that may be used for mechanistic studies and testing new reprogramming approaches.	[Chen, Jiekai; Liu, Jing; Han, Qingkai; Qin, Dajiang; Xu, Jianyong; Chen, You; Yang, Jiaqi; Song, Hong; Yang, Dongshan; Peng, Meixiu; He, Wenzhi; Li, Ronghui; Wang, Hao; Gan, Yi; Ding, Ke; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Chinese Acad Sci Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences	Pei, DQ (corresponding author), Chinese Acad Sci, Stem Cell & Canc Biol Grp, Chinese Acad Sci Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Ding, Ke/B-3257-2010; Li, Ronghui/AAB-4545-2019; Yang, Dongshan/N-3333-2014; Lai, Liangxue/H-4545-2011	Li, Ronghui/0000-0001-6329-5895; Yang, Dongshan/0000-0003-2449-8651; Ding, Ke/0000-0001-9016-812X; Chen, Jiekai/0000-0001-5168-7074; ding, ke/0000-0001-8167-0476	National Natural Science Foundation of China [30630039, 30700410, 30871404, 90813033]; National Natural Science Fund for Distinguished Young Scholars [30725012]; Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX1-YW-02-1]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]; Ministry of Science and Technology 973 program of China [2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality; Ministry of Science and Technology 973 program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30630039, 30700410, 30871404, and 90813033; National Natural Science Fund for Distinguished Young Scholars Grant 30725012; Knowledge Innovation Project of the Chinese Academy of Sciences Grants KSCX2-YW-R-48 and KSCX1-YW-02-1; Bureau of Science and Technology of Guangzhou Municipality Grant 2008A1-E4011; and Ministry of Science and Technology 973 program of China Grants 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, and 2009CB940902.	Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva N, 2008, REVSTAT-STAT J, V6, P253; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	50	53	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31066	31072		10.1074/jbc.M110.139436	http://dx.doi.org/10.1074/jbc.M110.139436			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20595395	Green Published, hybrid			2022-12-27	WOS:000282135500071
J	Dodd, D; Moon, YH; Swaminathan, K; Mackie, RI; Cann, IKO				Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.			Transcriptomic Analyses of Xylan Degradation by Prevotella bryantii and Insights into Energy Acquisition by Xylanolytic Bacteroidetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GUT SYMBIONT; BETA-D-XYLOSIDASE; ALKALINE CELLULASE; GENE-CLUSTER; SP NOV.; BACTERIA; PROTEIN; FERMENTATION; SEQUENCE; CATABOLISM	Enzymatic depolymerization of lignocellulose by microbes in the bovine rumen and the human colon is critical to gut health and function within the host. Prevotella bryantii B(1)4 is a rumen bacterium that efficiently degrades soluble xylan. To identify the genes harnessed by this bacterium to degrade xylan, the transcriptomes of P. bryantii cultured on either wheat arabinoxylan or a mixture of its monosaccharide components were compared by DNA microarray and RNA sequencing approaches. The most highly induced genes formed a cluster that contained putative outer membrane proteins analogous to the starch utilization system identified in the prominent human gut symbiont Bacteroides thetaiotaomicron. The arrangement of genes in the cluster was highly conserved in other xylanolytic Bacteroidetes, suggesting that the mechanism employed by xylan utilizers in this phylum is conserved. A number of genes encoding proteins with unassigned function were also induced on wheat arabinoxylan. Among these proteins, a hypothetical protein with low similarity to glycoside hydrolases was shown to possess endoxylanase activity and subsequently assigned to glycoside hydrolase family 5. The enzyme was designated PbXyn5A. Two of the most similar proteins to PbXyn5A were hypothetical proteins from human colonic Bacteroides spp., and when expressed each protein exhibited endoxylanase activity. By using site-directed mutagenesis, we identified two amino acid residues that likely serve as the catalytic acid/base and nucleophile as in other GH5 proteins. This study therefore provides insights into capture of energy by xylanolytic Bacteroidetes and the application of their enzymes as a resource in the biofuel industry.	[Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Dodd, Dylan; Moon, Young-Hwan; Swaminathan, Kankshita; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Swaminathan, Kankshita] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, IKO (corresponding author), Univ Illinois, Inst Genom Biol 1105, 1206 W Gregory Dr, Urbana, IL 61801 USA.	icann@illinois.edu		Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NIDDK, National Institutes of Health [1F30DK084726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Energy Biosciences Institute. D.D. was partially supported by National Institutes of Health Fellowship 1F30DK084726 from NIDDK.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bakir MA, 2006, INT J SYST EVOL MICR, V56, P151, DOI 10.1099/ijs.0.63914-0; BRYANT MP, 1958, J BACTERIOL, V76, P15, DOI 10.1128/JB.76.1.15-23.1958; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chassard C, 2006, FEMS MICROBIOL LETT, V254, P116, DOI 10.1111/j.1574-6968.2005.00016.x; Chassard C, 2008, INT J SYST EVOL MICR, V58, P1008, DOI 10.1099/ijs.0.65504-0; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; DEHORITY BA, 1967, APPL MICROBIOL, V15, P987, DOI 10.1128/AEM.15.5.987-993.1967; DEHORITY BA, 1966, J BACTERIOL, V91, P1724, DOI 10.1128/JB.91.5.1724-1729.1966; Della JN, 1996, J BACTERIOL, V178, P7180; Dodd D, 2010, J BACTERIOL, V192, P2335, DOI 10.1128/JB.01654-09; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; GASPARIC A, 1995, FEMS MICROBIOL LETT, V125, P135; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HESPELL RB, 1987, APPL ENVIRON MICROB, V53, P2849, DOI 10.1128/AEM.53.12.2849-2853.1987; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mirande C, 2010, J APPL MICROBIOL, V109, P451, DOI 10.1111/j.1365-2672.2010.04671.x; Miyazaki K, 2005, MICROBIOL-SGM, V151, P4121, DOI 10.1099/mic.0.28270-0; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; OZAKI K, 1990, J GEN MICROBIOL, V136, P1327, DOI 10.1099/00221287-136-7-1327; SALYERS AA, 1982, J FOOD BIOCHEM, V6, P39, DOI 10.1111/j.1745-4514.1982.tb00295.x; SALYERS AA, 1981, APPL ENVIRON MICROB, V41, P1065, DOI 10.1128/AEM.41.4.1065-1068.1981; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEAVER J, 1992, APPL ENVIRON MICROB, V58, P2764, DOI 10.1128/AEM.58.9.2764-2770.1992	43	81	90	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30261	30273		10.1074/jbc.M110.141788	http://dx.doi.org/10.1074/jbc.M110.141788			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20622018	hybrid, Green Published			2022-12-27	WOS:000281984300062
J	Gingras, AR; Bate, N; Goult, BT; Patel, B; Kopp, PM; Emsley, J; Barsukov, IL; Roberts, GCK; Critchley, DR				Gingras, Alexandre R.; Bate, Neil; Goult, Benjamin T.; Patel, Bipin; Kopp, Petra M.; Emsley, Jonas; Barsukov, Igor L.; Roberts, Gordon C. K.; Critchley, David R.			Central Region of Talin Has a Unique Fold That Binds Vinculin and Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL PROTEIN TALIN; INTEGRIN ACTIVATION; STRUCTURAL BASIS; MOLECULAR-GRAPHICS; ALPHA-SYNEMIN; I/LWEQ MODULE; F-ACTIN; DOMAIN; ADHESION; ROD	Talin is an adaptor protein that couples integrins to F-actin. Structural studies show that the N-terminal talin head contains an atypical FERM domain, whereas the N- and C-terminal parts of the talin rod include a series of alpha-helical bundles. However, determining the structure of the central part of the rod has proved problematic. Residues 1359-1659 are homologous to the MESDc1 gene product, and we therefore expressed this region of talin in Escherichia coli. The crystal structure shows a unique fold comprised of a 5- and 4-helix bundle. The 5-helix bundle is composed of nonsequential helices due to insertion of the 4-helix bundle into the loop at the C terminus of helix alpha 3. The linker connecting the bundles forms a two-stranded anti-parallel beta-sheet likely limiting the relative movement of the two bundles. Because the 5-helix bundle contains the N and C termini of this module, we propose that it is linked by short loops to adjacent bundles, whereas the 4-helix bundle protrudes from the rod. This suggests the 4-helix bundle has a unique role, and its pI (7.8) is higher than other rod domains. Both helical bundles contain vinculin-binding sites but that in the isolated 5-helix bundle is cryptic, whereas that in the isolated 4-helix bundle is constitutively active. In contrast, both bundles are required for actin binding. Finally, we show that the MESDc1 protein, which is predicted to have a similar fold, is a novel actin-binding protein.	[Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Leicester; University of Nottingham; University of Liverpool	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Goult, Benjamin T/B-3127-2009; Gingras, Alexandre R/E-1867-2011; emsley, jonas/A-8509-2016	Goult, Benjamin T/0000-0002-3438-2807; Gingras, Alexandre R/0000-0002-5373-0176; emsley, jonas/0000-0002-8949-8030; Roberts, Gordon/0000-0001-6200-1373	National Institutes of Health, NIGMS Cell Migration Consortium [U54GM64346]; Wellcome Trust; Cancer Research United Kingdom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G003637/1] Funding Source: researchfish; BBSRC [BB/G003637/1] Funding Source: UKRI	National Institutes of Health, NIGMS Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant U54GM64346 from NIGMS Cell Migration Consortium. This work was also supported by the Wellcome Trust, Cancer Research United Kingdom.	ALBIGESRIZO C, 1995, J CELL SCI, V108, P3317; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; DEL RIO A, 2009, SCIENCE, V323, P638; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2006, CURRENT PROTOCOLS S, P561; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, FEBS LETT, V584, P2237, DOI 10.1016/j.febslet.2010.04.028; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; Hemmings L, 1996, J CELL SCI, V109, P2715; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schmidt JM, 1999, ARCH BIOCHEM BIOPHYS, V366, P139, DOI 10.1006/abbi.1999.1204; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Sun N, 2008, BIOCHEM J, V409, P657, DOI 10.1042/BJ20071188; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; VALE RD, 1985, J NEUROSCI, V5, P2762; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Winkler J, 1997, EUR J BIOCHEM, V243, P430, DOI 10.1111/j.1432-1033.1997.0430a.x; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	65	46	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29577	29587		10.1074/jbc.M109.095455	http://dx.doi.org/10.1074/jbc.M109.095455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610383	hybrid, Green Published			2022-12-27	WOS:000281740100059
J	Golczak, M; Palczewski, K				Golczak, Marcin; Palczewski, Krzysztof			An Acyl-covalent Enzyme Intermediate of Lecithin: Retinol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PURIFICATION; ACCUMULATION; MECHANISM; ESTERS; CELLS; LIVER; CYCLE	Synthesis of fatty acid retinyl esters determines systemic vitamin A levels and provides substrate for production of visual chromophore (11-cis-retinal) in vertebrates. Lecithin: retinol acyltransferase (LRAT), the main enzyme responsible for retinyl ester formation, catalyzes the transfer of an acyl group from the sn-1 position of phosphatidylcholine to retinol. To delineate the catalytic mechanism of this reaction, we expressed and purified a fully active, soluble form of this enzyme and used it to examine the possible formation of a transient acyl-enzyme intermediate. Detailed mass spectrometry analyses revealed that LRAT undergoes spontaneous, covalent modification upon incubation with a variety of phosphatidylcholine substrates. The addition of an acyl chain occurs at the Cys(161) residue, indicating formation of a thioester intermediate. This observation provides the first direct experimental evidence of thioester intermediate formation that constitutes the initial step in the proposed LRAT catalytic reaction. Additionally, we examined the effect of increasing fatty acyl side chain length in phosphatidylcholine on substrate accessibility in this reaction, which provided insights into the function of the single membrane-spanning domain of LRAT. These observations are critical to understanding the catalytic mechanism of LRAT protein family members as well as other lecithin: acyltransferases wherein Cys residues are required for catalysis.	[Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Case Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Golczak, M (corresponding author), Aldelbert Rd, Cleveland, OH 44106 USA.	mxg149@case.edu			National Institutes of Health [EY009339, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY009339 and Core Grant P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Hoffman MD, 2006, J MASS SPECTROM, V41, P229, DOI 10.1002/jms.981; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PEREZGIL J, 1990, BIOCHEM J, V270, P761, DOI 10.1042/bj2700761; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; VON LINTIG J, 2010, TRENDS BIOCHEM SCI, V35, P400	24	23	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29217	29222		10.1074/jbc.M110.152314	http://dx.doi.org/10.1074/jbc.M110.152314			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628054	Green Published, hybrid			2022-12-27	WOS:000281740100022
J	Ragan, EJ; An, CJ; Yang, CT; Kanost, MR				Ragan, Emily J.; An, Chunju; Yang, Celeste T.; Kanost, Michael R.			Analysis of Mutually Exclusive Alternatively Spliced Serpin-1 Isoforms and Identification of Serpin-1 Proteinase Complexes in Manduca sexta Hemolymph	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE-ACTIVATING PROTEINASE-3; COMPARATIVE GENOMIC ANALYSIS; INNATE IMMUNE-RESPONSE; REACTIVE CENTER LOOP; ALPHA(1)-PROTEINASE INHIBITOR; FUNCTIONAL DIVERSIFICATION; TOLL ACTIVATION; DROSOPHILA; EXPRESSION; EVOLUTION	Mutually exclusive alternative splicing produces transcripts for 12 serpin-1 isoforms in Manduca sexta that differ only in the region encoding the carboxyl-terminal 36-40-amino acid residues. This variable region includes the reactive center loop, which determines the inhibitory selectivity of the serpin. We investigated mRNA levels of individual serpin-1 isoforms by quantitative PCR. The 12 isoforms were expressed at similar levels in hemocytes, but in fat body isoform B mRNA was present at significantly higher levels than isoforms C, D, E, F, G, J, K, and Z. To investigate the presence of individual serpin-1 isoforms in plasma we used immunoaffinity purification of serpin-1 isoforms from M. sexta plasma, followed by two-dimensional PAGE and identification of protein spots by digestion with a series of proteinases and analysis of the resulting peptides by MALDI-TOF/TOF. We identified nine of the 12 serpin-1 isoforms and, through analysis of putative serpin-1-proteinase complexes, identified three endogenous M. sexta proteinase targets of serpin-1. Our results suggest that M. sexta serpin-1 isoforms A, E, and J can inhibit hemolymph proteinase 8, which activates the cytokine spatzle. At least one isoform of serpin-1 can inhibit hemocyte proteinase 1, another M. sexta blood proteinase. In addition, a complex of serpin-1K in a complex with M. sexta midgut chymotrypsin was identified, suggesting serpin-1 isoforms may also function to protect insect tissues from digestive proteinases that may leak into the hemocoel.	[Ragan, Emily J.; An, Chunju; Yang, Celeste T.; Kanost, Michael R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Kanost, MR (corresponding author), 141Chalmers Hall, Manhattan, KS 66506 USA.	kanost@ksu.edu		Kanost, Michael/0000-0002-6827-0061	National Institutes of Health [GM41247]; National Institutes of Health, National Center for Research Resources [P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041247, R29GM041247, R01GM041247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41247. This is contribution 10-259-J from the Kansas Agricultural Experiment Station.; We thank Rebekah Woolsey from the Nevada Proteomics Center for sample digestion and mass spectrometry. The Nevada Proteomics Center is supported by National Institutes of Health Grant P20 RR-016464 from the INBRE Program of the National Center for Research Resources. We also thank Dr. Maureen Gorman for providing serpin-1I used for antiserum production, Dr. Haobo Jiang for antiserum to HP6, HP8, and prophenoloxidase-activating proteinase-3, Yang Wang for help characterizing isoform-specific antisera, and Dr. Rollie Clem for the use of the BioRad IEF unit.	An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Barbour KW, 2002, MOL BIOL EVOL, V19, P718, DOI 10.1093/oxfordjournals.molbev.a004130; Borner S, 2008, GENE, V415, P23, DOI 10.1016/j.gene.2008.02.004; Brandt KS, 2004, ARCH INSECT BIOCHEM, V55, P200, DOI 10.1002/arch.10139; Danielli A, 2003, J BIOL CHEM, V278, P4184, DOI 10.1074/jbc.M208187200; DE GREGORIO E, 2002, DEV CELL, V3, P581; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Furusawa T, 2008, J PROTEOME RES, V7, P938, DOI 10.1021/pr070405j; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hegedus DD, 2008, GENE, V418, P15, DOI 10.1016/j.gene.2008.03.015; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Hodges D, 1999, GENETICS, V151, P263; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang H, 1995, INSECT BIOCHEM MOLEC, V25, P1093, DOI 10.1016/0965-1748(95)00042-9; Jiang HB, 2008, INSECT SCI, V15, P53, DOI 10.1111/j.1744-7917.2008.00187.x; JIANG HB, 1994, J BIOL CHEM, V269, P55; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; John JPP, 2007, J PROTEOME RES, V6, P2695, DOI 10.1021/pr070157r; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost M.R., 1990, P139; KANOST MR, 1995, INSECT BIOCHEM MOLEC, V25, P285, DOI 10.1016/0965-1748(94)00067-R; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kruger O, 2002, GENE, V293, P97, DOI 10.1016/S0378-1119(02)00697-2; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li JP, 1999, STRUCTURE, V7, P103, DOI 10.1016/S0969-2126(99)80013-6; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Myung JK, 2008, AMINO ACIDS, V35, P485, DOI 10.1007/s00726-007-0551-y; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Odronitz F, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-21; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; Ragan EJ, 2008, THESIS KANSAS STATE; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; SASAKI T, 1991, EUR J BIOCHEM, V202, P255, DOI 10.1111/j.1432-1033.1991.tb16370.x; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2006, GENOMICS, V87, P399, DOI 10.1016/j.ygeno.2005.10.003; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P387, DOI 10.1016/j.ibmb.2003.12.005; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	60	21	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29642	29650		10.1074/jbc.M110.125419	http://dx.doi.org/10.1074/jbc.M110.125419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20624920	Green Published, hybrid			2022-12-27	WOS:000281740100065
J	Bogani, F; Corredeira, I; Fernandez, V; Sattler, U; Rutvisuttinunt, W; Defais, M; Boehmer, PE				Bogani, Federica; Corredeira, Ilsa; Fernandez, Virneliz; Sattler, Ulrike; Rutvisuttinunt, Wiriya; Defais, Martine; Boehmer, Paul E.			Association between the Herpes Simplex Virus-1 DNA Polymerase and Uracil DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN-BINDING-PROTEIN; BASE EXCISION-REPAIR; TYPE-1 ORIGIN; PROCESSIVITY FACTOR; REPLICATION COMPARTMENTS; VIRAL REPLICATION; HELICASE-PRIMASE; STRAND EXCHANGE; NERVOUS-SYSTEM; CATALYTIC-SITE	Herpes simplex virus-1 (HSV-1) is a large dsDNA virus that encodes its own DNA replication machinery and other enzymes involved in DNA transactions. We recently reported that the HSV-1 DNA polymerase catalytic subunit (UL30) exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities. Moreover, UL30, in conjunction with the viral uracil DNA glycosylase (UL2), cellular apurinic/apyrimidinic endonuclease, and DNA ligase III alpha-XRCC1, performs uracil-initiated base excision repair. Base excision repair is required to maintain genome stability as a means to counter the accumulation of unusual bases and to protect from the loss of DNA bases. Here we show that the HSV-1 UL2 associates with the viral replisome. We identified UL2 as a protein that co-purifies with the DNA polymerase through numerous chromatographic steps, an interaction that was verified by co-immunoprecipitation and direct binding studies. The interaction between UL2 and the DNA polymerase is mediated through the UL30 subunit. Moreover, UL2 co-localizes with UL30 to nuclear viral prereplicative sites. The functional consequence of this interaction is that replication of uracil-containing templates stalls at positions -1 and -2 relative to the template uracil because of the fact that these are converted into non-instructional abasic sites. These findings support the existence of a viral repair complex that may be capable of replication-coupled base excision repair and further highlight the role of DNA repair in the maintenance of the HSV-1 genome.	[Boehmer, Paul E.] Univ Arizona, Dept Basic Med Sci, Coll Med, Phoenix, AZ 85004 USA; [Sattler, Ulrike; Defais, Martine] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse 4, France	University of Arizona; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Boehmer, PE (corresponding author), 425 N 5th St, Phoenix, AZ 85004 USA.	boehmer@email.arizona.edu		Boehmer, Paul/0000-0003-4479-0529	National Institutes of Health [GM62643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62643 (to P. E. B.)	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Boehmer PE, 2003, PROG NUCLEIC ACID RE, V75, P139, DOI 10.1016/S0079-6603(03)75005-3; Boehmer PE, 2003, IUBMB LIFE, V55, P13, DOI 10.1080/1521654031000070645; Boehmer PE, 1996, METHOD ENZYMOL, V275, P16; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Bogani F, 2008, P NATL ACAD SCI USA, V105, P11709, DOI 10.1073/pnas.0806375105; Bogani F, 2009, J BIOL CHEM, V284, P16784, DOI 10.1074/jbc.M109.010413; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; De Silva FS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-145; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; FIERER DS, 1992, J VIROL, V66, P3986, DOI 10.1128/JVI.66.7.3986-3995.1992; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODRICH LD, 1990, J VIROL, V64, P5738, DOI 10.1128/JVI.64.12.5738-5749.1990; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; He XD, 2000, J VIROL, V74, P5726, DOI 10.1128/JVI.74.12.5726-5728.2000; HEILBRONN R, 1989, J VIROL, V63, P3683, DOI 10.1128/JVI.63.9.3683-3692.1989; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Liptak LM, 1996, J VIROL, V70, P1759, DOI 10.1128/JVI.70.3.1759-1767.1996; Lukonis CJ, 1996, J VIROL, V70, P1751, DOI 10.1128/JVI.70.3.1751-1758.1996; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Muylaert I, 2010, J BIOL CHEM, V285, P13761, DOI 10.1074/jbc.M110.107920; Nimonkar AV, 2003, NUCLEIC ACIDS RES, V31, P5275, DOI 10.1093/nar/gkg740; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Nimonkar AV, 2003, J BIOL CHEM, V278, P9678, DOI 10.1074/jbc.M212555200; Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Prichard MN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-55; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PURIFOY DJM, 1977, NATURE, V269, P621, DOI 10.1038/269621a0; PYLES RB, 1994, J VIROL, V68, P4963, DOI 10.1128/JVI.68.8.4963-4972.1994; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; QUINN JP, 1985, NUCLEIC ACIDS RES, V13, P8143, DOI 10.1093/nar/13.22.8143; Ranneberg-Nilsen T, 2008, J MOL BIOL, V381, P276, DOI 10.1016/j.jmb.2008.05.028; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Sampson DA, 2000, J BIOL CHEM, V275, P2931, DOI 10.1074/jbc.275.4.2931; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; STRANG BL, 2010, J GEN VIROL IN PRESS; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; VAUGHAN PJ, 1985, J VIROL, V53, P501, DOI 10.1128/JVI.53.2.501-508.1985; Villani G, 2002, NUCLEIC ACIDS RES, V30, P3323, DOI 10.1093/nar/gkf463; WILLIAMS MV, 1984, J BIOL CHEM, V259, P80; Wilson DM, 2007, NEUROSCIENCE, V145, P1187, DOI 10.1016/j.neuroscience.2006.07.011; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; Zhu Y, 2008, DNA REPAIR, V7, P95, DOI 10.1016/j.dnarep.2007.08.001	65	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27664	27672		10.1074/jbc.M110.131235	http://dx.doi.org/10.1074/jbc.M110.131235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601642	Green Published, hybrid			2022-12-27	WOS:000281404100022
J	Lobo, GP; Amengual, J; Li, HNM; Golczak, M; Bonet, ML; Palczewski, K; von Lintig, J				Lobo, Glenn P.; Amengual, Jaume; Li, Hua Nan M.; Golczak, Marcin; Luisa Bonet, M.; Palczewski, Krzysztof; von Lintig, Johannes			beta,beta-Carotene Decreases Peroxisome Proliferator Receptor gamma Activity and Reduces Lipid Storage Capacity of Adipocytes in a beta,beta-Carotene Oxygenase 1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-RETINOIC ACID; VITAMIN-A SUPPLEMENTATION; BETA-CAROTENE; DIABETES-MELLITUS; ADIPOSE-TISSUE; PPAR-GAMMA; METABOLIZING ENZYME; ACTIVATED RECEPTOR; LEPTIN EXPRESSION; SERUM CAROTENOIDS	Increasing evidence has been provided for a connection between retinoid metabolism and the activity of peroxisome proliferator receptors (Ppars) in the control of body fat reserves. Two different precursors for retinoids exist in the diet as preformed vitamin A (all-trans-retinol) and provitamin A (beta,beta-carotene). For retinoid production, beta,beta-carotene is converted to retinaldehyde by beta,beta-carotenemonooxygenase 1 (Bcmo1). Previous analysis showed that Bcmo1 knock-out mice develop dyslipidemia and are more susceptible to diet-induced obesity. However, the role of Bcmo1 for adipocyte retinoid metabolism has yet not been well defined. Here, we showed that Bcmo1 mRNA and protein expression are induced during adipogenesis in NIH 3T3-L1 cells. In mature adipocytes, beta,beta-carotene but not all-trans-retinol was metabolized to retinoic acid (RA). RA decreased the expression of Ppar gamma and CCAAT/enhancer-binding protein alpha, key lipogenic transcription factors, and reduced the lipid content of mature adipocytes. This process was inhibited by the retinoic acid receptor antagonist LE450, showing that it involves canonical retinoid signaling. Accordingly, gavage of beta,beta-carotenebut not all-trans-retinol induced retinoid signaling and decreased Ppar gamma expression in white adipose tissue of vitamin A-deficient mice. Our study identifies beta,beta-carotene as a critical physiological precursor for RA production in adipocytes and implicates provitamin A as a dietary regulator of body fat reserves.	[Lobo, Glenn P.; Amengual, Jaume; Li, Hua Nan M.; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca 07122, Spain; [Luisa Bonet, M.] CIBERobn, Palma de Mallorca 07122, Spain	Case Western Reserve University; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	von Lintig, J (corresponding author), Case Western Reserve Univ, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44160 USA.	Johannes.vonlintig@case.edu	Bonet, M.Luisa/H-6722-2015; Lobo, Glenn P./AAI-9736-2020	Bonet, M.Luisa/0000-0002-8698-0630; 	National Institutes of Health [EY019641, EY009339, T30-EY11373]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY019641, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641, EY009339, and T30-EY11373.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Gorocica-Buenfil MA, 2007, J ANIM SCI, V85, P3355, DOI 10.2527/jas.2007-0172; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hollung K, 2004, J CELL BIOCHEM, V92, P307, DOI 10.1002/jcb.20047; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Kagechika H, 1997, BIOCHEM BIOPH RES CO, V231, P243, DOI 10.1006/bbrc.1997.6087; Kawada T, 1996, INT J OBESITY, V20, pS52; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mercader J, 2008, CELL PHYSIOL BIOCHEM, V22, P363, DOI 10.1159/000149815; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; NOY N, 1992, BIOCHIM BIOPHYS ACTA, V1106, P151, DOI 10.1016/0005-2736(92)90233-C; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Sergeant MJ, 2009, J BIOL CHEM, V284, P5257, DOI 10.1074/jbc.M805453200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	50	104	107	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27891	27899		10.1074/jbc.M110.132571	http://dx.doi.org/10.1074/jbc.M110.132571			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573961	Green Published, hybrid			2022-12-27	WOS:000281404100044
J	Thielen, BK; McNevin, JP; McElrath, MJ; Hunt, BVS; Klein, KC; Lingappa, JR				Thielen, Beth K.; McNevin, John P.; McElrath, M. Juliana; Hunt, Brook Vander Stoep; Klein, Kevin C.; Lingappa, Jaisri R.			Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; VIF PROTEIN; ANTIVIRAL ACTIVITY; HIV-1 VIF; IN-VIVO; REVERSE TRANSCRIPTION; LINE-1 RETROTRANSPOSITION; INDEPENDENT INHIBITION; ANTIRETROVIRAL FACTOR	In HIV-1-infected individuals, G-to-A hypermutation is found in HIV-1 DNA isolated from peripheral blood mononuclear cells (PBMCs). These mutations are thought to result from editing by one or more host enzymes in the APOBEC3 (A3) family of cytidine deaminases, which act on CC (APOBEC3G) and TC (other A3 proteins) dinucleotide motifs in DNA (edited cytidine underlined). Although many A3 proteins display high levels of deaminase activity in model systems, only low levels of A3 deaminase activity have been found in primary cells examined to date. In contrast, here we report high levels of deaminase activity at TC motifs when whole PBMCs or isolated primary monocyte- derived cells were treated with interferon-alpha (IFN alpha) or IFN alpha-inducing toll-like receptor ligands. Induction of TC-specific deaminase activity required new transcription and translation and correlated with the appearance of two APOBEC3A (A3A) isoforms. Knockdown of A3A in monocytes with siRNA abolished TC-specific deaminase activity, confirming that A3A isoforms are responsible for all TC-specific deaminase activity observed. Both A3A isoforms appear to be enzymatically active; moreover, our mutational studies raise the possibility that the smaller isoform results from internal translational initiation. In contrast to the high levels of TC-specific activity observed in IFN alpha-treated monocytes, CC-specific activity remained low in PBMCs, suggesting that A3G deaminase activity is relatively inhibited, unlike that of A3A. Together, these findings suggest that deaminase activity of A3A isoforms in monocytes and macrophages may play an important role in host defense against viruses.	[Thielen, Beth K.; Hunt, Brook Vander Stoep; Klein, Kevin C.; Lingappa, Jaisri R.] Univ Washington, Dept Global Hlth, Seattle, WA 98102 USA; [McNevin, John P.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [McElrath, M. Juliana; Lingappa, Jaisri R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Box 358116,1616 Eastlake Ave E,Suite 305, Seattle, WA 98102 USA.	jais@u.washington.edu	Thielen, Beth Kristine/I-7811-2019	Thielen, Beth Kristine/0000-0001-5922-0241; mcnevin, john paul/0000-0002-9893-9256	National Institutes of Health [R01AI078781, T32 AI007140]; Poncin Scholarship Fund; University of Washington; NIGMS, National Institutes of Health [5 T32 GM07266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078781, T32AI007140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poncin Scholarship Fund; University of Washington(University of Washington); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI078781 (to J. R. L.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-3.; Supported by the University of Washington Medical Scientist Training Program (NIGMS, National Institutes of Health, Grant 5 T32 GM07266), an STD AIDS Research Training Fellowship (National Institutes of Health Grant T32 AI007140), the Poncin Scholarship Fund, and a University of Washington Achievement Rewards for College Scientists (ARCS) scholarship.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Anderson JL, 2008, VIROLOGY, V375, P1, DOI 10.1016/j.virol.2008.01.042; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kijak GH, 2008, VIROLOGY, V376, P101, DOI 10.1016/j.virol.2008.03.017; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Takahashi Y, 1998, Int Rev Immunol, V17, P309, DOI 10.3109/08830189809054408; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Turelli P, 2008, J VIROL, V82, P6585, DOI 10.1128/JVI.00216-08; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; VARTANIAN JP, 1994, P NATL ACAD SCI USA, V91, P3092, DOI 10.1073/pnas.91.8.3092; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	80	76	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27753	27766		10.1074/jbc.M110.102822	http://dx.doi.org/10.1074/jbc.M110.102822			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20615867	Green Published, hybrid			2022-12-27	WOS:000281404100031
J	Lamy, C; Goodchild, SJ; Weatherall, KL; Jane, DE; Liegeois, JF; Seutin, V; Marrion, NV				Lamy, Cedric; Goodchild, Samuel J.; Weatherall, Kate L.; Jane, David E.; Liegeois, Jean-Francois; Seutin, Vincent; Marrion, Neil V.			Allosteric Block of K(Ca)2 Channels by Apamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; METHYL-LAUDANOSINE; SKELETAL-MUSCLE; PORE REGION; BEE VENOM; TETRAETHYLAMMONIUM; BINDING; BRAIN	Activation of small conductance calcium-activated potassium (K(Ca)2) channels can regulate neuronal firing and synaptic plasticity. They are characterized by their high sensitivity to the bee venom toxin apamin, but the mechanism of block is not understood. For example, apamin binds to both K(Ca)2.2 and K(Ca)2.3 with the same high affinity (K-D similar to 5 pM for both subtypes) but requires significantly higher concentrations to block functional current (IC50 values of similar to 100 pM and similar to 5 nM, respectively). This suggests that steps beyond binding are needed for channel block to occur. We have combined patch clamp and binding experiments on cell lines with molecular modeling and mutagenesis to gain more insight into the mechanism of action of the toxin. An outer pore histidine residue common to both subtypes was found to be critical for both binding and block by the toxin but not for block by tetraethylammonium (TEA) ions. These data indicated that apamin blocks K(Ca)2 channels by binding to a site distinct from that used by TEA, supported by a finding that the onset of block by apamin was not affected by the presence of TEA. Structural modeling of ligand-channel interaction indicated that TEA binds deep within the channel pore, which contrasted with apamin being modeled to interact with the channel outer pore by utilizing the outer pore histidine residue. This multidisciplinary approach suggested that apamin does not behave as a classical pore blocker but blocks using an allosteric mechanism that is consistent with observed differences between binding affinity and potency of block.	[Goodchild, Samuel J.; Weatherall, Kate L.; Jane, David E.; Marrion, Neil V.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Lamy, Cedric; Seutin, Vincent] Univ Liege, Pharmacol Lab, B-4000 Liege, Belgium; [Lamy, Cedric; Seutin, Vincent] Univ Liege, Grp Interdisciplinaire Genoprote Appl Neurosci, B-4000 Liege, Belgium; [Liegeois, Jean-Francois] Univ Liege, Med Chem Lab, B-4000 Liege, Belgium; [Liegeois, Jean-Francois] Univ Liege, Ctr Interfac Rech Medicament, B-4000 Liege, Belgium	University of Bristol; University of Liege; University of Liege; University of Liege; University of Liege	Marrion, NV (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	N.V.Marrion@bris.ac.uk	Seutin, Vincent/A-7219-2011		Belgian Science Policy Interuniversity Attraction Poles program; Walloon region of Belgium [516131]; MRC [G0601812] Funding Source: UKRI; Medical Research Council [G0601841B, G0601812] Funding Source: researchfish	Belgian Science Policy Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Walloon region of Belgium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Belgian Science Policy Interuniversity Attraction Poles program and by a "FIRST-Doctorant Entreprise International" grant (Grant 516131) from the Walloon region of Belgium (to C. L.).	Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; Bretschneider F, 1999, BIOPHYS J, V76, P2351, DOI 10.1016/S0006-3495(99)77392-3; CASTLE NA, 1993, EUR J PHARMACOL, V236, P201, DOI 10.1016/0014-2999(93)90590-E; COOK NS, 1985, J PHYSIOL-LONDON, V358, P373, DOI 10.1113/jphysiol.1985.sp015556; Dale TJ, 2002, N-S ARCH PHARMACOL, V366, P470, DOI 10.1007/s00210-002-0622-2; Dilly S, 2005, J ENZYM INHIB MED CH, V20, P517, DOI 10.1080/14756360500210989; Finlayson K, 2001, NEUROPHARMACOLOGY, V41, P341, DOI 10.1016/S0028-3908(01)00067-3; Goodchild SJ, 2009, J GEN PHYSIOL, V134, P295, DOI 10.1085/jgp.200910252; Graulich A, 2005, BIOORGAN MED CHEM, V13, P1201, DOI 10.1016/j.bmc.2004.11.025; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 2001, IONIC CHANNELS EXCIT, P539; HUGUES M, 1982, J BIOL CHEM, V257, P2762; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jager H, 2004, TOXICON, V43, P951, DOI 10.1016/j.toxicon.2004.03.025; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; LABBEJULLIE C, 1991, EUR J BIOCHEM, V196, P639, DOI 10.1111/j.1432-1033.1991.tb15860.x; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106; Liegeois JF, 2003, CURR MED CHEM, V10, P625, DOI 10.2174/0929867033457908; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Nolting A, 2007, J BIOL CHEM, V282, P3478, DOI 10.1074/jbc.M607213200; PEASE JHB, 1988, BIOCHEMISTRY-US, V27, P8491, DOI 10.1021/bi00422a029; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Scuvee-Moreau J, 2002, J PHARMACOL EXP THER, V302, P1176, DOI 10.1124/jpet.302.3.1176; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Soh H, 2001, BIOPHYS J, V80, P2207, DOI 10.1016/S0006-3495(01)76193-0; Sorensen US, 2008, J MED CHEM, V51, P7625, DOI 10.1021/jm800809f; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; VINCENT JP, 1975, BIOCHEMISTRY-US, V14, P2521, DOI 10.1021/bi00682a035	35	61	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27067	27077		10.1074/jbc.M110.110072	http://dx.doi.org/10.1074/jbc.M110.110072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562108	Green Published, hybrid			2022-12-27	WOS:000281172700038
J	Bhat, KP; Truax, AD; Greer, SF				Bhat, Kavita Purnanda; Truax, Agnieszka Dorota; Greer, Susanna Fletcher			Phosphorylation and Ubiquitination of Degron Proximal Residues Are Essential for Class II Transactivator (CIITA) Transactivation and Major Histocompatibility Class II Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; GENE; PROTEIN; TRANSCRIPTION; ACTIVATION; PROMOTERS; BINDING; ACCUMULATION; ACETYLATION; COACTIVATOR	Major histocompatibility (MHC) class II molecules are cell surface glycoproteins that present extracellular antigens to CD4(+) T cells and are essential for initiation of the adaptive immune response. MHC class II expression requires recruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II promoter. Post-translational modifications to CIITA play important roles in modulating CIITA mediated transcription of various genes in different cell types. We have previously linked regulation of CIITA to the Ubiquitin Proteasome System (UPS), and we and others have demonstrated that mono-ubiquitination of CIITA dramatically increases its transactivity whereas poly-ubiquitination leads to CIITA degradation. Here we identify three degron proximal lysine residues, Lys-315, Lys-330, and Lys-333, and a phosphorylation site, Ser-280, located within the CIITA degron, that regulate CIITA ubiquitination, stability, and MHC class II expression. Together, these findings contribute to the developing post-translational modification code for CIITA.	[Greer, Susanna Fletcher] Georgia State Univ, Dept Biol, Coll Arts & Sci, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, Div Cellular & Mol Biol & Physiol, POB 4010, Atlanta, GA 30302 USA.	sgreer@gsu.edu			American Cancer Society; Georgia Cancer Coalition; Georgia Research Alliance; Georgia State University Molecular Basis of Disease Area of Focus	American Cancer Society(American Cancer Society); Georgia Cancer Coalition; Georgia Research Alliance; Georgia State University Molecular Basis of Disease Area of Focus	This work was supported by grants from the American Cancer Society, the Georgia Cancer Coalition, the Georgia Research Alliance (to S. F. G.) and by a Ph.D. fellowship from the Georgia State University Molecular Basis of Disease Area of Focus (to K. P. B. and A. D. T.).	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Barbash O, 2009, ONCOGENE, V28, P4317, DOI 10.1038/onc.2009.287; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Berghuis D, 2009, J PATHOL, V218, P222, DOI 10.1002/path.2537; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; BHAT KP, 2010, IMMUNOL CEL IN PRESS; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; Drozina G, 2006, J BIOL CHEM, V281, P39963, DOI 10.1074/jbc.M608538200; Friese MA, 2005, TRENDS IMMUNOL, V26, P559, DOI 10.1016/j.it.2005.08.011; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Gourley TS, 2001, J IMMUNOL, V166, P2917, DOI 10.4049/jimmunol.166.5.2917; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Greer SF, 2004, J IMMUNOL, V173, P376, DOI 10.4049/jimmunol.173.1.376; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Masternak K, 2000, GENE DEV, V14, P1156; Matheux F, 2004, NEWS PHYSIOL SCI, V19, P154, DOI 10.1152/nips.01462.2003; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Ramesh S, 2009, CELL CYCLE, V8, P11, DOI 10.4161/cc.8.1.7291; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Schnappauf F, 2003, EUR J IMMUNOL, V33, P2337, DOI 10.1002/eji.200323490; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Sisk TJ, 2003, INT IMMUNOL, V15, P1195, DOI 10.1093/intimm/dxg116; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; Voong LN, 2008, J BIOL CHEM, V283, P9031, DOI 10.1074/jbc.M706487200; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XY, 2009, MOL CELL BIOL, V29, P5639, DOI 10.1128/MCB.00661-09; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Yee CSK, 2005, J IMMUNOL, V174, P1222, DOI 10.4049/jimmunol.174.3.1222; Yee CSK, 2004, J IMMUNOL, V172, P5528, DOI 10.4049/jimmunol.172.9.5528; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25893	25903		10.1074/jbc.M110.127746	http://dx.doi.org/10.1074/jbc.M110.127746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538595	Green Published, hybrid			2022-12-27	WOS:000280921000004
J	Broser, M; Gabdulkhakov, A; Kern, J; Guskov, A; Muh, F; Saenger, W; Zouni, A				Broser, Matthias; Gabdulkhakov, Azat; Kern, Jan; Guskov, Albert; Mueh, Frank; Saenger, Wolfram; Zouni, Athina			Crystal Structure of Monomeric Photosystem II from Thermosynechococcus elongatus at 3.6-angstrom Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; OXYGEN-EVOLVING CENTER; ABSORPTION SPECTROSCOPY; ANGSTROM RESOLUTION; SINGLE-CRYSTALS; MN4CA CLUSTER; CYANOBACTERIAL; PROTEIN; CRYSTALLOGRAPHY; EVOLUTION	The membrane-embedded photosystem II core complex (PSIIcc) uses light energy to oxidize water in photosynthesis. Information about the spatial structure of PSIIcc obtained from x-ray crystallography was so far derived from homodimeric PSIIcc of thermophilic cyanobacteria. Here, we report the first crystallization and structural analysis of the monomeric form of PSIIcc with high oxygen evolution capacity, isolated from Thermosynechococcus elongatus. The crystals belong to the space group C222(1), contain one monomer per asymmetric unit, and diffract to a resolution of 3.6 angstrom. The x-ray diffraction pattern of the PSIIcc-monomer crystals exhibit less anisotropy (dependence of resolution on crystal orientation) compared with crystals of dimeric PSIIcc, and the packing of the molecules within the unit cell is different. In the monomer, 19 protein subunits, 35 chlorophylls, two pheophytins, the non-heme iron, the primary plastoquinone Q(A), two heme groups, 11 beta-carotenes, 22 lipids, seven detergent molecules, and the Mn4Ca cluster of the water oxidizing complex could be assigned analogous to the dimer. Based on the new structural information, the roles of lipids and protein subunits in dimer formation of PSIIcc are discussed. Due to the lack of non-crystallographic symmetry and the orientation of the membrane normal of PSIIcc perpendicular (similar to 87 degrees) to the crystallographic b-axis, further information about the structure of the Mn4Ca cluster is expected to become available from orientation-dependent spectroscopy on this new crystal form.	[Gabdulkhakov, Azat; Guskov, Albert; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Crystallog, D-14195 Berlin, Germany; [Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Crystallog, Takustr 6, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; athina.zouni@tu-berlin.de	Gabdulkhakov, Azat/H-4343-2013; Guskov, Albert/G-1286-2016; Kern, Jan/G-2586-2013	Gabdulkhakov, Azat/0000-0003-1016-5936; Guskov, Albert/0000-0003-2340-2216; Kern, Jan/0000-0002-7272-1603	Deutsche Forschungsgemeinschaft [Sfb 498, A4, C7]; Deutsche Forschungsgemeinschaft, Technische Universitat Berlin [B1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Technische Universitat Berlin(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of Sfb 498 (projects A4 and C7) and the Deutsche Forschungsgemeinschaft-Cluster of Excellence "UniCat" (project B1) coordinated by the Technische Universitat Berlin.	Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kern J, 2005, PHOTOSYNTH RES, V84, P153, DOI 10.1007/s11120-004-7077-x; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kruse O, 2000, J BIOL CHEM, V275, P6509, DOI 10.1074/jbc.275.9.6509; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B., 2005, THESIS FREIE U BERLI; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Matsuoka H, 2006, J PHYS CHEM B, V110, P13242, DOI 10.1021/jp055008f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muh F, 2008, BBA-BIOMEMBRANES, V1778, P2298, DOI 10.1016/j.bbamem.2008.05.016; Nakamura Y, 2002, DNA RES, V9, P135, DOI 10.1093/dnares/9.4.135; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2009, PHOTOSYNTH RES, V102, P487, DOI 10.1007/s11120-009-9434-2; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; ROTH M, 1991, BIOCHEMISTRY-US, V30, P9403, DOI 10.1021/bi00103a003; SCHLODDER E, 1987, BIOCHIM BIOPHYS ACTA, V890, P23, DOI 10.1016/0005-2728(87)90064-8; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sproviero EM, 2008, J AM CHEM SOC, V130, P6728, DOI 10.1021/ja801979n; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; Wydrzynski T. J., 2005, PHOTOSYSTEM; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2005, BIOCHEMISTRY-US, V44, P4572, DOI 10.1021/bi047685q; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	41	54	83	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26255	26262		10.1074/jbc.M110.127589	http://dx.doi.org/10.1074/jbc.M110.127589			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558739	hybrid, Green Published			2022-12-27	WOS:000280921000042
J	Fang, XH; Neyrinck, AP; Matthay, MA; Lee, JW				Fang, Xiaohui; Neyrinck, Arne P.; Matthay, Michael A.; Lee, Jae W.			Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; ENDOTHELIAL-CELLS; BARRIER FUNCTION; IN-VIVO; PROGENITOR CELLS; TIGHT JUNCTIONS; TIE2 RECEPTOR; STROMAL CELLS; GENE-THERAPY	Acute lung injury is characterized by injury to the lung epithelium that leads to impaired resolution of pulmonary edema and also facilitates accumulation of protein-rich edema fluid and inflammatory cells in the distal airspaces of the lung. Recent in vivo and in vitro studies suggest that mesenchymal stem cells (MSC) may have therapeutic value for the treatment of acute lung injury. Here we tested the ability of human allogeneic mesenchymal stem cells to restore epithelial permeability to protein across primary cultures of polarized human alveolar epithelial type II cells after an inflammatory insult. Alveolar epithelial type II cells were grown on a Transwell plate with an air-liquid interface and injured by cytomix, a combination of IL-1 beta, TNF alpha, and IFN gamma. Protein permeability measured by I-131-labeled albumin flux was increased by 5-fold over 24 h after cytokine-induced injury. Co-culture of human MSC restored type II cell epithelial permeability to protein to control levels. Using siRNA knockdown of potential paracrine soluble factors, we found that angiopoietin-1 secretion was responsible for this beneficial effect in part by preventing actin stress fiber formation and claudin 18 disorganization through suppression of NF kappa B activity. This study provides novel evidence for a beneficial effect of MSC on alveolar epithelial permeability to protein.	[Matthay, Michael A.; Lee, Jae W.] Univ Calif San Francisco, Dept Anesthesiol, San Francisco, CA 94143 USA; [Fang, Xiaohui; Neyrinck, Arne P.; Matthay, Michael A.; Lee, Jae W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, JW (corresponding author), Univ Calif San Francisco, Dept Anesthesiol, 505 Parnassus Ave,Box 0648, San Francisco, CA 94143 USA.	leejw@anesthesia.ucsf.edu		Lee, Jae/0000-0002-6521-8647	National Institutes of Health [HL-51856, HL-51854, HL-093026]; Foundation of Anesthesia Education and Research; National Institutes of Health, National Center for Research Resources [P40RR017447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, R01HL051854, R01HL051856, K08HL093026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Anesthesia Education and Research; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-51856 and HL-51854 (NHLBI; to M. A. M.) and HL-093026 (NHLBI, to J.W.L.). This work was also supported by the Foundation of Anesthesia Education and Research ( to J.W.L.).; We thank Dr. Naveen Gupta, University of Pittsburgh, for help with the permeability experiments. We thank the Northern California Transplant Donor Network as well as all the transplant coordinators involved for assistance in obtaining human research lungs for the isolation of human alveolar epithelial type II cells. Some of the materials (human allogeneic mesenchymal stem cells) employed in this work were provided by the Tulane Center for Gene Therapy through a National Institutes of Health Grant P40RR017447 (National Center for Research Resources).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kotton DN, 2004, EXP HEMATOL, V32, P340, DOI 10.1016/j.exphem.2004.01.009; Koval M, 2010, AM J RESP CELL MOL, V42, P172, DOI 10.1165/rcmb.2008-0270OC; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Liebler JM, 2008, AM J PHYSIOL-LUNG C, V295, pL285, DOI 10.1152/ajplung.00222.2007; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Spees JL, 2007, AM J RESP CRIT CARE, V176, P385, DOI 10.1164/rccm.200607-1004OC; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Zhen GH, 2008, FRONT BIOSCI, V13, P3415	54	196	210	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26211	26222		10.1074/jbc.M110.119917	http://dx.doi.org/10.1074/jbc.M110.119917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554518	Green Published, hybrid			2022-12-27	WOS:000280921000038
J	Liu, JY; Zhang, DY; Mi, XY; Xia, Q; Yu, YH; Zuo, ZH; Guo, W; Zhao, XW; Cao, J; Yang, Q; Zhu, A; Yang, WC; Shi, XL; Li, JX; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Mi, Xiaoyi; Xia, Qing; Yu, Yonghui; Zuo, Zhenghong; Guo, Wei; Zhao, Xuewei; Cao, Jia; Yang, Qing; Zhu, Angela; Yang, Wancai; Shi, Xianglin; Li, Jingxia; Huang, Chuanshu			p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 EXPRESSION; CELL-DEATH; P27(KIP1); CANCER; TRANSFORMATION; INDUCTION; APOPTOSIS; PROTEIN; GROWTH; HSP70	p27 is an atypical tumor suppressor that can regulate the activity of cyclin-dependent kinases and G(0)-to-S phase transitions. More recent studies reveal that p27 may also exhibit its tumor-suppressive function through regulating many other essential cellular events. However, the molecular mechanisms underlying these anticancer effects of p27 are largely unknown. In this study, we found that depletion of p27 expression by either gene knock-out or knockdown approaches resulted in up-regulation of both Hsp27 and Hsp70 expression at mRNA- and promoter-derived transcription as well as protein levels upon arsenite exposure, indicating that p27 provides a negative signal for regulating the expression of Hsp27 and Hsp70. Consistently, arsenite-induced activation of JNK2/c-Jun and HSF-1 pathways was also markedly elevated in p27 knock-out (p27(-/-)) and knockdown (p27 shRNA) cells. Moreover, interference with the expression or function of JNK2, c-Jun, and HSF-1, but not JNK1, led to dramatic inhibition of arsenite-induced Hsp27 and Hsp70 expression. Collectively, our results demonstrate that p27 suppresses Hsp27 and Hsp70 expression at the transcriptional level specifically through JNK2/c-Jun- and HSF-1-dependent pathways upon arsenite exposure, which provides additional important molecular mechanisms for the tumor-suppressive function of p27.	[Zhang, Dongyun; Mi, Xiaoyi; Xia, Qing; Yu, Yonghui; Zuo, Zhenghong; Guo, Wei; Zhao, Xuewei; Yang, Qing; Zhu, Angela; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Liu, Jinyi; Cao, Jia] Third Mil Med Univ, Prevent Med Coll, Dept Hyg Toxicol, Chongqing 400038, Peoples R China; [Liu, Jinyi; Cao, Jia] Third Mil Med Univ, Prevent Med Coll, Toxicogen Lab, Chongqing 400038, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	New York University; Army Medical University; Army Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kentucky	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Zuo, Zhenghong/G-4615-2010; Yu, Yonghui/AAZ-4093-2021; Yang, Wancai/G-3750-2010; Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197; Huang, Chuanshu/0000-0003-4133-5096	NCI [CA112557, CA119028-05S110]; NIEHS [ES012451, ES010344]; NATIONAL CANCER INSTITUTE [R01CA119028, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451, P42ES010344] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants CA112557 and CA119028-05S110 from NCI and Grants ES012451 and ES010344 from NIEHS.	Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Csermely P., 2007, MOL ASPECTS STRESS R; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Ding J, 2009, CURR CANCER DRUG TAR, V9, P81, DOI 10.2174/156800909787313995; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2007, CELL RES, V17, P832, DOI 10.1038/cr.2007.86; Leaner VD, 2005, MOL CELL BIOL, V25, P3324, DOI 10.1128/MCB.25.8.3324-3337.2005; Lee HY, 2005, CLIN CANCER RES, V11, P6065, DOI 10.1158/1078-0432.CCR-05-0009; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Oesterreich S, 1996, BIOCHEM BIOPH RES CO, V222, P155, DOI 10.1006/bbrc.1996.0714; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Prasad KV, 2007, J BIOSCIENCES, V32, P585, DOI 10.1007/s12038-007-0058-4; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; TSENG WP, 1968, J NATL CANCER I, V40, P453; Wang JP, 2002, TOXICOL LETT, V133, P17, DOI 10.1016/S0378-4274(02)00086-3; Wong HR, 2005, AM J PHYSIOL-CELL PH, V289, pC1152, DOI 10.1152/ajpcell.00138.2005; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002	28	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26058	26065		10.1074/jbc.M110.100271	http://dx.doi.org/10.1074/jbc.M110.100271			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566634	Green Published, hybrid			2022-12-27	WOS:000280921000021
J	Saxena, K; Schieborr, U; Anderka, O; Duchardt-Ferner, E; Elshorst, B; Gande, SL; Janzon, J; Kudlinzki, D; Sreeramulu, S; Dreyer, MK; Wendt, KU; Herbert, C; Duchaussoy, P; Bianciotto, M; Driguez, PA; Lassalle, G; Savi, P; Mohammadi, M; Bono, F; Schwalbe, H				Saxena, Krishna; Schieborr, Ulrich; Anderka, Oliver; Duchardt-Ferner, Elke; Elshorst, Bettina; Gande, Santosh Lakshmi; Janzon, Julia; Kudlinzki, Denis; Sreeramulu, Sridhar; Dreyer, Matthias K.; Wendt, K. Ulrich; Herbert, Corentin; Duchaussoy, Philippe; Bianciotto, Marc; Driguez, Pierre-Alexandre; Lassalle, Gilbert; Savi, Pierre; Mohammadi, Moosa; Bono, Francoise; Schwalbe, Harald			Influence of Heparin Mimetics on Assembly of the FGF center dot FGFR4 Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR; CRYSTAL-STRUCTURE; FACTOR FGF; STRUCTURAL BASIS; HOMOLOGOUS FACTORS; BINDING DOMAIN; SULFATE; PROTEIN; LIGAND	Fibroblast growth factor (FGF) signaling regulates mammalian development and metabolism, and its dysregulation is implicated in many inherited and acquired diseases, including cancer. Heparan sulfate glycosaminoglycans (HSGAGs) are essential for FGF signaling as they promote FGF center dot FGF receptor (FGFR) binding and dimerization. Using novel organic synthesis protocols to prepare homogeneously sulfated heparin mimetics (HM), including hexasaccharide (HM6), octasaccharide (HM8), and decasaccharide (HM10), we tested the ability of these HM to support FGF1 and FGF2 signaling through FGFR4. Biological assays show that both HM8 and HM10 are significantly more potent than HM6 in promoting FGF2-mediated FGFR4 signaling. In contrast, all three HM have comparable activity in promoting FGF1 center dot FGFR4 signaling. To understand the molecular basis for these differential activities in FGF1/2 center dot FGFR4 signaling, we used NMR spectroscopy, isothermal titration calorimetry, and size-exclusion chromatography to characterize binding interactions of FGF1/2 with the isolated Ig-domain 2 (D2) of FGFR4 in the presence of HM, and binary interactions of FGFs and D2 with HM. Our data confirm the existence of both a secondary FGF1 center dot FGFR4 interaction site and a direct FGFR4 center dot FGFR4 interaction site thus supporting the formation of the symmetric mode of FGF center dot FGFR dimerization in solution. Moreover, our results show that the observed higher activity of HM8 relative to HM6 in stimulating FGF2 center dot FGFR4 signaling correlates with the higher affinity of HM8 to bind and dimerize FGF2. Notably FGF2 center dot HM8 exhibits pronounced positive binding cooperativity. Based on our findings we propose a refined symmetric FGF center dot FGFR dimerization model, which incorporates the differential ability of HM to dimerize FGFs.	[Gande, Santosh Lakshmi; Janzon, Julia; Kudlinzki, Denis; Sreeramulu, Sridhar; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, D-60439 Frankfurt, Germany; [Dreyer, Matthias K.; Wendt, K. Ulrich] Sanofi Aventis Res & Dev, CAS Struct Biol, D-65926 Frankfurt, Germany; [Herbert, Corentin; Duchaussoy, Philippe; Driguez, Pierre-Alexandre; Lassalle, Gilbert; Savi, Pierre; Bono, Francoise] Sanofi Aventis Res & Dev, Thrombosis & Angiogenesis, F-31036 Toulouse, France; [Bianciotto, Marc] Sanofi Aventis Res & Dev, CAS Drug Design, F-31036 Toulouse, France; [Mohammadi, Moosa] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Goethe University Frankfurt; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; New York University	Schwalbe, H (corresponding author), Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020; Schwalbe, Harald J/F-9023-2010; Schwalbe, Harald/AAB-3143-2020	Mohammadi, Moosa/0000-0003-2434-9437; Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; Dreyer, Matthias K./0000-0001-6011-9124	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE013686] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Beer HD, 2000, J BIOL CHEM, V275, P16091, DOI 10.1074/jbc.275.21.16091; Bellosta P, 2001, MOL CELL BIOL, V21, P5946, DOI 10.1128/MCB.21.17.5946-5957.2001; Canales A, 2005, J AM CHEM SOC, V127, P5778, DOI 10.1021/ja043363y; de Paz JL, 2007, CHEM BIOL, V14, P879, DOI 10.1016/j.chembiol.2007.07.007; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Griffith BR, 2004, J AM CHEM SOC, V126, P1608, DOI 10.1021/ja037646m; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Hung KW, 2005, BIOCHEMISTRY-US, V44, P15787, DOI 10.1021/bi051030n; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kiselyov VV, 2006, PROTEIN SCI, V15, P2318, DOI 10.1110/ps.062206106; Kiselyov VV, 2006, PROTEIN SCI, V15, P1512, DOI 10.1110/ps.062207906; Kochoyan A, 2008, FEBS LETT, V582, P3374, DOI 10.1016/j.febslet.2008.08.033; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kwan CP, 2001, J BIOL CHEM, V276, P23421, DOI 10.1074/jbc.M010786200; Lin XH, 1999, DEVELOPMENT, V126, P3715; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; MOY FJ, 1995, J BIOMOL NMR, V6, P245; Ogura K, 1999, J BIOMOL NMR, V13, P11, DOI 10.1023/A:1008330622467; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Osslund TD, 1998, PROTEIN SCI, V7, P1681, DOI 10.1002/pro.5560070803; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Popovici C, 2005, BIOESSAYS, V27, P849, DOI 10.1002/bies.20261; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Ryu EK, 2006, PROTEIN EXPRES PURIF, V49, P15, DOI 10.1016/j.pep.2006.04.008; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shimizu A, 2001, J BIOL CHEM, V276, P11031, DOI 10.1074/jbc.M003535200; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Tabeur C, 1999, BIOORGAN MED CHEM, V7, P2003, DOI 10.1016/S0968-0896(99)00113-3; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2004, J BIOL CHEM, V279, P1861, DOI 10.1074/jbc.M311398200; Wuechner C, 1996, INT J DEV BIOL, V40, P1185; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	78	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26628	26640		10.1074/jbc.M109.095109	http://dx.doi.org/10.1074/jbc.M109.095109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547770	Green Published, hybrid			2022-12-27	WOS:000280921000078
J	Darwech, I; Otero, JE; Alhawagri, MA; Abu-Amer, Y				Darwech, Isra; Otero, Jesse E.; Alhawagri, Muhammad A.; Abu-Amer, Yousef			Tyrosine Phosphorylation Is Required for I kappa B Kinase-beta (IKK beta) Activation and Function in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BINDING DOMAIN PEPTIDE; C-SRC; BLOCKS OSTEOCLASTOGENESIS; BONE LOSS; INFLAMMATION; COMPLEX; INHIBITION; EXPRESSION; MECHANISM	The transcription factor NF-kappa B is crucial for numerous cellular functions such as survival, differentiation, immunity, and inflammation. A key function of this family of transcription factors is regulation of osteoclast differentiation and function, which in turn controls skeletal homeostasis. The I kappa B kinase (IKK) complex, which contains IKK alpha, IKK beta, and IKK gamma, is required for activation of NF-kappa B, and deletion of either IKK alpha or IKK beta resulted with defective osteoclast differentiation and survival. We have recently investigated the details of the mechanisms governing the role of IKK beta in osteoclastogenesis and found that constitutively active IKK beta in which serine residues 177/181 were mutated into negatively charged glutamic acids instigates spontaneous bona fide receptor activator of NF-kappa B ligand (RANKL)-independent osteoclastogenesis. To better understand and define the functional role of IKK beta domains capable of regulating the osteoclastogenic activity of IKK, we investigated key motifs in the activation T loop of IKK beta, which are potentially capable of modulating its osteoclastogenic activity. We discovered that dual serine (traditional serine residues 177/181) and tyrosine (188/199) phosphorylation events are crucial for IKK beta activation. Mutation of the latter tyrosine residues blunted the NF-kappa B activity of wild type and constitutively active IKK beta, and tyrosine 188/199-deficient IKK beta inhibited osteoclastogenesis. Thus, tyrosines 188/199 are a novel target for regulating IKK beta activity, at least in osteoclasts.	[Darwech, Isra; Otero, Jesse E.; Alhawagri, Muhammad A.; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA; [Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63110 USA.	abuamery@wustl.edu		Darwech, Isra/0000-0002-5042-3568	National Institutes of Health [AR055392, AR049192, AR054326]; Shriners Hospital for Children [8570, 8510]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047443, F31AR055392, R01AR049192, R01AR054326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055392 (to J.E.O.), AR049192, and AR054326 (to Y.A.-A.). This work was also supported by Shriners Hospital for Children Grants 8570 and 8510.	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Abu-Amer Y, 2001, J BIOL CHEM, V276, P30499, DOI 10.1074/jbc.M104725200; Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; AbuAmer Y, 1997, NAT MED, V3, P1189, DOI 10.1038/nm1197-1189; ABUAMER Y, 2003, MOL BIOL ORTHOPEDICS, P229; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mukhopadhyay A, 2000, J BIOL CHEM, V275, P8549, DOI 10.1074/jbc.275.12.8549; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620	43	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25522	25530		10.1074/jbc.M110.121533	http://dx.doi.org/10.1074/jbc.M110.121533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534585	Green Published, hybrid			2022-12-27	WOS:000280682400046
J	Lyons, DM; O'Brien, PJ				Lyons, Derek M.; O'Brien, Patrick J.			Human Base Excision Repair Creates a Bias Toward-1 Frameshift Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYLADENINE DNA GLYCOSYLASE; HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; SINGLE-STRANDED-DNA; MISMATCH REPAIR; MICROSATELLITE INSTABILITY; MUTATOR PHENOTYPE; POLYMERASE-BETA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE SUBSTITUTION; INTERCALATING AGENTS	Frameshift mutations are particularly deleterious to protein function and play a prominent role in carcinogenesis. Most commonly these mutations involve the insertion or omission of a single nucleotide by a DNA polymerase that slips on a damaged or undamaged template. The mismatch DNA repair pathway can repair these nascent polymerase errors. However, overexpression of enzymes of the base excision repair (BER) pathway is known to increase the frequency of frameshift mutations suggesting competition between these pathways. We have examined the fate of DNA containing single nucleotide bulges in human cell extracts and discovered that several deaminated or alkylated nucleotides are efficiently removed by BER. Because single nucleotide bulges are more highly exposed we anticipate that they would be highly susceptible to spontaneous DNA damage. As a model for this, we have shown that chloroacetaldehyde reacts more than 18-fold faster with an A-bulge than with a stable A center dot T base pair to create alkylated DNA adducts that can be removed by alkyladenine DNA glycosylase. Reconstitution of the BER pathway using purified components establishes that bulged DNA is efficiently processed. Single nucleotide deletion is predicted to repair +1 frameshift events, but to make -1 frameshift events permanent. Therefore, these findings suggest an additional factor contributing to the bias toward deletion mutations.	[Lyons, Derek M.; O'Brien, Patrick J.] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Lyons, Derek M.; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu	zhang, huidong/B-5667-2011		United States Public Health Service [R01 CA122254]; NATIONAL CANCER INSTITUTE [R01CA122254] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA122254 from the United States Public Health Service.	Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Bolt HM, 2005, CRIT REV TOXICOL, V35, P307, DOI 10.1080/10408440490915975; Cerda SR, 1998, FEBS LETT, V431, P12, DOI 10.1016/S0014-5793(98)00697-8; Chan K, 2007, MUTAGENESIS, V22, P183, DOI 10.1093/mutage/gel070; Colgin LM, 2002, P NATL ACAD SCI USA, V99, P1437, DOI 10.1073/pnas.032655699; Connor EE, 2002, CHEM BIOL, V9, P1033, DOI 10.1016/S1074-5521(02)00215-6; COQUERELLE T, 1995, MUTAT RES-DNA REPAIR, V336, P9, DOI 10.1016/0921-8777(94)00035-5; David SS, 1998, CHEM REV, V98, P1221, DOI 10.1021/cr980321h; Efrati E, 1997, J BIOL CHEM, V272, P2559; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Frosina G, 2000, EUR J BIOCHEM, V267, P2135, DOI 10.1046/j.1432-1327.2000.01266.x; Glassner BJ, 1998, P NATL ACAD SCI USA, V95, P9997, DOI 10.1073/pnas.95.17.9997; Greene CN, 2001, GENETICS, V159, P65; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hang B, 1997, P NATL ACAD SCI USA, V94, P12869, DOI 10.1073/pnas.94.24.12869; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jackson AL, 1998, GENETICS, V148, P1483; JOSHUATOR L, 1988, NATURE, V334, P82, DOI 10.1038/334082a0; Karimi-Busheri F, 1998, NUCLEIC ACIDS RES, V26, P4395, DOI 10.1093/nar/26.19.4395; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; Levine RL, 2000, CANCER RES, V60, P4098; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Loeb LA, 2001, CANCER RES, V61, P3230; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Marenstein DR, 2004, DNA REPAIR, V3, P527, DOI 10.1016/j.dnarep.2004.01.010; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Okochi E, 2002, MUTAT RES-FUND MOL M, V506, P101, DOI 10.1016/S0027-5107(02)00156-2; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Posnick LM, 1999, J BACTERIOL, V181, P6763, DOI 10.1128/JB.181.21.6763-6771.1999; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; RYDBERG B, 1991, P NATL ACAD SCI USA, V88, P6839, DOI 10.1073/pnas.88.15.6839; SCHARER OD, 1995, J AM CHEM SOC, V117, P10781, DOI 10.1021/ja00148a036; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; SHEARMAN CW, 1983, J BIOL CHEM, V258, P4485; SHEARMAN CW, 1983, J BIOL CHEM, V258, P4477; SINGER B, 1992, P NATL ACAD SCI USA, V89, P9386, DOI 10.1073/pnas.89.20.9386; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J BIOL CHEM, V284, P35144, DOI 10.1074/jbc.M109.067397; Zhang QM, 2005, DNA REPAIR, V4, P263, DOI 10.1016/j.dnarep.2004.10.004; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q	71	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25203	25212		10.1074/jbc.M110.118596	http://dx.doi.org/10.1074/jbc.M110.118596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547483	Green Published, hybrid			2022-12-27	WOS:000280682400013
J	Matranga, C; Pyle, AM				Matranga, Christian; Pyle, Anna Marie			Double-stranded RNA-dependent ATPase DRH-3 INSIGHT INTO ITS ROLE IN RNA SILENCING IN CAENORHABDITIS ELEGANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; C-ELEGANS; BOX HELICASE; DROSOPHILA; BINDING; PATHWAYS; SENSOR; VIRUS; DNA; RESPONSES	RNA helicases are proteins essential to almost every facet of RNA metabolism, including the gene-silencing pathways that employ small RNAs. A phylogenetically related group of helicases is required for the RNA-silencing mechanism in Caenorhabditis elegans. Dicer-related helicase 3 (DRH-3) is a Dicer-RIG-I family protein that is essential for RNA silencing and germline development in nematodes. Here we performed a biochemical characterization of the ligand binding and catalytic activities of DRH-3 in vitro. We identify signature motifs specific to this family of RNA helicases. We find that DRH-3 binds both single-stranded and double-stranded RNAs with high affinity. However, the ATPase activity of DRH-3 is stimulated only by double-stranded RNA. DRH-3 is a robust RNA-stimulated ATPase with a k(cat) value of 500/min when stimulated with short RNA duplexes. The DRH-3 ATPase may have allosteric regulation in cis that is controlled by the stoichiometry of double-stranded RNA to enzyme. We observe that the DRH-3 ATPase is stimulated only by duplexes containing RNA, suggesting a role for DRH-3 during or after transcription. Our findings provide clues to the role of DRH-3 during the RNA interference response in vivo.	[Matranga, Christian; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Matranga, Christian/0000-0002-9037-5468	National Institutes of Health National Research Service [F32GM086949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086949] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health National Research Service Award fellowship (F32GM086949) (to C. M.).	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Bowie AG, 2007, TRENDS IMMUNOL, V28, P147, DOI 10.1016/j.it.2007.02.002; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Laggerbauer B, 1996, NUCLEIC ACIDS RES, V24, P868, DOI 10.1093/nar/24.5.868; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li DN, 1997, EMBO J, V16, P1103, DOI 10.1093/emboj/16.5.1103; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; SEGEL IH, 1993, ENZYME KINETICS, P242; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	39	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25363	25371		10.1074/jbc.M110.117010	http://dx.doi.org/10.1074/jbc.M110.117010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20529861	Green Published, hybrid			2022-12-27	WOS:000280682400029
J	Roger, JE; Nellissery, J; Kim, DS; Swaroop, A				Roger, Jerome E.; Nellissery, Jacob; Kim, Douglas S.; Swaroop, Anand			Sumoylation of bZIP Transcription Factor NRL Modulates Target Gene Expression during Photoreceptor Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; HOMEOBOX GENE; SUBUNIT GENE; MOUSE RETINA; CELL-FATE; IN-VIVO; ROD; CRX; PHOSPHORYLATION; SUMO	Development of rod photoreceptors in the mammalian retina is critically dependent on the basic motif-leucine zipper transcription factor NRL (neural retina leucine zipper). In the absence of NRL, photoreceptor precursors in mouse retina produce only cones that primarily express S-opsin. Conversely, ectopic expression of NRL in post-mitotic precursors leads to a rod-only retina. To explore the role of signaling molecules in modulating NRL function, we identified putative sites of post-translational modification in the NRL protein by in silico analysis. Here, we demonstrate the sumoylation of NRL in vivo and in vitro, with two small ubiquitin-like modifier (SUMO) molecules attached to the Lys-20 residue. NRL-K20R and NRL-K20R/K24R sumoylation mutants show reduced transcriptional activation of Nr2e3 and rhodopsin promoters (two direct targets of NRL) in reporter assays when compared with wild-type NRL. Consistent with this, in vivo electroporation of the NRL-K20R/K24R mutant into newborn Nrl(-/-) mouse retina leads to reduced Nr2e3 activation and only a partial rescue of the Nrl(-/-) phenotype in contrast to the wild-type NRL that is able to convert cones to rod photoreceptors. Although PIAS3 (protein inhibitor of activated STAT3), an E3-SUMO ligase implicated in photoreceptor differentiation, can be immunoprecipitated with NRL, there appears to be redundancy in E3 ligases, and PIAS3 does not seem to be essential for NRL sumoylation. Our studies suggest an important role of sumoylation in fine-tuning the activity of NRL and thereby incorporating yet another layer of control in gene regulatory networks involved in photoreceptor development and homeostasis.	[Roger, Jerome E.; Nellissery, Jacob; Kim, Douglas S.; Swaroop, Anand] NEI, N NRL, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Swaroop, A (corresponding author), NEI, N NRL, NIH, 6 Ctr Dr,MSC0610, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov	Roger, Jerome/F-6225-2019; roger, jerome/P-3670-2019	Roger, Jerome/0000-0002-5061-230X; roger, jerome/0000-0002-5061-230X; NELLISSERY, JACOB/0000-0002-1209-664X; Kim, Douglas/0000-0001-9029-314X; Swaroop, Anand/0000-0002-1975-1141	National Institutes of Health through NEI; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER	National Institutes of Health through NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by a National Institutes of Health Grant through the NEI.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Bradford RL, 2005, DEV BIOL, V286, P31, DOI 10.1016/j.ydbio.2005.07.002; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Friedman JS, 2004, J BIOL CHEM, V279, P47233, DOI 10.1074/jbc.M408298200; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Kanda A, 2007, HUM MUTAT, V28, P589, DOI 10.1002/humu.20488; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Leavenworth JW, 2009, J IMMUNOL, V183, P1110, DOI 10.4049/jimmunol.0803671; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Morrow EM, 1998, J NEUROSCI, V18, P3738; Nasonkin I., 2010, ENCY EYE, V3, P332; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	63	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25637	25644		10.1074/jbc.M110.142810	http://dx.doi.org/10.1074/jbc.M110.142810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551322	Green Published, hybrid			2022-12-27	WOS:000280682400057
J	Weinman, EJ; Steplock, D; Zhang, YH; Biswas, R; Bloch, RJ; Shenolikar, S				Weinman, Edward J.; Steplock, Deborah; Zhang, Yinghua; Biswas, Rajatsubhra; Bloch, Robert J.; Shenolikar, Shirish			Cooperativity between the Phosphorylation of Thr(95) and Ser(77) of NHERF-1 in the Hormonal Regulation of Renal Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; PARATHYROID-HORMONE; FACTOR-I; EXCHANGER; DOPAMINE; NPT2A; PTH	The phosphorylation of the sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) plays a key role in the regulation of renal phosphate transport by parathyroid hormone (PTH) and dopamine. Ser(77) in the first PDZ domain of NHERF-1 is a downstream target of both hormones. The current experiments explore the role of Thr(95), another phosphate acceptor site in the PDZ I domain, on hormone-mediated regulation of phosphate transport in the proximal tubule of the kidney. The substitution of alanine for threonine at position 95 (T95A) significantly decreased the rate and extent of in vitro phosphorylation of Ser(77) by PKC. In NHERF-1-null proximal tubule cells, neither PTH nor dopamine inhibited sodium-dependent phosphate transport. Infection of the cells with adenovirus expressing full-length WT GFP-NHERF-1 increased basal phosphate transport and restored the inhibitory effect of both PTH and dopamine. Infection with full-length NHERF-1 containing a T95A mutation, however, increased basal phosphate transport but not the responsiveness to either hormone. As determined by surface plasmon resonance, the substitution of serine for aspartic acid (S77D) in the PDZ I domain decreased the binding affinity to the sodium-dependent phosphate transporter 2a (Npt2a) as compared with WT PDZ I, but a T95D mutation had no effect on binding. Finally, cellular studies indicated that both PTH and dopamine treatment increased the phosphorylation of Thr(95). These studies indicate a remarkable cooperativity between the phosphorylation of Thr(95) and Ser(77) of NHERF-1 in the hormonal regulation of renal phosphate transport. The phosphorylation of Thr(95) facilitates the phosphorylation of Ser(77). This, in turn, results in the dissociation of NHERF-1 from Npt2a and a decrease in phosphate transport in renal proximal tubule cells.	[Weinman, Edward J.; Steplock, Deborah; Biswas, Rajatsubhra] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.; Zhang, Yinghua; Bloch, Robert J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E.J.W.) and by a grant from the Research Service, Department of Veterans Affairs (to E.J.W.).	Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	12	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25134	25138		10.1074/jbc.M110.132423	http://dx.doi.org/10.1074/jbc.M110.132423			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20571032	Green Published, hybrid			2022-12-27	WOS:000280682400005
J	Zhao, YC; Kull, FJ; Cochran, JC				Zhao, Yu Cheng; Kull, F. Jon; Cochran, Jared C.			Modulation of the Kinesin ATPase Cycle by Neck Linker Docking and Microtubule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; MOTOR; EG5; THERMODYNAMICS; PROCESSIVITY; HYDROLYSIS; PATHWAY; DOMAIN; FORCE; NCD	Kinesin motor proteins use an ATP hydrolysis cycle to perform various functions in eukaryotic cells. Many questions remain about how the kinesin mechanochemical ATPase cycle is fine-tuned for specific work outputs. In this study, we use isothermal titration calorimetry and stopped-flow fluorometry to determine and analyze the thermodynamics of the human kinesin-5 (Eg5/KSP) ATPase cycle. In the absence of micro-tubules, the binding interactions of kinesin-5 with both ADP product and ATP substrate involve significant enthalpic gains coupled to smaller entropic penalties. However, when the wildtype enzyme is titrated with a non-hydrolyzable ATP analog or the enzyme is mutated such that it is able to bind but not hydrolyze ATP, substrate binding is 10-fold weaker than ADP binding because of a greater entropic penalty due to the structural re-arrangements of switch 1, switch 2, and loop L5 on ATP binding. We propose that these rearrangements are reversed upon ATP hydrolysis and phosphate release. In addition, experiments on a truncated kinesin-5 construct reveal that upon nucleotide binding, both the N-terminal cover strand and the neck linker interact to modulate kinesin-5 nucleotide affinity. Moreover, interactions with microtubules significantly weaken the affinity of kinesin-5 for ADP without altering the affinity of the enzyme for ATP in the absence of ATP hydrolysis. Together, these results define the energy landscape of a kinesin ATPase cycle in the absence and presence of microtubules and shed light on the role of molecular motor mechanochemistry in cellular microtubule dynamics.	[Zhao, Yu Cheng; Kull, F. Jon; Cochran, Jared C.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College	Cochran, JC (corresponding author), 6128 Burke Lab, Hanover, NH 03755 USA.	Jared.Cochran@Dartmouth.edu		Zhao, Peter/0000-0003-1430-1034	National Institutes of Health through the NIAMS [F32AR054653]; Dartmouth College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054653] Funding Source: NIH RePORTER	National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dartmouth College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant F32AR054653 through the NIAMS (to J.C.C.). This work was also supported by the Dartmouth College Zabriskie Fellowship (to Y.C.Z.). S The on-line version of this article (available at http://www.jbc.org) contains supplemental Experimental Procedures, Figs. S1-S3, and Tables S1 and S2.	Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; COLE DG, 1994, J BIOL CHEM, V269, P22913; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Kull FJ, 2002, J CELL SCI, V115, P15; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pretz MG, 2006, BIOCHEMISTRY-US, V45, P15056, DOI 10.1021/bi061230e; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394	33	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25213	25220		10.1074/jbc.M110.123067	http://dx.doi.org/10.1074/jbc.M110.123067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558732	hybrid, Green Published			2022-12-27	WOS:000280682400014
J	Daher, Z; Boulay, PL; Desjardins, F; Gratton, JP; Claing, A				Daher, Zeinab; Boulay, Pierre-Luc; Desjardins, Fanny; Gratton, Jean-Philippe; Claing, Audrey			Vascular Endothelial Growth Factor Receptor-2 Activates ADP-ribosylation Factor 1 to Promote Endothelial Nitric-oxide Synthase Activation and Nitric Oxide Release from Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS STIMULATES PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCED ANGIOGENESIS; PROTEIN; ARF6; VEGF; AKT; MIGRATION; SURVIVAL; NO	Vascular endothelial growth factor (VEGF) induces angiogenesis and regulates endothelial function via production and release of nitric oxide (NO), an important signaling molecule. The molecular basis leading to NO production involves phosphatidylinositiol-3 kinase (PI3K), Akt, and endothelial nitricoxide synthase (eNOS) activation. In this study, we have examined whether small GTP-binding proteins of the ADP-ribosylation factor (ARF) family act as molecular switches to regulate signaling cascades activated by VEGF in endothelial cells. Our results show that this growth factor can promote the rapid and transient activation of ARF1. In endothelial cells, this GTPase is present on dynamic plasma membrane ruffles. Inhibition of ARF1 expression, using RNA interference, markedly impaired VEGF-dependent eNOS phosphorylation and NO production by preventing the activation of the PI3K/Akt signaling axis. Furthermore, our data indicate that phosphorylation of Tyr(801), on VEGF receptor 2, is essential for activating Src- and ARF1-dependent signaling events leading to NO release from endothelial cells. Lastly, this mediator is known to regulate a broad variety of endothelial cell functions. Depletion of ARF1 markedly inhibits VEGF-dependent increase of vascular permeability as well as capillary tubule formation, a process important for angiogenesis. Taken together, our data indicate that ARF1 is a novel modulator of VEGF-stimulatedNOrelease and signaling in endothelial cells.	[Daher, Zeinab; Claing, Audrey] Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3C 3J7, Canada; [Boulay, Pierre-Luc; Gratton, Jean-Philippe; Claing, Audrey] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Daher, Zeinab; Boulay, Pierre-Luc; Claing, Audrey] Univ Montreal, Grp Etud Prot Membranaires, Fac Med, Montreal, PQ H3C 3J7, Canada; [Desjardins, Fanny; Gratton, Jean-Philippe] Inst Rech Clin Montreal, Lab Endothelial Cell Biol, Montreal, PQ H2W 1R7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Claing, A (corresponding author), Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca		Gratton, Jean-Philippe/0000-0001-9877-8520	Canadian Institutes of Health Research (CIHR) [MOP-79470]; Heart and Stoke Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stoke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant MOP-79470 and a Heart and Stoke Foundation of Canada grant (to A.C.).	Bednarek SY, 1996, TRENDS CELL BIOL, V6, P468, DOI 10.1016/0962-8924(96)84943-9; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Duval M, 2007, MOL BIOL CELL, V18, P4659, DOI 10.1091/mbc.E07-05-0467; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	54	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24591	24599		10.1074/jbc.M110.115311	http://dx.doi.org/10.1074/jbc.M110.115311			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529868	hybrid, Green Published			2022-12-27	WOS:000280542100031
J	Durlu-Kandilci, NT; Ruas, M; Chuang, KT; Brading, A; Parrington, J; Galione, A				Durlu-Kandilci, Nezahat Tugba; Ruas, Margarida; Chuang, Kai-Ting; Brading, Alison; Parrington, John; Galione, Antony			TPC2 Proteins Mediate Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)- and Agonist-evoked Contractions of Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-ACINAR-CELLS; MOBILIZES CA2+; INTRACELLULAR CALCIUM; 2-POOL MECHANISM; NAADP RECEPTORS; TRIGGER ZONE; BETA-CELLS; STORES; CADPR; RAT	Agonists such as those acting at muscarinic receptors are thought to induce contraction of smooth muscle primarily through inositol 1,4,5-trisphosphate production and release of Ca2+ from sarcoplasmic reticulum. However, the additional Ca2+ mobilizing messengers cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) may also be involved in this process, the former acting on the sarcoplasmic reticulum, the latter acting on lysosome-related organelles. In this study, we provide the first systematic analysis of the capacity of inositol 1,4,5-trisphosphate, cADPR, and NAADP to cause contraction in smooth muscle. Using permeabilized guinea pig detrusor and taenia caecum, we show that all three Ca2+ mobilizing messengers cause contractions in both types of smooth muscle. We demonstrate that cADPR and NAADP play differential roles in mediating contraction in response to muscarinic receptor activation, with a sizeable role for NAADP and acidic calcium stores in detrusor muscle but not in taenia caecum, underscoring the heterogeneity of smooth muscle signal transduction systems. Two-pore channel proteins (TPCs) have recently been shown to be key components of the NAADP receptor. We show that contractile responses to NAADP were completely abolished, and agonist-evoked contractions were reduced and now became independent of acidic calcium stores in Tpcn2(-/-) mouse detrusor smooth muscle. Our findings provide the first evidence that TPC proteins mediate a key NAADP-regulated tissue response brought about by agonist activation of a cell surface receptor.	[Durlu-Kandilci, Nezahat Tugba; Ruas, Margarida; Chuang, Kai-Ting; Brading, Alison; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Durlu-Kandilci, Nezahat Tugba] Hacettepe Univ, Fac Pharm, Dept Pharmacol, TR-06100 Ankara, Turkey	University of Oxford; Hacettepe University	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk	KANDILCI, NEZAHAT TUGBA/J-1080-2013; Galione, Antony/E-5884-2011	KANDILCI, NEZAHAT TUGBA/0000-0001-7236-2041; Ruas, Margarida/0000-0002-4872-7618; Galione, Antony/0000-0002-4132-7646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Programme Grant (to A.G. and J.P.).	Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; Barone F, 2002, FASEB J, V16, DOI 10.1096/fj.01-0749com; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Durlu-Kandilci NT, 2007, EUR J PHARMACOL, V566, P172, DOI 10.1016/j.ejphar.2007.03.041; Endo M, 1977, EXCITATION CONTRACTI, P199; Evans AM, 2005, PHARMACOL THERAPEUT, V107, P286, DOI 10.1016/j.pharmthera.2005.03.003; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; IACOVOU JW, 1990, J UROLOGY, V144, P775, DOI 10.1016/S0022-5347(17)39590-3; Iizuka K, 1998, J PHYSIOL-LONDON, V511, P915, DOI 10.1111/j.1469-7793.1998.915bg.x; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jude Joseph A, 2008, Proc Am Thorac Soc, V5, P15, DOI 10.1513/pats.200704-047VS; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; Li PL, 2003, ACTA PHYSIOL SCAND, V179, P339, DOI 10.1046/j.0001-6772.2003.01216.x; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yusufi ANK, 2002, EXP BIOL MED, V227, P36, DOI 10.1177/153537020222700107; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	36	61	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24925	24932		10.1074/jbc.M110.129833	http://dx.doi.org/10.1074/jbc.M110.129833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20547763	Green Published, hybrid			2022-12-27	WOS:000280542100065
J	Fernandes, MS; Reddy, MM; Croteau, NJ; Walz, C; Weisbach, H; Podar, K; Band, H; Carroll, M; Reiter, A; Larson, RA; Salgia, R; Griffin, JD; Sattler, M				Fernandes, Margret S.; Reddy, Mamatha M.; Croteau, Nicole J.; Walz, Christoph; Weisbach, Henry; Podar, Klaus; Band, Hamid; Carroll, Martin; Reiter, Andreas; Larson, Richard A.; Salgia, Ravi; Griffin, James D.; Sattler, Martin			Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRED UNIPARENTAL DISOMY; BCR/ABL-TRANSFORMED-CELLS; C-CBL; TYROSINE KINASES; DOWN-REGULATION; NEGATIVE REGULATION; V-CBL; FLT3; EXPRESSION; ABL	Acute myeloid leukemia (AML) is characterized by multiple mutagenic events that affect proliferation, survival, as well as differentiation. Recently, gain-of-function mutations in the alpha helical structure within the linker sequence of the E3 ubiquitin ligase CBL have been associated with AML. We identified four novel CBL mutations, including a point mutation (Y371H) and a putative splice site mutation in AML specimens. Characterization of these two CBL mutants revealed that coexpression with the receptor tyrosine kinases FLT3 (Fms-like tyrosine kinase 3) or KIT-induced ligand independent growth or ligand hyperresponsiveness, respectively. Growth of cells expressing mutant CBL required expression and kinase activity of FLT3. In addition to the CBL-dependent phosphorylation of FLT3 and CBL itself, transformation was associated with activation of Akt and STAT5 and required functional expression of the small GTPases Rho, Rac, and Cdc42. Furthermore, the mutations led to constitutively elevated intracellular reactive oxygen species levels, which is commonly linked to increased glucose metabolism in cancer cells. Inhibition of hexokinase with 2-deoxyglucose blocked the transforming activity of CBL mutants and reduced activation of signaling mechanisms. Overall, our data demonstrate that mutations of CBL alter cellular biology at multiple levels and require not only the activation of receptor proximal signaling events but also an increase in cellular glucose metabolism. Pathways that are activated by CBL gain-of-function mutations can be efficiently targeted by small molecule drugs.	[Fernandes, Margret S.; Reddy, Mamatha M.; Croteau, Nicole J.; Weisbach, Henry; Podar, Klaus; Griffin, James D.; Sattler, Martin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Fernandes, Margret S.; Reddy, Mamatha M.; Podar, Klaus; Griffin, James D.; Sattler, Martin] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Walz, Christoph] Heidelberg Univ, Univ Med Mannheim, Inst Pathol, D-69120 Heidelberg, Germany; [Walz, Christoph; Reiter, Andreas] Heidelberg Univ, Univ Med Mannheim, Med Klin 3, D-69120 Heidelberg, Germany; [Podar, Klaus] Heidelberg Univ, Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Genet, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Carroll, Martin] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Larson, Richard A.; Salgia, Ravi] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Pennsylvania; University of Chicago	Sattler, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	martin_sattler@dfci.harvard.edu	Larson, Richard A./AAE-7223-2019; Podar, Klaus/ABD-1112-2020; Band, Hamid/AAF-4701-2020	Larson, Richard A./0000-0001-9168-3203; Podar, Klaus/0000-0002-7414-3632; 	National Institutes of Health [5R01CA134660-02, 5R01CA116552-04, 5R01CA99163-09, 5R01CA87986-12, 5R01CA105489-06, 5R01CA10075006, 5R01CA125541-04, 5R01CA129501]; Leukemia and Lymphoma Society SCOR; German Jose Carreras Leukemia Foundation [DJCLS R06/02]; United States Department of Defense; Adams Barr Program in Innovative Cancer Research; NATIONAL CANCER INSTITUTE [R01CA100750, R01CA087986, R01CA099163, R01CA125541, R01CA116552, R01CA134660, R01CA061593, R01CA105489, R01CA129501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); German Jose Carreras Leukemia Foundation; United States Department of Defense(United States Department of Defense); Adams Barr Program in Innovative Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA134660-02 (to M.S.), 5R01CA116552-04, 5R01CA99163-09, 5R01CA87986-12, and 5R01CA105489-06 (to H.B.), and 5R01CA10075006, 5R01CA125541-04, and 5R01CA129501-02 (to R.S.), a Leukemia and Lymphoma Society SCOR grant (to J.D.G.), German Jose Carreras Leukemia Foundation Grant DJCLS R06/02 (to C.W.), the United States Department of Defense, and the Adams Barr Program in Innovative Cancer Research (to M.S.).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Banerji L, 2004, EXPERT OPIN THER TAR, V8, P221, DOI 10.1517/14728222.8.3.221; BLAKE TJ, 1991, ONCOGENE, V6, P653; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; FREDRICKSON TN, 1984, J NATL CANCER I, V72, P447; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marengere LEM, 1997, J IMMUNOL, V159, P70; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Sattler M, 1999, BLOOD, V93, P2928; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Sattler M, 2002, ONCOGENE, V21, P1423, DOI 10.1038/sj.onc.1205202; Sattler M, 1996, ONCOGENE, V12, P839; Sitnicka E, 2003, BLOOD, V102, P881, DOI 10.1182/blood-2002-06-1694; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186	42	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32596	32605		10.1074/jbc.M110.106161	http://dx.doi.org/10.1074/jbc.M110.106161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20622007	Green Published, hybrid			2022-12-27	WOS:000282683000074
J	Soundararajan, R; Pearce, D; Hughey, RP; Kleyman, TR				Soundararajan, Rama; Pearce, David; Hughey, Rebecca P.; Kleyman, Thomas R.			Role of Epithelial Sodium Channels and Their Regulators in Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-SURFACE EXPRESSION; INDUCIBLE KINASE SGK1; NA+ SELF-INHIBITION; BLOOD-PRESSURE; ALPHA-SUBUNIT; BETA-SUBUNIT; GAMMA-SUBUNIT; LIDDLES-SYNDROME; ENAC SUBUNITS; SGK1-KNOCKOUT MOUSE	The kidney has a central role in the regulation of blood pressure, in large part through its role in the regulated reabsorption of filtered Na+. Epithelial Na+ channels (ENaCs) are expressed in the most distal segments of the nephron and are a target of volume regulatory hormones. A variety of factors regulate ENaC activity, including several aldosterone-induced proteins that are present within an ENaC regulatory complex. Proteases also regulate ENaC by cleaving the channel and releasing intrinsic inhibitory tracts. Polymorphisms or mutations within channel subunits or regulatory pathways that enhance channel activity may contribute to an increase in blood pressure in individuals with essential hypertension.	[Soundararajan, Rama; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.	david.pearce@ucsf.edu			National Institutes of Health [DK078679, DK056695, DK085101, DK065161, DK054354]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078679, R01DK056695, R01DK054354, R56DK065161, R01DK085101, R01DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078679 (to R. S.), DK056695 and DK085101 (to D. P.), DK065161 (to T. R. K. and R. P. H.), and DK054354 (to T. R. K.). This is the third article in the "Biochemistry in Medicine: Hypertension Minireview Series." This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ambrosius WT, 1999, HYPERTENSION, V34, P631, DOI 10.1161/01.HYP.34.4.631; AMBROSIUS WT, 2003, HYPERTENSION, V41, P631; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baker EH, 2002, HYPERTENSION, V40, P13, DOI 10.1161/01.HYP.0000022570.02119.75; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Boyd C, 2005, AM J PHYSIOL-RENAL, V288, pF505, DOI 10.1152/ajprenal.00242.2004; Busjahn A, 2003, CELL PHYSIOL BIOCHEM, V13, P51, DOI 10.1159/000070249; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; BUTTERWORTH MB, 2010, BIOCH BIOPH IN PRESS; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; CANESSA CM, 1995, KIDNEY INT, V48, P950, DOI 10.1038/ki.1995.376; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Cui Y, 1997, P NATL ACAD SCI USA, V94, P9962, DOI 10.1073/pnas.94.18.9962; de la Rosa DA, 2006, AM J PHYSIOL-CELL PH, V290, pC492, DOI 10.1152/ajpcell.00556.2004; De la Rosa DA, 2003, AM J PHYSIOL-CELL PH, V284, pC404, DOI 10.1152/ajpcell.00398.2002; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Huang DY, 2006, AM J PHYSIOL-REG I, V290, pR935, DOI 10.1152/ajpregu.00382.2005; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lifton RP, 2002, COLD SPRING HARB SYM, V67, P445, DOI 10.1101/sqb.2002.67.445; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Mutesa L, 2009, CHEST, V135, P1233, DOI 10.1378/chest.08-2246; Nicod M, 2002, EMBO J, V21, P5109, DOI 10.1093/emboj/cdf509; Nkeh B, 2003, AM J HYPERTENS, V16, P847, DOI 10.1016/S0895-7061(03)01016-1; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pearce D, 2007, J CLIN INVEST, V117, P592, DOI 10.1172/JCI31538; Persu A, 1998, HYPERTENSION, V32, P129, DOI 10.1161/01.HYP.32.1.129; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Samaha FF, 2004, J BIOL CHEM, V279, P23900, DOI 10.1074/jbc.M401941200; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stokes JB, 1999, KIDNEY INT, V56, P2318, DOI 10.1046/j.1523-1755.1999.00803.x; Su YR, 1996, J AM SOC NEPHROL, V7, P2543; Sugiyama T, 2001, HYPERTENS RES, V24, P515, DOI 10.1291/hypres.24.515; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Swift PA, 2004, ADV RENAL REPLACE TH, V11, P76, DOI 10.1053/j.arrt.2003.10.011; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606; Tong QS, 2006, AM J PHYSIOL-RENAL, V290, pF821, DOI 10.1152/ajprenal.00312.2005; Vallon V, 2005, AM J PHYSIOL-REG I, V289, pR395, DOI 10.1152/ajpregu.00731.2004; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Verrey F, 1999, AM J PHYSIOL-RENAL, V277, pF319, DOI 10.1152/ajprenal.1999.277.3.F319; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang XF, 2008, KIDNEY BLOOD PRESS R, V31, P268, DOI 10.1159/000151286; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	99	77	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30363	30369		10.1074/jbc.R110.155341	http://dx.doi.org/10.1074/jbc.R110.155341			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20624922	Green Published, hybrid			2022-12-27	WOS:000282135500002
J	Studach, L; Wang, WH; Weber, G; Tang, JB; Hullinger, RL; Malbrue, R; Liu, XQ; Andrisani, O				Studach, Leo; Wang, Wen-Horng; Weber, Gregory; Tang, Jiabin; Hullinger, Ronald L.; Malbrue, Raphael; Liu, Xiaoqi; Andrisani, Ourania			Polo-like Kinase 1 Activated by the Hepatitis B Virus X Protein Attenuates Both the DNA Damage Checkpoint and DNA Repair Resulting in Partial Polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLK1 PHOSPHORYLATION; CHK1 ACTIVATION; GENE-EXPRESSION; P53; REPLICATION; CLASPIN; ADAPTATION; POLO-LIKE-KINASE-1; INHIBITOR; RECOVERY	Hepatitis B virus X protein (pX), implicated in hepatocarcinogenesis, induces DNA damage because of re-replication and allows propagation of damaged DNA, resulting in partial polyploidy and oncogenic transformation. The mechanism by which pX allows cells with DNA damage to continue proliferating is unknown. Herein, we show pX activates Polo-like kinase 1 (Plk1) in the G(2) phase, thereby attenuating the DNA damage checkpoint. Specifically, in the G(2) phase of pX-expressing cells, the checkpoint kinase Chk1 was inactive despite DNA damage, and protein levels of claspin, an adaptor of ataxia telangiectasia- mutated and Rad3-related protein-mediated Chk1 phosphorylation, were reduced. Pharmacologic inhibition or knockdown of Plk1 restored claspin protein levels, Chk1 activation, and p53 stabilization. Also, protein levels of DNA repair protein Mre11 were decreased in the G2 phase of pX-expressing cells but not with Plk1 knockdown. Interestingly, in pX-expressing cells, Mre11 co-immunoprecipitated with transfected Plk1 Polo-box domain, and inhibition of Plk1 increased Mre11 stability in cycloheximide-treated cells. These results suggest that pX-activated Plk1 by down-regulating Mre11 attenuates DNA repair. Importantly, concurrent inhibition of Plk1, p53, and Mre11 increased the number of pX-expressing cells with DNA damage entering mitosis, relative to Plk1 inhibition alone. By contrast, inhibition or knockdown of Plk1 reduced pX-induced polyploidy while increasing apoptosis. We conclude Plk1, activated by pX, allows propagation of DNA damage by concurrently attenuating the DNA damage checkpoint and DNA repair, resulting in polyploidy. We propose this novel Plk1 mechanism initiates pX-mediated hepatocyte transformation.	[Studach, Leo; Wang, Wen-Horng; Hullinger, Ronald L.; Malbrue, Raphael; Andrisani, Ourania] Purdue Univ, Ctr Canc Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Weber, Gregory; Tang, Jiabin; Liu, Xiaoqi] Purdue Univ, Ctr Canc Res, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, O (corresponding author), 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu		Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [DK044533, CA135192]; Purdue University Cytometry Laboratory; NATIONAL CANCER INSTITUTE [R21CA135192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044533, R29DK044533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Cytometry Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044533 and CA135192 (to O.A.).; We acknowledge support of the Purdue University Cytometry Laboratory.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Andrisani OM, 1999, INT J ONCOL, V15, P373; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chen J, 2006, FEBS LETT, V580, P3624, DOI 10.1016/j.febslet.2006.05.047; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Paulovich AG, 1998, GENETICS, V150, P75; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spardy N, 2009, CANCER RES, V69, P7022, DOI 10.1158/0008-5472.CAN-09-0925; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Studach LL, 2009, HEPATOLOGY, V50, P414, DOI 10.1002/hep.22996; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Syljuasen RG, 2007, ONCOGENE, V26, P5833, DOI 10.1038/sj.onc.1210402; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; VAN VUGT MATM, 2004, MOL CELL, V15, P799; VAN VUGT MATM, 2005, ONCOGENE, V24, P2844; VAN VUGT MATM, 2001, J BIOL CHEM, V276, P41656; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Yamada S, 2004, ONCOGENE, V23, P5901, DOI 10.1038/sj.onc.1207782; Yang XM, 2009, J BIOL CHEM, V284, P28775, DOI 10.1074/jbc.M109.017681; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhang H, 2007, CANCER LETT, V245, P184, DOI 10.1016/j.canlet.2006.01.005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	71	36	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30282	30293		10.1074/jbc.M109.093963	http://dx.doi.org/10.1074/jbc.M109.093963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624918	Green Published, hybrid			2022-12-27	WOS:000281984300064
J	Eot-Houllier, G; Venoux, M; Vidal-Eychenie, S; Hoang, MT; Giorgi, D; Rouquier, S				Eot-Houllier, Gregory; Venoux, Magali; Vidal-Eychenie, Sophie; Hoang, Minh-Thao; Giorgi, Dominique; Rouquier, Sylvie			Plk1 Regulates Both ASAP Localization and Its Role in Spindle Pole Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; CENTROSOME ABERRATIONS; MITOTIC CENTROSOMES; KINASE AURORA; PHOSPHORYLATION; RECRUITMENT; TARGET; SUBSTRATE; COMPLEX; BINDING	Bipolar spindle formation is essential for faithful chromosome segregation at mitosis. Because centrosomes define spindle poles, abnormal number and structural organization of centrosomes can lead to loss of spindle bipolarity and genetic integrity. ASAP (aster-associated protein or MAP9) is a centrosome- and spindle-associated protein, the deregulation of which induces severe mitotic defects. Its phosphorylation by Aurora A is required for spindle assembly and mitosis progression. Here, we show that ASAP is localized to the spindle poles by Polo-like kinase 1 (Plk1) (a mitotic kinase that plays an essential role in centrosome regulation and mitotic spindle assembly) through the gamma-TuRC-dependent pathway. We also demonstrate that ASAP is a novel substrate of Plk1 phosphorylation and have identified serine 289 as the major phosphorylation site by Plk1 in vivo. ASAP phosphorylated on serine 289 is localized to centrosomes during mitosis, but this phosphorylation is not required for its Plk1-dependent localization at the spindle poles. We show that phosphorylated ASAP on serine 289 contributes to spindle pole stability in a microtubule-dependent manner. These data reveal a novel function of ASAP in centrosome integrity. Our results highlight dual ASAP regulation by Plk1 and further confirm the importance of ASAP for spindle pole organization, bipolar spindle assembly, and mitosis.	[Eot-Houllier, Gregory; Venoux, Magali; Vidal-Eychenie, Sophie; Hoang, Minh-Thao; Giorgi, Dominique; Rouquier, Sylvie] CNRS, Inst Genet Humaine, Grp Microtubules & Cycle Cellularie, UPR 1142, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Rouquier, S (corresponding author), CNRS, Inst Genet Humaine, Grp Microtubules & Cycle Cellularie, UPR 1142, Rue Cardonille, F-34396 Montpellier 5, France.	rouquier@igh.cnrs.fr	giorgi, dominique/M-1529-2019	Rouquier, Sylvie/0000-0003-2448-6837	CNRS; Association pour la Recherche contre le Cancer [4027]; Ligue Nationale contre le Cancer; Fondation Jerome Lejeune; Institut National du Cancer (France); Ministere de l'Enseignement de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation Jerome Lejeune; Institut National du Cancer (France)(Institut National du Cancer (INCA) France); Ministere de l'Enseignement de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the CNRS and Association pour la Recherche contre le Cancer Grant 4027 (to S. R.), Ligue Nationale contre le Cancer Grants Comite de l'Herault-2007 and Comite de l'Aude-2009 (to S. R.), and by the Fondation Jerome Lejeune (S. R.).; Supported by postdoctoral fellowships from the Institut National du Cancer (France) (2008) and the Ligue Nationale contre le Cancer (2009).; Supported by fellowships from Ministere de l'Enseignement de la Recherche et de la Technologie and the Association pour la Recherche contre le Cancer.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Eckerdt F, 2009, CELL CYCLE, V8, P2413, DOI 10.4161/cc.8.15.9086; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Moudjou M, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P111; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Saffin JM, 2005, P NATL ACAD SCI USA, V102, P11302, DOI 10.1073/pnas.0500964102; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tamura Y, 2009, ONCOGENE, V28, P107, DOI 10.1038/onc.2008.368; Tillement V, 2009, BIOL CELL, V101, P1, DOI 10.1042/BC20070162; VAN DE WEERDT BCM, 2006, CELL CYCLE, V5, P853; VAN VUGT MATM, 2004, J BIOL CHEM, V279, P36841; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu H, 2009, J CELL SCI, V122, P2750, DOI 10.1242/jcs.048223; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	47	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29556	29568		10.1074/jbc.M110.144220	http://dx.doi.org/10.1074/jbc.M110.144220			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615875	Green Published, hybrid			2022-12-27	WOS:000281740100057
J	Fiuza, M; Letek, M; Leiba, J; Villadangos, AF; Vaquera, J; Zanella-Cleon, I; Mateos, LM; Molle, V; Gil, JA				Fiuza, Maria; Letek, Michal; Leiba, Jade; Villadangos, Almudena F.; Vaquera, Jose; Zanella-Cleon, Isabelle; Mateos, Luis M.; Molle, Virginie; Gil, Jose A.			Phosphorylation of a Novel Cytoskeletal Protein (RsmP) Regulates Rod-shaped Morphology in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; INTERMEDIATE-FILAMENT STRUCTURE; PREDICTING COILED COILS; CELL-WALL SYNTHESIS; ESCHERICHIA-COLI; CROSS-LINKING; POLAR GROWTH; DIVISION; DIVIVA; MREB	Corynebacteria grow by wall extension at the cell poles, with DivIVA being an essential protein orchestrating cell elongation and morphogenesis. DivIVA is considered a scaffolding protein able to recruit other proteins and enzymes involved in polar peptidoglycan biosynthesis. Partial depletion of DivIVA induced overexpression of cg3264, a previously uncharacterized gene that encodes a novel coiled coil-rich protein specific for corynebacteria and a few other actinomycetes. By partial depletion and overexpression of Cg3264, we demonstrated that this protein is an essential cytoskeletal element needed for maintenance of the rod-shaped morphology of Corynebacterium glutamicum, and it was therefore renamed RsmP (rod-shaped morphology protein). RsmP forms long polymers in vitro in the absence of any cofactors, thus resembling eukaryotic intermediate filaments. We also investigated whether RsmP could be regulated post-translationally by phosphorylation, like eukaryotic intermediate filaments. RsmP was phosphorylated in vitro by the PknA protein kinase and to a lesser extent by PknL. A mass spectrometric analysis indicated that phosphorylation exclusively occurred on a serine (Ser-6) and two threonine (Thr-168 and Thr-211) residues. We confirmed that mutagenesis to alanine (phosphoablative protein) totally abolished PknA-dependent phosphorylation of RsmP. Interestingly, when the three residues were converted to aspartic acid, the phosphomimetic protein accumulated at the cell poles instead of making filaments along the cell, as observed for the native or phosphoablative RsmP proteins, indicating that phosphorylation of RsmP is necessary for directing cell growth at the cell poles.	[Leiba, Jade; Zanella-Cleon, Isabelle; Molle, Virginie] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, BioSci IFR128,UMR 5086, F-69367 Lyon 07, France; [Fiuza, Maria; Letek, Michal; Villadangos, Almudena F.; Vaquera, Jose; Mateos, Luis M.; Gil, Jose A.] Univ Leon, Fac Biol, Dept Biol Mol, Area Microbiol, E-24071 Leon, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Leon	Molle, V (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, BioSci IFR128,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	vmolle@ibcp.fr; jagils@unileon.es	Letek, Michal/AAH-4292-2019; Gil, José A./L-1800-2019; Letek, Michal/K-3903-2019; Gil, Jose A./C-3902-2009; Letek, Michal/C-6345-2008; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; MOLLE, Virginie/D-4050-2019; Gil, Jose/A-3795-2010	Gil, José A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; Gil, Jose A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; MOLLE, Virginie/0000-0002-6573-3411; Leiba, Jade/0000-0003-0584-9524	National Research Agency [ANR-06-MIME-027-01, ANR-09-MIEN-004]; Junta de Castilla y Leon [LE040A07, LE28A10-2]; Ministerio de Ciencia y Tecnologia (Spain) [BIO2008-00519]; Ministerio de Educacion y Ciencia	National Research Agency(French National Research Agency (ANR)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by National Research Agency Grants ANR-06-MIME-027-01 and ANR-09-MIEN-004 (to V. M.), Junta de Castilla y Leon Grants LE040A07 and LE28A10-2 (to J. A. G. and L. M. M.), and Ministerio de Ciencia y Tecnologia (Spain) Grant BIO2008-00519 (to J. A. G.).; Recipient of a fellowship from the Ministerio de Educacion y Ciencia.	Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Ausmees N, 2006, J MOL MICROB BIOTECH, V11, P152, DOI 10.1159/000094051; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Charulatha V, 2001, J BIOMED MATER RES, V54, P122, DOI 10.1002/1097-4636(200101)54:1<122::AID-JBM15>3.0.CO;2-N; Chou SM, 1997, J NEUROL SCI, V152, P198, DOI 10.1016/S0022-510X(97)00161-5; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Daniel RA, 2000, MOL MICROBIOL, V35, P299, DOI 10.1046/j.1365-2958.2000.01724.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; DOMINGO A, 1992, P223; Downing DT, 1996, PROTEINS, V25, P215, DOI 10.1002/(SICI)1097-0134(199606)25:2<215::AID-PROT7>3.0.CO;2-G; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Fiuza M, 2008, J BIOL CHEM, V283, P36553, DOI 10.1074/jbc.M807175200; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Fuhrmann C, 1997, J VET MED B, V44, P287, DOI 10.1111/j.1439-0450.1997.tb00975.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Graumann PL, 2009, CELL MOTIL CYTOSKEL, V66, P909, DOI 10.1002/cm.20381; Hamasha K, 2010, BIOCHEM BIOPH RES CO, V391, P664, DOI 10.1016/j.bbrc.2009.11.117; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; JAMES GA, 1995, J BACTERIOL, V177, P907, DOI 10.1128/jb.177.4.907-915.1995; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; Muchova K, 2002, MICROBIOL-SGM, V148, P807, DOI 10.1099/00221287-148-3-807; Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTAMARIA RI, 1985, J BACTERIOL, V162, P463, DOI 10.1128/JB.162.1.463-467.1985; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; UMEDA A, 1983, MICROBIOL IMMUNOL, V27, P663, DOI 10.1111/j.1348-0421.1983.tb00629.x; Vats P, 2009, MOL MICROBIOL, V72, P170, DOI 10.1111/j.1365-2958.2009.06632.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Wang SB, 2009, FEMS MICROBIOL LETT, V297, P101, DOI 10.1111/j.1574-6968.2009.01678.x; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	72	24	24	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29387	29397		10.1074/jbc.M110.154427	http://dx.doi.org/10.1074/jbc.M110.154427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622015	Green Published, hybrid			2022-12-27	WOS:000281740100041
J	Johnson, E; Seachrist, DD; DeLeon-Rodriguez, CM; Lozada, KL; Miedler, J; Abdul-Karim, FW; Keri, RA				Johnson, Emhonta; Seachrist, Darcie D.; DeLeon-Rodriguez, Carlos M.; Lozada, Kristen L.; Miedler, John; Abdul-Karim, Fadi W.; Keri, Ruth A.			HER2/ErbB2-induced Breast Cancer Cell Migration and Invasion Require p120 Catenin Activation of Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; E-CADHERIN; EXPRESSION PATTERNS; BETA-CATENIN; ADHESION COMPLEX; TRANSGENIC MICE; ERBB2; P120-CATENIN; METASTASIS; CARCINOMA	Breast cancers that overexpress the receptor tyrosine kinase ErbB2/HER2/Neu result in poor patient outcome because of extensive metastatic progression. Herein, we delineate a molecular mechanism that may govern this malignant phenotype. ErbB2 induction of migration requires activation of the small GTPases Rac1 and Cdc42. The ability of ErbB2 to activate these small GTPases necessitated expression of p120 catenin, which is itself up-regulated by signaling through ErbB2 and the tyrosine kinase Src. Silencing p120 in ErbB2-dependent breast cancer cell lines dramatically inhibited migration and invasion as well as activation of Rac1 and Cdc42. In contrast, overexpression of constitutively active mutants of these GTPases reversed the effects of p120 silencing. Lastly, ectopic expression of p120 promoted migration and invasion and potentiated metastatic progression of a weakly metastatic, ErbB2-dependent breast cancer cell line. These results suggest that p120 acts as an obligate intermediate between ErbB2 and Rac1/Cdc42 to modulate the metastatic potential of breast cancer cells.	[Johnson, Emhonta; Seachrist, Darcie D.; DeLeon-Rodriguez, Carlos M.; Lozada, Kristen L.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Abdul-Karim, Fadi W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Miedler, John; Abdul-Karim, Fadi W.] Univ Hosp Cleveland, Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	rak5@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [R01 CA090398, T32 CA059366]; Department of Defense [W81XWH-09-1-0070]; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE [R01CA090398, T32CA059366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA090398. This work was also supported by National Institutes of Health Research Oncology Training Grant T32 CA059366, a Continuing Umbrella Research Experience (Cure) Supplement to National Institutes of Health Grant R01 CA090398, Department of Defense Grant USAMRMC W81XWH-09-1-0070, and a University Hospitals of Cleveland Pathology Research Associates Grant (to F. W. A.-K. and R. A. K.).	Aho S, 2002, J CELL SCI, V115, P1391; Alexe G, 2007, J BIOSCIENCES, V32, P1027, DOI 10.1007/s12038-007-0102-4; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Cleton-Jansen AM, 2002, BREAST CANCER RES, V4, P5, DOI 10.1186/bcr416; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; DA SILVA L, 2008, AM J SURG PATHOL, V32, P773; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dalgin GS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-291; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dillon DA, 1998, AM J PATHOL, V152, P75; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Howard Eugene M, 2004, Int J Clin Oncol, V9, P154; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kallakury BVS, 2001, HUM PATHOL, V32, P849, DOI 10.1053/hupa.2001.26463; Karatzas G, 2000, HEPATO-GASTROENTEROL, V47, P1465; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Karayiannakis AJ, 1999, ANTICANCER RES, V19, P4401; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kreizenbeck GM, 2008, CANCER EPIDEM BIOMAR, V17, P949, DOI 10.1158/1055-9965.EPI-07-2729; Landis MD, 2005, ONCOGENE, V24, P5173, DOI 10.1038/sj.onc.1208712; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Mastracci TL, 2005, MODERN PATHOL, V18, P741, DOI 10.1038/modpathol.3800362; MCGRATH PC, 1994, SURG ONCOL, V3, P69, DOI 10.1016/0960-7404(94)90002-7; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Nakopoulou L, 2000, ANTICANCER RES, V20, P4571; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Turashvili Gjulisa, 2007, Biomedical Papers (Olomouc), V151, P59; VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	59	63	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29491	29501		10.1074/jbc.M110.136770	http://dx.doi.org/10.1074/jbc.M110.136770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595387	hybrid, Green Published			2022-12-27	WOS:000281740100051
J	VanDuijn, MM; Dekker, LJM; Zeneyedpour, L; Smitt, PAES; Luider, TM				VanDuijn, Martijn M.; Dekker, Lennard J. M.; Zeneyedpour, L.; Smitt, Peter A. E. Sillevis; Luider, Theo M.			Immune Responses Are Characterized by Specific Shared Immunoglobulin Peptides That Can Be Detected by Proteomic Techniques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-H; ANTIBODY; CELL; REPERTOIRE; DIVERSITY; REACTIVITY; ANTIGENS; CANCER	In the adaptive immune response, immunoglobulins develop that bind specifically to the antigens to which the organism was exposed. Immunoglobulins may bind to known or unknown antigens in a variety of diseases and have been used in the past to identify novel antigens for use as a biomarker. We propose that the immunoglobulins themselves could also be used as biomarkers in antibody-mediated disease. In this proteomic study, rats were immunized with one of two purified antigens, and immunoglobulins from pre- and postimmune sera were analyzed with nano-LC coupled mass spectrometry. It was found that the two treatment groups could be distinguished based on cluster analysis of the immunoglobulin peptides from the immune sera. In addition, we identified 684 specific peptides that were differentially present in one of the two treated groups. We could find an amino acid sequence for 44% of the features in the mass spectra by combining database-driven and de novo sequencing techniques. The latter were essential for sequence identification, as the more common database-driven approach suffers from a poor representation of immunoglobulins in the available data-bases. Our data show that the development of immunoglobulins during an immune response is not a fully random process, but that instead selection pressures exist that favor the best binding amino acid sequences, and that this selection is shared between different animals. This finding implies that immunoglobulin peptides could indeed be a powerful and easily accessible class of biomarkers.	[VanDuijn, Martijn M.; Dekker, Lennard J. M.; Zeneyedpour, L.; Smitt, Peter A. E. Sillevis; Luider, Theo M.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus MC, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	t.luider@erasmusmc.nl		van Duijn, Martijn/0000-0002-6654-994X	TI Pharma; NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough [9351808]	TI Pharma; NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough(Netherlands Organization for Scientific Research (NWO))	This work was supported by TI Pharma (to M. M. V. D.) and the NWO (Nederlandse Organisatie voor Wetenschappelijke Onderzoek) Horizon Breakthrough Grant 9351808 (to L. D. and L.Z.).	Andersen PS, 2007, MOL IMMUNOL, V44, P412, DOI 10.1016/j.molimm.2006.02.021; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Hay F.C., 2008, PRACTICAL IMMUNOLOGY, P115; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leidinger P, 2008, INT J CANCER, V123, P1631, DOI 10.1002/ijc.23680; LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Saada R, 2007, IMMUNOL CELL BIOL, V85, P323, DOI 10.1038/sj.icb.7100055; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Sehgal D, 1998, J IMMUNOL, V161, P5347; Sodeyama N, 1999, J NEUROL NEUROSUR PS, V66, P97, DOI 10.1136/jnnp.66.1.97; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	19	20	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29247	29253		10.1074/jbc.M110.139071	http://dx.doi.org/10.1074/jbc.M110.139071			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615873	Green Published, hybrid			2022-12-27	WOS:000281740100026
J	Clark, EB; Jovov, B; Rooj, AK; Fuller, CM; Benos, DJ				Clark, Edlira B.; Jovov, Biljana; Rooj, Arun K.; Fuller, Catherine M.; Benos, Dale J.			Proteolytic Cleavage of Human Acid-sensing Ion Channel 1 by the Serine Protease Matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; SURFACE EXPRESSION; XENOPUS-OOCYTES; ACTIVATION; CELLS; ENAC; MIGRATION; SUBUNITS; DOMAINS; GLIOMAS	Acid-sensing ion channel 1 (ASIC1) is a H+-gated channel of the amiloride-sensitive epithelial Na+ channel (ENaC)/degenerin family. ASIC1 is expressed mostly in the central and peripheral nervous system neurons. ENaC and ASIC function is regulated by several serine proteases. The type II transmembrane serine protease matriptase activates the prototypical alpha beta gamma ENaC channel, but we found that matriptase is expressed in glioma cells and its expression is higher in glioma compared with normal astrocytes. Therefore, the goal of this study was to test the hypothesis that matriptase regulates ASIC1 function. Matriptase decreased the acid-activated ASIC1 current as measured by two-electrode voltage clamp in Xenopus oocytes and cleaved ASIC1 expressed in oocytes or CHO K1 cells. Inactive S805A matriptase had no effect on either the current or the cleavage of ASIC1. The effect of matriptase on ASIC1 was specific, because it did not affect the function of ASIC2 and no matriptase-specific ASIC2 fragments were detected in oocytes or in CHO cells. Three matriptase recognition sites were identified in ASIC1 (Arg-145, Lys-185, and Lys-384). Site-directed mutagenesis of these sites prevented matriptase cleavage of ASIC1. Our results show that matriptase is expressed in glioma cells and that matriptase specifically cleaves ASIC1 in heterologous expression systems.	[Clark, Edlira B.; Rooj, Arun K.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Jovov, Biljana] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Benos, DJ (corresponding author), 1918 Univ Blvd,MCLM 702, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011		National Institutes of Health [DK 37206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 37206.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kadurin I, 2008, BIOCHEM J, V412, P469, DOI 10.1042/BJ20071614; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014	29	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27130	27143		10.1074/jbc.M110.153213	http://dx.doi.org/10.1074/jbc.M110.153213			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20601429	Green Published, hybrid			2022-12-27	WOS:000281172700044
J	Habrukowich, C; Han, DK; Le, A; Rezaul, K; Pan, W; Ghosh, M; Li, ZG; Dodge-Kafka, K; Jiang, XJ; Bittman, R; Hla, T				Habrukowich, Cheryl; Han, David K.; Le, Andrew; Rezaul, Karim; Pan, Wei; Ghosh, Mallika; Li, Zaiguo; Dodge-Kafka, Kimberly; Jiang, Xuejun; Bittman, Robert; Hla, Timothy			Sphingosine Interaction with Acidic Leucine-rich Nuclear Phosphoprotein-32A (ANP32A) Regulates PP2A Activity and Cyclooxygenase (COX)-2 Expression in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCTION; APOPTOSIS; PATHWAY; DEATH; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; IDENTIFICATION; SPHINGOMYELIN; SPHINGOLIPIDS	Sphingolipid metabolites regulate cell fate by acting on specific cellular targets. Although the influence of sphingolipids in cellular signaling has been well recognized, the exact molecular targets and how these targets influence cellular signaling mechanisms remain poorly understood. Toward this goal, we used affinity chromatography coupled with proteomics technology and identified acidic leucine-rich nuclear phosphoprotein- 32A (ANP32A), an inhibitor of protein phosphatase 2A (PP2A) as a direct target of sphingosine, N, N'-dimethyl sphingosine (DMS) and phytosphingosine but not dihydrosphingosine or sphingosine 1-phosphate. Treatment of human umbilical vein endothelial cells (HUVEC) with DMS, which is not phosphorylated by sphingosine kinases, led to the activation of PP2A activity. Suppression of ANP32A with siRNA enhanced basal and DMS-activated PP2A activity suggesting that the sphingoid base binds to and relieves the inhibitory action of ANP32A on the PP2A complex. Indeed, DMS relieved the ANP32A-mediated inhibition of PP2A enzyme complex in vitro. Interestingly, DMS treatment induced the p38 stress-activated protein kinase (SAPK) and expression of cyclooxygenase (COX)-2 transcript and protein. Knockdown of ANP32A expression further induced p38 SAPK and COX-2. These data identify ANP32A as a novel molecular target of sphingoid bases that regulates cellular signaling events and inflammatory gene expression.	[Habrukowich, Cheryl; Han, David K.; Rezaul, Karim; Ghosh, Mallika; Hla, Timothy] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Habrukowich, Cheryl; Han, David K.; Rezaul, Karim; Ghosh, Mallika; Hla, Timothy] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Pan, Wei; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Li, Zaiguo; Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Connecticut; University of Connecticut; Cornell University; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Queens College NY (CUNY)	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA.	tih2002@med.cornell.edu	Hla, Timothy/G-5873-2012; Ghosh, Mallika/Q-2976-2016	Hla, Timothy/0000-0001-8355-4065; Ghosh, Mallika/0000-0002-5090-1275	National Institutes of Health [HL67330, CA77839, CA113890, HL83187]; NATIONAL CANCER INSTITUTE [P01CA077839, R01CA113890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187, R01HL082705, R01HL067330, R37HL067330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67330 and CA77839 (to T. H.), CA113890 (to X. J.), and HL83187 (to R. B.).	AMES BN, 1960, J BIOL CHEM, V235, P769; Argraves KM, 2002, ADV EXP MED BIOL, V507, P439; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Ghosh M, 2007, J EXP MED, V204, P2053, DOI 10.1084/jem.20070828; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Huyton T, 2007, PROTEIN SCI, V16, P1308, DOI 10.1110/ps.072803507; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lemonnier LA, 2003, ARCH BIOCHEM BIOPHYS, V419, P129, DOI 10.1016/j.abb.2003.08.023; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; MERRILL AH, 1997, J NUTR, V127, P830; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Nava VE, 2000, CANCER RES, V60, P4468; OHTA H, 1995, CANCER RES, V55, P691; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	36	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26825	26831		10.1074/jbc.M110.147058	http://dx.doi.org/10.1074/jbc.M110.147058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558741	Green Published, hybrid			2022-12-27	WOS:000281172700013
J	Lin, J; Yang, QY; Wilder, PT; Carrier, F; Weber, DJ				Lin, Jing; Yang, Qingyuan; Wilder, Paul T.; Carrier, France; Weber, David J.			The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; UV-RADIATION; CANCER-CELLS; PIFITHRIN-ALPHA; DIFFERENTIAL EXPRESSION; P53-MEDIATED APOPTOSIS; P53-INDUCED APOPTOSIS; CARCINOMA-CELLS; MDM2 GENE	The S100B-p53 protein complex was discovered in C8146A malignant melanoma, but the consequences of this interaction required further study. When S100B expression was inhibited in C8146As by siRNA (siRNA(S100B)), wt p53 mRNA levels were unchanged, but p53 protein, phosphorylated p53, and p53 gene products (i.e. p21 and PIDD) were increased. siRNAS100B transfections also restored p53-dependent apoptosis in C8146As as judged by poly (ADP-ribose) polymerase cleavage, DNA ladder formation, caspase 3 and 8 activation, and aggregation of the Fas death receptor (+UV); whereas, siRNA(S100B) had no effect in SK-MEL-28 cells containing elevated S100B and inactive p53 (p53R145L mutant). siRNA(S100B)-mediated apoptosis was independent of the mitochondria, because no changes were observed in mitochondrial membrane potential, cytochrome c release, caspase 9 activation, or ratios of pro- and anti-apoptotic proteins (BAX, Bcl-2, and Bcl-X-L). As expected, cells lacking S100B (LOX-IM VI) were not affected by siRNA(S100B), and introduction of S100B reduced their UV-induced apoptosis activity by 7-fold, further demonstrating that S100B inhibits apoptosis activities in p53-containing cells. In other wild-type p53 cells (i.e. C8146A, UACC-2571, and UACC-62), S100B was found to contribute to cell survival after UV treatment, and for C8146As, the decrease in survival after siRNAS100B transfection (+UV) could be reversed by the p53 inhibitor, pifithrin-alpha. In summary, reducing S100B expression with siRNA was sufficient to activate p53, its transcriptional activation activities, and p53-dependent apoptosis pathway(s) in melanoma involving the Fas death receptor and perhaps PIDD. Thus, a well known marker for malignant melanoma, S100B, likely contributes to cancer progression by down-regulating the tumor suppressor protein, p53.	[Yang, Qingyuan; Carrier, France] Univ Maryland, Dept Radiat Oncol, Sch Med, Baltimore, MD 21201 USA; [Lin, Jing; Wilder, Paul T.; Weber, David J.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Wilder, Paul T.; Carrier, France; Weber, David J.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Carrier, F (corresponding author), Univ Maryland, Dept Radiat Oncol, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	fcarr001@umaryland.edu; dweber@umaryland.edu	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Carrier, France/0000-0002-5517-5284	National Institutes of Health [GM58888, CA107331]; American Cancer Society [CDD107745]; NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58888 and CA107331 (to D.J.W.). This work was also supported by American Cancer Society Grant CDD107745 (to D.J.W.).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Benchimol S, 2001, CELL DEATH DIFFER, V8, P1049, DOI 10.1038/sj.cdd.4400918; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Butz K, 1998, ONCOGENE, V17, P781, DOI 10.1038/sj.onc.1201995; Camby I, 1999, BRAIN PATHOL, V9, P1; Camphausen K, 2003, CANCER RES, V63, P1990; Chen Y, 2001, CANCER RES, V61, P6437; Cheng LHH, 2001, HEAD NECK-J SCI SPEC, V23, P972, DOI 10.1002/hed.1141; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chopin V, 2004, ONCOGENE, V23, P21, DOI 10.1038/sj.onc.1207020; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Delphin C, 1999, J BIOL CHEM, V274, P10539, DOI 10.1074/jbc.274.15.10539; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fan XL, 2005, APOPTOSIS, V10, P63, DOI 10.1007/s10495-005-6062-y; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Fraser M, 2006, ONCOGENE, V25, P2203, DOI 10.1038/sj.onc.1209251; Geara FB, 1996, SURG CLIN N AM, V76, P1383, DOI 10.1016/S0039-6109(05)70521-1; Haapajarvi T, 1999, EXP CELL RES, V248, P272, DOI 10.1006/excr.1999.4403; Hansson LO, 1997, ANTICANCER RES, V17, P3071; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Hauschild A, 1999, MELANOMA RES, V9, P155, DOI 10.1097/00008390-199904000-00008; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huo JX, 2004, CELL DEATH DIFFER, V11, P99, DOI 10.1038/sj.cdd.4401322; Izumaru S, 2004, INT J ONCOL, V24, P1245; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kramer DL, 1999, CANCER RES, V59, P1278; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Kuo PC, 2004, J BIOL CHEM, V279, P55875, DOI 10.1074/jbc.M407985200; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; LIN J, 2006, AACR M, pA1168; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Magrini R, 2007, J CELL BIOCHEM, V100, P1276, DOI 10.1002/jcb.21122; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MEYSKENS F JR, 1981, Stem Cells (Basel), V1, P61; Meyskens F L Jr, 1981, Front Radiat Ther Oncol, V16, P55; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MONTANO X, 1994, ONCOGENE, V9, P1455; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; OConnor PM, 1997, CANCER RES, V57, P4285; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Rieber M, 2000, INT J CANCER, V86, P462, DOI 10.1002/(SICI)1097-0215(20000515)86:4<462::AID-IJC3>3.0.CO;2-B; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Saucedo LJ, 1998, CELL GROWTH DIFFER, V9, P119; Sawa H, 2001, Brain Tumor Pathol, V18, P109, DOI 10.1007/BF02479423; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; Takai D, 2006, FREE RADICAL RES, V40, P1138, DOI 10.1080/10715760600838381; THOMSON SP, 1982, CANCER RES, V42, P4606; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Wang JA, 1999, INT J RADIAT BIOL, V75, P301, DOI 10.1080/095530099140483; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Wu ZH, 2005, CELL, V123, P980, DOI 10.1016/j.cell.2005.11.025; Zeng XY, 2000, CANCER RES, V60, P6184; Zhang H, 2006, CANCER LETT, V244, P229, DOI 10.1016/j.canlet.2005.12.021; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	78	85	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27487	27498		10.1074/jbc.M110.155382	http://dx.doi.org/10.1074/jbc.M110.155382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20587415	hybrid, Green Published			2022-12-27	WOS:000281172700078
J	Liu, J; Luo, XJ; Xiong, AW; Zhang, ZD; Yue, S; Zhu, MS; Cheng, SY				Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Zhu, Ming-sheng; Cheng, Steven Y.			MicroRNA-214 Promotes Myogenic Differentiation by Facilitating Exit from Mitosis via Down-regulation of Proto-oncogene N-ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC MICRORNA; TUMOR-SUPPRESSOR SUFU; SKELETAL-MUSCLE; TERMINAL DIFFERENTIATION; STEM-CELLS; MYOD; EXPRESSION; PROLIFERATION; DEGRADATION; TARGETS	Vertebrate muscle differentiation is coordinated by an intricate network of transcription factors requiring proliferating myogenic precursors to withdraw irreversibly from the cell cycle. Recent studies have implicated a large number of microRNAs exerting another layer of control in many aspects of muscle differentiation. By annealing to short recognition sequences in the 3'-untranslated region, microRNAs attenuate target gene expression through translation repression or mRNA degradation. Here, we show that miR-214 promotes myogenic differentiation in mouse C2C12 myoblasts at a step preceding the induction of p21 and myogenin. Blocking miR-214 function with a 2'-O-methylated double-stranded inhibitor maintained C2C12 cells in the active cell cycle, thereby inhibiting the myogenic differentiation. By global gene expression profiling, we identified the proto-oncogene N-ras as one of miR-214 targets. Furthermore, manipulating the N-Ras level with small interfering RNA or adenovirus-mediated forced expression either augmented or attenuated the effect of miR-214, respectively. Thus, our data uncovered a novel microRNA-mediated mechanism that controls myogenic differentiation.	[Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, Nanjing 210029, Jiangsu, Peoples R China; [Liu, Jun; Luo, Xiao-ju; Xiong, An-wen; Zhang, Zeng-di; Yue, Shen; Cheng, Steven Y.] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhu, Ming-sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 21006, Jiangsu, Peoples R China; [Zhu, Ming-sheng] Nanjing Univ, Minist Educ, Key Lab Model Anim & Dis Study, Nanjing 21006, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing University	Cheng, SY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	sycheng@njmu.edu.cn			Chinese National Science Foundation [30871401]; 973 National Basic Research Program of China [2009CB942602]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); 973 National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Chinese National Science Foundation Grant 30871401 (to S. Y. C.) and 973 National Basic Research Program of China Grant 2009CB942602 (to M.-s. Z.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; Polesskaya A, 2002, DEV CELL, V3, P757, DOI 10.1016/S1534-5807(02)00372-6; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	40	71	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26599	26607		10.1074/jbc.M110.115824	http://dx.doi.org/10.1074/jbc.M110.115824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20534588	Green Published, hybrid			2022-12-27	WOS:000280921000075
J	Neerincx, A; Lautz, K; Menning, M; Kremmer, E; Zigrino, P; Hosel, M; Buning, H; Schwarzenbacher, R; Kufer, TA				Neerincx, Andreas; Lautz, Katja; Menning, Maureen; Kremmer, Elisabeth; Zigrino, Paola; Hoesel, Marianna; Buening, Hildegard; Schwarzenbacher, Robert; Kufer, Thomas A.			A Role for the Human Nucleotide-binding Domain, Leucine-rich Repeat-containing Family Member NLRC5 in Antiviral Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; PATTERN-RECOGNITION; SIGNALING PATHWAYS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; VIRAL-INFECTION; INNATE IMMUNITY; ACTIVATION; GENE	Proteins of the nucleotide-binding domain, leucine-rich repeat (NLR)-containing family recently gained attention as important components of the innate immune system. Although over 20 of these proteins are present in humans, only a few members including the cytosolic pattern recognition receptors NOD1, NOD2, and NLRP3 have been analyzed extensively. These NLRs were shown to be pivotal for mounting innate immune response toward microbial invasion. Here we report on the characterization of human NLRC5 and provide evidence that this NLR has a function in innate immune responses. We found that NLRC5 is a cytosolic protein expressed predominantly in hematopoetic cells. NLRC5 mRNA and protein expression was inducible by the double-stranded RNA analog poly(I.C) and Sendai virus. Overexpression of NLRC5 failed to trigger inflammatory responses such as the NF-kappa B or interferon pathways in HEK293T cells. However, knockdown of endogenous NLRC5 reduced Sendai virus-and poly(I.C)-mediated type I interferon pathway-dependent responses in THP-1 cells and human primary dermal fibroblasts. Taken together, this defines a function for NLRC5 in anti-viral innate immune responses.	[Neerincx, Andreas; Lautz, Katja; Menning, Maureen; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Zigrino, Paola] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Hoesel, Marianna; Buening, Hildegard] Univ Cologne, Innere Med Klin 1, D-50937 Cologne, Germany; [Hoesel, Marianna; Buening, Hildegard] Univ Cologne, Zentrum Mol Biol Koln, D-50931 Cologne, Germany; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; University of Cologne; University of Cologne; Salzburg University	Kufer, TA (corresponding author), Joseph Stelzmann Str 9,Geb 37, D-50931 Cologne, Germany.	thomas.kufer@uk-koeln.de	Kufer, Thomas A/I-5146-2015; Buening, Hildegard/AAV-9928-2021; Buening, Hildegard/AAJ-2352-2020	Kufer, Thomas A/0000-0003-4563-0412; Buening, Hildegard/0000-0002-3365-6933; Zigrino, Paola/0000-0002-7470-0064	Deutsche Forschungsgemeinschaft [SFB670-N01, SFB670-TP8]; European Commission [MEXT-CT-2006-033534]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB670-N01 (to T.A.K.) and SFB670-TP8 (to M.H. and H.B.) and European Commission Grant MEXT-CT-2006-033534 (to R.S. and A.N.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bielig H, 2009, MOL IMMUNOL, V46, P2647, DOI 10.1016/j.molimm.2009.04.022; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Hua J, 1996, J LEUKOCYTE BIOL, V60, P125, DOI 10.1002/jlb.60.1.125; Hughes AL, 2006, IMMUNOGENETICS, V58, P785, DOI 10.1007/s00251-006-0148-8; Inohara N, 2000, J BIOL CHEM, V275, P27823; Istomin AY, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-48; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; Matsukura S, 1998, AM J RESP CELL MOL, V18, P255, DOI 10.1165/ajrcmb.18.2.2822; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Quasdorff M, 2008, CELL MICROBIOL, V10, P1478, DOI 10.1111/j.1462-5822.2008.01141.x; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Vijay-Kumar M, 2005, J IMMUNOL, V174, P6322, DOI 10.4049/jimmunol.174.10.6322; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134	38	125	137	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26223	26232		10.1074/jbc.M110.109736	http://dx.doi.org/10.1074/jbc.M110.109736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538593	Green Published, hybrid			2022-12-27	WOS:000280921000039
J	Reinehr, R; Sommerfeld, A; Haussinger, D				Reinehr, Roland; Sommerfeld, Annika; Haeussinger, Dieter			Insulin Induces Swelling-dependent Activation of the Epidermal Growth Factor Receptor in Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD95 MEMBRANE TRAFFICKING; FAMILY KINASE YES; SIGNAL-TRANSDUCTION; SRC; INVOLVEMENT; PHOSPHORYLATION; HYPEROSMOLARITY; REGENERATION; PROTEOLYSIS; MODULATION	The aim of the study was to analyze whether the proliferative effects of insulin in rat liver involve cross-signaling toward the epidermal growth factor receptor (EGFR) and whether this is mediated by insulin-induced hepatocyte swelling. Studies were performed in the perfused rat liver and in primary rat hepatocytes. Insulin (35 nmol/liter) induced phosphorylation of the EGFR at position Tyr(845) and Tyr(1173), but not at Tyr(1045), suggesting that EGF is not involved in insulin-induced EGFR activation. Insulin-induced EGFR phosphorylation and subsequent ERK1/2 phosphorylation were sensitive to bumetanide, indicating an involvement of insulin-induced hepatocyte swelling. In line with this, hypoosmotic (225 mosmol/liter) hepatocyte swelling also induced EGFR and ERK1/2 activation. Insulin- and hypoosmolarity-induced EGFR activation were sensitive to inhibition by an integrin-antagonistic RGD peptide, an integrin beta 1 subtype-blocking antibody, and the c-Src inhibitor PP-2, indicating the involvement of the recently described integrin-dependent osmosensing/signaling pathway (Schliess, F., Reissmann, R., Reinehr, R., vom Dahl, S., and Haussinger, D. (2004) J. Biol. Chem. 279, 21294-21301). As shown by immunoprecipitation studies, insulin and hypoosmolarity induced a rapid, RGD peptide-, integrin beta 1-blocking antibody and PP-2-sensitive association of c-Src with the EGFR. As for control, insulin-induced insulin receptor substrate-1 phosphorylation remained unaffected by the RGD peptide, PP-2, or inhibition of the EGFR tyrosine kinase activity by AG1478. Both insulin and hypoosmolarity induced a significant increase in BrdU uptake in primary rat hepatocytes, which was sensitive to RGD peptide-, integrin beta 1-blocking antibody, PP-2, AG1478, and PD098059. It is concluded that insulin- or hypoosmolarity-induced hepatocyte swelling triggers an integrin- and c-Src kinase-dependent EGFR activation, which may explain the proliferative effects of insulin.	[Reinehr, Roland; Sommerfeld, Annika; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016		Deutsche Forschungsgemeinschaft (Dusseldorf) [575]	Deutsche Forschungsgemeinschaft (Dusseldorf)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 "Experimentelle Hepatologie" (Dusseldorf).	Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fujioka T, 2001, EUR J BIOCHEM, V268, P25, DOI 10.1046/j.1432-1327.2001.01831.x; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger Dieter, 2004, Molecular Aspects of Medicine, V25, P221, DOI 10.1016/j.mam.2004.02.001; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Ravid T, 2002, J BIOL CHEM, V277, P31214, DOI 10.1074/jbc.M204677200; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Schliess F, 2001, BIOL CHEM, V382, P1063, DOI 10.1515/BC.2001.133; Sies H, 1978, Methods Enzymol, V52, P48; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; VOMDAHL S, 1995, BIOCHEM J, V308, P529, DOI 10.1042/bj3080529; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	39	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25904	25912		10.1074/jbc.M110.125781	http://dx.doi.org/10.1074/jbc.M110.125781			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20571033	hybrid, Green Published			2022-12-27	WOS:000280921000005
J	Strauss, K; Goebel, C; Runz, H; Mobius, W; Weiss, S; Feussner, I; Simons, M; Schneider, A				Strauss, Katrin; Goebel, Cornelia; Runz, Heiko; Moebius, Wiebke; Weiss, Sievert; Feussner, Ivo; Simons, Mikael; Schneider, Anja			Exosome Secretion Ameliorates Lysosomal Storage of Cholesterol in Niemann-Pick Type C Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED EXOSOMES; PURIFIED NPC1 PROTEIN; ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; REGGIE/FLOTILLIN PROTEINS; BENZODIAZEPINE-RECEPTOR; MEMBRANE MICRODOMAINS; C1-DEFICIENT NEURONS; CORTICAL-NEURONS; DISTAL AXONS	Niemann-Pick type C1 disease is an autosomal-recessive lysosomal storage disorder. Loss of function of the npc1 gene leads to abnormal accumulation of free cholesterol and sphingolipids within the late endosomal and lysosomal compartments resulting in progressive neurodegeneration and dysmyelination. Here, we show that oligodendroglial cells secrete cholesterol by exosomes when challenged with cholesterol or U18666A, which induces late endosomal cholesterol accumulation. Up-regulation of exosomal cholesterol release was also observed after siRNA-mediated knockdown of NPC1 and in fibroblasts derived from NPC1 patients and could be reversed by expression of wild-type NPC1. We provide evidence that exosomal cholesterol secretion depends on the presence of flotillin. Our findings indicate that exosomal release of cholesterol may serve as a cellular mechanism to partially bypass the traffic block that results in the toxic lysosomal cholesterol accumulation in Niemann-Pick type C1 disease. Furthermore, we suggest that secretion of cholesterol by exosomes contributes to maintain cellular cholesterol homeostasis.	[Moebius, Wiebke; Schneider, Anja] Max Planck Inst Expt Med, Neurogenet Dept, D-37075 Gottingen, Germany; [Strauss, Katrin; Schneider, Anja] Univ Med Goettingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany; [Goebel, Cornelia; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, D-37077 Gottingen, Germany; [Runz, Heiko] Univ Heidelberg, Dept Human Genet, D-69120 Heidelberg, Germany; Univ Med Goettingen, Dept Neurol, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; Ruprecht Karls University Heidelberg	Schneider, A (corresponding author), Max Planck Inst Expt Med, Neurogenet Dept, Hermann Rein Str 3, D-37075 Gottingen, Germany.	aschnei8@gwdg.de	Feussner, Ivo/H-9320-2013; Schneider, Anja/F-5293-2010	Feussner, Ivo/0000-0002-9888-7003; Simons, Mikael/0000-0001-5329-192X; Schneider, Anja/0000-0001-9540-8700; /0000-0002-2902-7165	Faculty of Medicine, Georg-August-University Gottingen, Germany [0010/1401870]; Center of Molecular Physiology of the Brain Gottingen; Novartis; European Research Council	Faculty of Medicine, Georg-August-University Gottingen, Germany; Center of Molecular Physiology of the Brain Gottingen; Novartis(Novartis); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany (Grant 0010/1401870 and Heidenreich-Siebold-Program (to A.S.)), the Center of Molecular Physiology of the Brain Gottingen and a Novartis fellowship (to A.S.), and by an European Research Council starting grant (to M.S.).	Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Bauer SHJ, 2001, ANAL BIOCHEM, V298, P25, DOI 10.1006/abio.2001.5330; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2010, IUBMB LIFE, V62, P261, DOI 10.1002/iub.305; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Roitbak T, 2005, BIOCHEM J, V392, P29, DOI 10.1042/BJ20050645; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VIDAL M, 1989, J CELL PHYSIOL, V140, P455, DOI 10.1002/jcp.1041400308; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013	55	158	167	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26279	26288		10.1074/jbc.M110.134775	http://dx.doi.org/10.1074/jbc.M110.134775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554533	Green Published, hybrid			2022-12-27	WOS:000280921000045
J	Blais, DR; Lyn, RK; Joyce, MA; Rouleau, Y; Steenbergen, R; Barsby, N; Zhu, LF; Pegoraro, AF; Stolow, A; Tyrrell, DL; Pezacki, JP				Blais, David R.; Lyn, Rodney K.; Joyce, Michael A.; Rouleau, Yanouchka; Steenbergen, Rineke; Barsby, Nicola; Zhu, Lin-Fu; Pegoraro, Adrian F.; Stolow, Albert; Tyrrell, David L.; Pezacki, John Paul			Activity-based Protein Profiling Identifies a Host Enzyme, Carboxylesterase 1, Which Is Differentially Active during Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAMAN-SCATTERING MICROSCOPY; CHOLESTERYL ESTER HYDROLASE; ACTIVITY-BASED PROBES; LIPID DROPLETS; TRIACYLGLYCEROL HYDROLASE; CORE PROTEIN; IN-VIVO; ENDOPLASMIC-RETICULUM; CARS MICROSCOPY; RNA REPLICATION	Hepatitis C virus (HCV) relies on many interactions with host cell proteins for propagation. Successful HCV infection also requires enzymatic activity of host cell enzymes for key post-translational modifications. To identify such enzymes, we have applied activity-based protein profiling to examine the activity of serine hydrolases during HCV replication. Profiling of hydrolases in Huh7 cells replicating HCV identified CES1 (carboxylesterase 1) as a differentially active enzyme. CES1 is an endogenous liver protein involved in processing of triglycerides and cholesterol. We observe that CES1 expression and activity were altered in the presence of HCV. The knockdown of CES1 with siRNA resulted in lower levels of HCV replication, and up-regulation of CES1 was observed to favor HCV propagation, implying an important role for this host cell protein. Experiments in HCV JFH1-infected cells suggest that CES1 facilitates HCV release because less intracellular HCV core protein was observed, whereas HCV titers remained high. CES1 activity was observed to increase the size and density of lipid droplets, which are necessary for the maturation of very low density lipoproteins, one of the likely vehicles for HCV release. In transgenic mice containing human-mouse chimeric livers, HCV infection also correlates with higher levels of endogenous CES1, providing further evidence that CES1 has an important role in HCV propagation.	[Blais, David R.; Lyn, Rodney K.; Rouleau, Yanouchka; Pegoraro, Adrian F.; Stolow, Albert; Pezacki, John Paul] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biochem, Ottawa, ON K1N 6N5, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Microbiol, Ottawa, ON K1N 6N5, Canada; [Joyce, Michael A.; Steenbergen, Rineke; Barsby, Nicola; Zhu, Lin-Fu; Tyrrell, David L.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Pegoraro, Adrian F.; Stolow, Albert] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Immunol, Ottawa, ON K1N 6N5, Canada	National Research Council Canada; University of Ottawa; University of Ottawa; University of Alberta; Queens University - Canada; University of Ottawa	Pezacki, JP (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	john.pezacki@nrc-cnrc.gc.ca	Stolow, Albert/AAN-5609-2020	Pegoraro, Adrian/0000-0003-3334-227X	Canadian Liver Foundation; Canadian Institutes for Health Research; National Research Council Genomics and Health Initiative	Canadian Liver Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Research Council Genomics and Health Initiative	This work was supported by the Canadian Liver Foundation, the Canadian Institutes for Health Research, and the National Research Council Genomics and Health Initiative.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; Beckman M, 2006, SCIENCE, V311, P1232, DOI 10.1126/science.311.5765.1232; Blais DR, 2010, J PROTEOME RES, V9, P912, DOI 10.1021/pr900788a; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gilham D, 2005, MOL BIOL CELL, V16, P984, DOI 10.1091/mbc.e04-03-0224; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lehner R, 1999, BIOCHEM J, V338, P761, DOI 10.1042/0264-6021:3380761; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Listenberger LL, 2008, CURR BIOL, V18, pR237, DOI 10.1016/j.cub.2008.01.010; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nan XL, 2006, CHEMBIOCHEM, V7, P1895, DOI 10.1002/cbic.200600330; Noestheden M, 2007, ORG BIOMOL CHEM, V5, P2380, DOI 10.1039/b704812b; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Potter PM, 1998, CANCER RES, V58, P3627; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; ROBBI M, 1991, J BIOL CHEM, V266, P20498; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Singaravelu R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-5; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yang ZM, 2009, BIOORGAN MED CHEM, V17, P1071, DOI 10.1016/j.bmc.2008.02.089; Zhao B, 2005, J LIPID RES, V46, P2114, DOI 10.1194/jlr.M500207-JLR200; Zhao B, 2005, PHYSIOL GENOMICS, V23, P304, DOI 10.1152/physiolgenomics.00187.2005	63	52	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25602	25612		10.1074/jbc.M110.135483	http://dx.doi.org/10.1074/jbc.M110.135483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530478	hybrid, Green Published			2022-12-27	WOS:000280682400054
J	Cho, HJ; Park, SM; Hwang, EM; Baek, KE; Kim, IK; Nam, IK; Im, MJ; Park, SH; Bae, S; Park, JY; Yoo, J				Cho, Hee Jun; Park, Sun-Mi; Hwang, Eun Mi; Baek, Kyoung Eun; Kim, In-Kyu; Nam, In-Koo; Im, Min-Ju; Park, Seung-Ho; Bae, Seran; Park, Jae-Yong; Yoo, Jiyun			Gadd45b Mediates Fas-induced Apoptosis by Enhancing the Interaction between p38 and Retinoblastoma Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; PROTEIN; ACTIVATION; CELLS; MTK1/MEKK4; EXPRESSION; GADD45A-DEFICIENT; RADIATION; PATHWAY	Gadd45b has been known as a positive mediator of apoptosis induced by certain cytokines and oncogenes. Here, we identified Gadd45b as an effector of Fas-induced apoptosis and found that p38-mediated Rb hyperphosphorylation is one of the mechanisms of Fas-induced apoptosis in murine hepatocyte AML12 cells. Gadd45b has been shown to activate p38 through its physical interaction with MTK1 and induce apoptosis. However, in this study, we have showed that the function of Gadd45b during Fas-induced apoptosis in AML12 cells is different from that reported in previous studies. Depletion of Gadd45b expression did not inhibit the phosphorylation of p38, but it suppressed p38-mediated Rb phosphorylation and apoptosis in response to Fas stimulation by reducing the interaction between p38 and Rb. Ectopic expression of Gadd45b was sufficient to enhance this interaction. These findings suggest that Gadd45b mediates p38-induced Rb phosphorylation by enhancing the interaction between p38 and Rb during Fas-induced apoptosis in murine hepatocytes.	[Cho, Hee Jun; Park, Sun-Mi; Baek, Kyoung Eun; Kim, In-Kyu; Nam, In-Koo; Im, Min-Ju; Park, Seung-Ho; Bae, Seran; Yoo, Jiyun] Gyeongsang Natl Univ, Coll Nat Sci, Dept Microbiol, Life Sci Res Inst, Jinju 660701, South Korea; [Hwang, Eun Mi] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Physiol, Jinju 660751, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Med Res Ctr Neural Dysfunct, Jinju 660751, South Korea	Gyeongsang National University; Korea Institute of Science & Technology (KIST); Gyeongsang National University; Gyeongsang National University	Yoo, J (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci, Dept Microbiol, Life Sci Res Inst, Jinju 660701, South Korea.	yooj@gsnu.ac.kr	Hwang, Eun Mi/HHN-3030-2022	Kim, In-Kyu/0000-0002-8427-8311; Park, Jae-Yong/0000-0001-7698-7890	Ministry of Health and Welfare, Republic of Korea [0420050]; Korean government (MOEHRD) [KRF-2005-003-C00140]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This study was supported by Grant 0420050 from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea and Korea Research Foundation Grant KRF-2005-003-C00140 funded by the Korean government (MOEHRD, Basic Research Promotion Fund).	Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Engelmann A, 2008, ONCOGENE, V27, P1429, DOI 10.1038/sj.onc.1210772; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Fulda S, 2001, ONCOGENE, V20, P1063, DOI 10.1038/sj.onc.1204141; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; PAPATHANASIOU MA, 1991, MOL CELL BIOL, V11, P1009, DOI 10.1128/MCB.11.2.1009; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang W, 2001, INT J ONCOL, V18, P749	29	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25500	25505		10.1074/jbc.M109.091413	http://dx.doi.org/10.1074/jbc.M109.091413			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558744	Green Published, hybrid			2022-12-27	WOS:000280682400043
J	Fromigue, O; Hay, E; Barbara, A; Marie, PJ				Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.			Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX MINERALIZATION; BONE-FORMATION; CALCINEURIN; CALCIUM; NFAT; BETA; OSTEOCLASTOGENESIS; TRANSCRIPTION; OSTEOPOROSIS; PATHWAY	The antiosteoporotic treatment strontium ranelate (SrRan) was shown to increase bone mass and strength by dissociating bone resorption and bone formation. To identify the molecular mechanisms of action of SrRan on osteoblasts, we investigated its effects on calcineurin-NFAT (nuclear factor of activated T cells) signaling, an important calcium sensitive pathway controlling bone formation. Using murine MC3T3-E1 and primary murine osteoblasts, we demonstrate that SrRan induces NFATc1 nuclear translocation, as shown by immunocytochemical and Western blot analyses. Molecular analysis showed that SrRan increased NFATc1 transactivation in osteoblasts, an effect that was fully abrogated by the calcineurin inhibitors cyclosporin A or FK506, confirming that SrRan activates NFATc1 signaling in osteoblasts. This has functional implications because calcineurin inhibitors blunted the enhanced osteoblast replication and expression of the osteoblast phenotypic markers Runx2, alkaline phosphatase, and type I collagen induced by SrRan. We further found that SrRan increased the expression of Wnt3a and Wnt5a as well as beta-catenin transcriptional activity in osteoblasts, and these effects were abolished by calcineurin inhibitors. The Wnt inhibitors sFRP1 and DKK1 abolished SrRan-induced osteoblast gene expression. Furthermore, blunting the Wnt5a receptor Ryk or RhoA that acts downstream of Ryk abrogated cell proliferation and osteoblast gene expression induced by SrRan. These results indicate that activation of NFATc1 and downstream canonical and non-canonical Wnt signaling pathways mediate SrRan-induced osteoblastic cell replication and differentiation, which provides novel insights into the mechanisms of action of this antiosteoporotic agent in osteoblastogenesis.	[Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.] Hop Lariboisiere, INSERM, UMR606, Lab Osteoblast Biol & Pathol,U606, F-75475 Paris 10, France; [Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.] Univ Paris Diderot, UMR606, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR606, Lab Osteoblast Biol & Pathol,U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Fromigue, Olivia/B-8225-2013	Fromigue, Olivia/0000-0002-3050-6155; Hay, Eric/0000-0002-0131-9983	Inserm, University Paris Diderot; Institut de Recherches Servier (IRIS, Courbevoie, France)	Inserm, University Paris Diderot(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut de Recherches Servier (IRIS, Courbevoie, France)	This work was supported by grants from Inserm, University Paris Diderot, and the Institut de Recherches Servier (IRIS, Courbevoie, France).	Ali MM, 2007, J CELL SCI, V120, P2565, DOI 10.1242/jcs.005090; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arlot ME, 2008, J BONE MINER RES, V23, P215, DOI 10.1359/JBMR.071012; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; Ikeda F, 2006, J IMMUNOL, V177, P2384, DOI 10.4049/jimmunol.177.4.2384; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; Sun L, 2007, AM J PHYSIOL-RENAL, V292, pF285, DOI 10.1152/ajprenal.00415.2005; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120	53	98	111	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25251	25258		10.1074/jbc.M110.110502	http://dx.doi.org/10.1074/jbc.M110.110502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554534	Green Published, hybrid			2022-12-27	WOS:000280682400018
J	Anyatonwu, G; Khan, MT; Schug, ZT; da Fonseca, PCA; Morris, EP; Joseph, SK				Anyatonwu, Georgia; Khan, M. Tariq; Schug, Zachary T.; da Fonseca, Paula C. A.; Morris, Edward P.; Joseph, Suresh K.			Calcium-dependent Conformational Changes in Inositol Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; 1,4,5-TRISPHOSPHATE RECEPTOR; IP3 RECEPTORS; CRYSTAL-STRUCTURE; CA2+ RELEASE; DOMAIN; APOPTOSIS; CELLS; PORE; PHOSPHORYLATION	We have used limited trypsin digestion and reactivity with PEG-maleimides (MPEG) to study Ca2+-induced conformational changes of IP(3)Rs in their native membrane environment. We found that Ca2+ decreased the formation of the 95-kDa C-terminal tryptic fragment when detected by an Ab directed at a C-terminal epitope (CT-1) but not with an Ab recognizing a protected intraluminal epitope. This suggests that Ca2+ induces a conformational change in the IP3R that allows trypsin to cleave the C-terminal epitope. Half-maximal effects of Ca2+ were observed at similar to 0.5 mu M and was sensitive to inhibition by IP3. Ca2+ also stimulated the reaction of MPEG-5 with an endogenous thiol in the 95-kDa fragment. This effect was eliminated when six closely spaced cysteine residues proximal to the transmembrane domains were mutated (C2000S, C2008S, C2010S, C2043S, C2047S, and C2053S) or when the N-terminal suppressor domain (amino acids 1-225) was deleted. A cysteine substitution mutant introduced at the C-terminal residue (A2749C) was freely accessible to MPEG-5 or MPEG-20 in the absence of Ca2+. However, cysteine substitution mutants in the interior of the tail were poorly reactive with MPEG-5, although reactivity was enhanced by Ca2+. We conclude the following: a) that large conformational changes induced by Ca2+ can be detected in IP(3)Rs in situ; b) these changes may be driven by Ca2+ binding to the N-terminal suppressor domain and expose a group of closely spaced endogenous thiols in the channel domain; and c) that the C-terminal cytosol-exposed tail of the IP3R may be relatively inaccessible to regulatory proteins unless Ca2+ is present.	[Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 230A,JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041; Schug, Zachary/0000-0003-4197-8227	National Institutes of Health [DK34804, T32-AA-7463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant DK34804 (to S. K. J.) and Training Grant T32-AA-7463 (to G. A.).	Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Joseph SK, 2005, CELL CALCIUM, V38, P539, DOI 10.1016/j.ceca.2005.07.007; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200; Khan MT, 2003, BIOCHEM J, V375, P603, DOI 10.1042/BJ20030828; LIN JK, 1987, BIOTECHNOL BIOENG, V29, P976, DOI 10.1002/bit.260290809; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Shirakawa H, 2006, BIOCHEM BIOPH RES CO, V345, P781, DOI 10.1016/j.bbrc.2006.04.133; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vanderheyden V, 2009, CELL CALCIUM, V46, P56, DOI 10.1016/j.ceca.2009.04.004; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Zhang SB, 2009, J BIOL CHEM, V284, P29158, DOI 10.1074/jbc.M109.041509	46	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25085	25093		10.1074/jbc.M110.123208	http://dx.doi.org/10.1074/jbc.M110.123208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530483	Green Published, hybrid			2022-12-27	WOS:000280542100081
J	Huang, F; Chandrasekharan, MB; Chen, YC; Bhaskara, S; Hiebert, SW; Sun, ZW				Huang, Fu; Chandrasekharan, Mahesh B.; Chen, Yi-Chun; Bhaskara, Srividya; Hiebert, Scott W.; Sun, Zu-Wen			The JmjN Domain of Jhd2 Is Important for Its Protein Stability, and the Plant Homeodomain (PHD) Finger Mediates Its Chromatin Association Independent of H3K4 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; SACCHAROMYCES-CEREVISIAE; HISTONE DEMETHYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; BUDDING YEAST; JARID1C GENE; UBIQUITINATION; REPRESSION; FAMILY	Histone lysine methylation is a dynamic process that plays an important role in regulating chromatin structure and gene expression. Recent studies have identified Jhd2, a JmjC domain-containing protein, as an H3K4-specific demethylase in budding yeast. However, important questions regarding the regulation and functions of Jhd2 remain unanswered. In this study, we show that Jhd2 has intrinsic activity to remove all three states of H3K4 methylation in vivo and can dynamically associate with chromatin to modulate H3K4 methylation levels on both active and repressed genes and at the telomeric regions. We found that the plant homeodomain (PHD) finger of Jhd2 is important for its chromatin association in vivo. However, this association is not dependent on H3K4 methylation and the H3 N-terminal tail, suggesting the presence of an alternative mechanism by which Jhd2 binds nucleosomes. We also provide evidence that the JmjN domain and its interaction with the JmjC catalytic domain are important for Jhd2 function and that Not4 (an E3 ligase) monitors the structural integrity of this interdomain interaction to maintain the overall protein levels of Jhd2. We show that the S451R mutation in human SMCX (a homolog of Jhd2), which has been linked to mental retardation, and the homologous T359R mutation in Jhd2 affect the protein stability of both of these proteins. Therefore, our findings provide a mechanistic explanation for the observed defects in patients harboring this SMCX mutant and suggest the presence of a conserved pathway involving Not4 that modulates the protein stability of both yeast Jhd2 and human SMCX.	[Sun, Zu-Wen] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Sun, ZW (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 613C Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	zuwen.sun@vanderbilt.edu	Chandrasekharan, Mahesh/AAF-4793-2020; Hu, Ruogu/B-2203-2008	Chandrasekharan, Mahesh/0000-0002-9956-8354; Bhaskara, Srividya/0000-0002-2182-9585; Huang, Fu/0000-0001-9549-8937	National Institutes of Health [RO1 CA109355]; Vanderbilt-Ingram Cancer Center; Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA109355, T32CA009582, R01CA141071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA109355. This work was also supported by the Vanderbilt-Ingram Cancer Center and the Kleberg Foundation.	Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beranger F, 1997, NUCLEIC ACIDS RES, V25, P2035, DOI 10.1093/nar/25.10.2035; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; SCHULLER HJ, 1992, NUCLEIC ACIDS RES, V20, P5955, DOI 10.1093/nar/20.22.5955; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	53	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24548	24561		10.1074/jbc.M110.117333	http://dx.doi.org/10.1074/jbc.M110.117333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538609	hybrid, Green Published			2022-12-27	WOS:000280542100027
J	Deng, B; Parthasarathy, S; Wang, WF; Gibney, BR; Battaile, KP; Lovell, S; Benson, DR; Zhu, H				Deng, Bin; Parthasarathy, Sudharsan; Wang, WenFang; Gibney, Brian R.; Battaile, Kevin P.; Lovell, Scott; Benson, David R.; Zhu, Hao			Study of the Individual Cytochrome b(5) and Cytochrome b(5) Reductase Domains of Ncb5or Reveals a Unique Heme Pocket and a Possible Role of the CS Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; NITRATE REDUCTASE; SULFITE OXIDASE; MOLECULAR-REPLACEMENT; ANGSTROM RESOLUTION; APOCYTOCHROME B(5); FUSION PROTEIN; BIS-HISTIDINE; EXPRESSION; COMPLEXES	NADH cytochrome b(5) oxidoreductase (Ncb5or) is found in animals and contains three domains similar to cytochrome b5 (b(5)), CHORD-SGT1 (CS), and cytochrome b5 reductase (b(5)R). Ncb5or has an important function, as suggested by the diabetes and lipoatrophy phenotypes in Ncb5or null mice. To elucidate the structural and functional properties of human Ncb5or, we generated its individual b5 and b5R domains (Ncb5or-b(5) and Ncb5or-b(5)R, respectively) and compared them with human microsomal b5 (Cyb5A) and b(5)R(Cyb5R3). A1.25 angstrom x-ray crystal structure of Ncb5or-b(5) reveals nearly orthogonal planes of the imidazolyl rings of heme-ligating residues His(89) and His(112), consistent with a highly anisotropic low spin EPR spectrum. Ncb5or is the first member of the cytochrome b(5) family shown to have such a heme environment. Like other b(5) family members, Ncb5or-b(5) has two helix-loop-helix motifs surrounding heme. However, Ncb5or-b5 differs from Cyb5A with respect to location of the second heme ligand (His(112)) and of polypeptide conformation in its vicinity. Electron transfer from Ncb5or-b5R to Ncb5or-b(5) is much less efficient than from Cyb5R3 to Cyb5A, possibly as a consequence of weaker electrostatic interactions. The CS linkage probably obviates the need for strong interactions between b(5) and b5R domains in Ncb5or. Studies with a construct combining the Ncb5or CS and b(5)R domains suggest that the CS domain facilitates docking of the b(5) and b(5)R domains. Trp(114) is an invariant surface residue in all known Ncb5or orthologs but appears not to contribute to electron transfer from the b(5)R domain to the b(5) domain.	[Parthasarathy, Sudharsan; Benson, David R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Zhu, Hao] Univ Kansas, Med Ctr, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Deng, Bin; Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Zhu, Hao] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Benson, David R.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Struct Biol Ctr, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Argonne Natl Lab, Ind Macromol Crystallog Assoc Collaborat Access T, Adv Photon Source, Argonne, IL 60439 USA; [Gibney, Brian R.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA	University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory; City University of New York (CUNY) System; Brooklyn College (CUNY)	Benson, DR (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	drb@ku.edu; hzhu@kumc.edu		Battaile, Kevin/0000-0003-0833-3259; Gibney, Brian/0000-0002-8966-7463	National Institutes of Health [RO1 DK067355, 5P20 RR17708]; American Heart Association [0755879T]; United States Department of Energy [W-31-109-Eng-38]; Industrial Macromolecular Crystallography Association through Center for Advanced Radiation Sources at the University of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy(United States Department of Energy (DOE)); Industrial Macromolecular Crystallography Association through Center for Advanced Radiation Sources at the University of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK067355 (to H. Franklin Bunn and H.Z.) and by National Institutes of Health Centers of Biomedical Research Excellence-Protein Structure and Function award 5P20 RR17708 (to the University of Kansas, R. P. Hanzlik, P.I.). This work was also supported by American Heart Association Grant-in-Aid 0755879T (to B.R.G.). Use of the Advanced Photon Source was supported by the United States Department of Energy under Contract W-31-109-Eng-38, and use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barber MJ, 2002, ARCH BIOCHEM BIOPHYS, V402, P38, DOI 10.1016/S0003-9861(02)00035-8; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; BORGESE N, 1990, BIOCHEM J, V266, P341, DOI 10.1042/bj2660341; CANNONS AC, 1993, J BIOL CHEM, V268, P3268; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Cowley AB, 2004, PROTEIN SCI, V13, P2316, DOI 10.1110/ps.04817704; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis CA, 2002, ARCH BIOCHEM BIOPHYS, V400, P63, DOI 10.1006/abbi.2002.2783; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falzone CJ, 1996, BIOCHEMISTRY-US, V35, P6519, DOI 10.1021/bi960501q; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; HYDE GE, 1991, J BIOL CHEM, V266, P23542; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kawano M, 1998, BIOCHEM BIOPH RES CO, V245, P666, DOI 10.1006/bbrc.1998.8502; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; LEDERER F, 1994, BIOCHIMIE, V76, P674, DOI 10.1016/0300-9084(94)90144-9; LLOYD E, 1994, BIOCHEMISTRY-US, V33, P11432, DOI 10.1021/bi00204a005; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madej MG, 2006, EMBO J, V25, P4963, DOI 10.1038/sj.emboj.7601361; MATHEWS FS, 1972, J MOL BIOL, V64, P449, DOI 10.1016/0022-2836(72)90510-4; MATHEWS FS, 1971, NATURE-NEW BIOL, V233, P15, DOI 10.1038/newbio233015a0; MATHEWS FS, 1979, PORPHYRINS, V7, P107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLaughlin LA, 2010, MOL PHARMACOL, V78, P269, DOI 10.1124/mol.110.064246; MEYER TE, 1995, ARCH BIOCHEM BIOPHYS, V318, P457, DOI 10.1006/abbi.1995.1254; MIGITA CT, 1981, J AM CHEM SOC, V103, P4378, DOI 10.1021/ja00405a015; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1996, PROTEINS, V26, P32, DOI 10.1002/(SICI)1097-0134(199609)26:1<32::AID-PROT3>3.0.CO;2-I; PIETRINI G, 1988, P NATL ACAD SCI USA, V85, P7246, DOI 10.1073/pnas.85.19.7246; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RodriguezMaranon MJ, 1996, BIOCHEMISTRY-US, V35, P16378, DOI 10.1021/bi961895o; Roma GW, 2006, ARCH BIOCHEM BIOPHYS, V452, P69, DOI 10.1016/j.abb.2006.04.021; Rudolph MJ, 2003, ACTA CRYSTALLOGR D, V59, P1183, DOI 10.1107/S0907444903009934; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; SALERNO JC, 1984, J AM CHEM SOC, V106, P2156, DOI 10.1021/ja00319a041; Shirabe K, 1998, BBA-PROTEIN STRUCT M, V1384, P16, DOI 10.1016/S0167-4838(97)00146-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STRITTMATTER P, 1990, J BIOL CHEM, V265, P21709; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; Wirtz M, 2000, FARADAY DISCUSS, V116, P221, DOI 10.1039/b001520m; XIA ZX, 1987, P NATL ACAD SCI USA, V84, P2629, DOI 10.1073/pnas.84.9.2629; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Yantsevich AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1096, DOI 10.1134/S0006297908100052; Yatsunyk LA, 2006, INORG CHEM, V45, P5417, DOI 10.1021/ic060283h; YUBISUI T, 1987, P NATL ACAD SCI USA, V84, P3609, DOI 10.1073/pnas.84.11.3609; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YZ, 2010, J LIPID RES, V51, P53, DOI 10.1194/jlr.M900146-JLR200; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	67	23	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30181	30191		10.1074/jbc.M110.120329	http://dx.doi.org/10.1074/jbc.M110.120329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630863	Green Published, hybrid			2022-12-27	WOS:000281984300055
J	West, MB; Segu, ZM; Feasley, CL; Kang, P; Klouckova, I; Li, CL; Novotny, MV; West, CM; Mechref, Y; Hanigan, MH				West, Matthew B.; Segu, Zaneer M.; Feasley, Christa L.; Kang, Pilsoo; Klouckova, Iveta; Li, Chenglong; Novotny, Milos V.; West, Christopher M.; Mechref, Yehia; Hanigan, Marie H.			Analysis of Site-specific Glycosylation of Renal and Hepatic gamma-Glutamyl Transpeptidase from Normal Human Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; SOLID-PHASE PERMETHYLATION; ESCHERICHIA-COLI; N-GLYCOSYLATION; SUGAR CHAINS; HUMAN-KIDNEY; HUMAN-LIVER; TRANSFERASE; GLYCANS; GLUTATHIONE	The cell surface glycoprotein gamma-glutamyl transpeptidase (GGT) was isolated from healthy human kidney and liver to characterize its glycosylation in normal human tissue in vivo. GGT is expressed by a single cell type in the kidney. The spectrum of N-glycans released from kidney GGT constituted a subset of the N-glycans identified from renal membrane glycoproteins. Recent advances in mass spectrometry enabled us to identify the microheterogeneity and relative abundance of glycans on specific glycopeptides and revealed a broader spectrum of glycans than was observed among glycans enzymatically released from isolated GGT. A total of 36 glycan compositions, with 40 unique structures, were identified by site-specific glycan analysis. Up to 15 different glycans were observed at a single site, with site-specific variation in glycan composition. N-Glycans released from liver membrane glycoproteins included many glycans also identified in the kidney. However, analysis of hepatic GGT glycopeptides revealed 11 glycan compositions, with 12 unique structures, none of which were observed on kidney GGT. No variation in glycosylation was observed among multiple kidney and liver donors. Two glycosylation sites on renal GGT were modified exclusively by neutral glycans. In silico modeling of GGT predicts that these two glycans are located in clefts on the surface of the protein facing the cell membrane, and their synthesis may be subject to steric constraints. This is the first analysis at the level of individual glycopeptides of a human glycoprotein produced by two different tissues in vivo and provides novel insights into tissue-specific and site-specific glycosylation in normal human tissues.	[Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Biomed Res Ctr, Oklahoma City, OK 73104 USA; [Segu, Zaneer M.; Mechref, Yehia] Indiana Univ, Dept Chem, METACyt Biochem Anal Ctr, Bloomington, IN 47405 USA; [Feasley, Christa L.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA; [Kang, Pilsoo; Klouckova, Iveta; Novotny, Milos V.; Mechref, Yehia] Indiana Univ, Natl Ctr Glycom & Glycoproteom, Dept Chem, Bloomington, IN 47405 USA; [Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Indiana University System; Indiana University Bloomington; University of Oklahoma System; University of Oklahoma Health Sciences Center; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University	Hanigan, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Li, Chenglong/E-7182-2010; Mechref, Yehia/I-5126-2013	Li, Chenglong/0000-0003-3174-8719; Mechref, Yehia/0000-0002-6661-6073	National Institutes of Health [F32CA128338, RO1CA57530, R56CA057530]; NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University [RR018942]; Eli Lilly Endowment; Office of the Vice President for Research; Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center; NATIONAL CANCER INSTITUTE [F32CA128338, R56CA057530, R01CA057530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University; Eli Lilly Endowment(Eli Lilly); Office of the Vice President for Research; Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant F32CA128338 (to M. B. W.), Grants RO1CA57530 and R56CA057530 (to M. H. H.), and Grant RR018942 from the NCRR for the National Center for Glycomics and Glycoproteomics at Indiana University (to M.V.N. and Y.M.). This work was also supported by the Indiana Metabolomics and Cytomics Initiative (METACyt) funded by a grant from Eli Lilly Endowment (to Y.M.). The Oklahoma Center for Medical Glycobiology is supported by the Office of the Vice President for Research and the Department of Biochemistry and Molecular Biology at University of Oklahoma Health Sciences Center.	Alley WR, 2009, RAPID COMMUN MASS SP, V23, P495, DOI 10.1002/rcm.3899; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; ARAI K, 1989, CLIN CHIM ACTA, V184, P75, DOI 10.1016/0009-8981(89)90258-1; ARAI K, 1992, CLIN CHIM ACTA, V210, P35, DOI 10.1016/0009-8981(92)90043-P; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Czlapinski JL, 2006, CURR OPIN CHEM BIOL, V10, P645, DOI 10.1016/j.cbpa.2006.10.009; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; ESWAR N, 2006, COMP PROTEIN STRUC S, V15, P200; EVJEN G, 1992, CLIN CHIM ACTA, V209, P27, DOI 10.1016/0009-8981(92)90330-S; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; GARDELL SJ, 1981, J BIOL CHEM, V256, P4799; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; Goldberg D, 2009, BIOINFORMATICS, V25, P365, DOI 10.1093/bioinformatics/btn636; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HUGHEY RP, 1978, ARCH BIOCHEM BIOPHYS, V186, P211, DOI 10.1016/0003-9861(78)90430-7; HUSEBY NE, 1981, CLIN CHIM ACTA, V111, P39, DOI 10.1016/0009-8981(81)90418-6; Ikeda Y, 2005, METHOD ENZYMOL, V401, P408, DOI 10.1016/S0076-6879(05)01025-6; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Miki K, 2001, J NUCL MED, V42, P733; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; RUTENBERG HL, 1969, LANCET, V2, P559; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; SHAW LM, 1979, CLIN BIOCHEM, V12, P256, DOI 10.1016/S0009-9120(79)80120-4; SHAW LM, 1978, CLIN CHEM, V24, P905; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; TATE SS, 1988, ARCH BIOCHEM BIOPHYS, V262, P397, DOI 10.1016/0003-9861(88)90390-6; THIOUDELLET C, 1994, EUR J BIOCHEM, V222, P1009, DOI 10.1111/j.1432-1033.1994.tb18952.x; TSUCHIDA S, 1985, CLIN CHIM ACTA, V152, P17, DOI 10.1016/0009-8981(85)90171-8; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; YAMASHITA K, 1989, J BIOCHEM-TOKYO, V105, P728, DOI 10.1093/oxfordjournals.jbchem.a122736; YAMASHITA K, 1986, J BIOCHEM-TOKYO, V99, P55, DOI 10.1093/oxfordjournals.jbchem.a135479	52	36	40	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29511	29524		10.1074/jbc.M110.145938	http://dx.doi.org/10.1074/jbc.M110.145938			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622017	Green Published, hybrid			2022-12-27	WOS:000281740100053
J	Bartoccioni, P; del Rio, C; Ratera, M; Kowalczyk, L; Baldwin, JM; Zorzano, A; Quick, M; Baldwin, SA; Vazquez-Ibar, JL; Palacin, M				Bartoccioni, Paola; del Rio, Cesar; Ratera, Merce; Kowalczyk, Lukasz; Baldwin, Jocelyn M.; Zorzano, Antonio; Quick, Matthias; Baldwin, Stephen A.; Luis Vazquez-Ibar, Jose; Palacin, Manuel			Role of Transmembrane Domain 8 in Substrate Selectivity and Translocation of SteT, a Member of the L-Amino Acid Transporter (LAT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINURIC PROTEIN INTOLERANCE; FLAVIN-CONTAINING MONOOXYGENASE; ESCHERICHIA-COLI K-12; 4F2 HEAVY-CHAIN; LIGHT SUBUNIT; NEUROTRANSMITTER TRANSPORTERS; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; OXIDATIVE STRESS	System L-amino acid transporters (LAT) belong to the amino acid, polyamine, and organic cation superfamily of transporters and include the light subunits of heteromeric amino acid transporters and prokaryotic homologues. Cysteine reactivity of SteT (serine/threonine antiporter) has been used here to study the substrate-binding site of LAT transporters. Residue Cys-291, in transmembrane domain 8 (TM8), is inactivated by thiol reagents in a substrate protectable manner. Surprisingly, DTT activated the transporter by reducing residue Cys-291. Cysteine-scanning mutagenesis of TM8 showed DTT activation in the single-cysteine mutants S287C, G294C, and S298C, lining the same alpha-helical face. S-Thiolation in Escherichia coli cells resulted in complete inactivation of the single-cysteine mutant G294C. L-Serine blocked DTT activation with an EC50 similar to the apparent K-M of this mutant. Thus, S-thiolation abolished substrate translocation but not substrate binding. Mutation of Lys-295, to Cys (K295C) broadened the profile of inhibitors and the spectrum of substrates with the exception of imino acids. A structural model of SteT based on the structural homologue AdiC (arginine/agmatine antiporter) positions residues Cys-291 and Lys-295 in the putative substrate binding pocket. All this suggests that Lys-295 is a main determinant in the recognition of the side chain of SteT substrates. In contrast, Gly-294 is not facing the surface, suggesting conformational changes involving TM8 during the transport cycle. Our results suggest that TM8 sculpts the substrate-binding site and undergoes conformational changes during the transport cycle of SteT.	[Bartoccioni, Paola; del Rio, Cesar; Ratera, Merce; Kowalczyk, Lukasz; Zorzano, Antonio; Luis Vazquez-Ibar, Jose; Palacin, Manuel] Inst Biomed Res, Barcelona 08028, Spain; [Bartoccioni, Paola; Palacin, Manuel] Ctr Biomed Res Rare Dis, U731, Barcelona 08028, Spain; [Baldwin, Jocelyn M.; Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Zorzano, Antonio; Palacin, Manuel] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Quick, Matthias] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Luis Vazquez-Ibar, Jose] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Leeds; University of Barcelona; Columbia University; New York State Psychiatry Institute; ICREA	Vazquez-Ibar, JL (corresponding author), Inst Biomed Res, Barcelona 08028, Spain.	jose.luis.vazquez-ibar@irbbarcelona.org; manuel.palacin@irbbarcelona.org	Kowalczyk, Lukasz/E-7905-2013; Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018; Bartoccioni, Paola/AAS-8831-2020; Vazquez-Ibar, Jose-Luis/AAD-8827-2021	Kowalczyk, Lukasz/0000-0002-5771-2506; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Ratera, Merce/0000-0001-5224-9172; Palacin, Manuel/0000-0002-8670-293X; Bartoccioni, Paola Chiara/0000-0001-8835-8450	Spanish Ministry of Science and Innovation [BFU2006-14600-C02-01, SAF2009-12606-C02-01, BFU2008-04637]; EC [201924]; United Kingdom Biotechnology and Biological Sciences Research Council [BBS/B/14418]; Generalitat de Catalunya [SGR 1355]; University of Leeds; Biotechnology and Biological Sciences Research Council [BBS/B/14418] Funding Source: researchfish; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Generalitat de Catalunya(Generalitat de Catalunya); University of Leeds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICREA(ICREA)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2006-14600-C02-01 and SAF2009-12606-C02-01 (to M. P.), Grant BFU2008-04637 (to J. L. V.), EC FP7 Grant 201924 (EDICT) (to M. P. and S. A. B.), United Kingdom Biotechnology and Biological Sciences Research Council Grant BBS/B/14418 (Membrane Protein Structure Initiative) (to S. A. B.), Generalitat de Catalunya 2009 SGR 1355, and the University of Leeds.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bartoccioni P, 2008, HUM MOL GENET, V17, P1845, DOI 10.1093/hmg/ddn080; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delCardayre SB, 1998, J BIOL CHEM, V273, P5744, DOI 10.1074/jbc.273.10.5744; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fernandez E, 2005, J BIOL CHEM, V280, P19364, DOI 10.1074/jbc.M412516200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; GUO WXA, 1991, ANAL BIOCHEM, V198, P143; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Holmes AJ, 2000, J CHEM SOC PERK T 2, P1639, DOI 10.1039/b004028m; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Koyanagi T, 2004, J BACTERIOL, V186, P343, DOI 10.1128/JB.186.2.343-350.2004; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Suh JK, 2000, ARCH BIOCHEM BIOPHYS, V381, P317, DOI 10.1006/abbi.2000.1965; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	61	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28764	28776		10.1074/jbc.M110.116632	http://dx.doi.org/10.1074/jbc.M110.116632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610400	Green Published, hybrid			2022-12-27	WOS:000281594000042
J	Ingalla, EQ; Miller, JK; Wald, JH; Workman, HC; Kaur, RP; Yen, L; Fry, WHD; Borowsky, AD; Young, LJT; Sweeney, C; Carraway, KL				Ingalla, Ellen Q.; Miller, Jamie K.; Wald, Jessica H.; Workman, Heather C.; Kaur, Rouminder P.; Yen, Lily; Fry, William H. D.; Borowsky, Alexander D.; Young, Lawrence J. T.; Sweeney, Colleen; Carraway, Kermit L., III			Post-transcriptional Mechanisms Contribute to the Suppression of the ErbB3 Negative Regulator Protein Nrdp1 in Mammary Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST; NEU PROTOONCOGENE; TRANSGENIC MICE; EXPRESSION; CANCER; FAMILY; GROWTH; INDUCTION; BIOLOGY; HER3	The ErbB2 and ErbB3 receptor tyrosine kinases act synergistically to promote cellular properties associated with tumor development. Previous studies indicate that endogenous ErbB3 protein is markedly elevated in mouse mammary tumors induced by transgenic ErbB2 overexpression. However, this occurs in the absence of elevated ErbB3 transcript, indicating that post-transcriptional regulatory mechanisms play crucial roles in suppressing ErbB3 protein in normal tissue. Our previous studies also demonstrate that protein levels of Nrdp1, an E3 ubiquitin ligase that targets ErbB3 for degradation, are markedly suppressed in tumors from ErbB2 transgenic animals relative to normal tissue. Here we demonstrate that transgenic expression of Nrdp1 cDNA in the mouse mammary gland is not sufficient to suppress elevated ErbB3 levels or tumor initiation and growth in ErbB2 transgenic mice. Unexpectedly, Nrdp1 protein is absent in tumors from Nrdp1/ErbB2 bigenic mice, and real time PCR analysis indicates that Nrdp1 protein levels are suppressed post-transcriptionally. Nrdp1 protein is more resistant to proteasome-dependent degradation when exogenously expressed in cultured MCF10A nontransformed human breast epithelial cells than in breast tumor cells. These observations indicate that mammary tumors use potent post-transcriptional mechanisms to suppress Nrdp1 protein levels and that protein destabilization may play a central role in Nrdp1 loss in tumors.	[Ingalla, Ellen Q.; Miller, Jamie K.; Wald, Jessica H.; Workman, Heather C.; Kaur, Rouminder P.; Yen, Lily; Fry, William H. D.; Sweeney, Colleen; Carraway, Kermit L., III] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Borowsky, Alexander D.; Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Ctr Canc, Res Bldg 3,Rm 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu	Borowsky, Alexander D/S-5404-2017		National Institutes of Health [CA123541, GM068994, CA118384, T32 RR07038]; United States Army Medical Research and Materiel Command [W81XWH-06-1-0402]; Eugene Cota-Robles; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA118384, R01CA123541] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024037, T32RR007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Eugene Cota-Robles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA123541 and GM068994 (to K. L. C.), CA118384 (to C. S.), and T32 RR07038 (to H. C. W.).; Supported by United States Army Medical Research and Materiel Command Fellowship W81XWH-06-1-0402.; Recipient of a Eugene Cota-Robles graduate fellowship.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carraway Kermit L. III, 2008, P169, DOI 10.1007/978-1-59745-356-1_12; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Di Cosimo S, 2008, EUR J CANCER, V44, P2781, DOI 10.1016/j.ejca.2008.09.026; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Pal SK, 2007, REV ENDOCR METAB DIS, V8, P269, DOI 10.1007/s11154-007-9040-6; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rasmussen S. B., 2000, METHODS MAMMARY GLAN, P75; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; SASSEN A, 2008, BREAST CANCER RES, V10, P8; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Sweeney C, 2006, J MAMMARY GLAND BIOL, V11, P89, DOI 10.1007/s10911-006-9015-3; Travis A, 1996, BRIT J CANCER, V74, P229, DOI 10.1038/bjc.1996.342; Wakefield LM, 2003, COMPARATIVE MED, V53, P424; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Zaczek A, 2008, J CANCER RES CLIN, V134, P271, DOI 10.1007/s00432-007-0284-z	38	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28691	28697		10.1074/jbc.M110.127977	http://dx.doi.org/10.1074/jbc.M110.127977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628057	Green Published, hybrid			2022-12-27	WOS:000281594000034
J	Kepseu, WD; Sepulchre, JA; Reverchon, S; Nasser, W				Kepseu, Wilfred D.; Sepulchre, Jacques-Alexandre; Reverchon, Sylvie; Nasser, William			Toward a Quantitative Modeling of the Synthesis of the Pectate Lyases, Essential Virulence Factors in Dickeya dadantii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM ERWINIA-CHRYSANTHEMI; PECTINOLYSIS GENES; REGULATORY NETWORKS; KDGR; REPRESSOR; PROTEIN; DEGRADATION; INTEGRATION; SIMULATION; FIS	A dynamic mathematical model has been developed and validated to describe the synthesis of pectate lyases (Pels), the major virulence factors in Dickeya dadantii. This work focuses on the simultaneous modeling of the metabolic degradation of pectin by Pel enzymes and the genetic regulation of pel genes by 2-keto-3-deoxygluconate (KDG), a catabolite product of pectin that inactivates KdgR, one of the main repressors of pel genes. This modeling scheme takes into account the fact that the system is composed of two time-varying compartments: the extracellular medium, where Pel enzymes cleave pectin into oligomers, and the bacterial cytoplasm where, after internalization, oligomers are converted to KDG. Using the quasi-stationary state approximations, the model consists of some nonlinear differential equations for which most of the parameters could be estimated from the literature or from independent experiments. The few remaining unknown parameters were obtained by fitting the model equations against a set of Pel activity data. Model predictions were verified by measuring the time courses of bacterial growth, Pel production, pel mRNA accumulation, and pectin consumption under various growth conditions. This work reveals that pectin is almost totally consumed before the burst of Pel production. This paradoxical behavior can be interpreted as an evolutionary strategy to control the diffusion process so that as soon as a small amount of pectin is detected by the bacteria in its surroundings, it anticipates more pectin to come. The model also predicts the possibility of bistable steady states in the presence of constant pectin compounds.	Univ Nice Sophia Antipolis, CNRS, UMR 6618, Inst Non Lineaire Nice, F-06560 Valbonne, France; [Reverchon, Sylvie; Nasser, William] Univ Lyon 1, UMR CNRS 5240, Inst Natl Sci Appl BayerCorpSci, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1		jacques.alexandre-sepulchre@inln.cnrs.fr	Sylvie, Reverchon/P-7932-2016; NASSER, William/C-9611-2019	Sylvie, Reverchon/0000-0002-0478-3474; NASSER, William/0000-0001-9848-3597	French Ministry of Research [ANR-07-BLAN-0212]	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by Agence Nationale de la Recherche Program Regupath Grant ANR-07-BLAN-0212, which was financed by the French Ministry of Research.	Baldazzi V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000812; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07; Franza T, 2002, MOL PLANT MICROBE IN, V15, P1181, DOI 10.1094/MPMI.2002.15.11.1181; FUNAHASHI A, 2003, BIOSILICO, V1, P59; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1125, DOI 10.1046/j.1365-2958.2001.02565.x; HUGOUVIEUXCOTTEPATTAT N, 1994, J BACTERIOL, V176, P2386, DOI 10.1128/JB.176.8.2386-2392.1994; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Kepseu WD, 2010, J BIOL SYST, V18, P173, DOI 10.1142/S0218339010003172; Kohn KW, 2001, CHAOS, V11, P84, DOI 10.1063/1.1338126; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; Lautier T, 2007, MOL MICROBIOL, V66, P1474, DOI 10.1111/j.1365-2958.2007.06012.x; Lautier T, 2007, MOL MICROBIOL, V66, P1491, DOI 10.1111/j.1365-2958.2007.06010.x; Miller J. H., 1972, EXPT MOL GENETICS, P431; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; NASSER W, 1994, J MOL BIOL, V236, P427, DOI 10.1006/jmbi.1994.1155; NASSER W, 1991, FEMS MICROBIOL LETT, V81, P73, DOI [10.1016/S0378-1097(99)00516-9, 10.1111/j.1574-6968.1991.tb04715.x]; Nasser W, 2002, MOL MICROBIOL, V43, P733, DOI 10.1046/j.1365-2958.2002.02782.x; NASSER W, 1992, MOL MICROBIOL, V6, P257, DOI 10.1111/j.1365-2958.1992.tb02007.x; Nasser W, 1997, MOL MICROBIOL, V26, P1071, DOI 10.1046/j.1365-2958.1997.6472020.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverchon S, 1997, J BACTERIOL, V179, P3500, DOI 10.1128/jb.179.11.3500-3508.1997; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; Reverchon S, 1998, MOL MICROBIOL, V29, P1407, DOI 10.1046/j.1365-2958.1998.01023.x; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	33	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28565	28576		10.1074/jbc.M110.114710	http://dx.doi.org/10.1074/jbc.M110.114710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20581112	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000281594000020
J	Li, JD; Kline, CF; Hund, TJ; Anderson, ME; Mohler, PJ				Li, Jingdong; Kline, Crystal F.; Hund, Thomas J.; Anderson, Mark E.; Mohler, Peter J.			Ankyrin-B Regulates Kir6.2 Membrane Expression and Function in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; SINUS NODE DISEASE; ISOFORM SPECIFICITY; CARDIAC-ARRHYTHMIA; ACTIN CYTOSKELETON; HUMAN-ERYTHROCYTES; MOLECULAR-BASIS; CARDIOMYOCYTES; INHIBITION; MUTATIONS	Ankyrin polypeptides are critical for normal membrane protein expression in diverse cell types, including neurons, myocytes, epithelia, and erythrocytes. Ankyrin dysfunction results in defects in membrane expression of ankyrin-binding partners (including ion channels, transporters, and cell adhesion molecules), resulting in aberrant cellular function and disease. Here, we identify a new role for ankyrin-B in cardiac cell biology. We demonstrate that cardiac sarcolemmal K-ATP channels directly associate with ankyrin-B in heart via the K-ATP channel alpha-subunit Kir6.2. We demonstrate that primary myocytes lacking ankyrin-B display defects in Kir6.2 protein expression, membrane expression, and function. Moreover, we demonstrate a secondary role for ankyrin-B in regulating K-ATP channel gating. Finally, we demonstrate that ankyrin-B forms a membrane complex with K-ATP channels and the cardiac Na/K-ATPase, a second key membrane transporter involved in the cardiac ischemia response. Collectively, our new findings define a new role for cardiac ankyrin polypeptides in regulation of ion channel membrane expression in heart.	[Li, Jingdong; Kline, Crystal F.; Hund, Thomas J.; Anderson, Mark E.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA; [Anderson, Mark E.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Mohler, PJ (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, CBRB 2283,285 Newton Rd, Iowa City, IA 52242 USA.	peter-mohler@uiowa.edu	Hund, Thomas/C-9222-2012	Li, Jingdong/0000-0003-3914-5074	National Institutes of Health [HL084583, HL083422, HL079031, HL62494, HL70250, HL096805]; Pew Scholars Trust; Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096652, R00HL096805, K99HL096805, R01HL062494, R01HL070250, R01HL084583, R01HL083422, R01HL079031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.), HL079031, HL62494, and HL70250 (to M. E. A.), and HL096805 (to T. J. H.). This work was also supported by the Pew Scholars Trust (to P. J. M.) and the Fondation Leducq Award (Alliance for Calmodulin Kinase Signaling in Heart Disease) (to P. J. M. and M. E. A.).	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1985, ANNU REV BIOCHEM, V54, P273, DOI 10.1146/annurev.biochem.54.1.273; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Brady PA, 1996, AM J PHYSIOL-HEART C, V271, pH2710, DOI 10.1152/ajpheart.1996.271.6.H2710; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2006, CARDIOVASC RES, V71, P22, DOI 10.1016/j.cardiores.2006.03.018; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; Glavind-Kristensen M, 2004, BRIT J PHARMACOL, V143, P872, DOI 10.1038/sj.bjp.0706016; Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gumina RJ, 2003, AM J PHYSIOL-HEART C, V284, pH2106, DOI 10.1152/ajpheart.00057.2003; Haruna T, 1998, CIRCULATION, V98, P2905, DOI 10.1161/01.CIR.98.25.2905; Hibino H, 1999, CURR TOP MEMBR, V46, P243; Hund TJ, 2009, CARDIOVASC RES, V81, P742, DOI 10.1093/cvr/cvn348; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Mohler PJ, 2008, J CARDIOVASC ELECTR, V19, P516, DOI 10.1111/j.1540-8167.2007.01097.x; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; Nawada R, 1997, CIRCULATION, V96, P599; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nilsson KR, 2009, J CARDIOVASC PHARM, V54, P106, DOI 10.1097/FJC.0b013e3181b2b6ed; Proks P, 2006, DIABETES, V55, P1731, DOI 10.2337/db05-1420; Sedlacek K, 2008, CIRC-CARDIOVASC GENE, V1, P93, DOI 10.1161/CIRCGENETICS.108.792192; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tammaro P, 2006, J PHYSIOL-LONDON, V571, P3, DOI 10.1113/jphysiol.2005.099168; Tammaro P, 2005, EMBO J, V24, P2318, DOI 10.1038/sj.emboj.7600715; Terzic A, 1996, J PHYSIOL-LONDON, V492, P395, DOI 10.1113/jphysiol.1996.sp021316; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yokoshiki H, 1997, PFLUG ARCH EUR J PHY, V434, P203, DOI 10.1007/s004240050384	47	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28723	28730		10.1074/jbc.M110.147868	http://dx.doi.org/10.1074/jbc.M110.147868			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610380	Green Published, hybrid			2022-12-27	WOS:000281594000038
J	Petutschnig, EK; Jones, AME; Serazetdinova, L; Lipka, U; Lipka, V				Petutschnig, Elena K.; Jones, Alexandra M. E.; Serazetdinova, Liliya; Lipka, Ulrike; Lipka, Volker			The Lysin Motif Receptor-like Kinase (LysM-RLK) CERK1 Is a Major Chitin-binding Protein in Arabidopsis thaliana and Subject to Chitin-induced Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; PLASMA-MEMBRANE RECEPTOR; MASS-SPECTROMETRY; INNATE IMMUNITY; PTERIS-RYUKYUENSIS; MOLECULAR-PATTERNS; CELL-SEPARATION; PLANT; PERCEPTION; DOMAIN	Plants detect potential pathogens by sensing microbe-associated molecular patterns via pattern recognition receptors. In the dicot model plant Arabidopsis, the lysin motif (LysM)-containing chitin elicitor receptor kinase 1 (CERK1) has been shown to be essential for perception of the fungal cell wall component chitin and for resistance to fungal pathogens. Recent in vitro studies with CERK1 protein expressed heterologously in yeast suggested direct chitin binding activity. Here we show in an affinity purification approach that CERK1 is a major chitin-binding protein of Arabidopsis cells, along with several known and putative chitinases. The ectodomain of CERK1 harbors three distinct LysM domains with potential ligand binding capacity. We demonstrate that the CERK1 ectodomain binds chitin and partially deacetylated chitosan directly without any requirement for interacting proteins and that all three LysM domains are necessary for chitin binding. Ligand-induced phosphorylation events are a general feature of animal and plant signal transduction pathways. Our studies show that chitin, chitin oligomers, and chitosan rapidly induce in vivo phosphorylation of CERK1 at multiple residues in the juxtamembrane and kinase domain. Functional analyses with a kinase dead variant provide evidence that kinase activity of CERK1 is required for its chitin-dependent in vivo phosphorylation, as well as for early defense responses and downstream signaling. Collectively, our data suggest that in Arabidopsis, CERK1 is a major chitin, chitosan, and chito-oligomer binding component and that chitin signaling depends on CERK1 post-translational modification and kinase activity.	[Petutschnig, Elena K.; Lipka, Volker] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Cell Biol, D-37073 Gottingen, Germany; [Petutschnig, Elena K.; Jones, Alexandra M. E.; Serazetdinova, Liliya; Lipka, Ulrike; Lipka, Volker] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Gottingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lipka, V (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Cell Biol, Untere Karspuele 2, D-37073 Gottingen, Germany.	volker.lipka@biologie.uni-goettingen.de	poinssot, benoit/B-2569-2009; Jones, Alexandra/B-5227-2009	poinssot, benoit/0000-0001-5890-4318; Jones, Alexandra/0000-0003-2571-8708; Petutschnig, Elena/0000-0002-0846-1878	Gatsby Charitable Foundation; Deutsche Forschungsgemeinschaft [SPP1212/LI 1317/3-1]	Gatsby Charitable Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Gatsby Charitable Foundation and the Deutsche Forschungsgemeinschaft (Grant SPP1212/LI 1317/3-1).	Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Choi MY, 2008, MOL CELLS, V26, P200; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; MacLean Daniel, 2008, BMC Res Notes, V1, P30, DOI 10.1186/1756-0500-1-30; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MARGISPINHEIRO M, 1991, PLANT MOL BIOL, V17, P243, DOI 10.1007/BF00039499; McInnes C, 1997, BIOPOLYMERS, V43, P339, DOI 10.1002/(SICI)1097-0282(1997)43:5<339::AID-BIP2>3.0.CO;2-W; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roy I, 2003, ENZYME MICROB TECH, V32, P582, DOI 10.1016/S0141-0229(03)00027-9; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Shin-ya Y, 2001, BIOCHEM ENG J, V7, P85, DOI 10.1016/S1369-703X(00)00129-7; Staehelin C, 2000, MOL PLANT MICROBE IN, V13, P72, DOI 10.1094/MPMI.2000.13.1.72; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Vander P, 1998, PLANT PHYSIOL, V118, P1353, DOI 10.1104/pp.118.4.1353; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	47	292	308	6	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28902	28911		10.1074/jbc.M110.116657	http://dx.doi.org/10.1074/jbc.M110.116657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610395	Green Published, hybrid			2022-12-27	WOS:000281594000055
J	Abe, N; Borson, SH; Gambello, MJ; Wang, F; Cavalli, V				Abe, Namiko; Borson, Steven H.; Gambello, Michael J.; Wang, Fan; Cavalli, Valeria			Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGENERATION IN-VIVO; SENSORY NEURONS; PROTEIN-SYNTHESIS; MESSENGER-RNA; C-JUN; NERVOUS-SYSTEM; LESION SITE; TRANSPORT; TRANSLATION; PATHWAY	Unlike neurons in the central nervous system (CNS), injured neurons in the peripheral nervous system (PNS) can regenerate their axons and reinnervate their targets. However, functional recovery in the PNS often remains suboptimal, especially in cases of severe damage. The lack of regenerative ability of CNS neurons has been linked to down-regulation of the mTOR (mammalian target of rapamycin) pathway. We report here that PNS dorsal root ganglial neurons (DRGs) activate mTOR following damage and that this activity enhances axonal growth capacity. Furthermore, genetic up-regulation of mTOR activity by deletion of tuberous sclerosis complex 2 (TSC2) in DRGs is sufficient to enhance axonal growth capacity in vitro and in vivo. We further show that mTOR activity is linked to the expression of GAP-43, a crucial component of axonal outgrowth. However, although TSC2 deletion in DRGs facilitates axonal regrowth, it leads to defects in target innervation. Thus, whereas manipulation of mTOR activity could provide new strategies to stimulate nerve regeneration in the PNS, fine control of mTOR activity is required for proper target innervation.	[Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Gambello, Michael J.] Univ Texas Hlth Sci Ctr, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Duke University	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu			NINDS, National Institutes of Health [RO1NS060709]; Wings for Life Foundation; Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060709] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wings for Life Foundation; Washington University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NINDS, National Institutes of Health Grant RO1NS060709 (to V. C.). This work was also supported by the Wings for Life Foundation (to F. W.).; Supported by a Washington University Summer Undergraduate Research Fellowship.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Ackermann PW, 2002, J ORTHOP RES, V20, P849, DOI 10.1016/S0736-0266(01)00159-0; AIGNER L, 1995, J CELL BIOL, V128, P647, DOI 10.1083/jcb.128.4.647; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Caroni P, 1997, BIOESSAYS, V19, P767, DOI 10.1002/bies.950190906; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JENKINS R, 1991, NEUROSCI LETT, V129, P107, DOI 10.1016/0304-3940(91)90731-8; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Michaelevski I, 2010, MOL CELL PROTEOMICS, V9, P976, DOI 10.1074/mcp.M900369-MCP200; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; O'Brien JJ, 2007, J NEUROCHEM, V103, P288, DOI 10.1111/j.1471-4159.2007.04736.x; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schwaiger FW, 2000, EUR J NEUROSCI, V12, P1165, DOI 10.1046/j.1460-9568.2000.00005.x; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Smith DS, 1997, J NEUROSCI, V17, P646; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sung YJ, 2006, NEUROSCIENCE, V141, P697, DOI 10.1016/j.neuroscience.2006.04.033; Tanabe K, 2000, J NEUROSCI, V20, P4138; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; White DM, 2000, BRAIN RES, V868, P31, DOI 10.1016/S0006-8993(00)02259-9; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	58	164	172	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28034	28043		10.1074/jbc.M110.125336	http://dx.doi.org/10.1074/jbc.M110.125336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20615870	Green Published, hybrid			2022-12-27	WOS:000288742300002
J	Oinuma, I; Ito, Y; Katoh, H; Negishi, M				Oinuma, Izumi; Ito, Yuri; Katoh, Hironori; Negishi, Manabu			Semaphorin 4D/Plexin-B1 Stimulates PTEN Activity through R-Ras GTPase-activating Protein Activity, Inducing Growth Cone Collapse in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TUMOR-SUPPRESSOR PTEN; PHOSPHOINOSITIDE 3-KINASE; RECEPTOR PLEXIN-B1; AXON GUIDANCE; KINASE CK2; PDZ-RHOGEF; PHOSPHORYLATION; FAMILY; TRANSMEMBRANE	Plexins are receptors for axonal guidance molecules semaphorins. We recently reported that the semaphorin 4D (Sema4D) receptor, Plexin-B1, suppresses PI3K signaling through the R-Ras GTPase-activating protein (GAP) activity, inducing growth cone collapse. Phosphatidylinositol 3-phosphate level is critically regulated by PI3K and PTEN (phosphatase and tensin homologue deleted chromosome ten). Here we examined the involvement of PTEN in the Plexin-B1-induced repulsive response. Phosphorylation of PTEN at Ser-380 is known to suppress its phosphatase activity. Sema4D induced the dephosphorylation of PTEN at Ser-380 and stimulated PTEN phosphatase activity in hippocampal neurons. Knockdown of endogenous PTEN suppressed the Sema4D-induced growth cone collapse. Phosphorylation mimic PTEN mutant suppressed the Sema4D-induced growth cone collapse, whereas phosphorylation-resistant PTEN mutant by itself induced growth cone collapse. Plexin-B1-induced PTEN dephosphorylation through R-Ras GAP activity and R-Ras GAP activity was by itself sufficient for PTEN dephosphorylation and activation. We also suggested that the Sema4D-induced PTEN dephosphorylation and growth cone collapse were mediated by the inhibition of casein kinase 2 alpha activity. Thus, we propose that Sema4D/Plexin-B1 promotes the dephosphorylation and activation of PTEN through the R-Ras GAP activity, inducing growth cone collapse.	[Oinuma, Izumi; Ito, Yuri; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Christensen CRL, 1998, CANCER RES, V58, P1238; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2003, J CELL SCI, V116, P3463, DOI 10.1242/jcs.00674; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Saito Y, 2009, EMBO REP, V10, P614, DOI 10.1038/embor.2009.63; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	48	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28200	28209		10.1074/jbc.M110.147546	http://dx.doi.org/10.1074/jbc.M110.147546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610402	hybrid, Green Published			2022-12-27	WOS:000281404100063
J	Mall, MA; Button, B; Johannesson, B; Zhou, Z; Livraghi, A; Caldwell, RA; Schubert, SC; Schultz, C; O'Neal, WK; Pradervand, S; Hummler, E; Rossier, BC; Grubb, BR; Boucher, RC				Mall, Marcus A.; Button, Brian; Johannesson, Bjarki; Zhou, Zhe; Livraghi, Alessandra; Caldwell, Ray A.; Schubert, Susanne C.; Schultz, Carsten; O'Neal, Wanda K.; Pradervand, Sylvain; Hummler, Edith; Rossier, Bernard C.; Grubb, Barbara R.; Boucher, Richard C.			Airway Surface Liquid Volume Regulation Determines Different Airway Phenotypes in Liddle Compared with beta ENaC-overexpressing Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS AIRWAYS; NA+ CHANNEL; MOUSE MODEL; RESPIRATORY EPITHELIUM; SYNDROME MUTATIONS; GAMMA-SUBUNIT; LUNG-DISEASE; WILD-TYPE	Studies in cystic fibrosis patients and mice overexpressing the epithelial Na+ channel beta-subunit (beta ENaC-Tg) suggest that raised airway Na+ transport and airway surface liquid (ASL) depletion are central to the pathogenesis of cystic fibrosis lung disease. However, patients or mice with Liddle gain-of-function beta ENaC mutations exhibit hypertension but no lung disease. To investigate this apparent paradox, we compared the airway phenotype (nasal versus tracheal) of Liddle with CFTR-null, beta ENaC-Tg, and double mutant mice. In mouse nasal epithelium, the region that functionally mimics human airways, high levels of CFTR expression inhibited Liddle epithelial Na+ channel (ENaC) hyperfunction. Conversely, in mouse trachea, low levels of CFTR failed to suppress Liddle ENaC hyperfunction. Indeed, Na+ transport measured in Ussing chambers ("flooded" conditions) was raised in both Liddle and beta ENaC-Tg mice. Because enhanced Na+ transport did not correlate with lung disease in these mutant mice, measurements in tracheal cultures under physiologic "thin film" conditions and in vivo were performed. Regulation of ASL volume and ENaC-mediated Na+ absorption were intact in Liddle but defective in beta ENaC-Tg mice. We conclude that the capacity to regulate Na+ transport and ASL volume, not absolute Na+ transport rates in Ussing chambers, is the key physiologic function protecting airways from dehydration-induced lung disease.	[Mall, Marcus A.; Johannesson, Bjarki; Schubert, Susanne C.] Univ Heidelberg, Div Pediat Pulmonol, Dept Pediat 3, D-69120 Heidelberg, Germany; [Mall, Marcus A.; Johannesson, Bjarki; Schubert, Susanne C.] Univ Heidelberg, Cyst Fibrosis Ctr, Dept Pediat 3, D-69120 Heidelberg, Germany; [Mall, Marcus A.; Johannesson, Bjarki; Schultz, Carsten] Univ Heidelberg, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Mall, Marcus A.; Johannesson, Bjarki; Schultz, Carsten] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Button, Brian; Livraghi, Alessandra; Caldwell, Ray A.; O'Neal, Wanda K.; Grubb, Barbara R.; Boucher, Richard C.] Univ N Carolina, Sch Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Pradervand, Sylvain; Hummler, Edith; Rossier, Bernard C.] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Lausanne	Mall, MA (corresponding author), Univ Heidelberg, Div Pediat Pulmonol, Dept Pediat 3, Neuenheimer Feld 430, D-69120 Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Mall, Marcus A./AAA-1498-2022	Mall, Marcus A./0000-0002-4057-2199; Schultz, Carsten/0000-0002-5824-2171	National Institutes of Health [SCOR P50 HL60280, P01 HL 34322]; Deutsche Forschungsgemeinschaft [DFG MA 2081/3-2, MA 2081/3-3, MA 2081/4-1]; European Commission [MEXT-CT-2004-013666]; EMBL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, P50HL060280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); EMBL; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants SCOR P50 HL60280 and P01 HL 34322 (to R. C. B.). This work was also supported by Deutsche Forschungsgemeinschaft Grants DFG MA 2081/3-2, MA 2081/3-3, and MA 2081/4-1 (to M. A. M.) and European Commission Grant MEXT-CT-2004-013666 (to M. A. M.).; Supported by an EMBL Ph.D. fellowship.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Baker E, 1998, J CLIN INVEST, V102, P10, DOI 10.1172/JCI1795; Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dahlmann A, 2003, AM J PHYSIOL-RENAL, V285, pF310, DOI 10.1152/ajprenal.00016.2003; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dempster J., 1993, COMPUTER ANAL ELECTR; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Helms MN, 2006, AM J PHYSIOL-LUNG C, V291, pL610, DOI 10.1152/ajplung.00426.2005; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; Hopf A, 1999, J BIOL CHEM, V274, P13894, DOI 10.1074/jbc.274.20.13894; Ji HL, 2000, J BIOL CHEM, V275, P27947; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Livraghi A, 2008, AM J RESP CELL MOL, V38, P423, DOI 10.1165/rcmb.2007-0177OC; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pradervand S, 2003, J AM SOC NEPHROL, V14, P2219, DOI 10.1097/01.ASN.0000080204.65527.E6; PRadervand S, 1999, P NATL ACAD SCI USA, V96, P1732, DOI 10.1073/pnas.96.4.1732; Pradervand S, 1999, J AM SOC NEPHROL, V10, P2527; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Randrianarison N, 2007, J PHYSIOL-LONDON, V582, P777, DOI 10.1113/jphysiol.2007.131078; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; STUTTS MJ, 1998, PED PULMONOL S17, V217; Syntichaki P, 2002, EMBO REP, V3, P604, DOI 10.1093/embo-reports/kvf138; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1033, DOI 10.1152/ajpcell.1989.256.5.C1033; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC332, DOI 10.1152/ajpcell.1991.261.2.C332; Zhou Z, 2008, AM J RESP CRIT CARE, V178, P1245, DOI 10.1164/rccm.200803-442OC	65	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26945	26955		10.1074/jbc.M110.151803	http://dx.doi.org/10.1074/jbc.M110.151803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566636	Green Published, hybrid			2022-12-27	WOS:000281172700026
J	Chen, SG; Yadav, SP; Surewicz, WK				Chen, Shugui; Yadav, Satya P.; Surewicz, Witold K.			Interaction between Human Prion Protein and Amyloid-beta (A beta) Oligomers ROLE OF N-TERMINAL RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ALZHEIMERS-DISEASE; PEPTIDE; BINDING; NEURODEGENERATION; FIBRILLOGENESIS; CHAPERONE; AFFINITY; MEMORY; RISK	Soluble oligomers of A beta 42 peptide are believed to play a major role in the pathogenesis of Alzheimer disease (AD). It was recently found that at least some of the neurotoxic effects of these oligomers may be mediated by specific binding to the prion protein, PrPC, on the cell surface (Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Nature 457, 1128-1132). Here we characterized the interaction between synthetic A beta 42 oligomers and the recombinant human prion protein (PrP) using two biophysical techniques: site-directed spin labeling and surface plasmon resonance. Our data indicate that this binding is highly specific for a particular conformation adopted by the peptide in soluble oligomeric species. The binding appears to be essentially identical for the Met(129) and Val(129) polymorphic forms of human PrP, suggesting that the role of PrP codon 129 polymorphism as a risk factor in AD is due to factors unrelated to the interaction with A beta oligomers. It was also found that in addition to the previously identified similar to 95-110 segment, the second region of critical importance for the interaction with A beta 42 oligomers is a cluster of basic residues at the extreme N terminus of PrP (residues 23-27). The deletion of any of these segments results in a major loss of the binding function, indicating that these two regions likely act in concert to provide a high affinity binding site for A beta 42 oligomers. This insight may help explain the interplay between the postulated protective and pathogenic roles of PrP in AD and may contribute to the development of novel therapeutic strategies as well.	[Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Yadav, Satya P.] Cleveland Clin Fdn, Lerner Res Inst, Mol Biotechnol Core Lab, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Surewicz, WK (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			National Institutes of Health [NS38604, NS44158]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044158, R01NS038604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS38604 and NS44158 (to W. K. S.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Sorgato MC, 2009, PRION, V3, P202, DOI 10.4161/pri.3.4.10012; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Visudtiphole V, 2006, BIOCHEM BIOPH RES CO, V351, P113, DOI 10.1016/j.bbrc.2006.10.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	45	214	217	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26377	26383		10.1074/jbc.M110.145516	http://dx.doi.org/10.1074/jbc.M110.145516			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20576610	Green Published, hybrid			2022-12-27	WOS:000280921000056
J	Courson, DS; Rock, RS				Courson, David S.; Rock, Ronald S.			Actin Cross-link Assembly and Disassembly Mechanics for alpha-Actinin and Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URCHIN EGG EXTRACTS; FILOPODIA FORMATION; STRUCTURAL PROTEIN; FILAMENT NETWORKS; BINDING PROTEINS; STRIATED MUSCLE; STRESS FIBERS; SMOOTH-MUSCLE; CELL MOTILITY; MYOSIN-X	Self-assembly of complex structures is commonplace in biology but often poorly understood. In the case of the actin cytoskeleton, a great deal is known about the components that include higher order structures, such as lamellar meshes, filopodial bundles, and stress fibers. Each of these cytoskeletal structures contains actin filaments and cross-linking proteins, but the role of cross-linking proteins in the initial steps of structure formation has not been clearly elucidated. We employ an optical trapping assay to investigate the behaviors of two actin cross-linking proteins, fascin and alpha-actinin, during the first steps of structure assembly. Here, we show that these proteins have distinct binding characteristics that cause them to recognize and cross-link filaments that are arranged with specific geometries. alpha-Actinin is a promiscuous cross-linker, linking filaments over all angles. It retains this flexibility after cross-links are formed, maintaining a connection even when the link is rotated. Conversely, fascin is extremely selective, only cross-linking filaments in a parallel orientation. Surprisingly, bundles formed by either protein are extremely stable, persisting for over 0.5 h in a continuous wash. However, using fluorescence recovery after photobleaching and fluorescence decay experiments, we find that the stable fascin population can be rapidly competed away by free fascin. We present a simple avidity model for this crosslink dissociation behavior. Together, these results place constraints on how cytoskeletal structures assemble, organize, and disassemble in vivo.	[Courson, David S.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60615 USA	University of Chicago	Rock, RS (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, GCIS W240,929 E 57th St, Chicago, IL 60615 USA.	rrock@uchicago.edu			National Institutes of Health [GM078450]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078450 (to R. S. R.). This work was also supported by an American Heart Association predoctoral fellowship (to D. S. C.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Courson DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006479; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P20, DOI 10.1093/oxfordjournals.jbchem.a128159; EBASHI S, 1965, J BIOCHEM-TOKYO, V58, P7, DOI 10.1093/oxfordjournals.jbchem.a128167; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; GOLL DE, 1969, BIOCHIM BIOPHYS ACTA, V175, P174, DOI 10.1016/0005-2795(69)90156-1; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; HEGGENESS MH, 1977, P NATL ACAD SCI USA, V74, P3883, DOI 10.1073/pnas.74.9.3883; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; KANE RE, 1975, J CELL BIOL, V66, P305, DOI 10.1083/jcb.66.2.305; KANE RE, 1976, J CELL BIOL, V71, P704, DOI 10.1083/jcb.71.3.704; Kee AJ, 2008, ADV EXP MED BIOL, V644, P143; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; MARUYAMA K, 1965, J BIOCHEM-TOKYO, V58, P13, DOI 10.1093/oxfordjournals.jbchem.a128158; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; Miyata H, 1996, BBA-GEN SUBJECTS, V1290, P83, DOI 10.1016/0304-4165(96)00003-7; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pelletier O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148102; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Taylor KA, 2000, J CELL BIOL, V149, P635, DOI 10.1083/jcb.149.3.635; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0	52	77	78	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26350	26357		10.1074/jbc.M110.123117	http://dx.doi.org/10.1074/jbc.M110.123117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551315	Green Published, hybrid			2022-12-27	WOS:000280921000053
J	Einholm, AP; Toustrup-Jensen, MS; Holm, R; Andersen, JP; Vilsen, B				Einholm, Anja Pernille; Toustrup-Jensen, Mads S.; Holm, Rikke; Andersen, Jens Peter; Vilsen, Bente			The Rapid-onset Dystonia Parkinsonism Mutation D923N of the Na+,K+-ATPase alpha 3 Isoform Disrupts Na+ Interaction at the Third Na+ Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CYTOPLASMIC-BINDING SITES; CATION-BINDING; K+-ATPASE; FUNCTIONAL CONSEQUENCES; CONFORMATIONAL-CHANGES; ENERGY TRANSDUCTION; CRYSTAL-STRUCTURE; ION SELECTIVITY; AMINO-ACIDS	Rapid-onset dystonia parkinsonism (RDP), a rare neurological disorder, is caused by mutation of the neuron-specific alpha 3-isoform of Na+,K+-ATPase. Here, we present the functional consequences of RDP mutation D923N. Relative to the wild type, the mutant exhibits a remarkable similar to 200-fold reduction of Na+ affinity for activation of phosphorylation from ATP, reflecting a defective interaction of the E-1 form with intracellular Na+. This is the largest effect on Na+ affinity reported so far for any Na+, K+-ATPase mutant. D923N also affects the interaction with extracellular Na+ normally driving the E1P to E2P conformational transition backward. However, no impairment of K+ binding was observed for D923N, leading to the conclusion that Asp(923) is specifically associated with the third Na+ site that is selective toward Na+. The crystal structure of the Na+, K+-ATPase in E-2 form shows that Asp(923) is located in the cytoplasmic half of transmembrane helix M8 inside a putative transport channel, which is lined by residues from the transmembrane helices M5, M7, M8, and M10 and capped by the C terminus, recently found involved in recognition of the third Na+ ion. Structural modeling of the E-1 form of Na+, K+-ATPase based on the Ca2+-ATPase crystal structure is consistent with the hypothesis that Asp(923) contributes to a site binding the third Na+ ion. These results in conjunction with our previous findings with other RDP mutants suggest that a selective defect in the handling of Na+ may be a general feature of the RDP disorder.	[Einholm, Anja Pernille; Toustrup-Jensen, Mads S.; Holm, Rikke; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Vilsen, B (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; L'Oreal Denmark, UNESCO; Royal Danish Academy of Science	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); L'Oreal Denmark, UNESCO(L'Oreal Group); Royal Danish Academy of Science	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), and the Lundbeck Foundation (to B.V.) and from the Danish Medical Research Council and the "For Women in Science Program" of L'Oreal Denmark, UNESCO, and the Royal Danish Academy of Science (to A.P.E.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Arguello JM, 1999, ARCH BIOCHEM BIOPHYS, V367, P341, DOI 10.1006/abbi.1999.1278; Arguello JM, 1999, ARCH BIOCHEM BIOPHYS, V364, P254, DOI 10.1006/abbi.1999.1124; ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; ARGUELLO JM, 1995, J BIOL CHEM, V270, P22764, DOI 10.1074/jbc.270.39.22764; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; BLOSTEIN R, 1983, J BIOL CHEM, V258, P7948; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; FAHN S, 1968, J BIOL CHEM, V243, P1993; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; POST RL, 1972, J BIOL CHEM, V247, P6530; POULSEN H, 2010, NATURE IN PRESS; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vilsen B, 1999, BIOCHEMISTRY-US, V38, P11389, DOI 10.1021/bi990951t; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; VILSEN B, 1995, ACTA PHYSIOL SCAND, V154, P1; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; YODA A, 1987, J BIOL CHEM, V262, P110; YODA S, 1986, J BIOL CHEM, V261, P1147; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	57	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26245	26254		10.1074/jbc.M110.123976	http://dx.doi.org/10.1074/jbc.M110.123976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20576601	hybrid, Green Published			2022-12-27	WOS:000280921000041
J	Nunes-Xavier, CE; Tarrega, C; Cejudo-Marin, R; Frijhoff, J; Sandin, A; Ostman, A; Pulido, R				Nunes-Xavier, Caroline E.; Tarrega, Celine; Cejudo-Marin, Rocio; Frijhoff, Jeroen; Sandin, Asa; Ostman, Arne; Pulido, Rafael			Differential Up-regulation of MAP Kinase Phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun Converge in the Control of the Growth Arrest Versus Proliferation Response of MCF-7 Breast Cancer Cells to Phorbol Ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; MAMMARY-GLAND DEVELOPMENT; GENE-EXPRESSION; TRANSCRIPTION TARGET; FEEDBACK-REGULATION; CARCINOMA-CELLS; DOWN-REGULATION; FACTOR-BINDING; CYCLE ARREST; ACTIVATION	Different levels of regulation account for the inactivation of MAP kinases by MAPK phosphatases (MKPs), in a cell type-and stimuli-dependent manner. MCF-7 human breast carcinoma cells treated with the phorbol 12-myristate 13-acetate (PMA) suffer growth arrest and show morphological alterations, which depend on the activation of the ERK1/2 MAP kinases. MKP3/DUSP6 and DUSP5 MAP kinase phosphatases, two negative regulators of ERK1/2, were specifically up-regulated in MCF-7 and SKBR3 cells in response to PMA. MKP3 and DUSP5 up-regulation required the prolonged activation of the ERK1/2 pathway, and correlated with the shutdown of this route. MKP3 induction relied on the activation of the Ets2 transcription factor, whereas DUSP5 induction depended on the activation of c-Jun. Diminishing the expression of MKP3 and DUSP5 raised the activation of ERK1/2, and accelerated growth arrest of PMA-treated MCF-7 cells. Conversely, MCF-7 cell lines expressing high levels of MKP3 or DUSP5 did not undergo PMA-triggered growth arrest, displayed a migratory phenotype, and formed colonies in soft agar. We propose that the differential up-regulation of MKP3 by Ets2 and of DUSP5 by c-Jun may converge in similar functional roles for these MAP kinase phosphatases in the growth arrest versus proliferation decisions of breast cancer cells.	[Nunes-Xavier, Caroline E.; Tarrega, Celine; Cejudo-Marin, Rocio; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Frijhoff, Jeroen; Sandin, Asa; Ostman, Arne] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden	Prince Felipe Research Center; Karolinska Institutet	Pulido, R (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16-3, Valencia 46013, Spain.	rpulido@cipf.es	Cejudo, Rocio/I-2794-2015; Nunes-Xavier, Caroline E./R-5893-2018	Nunes-Xavier, Caroline E./0000-0002-1875-6645; Pulido, Rafael/0000-0001-9100-248X; Frijhoff, Jeroen/0000-0001-8953-3054; Cejudo Marin, Rocio/0000-0001-5389-7200	Ministerio de Educacion y Ciencia [SAF2006-08319]; Ministerio de Ciencia e Innovacion [SAF2009-10226]; (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana [AP-117/08, AP-040/10, ACOMP/2009/363, ACOMP/2010/222]; Instituto de Salud Carlos III [ISCIII-RETICS RD06/0020/0049]; European Union [MRTN-CT-2006-035830]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union(European Commission)	This work was supported in part by Ministerio de Educacion y Ciencia Grant SAF2006-08319 and by Ministerio de Ciencia e Innovacion Grant SAF2009-10226 (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Generalitat Valenciana Grants AP-117/08, AP-040/10, ACOMP/2009/363, and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional, FEDER) Grant ISCIII-RETICS RD06/0020/0049, and European Union Research Training Network Grant MRTN-CT-2006-035830. 1 Both authors were supported by the European Union Marie Curie Research Training Programme.	ABE M, 1986, J CELL PHYSIOL, V126, P126, DOI 10.1002/jcp.1041260117; Alblas J, 1998, ONCOGENE, V16, P131, DOI 10.1038/sj.onc.1201485; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Buggy Y, 2006, EUR J CANCER, V42, P485, DOI 10.1016/j.ejca.2005.10.018; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Dowd S, 1998, J CELL SCI, V111, P3389; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; ElAshry D, 1997, ONCOGENE, V15, P423, DOI 10.1038/sj.onc.1201198; Fortino V, 2008, CANCER INVEST, V26, P13, DOI 10.1080/07357900701637949; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; Gee JMW, 2000, INT J CANCER, V89, P177, DOI 10.1002/(SICI)1097-0215(20000320)89:2<177::AID-IJC13>3.0.CO;2-0; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Grill C, 2004, BIOCHEM J, V381, P635, DOI 10.1042/BJ20031688; GUILBAUD NF, 1990, J CELL PHYSIOL, V145, P162, DOI 10.1002/jcp.1041450122; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; KOGA M, 1990, CANCER RES, V50, P4849; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mester J, 2008, ANTI-CANCER AGENT ME, V8, P872, DOI 10.2174/187152008786847747; Miller DV, 2004, MODERN PATHOL, V17, P756, DOI 10.1038/modpathol.3800114; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park SK, 2009, CARCINOGENESIS, V30, P1225, DOI 10.1093/carcin/bgp111; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; REE AH, 1992, ENDOCRINOLOGY, V131, P1810, DOI 10.1210/en.131.4.1810; Reffas S, 2000, BIOCHEM J, V352, P701, DOI 10.1042/0264-6021:3520701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schaar D, 2006, CANCER CHEMOTH PHARM, V57, P789, DOI 10.1007/s00280-005-0125-1; Schaar DG, 2005, LEUKEMIA RES, V29, P1171, DOI 10.1016/j.leukres.2005.02.019; Sebolt-Leopold Judith S., 2007, V172, P155; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Small GW, 2004, MOL PHARMACOL, V66, P1478, DOI 10.1124/mol.104.003400; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Thottassery JV, 2004, CANCER RES, V64, P4637, DOI 10.1158/0008-5472.CAN-03-2645; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; VALETTE A, 1987, CANCER RES, V47, P1615; Venditti M, 2002, INT J CANCER, V99, P35, DOI 10.1002/ijc.10269; Visvader JE, 2003, INT J BIOCHEM CELL B, V35, P1034, DOI 10.1016/S1357-2725(03)00030-X; Wang HY, 2003, CANCER LETT, V191, P229, DOI 10.1016/S0304-3835(02)00612-2; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Weldon CB, 2005, INT J ONCOL, V26, P763; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Woessmann W, 2001, EXP CELL RES, V264, P193, DOI 10.1006/excr.2000.5124; Wu J, 2007, ONCOGENE, V26, P6526, DOI 10.1038/sj.onc.1210484; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	72	43	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26417	26430		10.1074/jbc.M110.121830	http://dx.doi.org/10.1074/jbc.M110.121830			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554528	hybrid, Green Published			2022-12-27	WOS:000280921000060
J	Jung, HJ; Kim, JH; Shim, JS; Kwon, HJ				Jung, Hye Jin; Kim, Jong Hyeon; Shim, Joong Sup; Kwon, Ho Jeong			A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE PROGRESSION; COLON-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; MAMMALIAN TARGET; GENE-EXPRESSION; CALMODULIN; CALCIUM	Recent reports have shown that Ca2+/calmodulin (Ca2+/CaM) signaling plays a crucial role in angiogenesis. We previously developed a new Ca2+/CaM antagonist, HBC (4-{3,5-bis-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-4,5-dihydropyrazol-1-yl}benzoic acid), from a curcumin-based synthetic chemical library. Here, we investigated its anti-angiogenic activity and mode of action. HBC potently inhibited the proliferation of human umbilical vascular endothelial cells with no cytotoxicity. Furthermore, HBC blocked in vitro characteristics of angiogenesis such as tube formation and chemoinvasion, as well as neo-vascularization of the chorioallantoic membrane of growing chick embryos in vivo. Notably, HBC markedly inhibited expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) at the translational level during hypoxia, thereby reducing HIF-1 transcriptional activity and expression of its major target gene, vascular endothelial growth factor. In addition, combination treatment with HBC and various HIF-1 inhibitors, including suberoylanilide hydroxamic acid, rapamycin, and terpestacin, had greater anti-angiogenic activity than treatment with each single agent. Collectively, our findings indicate that HBC is a new anti-angiogenic agent targeting HIF that can be used to explore the biological role of Ca2+/CaM in angiogenesis.	[Jung, Hye Jin; Kim, Jong Hyeon; Shim, Joong Sup; Kwon, Ho Jeong] Yonsei Univ, Coll Life Sci & Biotechnol, Chem Genom Lab, Dept Biotechnol,Translat Res Ctr Prot Funct Contr, Seoul 120749, South Korea	Yonsei University	Kwon, HJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Chem Genom Lab, Dept Biotechnol,Translat Res Ctr Prot Funct Contr, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	Shim, Joong Sup/G-8383-2011; Shim, Joong Sup/O-2848-2016; 권, 호정/AAS-3642-2021	Shim, Joong Sup/0000-0003-0167-7307; Shim, Joong Sup/0000-0003-0167-7307; 	National R&D Program for Cancer Control [0620350]; Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF [2009-0083522]; Korean Government (MEST) [2009-0092964, 2010-0017984]; Brain Korea 21 project, Republic of Korea	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 project, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the National R&D Program for Cancer Control (0620350), Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF (2009-0083522), the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (2009-0092964 and 2010-0017984), and from the Brain Korea 21 project, Republic of Korea.	Andre T, 1998, REV MED INTERNE, V19, P904, DOI 10.1016/S0248-8663(99)80063-0; ARNOULD T, 1992, J CELL PHYSIOL, V152, P215, DOI 10.1002/jcp.1041520127; Bangoura G, 2004, WORLD J GASTROENTERO, V10, P525, DOI 10.3748/wjg.v10.i4.525; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Capuozzo E, 1997, BBA-MOL CELL RES, V1357, P123, DOI 10.1016/S0167-4889(97)00021-9; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Das SB, 2005, ONCOL REP, V14, P1059; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Jeon KS, 2005, BIOCHEM BIOPH RES CO, V330, P1268, DOI 10.1016/j.bbrc.2005.03.109; Jung HJ, 2003, J ANTIBIOT, V56, P492, DOI 10.7164/antibiotics.56.492; Jung HJ, 2010, J BIOL CHEM, V285, P11584, DOI 10.1074/jbc.M109.087809; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176; Mukhopadhyay D, 1996, BIOCHEM BIOPH RES CO, V229, P733, DOI 10.1006/bbrc.1996.1873; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Pang R, 2006, CANCER LETT, V242, P151, DOI 10.1016/j.canlet.2006.01.008; Pencreach E, 2009, CLIN CANCER RES, V15, P1297, DOI 10.1158/1078-0432.CCR-08-0889; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SCHULLER HM, 1991, CARCINOGENESIS, V12, P2301, DOI 10.1093/carcin/12.12.2301; SCHULLER HM, 1990, CANCER RES, V50, P1645; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Seta KA, 2004, CELL CALCIUM, V36, P331, DOI 10.1016/j.ceca.2004.02.006; Shen WG, 2007, CELL BIOL INT, V31, P126, DOI 10.1016/j.cellbi.2006.09.017; Shim JS, 2004, CHEM BIOL, V11, P1455, DOI 10.1016/j.chembiol.2004.08.015; Shim JS, 2002, BIOORGAN MED CHEM, V10, P2987, DOI 10.1016/S0968-0896(02)00129-3; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tang XW, 2003, BIOCHEM J, V374, P137, DOI 10.1042/BJ20021910; Torimura T, 1998, HUM PATHOL, V29, P986, DOI 10.1016/S0046-8177(98)90205-2; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; VEIGL ML, 1983, BIOCHIM BIOPHYS ACTA, V738, P21, DOI 10.1016/0304-419X(84)90018-0; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEI JW, 1982, CANCER RES, V42, P2571; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25867	25874		10.1074/jbc.M110.135632	http://dx.doi.org/10.1074/jbc.M110.135632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554536	Green Published, hybrid			2022-12-27	WOS:000280682400079
J	Zwolak, A; Fujiwara, I; Hammer, JA; Tjandra, N				Zwolak, Adam; Fujiwara, Ikuko; Hammer, John A., III; Tjandra, Nico			Structural Basis for Capping Protein Sequestration by Myotrophin (V-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT BARBED END; 4-DIMENSIONAL NMR-SPECTROSCOPY; CHEMICAL-SHIFT ASSIGNMENTS; NUCLEAR-MAGNETIC-RESONANCE; CAPPED ACTIN-FILAMENTS; SECONDARY STRUCTURE; ARP2/3 COMPLEX; IN-VITRO; MYOSIN-I; BINDING	Capping protein (CP) is a ubiquitously expressed, heterodimeric 62-kDa protein that binds the barbed end of the actin filament with high affinity to block further filament elongation. Myotrophin (V-1) is a 13-kDa ankyrin repeat-containing protein that binds CP tightly, sequestering it in a totally inactive complex in vitro. Here, we elucidate the molecular interaction between CP and V-1 by NMR. Specifically, chemical shift mapping and intermolecular paramagnetic relaxation enhancement experiments reveal that the ankyrin loops of V-1, which are essential for V-1/CP interaction, bind the basic patch near the joint of the alpha tentacle of CP shown previously to drive most of the association of CP with and affinity for the barbed end. Consistently, site-directed mutagenesis of CP shows that V-1 and the strong electrostatic binding site for CP on the barbed end compete for this basic patch on CP. These results can explain how V-1 inactivates barbed end capping by CP and why V-1 is incapable of uncapping CP-capped actin filaments, the two signature biochemical activities of V-1.	[Fujiwara, Ikuko; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Zwolak, Adam] NYU, Sch Med, Sackler Inst Biomed Sci, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Bldg 50,Rm 2306, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov; tjandran@nhlbi.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Hammer, John/0000-0002-2496-5179	NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL006120] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grants from Intramural Research Program, NHLBI (to J. A. H. III and N. T.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Anderson KM, 1999, J MOL CELL CARDIOL, V31, P705, DOI 10.1006/jmcc.1998.0903; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Gardner KH, 1998, J AM CHEM SOC, V120, P11738, DOI 10.1021/ja982019w; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Kitazawa M, 2005, BIOCHEM BIOPH RES CO, V331, P181, DOI 10.1016/j.bbrc.2005.03.127; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sivasubramanian N, 1996, J BIOL CHEM, V271, P2812, DOI 10.1074/jbc.271.5.2812; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Yang YW, 1997, PROTEIN SCI, V6, P1347, DOI 10.1002/pro.5560060625	62	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25767	25781		10.1074/jbc.M110.135848	http://dx.doi.org/10.1074/jbc.M110.135848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538588	Green Published, hybrid			2022-12-27	WOS:000280682400069
J	Mendelson, K; Swendeman, S; Saftig, P; Blobel, CP				Mendelson, Karen; Swendeman, Steven; Saftig, Paul; Blobel, Carl P.			Stimulation of Platelet-derived Growth Factor Receptor beta (PDGFR beta) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFR beta and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CONVERTASE TACE; PROTEIN; DISINTEGRIN; CLEAVAGE; CELLS; MICE; TRANSACTIVATION; COMPONENTS; MIGRATION	Binding of the platelet-derived growth factor (PDGF)-B to its receptor PDGFR beta promotes proliferation, migration, and recruitment of pericytes and smooth muscle cells to endothelial cells, serving to stabilize developing blood vessels. The main goals of this study were to determine whether the extracellular domain of the PDGFR beta can be proteolytically released from cell membranes and, if so, to identify the responsible sheddase and determine whether activation of the PDGFR beta stimulates its shedding and potentially that of other membrane proteins. We found that the PDGFR beta is shed from cells by a metalloproteinase and used loss-of-function experiments to identify ADAM10 as the sheddase responsible for constitutive and ionomycin-stimulated processing of the PDGFR beta. Moreover, we showed that ligand-dependent activation of the PDGFR beta does not trigger its own shedding by ADAM10, but instead it stimulates ADAM17 and shedding of substrates of ADAM17, including tumor necrosis factor alpha and transforming growth factor alpha. Finally, we demonstrated that treatment of mouse embryonic fibroblasts with PDGF-B triggers a metalloproteinase-dependent cross-talk between the PDGFR beta and the epidermal growth factor receptor (EGFR)/ERK1/2 signaling axis that is also critical for PDGF-B-stimulated cell migration, most likely via ADAM17-dependent release and activation of ligands of the EGFR. This study identifies the principal sheddase for the PDGFR beta and provides new insights into the mechanism of PDGFR beta-dependent signal transduction and cross-talk with the EGFR.	[Mendelson, Karen; Swendeman, Steven; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Mendelson, Karen; Blobel, Carl P.] Cornell Univ, Weill Med Coll, Physiol Biophys & Syst Biol Program, New York, NY 10021 USA; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Blobel, Carl P.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; University of Kiel; Cornell University	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu	Saftig, Paul/A-7966-2010		National Institutes of Health [GM64750, EY015719]; Deutsche Forschungsgemeinschaft [SFB 877]; European Union-DeZenit; NATIONAL EYE INSTITUTE [R01EY015719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union-DeZenit; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM64750 and EY015719 (to C.P.B.) and the Deutsche Forschungsgemeinschaft SFB 877 and the European Union-DeZenit (to P.S.).	Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cain JA, 2004, BLOOD, V104, P561, DOI 10.1182/blood-2003-11-3801; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KEATING MT, 1987, J BIOL CHEM, V262, P7932; KELLY JD, 1991, J BIOL CHEM, V266, P8987; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sahin Umut, 2006, V327, P99; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Toffalini F, 2010, J BIOL CHEM, V285, P12268, DOI 10.1074/jbc.M109.076638; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	36	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25024	25032		10.1074/jbc.M110.102566	http://dx.doi.org/10.1074/jbc.M110.102566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529858	Green Published, hybrid			2022-12-27	WOS:000280542100075
J	Gosmain, Y; Marthinet, E; Cheyssac, C; Guerardel, A; Mamin, A; Katz, LS; Bouzakri, K; Philippe, J				Gosmain, Yvan; Marthinet, Eric; Cheyssac, Claire; Guerardel, Audrey; Mamin, Aline; Katz, Liora S.; Bouzakri, Karim; Philippe, Jacques			Pax6 Controls the Expression of Critical Genes Involved in Pancreatic alpha Cell Differentiation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON GENE; BETA-CELLS; TRANSCRIPTION FACTORS; PROMOTER ELEMENT; EARLY-ONSET; MAF; ACTIVATION; INTERACT; BINDING; IDENTIFICATION	The paired box homeodomain Pax6 is crucial for endocrine cell development and function and plays an essential role in glucose homeostasis. Indeed, mutations of Pax6 are associated with diabetic phenotype. Importantly, homozygous mutant mice for Pax6 are characterized by markedly decreased beta and delta cells and absent alpha cells. To better understand the critical role that Pax6 exerts in glucagon-producing cells, we developed a model of primary rat alpha cells. To study the transcriptional network of Pax6 in adult and differentiated alpha cells, we generated Pax6-deficient primary rat alpha cells and glucagon-producing cells, using either specific siRNA or cells expressing constitutively a dominant-negative form of Pax6. In primary rat alpha cells, we confirm that Pax6 controls the transcription of the Proglucagon and processing enzyme PC2 genes and identify three new target genes coding for MafB, cMaf, and NeuroD1/Beta2, which are all critical for Glucagon gene transcription and alpha cell differentiation. Furthermore, we demonstrate that Pax6 directly binds and activates the promoter region of the three genes through specific binding sites and that constitutive expression of a dominant-negative form of Pax6 in glucagon-producing cells (InR1G9) inhibits the activities of the promoters. Finally our results suggest that the critical role of Pax6 action on alpha cell differentiation is independent of those of Arx and Foxa2, two transcription factors that are necessary for alpha cell development. We conclude that Pax6 is critical for alpha cell function and differentiation through the transcriptional control of key genes involved in glucagon gene transcription, proglucagon processing, and alpha cell differentiation.	[Philippe, Jacques] Univ Geneva, Diabet Unit, Div Endocrinol Diabet & Nutr, Univ Hosp, CH-1211 Geneva 4, Switzerland; [Bouzakri, Karim] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva		Yvan.Gosmain@hcuge.ch			Swiss National Science Foundation; Novo-Nordisk, Switzerland; Biology and Cancer Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo-Nordisk, Switzerland(Novo Nordisk); Biology and Cancer Research Foundation	This work was supported by the Swiss National Science Foundation, Novo-Nordisk, Switzerland, and the Biology and Cancer Research Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Bernier G, 2001, DEVELOPMENT, V128, P3987; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; CORDIERBUSSAT M, 1995, MOL CELL BIOL, V15, P3904; Dumonteil E, 1998, J BIOL CHEM, V273, P19945, DOI 10.1074/jbc.273.32.19945; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Huang K, 1999, Hokkaido Igaku Zasshi, V74, P419; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Jin TR, 1996, MOL CELL BIOL, V16, P19; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Meyer K, 1998, DIABETES, V47, P1974, DOI 10.2337/diabetes.47.12.1974; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2006, DIABETES, V55, pA362; Parnaud G, 2009, MOL ENDOCRINOL, V23, P1264, DOI 10.1210/me.2009-0008; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1995, J BIOL CHEM, V270, P3039, DOI 10.1074/jbc.270.7.3039; Planque N, 2001, J BIOL CHEM, V276, P35751, DOI 10.1074/jbc.M104523200; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; TAKAKI R, 1986, IN VITRO CELL DEV B, V22, P120; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224	51	53	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33381	33393		10.1074/jbc.M110.147215	http://dx.doi.org/10.1074/jbc.M110.147215			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20592023	Green Published, hybrid			2022-12-27	WOS:000283048200073
J	Vergara, A; Vitagliano, L; Merlino, A; Sica, F; Marino, K; Verde, C; di Prisco, G; Mazzarella, L				Vergara, Alessandro; Vitagliano, Luigi; Merlino, Antonello; Sica, Filomena; Marino, Katia; Verde, Cinzia; di Prisco, Guido; Mazzarella, Lelio			An Order-Disorder Transition Plays a Role in Switching Off the Root Effect in Fish Hemoglobins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TREMATOMUS-BERNACCHII; STRUCTURAL BASIS; PAGOTHENIA-BERNACCHII; TETRAMERIC HEMOGLOBIN; DEOXY; NEWNESI; BINDING; EQUILIBRIA; STABILITY	The Root effect is a widespread property among fish hemoglobins whose structural basis remains largely obscure. Here we report a crystallographic and spectroscopic characterization of the non-Root-effect hemoglobin isolated from the Antarctic fish Trematomus newnesi in the deoxygenated form. The crystal structure unveils that the T state of this hemoglobin is stabilized by a strong H-bond between the side chains of Asp95 alpha and Asp101 beta at the alpha(1)beta(2) and alpha(2)beta(1) interfaces. This unexpected finding undermines the accepted paradigm that correlates the presence of this unusual H-bond with the occurrence of the Root effect. Surprisingly, the T state is characterized by an atypical flexibility of two alpha chains within the tetramer. Indeed, regions such as the CD alpha corner and the EF alpha pocket, which are normally well ordered in the T state of tetrameric hemoglobins, display high B-factors and non-continuous electron densities. This flexibility also leads to unusual distances between the heme iron and the proximal and distal His residues. These observations are in line with Raman micro-spectroscopy studies carried out both in solution and in the crystal state. The findings here presented suggest that in fish hemoglobins the Root effect may be switched off through a significant destabilization of the T state regardless of the presence of the inter-aspartic H-bond. Similar mechanisms may also operate for other non-Root effect hemoglobins. The implications of the flexibility of the CD alpha corner for the mechanism of the T-R transition in tetrameric hemoglobins are also discussed.	[Mazzarella, Lelio] Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy; [Vergara, Alessandro; Vitagliano, Luigi; Merlino, Antonello; Sica, Filomena; Mazzarella, Lelio] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Marino, Katia; Verde, Cinzia; di Prisco, Guido] CNR, Inst Prot Biochem, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Mazzarella, L (corresponding author), Complesso Univ Monte S Angelo, Via Cinthia, I-80126 Naples, Italy.	lelio.mazzarella@unina.it	Vergara, Alessandro/C-4435-2013; Merlino, Antonello/AAI-2114-2020	Vergara, Alessandro/0000-0003-4135-0245; Merlino, Antonello/0000-0002-1045-7720; VERDE, Cinzia/0000-0001-6185-282X	PNRA (Italian National Programme for Antarctic Research); Evolution and Biodiversity in the Antarctic (EBA); Scientific Committee for Antarctic Research (SCAR); Ministero Italiano dell'Universita e della Ricerca Scientifica	PNRA (Italian National Programme for Antarctic Research); Evolution and Biodiversity in the Antarctic (EBA); Scientific Committee for Antarctic Research (SCAR); Ministero Italiano dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was financially supported by PNRA (Italian National Programme for Antarctic Research) and is in the framework of the programme Evolution and Biodiversity in the Antarctic (EBA), sponsored by the Scientific Committee for Antarctic Research (SCAR). This study was also supported in part by the Ministero Italiano dell'Universita e della Ricerca Scientifica (PRIN 2007 "Struttura, funzione ed evoluzione di emoproteine da organismi marini artici ed antartici: meccanismi di adattamento al freddo e acquisizione di nuove funzioni").	BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Bonaventura C, 2004, ACTA PHYSIOL SCAND, V182, P245, DOI 10.1111/j.1365-201X.2004.01359.x; Brittain T, 2005, J INORG BIOCHEM, V99, P120, DOI 10.1016/j.jinorgbio.2004.09.025; BRITTAIN T, 1987, COMP BIOCHEM PHYS B, V86, P473, DOI 10.1016/0305-0491(87)90434-2; CAMARDELLA L, 1992, J MOL BIOL, V224, P449, DOI 10.1016/0022-2836(92)91007-C; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; DAVINO R, 1994, J BIOL CHEM, V269, P9675; Giangiacomo L, 2001, BIOCHEMISTRY-US, V40, P3062, DOI 10.1021/bi002297j; Giordano D, 2009, FEBS J, V276, P2266, DOI 10.1111/j.1742-4658.2009.06954.x; ITO N, 1995, J MOL BIOL, V250, P648, DOI 10.1006/jmbi.1995.0405; JONES TA, 1991, ACTA CRYSTALLOGR D, V56, P714; Mazzarella L, 2006, PROTEINS, V62, P316, DOI 10.1002/prot.20709; Mazzarella L, 1999, J MOL BIOL, V287, P897, DOI 10.1006/jmbi.1999.2632; Mazzarella L, 2006, PROTEINS, V65, P490, DOI 10.1002/prot.21114; Merlino A, 2008, SPECTROSC-INT J, V22, P143, DOI 10.1155/2008/328463; Merlino A, 2010, J PHYS CHEM B, V114, P7002, DOI 10.1021/jp908525s; Merlino A, 2009, MAR GENOM, V2, P51, DOI 10.1016/j.margen.2009.04.003; Merlino A, 2009, BIOPOLYMERS, V91, P1117, DOI 10.1002/bip.21206; Mylvaganam SE, 1996, NAT STRUCT BIOL, V3, P275, DOI 10.1038/nsb0396-275; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1996, NAT STRUCT BIOL, V3, P211, DOI 10.1038/nsb0396-211; PERUTZ MF, 1980, PROC R SOC SER B-BIO, V208, P135, DOI 10.1098/rspb.1980.0047; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Riccio A, 2001, ACTA CRYSTALLOGR D, V57, P1144, DOI 10.1107/S0907444901007739; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Smulevich G, 1998, J RAMAN SPECTROSC, V29, P57, DOI 10.1002/(SICI)1097-4555(199801)29:1<57::AID-JRS209>3.0.CO;2-P; Tame JRH, 1996, J MOL BIOL, V259, P749, DOI 10.1006/jmbi.1996.0355; UNZAI S, 2008, MUTAGENIC STUDIES OR; Verde C, 2004, PROTEIN SCI, V13, P2766, DOI 10.1110/ps.04861504; Verde C, 2008, CURR PROTEIN PEPT SC, V9, P578, DOI 10.2174/138920308786733895; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Vergara A, 2009, BIOPHYS J, V97, P866, DOI 10.1016/j.bpj.2009.04.056; Vitagliano L, 2008, J AM CHEM SOC, V130, P10527, DOI 10.1021/ja803363p; Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200	38	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32568	32575		10.1074/jbc.M110.143537	http://dx.doi.org/10.1074/jbc.M110.143537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20610398	hybrid, Green Published			2022-12-27	WOS:000282683000071
J	Dai, XP; Hao, J; Hou, XJ; Hai, T; Fan, Y; Yu, Y; Jouneau, A; Wang, L; Zhou, Q				Dai, Xiangpeng; Hao, Jie; Hou, Xiao-jun; Hai, Tang; Fan, Yong; Yu, Yang; Jouneau, Alice; Wang, Liu; Zhou, Qi			Somatic Nucleus Reprogramming Is Significantly Improved by m-Carboxycinnamic Acid Bishydroxamide, a Histone Deacetylase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL LINES; MOUSE EMBRYOS; MAMMALIAN DEVELOPMENT; DNA METHYLATION; TRICHOSTATIN-A; IN-VITRO; ACETYLATION; CLONING; HETEROCHROMATIN; ESTABLISHMENT	Somatic cell nuclear transfer (SCNT) has shown tremendous potential for understanding the mechanisms of reprogramming and creating applications in the realms of agriculture, therapeutics, and regenerative medicine, although the efficiency of reprogramming is still low. Somatic nucleus reprogramming is triggered in the short time after transfer into recipient cytoplasm, and therefore, this period is regarded as a key stage for optimizing SCNT. Here we report that CBHA, a histone deacetylase inhibitor, modifies the acetylation status of somatic nuclei and increases the developmental potential of mouse cloned embryos to reach pre- and post-implantation stages. Furthermore, the cloned embryos treated by CBHA displayed higher efficiency in the derivation of nuclear transfer embryonic stem cell lines by promoting outgrowths. More importantly, CBHA increased blastocyst quality compared with trichostatin A, another prevalent histone deacetylase inhibitor reported previously. Use of CBHA should improve the productivity of SCNT for a variety of research and clinical applications, and comparisons of cells with different levels of pluripotency and treated with CBHA versus trichostatin A will facilitate studies of the mechanisms of reprogramming.	[Dai, Xiangpeng; Hao, Jie; Hou, Xiao-jun; Hai, Tang; Fan, Yong; Yu, Yang; Wang, Liu; Zhou, Qi] Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, Beijing 100101, Peoples R China; [Dai, Xiangpeng; Hao, Jie] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Jouneau, Alice] INRA, UMR Biol Dev & Reprod 1198, F-78352 Jouy En Josas, France; [Jouneau, Alice] Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA)	Zhou, Q (corresponding author), Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, 1st Beichen West Rd, Beijing 100101, Peoples R China.	qzhou@ioz.ac.cn		, Haitang/0000-0002-3192-0753; Jouneau, Alice/0000-0001-5985-9862	973 Program [2006CB944003, 2007CB947702]; 863 Program [2006AA02A101]; National Science Foundation of China [30525040]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by 973 Program Grants 2006CB944003 and 2007CB947702, 863 Program Grant 2006AA02A101, and National Science Foundation of China Grant 30525040.	Bartova E, 2005, J CELL SCI, V118, P5035, DOI 10.1242/jcs.02621; Bi GF, 2006, CELL MOL IMMUNOL, V3, P285; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Campbell KHS, 2007, THERIOGENOLOGY, V68, pS214, DOI 10.1016/j.theriogenology.2007.05.059; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Gao SR, 2004, BIOL REPROD, V70, P1162, DOI 10.1095/biolreprod.103.024216; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Jeon BG, 2008, REPRODUCTION, V135, P815, DOI 10.1530/REP-07-0442; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2006, FEBS LETT, V580, P1801, DOI 10.1016/j.febslet.2006.02.036; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; POWER MA, 1993, ANAT EMBRYOL, V187, P493; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; STADTFELD M, 2010, NATURE IN PRESS; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhao CL, 2007, CELL RES, V17, P80, DOI 10.1038/sj.cr.7310139; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; Zhou Q, 2001, BIOL REPROD, V65, P412, DOI 10.1093/biolreprod/65.2.412	42	57	61	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31002	31010		10.1074/jbc.M110.136085	http://dx.doi.org/10.1074/jbc.M110.136085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20566633	Green Published, hybrid			2022-12-27	WOS:000282135500065
J	Denoncin, K; Vertommen, D; Paek, E; Collet, JF				Denoncin, Katleen; Vertommen, Didier; Paek, Eunok; Collet, Jean-Francois			The Protein-disulfide Isomerase DsbC Cooperates with SurA and DsbA in the Assembly of the Essential beta-Barrel Protein LptD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE BIOGENESIS; ESCHERICHIA-COLI; NONCONSECUTIVE DISULFIDE; CHAPERONE ACTIVITY; CELL-ENVELOPE; OXIDASE DSBA; COMPLEX; BOND; LIPOPOLYSACCHARIDE; IDENTIFICATION	The assembly of the beta-barrel proteins present in the outermembrane (OM) of Gram-negative bacteria is poorly characterized. After translocation across the inner membrane, unfolded beta-barrel proteins are escorted across the periplasm by chaperones that reside within this compartment. Two partially redundant chaperones, SurA and Skp, are considered to transport the bulk mass of beta-barrel proteins. We found that the periplasmic disulfide isomerase DsbC cooperates with SurA and the thiol oxidase DsbA in the folding of the essential beta-barrel protein LptD. LptD inserts lipopolysaccharides in the OM. It is also the only beta-barrel protein with more than two cysteine residues. We found that surAdsbC mutants, but not skpdsbC mutants, exhibit a synthetic phenotype. They have a decreased OM integrity, which is due to the lack of the isomerase activity of DsbC. We also isolated DsbC in a mixed disulfide complex with LptD. As such, LptD is identified as the first substrate of DsbC that is localized in the OM. Thus, electrons flowing from the cytoplasmic thioredoxin system maintain the integrity of the OM by assisting the folding of one of the most important beta-barrel proteins.	Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Denoncin, Katleen; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Paek, Eunok] Univ Seoul, Dept Mech & Informat Engn, Seoul 130743, South Korea	Universite Catholique Louvain; University of Seoul	Collet, JF (corresponding author), 75-39 Ave Hippocrate, B-1200 Brussels, Belgium.	jfcollet@uclouvain.be	Collet, Jean Francois/F-2105-2010	Collet, Jean-Francois/0000-0001-8069-7036; Vertommen, Didier/0000-0001-7648-8282	Interuniversity Attraction Pole Programme-Belgian Science Policy Network [P6/05, P6/28]; Korean Ministry of Education, Science and Technology [FPR-08-A1-020]; Center for Cell Signaling Research and Drug Discovery Research [R15-2006-020]; Fonds de la Recherche Scientifique-FNRS	Interuniversity Attraction Pole Programme-Belgian Science Policy Network; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Center for Cell Signaling Research and Drug Discovery Research; Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by funds from Interuniversity Attraction Pole Programme-Belgian Science Policy Network P6/05 (to J.-F. C. and K. D.), and P6/28 (to D. V.) 21C Frontier Functional Proteomics Project Grant FPR-08-A1-020 from the Korean Ministry of Education, Science and Technology, National Core Research Center Program Grant R15-2006-020 through the Center for Cell Signaling Research and Drug Discovery Research (to E. P.), and grants from the Fonds de la Recherche Scientifique-FNRS (to J.-F. C.).	Abe S, 2003, MICROBIOL-SGM, V149, P1265, DOI 10.1099/mic.0.25927-0; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; COLLET JF, 2010, ANTIOXID RE IN PRESS; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Leverrier P, 2010, PROTEOMICS, V10, P771, DOI 10.1002/pmic.200900461; Liu XQ, 2001, J BIOL CHEM, V276, P1146, DOI 10.1074/jbc.M004929200; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Shouldice SR, 2010, MOL MICROBIOL, V75, P13, DOI 10.1111/j.1365-2958.2009.06952.x; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193	35	40	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29425	29433		10.1074/jbc.M110.119321	http://dx.doi.org/10.1074/jbc.M110.119321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615876	Green Published, hybrid			2022-12-27	WOS:000281740100045
J	Kaddatz, K; Adhikary, T; Finkernagel, F; Meissner, W; Muller-Brusselbach, S; Muller, R				Kaddatz, Kerstin; Adhikary, Till; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf			Transcriptional Profiling Identifies Functional Interactions of TGF beta and PPAR beta/delta Signaling SYNERGISTIC INDUCTION OF ANGPTL4 TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PROLIFERATOR-ACTIVATED RECEPTORS; TUMOR-SUPPRESSOR; TARGET GENES; ALPHA; DELTA; EXPRESSION; SMAD3; INFLAMMATION; LIGANDS	Peroxisome proliferator-activated receptors (PPARs) not only play a key role in regulating metabolic pathways but also modulate inflammatory processes, pointing to a functional interaction between PPAR and cytokine signaling pathways. In this study, we show by genome-wide transcriptional profiling that PPAR beta/delta and transforming growth factor-beta (TGF beta) pathways functionally interact in human myofibroblasts and that a subset of these genes is cooperatively activated by TGF beta and PPAR beta/delta. Using the angiopoietin-like 4 (ANGPTL4) gene as a model, we demonstrate that two enhancer regions cooperate to mediate the observed synergistic response. A TGF beta-responsive enhancer located similar to 8 kb upstream of the transcriptional start site is regulated by a mechanism involving SMAD3, ETS1, RUNX, and AP-1 transcription factors that interact with multiple contiguous binding sites. A second enhancer (PPAR-E) consisting of three juxtaposed PPAR response elements is located in the third intron similar to 3.5 kb downstream of the transcriptional start site. The PPAR-E is strongly activated by all three PPAR subtypes, with a novel type of PPAR response element motif playing a central role. Although the PPAR-E is not regulated by TGF beta, it interacts with SMAD3, ETS1, RUNX2, and AP-1 in vivo, providing a possible mechanistic explanation for the observed synergism.	[Kaddatz, Kerstin; Adhikary, Till; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany	Philipps University Marburg	Muller, R (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Emil Mannkopff Str 2, D-35032 Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016; Adhikary, Till/O-5678-2018	Müller, Rolf/0000-0003-3339-4248; Adhikary, Till/0000-0003-1951-5605	Deutsche Forschungsgemeinschaft [Mu601/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Mu601/12-1, the core facility of the SFB-TR17, and the LOEWE-Schwerpunkt "Tumor and Inflammation."	*AG TECHN, 2006, AG MICR HYBR CHAMB U; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Brown RJ, 2007, CURR DRUG TARGETS, V8, P1307, DOI 10.2174/138945007783220614; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gehrke S, 2003, GENE, V322, P137, DOI 10.1016/j.gene.2003.08.010; Giehl K, 2007, CELLS TISSUES ORGANS, V185, P123, DOI 10.1159/000101313; Graulich W, 1999, GENE, V227, P55, DOI 10.1016/S0378-1119(98)00585-X; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Ito Y, 2003, CANCER RES, V63, P6651; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jerome V, 1998, HUM GENE THER, V9, P2653, DOI 10.1089/hum.1998.9.18-2653; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; King AN, 2010, ANTI-CANCER AGENT ME, V10, P213; Kino T, 2007, EUR J CLIN INVEST, V37, P425, DOI 10.1111/j.1365-2362.2007.01796.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; LICHTENSTEIN L, BIOCH BIOPHYS ACTA, V1801, P415; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nawa T, 2000, BIOCHEM BIOPH RES CO, V275, P406, DOI 10.1006/bbrc.2000.3332; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	59	49	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29469	29479		10.1074/jbc.M110.142018	http://dx.doi.org/10.1074/jbc.M110.142018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595396	Green Published, hybrid			2022-12-27	WOS:000281740100049
J	Kimball, SR; Jefferson, LS				Kimball, Scot R.; Jefferson, Leonard S.			Control of Translation Initiation through Integration of Signals Generated by Hormones, Nutrients, and Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RAT SKELETAL-MUSCLE; LEUCINE REGULATES TRANSLATION; ACUTE RESISTANCE EXERCISE; PEPTIDE-CHAIN INITIATION; RIBOSOMAL-PROTEIN S6; MAMMALIAN TARGET; AMINO-ACIDS; DIABETIC-RATS; CELLULAR MECHANISMS; POSTABSORPTIVE RATS	Control of translation initiation in a tissue of an intact mammalian organism is a highly complex process requiring the continuous integration of multiple positive and negative stimuli. For a tissue such as skeletal muscle, which has the capacity to undergo dramatic changes in size and protein content, translation initiation contributes importantly to the regulation of global rates of protein synthesis and is controlled by numerous stimuli, including those arising from nutrients and hormones in the circulating blood, as well as from contraction-induced signaling within the tissue. Many of the pathways conveying signals generated by these stimuli converge on mTORC1, a serine-threonine protein kinase that has been termed the nutrient and energy sensor of the cell and that plays a prominent role in the regulation of cell growth. Control of translation initiation by mTORC1 is mediated through phosphorylation of downstream targets that modulate the binding of mRNA to the 43 S preinitiation complex. Control of translation initiation is also mediated through modulation of binding of initiator methionyl-tRNA to the 40 S ribosomal subunit. Together, modulation of these two regulatory steps in translation initiation accounts in large part for changes in protein synthesis in skeletal muscle produced by the integration of inputs from hormones, nutrients, and exercise.	[Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	skimball@psu.edu			National Institutes of Health [DK-15658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-15658. This is the fourth article in the Thematic Minireview Series on Protein Synthesis. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Adegoke OAJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE105, DOI 10.1152/ajpendo.90752.2008; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Anthony JC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1092, DOI 10.1152/ajpendo.00208.2001; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2003, EXERC SPORT SCI REV, V31, P111, DOI 10.1097/00003677-200307000-00002; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; BULLOCK GR, 1972, BIOCHEM J, V127, P881, DOI 10.1042/bj1270881; Chale-Rush A, 2009, J GERONTOL A-BIOL, V64, P1232, DOI 10.1093/gerona/glp146; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Drummond MJ, 2008, J APPL PHYSIOL, V104, P1452, DOI 10.1152/japplphysiol.00021.2008; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1403, DOI 10.1152/japplphysiol.90842.2008; Farrell PA, 1999, AM J PHYSIOL-ENDOC M, V276, pE721, DOI 10.1152/ajpendo.1999.276.4.E721; FLAIM KE, 1980, AM J PHYSIOL, V239, pE88, DOI 10.1152/ajpendo.1980.239.1.E88; FULKS RM, 1975, J BIOL CHEM, V250, P290; GARLICK PJ, 1973, BIOCHEM J, V136, P935, DOI 10.1042/bj1360935; GARLICK PJ, 1983, BIOCHEM J, V210, P669, DOI 10.1042/bj2100669; GOLDBERG AL, 1969, J PHYSIOL-LONDON, V200, P667, DOI 10.1113/jphysiol.1969.sp008715; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; Hornberger TA, 2003, J NUTR, V133, P3091, DOI 10.1093/jn/133.10.3091; Hwee DT, 2009, J GERONTOL A-BIOL, V64, P618, DOI 10.1093/gerona/glp026; JEFFERSON LS, 1974, FED PROC, V33, P1098; JEFFERSON LS, 1977, J BIOL CHEM, V252, P1476; JEFFREY IW, 1990, BIOCHIMIE, V72, P751, DOI 10.1016/0300-9084(90)90160-I; KARINCH AM, 1993, AM J PHYSIOL, V264, pE101, DOI 10.1152/ajpendo.1993.264.1.E101; KELLY FJ, 1985, J BIOL CHEM, V260, P6677; Kim E, 2009, CELL CYCLE, V8, P1014, DOI 10.4161/cc.8.7.8124; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; KIMBALL SR, 1988, BIOCHEM BIOPH RES CO, V156, P706, DOI 10.1016/S0006-291X(88)80900-8; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1996, AM J PHYSIOL-CELL PH, V270, pC705, DOI 10.1152/ajpcell.1996.270.2.C705; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; Kubica N, 2004, J APPL PHYSIOL, V96, P679, DOI 10.1152/japplphysiol.00962.2003; Kubica N, 2008, INT J BIOCHEM CELL B, V40, P2522, DOI 10.1016/j.biocel.2008.04.010; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; LI JB, 1978, BIOCHIM BIOPHYS ACTA, V544, P351, DOI 10.1016/0304-4165(78)90103-4; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; PREEDY VR, 1986, BIOSCIENCE REP, V6, P177, DOI 10.1007/BF01115004; Rannels D E, 1980, Adv Myocardiol, V1, P493; RANNELS SR, 1978, AM J PHYSIOL, V235, pE134, DOI 10.1152/ajpendo.1978.235.2.E134; RANNELS SR, 1980, AM J PHYSIOL, V238, pE564, DOI 10.1152/ajpendo.1980.238.6.E564; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; RENNIE MJ, 1982, CLIN SCI, V63, P519, DOI 10.1042/cs0630519; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2002, J BIOL CHEM, V277, P2525, DOI 10.1074/jbc.M105935200; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; SHOJI S, 1977, MOL CELL ENDOCRINOL, V6, P159, DOI 10.1016/0303-7207(77)90082-X; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Thomson DM, 2006, J PHYSIOL-LONDON, V574, P291, DOI 10.1113/jphysiol.2006.107490; TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139; Vary TC, 1999, AM J PHYSIOL-ENDOC M, V277, pE1077, DOI 10.1152/ajpendo.1999.277.6.E1077; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; WOOL IG, 1959, AM J PHYSIOL, V197, P1089, DOI 10.1152/ajplegacy.1959.197.5.1089	68	84	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29027	29032		10.1074/jbc.R110.137208	http://dx.doi.org/10.1074/jbc.R110.137208			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20576612	Green Published, hybrid			2022-12-27	WOS:000281740100001
J	Li, DH; Harper, SL; Tang, HY; Maksimova, Y; Gallagher, PG; Speicher, DW				Li, Donghai; Harper, Sandra L.; Tang, Hsin-Yao; Maksimova, Yelena; Gallagher, Patrick G.; Speicher, David W.			A Comprehensive Model of the Spectrin Divalent Tetramer Binding Region Deduced Using Homology Modeling and Chemical Cross-linking of a Mini-spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ERYTHROCYTE SPECTRIN; ALPHA-SPECTRIN; CRYSTAL-STRUCTURE; HEMOLYTIC-ANEMIA; INITIATION SITE; MEMBRANE; DOCKING; COMPLEX; ACTIN	Spectrin dimer-tetramer interconversion is a critical contributor to red cell membrane stability, but some properties of spectrin tetramer formation cannot be studied effectively using monomeric recombinant domains. To address these limitations, a fused alpha beta mini-spectrin was produced that forms wildtype divalent tetramer complexes. Using this mini-spectrin, a medium-resolution structure of a seven-repeat bivalent tetramer was produced using homology modeling coupled with chemical cross-linking. Inter-and intramolecular cross-links provided critical distance constraints for evaluating and optimizing the best conformational model and appropriate docking interfaces. The two strands twist around each other to form a super-coiled, rope-like structure with the AB helix face of one strand associating with the opposing AC helix face. Interestingly, two tetramer site hereditary anemia mutations that exhibit wild-type binding in univalent head-to-head assays are located in the interstrand region. This suggests that perturbations of the interstrand region can destabilize spectrin tetramers and the membrane skeleton. The alpha subunit N-terminal cross-links to multiple sites on both strands, demonstrating that this non-homologous tail remains flexible and forms heterogeneous structures in the tetramer complex. Although no cross-links were observed involving the beta subunit non-homologous C-terminal tail, several cross-links were observed only when this domain was present, suggesting it induces subtle conformational changes to the tetramer site region. This medium-resolution model provides a basis for further studies of the bivalent spectrin tetramer site, including analysis of functional consequences of interstrand interactions and mutations located at substantial molecular distances from the tetramer site.	[Li, Donghai; Harper, Sandra L.; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Li, Donghai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Maksimova, Yelena; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	The Wistar Institute; Nanjing University; Yale University	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org		Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health [HL38794, HL64558]; NCI [CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL064558, R01HL065448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38794 (to D. W. S.) and HL64558 (to P. G. G.) and CA10815 (NCI core grant to the Wistar Institute).	AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; BRENNER SL, 1980, J BIOL CHEM, V255, P1670; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DeLano W.L, PYMOL MOL GRAPHICS S; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; FOWLER V, 1980, J CELL BIOL, V85, P361, DOI 10.1083/jcb.85.2.361; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gallagher PG, 2004, SEMIN HEMATOL, V41, P142, DOI 10.1053/j.seminhematol.2004.01.003; Harper SL, 2010, J BIOL CHEM, V285, P11003, DOI 10.1074/jbc.M109.083048; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; LIU SC, 1984, CELL, V37, P587, DOI 10.1016/0092-8674(84)90389-1; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; Park S, 2000, FEBS LETT, V485, P81, DOI 10.1016/S0014-5793(00)02186-4; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; Speicher K D, 2000, J Biomol Tech, V11, P74; Tang HY, 2004, BIOCHEMISTRY-US, V43, P4251, DOI 10.1021/bi036092x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNGEWICKELL E, 1979, NATURE, V280, P811, DOI 10.1038/280811a0; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; ZARKOWSKY HS, 1975, BRIT J HAEMATOL, V29, P537, DOI 10.1111/j.1365-2141.1975.tb02740.x	36	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29535	29545		10.1074/jbc.M110.145573	http://dx.doi.org/10.1074/jbc.M110.145573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610390	Green Published, hybrid			2022-12-27	WOS:000281740100055
J	Yamamoto, K; Miyazaki, K; Higashi, S				Yamamoto, Kazuhiro; Miyazaki, Kaoru; Higashi, Shouichi			Cholesterol Sulfate Alters Substrate Preference of Matrix Metalloproteinase-7 and Promotes Degradations of Pericellular Laminin-332 and Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; CELLULAR ADHESION; TUMOR INVASION; MEMBRANE RAFTS; LIPID RAFTS; MATRILYSIN; CELLS; BETA; INTEGRIN; SURFACE	Localization of secreted matrix metalloproteinases (MMPs) on the cell surface is required not only for processing of cell surface proteins, but also for controlled degradation of the extracellular matrix (ECM). Our previous study demonstrated that binding of MMP-7 (matrilysin) to cell surface cholesterol sulfate (CS) is essential for the cell membrane-associated proteolytic action of this MMP. In this study, we investigated the role of CS in the MMP-7-catalyzed degradation of protein components of ECM. We found that the degradation of laminin-332 (laminin-5) catalyzed by MMP-7 was accelerated dramatically in the presence of CS, whereas the sulfated lipid inhibited the degradation of casein catalyzed by the protease. The MMP-7 catalyzed degradation of fibronectin was partially inhibited in the presence of low concentrations of CS, whereas it was accelerated significantly at high concentrations of the lipid. Therefore, it is likely that CS alters the substrate preference of MMP-7. We also found that the proteins of which MMP-7-catalyzed degradation were accelerated by CS also had affinities for CS, suggesting that CS facilitates the proteolyses by cross-linking MMP-7 to its substrates. Moreover, MMP-7 tethered to cancer cell surface via CS degraded fibronectin and laminin-332 coated on a culture plate. The degradations of the adhesive proteins led to significant detachment of the cells from the plate. Taken together, our findings provide a novel mechanism in which cell surface CS promotes the proteolytic activities of MMP-7 toward selective substrates in the pericellular ECM, thereby contributing to cancer cell migration and metastasis.	[Higashi, Shouichi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Cell Biol, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Div Cell Biol, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp	Yamamoto, Kazuhiro/AAD-9650-2019		JST; Ministry of Education, Culture, Sports, Science and Technology of Japan [17014077, 21570118]	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by JST (Research for Promoting Technological Seeds to S.H.) and Grants-in-Aid for Scientific Research on Priority Areas 17014077 (to K.M.) and Research (C) 21570118 (to S.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1998, INT J HEMATOL, V67, P229; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; Ishikawa T, 1996, CANCER LETT, V107, P5, DOI 10.1016/0304-3835(96)04336-4; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; KITSON N, 1992, BIOCHIM BIOPHYS ACTA, V1111, P127, DOI 10.1016/0005-2736(92)90282-Q; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mitsiades N, 2001, CANCER RES, V61, P577; MIYAZAKI K, 1990, CANCER RES, V50, P7758; Mizushima H, 1998, HORM RES, V50, P7, DOI 10.1159/000053118; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagashima Y, 1997, INT J CANCER, V72, P441, DOI 10.1002/(SICI)1097-0215(19970729)72:3<441::AID-IJC11>3.0.CO;2-F; Noe V, 2001, J CELL SCI, V114, P111; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; RUOSLAHTI E, 1992, BRIT J CANCER, V66, P239, DOI 10.1038/bjc.1992.250; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; vonBredow DC, 1997, EXP CELL RES, V236, P341, DOI 10.1006/excr.1997.3711; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yu Q, 2000, GENE DEV, V14, P163	43	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28862	28873		10.1074/jbc.M110.136994	http://dx.doi.org/10.1074/jbc.M110.136994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605794	Green Published, hybrid			2022-12-27	WOS:000281594000051
J	Itoh, T; Takeda, S; Akao, Y				Itoh, Tomohiro; Takeda, Shu; Akao, Yukihiro			MicroRNA-208 Modulates BMP-2-stimulated Mouse Preosteoblast Differentiation by Directly Targeting V-ets Erythroblastosis Virus E26 Oncogene Homolog 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; OSTEOGENIC DIFFERENTIATION; UP-REGULATION; STEM-CELLS; GROWTH; GENE; EXPRESSION; OSTEOPONTIN; DEGRADATION	MicroRNAs (miRs) represent a class of endogenous similar to 18-25 nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. These miRs regulate several biological functions, such as cell growth, cell differentiation, carcinogenesis, and so on. In a previous report, we have indicated that miR-141 and -200a act as preosteoblast differentiation modulators. In the present study, using microRNA array and in silico analyses, we found that miR-208 is closely involved in preosteoblast differentiation by partially regulating the expression of Ets1 (V-ets erythroblastosis virus E26 oncogene homolog 1), which transactivates osteopontin, runt-related transcription factor 2, parathyroid hormone-related protein, and type I procollagen. Furthermore, the enforced expression of mature miR-208 in murine preosteoblast in MC3T3-E1 cells or primary osteoblast cells remarkably attenuated BMP-2-induced preosteoblast differentiation. In addition, we determined that Ets1 is a target gene of miR-208 by using a sensor luciferase reporter assay. Taken together, these results suggest that the down-regulation of miR-208 in BMP-2-stimulated osteoblast differentiation is an important part of the regulatory machinery involved in early osteogenesis.	[Itoh, Tomohiro; Akao, Yukihiro] Gifu Int Inst Biotechnol, Gifu 5040838, Japan; [Takeda, Shu] Keio Univ, Div Endocrinol Metab & Nephrol, Shinjuku Ku, Tokyo 1608582, Japan; [Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan	Keio University; Gifu University	Itoh, T (corresponding author), Gifu Int Inst Biotechnol, 1-1 Naka Fudogaoka, Gifu 5040838, Japan.	titoh@giib.or.jp	ITOH, Tomohiro/ABG-7076-2020		Ministry of Education, Culture, Sports, Science and Technology [21700715]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Young Scientists (B) 21700715 from the Ministry of Education, Culture, Sports, Science and Technology.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Azmi PB, 2009, ANTICANCER RES, V29, P2253; Cataisson C, 2003, MOL CELL ENDOCRINOL, V204, P155, DOI 10.1016/S0303-7207(02)00298-8; Connor MK, 2005, MOL CANCER RES, V3, P453, DOI 10.1158/1541-7786.MCR-04-0166; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gao YG, 2005, EXP CELL RES, V304, P127, DOI 10.1016/j.yexcr.2004.10.031; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; INOSE H, 2010, P NATL ACAD IN PRESS; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Newberry EP, 1997, MOL ENDOCRINOL, V11, P1129, DOI 10.1210/me.11.8.1129; Pei HP, 2005, CANCER RES, V65, P7205, DOI 10.1158/0008-5472.CAN-04-3566; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Raouf A, 2000, ONCOGENE, V19, P1969, DOI 10.1038/sj.onc.1203505; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Vary CPH, 2000, EXP CELL RES, V257, P213, DOI 10.1006/excr.2000.4879; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; ZHAO C, P NATL ACAD SCI, V107, P1876	37	61	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27745	27752		10.1074/jbc.M110.105080	http://dx.doi.org/10.1074/jbc.M110.105080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576608	Green Published, hybrid			2022-12-27	WOS:000281404100030
J	Liu, J; Afroza, H; Rader, DJ; Jin, WJ				Liu, Jun; Afroza, Huq; Rader, Daniel J.; Jin, Weijun			Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; PROHORMONE CONVERTASES; BINDING; METABOLISM; ANGPTL3; FAMILY; DOMAIN; HYPERTRIGLYCERIDEMIA; IDENTIFICATION; POPULATION	Lipoprotein lipase (LPL)-mediated lipolysis of triglycerides is the first and rate-limiting step in chylomicron/very low density lipoprotein clearance at the luminal surface of the capillaries. Angiopoietin-like protein 3 (ANGPTL3) is shown to inhibit LPL activity and plays important roles in modulating lipoprotein metabolism in vivo. However, the mechanism by which it inhibits LPL activity remains poorly understood. Using cell-based analysis of the interaction between ANGPTL3, furin, proprotein convertase subtilisin/kexin type 5 (PCSK5), paired amino acid converting enzyme-4 (PACE4), and LPL, we demonstrated that the cleavage of LPL by proprotein convertases is an inactivation process, similar to that seen for endothelial lipase cleavage. At physiological concentrations and in the presence of cells, ANGPTL3 is a potent inhibitor of LPL. This action is due to the fact that ANGPTL3 can enhance LPL cleavage by endogenous furin and PACE4 but not by PCSK5. This effect is specific to LPL but not endothelial lipase. Both N- and C-terminal domains of LPL are required for ANGPTL3-enhanced cleavage, and the N-terminal domain of ANGPTL3 is sufficient to exert its effect on LPL cleavage. Moreover, ANGPTL3 enhances LPL cleavage in the presence of either heparan sulfate proteoglycans or glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1). By enhancing LPL cleavage, ANGPTL3 dissociates LPL from the cell surface, inhibiting both the catalytic and noncatalytic functions of LPL. Taken together, our data provide a molecular connection between ANGPTL3, LPL, and proprotein convertases, which may represent a rapid signal communication among different metabolically active tissues to maintain energy homeostasis. These novel findings provide a new paradigm of specific protease-substrate interaction and further improve our knowledge of LPL biology.	[Afroza, Huq; Jin, Weijun] SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Liu, Jun; Rader, Daniel J.; Jin, Weijun] Univ Penn, Sch Med, Translat Med & Therapeut & Cardiovasc Inst, Philadelphia, PA 19104 USA; [Liu, Jun] Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University	Jin, WJ (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, BSB 2-106,450 Clarkson Ave, Brooklyn, NY 11203 USA.	weijun.jin@downstate.edu			NHLBI, National Institutes of Health [HL081861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081861] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL081861 from NHLBI.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Hegele RA, 2009, HUM MOL GENET, V18, P4189, DOI 10.1093/hmg/ddp361; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Li YL, 2008, ACTA BIOCH BIOPH SIN, V40, P459, DOI 10.1111/j.1745-7270.2008.00421.x; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, ANN NY ACAD SCI, V885, P57; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Stejskal D, 2007, GEN PHYSIOL BIOPHYS, V26, P230; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Wicher I, 1996, J IMMUNOL METHODS, V192, P1, DOI 10.1016/0022-1759(95)00260-X; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yimaz Y, 2009, EUR J GASTROEN HEPAT, V21, P1247, DOI 10.1097/MEG.0b013e32832b77ae	33	88	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27561	27570		10.1074/jbc.M110.144279	http://dx.doi.org/10.1074/jbc.M110.144279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581395	Green Published, hybrid			2022-12-27	WOS:000281404100011
J	Parvatiyar, MS; Pinto, JR; Liang, JS; Potter, JD				Parvatiyar, Michelle S.; Pinto, Jose Renato; Liang, Jingsheng; Potter, James D.			Predicting Cardiomyopathic Phenotypes by Altering Ca2+ Affinity of Cardiac Troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; INDUCED STRUCTURAL-CHANGE; MAGNESIUM BINDING-SITES; SKINNED RABBIT PSOAS; THIN FILAMENT; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; FORCE DEVELOPMENT	Cardiac diseases associated with mutations in troponin sub-units include hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM). Altered calcium handling in these diseases is evidenced by changes in the Ca2+ sensitivity of contraction. Mutations in the Ca2+ sensor, troponin C (TnC), were generated to increase/decrease the Ca2+ sensitivity of cardiac skinned fibers to create the characteristic effects of DCM, HCM, and RCM. We also used a reconstituted assay to determine the mutation effects on ATPase activation and inhibition. One mutant (A23Q) was found with HCM-like properties (increased Ca2+ sensitivity of force and normal levels of ATPase inhibition). Three mutants (S37G, V44Q, and L48Q) were identified with RCM-like properties (a large increase in Ca2+ sensitivity, partial loss of ATPase inhibition, and increased basal force). Two mutations were identified (E40A and I61Q) with DCM properties (decreased Ca2+ sensitivity, maximal force recovery, and activation of the ATPase at high [Ca2+]). Steady-state fluorescence was utilized to assess Ca2+ affinity in isolated cardiac (c) TnCs containing F27W and did not necessarily mirror the fiber Ca2+ sensitivity. Circular dichroism of mutant cTnCs revealed a trend where increased alpha-helical content correlated with increased Ca2+ sensitivity in skinned fibers and vice versa. The main findings from this study were as follows: 1) cTnC mutants demonstrated distinct functional phenotypes reminiscent of bona fide HCM, RCM, and DCM mutations; 2) a region in cTnC associated with increased Ca2+ sensitivity in skinned fibers was identified; and 3) the F27W reporter mutation affected Ca2+ sensitivity, maximal force, and ATPase activation of some mutants.	[Parvatiyar, Michelle S.; Pinto, Jose Renato; Liang, Jingsheng; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rm 6083A,RMSB,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	parvatiyar, michelle/ABH-7542-2020; Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL-42325]; American Heart Postdoctoral Fellowships [AHA 0825368E, AHA 09POST2300030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Postdoctoral Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-42325 (to J. D. P.). This work was also supported by American Heart Postdoctoral Fellowships AHA 0825368E (to J. R. P.) and AHA 09POST2300030 (to M. S. P.).	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Brenner B, 1998, ADV EXP MED BIOL, V453, P177; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Chen ZY, 1997, J MOL CELL CARDIOL, V29, P2345, DOI 10.1006/jmcc.1997.0468; DASILVA ACR, 1993, EUR J BIOCHEM, V213, P599; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; EASTWOOD AB, 1979, TISSUE CELL, V11, P553, DOI 10.1016/0040-8166(79)90062-4; ELSALEH SC, 1987, J BIOL CHEM, V262, P17240; Endoh M, 1998, JPN HEART J, V39, P1; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Knott A, 2002, J MOL CELL CARDIOL, V34, P469, DOI 10.1006/jmcc.2002.1528; Kreutziger KL, 2008, J PHYSIOL-LONDON, V586, P3683, DOI 10.1113/jphysiol.2008.152181; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; KUREBAYASHI N, 1988, J PHYSIOL-LONDON, V403, P407, DOI 10.1113/jphysiol.1988.sp017256; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Leblanc L, 2000, ARCH BIOCHEM BIOPHYS, V384, P296, DOI 10.1006/abbi.2000.2103; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li MX, 1997, BIOCHEMISTRY-US, V36, P12519, DOI 10.1021/bi971222l; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Mathew L, 1998, DRUG AGING, V12, P191, DOI 10.2165/00002512-199812030-00003; McKay RT, 2000, BIOCHEMISTRY-US, V39, P12731, DOI 10.1021/bi001240u; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; MOEWS PC, 1975, J MOL BIOL, V91, P201, DOI 10.1016/0022-2836(75)90160-6; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PEARLSTONE JR, 1992, BIOCHEMISTRY-US, V31, P6545, DOI 10.1021/bi00143a026; Pearlstone JR, 2000, J BIOL CHEM, V275, P35106, DOI 10.1074/jbc.M001000200; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POLLESELLO P, 1994, J BIOL CHEM, V269, P28584; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SCHOLZ H, 1986, J MOL CELL CARDIOL, V18, P79, DOI 10.1016/S0022-2828(86)80463-1; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SMITH L, 1994, J BIOL CHEM, V269, P9857; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; Sorsa T, 2001, J BIOL CHEM, V276, P9337, DOI 10.1074/jbc.M007484200; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031; ZOT AS, 1987, J BIOL CHEM, V262, P1966	74	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27785	27797		10.1074/jbc.M110.112326	http://dx.doi.org/10.1074/jbc.M110.112326			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566645	Green Published, hybrid			2022-12-27	WOS:000281404100034
J	Casutt, MS; Huber, T; Brunisholz, R; Tao, ML; Fritz, G; Steuber, J				Casutt, Marco S.; Huber, Tamara; Brunisholz, Rene; Tao, Minli; Fritz, Guenter; Steuber, Julia			Localization and Function of the Membrane-bound Riboflavin in the Na+-translocating NADH:Quinone Oxidoreductase (Na+-NQR) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; MULTIPLE SEQUENCE ALIGNMENT; PUMPING NADH; DETERGENT BINDING; NADHUBIQUINONE OXIDOREDUCTASE; UBIQUINONE OXIDOREDUCTASE; PROTEIN STRUCTURE; CRYSTAL-STRUCTURE; PROSTHETIC GROUPS; ESCHERICHIA-COLI	The sodium ion-translocating NADH: quinone oxidoreductase (Na+-NQR) from the human pathogen Vibrio cholerae is a respiratory membrane protein complex that couples the oxidation of NADH to the transport of Na+ across the bacterial membrane. The Na+-NQR comprises the six subunits NqrABCDEF, but the stoichiometry and arrangement of these subunits are unknown. Redox-active cofactors are FAD and a 2Fe-2S cluster on NqrF, covalently attached FMNs on NqrB and NqrC, and riboflavin and ubiquinone-8 with unknown localization in the complex. By analyzing the cofactor content and NADH oxidation activity of subcomplexes of the Na+-NQR lacking individual subunits, the riboflavin cofactor was unequivocally assigned to the membrane-bound NqrB subunit. Quantitative analysis of the N-terminal amino acids of the holo-complex revealed that NqrB is present in a single copy in the holo-complex. It is concluded that the hydrophobic NqrB harbors one riboflavin in addition to its covalently attached FMN. The catalytic role of two flavins in subunit NqrB during the reduction of ubiquinone to ubiquinol by the Na+-NQR is discussed.	[Huber, Tamara; Tao, Minli; Steuber, Julia] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Brunisholz, Rene] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Casutt, Marco S.; Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	University of Zurich; University of Freiburg	Steuber, J (corresponding author), Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany.	julia.steuber@uni-hohenheim.de	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812	Research Commission of the University of Zurich; EMDO Stiftung; Swiss National Science Foundation; Parkinson Schweiz	Research Commission of the University of Zurich; EMDO Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Parkinson Schweiz	This work was supported by fellowships from the Research Commission of the University of Zurich and the EMDO Stiftung (to M. S. C.), and by grants from the Swiss National Science Foundation and from Parkinson Schweiz (to J. S.).	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2001, BIOCHEMISTRY-US, V40, P7318, DOI 10.1021/bi002545b; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DEMELER B, 2005, MODERN ANAL ULTRACEN; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; FLEMING KG, 2008, CURR PROTOC PROTEIN, P1; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gemperli AC, 2002, J BIOL CHEM, V277, P33811, DOI 10.1074/jbc.M204860200; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1992, BIOCHIM BIOPHYS ACTA, V1099, P145, DOI 10.1016/0005-2728(92)90211-J; HEMPEL J, 2002, MODERN PROTEIN CHEM; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; MARCUS H, 1990, FEMS MICROBIOL LETT, V68, P149, DOI 10.1016/0378-1097(90)90141-C; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Mokhonov V, 2005, PROTEIN EXPRES PURIF, V40, P91, DOI 10.1016/j.pep.2004.10.002; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1998, FEBS LETT, V422, P240, DOI 10.1016/S0014-5793(98)00016-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Pueyo JJ, 1996, BIOCHEM J, V313, P855, DOI 10.1042/bj3130855; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; ROST B, 1995, PROTEIN SCI, V4, P521; ROUGHEAD ZK, 1990, J NUTR, V120, P382, DOI 10.1093/jn/120.4.382; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Walsh MA, 1998, EUR J BIOCHEM, V258, P362, DOI 10.1046/j.1432-1327.1998.2580362.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	68	34	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27088	27099		10.1074/jbc.M109.071126	http://dx.doi.org/10.1074/jbc.M109.071126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558724	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000281172700040
J	Connerth, M; Czabany, T; Wagner, A; Zellnig, G; Leitner, E; Steyrer, E; Daum, G				Connerth, Melanie; Czabany, Tibor; Wagner, Andrea; Zellnig, Guenther; Leitner, Erich; Steyrer, Ernst; Daum, Guenther			Oleate Inhibits Steryl Ester Synthesis and Causes Liposensitivity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; ENDOPLASMIC-RETICULUM STRESS; LIPOTOXIC CELL-DEATH; SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; PEROXISOME; MEMBRANE; ACYLTRANSFERASE; PROLIFERATION; ESTERIFICATION	In the yeast Saccharomyces cerevisiae, neutral lipids can be synthesized by four acyltransferases, namely Dga1p and Lro1p producing triacylglycerols (TAG) and Are1p and Are2p forming steryl esters (SE). TAG and SE are stored in an organelle called lipid particles/droplet. Growth of yeast cells on oleate-supplemented media strongly induced proliferation of lipid particles and specifically the synthesis of TAG, which serve as the major pool for the excess of fatty acids. Surprisingly, SE synthesis was strongly inhibited under these conditions. Here, we show that this effect was not due to decreased expression of ARE2 encoding the major yeast SE synthase at the transcriptional level but to competitive enzymatic inhibition of Are2p by free oleate. Consequently, a triple mutant dga1 Delta lro1 Delta are1 Delta ARE2(+) grown on oleate did not form substantial amounts of SE and exhibited a growth phenotype similar to the dga1 Delta lro1 Delta are1 Delta are2(+) quadruple mutant, including lack of lipid particles. Growth of these mutants on oleate was strongly delayed, and cell viability was decreased but rescued by adaptation. In these strains, oleate stress caused morphological changes of intracellular membranes, altered phospholipid composition and formation of an additional lipid class, ethyl esters of fatty acids. In summary, our data showed that exposure to oleate led to disturbed lipid and membrane homeostasis along with liposensitivity of the yeast.	[Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Wagner, Andrea; Steyrer, Ernst] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Zellnig, Guenther] Karl Franzens Univ Graz, Inst Plant Sci, A-8010 Graz, Austria; [Leitner, Erich] Graz Univ Technol, Inst Analyt Chem & Food Chem, A-8010 Graz, Austria	Graz University of Technology; Medical University of Graz; University of Graz; Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at	Leitner, Erich/AAG-8826-2021	Leitner, Erich/0000-0003-2520-2111; Czabany, Tibor/0000-0003-1754-6723	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich [18857, W901-B05]	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF))	This work was supported by the Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich, Projects 18857 and W901-B05 (to G. D.).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Alhomsi K, 2006, ALCOHOL CLIN EXP RES, V30, P1121, DOI 10.1111/j.1530-0277.2006.00129.x; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; CASEY WM, 1993, BIOCHEM BIOPH RES CO, V193, P1297, DOI 10.1006/bbrc.1993.1766; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; DUROCHER V, 1990, CAN J PHYSIOL PHARM, V68, P1255, DOI 10.1139/y90-188; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; FERDINANDUS J, 1969, J BACTERIOL, V98, P1109, DOI 10.1128/JB.98.3.1109-1113.1969; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2005, BIOCHEM SOC T, V33, P1182, DOI 10.1042/BST20051182; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; GRAU R, 1993, MOL MICROBIOL, V8, P535, DOI 10.1111/j.1365-2958.1993.tb01598.x; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Hamel FG, 2009, METABOLISM, V58, P1047, DOI 10.1016/j.metabol.2009.04.005; JONES AL, 1966, J HISTOCHEM CYTOCHEM, V14, P215, DOI 10.1177/14.3.215; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kohlwein SD, 2007, CURR HYPERTENS REP, V9, P455, DOI 10.1007/s11906-007-0084-5; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MORIKAWA M, 1978, EUR J BIOCHEM, V84, P61, DOI 10.1111/j.1432-1033.1978.tb12141.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RESNICK RJ, 1994, J BIOL CHEM, V269, P32336; Rosenberger S, 2009, BBA-MOL CELL BIOL L, V1791, P379, DOI 10.1016/j.bbalip.2009.01.015; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Valachovic M, 2002, FEMS MICROBIOL LETT, V206, P121, DOI 10.1016/S0378-1097(01)00529-8; Valachovic M, 2001, FEMS MICROBIOL LETT, V197, P41, DOI 10.1111/j.1574-6968.2001.tb10580.x; VERGERES G, 1993, J CELL SCI, V106, P249; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	66	56	58	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26832	26841		10.1074/jbc.M110.122085	http://dx.doi.org/10.1074/jbc.M110.122085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571028	Green Published, hybrid			2022-12-27	WOS:000281172700014
J	Loukin, S; Zhou, XL; Su, ZW; Saimi, Y; Kung, C				Loukin, Stephen; Zhou, Xinliang; Su, Zhenwei; Saimi, Yoshiro; Kung, Ching			Wild-type and Brachyolmia-causing Mutant TRPV4 Channels Respond Directly to Stretch Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNEL; VR-OAC; MECHANISMS; CELL; MUTATIONS; REVEALS; CALCIUM; PATCH	Whether animal ion channels functioning as mechanosensors are directly activated by stretch force or indirectly by ligands produced by the stretch is a crucial question. TRPV4, a key molecular model, can be activated by hypotonicity, but the mechanism of activation is unclear. One model has this channel being activated by a downstream product of phospholipase A(2), relegating mechanosensitivity to the enzymes or their regulators. We expressed rat TRPV4 in Xenopus oocytes and repeatedly examined >200 excised patches bathed in a simple buffer. We found that TRPV4 can be activated by tens of mm Hg pipette suctions with open probability rising with suction even in the presence of relevant enzyme inhibitors. Mechanosensitivity of TRPV4 provides the simplest explanation of its various force-related physiological roles, one of which is in the sensing of weight load during bone development. Gain-of-function mutants cause heritable skeletal dysplasias in human. We therefore examined the brachyolmia-causing R616Q gain-of-function channel and found increased whole-cell current densities compared with wild-type channels. Single-channel analysis revealed that R616Q channels maintain mechanosensitivity but have greater constitutive activity and no change in unitary conductance or rectification.	[Loukin, Stephen; Zhou, Xinliang; Su, Zhenwei; Saimi, Yoshiro; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), Univ Wisconsin, Mol Biol Lab, 1525 Linden Dr, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health [GM054867, NS067360, GM047856]; Vilas Trust of the University of Wisconsin, Madison, WI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054867, R01GM047856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS067360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison, WI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054867 (to Y. S.) and NS067360 and GM047856 (to C. K.). This work was also supported by the Vilas Trust of the University of Wisconsin, Madison, WI.	Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; EVERAERTS W, 2009, PROG BIOPHY IN PRESS; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2009, PFLUG ARCH EUR J PHY, V458, P861, DOI 10.1007/s00424-009-0680-0; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P101, DOI 10.1111/j.1469-7793.2000.00101.x; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P83, DOI 10.1111/j.1469-7793.2000.t01-2-00083.x; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	36	101	101	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27176	27181		10.1074/jbc.M110.143370	http://dx.doi.org/10.1074/jbc.M110.143370			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605796	hybrid, Green Published			2022-12-27	WOS:000281172700048
J	Dhayalan, A; Rajavelu, A; Rathert, P; Tamas, R; Jurkowska, RZ; Ragozin, S; Jeltsch, A				Dhayalan, Arunkumar; Rajavelu, Arumugam; Rathert, Philipp; Tamas, Raluca; Jurkowska, Renata Z.; Ragozin, Sergey; Jeltsch, Albert			The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; STRUCTURAL BASIS; METHYLTRANSFERASES DNMT3A; MAMMALIAN DEVELOPMENT; H3K36 TRIMETHYLATION; DEACETYLASE COMPLEX; HUMAN GENOME; CHROMATIN; RECOGNITION; H3	The Dnmt3a DNA methyltransferase contains in its N-terminal part a PWWP domain that is involved in chromatin targeting. Here, we have investigated the interaction of the PWWP domain with modified histone tails using peptide arrays and show that it specifically recognizes the histone 3 lysine 36 trimethylation mark. H3K36me3 is known to be a repressive modification correlated with DNA methylation in mammals and heterochromatin in Schizosaccharomyces pombe. These results were confirmed by equilibrium peptide binding studies and pulldown experiments with native histones and purified native nucleosomes. The PWWP-H3K36me3 interaction is important for the subnuclear localization of enhanced yellow fluorescent protein-fused Dnmt3a. Furthermore, the PWWP-H3K36me3 interaction increases the activity of Dnmt3a for methylation of nucleosomal DNA as observed using native nucleosomes isolated from human cells after demethylation of the DNA with 5-aza-2'-deoxycytidine as substrate for methylation with Dnmt3a. These data suggest that the interaction of the PWWP domain with H3K36me3 is involved in targeting of Dnmt3a to chromatin carrying that mark, a model that is in agreement with several studies on the genome-wide distribution of DNA methylation and H3K36me3.	[Ragozin, Sergey; Jeltsch, Albert] Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Tamas, Raluca] Jacobs Univ Bremen, Sch Sci & Engn, MoLife Grad Program, D-28759 Bremen, Germany; [Rathert, Philipp] Act Motif Europe, BE-1330 Rixensart, Belgium	Jacobs University; Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Jurkowska, Renata/AAE-2504-2020; Rajavelu, Arumugam/B-7832-2013; Jeltsch, Albert/O-7404-2014	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Rajavelu, Arumugam/0000-0001-6666-8925; Rathert, Philipp/0000-0003-1477-136X; Dhayalan, Arunkumar/0000-0003-2588-9865	National Institutes of Health [GM068680, DK082678]; Deutsche Forschungsgemeinschaft [JE 252/6-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK082678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068680 and DK082678. This work was also supported by Deutsche Forschungsgemeinschaft Grant JE 252/6-1.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hata K, 2002, DEVELOPMENT, V129, P1983; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohde C, 2009, BIOTECHNIQUES, V47, P781, DOI 10.2144/000113196; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; ZHANG Y, 2010, NUCL ACIDS IN PRESS; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	51	343	355	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26114	26120		10.1074/jbc.M109.089433	http://dx.doi.org/10.1074/jbc.M109.089433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547484	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000280921000028
J	Ding, L; Feng, HJ; Macdonald, RL; Botzolakis, EJ; Hu, NN; Gallagher, MJ				Ding, Li; Feng, Hua-Jun; Macdonald, Robert L.; Botzolakis, Emanuel J.; Hu, Ningning; Gallagher, Martin J.			GABA(A) Receptor alpha 1 Subunit Mutation A322D Associated with Autosomal Dominant Juvenile Myoclonic Epilepsy Reduces the Expression and Alters the Composition of Wild Type GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDHOOD ABSENCE EPILEPSY; ENDOPLASMIC-RETICULUM; MESSENGER-RNAS; KNOCKOUT MICE; SEIZURE THRESHOLD; ASSEMBLY SIGNALS; CELL-SURFACE; A RECEPTORS; RAT-BRAIN; IN-VITRO	A GABA(A) receptor (GABA(A)R) alpha 1 subunit mutation, A322D (AD), causes an autosomal dominant form of juvenile myoclonic epilepsy (ADJME). Previous studies demonstrated that the mutation caused alpha 1(AD) subunit misfolding and rapid degradation, reducing its total and surface expression substantially. Here, we determined the effects of the residual alpha 1(AD) subunit expression on wild type GABA(A)R expression to determine whether the AD mutation conferred a dominant negative effect. We found that although the alpha 1(AD) subunit did not substitute for wild type alpha 1 subunits on the cell surface, it reduced the surface expression of alpha 1 beta 2 gamma 2 and alpha 3 beta 2 gamma 2 receptors by associating with the wild type subunits within the endoplasmic reticulum and preventing them from trafficking to the cell surface. The alpha 1(AD) subunit reduced surface expression of alpha 3 beta 2 gamma 2 receptors by a greater amount than alpha 1 beta 2 gamma 2 receptors, thus altering cell surface GABAAR composition. When transfected into cultured cortical neurons, the alpha 1(AD) subunit altered the time course of miniature inhibitory postsynaptic current kinetics and reduced miniature inhibitory postsynaptic current amplitudes. These findings demonstrated that, in addition to causing a heterozygous loss of function of alpha 1(AD) subunits, this epilepsy mutation also elicited a modest dominant negative effect that likely shapes the epilepsy phenotype.	[Ding, Li; Feng, Hua-Jun; Macdonald, Robert L.; Botzolakis, Emanuel J.; Hu, Ningning; Gallagher, Martin J.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Gallagher, MJ (corresponding author), Vanderbilt Univ, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	Martin.Gallagher@Vanderbilt.edu		Feng, Huajun/0000-0003-1544-4248; Gallagher, Martin/0000-0002-3537-4200	National Institutes of Health [NS055979, NS33300]; USPHS [NS51590]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NCRR [5UL1 RR024975-03]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300, K02NS055979, R01NS051590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055979 (to M. J. G.), NS33300 (to R. L. M.), and NS51590 (to R. L. M.) from the USPHS.; We thank Dr. Bruce Carter (Vanderbilt University) for helpful comments concerning this manuscript. Flow cytometry experiments were performed in the VMC Flow Cytometry Shared Resource. The Vanderbilt University Medical Center Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center Grant P30 CA68485 and the Vanderbilt Digestive Disease Research Center Grant DK058404. Flow cytometry was supported in part by National Institutes of Health Vanderbilt CTSA Grant 5UL1 RR024975-03 from NCRR.	Alfradique I, 2007, ARQ NEURO-PSIQUIAT, V65, P1266, DOI 10.1590/S0004-282X2007000700036; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Berry RB, 2009, NEUROSCI LETT, V455, P84, DOI 10.1016/j.neulet.2009.03.046; Bollan K, 2003, BIOCHEM SOC T, V31, P875, DOI 10.1042/bst0310875; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bosman LWJ, 2005, J NEUROPHYSIOL, V94, P338, DOI 10.1152/jn.00084.2005; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Chiu C, 2008, ANN NEUROL, V64, P284, DOI 10.1002/ana.21440; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; Fisher JL, 2004, NEUROPHARMACOLOGY, V46, P629, DOI 10.1016/j.neuropharm.2003.11.015; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones A, 1997, J NEUROSCI, V17, P1350; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Kralic JE, 2002, NEUROPHARMACOLOGY, V43, P685, DOI 10.1016/S0028-3908(02)00174-0; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Kumar A, 2009, METHOD ENZYMOL, V460, P379, DOI 10.1016/S0076-6879(09)05219-7; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Picton AJ, 2007, BRAIN RES, V1165, P40, DOI 10.1016/j.brainres.2007.06.050; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; POULTER MO, 1992, J NEUROSCI, V12, P2888, DOI 10.1523/JNEUROSCI.12-08-02888.1992; Saliba RS, 2008, J BIOL CHEM, V283, P18538, DOI 10.1074/jbc.M802077200; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Thomas EA, 2009, ARCH NEUROL-CHICAGO, V66, P1225, DOI 10.1001/archneurol.2009.219; Tretter V, 1997, J NEUROSCI, V17, P2728; Vlainic J, 2009, NEUROPHARMACOLOGY, V56, P1124, DOI 10.1016/j.neuropharm.2009.03.010; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011; Zhang JL, 2008, MOL PHARMACOL, V74, P941, DOI 10.1124/mol.108.048710; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	53	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26390	26405		10.1074/jbc.M110.142299	http://dx.doi.org/10.1074/jbc.M110.142299			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551311	hybrid, Green Published			2022-12-27	WOS:000280921000058
J	Kang, SA; Lee, ES; Yoon, HY; Randazzo, PA; Lee, ST				Kang, Shin-Ae; Lee, Eun-Saem; Yoon, Hye-Young; Randazzo, Paul A.; Lee, Seung-Taek			PTK6 Inhibits Down-regulation of EGF Receptor through Phosphorylation of ARAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-TUMOR KINASE; NONRECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; INDEPENDENT ENDOCYTOSIS; GASTROINTESTINAL-TRACT; STAT3 ACTIVATION; PLASMA-MEMBRANE; FAMILY KINASES; ARF GAPS	PTK6 (also known as Brk) is a non-receptor-tyrosine kinase containing SH3, SH2, and catalytic domains, that is expressed in more than 60% of breast carcinomas but not in normal mammary tissues. To analyze PTK6-interacting proteins, we have expressed Flag-tagged PTK6 in HEK293 cells and performed co-immunoprecipitation assays with Flag antibody-conjugated agarose. A 164-kDa protein in the precipitated fraction was identified as ARAP1 (also known as centaurin delta-2) by MALDI-TOF mass analysis. ARAP1 associated with PTK6 in an EGF/EGF receptor (EGFR)-dependent manner. In addition, the SH2 domain of PTK6, particularly the Arg(105) residue that contacts the phosphate group of the tyrosine residue, was essential for the association. Moreover, PTK6 phosphorylated residue Tyr(231) in the N-terminal domain of ARAP1. Expression of ARAP1, but not of the Y231F mutant, inhibited the down-regulation of EGFR in HEK293 cells expressing PTK6. Silencing of endogenous PTK6 expression in breast carcinoma cells decreased EGFR levels. These results demonstrate that PTK6 enhances EGFR signaling by inhibition of EGFR down-regulation through phosphorylation of ARAP1 in breast cancer cells.	[Kang, Shin-Ae; Lee, Eun-Saem; Lee, Seung-Taek] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Yoon, Hye-Young; Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Yonsei University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, ST (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	stlee@yonsei.ac.kr		Lee, Seung-Taek/0000-0001-7300-9784	Seoul Research and Business Development [10527]; Korea Science and Engineering Foundation; Brain Korea 21 trainee program; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	Seoul Research and Business Development(Seoul RBD program); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Brain Korea 21 trainee program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Seoul Research and Business Development Grant 10527, the project for Studies on Ubiquitome Functions from the Korea Science and Engineering Foundation, and the Brain Korea 21 trainee program.	BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daniele T, 2008, TRAFFIC, V9, P2221, DOI 10.1111/j.1600-0854.2008.00823.x; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; He H, 2001, J BIOL CHEM, V276, P26741, DOI 10.1074/jbc.C100229200; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Kim HI, 2005, J BIOL CHEM, V280, P28973, DOI 10.1074/jbc.M504568200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee HY, 1998, MOL CELLS, V8, P401; LEE ST, 1993, ONCOGENE, V8, P3403; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2008, CELL SIGNAL, V20, P432, DOI 10.1016/j.cellsig.2007.11.003; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; Stacey TTI, 2004, J CELL SCI, V117, P6071, DOI 10.1242/jcs.01526; Vasioukhin V, 1997, P NATL ACAD SCI USA, V94, P14477, DOI 10.1073/pnas.94.26.14477; VASIOUKHIN V, 1995, ONCOGENE, V10, P349; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200	49	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26013	26021		10.1074/jbc.M109.088971	http://dx.doi.org/10.1074/jbc.M109.088971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554524	Green Published, hybrid			2022-12-27	WOS:000280921000016
J	Ohnesorge, N; Viemann, D; Schmidt, N; Czymai, T; Spiering, D; Schmolke, M; Ludwig, S; Roth, J; Goebeler, M; Schmidt, M				Ohnesorge, Nils; Viemann, Dorothee; Schmidt, Nicole; Czymai, Tobias; Spiering, Desiree; Schmolke, Mirco; Ludwig, Stephan; Roth, Johannes; Goebeler, Matthias; Schmidt, Marc			Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Kruppel-like Factor 4 (KLF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; SHEAR-STRESS; 1 BMK1; CELLS; STATINS; DIFFERENTIATION	The MEK5/Erk5 MAPK cascade has recently been implicated in the regulation of endothelial integrity and represents a candidate pathway mediating the beneficial effects of laminar flow, a major factor preventing vascular dysfunction and disease. Here we expressed a constitutively active mutant of MEK5 (MEK5D) to study the transcriptional and functional responses to Erk5 activation in human primary endothelial cells. We provide evidence that constitutive Erk5 activation elicits an overall protective phenotype characterized by increased apoptosis resistance and a decreased angiogenic, migratory, and inflammatory potential. This is supported by bioinformatic microarray analysis, which uncovered a statistical overrepresentation of corresponding functional clusters as well as a significant induction of anti-thrombotic, hemostatic, and vasodilatory genes. We identify KLF4 as a novel Erk5 target and demonstrate a critical role of this transcription factor downstream of Erk5. We show that KLF4 expression largely reproduces the protective phenotype in endothelial cells, whereas KLF4 siRNA suppresses expression of various Erk5 targets. Additionally, we show that vasoprotective statins potently induce KLF4 and KLF4-dependent gene expression via activation of Erk5. Our data underscore a major protective function of the MEK5/Erk5/KLF4 module in ECs and implicate agonistic Erk5 activation as potential strategy for treatment of vascular diseases.	[Goebeler, Matthias; Schmidt, Marc] Heidelberg Univ, Dept Dermatol, Univ Hosp Mannheim, D-68167 Mannheim, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Mol Virol, D-48149 Munster, Germany; [Spiering, Desiree; Schmolke, Mirco; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat ZMBE, D-48149 Munster, Germany; [Ohnesorge, Nils; Goebeler, Matthias; Schmidt, Marc] Univ Giessen, Univ Hosp Giessen, Dept Dermatol, D-35392 Giessen, Germany	Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Munster; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Schmidt, M (corresponding author), Univ Giessen, Dept Dermatol, Gaffkystr 14, D-35392 Giessen, Germany.	marc.schmidt@derma.med.uni-giessen.de	Goebeler, Matthias/P-3612-2019; Goebeler, Matthias/F-7118-2013; Schmidt, Marc/E-8821-2010; Schmolke, Mirco/AAI-9081-2020	Schmidt, Marc/0000-0002-8643-1615; Schmolke, Mirco/0000-0002-2491-3029; Ludwig, Stephan/0000-0003-4490-3052; Viemann, Dorothee/0000-0002-9009-3559	Deutsche Forschungsgemeinschaft [GO 811/1-5]; Deutsche Forschungsgemeinschaft, International Research Training Group Vascular Medicine [GRK880/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, International Research Training Group Vascular Medicine(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft Grants GO 811/1-5 (to M. G.) and GRK880/3 (International Research Training Group Vascular Medicine, Graduiertenkolleg 880/3 (to M. S. and M. G.)).	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Atkins GB, 2008, CIRC RES, V103, P690, DOI 10.1161/CIRCRESAHA.108.184663; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Eccles KA, 2008, ATHEROSCLEROSIS, V200, P69, DOI 10.1016/j.atherosclerosis.2007.12.018; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Spiering D, 2009, J BIOL CHEM, V284, P24972, DOI 10.1074/jbc.M109.042911; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Zakkar M, 2008, CIRC RES, V103, P726, DOI 10.1161/CIRCRESAHA.108.183913	49	99	101	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26199	26210		10.1074/jbc.M110.103127	http://dx.doi.org/10.1074/jbc.M110.103127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20551324	Green Published, hybrid			2022-12-27	WOS:000280921000037
J	Schelter, F; Kobuch, J; Moss, ML; Becherer, JD; Comoglio, PM; Boccaccio, C; Kruger, A				Schelter, Florian; Kobuch, Julia; Moss, Marcia L.; Becherer, J. David; Comoglio, Paolo M.; Boccaccio, Carla; Krueger, Achim			A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE RECEPTOR; NECROSIS-FACTOR-ALPHA; C-MET; DOWN-REGULATION; SCATTER FACTOR; PROTEIN; CANCER; METASTASIS; INHIBITORS	Met, the tyrosine kinase receptor for the hepatocyte growth factor is a prominent regulator of cancer cell invasiveness and has emerged as a promising therapeutic target. Binding of the anti-Met monoclonal antibody DN30 to its epitope induces the proteolytic cleavage of Met, thereby impairing the invasive growth of tumors. The molecular mechanism controlling this therapeutic shedding process has so far been unknown. Here, we report that A Disintegrin And Metalloproteinase (ADAM)-10, but not ADAM-17, is required for DN30-induced Met shedding. Knockdown of ADAM-10 in different tumor cell lines or abrogation of its proteolytic activity by natural or synthetic inhibitors abolished Met down-regulation on the cell surface as well as reduction of Met activation. Moreover, hepatocyte growth factor-induced tumor cell migration and invasion were impaired upon ADAM-10 knockdown. Thus, the therapeutic effect of DN30 involves ADAM-10-dependent Met shedding, linking for the first time a specific metalloprotease to target therapy against a receptor tyrosine kinase.	[Schelter, Florian; Kobuch, Julia; Krueger, Achim] Tech Univ Munich, Klinikums Rechts Isar, Inst Expt Onkol & Therapieforsch, D-81675 Munich, Germany; [Moss, Marcia L.] BioZyme, Apex, NC 27523 USA; [Becherer, J. David] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; [Comoglio, Paolo M.; Boccaccio, Carla] Univ Turin, Inst Canc Res & Treatment, I-10060 Candiolo, Italy	Technical University of Munich; GlaxoSmithKline; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Kruger, A (corresponding author), Tech Univ Munich, Klinikums Rechts Isar, Inst Expt Onkol & Therapieforsch, Ismaninger Str 22, D-81675 Munich, Germany.	achim.krueger@lrz.tu-muenchen.de	Boccaccio, Carla/AHE-7875-2022	Boccaccio, Carla/0000-0003-2620-9083; Comoglio, Paolo/0000-0002-7056-5328	Framework Programme 7 Project [HEALTH-2007-201279]; Deutsche Forschungsgemeinschaft [KR2047/1-1]	Framework Programme 7 Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Framework Programme 7 Project HEALTH-2007-201279, Microenvimet (to C. B., P. M. C., and A. K.) and Deutsche Forschungsgemeinschaft Grant KR2047/1-1 (to A. K.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1999, ANN NY ACAD SCI, V878, P728, DOI 10.1111/j.1749-6632.1999.tb07774.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arlt M, 2002, CANCER RES, V62, P5543; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; DIRENZO MF, 1991, ONCOGENE, V6, P1997; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Gentile A, 2004, INT J DEV BIOL, V48, P451, DOI 10.1387/ijdb.041799ag; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; NALDINI L, 1991, MOL CELL BIOL, V11, P1793, DOI 10.1128/MCB.11.4.1793; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; PONZETTO C, 1991, ONCOGENE, V6, P553; Prat M, 1998, J CELL SCI, V111, P237; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; Zarnegar R, 1993, EXS, V65, P181	32	56	58	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26335	26340		10.1074/jbc.M110.106435	http://dx.doi.org/10.1074/jbc.M110.106435			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554517	hybrid, Green Published			2022-12-27	WOS:000280921000051
J	Cerutti, N; Mendelow, BV; Napier, GB; Papathanasopoulos, MA; Killick, M; Khati, M; Stevens, W; Capovilla, A				Cerutti, Nichole; Mendelow, Barry V.; Napier, Grant B.; Papathanasopoulos, Maria A.; Killick, Mark; Khati, Makobetsa; Stevens, Wendy; Capovilla, Alexio			Stabilization of HIV-1 gp120-CD4 Receptor Complex through Targeted Interchain Disulfide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 BINDING-SITE; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; PROTEIN; INHIBITOR; IMMUNOGENICITY; PURIFICATION; EXPRESSION; INDUCTION	HIV-1 enters cells via interaction between the trimeric envelope (Env) glycoprotein gp120/gp41 and the host cell surface receptor molecule CD4. The requirement of CD4 for viral entry has rationalized the development of recombinant CD4-based proteins as competitive viral attachment inhibitors and immunotherapeutic agents. In this study, we describe a novel recombinant CD4 protein designed to bind gp120 through a targeted disulfide-exchange mechanism. According to structural models of the gp120-CD4 receptor complex, substitution of Ser(60) on the CD4 domain 1 alpha-helix with Cys positions a thiol in proximity of the gp120 V1/V2 loop disulfide (Cys(126)-Cys(196)), satisfying the stereochemical and geometric conditions for redox exchange between CD4 Cys(60) and gp120 Cys(126), and the consequent formation of an interchain disulfide bond. In this study, we provide experimental evidence for this effect by describing the expression, purification, refolding, receptor binding and antiviral activity analysis of a recombinant two-domain CD4 variant containing the S60C mutation (2dCD4-S60C). We show that 2dCD4-S60C binds HIV-1 gp120 with a significantly higher affinity than wild-type protein under conditions that facilitate disulfide exchange and that this translates into a corresponding increase in the efficacy of CD4-mediated viral entry inhibition. We propose that targeted redox exchange between conserved gp120 disulfides and nucleophilic moieties positioned strategically on CD4 (or CD4-like scaffolds) conceptualizes a new strategy in the development of high affinity HIV-1 Env ligands, with important implications for therapy and vaccine development. More generally, this chalcogen substitution approach provides a general means of stabilizing receptor-ligand complexes where the structural and biophysical conditions for disulfide exchange are satisfied.	[Capovilla, Alexio] Elevat Biotech, ZA-2193 Johannesburg, South Africa; [Mendelow, Barry V.; Papathanasopoulos, Maria A.; Stevens, Wendy; Capovilla, Alexio] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, ZA-2193 Johannesburg, South Africa; [Khati, Makobetsa] CSIR, ZA-0001 Pretoria, South Africa	University of Witwatersrand; Council for Scientific & Industrial Research (CSIR) - South Africa	Capovilla, A (corresponding author), Elevat Biotech, 8 Blackwood Ave, ZA-2193 Johannesburg, South Africa.	alexio.capovilla@wits.ac.za			Technology Innovation Agency of the South African Department of Science and Technology; Poliomyelitis Research Foundation; National Research Foundation	Technology Innovation Agency of the South African Department of Science and Technology; Poliomyelitis Research Foundation; National Research Foundation	This work was supported by funding from the Technology Innovation Agency of the South African Department of Science and Technology, the Poliomyelitis Research Foundation, and the National Research Foundation.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; ASHKENAZI A, 1991, P NATL ACAD SCI USA, V88, P7056, DOI 10.1073/pnas.88.16.7056; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Berkower I, 2008, VIROLOGY, V377, P330, DOI 10.1016/j.virol.2008.03.040; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Ferrer M, 1997, J IMMUNOL METHODS, V210, P215, DOI 10.1016/S0022-1759(97)00195-6; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; GARLICK RL, 1990, AIDS RES HUM RETROV, V6, P465, DOI 10.1089/aid.1990.6.465; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; HAYNES BF, 1993, J IMMUNOL, V151, P1646; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; KANG CY, 1994, J VIROL, V68, P5854, DOI 10.1128/JVI.68.9.5854-5862.1994; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagenaur LA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-11; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Matthias LJ, 2003, ANTIOXID REDOX SIGN, V5, P133, DOI 10.1089/152308603321223621; Meyuhas R, 2009, BIOCHEM BIOPH RES CO, V386, P402, DOI 10.1016/j.bbrc.2009.06.057; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Osburne MS, 1999, J IMMUNOL METHODS, V224, P19, DOI 10.1016/S0022-1759(99)00002-2; PAIN RH, 2001, CURR PROTOC PROTEIN, V1; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; THOMAS DJ, 1991, J VIROL, V65, P3797, DOI 10.1128/JVI.65.7.3797-3803.1991; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wang WC, 1997, BIOCHEM BIOPH RES CO, V240, P530, DOI 10.1006/bbrc.1997.7688; West AP, 2010, J VIROL, V84, P261, DOI 10.1128/JVI.01528-09; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Xiao XD, 2003, VACCINE, V21, P4275, DOI 10.1016/S0264-410X(03)00494-8; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	49	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25743	25752		10.1074/jbc.M110.144121	http://dx.doi.org/10.1074/jbc.M110.144121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538591	Green Published, hybrid			2022-12-27	WOS:000280682400067
J	Kapinas, K; Kessler, C; Ricks, T; Gronowicz, G; Delany, AM				Kapinas, Kristina; Kessler, Catherine; Ricks, Tinisha; Gronowicz, Gloria; Delany, Anne M.			miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BONE CELLS; OSTEOGENIC DIFFERENTIATION; MICRORNA EXPRESSION; STEM-CELLS; TRANSCRIPTION; PROLIFERATION; OSTEOCALCIN; MATURATION; SKELETAL; LINEAGE	Differentiation of human mesenchymal stem cells into osteoblasts is controlled by extracellular cues. Canonical Wnt signaling is particularly important for maintenance of bone mass in humans. Post-transcriptional regulation of gene expression, mediated by microRNAs, plays an essential role in the control of osteoblast differentiation. Here, we find that miR-29a is necessary for human osteoblast differentiation, and miR-29a is increased during differentiation in the mesenchymal precursor cell line hFOB1.19 and in primary cultures of human osteoblasts. Furthermore, the promoter of the expressed sequence tag containing the human miR-29a gene is induced by canonical Wnt signaling. This effect is mediated, at least in part, by two T-cell factor/LEF-binding sites within the proximal promoter. Furthermore, we show that the negative regulators of Wnt signaling, Dikkopf-1 (Dkk1), Kremen2, and secreted frizzled related protein 2 (sFRP2), are direct targets of miR-29a. Endogenous protein levels for these Wnt antagonists are increased in cells transfected with synthetic miR-29a inhibitor. In contrast, transfection with miR-29a mimic decreases expression of these antagonists and potentiates Wnt signaling. Overall, we demonstrate that miR-29 and Wnt signaling are involved in a regulatory circuit that can modulate osteoblast differentiation. Specifically, canonical Wnt signaling induces miR-29a transcription. The subsequent down-regulation of key Wnt signaling antagonists, Dkk1, Kremen2, and sFRP2, by miR-29a potentiates Wnt signaling, contributing to a gene expression program important for osteoblast differentiation. This novel regulatory circuit provides additional insight into how microRNAs interact with signaling molecules during osteoblast differentiation, allowing for fine-tuning of intricate cellular processes.	[Delany, Anne M.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Gronowicz, Gloria] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Delany, AM (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Gronowicz, Gloria/0000-0001-7158-3598	National Institutes of Health [AR44877]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044877, R01AR044877, R29AR044877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR44877 from NIAMS (to A.M.D.).	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; AUBIN JE, 1993, CELLULAR MOL BIOL BO, P10; AUFMKOLK B, 1985, CALCIFIED TISSUE INT, V37, P228, DOI 10.1007/BF02554868; Barker N, 2000, ADV CANCER RES, V77, P1; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CHAVASSIEUX PM, 1990, J BONE MINER RES, V5, P337, DOI 10.1002/jbmr.5650050406; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; FRIEDENSTEIN A, 1971, TRANSPLANTATION, V12, P99, DOI 10.1097/00007890-197108000-00001; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Krause C., 2008, PRIMER METABOLIC BON, V7, P10; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; KURIHARA N, 1984, BIOCHEM BIOPH RES CO, V119, P767, DOI 10.1016/S0006-291X(84)80316-2; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liang RQ, 2009, CURR GENOMICS, V10, P184, DOI 10.2174/138920209788185225; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Rauner M, 2008, AGE, V30, P273, DOI 10.1007/s11357-008-9069-9; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ryves WJ, 2002, BIOCHEM BIOPH RES CO, V290, P967, DOI 10.1006/bbrc.2001.6305; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang H, 2004, J ORTHOP RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	75	330	365	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25221	25231		10.1074/jbc.M110.116137	http://dx.doi.org/10.1074/jbc.M110.116137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551325	hybrid, Green Published			2022-12-27	WOS:000280682400015
J	Yang, JQ; Huang, J; Chatterjee, TK; Twait, E; Fisher, RA				Yang, Jianqi; Huang, Jie; Chatterjee, Tapan K.; Twait, Erik; Fisher, Rory A.			A Novel Mechanism Involving Coordinated Regulation of Nuclear Levels and Acetylation of NF-YA and Bcl6 Activates RGS4 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; SIGNAL-TRANSDUCTION; C/EBP-BETA; HISTONE DEACETYLASE; GENE-TRANSCRIPTION; NERVOUS-SYSTEM; CELL LYMPHOMA; SMOOTH-MUSCLE; CCAAT BOX; EXPRESSION	Neuronally enriched RGS4 plays a critical role attenuating G protein signaling in brain, although the mechanisms regulating RGS4 expression are unknown. Here we describe a novel mechanism for transcriptional activation of RGS4 in neuron-like PC6 cells, where RGS4 is markedly induced during confluence-induced growth arrest. Transcriptional activation of RGS4 in confluent PC6 cells was accompanied by impaired G(i/o)-dependent MAPK activation. In the human RGS4 gene promoter, we identified three phylogenetically conserved cis-elements: an inverted CCAAT box element (ICE), a cAMP response element, and a B-cell lymphoma 6 (Bcl6)-binding site. The ICE and the cAMP response element mediate activation, and the Bcl6 site mediates repression of RGS4 transcription. Activation of RGS4 transcription in confluent PC6 cells is accompanied by increases in NF-YA and C/EBP beta and decreases in Bcl6 levels in the nucleus. Increases in NF-YA and C/EBP beta lead to their increased binding to the RGS4 promoter in vivo, and dominant negative forms of these proteins repressed RGS4 promoter activity. Acetylation of NF-YA and Bcl6 were increased in postconfluent cells. Trichostatin A stimulation of RGS4 promoter activity, accompanied by increased binding of NF-YA and decreased binding of Bcl6 to the promoter, was abolished by mutation of the ICE and enhanced by mutation of the Bcl6 site. These findings demonstrate a dynamic and coordinated regulation of nuclear levels and acetylation status of trans-acting factors critical in determining the off/on state of the RGS4 promoter.	[Yang, Jianqi; Huang, Jie; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Twait, Erik] Univ Iowa, Dept Surg, Carver Coll Med, Iowa City, IA 52242 USA; [Chatterjee, Tapan K.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA	University of Iowa; University of Iowa; University of Cincinnati	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Chatterjee, Rima/J-8066-2017	Fisher, Rory/0000-0003-3108-4836	National Institutes of Health [GM075033, GM075033-03s1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033 and GM075033-03s1 (to R.A.F.).	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; APARICIO O, 2005, CURRENT PROTOCOLS MO; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Buckholtz JW, 2007, J NEUROSCI, V27, P1584, DOI 10.1523/JNEUROSCI.5112-06.2007; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Cheng YS, 2008, J CELL BIOCHEM, V105, P922, DOI 10.1002/jcb.21893; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Grillet N, 2003, J NEUROSCI, V23, P10613; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; HONG JX, 1993, J IMMUNOL, V150, P3895; Hopfner R, 2000, CANCER RES, V60, P121; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Jump DB, 1997, J BIOL CHEM, V272, P27778, DOI 10.1074/jbc.272.44.27778; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lin TC, 2009, EPILEPSY BEHAV, V14, P316, DOI 10.1016/j.yebeh.2008.12.005; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Sikder H, 2009, J IMMUNOL, V183, P1657, DOI 10.4049/jimmunol.0900057; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Wong CW, 1998, MOL CELL BIOL, V18, P5500, DOI 10.1128/MCB.18.9.5500; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YU LJ, 1995, CELL GROWTH DIFFER, V6, P1505; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhu QS, 2004, J BIOL CHEM, V279, P29902, DOI 10.1074/jbc.M400438200	55	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29760	29769		10.1074/jbc.M110.121459	http://dx.doi.org/10.1074/jbc.M110.121459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630860	Green Published, hybrid			2022-12-27	WOS:000281984300011
J	Chu, PY; Li, TK; Ding, ST; Lai, IR; Shen, TL				Chu, Pei-Yu; Li, Tsai-Kun; Ding, Shih-Torng; Lai, I-Rue; Shen, Tang-Long			EGF-induced Grb7 Recruits and Promotes Ras Activity Essential for the Tumorigenicity of Sk-Br3 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND PROTEIN-7; FOCAL ADHESION KINASE; SIGNAL-TRANSDUCTION PROTEIN; MIGRATION; FAMILY; PHOSPHORYLATION; PROLIFERATION; ASSOCIATION; PROGRESSION; CARCINOMA	Co-amplification and co-overexpression of ErbB2 and Grb7 are frequently found in various cancers, including breast cancer. Biochemical and functional correlations of the two molecules have identified Grb7 to be a pivotal mediator downstream of ErbB2-mediated oncogenesis. However, it remains largely unknown how Grb7 is involve in the ErbB2-mediated tumorigenesis. In this study, we show that Grb7-mediated cell proliferation and growth are essential for the tumorigenesis that occurs in ErbB2-Grb7-overexpressing breast cancer cells. Intrinsically, EGF-induced de novo Grb7 tyrosine phosphorylation/activation recruits and activates Ras-GTPases and subsequently promotes the phosphorylation of ERK1/2, thereby stimulating tumor growth. Furthermore, we also found the anti-tumor effect could be synergized by co-treatment with Herceptin plus Grb7 knockdown in Sk-Br3 breast cancer cells. Our findings illustrate an underlying mechanism by which Grb7 promotes tumorigenesis through the formation of a novel EGFR-Grb7-Ras signaling complex, thereby highlighting the potential strategy of targeting Grb7 as an anti-breast cancer therapy.	Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10051, Taiwan; [Li, Tsai-Kun; Ding, Shih-Torng; Shen, Tang-Long] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10617, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan; [Lai, I-Rue] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University		shentl@ntu.edu.tw	Shen, Tang-Long/C-7460-2011	Lai, I-Rue/0000-0002-3444-8255; LI, TSAI-KUN/0000-0003-0393-2340; Ding, Shih-Torng/0000-0002-9866-1776; Shen, Tang-Long/0000-0001-6264-3608	National Science Council [NSC-96-2311-B-002-023-MY3]; National Taiwan University [98R0311]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grant NSC-96-2311-B-002-023-MY3 and Frontier Research Grant of National Taiwan University 98R0311 (to T.-L. S.).	Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Benusiglio PR, 2006, BRIT J CANCER, V95, P1689, DOI 10.1038/sj.bjc.6603473; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Itoh S, 2007, MOL CANCER RES, V5, P667, DOI 10.1158/1541-7786.MCR-06-0282; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Lucas-Fernandez E, 2008, CURR GENOMICS, V9, P60, DOI 10.2174/138920208783884847; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Shen TL, 2001, FEBS LETT, V499, P176, DOI 10.1016/S0014-5793(01)02545-5; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shen TL, 2002, J BIOL CHEM, V277, P29069, DOI 10.1074/jbc.M203085200; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Wojcik J, 1999, BIOCHEM BIOPH RES CO, V259, P113, DOI 10.1006/bbrc.1999.0727	27	38	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29279	29285		10.1074/jbc.C110.114124	http://dx.doi.org/10.1074/jbc.C110.114124			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622016	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000281740100030
J	Li, XJ; Moore, DJ; Xiong, YL; Dawson, TM; Dawson, VL				Li, Xiaojie; Moore, Darren J.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.			Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL TOXICITY; LRRK2 MUTATION; G2019S; PREVALENCE; GENE	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified as an important cause of late-onset, autosomal dominant familial Parkinson disease and contribute to sporadic Parkinson disease. LRRK2 is a large complex protein with multiple functional domains, including a Roc-GTPase, protein kinase, and multiple protein-protein interaction domains. Previous studies have suggested an important role for kinase activity in LRRK2-induced neuronal toxicity and inclusion body formation. Disease-associated mutations in LRRK2 also tend to increase kinase activity. Thus, enhanced kinase activity may therefore underlie LRRK2-linked disease. Similar to the closely related mixed-lineage kinases, LRRK2 can undergo autophosphorylation in vitro. Three putative autophosphorylation sites (Thr-2031, Ser-2032, and Thr-2035) have been identified within the activation segment of the LRRK2 kinase domain based on sequence homology to mixed-lineage kinases. Phosphorylation at one or more of these sites is critical for the kinase activity of LRRK2. Sensitive phopho-specific antibodies to each of these three sites have been developed and validated by ELISA, dot-blot, and Western blot analysis. Using these antibodies, we have found that all three putative sites are phosphorylated in LRRK2, and Ser-2032 and Thr-2035 are the two important sites that regulate LRRK2 kinase activity.	[Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Li, Xiaojie; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Moore, Darren J.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, 733 N Broadway,Suite 711, Baltimore, MD 21205 USA.	vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Moore, Darren/0000-0003-2359-5679; Dawson, Valina/0000-0002-2915-3970	National Institutes of Health [NS38377]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS38377.	Aasly JO, 2005, ANN NEUROL, V57, P762, DOI 10.1002/ana.20456; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Floris G, 2009, PARKINSONISM RELAT D, V15, P277, DOI 10.1016/j.parkreldis.2008.06.009; Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gorostidi A, 2009, NEUROGENETICS, V10, P157, DOI 10.1007/s10048-008-0162-0; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Haugarvoll K, 2008, NEUROLOGY, V70, P1456, DOI 10.1212/01.wnl.0000304044.22253.03; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2009, NEUROGENETICS, V10, P347, DOI 10.1007/s10048-009-0187-z; Moller JC, 2008, EUR J NEUROL, V15, P743, DOI 10.1111/j.1468-1331.2008.02154.x; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; XIONG Y, PLOS GENET, V6; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	26	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29569	29576		10.1074/jbc.M110.127639	http://dx.doi.org/10.1074/jbc.M110.127639			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595391	Green Published, hybrid			2022-12-27	WOS:000281740100058
J	Evesson, FJ; Peat, RA; Lek, A; Brilot, F; Lo, HP; Dale, RC; Parton, RG; North, KN; Cooper, ST				Evesson, Frances J.; Peat, Rachel A.; Lek, Angela; Brilot, Fabienne; Lo, Harriet P.; Dale, Russell C.; Parton, Robert G.; North, Kathryn N.; Cooper, Sandra T.			Reduced Plasma Membrane Expression of Dysferlin Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; FER-1-LIKE PROTEIN; 3T3-L1 ADIPOCYTES; SYNTAXIN 4; T-SNARE; REPAIR; BINDING; SYNAPTOTAGMIN; CAVEOLIN-3	Ferlins are an ancient family of C2 domain-containing proteins, with emerging roles in vesicular trafficking and human disease. Dysferlin mutations cause inherited muscular dystrophy, and dysferlin also shows abnormal plasma membrane expression in other forms of muscular dystrophy. We establish dysferlin as a short-lived (protein half-life similar to 4-6 h) and transitory transmembrane protein (plasma membrane half-life similar to 3 h), with a propensity for rapid endocytosis when mutated, and an association with a syntaxin-4 endocytic route. Dysferlin plasma membrane expression and endocytic rate is regulated by the C2B-FerI-C2C motif, with a critical role identified for C2C. Disruption of C2C dramatically reduces plasma membrane dysferlin (by 2.5-fold), due largely to accelerated endocytosis (by 2.5-fold). These properties of reduced efficiency of plasma membrane expression due to accelerated endocytosis are also a feature of patient missense mutant L344P (within FerI, adjacent to C2C). Importantly, dysferlin mutants that demonstrate accelerated endocytosis also display increased protein lability via endosomal proteolysis, implicating endosomal-mediated proteolytic degradation as a novel basis for dysferlin-deficiency in patients with single missense mutations. Vesicular labeling studies establish that dysferlin mutants rapidly transit from EEA1-positive early endosomes through to dextran-positive lysosomes, co-labeled by syntaxin-4 at multiple stages of endosomal transit. In summary, our studies define a transient biology for dysferlin, relevant to emerging patient therapeutics targeting dysferlin replacement. We introduce accelerated endosomal-directed degradation as a basis for lability of dysferlin missense mutants in dysferlinopathy, and show that dysferlin and syntaxin- 4 similarly transit a common endosomal pathway in skeletal muscle cells.	[Evesson, Frances J.; Peat, Rachel A.; Lek, Angela; Brilot, Fabienne; Dale, Russell C.; North, Kathryn N.; Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW 2145, Australia; [Evesson, Frances J.; Lek, Angela; North, Kathryn N.; Cooper, Sandra T.] Univ Sydney, Fac Med, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia; [Lo, Harriet P.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Lo, Harriet P.; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Sydney; University of Sydney; University of Queensland; University of Queensland	Cooper, ST (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Locked Bag 4001, Westmead, NSW 2145, Australia.	SandraC3@chw.edu.au	Brilot, Fabienne/AAT-3138-2020; North, Kathryn N/K-6476-2012; Parton, Robert G/C-5673-2009; Lo, Harriet P/D-2052-2017	Brilot, Fabienne/0000-0002-7025-2276; North, Kathryn N/0000-0003-0841-8009; Parton, Robert G/0000-0002-7494-5248; Lo, Harriet P/0000-0002-3998-6132; Cooper, Sandra/0000-0002-7314-5097	Muscular Dystrophy Association, USA; NSW Muscular Dystrophy Association; Australian National Health and Medical Research Council; Brain Foundation Australia; Jain Foundation	Muscular Dystrophy Association, USA(Muscular Dystrophy Association); NSW Muscular Dystrophy Association; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Brain Foundation Australia; Jain Foundation	This work was supported by the Muscular Dystrophy Association, USA (STC Development Grant), the NSW Muscular Dystrophy Association (to S. T. C. and K. N. N.), the Australian National Health and Medical Research Council (301946 to K. N. N. and S. T. C.), the Brain Foundation Australia (to S. T. C.), and the Jain Foundation (to S. T. C.).	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gerasimenko JV, 2001, CURR BIOL, V11, pR971, DOI 10.1016/S0960-9822(01)00577-2; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jackaman C, 2007, CELL MOTIL CYTOSKEL, V64, P914, DOI 10.1002/cm.20239; Jagadish MN, 1996, BIOCHEM J, V317, P945, DOI 10.1042/bj3170945; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNally EM, 2000, AM J MED GENET, V91, P305, DOI 10.1002/(SICI)1096-8628(20000410)91:4<305::AID-AJMG12>3.0.CO;2-S; McNeil PL, 2000, J CELL SCI, V113, P1891; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Roche JA, 2010, AM J PHYSIOL-CELL PH, V298, pC298, DOI 10.1152/ajpcell.00122.2009; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUMITANI S, 1995, BIOCHEM BIOPH RES CO, V213, P462, DOI 10.1006/bbrc.1995.2154; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28529	28539		10.1074/jbc.M110.111120	http://dx.doi.org/10.1074/jbc.M110.111120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595382	Green Published, hybrid			2022-12-27	WOS:000281594000017
J	Gao, N; Hibi, Y; Cueno, M; Asamitsu, K; Okamoto, T				Gao, Nan; Hibi, Yurina; Cueno, Marni; Asamitsu, Kaori; Okamoto, Takashi			A-kinase-interacting Protein 1 (AKIP1) Acts as a Molecular Determinant of PKA in NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MULTIPLE-MYELOMA CELLS; TRANSCRIPTIONAL ACTIVITY; ENDOTHELIAL-CELLS; SERINE KINASE; ACTIVATION; PHOSPHORYLATION; PATHWAY; ALPHA; P65	The cAMP-dependent protein kinase (PKA) signaling pathway plays a crucial role in the pathogenesis of many NF-kappa B-related diseases. However, there have been controversial reports with regard to the PKA actions in the regulation of NF-kappa B activity. In this study, we have demonstrated the effect of PKA on NF-kappa B activity in view of AKIP1 action; and in 293 and HeLa cells, where the endogenous AKIP1 expression is minimal, PKA-activating agents inhibited the NF-kappa B-dependent reporter gene expression, blocked the interaction of PKAc and p65 subunit of NF-kappa B, and attenuated PKA-dependent phosphorylation of p65 on Ser-276. This inhibitory function of PKAc in NF-kappa B signaling was reversed by overexpression of AKIP1 in 293 cells. In the breast cancer cell line, MDA-MB231 cells and MCF7 cells, where the endogenous AKIP1 is abundant, the PKA signal was found to be synergized with NF-kappa B activation; PKA-activating agents enhanced NF-kappa B-dependent transcriptional activity and the interaction between p65 and PKAc and augmented the phosphorylation of p65 on Ser-276. After RNAi knockdown of AKIP1 in these breast cancer cells, we observed that PKA-activating agents antagonized NF-kappa B-dependent activation. Meanwhile, PKA inhibitor suppressed NF-kappa B-induced breast cancer cell proliferation and multiple NF-kappa B-dependent anti-apoptotic gene expression. It is likely that expression of AKIP1 determines the relationship between these two signal transduction pathways. These findings explained controversial results from various independent groups regarding the action of PKA signaling on the NF-kappa B activation cascade and suggested a possible therapeutic potential of PKA inhibitor in developing anti-cancer strategies.	[Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011				Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bendre MS, 2002, CANCER RES, V62, P5571; Carnegie GK, 2003, GENE DEV, V17, P1557, DOI 10.1101/gad.1095803; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Dai Y, 2004, BLOOD, V103, P2761, DOI 10.1182/blood-2003-09-3037; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Ghosh Sagar, 2008, Int J Biomed Sci, V4, P260; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kajino S, 2000, ONCOGENE, V19, P2233, DOI 10.1038/sj.onc.1203560; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Majumdar S, 2003, ONCOGENE, V22, P1206, DOI 10.1038/sj.onc.1206184; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Shono T, 1996, MOL CELL BIOL, V16, P4231; Specht K, 2004, BLOOD, V104, P1120, DOI 10.1182/blood-2003-11-3837; Srivastava RK, 1999, MOL CELL BIOCHEM, V195, P25, DOI 10.1023/A:1006990231186; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	47	63	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28097	28104		10.1074/jbc.M110.116566	http://dx.doi.org/10.1074/jbc.M110.116566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20562110	Green Published, hybrid			2022-12-27	WOS:000288742300008
J	Gonzalez, DJ; Lee, SW; Hensler, ME; Markley, AL; Dahesh, S; Mitchell, DA; Bandeira, N; Nizet, V; Dixon, JE; Dorrestein, PC				Gonzalez, David J.; Lee, Shaun W.; Hensler, Mary E.; Markley, Andrew L.; Dahesh, Samira; Mitchell, Douglas A.; Bandeira, Nuno; Nizet, Victor; Dixon, Jack E.; Dorrestein, Pieter C.			Clostridiolysin S, a Post-translationally Modified Biotoxin from Clostridium botulinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOLYSIN-S; MASS-SPECTROMETRY; MICROCIN C7; BIOSYNTHESIS; PEPTIDE; STREPTOCOCCUS; IDENTIFICATION; SPOROGENES; COMPONENT; PATHWAY	Through elaboration of its botulinum toxins, Clostridium botulinum produces clinical syndromes of infant botulism, wound botulism, and other invasive infections. Using comparative genomic analysis, an orphan nine-gene cluster was identified in C. botulinum and the related foodborne pathogen Clostridium sporogenes that resembled the biosynthetic machinery for streptolysin S, a key virulence factor from group A Streptococcus responsible for its hallmark beta-hemolytic phenotype. Genetic complementation, in vitro reconstitution, mass spectral analysis, and plasmid intergrational mutagenesis demonstrate that the streptolysin S-like gene cluster from Clostridium sp. is responsible for the biogenesis of a novel post-translationally modified hemolytic toxin, clostridiolysin S.	[Nizet, Victor; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gonzalez, David J.; Markley, Andrew L.; Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hensler, Mary E.; Dahesh, Samira; Nizet, Victor] Univ Calif San Diego, Div Pharmacol & Drug Discovery, Dept Pediat, La Jolla, CA 92093 USA; [Bandeira, Nuno] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dorrestein, PC (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Biomed Sci Bldg,Rm 4090,9500 Gilman Dr,MC 0636, La Jolla, CA 92093 USA.	pdorrestein@ucsd.edu	Nizet, Victor/AAF-3190-2019; Mitchell, Doug/B-6349-2012; Dorrestein, Pieter/D-5012-2012; Dorrestein, Pieter/ABF-2930-2020; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Nizet, Victor/0000-0003-3847-0422; Bandeira, Nuno/0000-0001-8385-3655	National Institutes of Health Hemoglobin and Blood Protein Chemistry [5T32DK007233-34]; Beckman Foundation; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090328] Funding Source: NIH RePORTER	National Institutes of Health Hemoglobin and Blood Protein Chemistry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Hemoglobin and Blood Protein Chemistry Training Program Grant 5T32DK007233-34. This work was also supported by the Beckman Foundation.	Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; CINADER B, 1950, J EXP MED, V92, P219, DOI 10.1084/jem.92.3.219; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; HaraKudo Y, 1997, MICROB PATHOGENESIS, V22, P31, DOI 10.1006/mpat.1996.0088; Hopkins CE, 2002, PROTEIN SCI, V11, P1591, DOI 10.1110/ps.3900102; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; SAVANI J, 1978, J FOOD SCI, V43, P222, DOI 10.1111/j.1365-2621.1978.tb09776.x; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; TSAIHONG JC, 1983, CURR MICROBIOL, V9, P333, DOI 10.1007/BF01588830; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Zamble DB, 2001, P NATL ACAD SCI USA, V98, P7712, DOI 10.1073/pnas.141225698; Zamble DB, 2000, BIOCHEMISTRY-US, V39, P16190, DOI 10.1021/bi001398e	31	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28220	28228		10.1074/jbc.M110.118554	http://dx.doi.org/10.1074/jbc.M110.118554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581111	Green Published, hybrid			2022-12-27	WOS:000281404100065
J	Yang, YC; Fann, MJ; Chang, WH; Tai, LH; Jiang, JH; Kao, LS				Yang, Ya-Chi; Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen			Regulation of Sodium-Calcium Exchanger Activity by Creatine Kinase under Energy-compromised Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; CARDIAC NA+-CA2+ EXCHANGER; K+-CL-COTRANSPORTER; NA+/CA2+ EXCHANGER; PLASMA-MEMBRANE; SODIUM/CALCIUM EXCHANGER; DEPENDENT REGULATION; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; MITOCHONDRIAL	Na+/Ca2+ exchanger (NCX) is one of the major mechanisms for removing Ca2+ from the cytosol especially in cardiac myocytes and neurons, where their physiological activities are triggered by an influx of Ca2+. NCX contains a large intracellular loop (NCXIL) that is responsible for regulating NCX activity. Recent evidence has shown that proteins, including kinases and phosphatases, associate with NCX1IL to form a NCX1 macromolecular complex. To search for the molecules that interact with NCX1IL and regulate NCX1 activity, we used the yeast two-hybrid method to screen a human heart cDNA library and found that the C-terminal region of sarcomeric mitochondrial creatine kinase (sMiCK) interacted with NCX1IL. Moreover, both sMiCK and the muscle-type creatine kinase (CKM) coimmuno-precipitated with NCX1 using lysates of cardiacmyocytes and HEK293T cells that transiently expressed NCX1 and various creatine kinases. Both sMiCK and CKM were able to produce a recovery in the decreased NCX1 activity that was lost under energy-compromised conditions. This regulation is mediated through a putative PKC phosphorylation site of sMiCK and CKM. The autophosphorylation and the catalytic activity of sMiCK and CKM are not required for their regulation of NCX1 activity. Our results suggest a novel mechanism for the regulation of NCX1 activity.	[Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Kao, Lung-Sen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Kao, LS (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	lskao@ym.edu.tw	Jiang, Jhih-Hang/M-8237-2019	Jiang, Jhih-Hang/0000-0002-1543-1634	National Science Council [NSC94-2320-B010-032, NSC95-2320-B010-026-MY3]; Ministry of Education, Aim for the Top University Plan.	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan.(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council (NSC94-2320-B010-032, NSC95-2320-B010-026-MY3) and the Ministry of Education, Aim for the Top University Plan.	ACETO JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P553, DOI 10.1016/0003-9861(92)90449-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; Crawford RM, 2001, FASEB J, V15, P102, DOI 10.1096/fj.01-0446fje; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Eder M, 2000, J BIOL CHEM, V275, P27094; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GROSSE R, 1980, BIOCHIM BIOPHYS ACTA, V603, P142, DOI 10.1016/0005-2736(80)90397-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haworth RA, 1997, J MOL CELL CARDIOL, V29, P503, DOI 10.1006/jmcc.1996.0294; Ikari A, 1998, EUR J PHARMACOL, V360, P91, DOI 10.1016/S0014-2999(98)00659-1; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; IWAMOTO T, 1995, J BIOL CHEM, V270, P8996, DOI 10.1074/jbc.270.15.8996; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; KOMURO I, 1992, P NATL ACAD SCI USA, V89, P4769, DOI 10.1073/pnas.89.10.4769; KUSUOKA H, 1993, J AM COLL CARDIOL, V21, P240, DOI 10.1016/0735-1097(93)90743-K; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; LI ZP, 1994, J BIOL CHEM, V269, P17434; Lin G, 2009, CELL MOL LIFE SCI, V66, P135, DOI 10.1007/s00018-008-8575-3; Mattiello JA, 1998, CARDIOVASC RES, V37, P424, DOI 10.1016/S0008-6363(97)00271-X; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Pan CY, 1998, BIOCHEM J, V336, P305, DOI 10.1042/bj3360305; Pan CY, 1997, J NEUROCHEM, V69, P1085; Pen CY, 2008, J NEUROCHEM, V107, P658, DOI 10.1111/j.1471-4159.2008.05637.x; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ren XY, 2006, J BIOL CHEM, V281, P22808, DOI 10.1074/jbc.M604753200; Reppel M, 2007, CARDIOVASC RES, V75, P99, DOI 10.1016/j.cardiores.2007.03.018; SAKS VA, 1977, BIOCHIM BIOPHYS ACTA, V465, P550, DOI 10.1016/0005-2736(77)90272-3; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Spindler M, 2004, AM J PHYSIOL-HEART C, V287, pH1039, DOI 10.1152/ajpheart.01016.2003; Steeghs K, 1997, J NEUROSCI METH, V71, P29, DOI 10.1016/S0165-0270(96)00124-0; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Stolz M, 2002, BIOCHEM J, V363, P785, DOI 10.1042/0264-6021:3630785; Tokumura A, 1998, BBA-LIPID LIPID MET, V1389, P67, DOI 10.1016/S0005-2760(97)00130-6; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Weber CR, 2003, CIRCULATION, V108, P2224, DOI 10.1161/01.CIR.0000095274.72486.94; Xu WY, 1997, ARCH BIOCHEM BIOPHYS, V341, P273, DOI 10.1006/abbi.1997.9954	52	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28275	28285		10.1074/jbc.M110.141424	http://dx.doi.org/10.1074/jbc.M110.141424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576602	Green Published, hybrid			2022-12-27	WOS:000281404100070
J	Da Paula, AC; Sousa, M; Xu, Z; Dawson, ES; Boyd, AC; Sheppard, DN; Amaral, MD				Da Paula, Ana Carina; Sousa, Marisa; Xu, Zhe; Dawson, Elizabeth S.; Boyd, A. Christopher; Sheppard, David N.; Amaral, Margarida D.			Folding and Rescue of a Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Mutant Identified Using Human-Murine Chimeric Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN-1; CFTR CHLORIDE CHANNELS; DELTA-F508 MUTATION; GATING BEHAVIOR; MEMBRANE; STABILITY; DEFECTS; CELLS; DEGRADATION; MATURATION	Impairment of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel causes cystic fibrosis, a fatal genetic disease. Here, to gain insight into CFTR structure and function, we exploited interspecies differences between CFTR homologues using human (h)-murine (m) CFTR chimeras containing murine nucleotide-binding domains (NBDs) or regulatory domain on an hCFTR backbone. Among 15 hmCFTR chimeras analyzed, all but two were correctly processed, one containing part of mNBD1 and another containing part of mNBD2. Based on physicochemical distance analysis of divergent residues between human and murine CFTR in the two misprocessed hmCFTR chimeras, we generated point mutations for analysis of respective CFTR processing and functional properties. We identified one amino acid substitution (K584E-CFTR) that disrupts CFTR processing in NBD1. No single mutation was identified in NBD2 that disrupts protein processing. However, a number of NBD2 mutants altered channel function. Analysis of structural models of CFTR identified that although Lys(584) interacts with residue Leu(581) in human CFTR Glu(584) interacts with Phe(581) in mouse CFTR. Introduction of the murine residue (Phe(581)) in cis with K584E in human CFTR rescued the processing and trafficking defects of K584E-CFTR. Our data demonstrate that human-murine CFTR chimeras may be used to validate structural models of full-length CFTR. We also conclude that hmCFTR chimeras are a valuable tool to elucidate interactions between different domains of CFTR.	[Da Paula, Ana Carina; Sousa, Marisa; Amaral, Margarida D.] Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Da Paula, Ana Carina; Sousa, Marisa; Amaral, Margarida D.] Natl Inst Hlth, Dept Genet, P-1649016 Lisbon, Portugal; [Xu, Zhe; Sheppard, David N.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Dawson, Elizabeth S.; Boyd, A. Christopher] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Genet Sect,Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	Universidade de Lisboa; University of Bristol; University of Edinburgh	Amaral, MD (corresponding author), Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal.	mdamaral@fc.ul.pt	Sheppard, David N/AAV-4187-2021; Amaral, Margarida D/E-5748-2012	Sheppard, David N/0000-0001-5533-9130; Amaral, Margarida D/0000-0002-0828-8630; SOUSA, MARISA/0000-0003-2305-4813	Fundacao para a Ciencia ea Tecnologia (FCT), Portugal [PIC/IC/83103/2007, POCTI/MGI/47382/2002, SFRH/BD/17475/2004, SFRH/BD/35936/2007]; BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union); Biotechnology and Biological Sciences Research Council [BB/C517517/1]; CF Trust	Fundacao para a Ciencia ea Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CF Trust	This work was supported in part by Fundacao para a Ciencia ea Tecnologia (FCT), Portugal Grants PIC/IC/83103/2007; and POCTI/MGI/47382/2002 and pluriannual funding of BioFIG from FCT, Portugal (Fonds Europeen de Developpement Regional-European Union) (to M. D. A.) and by Biotechnology and Biological Sciences Research Council Grant BB/C517517/1 and the CF Trust (to D. N. S. and A. C. B.).; Recipient of FCT, Portugal Doctoral Fellowship SFRH/BD/17475/2004.; Recipient of FCT, Portugal Doctoral Fellowship SFRH/BD/35936/2007.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; AMARAL MD, 2010, CURR DRUG T IN PRESS; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JM, 2001, MOL BIOL EVOL, V18, P1771, DOI 10.1093/oxfordjournals.molbev.a003965; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; de Jonge H., 2009, PEDIATR PULM, V32, P291; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Farinha CM, 2004, MOL CELL PROBE, V18, P235, DOI 10.1016/j.mcp.2004.03.005; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; HELLIWELL PS, 1994, ANN RHEUM DIS, V53, P726, DOI 10.1136/ard.53.11.726; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Kleinbaum DG, 2008, APPL REGRESSION ANAL, P114; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Lansdell KA, 1998, J PHYSIOL-LONDON, V512, P751, DOI 10.1111/j.1469-7793.1998.751bd.x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendes F, 2005, CELL PHYSIOL BIOCHEM, V16, P281, DOI 10.1159/000089857; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; WARD CL, 1994, J BIOL CHEM, V269, P25710; Welsh MJ, 2001, METABOLIC MOL BASES, P5121	48	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27033	27044		10.1074/jbc.M110.120352	http://dx.doi.org/10.1074/jbc.M110.120352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551307	Green Published, hybrid			2022-12-27	WOS:000281172700035
J	Hernandez-Guillamon, M; Mawhirt, S; Fossati, S; Blais, S; Pares, M; Penalba, A; Boada, M; Couraud, PO; Neubert, TA; Montaner, J; Ghiso, J; Rostagno, A				Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Fossati, Silvia; Blais, Steven; Pares, Mireia; Penalba, Anna; Boada, Merce; Couraud, Pierre-Olivier; Neubert, Thomas A.; Montaner, Joan; Ghiso, Jorge; Rostagno, Agueda			Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-beta E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; APOLIPOPROTEIN-E GENOTYPE; SMOOTH-MUSCLE-CELLS; DUTCH-TYPE MUTANT; A-BETA; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; COMPACT PLAQUES; FOCAL ISCHEMIA	Patients carrying mutations within the amyloid-beta (A beta) sequence develop severe early-onset cerebral amyloid angiopathy with some of the related variants manifesting primarily with hemorrhagic phenotypes. Matrix metalloproteases (MMPs) are typically associated with blood brain barrier disruption and hemorrhagic transformations after ischemic stroke. However, their contribution to cerebral amyloid angiopathy-related hemorrhage remains unclear. Human brain endothelial cells challenged with A beta synthetic homologues containing mutations known to be associated in vivo with hemorrhagic manifestations (A beta E22Q and A beta L34V) showed enhanced production and activation of MMP-2, evaluated via Multiplex MMP antibody arrays, gel zymography, and Western blot, which in turn proteolytically cleaved in situ the A beta peptides. Immunoprecipitation followed by mass spectrometry analysis highlighted the generation of specific C-terminal proteolytic fragments, in particular the accumulation of A beta-(1-16), a result validated in vitro with recombinant MMP-2 and quantitatively evaluated using deuterium-labeled internal standards. Silencing MMP-2 gene expression resulted in reduced A beta degradation and enhanced apoptosis. Secretion and activation of MMP-2 as well as susceptibility of the A beta peptides to MMP-2 degradation were dependent on the peptide conformation, with fibrillar elements of A beta E22Q exhibiting negligible effects. Our results indicate that MMP-2 release and activation differentially degrades A beta species, delaying their toxicity for endothelial cells. However, taking into consideration MMP ability to degrade basement membrane components, these protective effects might also undesirably compromise blood brain barrier integrity and precipitate a hemorrhagic phenotype.	[Mawhirt, Stephanie; Fossati, Silvia; Ghiso, Jorge; Rostagno, Agueda] NYU, Sch Med, Dept Pathol, Skirball Inst, New York, NY 10016 USA; [Ghiso, Jorge] NYU, Sch Med, Dept Psychiat, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Hernandez-Guillamon, Mar; Pares, Mireia; Penalba, Anna; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall Hebron, Inst Recerca, Neurovasc Res Lab, Barcelona 08035, Spain; [Boada, Merce; Montaner, Joan] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Neurol, Neurovasc Unit, Barcelona 08035, Spain; [Couraud, Pierre-Olivier] INSERM, Inst COCHIN, F-75014 Paris, France	New York University; New York University; New York University; New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rostagno, A (corresponding author), NYU, Sch Med, Dept Pathol, Skirball Inst, 560 1st Ave,TH Rm 435, New York, NY 10016 USA.	agueda.rostagno@nyumc.org	Montaner, Joan/D-3063-2015	Montaner, Joan/0000-0003-4845-2279; Rostagno, Agueda/0000-0002-6817-2074; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; Fossati, Silvia/0000-0002-2047-222X	National Institutes of Health [NS051715, AG30539, NS050276]; Spanish Ministry of Health [PI070737]; Instituto de Salud Carlos III; Alzheimer's Association; American Heart Association; Spanish Ministry of Health (Instituto de Salud Carlos III); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS051715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS051715, AG30539, and NS050276. The work was also supported by Spanish Ministry of Health Grant PI070737, the Instituto de Salud Carlos III, the Alzheimer's Association, and the American Heart Association.; Recipient of a postdoctoral grant from the Spanish Ministry of Health (Instituto de Salud Carlos III).	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bornebroek M, 1997, ANN NEUROL, V41, P695, DOI 10.1002/ana.410410523; Castano EM, 1996, J BIOL CHEM, V271, P32185, DOI 10.1074/jbc.271.50.32185; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Crouch PJ, 2009, J NEUROCHEM, V108, P1198, DOI 10.1111/j.1471-4159.2009.05870.x; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; Du R, 2008, NEURO-ONCOLOGY, V10, P254, DOI 10.1215/15228517-2008-001; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; Esiri MM, 2001, LANCET, V357, P169; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Garcia-Alloza M, 2009, J NEUROCHEM, V109, P1636, DOI 10.1111/j.1471-4159.2009.06096.x; Gelfanova Valentina, 2007, Briefings in Functional Genomics & Proteomics, V6, P149, DOI 10.1093/bfgp/elm010; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; GRAF K, 1995, HYPERTENSION, V26, P230, DOI 10.1161/01.HYP.26.2.230; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Jung SS, 2003, J NEUROCHEM, V85, P1208, DOI 10.1046/j.1471-4159.2003.01745.x; KALARIA RN, 1992, CEREBROVAS BRAIN MET, V4, P226; Kumar-Singh S, 2009, INT J MOL SCI, V10, P1872, DOI 10.3390/ijms10041872; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Lee JM, 2005, J NEUROL SCI, V229, P249, DOI 10.1016/j.jns.2004.11.041; Lee JM, 2003, ANN NEUROL, V54, P379, DOI 10.1002/ana.10671; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Maat-Schieman M, 2005, NEUROPATHOLOGY, V25, P288, DOI 10.1111/j.1440-1789.2005.00631.x; Maia LF, 2006, CEREBROVASC DIS, V22, P155, DOI 10.1159/000093245; MANDYBUR TI, 1986, J NEUROPATH EXP NEUR, V45, P79, DOI 10.1097/00005072-198601000-00007; McCarty JH, 2005, ASSAY DRUG DEV TECHN, V3, P89, DOI 10.1089/adt.2005.3.89; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Morelli L, 2002, NEUROCHEM RES, V27, P1387, DOI 10.1023/A:1021679817756; Munoz FJ, 2002, J NEUROSCI, V22, P3081, DOI 10.1523/JNEUROSCI.22-08-03081.2002; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Petty MA, 2001, BRAIN RES REV, V36, P23, DOI 10.1016/S0165-0173(01)00062-5; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; ROSENBERG GA, 1992, BRAIN RES, V576, P203, DOI 10.1016/0006-8993(92)90681-X; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Rostagno A., 2009, CURR PROTOC CELL BIO, P31; Rostagno A, 2008, NEURODEGENER DIS, V5, P173, DOI 10.1159/000113694; Solito R, 2009, EXP CELL RES, V315, P385, DOI 10.1016/j.yexcr.2008.11.002; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Tomidokoro Y, 2010, AM J PATHOL, V176, P1841, DOI 10.2353/ajpath.2010.090636; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tucker HM, 2000, J NEUROSCI, V20, P3937; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; Viana RJS, 2009, CELL MOL LIFE SCI, V66, P1094, DOI 10.1007/s00018-009-8746-x; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	81	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27144	27158		10.1074/jbc.M110.135228	http://dx.doi.org/10.1074/jbc.M110.135228			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576603	Green Published, hybrid			2022-12-27	WOS:000281172700045
J	Yoshida, A; Tomita, T; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Mechanism of Concerted Inhibition of alpha(2)beta(2)-type Hetero-oligomeric Aspartate Kinase from Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; THERMUS-THERMOPHILUS; ALLOSTERIC ENZYMES; CRYSTAL-STRUCTURE; ACT DOMAINS; ASPARTOKINASE; LYSINE; PROTEINS; PATHWAY; OPERON	Aspartate kinase (AK) is the first and committed enzyme of the biosynthetic pathway producing aspartate family amino acids, lysine, threonine, and methionine. AK from Corynebacterium glutamicum (CgAK), a bacterium used for industrial fermentation of amino acids, including glutamate and lysine, is inhibited by lysine and threonine in a concerted manner. To elucidate the mechanism of this unique regulation in CgAK, we determined the crystal structures in several forms: an inhibitory form complexed with both lysine and threonine, an active form complexed with only threonine, and a feedback inhibition-resistant mutant (S301F) complexed with both lysine and threonine. CgAK has a characteristic alpha(2)beta(2)-type heterotetrameric structure made up of two alpha subunits and two beta subunits. Comparison of the crystal structures between inhibitory and active forms revealed that binding inhibitors causes a conformational change to a closed inhibitory form, and the interaction between the catalytic domain in the alpha subunit and beta subunit (regulatory subunit) is a key event for stabilizing the inhibitory form. This study shows not only the first crystal structures of alpha(2)beta(2)-type AK but also the mechanism of concerted inhibition in CgAK.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858; Yoshida, Ayako/0000-0002-3668-9001	Ministry of Education, Culture, Sports, Science, and Technology Japan; Noda Institute for Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology Japan and the Noda Institute for Scientific Research.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BLACK S, 1955, J BIOL CHEM, V213, P27; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; CIRILLO JD, 1994, MOL MICROBIOL, V11, P629, DOI 10.1111/j.1365-2958.1994.tb00342.x; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; KALINOWSKI J, 1991, MOL MICROBIOL, V5, P1197, DOI 10.1111/j.1365-2958.1991.tb01893.x; KALINOWSKI J, 1990, MOL GEN GENET, V224, P317, DOI 10.1007/BF00262424; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Liu XY, 2008, J BIOL CHEM, V283, P16216, DOI 10.1074/jbc.M800760200; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; NISHIYAMA M, 1995, MICROBIOL-SGM, V141, P1211, DOI 10.1099/13500872-141-5-1211; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Robin AY, 2010, J MOL BIOL, V399, P283, DOI 10.1016/j.jmb.2010.04.014; ROGNES SE, 1980, NATURE, V287, P357, DOI 10.1038/287357a0; SHIIO I, 1969, J BIOCHEM-TOKYO, V65, P849, DOI 10.1093/oxfordjournals.jbchem.a129089; Somerville R. L., 1983, AMINO ACIDS BIOSYNTH, P147; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshida A, 2007, J MOL BIOL, V368, P521, DOI 10.1016/j.jmb.2007.02.017; Yoshida A, 2009, FEBS J, V276, P3124, DOI 10.1111/j.1742-4658.2009.07030.x	31	25	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27477	27486		10.1074/jbc.M110.111153	http://dx.doi.org/10.1074/jbc.M110.111153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573952	hybrid, Green Published			2022-12-27	WOS:000281172700077
J	Lassen, KG; Wissing, S; Lobritz, MA; Santiago, M; Greene, WC				Lassen, Kara G.; Wissing, Silke; Lobritz, Michael A.; Santiago, Mario; Greene, Warner C.			Identification of Two APOBEC3F Splice Variants Displaying HIV-1 Antiviral Activity and Contrasting Sensitivity to Vif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VIF; CYTIDINE DEAMINATION; ENZYME APOBEC3G; DNA; HYPERMUTATION; EXPRESSION; RESTRICTION; DEGRADATION; EVOLUTION; INFECTION	Approximately half of all human genes undergo alternative mRNA splicing. This process often yields homologous gene products exhibiting diverse functions. Alternative splicing of APOBEC3G (A3G) and APOBEC3F (A3F), the major host resistance factors targeted by the HIV-1 protein Vif, has not been explored. We investigated the effects of alternative splicing on A3G/A3F gene expression and antiviral activity. Three alternatively spliced A3G mRNAs and two alternatively spliced A3F mRNAs were detected in peripheral blood mononuclear cells in each of 10 uninfected, healthy donors. Expression of these splice variants was altered in different cell subsets and in response to cellular stimulation. Alternatively spliced A3G variants were insensitive to degradation by Vif but displayed no antiviral activity against HIV-1. Conversely, alternative splicing of A3F produced a 37-kDa variant lacking exon 2 (A3F Delta 2) that was prominently expressed in macrophages and monocytes and was resistant to Vif-mediated degradation. Alternative splicing also produced a 24-kDa variant of A3F lacking exons 2-4 (A3F Delta 2-4) that was highly sensitive to Vif. Both A3F Delta 2 and A3F Delta 2-4 displayed reduced cytidine deaminase activity and moderate antiviral activity. These alternatively spliced A3F gene products, particularly A3F Delta 2, were incorporated into HIV virions, albeit at levels less than wild-type A3F. Thus, alternative splicing of A3F mRNA generates truncated antiviral proteins that differ sharply in their sensitivity to Vif.	Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lobritz, Michael A.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Greene, WC (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu		Santiago, Mario L./0000-0001-7792-2706	NIAID Division of Intramural Research [R01 AI065329]; amfAR; Foundation for AIDS Research [107395-43-RFRL]; California Institute of Regenerative Medicine; Case Western Reserve University [T32 GM07250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); amfAR; Foundation for AIDS Research; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Case Western Reserve University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI065329 (to W. C. G.) from the NIAID Division of Intramural Research.; Supported by the Mathilde Krim Fellowship from amfAR, the Foundation for AIDS Research (107395-43-RFRL).; Supported by a post-doctoral fellowship from California Institute of Regenerative Medicine.; Supported by the Case Western Reserve University Medical Scientist Training Program Grant T32 GM07250.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen L, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r3; Cho SJ, 2006, J VIROL, V80, P2069, DOI 10.1128/JVI.80.4.2069-2072.2006; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Hache G, 2006, AIDS REV, V8, P148; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; MBISA JL, 2007, J VIROL; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Okeoma CM, 2009, J VIROL, V83, P3029, DOI 10.1128/JVI.02536-08; REFSLAND EW, NUCL ACIDS RES; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	54	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29326	29335		10.1074/jbc.M110.154054	http://dx.doi.org/10.1074/jbc.M110.154054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20624919	Green Published, hybrid			2022-12-27	WOS:000281740100035
J	Lin, XH; Novotny, M; Soderhall, K; Soderhall, I				Lin, Xionghui; Novotny, Marian; Soderhall, Kenneth; Soderhall, Irene			Ancient Cytokines, the Role of Astakines as Hematopoietic Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACIFASTACUS-LENIUSCULUS; DROSOPHILA; PROTEINS; CELL; IDENTIFICATION; PROLIFERATION; CRUSTACEAN; HOMOLOGY; FAMILY	Hematopoiesis is the process by which hemocytes mature and subsequently enter the circulation. Vertebrate prokineticins (PKs) are known to take part in this process, as are the invertebrate prokineticin domain proteins, astakines. In Pacifastacus leniusculus, astakine 1 is essential for the release of new hemocytes into the open circulatory system of these animals. In addition to astakine 1, we have now cloned a homologue of astakine 1 with an insert of 13 amino acids, named as astakine 2. Both crustacean astakines lack the N-terminal AVIT motif, which is present in vertebrate PKs, and hence receptor binding differs from that of vertebrate PKs. We have found astakine-like sequences in 19 different invertebrate species, and the sequences show that some motifs are conserved among invertebrate groups. Previously we showed that astakine 1 is directly involved in hematopoiesis, and now we show that astakine 1 and astakine 2 have different roles in hemocyte lineage differentiation. Astakine 1 can stimulate proliferation of hematopoietic tissue (Hpt) cells (precursor of hemocytes) as well as specifically induce differentiation of Hpt cells along the semigranular cell lineage, whereas astakine 2 plays a role in granular cell differentiation. Moreover, we discuss the impact of the putative structures of different astakines in comparison with the vertebrate prokineticins.	[Lin, Xionghui; Soderhall, Kenneth; Soderhall, Irene] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden; [Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 12843, Czech Republic	Uppsala University; Charles University Prague	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Novotny, Marian/B-7036-2008; Soderhall, Irene/AAS-5433-2020	Novotny, Marian/0000-0001-8788-3202; Lin, Xionghui/0000-0001-7488-1435	Swedish Science Research Council; Swedish Research Council Formas	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Science Research Council and the Swedish Research Council Formas.	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Chaga Oleg, 1995, Animal Biology, V4, P59; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Negri L, 2007, LIFE SCI, V81, P1103, DOI 10.1016/j.lfs.2007.08.011; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Wu CL, 2008, PROTEOMICS, V8, P4226, DOI 10.1002/pmic.200800177	27	52	55	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28577	28586		10.1074/jbc.M110.138560	http://dx.doi.org/10.1074/jbc.M110.138560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592028	Green Published, hybrid			2022-12-27	WOS:000281594000021
J	Marbois, B; Xie, LX; Choi, S; Hirano, K; Hyman, K; Clarke, CF				Marbois, Beth; Xie, Letian X.; Choi, Samuel; Hirano, Kathleen; Hyman, Kyle; Clarke, Catherine F.			para-Aminobenzoic Acid Is a Precursor in Coenzyme Q(6) Biosynthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; UBIQUINONE BIOSYNTHESIS; P-AMINOBENZOATE; GENE DISRUPTION; GLUCOSE ESTER; YEAST; MUTANTS; ENZYME; 4-HYDROXYBENZOATE; MICROORGANISMS	Coenzyme Q (ubiquinone or Q) is a crucial mitochondrial lipid required for respiratory electron transport in eukaryotes. 4-Hydroxybenozoate (4HB) is an aromatic ring precursor that forms the benzoquinone ring of Q and is used extensively to examine Q biosynthesis. However, the direct precursor compounds and enzymatic steps for synthesis of 4HB in yeast are unknown. Here we show that para-aminobenzoic acid (pABA), a well known precursor of folate, also functions as a precursor for Q biosynthesis. A hexaprenylated form of pABA (prenyl-pABA) is normally present in wild-type yeast crude lipid extracts but is absent in yeast abz1 mutants starved for pABA. A stable C-13(6)-isotope of pABA (p-amino[aromatic-C-13(6)]benzoic acid ([C-13(6)]pABA)), is prenylated in either wild-type or abz1 mutant yeast to form prenyl-[C-13(6)]pABA. We demonstrate by HPLC and mass spectrometry that yeast incubated with either [C-13(6)]pABA or [C-13(6)]4HB generate both C-13(6)-demethoxy-Q (DMQ), a late stage Q biosynthetic intermediate, as well as the final product C-13(6)-coenzyme Q. Pulse-labeling analyses show that formation of prenyl-pABA occurs within minutes and precedes the synthesis of Q. Yeast utilizing pABA as a ring precursor produce another nitrogen containing intermediate, 4-imino-DMQ(6). This intermediate is produced in small quantities in wildtype yeast cultured in standard media and in abz1 mutants supplemented with pABA. We suggest a mechanism where Schiff base-mediated deimination forms DMQ(6) quinone, thereby eliminating the nitrogen contributed by pABA. This scheme results in the convergence of the 4HB and pABA pathways in eukaryotic Q biosynthesis and has implications regarding the action of pABA-based antifolates.	[Marbois, Beth; Xie, Letian X.; Choi, Samuel; Hirano, Kathleen; Hyman, Kyle; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Marbois, Beth; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu			National Institutes of Health [GM4592, 4000QT]; National Science Foundation [0919609]; National Center For Research Resources [S10RR024605]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; Direct For Biological Sciences [0919609] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM4592 (to C. F. C.). This work was also supported by National Science Foundation Grant 0919609 (to C. F. C. and B. M.). UCLA mass spectrometry resources were funded by a NIH grant 4000QT for mass spectrometry resources and Grant S10RR024605 from the National Center For Research Resources.	ALAM SS, 1975, ARCH BIOCHEM BIOPHYS, V171, P183, DOI 10.1016/0003-9861(75)90022-3; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Brachmann CB, 1998, YEAST, V14, P115; Brajcich BC, 2010, J BACTERIOL, V192, P436, DOI 10.1128/JB.01040-09; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Castelli LA, 2001, FEMS MICROBIOL LETT, V199, P181, DOI 10.1111/j.1574-6968.2001.tb10671.x; COHEN FS, 1977, J MEMBRANE BIOL, V37, P361, DOI 10.1007/BF01940940; COX GB, 1968, J BACTERIOL, V95, P1591, DOI 10.1128/JB.95.5.1591-1598.1968; DAVIS BD, 1951, J EXP MED, V94, P243, DOI 10.1084/jem.94.3.243; DAWSON RM, 1986, DATA BIOCH RES, P42; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Forsman U, 2010, NAT CHEM BIOL, V6, P515, DOI [10.1038/NCHEMBIO.372, 10.1038/nchembio.372]; GOEWERT RR, 1981, THESIS U ST LOUIS ST; Guldener U, 2004, MOL BIOL CELL, V15, P3811, DOI 10.1091/mbc.E03-09-0680; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAMILTON JA, 1971, BIOCHEM J, V123, P435, DOI 10.1042/bj1230435; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Iliades P, 2003, MICROB DRUG RESIST, V9, P249, DOI 10.1089/107662903322286454; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Lenaz G., 1985, COENZYME Q, P165; LESTER RL, 1959, J BIOL CHEM, V234, P2169; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Olson R E, 1966, Vitam Horm, V24, P551; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; PARSON WW, 1964, P NATL ACAD SCI USA, V51, P444, DOI 10.1073/pnas.51.3.444; PENNOCK JF, 1983, BIOSYNTHESIS ISOPREN, P191; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; POON WW, 1995, ARCH BIOCHEM BIOPHYS, V320, P305, DOI 10.1016/0003-9861(95)90014-4; POON WW, 1997, MOL ASPECTS MED, V18, P121; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; REED LJ, 1959, J BIOL CHEM, V234, P904; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Sircar D, 2009, J PLANT PHYSIOL, V166, P1370, DOI 10.1016/j.jplph.2009.02.006; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; THRELFALL DR, 1970, BIOCHEM J, V118, pP55; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; TRUMPOWER BL, 1972, J BIOL CHEM, V247, P2499; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; YOUNG IG, 1973, J BACTERIOL, V114, P42, DOI 10.1128/JB.114.1.42-52.1973; [No title captured]	52	77	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27827	27838		10.1074/jbc.M110.151894	http://dx.doi.org/10.1074/jbc.M110.151894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592037	hybrid, Green Published			2022-12-27	WOS:000281404100038
J	Qin, JZ; Van Buren, D; Huang, HS; Zhong, L; Mostoslavsky, R; Akbarian, S; Hock, H				Qin, Jinzhong; Van Buren, Denille; Huang, Hsien-Sung; Zhong, Lei; Mostoslavsky, Raul; Akbarian, Schahram; Hock, Hanno			Chromatin Protein L3MBTL1 Is Dispensable for Development and Tumor Suppression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; POLYCOMB GROUP PROTEIN; HISTONE LYSINE METHYLATION; SEX-COMB; ZINC-FINGER; BINDING MODULES; HUMAN HOMOLOG; MBT REPEATS; MIDLEG SCM; GENE	L3MBTL1, a paralogue of Drosophila tumor suppressor lethal(3)malignant brain tumor (l(3)mbt), binds histones in a methylation state-dependent manner and contributes to higher order chromatin structure and transcriptional repression. It is the founding member of a family of MBT domain-containing proteins that has three members in Drosophila and nine in mice and humans. Knockdown experiments in cell lines suggested that L3MBTL1 has non-redundant roles in the suppression of oncogene expression. We generated a mutant mouse strain that lacks exons 13-20 of L3mbtl1. Markedly reduced levels of a mutant mRNA with an out-of-frame fusion of exons 12 and 21 were expressed, but a mutant protein was undetectable by Western blot analysis. L3MBTL1(-/-) mice developed and reproduced normally. The highest expression of L3MBTL1 was detected in the brain, but its disruption did not affect brain development, spontaneous movement, and motor coordination. Despite previous implications of L3mbtl1 in the biology of hematopoietic transcriptional regulators, lack of L3MBTL1 did not result in deficiencies in lymphopoiesis or hematopoiesis. In contrast with its demonstrated biochemical activities, embryonic stem (ES) cells lacking L3MBTL1 displayed no abnormalities in H4 lysine 20 (H4K20) mono-, di-, or trimethylation; had normal global chromatin density as assessed by micrococcal nuclease digests; and expressed normal levels of c-myc. Embryonic fibroblasts lacking L3MBTL1 displayed unaltered cell cycle arrest and down-regulation of cyclin E expression after irradiation. In cohorts of mice followed for more than 2 years, lack of L3MBTL1 did not alter normal lifespan or survival with or without sublethal irradiation.	[Qin, Jinzhong; Van Buren, Denille; Zhong, Lei; Mostoslavsky, Raul; Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Qin, Jinzhong; Van Buren, Denille; Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Qin, Jinzhong; Zhong, Lei; Mostoslavsky, Raul; Hock, Hanno] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hock, Hanno] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Huang, Hsien-Sung; Akbarian, Schahram] Univ Massachusetts, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester	Hock, H (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St,CPZN-4212, Boston, MA 02114 USA.	Hock.Hanno@mgh.harvard.edu		Huang, Hsien-Sung/0000-0003-2657-3635	NICHD, National Institutes of Health [HD 048489]; V Foundation; Kimmel Foundation; Ellison Foundation; Harvard Stem Cell Institute; Medical Discovery Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); V Foundation; Kimmel Foundation; Ellison Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; Medical Discovery Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD 048489 from the NICHD (to S. A.). This work was also supported by a V Foundation Scholar Award and a Kimmel Foundation Scholar Award (to R. M.), a contribution from the Ellison Foundation to Massachusetts General Hospital (MGH) startup funds (to H. H.), and the Harvard Stem Cell Institute (to H. H.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S4.; Recipient of an MGH Executive Committee on Research Fund for Medical Discovery Award.	Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Berger J, 1999, GENE, V237, P185, DOI 10.1016/S0378-1119(99)00285-1; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Koga H, 1999, ONCOGENE, V18, P3799, DOI 10.1038/sj.onc.1202732; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li J, 2004, P NATL ACAD SCI USA, V101, P7341, DOI 10.1073/pnas.0308195101; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; MacGrogan D, 2004, GENE CHROMOSOME CANC, V41, P203, DOI 10.1002/gcc.20087; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Montini E, 1999, GENOMICS, V58, P65, DOI 10.1006/geno.1999.5755; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sathyamurthy A, 2003, J BIOL CHEM, V278, P46968, DOI 10.1074/jbc.M306469200; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; SIMON J, 1992, DEVELOPMENT, V114, P493; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Usui H, 2000, GENE, V248, P127, DOI 10.1016/S0378-1119(00)00131-1; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wismar J, 2001, FEBS LETT, V507, P119, DOI 10.1016/S0014-5793(01)02959-3	48	22	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27767	27775		10.1074/jbc.M110.115410	http://dx.doi.org/10.1074/jbc.M110.115410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592034	Green Published, hybrid			2022-12-27	WOS:000281404100032
J	Broecker, MJ; Schomburg, S; Heinz, DW; Jahn, D; Schubert, WD; Moser, J				Broecker, Markus J.; Schomburg, Sebastian; Heinz, Dirk W.; Jahn, Dieter; Schubert, Wolf-Dieter; Moser, Juergen			Crystal Structure of the Nitrogenase-like Dark Operative Protochlorophyllide Oxidoreductase Catalytic Complex (ChlN/ChlB)(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM; ESCHERICHIA-COLI; PROTEIN; CLUSTER; BIOSYNTHESIS; CHLOROPHYLL; FERREDOXIN; REDUCTASE; MODEL; SITE	During (bacterio) chlorophyll biosynthesis of many photosynthetically active organisms, dark operative protochlorophyllide oxidoreductase (DPOR) catalyzes the two-electron reduction of ring D of protochlorophyllide to form chlorophyllide. DPOR is composed of the subunits ChlL, ChlN, and ChlB. Homodimeric ChlL(2) bearing an intersubunit [4Fe-4S] cluster is an ATP-dependent reductase transferring single electrons to the heterotetrameric (ChlN/ChlB)(2) complex. The latter contains two intersubunit [4Fe-4S] clusters and two protochlorophyllide binding sites, respectively. Here we present the crystal structure of the catalytic (ChlN/ChlB)(2) complex of DPOR from the cyanobacterium Thermosynechococcus elongatus at a resolution of 2.4 angstrom. Subunits ChlN and ChlB exhibit a related architecture of three subdomains each built around a central, parallel beta-sheet surrounded by alpha-helices. The (ChlN/ChlB)(2) crystal structure reveals a [4Fe-4S] cluster coordinated by an aspartate oxygen alongside three cysteine ligands. Two equivalent substrate binding sites enriched in aromatic residues for protochlorophyllide substrate binding are located at the interface of each ChlN/ChlB half-tetramer. The complete octameric (ChlN/ChlB)(2)(ChlL2)(2) complex of DPOR was modeled based on the crystal structure and earlier functional studies. The electron transfer pathway via the various redox centers of DPOR to the substrate is proposed.	[Schubert, Wolf-Dieter] Univ Western Cape, Chair Struct Biol, Dept Biotechnol, ZA-7535 Bellville, Cape Town, South Africa; [Broecker, Markus J.; Schomburg, Sebastian; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Heinz, Dirk W.; Schubert, Wolf-Dieter] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany	University of the Western Cape; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schubert, WD (corresponding author), Univ Western Cape, Chair Struct Biol, Dept Biotechnol, Private Bag X17, ZA-7535 Bellville, Cape Town, South Africa.	wschubert@uwc.ac.za	Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	APEL K, 2001, REGULATION PHOTOSYNT; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W.L, PYMOL MOL GRAPHICS S; Dobbek H, 2004, J AM CHEM SOC, V126, P5382, DOI 10.1021/ja037776v; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2009, P NATL ACAD SCI USA, V106, P16962, DOI 10.1073/pnas.0907872106; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Mannan RM, 1996, EMBO J, V15, P1826, DOI 10.1002/j.1460-2075.1996.tb00532.x; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rousset C, 2008, FEBS LETT, V582, P2937, DOI 10.1016/j.febslet.2008.07.032; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; Sham S, 2002, BIOCHEMISTRY-US, V41, P12498, DOI 10.1021/bi020347+; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Staples CR, 2007, J BACTERIOL, V189, P7392, DOI 10.1128/JB.00876-07; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; ZHAO JD, 1992, BIOCHEMISTRY-US, V31, P5093, DOI 10.1021/bi00137a001	55	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27336	27345		10.1074/jbc.M110.126698	http://dx.doi.org/10.1074/jbc.M110.126698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558746	hybrid, Green Published			2022-12-27	WOS:000281172700063
J	Dmitriev, SE; Terenin, IM; Andreev, DE; Ivanov, PA; Dunaevsky, JE; Merrick, WC; Shatsky, IN				Dmitriev, Sergey E.; Terenin, Ilya M.; Andreev, Dmitri E.; Ivanov, Pavel A.; Dunaevsky, Jacov E.; Merrick, William C.; Shatsky, Ivan N.			GTP-independent tRNA Delivery to the Ribosomal P-site by a Novel Eukaryotic Translation Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR EIF1; MESSENGER-RNA; START CODON; MEMBRANE PROTEINS; GENE-EXPRESSION; IDENTIFICATION; BINDING; CELL; RECOGNITION; COMPLEXES	During translation, aminoacyl-tRNAs are delivered to the ribosome by specialized GTPases called translation factors. Here, we report the tRNA binding to the P-site of 40 S ribosomes by a novel GTP-independent factor eIF2D isolated from mammalian cells. The binding of tRNA(i)(Met) occurs after the AUG codon finds its position in the P-site of 40 S ribosomes, the situation that takes place during initiation complex formation on the hepatitis C virus internal ribosome entry site or on some other specific RNAs (leaderless mRNA and A-rich mRNAs with relaxed scanning dependence). Its activity in tRNA binding with 40 S subunits does not require the presence of the aminoacyl moiety. Moreover, the factor possesses the unique ability to deliver non-Met (elongator) tRNAs into the P-site of the 40 S subunit. The corresponding gene is found in all eukaryotes and includes an SUI1 domain present also in translation initiation factor eIF1. The versatility of translation initiation strategies in eukaryotes is discussed.	[Shatsky, Ivan N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Ivanov, Pavel A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia; [Merrick, William C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Lomonosov Moscow State University; Lomonosov Moscow State University; Case Western Reserve University	Shatsky, IN (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Bldg A, Moscow 119992, Russia.	shatsky@genebee.msu.su	Dunaevsky, Yakov E/H-6105-2012; Shatsky, Ivan N/A-5331-2012; Dmitriev, Sergey/D-9694-2011; Andreev, Dmitry/I-6346-2012; Terenin, Ilya/Q-6470-2019; Terenin, Ilya M/G-5306-2011	Dmitriev, Sergey/0000-0002-1774-8475; Andreev, Dmitry/0000-0001-5320-3045; Terenin, Ilya/0000-0002-4459-0781; 	Russian Foundation for Basic Research [08-04-00399]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Grant 08-04-00399 from the Russian Foundation for Basic Research (to I. N. S.).	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Andreev D, 2008, RNA, V14, P233, DOI 10.1261/rna.693208; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dang C, 2006, ONCOL REP, V16, P513; Dever TE, 2001, COLD SPRING HARB SYM, V66, P417, DOI 10.1101/sqb.2001.66.417; Deyo JE, 1998, DNA CELL BIOL, V17, P437, DOI 10.1089/dna.1998.17.437; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; FILIPOWICZ W, 1976, P NATL ACAD SCI USA, V73, P44, DOI 10.1073/pnas.73.1.44; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; JAKOI ER, 1995, BRAIN RES, V693, P124, DOI 10.1016/0006-8993(95)00599-L; JAKOI ER, 1987, J BIOL CHEM, V262, P1300; JAKOI ER, 1989, J CELL SCI, V93, P227; JAKOI ER, 1976, J CELL BIOL, V70, P97, DOI 10.1083/jcb.70.1.97; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; Komar AA, 2005, J BIOL CHEM, V280, P15601, DOI 10.1074/jbc.M413728200; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Malygin A A, 2009, Mol Biol (Mosk), V43, P1070; MARCHASE RB, 1982, CELL, V28, P813, DOI 10.1016/0092-8674(82)90060-5; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Reinert LS, 2006, CANCER RES, V66, P8994, DOI 10.1158/0008-5472.CAN-06-1999; RON D, 2006, TRANSLATIONAL CONTRO, P345; Severt WL, 1999, J CELL SCI, V112, P3691; Shanina N. A., 2001, Molekulyarnaya Biologiya (Moscow), V35, P638; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Terenin IM, 2005, MOL CELL BIOL, V25, P7879, DOI 10.1128/MCB.25.17.7879-7888.2005; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wong QWL, 2008, MAR BIOTECHNOL, V10, P91, DOI 10.1007/s10126-007-9042-0; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200	50	109	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26779	26787		10.1074/jbc.M110.119693	http://dx.doi.org/10.1074/jbc.M110.119693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566627	Green Published, hybrid			2022-12-27	WOS:000281172700008
J	Massaeli, H; Sun, T; Li, XA; Shallow, H; Wu, J; Xu, JM; Li, WT; Hanson, C; Guo, J; Zhang, ST				Massaeli, Hamid; Sun, Tao; Li, Xian; Shallow, Heidi; Wu, Jimmy; Xu, Jianmin; Li, Wentao; Hanson, Christian; Guo, Jun; Zhang, Shetuan			Involvement of Caveolin in Low K+-induced Endocytic Degradation of Cell-surface Human Ether-a-go-go-related Gene (hERG) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; LONG-QT SYNDROME; I-KR; DEPENDENT ENDOCYTOSIS; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNEL; EXTRACELLULAR K+; INTERNALIZATION; CARDIOMYOCYTES; IDENTIFICATION	Reduction in the rapidly activating delayed rectifier K+ channel current (I-Kr) due to either mutations in the human ether-a-go-go-related gene (hERG) or drug block causes inherited or drug-induced long QT syndrome. A reduction in extracellular K+ concentration ([K+](o)) exacerbates long QT syndrome. Recently, we demonstrated that lowering [K+](o) promotes degradation of I-Kr in rabbit ventricular myocytes and of the hERG channel stably expressed in HEK 293 cells. In this study, we investigated the degradation pathways of hERG channels under low K+ conditions. We demonstrate that under low K+ conditions, mature hERG channels and caveolin-1 (Cav1) displayed a parallel time-dependent reduction. Mature hERG channels coprecipitated with Cav1 in co-immunoprecipitation analysis, and internalized hERG channels colocalized with Cav1 in immunocytochemistry analysis. Overexpression of Cav1 accelerated internalization of mature hERG channels in 0 mM K-o(+), whereas knockdown of Cav1 impeded this process. In addition, knockdown of dynamin 2 using siRNA transfection significantly impeded hERG internalization and degradation under low K-o(+) conditions. In cultured neonatal rat ventricular myocytes, knockdown of caveolin-3 significantly impeded low K-o(+)-induced reduction of IKr. Our data indicate that a caveolin-dependent endocytic route is involved in low K-o(+)-induced degradation of mature hERG channels.	[Massaeli, Hamid; Sun, Tao; Li, Xian; Shallow, Heidi; Wu, Jimmy; Xu, Jianmin; Li, Wentao; Hanson, Christian; Guo, Jun; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP 72911 (to S.Z.).	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Choy AM, 1997, CIRCULATION, V96, P2149; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Garcia E, 2008, PEDIATR EMERG CARE, V24, P157, DOI 10.1097/PEC.0b013e318166868e; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Pierini LM, 2000, BLOOD, V95, P2471; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Rybin VO, 2003, AM J PHYSIOL-HEART C, V285, pH325, DOI 10.1152/ajpheart.00946.2002; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005	33	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27259	27264		10.1074/jbc.M110.124909	http://dx.doi.org/10.1074/jbc.M110.124909			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20605793	hybrid, Green Published			2022-12-27	WOS:000281172700079
J	Siponen, MI; Wisniewska, M; Lehtio, L; Johansson, I; Svensson, L; Raszewski, G; Nilsson, L; Sigvardsson, M; Berglund, H				Siponen, Marina I.; Wisniewska, Magdalena; Lehtio, Lari; Johansson, Ida; Svensson, Linda; Raszewski, Grzegorz; Nilsson, Lennart; Sigvardsson, Mikael; Berglund, Helena			Structural Determination of Functional Domains in Early B-cell Factor (EBF) Family of Transcription Factors Reveals Similarities to Rel DNA-binding Proteins and a Novel Dimerization Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; ACTIVATION; SELECTION; CLONING	The early B-cell factor (EBF) transcription factors are central regulators of development in several organs and tissues. This protein family shows low sequence similarity to other protein families, which is why structural information for the functional domains of these proteins is crucial to understand their biochemical features. We have used a modular approach to determine the crystal structures of the structured domains in the EBF family. The DNA binding domain reveals a striking resemblance to the DNA binding domains of the Rel homology superfamily of transcription factors but contains a unique zinc binding structure, termed zinc knuckle. Further the EBF proteins contain an IPT/TIG domain and an atypical helix-loop-helix domain with a novel type of dimerization motif. The data presented here provide insights into unique structural features of the EBF proteins and open possibilities for detailed molecular investigations of this important transcription factor family.	[Siponen, Marina I.; Wisniewska, Magdalena; Johansson, Ida; Svensson, Linda] Karolinska Inst, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Siponen, Marina I.; Wisniewska, Magdalena; Johansson, Ida; Svensson, Linda] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Raszewski, Grzegorz; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; [Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Abo Akademi University; Karolinska Institutet; Linkoping University		Helena.Berglund@ki.se	Raszewski, Grzegorz/AAF-3418-2019; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397; Sigvardsson, Mikael/0000-0001-8527-7276; Lehtio, Lari/0000-0001-7250-832X	Academy of Finland [128322]; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Academy of Finland(Academy of Finland); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Academy of Finland (Grant 128322 to L. L.).; We gratefully acknowledge the beamline personnel at the BESSY (Berlin, Germany) and Diamond (Oxford, United Kingdom) synchrotron radiation facilities. We thank Par Nordlund and Johan Weigelt for useful discussions. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fields S, 2008, MOL IMMUNOL, V45, P3786, DOI 10.1016/j.molimm.2008.05.018; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smith EMK, 2005, BLOOD, V106, P1995, DOI 10.1182/blood-2004-12-4744; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Zhao F, 2003, MOL CELL BIOL, V23, P3837, DOI 10.1128/MCB.23.11.3837-3846.2003	36	16	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25875	25879		10.1074/jbc.C110.150482	http://dx.doi.org/10.1074/jbc.C110.150482			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20592035	Green Published, hybrid			2022-12-27	WOS:000280921000001
J	Wei, J; Liu, WH; Yan, Z				Wei, Jing; Liu, Wenhua; Yan, Zhen			Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; RAB PROTEINS; SMALL GTPASE; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; GSK3; PHOSPHORYLATION; INTERNALIZATION; EXPRESSION; GSK-3-BETA	Accumulating evidence suggests that glycogen synthase kinase 3 (GSK-3) is a multifunctional kinase implicated in neuronal development, moodstabilization, and neurodegeneration. However, the synaptic actions of GSK-3 are largely unknown. In this study, we examined the impact of GSK-3 on AMPA receptor (AMPAR) channels, the major mediator of excitatory transmission, in cortical neurons. Application of GSK-3 inhibitors or knockdown of GSK-3 caused a significant reduction of the amplitude of miniature excitatory postsynaptic current (mEPSC), a readout of the unitary strength of synaptic AMPARs. Treatment with GSK-3 inhibitors also decreased surface and synaptic GluR1 clusters on dendrites and increased internalized GluR1 in cortical cultures. Rab5, the small GTPase controlling the transport from plasma membrane to early endosomes, was activated by GSK-3 inhibitors. Knockdown of Rab5 prevented GSK-3 inhibitors from regulating mEPSC amplitude. Guanyl nucleotide dissociation inhibitor (GDI), which regulates the cycle of Rab5 between membrane and cytosol, formed an increased complex with Rab5 after treatment with GSK-3 inhibitors. Blocking the function of GDI occluded the effect of GSK-3 inhibitors on mEPSC amplitude. In cells transfected with the non-phosphorylatable GDI mutant, GDI(S45A), GSK-3 inhibitors lost the capability to regulate GDI-Rab5 complex, mEPSC amplitude, and AMPAR surface expression. These results suggest that GSK-3, via altering the GDI-Rab5 complex, regulates Rab5-mediated endocytosis of AMPARs. It provides a potential mechanism underlying the role of GSK-3 in synaptic transmission and plasticity.	[Wei, Jing] Southeast Univ, Minist Educ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China; [Wei, Jing; Liu, Wenhua; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA	Southeast University - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wei, J (corresponding author), Southeast Univ, Minist Educ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China.	jwei83@yahoo.com.cn; zhenyan@buffalo.edu			National Institutes of Health [NS69929, MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS69929 and MH84233 (to Z. Y.).	Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Shisheva A, 1999, BIOCHEMISTRY-US, V38, P11711, DOI 10.1021/bi990200r; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	41	73	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26369	26376		10.1074/jbc.M110.121376	http://dx.doi.org/10.1074/jbc.M110.121376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20584904	hybrid, Green Published			2022-12-27	WOS:000280921000055
J	Haldar, S; Mitra, S; Chattopadhyay, K				Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda			Role of Protein Stabilizers on the Conformation of the Unfolded State of Cytochrome c and Its Early Folding Kinetics INVESTIGATION AT SINGLE MOLECULAR RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACID-BINDING PROTEIN; MAGNETIC CIRCULAR-DICHROISM; X-RAY-SCATTERING; DENATURED STATE; ELECTRON-TRANSFER; EARLY EVENTS; AGGREGATION; ARGININE; MECHANISM	An insight into the conformation and dynamics of unfolded and early intermediate states of a protein is essential to understand the mechanism of its aggregation and to design potent inhibitor molecules. Fluorescence correlation spectroscopy has been used to study the effects of several model protein stabilizers on the conformation of the unfolded state and early folding dynamics of tetramethyl rhodamine-labeled cytochrome c from Saccharomyces cerevisiae at single molecular resolution. Special attention has been given to arginine, which is a widely used stabilizer for improving refolding yield of different proteins. The value of the hydrodynamic radius (r(H)) obtained by analyzing the intensity fluctuations of the diffusing molecules has been found to increase in a two-state manner as the protein is unfolded by urea. The results further show that the presence of arginine and other protein stabilizers favors a relatively structured conformation of the unfolded states (r(H) of 29 angstrom) over an extended one (r(H) of 40 angstrom), which forms in their absence. Also, the time constant of a kinetic component (tau(R)) of about 30 mu s has been observed by analyzing the correlation functions, which represents formation of a collapsed state. This time constant varies with urea concentration representing an inverted Chevron plot that shows a roll-over behavior in the absence of arginine. To the best of our knowledge, this is one of the first applications of fluorescence correlation spectroscopy to study direct folding kinetics of a protein.	[Haldar, Shubhasis; Mitra, Samaresh; Chattopadhyay, Krishnananda] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	Council of Scientific and Industrial Research Network [NWP005]; Indian National Science Academy	Council of Scientific and Industrial Research Network; Indian National Science Academy	The work was supported by Council of Scientific and Industrial Research Network Project Grant NWP005 and by a grant from the acknowledges Indian National Science Academy (to S.M.).	Andya JD, 2003, AAPS PHARMSCI, V5; Andya JD, 1999, PHARMACEUT RES, V16, P350, DOI 10.1023/A:1018805232453; ARAKAWA T, 1990, BIOCHEMISTRY-US, V29, P1924, DOI 10.1021/bi00459a037; Arakawa T, 2007, PROTEIN EXPRES PURIF, V52, P410, DOI 10.1016/j.pep.2006.10.005; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arakawa T, 2006, PROTEIN PEPTIDE LETT, V13, P921, DOI 10.2174/092986606778256171; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Bee JS, 2010, BIOTECHNOL BIOENG, V105, P121, DOI 10.1002/bit.22525; BOWLER BE, 1993, BIOCHEMISTRY-US, V32, P183, DOI 10.1021/bi00052a024; CARPENTER JF, 2002, CURRENT PROTOCOLS PR; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2003, BIOCHEMISTRY-US, V42, P14606, DOI 10.1021/bi0351662; Chattopadhyay K, 2002, BIOCHEMISTRY-US, V41, P4040, DOI 10.1021/bi012042l; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Chen E, 2009, CURR PROTEIN PEPT SC, V10, P464, DOI 10.2174/138920309789352001; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Colon W, 1997, BIOCHEMISTRY-US, V36, P12535, DOI 10.1021/bi971697c; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; Frieden C, 2002, ADV PROTEIN CHEM, V62, P91; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Godbole S, 2000, J MOL BIOL, V296, P217, DOI 10.1006/jmbi.1999.3454; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hammack BN, 2001, J MOL BIOL, V311, P1091, DOI 10.1006/jmbi.2001.4909; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Kim KY, 1998, PROTEIN SCI, V7, P1821, DOI 10.1002/pro.5560070818; Krishna MMG, 2006, J MOL BIOL, V359, P1410, DOI 10.1016/j.jmb.2006.04.035; Kurchan E, 2005, J MOL BIOL, V353, P730, DOI 10.1016/j.jmb.2005.08.034; Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055; Lee JC, 2002, J MOL BIOL, V320, P159, DOI 10.1016/S0022-2836(02)00466-7; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; Perroud TD, 2005, P NATL ACAD SCI USA, V102, P17570, DOI 10.1073/pnas.0508975102; Pletneva EV, 2005, J MOL BIOL, V345, P855, DOI 10.1016/j.jmb.2004.10.085; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Qiu LL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168103; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; SHASTRY MC, 1996, PROTEINS, V24, P413; Sosnick TR, 1997, P NATL ACAD SCI USA, V94, P8545, DOI 10.1073/pnas.94.16.8545; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Thomas YG, 2000, BIOPOLYMERS, V57, P29, DOI 10.1002/(SICI)1097-0282(2000)57:1<29::AID-BIP5>3.0.CO;2-V; Werner JH, 2006, P NATL ACAD SCI USA, V103, P11130, DOI 10.1073/pnas.0604712103; Wilkins DK, 2000, EUR J BIOCHEM, V267, P2609, DOI 10.1046/j.1432-1327.2000.01270.x; Xia Y, 2007, INT J BIOL MACROMOL, V40, P437, DOI 10.1016/j.ijbiomac.2006.10.004	58	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25314	25323		10.1074/jbc.M110.116673	http://dx.doi.org/10.1074/jbc.M110.116673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538585	Green Published, hybrid			2022-12-27	WOS:000280682400024
J	Kudryashov, DS; Grintsevich, EE; Rubenstein, PA; Reisler, E				Kudryashov, Dmitri S.; Grintsevich, Elena E.; Rubenstein, Peter A.; Reisler, Emil			A Nucleotide State-sensing Region on Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; D-BINDING PROTEIN; MONOMERIC ACTIN; ATP HYDROLYSIS; ADP-ACTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST ACTIN; BETA-ACTIN; F-ACTIN	The nucleotide state of actin (ATP, ADP-Pi, or ADP) is known to impact its interactions with other actin molecules upon polymerization as well as with multiple actin binding proteins both in the monomeric and filamentous states of actin. Recently, molecular dynamics simulations predicted that a sequence located at the interface of subdomains 1 and 3 (W-loop; residues 165-172) changes from an unstructured loop to a beta-turn conformation upon ATP hydrolysis (Zheng, X., Diraviyam, K., and Sept, D. (2007) Biophys. J. 93, 1277-1283). This region participates directly in the binding to other subunits in F-actin as well as to cofilin, profilin, and WH2 domain proteins and, therefore, could contribute to the nucleotide sensitivity of these interactions. The present study demonstrates a reciprocal communication between the W-loop region and the nucleotide binding cleft on actin. Point mutagenesis of residues 167, 169, and 170 and their site-specific labeling significantly affect the nucleotide release from the cleft region, whereas the ATP/ADP switch alters the fluorescence of probes located in the W-loop. In the ADP-Pi state, the W-loop adopts a conformation similar to that in the ATP state but different from the ADP state. Binding of latrunculin A to the nucleotide cleft favors the ATP-like conformation of the W-loop, whereas ADP-ribosylation of Arg-177 forces the W-loop into a conformation distinct from those in the ADP and ATP-states. Overall, our experimental data suggest that the W-loop of actin is a nucleotide sensor, which may contribute to the nucleotide state-dependent changes in F-actin and nucleotide state-modulated interactions of both G-and F-actin with actin-binding proteins.	[Kudryashov, Dmitri S.; Grintsevich, Elena E.; Reisler, Emil] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Iowa	Kudryashov, DS (corresponding author), 405 Hilgard Ave,MBI Boyer Hall,Rm 405, Los Angeles, CA 90095 USA.	dkudryas@ucla.edu	Kudryashov, Dmitri/P-9004-2014	Rubenstein, Peter/0000-0003-1225-4414; Kudryashov, Dmitri/0000-0003-1782-3305	National Institutes of Health [GM077190, GM33689]; National Science Foundation [MCB0316269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190, R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077190 (to E. R.) and GM33689 (to P. A. R.). This work was also supported by National Science Foundation Grant MCB0316269 (to E. R.).	Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Bugyi B, 2008, FEBS LETT, V582, P2086, DOI 10.1016/j.febslet.2008.02.065; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; COOKE R, 1975, BIOCHEMISTRY-US, V14, P3250, DOI 10.1021/bi00685a035; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Head JF, 2002, BIOCHEMISTRY-US, V41, P9015, DOI 10.1021/bi026054y; HERTZOG M, 2005, CURR PROTOC CELL BIO, pCH13; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAHAM LE, 1995, EUR J BIOCHEM, V234, P1, DOI 10.1111/j.1432-1033.1995.001_c.x; LAL AA, 1984, J BIOL CHEM, V259, P3061; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otterbein LR, 2002, P NATL ACAD SCI USA, V99, P8003, DOI 10.1073/pnas.122126299; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schuler H, 2000, EUR J BIOCHEM, V267, P4054, DOI 10.1046/j.1432-1033.2000.01466.x; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Splettstoesser T, 2009, PROTEINS, V76, P353, DOI 10.1002/prot.22350; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Verboven C, 2003, ACTA CRYSTALLOGR D, V59, P263, DOI 10.1107/S0907444902021455; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	62	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25591	25601		10.1074/jbc.M110.123869	http://dx.doi.org/10.1074/jbc.M110.123869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530485	hybrid, Green Published			2022-12-27	WOS:000280682400053
J	Morino, M; Natsui, S; Ono, T; Swartz, TH; Krulwich, TA; Ito, M				Morino, Masato; Natsui, Shinsuke; Ono, Tomohiro; Swartz, Talia H.; Krulwich, Terry A.; Ito, Masahiro			Single Site Mutations in the Hetero-oligomeric Mrp Antiporter from Alkaliphilic Bacillus pseudofirmus OF4 That Affect Na+/H+ Antiport Activity, Sodium Exclusion, Individual Mrp Protein Levels, or Mrp Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PH HOMEOSTASIS; ALKALOPHILIC BACILLUS; VIBRIO-PARAHAEMOLYTICUS; QUINONE OXIDOREDUCTASE; STAPHYLOCOCCUS-AUREUS; ACIDIC RESIDUES; H+ ANTIPORTER; GENE-PRODUCTS; STRAIN C-125	Mrp systems are widely distributed and structurally complex cation/proton antiporters. Antiport activity requires hetero-oligomeric complexes of all six or seven hydrophobic Mrp proteins (MrpA-MrpG). Here, a panel of site-directed mutants in conserved or proposed motif residues was made in the Mrp Na+(Li+)/H+ antiporter from an alkaliphilic Bacillus. The mutant operons were expressed in antiporter-deficient Escherichia coli KNabc and assessed for antiport properties, support of sodium resistance, membrane levels of each Mrp protein, and presence of monomeric and dimeric Mrp complexes. Antiport did not depend on a VFF motif or a conserved tyrosine pair, but a role for a conserved histidine in a potential quinone binding site of MrpA was supported. The importance of several acidic residues for antiport was confirmed, and the importance of additional residues was demonstrated (e. g. three lysine residues conserved across MrpA, MrpD, and membrane-bound respiratory Complex I subunits (NuoL/M/N)). The results extended indications that MrpE is required for normal membrane levels of other Mrp proteins and for complex formation. Moreover, mutations in several other Mrp proteins lead to greatly reduced membrane levels of MrpE. Thus, changes in either of the two Mrp modules, MrpA-MrpD and MrpE-MrpG, influence the other. Two mutants, MrpB-P37G and MrpC-Q70A, showed a normal phenotype but lacked the MrpA-MrpG monomeric complex while retaining the dimeric hetero-oligomeric complex. Finally, MrpG-P81A and MrpG-P81G mutants exhibited no antiport activity but supported sodium resistance and a low [Na+](in). Such mutants could be used to screen hypothesized but uncharacterized sodium efflux functions of Mrp apart from Na+(Li+)/H+ antiport.	[Ono, Tomohiro; Ito, Masahiro] Toyo Univ, Fac Life Sci, Itakura, Gunma 3740193, Japan; [Morino, Masato; Natsui, Shinsuke; Ito, Masahiro] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma 3740193, Japan; [Ito, Masahiro] Toyo Univ, Bionano Elect Res Ctr, Itakura, Gunma 3740193, Japan; [Swartz, Talia H.; Krulwich, Terry A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Toyo University; Toyo University; Toyo University; Icahn School of Medicine at Mount Sinai	Ito, M (corresponding author), Toyo Univ, Fac Life Sci, 1-1-1 Izumino, Itakura, Gunma 3740193, Japan.	ito1107@toyonet.toyo.ac.jp	Swartz, Talia H./AAN-8591-2020; ITO, MASAHIRO/H-1960-2013; Swartz, Talia H./AAU-2000-2020	Swartz, Talia H./0000-0003-1572-045X; ITO, MASAHIRO/0000-0002-4976-762X; Swartz, Talia H./0000-0003-1572-045X	National Institutes of Health [GM28454]; Toyo University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toyo University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 (to T. A. K.). This work was also supported by a special grant-in-aid from Toyo University, a grant from a High-Tech Research Center program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. I.), and a grant from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to M. M.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Dzioba-Winogrodzki J, 2009, J MOL MICROB BIOTECH, V16, P176, DOI 10.1159/000119547; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hiramatsu T, 1998, J BACTERIOL, V180, P6642, DOI 10.1128/JB.180.24.6642-6648.1998; HIROTA N, 1981, FEBS LETT, V132, P278, DOI 10.1016/0014-5793(81)81178-7; Ito M, 2004, MOL MICROBIOL, V53, P1035, DOI 10.1111/j.1365-2958.2004.04173.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Ito M, 1999, J BACTERIOL, V181, P2394, DOI 10.1128/JB.181.8.2394-2402.1999; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Kajiyama Y, 2007, J BACTERIOL, V189, P7511, DOI 10.1128/JB.00968-07; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kashyap DR, 2006, J BACTERIOL, V188, P1577, DOI 10.1128/JB.188.4.1577-1584.2006; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; KRULWICH TA, 1985, J BIOL CHEM, V260, P4055; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; Kuroda T, 1997, J BACTERIOL, V179, P7600, DOI 10.1128/jb.179.23.7600-7602.1997; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACNAB RM, 1987, BIOPHYS J, V52, P637, DOI 10.1016/S0006-3495(87)83255-1; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mesbah NM, 2009, MOL MICROBIOL, V74, P270, DOI 10.1111/j.1365-2958.2009.06845.x; Morino M, 2008, J BACTERIOL, V190, P4162, DOI 10.1128/JB.00294-08; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SETO Y, 1995, BIOSCI BIOTECH BIOCH, V59, P1364, DOI 10.1271/bbb.59.1364; Slonczewski J. L., 2009, ADV MICROB PHYSL, V55, P317, DOI DOI 10.1016/S0065-2911(09)05501-5; Steuber J, 2001, J BIOENERG BIOMEMBR, V33, P179, DOI 10.1023/A:1010774701327; Swartz TH, 2007, J BACTERIOL, V189, P3081, DOI 10.1128/JB.00021-07; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916	42	33	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30942	30950		10.1074/jbc.M110.118661	http://dx.doi.org/10.1074/jbc.M110.118661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20624916	Green Published, hybrid			2022-12-27	WOS:000282135500059
J	Nijmeijer, S; Leurs, R; Smit, MJ; Vischer, HF				Nijmeijer, Saskia; Leurs, Rob; Smit, Martine J.; Vischer, Henry F.			The Epstein-Barr Virus-encoded G Protein-coupled Receptor BILF1 Hetero-oligomerizes with Human CXCR4, Scavenges G alpha(i) Proteins, and Constitutively Impairs CXCR4 Functioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; MU-OPIOID RECEPTORS; CHEMOKINE RECEPTOR; LIGAND-BINDING; TRANSFER BRET; CROSS-TALK; EXPRESSION; CELLS; HETERODIMERIZATION; DIMERIZATION	Cells express distinct G protein-coupled receptor (GPCR) subtypes on their surface, allowing them to react to a corresponding variety of extracellular stimuli. Cross-regulation between different ligand-GPCR pairs is essential to generate appropriate physiological responses. GPCRs can physically affect each other's functioning by forming heteromeric complexes, whereas cross-regulation between activated GPCRs also occurs through integration of shared intracellular signaling networks. Human herpesviruses utilize virally encoded GPCRs to hijack cellular signaling networks for their own benefit. Previously, we demonstrated that the Epstein-Barr virus-encoded GPCR BILF1 forms heterodimeric complexes with human chemokine receptors. Using a combination of bimolecular complementation and bioluminescence resonance energy transfer approaches, we now show the formation of hetero-oligomeric complexes between this viral GPCR and human CXCR4. BILF1 impaired CXCL12 binding to CXCR4 and, consequently, also CXCL12-induced signaling. In contrast, the G protein uncoupled mutant BILF1-K(3.50)A affected CXCL12-induced CXCR4 signaling to a much lesser extent, indicating that BILF1-mediated CXCR4 inhibition is a consequence of its constitutive activity. Co-expression of G alpha(i1) with BILF1 and CXCR4 restored CXCL12-induced signaling. Likewise, BILF1 formed heteromers with the human histamine H-4 receptor (H4R). BILF1 inhibited histamine-induced G alpha(i)-mediated signaling by H4R, however, without affecting histamine binding to this receptor. These data indicate that functional cross-regulation of G alpha(i)-coupled GPCRs by BILF1 is at the level of G proteins, even though these GPCRs are assembled in hetero-oligomeric complexes.	[Nijmeijer, Saskia; Leurs, Rob; Smit, Martine J.; Vischer, Henry F.] Vrije Univ Amsterdam, LACDR, Div Med Chem, Fac Sci, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Vischer, HF (corresponding author), Vrije Univ Amsterdam, LACDR, Div Med Chem, Fac Sci, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	vischer@few.vu.nl	Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; Nijmeijer, Saskia/0000-0001-8037-4659; Smit, Martine/0000-0003-2713-0238	Netherlands Organization for Scientific Research [700.55.403, 700.54.425]; Netherlands Genomics Initiative [93518006]; COST Action [BM0806]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; COST Action(European Cooperation in Science and Technology (COST))	This work was supported by Veni Grant 700.55.403 (to H. F. V.) and Vidi Grant 700.54.425 (to M. J. S.) from the Netherlands Organization for Scientific Research and by Breakthrough Grant 93518006 from the Netherlands Genomics Initiative (to H. F. V.) and COST Action BM0806 (to S. N. and R. L.).	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bakker RA, 2004, J BIOL CHEM, V279, P5152, DOI 10.1074/jbc.M309200200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Bouvier M, 1998, CURR OPIN BIOTECH, V9, P522; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Maeda Y, 2004, EUR J BIOCHEM, V271, P1677, DOI 10.1111/j.1432-1033.2004.04064.x; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Park PSH, 2004, J NEUROCHEM, V90, P537, DOI 10.1111/j.1471-4159.2004.02536.x; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Piovan E, 2005, BLOOD, V105, P931, DOI 10.1182/blood-2004-03-0799; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; VAN RIJN RM, 2006, MOL PHARMACOL, V70, P604; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vischer HF, 2006, CURR TOP MICROBIOL, V303, P121, DOI 10.1007/978-3-540-33397-5_6; Vischer HF, 2008, BIOCHEM BIOPH RES CO, V377, P93, DOI 10.1016/j.bbrc.2008.09.082; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	55	74	75	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29632	29641		10.1074/jbc.M110.115618	http://dx.doi.org/10.1074/jbc.M110.115618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622011	Green Published, hybrid			2022-12-27	WOS:000281740100064
J	Benet, M; Lahoz, A; Guzman, C; Castell, JV; Jover, R				Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro			CCAAT/Enhancer-binding Protein alpha (C/EBP alpha) and Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) Synergistically Cooperate with Constitutive Androstane Receptor to Transactivate the Human Cytochrome P450 2B6 (CYP2B6) Gene APPLICATION TO THE DEVELOPMENT OF A METABOLICALLY COMPETENT HUMAN HEPATIC CELL MODEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; CULTURED HUMAN HEPATOCYTES; HUMAN LIVER-MICROSOMES; QUANTITATIVE RT-PCR; IN-VITRO; INTERINDIVIDUAL VARIABILITY; TRANSCRIPTIONAL REGULATION; ORNITHINE TRANSCARBAMYLASE; BASAL EXPRESSION; N-DEMETHYLATION	The transcription of tissue-specific and inducible genes is usually subject to the dynamic control of multiple activators. Dedifferentiated hepatic cell lines lose the expression of tissue-specific activators and many characteristic hepatic genes, such as drug-metabolizing cytochrome P450. Here we demonstrate that by combining adenoviral vectors for CCAAT/enhancer-binding protein alpha (C/EBP alpha), hepatocyte nuclear factor 4 alpha (HNF4 alpha), and constitutive androstane receptor, the CYP2B6 expression and inducibility by CITCO are restored in human hepatoma HepG2 cells at levels similar to those in cultured human hepatocytes. Moreover, several other phase I and II genes are simultaneously activated, which suggests that this is an effective approach to endow dedifferentiated human hepatoma cells with a particular metabolic competence and response to inducers. In order to gain insight into the molecular mechanism, we examined the cooperation of these three transcription factors on the CYP2B6 5'-flanking region. We show new CYP2B6-responsive sequences for C/EBP alpha and HNF4 alpha and a novel synergistic regulatory mechanism whereby C/EBP alpha, HNF4 alpha, and constitutive androstane receptor bind and cooperate through proximal and distal response elements to confer a maximal level of expression. The results obtained from human liver also suggest that important differences in the expression and binding of C/EBP alpha and HNF4 alpha could account for the large interindividual variability of the hepatic CYP2B6 enzyme, which metabolizes commonly used drugs.	[Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro] Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, Valencia 46009, Spain; [Benet, Marta; Lahoz, Agustin; Guzman, Carla; Castell, Jose V.; Jover, Ramiro] Hosp Univ La Fe, CIBERehd, Valencia 46009, Spain; [Castell, Jose V.; Jover, Ramiro] Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, Valencia 46010, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari i Politecnic La Fe; University of Valencia	Jover, R (corresponding author), Hosp La Fe, Ctr Invest, Unidad Hepatol Expt, Ave Campanar 21, E-46009 Valencia, Spain.	ramiro.jover@uv.es	Lahoz, Agustin/B-8048-2014; Jover, Ramiro/O-9796-2017; Benet, Marta/H-4168-2017; Castell, Jose V/I-9529-2016	Lahoz, Agustin/0000-0001-7232-0626; Jover, Ramiro/0000-0002-4914-5804; Castell, Jose V/0000-0003-1179-6430; Benet Gimenez, Marta/0000-0002-7910-4755	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) [PI 070550]; EC [PL037712]; Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet [CP08/00125]	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) Grant PI 070550; by the EC Integrated Project, CARCINOGENOMICS, Grant PL037712; and by Spanish Ministry of Science and Innovation/Instituto de Salud Carlos III Miguel Servet Contract CP08/00125 (to A. L.).	Auerbach SS, 2007, DRUG METAB DISPOS, V35, P428, DOI 10.1124/dmd.106.012641; Bort R, 2004, ARCH BIOCHEM BIOPHYS, V426, P63, DOI 10.1016/j.abb.2004.03.032; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Castell JV, 1997, GENE THER, V4, P455, DOI 10.1038/sj.gt.3300416; Chang TKH, 2003, DRUG METAB DISPOS, V31, P7, DOI 10.1124/dmd.31.1.7; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Coller JK, 2002, BRIT J CLIN PHARMACO, V54, P157, DOI 10.1046/j.1365-2125.2002.01614.x; Court MH, 2001, ANESTHESIOLOGY, V94, P110, DOI 10.1097/00000542-200101000-00021; Desta Z, 2007, PHARMACOGENOMICS, V8, P547, DOI 10.2217/14622416.8.6.547; Duret C, 2006, MOL PHARMACOL, V70, P329, DOI 10.1124/mol.105.022046; Erickson DA, 1999, DRUG METAB DISPOS, V27, P1488; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Faucette SR, 2006, J PHARMACOL EXP THER, V317, P1200, DOI 10.1124/jpet.105.098160; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242; Hidestrand M, 2001, DRUG METAB DISPOS, V29, P1480; Hodgson E, 2007, PHARMACOL THERAPEUT, V113, P420, DOI 10.1016/j.pharmthera.2006.10.002; Honkakoski P, 2004, BIOCHEM PHARMACOL, V67, P97, DOI 10.1016/j.bcp.2003.08.037; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; Jover R, 1998, FEBS LETT, V431, P227, DOI 10.1016/S0014-5793(98)00746-7; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kobayashi K, 1999, DRUG METAB DISPOS, V27, P1429; Lahoz A, 2008, CURR DRUG METAB, V9, P12, DOI 10.2174/138920008783331112; Lahoz Agustin, 2008, Drug Metab Lett, V2, P205, DOI 10.2174/187231208785425845; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li HS, 2009, DRUG METAB DISPOS, V37, P1098, DOI 10.1124/dmd.108.026005; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Martinez E, 2002, PLANT MOL BIOL, V50, P925, DOI 10.1023/A:1021258713850; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Martinez-Jimenez CP, 2005, MOL PHARMACOL, V67, P2088, DOI 10.1124/mol.104.008169; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008; Naiki T, 2004, CELL TRANSPLANT, V13, P393, DOI 10.3727/000000004783983855; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Perez G, 2003, TOXICOL IN VITRO, V17, P643, DOI 10.1016/S0887-2333(03)00109-7; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rana R, 2010, DRUG METAB DISPOS, V38, P591, DOI 10.1124/dmd.109.030387; Rodriguez-Antona C, 2000, ARCH BIOCHEM BIOPHYS, V376, P109, DOI 10.1006/abbi.2000.1697; Rodriguez-Antona C, 2003, MOL PHARMACOL, V63, P1180, DOI 10.1124/mol.63.5.1180; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Surapureddi S, 2008, MOL PHARMACOL, V74, P913, DOI 10.1124/mol.108.048983; Svensson USH, 1999, BRIT J CLIN PHARMACO, V48, P528, DOI 10.1046/j.1365-2125.1999.00044.x; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Vyhlidal CA, 2006, DRUG METAB DISPOS, V34, P131, DOI 10.1124/dmd.105.005967; Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Yanagihara Y, 2001, DRUG METAB DISPOS, V29, P887	68	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28457	28471		10.1074/jbc.M110.118364	http://dx.doi.org/10.1074/jbc.M110.118364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622021	hybrid, Green Published			2022-12-27	WOS:000281594000009
J	Ebrahimi, S; Fraval, H; Murray, M; Saint, R; Gregory, SL				Ebrahimi, Saman; Fraval, Hamilton; Murray, Michael; Saint, Robert; Gregory, Stephen L.			Polo Kinase Interacts with RacGAP50C and Is Required to Localize the Cytokinesis Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE RING; CENTRAL SPINDLE; DROSOPHILA-MELANOGASTER; BIPOLAR SPINDLE; EXCHANGE FACTOR; MITOTIC ROLES; HUMAN-CELLS; MITOSIS; GTPASE; FAMILY	The assembly and constriction of an actomyosin contractile ring in cytokinesis is dependent on the activation of Rho at the equatorial cortex by a complex, here termed the cytokinesis initiation complex, between a microtubule-associated kinesin-like protein (KLP), a member of the RacGAP family, and the RhoGEF Pebble. Recently, the activity of the mammalian Polo kinase ortholog Plk1 has been implicated in the formation of this complex. We show here that Polo kinase interacts directly with the cytokinesis initiation complex by binding RacGAP50C. We find that a new domain of Polo kinase, termed the intermediate domain, interacts directly with RacGAP50C and that Polo kinase is essential for localization of the KLP-RacGAP centralspindlin complex to the cell equator and spindle midzone. In the absence of Polo kinase, RacGAP50C and Pav-KLP fail to localize normally, instead decorating microtubules along their length. Our results indicate that Polo kinase directly binds the conserved cytokinesis initiation complex and is required to trigger centralspindlin localization as a first step in cytokinesis.	[Ebrahimi, Saman; Gregory, Stephen L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Fraval, Hamilton; Murray, Michael; Saint, Robert] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia	University of Adelaide; University of Melbourne	Gregory, SL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	stephen.gregory@adelaide.edu.au	Gregory, Stephen L/B-9918-2008; Saint, Robert/A-4190-2008	Gregory, Stephen L/0000-0002-0046-5815; Saint, Robert/0000-0002-7989-6043; Murray, Michael/0000-0002-7427-590X	National Health and Medical Research Council of Australia; Australian Research Council; Australian National University; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian National University(Australian National University); University of Adelaide	This work was supported by funding from the National Health and Medical Research Council of Australia, the Australian Research Council, the Australian National University, and the University of Adelaide.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; D'Avino PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000572; Donaldson MM, 2001, J CELL SCI, V114, P2357; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FENTON B, 1993, NATURE, V363, P637, DOI 10.1038/363637a0; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Herrmann S, 1998, CHROMOSOMA, V107, P440, DOI 10.1007/PL00013778; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Savoian MS, 2002, J CELL SCI, V115, P3061; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	44	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28667	28673		10.1074/jbc.M110.103887	http://dx.doi.org/10.1074/jbc.M110.103887			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628062	hybrid, Green Published			2022-12-27	WOS:000281594000031
J	Hakalahti, AE; Vierimaa, MM; Lilja, MK; Kumpula, EP; Tuusa, JT; Petaja-Repo, UE				Hakalahti, Anna E.; Vierimaa, Miia M.; Lilja, Minna K.; Kumpula, Esa-Pekka; Tuusa, Jussi T.; Petaja-Repo, Ulla E.			Human beta(1)-Adrenergic Receptor Is Subject to Constitutive and Regulated N-terminal Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DELTA-OPIOID RECEPTOR; LUTEINIZING-HORMONE RECEPTOR; BETA-ADRENERGIC-RECEPTORS; V-2 VASOPRESSIN RECEPTOR; MEDIATED DOWN-REGULATION; ALPHA-CONVERTING ENZYME; ENDOPLASMIC-RETICULUM; BETA(2)-ADRENERGIC RECEPTORS; O-GLYCOSYLATION	The beta(1)-adrenergic receptor (beta(1)AR) is the predominant beta AR in the heart, mediating the catecholamine-stimulated increase in cardiac rate and force of contraction. Regulation of this important G protein-coupled receptor is nevertheless poorly understood. We describe here the biosynthetic profile of the human beta(1)AR and reveal novel features relevant to its regulation using an inducible heterologous expression system in HEK293(i) cells. Metabolic pulse-chase labeling and cell surface biotinylation assays showed that the synthesized receptors are efficiently and rapidly transported to the cell surface. The N terminus of the mature receptor is extensively modified by sialylated mucin-type O-glycosylation in addition to one N-glycan attached to Asn(15). Furthermore, the N terminus was found to be subject to limited proteolysis, resulting in two membrane-bound C-terminal fragments. N-terminal sequencing of the fragments identified two cleavage sites between Arg(31) and Leu(32) and Pro(52) and Leu(53), which were confirmed by cleavage site and truncation mutants. Metalloproteinase inhibitors were able to inhibit the cleavage, suggesting that it is mediated by a matrix metalloproteinase or a disintegrin and metalloproteinase (ADAM) family member. Most importantly, the N-terminal cleavage was found to occur not only in vitro but also in vivo. Receptor activation mediated by the beta AR agonist isoproterenol enhanced the cleavage in a concentration-and time-dependent manner, and it was also enhanced by direct stimulation of protein kinase C and adenylyl cyclase. Mutation of the Arg(31)-Leu(32) cleavage site stabilized the mature receptor. We hypothesize that the N-terminal cleavage represents a novel regulatory mechanism of cell surface beta(1)ARs.	[Hakalahti, Anna E.; Vierimaa, Miia M.; Lilja, Minna K.; Kumpula, Esa-Pekka; Tuusa, Jussi T.; Petaja-Repo, Ulla E.] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland	University of Oulu	Petaja-Repo, UE (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021	Kumpula, Esa-Pekka/0000-0003-0335-5993	Sigrid Juselius Foundation; Academy of Finland [107922, 127199]; Finnish Foundation for Cardiovascular Research; Finnish Medical Society Duodecim	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Finnish Medical Society Duodecim	This work was supported in part by the Sigrid Juselius Foundation and Grants 107922 and 127199 from the Academy of Finland.; Supported by the Finnish Foundation for Cardiovascular Research and the Finnish Medical Society Duodecim.	Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; BENOVIC JL, 1983, BIOCHEM BIOPH RES CO, V110, P504, DOI 10.1016/0006-291X(83)91178-6; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Chazenbalk GD, 2004, ENDOCRINOLOGY, V145, P4, DOI 10.1210/en.2003-1002; Couet J, 1996, J BIOL CHEM, V271, P4545; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dunigan CD, 2002, BIOCHEMISTRY-US, V41, P8019, DOI 10.1021/bi025538r; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; GREEN SA, 1994, J BIOL CHEM, V269, P26215; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jockers R, 1999, J BIOL CHEM, V274, P28900, DOI 10.1074/jbc.274.41.28900; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; JURSS R, 1985, BIOCHEMISTRY-US, V24, P3349; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Kojro E, 1999, EUR J BIOCHEM, V266, P538, DOI 10.1046/j.1432-1327.1999.00892.x; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; KOZUKA M, 1991, J BIOL CHEM, V266, P16892; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Nakagawa M, 2001, FEBS LETT, V496, P19, DOI 10.1016/S0014-5793(01)02392-4; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rousseau G, 1996, MOL PHARMACOL, V49, P752; RUTLEDGE EA, 1994, BLOOD, V83, P580; Sadeghi H, 1999, GLYCOBIOLOGY, V9, P731, DOI 10.1093/glycob/9.7.731; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; STILES GL, 1983, J BIOL CHEM, V258, P8443; SUZUKI T, 1992, MOL PHARMACOL, V41, P542; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795	59	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28850	28861		10.1074/jbc.M110.149989	http://dx.doi.org/10.1074/jbc.M110.149989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20587416	Green Published, hybrid			2022-12-27	WOS:000281594000050
J	Meng, J; Xia, WH; Tang, JH; Tang, BL; Liang, FY				Meng, Jun; Xia, Wenhao; Tang, Junhong; Tang, Bor Luen; Liang, Fengyi			Dephosphorylation-dependent Inhibitory Activity of Juxtanodin on Filamentous Actin Disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ERM PROTEINS; IN-VITRO; LATERAL ASSOCIATION; BUNDLING PROTEINS; SCHWANN-CELLS; THREONINE 558; BINDING; PHOSPHORYLATION; MYELINATION	In the vertebrate central nervous system, maturation of oligodendrocytes is accompanied by a dramatic transformation of cell morphology. Juxtanodin (JN) is an actin cytoskeleton-related oligodendroglial protein that promotes arborization of cultured oligodendrocytes. We performed in vitro and in culture experiments to further elucidate the biochemical effects, molecular interactions, and activity regulation of JN. Pulldown and co-sedimentation assays confirmed JN binding to filamentous but not globular beta-actin largely through a C-terminal domain of 14 amino acid residues. JN had much lower affinity to F-alpha-actin than to F-beta-actin. Bundling and actin polymerization assays revealed no JN influence on F-beta-actin cross-linking or G-beta-actin polymerization. Sedimentation assay, however, demonstrated that JN slowed the rate of F-beta-actin disassembly induced by dilution with F-actin depolymerization buffer. JN-S278E mutant, a mimic of phosphorylated JN at serine 278, exhibited a much diminished affinity/stabilizing effect on F-beta-actin. Immunoblotting revealed both phosphorylated and dephosphorylated native JN of the brain, with the former migrating slightly slower than the latter and becoming undetectable when brain lysate was subjected to in vitro dephosphorylation prior to being loaded for electrophoresis. In cultured OLN-93 cells, overexpression of JN promoted the formation of actin fibers and inhibited F-actin disassembly induced by latrunculin A. S278E phosphomimetic mutation resulted in loss of JN activity in cultured cells, whereas S278A, T258A, and T258E dephospho-/phosphomimetic mutations did not. These findings establish JN as an actin cytoskeleton-stabilizing protein that may play active roles in oligodendroglial differentiation and myelin formation. Specific phosphorylation of JN might serve as an important mechanism regulating JN functions.	[Meng, Jun; Xia, Wenhao; Tang, Junhong; Liang, Fengyi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Liang, FY (corresponding author), Block MD10,4 Med Dr, Singapore 117597, Singapore.		Liang, Fengyi/A-7521-2018; Tang, Bor Luen/E-4548-2012; MENG, Jun/C-8250-2012	Liang, Fengyi/0000-0003-1162-6212; Tang, Bor Luen/0000-0002-1925-636X; 	Singapore Biomedical Research Council [BMRC/04/1/21/19/305]; National Medical Research Council [0946/2005]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore Biomedical Research Council Research Grant BMRC/04/1/21/19/305 and National Medical Research Council Grant 0946/2005 (to F. L.).	ATTRI AK, 1991, J BIOL CHEM, V266, P6815; Bacon C, 2007, GLIA, V55, P844, DOI 10.1002/glia.20505; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brockschnieder D, 2006, J NEUROSCI, V26, P757, DOI 10.1523/JNEUROSCI.4317-05.2006; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; CHANG KS, 1984, MOL CELL BIOL, V4, P2498, DOI 10.1128/MCB.4.11.2498; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gallagher SR, 2001, CURR PROTOC CELL BIO; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Richter-Landsberg C, 2000, J NEUROSCI RES, V59, P11, DOI 10.1002/(SICI)1097-4547(20000101)59:1<11::AID-JNR2>3.0.CO;2-O; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; ROZYCKI M, 1991, METHOD ENZYMOL, V196, P100; Rumsby M, 2003, GLIA, V42, P118, DOI 10.1002/glia.10211; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shu HJ, 2004, MOL CELL PROTEOMICS, V3, P279, DOI 10.1074/mcp.D300003-MCP200; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Song J, 2001, MOL CELL NEUROSCI, V17, P624, DOI 10.1006/mcne.2001.0974; Tang J, 2009, NEUROSCIENCE, V161, P249, DOI 10.1016/j.neuroscience.2009.03.051; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Winder SJ, 2003, CURR OPIN CELL BIOL, V15, P14, DOI 10.1016/S0955-0674(02)00002-9; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Zhang B, 2005, P NATL ACAD SCI USA, V102, P11527, DOI 10.1073/pnas.0500952102	43	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28838	28849		10.1074/jbc.M110.117887	http://dx.doi.org/10.1074/jbc.M110.117887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20610382	hybrid, Green Published			2022-12-27	WOS:000281594000049
J	St-Andre, O; Lemieux, C; Perreault, A; Lackner, DH; Bahler, J; Bachand, F				St-Andre, Olivier; Lemieux, Caroline; Perreault, Audrey; Lackner, Daniel H.; Baehler, Juerg; Bachand, Francois			Negative Regulation of Meiotic Gene Expression by the Nuclear Poly(a)-binding Protein in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-QUALITY-CONTROL; SMALL NUCLEOLAR RNAS; MESSENGER-RNA; POLY(A) POLYMERASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL PROGRAM; CAENORHABDITIS-ELEGANS; SELECTIVE ELIMINATION; EXOSOME	Meiosis is a cellular differentiation process in which hundreds of genes are temporally induced. Because the expression of meiotic genes during mitosis is detrimental to proliferation, meiotic genes must be negatively regulated in the mitotic cell cycle. Yet, little is known about mechanisms used by mitotic cells to repress meiosis-specific genes. Here we show that the poly(A)binding protein Pab2, the fission yeast homolog of mammalian PABPN1, controls the expression of several meiotic transcripts during mitotic division. Our results from chromatin immunoprecipitation and promoter-swapping experiments indicate that Pab2 controls meiotic genes post-transcriptionally. Consistently, we show that the nuclear exosome complex cooperates with Pab2 in the negative regulation of meiotic genes. We also found that Pab2 plays a role in the RNA decay pathway orchestrated by Mmi1, a previously described factor that functions in the post-transcriptional elimination of meiotic transcripts. Our results support a model in which Mmi1 selectively targets meiotic transcripts for degradation via Pab2 and the exosome. Our findings have therefore uncovered a mode of gene regulation whereby a poly(A)-binding protein promotes RNA degradation in the nucleus to prevent untimely expression.	[Bachand, Francois] Univ Sherbrooke, Fac Med, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Lackner, Daniel H.; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Lackner, Daniel H.; Baehler, Juerg] UCL, Univ Coll London Canc Inst, London WC1E 6BT, England	University of Sherbrooke; University of London; University College London; University of London; University College London	Bachand, F (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada.	f.bachand@usherbrooke.ca	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532	Natural Sciences and Engineering Research Council of Canada; Cancer Research UK; Canadian Institutes for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cancer Research UK(Cancer Research UK); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from Natural Sciences and Engineering Research Council of Canada (to F. B.) and Cancer Research UK (to J. B.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1, Tables 1-3, and references.; Supported by a Scholarship from the Canadian Institutes for Health Research (CIHR).; Recipient of a New Investigator Award from the CIHR. To whom correspondence should be addressed: Faculte de Medecine, Universite de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada. Tel.: 819-820-6868 (ext: 12733); E-mail: f.bachand@usherbrooke.ca.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KEENEY JB, 1994, GENETICS, V136, P849; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Lemieux C, 2009, NUCLEIC ACIDS RES, V37, P3418, DOI 10.1093/nar/gkp207; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moore MJ, 2006, MOL CELL, V24, P903, DOI 10.1016/j.molcel.2006.12.006; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0	57	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27859	27868		10.1074/jbc.M110.150748	http://dx.doi.org/10.1074/jbc.M110.150748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20622014	Green Published, hybrid			2022-12-27	WOS:000281404100041
J	Stratton, RC; Squires, PE; Green, AK				Stratton, Rebecca C.; Squires, Paul E.; Green, Anne K.			17 beta-Estradiol Elevates cGMP and, via Plasma Membrane Recruitment of Protein Kinase GI alpha, Stimulates Ca2+ Efflux from Rat Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ATRIAL-NATRIURETIC-PEPTIDE; ESTROGEN-RECEPTOR-ALPHA; PARTICULATE GUANYLYL CYCLASE; NON-GENOMIC ACTIONS; ER-ALPHA; CALCIUM OSCILLATIONS; PUMP ISOFORMS; ESTRADIOL; CELLS	Rapid non-genomic effects of 17 beta-estradiol, the principal circulating estrogen, have been observed in a wide variety of cell types. Here we investigate rapid signaling effects of 17 beta-estradiol in rat hepatocytes. We show that, above a threshold concentration of 1 nM, 17 beta-estradiol, but not 17 alpha-estradiol, stimulates particulate guanylyl cyclase to elevate cGMP, which through activation and plasma membrane recruitment of protein kinase G isoform I alpha, stimulates plasma membrane Ca2+-ATPase-mediated Ca2+ efflux from rat hepatocytes. These effects are extremely rapid in onset and are mimicked by a membrane-impermeant 17 beta-estradiol-BSA conjugate, suggesting that 17 beta-estradiol acts at the extracellular face of the plasma membrane. We also show that 17 beta-estradiol binds specifically to the intact hepatocyte plasma membrane through an interaction that is competed by an excess of atrial natriuretic peptide but also shows many similarities to the pharmacological characteristics of the putative gamma-adrenergic receptor. We, therefore, propose that the observed rapid signaling effects of 17 beta-estradiol are mediated either through the guanylyl cyclase A receptor for atrial natriuretic peptide or through the gamma-adrenergic receptor, which is either itself a transmembrane guanylyl cyclase or activates a transmembrane guanylyl cyclase through cross-talk signaling.	[Stratton, Rebecca C.; Squires, Paul E.; Green, Anne K.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Green, AK (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	A.K.Green@warwick.ac.uk		Squires, Paul/0000-0003-4547-6777	University of Warwick; Biotechnology and Biological Sciences Research Council	University of Warwick; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The University of Warwick Research Development Fund and a Biotechnology and Biological Sciences Research Council-funded Ph.D. studentship (to R. C. S.).	Abou-Mohamed G, 2003, PHARMACOLOGY, V69, P20, DOI 10.1159/000071268; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BENHAM CD, 1988, J PHYSIOL-LONDON, V404, P767, DOI 10.1113/jphysiol.1988.sp017318; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bracamonte MP, 2002, AM J PHYSIOL-HEART C, V283, pH2389, DOI 10.1152/ajpheart.00184.2002; Bruges G, 2007, J RECEPT SIG TRANSD, V27, P189, DOI 10.1080/10799890701417899; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Chen ZJ, 1998, BIOCHEM BIOPH RES CO, V252, P639, DOI 10.1006/bbrc.1998.9716; Clarke R, 2001, PHARMACOL REV, V53, P25; de Vries AH, 2009, J HEPATOL, V50, pS66, DOI 10.1016/S0168-8278(09)60157-4; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Dostmann WRG, 2002, PHARMACOL THERAPEUT, V93, P203, DOI 10.1016/S0163-7258(02)00189-4; El-Mowafy AM, 2007, NUTR METAB CARDIOVAS, V17, P508, DOI 10.1016/j.numecd.2006.04.008; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Golden GA, 1998, CLIN NEUROPHARMACOL, V21, P181; Green AK, 2002, GASTROENTEROLOGY, V123, P1291, DOI 10.1053/gast.2002.35994; Green AK, 1999, CELL CALCIUM, V25, P173, DOI 10.1054/ceca.1998.0017; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; Green AK, 2007, J BIOL CHEM, V282, P34542, DOI 10.1074/jbc.M707115200; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; HIRST GDS, 1980, NATURE, V283, P767, DOI 10.1038/283767a0; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; HOWARD A, 1994, BIOCHEM J, V303, P275, DOI 10.1042/bj3030275; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Kan WH, 2008, ANN SURG, V248, P294, DOI 10.1097/SLA.0b013e318180a3db; Keung W, 2005, BRIT J PHARMACOL, V144, P71, DOI 10.1038/sj.bjp.0706018; Kim KH, 2009, IET ELECTR POWER APP, V3, P8, DOI 10.1049/iet-epa:20080030; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Leal AM, 1998, BIOCHEM PHARMACOL, V56, P1463, DOI 10.1016/S0006-2952(98)00248-2; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Marhl M, 2008, J THEOR BIOL, V252, P419, DOI 10.1016/j.jtbi.2007.11.006; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Morales A, 2005, EUR J NEUROSCI, V22, P2207, DOI 10.1111/j.1460-9568.2005.04432.x; Morales A, 2003, EUR J NEUROSCI, V18, P2505, DOI 10.1046/j.1460-9568.2003.02997.x; MURDOCH FE, 1991, MOL CELL ENDOCRINOL, V78, pC103, DOI 10.1016/0303-7207(91)90114-8; Nadal A, 2004, STEROIDS, V69, P531, DOI 10.1016/j.steroids.2004.05.010; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Nethrapalli IS, 2005, ENDOCRINOLOGY, V146, P56, DOI 10.1210/en.2004-1106; Numakawa Y, 2007, ENDOCRINOLOGY, V148, P627, DOI 10.1210/en.2006-1210; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; PIETRAS RJ, 1980, BIOCHEM J, V191, P743, DOI 10.1042/bj1910743; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; Pinkse MWH, 2009, J BIOL CHEM, V284, P16354, DOI 10.1074/jbc.M808521200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Prakash YS, 1999, AM J PHYSIOL-HEART C, V276, pH926, DOI 10.1152/ajpheart.1999.276.3.H926; Prevot V, 1999, ENDOCRINOLOGY, V140, P652, DOI 10.1210/en.140.2.652; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; Rambotti MG, 2000, HISTOCHEM J, V32, P231, DOI 10.1023/A:1004003101495; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Rho EH, 2002, J APPL PHYSIOL, V92, P257, DOI 10.1152/jappl.2002.92.1.257; Ricchi M, 2006, J GASTROEN HEPATOL, V21, P894, DOI 10.1111/j.1440-1746.2006.04144.x; Ropero AB, 2002, MOL ENDOCRINOL, V16, P497, DOI 10.1210/me.16.3.497; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Rossi AM, 2002, J CELL BIOCHEM, V87, P324, DOI 10.1002/jcb.10303; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Samadi A, 2002, PFLUG ARCH EUR J PHY, V444, P700, DOI 10.1007/s00424-002-0889-7; SanchezBueno A, 1997, CELL CALCIUM, V21, P125, DOI 10.1016/S0143-4160(97)90036-1; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Scheving LA, 1996, CANCER RES, V56, P5186; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stratton RC, 2008, BIOCHEM BIOPH RES CO, V368, P965, DOI 10.1016/j.bbrc.2008.02.030; Su J, 2005, EXP BIOL MED, V230, P242; Szemraj J, 2003, POL J PHARMACOL, V55, P887; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Walf AA, 2008, STEROIDS, V73, P997, DOI 10.1016/j.steroids.2008.01.025; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Yawo H, 1999, J NEUROSCI, V19, P5293; Yoshida Y, 1999, MOL CELL BIOCHEM, V190, P157, DOI 10.1023/A:1006991032073; Yunoki M, 2003, N-S ARCH PHARMACOL, V367, P76, DOI 10.1007/s00210-002-0667-2; Zabel U, 2002, NAT CELL BIOL, V4, P307, DOI 10.1038/ncb775; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zolle O, 2000, J BIOL CHEM, V275, P25892, DOI 10.1074/jbc.M000786200; Zylinska L, 1999, BBA-MOL CELL BIOL L, V1437, P257, DOI 10.1016/S1388-1981(99)00015-3	97	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27201	27212		10.1074/jbc.M110.103630	http://dx.doi.org/10.1074/jbc.M110.103630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566641	Green Published, hybrid			2022-12-27	WOS:000281172700051
J	Sun, TJ; Hayakawa, K; Bateman, KS; Fraser, ME				Sun, Tianjun; Hayakawa, Koto; Bateman, Katherine S.; Fraser, Marie E.			Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINYL-COA SYNTHETASE; ESCHERICHIA-COLI; PROTEIN-KINASE; CRYSTAL-STRUCTURE; COENZYME-A; ENZYME; LIVER; PHOSPHORYLATION; DIPHOSPHATE; ACTIVATION	ATP-citrate lyase (ACLY) catalyzes the conversion of citrate and CoA into acetyl-CoA and oxaloacetate, coupled with the hydrolysis of ATP. In humans, ACLY is the cytoplasmic enzyme linking energy metabolism from carbohydrates to the production of fatty acids. In situ proteolysis of full-length human ACLY gave crystals of a truncated form, revealing the conformations of residues 2-425, 487-750, and 767-820 of the 1101-amino acid protein. Residues 2-425 form three domains homologous to the beta-subunit of succinyl-CoA synthetase (SCS), while residues 487-820 form two domains homologous to the alpha-subunit of SCS. The crystals were grown in the presence of tartrate or the substrate, citrate, and the structure revealed the citrate-binding site. A loop formed by residues 343-348 interacts via specific hydrogen bonds with the hydroxyl and carboxyl groups on the prochiral center of citrate. Arg-379 forms a salt bridge with the pro-R carboxylate of citrate. The pro-S carboxylate is free to react, providing insight into the stereospecificity of ACLY. Because this is the first structure of any member of the acyl-CoA synthetase (NDP-forming) superfamily in complex with its organic acid substrate, locating the citrate-binding site is significant for understanding the catalytic mechanism of each member, including the prototype SCS. Comparison of the CoA-binding site of SCSs with the similar structure in ACLY showed that ACLY possesses a different CoA-binding site. Comparisons of the nucleotide-binding site of SCSs with the similar structure in ACLY indicates that this is the ATP-binding site of ACLY.	[Sun, Tianjun; Hayakawa, Koto; Bateman, Katherine S.; Fraser, Marie E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Fraser, ME (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	frasm@ucalgary.ca		Fraser, Marie/0000-0001-8501-1494	Canadian Institutes of Health Research (CIHR) [MOP-42446]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health; National Science Foundation; University of California; Henry Wheeler; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research; NSERC; NRC; University of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); Henry Wheeler; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC(National Research Centre (NRC)); University of Saskatchewan	The work was supported through an operating grant from the Canadian Institutes of Health Research (CIHR) (Grant MOP-42446) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). X-ray diffraction data were collected at the Canadian Macromolecular Crystallography Facility, beamline 08ID-1, of the Canadian Light Source (CLS) and at beamline 8.3.1 of the Advanced Light Source (ALS) at Lawrence Berkeley Lab, under an agreement with the Alberta Synchrotron Institute (ASI). The ALS is operated by the Dept. of Energy and supported by the National Institutes of Health. Beamline 8.3.1 was funded by the National Science Foundation, the University of California and Henry Wheeler. The ASI synchrotron access program was supported by grants from the Alberta Science and Research Authority and the Alberta Heritage Foundation for Medical Research. The CLS is supported by NSERC, NRC, CIHR, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman KS, 2002, BIOCHEMISTRY-US, V41, P14455, DOI 10.1021/bi020568f; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Clapham JC, 2007, DIABETES OBES METAB, V9, P259, DOI 10.1111/j.1463-1326.2006.00608.x; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; COTTAM GL, 1969, ARCH BIOCHEM BIOPHYS, V130, P304, DOI 10.1016/0003-9861(69)90037-X; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; ELSHOURBAGY NA, 1992, EUR J BIOCHEM, V204, P491, DOI 10.1111/j.1432-1033.1992.tb16659.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Fraser ME, 2006, J BIOL CHEM, V281, P11058, DOI 10.1074/jbc.M511785200; Fraser ME, 2000, J MOL BIOL, V299, P1325, DOI 10.1006/jmbi.2000.3807; Fraser ME, 1999, J MOL BIOL, V285, P1633, DOI 10.1006/jmbi.1998.2324; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Groot Pieter H. E., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P211, DOI 10.2174/1568013033483357; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSON KR, 1966, J AM CHEM SOC, V88, P2731, DOI 10.1021/ja00964a022; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; INOUE H, 1967, BIOCHEM BIOPH RES CO, V26, P602, DOI 10.1016/0006-291X(67)90108-8; INOUE H, 1966, J BIOCHEM, V60, P543, DOI 10.1093/oxfordjournals.jbchem.a128474; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce MA, 1999, BIOCHEMISTRY-US, V38, P7273, DOI 10.1021/bi990527s; Joyce MA, 2000, BIOCHEMISTRY-US, V39, P17, DOI 10.1021/bi991696f; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; KAUFMAN S, 1953, Fed Proc, V12, P704; Kim W, 2006, J BACTERIOL, V188, P6544, DOI 10.1128/JB.00523-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; PIERCE MW, 1981, J BIOL CHEM, V256, P8867; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; RAMAKRISHNA S, 1990, BIOCHEMISTRY-US, V29, P7617, DOI 10.1021/bi00485a011; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Sambrook J., 2001, MOL CLONING LAB MANU; SANADI DR, 1956, J BIOL CHEM, V218, P505; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; SINGH M, 1976, J BIOL CHEM, V251, P5242; SRERE PA, 1964, J BIOL CHEM, V239, P714; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Traini M, 1998, ELECTROPHORESIS, V19, P1941, DOI 10.1002/elps.1150191112; WEITZMAN PDJ, 1981, ADV MICROB PHYSIOL, V22, P185, DOI 10.1016/S0065-2911(08)60328-8; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WELLS TNC, 1991, EUR J BIOCHEM, V199, P163, DOI 10.1111/j.1432-1033.1991.tb16105.x; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883	60	65	70	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27418	27428		10.1074/jbc.M109.078667	http://dx.doi.org/10.1074/jbc.M109.078667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558738	hybrid, Green Published			2022-12-27	WOS:000281172700071
J	Fiorillo, E; Orru, V; Stanford, SM; Liu, YG; Salek, M; Rapini, N; Schenone, AD; Saccucci, P; Delogu, LG; Angelini, F; Bitti, MLM; Schmedt, C; Chan, AC; Acuto, O; Bottini, N				Fiorillo, Edoardo; Orru, Valeria; Stanford, Stephanie M.; Liu, Yingge; Salek, Mogjiborahman; Rapini, Novella; Schenone, Aaron D.; Saccucci, Patrizia; Delogu, Lucia G.; Angelini, Federica; Bitti, Maria Luisa Manca; Schmedt, Christian; Chan, Andrew C.; Acuto, Oreste; Bottini, Nunzio			Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; TERMINAL SRC KINASE; T-CELLS; PROTEIN; PHOSPHOTYROSINE; ACTIVATION; PEPTIDE; VARIANT; DOMAIN; PEP	A missense C1858T single nucleotide polymorphism in the PTPN22 gene recently emerged as a major risk factor for human autoimmunity. PTPN22 encodes the lymphoid tyrosine phosphatase (LYP), which forms a complex with the kinase Csk and is a critical negative regulator of signaling through the T cell receptor. The C1858T single nucleotide polymorphism results in the LYP-R620W variation within the LYP-Csk interaction motif. LYP-W620 exhibits a greatly reduced interaction with Csk and is a gain-of-function inhibitor of signaling. Here we show that LYP constitutively interacts with its substrate Lck in a Csk-dependent manner. T cell receptor-induced phosphorylation of LYP by Lck on an inhibitory tyrosine residue releases tonic inhibition of signaling by LYP. The R620W variation disrupts the interaction between Lck and LYP, leading to reduced phosphorylation of LYP, which ultimately contributes to gain-of-function inhibition of T cell signaling.	[Stanford, Stephanie M.; Schenone, Aaron D.; Bottini, Nunzio] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Fiorillo, Edoardo; Orru, Valeria; Stanford, Stephanie M.; Liu, Yingge; Delogu, Lucia G.; Bottini, Nunzio] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Salek, Mogjiborahman; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rapini, Novella; Angelini, Federica; Bitti, Maria Luisa Manca] Tor Vergata Univ, Dept Pediat, I-00133 Rome, Italy; [Saccucci, Patrizia] Tor Vergata Univ, Dept Biopathol, I-00133 Rome, Italy; [Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Chan, Andrew C.] Genentech Inc, Div Immunol, San Francisco, CA 94080 USA	La Jolla Institute for Immunology; University of Southern California; University of Oxford; University of Rome Tor Vergata; University of Rome Tor Vergata; Novartis; Roche Holding; Genentech	Bottini, N (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	nunzio@liai.org	Fiorillo, Edoardo/AAY-3804-2020; Valeria, Orru/AAY-3805-2020; Delogu, Lucia Gemma/AAM-9078-2020; novella, rapini/AAA-7970-2020; Ingegnoli, Francesca/B-6226-2017	Delogu, Lucia Gemma/0000-0002-2329-7260; novella, rapini/0000-0002-3104-5776; Ingegnoli, Francesca/0000-0002-6727-1273; Salek, Mogjiborahman/0000-0002-6664-4752; Orru, Valeria/0000-0002-6047-4625	National Institutes of Health [R01AI070544]; Juvenile Diabetes Research Foundation [1-2005-342]; Sardinian Regional Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Sardinian Regional Government(Regione Sardegna); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI070544 (to N. B.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2005-342. This is manuscript 1298 from the La Jolla Institute for Allergy and Immunology.; Supported by Master and Back Fellowships from the Sardinian Regional Government.; Supported by the National Institutes of Health Training Grant in Cellular, Biochemical, and Molecular Biology at the University of Southern California.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Aoki N, 2004, J BIOL CHEM, V279, P10765, DOI 10.1074/jbc.M310401200; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hill RJ, 2002, EXP HEMATOL, V30, P237, DOI 10.1016/S0301-472X(01)00794-9; KIM JS, 1993, PROTEIN SCI, V2, P348; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; Liu YG, 2009, BIOCHEMISTRY-US, V48, P7525, DOI 10.1021/bi900332f; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Mitra S, 2005, BIOORG MED CHEM LETT, V15, P5142, DOI 10.1016/j.bmcl.2005.08.054; Mitra S, 2007, ANAL BIOCHEM, V370, P249, DOI 10.1016/j.ab.2007.06.012; Nielsen C, 2007, GENES IMMUN, V8, P131, DOI 10.1038/sj.gene.6364369; Rahmouni S, 2005, MOL CELL BIOL, V25, P2227, DOI 10.1128/MCB.25.6.2227-2241.2005; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Taylor PJ, 1997, WOOL TECH SHEEP BREE, V45, P92; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200	41	74	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26506	26518		10.1074/jbc.M110.111104	http://dx.doi.org/10.1074/jbc.M110.111104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538612	Green Published, hybrid			2022-12-27	WOS:000280921000068
J	Ishii, I; Akahoshi, N; Yamada, H; Nakano, S; Izumi, T; Suematsu, M				Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori; Nakano, Shintaro; Izumi, Takashi; Suematsu, Makoto			Cystathionine gamma-Lyase-deficient Mice Require Dietary Cysteine to Protect against Acute Lethal Myopathy and Oxidative Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; BETA-SYNTHASE; ENDOTHELIAL DYSFUNCTION; HOMOCYSTEINE METABOLISM; GLUTATHIONE SYNTHESIS; TRANS-SULFURATION; ANIMAL-MODEL; METHIONINE; MOUSE; PATHWAY	Cysteine is considered a nonessential amino acid in mammals as it is synthesized from methionine via trans-sulfuration. However, premature infants or patients with hepatic failure may require dietary cysteine due to a lack of cystathionine gamma-lyase (CTH), a key trans-sulfuration enzyme. Here, we generated CTH-deficient (Cth(-/-)) mice as an animal model of cystathioninemia/cystathioninuria. Cth(-/-) mice developed normally in general but displayed hypercystathioninemia/hyperhomocysteinemia though not hypermethioninemia. When fed a low cyst(e)ine diet, Cth(-/-) mice showed acute skeletal muscle atrophy (myopathy) accompanied by enhanced gene expression of asparagine synthetase and reduced contents of glutathione in livers and skeletal muscles, and intracellular accumulation of LC3 and p62 in skeletal myofibers; they finally died of severe paralysis of the extremities. Cth(-/-) hepatocytes required cystine in a culture medium and showed greater sensitivity to oxidative stress. Cth(-/-) mice exhibited systemic vulnerability to oxidative injury, which became more prominent when they were fed the low cyst(e) ine diet. These results reveal novel roles of trans-sulfuration previously unrecognized in mice lacking another trans-sulfuration enzyme cystathionine beta-synthase (Cbs(-/-)). Because Cbs(-/-) mice display hyperhomocysteinemia and hypermethioninemia, our results raise questions against the homocysteine-based etiology of CBS deficiency and the current newborn screening for homocysteinemia using Guthrie's method, which detects hypermethioninemia.	[Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori; Nakano, Shintaro; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Gunma 3718511, Japan; [Izumi, Takashi] Gunma Univ, Grad Sch Med, Dept Biochem, Gunma 3718511, Japan	Keio University; Gunma University; Gunma University	Ishii, I (corresponding author), Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	isao-ishii@umin.ac.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Ishii, Isao/0000-0002-5367-205X	Ministry of Education, Culture, Sports, Science and Technology of Japan [18590047, 22590292, 22790219, 17GS0419]; Japan Science and Technology Agency; Gunma University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Gunma University	This work was supported by Grants-in-aid for Scientific Research 18590047 and 22590292 (to I. I.) and 22790219 (to N. A.), Leading Project for Biosimulation (to M. S.), and Creative Science Research 17GS0419 (to M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a research grant for Feasibility Study (to I. I.) from the Japan Science and Technology Agency; and research grants from Gunma University (to I. I. and N. A.)	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Akahoshi N, 2006, BIOL PHARM BULL, V29, P1799, DOI 10.1248/bpb.29.1799; AWATA S, 1984, BIOCHEM INT, V8, P171; Banta-Wright SA, 2004, J PERINAT NEONAT NUR, V18, P41, DOI 10.1097/00005237-200401000-00005; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; BITTLES AH, 1974, J MED GENET, V11, P121, DOI 10.1136/jmg.11.2.121; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; FERRER JV, 1990, BIOCHEM J, V269, P531, DOI 10.1042/bj2690531; FINKELST.JD, 1966, P NATL ACAD SCI USA, V55, P865, DOI 10.1073/pnas.55.4.865; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; FRIMPTER GW, 1963, NEW ENGL J MED, V268, P333, DOI 10.1056/NEJM196302142680701; Gan-Schreier H, 2010, J PEDIATR-US, V156, P427, DOI 10.1016/j.jpeds.2009.09.054; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HARRIS H, 1959, ANN HUM GENET, V23, P442, DOI 10.1111/j.1469-1809.1959.tb01485.x; HARVEY, 2003, MOL GENET METAB, V79, P6; Herrmann Wolfgang, 2002, Clin Lab, V48, P471; Ichinohe A, 2005, BIOCHEM BIOPH RES CO, V338, P1547, DOI 10.1016/j.bbrc.2005.10.118; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kaye CI, 2006, PEDIATRICS, V118, pE934, DOI 10.1542/peds.2006-1782; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraus JP, 2009, MOL GENET METAB, V97, P250, DOI 10.1016/j.ymgme.2009.04.001; LAIDLAW SA, 1987, AM J CLIN NUTR, V46, P593, DOI 10.1093/ajcn/46.4.593; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsuyama N, 2001, CLIN CHEM, V47, P2155; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mudd S., 2001, METABOLIC MOL BASES, P2007; Mudd SH, 2000, ARTERIOSCL THROM VAS, V20, P1704, DOI 10.1161/01.ATV.20.7.1704; Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X; Nambu M, 1996, LIVER, V16, P19; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Naughten ER, 1998, EUR J PEDIATR, V157, pS84, DOI 10.1007/PL00014310; PERRY TL, 1968, NEW ENGL J MED, V278, P590, DOI 10.1056/NEJM196803142781104; Peterschmitt MJ, 1999, NEW ENGL J MED, V341, P1572, DOI 10.1056/NEJM199911183412103; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sastre J, 2005, FREE RADICAL BIO MED, V38, P575, DOI 10.1016/j.freeradbiomed.2004.11.029; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Stabler SP, 2002, METABOLISM, V51, P981, DOI 10.1053/meta.2002.34017; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Triguero A, 1997, BRIT J NUTR, V78, P823, DOI 10.1079/BJN19970198; Troen AM, 2003, P NATL ACAD SCI USA, V100, P15089, DOI 10.1073/pnas.2436385100; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vargas JE, 1999, AM J OBSTET GYNECOL, V181, P753, DOI 10.1016/S0002-9378(99)70525-9; VINA J, 1995, AM J CLIN NUTR, V61, P1067, DOI 10.1093/ajcn/61.5.1067; VINA J, 1992, BRIT J NUTR, V68, P421, DOI 10.1079/BJN19920099; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	62	176	183	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26358	26368		10.1074/jbc.M110.147439	http://dx.doi.org/10.1074/jbc.M110.147439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566639	Green Published, hybrid			2022-12-27	WOS:000280921000054
J	McMichael, BK; Meyer, SM; Lee, BS				McMichael, Brooke K.; Meyer, Stephanie M.; Lee, Beth S.			c-Src-mediated Phosphorylation of Thyroid Hormone Receptor-interacting Protein 6 (TRIP6) Promotes Osteoclast Sealing Zone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM DOMAIN PROTEINS; VACUOLAR H+-ATPASE; LYSOPHOSPHATIDIC ACID; BONE; PODOSOMES; EXPRESSION; OSTEOPETROSIS; LOCALIZATION; ORGANIZATION; P130(CAS)	Osteoclasts resorb bone through the formation of a unique attachment structure called the sealing zone. In this study, a role for thyroid hormone receptor-interacting protein 6 (TRIP6) in sealing zone formation and osteoclast activity was examined. TRIP6 was shown to reside in the sealing zone through its association with tropomyosin 4, an actin-binding protein that regulates sealing dimensions and bone resorptive capacity. Suppression of TRIP6 in mature osteoclasts by RNA interference altered sealing zone dimensions and inhibited bone resorption, whereas overexpression of TRIP6 increased the sealing zone perimeter and enhanced bone resorption. Treatment of osteoclasts with lysophosphatidic acid (LPA), which phosphorylates TRIP6 at tyrosine 55 through a c-Src-dependent mechanism, caused increased association of TRIP6 with the sealing zone, as did overexpression of a TRIP6 cDNA bearing a phosphomimetic mutation at tyrosine 55. Further, LPA treatment caused increases in osteoclast fusion, sealing zone perimeter, and bone resorptive capacity. In contrast, overexpression of TRIP6 containing a nonphosphorylatable amino acid residue at position 55 severely diminished sealing zone formation and bone resorption and suppressed the effects of LPA on the cytoskeleton. LPA effects were mediated through its receptor isoform LPA(2), as indicated by treatments with receptor-specific agonists and antagonists. Thus, these studies suggest that TRIP6 is a critical downstream regulator of c-Src signaling and that its phosphorylation is permissive for its presence in the sealing zone where it plays a positive role in osteoclast bone resorptive capacity.	[McMichael, Brooke K.; Meyer, Stephanie M.; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	Campus Microscopy and Imaging Facility at the Ohio State University	Campus Microscopy and Imaging Facility at the Ohio State University	We thank the Campus Microscopy and Imaging Facility at the Ohio State University for continued technical advice and support.	Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hurst-Kennedy J, 2009, BBA-MOL CELL RES, V1793, P836, DOI 10.1016/j.bbamcr.2009.01.020; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Zhao MK, 1999, GENE EXPRESSION, V8, P207; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	41	19	21	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26641	26651		10.1074/jbc.M110.119909	http://dx.doi.org/10.1074/jbc.M110.119909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547766	Green Published, hybrid			2022-12-27	WOS:000280921000079
J	Wetzelberger, K; Baba, SP; Thirunavukkarasu, M; Ho, YS; Maulik, N; Barski, OA; Conklin, DJ; Bhatnagar, A				Wetzelberger, Karin; Baba, Shahid P.; Thirunavukkarasu, Mahesh; Ho, Ye-Shih; Maulik, Nilanjana; Barski, Oleg A.; Conklin, Daniel J.; Bhatnagar, Aruni			Postischemic Deactivation of Cardiac Aldose Reductase ROLE OF GLUTATHIONE S-TRANSFERASE P AND GLUTAREDOXIN IN REGENERATION OF REDUCED THIOLS FROM SULFENIC ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; REDOX REGULATION; SULFENIC ACID; STUNNED MYOCARDIUM; LIPID-PEROXIDATION; NITRIC-OXIDE	Aldose reductase (AR) is a multifunctional enzyme that catalyzes the reduction of glucose and lipid peroxidation-derived aldehydes. During myocardial ischemia, the activity of AR is increased due to the oxidation of its cysteine residues to sulfenic acids. It is not known, however, whether the activated, sulfenic form of the protein (AR-SOH) is converted back to its reduced, unactivated state (AR-SH). We report here that in perfused mouse hearts activation of AR during 15 min of global ischemia is completely reversed by 30 min of reperfusion. During reperfusion, AR-SOH was converted to a mixed disulfide (AR-SSG). Deactivation of AR and the appearance of AR-SSG during reperfusion were delayed in hearts of mice lacking glutathione S-transferase P (GSTP). In vitro, GSTP accelerated glutathiolation and inactivation of AR-SOH. Reduction of AR-SSG to AR-SH was facilitated by glutaredoxin (GRX). Ischemic activation of AR was increased in GRX-null hearts but was attenuated in the hearts of cardiospecific GRX transgenic mice. Incubation of AR-SSG with GRX led to the regeneration of the reduced form of the enzyme. In ischemic cardiospecific AR transgenic hearts, AR was co-immunoprecipitated with GSTP, whereas in reperfused hearts, the association of AR with GRX was increased. These findings suggest that upon reperfusion of the ischemic heart AR-SOH is converted to AR-SSG via GSTP-assisted glutathiolation. AR-SSG is then reduced by GRX to AR-SH. Sequential catalysis by GSTP and GRX may be a general redox switching mechanism that regulates the reduction of protein sulfenic acids to cysteines.	[Conklin, Daniel J.; Bhatnagar, Aruni] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Thirunavukkarasu, Mahesh; Maulik, Nilanjana] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA; [Ho, Ye-Shih] Wayne State Univ, Coll Pharm & Hlth Sci, Detroit, MI 48201 USA	University of Louisville; University of Connecticut; Wayne State University	Bhatnagar, A (corresponding author), Univ Louisville, Diabet & Obes Ctr, 580 S Preston St,Delia Baxter Bldg,Rm 421, Louisville, KY 40202 USA.	aruni@lousiville.edu			National Institutes of Health [HL55477, HL59378, HL78825, HL89380, HL893802S1, RR024489]; America Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825, R01HL089380, R01HL055477, R01HL059378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); America Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55477, HL59378, HL78825, HL89380, HL893802S1, and RR024489. This work was also supported by a postdoctoral fellowship from the America Heart Association (to K.W.).	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Ananthakrishnan R, 2009, AM J PHYSIOL-HEART C, V296, pH333, DOI 10.1152/ajpheart.01012.2008; Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200; Awasthi Y. C., 2007, TOXICOLOGY GLUTATHIO; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; BHATNAGAR A, 1990, BIOCHEM PHARMACOL, V39, P1115, DOI 10.1016/0006-2952(90)90292-S; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BOLLI R, 1995, J CLIN INVEST, V96, P1066, DOI 10.1172/JCI118093; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; Bolli R, 1998, PROG CARDIOVASC DIS, V40, P477, DOI 10.1016/S0033-0620(98)80001-7; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Conklin DJ, 2009, AM J PHYSIOL-HEART C, V296, pH1586, DOI 10.1152/ajpheart.00867.2008; Conklin DJ, 2008, CIRCULATION, V118, pS546; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; Hill BG, 2009, BIOCHEM J, V417, P513, DOI 10.1042/BJ20081615; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Kaiserova K, 2008, J BIOL CHEM, V283, P9101, DOI 10.1074/jbc.M709671200; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Keith RJ, 2009, CHEM-BIOL INTERACT, V178, P242, DOI 10.1016/j.cbi.2008.10.055; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; LI XY, 1993, J CLIN INVEST, V92, P1025, DOI 10.1172/JCI116608; Malik G, 2008, J MOL CELL CARDIOL, V44, P261, DOI 10.1016/j.yjmcc.2007.08.022; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Spite M, 2007, BIOCHEM J, V405, P95, DOI 10.1042/BJ20061743; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; TORTOLANI AJ, 1993, FREE RADICAL BIO MED, V14, P421, DOI 10.1016/0891-5849(93)90091-8; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; West MB, 2008, CIRCULATION, V118, P1970, DOI 10.1161/CIRCULATIONAHA.108.791533; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797	52	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26135	26148		10.1074/jbc.M110.146423	http://dx.doi.org/10.1074/jbc.M110.146423			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538586	Green Published, hybrid			2022-12-27	WOS:000280921000031
J	Lapierre, DM; Tanabe, N; Pereverzev, A; Spencer, M; Shugg, RPP; Dixon, SJ; Sims, SM				Lapierre, Danielle M.; Tanabe, Natsuko; Pereverzev, Alexey; Spencer, Martha; Shugg, Ryan P. P.; Dixon, S. Jeffrey; Sims, Stephen M.			Lysophosphatidic Acid Signals through Multiple Receptors in Osteoclasts to Elevate Cytosolic Calcium Concentration, Evoke Retraction, and Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; NF-KAPPA-B; PROTEIN-KINASE-C; EXPRESSION; RHO; CALCITONIN; INFLAMMATION; PATHOGENESIS; REQUIREMENT; OSTEOBLASTS	Lysophosphatidic acid (LPA) is a bioactive phospholipid whose functions are mediated by multiple G protein-coupled receptors. We have shown that osteoblasts produce LPA, raising the possibility that it mediates intercellular signaling among osteoblasts and osteoclasts. Here we investigated the expression, signaling and function of LPA receptors in osteoclasts. Focal application of LPA elicited transient increases in cytosolic calcium concentration ([Ca2+](i)), with 50% of osteoclasts responding at similar to 400 nM LPA. LPA-induced elevation of [Ca2+](i) was blocked by pertussis toxin or the LPA(1/3) receptor antagonist VPC-32183. LPA caused sustained retraction of osteoclast lamellipodia and disrupted peripheral actin belts. Retraction was insensitive to VPC-32183 or pertussis toxin, indicating involvement of a distinct signaling pathway. In this regard, inhibition of Rho-associated kinase stimulated respreading after LPA-induced retraction. Real-time reverse transcription-PCR revealed transcripts encoding LPA(1) and to a lesser extent LPA(2), LPA(4), and LPA(5) receptor subtypes. LPA induced nuclear translocation of NFATc1 and enhanced osteoclast survival, effects that were blocked by VPC-32183 or by a specific peptide inhibitor of NFAT activation. LPA slightly reduced the resorptive activity of osteoclasts in vitro. Thus, LPA binds to at least two receptor subtypes on osteoclasts: LPA(1), which couples through G(i/o) to elevate [Ca2+](i), activate NFATc1, and promote survival, and a second receptor that likely couples through G(12/13) and Rho to evoke and maintain retraction through reorganization of the actin cytoskeleton. These findings reveal a signaling axis in bone through which LPA, produced by osteoblasts, acts on multiple receptor subtypes to induce pleiotropic effects on osteoclast activity and function.	[Lapierre, Danielle M.; Tanabe, Natsuko; Pereverzev, Alexey; Spencer, Martha; Shugg, Ryan P. P.; Dixon, S. Jeffrey; Sims, Stephen M.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 1018310, Japan	Western University (University of Western Ontario); Nihon University	Sims, SM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	stephen.sims@schulich.uwo.ca	Sims, Stephen/G-4510-2013; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research; Nihon University School of Dentistry, Tokyo, Japan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nihon University School of Dentistry, Tokyo, Japan	This study was supported by the Canadian Institutes of Health Research.; Supported by the Sato Fund, Nihon University School of Dentistry, Tokyo, Japan.	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boyce BF, 1999, LAB INVEST, V79, P83; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; GRAVEL MR, 1994, J BONE MINER RES, V9, P1769; Grey A, 2001, ENDOCRINOLOGY, V142, P1098, DOI 10.1210/en.142.3.1098; Heasley BH, 2004, BIOORG MED CHEM LETT, V14, P2735, DOI 10.1016/j.bmcl.2004.03.076; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Hosogaya S, 2008, ANN CLIN BIOCHEM, V45, P364, DOI 10.1258/acb.2008.007242; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Korcok J, 2005, J BIOL CHEM, V280, P16909, DOI 10.1074/jbc.M410764200; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Masiello LM, 2006, BONE, V39, P72, DOI 10.1016/j.bone.2005.12.013; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ory S, 2000, J CELL SCI, V113, P1177; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Panupinthu N, 2007, J BIOL CHEM, V282, P3403, DOI 10.1074/jbc.M605620200; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Sugimoto N, 2006, EXP CELL RES, V312, P1899, DOI 10.1016/j.yexcr.2006.02.020; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Weidema AF, 1997, J PHYSIOL-LONDON, V503, P303, DOI 10.1111/j.1469-7793.1997.303bh.x; Weidema AF, 2001, AM J PHYSIOL-CELL PH, V280, pC1531, DOI 10.1152/ajpcell.2001.280.6.C1531; WOOD DA, 1991, J BIOL CHEM, V266, P15369; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; ZHENG ZG, 1993, AM J PHYSIOL, V264, pE74, DOI 10.1152/ajpendo.1993.264.1.E74; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	48	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25792	25801		10.1074/jbc.M110.109322	http://dx.doi.org/10.1074/jbc.M110.109322			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20551326	Green Published, hybrid			2022-12-27	WOS:000280682400071
J	Wentz, AE; d'Avignon, DA; Weber, ML; Cotter, DG; Doherty, JM; Kerns, R; Nagarajan, R; Reddy, N; Sambandam, N; Crawford, PA				Wentz, Anna E.; d'Avignon, D. Andre; Weber, Mary L.; Cotter, David G.; Doherty, Jason M.; Kerns, Robnet; Nagarajan, Rakesh; Reddy, Naveen; Sambandam, Nandakumar; Crawford, Peter A.			Adaptation of Myocardial Substrate Metabolism to a Ketogenic Nutrient Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETONE-BODY METABOLISM; FATTY-ACID OXIDATION; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL COENZYME; SUCCINYL-COA-3-OXOACID COA-TRANSFERASE; HEARTS OXIDIZING ACETOACETATE; PPAR-ALPHA; RAT HEARTS; PYRUVATE CARBOXYLATION; CONTRACTILE FUNCTION; FASTING RESPONSE	Heart muscle is metabolically versatile, converting energy stored in fatty acids, glucose, lactate, amino acids, and ketone bodies. Here, we use mouse models in ketotic nutritional states (24 h of fasting and a very low carbohydrate ketogenic diet) to demonstrate that heart muscle engages a metabolic response that limits ketone body utilization. Pathway reconstruction from microarray data sets, gene expression analysis, protein immunoblotting, and immunohistochemical analysis of myocardial tissue from nutritionally modified mouse models reveal that ketotic states promote transcriptional suppression of the key ketolytic enzyme, succinyl-CoA:3-oxoacid CoA transferase (SCOT; encoded by Oxct1), as well as peroxisome proliferator-activated receptor alpha-dependent induction of the key ketogenic enzyme HMGCS2. Consistent with reduction of SCOT, NMR profiling demonstrates that maintenance on a ketogenic diet causes a 25% reduction of myocardial C-13 enrichment of glutamate when C-13-labeled ketone bodies are delivered in vivo or ex vivo, indicating reduced procession of ketones through oxidative metabolism. Accordingly, unmetabolized substrate concentrations are higher within the hearts of ketogenic diet-fed mice challenged with ketones compared with those of chow-fed controls. Furthermore, reduced ketone body oxidation correlates with failure of ketone bodies to inhibit fatty acid oxidation. These results indicate that ketotic nutrient environments engage mechanisms that curtail ketolytic capacity, controlling the utilization of ketone bodies in ketotic states.	[Sambandam, Nandakumar; Crawford, Peter A.] Washington Univ, Dept Med, St Louis, MO 63108 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, St Louis, MO 63108 USA; [Kerns, Robnet; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), 660 S Euclid Ave,Box 8086, St Louis, MO 63108 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426; Wentz, Anna/0000-0002-3585-8379	National Institutes of Health [DK073282, DK020579]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073282, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073282 and DK020579.	Abel ED, 2004, FRONT BIOSCI-LANDMRK, V9, P201, DOI 10.2741/1216; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; AVOGARO A, 1990, AM J PHYSIOL, V258, pE606, DOI 10.1152/ajpendo.1990.258.4.E606; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bergman BC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1103, DOI 10.1152/ajpendo.00613.2006; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Comte B, 1997, J BIOL CHEM, V272, P26125, DOI 10.1074/jbc.272.42.26125; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FINK G, 1988, J BIOL CHEM, V263, P18036; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; GE Y, 2003, SOCIEDAD ESTADISTICA, V12, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRINBLAT L, 1986, BIOCHEM J, V240, P49, DOI 10.1042/bj2400049; Hasselbaink DM, 2003, BIOCHEM J, V371, P753, DOI 10.1042/BJ20021617; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; JEFFREY FMH, 1995, BASIC RES CARDIOL, V90, P388, DOI 10.1007/BF00788500; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Leong HS, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp310; Lopaschuk GD, 2006, SEMIN CARDIOTHORAC V, V10, P228, DOI 10.1177/1089253206291150; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Marcondes S, 2001, P NATL ACAD SCI USA, V98, P7146, DOI 10.1073/pnas.141222598; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Oakes ND, 2006, AM J PHYSIOL-ENDOC M, V290, pE870, DOI 10.1152/ajpendo.00233.2005; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; QUANT PA, 1989, BIOCHEM SOC T, V17, P1089, DOI 10.1042/bst0171089; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; RUSSELL RR, 1991, J CLIN INVEST, V87, P384, DOI 10.1172/JCI115008; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; RUSSELL RR, 1992, J CLIN INVEST, V89, P968, DOI 10.1172/JCI115679; RUSSELL RR, 1995, AM J PHYSIOL-HEART C, V268, pH441, DOI 10.1152/ajpheart.1995.268.1.H441; Schneider JG, 2005, CELL METAB, V2, P341, DOI 10.1016/j.cmet.2005.11.006; Serra D, 1996, J BIOL CHEM, V271, P7529, DOI 10.1074/jbc.271.13.7529; Soeters MR, 2009, OBESITY, V17, P1326, DOI 10.1038/oby.2008.678; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2003, AM J PHYSIOL-HEART C, V285, pH1626, DOI 10.1152/ajpheart.00332.2003; Stowe KA, 2006, FEBS LETT, V580, P4282, DOI 10.1016/j.febslet.2006.06.068; SULTAN AMN, 1992, MOL CELL BIOCHEM, V110, P17, DOI 10.1007/BF02385001; Suzuki J, 2002, AM J PHYSIOL-ENDOC M, V283, pE94, DOI 10.1152/ajpendo.00017.2002; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; TORAASON M, 1989, TOXICOLOGY, V56, P107, DOI 10.1016/0300-483X(89)90216-3; Turko IV, 2001, AM J PHYSIOL-HEART C, V281, pH2289, DOI 10.1152/ajpheart.2001.281.6.H2289; van der Laan MJ, 2006, STAT APPL GENET MOL, V5; VANOVERSCHELDE JLJ, 1993, AM J PHYSIOL, V264, pH701, DOI 10.1152/ajpheart.1993.264.3.H701; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vice E, 2005, METABOLISM, V54, P1542, DOI 10.1016/j.metabol.2005.05.023; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	66	84	85	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24447	24456		10.1074/jbc.M110.100651	http://dx.doi.org/10.1074/jbc.M110.100651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529848	Green Published, hybrid			2022-12-27	WOS:000280542100017
J	Someya, A; Moss, J; Nagaoka, I				Someya, Akimasa; Moss, Joel; Nagaoka, Isao			The Guanine Nucleotide Exchange Protein for ADP-ribosylation Factor 6, ARF-GEP100/BRAG2, Regulates Phagocytosis of Monocytic Phagocytes in an ARF6-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; ARF6 ACTIVATION; PHOSPHOLIPASE-D; CELL-ADHESION; GROWTH-FACTOR; MACROPHAGES; COMPONENTS; EFFECTOR	Phagocytosis is a complex multistep process requiring diverse signaling and regulatory molecules. ADP-ribosylation factor 6 (ARF6), a small GTPase, is known to regulate membrane trafficking and the actin cytoskeketon at the plasma membrane and functions as a regulatory molecule of phagocytosis. ARF activity is regulated by cycling between GDP-bound and GTP-bound forms. ARF activation is catalyzed by guanine nucleotide exchange factors (GEFs) that facilitate GTP binding. We had earlier reported a 100-kDa ARF-GEF, termed ARF-guanine nucleotide exchange protein 100, GEP100, that preferentially activates ARF6 and was also described by Dunphy et al. (Dunphy, J. L., Moravec, R., Ly, K., Lasell, T. K., Melancon, P., and Casanova, J. E. (2006) Curr. Biol. 16, 315-320) as brefeldin A-resistant ARF-GEF2 (BRAG2). We have now examined a role for GEP100 in phagocytosis. Stable depletion of GEP100 decreased phagocytosis of serum-treated zymosan and IgG-coated latex beads by human monocyte-macrophage-like U937 cells differentiated with phorbol 12-myristate 13-acetate. Decrease of phagocytic activity by RNAi was not rescued by GEP100 Delta Sec7, a deletion mutant lacking the ARF-activating domain. GEP100-depleted cells also exhibited reduced F-actin fibers around internalized particles. Attachment of these particles to cells and amounts of C3bi and Fc gamma receptors, however, were not affected by GEP100 depletion. On immunofluorescence microscopy, GEP100 and ARF6 were concentrated and partially colocalized around internalized particles. Phagocytosis by GEP100-depleted cells was not further affected by depletion of ARF6. Phagocytic activity of GEP100-depleted cells was, however, rescued by expression of the constitutively active ARF6Q67N mutant but not by the dominant-negative ARF6T27N mutant. These data are consistent with the conclusion that GEP100 functions in phago-cytosis via its role in ARF6-dependent actin remodeling.	[Someya, Akimasa] Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, Tokyo 1138421, Japan; [Moss, Joel] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	Juntendo University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Someya, A (corresponding author), Juntendo Univ, Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	someya@juntendo.ac.jp			National Institutes of Health, NHLBI; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by the Intramural Research Program, National Institutes of Health, NHLBI. This work was also supported by the "High-Tech Research Center" Project for Private Universities (a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Braun V, 2007, MOL BIOL CELL, V18, P4921, DOI 10.1091/mbc.E07-04-0392; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Criss AK, 2001, J BIOL CHEM, V276, P48431, DOI 10.1074/jbc.M106969200; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dana RR, 2000, J BIOL CHEM, V275, P32566, DOI 10.1074/jbc.M005406200; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2007, TRAFFIC, V8, P661, DOI 10.1111/j.1600-0854.2007.00561.x; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; May RC, 2001, J CELL SCI, V114, P1061; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; NAGAOKA I, 1981, BIOCHIM BIOPHYS ACTA, V678, P342, DOI 10.1016/0304-4165(81)90113-6; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Schafer DA, 2000, TRAFFIC, V1, P892; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2006, J LEUKOCYTE BIOL, V80, P915, DOI 10.1189/jlb.0106059; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Uchida H, 2001, J EXP MED, V193, P955, DOI 10.1084/jem.193.8.955; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Yomogida S, 1996, INFLAMM RES, V45, P62, DOI 10.1007/BF02265117; Zhang Q, 1999, MOL CELL BIOL, V19, P8158; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	48	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30698	30707		10.1074/jbc.M110.107458	http://dx.doi.org/10.1074/jbc.M110.107458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20601426	hybrid, Green Published			2022-12-27	WOS:000282135500038
J	Hinz, AK; Wang, Y; Smerdon, MJ				Hinz, Angela K.; Wang, Yan; Smerdon, Michael J.			Base Excision Repair in a Glucocorticoid Response Element EFFECT OF GLUCOCORTICOID RECEPTOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; TRANSCRIPTION FACTOR IIIA; MAMMARY-TUMOR VIRUS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; LIGASE I; SEQUENCE; PROTEIN; COMPLEX; PROMOTER	DNA repair takes place in the context of chromatin. Previous studies showed that histones impair base excision repair (BER) of modified bases at both the excision and synthesis steps. We examined BER of uracil in a glucocorticoid response element (GRE) complexed with the glucocorticoid receptor DNA binding domain (GR-DBD). Five substrates were designed, each containing a unique C -> U substitution within the mouse mammary tumor virus promoter, one located within each GRE half-site and the others located outside the GRE. To examine distinct steps of BER, DNA cleavage by uracil-DNA glycosylase and Ape1 endonuclease was used to assess initiation, dCTP incorporation by DNA polymerase (pol) beta was used to measure repair synthesis, and DNA ligase I was used to seal the nick. For uracil sites within the GRE, there was a reduced rate of uracil-DNA glycosylase/Ape1 activity following GR-DBD binding. Cleavage in the right half-site, with higher GR-DBD binding affinity, was reduced similar to 5-fold, whereas cleavage in the left half-site was reduced similar to 3.8-fold. Conversely, uracil-directed cleavage outside the GRE was unaffected by GR-DBD binding. Surprisingly, there was no reduction in the rate of pol beta synthesis or DNA ligase activity on any of the fragments bound to GR-DBD. Indeed, we observed a small increase (similar to 1.5-2.2-fold) in the rate of pol beta synthesis at uracil residues in both the GRE and one site six nucleotides downstream. These results highlight the potential for both positive and negative impacts of DNA-transcription factor binding on the rate of BER.	[Hinz, Angela K.; Wang, Yan; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			NIEHS [ES004106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS.	Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bishop TC, 1996, PROTEINS, V24, P115; BUETTI E, 1986, J MOL BIOL, V190, P379, DOI 10.1016/0022-2836(86)90009-4; CAIRNS W, 1991, J BIOL CHEM, V266, P11221; CLEMENS KR, 1994, J MOL BIOL, V244, P23, DOI 10.1006/jmbi.1994.1701; Conconi A, 1999, EMBO J, V18, P1387, DOI 10.1093/emboj/18.5.1387; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; DAHLMANWRIGHT K, 1992, J STEROID BIOCHEM, V41, P249, DOI 10.1016/0960-0760(92)90351-I; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dimitriadis EK, 1998, J BIOL CHEM, V273, P20540, DOI 10.1074/jbc.273.32.20540; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; Hanawalt PC, 2007, MOL CELL, V28, P702, DOI 10.1016/j.molcel.2007.11.014; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HARRIS LF, 1994, J BIOMOL STRUCT DYN, V12, P249, DOI 10.1080/07391102.1994.10508740; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kwon Y, 2005, MUTAT RES-FUND MOL M, V577, P118, DOI 10.1016/j.mrfmmm.2005.02.013; Kwon YH, 2003, J BIOL CHEM, V278, P45451, DOI 10.1074/jbc.M308645200; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; VERRI A, 1990, NUCLEIC ACIDS RES, V18, P5775, DOI 10.1093/nar/18.19.5775; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176	35	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28683	28690		10.1074/jbc.M110.113530	http://dx.doi.org/10.1074/jbc.M110.113530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628060	hybrid, Green Published			2022-12-27	WOS:000281594000033
J	Vempati, RK; Jayani, RS; Notani, D; Sengupta, A; Galande, S; Haldar, D				Vempati, Rahul K.; Jayani, Ranveer S.; Notani, Dimple; Sengupta, Amrita; Galande, Sanjeev; Haldar, Devyani			p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; H3K56 ACETYLATION; CELL-CYCLE; CHROMATIN DYNAMICS; H3-K56 ACETYLATION; REPLICATION; REPAIR; DEACETYLASE; ACETYLTRANSFERASE; STABILITY	The packaging of newly replicated and repaired DNA into chromatin is crucial for the maintenance of genomic integrity. Acetylation of histone H3 core domain lysine 56 (H3K56ac) has been shown to play a crucial role in compaction of DNA into chromatin following replication and repair in Saccharomyces cerevisiae. However, the occurrence and function of such acetylation has not been reported in mammals. Here we show that H3K56 is acetylated and that this modification is regulated in a cell cycle-dependent manner in mammalian cells. We also demonstrate that the histone acetyltransferase p300 acetylates H3K56 in vitro and in vivo, whereas hSIRT2 and hSIRT3 deacetylate H3K56ac in vivo. Further we show that following DNA damage H3K56 acetylation levels increased, and acetylated H3K56, which is localized at the sites of DNA repair. It also colocalized with other proteins involved in DNA damage signaling pathways such as phospho-ATM, CHK2, and p53. Interestingly, analysis of occurrence of H3K56 acetylation using ChIP-on-chip revealed its genome-wide spread, affecting genes involved in several pathways that are implicated in tumorigenesis such as cell cycle, DNA damage response, DNA repair, and apoptosis.	[Haldar, Devyani] Inst Life Sci, Dept Biol, Hyderabad 500046, Andhra Pradesh, India; [Jayani, Ranveer S.; Notani, Dimple; Galande, Sanjeev] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Galande, Sanjeev] Indian Inst Sci Educ & Res, Pune 411021, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Science Education & Research (IISER) Pune	Haldar, D (corresponding author), Inst Life Sci, Dept Biol, Univ Hyderabad Campus, Hyderabad 500046, Andhra Pradesh, India.	devyanih@ilsresearch.org	Jayani, Ranveer/O-1939-2016	Jayani, Ranveer/0000-0002-7646-0711; Notani, Dimple/0000-0002-9460-8070	Institute of Life Sciences; Department of Biotechnology of the Government of India; Wellcome Trust	Institute of Life Sciences; Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Institute of Life Sciences (to D. H.) and grants from the Department of Biotechnology of the Government of India and the Wellcome Trust (to S. G.).	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Miller KM, 2006, CELL CYCLE, V5, P2561, DOI 10.4161/cc.5.22.3501; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Purbey PK, 2006, NAT PROTOC, V1, P1820, DOI 10.1038/nprot.2006.310; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin JS, 2008, INT J ONCOL, V32, P435; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	44	119	128	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28553	28564		10.1074/jbc.M110.149393	http://dx.doi.org/10.1074/jbc.M110.149393			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20587414	Green Published, hybrid			2022-12-27	WOS:000281594000019
J	Dangi-Garimella, S; Redig, AJ; Shields, MA; Siddiqui, MA; Munshi, HG				Dangi-Garimella, Surabhi; Redig, Amanda J.; Shields, Mario A.; Siddiqui, Mohammed A.; Munshi, Hidayatullah G.			Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL BODY-WALL; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; TERMINAL DIFFERENTIATION; CALCIUM REGULATION; TISSUE INHIBITOR; CARCINOMA-CELLS; CANCER INVASION; TUMOR-GROWTH; EXPRESSION	Membrane type 1-matrix metalloproteinase (MT1-MMP, MMP14), which is associated with extracellular matrix (ECM) breakdown in squamous cell carcinoma (SCC), promotes tumor formation and epithelial-mesenchymal transition. However, in this report we demonstrate that MT1-MMP, by cleaving the underlying ECM, causes cellular aggregation of keratinocytes and SCC cells. Treatment with an MMP inhibitor abrogated MT1-MMP-induced phenotypic changes, but decreasing E-cadherin expression did not affect MT1-MMP-induced cellular aggregation. As ROCK1/2 can regulate cell-cell and cell-ECM interaction, we examined its role in mediating MT1-MMP-induced phenotypic changes. Blocking ROCK1/2 expression or activity abrogated the cellular aggregation resulting from MT1-MMP expression. Additionally, blocking Rho and nonmuscle myosin attenuated MT1-MMP-induced phenotypic changes. Moreover, SCC cells expressing only the catalytically active MT1-MMP protein demonstrated increased cellular aggregation and increased myosin II activity in vivo when injected subcutaneously into nude mice. Together, these results demonstrate that expression of MT1-MMP may be anti-tumorigenic in keratinocytes by promoting cellular aggregation.	[Munshi, Hidayatullah G.] Northwestern Univ, Sch Med, Dept Med, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Dangi-Garimella, Surabhi; Redig, Amanda J.; Shields, Mario A.; Siddiqui, Mohammed A.; Munshi, Hidayatullah G.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, Jesse Brown Vet Affairs Med Ctr, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu			National Institutes of Health (NCI) [R01CA126888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA126888, K08CA094877] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (NCI, to H. G. M.). This work was also supported by a merit grant from the Department of Veterans Affairs (to H. G. M.).	AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Grossi M, 2005, P NATL ACAD SCI USA, V102, P11313, DOI 10.1073/pnas.0505011102; Ha HY, 2001, CANCER RES, V61, P984; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; JENSEN PKA, 1991, J CELL SCI, V100, P255; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; KNIGHT J, 1984, ULTRASTRUCT PATHOL, V7, P133, DOI 10.3109/01913128409141470; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878; McCawley LJ, 2008, AM J PATHOL, V173, P1528, DOI 10.2353/ajpath.2008.080132; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shimada T, 2000, CLIN EXP METASTAS, V18, P179, DOI 10.1023/A:1006749501682; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; WITTY EP, 1995, MOL BIOL CELL, V6, P1287, DOI 10.1091/mbc.6.10.1287; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zhu AJ, 1996, J CELL SCI, V109, P3013	77	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28363	28372		10.1074/jbc.M110.146019	http://dx.doi.org/10.1074/jbc.M110.146019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605790	hybrid, Green Published			2022-12-27	WOS:000281404100078
J	Kaur, SJ; Nerlich, A; Bergmann, S; Rohde, M; Fulde, M; Zahner, D; Hanski, E; Zinkernagel, A; Nizet, V; Chhatwal, GS; Talay, SR				Kaur, Simran Jeet; Nerlich, Andreas; Bergmann, Simone; Rohde, Manfred; Fulde, Marcus; Zaehner, Dorothea; Hanski, Emanuel; Zinkernagel, Annelies; Nizet, Victor; Chhatwal, Gursharan S.; Talay, Susanne R.			The CXC Chemokine-degrading Protease SpyCep of Streptococcus pyogenes Promotes Its Uptake into Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; BINDING; INVASION; PHAGOCYTOSIS; FIBRONECTIN; DEGRADATION; SUFFICIENT; PEPTIDE; ENTRY; SFBI	Streptococcus pyogenes expresses the LPXTG motif-containing cell envelope serine protease SpyCep (also called ScpC, PrtS) that degrades and inactivates the major chemoattractant interleukin 8 (IL-8), thereby impairing host neutrophil recruitment. In this study, we identified a novel function of SpyCep: the ability to mediate uptake into primary human endothelial cells. SpyCep triggered its uptake into endothelial cells but not into human epithelial cells originating from pharynx or lung, indicating an endothelial cell-specific uptake mechanism. SpyCep mediated cellular invasion by an endosomal/lysosomal pathway distinct from the caveolae-mediated invasion pathway of S. pyogenes. Recombinant expression and purification of proteolytically active SpyCep and a series of subfragments allowed functional dissection of the domains responsible for endothelial cell invasion and IL-8 degradation. The N-terminal PR domain was sufficient to mediate endothelial cell invasion, whereas for IL-8-degrading activity, the protease domain and the flanking A domain were required. A polyclonal rabbit serum raised against the recombinant protease efficiently blocked the invasion-mediating activity of SpyCep but not its proteolytic function, further indicating that SpyCep-mediated internalization is independent from its enzymatic activity. SpyCep may thus specifically mediate its own uptake as secreted protein into human endothelial cells.	[Kaur, Simran Jeet; Nerlich, Andreas; Bergmann, Simone; Rohde, Manfred; Fulde, Marcus; Zaehner, Dorothea; Chhatwal, Gursharan S.; Talay, Susanne R.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Hanski, Emanuel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Microbiol, IL-91010 Jerusalem, Israel; [Zinkernagel, Annelies; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Zinkernagel, Annelies; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Helmholtz Association; Helmholtz-Center for Infection Research; Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego	Talay, SR (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Inhoffenstr 7, D-38124 Braunschweig, Germany.	susanne.talay@helmholtz-hzi.de	Zinkernagel, Annelies S/F-1780-2017; Nerlich, Andreas/F-9336-2012; Nizet, Victor/AAF-3190-2019; hanski, emanuel/M-2696-2018	Zinkernagel, Annelies S/0000-0003-4700-1118; Nerlich, Andreas/0000-0001-8577-2744; hanski, emanuel/0000-0001-5054-0628; Nizet, Victor/0000-0003-3847-0422	Helmholtz Association, Germany [VWZN2038]; European Union [EU-CP223111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	Helmholtz Association, Germany(Helmholtz Association); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant VWZN2038 from the Niedersachsisches Ministerium fur Wissenschaft und Kultur of Lower Saxony the "Wiederein-stiegsprogramm" given by the Helmholtz Association, Germany (to S. R. T.), and "CAREPNEUMO" (Grant EU-CP223111, European Union) (to S. R. T. and S. B.).	Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Eran Y, 2007, MOL MICROBIOL, V63, P1209, DOI 10.1111/j.1365-2958.2007.05581.x; Fritzer A, 2009, BIOCHEM J, V422, P533, DOI 10.1042/BJ20090278; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nerlich A, 2009, J BIOL CHEM, V284, P20319, DOI 10.1074/jbc.M109.016501; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Siezen RJ, 1999, ANTON LEEUW INT J G, V76, P139, DOI 10.1023/A:1002036906922; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; ZINGARETTI C, 2010, FASEB J IN PRESS; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	24	13	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27798	27805		10.1074/jbc.M109.098053	http://dx.doi.org/10.1074/jbc.M109.098053			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20562101	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000281404100035
J	Headey, SJ; MacAskill, UK; Wright, MA; Claridge, JK; Edwards, PJB; Farley, PC; Christeller, JT; Laing, WA; Pascal, SM				Headey, Stephen J.; MacAskill, Ursula K.; Wright, Michele A.; Claridge, Jolyon K.; Edwards, Patrick J. B.; Farley, Peter C.; Christeller, John T.; Laing, William A.; Pascal, Steven M.			Solution Structure of the Squash Aspartic Acid Proteinase Inhibitor (SQAPI) and Mutational Analysis of Pepsin Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROGLOBULIN TYPE-1 DOMAINS; NMR STRUCTURE DETERMINATION; NEMATODE ASCARIS-SUUM; PORCINE PEPSIN; CYSTEINE PROTEINASES; CHEMICAL-SHIFT; CATHEPSIN-D; BINDING; SPECTROSCOPY; EQUISTATIN	The squash aspartic acid proteinase inhibitor (SQAPI), a proteinaceous proteinase inhibitor from squash, is an effective inhibitor of a range of aspartic proteinases. Proteinaceous aspartic proteinase inhibitors are rare in nature. The only other example in plants probably evolved from a precursor serine proteinase inhibitor. Earlier work based on sequence homology modeling suggested SQAPI evolved from an ancestral cystatin. In this work, we determined the solution structure of SQAPI using NMR and show that SQAPI shares the same fold as a plant cystatin. The structure is characterized by a four-strand anti-parallel beta-sheet gripping an alpha-helix in an analogous manner to fingers of a hand gripping a tennis racquet. Truncation and site-specific mutagenesis revealed that the unstructured N terminus and the loop connecting beta-strands 1 and 2 are important for pepsin inhibition, but the loop connecting strands 3 and 4 is not. Using ambiguous restraints based on the mutagenesis results, SQAPI was then docked computationally to pepsin. The resulting model places the N-terminal strand of SQAPI in the S' side of the substrate binding cleft, whereas the first SQAPI loop binds on the S side of the cleft. The backbone of SQAPI does not interact with the pepsin catalytic Asp(32)-Asp(215) diad, thus avoiding cleavage. The data show that SQAPI does share homologous structural elements with cystatin and appears to retain a similar protease inhibitory mechanism despite its different target. This strongly supports our hypothesis that SQAPI evolved from an ancestral cystatin.	[Wright, Michele A.; Laing, William A.] New Zealand Inst Plant & Food Res Ltd, Auckland 1142, New Zealand; [Headey, Stephen J.; Claridge, Jolyon K.; Edwards, Patrick J. B.; Pascal, Steven M.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand; [MacAskill, Ursula K.; Farley, Peter C.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand; [Christeller, John T.] New Zealand Inst Plant & Food Res Ltd, Palmerston North 4442, New Zealand	New Zealand Institute for Plant & Food Research Ltd; Massey University; Massey University; New Zealand Institute for Plant & Food Research Ltd	Laing, WA (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland 1142, New Zealand.	william.laing@plantandfood.co.nz; s.pascal@massey.ac.nz	Pascal, Steven/AAP-5684-2021; Laing, William A/E-3636-2010; Edwards, P/E-2804-2018; Laing, William A/B-2800-2015; Christeller, John T/E-6904-2010	Laing, William A/0000-0003-0458-6590; Edwards, P/0000-0003-3776-7582; Laing, William A/0000-0003-0458-6590; Headey, Stephen/0000-0001-8015-7064				BARTELS THX, 1995, J BIOMOL NMR, V6, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Christeller J, 2005, PROTEIN PEPTIDE LETT, V12, P439, DOI 10.2174/0929866054395329; Christeller JT, 2006, J MOL EVOL, V63, P747, DOI 10.1007/s00239-005-0304-z; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Christeller JT, 1998, EUR J BIOCHEM, V254, P160, DOI 10.1046/j.1432-1327.1998.2540160.x; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dash C, 2001, BIOCHEMISTRY-US, V40, P11525, DOI 10.1021/bi010594y; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Farley PC, 2002, J MOL RECOGNIT, V15, P135, DOI 10.1002/jmr.568; Galesa K, 2003, FEBS LETT, V539, P120, DOI 10.1016/S0014-5793(03)00215-1; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; LAING W, 2002, PROTEIN PROTEIN INTE, P77; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Li M, 2000, NAT STRUCT BIOL, V7, P113, DOI 10.1038/72378; MARES M, 1989, FEBS LETT, V251, P94, DOI 10.1016/0014-5793(89)81435-8; Margis R, 1998, ARCH BIOCHEM BIOPHYS, V359, P24, DOI 10.1006/abbi.1998.0875; Marin A, 2004, J BIOMOL NMR, V30, P47, DOI 10.1023/B:JNMR.0000042948.12381.88; MARTZEN MR, 1990, BIOCHEMISTRY-US, V29, P7366, DOI 10.1021/bi00484a003; Mathialagan N, 1996, P NATL ACAD SCI USA, V93, P13653, DOI 10.1073/pnas.93.24.13653; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Nagata K, 2000, BIOCHEMISTRY-US, V39, P14753, DOI 10.1021/bi0006971; Ng KKS, 2000, NAT STRUCT BIOL, V7, P653, DOI 10.1038/77950; Petersen JFW, 1998, ADV EXP MED BIOL, V436, P391; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pol E, 1999, BIOCHEMISTRY-US, V38, P10519, DOI 10.1021/bi990488k; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; SCHU P, 1991, EUR J BIOCHEM, V197, P1, DOI 10.1111/j.1432-1033.1991.tb15874.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yao SG, 2004, BIOCHEMISTRY-US, V43, P11187, DOI 10.1021/bi049456+	36	11	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27019	27025		10.1074/jbc.M110.137018	http://dx.doi.org/10.1074/jbc.M110.137018			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20538608	Green Published, hybrid			2022-12-27	WOS:000281172700033
J	Mo, PL; Wang, HB; Lu, H; Boyd, DD; Yan, CH				Mo, Pingli; Wang, Hongbo; Lu, Hua; Boyd, Douglas D.; Yan, Chunhong			MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE GENE; DNA-DAMAGE; P53 PROTEIN; ATF3; EXPRESSION; PATHWAYS; PROMOTER; TRANSACTIVATION; ONCOPROTEIN; REPRESSION	Activating transcription factor 3 (ATF3) is a common stress sensor, and its rapid induction by cellular stresses (e.g. DNA damage) is crucial for cells to mount appropriate responses (e.g. activating the tumor suppressor p53) and maintain homeostasis. Although emerging evidence suggests that dysregulation of ATF3 contributes to occurrences of human diseases including cancer, the mechanism(s) by which ATF3 expression is regulated is largely unknown. Here, we demonstrate that mouse double minute 2 (MDM2) is a bona fide E3 ubiquitin ligase for ATF3 and regulates ATF3 expression by promoting its degradation. MDM2 via its C-terminal RING finger can bind to the Basic region of ATF3 and mediate the addition of ubiquitin moieties to the ATF3 leucine zipper domain. As a consequence, ATF3, but not a mutant deficient in MDM2 binding (Delta 80-100), is degraded by MDM2-mediated proteolysis. Consistent with these results, ablation of MDM2 in cells not only increases basal ATF3 levels, but results in stabilization of ATF3 in late stages of DNA damage responses. Because ATF3 was recently identified as a p53 activator, these results suggest that MDM2 could inactivate p53 through an additional feedback mechanism involving ATF3. Therefore, we provide the first evidence demonstrating that ATF3 is regulated by a posttranslational mechanism.	Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Lu, Hua] Indiana Univ, Sch Med, Dept Biochem Mol Biol, Indianapolis, IN 46202 USA; [Lu, Hua] IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Boyd, Douglas D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Albany Medical College; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; University of Texas System; UTMD Anderson Cancer Center	Yan, CH (corresponding author), 47 New Scotland Ave,MC165, Albany, NY 12208 USA.	yanc@mail.amc.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Yan, Chunhong/0000-0002-3974-7991	Department of Defense [PC061106 (W81XWH-07-1-0095)]; National Institutes of Health/NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA127724, R01CA095441, R01CA129828] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant PC061106 (W81XWH-07-1-0095) (to C. Y.) and National Institutes of Health/NCI Grants CA127724, CA095441, and CA129828 (to H. L.).	Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; DEOCALUNA R, 1995, NATURE, V0378; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Freedman DA, 1999, CANCER RES, V59, P1; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 1999, GENE EXPRESSION, V7, P321; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Robles AI, 2001, CANCER RES, V61, P6660; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	35	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26908	26915		10.1074/jbc.M110.132597	http://dx.doi.org/10.1074/jbc.M110.132597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592017	Green Published, hybrid			2022-12-27	WOS:000281172700022
J	Duan, MR; Smerdon, MJ				Duan, Ming-Rui; Smerdon, Michael J.			UV Damage in DNA Promotes Nucleosome Unwrapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEOTIDE EXCISION-REPAIR; CHROMATIN REMODELING ACTIVITIES; CORE PARTICLE; HISTONE ACETYLATION; ANGSTROM RESOLUTION; SPONTANEOUS ACCESS; PYRIMIDINE DIMERS; CRYSTAL-STRUCTURE; TARGET SITES	The association of DNA with histones in chromatin impedes DNA repair enzymes from accessing DNA lesions. Nucleosomes exist in a dynamic equilibrium in which portions of the DNA molecule spontaneously unwrap, transiently exposing buried DNA sites. Thus, nucleosome dynamics in certain regions of chromatin may provide the exposure time and space needed for efficient repair of buried DNA lesions. We have used FRET and restriction enzyme accessibility to study nucleosome dynamics following DNA damage by UV radiation. We find that FRET efficiency is reduced in a dose-dependent manner, showing that the presence of UV photoproducts enhances spontaneous unwrapping of DNA from histones. Furthermore, this UV-induced shift in unwrapping dynamics is associated with increased restriction enzyme accessibility of histone-bound DNA after UV treatment. Surprisingly, the increased unwrapping dynamics is even observed in nucleosome core particles containing a single UV lesion at a specific site. These results highlight the potential for increased "intrinsic exposure" of nucleosome-associated DNA lesions in chromatin to repair proteins.	[Duan, Ming-Rui; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu	Duan, Mingrui/C-6644-2011		NIEHS [ES004106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS.	ALLIS CD, 2007, EPIGENETICS, P193; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P617; Gaillard H, 2003, J BIOL CHEM, V278, P17655, DOI 10.1074/jbc.M300770200; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Hanawalt PC, 1998, MUTAT RES-FUND MOL M, V400, P117, DOI 10.1016/S0027-5107(98)00084-0; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hoch DA, 2007, J MOL BIOL, V371, P971, DOI 10.1016/j.jmb.2007.05.075; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelbauskas L, 2007, BIOCHEMISTRY-US, V46, P2239, DOI 10.1021/bi061289l; Kelbauskas L, 2008, BIOCHEMISTRY-US, V47, P9627, DOI 10.1021/bi8000775; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P13; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Liu XQ, 2000, BIOCHEMISTRY-US, V39, P557, DOI 10.1021/bi991771m; LIU XQ, 1995, ANAL BIOCHEM, V229, P323, DOI 10.1006/abio.1995.1420; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Polach KJ, 1999, METHOD ENZYMOL, V304, P278; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Schieferstein U, 1998, EMBO J, V17, P306, DOI 10.1093/emboj/17.1.306; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Suter B, 2002, J MOL BIOL, V319, P395, DOI 10.1016/S0022-2836(02)00291-7; Svedruzic ZM, 2005, J BIOL CHEM, V280, P40051, DOI 10.1074/jbc.M509478200; Teng YM, 2005, DNA REPAIR, V4, P870, DOI 10.1016/j.dnarep.2005.04.006; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101	56	47	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26295	26303		10.1074/jbc.M110.140087	http://dx.doi.org/10.1074/jbc.M110.140087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20562439	Green Published, hybrid			2022-12-27	WOS:000280921000047
J	Lee, J; Moon, HJ; Lee, JM; Joo, CK				Lee, Jungeun; Moon, Hyun-Jeong; Lee, Jong-Min; Joo, Choun-Ki			Smad3 Regulates Rho Signaling via NET1 in the Transforming Growth Factor-beta-induced Epithelial-Mesenchymal Transition of Human Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING SMAD3; TGF-BETA; GENE-EXPRESSION; POTENTIAL ROLE; TRANSDIFFERENTIATION; DIFFERENTIATION; REORGANIZATION; PLASTICITY; INDUCTION; PATHWAYS	We previously demonstrated that RhoA-dependent signaling regulates transforming growth factor-beta 1 (TGF-beta 1)-induced cytoskeletal reorganization in the human retinal pigment epithelial cell line ARPE-19. Smad pathways have also been shown to mediate TGF-beta 1 activity. Here, we examined what regulates Rho GTPase activity and tested whether Smad signaling cross-talks with Rho pathways during TGF-beta 1-induced actin rearrangement. Using small interfering RNAs, we found that NET1, the guanine nucleotide exchange factor of RhoA, is critical for TGF-beta 1-induced cytoskeletal reorganization, N-cadherin expression, and RhoA activation. In ARPE-19 cells lacking NET1, TGF-beta 1-induced stress fibers and N-cadherin expression were not observed. Interestingly, in dominant-negative Smad3-expressing or constitutively active Smad7 cells, TGF-beta 1 failed to induce NET1 mRNA and protein expression. Consistent with these results, both dominant-negative Smad3 and constitutively active Smad7 blocked the cytoplasmic localization of NET1 and inhibited interactions between NET1 and RhoA. Finally, we found that NET1 is a direct gene target of TGF-beta 1 via Smad3. Taken together, our results demonstrate that Smad3 regulates RhoA activation and cytoskeletal reorganization by controlling NET1 in TGF-beta 1-induced ARPE-19 cells. These data define a new role for Smad3 as a modulator of RhoA activation in the regulation of TGF-beta 1-induced epithelial-mesenchymal transitions.	[Lee, Jungeun; Moon, Hyun-Jeong; Lee, Jong-Min; Joo, Choun-Ki] Catholic Univ Korea, Lab Ophthalmol & Visual Sci, Catholic Res Inst Med Sci, Coll Med, Seoul 137040, South Korea	Catholic University of Korea	Joo, CK (corresponding author), Catholic Univ Korea, Lab Ophthalmol & Visual Sci, Catholic Res Inst Med Sci, Coll Med, 505 Banpo Dong, Seoul 137040, South Korea.	leeje@catholic.ac.kr			Ministry of Education, Science, and Technology [CBM34-B3003-01-00-00]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Center for Biological Modulators of the 21C Frontier R&D Program, Ministry of Education, Science, and Technology Grant CBM34-B3003-01-00-00.	Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Broders-Bondon F, 2007, DEV DYNAM, V236, P2555, DOI 10.1002/dvdy.21273; Carrington L, 2000, INVEST OPHTH VIS SCI, V41, P1210; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Casellas R, 1998, DEV BIOL, V198, P1; Cassidy L, 1998, BRIT J OPHTHALMOL, V82, P181, DOI 10.1136/bjo.82.2.181; Chan AML, 1996, ONCOGENE, V12, P1259; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hay ED, 1995, ACTA ANAT, V154, P8; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Ka SM, 2007, J AM SOC NEPHROL, V18, P1777, DOI 10.1681/ASN.2006080901; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Lee KM, 1999, CELL BIOL INT, V23, P507, DOI 10.1006/cbir.1998.0401; Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lu J, 2005, DEVELOPMENT, V132, P3231, DOI 10.1242/dev.01893; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Moustakas A, 1999, J CELL SCI, V112, P1169; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Saika S, 2004, AM J PATHOL, V164, P651, DOI 10.1016/S0002-9440(10)63153-7; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	59	40	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26618	26627		10.1074/jbc.M109.073155	http://dx.doi.org/10.1074/jbc.M109.073155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547485	Green Published, hybrid			2022-12-27	WOS:000280921000077
J	Bartsch, M; Bednarek, P; Vivancos, PD; Schneider, B; von Roepenack-Lahaye, E; Foyer, CH; Kombrink, E; Scheel, D; Parker, JE				Bartsch, Michael; Bednarek, Pawel; Vivancos, Pedro D.; Schneider, Bernd; von Roepenack-Lahaye, Edda; Foyer, Christine H.; Kombrink, Erich; Scheel, Dierk; Parker, Jane E.			Accumulation of Isochorismate-derived 2,3-Dihydroxybenzoic 3-O-beta-D-Xyloside in Arabidopsis Resistance to Pathogens and Ageing of Leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BENZOIC-ACID DERIVATIVES; SALICYLIC-ACID; CELL-DEATH; DEFENSE RESPONSES; BRUCELLA-ABORTUS; GENTISIC ACID; DISEASE RESISTANCE; MONOOXYGENASE FMO1; METHYL SALICYLATE	An intricate network of hormone signals regulates plant development and responses to biotic and abiotic stress. Salicylic acid (SA), derived from the shikimate/isochorismate pathway, is a key hormone in resistance to biotrophic pathogens. Several SA derivatives and associated modifying enzymes have been identified and implicated in the storage and channeling of benzoic acid intermediates or as bioactive molecules. However, the range and modes of action of SA-related metabolites remain elusive. In Arabidopsis, Enhanced Disease Susceptibility 1 (EDS1) promotes SA-dependent and SA-independent responses in resistance against pathogens. Here, we used metabolite profiling of Arabidopsis wild type and eds1 mutant leaf extracts to identify molecules, other than SA, whose accumulation requires EDS1 signaling. Nuclear magnetic resonance and mass spectrometry of isolated and purified compounds revealed 2,3-dihydroxybenzoic acid (2,3-DHBA) as an isochorismate-derived secondary metabolite whose accumulation depends on EDS1 in resistance responses and during ageing of plants. 2,3-DHBA exists predominantly as a xylose-conjugated form (2-hydroxy-3-beta-O-D-xylopyranosyloxy benzoic acid) that is structurally distinct from known SA-glucose conjugates. Analysis of DHBA accumulation profiles in various Arabidopsis mutants suggests an enzymatic route to 2,3-DHBA synthesis that is under the control of EDS1. We propose that components of the EDS1 pathway direct the generation or stabilization of 2,3-DHBA, which as a potentially bioactive molecule is sequestered as a xylose conjugate.	[Bartsch, Michael; Bednarek, Pawel; Kombrink, Erich; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Vivancos, Pedro D.; Foyer, Christine H.] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Schneider, Bernd] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [von Roepenack-Lahaye, Edda; Scheel, Dierk] Leibniz Inst Pflanzenbiochem, Abt Stress & Entwicklungsbiol, D-06120 Halle, Saale, Germany	Max Planck Society; University of Leeds; Max Planck Society; Leibniz Institut fur Pflanzenbiochemie	Parker, JE (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	parker@mpiz-koeln.mpg.de	Foyer, Christine/K-2143-2012; Díaz-Vivancos, Pedro/G-5301-2011; Bednarek, Pawel/D-2561-2009; Schneider, Bernd/A-3287-2014	Díaz-Vivancos, Pedro/0000-0001-6041-2128; Bednarek, Pawel/0000-0002-3064-7775; Schneider, Bernd/0000-0003-4788-1565; Foyer, Christine/0000-0001-5989-6989	Max Planck Society; Bundesministerium fur Bildung und Forschung GABI DILEMA; Deutsche Forschungsgemeinschaft [1212]; Fundacion Seneca	Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung GABI DILEMA(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Seneca(Fundacion Seneca)	This work was supported by the Max Planck Society, Bundesministerium fur Bildung und Forschung GABI DILEMA, and Deutsche Forschungsgemeinschaft Schwerpunkt programm 1212 (Plant-Microbe) grants (to J. E. P. and M. B.).; Recipient of a Fundacion Seneca post-doctoral research fellowship.	ABAD P, 1988, ANTIVIR RES, V9, P315, DOI 10.1016/0166-3542(88)90026-5; Amborabe BE, 2002, PLANT PHYSIOL BIOCH, V40, P1051, DOI 10.1016/S0981-9428(02)01470-5; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bednarek P, 2005, PLANT PHYSIOL, V138, P1058, DOI 10.1104/pp.104.057794; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bellaire BH, 2003, INFECT IMMUN, V71, P2927, DOI 10.1128/IAI.71.5.2927-2932.2003; Belles JM, 1999, MOL PLANT MICROBE IN, V12, P227, DOI 10.1094/MPMI.1999.12.3.227; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Carviel JL, 2009, MOL PLANT PATHOL, V10, P621, DOI [10.1111/j.1364-3703.2009.00557.x, 10.1111/J.1364-3703.2009.00557.X]; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Fayos J, 2006, PHYTOCHEMISTRY, V67, P142, DOI 10.1016/j.phytochem.2005.10.014; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; Fobert PR, 2005, CURR OPIN PLANT BIOL, V8, P378, DOI 10.1016/j.pbi.2005.05.003; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GROOTVELD M, 1986, BIOCHEM J, V237, P499, DOI 10.1042/bj2370499; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; IBRAHIM RK, 1959, NATURE, V184, P1803, DOI 10.1038/1841803a0; Ishikawa K, 2009, PLANT PHYSIOL, V151, P741, DOI 10.1104/pp.109.140442; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Karegoudar TB, 2000, J MICROBIOL, V38, P53; Kienow L, 2008, J EXP BOT, V59, P403, DOI 10.1093/jxb/erm325; Kim JH, 2008, FEMS MICROBIOL LETT, V281, P64, DOI 10.1111/j.1574-6968.2008.01072.x; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Lee HI, 1998, PHYTOPATHOLOGY, V88, P692, DOI 10.1094/PHYTO.1998.88.7.692; Leonard BA, 1997, VET RES, V28, P87; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; MORENO PRH, 1994, PLANT CELL REP, V14, P188, DOI 10.1007/BF00233788; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muljono RAB, 2002, PLANT PHYSIOL BIOCH, V40, P231, DOI 10.1016/S0981-9428(02)01369-4; Mustafa NR, 2009, PHYTOCHEMISTRY, V70, P532, DOI 10.1016/j.phytochem.2009.01.009; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Parent MA, 2002, MICROB PATHOGENESIS, V32, P239, DOI 10.1006/mpat.2002.0500; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; Shapiro AD, 2001, PLANT PHYSIOL, V127, P1089, DOI 10.1104/pp.010096; Straus MR, 2010, PLANT J, V62, P628, DOI 10.1111/j.1365-313X.2010.04178.x; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2006, CURR OPIN PLANT BIOL, V9, P288, DOI 10.1016/j.pbi.2006.03.006; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; YOUNG IG, 1968, BIOCHIM BIOPHYS ACTA, V165, P567, DOI 10.1016/0304-4165(68)90245-6; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021; Zimmermann P, 2005, CELL MOL BIOL LETT, V10, P515	73	60	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25654	25665		10.1074/jbc.M109.092569	http://dx.doi.org/10.1074/jbc.M109.092569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538606	hybrid, Green Published			2022-12-27	WOS:000280682400059
J	DePaoli-Roach, AA; Tagliabracci, VS; Segvich, DM; Meyer, CM; Irimia, JM; Roach, PJ				DePaoli-Roach, Anna A.; Tagliabracci, Vincent S.; Segvich, Dyann M.; Meyer, Catalina M.; Irimia, Jose M.; Roach, Peter J.			Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCLONUS EPILEPSY; GLYCOGEN-METABOLISM; PHOSPHATASE; DEGRADATION; MUTATIONS; COMPLEX; PHOSPHORYLATION; POLYGLUCOSANS; PROTEINS; DISEASE	Approximately 90% of cases of Lafora disease, a fatal teen-age-onset progressive myoclonus epilepsy, are caused by mutations in either the EPM2A or the EPM2B genes that encode, respectively, a glycogen phosphatase called laforin and an E3 ubiquitin ligase called malin. Lafora disease is characterized by the formation of Lafora bodies, insoluble deposits containing poorly branched glycogen or polyglucosan, in many tissues including skeletal muscle, liver, and brain. Disruption of the Epm2b gene in mice resulted in viable animals that, by 3 months of age, accumulated Lafora bodies in the brain and to a lesser extent in heart and skeletal muscle. Analysis of muscle and brain of the Epm2b(-/-) mice by Western blotting indicated no effect on the levels of glycogen synthase, PTG (type 1 phosphatase-targeting subunit), or debranching enzyme, making it unlikely that these proteins are targeted for destruction by malin, as has been proposed. Total laforin protein was increased in the brain of Epm2b(-/-) mice and, most notably, was redistributed from the soluble, low speed supernatant to the insoluble low speed pellet, which now contained 90% of the total laforin. This result correlated with elevated insolubility of glycogen and glycogen synthase. Because up-regulation of laforin cannot explain Lafora body formation, we conclude that malin functions to maintain laforin associated with soluble glycogen and that its absence causes sequestration of laforin to an insoluble polysaccharide fraction where it is functionally inert.	[DePaoli-Roach, Anna A.; Tagliabracci, Vincent S.; Segvich, Dyann M.; Meyer, Catalina M.; Irimia, Jose M.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	DePaoli-Roach, AA (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	adepaoli@iupui.edu; proach@iupui.edu			National Institutes of Health [NS05645, DK27221]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R56DK027221, R01DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NS05645 and DK27221 (to P. J. R.).	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; BERGMEYER H, 1974, METHOD ENZYMAT AN, P1128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Graham TE, 2009, APPL PHYSIOL NUTR ME, V34, P488, DOI 10.1139/H09-048; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramachandran N, 2009, EPILEPSIA, V50, P29, DOI 10.1111/j.1528-1167.2009.02117.x; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 1977, MOL CELL BIOCHEM, V15, P179, DOI 10.1007/BF01734108; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Savage David B, 2008, PLoS Med, V5, pe27, DOI 10.1371/journal.pmed.0050027; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	38	89	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25372	25381		10.1074/jbc.M110.148668	http://dx.doi.org/10.1074/jbc.M110.148668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538597	Green Published, hybrid			2022-12-27	WOS:000280682400030
J	Mueller, GA; Gosavi, RA; Krahn, JM; Edwards, LL; Cuneo, MJ; Glesner, J; Pomes, A; Chapman, MD; London, RE; Pedersen, LC				Mueller, Geoffrey A.; Gosavi, Rajendrakumar A.; Krahn, Joseph M.; Edwards, Lori L.; Cuneo, Matthew J.; Glesner, Jill; Pomes, Anna; Chapman, Martin D.; London, Robert E.; Pedersen, Lars C.			Der p 5 Crystal Structure Provides Insight into the Group 5 Dust Mite Allergens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOMIA-TROPICALIS; X-RAY; CROSS-REACTIVITY; T-CELL; RECOMBINANT; SENSITIZATION; PROTEIN; EXPOSURE; SUBUNIT; BIOLOGY	Group 5 allergens from house dust mites elicit strong IgE antibody binding in mite-allergic patients. The structure of Der p 5 was determined by x-ray crystallography to better understand the IgE epitopes, to investigate the biologic function in mites, and to compare with the conflicting published Blo t 5 structures, designated 2JMH and 2JRK in the Protein Data Bank. Der p 5 is a three-helical bundle similar to Blo t 5, but the interactions of the helices are more similar to 2JMH than 2JRK. The crystallo-graphic asymmetric unit contains three dimers of Der p 5 that are not exactly alike. Solution scattering techniques were used to assess the multimeric state of Der p 5 in vitro and showed that the predominant state was monomeric, similar to Blo t 5, but larger multimeric species are also present. In the crystal, the formation of the Der p 5 dimer creates a large hydrophobic cavity of similar to 3000 angstrom(3) that could be a ligand-binding site. Many allergens are known to bind hydrophobic ligands, which are thought to stimulate the innate immune system and have adjuvant-like effects on IgE-mediated inflammatory responses.	[London, Robert E.; Pedersen, Lars C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Edwards, Lori L.] NIEHS, Prot Express Core Facil, NIH, Res Triangle Pk, NC 27709 USA; [Glesner, Jill; Pomes, Anna; Chapman, Martin D.] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); INDOOR Biotechnologies	Mueller, GA (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	mueller3@niehs.nih.gov	London, Robert E/F-7990-2019; Pedersen, Lars/C-6173-2019; Mueller, Geoffrey A/I-2909-2017; Pomés, Anna/H-7010-2019	London, Robert E/0000-0001-9108-8463; Pedersen, Lars/0000-0002-4488-4077; Mueller, Geoffrey A/0000-0001-8361-5323; Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632; Cuneo, Matthew/0000-0002-1475-6656	NIAID [R01AI077653]; Intramural Research Program; NIEHS; National Institutes of Health, NIEHS [HHSN273200700046U]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102906, ZIAES102645] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI077653 from NIAID (to A. P. and M. D. C.), by the Intramural Research Program, and by NIEHS.; Supported by National Institutes of Health, NIEHS, under Delivery Order HHSN273200700046U to SRA International, Inc.	ARRUDA LK, 1991, CLIN EXP ALLERGY, V21, P433, DOI 10.1111/j.1365-2222.1991.tb01683.x; Arruda LK, 1997, AM J RESP CRIT CARE, V155, P343, DOI 10.1164/ajrccm.155.1.9001334; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caraballo L, 1998, J INVEST ALLERG CLIN, V8, P281; Caraballo L, 1998, INT ARCH ALLERGY IMM, V117, P38, DOI 10.1159/000023988; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; DeRose EF, 2004, STRUCTURE, V12, P2221, DOI 10.1016/j.str.2004.09.019; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; HEWITT CRA, 1995, J EXP MED, V182, P1537, DOI 10.1084/jem.182.5.1537; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; King C, 1998, J IMMUNOL, V161, P3645; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liaw SH, 2001, BIOCHEM BIOPH RES CO, V285, P308, DOI 10.1006/bbrc.2001.5184; Liaw SH, 1998, J STRUCT BIOL, V123, P265, DOI 10.1006/jsbi.1998.4031; LIN KL, 1994, J ALLERGY CLIN IMMUN, V94, P989, DOI 10.1016/0091-6749(94)90117-1; Mueller GA, 2005, J BACTERIOL, V187, P7081, DOI 10.1128/JB.187.20.7081-7089.2005; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Simpson A, 2003, ALLERGY, V58, P53, DOI 10.1034/j.1398-9995.2003.23354.x; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thomas WR, 2007, IMMUNOL RES, V37, P187, DOI 10.1007/BF02697369; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Tomee JFC, 1998, J ALLERGY CLIN IMMUN, V102, P75, DOI 10.1016/S0091-6749(98)70057-0; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; Weghofer M, 2008, INT ARCH ALLERGY IMM, V147, P101, DOI 10.1159/000135696; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	44	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25394	25401		10.1074/jbc.M110.128306	http://dx.doi.org/10.1074/jbc.M110.128306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534590	Green Published, hybrid			2022-12-27	WOS:000280682400032
J	Stamnaes, J; Pinkas, DM; Fleckenstein, B; Khosla, C; Sollid, LM				Stamnaes, Jorunn; Pinkas, Daniel M.; Fleckenstein, Burkhard; Khosla, Chaitan; Sollid, Ludvig M.			Redox Regulation of Transglutaminase 2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; TISSUE TRANSGLUTAMINASE; CELIAC-DISEASE; GLIADIN PEPTIDES; STRUCTURAL BASIS; CALCIUM-IONS; INACTIVATION; MECHANISM; ENZYME; TRANSAMIDATION	Transglutaminase 2 (TG2) in the extracellular matrix is largely inactive but is transiently activated upon certain types of inflammation and cell injury. The enzymatic activity of extracellular TG2 thus appears to be tightly regulated. As TG2 is known to be sensitive to changes in the redox environment, inactivation through oxidation presents a plausible mechanism. Using mass spectrometry, we have identified a redox-sensitive cysteine triad consisting of Cys(230), Cys(370), and Cys(371) that is involved in oxidative inactivation of TG2. Within this triad, Cys(370) was found to participate in disulfide bonds with both Cys(230) and its neighbor, Cys(371). Notably, Ca2+ was found to protect against formation of these disulfide bonds. To investigate the role of each cysteine residue, we created alanine mutants and found that Cys230 appears to promote oxidation and inactivation of TG2 by facilitating formation of Cys(370)-Cys(371) through formation of the Cys(230)-Cys(370) disulfide bond. Although vicinal disulfide pairs are found in several transglutaminase isoforms, Cys(230) is unique for TG2, suggesting that this residue acts as an isoform-specific redox sensor. Our findings suggest that oxidation is likely to influence the amount of active TG2 present in the extracellular environment.	[Stamnaes, Jorunn; Fleckenstein, Burkhard; Sollid, Ludvig M.] Univ Oslo, Inst Immunol, Ctr Immune Regulat, N-0027 Oslo, Norway; [Sollid, Ludvig M.] Oslo Univ Hosp, N-0027 Oslo, Norway; [Pinkas, Daniel M.; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of Oslo; University of Oslo; Stanford University; Stanford University; Stanford University	Stamnaes, J (corresponding author), Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway.	jorunn.stamnas@rr-research.no	Pinkas, Daniel/AAE-3210-2020; Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Stamnaes, Jorunn/0000-0002-0257-2112; Khosla, Chaitan/0000-0001-6529-495X; Pinkas, Daniel/0000-0002-4740-6695	National Institutes of Health [DK 063158]; Research Council of Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 063158 (to C. K.). This work was also supported by a grant from the Research Council of Norway (to L. M. S.).	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Casadio R, 1999, EUR J BIOCHEM, V262, P672, DOI 10.1046/j.1432-1327.1999.00437.x; CHUNG SI, 1970, J BIOL CHEM, V245, P681; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; FOLK JE, 1967, J BIOL CHEM, V242, P1838; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mariani P, 2000, BIOPHYS J, V78, P3240, DOI 10.1016/S0006-3495(00)76860-3; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; ROTH WJ, 1986, J LEUKOCYTE BIOL, V39, P629, DOI 10.1002/jlb.39.6.629; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028	26	131	133	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25402	25409		10.1074/jbc.M109.097162	http://dx.doi.org/10.1074/jbc.M109.097162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20547769	Green Published, hybrid			2022-12-27	WOS:000280682400033
J	Yi, L; Rosales, T; Rose, JJ; Chaudhury, B; Knutson, JR; Venkatesan, S				Yi, Ling; Rosales, Tilman; Rose, Jeremy J.; Chaudhury, Bhabhadeb; Knutson, Jay R.; Venkatesan, Sundararajan			HIV-1 Nef Binds a Subpopulation of MHC-I throughout Its Trafficking Itinerary and Down-regulates MHC-I by Perturbing Both Anterograde and Retrograde Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; FLUORESCENCE CORRELATION SPECTROSCOPY; ANTIGEN PRESENTATION; PHOTOBLEACHING RECOVERY; CYTOPLASMIC DOMAIN; ENDOCYTIC PATHWAY; LATERAL DIFFUSION; PLASMA-MEMBRANE; CD4 ENDOCYTOSIS; LIVING CELLS	The HIV protein Nef is thought to mediate immune evasion and promote viral persistence in part by down-regulating major histocompatibility complex class I protein (MHC-I or HLA-I) from the cell surface. Two different models have been proposed to explain this phenomenon as follows: 1) stimulation of MHC-I retrograde trafficking from and aberrant recycling to the plasma membrane, and 2) inhibition of anterograde trafficking of newly synthesized HLA-I from the endoplasmic reticulum to the plasma membrane. We show here that Nef simultaneously uses both mechanisms to down-regulate HLA-I in peripheral blood mononuclear cells or HeLa cells. Consistent with this, we found by using fluorescence correlation spectroscopy that a third of diffusing HLA-I at the endoplasmic reticulum, Golgi/trans-Golgi network, and the plasma membrane (PM) was associated with Nef. The binding of Nef was similarly avid for native HLA-I and recombinant HLA-I A2 at the PM. Nef binding to HLA-I at the PM was sensitive to specific inhibition of endocytosis. It was also attenuated by cyclodextrin disruption of PM lipid microdomain architecture, a change that also retarded lateral diffusion and induced large clusters of HLA-I. In all, our data support a model for Nef down-regulation of HLA-I that involves both major trafficking itineraries and persistent protein-protein interactions throughout the cell.	[Venkatesan, Sundararajan] NIAID, MCBU, LMI, NIH, Bethesda, MD 20892 USA; [Rosales, Tilman; Knutson, Jay R.] NHLBI, Opt Spect Sect, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Venkatesan, S (corresponding author), NIAID, MCBU, LMI, NIH, Bldg 10,Rm 6A05, Bethesda, MD 20892 USA.	sv1s@nih.gov			National Institutes of Health, Division of Intramural Research, NIAID; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006065, ZIAHL006066, ZIAHL001452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000528] Funding Source: NIH RePORTER	National Institutes of Health, Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grant from Division of Intramural Research, NIAID.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Benmerah A, 1999, J CELL SCI, V112, P1303; Bentham M, 2003, J GEN VIROL, V84, P2705, DOI 10.1099/vir.0.19274-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Edidin M, 1997, IMMUNOGENETICS, V46, P41, DOI 10.1007/s002510050240; Fooksman DR, 2006, J IMMUNOL, V176, P6673, DOI 10.4049/jimmunol.176.11.6673; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Georgiou G, 2002, BIOPHYS J, V82, P1828, DOI 10.1016/S0006-3495(02)75533-1; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HARRIS MPG, 1994, J MOL BIOL, V241, P136; HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; Knorr R, 2009, J CELL SCI, V122, P1584, DOI 10.1242/jcs.039727; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Su RC, 2001, J IMMUNOL, V167, P4869, DOI 10.4049/jimmunol.167.9.4869; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tang Q, 2001, BIOPHYS J, V81, P196, DOI 10.1016/S0006-3495(01)75691-3; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Willems PHGM, 2009, METHOD ENZYMOL, V456, P287, DOI 10.1016/S0076-6879(08)04416-9; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200	78	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30884	30905		10.1074/jbc.M110.135947	http://dx.doi.org/10.1074/jbc.M110.135947			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20622010	Green Published, hybrid			2022-12-27	WOS:000282135500055
J	Doebbe, A; Keck, M; La Russa, M; Mussgnug, JH; Hankamer, B; Tekce, E; Niehaus, K; Kruse, O				Doebbe, Anja; Keck, Matthias; La Russa, Marco; Mussgnug, Jan H.; Hankamer, Ben; Tekce, Ercan; Niehaus, Karsten; Kruse, Olaf			The Interplay of Proton, Electron, and Metabolite Supply for Photosynthetic H-2 Production in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN PHOTOPRODUCTION; GENE-EXPRESSION; GREEN-ALGAE; DEPRIVATION; INDUCTION; PATHWAYS; BIOMASS	To obtain a detailed picture of sulfur deprivation-induced H-2 production in microalgae, metabolome analyses were performed during key time points of the anaerobic H-2 production process of Chlamydomonas reinhardtii. Analyses were performed using gas chromatography coupled to mass spectrometry (GC/MS), two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC-TOFMS), lipid and starch analysis, and enzymatic determination of fermentative products. The studies were designed to provide a detailed metabolite profile of the solar Bio-H-2 production process. This work reports on the differential analysis of metabolic profiles of the high H-2-producing strain Stm6Glc4 and the wild-type cc406 (WT) before and during the H-2 production phase. Using GCxGC-TOFMS analysis the number of detected peaks increased from 128 peaks, previously detected by GC/MS techniques, to similar to 1168. More detailed analysis of the anaerobic H-2 production phase revealed remarkable differences between wild-type and mutant cells in a number of metabolic pathways. Under these physiological conditions the WT produced up to 2.6 times more fatty acids, 2.2 times more neutral lipids, and up to 4 times more fermentation products compared with Stm6Glc4. Based on these results, specific metabolic pathways involving the synthesis of fatty acids, neutral lipids, and fermentation products during anaerobiosis in C. reinhardtii have been identified as potential targets for metabolic engineering to further enhance substrate supply for the hydrogenase(s) in the chloroplast.	[Kruse, Olaf] Univ Bielefeld, Algae Biotech & Bioenergy Grp, D-33615 Bielefeld, Germany; [Keck, Matthias; Niehaus, Karsten] Univ Bielefeld, Proteome & Metabolome Res Grp, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany; [Hankamer, Ben] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tekce, Ercan] LECO Instruments GmbH, D-41199 Monchengladbach, Germany	University of Bielefeld; University of Bielefeld; University of Queensland	Kruse, O (corresponding author), Univ Bielefeld, Algae Biotech & Bioenergy Grp, D-33615 Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015; Niehaus, Karsten/A-3966-2010; Hankamer, Ben D/C-9688-2015	Hankamer, Ben D/0000-0001-9284-4929; Kruse, Olaf/0000-0001-9874-382X	Deutsche Bundesstiftung Umwelt [DBU 20006/828]	Deutsche Bundesstiftung Umwelt	This work was supported in part by the Deutsche Bundesstiftung Umwelt (Grant DBU 20006/828 to A.D.).	Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Doebbe A, 2007, J BIOTECHNOL, V131, P27, DOI 10.1016/j.jbiotec.2007.05.017; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HEIM J, 2009, URINE DIABETIC VS NO; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kosourov S, 2007, J BIOTECHNOL, V128, P776, DOI 10.1016/j.jbiotec.2006.12.025; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Lohr M, 2009, CHLAMYDOMONAS SOURCE, P799, DOI [10.1016/B978-0-12-370873-1.00029-0, DOI 10.1016/B978-0-12-370873-1.00029-0]; Makarova VV, 2007, PHOTOSYNTH RES, V94, P79, DOI 10.1007/s11120-007-9219-4; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Niyogi K, 2009, CHLAMYDOMONAS SOURCE, P847, DOI DOI 10.1016/B978-0-12-370873-1.00031-9; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Posewitz MC, 2009, CHLAMYDOMONAS SOURCE, P217, DOI [10.1016/B978-0-12-370873, DOI 10.1016/B978-0-12-370873]; R- Development-Core-Team, 2009, R FDN STAT COMP; Ruhle T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-107; Rupprecht J, 2006, APPL MICROBIOL BIOT, V72, P442, DOI 10.1007/s00253-006-0528-x; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Stern D. B., 2009, CHLAMYDOMONAS SOURCE, V2, P257; Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104; Torzillo G, 2009, INT J HYDROGEN ENERG, V34, P4529, DOI 10.1016/j.ijhydene.2008.07.093; Tsygankov A, 2002, INT J HYDROGEN ENERG, V27, P1239, DOI 10.1016/S0360-3199(02)00108-8; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; VALLON H, 2009, CHLAMYDOMONAS SOURCE, V2, P115; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003; Welthagen W, 2005, METABOLOMICS, V1, P65, DOI 10.1007/s11306-005-1108-2; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Zhang LP, 2002, PHILOS T R SOC B, V357, P1499, DOI 10.1098/rstb.2002.1152; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	52	55	55	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30247	30260		10.1074/jbc.M110.122812	http://dx.doi.org/10.1074/jbc.M110.122812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20581114	hybrid, Green Published			2022-12-27	WOS:000281984300061
J	Naula, CM; Logan, FM; Wong, PE; Barrett, MP; Burchmore, RJ				Naula, Christina M.; Logan, Flora M.; Wong, Pui Ee; Barrett, Michael P.; Burchmore, Richard J.			A Glucose Transporter Can Mediate Ribose Uptake DEFINITION OF RESIDUES THAT CONFER SUBSTRATE SPECIFICITY IN A SUGAR TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE TRANSPORTERS; LEISHMANIA-DONOVANI; GLUT1; FRUCTOSE; MOTIF; FERMENTATION; DETERMINANT; METABOLISM; EXPRESSION; MECHANISM	Sugars, the major energy source for many organisms, must be transported across biological membranes. Glucose is the most abundant sugar in human plasma and in many other biological systems and has been the primary focus of sugar transporter studies in eukaryotes. We have previously cloned and characterized a family of glucose transporter genes from the protozoan parasite Leishmania. These transporters, called LmGT1, LmGT2, and LmGT3, are homologous to the well characterized glucose transporter (GLUT) family of mammalian glucose transporters. We have demonstrated that LmGT proteins are important for parasite viability. Here we show that one of these transporters, LmGT2, is a more effective carrier of the pentose sugar D-ribose than LmGT3, which has a 6-fold lower relative specificity (V-max/K-m) for ribose. A pair of threonine residues, located in the putative extracellular loops joining transmembrane helices 3 to 4 and 7 to 8, define a filter that limits ribose approaching the exo-facial substrate binding pocket in LmGT3. When these threonines are substituted by alanine residues, as found in LmGT2, the LmGT3 permease acquires ribose permease activity that is similar to that of LmGT2. The location of these residues in hydrophilic loops supports recent suggestions that substrate recognition is separated from substrate binding and translocation in this important group of transporters.	Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Barrett, Michael P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow		r.burchmore@bio.gla.ac.uk	Burchmore, Richard/A-1896-2011	Barrett, Mike/0000-0001-9447-3519; Burchmore, Richard/0000-0003-1663-9004; Naula, Christina/0000-0003-1165-693X	The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant from The Wellcome Trust.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arbuckle MI, 1996, BIOCHEMISTRY-US, V35, P16519, DOI 10.1021/bi962210n; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; BERENS RL, 1980, EXP PARASITOL, V49, P1, DOI 10.1016/0014-4894(80)90049-1; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; BRUN R, 1979, ACTA TROP, V36, P289; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; Burchmore RJS, 1995, MOL BIOCHEM PARASIT, V74, P77, DOI 10.1016/0166-6851(95)02485-9; CAMERON MM, 1995, MED VET ENTOMOL, V9, P263, DOI 10.1111/j.1365-2915.1995.tb00132.x; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Dauterive R, 1996, J BIOL CHEM, V271, P11414, DOI 10.1074/jbc.271.19.11414; HARTZ KE, 1981, CONSERV RECYCLING, V4, P39, DOI 10.1016/0361-3658(81)90006-0; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Manning SK, 2002, J BIOL CHEM, V277, P30942, DOI 10.1074/jbc.M204337200; Manolescu A, 2005, J BIOL CHEM, V280, P42978, DOI 10.1074/jbc.M508678200; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Molyneux D.H., 1991, Parassitologia (Rome), V33, P431; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; PASTOR GM, 1987, PROG SURF SCI, V26, P175, DOI 10.1016/0079-6816(87)90057-8; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Snapp EL, 1997, J CELL BIOL, V139, P1775, DOI 10.1083/jcb.139.7.1775; Snapp EL, 1999, J BIOL CHEM, V274, P29543, DOI 10.1074/jbc.274.41.29543; STEIGER RF, 1980, ACTA TROP, V37, P195; YOUNG CJ, 1980, T ROY SOC TROP MED H, V74, P363, DOI 10.1016/0035-9203(80)90100-5	39	22	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29721	29728		10.1074/jbc.M110.106815	http://dx.doi.org/10.1074/jbc.M110.106815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20601430	Green Published, hybrid			2022-12-27	WOS:000281984300007
J	Mao, ZH; Sun, W; Xu, RJ; Novgorodov, S; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Mao, Zhehao; Sun, Wei; Xu, Ruijuan; Novgorodov, Sergei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Alkaline Ceramidase 2 (ACER2) and Its Product Dihydrosphingosine Mediate the Cytotoxicity of N-(4-Hydroxyphenyl)retinamide in Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROCERAMIDE DESATURASE; PROSTATE-CANCER; FENRETINIDE; APOPTOSIS; INDUCTION; SPHINGOSINE; ACID; PROLIFERATION; SPHINGANINE; SPECIFICITY	Increased generation of dihydrosphingosine (DHS), a bioactive sphingolipid, has been implicated in the cytotoxicity of the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) in tumor cells. However, how 4-HPR increases DHS remains unclear. Here we demonstrate that 4-HPR increases the expression of ACER2, which catalyzes the hydrolysis of dihydroceramides to generate DHS, and that ACER2 up-regulation plays a key role in mediating the 4-HPR-induced generation of DHS as well as the cytotoxicity of 4-HPR in tumor cells. Treatment with 4-HPR induced the accumulation of dihydroceramides (DHCs) in tumor cells by inhibiting dihydroceramide desaturase (DES) activity, which catalyzes the conversion of DHCs to ceramides. Treatment with 4-HPR also increased ACER2 expression through a retinoic acid receptor-independent and caspase-dependent manner. Overexpression of ACER2 augmented the 4-HPR-induced generation of DHS as well as 4-HPR cytotoxicity, and 4-HPR-induced death in tumor cells, whereas knocking down ACER2 had the opposite effects. ACER2 overexpression, along with treatment with GT11, another DES inhibitor, markedly increased cellular DHS, leading to tumor cell death, whereas ACER2 overexpression or GT11 treatment alone failed to do so, suggesting that both ACER2 up-regulation and DES inhibition are necessary and sufficient to mediate 4-HPR-induced DHS accumulation, cytotoxicity, and death in tumor cells. Taken together, these results suggest that up-regulation of the ACER2/DHS pathway mediates the cytotoxicity of 4-HPR in tumor cells and that up-regulating or activating ACER2 may improve the anti-cancer activity of 4-HRR and other DHC-inducing agents.	[Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.; Mao, Cungui] Ralph H Johnson Vet Adm Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med, 114 Doughty St,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022		National Institutes of Health [R01CA104834, P20RR017677]; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA104834 (to C. M.) and P20RR017677 (to L. M. O.). This work was also supported by a Veterans Affairs merit award (to L. M. O.).	Ahn EH, 2002, EXP BIOL MED, V227, P345, DOI 10.1177/153537020222700507; Ahn EH, 2006, ANTICANCER RES, V26, P121; Ahn EH, 2006, EXP BIOL MED, V231, P1664; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonanni B, 2009, RECENT RES CANCER, V181, P77; Bu PL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-236; Cheung E, 2009, CLIN GENITOURIN CANC, V7, P43, DOI 10.3816/CGC.2009.n.008; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; DE PALO G, 2002, GYNECOL ONCOL, V86, P24; DiPietrantonio AM, 1998, INT J CANCER, V78, P53, DOI 10.1002/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6; EL BAWAB S, 2002, J LIPID RES, V43, P141; Fazi B, 2008, AUTOPHAGY, V4, P435, DOI 10.4161/auto.5669; Fillet M, 2003, BIOCHEM PHARMACOL, V65, P1633, DOI 10.1016/S0006-2952(03)00125-4; Hail N, 2009, APOPTOSIS, V14, P849, DOI 10.1007/s10495-009-0356-4; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; IGAWA M, 1994, PROSTATE, V24, P299, DOI 10.1002/pros.2990240605; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kadara H, 2008, CANCER RES, V68, P4416, DOI 10.1158/0008-5472.CAN-08-0031; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Mihai R, 2000, BIOCHEM BIOPH RES CO, V268, P636, DOI 10.1006/bbrc.2000.2159; MOMOI T, 1982, BIOCHEM J, V205, P419, DOI 10.1042/bj2050419; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Noda T, 2009, APOPTOSIS, V14, P287, DOI 10.1007/s10495-009-0319-9; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Rozzo C, 1997, INT J CANCER, V70, P688, DOI 10.1002/(SICI)1097-0215(19970317)70:6<688::AID-IJC11>3.3.CO;2-V; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Tamama K, 2001, BIOCHEM J, V353, P139, DOI 10.1042/bj3530139; Triola G, 2004, MOL PHARMACOL, V66, P1671, DOI 10.1124/mol.104.003681; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	48	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29078	29090		10.1074/jbc.M110.105296	http://dx.doi.org/10.1074/jbc.M110.105296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628055	Green Published, hybrid			2022-12-27	WOS:000281740100009
J	Al-Hashimi, AA; Caldwell, J; Gonzalez-Gronow, M; Pizzo, SV; Aboumrad, D; Pozza, L; Al-Bayati, H; Weitz, JI; Stafford, A; Chan, H; Kapoor, A; Jacobsen, DW; Dickhout, JG; Austin, RC				Al-Hashimi, Ali A.; Caldwell, Jennifer; Gonzalez-Gronow, Mario; Pizzo, Salvatore V.; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard; Kapoor, Anil; Jacobsen, Donald W.; Dickhout, Jeffrey G.; Austin, Richard C.			Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-ASSOCIATED THROMBOSIS; FACTOR EXPRESSION; TUMOR PROGRESSION; ENDOTHELIAL-CELLS; PROTEIN GRP78/BIP; CHAPERONE PROTEIN; FACTOR ACTIVATION; FOCAL ADHESIONS; MEMBRANE; RECEPTOR	The increased risk of venous thromboembolism in cancer patients has been attributed to enhanced tissue factor (TF) procoagulant activity (PCA) on the surface of cancer cells. Recent studies have shown that TFPCA can be modulated by GRP78, an endoplasmic reticulum (ER)-resident molecular chaperone. In this study, we investigated the role of cell surface GRP78 in modulating TF PCA in several human cancer cell lines. Although both GRP78 and TF are present on the cell surface of cancer cells, there was no evidence of a stable interaction between recombinant human GRP78 and TF, nor was there any effect of exogenously added recombinant GRP78 on cell surface TF PCA. Treatment of cells with the ER stress-inducing agent thapsigargin, an inhibitor of the sarco(endo)plasmic reticulum Ca2+ pump that causes Ca2+ efflux from ER stores, increased cytosolic [Ca2+] and induced TF PCA. Consistent with these findings, anti-GRP78 autoantibodies that were isolated from the serum of patients with prostate cancer and bind to a specific N-terminal epitope (Leu(98)-Leu(115)) on cell surface GRP78, caused a dose-dependent increase in cytosolic [Ca2+] and enhanced TF PCA. The ability to interfere with cell surface GRP78 binding, block phospholipase C activity, sequester ER Ca2+, or prevent plasma membrane phosphatidylserine exposure resulted in a significant decrease in the TF PCA induced by anti-GRP78 autoantibodies. Taken together, these findings provide evidence that engagement of the anti-GRP78 autoantibodies with cell surface GRP78 increases TFPCA through a mechanism that involves the release of Ca2+ from ER stores. Furthermore, blocking GRP78 signaling on the surface of cancer cells attenuates TF PCA and has the potential to reduce the risk of cancer-related venous thromboembolism.	[Al-Hashimi, Ali A.; Caldwell, Jennifer; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Austin, Richard C.] St Josephs Hosp, Dept Med, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Caldwell, Jennifer; Aboumrad, Danya; Pozza, Lindsay; Al-Bayati, Hiam; Austin, Richard C.] St Josephs Hosp, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] St Josephs Hosp, Dept Surg, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] St Josephs Hosp, Div Urol, Hamilton, ON L8N 4A6, Canada; [Kapoor, Anil] McMaster Univ, Hamilton, ON L8N 4A6, Canada; [Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard] Hamilton Gen Hosp, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.; Stafford, Alan; Chan, Howard] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Gonzalez-Gronow, Mario; Pizzo, Salvatore V.; Weitz, Jeffrey I.; Dickhout, Jeffrey G.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Jacobsen, Donald W.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	McGill University; McMaster University; McGill University; McMaster University; McGill University; McMaster University; McGill University; McMaster University; McMaster University; McMaster University; McMaster University; Duke University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Dickhout, Jeffrey/R-2606-2019; Kapoor, Anil/AAQ-7184-2021; Weitz, Jeffrey/AAD-1929-2019	Kapoor, Anil/0000-0001-9180-8029; Weitz, Jeffrey/0000-0002-1092-7550	Heart and Stroke Foundation of Ontario [T-6146]; Canadian Institutes of Health Research [MOP-74477, FRN-79846]; Ontario Research and Development Challenge Fund; St Joseph's Healthcare Hamilton; St Joseph's Healthcare Hamilton Division of Nephrology; Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University; National Heart, Lung and Blood Institute of the National Institutes of Health [HL52234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052234, R01HL052234] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); St Joseph's Healthcare Hamilton; St Joseph's Healthcare Hamilton Division of Nephrology; Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University; National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by research grants from the Heart and Stroke Foundation of Ontario (T-6146), the Canadian Institutes of Health Research (MOP-74477), and the Ontario Research and Development Challenge Fund (to R.C.A.). This work was also supported by St Joseph's Healthcare Hamilton and by a Canadian Institutes of Health Research Team Grant in Thromboembolism (FRN-79846).; Supported by a St Joseph's Healthcare Hamilton Division of Nephrology Junior Research Award.; A Career Investigator of the Heart and Stroke Foundation of Ontario and holder of the Amgen Canada Research Chair in the Division of Nephrology at St Joseph's Healthcare and McMaster University. To whom correspondence should be addressed: 50 Charlton Ave. East, Rm. T-3313, Hamilton, Ontario L8N 4A6, Canada. Tel.: 905-522-1155 (ext. 35175); Fax: 905-540-6589; E-mail: austinr@taari.ca.; Supported in part by the National Heart, Lung and Blood Institute of the National Institutes of Health (HL52234).	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; ANDRES DA, 1991, J BIOL CHEM, V266, P14277; BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Bach RR, 1997, BLOOD, V89, P3270, DOI 10.1182/blood.V89.9.3270; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Bookout AL, 2003, NUCL RECEPT SIGNAL, V1, pe012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldwell JA, 2010, LAB INVEST, V90, P953, DOI 10.1038/labinvest.2010.59; CARSON SD, 1994, BLOOD, V84, P526; CONSONNI R, 1995, THROMB HAEMOSTASIS, V74, P904; CONWAY EM, 1989, THROMB RES, V53, P231, DOI 10.1016/0049-3848(89)90098-4; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Erlich J, 1999, INFECT IMMUN, V67, P2540, DOI 10.1128/IAI.67.5.2540-2546.1999; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; GONZALEZGRONOW M, 1993, J BIOL CHEM, V268, P20791; Greeno EW, 1996, LAB INVEST, V75, P281; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hembrough TA, 2003, CANCER RES, V63, P2997; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Inesi G, 2005, J BIOENERG BIOMEMBR, V37, P365, DOI 10.1007/s10863-005-9472-1; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kaushal V, 2008, APPL IMMUNOHISTO M M, V16, P1; Kobayashi Y, 1998, TRANSPLANTATION, V66, P708, DOI 10.1097/00007890-199809270-00004; Kunzelmann-Marche C, 2000, THROMB HAEMOSTASIS, V83, P282, DOI 10.1055/s-0037-1613800; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LopezPedrera C, 1997, AM J HEMATOL, V56, P71, DOI 10.1002/(SICI)1096-8652(199710)56:2<71::AID-AJH1>3.0.CO;2-Y; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mavropoulos JC, 2005, J RHEUMATOL, V32, P2116; Milsom C, 2007, PATHOPHYSIOL HAEMO T, V36, P160, DOI 10.1159/000175154; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2008, J CELL BIOCHEM, V104, P96, DOI 10.1002/jcb.21607; Molins B, 2010, ARTERIOSCL THROM VAS, V30, P1246, DOI 10.1161/ATVBAHA.110.205112; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Pozza LM, 2005, ARTERIOSCL THROM VAS, V25, P1529, DOI 10.1161/01.ATV.0000177041.47444.e2; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; Rak J, 2008, CURR OPIN HEMATOL, V15, P522, DOI 10.1097/MOH.0b013e3283063a3e; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Sergeev IN, 2005, J STEROID BIOCHEM, V97, P145, DOI 10.1016/j.jsbmb.2005.06.007; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sousou T, 2009, ARTERIOSCL THROM VAS, V29, P316, DOI 10.1161/ATVBAHA.108.182196; Sud R, 2009, THROMB RES, V123, pS18, DOI 10.1016/S0049-3848(09)70137-9; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Triantafilou M, 2001, CYTOMETRY, V43, P279, DOI 10.1002/1097-0320(20010401)43:4<279::AID-CYTO1060>3.0.CO;2-B; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Wolberg AS, 1999, BLOOD COAGUL FIBRIN, V10, P201, DOI 10.1097/00001721-199906000-00007; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	69	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28912	28923		10.1074/jbc.M110.119107	http://dx.doi.org/10.1074/jbc.M110.119107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605795	Green Published, hybrid			2022-12-27	WOS:000281594000056
J	Haller, O; Gao, S; von der Malsburg, A; Daumke, O; Kochs, G				Haller, Otto; Gao, Song; von der Malsburg, Alexander; Daumke, Oliver; Kochs, Georg			Dynamin-like MxA GTPase: Structural Insights into Oligomerization and Implications for Antiviral Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEPENDENT CONFORMATIONAL-CHANGE; SMOOTH ENDOPLASMIC-RETICULUM; INFLUENZA-VIRUS RESISTANCE; LA-CROSSE VIRUS; CRYSTAL-STRUCTURE; BINDING PROTEINS; INTERFERON; MICE; GENE; EXPRESSION	The interferon-inducible MxA GTPase is a key mediator of cell-autonomous innate immunity against a broad range of viruses such as influenza and bunyaviruses. MxA shares a similar domain structure with the dynamin superfamily of mechanochemical enzymes, including an N-terminal GTPase domain, a central middle domain, and a C-terminal GTPase effector domain. Recently, crystal structures of a GTPase domain dimer of dynamin 1 and of the oligomerized stalk of MxA (built by the middle and GTPase effector domains) were determined. These data provide exciting insights into the architecture and antiviral function of the MxA oligomer. Moreover, the structural knowledge paves the way for the development of novel antiviral drugs against influenza and other highly pathogenic viruses.	[Haller, Otto; von der Malsburg, Alexander; Kochs, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-79104 Freiburg, Germany; [Gao, Song; Daumke, Oliver] Max Delbruck Ctr Mol Med, Dept Crystallog, D-13125 Berlin, Germany	University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Haller, O (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	otto.haller@uniklinik-freiburg.de		Gao, Song/0000-0001-7427-6681	German-Israeli Foundation for Scientific Research and Development [GIF-841/04]; Deutsche Forschungsgemeinschaft [Ko1579/1-8, SFB 740]; International Human Frontier Science Program Organization	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by German-Israeli Foundation for Scientific Research and Development Grant GIF-841/04 (to O. H. and G. K.), Deutsche Forschungsgemeinschaft Grants Ko1579/1-8 and SFB 740 (From Molecules to Modules), and a career development fellowship from the International Human Frontier Science Program Organization (to O. D.). This is the third article in the Thematic Minireview Series on Influenza Virus. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; ARNHEITER H, 1988, EMBO J, V7, P1315, DOI 10.1002/j.1460-2075.1988.tb02946.x; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Engelhardt OG, 2001, EXP CELL RES, V271, P286, DOI 10.1006/excr.2001.5380; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; HALLER O, 1980, NATURE, V283, P660, DOI 10.1038/283660a0; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; HALLER O, 1987, J INTERFERON RES, V7, P647, DOI 10.1089/jir.1987.7.647; HALLER O, 1979, J EXP MED, V149, P601, DOI 10.1084/jem.149.3.601; HALLER O, 1974, NATURE, V250, P679, DOI 10.1038/250679a0; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; HORISBERGER MA, 1989, J INTERFERON RES, V9, P583, DOI 10.1089/jir.1989.9.583; HORISBERGER MA, 1988, SOMAT CELL MOLEC GEN, V14, P123, DOI 10.1007/BF01534397; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; HORISBERGER MA, 1990, J VIROL, V64, P1171, DOI 10.1128/JVI.64.3.1171-1181.1990; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Jin HK, 1998, BIOCHEM GENET, V36, P311, DOI 10.1023/A:1018741312058; Johannes L, 1997, J VIROL, V71, P9792, DOI 10.1128/JVI.71.12.9792-9795.1997; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; LINDENMANN J, 1962, VIROLOGY, V16, P203, DOI 10.1016/0042-6822(62)90297-0; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MELEN K, 1992, J BIOL CHEM, V267, P25898; NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Palm M, 2007, J INTERF CYTOK RES, V27, P147, DOI 10.1089/jir.2006.0119; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; REEVES RH, 1988, J VIROL, V62, P4372, DOI 10.1128/JVI.62.11.4372-4375.1988; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Seyama T, 2006, BIOCHEM GENET, V44, P437, DOI 10.1007/s10528-006-9040-3; STAEHELI P, 1985, MOL CELL BIOL, V5, P2150, DOI 10.1128/MCB.5.8.2150; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAEHELI P, 1988, MOL CELL BIOL, V8, P4524, DOI 10.1128/MCB.8.10.4524; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x; ZURCHER T, 1992, J VIROL, V66, P5059	64	73	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28419	28424		10.1074/jbc.R110.145839	http://dx.doi.org/10.1074/jbc.R110.145839			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20538602	Green Published, hybrid			2022-12-27	WOS:000281594000004
J	Kinne, A; Kleinau, G; Hoefig, CS; Gruters, A; Kohrle, J; Krause, G; Schweizer, U				Kinne, Anita; Kleinau, Gunnar; Hoefig, Carolin S.; Grueters, Annette; Koehrle, Josef; Krause, Gerd; Schweizer, Ulrich			Essential Molecular Determinants for Thyroid Hormone Transport and First Structural Implications for Monocarboxylate Transporter 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERNDON-DUDLEY-SYNDROME; LIGAND-BINDING SITE; PSYCHOMOTOR RETARDATION; ESCHERICHIA-COLI; MCT8; IDENTIFICATION; MUTATIONS; GENE; METABOLISM; PHENOTYPE	Monocarboxylate transporter 8 (MCT8, SLC16A2) is a thyroid hormone (TH) transmembrane transport protein mutated in Allan-Herndon-Dudley syndrome, a severe X-linked psychomotor retardation. The neurological and endocrine phenotypes of patients deficient in MCT8 function underscore the physiological significance of carrier-mediated TH transmembrane transport. MCT8 belongs to the major facilitator superfamily of 12 transmembrane-spanning proteins and mediates energy-independent bidirectional transport of iodothyronines across the plasma membrane. Structural information is lacking for all TH transmembrane transporters. To gain insight into structure-function relations in TH transport, we chose human MCT8 as a paradigm. We systematically performed conventional and liquid chromatography-tandem mass spectrometry-based uptake measurements into MCT8-transfected cells using a large number of compounds structurally related to iodothyronines. We found that human MCT8 is specific for L-iodothyronines and requires at least one iodine atom per aromatic ring. Neither thyronamines, decarboxylated metabolites of iodothyronines, nor triiodothyroacetic acid and tetraiodothyroacetic acid, TH derivatives lacking both chiral center and amino group, are substrates for MCT8. The polyphenolic flavonoids naringenin and F21388, potent competitors for TH binding at transthyretin, did not inhibit T-3 transport, suggesting that MCT8 can discriminate its ligand better than transthyretin. Bioinformatic studies and a first molecular homology model of MCT8 suggested amino acids potentially involved in substrate interaction. Indeed, alanine mutation of either Arg(445) (helix 8) or Asp(498) (helix 10) abrogated T-3 transport activity of MCT8, supporting their predicted role in substrate recognition. The MCT8 model allows us to rationalize potential interactions of amino acids including those mutated in patients with Allan-Herndon-Dudley syndrome.	[Kinne, Anita; Hoefig, Carolin S.; Koehrle, Josef; Schweizer, Ulrich] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Kleinau, Gunnar; Grueters, Annette] Charite, Inst Expt Padiatr Endokrinol, D-13353 Berlin, Germany; [Kleinau, Gunnar; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Schweizer, U (corresponding author), Charite, Inst Expt Endokrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	ulrich.schweizer@charite.de	Kleinau, Gunnar/GPX-6330-2022; Schweizer, Ulrich/E-8105-2013; Köhrle, Josef/AAH-6438-2020	Köhrle, Josef/0000-0002-9187-9078; Schweizer, Ulrich/0000-0003-1380-4780	Deutsche Forschungsgemeinschaft (DFG) [SFB665 TP A7-2]; Charite; EnForCe	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Charite; EnForCe	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) Project SFB665 TP A7-2, Charite, and EnForCe.	Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; AUFMKOLK M, 1986, J BIOL CHEM, V261, P1623; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 2005, EUR J ENDOCRINOL, V153, P359, DOI 10.1530/eje.1.01980; CAPRI Y, 2009, 2 ELA RES FDN C LUX; DeLano W.L, PYMOL MOL GRAPHICS S; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; FRIESEMA EC, 2009, 34 ANN M EUR THYR AS; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2010, MOL CELL ENDOCRINOL, V322, P107, DOI 10.1016/j.mce.2010.01.016; Frints SGM, 2008, EUR J HUM GENET, V16, P1029, DOI 10.1038/ejhg.2008.66; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Ianculescu AG, 2009, ENDOCRINOLOGY, V150, P1991, DOI 10.1210/en.2008-1339; Jansen J, 2008, ENDOCRINOLOGY, V149, P2184, DOI 10.1210/en.2007-1475; Kinne A, 2009, J MOL ENDOCRINOL, V43, P263, DOI 10.1677/JME-09-0043; KOEHRLE J, 1986, J BIOL CHEM, V261, P1613; Kohrle J, 1984, Horm Metab Res Suppl, V14, P42; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; NAMBA N, 2009, 91 ANN M END SOC WAS; Nascimento AS, 2006, J MOL BIOL, V360, P586, DOI 10.1016/j.jmb.2006.05.008; Papadimitriou A, 2008, PEDIATRICS, V121, pE199, DOI 10.1542/peds.2007-1247; Piehl S, 2008, ENDOCRINOLOGY, V149, P3037, DOI 10.1210/en.2007-1678; Piehl S, 2008, RAPID COMMUN MASS SP, V22, P3286, DOI 10.1002/rcm.3732; RAYMOND L, 2008, EUR HUM GEN C BARC S; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Schweizer U, 2008, MOL CELL ENDOCRINOL, V289, P1, DOI 10.1016/j.mce.2008.04.007; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Vaurs-Barriere C, 2009, ANN NEUROL, V65, P114, DOI 10.1002/ana.21579; Visser WE, 2009, ENDOCRINOLOGY, V150, P5163, DOI 10.1210/en.2009-0699; Visser WE, 2009, HUM MUTAT, V30, P29, DOI 10.1002/humu.20808; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; WOOD T, 2008, EUR HUM GEN C BARC S; Wu SY, 2005, THYROID, V15, P943, DOI 10.1089/thy.2005.15.943	51	83	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28054	28063		10.1074/jbc.M110.129577	http://dx.doi.org/10.1074/jbc.M110.129577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20628049	Green Published, hybrid			2022-12-27	WOS:000288742300004
J	Shu, S; Liu, XO; Kriebel, PW; Hong, MS; Daniels, MP; Parent, CA; Korn, ED				Shu, Shi; Liu, Xiong; Kriebel, Paul W.; Hong, Myoung-Soon; Daniels, Mathew P.; Parent, Carole A.; Korn, Edward D.			Expression of Y53A-Actin in Dictyostelium Disrupts the Cytoskeleton and Inhibits Intracellular and Intercellular Chemotactic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN TYROSINE PHOSPHORYLATION; COLLECTIVE CELL-MIGRATION; II-INDEPENDENT PROCESSES; HEAVY-CHAIN GENE; MYOSIN-II; ADENYLYL-CYCLASE; IN-VIVO; ACANTHAMOEBA MYOSIN; DISCOIDEUM CELLS; CLEAVAGE FURROW	We showed previously that phosphorylation of Tyr(53), or its mutation to Ala, inhibits actin polymerization in vitro with formation of aggregates of short filaments, and that expression of Y53A-actin in Dictyostelium blocks differentiation and development at the mound stage (Liu, X., Shu, S., Hong, M. S., Levine, R. L., and Korn, E. D. (2006) Proc. Natl. Acad. Sci. U.S.A. 103, 13694-13699; Liu, X., Shu, S., Hong, M. S., Yu, B., and Korn, E. D. (2010) J. Biol. Chem. 285, 9729-9739). We now show that expression of Y53A-actin, which does not affect cell growth, phagocytosis, or pinocytosis, inhibits the formation of head-to-tail cell streams during cAMP-induced aggregation, although individual amoebae chemotax normally. We show that expression of Y53A-actin causes a 50% reduction of cell surface cAMP receptors, and inhibits cAMP-induced increases in adenylyl cyclase A activity, phosphorylation of ERK2, and actin polymerization. Trafficking of vesicles containing adenylyl cyclase A to the rear of the cell and secretion of the ACA vesicles are also inhibited. The actin cytoskeleton of cells expressing Y53A-actin is characterized by numerous short filaments, and bundled and aggregated filaments similar to the structures formed by copolymerization of purified Y53A-actin and wild-type actin in vitro. This disorganized actin cytoskeleton may be responsible for the inhibition of intracellular and intercellular cAMP signaling in cells expressing F-Y53A-actin.	[Shu, Shi; Liu, Xiong; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Kriebel, Paul W.; Parent, Carole A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hong, Myoung-Soon; Daniels, Mathew P.] NHLBI, Electtron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	National Institutes of Health, NHLBI; NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010418] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035, ZIAHL000506, ZICHL005906] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the National Institute of Health, NHLBI, and NCI, Center for Cancer Research.	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Breshears LM, 2010, P NATL ACAD SCI USA, V107, P6918, DOI 10.1073/pnas.0909796107; Brzostowski JA, 2006, MOL BIOL CELL, V17, P4220, DOI 10.1091/mbc.E06-05-0376; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Clow PA, 1999, MOL BIOL CELL, V10, P1309, DOI 10.1091/mbc.10.5.1309; COMBEAU C, 1992, J BIOL CHEM, V267, P14038; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; COOK RK, 1992, J BIOL CHEM, V267, P9430; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; EGELHOFF TT, 1991, J CELL BIOL, V112, P677, DOI 10.1083/jcb.112.4.677; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Fey P, 1999, DEV BIOL, V212, P414, DOI 10.1006/dbio.1999.9353; Garcia GL, 2008, J MICROSC-OXFORD, V231, P529, DOI 10.1111/j.1365-2818.2008.02066.x; Gauthier ML, 1997, CELL SIGNAL, V9, P79, DOI 10.1016/S0898-6568(96)00113-1; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; Kamimura Y, 2009, METHODS MOL BIOL, V571, P255, DOI 10.1007/978-1-60761-198-1_17; Kishi Y, 1998, J CELL SCI, V111, P2923; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kriebel PW, 2009, METHODS MOL BIOL, V571, P111, DOI 10.1007/978-1-60761-198-1_7; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Liao XH, 2009, METHODS MOL BIOL, V571, P271, DOI 10.1007/978-1-60761-198-1_18; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Liu X, 2010, J BIOL CHEM, V285, P9729, DOI 10.1074/jbc.M109.073452; Maeda M, 1996, J BIOL CHEM, V271, P3351; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Neujahr R, 1997, J CELL SCI, V110, P123; Noegel AA, 2000, J CELL SCI, V113, P759; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; SAXE CL, 1991, GENE DEV, V5, P1, DOI 10.1101/gad.5.1.1; SCHWEIGER A, 1992, J CELL SCI, V102, P601; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Shu S, 2003, P NATL ACAD SCI USA, V100, P6499, DOI 10.1073/pnas.0732155100; Shu S, 2002, J CELL SCI, V115, P4237, DOI 10.1242/jcs.00112; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; Vicker MG, 2008, EUR J CELL BIOL, V87, P845, DOI 10.1016/j.ejcb.2008.03.010; Wang YW, 1998, BIOCHEM BIOPH RES CO, V244, P149, DOI 10.1006/bbrc.1997.8118; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Zang JH, 1997, MOL BIOL CELL, V8, P2617, DOI 10.1091/mbc.8.12.2617	65	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27713	27725		10.1074/jbc.M110.116277	http://dx.doi.org/10.1074/jbc.M110.116277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20610381	hybrid, Green Published			2022-12-27	WOS:000281404100027
J	Damkier, HH; Aalkjaer, C; Praetorius, J				Damkier, Helle Hasager; Aalkjaer, Christian; Praetorius, Jeppe			Na+-dependent HCO3- Import by the slc4a10 Gene Product Involves Cl- Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROGENIC NA+-HCO3-COTRANSPORTER; MOUSE CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; PLASMA-MEMBRANE; EXCHANGER; STOICHIOMETRY; DISRUPTION; EXPRESSION; CLONING; NBC4	The slc4a10 gene encodes an electroneutral Na+-dependent HCO3- importer for which the precise mode of action remains unsettled. To resolve this issue, intracellular pH (pH(i)) recordings were performed upon acidification in the presence of CO2/HCO3- by 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF) fluorometry of stably slc4a10-transfected NIH-3T3 fibroblasts. slc4a10 expression induced a significant Na+-dependent pHi recovery, which was accompanied by an increase in the intracellular Na+ concentration evaluated by use of the Na+-sensitive fluorophore CoroNa Green. The estimated Na+:HCO3- stoichiometry was 1:2. Cl- is most likely the counterion maintaining electroneutrality because (i) Na+-dependent pH(i) recovery was eliminated in Cl--depleted cells; (ii) acute extracellular Cl- removal led to a larger alkalization in slc4a10-transfected cells than in control cells; and (iii) the 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (DIDS)sensitive and Na+- and HCO3--dependent Cl-36(-)-efflux during pHi recovery was significantly greater in acidified slc4a10-transfected cells than in control cells. Charged amino acids specific to slc4a gene family members that transport Na+ and are expected to move more HCO3- molecules/turnover were targeted by site-directed mutagenesis. Na+-dependent pHi recovery was reduced in each of the single amino acid mutated cell lines (E890A, E892A, H976L, and H980G) compared with wild type slc4a10-transfected cells and completely eliminated in quadruple mutant cells. In conclusion, the data suggest that slc4a10 expressed in mammalian cells encodes a Na+-dependent Cl-/HCO3- exchanger in which four specific charged amino acids seem necessary for ion transport.	[Damkier, Helle Hasager; Aalkjaer, Christian; Praetorius, Jeppe] Aarhus Univ, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; [Damkier, Helle Hasager; Praetorius, Jeppe] Aarhus Univ, Dept Anat, DK-8000 Aarhus, Denmark; [Aalkjaer, Christian] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Damkier, HH (corresponding author), Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	hd@ana.au.dk	Praetorius, Jeppe/AAU-7893-2020	Praetorius, Jeppe/0000-0001-6109-247X; Damkier, Helle/0000-0001-7518-4017; Aalkjaer, Christian/0000-0003-2618-4015	Danish Medical Research Council; Karen Elise Jensens Fond; Lundbeck Foundation; Aarhus University Research Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danmarks Grundforskningsfond); Faculty of Health Sciences, Aarhus University	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Karen Elise Jensens Fond; Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond); Faculty of Health Sciences, Aarhus University	This work was supported by the Danish Medical Research Council, Karen Elise Jensens Fond, the Lundbeck Foundation, Aarhus University Research Foundation, and the Novo Nordisk Foundation. The Water and Salt Research Center at Aarhus University was established and funded by the Danish National Research Foundation (Danmarks Grundforskningsfond).; Supported by the Faculty of Health Sciences, Aarhus University.	BORON W, 2009, MED PHYSL, P667; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Gross E, 2001, J PHYSIOL-LONDON, V531, P597, DOI 10.1111/j.1469-7793.2001.0597h.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Millar ID, 2008, BIOCHEM BIOPH RES CO, V373, P550, DOI 10.1016/j.bbrc.2008.06.053; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	19	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26998	27007		10.1074/jbc.M110.108712	http://dx.doi.org/10.1074/jbc.M110.108712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566632	hybrid, Green Published			2022-12-27	WOS:000281172700031
J	Ohkawa, Y; Miyazaki, S; Hamamura, K; Kambe, M; Miyata, M; Tajima, O; Ohmi, Y; Yamauchi, Y; Furukawa, K; Furukawa, K				Ohkawa, Yuki; Miyazaki, Sayaka; Hamamura, Kazunori; Kambe, Mariko; Miyata, Maiko; Tajima, Orie; Ohmi, Yuhsuke; Yamauchi, Yoshio; Furukawa, Koichi; Furukawa, Keiko			Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY; LINKED KINASE; TUMOR GANGLIOSIDES; PLATELET-ADHESION; SYNTHASE GENE; LIPID RAFTS; PHASE-I	Ganglioside GD3 is widely expressed in human malignant melanoma cell lines and tumors. Previously, we reported that GD(3+) cells show stronger tyrosine phosphorylation of focal adhesion kinase (FAK), p130(Cas), and paxillin when treated with fetal calf serum than GD3 - cells. In this study, we analyzed the changes in the signals mediated by the interaction between integrins and extracellular matrices (ECM) to clarify how GD3 enhances cell signals in the vicinity of the cell membrane. An adhesion assay with a real time cell electronic sensing system revealed that GD3 + cells had stronger adhesion to all extracellular matrices examined. In particular, GD3 + cells attached more strongly to collagen type I and type IV than controls. Correspondingly, they showed stronger tyrosine phosphorylation of FAK and paxillin during adhesion to collagen type I. In the floating pattern of detergent extracts, a high level of integrin beta 1 was found in glycolipid-enriched microdomain (GEM)/rafts in GD3 + cells before adhesion, whereas a smaller amount of integrin beta 1 was detected in the GEM/rafts of controls. Some phosphorylated forms of FAK as well as total FAK were found in GEM/rafts during cell adhesion only in GD3 + cells. Another signal consisting of integrin-linked kinase/Akt was also activated during adhesion more strongly in GD3 + cells than in controls. In double stained GD3 + cells, GD3 and integrin beta 1 co-localized at the focal adhesion with a punctate pattern. All these results suggested that integrins assembled and formed a cluster in GEM/rafts, leading to the enhanced signaling and malignant properties under GD3 expression.	[Ohkawa, Yuki; Miyazaki, Sayaka; Hamamura, Kazunori; Tajima, Orie; Ohmi, Yuhsuke; Yamauchi, Yoshio; Furukawa, Koichi; Furukawa, Keiko] Nagoya Univ, Dept Biochem 2, Grad Sch Med, Showa Ku, Nagoya, Aichi 4660065, Japan; [Kambe, Mariko; Miyata, Maiko; Tajima, Orie; Furukawa, Keiko] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan; [Kambe, Mariko; Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Chubu University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Dept Biochem 2, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp; keikofu@isc.chubu.ac.jp	OHMI, Yuhsuke/I-7302-2014; Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Hamamura, Kazunori/0000-0002-8143-338X	Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid from Japan Science and Technology Agency (JST), a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and a grant from the COE Project for Private Universities from MEXT.	Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; CARUBIA JM, 1984, BIOCHEM BIOPH RES CO, V120, P500, DOI 10.1016/0006-291X(84)91282-8; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Charalabopoulos K, 2005, EXP ONCOL, V27, P86; Chen HH, 2003, INT J CANCER, V103, P169, DOI 10.1002/ijc.10797; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; DIPPOLD WG, 1984, CANCER RES, V44, P806; Fang LH, 1997, CLIN EXP METASTAS, V15, P33; Forero A, 2006, CANCER BIOTHER RADIO, V21, P561, DOI 10.1089/cbr.2006.21.561; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Furukawa K., 1990, HUMAN MELANOMA BASIC, P15; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GRIFFITHS SL, 1986, J CELL BIOL, V102, P469, DOI 10.1083/jcb.102.2.469; HAKOMORI SI, 1993, ADV LIPID RES, V25, P147; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Hur EM, 2004, J BIOL CHEM, V279, P5852, DOI 10.1074/jbc.M311687200; ILIOPOULOS D, 1989, J NATL CANCER I, V81, P440, DOI 10.1093/jnci/81.6.440; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakano J, 1996, J INVEST DERMATOL, V107, P543, DOI 10.1111/1523-1747.ep12582802; Nakano J, 1999, J INVEST DERM SYMP P, V4, P173, DOI 10.1038/sj.jidsp.5640204; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ogita H, 2008, INT REV CYTOL, V265, P1, DOI 10.1016/S0074-7696(07)65001-3; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; PORTOUKALIAN J, 1979, EUR J BIOCHEM, V94, P19, DOI 10.1111/j.1432-1033.1979.tb12866.x; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Saito M, 1999, J BONE MINER RES, V14, P65, DOI 10.1359/jbmr.1999.14.1.65; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Turner CE, 2000, J CELL SCI, V113, P4139; Valentino LA, 1996, BBA-MOL BASIS DIS, V1316, P19, DOI 10.1016/0925-4439(95)00092-5; Wang XQ, 2001, J BIOL CHEM, V276, P8436, DOI 10.1074/jbc.M006097200; Weiss M, 2003, CANCER RES, V63, P3654; Wen FQ, 1999, ARTERIOSCL THROM VAS, V19, P519, DOI 10.1161/01.ATV.19.3.519; Wong RPC, 2007, MOL CANCER THER, V6, P1692, DOI 10.1158/1535-7163.MCT-07-0134; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yoshida S, 2001, CANCER RES, V61, P4244; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	55	76	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27213	27223		10.1074/jbc.M109.087791	http://dx.doi.org/10.1074/jbc.M109.087791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20581115	Green Published, hybrid			2022-12-27	WOS:000281172700052
J	Bi, LK; Gojestani, S; Wu, WH; Hsu, YMS; Zhu, JY; Ariizumi, K; Lin, X				Bi, Liangkuan; Gojestani, Sara; Wu, Weihui; Hsu, Yen-Michael S.; Zhu, Jiayuan; Ariizumi, Kiyoshi; Lin, Xin			CARD9 Mediates Dectin-2-induced I kappa B alpha Kinase Ubiquitination Leading to Activation of NF-kappa B in Response to Stimulation by the Hyphal Form of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; C-TYPE LECTIN; INNATE IMMUNE-RESPONSES; ADAPTER PROTEIN CARD9; ANTIFUNGAL IMMUNITY; FUNGAL-INFECTIONS; HOST-DEFENSE; DECTIN-1; INDUCTION; CELLS	The scaffold protein CARD9 plays an essential role in anti-fungus immunity and is implicated in mediating Dectin-1/Syk-induced NF-kappa B activation in response to Candida albicans infection. However, the molecular mechanism by which CARD9 mediates C. albicans-induced NF-kappa B activation is not fully characterized. Here we demonstrate that CARD9 is involved in mediating NF-kappa B activation induced by the hyphal form of C. albicans hyphae (Hyphae) but not by its heat-inactivated unicellular form. Our data show that inhibiting Dectin-2 expression selectively blocked Hyphae-induced NF-kappa B, whereas inhibiting Dectin-1 mainly suppressed zymosan-induced NF-kappa B, indicating that Hyphae-induced NF-kappa B activation is mainly through Dectin-2 and not Dectin-1. Consistently, we find that the hyphae stimulation induces CARD9 association with Bcl10, an adaptor protein that functions downstream of CARD9 and is also involved in C. albicans-induced NF-kappa B activation. This association is dependent on Dectin-2 but not Dectin-1 following the hyphae stimulation. Finally, we find that although both CARD9 and Syk are required for Hyphae-induced NF-kappa B activation, they regulate different signaling events in which CARD9 mediates I kappa B alpha kinase ubiquitination, whereas Syk regulates I kappa B alpha kinase phosphorylation. Together, our data demonstrated that CARD9 is selectively involved in Dectin-2-induced NF-kappa B activation in response to C. albicans hyphae challenging.	[Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 108, Houston, TX 77030 USA; [Bi, Liangkuan; Zhu, Jiayuan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510080, Guangdong, Peoples R China; [Gojestani, Sara; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Hsu, Yen-Michael S.; Lin, Xin] Univ Texas Houston, Grad Sch Biomed Sci, Program Immunol, Houston, TX 77030 USA; [Ariizumi, Kiyoshi] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Unit 108, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xllin@mdanderson.org			National Institutes of Health [RO1AI050848, RO1GM079451, R01GM065899]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079451, R01GM065899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI050848, RO1GM079451, and R01GM065899 (to X. L.). This work was also supported in part by a Graduate Student Fellowship from the China Scholarship Council (to L. B.).	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mora-Montes HM, 2004, GLYCOBIOLOGY, V14, P593, DOI 10.1093/glycob/cwh091; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963	35	85	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25969	25977		10.1074/jbc.M110.131300	http://dx.doi.org/10.1074/jbc.M110.131300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20538615	Green Published, hybrid			2022-12-27	WOS:000280921000011
J	Fuentealba, RA; Udan, M; Bell, S; Wegorzewska, I; Shao, J; Diamond, MI; Weihl, CC; Baloh, RH				Fuentealba, Rodrigo A.; Udan, Maria; Bell, Shaughn; Wegorzewska, Iga; Shao, Jieya; Diamond, Marc I.; Weihl, Conrad C.; Baloh, Robert H.			Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; MOTOR-NEURON DISEASE; MUTANT HUNTINGTIN; CELLULAR TOXICITY; IN-VITRO; FUNCTIONAL IMPLICATIONS; TRANSCRIPTION FACTOR; BINDING-PROPERTIES	The identification of pathologic TDP-43 aggregates in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, followed by the discovery of dominantly inherited point mutations in TDP-43 in familial ALS, have been critical insights into the mechanism of these untreatable neurodegenerative diseases. However, the biochemical basis of TDP-43 aggregation and the mechanism of how mutations in TDP-43 lead to disease remain enigmatic. In efforts to understand how TDP-43 alters its cellular localization in response to proteotoxic stress, we found that TDP-43 is sequestered into polyglutamine aggregates. Furthermore, we found that binding to polyglutamine aggregates requires a previously uncharacterized glutamine/asparagine (Q/N)-rich region in the C-terminal domain of TDP-43. Sequestration into polyglutamine aggregates causes TDP-43 to be cleared from the nucleus and become detergent-insoluble. Finally, we observed that sequestration into polyglutamine aggregates led to loss of TDP-43-mediated splicing in the nucleus and that polyglutamine toxicity could be partially rescued by increasing expression of TDP-43. These data indicate pathologic sequestration into polyglutamine aggregates, and loss of nuclear TDP-43 function may play an unexpected role in polyglutamine disease pathogenesis. Furthermore, as Q/N domains have a strong tendency to self-aggregate and in some cases can function as prions, the identification of a Q/N domain in TDP-43 has important implications for the mechanism of pathologic aggregation of TDP-43 in ALS and other neurodegenerative diseases.	[Weihl, Conrad C.; Baloh, Robert H.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Diamond, Marc I.; Weihl, Conrad C.; Baloh, Robert H.] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Baloh, RH (corresponding author), Washington Univ, Dept Neurol, Sch Med, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	rbaloh@wustl.edu		Fuentealba, Rodrigo/0000-0001-8724-091X	National Institutes of Health [NS055980, R01NS069669, R01AG031867, K08AG026271]; Neuroscience Blueprint Core [NS057105]; Hope Center for Neurological Disorders; McDonnell Center for Cellular and Molecular Neurobiology; Muscular Dystrophy Association [135428]; Children's Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069669, P30NS057105, K08NS055980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Core; Hope Center for Neurological Disorders; McDonnell Center for Cellular and Molecular Neurobiology; Muscular Dystrophy Association(Muscular Dystrophy Association); Children's Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055980 and R01NS069669 (to R. H. B.). This work was also supported by the Neuroscience Blueprint Core Grant NS057105 (to Washington University), the Hope Center for Neurological Disorders, the McDonnell Center for Cellular and Molecular Neurobiology, the Muscular Dystrophy Association Grant 135428, and Children's Discovery Institute.; Supported by National Institutes of Health Grants R01AG031867 and K08AG026271.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; KING A, NEUROPATHOL IN PRESS; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mitsui K, 2002, J NEUROSCI, V22, P9267; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Salazar AM, 2010, J NEUROSCI, V30, P515, DOI 10.1523/JNEUROSCI.2523-09.2010; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	77	119	122	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26304	26314		10.1074/jbc.M110.125039	http://dx.doi.org/10.1074/jbc.M110.125039			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554523	hybrid, Green Published			2022-12-27	WOS:000280921000048
J	Kashiwayama, Y; Tomohiro, T; Narita, K; Suzumura, M; Glumoff, T; Hiltunen, JK; Van Veldhoven, PP; Hatanaka, Y; Imanaka, T				Kashiwayama, Yoshinori; Tomohiro, Takenori; Narita, Kotomi; Suzumura, Miyuki; Glumoff, Tuomo; Hiltunen, J. Kalervo; Van Veldhoven, Paul P.; Hatanaka, Yasumaru; Imanaka, Tsuneo			Identification of a Substrate-binding Site in a Peroxisomal beta-Oxidation Enzyme by Photoaffinity Labeling with a Novel Palmitoyl Derivative	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL PROTEIN-DEFICIENCY; CHAIN FATTY-ACIDS; ACYL-COA OXIDASE; RAT-LIVER PEROXISOMES; MEMBRANE-PROTEIN; D-3-HYDROXYACYL-COA DEHYDRATASE; MULTIFUNCTIONAL ENZYME; ZELLWEGER-SYNDROME; BIOGENESIS DISORDERS; MOLECULAR-BASIS	Peroxisomes play an essential role in a number of important metabolic pathways including beta-oxidation of fatty acids and their derivatives. Therefore, peroxisomes possess various beta-oxidation enzymes and specialized fatty acid transport systems. However, the molecular mechanisms of these proteins, especially in terms of substrate binding, are still unknown. In this study, to identify the substrate-binding sites of these proteins, we synthesized a photoreactive palmitic acid analogue bearing a diazirine moiety as a photophore, and performed photoaffinity labeling of purified rat liver peroxisomes. As a result, an 80-kDa peroxisomal protein was specifically labeled by the photoaffinity ligand, and the labeling efficiency competitively decreased in the presence of palmitoyl-CoA. Mass spectrometric analysis identified the 80-kDa protein as peroxisomal multifunctional enzyme type 2 (MFE2), one of the peroxisomal beta-oxidation enzymes. Recombinant rat MFE2 was also labeled by the photoaffinity ligand, and mass spectrometric analysis revealed that a fragment of rat MFE2 (residues Trp(249) to Arg(251)) was labeled by the ligand. MFE2 mutants bearing these residues, MFE2(W249A) and MFE2(R251A), exhibited decreased labeling efficiency. Furthermore, MFE2(W249G), which corresponds to one of the disease-causing mutations in human MFE2, also exhibited a decreased efficiency. Based on the crystal structure of rat MFE2, these residues are located on the top of a hydrophobic cavity leading to an active site of MFE2. These data suggest that MFE2 anchors its substrate around the region from Trp(249) to Arg(251) and positions the substrate along the hydrophobic cavity in the proper direction toward the catalytic center.	[Tomohiro, Takenori; Suzumura, Miyuki; Hatanaka, Yasumaru] Toyama Univ, Lab Biorecognit Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Kashiwayama, Yoshinori; Narita, Kotomi; Imanaka, Tsuneo] Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Glumoff, Tuomo; Hiltunen, J. Kalervo] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Glumoff, Tuomo; Hiltunen, J. Kalervo] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Mol Cell Biol, LIPIT, B-3000 Louvain, Belgium	University of Toyama; University of Toyama; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; KU Leuven	Hatanaka, Y (corresponding author), Toyama Univ, Lab Biorecognit Chem, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	yasu@pha.u-toyama.ac.jp; imanaka@pha.u-toyama.ac.jp	, Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Imanaka, Tsuneo/0000-0003-4677-1356; Hiltunen, Kalervo/0000-0002-3073-9602	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [18590049, 18790050, 18390036, 20390032]; CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization); Fugaku Trust	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization); Fugaku Trust	This work was supported in part by Grants-in-aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan and for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18590049, 18790050, 18390036, and 20390032). This work also supported in part by grants from CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization) and the Fugaku Trust for Medicinal Research.	Adamski J, 1997, STEROIDS, V62, P159, DOI 10.1016/S0039-128X(96)00175-4; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Corey EJ, 1997, J AM CHEM SOC, V119, P12414, DOI 10.1021/ja973174y; DieuaideNoubhani M, 1997, BIOCHEM J, V321, P253, DOI 10.1042/bj3210253; DieuaideNoubhani M, 1996, EUR J BIOCHEM, V240, P660, DOI 10.1111/j.1432-1033.1996.0660h.x; DieuaideNoubhani M, 1997, BIOCHEM J, V325, P367, DOI 10.1042/bj3250367; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ferdinandusse S, 2006, AM J HUM GENET, V78, P112, DOI 10.1086/498880; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0; Hashimoto M, 2002, BIOORG MED CHEM LETT, V12, P2507, DOI 10.1016/S0960-894X(02)00522-X; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Huyghe S, 2006, BBA-MOL CELL BIOL L, V1761, P973, DOI 10.1016/j.bbalip.2006.04.006; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 1996, J BIOL CHEM, V271, P3706; Jiang LL, 1996, J BIOCHEM, V120, P633; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; Leenders F, 1996, J BIOL CHEM, V271, P5438, DOI 10.1074/jbc.271.10.5438; LI JX, 1990, J BIOL CHEM, V265, P13629; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MANGROO D, 1993, BIOCHIM BIOPHYS ACTA, V1168, P280, DOI 10.1016/0005-2760(93)90183-A; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Nakashima H, 2006, J AM CHEM SOC, V128, P15092, DOI 10.1021/ja066479y; Novikov D, 1997, BBA-MOL BASIS DIS, V1360, P229, DOI 10.1016/S0925-4439(97)00003-3; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; OSUMI T, 1979, BIOCHEM BIOPH RES CO, V89, P580, DOI 10.1016/0006-291X(79)90669-7; Qin YM, 1997, BIOCHEM J, V321, P21, DOI 10.1042/bj3210021; Qin YM, 1997, BIOCHEM J, V328, P377, DOI 10.1042/bj3280377; RAJASEKHARAN R, 1993, BIOCHEMISTRY-US, V32, P12386, DOI 10.1021/bi00097a016; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; VANHOVE GF, 1993, J BIOL CHEM, V268, P10335; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001	53	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26315	26325		10.1074/jbc.M110.104547	http://dx.doi.org/10.1074/jbc.M110.104547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566640	Green Published, hybrid			2022-12-27	WOS:000280921000049
J	Kawano, S; Miyaji, M; Ichiyasu, S; Tsutsui, KM; Tsutsui, K				Kawano, Shinji; Miyaji, Mary; Ichiyasu, Shoko; Tsutsui, Kimiko M.; Tsutsui, Ken			Regulation of DNA Topoisomerase II beta through RNA-dependent Association with Heterogeneous Nuclear Ribonucleoprotein U (hnRNP U)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT REGION DNA; BINDING-PROTEIN; SAF-A; EXPRESSION; TRANSCRIPTION; GENES; IDENTIFICATION; ISOFORMS; ELEMENTS; BRAIN	Recent studies suggest that DNA topoisomerase II beta (topo II beta) is involved in transcriptional activation of certain genes, which assumes accurate targeting of the enzyme to its action site. The target selection may be achieved by cooperation with unknown regulatory factors. To seek out such factors, we looked for proteins associated with the enzyme in differentiating cerebellar neurons. Antibody against topo II beta co-precipitated RNA-binding proteins including PSF, NonO/p54nrb, as well as hnRNP U/SAF-A/SP120. Reconstitution experiments with tag-purified proteins showed that topo II beta associates stoichiometrically with SP120 in the presence of RNA that was co-purified with SP120. The most effective RNA species for the complex formation was a subset of cellular polyadenylated RNAs. The C-terminal 187-residue domain of SP120 was necessary and sufficient for the association with both topo II beta and the endogenous RNA. The RNA isolated from the tag-purified SP120 inhibited the relaxation of supercoiled DNA by topo II beta. When the enzyme associates with SP120, however, the inhibition was abolished and the catalytic property was modulated to more processive mode, which may prolong its residence time at the genomic target site. Furthermore, the presence of SP120 was required for the stable expression of topo II beta in vivo. Thus, SP120 regulates the enzyme in dual ways.	[Tsutsui, Ken] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Dynam, Okayama 7008558, Japan; [Kawano, Shinji; Miyaji, Mary; Ichiyasu, Shoko; Tsutsui, Kimiko M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurogenom, Okayama 7008558, Japan	Okayama University; Okayama University	Tsutsui, K (corresponding author), 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tsukken@cc.okayama-u.ac.jp	Tsutsui, Ken/B-1863-2011; TSUTSUI, Kimiko M/B-1955-2011; MIYAJI, Mary/B-2294-2011		MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for scientific research funding (to K. T.) from the MEXT, Japan.	Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; CHUNG TDY, 1989, P NATL ACAD SCI USA, V86, P9431, DOI 10.1073/pnas.86.23.9431; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Eggert H, 2001, J STEROID BIOCHEM, V78, P59, DOI 10.1016/S0960-0760(01)00074-7; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Park SW, 2008, NUCLEIC ACIDS RES, V36, P6080, DOI 10.1093/nar/gkn614; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Roshon MJ, 2005, TRANSGENIC RES, V14, P179, DOI 10.1007/s11248-004-8147-8; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; TSUTSUI K, 1993, J BIOL CHEM, V268, P12886; TSUTSUI K, 1993, J BIOL CHEM, V268, P19076; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	28	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26451	26460		10.1074/jbc.M110.112979	http://dx.doi.org/10.1074/jbc.M110.112979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554522	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000280921000063
J	Basu, A; Datta, D; Zurakowski, D; Pal, S				Basu, Aninda; Datta, Dipak; Zurakowski, David; Pal, Soumitro			Altered VEGF mRNA Stability following Treatments with Immunosuppressive Agents IMPLICATIONS FOR CANCER DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYCLOSPORINE-A; BINDING PROTEIN; ACTIVATION; HUR; OVEREXPRESSION; CALCINEURIN; CELLS; TRANSPLANTATION; STABILIZATION	The high incidence of cancer and its aggressive progression is a common and major problem in patients receiving immunosuppressive therapy. The calcineurin inhibitors (CNIs) may have protumorigenic effects and can promote the overexpression of several molecules inducing tumor growth. We have recently demonstrated that CNIs can mediate the transcriptional activation of the angiogenic cytokine vascular endothelial growth factor (VEGF) and promote a rapid progression of human renal cancer. Here, we investigated whether the CNI cyclosporine (CsA) and the mTOR inhibitor rapamycin (RAPA) could alter the mRNA stability of VEGF in 786-0 and Caki-1 renal cancer cells. Following actinomycin D treatment, we observed that CsA increased, whereas RAPA decreased the VEGF mRNA stability as observed by real time PCR. It is established that the mRNA-binding protein HuR may play a critical role in VEGF mRNA stability. By using HuR-siRNA, we found that the knockdown of HuR significantly decreased the CNI-induced VEGF mRNA stability. By Western blot analysis, it has been observed that CNI treatment induced the translocation of HuR from the nucleus to the cytoplasm; CNIs also induced the association between HuR and PKC-delta and promoted the phosphorylation of HuR. Finally, we found that the inhibition of PKC-delta using a dominant negative plasmid significantly decreased the CsA-induced cytoplasmic translocation of HuR and VEGF mRNA stability. Together, targeting the pathways that promote CNI-induced transcription as well as the mRNA stability of VEGF might serve as novel therapeutics for the prevention and treatment of cancer in immunosuppressed patients.	[Basu, Aninda; Datta, Dipak; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Basu, Aninda; Datta, Dipak; Pal, Soumitro] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Zurakowski, David] Childrens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Basu, Aninda; Datta, Dipak; Zurakowski, David; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 and John-Merrill Grant ASN-AST (to S.P.).	Basu A, 2008, CANCER RES, V68, P5689, DOI 10.1158/0008-5472.CAN-07-6603; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Chen CG, 2009, J SURG RES, V153, P156, DOI 10.1016/j.jss.2008.03.017; Cho CS, 2003, INT IMMUNOL, V15, P1369, DOI 10.1093/intimm/dxg138; Cho CS, 2003, CELL SIGNAL, V15, P85, DOI 10.1016/S0898-6568(02)00046-3; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Flaxenburg JA, 2004, J IMMUNOL, V172, P7503, DOI 10.4049/jimmunol.172.12.7503; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jamil B, 1999, TRANSPLANTATION, V68, P1597, DOI 10.1097/00007890-199911270-00027; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Murakami R, 2003, ARTERIOSCL THROM VAS, V23, P2034, DOI 10.1161/01.ATV.0000094234.60166.78; Nabors LB, 2001, CANCER RES, V61, P2154; Pal S, 1998, J BIOL CHEM, V273, P26277, DOI 10.1074/jbc.273.41.26277; Sindermann JR, 2002, BASIC RES CARDIOL, V97, P125, DOI 10.1007/s003950200002; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154	32	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25196	25202		10.1074/jbc.M110.119446	http://dx.doi.org/10.1074/jbc.M110.119446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554520	Green Published, hybrid			2022-12-27	WOS:000280682400012
J	Chaturvedi, R; Bansal, K; Narayana, Y; Kapoor, N; Sukumar, N; Togarsimalemath, SK; Chandra, N; Mishra, S; Ajitkumar, P; Joshi, B; Katoch, VM; Patil, SA; Balaji, KN				Chaturvedi, Rashmi; Bansal, Kushagra; Narayana, Yeddula; Kapoor, Nisha; Sukumar, Namineni; Togarsimalemath, Shambhuprasad Kotresh; Chandra, Nagasuma; Mishra, Saurabh; Ajitkumar, Parthasarathi; Joshi, Beenu; Katoch, Vishwa Mohan; Patil, Shripad A.; Balaji, Kithiganahalli N.			The Multifunctional PE_PGRS11 Protein from Mycobacterium tuberculosis Plays a Role in Regulating Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; BOVIS BCG; PHOSPHOGLYCERATE MUTASE; P38 MAPK; CYCLOOXYGENASE-2 EXPRESSION; NONREPLICATING PERSISTENCE; SCANNING MUTAGENESIS; INFECTED MACROPHAGES; ACTIVE TUBERCULOSIS; INDUCED APOPTOSIS	Mycobacterium tuberculosis utilizes unique strategies to survive amid the hostile environment of infected host cells. Infection-specific expression of a unique mycobacterial cell surface antigen that could modulate key signaling cascades can act as a key survival strategy in curtailing host effector responses like oxidative stress. We demonstrate here that hypothetical PE_PGRS11 ORF encodes a functional phosphoglycerate mutase. The transcriptional analysis revealed that PE_PGRS11 is a hypoxia-responsive gene, and enforced expression of PE_PGRS11 by recombinant adenovirus or Mycobacterium smegmatis imparted resistance to alveolar epithelial cells against oxidative stress. PE_PGRS11-induced resistance to oxidative stress necessitated the modulation of genetic signatures like induced expression of Bcl2 or COX-2. This modulation of specific antiapoptotic molecular signatures involved recognition of PE_PGRS11 by TLR2 and subsequent activation of the PI3K-ERK1/ 2-NF-kappa B signaling axis. Furthermore, PE_PGRS11 markedly diminished H2O2-induced p38 MAPK activation. Interestingly, PE_PGRS11 protein was exposed at the mycobacterial cell surface and was involved in survival of mycobacteria under oxidative stress. Furthermore, PE_PGRS11 displayed differential B cell responses during tuberculosis infection. Taken together, our investigation identified PE_PGRS11 as an in vivo expressed immunodominant antigen that plays a crucial role in modulating cellular life span restrictions imposed during oxidative stress by triggering TLR2-dependent expression of COX-2 and Bcl2. These observations clearly provide a mechanistic basis for the rescue of pathogenic Mycobacterium-infected lung epithelial cells from oxidative stress.	[Chaturvedi, Rashmi; Bansal, Kushagra; Narayana, Yeddula; Kapoor, Nisha; Sukumar, Namineni; Togarsimalemath, Shambhuprasad Kotresh; Mishra, Saurabh; Ajitkumar, Parthasarathi; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Chandra, Nagasuma] Indian Inst Sci, Supercomp Educ & Res Ctr, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Joshi, Beenu; Katoch, Vishwa Mohan] Natl Jalma Inst Leprosy & Other Mycobacterial Dis, Agra 282001, Uttar Pradesh, India; [Patil, Shripad A.] Natl Inst Mental Hlth & Neurosci, Dept Microbiol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; National Institute of Mental Health & Neurosciences - India	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	MISHRA, SAURABH/N-5686-2017; Yeddula, Narayana/H-4893-2011	MISHRA, SAURABH/0000-0003-1590-884X; KOTRESH TOGARSIMALEMATH, SHAMBHUPRASAD/0000-0003-2935-5377; Chandra, Nagasuma/0000-0002-9939-8439	Department of Biotechnology (DBT); VINNOVA (The Swedish Governmental Agency for Innovation Systems); DBT, India; Department of Science and Technology (DST); Council for Scientific and Industrial Research	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); VINNOVA (The Swedish Governmental Agency for Innovation Systems)(Vinnova); DBT, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funds from the Department of Biotechnology (DBT); a collaborative grant (to the Indian Institute of Science and Karolinska Institute) from VINNOVA (The Swedish Governmental Agency for Innovation Systems) and DBT, India; the Department of Science and Technology (DST); and the Council for Scientific and Industrial Research and by infrastructure support from the Indian Council of Medical Research (Center for Advanced Study in Molecular Medicine), DST (Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions), and University Grants Commission (special assistance).	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bansal K, 2009, SCAND J IMMUNOL, V69, P11, DOI 10.1111/j.1365-3083.2008.02190.x; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Barker LP, 2007, PLANTA MED, V73, P559, DOI 10.1055/s-2007-981522; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chao S, 2008, FLAVOUR FRAG J, V23, P444, DOI 10.1002/ffj.1904; Choi EM, 2005, BIOCHEM BIOPH RES CO, V328, P1107, DOI 10.1016/j.bbrc.2005.01.072; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; GRISOLIA S, 1975, PHYSIOL CHEM PHYS M, V7, P219; GRISOLIA S, 1967, BIOCHIM BIOPHYS ACTA, V132, P56, DOI 10.1016/0005-2744(67)90191-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2; HILL B, 1976, J GEN MICROBIOL, V96, P185, DOI 10.1099/00221287-96-1-185; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2005, DRUG DISCOV TODAY, V2, P263; Kralova J, 2008, ONCOGENE, V27, P3010, DOI 10.1038/sj.onc.1210960; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mendez-Samperio P, 2009, CELL IMMUNOL, V256, P12, DOI 10.1016/j.cellimm.2008.12.002; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; Paterson GK, 2009, MICROBIOL-SGM, V155, P3403, DOI 10.1099/mic.0.029553-0; PAYNE CM, 1995, LEUKEMIA LYMPHOMA, V19, P43, DOI 10.3109/10428199509059662; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Raverdy S, 2007, MOL BIOCHEM PARASIT, V156, P210, DOI 10.1016/j.molbiopara.2007.08.002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Souto EO, 2001, AM J PHYSIOL-GASTR L, V280, pG805, DOI 10.1152/ajpgi.2001.280.5.G805; STANKIEWICZ PJ, 1986, J BIOL CHEM, V261, P2715; Sun WM, 1996, J BIOL CHEM, V271, P17226, DOI 10.1074/jbc.271.29.17226; Takahashi Y, 1998, EUR J BIOCHEM, V254, P497, DOI 10.1046/j.1432-1327.1998.2540497.x; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tse HM, 2002, J IMMUNOL, V168, P825, DOI 10.4049/jimmunol.168.2.825; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10934, DOI 10.1093/nar/16.22.10934; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x	77	47	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30389	30403		10.1074/jbc.M110.135251	http://dx.doi.org/10.1074/jbc.M110.135251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20558725	Green Published, hybrid			2022-12-27	WOS:000282135500005
J	He, LJ; Horton, W; Hristova, K				He, Lijuan; Horton, William; Hristova, Kalina			Physical Basis behind Achondroplasia, the Most Common Form of Human Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-3; TRANSMEMBRANE DOMAIN; TYROSINE KINASE; FGF RECEPTORS; HEPARAN-SULFATE; DOWN-REGULATION; EGF RECEPTOR; ACTIVATION; MUTATIONS; UBIQUITYLATION	Fibroblast growth factor receptor 3 (FGFR3) is a receptor tyrosine kinase that plays an important role in long bone development. The G380R mutation in FGFR3 transmembrane domain is known as the genetic cause for achondroplasia, the most common form of human dwarfism. Despite many studies, there is no consensus about the exact mechanism underlying the pathology. To gain further understanding into the physical basis behind the disorder, here we measure the activation of wild-type and mutant FGFR3 in mammalian cells using Western blots, and we analyze the activation within the frame of a physicalchemical model describing dimerization, ligand binding, and phosphorylation probabilities within the dimers. The data analysis presented here suggests that the mutation does not increase FGFR3 dimerization, as proposed previously. Instead, FGFR3 activity in achondroplasia is increased due to increased probability for phosphorylation of the unliganded mutant dimers. This finding has implications for the design of targeted molecular treatments for achondroplasia.	[Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Horton, William] Oregon Hlth & Sci Univ, Res Ctr, Shriners Hosp Children, Dept Mol & Med Genet, Portland, OR 97239 USA	Johns Hopkins University; Oregon Health & Science University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM068619]; National Science Foundation [MCB 0718841]; Shriners Hospitals for Children [10-POR-007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068619. This work was also supported by National Science Foundation Grant MCB 0718841 and Shriners Hospitals for Children Research Grant 10-POR-007.	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; ADAMS PD, 1997, MOL B INT U, P251; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Monsonego-Ornan E, 2002, FEBS LETT, V528, P83, DOI 10.1016/S0014-5793(02)03255-6; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; VAN RHIJN BWG, 2002, EUR J HUM GENET, V10, P819; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	33	33	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30103	30114		10.1074/jbc.M109.094086	http://dx.doi.org/10.1074/jbc.M109.094086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20624921	Green Published, hybrid			2022-12-27	WOS:000281984300048
J	Planamente, S; Vigouroux, A; Mondy, S; Nicaise, M; Faure, D; Morera, S				Planamente, Sara; Vigouroux, Armelle; Mondy, Samuel; Nicaise, Magali; Faure, Denis; Morera, Solange			A Conserved Mechanism of GABA Binding and Antagonism Is Revealed by Structure-Function Analysis of the Periplasmic Binding Protein Atu2422 in Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; RHIZOBIUM-LEGUMINOSARUM; LIGAND-BINDING; SALICYLIC-ACID; RECEPTOR; LEUCINE; RECOGNITION; ARABIDOPSIS; METABOLISM; EXPRESSION	Bacterial periplasmic binding proteins (PBPs) and eukaryotic PBP-like domains (also called as Venus flytrap modules) of G-protein-coupled receptors are involved in extracellular GABA perception. We investigated the structural and functional basis of ligand specificity of the PBP Atu2422, which is implicated in virulence and transport of GABA in the plant pathogen Agrobacterium tumefaciens. Five high-resolution x-ray structures of Atu2422 liganded to GABA, Pro, Ala, and Val and of point mutant Atu2422-F77A liganded to Leu were determined. Structural analysis of the ligand-binding site revealed two essential residues, Phe77 and Tyr275, the implication of which in GABA signaling and virulence was confirmed using A. tumefaciens cells expressing corresponding Atu2422 mutants. Phe77 restricts ligand specificity to alpha-amino acids with a short lateral chain, which act as antagonists of GABA signaling in A. tumefaciens. Tyr275 specifically interacts with the GABA alpha-amino group. Conservation of these two key residues in proteins phylogenetically related to Atu2422 brought to light a subfamily of PBPs in which all members could bind GABA and short alpha-amino acids. This work led to the identification of a fingerprint sequence and structural features for defining PBPs that bind GABA and its competitors and revealed their occurrence among host-interacting proteobacteria.	[Planamente, Sara; Mondy, Samuel; Faure, Denis] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Planamente, Sara; Vigouroux, Armelle; Morera, Solange] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Nicaise, Magali] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, CNRS, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Faure, D (corresponding author), CNRS, Inst Sci Vegetal, Ave Terrasse, F-91198 Gif Sur Yvette, France.	faure@isv.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019; Planamente, Sara/ABB-4551-2020	Mondy, Samuel/0000-0002-9203-6398; Planamente, Sara/0000-0003-2778-1356	French Research Minister [ED145]; CNRS	French Research Minister; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the French Research Minister (Ecole Doctorale Sciences du Vegetal ED145, to S. P.) and by CNRS (to A.V.,S. Mondy, M.N., D.F., and S.Morera).	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Cao JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-67; Carlier A, 2004, MOL PLANT MICROBE IN, V17, P951, DOI 10.1094/MPMI.2004.17.9.951; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Crittenden DL, 2005, J PHYS CHEM A, V109, P4195, DOI 10.1021/jp050320a; Deeken R, 2006, PLANT CELL, V18, P3617, DOI 10.1105/tpc.106.044743; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Haudecoeur Elise, 2010, Commun Integr Biol, V3, P84; Haudecoeur E, 2009, MOL PLANT MICROBE IN, V22, P529, DOI 10.1094/MPMI-22-5-0529; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Huvent I, 2006, ACTA CRYSTALLOGR D, V62, P1375, DOI 10.1107/S0907444906032653; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Kumpost J, 2008, NEUROPHARMACOLOGY, V55, P409, DOI 10.1016/j.neuropharm.2008.06.073; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morera S, 2008, ACTA CRYSTALLOGR F, V64, P1153, DOI 10.1107/S1744309108036555; Prell J, 2009, J BACTERIOL, V191, P2177, DOI 10.1128/JB.01714-08; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350, DOI 10.1104/pp.106.088955; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Solomon PS, 2002, PLANTA, V214, P414, DOI 10.1007/s004250100632; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; ZUCKERKANDL E, 1965, GENES PROTEINS, P97	45	34	36	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30294	30303		10.1074/jbc.M110.140715	http://dx.doi.org/10.1074/jbc.M110.140715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630861	Green Published, hybrid			2022-12-27	WOS:000281984300065
J	Pulagam, LP; Palczewski, K				Pulagam, Lakshmi Padmavathi; Palczewski, Krzysztof			Electrostatic Compensation Restores Trafficking of the Autosomal Recessive Retinitis Pigmentosa E150K Opsin Mutant to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR RHODOPSIN; MOLECULAR-GENETICS; POINT MUTANTS; MUTATION; ORGANIZATION; EXPRESSION; STABILITY; CLONING; DOMAIN; CONES	Rhodopsin is the rod photoreceptor G protein-coupled receptor responsible for capturing light. Mutations in the gene encoding this protein can lead to a blinding disease called retinitis pigmentosa, which is inherited frequently in an autosomal dominant manner. The E150K opsin mutant associated with rarely occurring autosomal recessive retinitis pigmentosa localizes to trans-Golgi network membranes rather than to plasma membranes of rod photoreceptor cells. We investigated the molecular mechanisms underlying opsin retention in the Golgi apparatus. Electrostatic calculations reveal that the E150K mutant features an overall accumulation of positive charges between helices H-IV and H-II. Human E150K and several other closely related opsin mutants were then expressed in HEK-293 cells. Spectral characteristics and functional biochemistry of each mutant were analyzed after reconstitution with the cis-retinoid chromophore. UV-visible spectra and rhodopsin/transducin activation assays revealed only minor differences between the purified wild type control and rhodopsin mutants. However, partial restoration of the surface electrostatic charge in the compensatory R69E/E150K double mutant rescues the plasma membrane localization of opsin. These findings emphasize the fundamental importance of electrostatic interactions for appropriate membrane trafficking of opsin and advance our understanding of the pathophysiology of autosomal recessive retinitis pigmentosa due to the E150K mutation.	[Pulagam, Lakshmi Padmavathi; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Pulagam, Lakshmi/E-8166-2012		National Institutes of Health [EY008061, GM079191, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R29EY008061, P30EY011373, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061, GM079191, and P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azam M, 2009, MOL VIS, V15, P2526; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Curcio CA, 2000, INVEST OPHTH VIS SCI, V41, P2015; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gould DJ, 2000, GENE THER, V7, P2061, DOI 10.1038/sj.gt.3301354; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kienle N, 2009, BIOCHEM SOC T, V37, P787, DOI 10.1042/BST0370787; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KUMARAMANICKAVEL G, 1994, NAT GENET, V8, P10, DOI 10.1038/ng0994-10; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; NATHANS J, 1992, ANNU REV GENET, V26, P403, DOI 10.1146/annurev.ge.26.120192.002155; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; OBrien J, 1997, GENE, V193, P141, DOI 10.1016/S0378-1119(97)00079-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; RODIECK RW, 1998, 1 STEPS SEEING, P36; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	51	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29446	29456		10.1074/jbc.M110.151407	http://dx.doi.org/10.1074/jbc.M110.151407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628051	Green Published, hybrid			2022-12-27	WOS:000281740100047
J	Arragain, S; Handelman, SK; Forouhar, F; Wei, FY; Tomizawa, K; Hunt, JF; Douki, T; Fontecave, M; Mulliez, E; Atta, M				Arragain, Simon; Handelman, Samuel K.; Forouhar, Farhad; Wei, Fan-Yan; Tomizawa, Kazuhito; Hunt, John F.; Douki, Thierry; Fontecave, Marc; Mulliez, Etienne; Atta, Mohamed			Identification of Eukaryotic and Prokaryotic Methylthiotransferase for Biosynthesis of 2-Methylthio-N-6-threonylcarbamoyladenosine in tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIAB PROTEIN; ADENOSYLMETHIONINE; METHYLATION; THIOLATION; ENZYME; GENE; METHYLTHIOLATION; DERIVATIVES; EXPRESSION; IRON	Bacterial and eukaryotic transfer RNAs have been shown to contain hypermodified adenosine, 2-methylthio-N-6-threonylcarbamoyladenosine, at position 37 (A(37)) adjacent to the 3'-end of the anticodon, which is essential for efficient and highly accurate protein translation by the ribosome. Using a combination of bioinformatic sequence analysis and in vivo assay coupled to HPLC/MS technique, we have identified, from distinct sequence signatures, two methylthiotransferase (MTTase) subfamilies, designated as MtaB in bacterial cells and e-MtaB in eukaryotic and archaeal cells. Both subfamilies are responsible for the transformation of N-6-threonylcarbamoyladenosine into 2-methylthio-N-6-threonylcarbamoyladenosine. Recently, a variant within the human CDKAL1 gene belonging to the e-MtaB subfamily was shown to predispose for type 2 diabetes. CDKAL1 is thus the first eukaryotic MTTase identified so far. Using purified preparations of Bacillus subtilis MtaB (YqeV), a CDKAL1 bacterial homolog, we demonstrate that YqeV/CDKAL1 enzymes, as the previously studied MTTases MiaB and RimO, contain two [4Fe-4S] clusters. This work lays the foundation for elucidating the function of CDKAL1.	[Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Arragain, Simon; Fontecave, Marc; Mulliez, Etienne; Atta, Mohamed] Commissariat Energie Atom Grenoble, UMR CEA CNRS UJF 5249, IRTSV LCBM, F-38054 Grenoble 09, France; [Handelman, Samuel K.; Forouhar, Farhad; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Handelman, Samuel K.; Forouhar, Farhad; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Douki, Thierry] Commissariat Energie Atom Grenoble, DSM INaC SCIB UMR E3 CEA UJF, Lab Les Acides Nucle, F-38054 Grenoble 09, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	Kumamoto University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Columbia University; Columbia University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France	Wei, FY (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Honjo 1-1-1, Kumamoto 8608556, Japan.	fywei@kumamoto-u.ac.jp; mohamed.atta@cea.fr	Arragain, Simon/AAA-6356-2019; Thierry, Douki/H-2108-2018; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015	Arragain, Simon/0000-0002-6500-0066; Thierry, Douki/0000-0002-5022-071X; Tomizawa, Kazuhito/0000-0002-5663-2627; Wei, Fan-Yan/0000-0002-4843-724X; Handelman, Samuel/0000-0001-6970-2172	Region Rhone Alpes [CIBLE2010]	Region Rhone Alpes(Region Auvergne-Rhone-Alpes)	Supported by Region Rhone Alpes CIBLE2010.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516; Auxilien S, 1999, J BIOL CHEM, V274, P4412, DOI 10.1074/jbc.274.7.4412; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Durant PC, 2005, BIOCHEMISTRY-US, V44, P8078, DOI 10.1021/bi050343f; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2008, CHEM BIOL, V15, P209, DOI 10.1016/j.chembiol.2008.02.011; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; McCrate NE, 2006, NUCLEIC ACIDS RES, V34, P5361, DOI 10.1093/nar/gkl580; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; REDDY DM, 1992, NUCLEIC ACIDS RES, V20, P5607, DOI 10.1093/nar/20.21.5607; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turgay K, 1998, EMBO J, V17, P6730; Yang MM, 2010, MOL BIOL REP, V37, P2207, DOI 10.1007/s11033-009-9704-2	30	92	98	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28425	28433		10.1074/jbc.M110.106831	http://dx.doi.org/10.1074/jbc.M110.106831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20584901	hybrid, Green Published			2022-12-27	WOS:000281594000005
J	Heiny, JA; Kravtsova, VV; Mandel, F; Radzyukevich, TL; Benziane, B; Prokofiev, AV; Pedersen, SE; Chibalin, AV; Krivoi, II				Heiny, Judith A.; Kravtsova, Violetta V.; Mandel, Frederic; Radzyukevich, Tatiana L.; Benziane, Boubacar; Prokofiev, Alexander V.; Pedersen, Steen E.; Chibalin, Alexander V.; Krivoi, Igor I.			The Nicotinic Acetylcholine Receptor and the Na,K-ATPase alpha 2 Isoform Interact to Regulate Membrane Electrogenesis in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SODIUM-CHANNEL INACTIVATION; DESENSITIZED STATES; AGONIST BINDING; BETA-SUBUNIT; T-TUBULES; CAVEOLIN-3; SITE; STIMULATION; INHIBIT	The nicotinic acetylcholine receptor (nAChR) and the Na,K-ATPase functionally interact in skeletal muscle (Krivoi, I. I., Drabkina, T. M., Kravtsova, V. V., Vasiliev, A. N., Eaton, M. J., Skatchkov, S. N., and Mandel, F. (2006) Pflugers Arch. 452, 756765; Krivoi, I., Vasiliev, A., Kravtsova, V., Dobretsov, M., and Mandel, F. (2003) Ann. N.Y. Acad. Sci. 986, 639-641). In this interaction, the specific binding of nanomolar concentrations of nicotinic agonists to the nAChR stimulates electrogenic transport by the Na,K-ATPase alpha 2 isozyme, causing membrane hyperpolarization. This study examines the molecular nature and membrane localization of this interaction. Stimulation of Na,K-ATPase activity by the nAChR does not require ion flow through open nAChRs. It can be induced by nAChR desensitization alone, in the absence of nicotinic agonist, and saturates when the nAChR is fully desensitized. It is enhanced by noncompetitive blockers of the nAChR (proadifen, QX-222), which promote non-conducting or desensitized states; and retarded by tetracaine, which stabilizes the resting nAChR conformation. The interaction operates at the neuromuscular junction as well as on extrajunctional sarcolemma. The Na,K-ATPase alpha 2 isozyme is enriched at the postsynaptic neuromuscular junction and co-localizes with nAChRs. The nAChR and Na,K-ATPase alpha subunits specifically coimmunoprecipitate with each other, phospholemman, and caveolin-3. In a purified membrane preparation from Torpedo californica enriched in nAChRs and the Na,K-ATPase, a ouabain-induced conformational change of the Na,K-ATPase enhances a conformational transition of the nAChR to a desensitized state. These results suggest a mechanism by which the nAChR in a desensitized state with high apparent affinity for agonist interacts with the Na,K-ATPase to stimulate active transport. The interaction utilizes a membrane-delimited complex involving protein-protein interactions, either directly or through additional protein partners. This interaction is expected to enhance neuromuscular transmission and muscle excitation.	[Kravtsova, Violetta V.; Prokofiev, Alexander V.; Krivoi, Igor I.] St Petersburg State Univ, Dept Gen Physiol, St Petersburg 199034, Russia; [Heiny, Judith A.; Mandel, Frederic; Radzyukevich, Tatiana L.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Pedersen, Steen E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Benziane, Boubacar; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Saint Petersburg State University; University System of Ohio; University of Cincinnati; Baylor College of Medicine; Karolinska Institutet	Krivoi, II (corresponding author), St Petersburg State Univ, Dept Gen Physiol, 7-9 Univ Emb, St Petersburg 199034, Russia.	iikrivoi@gmail.com	Krivoi, Igor/K-3546-2013; Kravtsova, Violetta V/K-1816-2013	Krivoi, Igor/0000-0002-2690-9226; Kravtsova, Violetta V/0000-0002-3382-5848; Chibalin, Alexander/0000-0002-6339-6271; Pedersen, Steen E./0000-0001-8755-8899	National Institutes of Health [HL6606]; Russian Foundation for Basic Research [10-04-00970a]; University of Cincinnati; Swedish Research Council; Novo-Nordisk Foundation; Hedlunds Foundation; Commission of the European Communities [LSHM-CT-2004-512013, LSHM-CT-2004-005272]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); University of Cincinnati; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); Hedlunds Foundation; Commission of the European Communities(European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant HL6606, Russian Foundation for Basic Research 10-04-00970a, the Physiology Research Fund of the University of Cincinnati, the Swedish Research Council, Novo-Nordisk Foundation, Hedlunds Foundation, and Commission of the European Communities Grants LSHM-CT-2004-512013 EUGENEHEART and LSHM-CT-2004-005272 EXGENESIS.	Akk G, 1999, BRIT J PHARMACOL, V128, P1467, DOI 10.1038/sj.bjp.0702941; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; Caldwell JH, 2000, MICROSC RES TECHNIQ, V49, P84, DOI 10.1002/(SICI)1097-0029(20000401)49:1<84::AID-JEMT9>3.0.CO;2-E; Carlson BM, 2003, J HISTOCHEM CYTOCHEM, V51, P1113, DOI 10.1177/002215540305100901; Carlson CG, 2001, PFLUG ARCH EUR J PHY, V442, P369; Dobretsov M, 2003, NEUROSCIENCE, V116, P1069, DOI 10.1016/S0306-4522(02)00922-3; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; EVERTS ME, 1994, AM J PHYSIOL, V266, pC925, DOI 10.1152/ajpcell.1994.266.4.C925; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gentry CL, 2001, J PHARMACOL EXP THER, V299, P1038; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hazelwood LA, 2008, J BIOL CHEM, V283, P36441, DOI 10.1074/jbc.M805520200; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; HENNING RH, 1994, BRIT J PHARMACOL, V111, P459, DOI 10.1111/j.1476-5381.1994.tb14758.x; HICKS A, 1989, J PHYSIOL-LONDON, V414, P337, DOI 10.1113/jphysiol.1989.sp017691; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; JAIMOVICH E, 1986, BIOCHIM BIOPHYS ACTA, V855, P89, DOI 10.1016/0005-2736(86)90192-6; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; Kragenbrink R, 1996, SYNAPSE, V23, P219, DOI 10.1002/(SICI)1098-2396(199607)23:3<219::AID-SYN11>3.0.CO;2-U; Kravtsova V V, 2008, Ross Fiziol Zh Im I M Sechenova, V94, P1181; Krivoi I, 2003, ANN NY ACAD SCI, V986, P639, DOI 10.1111/j.1749-6632.2003.tb07272.x; Krivoi I I, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P59; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Mourot A, 2006, MOL PHARMACOL, V69, P452, DOI 10.1124/mol.105.017566; Nazarian J, 2007, PROTEOMICS, V7, P617, DOI 10.1002/pmic.200600686; NIKOLSKY EE, 1994, J PHYSIOL-LONDON, V477, P497, DOI 10.1113/jphysiol.1994.sp020210; Ockleford CD, 2002, J MICROSC-OXFORD, V206, P93, DOI 10.1046/j.1365-2818.2002.01011.x; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Pritchard TJ, 2007, AM J PHYSIOL-HEART C, V293, pH1172, DOI 10.1152/ajpheart.00279.2007; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2004, AM J PHYSIOL-CELL PH, V287, pC1300, DOI 10.1152/ajpcell.00231.2004; Rahkila P, 2001, EXP CELL RES, V267, P61, DOI 10.1006/excr.2001.5101; Raines DE, 1998, BIOCHEMISTRY-US, V37, P956, DOI 10.1021/bi971689w; Ralston E, 1999, EXP CELL RES, V246, P510, DOI 10.1006/excr.1998.4305; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; RUFF RL, 1988, MUSCLE NERVE, V11, P502, DOI 10.1002/mus.880110514; RUFF RL, 1987, J PHYSIOL-LONDON, V383, P339; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Song XZ, 2000, BIOPHYS J, V78, P1324, DOI 10.1016/S0006-3495(00)76687-2; Song XZ, 2003, BIOCHEMISTRY-US, V42, P4197, DOI 10.1021/bi027405b; Sperelakis N, 2001, CELL PHYSL SOURCEBOO, P231; Spitzmaul G, 2009, BRIT J PHARMACOL, V157, P804, DOI 10.1111/j.1476-5381.2009.00214.x; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Voldstedlund M, 2001, CELL TISSUE RES, V306, P265, DOI 10.1007/s004410100439; VYSKOCIL F, 1983, NEUROSCIENCE, V9, P429, DOI 10.1016/0306-4522(83)90305-6; WAKSMAN G, 1976, FEBS LETT, V67, P335, DOI 10.1016/0014-5793(76)80560-1; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Williams MW, 2001, J CELL SCI, V114, P751; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870	68	41	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28614	28626		10.1074/jbc.M110.150961	http://dx.doi.org/10.1074/jbc.M110.150961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595385	Green Published, hybrid			2022-12-27	WOS:000281594000025
J	Chen, HY; Yong, WD; Hinds, TD; Yang, ZC; Zhou, YH; Sanchez, ER; Shou, WN				Chen, Hanying; Yong, Weidong; Hinds, Terry D., Jr.; Yang, Zuocheng; Zhou, Yuhong; Sanchez, Edwin R.; Shou, Weinian			Fkbp52 Regulates Androgen Receptor Transactivation Activity and Male Urethra Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; IMMUNOPHILIN; CHAPERONES; PROTEIN; GROWTH; PENIS; MICE; FGF8	Hypospadias is a common birth defect in humans, yet its etiology and pattern of onset are largely unknown. Recent studies have shown that male mice with targeted ablation of FK506-binding protein-52 (Fkbp52) develop hypospadias, most likely due to actions of Fkbp52 as a molecular co-chaperone of the androgen receptor (AR). Here, we further dissect the developmental and molecular mechanisms that underlie hypospadias in Fkbp52-deficient mice. Scanning electron microscopy revealed a defect in the elevation of prepucial swelling that led to the onset of the ventral penile cleft. Interestingly, expression of Fkbp52 was highest in the ventral aspect of the developing penis that undergoes fusion of the urethral epithelium. Although in situ hybridization and immunohistochemical analyses suggested that Fkbp52 mutants had a normal urethral epithelium signaling center and epithelial differentiation, a reduced apoptotic cell index at ventral epithelial cells at the site of fusion and a defect of genital mesenchymal cell migration were observed. Supplementation of gestating females with excess testosterone partially rescued the hypospadic phenotype in Fkbp52 mutant males, showing that loss of Fkbp52 desensitizes AR to hormonal activation. Direct measurement of AR activity was performed in mouse embryonic fibroblast cells treated with dihydrotestosterone or synthetic agonist R1881. Reduced AR activity at genes controlling sexual dimorphism and cell growth was found in Fkbp52-deficient mouse embryonic fibroblast cells. However, chromatin immunoprecipitation analysis revealed normal occupancy of AR at gene promoters, suggesting that Fkbp52 exerts downstream effects on the transactivation function of AR. Taken together, our data show Fkbp52 to be an important molecular regulator in the androgen-mediated pathway of urethra morphogenesis.	[Chen, Hanying; Yong, Weidong; Yang, Zuocheng; Zhou, Yuhong; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Hinds, Terry D., Jr.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Yang, Zuocheng] Cent S Univ, Xiang Ya Hosp 3, Xiang Ya Sch Med, Dept Pediat, Changsha 410013, Peoples R China; [Zhou, Yuhong] Harbin Med Univ, Dept Pharmacol, Harbin 150086, Peoples R China	Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; University of Toledo; Central South University; Harbin Medical University	Shou, WN (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, R4-302D,1044 W Walnut, Indianapolis, IN 46202 USA.	wshou@iupui.edu	Zhou, Yu/HHN-3071-2022; Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK73402, DK70127]; Riley Children's Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073402, F31DK084958, R01DK070127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK73402 (to W. S. and E. R. S.) and DK70127 (to E. R. S. and W. S.). This work was also supported by the Riley Children's Foundation (W. S.).	Amler LC, 2000, CANCER RES, V60, P6134; Baskin LS, 2004, ADV EXP MED BIOL, V545, P103; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Kim KS, 2002, CELL TISSUE RES, V307, P145, DOI 10.1007/s004410100464; Kurzrock EA, 1999, CELLS TISSUES ORGANS, V164, P125, DOI 10.1159/000016650; Kuslak SL, 2007, DIFFERENTIATION, V75, P638, DOI 10.1111/j.1432-0436.2006.00161.x; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; MURAKAMI R, 1986, J EMBRYOL EXP MORPH, V92, P133; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Petiot A, 2005, DEVELOPMENT, V132, P2441, DOI 10.1242/dev.01778; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Seifert AW, 2009, DEVELOPMENT, V136, P2643, DOI 10.1242/dev.036830; SEIFERT AW, 2010, NAT COMMUN IN PRESS; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Stadler HS, 2003, NAT REV GENET, V4, P478, DOI 10.1038/nrg1083; Traish AM, 2009, J ANDROL, V30, P363, DOI 10.2164/jandrol.108.006007; Vanaja DK, 2002, CELL STRESS CHAPERON, V7, P55, DOI 10.1379/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200	30	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27776	27784		10.1074/jbc.M110.156091	http://dx.doi.org/10.1074/jbc.M110.156091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605780	Green Published, hybrid			2022-12-27	WOS:000281404100033
J	Tkacz, ID; Gupta, SK; Volkov, V; Romano, M; Haham, T; Tulinski, P; Lebenthal, I; Michaeli, S				Tkacz, Itai Dov; Gupta, Sachin Kumar; Volkov, Vadim; Romano, Mali; Haham, Tomer; Tulinski, Pawel; Lebenthal, Ilana; Michaeli, Shulamit			Analysis of Spliceosomal Proteins in Trypanosomatids Reveals Novel Functions in mRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED-LEADER RNA; SMALL NUCLEAR-RNA; POLY(A) POLYMERASE; GENE-EXPRESSION; EDITING COMPLEX; SM PROTEINS; BRUCEI; POLYADENYLATION; SNRNP; CORE	In trypanosomatids, all mRNAs are processed via trans-splicing, although cis-splicing also occurs. In trans-splicing, a common small exon, the spliced leader (SL), which is derived from a small SL RNA species, is added to all mRNAs. Sm and Lsm proteins are core proteins that bind to U snRNAs and are essential for both these splicing processes. In this study, SmD3- and Lsm3-associated complexes were purified to homogeneity from Leishmania tarentolae. The purified complexes were analyzed by mass spectrometry, and 54 and 39 proteins were purified from SmD3 and Lsm complexes, respectively. Interestingly, among the proteins purified from Lsm3, no mRNA degradation factors were detected, as in Lsm complexes from other eukaryotes. The U1A complex was purified and mass spectrometry analysis identified, in addition to U1 small nuclear ribonucleoprotein (snRNP) proteins, additional co-purified proteins, including the polyadenylation factor CPSF73. Defects observed in cells silenced for U1 snRNP proteins suggest that the U1 snRNP functions exclusively in cis-splicing, although U1A also participates in polyadenylation and affects trans-splicing. The study characterized several trypanosome-specific nuclear factors involved in snRNP biogenesis, whose function was elucidated in Trypanosoma brucei. Conserved factors, such as PRP19, which functions at the heart of every cis-spliceosome, also affect SL RNA modification; GEMIN2, a protein associated with SMN (survival of motor neurons) and implicated in selective association of U snRNA with core Sm proteins in trypanosomes, is a master regulator of snRNP assembly. This study demonstrates the existence of trypanosomatid-specific splicing factors but also that conserved snRNP proteins possess trypanosome-specific functions.	[Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	michaes@mail.biu.ac.il	Tulinski, Pawel/P-8365-2014; Michaeli, Shulamit/AAC-8255-2022	Tulinski, Pawel/0000-0002-5033-5859	Deutsche Forcshungsgemeinschaft; Howard Hughes Medical Institute	Deutsche Forcshungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported the Deutsche Forcshungsgemeinschaft and by an International Research Scholar grant from the Howard Hughes Medical Institute (to S. M.).	Abelson J, 2008, NAT STRUCT MOL BIOL, V15, P1235, DOI 10.1038/nsmb1208-1235; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Arhin GK, 2006, RNA, V12, P53, DOI 10.1261/rna.2223406; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Biton M, 2006, MOL BIOCHEM PARASIT, V150, P132, DOI 10.1016/j.molbiopara.2006.07.004; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; delOlmo M, 1997, MOL GEN GENET, V255, P209, DOI 10.1007/s004380050491; Denker JA, 1996, RNA, V2, P746; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Goncharov I, 1999, J BIOL CHEM, V274, P12217, DOI 10.1074/jbc.274.18.12217; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Hury A, 2009, EUKARYOT CELL, V8, P56, DOI 10.1128/EC.00322-08; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee JH, 2007, EUKARYOT CELL, V6, P641, DOI 10.1128/EC.00411-06; Lee JH, 2009, NUCLEIC ACIDS RES, V37, P3811, DOI 10.1093/nar/gkp236; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Li HJ, 2005, MOL CELL BIOL, V25, P2216, DOI 10.1128/MCB.25.6.2216-2226.2005; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lucke S, 1997, EMBO J, V16, P4433, DOI 10.1093/emboj/16.14.4433; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; NAKAAR V, 1994, MOL CELL BIOL, V14, P6736, DOI 10.1128/MCB.14.10.6736; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Palfi Z, 2000, P NATL ACAD SCI USA, V97, P8967, DOI 10.1073/pnas.150236097; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Sturm NR, 1999, J BIOL CHEM, V274, P19361, DOI 10.1074/jbc.274.27.19361; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang PP, 2006, EMBO J, V25, P4513, DOI 10.1038/sj.emboj.7601328; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Xu YX, 2000, J BIOL CHEM, V275, P27883; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zeiner GM, 2004, MOL CELL BIOL, V24, P10390, DOI 10.1128/MCB.24.23.10390-10396.2004	66	37	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27982	27999		10.1074/jbc.M109.095349	http://dx.doi.org/10.1074/jbc.M109.095349			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592024	Green Published, hybrid			2022-12-27	WOS:000281404100052
J	Zhao, XY; Zhao, L; Tian, TA; Zhang, Y; Tong, JY; Zheng, XF; Meng, AM				Zhao, Xinyi; Zhao, Long; Tian, Tian; Zhang, Yu; Tong, Jingyuan; Zheng, Xiaofeng; Meng, Anming			Interruption of cenph Causes Mitotic Failure and Embryonic Death, and Its Haploinsufficiency Suppresses Cancer in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-PROTEIN-H; CAUSES GENOME INSTABILITY; CHROMOSOME MISSEGREGATION; KINETOCHORE PROTEIN; PROGNOSTIC MARKER; VERTEBRATE CELLS; PATIENT SURVIVAL; NULL MICE; APOPTOSIS; GENE	Kinetochore proteins associate with centromeric DNA and spindle microtubules and play essential roles in chromosome segregation during mitosis. In this study, we uncovered a zebrafish mutant, stagnant and curly (stac), that carries the Tol2 transposon element inserted at the kinetochore protein H (cenph) locus. Mutant embryos exhibit discernible cell death as early as 20 hours postfertilization, extensive apoptosis, and upward curly tail during the pharyngula period and deform around 5 days postfertilization. The stac mutant phenotype can be rescued by cenph mRNA overexpression and mimicked by cenph knockdown with antisense morpholinos, suggesting the responsibility of cenph deficiency for stac mutants. We demonstrate that the intrinsic apoptosis pathway is hyperactivated in stac mutants and that p53 knockdown partially blocks excess apoptosis in stac mutants. Mitotic cells in stac mutants show chromosome missegregation and are usually arrested in G(2)/M phase. Furthermore, compared with wild type siblings, heterozygous stac fish develop invasive tumors at a dramatically reduced rate, suggesting a reduced cancer risk. Taken together, our findings uncover an essential role of cenph in mitosis and embryonic development and its association with tumor development.	[Zhao, Xinyi; Zhao, Long; Tian, Tian; Zhang, Yu; Tong, Jingyuan; Zheng, Xiaofeng; Meng, Anming] Tsinghua Univ, Coll Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Engn, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Coll Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Zhang, Yu/F-6583-2016; Zhao, Long/A-6439-2014; Meng, Anming/A-4785-2012	Zhao, Long/0000-0003-2691-7055; Meng, Anming/0000-0001-7228-3431; Zhang, Yu/0000-0001-5512-9272	Major Science Programs of China [2006CB943401]; National Basic Research Program of China [2005CB522502]; 863 Program [2006AA02Z167]	Major Science Programs of China; National Basic Research Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by Major Science Programs of China Grant 2006CB943401, National Basic Research Program of China Grant 2005CB522502, and the 863 Program Grant 2006AA02Z167.	Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Fowler KJ, 2000, GENOME RES, V10, P30; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Geiger GA, 2006, CANCER RES, V66, P8172, DOI 10.1158/0008-5472.CAN-06-0466; Guo XZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-233; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Kalitsis P, 2003, CHROMOSOME RES, V11, P345, DOI 10.1023/A:1024044008009; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Liao WT, 2007, CLIN CANCER RES, V13, P508, DOI 10.1158/1078-0432.CCR-06-1512; Liao WT, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-74; Liao WT, 2009, CANCER-AM CANCER SOC, V115, P1507, DOI 10.1002/cncr.24128; McEwen BF, 2007, METHOD CELL BIOL, V79, P259, DOI 10.1016/S0091-679X(06)79011-2; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shigeishi H, 2006, ONCOL REP, V16, P1071; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P716, DOI 10.1177/019262330002800512; Sugata N, 2000, HUM MOL GENET, V9, P2919, DOI 10.1093/hmg/9.19.2919; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Tian T, 2009, J GENET GENOMICS, V36, P581, DOI 10.1016/S1673-8527(08)60150-2; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177	48	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27924	27934		10.1074/jbc.M110.136077	http://dx.doi.org/10.1074/jbc.M110.136077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573960	Green Published, hybrid			2022-12-27	WOS:000281404100047
J	D'Argenio, G; Petillo, O; Margarucci, S; Torpedine, A; Calarco, A; Koverech, A; Boccia, A; Paolella, G; Peluso, G				D'Argenio, Giuseppe; Petillo, Orsolina; Margarucci, Sabrina; Torpedine, Angela; Calarco, Anna; Koverech, Angela; Boccia, Angelo; Paolella, Giovanni; Peluso, Gianfranco			Colon OCTN2 Gene Expression Is Up-regulated by Peroxisome Proliferator-activated Receptor gamma in Humans and Mice and Contributes to Local and Systemic Carnitine Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTER; TISSUE DISTRIBUTION PATTERN; CATION/CARNITINE TRANSPORTER; FUNCTIONAL-CHARACTERISTICS; ULCERATIVE-COLITIS; SMALL-INTESTINE; ADIPOSE-TISSUE; PPAR-ALPHA; METABOLISM; RAT	In the large intestine organic cation transporter type-2 (OCTN2) is recognized as a transporter of compounds such as carnitine and colony sporulation factor, promoting health of the colon intestinal epithelium. Recent reports suggest that OCTN2 expression in small intestine is under control of peroxisome proliferator-activated receptor-alpha (PPAR alpha). However, PPAR alpha contribution to colonic OCTN2 expression remains controversial. Here we examined the transcriptional regulation of colon OCTN2 gene by PPAR alpha. To exclude any additional modulation of other PPAR to OCTN2 expression, we used both in vivo and in vitro PPAR-null models and specific PPAR inhibitors. The PPAR gamma agonists thiazolidinediones increased both OCTN2 mRNA and protein expression in colonic epithelial cell lines independently by PPAR alpha expression. The induction was blocked only by PPAR gamma antagonists or by gamma ORF4, a PPAR gamma isoform with dominant negative activity, suggesting a PPAR gamma-dependent mechanism. A conserved noncanonical PPAR-responsive element was found by computational analysis in the first intron of human OCTN2 gene and validated by EMSA assay. Promoter-reporter assays further confirmed transcriptional functionality of the putative PPAR response element, whereas selective mutation caused complete loss of responsiveness to PPAR gamma activation. Finally, adenovirus-mediated overexpression of constitutively active PPAR gamma mutant increased colon OCTN2 expression in PPAR alpha(-/-) mice. Interestingly, animals overexpressing colon PPAR gamma showed a significant increase in plasma carnitine, thus demonstrating the functional contribution of large intestine to systemic carnitine homeostasis. This study reveals a PPAR gamma-dependent absorption machinery in colon that is likely involved in the health of colon epithelium, in the microbiota-host interactions and in the absorption of nutraceuticals and drugs.	[Petillo, Orsolina; Margarucci, Sabrina; Torpedine, Angela; Calarco, Anna; Peluso, Gianfranco] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [D'Argenio, Giuseppe] Univ Naples Federico 2, Dipartimento Med Clin & Sperimentale, I-80131 Naples, Italy; [Koverech, Angela] Fac Med, I-00185 Rome, Italy; [Boccia, Angelo; Paolella, Giovanni] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, CEINGE Biotecnol Avanzate, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Peluso, G (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	g.peluso@ibp.cnr.it	Calarco, Anna/P-2568-2019	Calarco, Anna/0000-0002-1441-7662; MARGARUCCI, SABRINA/0000-0001-5361-1241				Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Ciacci C, 2007, DIGEST LIVER DIS, V39, P922, DOI 10.1016/j.dld.2007.06.013; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; D'Argenio G, 2006, FASEB J, V20, P2544, DOI 10.1096/fj.06-5950fje; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; HAMILTON JW, 1986, GASTROENTEROLOGY, V91, P10, DOI 10.1016/0016-5085(86)90432-4; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lahjouji K, 2001, MOL GENET METAB, V73, P287, DOI 10.1006/mgme.2001.3207; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lohninger A, 2005, MONATSH CHEM, V136, P1255, DOI 10.1007/s00706-005-0339-2; Maeda T, 2008, BIOL PHARM BULL, V31, P1230, DOI 10.1248/bpb.31.1230; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Ohashi R, 1999, J PHARMACOL EXP THER, V291, P778; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; SAHI J, 1994, AM J PHYSIOL-GASTR L, V266, P846; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002; Slitt AL, 2002, DRUG METAB DISPOS, V30, P212, DOI 10.1124/dmd.30.2.212; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187; Wang K, 2008, EXP BIOL MED, V233, P496, DOI 10.3181/0708-MR-231; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482; Xuan WL, 2003, BIOCHEM BIOPH RES CO, V306, P121, DOI 10.1016/S0006-291X(03)00930-6	42	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27078	27087		10.1074/jbc.M110.109678	http://dx.doi.org/10.1074/jbc.M110.109678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558736	hybrid, Green Published			2022-12-27	WOS:000281172700039
J	Navarro, G; Ferre, S; Cordomi, A; Moreno, E; Mallol, J; Casado, V; Cortes, A; Hoffmann, H; Ortiz, J; Canela, EI; Lluis, C; Pardo, L; Franco, R; Woods, AS				Navarro, Gemma; Ferre, Sergi; Cordomi, Arnau; Moreno, Estefania; Mallol, Josefa; Casado, Vicent; Cortes, Antoni; Hoffmann, Hanne; Ortiz, Jordi; Canela, Enric I.; Lluis, Carme; Pardo, Leonardo; Franco, Rafael; Woods, Amina S.			Interactions between Intracellular Domains as Key Determinants of the Quaternary Structure and Function of Receptor Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; ADENOSINE A(2A); KNOCKOUT MICE; RHODOPSIN; OLIGOMERS; DIMERS; FRET; DOPAMINE-D-2; ACTIVATION	G protein-coupled receptor (GPCR) heteromers are macromolecular complexes with unique functional properties different from those of its individual protomers. Little is known about what determines the quaternary structure of GPCR heteromers resulting in their unique functional properties. In this study, using resonance energy transfer techniques in experiments with mutated receptors, we provide for the first time clear evidence for a key role of intracellular domains in the determination of the quaternary structure of GPCR heteromers between adenosine A(2A), cannabinoid CB1, and dopamine D-2 receptors. In these interactions, arginine-rich epitopes form salt bridges with phosphorylated serine or threonine residues from CK1/2 consensus sites. Each receptor (A(2A), CB1, and D-2) was found to include two evolutionarily conserved intracellular domains to establish selective electrostatic interactions with intracellular domains of the other two receptors, indicating that these particular electrostatic interactions constitute a general mechanism for receptor heteromerization. Mutation experiments indicated that the interactions of the intracellular domains of the CB1 receptor with A(2A) and D-2 receptors are fundamental for the correct formation of the quaternary structure needed for the function (MAPK signaling) of the A(2A)-CB1-D-2 receptor heteromers. Analysis of MAPK signaling in striatal slices of CB1 receptor KO mice and wild-type littermates supported the existence of A(1)-CB1-D-2 receptor heteromer in the brain. These findings allowed us to propose the first molecular model of the quaternary structure of a receptor heteromultimer.	[Ferre, Sergi; Woods, Amina S.] Natl Inst Drug Abuse, Intramural Res Program, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Navarro, Gemma; Moreno, Estefania; Mallol, Josefa; Casado, Vicent; Cortes, Antoni; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Dept Biochem & Mol Biol, Fac Biol, E-08028 Barcelona, Spain; [Cordomi, Arnau; Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain; [Hoffmann, Hanne; Ortiz, Jordi] Univ Autonoma Barcelona, Inst Neurosci, Bellaterra 08193, Spain; [Hoffmann, Hanne; Ortiz, Jordi] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Facultat Medicina, Bellaterra 08193, Spain; [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); CIBERNED; University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Navarra	Woods, AS (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Dept Hlth & Human Serv, 333 Cassell Dr, Baltimore, MD 21224 USA.	awoods@intra.nida.nih.gov	soler, martha maricel m gomez/L-6025-2014; Casadó, Vicent/K-1660-2014; Navarro, Gemma/AAO-7866-2021; Franco, Rafael/C-3694-2015; Mallol, Josefa/I-4194-2015; Ortiz, Jordi/E-9018-2011; Hoffmann, Hanne/W-6557-2019; Ferre, Sergi/K-6115-2014; Canela, Enric I./M-8726-2013; Guillén, Estefanía Moreno/ABE-4371-2020; Cordomí, Arnau/A-1686-2009	soler, martha maricel m gomez/0000-0002-4412-8108; Casadó, Vicent/0000-0002-1764-3825; Navarro, Gemma/0000-0003-4654-0873; Franco, Rafael/0000-0003-2549-4919; Mallol, Josefa/0000-0002-2479-4162; Ortiz, Jordi/0000-0002-9748-2290; Ferre, Sergi/0000-0002-1747-1779; Canela, Enric I./0000-0003-4992-7440; Cordomí, Arnau/0000-0002-3848-2928; Hoffmann, Hanne Mette/0000-0003-1555-1369; Moreno, Estefania/0000-0002-2491-5753; Pardo, Leonardo/0000-0003-1778-7420	National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2006-05481, SAF2008-03229-E/]; Fundacio La Marato de TV3 [RD07/0067/0008, 060110]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant from intramural funds to NIDA. This work was also supported by Spanish Ministerio de Ciencia y Tecnologia Grants SAF2008-00146, SAF2006-05481, and SAF2008-03229-E/ for ERA-NET Coordination of Research Activities and Instituto de Salud Carlos III (RD07/0067/0008) Grant 060110 from Fundacio La Marato de TV3.	Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Azdad K, 2009, NEUROPSYCHOPHARMACOL, V34, P972, DOI 10.1038/npp.2008.144; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jackson SN, 2008, J AM SOC MASS SPECTR, V19, P1535, DOI 10.1016/j.jasms.2008.06.023; Jackson SN, 2006, J PROTEOME RES, V5, P122, DOI 10.1021/pr0503578; Jackson SN, 2005, J PROTEOME RES, V4, P2360, DOI 10.1021/pr050261d; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	34	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27346	27359		10.1074/jbc.M110.115634	http://dx.doi.org/10.1074/jbc.M110.115634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562103	Green Published, hybrid			2022-12-27	WOS:000281172700064
J	Kaufman, L; Potla, U; Coleman, S; Dikiy, S; Hata, Y; Kurihara, H; He, JC; D'Agati, VD; Klotman, PE				Kaufman, Lewis; Potla, Uma; Coleman, Sarah; Dikiy, Stanislav; Hata, Yutaka; Kurihara, Hidetake; He, John C.; D'Agati, Vivette D.; Klotman, Paul E.			Up-regulation of the Homophilic Adhesion Molecule Sidekick-1 in Podocytes Contributes to Glomerulosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HIV-ASSOCIATED NEPHROPATHY; GLOMERULAR SLIT DIAPHRAGM; TIGHT JUNCTION PROTEIN; CELL-ADHESION; NEPHROTIC SYNDROME; GUANYLATE KINASE; RENAL-DISEASE; MAGI-1; MICE	Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome and end-stage renal disease worldwide. Although the mechanisms underlying this important disease are poorly understood, the glomerular podocyte clearly plays a central role in disease pathogenesis. In the current work, we demonstrate that the homophilic adhesion molecule sidekick-1 (sdk-1) is up-regulated in podocytes in FSGS both in rodent models and in human kidney biopsy samples. Transgenic mice that have podocyte-specific overexpression of sdk-1 develop gradually progressive heavy proteinuria and severe FSGS. We also show that sdk-1 associates with the slit diaphragm linker protein MAGI-1, which is already known to interact with several critical podocyte proteins including synaptopodin, alpha-actinin-4, nephrin, JAM4, and beta-catenin. This interaction is mediated through a direct interaction between the carboxyl terminus of sdk-1 and specific PDZ domains of MAGI-1. In vitro expression of sdk-1 enables a dramatic recruitment of MAGI-1 to the cell membrane. Furthermore, a truncated version of sdk-1 that is unable to bind to MAGI-1 does not induce podocyte dysfunction when overexpressed. We conclude that the up-regulation of sdk-1 in podocytes is an important pathogenic factor in FSGS and that the mechanism involves disruption of the actin cytoskeleton possibly via alterations in MAGI-1 function.	[Kaufman, Lewis; Klotman, Paul E.] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Kaufman, Lewis; He, John C.] James J Peters Vet Affairs Med Ctr, Div Nephrol, Bronx, NY 10468 USA; [Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Tokyo 1138519, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Tokyo 1138421, Japan; [D'Agati, Vivette D.] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Tokyo Medical & Dental University (TMDU); Juntendo University; Columbia University	Kaufman, L (corresponding author), Mt Sinai Sch Med, Div Nephrol, 1 Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	lewis.kaufman@mssm.edu	Dikiy, Stanislav/GWR-2104-2022; Dikiy, Stanislav/HIR-5027-2022	Dikiy, Stanislav/0000-0002-8287-6561	National Institutes of Health [K08 DK070530, R01 DK084006, P01 DK056492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK070530, P01DK056492, R01DK084006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK070530 (to L. K.) R01 DK084006 (to L. K.) and P01 DK056492 (to P. E. K.).	Barisoni L, 2005, J AM SOC NEPHROL, V16, P2847, DOI 10.1681/ASN.2005050494; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Hayashi K, 2005, FASEB J, V19, P614, DOI 10.1096/fj.04-2947fje; Henderson J, 2008, KIDNEY INT, V73, P741, DOI 10.1038/sj.ki.5002751; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kaufman L, 2004, J AM SOC NEPHROL, V15, P1721, DOI 10.1097/01.ASN.0000128975.28958.C2; Kaufman L, 2007, FASEB J, V21, P1367, DOI 10.1096/fj.06-7191com; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KORBET SM, 1994, AM J KIDNEY DIS, V23, P773, DOI 10.1016/S0272-6386(12)80128-4; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; RYDEL JJ, 1995, AM J KIDNEY DIS, V25, P534, DOI 10.1016/0272-6386(95)90120-5; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	39	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25677	25685		10.1074/jbc.M110.133959	http://dx.doi.org/10.1074/jbc.M110.133959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562105	Green Published, hybrid			2022-12-27	WOS:000280682400061
J	Kawasaki, T; Ueyama, T; Lange, I; Feske, S; Saito, N				Kawasaki, Takumi; Ueyama, Takehiko; Lange, Ingo; Feske, Stefan; Saito, Naoaki			Protein Kinase C-induced Phosphorylation of Orai1 Regulates the Intracellular Ca2+ Level via the Store-operated Ca2+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CALCIUM-ENTRY; STIM1; ACTIVATION; DOMAIN; CELLS; DEFICIENCY; INHIBITION; COMPLEX; BINDING	Ca2+ signals through store-operated Ca2+ (SOC) channels, activated by the depletion of Ca2+ from the endoplasmic reticulum, regulate various physiological events. Orai1 is the pore-forming subunit of the Ca2+ release-activated Ca2+ (CRAC) channel, the best characterized SOC channel. Orai1 is activated by stromal interaction molecule (STIM) 1, a Ca2+ sensor located in the endoplasmic reticulum. Orai1 and STIM1 are crucial for SOC channel activation, but the molecular mechanisms regulating Orai1 function are not fully understood. In this study, we demonstrate that protein kinase C (PKC) suppresses store-operated Ca2+ entry (SOCE) by phosphorylation of Orai1. PKC inhibitors and knockdown of PKC beta both resulted in increased Ca2+ influx. Orai1 is strongly phosphorylated by PKC in vitro and in vivo at N-terminal Ser-27 and Ser-30 residues. Consistent with these results, substitution of endogenous Orai1 with an Orai1 S27A/S30A mutant resulted in increased SOCE and CRAC channel currents. We propose that PKC suppresses SOCE and CRAC channel function by phosphorylation of Orai1 at N-terminal serine residues Ser-27 and Ser-30.	[Kawasaki, Takumi; Lange, Ingo; Feske, Stefan] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Kawasaki, Takumi; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	New York University; NYU Langone Medical Center; Kobe University	Feske, S (corresponding author), NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	feskes01@nyumc.org; naosaito@kobe-u.ac.jp	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Lange, Ingo/0000-0002-6703-0015	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Hyogo Science and Technology Association; Takeda Science Foundation; Uehara Foundation; National Institutes of Health [AI066128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066128] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Foundation(Uehara Memorial Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant-in-aid for scientific research from the Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. S.), grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. S.), the Hyogo Science and Technology Association (to N. S.), the Takeda Science Foundation (to N. S.), and an Uehara Foundation postdoctoral fellowship (to T. K.). This work was also supported in part by National Institutes of Health Grant AI066128 (to S. F.).	Albert AP, 2003, CELL CALCIUM, V33, P345, DOI 10.1016/S0143-4160(03)00048-4; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cejas PJ, 2005, MOL CELL BIOL, V25, P7900, DOI 10.1128/MCB.25.17.7900-7916.2005; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Haverstick DM, 1997, J BIOL CHEM, V272, P15426, DOI 10.1074/jbc.272.24.15426; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Lee H, 1997, J BIOL CHEM, V272, P21831, DOI 10.1074/jbc.272.35.21831; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Lin X, 2006, CARCINOGENESIS, V27, P1538, DOI 10.1093/carcin/bgl002; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PETERSEN CCH, 1994, J BIOL CHEM, V269, P32246; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	46	104	105	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25720	25730		10.1074/jbc.M109.022996	http://dx.doi.org/10.1074/jbc.M109.022996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20534587	Green Published, hybrid			2022-12-27	WOS:000280682400065
J	Moreno, R; Fonseca, P; Rojo, F				Moreno, Renata; Fonseca, Pilar; Rojo, Fernando			The Crc Global Regulator Inhibits the Pseudomonas putida pWW0 Toluene/Xylene Assimilation Pathway by Repressing the Translation of Regulatory and Structural Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; TOL PLASMID PWW0; META-CLEAVAGE PATHWAY; ESCHERICHIA-COLI; DEGRADATION PATHWAY; TRANSCRIPTIONAL REGULATOR; NUTRIENT LIMITATION; CHEMOSTAT CULTURES; AROMATIC-COMPOUNDS; ARVILLA MT-2	In Pseudomonas putida, the expression of the pWW0 plasmid genes for the toluene/xylene assimilation pathway (the TOL pathway) is subject to complex regulation in response to environmental and physiological signals. This includes strong inhibition via catabolite repression, elicited by the carbon sources that the cells prefer to hydrocarbons. The Crc protein, a global regulator that controls carbon flow in pseudomonads, has an important role in this inhibition. Crc is a translational repressor that regulates the TOL genes, but how it does this has remained unknown. This study reports that Crc binds to sites located at the translation initiation regions of the mRNAs coding for XylR and XylS, two specific transcription activators of the TOL genes. Unexpectedly, eight additional Crc binding sites were found overlapping the translation initiation sites of genes coding for several enzymes of the pathway, all encoded within two polycistronic mRNAs. Evidence is provided supporting the idea that these sites are functional. This implies that Crc can differentially modulate the expression of particular genes within polycistronic mRNAs. It is proposed that Crc controls TOL genes in two ways. First, Crc inhibits the translation of the XylR and XylS regulators, thereby reducing the transcription of all TOL pathway genes. Second, Crc inhibits the translation of specific structural genes of the pathway, acting mainly on proteins involved in the first steps of toluene assimilation. This ensures a rapid inhibitory response that reduces the expression of the toluene/xylene degradation proteins when preferred carbon sources become available.	[Moreno, Renata; Fonseca, Pilar; Rojo, Fernando] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rojo, F (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	frojo@cnb.csic.es	Moreno, Renata/D-6139-2014; Rojo, Fernando/A-7038-2008	Moreno, Renata/0000-0001-5125-6995; Rojo, Fernando/0000-0003-1848-7745	Spanish Ministry of Science and Innovation [BFU2009-07009/BMC, CSD2007-00005]; Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases) [REIPI RD06/0008]; European Development Regional Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases)(Instituto de Salud Carlos III); European Development Regional Fund(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (Grants BFU2009-07009/BMC and CSD2007-00005) and from the Instituto de Salud Carlos III (Spanish Network for Research into Infectious Diseases; Grant REIPI RD06/0008), co-financed by the European Development Regional Fund.	Aranda-Olmedo I, 2005, APPL ENVIRON MICROB, V71, P4191, DOI 10.1128/AEM.71.8.4191-4198.2005; Aranda-Olmedo I, 2006, APPL ENVIRON MICROB, V72, P7418, DOI 10.1128/AEM.01067-06; Cases I, 1996, MOL MICROBIOL, V19, P7, DOI 10.1046/j.1365-2958.1996.345873.x; CERRETTI DP, 1988, J MOL BIOL, V204, P309, DOI 10.1016/0022-2836(88)90578-5; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DEAN D, 1980, P NATL ACAD SCI-BIOL, V77, P3590, DOI 10.1073/pnas.77.6.3590; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Duetz WA, 1996, APPL ENVIRON MICROB, V62, P601, DOI 10.1128/AEM.62.2.601-606.1996; Duetz WA, 1997, MICROBIOL-SGM, V143, P2331, DOI 10.1099/00221287-143-7-2331; DUETZ WA, 1994, J BACTERIOL, V176, P2354, DOI 10.1128/JB.176.8.2354-2361.1994; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gallegos MT, 1996, J BACTERIOL, V178, P2356, DOI 10.1128/jb.178.8.2356-2361.1996; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez-Perez MM, 2004, J BACTERIOL, V186, P1898, DOI 10.1128/JB.186.6.1898-1901.2003; Greated A, 2002, ENVIRON MICROBIOL, V4, P856, DOI 10.1046/j.1462-2920.2002.00305.x; Hester KL, 2000, J BACTERIOL, V182, P1144, DOI 10.1128/JB.182.4.1144-1149.2000; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; HOLTEL A, 1994, J BACTERIOL, V176, P1773, DOI 10.1128/jb.176.6.1773-1776.1994; INOUYE S, 1985, J BACTERIOL, V163, P863, DOI 10.1128/JB.163.3.863-869.1985; INOUYE S, 1987, P NATL ACAD SCI USA, V84, P5182, DOI 10.1073/pnas.84.15.5182; Kasai Y, 2001, J BACTERIOL, V183, P6662, DOI 10.1128/JB.183.22.6662-6666.2001; MACGREGOR CH, 1991, J BACTERIOL, V173, P7204, DOI 10.1128/jb.173.22.7204-7212.1991; MARQUES S, 1994, J BACTERIOL, V176, P2517; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Moreno R, 2008, J BACTERIOL, V190, P1539, DOI 10.1128/JB.01604-07; Moreno R, 2007, MOL MICROBIOL, V64, P665, DOI 10.1111/j.1365-2958.2007.05685.x; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; RAMOS JL, 1987, MOL MICROBIOL, V1, P293, DOI 10.1111/j.1365-2958.1987.tb01935.x; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; Romby P, 2003, TRENDS GENET, V19, P155, DOI 10.1016/S0168-9525(03)00020-9; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SALATREP.JM, 1971, EUR J BIOCHEM, V20, P400, DOI 10.1111/j.1432-1033.1971.tb01406.x; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; WILLIAMS PA, 1974, J BACTERIOL, V120, P416, DOI 10.1128/JB.120.1.416-423.1974; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x; Yuste L, 2001, J BACTERIOL, V183, P6197, DOI 10.1128/JB.183.21.6197-6206.2001	48	46	47	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24412	24419		10.1074/jbc.M110.126615	http://dx.doi.org/10.1074/jbc.M110.126615			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529863	hybrid, Green Published			2022-12-27	WOS:000280542100013
J	Swiatkowska, M; Padula, G; Michalec, L; Stasiak, M; Skurzynski, S; Cierniewski, CS				Swiatkowska, Maria; Padula, Gianluca; Michalec, Lidia; Stasiak, Marta; Skurzynski, Szymon; Cierniewski, Czeslaw S.			Ero1 alpha Is Expressed on Blood Platelets in Association with Protein-disulfide Isomerase and Contributes to Redox-controlled Remodeling of alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; FUNCTIONAL ASSOCIATION; INTEGRIN ACTIVATION; PLASMA-MEMBRANE; TISSUE FACTOR; SURFACE; EXCHANGE; FAMILY; LOCALIZATION; CYSTEINES	Recent evidence supports a role of protein-disulfide isomerase (PDI) in redox-controlled remodeling of the exofacial domains of alpha(IIb)beta(3) in blood platelets. The aim of this study was to explain whether Ero1 alpha can be responsible for extracellular reoxidation of the PDI active site. We showed that Ero1 alpha can be found on platelets and is rapidly recruited to the cell surface in response to platelet agonists. It is physically associated with PDI and alpha(IIb)beta(3), as suggested by colocalization analysis in confocal microscopy and confirmed by immunoprecipitation experiments. Apart from monomeric oxidized Ero1 alpha, anti-alpha(IIb)beta(3) immunoprecipitates showed the presence of several Ero1 alpha-positive bands that corresponded to the complexes alpha(IIb)beta(3)-PDI-Ero1 alpha, PDI-Ero1 alpha, and Ero1 alpha-Ero1 alpha dimers. It binds more efficiently to the activated alpha(IIb)beta(3) conformer, and its interaction is inhibited by RGD peptides. Ero1 alpha appears to be involved in the regulation of alpha(IIb)beta(3) receptor activity because of the following: (a) blocking the cell surface Ero1 alpha by antibodies leads to a decrease in platelet aggregation in response to agonists and a decrease in fibrinogen and PAC-1 binding, and (b) transfection of MEG01 with Ero1 alpha increases alpha(IIb)beta(3) receptor activity, as indicated by increased binding of fibrinogen.	[Swiatkowska, Maria; Padula, Gianluca; Michalec, Lidia; Stasiak, Marta; Skurzynski, Szymon; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-92232 Lodz, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl		Stasiak, Marta/0000-0003-0969-1162	Polish Ministry of Scientific Research and Higher Education [N301 012 31/0230, 343/N-INCA/2008/0]	Polish Ministry of Scientific Research and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Projects N301 012 31/0230 and 343/N-INCA/2008/0 from Polish Ministry of Scientific Research and Higher Education.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; CIERNIEWSKI CS, 1982, THROMB HAEMOSTASIS, V48, P33; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; Mou YL, 1998, J IMMUNOL, V161, P6323; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Walsh GM, 2004, BIOCHEMISTRY-US, V43, P473, DOI 10.1021/bi0354536; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200	36	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29874	29883		10.1074/jbc.M109.092486	http://dx.doi.org/10.1074/jbc.M109.092486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20562109	Green Published, hybrid			2022-12-27	WOS:000281984300024
J	Sepramaniam, S; Armugam, A; Lim, KY; Karolina, DS; Swaminathan, P; Tan, JR; Jeyaseelan, K				Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Lim, Kai Ying; Karolina, Dwi Setyowati; Swaminathan, Priyadharshni; Tan, Jun Rong; Jeyaseelan, Kandiah			MicroRNA 320a Functions as a Novel Endogenous Modulator of Aquaporins 1 and 4 as Well as a Potential Therapeutic Target in Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT FOCAL ISCHEMIA; BRAIN EDEMA; MESSENGER-RNAS; EXPRESSION; GENES; ASTROCYTES; APOPTOSIS; MIGRATION; MIRNAS; GROWTH	Aquaporins facilitate efficient diffusion of water across cellular membranes, and water homeostasis is critically important in conditions such as cerebral edema. Changes in aquaporin 1 and 4 expression in the brain are associated with cerebral edema, and the lack of water channel modulators is often highlighted. Here we present evidence of an endogenous modulator of aquaporin 1 and 4. We identify miR-320a as a potential modulator of aquaporin 1 and 4 and explore the possibility of using miR-320a to alter the expression of aquaporin 1 and 4 in normal and ischemic conditions. We show that precursor miR-320a can function as an inhibitor, whereas anti-miR-320a can act as an activator of aquaporin 1 and 4 expressions. We have also shown that anti-miR-320a could bring about a reduction of infarct volume in cerebral ischemia with a concomitant increase in aquaporins 1 and 4 mRNA and protein expression.	[Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Lim, Kai Ying; Karolina, Dwi Setyowati; Swaminathan, Priyadharshni; Tan, Jun Rong; Jeyaseelan, Kandiah] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117597, Singapore	National University of Singapore	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, 8 Med Dr, Singapore 117597, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Research Foundation [R-184-002-165-281]; Medical Research Council [EDG: R-183-000-230-275]; National Kidney Foundation [NKFRC/2008/10]	National Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Kidney Foundation	This work was supported by National Research Foundation Grant R-184-002-165-281, National Medical Research Council Grant EDG: R-183-000-230-275, and National Kidney Foundation Grant NKFRC/2008/10.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Aoki K, 2003, ACTA NEUROPATHOL, V106, P121, DOI 10.1007/s00401-003-0709-y; Armugam A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-120; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiromatzo AO, 2007, GENET MOL RES, V6, P859; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jablonski EM, 2007, CANCER LETT, V250, P36, DOI 10.1016/j.canlet.2006.09.013; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim SJ, 2000, ONCOGENE, V19, P6271, DOI 10.1038/sj.onc.1204014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARMAROU A, 2007, FOCUS           0927, DOI DOI 10.3171/FOC.2007.22.5.2; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VAN ROOIJ E, 2006, P NATL ACAD SCI USA, V103, P18255; Yang M, 2009, BRAIN RES, V1290, P121, DOI 10.1016/j.brainres.2009.07.018; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	49	127	139	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29223	29230		10.1074/jbc.M110.144576	http://dx.doi.org/10.1074/jbc.M110.144576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20628061	hybrid, Green Published			2022-12-27	WOS:000281740100023
J	De Jaco, A; Lin, MZ; Dubi, N; Comoletti, D; Miller, MT; Camp, S; Ellisman, M; Butko, MT; Tsien, RY; Taylor, P				De Jaco, Antonella; Lin, Michael Z.; Dubi, Noga; Comoletti, Davide; Miller, Meghan T.; Camp, Shelley; Ellisman, Mark; Butko, Margaret T.; Tsien, Roger Y.; Taylor, Palmer			Neuroligin Trafficking Deficiencies Arising from Mutations in the alpha/beta-Hydrolase Fold Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROGLOBULIN GENE; DISULFIDE-ISOMERASE; CONGENITAL HYPOTHYROIDISM; STRUCTURAL VARIANTS; AUTISM REVEALS; CELL-ADHESION; NLGN4; NEUREXIN-1-BETA; DEGRADATION; SYNAPSES	Despite great functional diversity, characterization of the alpha/beta-hydrolase fold proteins that encompass a superfamily of hydrolases, heterophilic adhesion proteins, and chaperone domains reveals a common structural motif. By incorporating the R451C mutation found in neuroligin(NLGN) and associated with autism and the thyroglobulin G2320R (G221R in NLGN) mutation responsible for congenital hypothyroidism into NLGN3, we show that mutations in the alpha/beta-hydrolase fold domain influence folding and biosynthetic processing of neuroligin3 as determined by in vitro susceptibility to proteases, glycosylation processing, turnover, and processing rates. We also show altered interactions of the mutant proteins with chaperones in the endoplasmic reticulum and arrest of transport along the secretory pathway with diversion to the proteasome. Time-controlled expression of a fluorescently tagged neuroligin in hippocampal neurons shows that these mutations compromise neuronal trafficking of the protein, with the R451C mutation reducing and the G221R mutation virtually abolishing the export of NLGN3 from the soma to the dendritic spines. Although the R451C mutation causes a local folding defect, the G221R mutation appears responsible for more global misfolding of the protein, reflecting their sequence positions in the structure of the protein. Our results suggest that disease-related mutations in the alpha/beta-hydrolase fold domain share common trafficking deficiencies yet lead to discrete congenital disorders of differing severity in the endocrine and nervous systems.	[Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Lin, Michael Z.; Butko, Margaret T.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lin, Michael Z.; Butko, Margaret T.; Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ellisman, Mark] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [De Jaco, Antonella] Univ Roma La Sapienza, Dept Cell & Dev Biol, Daniel Bovet Neurobiol Res Ctr, I-00185 Rome, Italy; [De Jaco, Antonella] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Lin, Michael/0000-0002-0492-1961; DE JACO, Antonella/0000-0002-9394-0207	United States Public Health Service [P42 ES010337, R37 GM-18360]; Compagnia San Paolo Bando Programma in Neuroscienze; Autism Speaks Grant [2617]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R37GM018360, R01GM018360] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Compagnia San Paolo Bando Programma in Neuroscienze(Compagnia di San Paolo); Autism Speaks Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P42 ES010337 and R37 GM-18360 from the United States Public Health Service (to P. T.). This work was also supported by a grant from the Compagnia San Paolo Bando Programma in Neuroscienze 2008 (to A. D. J.) and Autism Speaks Grant 2617 (to D. C.).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bourgeron T, 2009, B ACAD NAT MED PARIS, V193, P299, DOI 10.1016/S0001-4079(19)32583-X; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Cousin X, 1997, NUCLEIC ACIDS RES, V25, P143, DOI 10.1093/nar/25.1.143; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; DOLGINOVA EA, 1992, BIOCHEMISTRY-US, V31, P12248, DOI 10.1021/bi00163a039; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Yen T, 2003, CLIN CHEM, V49, P1297, DOI 10.1373/49.8.1297; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	48	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28674	28682		10.1074/jbc.M110.139519	http://dx.doi.org/10.1074/jbc.M110.139519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615874	Green Published, hybrid			2022-12-27	WOS:000281594000032
J	Hegde, ML; Hegde, PM; Holthauzen, LMF; Hazra, TK; Rao, KSJ; Mitra, S				Hegde, Muralidhar L.; Hegde, Pavana M.; Holthauzen, Luis M. F.; Hazra, Tapas K.; Rao, K. S. Jagannatha; Mitra, Sankar			Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron POTENTIAL ETIOLOGICAL LINKAGE TO NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA GLYCOSYLASE NEIL1; CARCINOGENIC METAL-COMPOUNDS; PARKINSONS-DISEASE; EXCISION-REPAIR; ALZHEIMERS-DISEASE; 8-OXOGUANINE-DNA GLYCOSYLASE; SUBSTANTIA-NIGRA; HUMAN-CELLS; CURCUMIN PROTECTS; MAMMALIAN-CELLS	Dyshomeostasis of transition metals iron and copper as well as accumulation of oxidative DNA damage have been implicated in multitude of human neurodegenerative diseases, including Alzheimer disease and Parkinson disease. These metals oxidize DNA bases by generating reactive oxygen species. Most oxidized bases in mammalian genomes are repaired via the base excision repair pathway, initiated with one of four major DNA glycosylases: NTH1 or OGG1 (of the Nth family) or NEIL1 or NEIL2 (of the Nei family). Here we show that Fe(II/III) and Cu(II) at physiological levels bind to NEIL1 and NEIL2 to alter their secondary structure and strongly inhibit repair of mutagenic 5-hydroxyuracil, a common cytosine oxidation product, both in vitro and in neuroblastoma (SH-SY5Y) cell extract by affecting the base excision and AP lyase activities of NEILs. The specificity of iron/copper inhibition of NEILs is indicated by a lack of similar inhibition of OGG1, which also indicated that the inhibition is due to metal binding to the enzymes and not DNA. Fluorescence and surface plasmon resonance studies show sub-micromolar binding of copper/iron to NEILs but not OGG1. Furthermore, Fe(II) inhibits the interaction of NEIL1 with downstream base excision repair proteins DNA polymerase beta and flap endonuclease-1 by 4-6-fold. These results indicate that iron/copper overload in the neurodegenerative diseases could act as a double-edged sword by both increasing oxidative genome damage and preventing their repair. Interestingly, specific chelators, including the natural chemopreventive compound curcumin, reverse the inhibition of NEILs both in vitro and in cells, suggesting their therapeutic potential.	[Hegde, Muralidhar L.; Hegde, Pavana M.; Holthauzen, Luis M. F.; Hazra, Tapas K.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Rao, K. S. Jagannatha] Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570020, Karnataka, India	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Mitra, S (corresponding author), 301 Univ Blvd, Galveston, TX 77555 USA.	samitra@utmb.edu	Classen, Scott/AAY-8176-2020; Kosagisharaf, Jagannatha Rao/N-6788-2014	Kosagisharaf, Jagannatha Rao/0000-0003-4290-7666; Dixit, Pavana/0000-0003-0811-3942; Hegde, Muralidhar/0000-0001-7333-8123	National Institutes of Health; American Parkinson's Disease Association; USPHS [CA81063, P01 CA092584, CA102271]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063, R01CA102271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson's Disease Association; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, USPHS, Grants CA81063 and P01 CA092584 (to S. M.) and CA102271 (to T. K. H.). This research was also supported by an American Parkinson's Disease Association postdoctoral fellowship award (to M. L. H.).	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; BANAS A, 2010, J BIOL INOR IN PRESS; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Barik A, 2005, FREE RADICAL BIO MED, V39, P811, DOI 10.1016/j.freeradbiomed.2005.05.005; Barreto R, 2005, Chin J Dig Dis, V6, P31, DOI 10.1111/j.1443-9573.2005.00184.x; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Bravard A, 2010, MUTAT RES-FUND MOL M, V685, P61, DOI 10.1016/j.mrfmmm.2009.09.013; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Cuajungco MP, 2005, SUB CELL BIOCHEM, V38, P235; Dairam A, 2007, J AGR FOOD CHEM, V55, P1039, DOI 10.1021/jf063446t; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Das A, 2004, J BIOL CHEM, V279, P47132, DOI 10.1074/jbc.M406224200; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Englander EW, 2006, MECH AGEING DEV, V127, P64, DOI 10.1016/j.mad.2005.09.008; Farah Ibrahim O, 2010, Biomed Sci Instrum, V46, P404; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Grin IR, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1253, DOI 10.1134/S000629790911011X; Grossoehme NE, 2007, BIOCHEMISTRY-US, V46, P10506, DOI 10.1021/bi700171v; Gupta Veer Bala, 2006, Current Alzheimer Research, V3, P297; Hamann I, 2009, MUTAT RES-FUND MOL M, V669, P122, DOI 10.1016/j.mrfmmm.2009.05.011; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Hartwig A, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110s5797; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; Hartwig A, 2002, TOXICOL LETT, V127, P47, DOI 10.1016/S0378-4274(01)00482-9; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2004, J TRACE ELEM MED BIO, V18, P163, DOI 10.1016/j.jtemb.2004.09.003; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2007, ARCH BIOCHEM BIOPHYS, V464, P57, DOI 10.1016/j.abb.2007.03.042; Hegde ML, 2006, ARCH BIOCHEM BIOPHYS, V449, P143, DOI 10.1016/j.abb.2006.02.018; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Jalilehvand F, 2009, INORG CHEM, V48, P4219, DOI 10.1021/ic900145n; Koeppen AH, 2003, J NEUROL SCI, V207, P95, DOI 10.1016/S0022-510X(02)00429-X; Li H, 2009, J NEUROCHEM, V110, P1774, DOI 10.1111/j.1471-4159.2009.06271.x; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Llanos RM, 2002, DNA CELL BIOL, V21, P259, DOI 10.1089/104454902753759681; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maiti AK, 2008, DNA REPAIR, V7, P1213, DOI 10.1016/j.dnarep.2008.03.025; Mendonca LM, 2009, MUTAT RES-GEN TOX EN, V675, P29, DOI 10.1016/j.mrgentox.2009.02.003; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; PRASAD R, 1993, J BIOL CHEM, V268, P22746; Rao KS, 2007, NEUROSCIENCE, V145, P1330, DOI 10.1016/j.neuroscience.2006.09.032; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Wang P, 2006, TOXICOL LETT, V166, P237, DOI 10.1016/j.toxlet.2006.06.647; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yasuhara T, 2007, BRAIN RES, V1133, P49, DOI 10.1016/j.brainres.2006.11.072; Zatta P, 2003, BRAIN RES BULL, V62, P15, DOI 10.1016/S0361-9230(03)00182-5; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200; Zharkov DO, 2002, DNA REPAIR, V1, P661, DOI 10.1016/S1568-7864(02)00074-5	76	49	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28812	28825		10.1074/jbc.M110.126664	http://dx.doi.org/10.1074/jbc.M110.126664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622253	hybrid, Green Published			2022-12-27	WOS:000281594000047
J	Ishii, K; Hamamoto, H; Kamimura, M; Nakamura, Y; Noda, H; Imamura, K; Mita, K; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Kamimura, Manabu; Nakamura, Yuki; Noda, Hiroaki; Imamura, Katsutoshi; Mita, Kazuei; Sekimizu, Kazuhisa			Insect Cytokine Paralytic Peptide (PP) Induces Cellular and Humoral Immune Responses in the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT-LIKE PROTEIN; GENOME-WIDE ANALYSIS; INNATE IMMUNITY; KINASE PATHWAY; DROSOPHILA; PHAGOCYTOSIS; GENE; EXPRESSION; HEMOLYMPH; TOLL	In the blood (hemolymph) of the silkworm Bombyx mori, the insect cytokine paralytic peptide (PP) is converted from an inactive precursor to an active form in response to the cell wall components of microorganisms and contributes to silkworm resistance to infection. To investigate the molecular mechanism underlying the up-regulation of host resistance induced by PP, we performed an oligonucleotide microarray analysis on RNA of blood cells (hemocytes) and fat body tissues of silkworm larvae injected with active PP. Expression levels of a large number of immune-related genes increased rapidly within 3 h after injecting active PP, including phagocytosis-related genes such as tetraspanin E, actin A1, and ced-6 in hemocytes, and antimicrobial peptide genes cecropin A and moricin in the fat body. Active PP promoted in vitro and in vivo phagocytosis of Staphyloccocus aureus by the hemocytes. Moreover, active PP induced in vivo phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) in the fat body. Pretreatment of silkworm larvae with ML3403, a pharmacologic p38 MAPK inhibitor, suppressed the PP-dependent induction of cecropin A and moricin genes in the fat body. Injection of active PP delayed the killing of silkworm larvae by S. aureus, whereas its effect was abolished by preinjection of the p38 MAPK inhibitor, suggesting that p38 MAPK activation is required for PP-dependent defensive responses. These findings suggest that PP acts on multiple tissues in silkworm larvae and acutely activates cellular and humoral immune responses, leading to host protection against infection.	[Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Kamimura, Manabu; Nakamura, Yuki; Noda, Hiroaki; Mita, Kazuei] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019	Hamamoto, Hiroshi/0000-0001-9315-7442; 	Japan Society for the Promotion of Science [21790063, 21-10519]; Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation; Genome Pharmaceuticals Co. Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Co. Ltd.	This work was supported by Grant-in-aid for Young Scientists (B) 21790063 and Grant-in-aid for Japan Society for the Promotion of Science fellows (21-10519) from Japan Society for the Promotion of Science. This study was also supported by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation and grants from Genome Pharmaceuticals Co. Ltd.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Aizawa T, 2002, MOL CELLS, V14, P1; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; Davis MM, 2008, MOL CELL BIOL, V28, P4883, DOI 10.1128/MCB.02074-07; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Fujiwara Y, 2006, INSECT BIOCHEM MOLEC, V36, P47, DOI 10.1016/j.ibmb.2005.10.005; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Laufer SA, 2003, J MED CHEM, V46, P3230, DOI 10.1021/jm030766k; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; OKADA M, 1985, J BIOL CHEM, V260, P7174; OKADA M, 1983, BIOCHEM J, V211, P727, DOI 10.1042/bj2110727; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Wu RCC, 2007, INSECT MOL BIOL, V16, P389, DOI 10.1111/j.1365-2583.2007.00734.x; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200	46	67	74	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28635	28642		10.1074/jbc.M110.138446	http://dx.doi.org/10.1074/jbc.M110.138446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622022	Green Published, hybrid			2022-12-27	WOS:000281594000027
J	Li, FC; Nandini, CD; Hattori, T; Bao, XF; Murayama, D; Nakamura, T; Fukushima, N; Sugahara, K				Li, Fuchuan; Nandini, Chilkunda D.; Hattori, Tomohide; Bao, Xingfeng; Murayama, Daisuke; Nakamura, Toshikazu; Fukushima, Nobuhiro; Sugahara, Kazuyuki			Structure of Pleiotrophin- and Hepatocyte Growth Factor-binding Sulfated Hexasaccharide Determined by Biochemical and Computational Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC PIG BRAIN; CHONDROITIN SULFATE; HYBRID CHAINS; NEURITE OUTGROWTH; HEPARAN-SULFATE; NEURITOGENIC ACTIVITY; DERMATAN SULFATE; FACTOR/SCATTER FACTOR; HIPPOCAMPAL-NEURONS; SHARK CARTILAGE	Endogenous pleiotrophin and hepatocyte growth factor (HGF) mediate the neurite outgrowth-promoting activity of chondroitin sulfate (CS)/dermatan sulfate (DS) hybrid chains isolated from embryonic pig brain. CS/DS hybrid chains isolated from shark skin have a different disaccharide composition, but also display these activities. In this study, pleiotrophin-and HGF-binding domains in shark skin CS/DS were investigated. A high affinity CS/DS fraction was isolated using a pleiotrophin-immobilized column. It showed marked neurite outgrowth-promoting activity and strong inhibitory activity against the binding of pleiotrophin to immobilized CS/DS chains from embryonic pig brain. The inhibitory activity was abolished by chondroitinase ABC or B, and partially reduced by chondroitinase AC-I. A pentasulfated hexasaccharide with a novel structure was isolated from the chondroitinase AC-I digest using pleiotrophin affinity and anion exchange chromatographies. It displayed a potent inhibitory effect on the binding of HGF to immobilized shark skin CS/DS chains, suggesting that the pleiotrophin-and HGF-binding domains at least partially overlap in the CS/DS chains involved in the neuritogenic activity. Computational chemistry using molecular modeling and calculations of the electrostatic potential of the hexasaccharide and two pleiotrophin-binding octasaccharides previously isolated from CS/DS hybrid chains of embryonic pig brain identified an electronegative zone potentially involved in the molecular recognition of the oligosaccharides by pleiotrophin. Homology modeling of pleiotrophin based on a related midkine protein structure predicted the binding pocket of pleiotrophin for the oligosaccharides and provided new insights into the molecular mechanism of the interactions between the oligosaccharides and pleiotrophin.	[Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Fac Adv Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Li, Fuchuan; Nandini, Chilkunda D.; Bao, Xingfeng; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan; [Hattori, Tomohide; Murayama, Daisuke; Fukushima, Nobuhiro] Sci Technol Syst Inc, Tokyo 1130033, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan	Hokkaido University; Kobe Pharmaceutical University; Osaka University	Sugahara, K (corresponding author), Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Fac Adv Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [17659020, 16390026, 18390030, 20390019, 14082207]; Human Frontier Science Program [RGP18/2005]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Exploratory Research 17659020 (to K. S.), Scientific Research B 16390026, 18390030, and 20390019 (to K. S.), Scientific Research on Priority Areas 14082207 (to K. S.), the Future Drug Discovery and Medical Care Innovation Program (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and the Human Frontier Science Program RGP18/2005 (to K. S.).; Supported in part by a postdoctoral fellowship from the Japan Society for the Promotion of Science.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CACERES A, 1986, J NEUROSCI, V6, P714; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deakin JA, 1999, J CELL SCI, V112, P1999; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Delley B, 2006, MOL SIMULAT, V32, P117, DOI 10.1080/08927020600589684; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Eswar N, 2006, CURRENT PROTOCOLS S, P561; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fath M, 1999, FEBS LETT, V454, P105, DOI 10.1016/S0014-5793(99)00785-1; FERNANDEZ DP, 1995, J PHYS CHEM REF DATA, V24, P33, DOI 10.1063/1.555977; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HASCALL VC, 1977, J SUPRAMOL STR CELL, V7, P101, DOI 10.1002/jss.400070110; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAIMONE MM, 1991, J BIOL CHEM, V266, P14830; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUMOTO K, 1993, J BIOCHEM-TOKYO, V114, P820, DOI 10.1093/oxfordjournals.jbchem.a124262; Matsumoto K, 2008, PROTEOMICS, V8, P3360, DOI 10.1002/pmic.200800156; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; POOLE AR, 1986, BIOCHEM J, V236, P1; Pothacharoen P, 2007, J BIOL CHEM, V282, P35232, DOI 10.1074/jbc.M702255200; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RODEN L, 1980, BIOCH GLYCOPROTEINS, P491; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sakiyama R, 2007, J BIOCHEM, V141, P653, DOI 10.1093/jb/mvm067; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	69	27	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27673	27685		10.1074/jbc.M110.118703	http://dx.doi.org/10.1074/jbc.M110.118703			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584902	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000281404100023
J	Mistafa, O; Ghalali, A; Kadekar, S; Hogberg, J; Stenius, U				Mistafa, Oras; Ghalali, Aram; Kadekar, Sandeep; Hogberg, Johan; Stenius, Ulla			Purinergic Receptor-mediated Rapid Depletion of Nuclear Phosphorylated Akt Depends on Pleckstrin Homology Domain Leucine-rich Repeat Phosphatase, Calcineurin, Protein Phosphatase 2A, and PTEN Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-CYCLE; P53-DEFICIENT CELLS; UBIQUITIN LIGASE; LOCALIZATION; BINDING; KINASE; PCNA; DEGRADATION; D1	Akt is an important oncoprotein, and data suggest a critical role for nuclear Akt in cancer development. We have previously described a rapid (3-5 min) and P2X7-dependent depletion of nuclear phosphorylated Akt (pAkt) and effects on downstream targets, and here we studied mechanisms behind the pAkt depletion. We show that cholesterol-lowering drugs, statins, or extracellular ATP, induced a complex and coordinated response in insulin-stimulated A549 cells leading to depletion of nuclear pAkt. It involved protein/lipid phosphatases PTEN, pleckstrin homology domain leucine-rich repeat phosphatase (PHLPP1 and -2), protein phosphatase 2A (PP2A), and calcineurin. We employed immunocytology, immunoprecipitation, and proximity ligation assay techniques and show that PHLPP and calcineurin translocated to the nucleus and formed complexes with Akt within 3 min. Also PTEN translocated to the nucleus and then co-localized with pAkt close to the nuclear membrane. An inhibitor of the scaffolding immunophilin FK506-binding protein 51 (FKBP51) and calcineurin, FK506, prevented depletion of nuclear pAkt. Furthermore, okadaic acid, an inhibitor of PP2A, prevented the nuclear pAkt depletion. Chemical inhibition and siRNA indicated that PHLPP, PP2A, and PTEN were required for a robust depletion of nuclear pAkt, and in prostate cancer cells lacking PTEN, transfection of PTEN restored the statin-induced pAkt depletion. The activation of protein and lipid phosphatases was paralleled by a rapid proliferating cell nuclear antigen (PCNA) translocation to the nucleus, a PCNA-p21(cip1) complex formation, and cyclin D1 degradation. We conclude that these effects reflect a signaling pathway for rapid depletion of pAkt that may stop the cell cycle.	[Mistafa, Oras; Ghalali, Aram; Kadekar, Sandeep; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet	Ghalali, A (corresponding author), Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.	aram.ghalali@ki.se			Swedish Research Council; Karolinska Insititutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Insititutet(Karolinska Institutet)	This work was supported by the Swedish Research Council for the Environment, Agriculture Science, and Spatial Planning (Formas) and funds from Karolinska Insititutet.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Cen XB, 2006, J NEUROSCI, V26, P3335, DOI 10.1523/JNEUROSCI.5010-05.2006; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fukami-Kobayashi J, 1999, EXP CELL RES, V246, P338, DOI 10.1006/excr.1998.4306; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hamilton Robert J, 2008, Curr Urol Rep, V9, P189, DOI 10.1007/s11934-008-0034-z; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Li TK, 2002, J CELL BIOCHEM, V84, P460, DOI 10.1002/jcb.10026.abs; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Mistafa O, 2008, BIOCHEM BIOPH RES CO, V365, P131, DOI 10.1016/j.bbrc.2007.10.148; Mistafa O, 2009, BIOCHEM PHARMACOL, V78, P1115, DOI 10.1016/j.bcp.2009.06.016; Morrow PW, 2004, BIOCHEM BIOPH RES CO, V323, P645, DOI 10.1016/j.bbrc.2004.08.147; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Paajarvi G, 2004, FASEB J, V18, P476, DOI 10.1096/fj.04-2745fje; Park CH, 2008, BRAIN RES, V1234, P148, DOI 10.1016/j.brainres.2008.07.082; Pawar SA, 2010, P NATL ACAD SCI USA, V107, P9210, DOI 10.1073/pnas.0913813107; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhu Q, 2008, ONCOGENE, V27, P4569, DOI 10.1038/onc.2008.91	45	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27900	27910		10.1074/jbc.M110.117093	http://dx.doi.org/10.1074/jbc.M110.117093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605778	Green Published, hybrid			2022-12-27	WOS:000281404100045
J	Tseng, CN; Zhang, LL; Wu, SL; Wang, WF; Wang, ZZ; Cascio, M				Tseng, Chao-Neng; Zhang, Lili; Wu, Shey-Lin; Wang, Wen-Fu; Wang, Zuo-Zhong; Cascio, Michael			Asparagine of z8 Insert Is Critical for the Affinity, Conformation, and Acetylcholine Receptor-clustering Activity of Neural Agrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; NEUROMUSCULAR-JUNCTION; CULTURED MYOTUBES; MUSCLE-CELLS; LIPID RAFTS; BINDING; PROTEIN; DYSTROGLYCAN; AGGREGATION; RNA	Agrin isoforms with different bioactivities are synthesized by the nerve and the muscle. Neural agrin containing an 8-amino acid insert (z8) introduced by alternative splicing is the active form that induces synaptic differentiation at the neuromuscular junction. In addition to alternative splicing, extracellular calcium is also required for the activity of neural agrin. To understand better how the activity of agrin is regulated by alternative splicing, we have applied alanine substitution mutagenesis to the z8 insert and the calcium binding site in the minimally functional AgG3z8 fragment. Single alanine substitutions in the 4th through the 7th amino acid of the z8 splice insert significantly reduced the function of agrin, in terms of acetylcholine receptor clustering activity and the affinity for binding to the muscle surface. Mutation of the asparagine at the 4th position drastically reduces bioactivity such that it is equivalent to that of muscle form AgG3z0. These reduced activity mutants also show reduced magnitudes of the calcium-induced CD spectrum change from that observed in AgG3z8 fragments, indicating that cross-talk between calcium and the z8 insert is critical for the normal activity of agrin. However, removal of Ca2+ binding via mutation of both aspartic acids in the calcium binding site did not totally eliminate the activity of AgG3z8. These results suggest a model wherein the z8 insert is a Ca2+-responsive allosteric element that is essential in forming an active conformation in neuronal agrin.	[Cascio, Michael] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Tseng, Chao-Neng] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan; [Tseng, Chao-Neng] Kaohsiung Med Univ, Dept Pharm, Kaohsiung 807, Taiwan; [Tseng, Chao-Neng; Zhang, Lili; Wang, Zuo-Zhong] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Cascio, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Wu, Shey-Lin; Wang, Wen-Fu] Changhua Christian Hosp, Dept Neurol, Changhua 500, Taiwan	Duquesne University; Kaohsiung Medical University; Kaohsiung Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Changhua Christian Hospital	Cascio, M (corresponding author), Duquesne Univ, Dept Chem & Biochem, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	casciom@duq.edu	Tseng, Chao-Neng/A-3798-2014	Tseng, Chao-Neng/0000-0001-9972-7987	National Institutes of Health [NS38301]; Muscular Dystrophy Association; National Science Council in Taiwan [NSC 95-2314-B-037-108, NSC96-2320-B037-033-MY2]; Kaohsiung Medical University [Q095006, Q097007]; National Institutes of Health/National Center for Research Resources [1S10RR11998]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS38301 and the Muscular Dystrophy Association (to Z.-Z. W.), National Science Council in Taiwan Grants NSC 95-2314-B-037-108 and NSC96-2320-B037-033-MY2, and Kaohsiung Medical University Faculty Development Grants Q095006 and Q097007 (to C.-N. T.). The CD studies were supported by National Institutes of Health/National Center for Research Resources Shared Instrumentation Grant 1S10RR11998 (to M. C.).	Alexandrescu AT, 2001, J BIOMOL NMR, V20, P295, DOI 10.1023/A:1011256008944; Bhalla J, 2006, MOL CELL PROTEOMICS, V5, P1212, DOI 10.1074/mcp.M500315-MCP200; BLOCH RJ, 1983, J NEUROSCI, V3, P2670; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; Bowen DC, 1996, J NEUROSCI, V16, P3791; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Deyst KA, 1998, DEV BRAIN RES, V110, P185, DOI 10.1016/S0165-3806(98)00105-9; Dobbins GC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-18; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gautam M, 1999, DEV BRAIN RES, V114, P171, DOI 10.1016/S0165-3806(99)00013-9; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Gingras J, 2005, CELL TISSUE RES, V320, P115, DOI 10.1007/s00441-004-1045-9; Gingras J, 2007, DEV NEUROBIOL, V67, P521, DOI 10.1002/dneu.20304; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; HUNTER WM, 1964, BIOCHEM J, V91, P43, DOI 10.1042/bj0910043; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Koirala S, 2003, J NEUROCYTOL, V32, P987, DOI 10.1023/B:NEUR.0000020637.71452.3c; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Pato C, 2008, CHEM-BIOL INTERACT, V175, P64, DOI 10.1016/j.cbi.2008.03.020; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; SHADIACK AM, 1991, J NEUROBIOL, V22, P617, DOI 10.1002/neu.480220607; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	48	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27641	27651		10.1074/jbc.M110.130625	http://dx.doi.org/10.1074/jbc.M110.130625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566625	Green Published, hybrid			2022-12-27	WOS:000281404100020
J	Takenaka, M; Verbitskiy, D; Zehrmann, A; Brennicke, A				Takenaka, Mizuki; Verbitskiy, Daniil; Zehrmann, Anja; Brennicke, Axel			Reverse Genetic Screening Identifies Five E-class PPR Proteins Involved in RNA Editing in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPLAST TRANSCRIPTS; DYW PROTEIN; PLANT-MITOCHONDRIA; SITES; RECOGNITION; SEQUENCE; ELEMENTS; REVEALS; GENOME	RNA editing in flowering plant mitochondria post-transcriptionally alters several hundred nucleotides from C to U, mostly in mRNAs. Several factors required for specific RNA-editing events in plant mitochondria and plastids have been identified, all of them PPR proteins of the PLS subclass with a C-terminal E-domain and about half also with an additional DYW domain. Based on this information, we here probe the connection between E-PPR proteins and RNA editing in plant mitochondria. We initiated a reverse genetics screen of T-DNA insertion lines in Arabidopsis thaliana and investigated 58 of the 150 E-PPR-coding genes for a function in RNA editing. Six genes were identified to be involved in mitochondrial RNA editing at specific sites. Homozygous mutants of the five genes MEF18-MEF22 display no gross disturbance in their growth or development patterns, suggesting that the editing sites affected are not crucial at least in the greenhouse. These results show that a considerable percentage of the E-PPR proteins are involved in the functional processing of site-specific RNA editing in plant mitochondria.	[Takenaka, Mizuki; Verbitskiy, Daniil; Zehrmann, Anja; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M. T. and A. B.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Bock R, 1997, EMBO J, V16, P3282, DOI 10.1093/emboj/16.11.3282; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Kempken F, 2009, ENDOCYT CELL RES, V19, P1; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Tillich M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-201; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	52	69	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27122	27129		10.1074/jbc.M110.128611	http://dx.doi.org/10.1074/jbc.M110.128611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566637	Green Published, hybrid			2022-12-27	WOS:000281172700043
J	Yang, W; Bell, SG; Wang, H; Zhou, WH; Hoskins, N; Dale, A; Bartlam, M; Wong, LL; Rao, ZH				Yang, Wen; Bell, Stephen G.; Wang, Hui; Zhou, Weihong; Hoskins, Nicola; Dale, Alison; Bartlam, Mark; Wong, Luet-Lok; Rao, Zihe			Molecular Characterization of a Class I P450 Electron Transfer System from Novosphingobium aromaticivorans DSM12444	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BACTERIAL CYTOCHROMES P450; NADH-DEPENDENT FERREDOXIN; CRYSTAL-STRUCTURE; PUTIDAREDOXIN REDUCTASE; RHODOPSEUDOMONAS-PALUSTRIS; TRANSFER COMPLEX; REDOX PARTNER; THERMOSTABLE CYP175A1; BOVINE ADRENODOXIN	Cytochrome P450 (CYP) enzymes of the CYP101 and CYP111 families from the oligotrophic bacterium Novosphingobium aromaticivorans DSM12444 are heme monooxygenases that receive electrons from NADH via Arx, a [2Fe-2S] ferredoxin, and ArR, a ferredoxin reductase. These systems show fast NADH turnovers (k(cat) = 39-91 s(-1)) that are efficiently coupled to product formation. The three-dimensional structures of ArR, Arx, and CYP101D1, which form a physiological class I P450 electron transfer chain, have been resolved by x-ray crystallography. The general structural features of these proteins are similar to their counterparts in other class I systems such as putidaredoxin reductase (PdR), putidaredoxin (Pdx), and CYP101A1 of the camphor hydroxylase system from Pseudomonas putida, and adrenodoxin (Adx) of the mitochondrial steroidogenic CYP11 and CYP24A1 systems. However, significant differences in the proposed protein-protein interaction surfaces of the ferredoxin reductase, ferredoxin, and P450 enzyme are found. There are regions of positive charge on the likely interaction face of ArR and CYP101D1 and a corresponding negatively charged area on the surface of Arx. The [2Fe-2S] cluster binding loop in Arx also has a neutral, hydrophobic patch on the surface. These surface characteristics are more in common with those of Adx than Pdx. The observed structural features are consistent with the ionic strength dependence of the activity.	[Bell, Stephen G.; Hoskins, Nicola; Dale, Alison; Wong, Luet-Lok] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; [Yang, Wen; Zhou, Weihong; Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Hui; Bartlam, Mark; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China	University of Oxford; Nankai University; Tsinghua University	Bell, SG (corresponding author), Univ Oxford, Inorgan Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	stephen.bell@chem.ox.ac.uk; bartlam@nankai.edu.cn	WANG, HUI/AAL-7764-2020; YANG, WEN/A-1993-2014; Bell, Stephen/E-8222-2011; Rao, Zihe/HCH-6944-2022	Bell, Stephen/0000-0002-7457-9727; Bartlam, Mark/0000-0001-5173-5080; Wang, Hui/0000-0002-5745-2599	Ministry of Science and Technology of China [2007CB914301]; Tianjin Municipal Science and Technology Commission [08SYSYTC00200]; Higher Education Funding Council for England, UK	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Tianjin Municipal Science and Technology Commission; Higher Education Funding Council for England, UK(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	The work was supported by Grant 2007CB914301 from the Ministry of Science and Technology of China Project 973 (to M. B.), Tianjin Municipal Science and Technology Commission Grant 08SYSYTC00200, and a grant from the Higher Education Funding Council for England, UK (to L.-L. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agematu H, 2006, BIOSCI BIOTECH BIOCH, V70, P307, DOI 10.1271/bbb.70.307; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Bell SG, 2008, J MOL BIOL, V383, P561, DOI 10.1016/j.jmb.2008.08.033; Bell SG, 2007, BIOCHEM BIOPH RES CO, V360, P666, DOI 10.1016/j.bbrc.2007.06.119; Bell SG, 2010, J BIOL INORG CHEM, V15, P315, DOI 10.1007/s00775-009-0604-7; Bell SG, 2010, APPL MICROBIOL BIOT, V86, P163, DOI 10.1007/s00253-009-2234-y; Bell SG, 2010, MOL BIOSYST, V6, P206, DOI 10.1039/b913487e; Brazeau BJ, 2003, BIOCHEM BIOPH RES CO, V312, P143, DOI 10.1016/j.bbrc.2003.09.242; Churbanova IY, 2010, BIOCHEMISTRY-US, V49, P58, DOI 10.1021/bi901872s; Crowley PB, 2004, PROTEINS, V55, P603, DOI 10.1002/prot.20043; Cryle MJ, 2003, AUST J CHEM, V56, P749, DOI 10.1071/CH03040; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; DEPREZ E, 1994, FEBS LETT, V347, P207, DOI 10.1016/0014-5793(94)00545-1; DEPREZ E, 1994, BIOCHEMISTRY-US, V33, P14464, DOI 10.1021/bi00252a012; Deprez E, 2002, J INORG BIOCHEM, V91, P597, DOI 10.1016/S0162-0134(02)00467-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2001, CURR DRUG METAB, V2, P93, DOI 10.2174/1389200013338694; HAMAMOTO I, 1993, J STEROID BIOCHEM, V46, P33, DOI 10.1016/0960-0760(93)90206-C; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I., 1996, ADV MOL CEL, V14, P29; Holden M, 1997, J BIOL CHEM, V272, P21720, DOI 10.1074/jbc.272.35.21720; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Kakuta Y, 2001, BIOCHEMISTRY-US, V40, P11007, DOI 10.1021/bi010544t; Karyakin A, 2007, BBA-GEN SUBJECTS, V1770, P420, DOI 10.1016/j.bbagen.2006.08.020; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; LAMBETH JD, 1979, J BIOL CHEM, V254, P7255; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovett JE, 2009, PHYS CHEM CHEM PHYS, V11, P6840, DOI 10.1039/b907010a; Mandai T, 2009, FEBS J, V276, P2416, DOI 10.1111/j.1742-4658.2009.06974.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo HP, 1999, BIOCHEMISTRY-US, V38, P5666, DOI 10.1021/bi983063r; Momoi K, 2006, BIOCHEM BIOPH RES CO, V339, P331, DOI 10.1016/j.bbrc.2005.11.023; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nodate M, 2006, APPL MICROBIOL BIOT, V71, P455, DOI 10.1007/s00253-005-0147-y; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; PROJECT TC, 1994, ACTA CRYSTALLOGR D, V50, P760; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; Roitberg AE, 1998, J AM CHEM SOC, V120, P8927, DOI 10.1021/ja9739906; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Romine MF, 1999, J IND MICROBIOL BIOT, V23, P303, DOI 10.1038/sj.jim.2900750; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P32, DOI 10.1016/0003-9861(88)90233-0; Sainz G, 2006, J BIOL INORG CHEM, V11, P235, DOI 10.1007/s00775-005-0069-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schiffler B, 2003, BIOCHEM BIOPH RES CO, V312, P223, DOI 10.1016/j.bbrc.2003.09.214; Schiffler B, 2001, J BIOL CHEM, V276, P36225, DOI 10.1074/jbc.M102320200; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 2001, BIOCHEMISTRY-US, V40, P10592, DOI 10.1021/bi010874d; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Sigel A., 2007, UBIQUITOUS ROLES CYT; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; WADA A, 1992, J BIOL CHEM, V267, P22877; Westlake ACG, 1999, EUR J BIOCHEM, V265, P929, DOI 10.1046/j.1432-1327.1999.00793.x; Williams J W, 1979, Methods Enzymol, V63, P437; Xu F, 2009, PROTEINS, V77, P867, DOI 10.1002/prot.22510; Zhang W, 2008, J MOL BIOL, V384, P349, DOI 10.1016/j.jmb.2008.09.037	75	66	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27372	27384		10.1074/jbc.M110.118349	http://dx.doi.org/10.1074/jbc.M110.118349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576606	Green Published, hybrid			2022-12-27	WOS:000281172700066
J	Solomon, IH; Huettner, JE; Harris, DA				Solomon, Isaac H.; Huettner, James E.; Harris, David A.			Neurotoxic Mutants of the Prion Protein Induce Spontaneous Ionic Currents in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; TRANSMEMBRANE FORM; IN-VIVO; SCRAPIE; DISEASE; PRP; FRAGMENT; TOXICITY; CHANNELS; PERMEABILIZATION	The mechanisms by which prions kill neurons and the role of the cellular prion protein in this process are enigmatic. Insight into these questions is provided by the neurodegenerative phenotypes of transgenic mice expressing prion protein (PrP) molecules with deletions of conserved amino acids in the central region. We report here that expression in transfected cells of the most toxic of these PrP deletion mutants (Delta 105-125) induces large, spontaneous ionic currents that can be detected by patch-clamping techniques. These currents are produced by relatively non-selective, cation-permeable channels or pores in the cell membrane and can be silenced by overexpression of wild-type PrP, as well as by treatment with a sulfated glycosaminoglycan. Similar currents are induced by PrP molecules carrying several different point mutations in the central region that cause familial prion diseases in humans. The ionic currents described here are distinct from those produced in artificial lipid membranes by synthetic peptides derived from the PrP sequence because they are induced by membrane-anchored forms of PrP that are synthesized by cells and that are found in vivo. Our results indicate that the neurotoxicity of some mutant forms of PrP is attributable to enhanced ion channel activity and that wild-type PrP possesses a channel-silencing activity. Drugs that block PrP-associated channels or pores may therefore represent novel therapeutic agents for treatment of patients with prion diseases.	[Solomon, Isaac H.; Huettner, James E.; Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Huettner, James E/C-5219-2012	Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975, NS30888, NS063547, T32GM007200, P30 NS057105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052526, R01NS030888, P30NS057105, R01NS040975, R01NS065244, F30NS063547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.) and NS30888 (to J. E. H.) and by National Institutes of Health Predoctoral Fellowship NS063547 and the Medical Scientist Training Program at Washington University (National Institutes of Health Grant T32GM007200) (to I. H. S.).; We thank Tim Wilding, Joe Amatrudo, and Jennifer Leubke for advice and technical assistance with patch clamping. We also acknowledge Aimin Li for help with Sf9 cells, Till Voigtlaender and Nada Husic for assistance with lentiviral preparation, and Tania Massignan for generation of several of the HEK cell lines. Lentiviral constructs were created by the Hope Center Viral Vectors Core at Washington University, which is supported by a Neuroscience Blueprint Core grant (Grant P30 NS057105) from the National Institutes of Health.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chich JF, 2010, J MOL BIOL, V397, P1017, DOI 10.1016/j.jmb.2010.02.013; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063, DOI 10.1152/ajpcell.2000.278.6.C1063; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Larsen EH, 1996, J GEN PHYSIOL, V107, P695, DOI 10.1085/jgp.107.6.695; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li MJ, 2005, METH MOL B, V309, P261; Lin MX, 1997, J BIOL CHEM, V272, P44; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Palasz A, 2000, ACTA BIOCHIM POL, V47, P1107; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	56	54	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26719	26726		10.1074/jbc.M110.134619	http://dx.doi.org/10.1074/jbc.M110.134619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573963	hybrid, Green Published			2022-12-27	WOS:000280921000086
J	Vendrov, AE; Madamanchi, NR; Niu, XL; Molnar, KC; Runge, M; Szyndralewiez, C; Page, P; Runge, MS				Vendrov, Aleksandr E.; Madamanchi, Nageswara R.; Niu, Xi-Lin; Molnar, Kimberly C.; Runge, Mason; Szyndralewiez, Cedric; Page, Patrick; Runge, Marschall S.			NADPH Oxidases Regulate CD44 and Hyaluronic Acid Expression in Thrombin-treated Vascular Smooth Muscle Cells and in Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; OXIDATIVE STRESS; TYROSINE KINASE; SOLUBLE CD44; TNF-ALPHA; MACROPHAGES; ACTIVATION	The intracellular signaling events by which NADPH oxidase-generated reactive oxygen species (ROS) modulate vascular smooth muscle cell (VSMC) function and atherogenesis are yet to be entirely elucidated. We previously demonstrated that NADPH oxidase deficiency decreased atherosclerosis in apoE(-/-) mice and identified adhesion protein CD44 as an important ROS-sensitive gene expressed in VSMC and atherosclerotic lesions. Here, we examined the molecular mechanisms by which NADPH oxidase-generated ROS regulate the expression of CD44 and its principal ligand, hyaluronan (HA), and how CD44-HA interaction affects VSMC proliferation and migration and inflammatory gene expression in apoE(-/-) mice aortas. Thrombin-induced CD44 expression is mediated by transcription factor AP-1 in a NADPH oxidase-dependent manner. NADPH oxidase-mediated ROS generation enhanced thrombin-induced HA synthesis, and hyaluronan synthase 2 expression in VSMC. Hyaluronidase, which generates low molecular weight HA (LMW-HA), is induced in VSMC in a NADPH oxidase-dependent manner and LMW-HA stimulated ROS generation and cell proliferation in wild-type but not p47(phox-/-) VSMC, effects that were enhanced by thrombin pretreatment. Haptotactic VSMC migration toward HA was increased by thrombin in a CD44dependent manner. HA expression in atherosclerotic lesions and plasma-soluble CD44 and HA levels were higher in apoE(-/-) compared with apoE(-/-)/p47(phox-/-) mice. HA-regulated pro-inflammatory gene expression was higher in apoE(-/-) than apoE(-/-)/p47(phox-/-) mouse aortas. GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions. Together, these data suggest that increased CD44 and HA expression and CD44-HA-dependent gene regulation may play a role in atherosclerosis stimulated by NADPH oxidase activation.	[Vendrov, Aleksandr E.; Madamanchi, Nageswara R.; Niu, Xi-Lin; Molnar, Kimberly C.; Runge, Mason; Runge, Marschall S.] Univ N Carolina, McAllister Heart Inst, Dept Med, Chapel Hill, NC 27599 USA; [Szyndralewiez, Cedric; Page, Patrick] GenKyoTex SA, CH-1228 Geneva, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; Genkyotex	Runge, MS (corresponding author), Univ N Carolina, McAllister Heart Inst, Dept Med, 125 MacNider Hall, Chapel Hill, NC 27599 USA.	mrunge@med.unc.edu	Vendrov, Aleksandr/A-4115-2010; Vendrov, Aleksandr E./AHE-8649-2022; Vendrov, Aleksandr E./ABF-1266-2021	Vendrov, Aleksandr/0000-0003-4971-8040; Vendrov, Aleksandr E./0000-0003-4971-8040; Madamanchi, Nageswara/0000-0003-0590-0908; Vendrov, Kimberly/0000-0002-9131-5272	National Institutes of Health [HL-57352, AG 024282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-57352 and AG 024282.	Ali ZA, 2008, CIRCULATION, V118, pS71, DOI 10.1161/CIRCULATIONAHA.107.753558; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Basoni C, 2006, BIOCHEM BIOPH RES CO, V343, P609, DOI 10.1016/j.bbrc.2006.03.003; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bennet AM, 2006, ATHEROSCLEROSIS, V187, P408, DOI 10.1016/j.atherosclerosis.2005.09.022; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cichy J, 2005, BBA-MOL CELL RES, V1745, P59, DOI 10.1016/j.bbamcr.2005.02.006; Colao A, 2005, J ENDOCRINOL INVEST, V28, P440, DOI 10.1007/BF03347225; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; Flannery CR, 1998, BIOCHEM BIOPH RES CO, V251, P824, DOI 10.1006/bbrc.1998.9561; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Hagg D, 2007, ATHEROSCLEROSIS, V190, P291, DOI 10.1016/j.atherosclerosis.2006.03.020; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kawachi S, 2005, ARTERIOSCL THROM VAS, V25, P617, DOI 10.1161/01.ATV.0000154486.03017.35; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Krettek A, 2004, AM J PATHOL, V165, P1571, DOI 10.1016/S0002-9440(10)63414-1; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mayer S, 2008, J CANCER RES CLIN, V134, P1229, DOI 10.1007/s00432-008-0397-z; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; Miyazaki T, 2001, POLYM DEGRAD STABIL, V74, P77, DOI 10.1016/S0141-3910(01)00104-5; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; PAGE P, 2008, Patent No. 2008113856; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PHILIPSON LH, 1985, BIOCHEMISTRY-US, V24, P7899, DOI 10.1021/bi00348a008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Sjoberg S, 2005, METABOLISM, V54, P139, DOI 10.1016/j.metabol.2004.09.001; SRINIVASAN SR, 1980, ATHEROSCLEROSIS, V36, P25, DOI 10.1016/0021-9150(80)90195-1; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2005, J IMMUNOL, V174, P7376, DOI 10.4049/jimmunol.174.11.7376; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tucci M, 2006, J HYPERTENS, V24, P1307, DOI 10.1097/01.hjh.0000234111.31239.c3; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; WALTERS TK, 1994, J VASC RES, V31, P173, DOI 10.1159/000319584; Wei Y, 2007, HYPERTENSION, V50, P384, DOI 10.1161/HYPERTENSIONAHA.107.089284; Westmuckett AD, 2000, THROMB HAEMOSTASIS, V84, P904, DOI 10.1055/s-0037-1614135; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P871, DOI 10.1161/01.ATV.0000259358.31234.37; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003; Zhao L, 2007, ARTERIOSCL THROM VAS, V27, P886, DOI 10.1161/01.ATV.0000259362.10882.c5	74	74	81	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26545	26557		10.1074/jbc.M110.143917	http://dx.doi.org/10.1074/jbc.M110.143917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558727	Green Published, hybrid			2022-12-27	WOS:000280921000071
J	Gu, XG; Glushka, J; Lee, SG; Bar-Peled, M				Gu, Xiaogang; Glushka, John; Lee, Sung G.; Bar-Peled, Maor			Biosynthesis of a New UDP-sugar, UDP-2-acetamido-2-deoxyxylose, in the Human Pathogen Bacillus cereus Subspecies cytotoxis NVH 391-98.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCURONIC ACID DECARBOXYLASE; BETA-D-XYLOSYLTRANSFERASE; CRYPTOCOCCUS-NEOFORMANS; GLUCOSE 4,6-DEHYDRATASE; D-XYLOSE; CLONING; POLYSACCHARIDES; ANTIBIOTICS; PATHWAY; CAPSULE	We have identified an operon and characterized the functions of two genes from the severe food-poisoning bacterium, Bacillus cereus subsp. cytotoxis NVH 391-98, that are involved in the synthesis of a unique UDP-sugar, UDP-2-acetamido-2-deoxyxylose (UDP-N-acetyl-xylosamine, UDP-XylNAc). UGlcNAcDH encodes a UDP-N-acetyl-glucosamine 6-dehydrogenase, converting UDPN-acetylglucosamine (UDP-GlcNAc) to UDP-N-acetyl-glucosaminuronic acid (UDP-GlcNAcA). The second gene in the operon, UXNAcS, encodes a distinct decarboxylase not previously described in the literature, which catalyzes the formation of UDP-XylNAc from UDP-GlcNAcA in the presence of exogenous NAD(+). UXNAcS is specific and cannot utilize UDP-glucuronic acid and UDP-galacturonic acid as substrates. UXNAcS is active as a dimer with catalytic efficiency of 7 mM(-1) s(-1). The activity of UXNAcS is completely abolished by NADH but unaffected by UDP-xylose. A real-time NMR-based assay showed unambiguously the dual enzymatic conversions of UDP-GlcNAc to UDP-GlcNAcA and subsequently to UDP-XylNAc. From the analyses of all publicly available sequenced genomes, it appears that UXNAcS is restricted to pathogenic Bacillus species, including Bacillus anthracis and Bacillus thuringiensis. The identification of UXNAcS provides insight into the formation of UDP-XylNAc. Understanding the metabolic pathways involved in the utilization of this amino-sugar may allow the development of drugs to combat and eradicate the disease.	[Gu, Xiaogang; Glushka, John; Lee, Sung G.; Bar-Peled, Maor] Univ Georgia, CCRC, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, CCRC, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	gu, xiaogang/F-7440-2015		National Science Foundation [IOB-0453664]; BESC; Office of Biological and Environmental Research in the Department of Energy Office of Science; NIGMS, National Institutes of Health [GM66340]; Georgia Research Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340, P41GM103390] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); BESC; Office of Biological and Environmental Research in the Department of Energy Office of Science; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Georgia Research Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant IOB-0453664 (to M.B.-P.). This work was also supported in part by BESC, the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. This research also benefited from activities at the SE Collaboratory for High-Field Biomolecular NMR, a research resource at the University of Georgia, funded by NIGMS, National Institutes of Health, Grant GM66340 and the Georgia Research Alliance.	Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BALLARDIE FW, 1977, BIOORG CHEM, V6, P483, DOI 10.1016/0045-2068(77)90047-5; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Fox A, 2003, J MICROBIOL METH, V54, P143, DOI 10.1016/S0167-7012(03)00095-2; Gerratana B, 2001, BIOCHEMISTRY-US, V40, P9187, DOI 10.1021/bi0108249; GLASER L, 1973, ANNU REV BIOCHEM, V42, P91, DOI 10.1146/annurev.bi.42.070173.000515; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Gu XG, 2009, J BIOCHEM, V146, P527, DOI 10.1093/jb/mvp099; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Kudo F, 2009, J ANTIBIOT, V62, P471, DOI 10.1038/ja.2009.76; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lapidus A, 2008, CHEM-BIOL INTERACT, V171, P236, DOI 10.1016/j.cbi.2007.03.003; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; MARTIN JH, 1978, J ANTIBIOT, V31, P398, DOI 10.7164/antibiotics.31.398; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Takaishi M, 2008, TETRAHEDRON, V64, P6651, DOI 10.1016/j.tet.2008.05.024; TEMEYER KB, 1987, J GEN MICROBIOL, V133, P503; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; WEIRENGA RK, 1986, J MOL BIOL, V187, P101	36	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24825	24833		10.1074/jbc.M110.125872	http://dx.doi.org/10.1074/jbc.M110.125872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529859	Green Published, hybrid			2022-12-27	WOS:000280542100055
J	Ramboarina, S; Garnett, JA; Zhou, MX; Li, YB; Peng, ZX; Taylor, JD; Lee, WC; Bodey, A; Murray, JW; Alguel, Y; Bergeron, J; Bardiaux, B; Sawyer, E; Isaacson, R; Tagliaferri, C; Cota, E; Nilges, M; Simpson, P; Ruiz, T; Wu, H; Matthews, S				Ramboarina, Stephanie; Garnett, James A.; Zhou, Meixian; Li, Yuebin; Peng, Zhixiang; Taylor, Jonathan D.; Lee, Wei-chao; Bodey, Andrew; Murray, James W.; Alguel, Yilmaz; Bergeron, Julien; Bardiaux, Benjamin; Sawyer, Elizabeth; Isaacson, Rivka; Tagliaferri, Camille; Cota, Ernesto; Nilges, Michael; Simpson, Peter; Ruiz, Teresa; Wu, Hui; Matthews, Stephen			Structural Insights into Serine-rich Fimbriae from Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE GLYCOPROTEINS GSPB; AUTOMATED NOE ASSIGNMENT; STREPTOCOCCUS-PARASANGUIS; STAPHYLOCOCCUS-AUREUS; ACID TOLERANCE; FIBRONECTIN-BINDING; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; CHEMICAL-SHIFT	The serine-rich repeat family of fimbriae play important roles in the pathogenesis of streptococci and staphylococci. Despite recent attention, their finer structural details and precise adhesion mechanisms have yet to be determined. Fap1 (Fimbriae-associated protein 1) is the major structural subunit of serine-rich repeat fimbriae from Streptococcus parasanguinis and plays an essential role in fimbrial biogenesis, adhesion, and the early stages of dental plaque formation. Combining multidisciplinary, high resolution structural studies with biological assays, we provide new structural insight into adhesion by Fap1. We propose a model in which the serine-rich repeats of Fap1 subunits form an extended structure that projects the N-terminal globular domains away from the bacterial surface for adhesion to the salivary pellicle. We also uncover a novel pH-dependent conformational change that modulates adhesion and likely plays a role in survival in acidic environments.	[Zhou, Meixian; Li, Yuebin; Peng, Zhixiang; Wu, Hui] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Lee, Wei-chao; Bodey, Andrew; Murray, James W.; Alguel, Yilmaz; Bergeron, Julien; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Struct Biol Ctr, London SW7 2AZ, England; [Bergeron, Julien] Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England; [Bardiaux, Benjamin] Leibniz Inst Mol Pharmacol, Struct Biol Unit, D-13125 Berlin, Germany; [Nilges, Michael] Inst Pasteur, Unite Bioinformat Struct, F-75724 Paris 15, France; [Ruiz, Teresa] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; Imperial College London; University of London; King's College London; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Vermont	Wu, H (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA.	hwu@uab.edu; s.j.matthews@imperial.ac.uk	Sawyer, Elizabeth B/E-6906-2010; Sawyer, Elizabeth/J-6962-2012; Bergeron, Julien/AGY-1707-2022; Taylor, Jonathan/A-1416-2013; Bardiaux, Benjamin/AAN-2741-2021; Nilges, Michael/E-4803-2011; Bardiaux, Benjamin/A-4799-2011	Taylor, Jonathan/0000-0003-0119-433X; Bardiaux, Benjamin/0000-0003-4014-9195; Nilges, Michael/0000-0002-1451-8092; Isaacson, Rivka Leah/0000-0002-9978-8904; Taylor, Jonathan/0000-0002-9797-3989; Sawyer, Elizabeth/0000-0003-0389-2692; Murray, James/0000-0002-8897-0161; Simpson, Pete/0000-0002-2679-9303; Matthews, Steve/0000-0003-0676-0927	National Institutes of Health [R01DE017474, R01DE011000, R01DE017954]; Wellcome Trust [079819, 085464]; E.P. Abraham Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017474, R01DE017954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); E.P. Abraham Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE017474 (to T.R.) and R01DE011000 and R01DE017954 (to H.W.). This work was also supported by Wellcome Trust Program Grant 079819 and Equipment Grant 085464 (to S.M.).; We thank the beamline scientists at ID29 of the European Synchrotron Radiation Facility and X33 at the DORIS-III ring of the Deutsches Elektronen-Synchrotron. Weare also indebted to Christina Redfield at Oxford University for the provision of 950 MHz instrument time. The 950 MHz NMR facility was funded by the Wellcome Trust Joint Infrastructure Fund and the E.P. Abraham Fund.	Asakura T, 2005, MACROMOLECULES, V38, P7397, DOI 10.1021/ma050936y; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; BROOKS DE, 1983, J GEN MICROBIOL, V129, P3661; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fujitani S, 2008, CLIN INFECT DIS, V46, P1064, DOI 10.1086/529199; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; Guglielmetti S, 2009, CURR MICROBIOL, V59, P167, DOI 10.1007/s00284-009-9415-x; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito HO, 2003, J MICROBIOL METH, V55, P29, DOI 10.1016/S0167-7012(03)00111-8; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kim SB, 2008, COLLOID SURFACE B, V63, P236, DOI 10.1016/j.colsurfb.2007.12.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Paju S, 2007, ORAL DIS, V13, P508, DOI 10.1111/j.1601-0825.2007.01410a.x; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Ruiz T, 2003, J STRUCT BIOL, V143, P124, DOI 10.1016/S1047-8477(03)00140-0; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Sangappa, 2005, J BIOSCIENCES, V30, P259, DOI 10.1007/BF02703707; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Svensater G, 1997, ORAL MICROBIOL IMMUN, V12, P266, DOI 10.1111/j.1399-302X.1997.tb00390.x; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; TAKAI S, 1980, INFECT IMMUN, V28, P669; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Tanaka Y, 2008, STRUCTURE, V16, P488, DOI 10.1016/j.str.2007.12.018; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Welin-Neilands J, 2007, APPL ENVIRON MICROB, V73, P5633, DOI 10.1128/AEM.01049-07; Westling K, 2006, INT J ANTIMICROB AG, V28, P292, DOI 10.1016/j.ijantimicag.2006.05.032; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	87	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32446	32457		10.1074/jbc.M110.128165	http://dx.doi.org/10.1074/jbc.M110.128165			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20584910	Green Published, hybrid			2022-12-27	WOS:000282683000058
J	Masserdotti, G; Badaloni, A; Green, YS; Croci, L; Barili, V; Bergamini, G; Vetter, ML; Consalez, GG				Masserdotti, Giacomo; Badaloni, Aurora; Green, Yangsook Song; Croci, Laura; Barili, Valeria; Bergamini, Giorgio; Vetter, Monica L.; Consalez, G. Giacomo			ZFP423 Coordinates Notch and Bone Morphogenetic Protein Signaling, Selectively Up-regulating Hes5 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; TRANSCRIPTION FACTOR; XENOPUS-EMBRYOS; NEURONAL DIFFERENTIATION; CEREBELLAR DEVELOPMENT; PRIMARY NEUROGENESIS; LATERAL INHIBITION; FINGER PROTEIN; NERVOUS-SYSTEM; ACTIVATION	Zinc finger protein 423 encodes a 30 Zn-finger transcription factor involved in cerebellar and olfactory development. ZFP423 is a known interactor of SMAD1-SMAD4 and of Collier/Olf-1/EBF proteins, and acts as a modifier of retinoic acid-induced differentiation. In the present article, we show that ZFP423 interacts with the Notch1 intracellular domain in mammalian cell lines and in Xenopus neurula embryos, to activate the expression of the Notch1 target Hes5/ESR1. This effect is antagonized by EBF transcription factors, both in cultured cells and in Xenopus embryos, and amplified in vitro by BMP4, suggesting that ZFP423 acts to integrate BMP and Notch signaling, selectively promoting their convergence onto the Hes5 gene promoter.	[Bergamini, Giorgio; Consalez, G. Giacomo] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Masserdotti, Giacomo; Barili, Valeria; Bergamini, Giorgio; Consalez, G. Giacomo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Green, Yangsook Song; Vetter, Monica L.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Utah System of Higher Education; University of Utah	Consalez, GG (corresponding author), Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy.	g.consalez@hsr.it	Barili, Valeria/J-4899-2016; Consalez, Giacomo/AAA-2146-2019; Croci, Laura/AAN-3841-2020	Barili, Valeria/0000-0001-7711-2156; Consalez, Giacomo/0000-0003-4594-6273; Croci, Laura/0000-0002-7826-428X; Green, Yangsook/0000-0003-3620-0971; Vetter, Monica/0000-0001-6262-8504	National Institutes of Health [EY012274]; EU; Italian Ministry of University and Research [MIUR-PRIN 2007]; San Raffaele Scientific Institute; NATIONAL EYE INSTITUTE [P30EY014800, R01EY012274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); San Raffaele Scientific Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012274 (to M. L. V.). This work was also supported by the EU consortium contract EuroSyStem (to G. G. C.) and the Fondazione CARIPLO (Network Operativo per la Biomedicina di Eccellenza in Lombardia), from the Italian Ministry of University and Research (MIUR-PRIN 2007).; Supported by a Ph.D. fellowship provided by the San Raffaele Scientific Institute.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSUBEL FM, 1995, CURR PROT MOL BIOL; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; CROCI L, 2010, CELL DEATH IN PRESS; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Davis JA, 1996, J NEUROSCI, V16, P5082; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Dubois L, 1998, CURR BIOL, V8, P199, DOI 10.1016/S0960-9822(98)70084-3; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; HARLAND RM, 1991, XENOPUS LAEVIS PRACT; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; Lamar E, 2005, DEVELOPMENT, V132, P3619, DOI 10.1242/dev.01937; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Machold RP, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-5; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vincent VAM, 2002, J NEUROSCI RES, V69, P578, DOI 10.1002/jnr.10329; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	67	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30814	30824		10.1074/jbc.M110.142869	http://dx.doi.org/10.1074/jbc.M110.142869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20547764	Green Published, hybrid			2022-12-27	WOS:000282135500049
J	Pawelzik, SC; Uda, NR; Spahiu, L; Jegerschold, C; Stenberg, P; Hebert, H; Morgenstern, R; Jakobsson, PJ				Pawelzik, Sven-Christian; Uda, Narasimha Rao; Spahiu, Linda; Jegerschold, Caroline; Stenberg, Patric; Hebert, Hans; Morgenstern, Ralf; Jakobsson, Per-Johan			Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; HUMAN PLATELETS; PAIN; BIOSYNTHESIS; PROTEIN; MODELS; COX-2; PROSTACYCLIN; INFLAMMATION	Microsomal prostaglandin E synthase-1 (MPGES1) is induced during an inflammatory reaction from low basal levels by pro-inflammatory cytokines and subsequently involved in the production of the important mediator of inflammation, prostaglandin E-2. Nonsteroidal anti-inflammatory drugs prevent prostaglandin E-2 production by inhibiting the upstream enzymes cyclooxygenases 1 and 2. In contrast to these conventional drugs, a new generation of NSAIDs targets the terminal enzyme MPGES1. Some of these compounds potently inhibit human MPGES1 but do not have an effect on the rat orthologue. We investigated this interspecies difference in a rat/human chimeric form of the enzyme as well as in several mutants and identified key residues Thr-131, Leu-135, and Ala-138 in human MPGES1, which play a crucial role as gate keepers for the active site of MPGES1. These residues are situated in transmembrane helix 4, lining the entrance to the cleft between two subunits in the protein trimer, and regulate access of the inhibitor in the rat enzyme. Exchange toward the human residues in rat MPGES1 was accompanied with a gain of inhibitor activity, whereas exchange in human MPGES1 toward the residues found in rat abrogated inhibitor activity. Our data give evidence for the location of the active site at the interface between subunits in the homotrimeric enzyme and suggest a model of how the natural substratePGH(2), or competitive inhibitors of MPGES1, enter the active site via the phospholipid bilayer of the membrane.	[Morgenstern, Ralf] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Pawelzik, Sven-Christian; Uda, Narasimha Rao; Jakobsson, Per-Johan] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Spahiu, Linda; Stenberg, Patric] Actar AB, S-17177 Solna, Sweden; [Spahiu, Linda; Stenberg, Patric] NovaSAID AB, S-17177 Solna, Sweden; [Jegerschold, Caroline; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Jegerschold, Caroline; Hebert, Hans] Royal Inst Technol, Sch Technol & Hlth, Novum, S-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology	Morgenstern, R (corresponding author), Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden.	Ralf.Morgenstern@ki.se; Per-Johan.Jakobsson@ki.se	Jakobsson, Per-Johan/ABC-5594-2021; Morgenstern, Ralf/GZH-0158-2022	Uda, Narasimha Rao/0000-0001-5967-6118; Jegerschold, Caroline/0000-0003-2419-6354; Pawelzik, Sven-Christian/0000-0001-8704-6607	Swedish Research Council; Karolinska Institutet; Swedish County Council; Swedish Rheumatism Association; King Gustaf V 80-Year Fund; Marianne and Marcus Wallenberg Foundation; Borje Dahlin Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish County Council; Swedish Rheumatism Association; King Gustaf V 80-Year Fund; Marianne and Marcus Wallenberg Foundation; Borje Dahlin Fund	This work was supported by funds from the Swedish Research Council, Karolinska Institutet, The Swedish County Council, The Swedish Rheumatism Association, the King Gustaf V 80-Year Fund, the Marianne and Marcus Wallenberg Foundation, and the Borje Dahlin Fund.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BASEVICH VV, 1983, BIOORG KHIM+, V9, P658; Clark P, 2008, J PHARMACOL EXP THER, V325, P425, DOI 10.1124/jpet.107.134510; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleishman SJ, 2006, TRENDS BIOCHEM SCI, V31, P106, DOI 10.1016/j.tibs.2005.12.005; Giroux A, 2009, BIOORG MED CHEM LETT, V19, P5837, DOI 10.1016/j.bmcl.2009.08.085; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; Hamza A, 2008, J PHYS CHEM B, V112, P7320, DOI 10.1021/jp8007688; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kuwabara K, 2002, INFLAMM RES, V51, P541, DOI 10.1007/PL00012425; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Patrignani P, 1999, J PHYSIOL PHARMACOL, V50, P661; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vermeirsch H, 2007, PHARMACOL BIOCHEM BE, V87, P349, DOI 10.1016/j.pbb.2007.05.010; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Xing L, 2009, J COMPUT AID MOL DES, V23, P13, DOI 10.1007/s10822-008-9233-4; Xu DG, 2008, J PHARMACOL EXP THER, V326, P754, DOI 10.1124/jpet.108.138776	26	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29254	29261		10.1074/jbc.M110.114454	http://dx.doi.org/10.1074/jbc.M110.114454			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20605783	hybrid, Green Published			2022-12-27	WOS:000281740100027
J	Yamaguchi, M; Noda, NN; Nakatogawa, H; Kumeta, H; Ohsumi, Y; Inagaki, F				Yamaguchi, Masaya; Noda, Nobuo N.; Nakatogawa, Hitoshi; Kumeta, Hiroyuki; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Autophagy-related Protein 8 (Atg8) Family Interacting Motif in Atg3 Mediates the Atg3-Atg8 Interaction and Is Crucial for the Cytoplasm-to-Vacuole Targeting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO RECONSTITUTION; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; ATG12-ATG5 CONJUGATE; STRUCTURAL BASIS; LIPIDATION; DEGRADATION; MECHANISM; COMPLEX; SYSTEM	The autophagy-related protein 8 (Atg8) conjugation system is essential for the formation of double-membrane vesicles called autophagosomes during autophagy, a bulk degradation process conserved among most eukaryotes. It is also important in yeast for recognizing target vacuolar enzymes through the receptor protein Atg19 during the cytoplasm-to-vacuole targeting (Cvt) pathway, a selective type of autophagy. Atg3 is an E2-like enzyme that conjugates Atg8 with phosphatidylethanolamine. Here, we show that Atg3 directly interacts with Atg8 through the WEDL sequence, which is distinct from canonical interaction between E2 and ubiquitin-like modifiers. Moreover, NMR experiments suggest that the mode of interaction between Atg8 and Atg3 is quite similar to that between Atg8/LC3 and the Atg8 family interacting motif (AIM) conserved in autophagic receptors, such as Atg19 and p62. Thus, the WEDL sequence in Atg3 is a canonical AIM. In vitro analyses showed that Atg3 AIM is crucial for the transfer of Atg8 from the Atg8 similar to Atg3 thioester intermediate to phosphatidylethanolamine but not for the formation of the intermediate. Intriguingly, in vivo experiments showed that it is necessary for the Cvt pathway but not for starvation-induced autophagy. Atg3 AIM attenuated the inhibitory effect of Atg19 on Atg8 lipidation in vitro, suggesting that Atg3 AIM may be important for the lipidation of Atg19-bound Atg8 during the Cvt pathway.	[Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Inagaki, F (corresponding author), Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Nakatogawa, Hitoshi/D-5155-2015; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Nakatogawa, Hitoshi/0000-0002-5828-0741; Yamaguchi, Masaya/0000-0001-6886-8058; Noda, Nobuo/0000-0002-6940-8069; Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research on Priority Areas and Targeted Proteins Research Program from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kneller D., 1997, SPARKY 3 105; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Kupce E, 1995, J MAGN RESON SER B, V109, P329, DOI 10.1006/jmrb.1995.9985; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2008, J SYNCHROTRON RADIAT, V15, P266, DOI 10.1107/S0909049507054799; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oh-Oka K, 2008, J BIOL CHEM, V283, P21847, DOI 10.1074/jbc.M801836200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200	39	82	89	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29599	29607		10.1074/jbc.M110.113670	http://dx.doi.org/10.1074/jbc.M110.113670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20615880	Green Published, hybrid			2022-12-27	WOS:000281740100061
J	Henry, RA; Balakrishnan, L; Ying-Lin, ST; Campbell, JL; Bambara, RA				Henry, Ryan A.; Balakrishnan, Lata; Ying-Lin, Stefanie Tan; Campbell, Judith L.; Bambara, Robert A.			Components of the Secondary Pathway Stimulate the Primary Pathway of Eukaryotic Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; SINGLE-STRANDED-DNA; CELL NUCLEAR ANTIGEN; FLAP ENDONUCLEASE-1; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; FEN-1 NUCLEASE; PRIMER REMOVAL; LIGATABLE NICK; IN-VIVO	Reconstitution of eukaryotic Okazaki fragment processing implicates both one- and two-nuclease pathways for processing flap intermediates. In most cases, FEN1 (flap endonuclease 1) is able to efficiently cleave short flaps as they form. However, flaps escaping cleavage bind replication protein A (RPA) inhibiting FEN1. The flaps must then be cleaved by Dna2 nuclease/helicase before FEN1 can act. Pif1 helicase aids creation of long flaps. The pathways were considered connected only in that the products of Dna2 cleavage are substrates for FEN1. However, results presented here show that Dna2, Pif1, and RPA, the unique proteins of the two-nuclease pathway from Saccharomyces cerevisiae, all stimulate FEN1 acting in the one- nuclease pathway. Stimulation is observed on RNA flaps representing the initial displacement and on short DNA flaps, subsequently displaced. Neither the RNA nor the short DNA flaps can bind the two-nuclease pathway proteins. Instead, direct interactions between FEN1 and the two-nuclease pathway proteins have been detected. These results suggest that the proteins are either part of a complex or interact successively with FEN1 because the level of stimulation would be similar either way. Proteins bound to FEN1 could be tethered to the flap base by the interaction of FEN1 with PCNA, potentially improving their availability when flaps become long. These findings also support a model in which cleavage by FEN1 alone is the preferred pathway, with the first opportunity to complete cleavage, and is stimulated by components of the backup pathway.	[Henry, Ryan A.; Balakrishnan, Lata; Ying-Lin, Stefanie Tan; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P5955, DOI 10.1021/bi962890u; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Chai Q, 2003, BIOCHEMISTRY-US, V42, P15045, DOI 10.1021/bi035364t; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	42	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28496	28505		10.1074/jbc.M110.131870	http://dx.doi.org/10.1074/jbc.M110.131870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628185	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000281594000013
J	He, PJ; Klein, J; Yun, CC				He, Peijian; Klein, Janet; Yun, C. Chris			Activation of Na+/H+ Exchanger NHE3 by Angiotensin II Is Mediated by Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3 (IRBIT) and Ca2+/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL BICARBONATE ABSORPTION; 1,4,5-TRISPHOSPHATE RECEPTOR; SIGNALING PATHWAYS; INHIBITOR PROTEIN; RAT; PHOSPHORYLATION; REQUIRES; CALCIUM; ISOFORM; KIDNEY	Angiotensin II (ANG II) stimulates renal tubular reabsorption of NaCl by targeting Na+/H+ exchanger NHE3. We have shown previously that inositol 1,4,5-triphosphate receptor-binding protein released with inositol 1,4,5-triphosphate (IRBIT) plays a critical role in stimulation of NHE3 in response to elevated intracellular Ca2+ concentration ([Ca2+](i)). In this study, we investigated the role of IRBIT in mediating NHE3 activation by ANG II. IRBIT is abundantly expressed in the proximal tubules where NHE3 is located. ANG II at physiological concentrations stimulates NHE3 transport activity in a model proximal tubule cell line. ANG II-induced activation of NHE3 was abrogated by knockdown of IRBIT, whereas overexpression of IRBIT enhanced the effect of ANG II on NHE3. ANG II transiently increased binding of IRBIT to NHE3 at 5 min but became dissociated by 45 min. In comparison, it took at least 15 min of ANG II treatment for an increase in NHE3 activity and NHE3 surface expression. The stimulation of NHE3 by ANG II was dependent on changes in [Ca2+](i) and Ca2+/calmodulin-dependent protein kinases II. Inhibition of CaMKII completely blocked the ANG II-induced binding of IRBIT to NHE3 and the increase in NHE3 surface abundance. Several serine residues of IRBIT are thought to be important for IRBIT binding. Mutations of Ser-68, Ser-71, and Ser-74 of IRBIT decreased binding of IRBIT to NHE3 and its effect on NHE3 activity. In conclusion, our current findings demonstrate that IRBIT is critically involved in mediating activation of NHE3 by ANG II via a Ca2+/calmodulin-dependent protein kinases II-dependent pathway.	[He, Peijian; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA; [Klein, Janet] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30324 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Dept Med, Whitehead Bldg,Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu	He, Peijian/F-4790-2011	He, Peijian/0000-0002-9526-8004	National Institutes of Health [DK061418, DK061418S1, DK064399]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061418 and DK061418S1.; Supported by a postdoctoral fellowship from the American Heart Association.; We acknowledge the Emory Digestive Disease Research Development Center (supported by National Institutes of Health Grant DK064399) for the use of the confocal microscope. We are grateful to Dr. Tom Soderling for the CaMKIIN2 construct.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Aronson PS, 1996, KIDNEY INT, V49, P1665, DOI 10.1038/ki.1996.243; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; BROWN GP, 1982, ENDOCRINOLOGY, V111, P1830, DOI 10.1210/endo-111-6-1830; Carraro-Lacroix LR, 2006, PFLUG ARCH EUR J PHY, V452, P728, DOI 10.1007/s00424-006-0085-2; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chu TS, 1996, J CLIN INVEST, V97, P1454, DOI 10.1172/JCI118567; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Devogelaere B, 2008, BIOESSAYS, V30, P642, DOI 10.1002/bies.20772; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Di Sole F, 2003, J AM SOC NEPHROL, V14, P1720, DOI 10.1097/01.ASN.0000072743.97583.DB; du Cheyron D, 2003, KIDNEY INT, V64, P939, DOI 10.1046/j.1523-1755.2003.00189.x; Feng Z, 2006, KIDNEY INT, V70, P130, DOI 10.1038/sj.ki.5000342; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Houillier P, 1996, KIDNEY INT, V50, P1496, DOI 10.1038/ki.1996.464; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LIU FY, 1990, AM J PHYSIOL, V258, pF927, DOI 10.1152/ajprenal.1990.258.4.F927; LIU FY, 1989, J CLIN INVEST, V84, P83, DOI 10.1172/JCI114174; LIU FY, 1988, J CLIN INVEST, V82, P601, DOI 10.1172/JCI113638; LIU FY, 1990, AM J PHYSIOL, V259, pF451, DOI 10.1152/ajprenal.1990.259.3.F451; Purkiss JR, 1996, CELL CALCIUM, V20, P21, DOI 10.1016/S0143-4160(96)90047-0; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rossig L, 1996, J BIOL CHEM, V271, P22063; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; SCHUSTER VL, 1984, J CLIN INVEST, V73, P507, DOI 10.1172/JCI111237; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Sudo T, 2001, J NEUROENDOCRINOL, V13, P942, DOI 10.1046/j.1365-2826.2001.00699.x; Tsuganezawa H, 1998, KIDNEY INT, V54, P394, DOI 10.1046/j.1523-1755.1998.00029.x; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Wang DS, 2006, AM J PHYSIOL-RENAL, V290, pF428, DOI 10.1152/ajprenal.00161.2005; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; WELSH C, 1988, J CLIN INVEST, V81, P710, DOI 10.1172/JCI113376; Williams MR, 2001, INVEST OPHTH VIS SCI, V42, P1009; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	47	57	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27869	27878		10.1074/jbc.M110.133066	http://dx.doi.org/10.1074/jbc.M110.133066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584908	Green Published, hybrid			2022-12-27	WOS:000281404100042
J	Liang, B; Duan, BY; Zhou, XP; Gong, JX; Luo, ZG				Liang, Bin; Duan, Bao-Yu; Zhou, Xiu-Ping; Gong, Jia-Xin; Luo, Zhen-Ge			Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE ACTIVITY; IN-VIVO; BRAIN-INJURY; WATER-MAZE; MICE; PRESENILIN-1; NEURODEGENERATION; DEPOSITION; CALCIUM; P25	Abnormal activation of calpain is implicated in synaptic dysfunction and participates in neuronal death in Alzheimer disease (AD) and other neurological disorders. Pharmacological inhibition of calpain has been shown to improve memory and synaptic transmission in the mouse model of AD. However, the role and mechanism of calpain in AD progression remain elusive. Here we demonstrate a role of calpain in the neuropathology in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice, an established mouse model of AD. We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulindependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses. Furthermore, CAST overexpression prevented the decrease in the phosphorylation of the memory-related molecules CREB and ERK in the brain of APP/PS1 mice and improved spatial learning and memory. Interestingly, treatment of cultured primary neurons with amyloid-beta (A beta) peptides caused an increase in the level of beta-site APP-cleaving enzyme 1 (BACE1), the key enzyme responsible for APP processing and A beta production. This effect was inhibited by CAST overexpression. Consistently, overexpression of calpain in heterologous APP expressing cells up-regulated the level of BACE1 and increased A beta production. Finally, CAST transgene prevented the increase of BACE1 in APP/PS1 mice. Thus, calpain activation plays an important role in APP processing and plaque formation, probably by regulating the expression of BACE1.	[Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Luo, Zhen-Ge/GNM-7635-2022; zhou, xiuping/AAH-6334-2020; gong, jiaxin/AAL-5510-2020	Luo, Zhen-Ge/0000-0001-5037-0542; gong, jiaxin/0000-0001-5101-3109	National Natural Science Foundation of China [30721004, 30825013]; National Basic Research Program [2006CB806600, 2011CB809002]; Key State Research Program of China [2006CB943900]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Program of Shanghai Subject Chief Scientist [08XD14050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Key State Research Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Shanghai Subject Chief Scientist	This work was supported by National Natural Science Foundation of China Grants 30721004 and 30825013, National Basic Research Program Grant 2006CB806600 and 2011CB809002, Key State Research Program of China Grant 2006CB943900, Chinese Academy of Sciences Grant KSCX2-YW-R-102, and Program of Shanghai Subject Chief Scientist Grant 08XD14050.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brendza RP, 2005, J CLIN INVEST, V115, P428, DOI 10.1172/JCI200523269; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Chen M, 2004, BIOCHEM BIOPH RES CO, V316, P332, DOI 10.1016/j.bbrc.2004.02.052; Chen M, 2000, BIOCHEM BIOPH RES CO, V273, P170, DOI 10.1006/bbrc.2000.2919; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; D'Amore JD, 2003, J NEUROPATH EXP NEUR, V62, P137, DOI 10.1093/jnen/62.2.137; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Imahori K, 1997, J BIOCHEM, V121, P179; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lombardo JA, 2003, J NEUROSCI, V23, P10879, DOI 10.1523/jneurosci.23-34-10879.2003; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	67	85	89	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27737	27744		10.1074/jbc.M110.117960	http://dx.doi.org/10.1074/jbc.M110.117960			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595388	Green Published, hybrid			2022-12-27	WOS:000281404100029
J	Yang, JL; Tadokoro, T; Keijzers, G; Mattson, MP; Bohr, VA				Yang, Jenq-Lin; Tadokoro, Takashi; Keijzers, Guido; Mattson, Mark P.; Bohr, Vilhelm A.			Neurons Efficiently Repair Glutamate-induced Oxidative DNA Damage by a Process Involving CREB-mediated Up-regulation of Apurinic Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; EXTRACELLULAR-SUPEROXIDE DISMUTASE; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; POLYMERASE-BETA; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE	Glutamate, the major excitatory neurotransmitter in the brain, activates receptors coupled to membrane depolarization and Ca2+ influx that mediates functional responses of neurons including processes such as learning and memory. Here we show that reversible nuclear oxidative DNA damage occurs in cerebral cortical neurons in response to transient glutamate receptor activation using non-toxic physiological levels of glutamate. This DNA damage was prevented by intracellular Ca2+ chelation, the mitochondrial superoxide dismutase mimetic MnTMPyP (Mn-5,10,15,20-tetra(4-pyridyl)-21H, 23H-porphine chloride tetrakis( methochloride)), and blockade of the permeability transition pore. The repair of glutamate-induced DNA damage was associated with increased DNA repair activity and increased mRNA and protein levels of apurinic endonuclease 1 (APE1). APE1 knockdown induced accumulation of oxidative DNA damage after glutamate treatment, suggesting that APE1 is a key repair protein for glutamate-induced DNA damage. A cAMP-response element-binding protein (CREB) binding sequence is present in the Ape1 gene (encodes APE1 protein) promoter and treatment of neurons with a Ca2+/calmodulin-dependent kinase inhibitor (KN-93) blocked the ability of glutamate to induce CREB phosphorylation and APE1 expression. Selective depletion of CREB using RNA interference prevented glutamate-induced up-regulation of APE1. Thus, glutamate receptor stimulation triggers Ca2+- and mitochondrial reactive oxygen species-mediated DNA damage that is then rapidly repaired by a mechanism involving Ca2+-induced, CREB-mediated APE1 expression. Our findings reveal a previously unknown ability of neurons to efficiently repair oxidative DNA lesions after transient activation of glutamate receptors.	[Yang, Jenq-Lin; Tadokoro, Takashi; Keijzers, Guido; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, Baltimore, MD 21224 USA; [Yang, Jenq-Lin; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	bohrv@grc.nia.nih.gov	Bohr, Vilhelm/AAP-5931-2020; Keijzers, Guido/M-2843-2019; Mattson, Mark P/F-6038-2012	Keijzers, Guido/0000-0001-9353-8042; Yang, Jenq-Lin/0000-0002-9897-8087	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000312, ZIAAG000331, ZIAAG000735, ZIAAG000313, ZIAAG000727, ZIAAG000317, ZIAAG000314, ZIAAG000723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bianchi M, 2007, BBA-MOL CELL RES, V1773, P774, DOI 10.1016/j.bbamcr.2007.01.014; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Chinopoulos C, 2000, J NEUROSCI, V20, P2094; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Culmsee C, 2001, MOL BRAIN RES, V87, P257, DOI 10.1016/S0169-328X(01)00008-0; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Didier M, 1996, J NEUROSCI, V16, P2238; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Grosch S, 1998, CANCER RES, V58, P4410; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hongpaisan J, 2003, MOL CELL NEUROSCI, V24, P1103, DOI 10.1016/j.mcn.2003.09.003; Hongpaisan J, 2004, J NEUROSCI, V24, P10878, DOI 10.1523/JNEUROSCI.3278-04.2004; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; Izumi T, 1996, BIOCHEMISTRY-US, V35, P14679, DOI 10.1021/bi961995u; Keller JN, 1998, J NEUROSCI, V18, P687; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Li N, 2007, DNA REPAIR, V6, P1297, DOI 10.1016/j.dnarep.2007.02.027; Li YB, 1998, BRAIN RES, V814, P164, DOI 10.1016/S0006-8993(98)01082-8; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Morris EJ, 1999, BIOTECHNIQUES, V26, P282, DOI 10.2144/99262st02; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; Raffoul JJ, 2004, J BIOL CHEM, V279, P18425, DOI 10.1074/jbc.M313983200; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; SODERLING TR, 1994, J NEUROBIOL, V25, P304, DOI 10.1002/neu.480250310; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Thiels E, 2000, J NEUROSCI, V20, P7631; Uz T, 1996, NEUROSCIENCE, V73, P631, DOI 10.1016/0306-4522(96)00155-8; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wei F, 2006, J NEUROSCI, V26, P851, DOI 10.1523/JNEUROSCI.3292-05.2006; Wei W, 2008, J NEUROCHEM, V107, P734, DOI 10.1111/j.1471-4159.2008.05644.x; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Weissman L, 2009, NEUROBIOL AGING, V30, P2080, DOI 10.1016/j.neurobiolaging.2008.02.014; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; Zhao JF, 2008, J BIOL CHEM, V283, P9925, DOI 10.1074/jbc.M708345200	63	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28191	28199		10.1074/jbc.M109.082883	http://dx.doi.org/10.1074/jbc.M109.082883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573957	Green Published, hybrid			2022-12-27	WOS:000281404100062
J	Bhattacharyya, S; Rajan, RE; Swarupa, Y; Rathore, U; Verma, A; Udaykumar, R; Varadarajan, R				Bhattacharyya, Sanchari; Rajan, Roshan Elizabeth; Swarupa, Yalla; Rathore, Ujjwal; Verma, Anjali; Udaykumar, Ranga; Varadarajan, Raghavan			Design of a Non-glycosylated Outer Domain-derived HIV-1 gp120 Immunogen That Binds to CD4 and Induces Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; ENVELOPE GLYCOPROTEINS; CD4-BINDING SITE; MYCOBACTERIUM-W; FAB FRAGMENTS; ENV CLONES; EPITOPE; INFECTIONS; PROTEIN	The outer domain (OD) of the HIV-1 envelope glycoprotein gp120 is an important target for vaccine design as it contains a number of conserved epitopes, including a large fraction of the CD4 binding site. Attempts to design OD-based immunogens in the past have met with little success. We report the design and characterization of an Escherichia coli-expressed OD-based immunogen (ODEC), based on the sequence of the HxBc2 strain. The ODEC-designed immunogen lacks the variable loops V1V2 and V3 and incorporates 11 designed mutations at the interface of the inner and the outer domains of gp120. Biophysical studies showed that ODEC is folded and protease-resistant, whereas ODEC lacking the designed mutations is highly aggregation-prone. In contrast to previously characterized OD constructs, ODEC bound CD4 and the broadly neutralizing antibody b12 but not the non-neutralizing antibodies b6 and F105. Upon immunization in rabbits, ODEC was highly immunogenic, and the sera showed measurable neutralization for four subtype B and one subtype C virus including two b12-resistant viruses. In contrast, sera from rabbits immunized with gp120 did not neutralize any of the viruses. ODEC is the first example of a gp120 fragment-based immunogen that yields significant neutralizing antibodies.	[Bhattacharyya, Sanchari; Rathore, Ujjwal; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560064, Karnataka, India; [Rajan, Roshan Elizabeth; Swarupa, Yalla; Verma, Anjali; Udaykumar, Ranga] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Rathore, Ujjwal/AAD-9974-2021; Bhattacharyya, Sanchari/L-4344-2019	Rathore, Ujjwal/0000-0002-0329-7431; Bhattacharyya, Sanchari/0000-0003-3421-4755	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, Government of India (to R. V. and R. U.).; Recipient of a fellowship from Council of Scientific and Industrial Research, Government of India.	Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; GRAHAM BS, 1995, NEW ENGL J MED, V333, P1331, DOI 10.1056/NEJM199511163332007; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	51	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27100	27110		10.1074/jbc.M110.152272	http://dx.doi.org/10.1074/jbc.M110.152272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558728	hybrid, Green Published			2022-12-27	WOS:000281172700041
J	Foley, DA; Swartzentruber, KG; Lavie, A; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Lavie, Arnon; Colley, Karen J.			Structure and Mutagenesis of Neural Cell Adhesion Molecule Domains EVIDENCE FOR FLEXIBILITY IN THE PLACEMENT OF POLYSIALIC ACID ATTACHMENT SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ST8SIA II STX; N-CAM; HUMAN POLYSIALYLTRANSFERASE; NCAM; POLYSIALYLATION; EXPRESSION; TUMOR; PST; LOCALIZATION; PLASTICITY	The addition of alpha 2,8-polysialic acid to the N-glycans of the neural cell adhesion molecule, NCAM, is critical for brain development and plays roles in synaptic plasticity, learning and memory, neuronal regeneration, and the growth and invasiveness of cancer cells. Our previous work indicates that the polysialylation of two N-glycans located on the fifth immunoglobulin domain (Ig5) of NCAM requires the presence of specific sequences in the adjacent fibronectin type III repeat (FN1). To understand the relationship of these two domains, we have solved the crystal structure of the NCAM Ig5-FN1 tandem. Unexpectedly, the structure reveals that the sites of Ig5 polysialylation are on the opposite face from the FN1 residues previously found to be critical for N-glycan polysialylation, suggesting that the Ig5-FN1 domain relationship may be flexible and/or that there is flexibility in the placement of Ig5 glycosylation sites for polysialylation. To test the latter possibility, new Ig5 glycosylation sites were engineered and their polysialylation tested. We observed some flexibility in glycosylation site location for polysialylation and demonstrate that the lack of polysialylation of a glycan attached to Asn-423 may be in part related to a lack of terminal processing. The data also suggest that, although the polysialyltransferases do not require the Ig5 domain for NCAM recognition, their ability to engage with this domain is necessary for polysialylation to occur on Ig5 N-glycans.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Lavie, Arnon; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Albach C, 2004, ANAL BIOANAL CHEM, V378, P1129, DOI 10.1007/s00216-003-2383-2; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Atkins AR, 2001, J MOL BIOL, V311, P161, DOI 10.1006/jmbi.2001.4861; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DeLano W.L, PYMOL MOL GRAPHICS S; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gluer S, 1998, J PEDIATR SURG, V33, P1516, DOI 10.1016/S0022-3468(98)90488-2; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hildebrandt H, 1998, CANCER RES, V58, P779; Jensen PH, 1999, NAT STRUCT BIOL, V6, P486; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wuhrer M, 2003, BIOCHIMIE, V85, P207, DOI 10.1016/S0300-9084(03)00043-9; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	64	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27360	27371		10.1074/jbc.M110.140038	http://dx.doi.org/10.1074/jbc.M110.140038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573953	Green Published, hybrid			2022-12-27	WOS:000281172700065
J	Liu, Y; Li, PK; Li, CL; Lin, JY				Liu, Yan; Li, Pui-Kai; Li, Chenglong; Lin, Jiayuh			Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; EPITHELIAL-CELLS; VEGF EXPRESSION; AUTOCRINE IL-6; MYELOMA CELLS; UP-REGULATION; IN-VIVO; INTERLEUKIN-6	Interleukin-6 (IL-6) is a multifunctional cytokine, which may block apoptosis during inflammation to protect cells under very toxic conditions. However, IL-6 also activates STAT3 in many types of human cancer. Recent studies demonstrate that high levels of IL-6 are associated with hepatocellular carcinoma, the most common type of liver cancer. Here we reported that IL-6 promoted survival of human liver cancer cells through activating STAT3 in response to doxorubicin treatment. Endogenous IL-6 levels in SNU-449 cells were higher than in Hep3B cells. Meanwhile, SNU-449 cells were more resistant to doxorubicin than Hep3B cells. Addition of IL-6 induced STAT3 activation in Hep3B cells and led to protection against doxorubicin. In contrast, neutralizing IL-6 with anti-IL-6 antibody decreased survival of SNU-449 cells in response to doxorubicin. To elucidate the mechanism of the anti-apoptotic function of IL-6, we investigated if STAT3 mediated this drug resistance. Targeting STAT3 with STAT3 siRNA reduced the protection of IL-6 against doxorubicin-induced apoptosis, indicating that STAT3 signaling contributed to the anti-apoptotic effect of IL-6. Moreover, we further explored if a STAT3 small molecule inhibitor could abolish this anti-apoptotic effect. LLL12, a STAT3 small molecule inhibitor, blocked IL-6-induced STAT3 phosphorylation, resulting in attenuation of the anti-apoptotic activity of IL-6. Finally, neutralization of endogenous IL-6 with anti-IL-6 antibody or blockade of STAT3 with LLL12 lowered the recovery in SNU-449 cells after doxorubicin treatment. Therefore, our results demonstrated that targeting STAT3 signaling could interrupt the anti-apoptotic function of IL-6 in human liver cancer cells.	[Liu, Yan; Lin, Jiayuh] Ohio State Univ, Ctr Childhood Canc, Dept Pediat, Nationwide Childrens Hosp,Res Inst, Columbus, OH 43205 USA; [Li, Pui-Kai; Li, Chenglong] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43205 USA; [Lin, Jiayuh] Ohio State Univ, Expt Therapeut Program, Ctr Comprehens Canc, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lin, JY (corresponding author), Ohio State Univ, Ctr Childhood Canc, Dept Pediat, Coll Med, 700 Childrens Dr, Columbus, OH 43205 USA.	lin.674@osu.edu	Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Li, Pui Kai/0000-0002-4831-7213	National Institutes of Health [R21CA133652-01]; Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R21CA133652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R21 Grant R21CA133652-01 (to J. L.). This work was also supported by a Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research grant.	Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Choudhari SR, 2007, MOL CANCER THER, V6, P112, DOI 10.1158/1535-7163.MCT-06-0561; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gao LF, 2005, CLIN CANCER RES, V11, P6333, DOI 10.1158/1078-0432.CCR-05-0148; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hodge DR, 2002, BIOCHEM BIOPH RES CO, V292, P287, DOI 10.1006/bbrc.2002.6652; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kudo M, 2009, J NEUROSURG, V111, P219, DOI 10.3171/2008.12.JNS081284; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Li GH, 2009, J NEURO-ONCOL, V91, P165, DOI 10.1007/s11060-008-9696-0; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; Liu SQ, 2010, EUR J HAEMATOL, V84, P137, DOI 10.1111/j.1600-0609.2009.01365.x; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Rabinovich A, 2007, ANTICANCER RES, V27, P267; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Smith PC, 2001, PROSTATE, V48, P47; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2001, ONCOGENE, V20, P5799, DOI 10.1038/sj.onc.1204733; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	54	127	135	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27429	27439		10.1074/jbc.M110.142752	http://dx.doi.org/10.1074/jbc.M110.142752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562100	Green Published, hybrid			2022-12-27	WOS:000281172700072
J	Chen, WM; Yu, B; Zhang, Q; Xu, PL				Chen, Wei-Min; Yu, Bo; Zhang, Qing; Xu, Peilin			Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION GENE NUDC; STIMULATING FACTOR-RECEPTOR; C-MPL; ERYTHROPOIETIN RECEPTOR; CELL-PROLIFERATION; MOVEMENT PROTEIN; IN-VITRO; HNUDC; MEGAKARYOCYTOPOIESIS; DIFFERENTIATION	Thrombopoietin (TPO) and its receptor (Mpl) have long been associated with megakaryocyte proliferation, differentiation, and platelet formation. However, studies have also shown that the extracellular domain of Mpl (Mpl-EC) interacts with human (h) NUDC, a protein previously characterized as a human homolog of a fungal nuclear migration protein. This study was undertaken to further delineate the putative binding domain on the Mpl receptor. Using the yeast two-hybrid system assay and co-immunoprecipitation, we identified that within the Mpl-EC domain 1 (Mpl-EC-D1), amino acids 102-251 were strongly involved in ligand binding. We subsequently expressed five sub-domains within this region with T7 phage display. Enzyme-linked immunosorbent binding assays identified a short stretch of peptide located between residues 206 and 251 as the minimum binding domain for both TPO and hNUDC. A series of sequential Ala replacement mutations in the region were subsequently used to identify the specific residues most involved in ligand binding. Our results point to two hydrophobic residues, Leu(228) and Leu(230), as having substantial effects on hNUDC binding. For TPO binding, mutations in residues Asp(235) and Leu(239) had the largest effect on binding efficacy. In addition, deletion of the conservative motif WGSWS reduced binding capacity for hNUDC but not for TPO. These separate binding sites on the Mpl receptor for TPO and hNUDC raise interesting implications for the cytokine-receptor interactions.	[Chen, Wei-Min; Yu, Bo; Zhang, Qing; Xu, Peilin] Zhongshan Univ, Key Lab Gene Engn, Educ Minist, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, PL (corresponding author), Zhongshan Univ, Key Lab Gene Engn, Educ Minist, Guangzhou 510275, Guangdong, Peoples R China.	xupeilin@hotmail.com		ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [30971069]; National High-Tech Research and Development Program of China [2007AA21009]; Guang Dong National High-Tech Research and Development Program [2007B030702002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Guang Dong National High-Tech Research and Development Program	This work was supported by National Natural Science Foundation of China Grant 30971069, National High-Tech Research and Development Program of China Grant 2007AA21009, and Guang Dong National High-Tech Research and Development Program 2007B030702002.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Alexander WS, 1998, CYTOKINES CELL MOL T, V4, P25; ALEXANDER WS, 1995, ONCOGENE, V10, P795; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; Deane CM, 1997, J MOL GRAPH MODEL, V15, P170, DOI 10.1016/S1093-3263(97)00102-2; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Feese MD, 2004, P NATL ACAD SCI USA, V101, P1816, DOI 10.1073/pnas.0308530100; Gocke CD, 2000, LEUKEMIA LYMPHOMA, V39, P447, DOI 10.3109/10428190009113375; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Jagerschmidt A, 1998, BIOCHEM J, V333, P729, DOI 10.1042/bj3330729; Kaushansky K, 2003, ANN NY ACAD SCI, V996, P39, DOI 10.1111/j.1749-6632.2003.tb03230.x; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Layton JE, 1997, J BIOL CHEM, V272, P29735, DOI 10.1074/jbc.272.47.29735; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Luoh SM, 2000, MOL CELL BIOL, V20, P507, DOI 10.1128/MCB.20.2.507-515.2000; Middleton SA, 1999, J BIOL CHEM, V274, P14163, DOI 10.1074/jbc.274.20.14163; Middleton SA, 1996, J BIOL CHEM, V271, P14045, DOI 10.1074/jbc.271.24.14045; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Murone MM, 1998, STEM CELLS, V16, P1, DOI 10.1002/stem.160001; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pan RM, 2005, J CELL BIOCHEM, V96, P741, DOI 10.1002/jcb.20573; Pang SF, 2009, EXP CELL RES, V315, P3563, DOI 10.1016/j.yexcr.2009.06.020; Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595; Rajotte D, 1997, J EXP MED, V185, P1939, DOI 10.1084/jem.185.11.1939; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Sabath DF, 2002, BBA-GENE STRUCT EXPR, V1574, P383, DOI 10.1016/S0167-4781(01)00357-8; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; VAINCHENKER W, 1995, THROMB HAEMOSTASIS, V74, P526; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Zhang MY, 2002, EXP CELL RES, V273, P73, DOI 10.1006/excr.2001.5414; Zhang YP, 2007, EXP CELL RES, V313, P3210, DOI 10.1016/j.yexcr.2007.06.021	41	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26697	26709		10.1074/jbc.M110.120956	http://dx.doi.org/10.1074/jbc.M110.120956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20529857	hybrid, Green Published			2022-12-27	WOS:000280921000084
J	Hohle, TH; O'Brian, MR				Hohle, Thomas H.; O'Brian, Mark R.			Transcriptional Control of the Bradyrhizobium japonicum irr Gene Requires Repression by Fur and Antirepression by Irr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON RESPONSE REGULATOR; RHIZOBIUM-LEGUMINOSARUM; SINORHIZOBIUM-MELILOTI; HEME-BIOSYNTHESIS; ALPHA-PROTEOBACTERIA; BINDING SITES; PROTEIN; MANGANESE; EXPRESSION; DEGRADATION	Bradyrhizobium japonicum Fur mediates manganese-responsive transcriptional control of the mntH gene independently of iron, but it also has been implicated in iron-dependent regulation of the irr gene. Thus, we sought to address the apparent discrepancy in Fur responsiveness to metals. Irr is a transcriptional regulator found in iron-limited cells. Here, we show that irr gene mRNA was regulated by both iron and manganese, and repression occurred only in the presence of both metals. Under these conditions, Fur occupied the irr promoter in vivo in the parent strain, and irr mRNA expression was derepressed in a fur mutant. Under low iron conditions, the irr promoter was occupied by Irr, but not by Fur, and control by manganese was lost. Fur occupancy of the irr promoter was dependent on manganese, but not iron, in an irr mutant, suggesting that Irr normally interferes with Fur binding. Correspondingly, regulation of irr mRNA was dependent only on manganese in the irr strain. The Irr binding site within the irr promoter partially overlaps the Fur binding site. DNase I footprinting analysis showed that Irr interfered with Fur binding in vitro. In addition, Fur repression of transcription from the irr promoter in vitro was relieved by Irr. We conclude that Fur mediates manganese-dependent repression of irr transcription and that Irr acts as an antirepressor under iron limitation by preventing Fur binding to the promoter.	[Hohle, Thomas H.; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu			National Institutes of Health [R01 GM067966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM067966 to (M. R. O'B.).	Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Chao TC, 2004, J BACTERIOL, V186, P3609, DOI 10.1128/JB.186.11.3609-3620.2004; Diaz-Mireles E, 2005, MICROBIOL-SGM, V151, P4071, DOI 10.1099/mic.0.28342-0; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Friedman YE, 2004, J BIOL CHEM, V279, P32100, DOI 10.1074/jbc.M404924200; Friedman YE, 2003, J BIOL CHEM, V278, P38395, DOI 10.1074/jbc.M306710200; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Hamza I, 1999, J BACTERIOL, V181, P5843, DOI 10.1128/JB.181.18.5843-5846.1999; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hamza I, 2000, MICROBIOL-SGM, V146, P669, DOI 10.1099/00221287-146-3-669; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Platero R, 2004, APPL ENVIRON MICROB, V70, P4349, DOI 10.1128/AEM.70.7.4349-4355.2004; Platero R, 2007, APPL ENVIRON MICROB, V73, P4832, DOI 10.1128/AEM.00686-07; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Todd JD, 2006, MOL GENET GENOMICS, V275, P564, DOI 10.1007/s00438-006-0115-y; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2006, MOL GENET GENOMICS, V276, P555, DOI 10.1007/s00438-006-0162-4	31	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26074	26080		10.1074/jbc.M110.145979	http://dx.doi.org/10.1074/jbc.M110.145979			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573962	hybrid, Green Published			2022-12-27	WOS:000280921000023
J	Wiseman, B; Carpena, X; Feliz, M; Donald, LJ; Pons, M; Fita, I; Loewen, PC				Wiseman, Ben; Carpena, Xavi; Feliz, Miguel; Donald, Lynda J.; Pons, Miquel; Fita, Ignacio; Loewen, Peter C.			Isonicotinic Acid Hydrazide Conversion to Isonicotinyl-NAD by Catalase-peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS KATG; X-RAY ANALYSIS; ISONIAZID RESISTANCE; BURKHOLDERIA-PSEUDOMALLEI; SUPEROXIDE REACTIVITY; CRYSTAL-STRUCTURE; EPR SPECTROSCOPY; OXIDATION; BINDING; INHA	Activation of the pro-drug isoniazid (INH) as an anti-tubercular drug in Mycobacterium tuberculosis involves its conversion to isonicotinyl-NAD, a reaction that requires the catalase-peroxidase KatG. This report shows that the reaction proceeds in the absence of KatG at a slow rate in a mixture of INH, NAD(+), Mn2+, and O-2, and that the inclusion of KatG increases the rate by >7 times. Superoxide, generated by either Mn2+- or KatG-catalyzed reduction of O-2, is an essential intermediate in the reaction. Elimination of the peroxidatic process by mutation slows the rate of reaction by 60% revealing that the peroxidatic process enhances, but is not essential for isonicotinyl-NAD formation. The isonicotinyl-NAD(center dot+) radical is identified as a reaction intermediate, and its reduction by superoxide is proposed. Binding sites for INH and its co-substrate, NAD(+), are identified for the first time in crystal complexes of Burkholderia pseudomallei catalase-peroxidase with INH and NAD(+) grown by co-crystallization. The best defined INH binding sites were identified, one in each subunit, on the opposite side of the protein from the entrance to the heme cavity in a funnel-shaped channel. The NAD(+) binding site is similar to 20 angstrom from the entrance to the heme cavity and involves interactions primarily with the AMP portion of the molecule in agreement with the NMR saturation transfer difference results.	[Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Donald, Lynda J.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Carpena, Xavi; Pons, Miquel; Fita, Ignacio] Inst Biomed Res, Barcelona 08028, Spain; [Carpena, Xavi; Fita, Ignacio] Inst Mol Biol, Barcelona 08028, Spain; [Feliz, Miguel; Pons, Miquel] Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Spain	University of Manitoba; University of Manitoba; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona	Loewen, PC (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	ploewen@ms.umanitoba.ca	Fita, Ignasi/R-4515-2019; pons, miquel/C-8657-2011; Carpena, Xavi/J-5877-2017; Feliz, Miguel/F-3792-2016	Fita, Ignasi/0000-0002-7521-2679; pons, miquel/0000-0002-0586-8322; Carpena, Xavi/0000-0002-8646-0440; Feliz, Miguel/0000-0002-7676-3309; Wiseman, Benjamin/0000-0002-2994-5839	Natural Sciences and Engineering Research Council (NSERC) of Canada [9600]; Canada Research Chair; NSERC; National Research Council; Canadian Institutes for Health Research; University of Saskatchewan; Spanish Ministry of Science and Innovation; Generalitat de Catalunya [SGR2009-1352];  [BFU2005-08686-C02-01];  [BIO2007-63458]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ; 	This work was supported by a Discovery Grant 9600 from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to P. C. L.) and by the Canada Research Chair Program (to P. C. L.). The diffraction data were collected at the Canadian Light Source, which is supported by NSERC, National Research Council, Canadian Institutes for Health Research, and the University of Saskatchewan. This work was supported by Grants BFU2005-08686-C02-01 (to I. F.), BIO2007-63458 (to M. P.), both from the Spanish Ministry of Science and Innovation, and SGR2009-1352 (to M. P.) from the Generalitat de Catalunya.	Amos RIJ, 2008, CHEM COMMUN, P1695, DOI 10.1039/b719570b; AUCLAIR C, 1978, FEBS LETT, V89, P26, DOI 10.1016/0014-5793(78)80514-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Carpena X, 2002, ACTA CRYSTALLOGR D, V58, P2184, DOI 10.1107/S0907444902017869; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Colin J, 2009, J AM CHEM SOC, V131, P8557, DOI 10.1021/ja901402v; Deemagarn T, 2005, J MOL BIOL, V345, P21, DOI 10.1016/j.jmb.2004.10.020; Deemagarn T, 2007, PROTEINS, V66, P219, DOI 10.1002/prot.21209; DUNFORD HB, 1999, HEME PEROXIDASES, P97; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRINGTON JA, 1980, BIOCHIM BIOPHYS ACTA, V590, P273, DOI 10.1016/0005-2728(80)90031-6; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2004, J AM CHEM SOC, V126, P4772, DOI 10.1021/ja031728t; Klein J, 1999, J AM CHEM SOC, V121, P5336, DOI 10.1021/ja990706x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P399, DOI 10.1128/AAC.27.3.399; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P404, DOI 10.1128/AAC.27.3.404; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P408, DOI 10.1128/AAC.27.3.408; Singh AK, 2010, J BIOL CHEM, V285, P1569, DOI 10.1074/jbc.M109.060327; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; Todorovic S, 1999, J AM CHEM SOC, V121, P10962, DOI 10.1021/ja9918674; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Wada K, 2002, ACTA CRYSTALLOGR D, V58, P157, DOI 10.1107/S0907444901017735; Wang JY, 1998, ANTIMICROB AGENTS CH, V42, P709, DOI 10.1128/AAC.42.3.709; Wengenack NL, 1997, J INFECT DIS, V176, P722, DOI 10.1086/514096; Wengenack NL, 1999, J AM CHEM SOC, V121, P9748, DOI 10.1021/ja992590a; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yamada Y, 2001, ACTA CRYSTALLOGR D, V57, P1157, DOI 10.1107/S0907444901008927; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o	50	51	52	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26662	26673		10.1074/jbc.M110.139428	http://dx.doi.org/10.1074/jbc.M110.139428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554537	Green Published, hybrid			2022-12-27	WOS:000280921000081
J	Liao, WQ; Elfrink, K; Bahler, M				Liao, Wanqin; Elfrink, Kerstin; Baehler, Martin			Head of Myosin IX Binds Calmodulin and Moves Processively toward the Plus-end of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; STEP-SIZE; LIGHT-CHAIN; CHLAMYDOMONAS-REINHARDTII; DIRECTED MOTOR; UNIQUE INSERT; NECK LENGTH; LEVER ARM; VI MOTOR; MECHANISM	Mammalian myosin IXb (Myo9b) has been shown to exhibit unique motor properties in that it is a single-headed processive motor and the rate-limiting step in its chemical cycle is ATP hydrolysis. Furthermore, it has been reported to move toward the minus-and the plus-end of actin filaments. To analyze the contribution of the light chain-binding domain to the movement, processivity, and directionality of a single-headed processive myosin, we expressed constructs of Caenorhabditis elegans myosin IX (Myo9) containing either the head (Myo9-head) or the head and the light chain-binding domain (Myo9-head-4IQ). Both constructs supported actin filament gliding and moved toward the plus-end of actin filaments. We identified in the head of class IX myosins a calmodulin-binding site at the N terminus of loop 2 that is unique among the myosin superfamily members. Ca2+/calmodulin negatively regulated ATPase and motility of the Myo9-head. The Myo9-head demonstrated characteristics of a processive motor in that it supported actin filament gliding and pivoting at low motor densities. Quantum dot-labeled Myo9-head moved along actin filaments with a considerable run length and frequently paused without dissociating even in the presence of obstacles. We conclude that class IX myosins are plus-end-directed motors and that even a single head exhibits characteristics of a processive motor.	[Liao, Wanqin; Elfrink, Kerstin; Baehler, Martin] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Mol Cell Biol, Schlosspl 5, D-48149 Munster, Germany.	baehler@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG BA 1354/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant DFG BA 1354/9-1.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Kohler D, 2003, J CELL BIOL, V161, P237, DOI 10.1083/jcb.200212039; Liao JC, 2009, J MOL BIOL, V392, P862, DOI 10.1016/j.jmb.2009.07.046; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; TOYOSHIMA YY, 1990, P NATL ACAD SCI USA, V87, P7130, DOI 10.1073/pnas.87.18.7130; van den Boom F, 2007, MOL BIOL CELL, V18, P1507, DOI 10.1091/mbc.E06-08-0771; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Xie P, 2006, BIOPHYS CHEM, V122, P90, DOI 10.1016/j.bpc.2006.02.010; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	45	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24933	24942		10.1074/jbc.M110.101105	http://dx.doi.org/10.1074/jbc.M110.101105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538589	Green Published, hybrid			2022-12-27	WOS:000280542100066
J	Xu, YX; Liu, L; Caffaro, CE; Hirschberg, CB				Xu, Yu-Xin; Liu, Li; Caffaro, Carolina E.; Hirschberg, Carlos B.			Inhibition of Golgi Apparatus Glycosylation Causes Endoplasmic Reticulum Stress and Decreased Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; CAENORHABDITIS-ELEGANS; UDP-GALACTOSE; GENE; DEFICIENT; RESISTANT; VIRULENCE; DISEASES; MUTANTS; SULFATE	Nucleotide sugar transporters of the Golgi apparatus play an essential role in the glycosylation of proteins, lipids, and proteoglycans. Down-regulation of expression of the transporters for CMP-sialic acid, GDP-fucose, or both unexpectedly resulted in accumulation of glycoconjugates in the Golgi apparatus rather than in the plasma membrane. Pulse-chase experiments with radiolabeled sugars and amino acids showed decreased synthesis and secretion of both nonglycoproteins and glycoproteins. Further studies revealed that the above silencing induced endoplasmic reticulum stress and inhibited protein translation initiation. Together these results suggest that global inhibition of Golgi apparatus glycosylation may lead to important secondary metabolic changes, unrelated to glycosylation.	[Xu, Yu-Xin; Liu, Li; Caffaro, Carolina E.; Hirschberg, Carlos B.] Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Boston, MA 02118 USA	Boston University	Hirschberg, CB (corresponding author), Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Evans E438,72 E Concord St, Boston, MA 02118 USA.	caffaro@stanford.edu; chirschb@bu.edu	Xu, Yu-Xin/G-4041-2010	Hirschberg, Carlos/0000-0003-2299-7721; Xu, Yu-Xin/0000-0002-0200-4633; Liu, Li/0000-0002-3733-6961	National Institutes of Health [GM 30365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365, R37GM030365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Grant GM 30365 (to C.B.H.).	Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; DALESSIO C, 2010, SEMIN CELL IN PRESS; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Furuichi T, 2009, J MED GENET, V46, P562, DOI 10.1136/jmg.2008.065201; Gaur U, 2009, EXP PARASITOL, V122, P182, DOI 10.1016/j.exppara.2009.03.014; GUAN JL, 1985, CELL, V42, P489, DOI 10.1016/0092-8674(85)90106-0; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; LIU L, 2010, SEMIN CELL IN PRESS; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Smith TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007532; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toma L, 1996, J BIOL CHEM, V271, P3897; Uccelletti D, 2004, J BIOL CHEM, V279, P27390, DOI 10.1074/jbc.M402624200; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; ZHAO W, 2008, NUCLEOTIDE SUGAR TRA, P190	27	36	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24600	24608		10.1074/jbc.M110.134544	http://dx.doi.org/10.1074/jbc.M110.134544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529871	hybrid, Green Published			2022-12-27	WOS:000280542100032
J	Phillips, D; Reilley, MJ; Aponte, AM; Wang, GH; Boja, E; Gucek, M; Balaban, RS				Phillips, Darci; Reilley, Matthew J.; Aponte, Angel M.; Wang, Guanghui; Boja, Emily; Gucek, Marjan; Balaban, Robert S.			Stoichiometry of STAT3 and Mitochondrial Proteins IMPLICATIONS FOR THE REGULATION OF OXIDATIVE PHOSPHORYLATION BY PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART; CELL; PHOSPHOPROTEOME; DYNAMICS; BIOLOGY	The signal transducer and activator of transcription 3 (STAT3) is a transcription factor and downstream product of cytokine and growth factor pathways. Among members of the STAT family, STAT3 has garnered particular interest due to its role in cancer and development. Recently, it was proposed that STAT3 regulates cardiac ATP generation in vivo through protein interaction with the mitochondrial complexes of oxidative phosphorylation, specifically Complexes I/II. For this mechanism to work effectively, the cellular ratio of Complexes I/II and STAT3 must approach one. However, using three different proteomic approaches in cardiac tissue, we determined the ratio of Complexes I/II and STAT3 to be similar to 10(5). This finding suggests that direct protein interaction between Complexes I/II and STAT3 cannot be required for optimal ATP production, nor can it dramatically modulate oxidative phosphorylation in vivo. Thus, STAT3 is likely altering mitochondrial function via transcriptional regulation or indirect signaling pathways that warrant further investigation.	[Phillips, Darci; Reilley, Matthew J.; Balaban, Robert S.] NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA; [Aponte, Angel M.; Wang, Guanghui; Boja, Emily; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Balaban, RS (corresponding author), 9000 Rockville Pike,Bldg 10,Rm B1D 416, Bethesda, MD 20892 USA.	balabanr@nhlbi.nih.gov		Phillips, Darci/0000-0002-0804-3342	National Institutes of Health Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL004601] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Division of Intramural Research.	Aponte AM, 2009, J PROTEOME RES, V8, P2679, DOI 10.1021/pr800913j; Balaban RS, 2006, ANN NY ACAD SCI, V1080, P140, DOI 10.1196/annals.1380.013; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GOMEZFERNANDEZ JC, 1978, BIOCHEM J, V176, P967, DOI 10.1042/bj1760967; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Myers MG, 2009, SCIENCE, V323, P723, DOI 10.1126/science.1169660; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Phillips D, 2010, J MOL CELL CARDIOL, V48, P582, DOI 10.1016/j.yjmcc.2009.10.033; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Schagger H, 2001, J BIOL CHEM, V276, P37861; VOLPE P, 1970, EUR J BIOCHEM, V12, P195, DOI 10.1111/j.1432-1033.1970.tb00837.x; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Zeiser S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-11	22	68	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23532	23536		10.1074/jbc.C110.152652	http://dx.doi.org/10.1074/jbc.C110.152652			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20558729	Green Published, hybrid			2022-12-27	WOS:000280291400002
J	Girish, TS; Gopal, B				Girish, Tavarekere S.; Gopal, Balasubramanian			Crystal Structure of Staphylococcus aureus Metallopeptidase (Sapep) Reveals Large Domain Motions between the Manganese-bound and Apo-states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOPEPTIDASE; RESISTANCE; PEPTIDASE; CATALYSIS; BINDING; ENZYME; TOOLS	Proteases belonging to the M20 family are characterized by diverse substrate specificity and participate in several metabolic pathways. The Staphylococcus aureus metallopeptidase, Sapep, is a member of the aminoacylase-I/M20 protein family. This protein is a Mn2+-dependent dipeptidase. The crystal structure of this protein in the Mn2+-bound form and in the open, metal-free state suggests that large interdomain movements could potentially regulate the activity of this enzyme. We note that the extended inactive conformation is stabilized by a disulfide bond in the vicinity of the active site. Although these cysteines, Cys(155) and Cys(178), are not active site residues, the reduced form of this enzyme is substantially more active as a dipeptidase. These findings acquire further relevance given a recent observation that this enzyme is only active in methicillin-resistant S. aureus. The structural and biochemical features of this enzyme provide a template for the design of novel methicillin-resistant S. aureus-specific therapeutics.	[Girish, Tavarekere S.; Gopal, Balasubramanian] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gopal, B (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	bgopal@mbu.iisc.ernet.in	Gopal, Balasubramanian/K-4566-2012; Gopal, Balasubramanian/ABG-3754-2021		Department of Science and Technology; Department of Biotechnology, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from the Department of Science and Technology and the Department of Biotechnology, Government of India.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; Broder DH, 2003, J BACTERIOL, V185, P4748, DOI 10.1128/JB.185.16.4748-4754.2003; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lundgren S, 2007, J BIOL CHEM, V282, P36037, DOI 10.1074/jbc.M705517200; MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Munih P, 2007, J INORG BIOCHEM, V101, P1099, DOI 10.1016/j.jinorgbio.2007.03.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Staub I, 2009, J AM CHEM SOC, V131, P6271, DOI 10.1021/ja901304n; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	27	15	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29406	29415		10.1074/jbc.M110.147579	http://dx.doi.org/10.1074/jbc.M110.147579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20610394	Green Published, hybrid			2022-12-27	WOS:000281740100043
J	Bartoszewski, RA; Jablonsky, M; Bartoszewska, S; Stevenson, L; Dai, Q; Kappes, J; Collawn, JF; Bebok, Z				Bartoszewski, Rafal A.; Jablonsky, Michael; Bartoszewska, Sylwia; Stevenson, Lauren; Dai, Qun; Kappes, John; Collawn, James F.; Bebok, Zsuzsa			A Synonymous Single Nucleotide Polymorphism in Delta F508 CFTR Alters the Secondary Structure of the mRNA and the Expression of the Mutant Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SELECTIVE 2'-HYDROXYL ACYLATION; PRIMER EXTENSION SHAPE; ENDOPLASMIC-RETICULUM; IN-VITRO; CIRCULAR-DICHROISM; LENTIVIRAL VECTOR; STRUCTURE PREDICTION; ESCHERICHIA-COLI	Recent advances in our understanding of translational dynamics indicate that codon usage and mRNA secondary structure influence translation and protein folding. The most frequent cause of cystic fibrosis (CF) is the deletion of three nucleotides (CTT) from the cystic fibrosis transmembrane conductance regulator (CFTR) gene that includes the last cytosine (C) of isoleucine 507 (Ile507ATC) and the two thymidines (T) of phenylalanine 508 (Phe508TTT) codons. The consequences of the deletion are the loss of phenylalanine at the 508 position of the CFTR protein (Delta F508), a synonymous codon change for isoleucine 507 (Ile507ATT), and protein misfolding. Here we demonstrate that the Delta F508 mutation alters the secondary structure of the CFTR mRNA. Molecular modeling predicts and RNase assays support the presence of two enlarged single stranded loops in the Delta F508 CFTR mRNA in the vicinity of the mutation. The consequence of Delta F508 CFTR mRNA "misfolding" is decreased translational rate. A synonymous single nucleotide variant of the Delta F508 CFTR (Ile507ATC), that could exist naturally if Phe-508 was encoded by TTC, has wild type-like mRNA structure, and enhanced expression levels when compared with native Delta F508 CFTR. Because CFTR folding is predominantly cotranslational, changes in translational dynamics may promote Delta F508 CFTR misfolding. Therefore, we propose that mRNA "misfolding" contributes to Delta F508 CFTR protein misfolding and consequently to the severity of the human Delta F508 phenotype. Our studies suggest that in addition to modifier genes, SNPs may also contribute to the differences observed in the symptoms of various Delta F508 homozygous CF patients.	[Jablonsky, Michael] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA; [Bartoszewski, Rafal A.; Bartoszewska, Sylwia; Stevenson, Lauren; Collawn, James F.; Bebok, Zsuzsa] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Dai, Qun; Kappes, John] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Dai, Qun; Kappes, John] Univ Alabama, Dept Hematol & Oncol, Birmingham, AL 35294 USA; [Collawn, James F.; Bebok, Zsuzsa] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama, Dept Cell Biol, 1918 Univ Blvd,MCLM 350, Birmingham, AL 35294 USA.	bebok@uab.edu	Bartoszewska, Sylwia/L-3922-2019; Bartoszewski, Rafal A/D-6311-2011	Bartoszewska, Sylwia/0000-0001-8063-1272; Bartoszewski, Rafal A/0000-0002-2864-6757	National Institutes of Health [R01HL076587, DK060065, R24DK64400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065, R24DK064400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01HL076587 (to Z. B.) and DK060065 (to J. F. C.), CFF, and the Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center Grant R24DK64400 (to J. K.) from the National Institutes of Health.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chen WY, 2000, STEM CELLS, V18, P352, DOI 10.1634/stemcells.18-5-352; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DOERFLER W, 1989, CELL BIOPHYS, V15, P21, DOI 10.1007/BF02991576; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Fadiel A, 2007, CURR PROTEIN PEPT SC, V8, P29, DOI 10.2174/138920307779941532; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; HOOF T, 1994, J BIOL CHEM, V269, P20575; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Marin Monica, 2008, Biotechnology Journal, V3, P1047, DOI 10.1002/biot.200800089; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Merrick WC, 2007, METHOD ENZYMOL, V429, P1, DOI 10.1016/S0076-6879(07)29001-9; Nuzzaci M, 2009, J VIROL METHODS, V155, P118, DOI 10.1016/j.jviromet.2008.10.005; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Piazzolla P, 1998, ARCH VIROL, V143, P2305, DOI 10.1007/s007050050462; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Ramachandiran V, 2002, FEBS LETT, V512, P209, DOI 10.1016/S0014-5793(02)02261-5; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELLS BD, 1974, BIOCHEMISTRY-US, V13, P1311, DOI 10.1021/bi00704a001; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9; ZUKER M, 1999, ALGORITHMS THERMODYN	61	139	145	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28741	28748		10.1074/jbc.M110.154575	http://dx.doi.org/10.1074/jbc.M110.154575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628052	Green Published, hybrid			2022-12-27	WOS:000281594000040
J	Cassens, C; Kleene, R; Xiao, MF; Friedrich, C; Dityateva, G; Schafer-Nielsen, C; Schachner, M				Cassens, Claas; Kleene, Ralf; Xiao, Mei-Fang; Friedrich, Claudia; Dityateva, Galina; Schafer-Nielsen, Claus; Schachner, Melitta			Binding of the Receptor Tyrosine Kinase TrkB to the Neural Cell Adhesion Molecule (NCAM) Regulates Phosphorylation of NCAM and NCAM-dependent Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; POLYSIALIC ACID; PSA-NCAM; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; OLFACTORY-BULB; PROTEIN-KINASE; DENTATE GYRUS; FGF RECEPTOR	Recognition molecules and neurotrophins play important roles during development and maintenance of nervous system functions. In this study, we provide evidence that the neural cell adhesion molecule (NCAM) and the neurotrophin receptor TrkB directly interact via sequences in their intracellular domains. Stimulation of TrkB by brain-derived neurotrophic factor leads to tyrosine phosphorylation of NCAM at position 734. Mutation of this tyrosine to phenylalanine completely abolishes tyrosine phosphorylation of NCAM by TrkB. Moreover, the knockdown of TrkB in hippocampal neurons leads to a reduction of NCAM-induced neurite outgrowth. Transfection of NCAM-deficient hippocampal neurons with mutated NCAM carrying an exchange of tyrosine by phenylalanine at position 734 leads to promotion of NCAM-induced neurite outgrowth in comparison with that observed after transfection with wild-type NCAM, whereas a reduction of neurite outgrowth was observed after transfection with mutated NCAM, which carries an exchange of tyrosine by glutamate that mimics the phosphorylated tyrosine. Our observations indicate a functional relationship between TrkB and NCAM.	[Cassens, Claas; Kleene, Ralf; Xiao, Mei-Fang; Friedrich, Claudia; Dityateva, Galina; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schafer-Nielsen, Claus] Schafer N ApS, DK-2100 Copenhagen, Denmark; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 85, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553	Deutsche Forschungsgemeinschaft [SCHA185/17-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA185/17-4.	AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Brennaman LH, 2010, ADV EXP MED BIOL, V663, P299, DOI 10.1007/978-1-4419-1170-4_19; Burgess A, 2006, J NEUROCHEM, V99, P797, DOI 10.1111/j.1471-4159.2006.04110.x; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Danzer SC, 2008, HIPPOCAMPUS, V18, P668, DOI 10.1002/hipo.20426; Diestel S, 2004, BIOCHEM BIOPH RES CO, V322, P186, DOI 10.1016/j.bbrc.2004.07.100; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; Gascon E, 2007, DEVELOPMENT, V134, P1181, DOI 10.1242/dev.02808; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; HAYRINEN J, 1995, J INFECT DIS, V171, P1481, DOI 10.1093/infdis/171.6.1481; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HONG SS, 1995, EMBO J, V14, P4714, DOI 10.1002/j.1460-2075.1995.tb00153.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iwasaki Y, 1997, BIOCHEMISTRY-US, V36, P2694, DOI 10.1021/bi962057x; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mackowiak M, 2005, BRAIN RES, V1055, P149, DOI 10.1016/j.brainres.2005.07.001; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Otal R, 2005, CELL TISSUE RES, V319, P349, DOI 10.1007/s00441-004-1020-5; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; TANNAHILL L, 1995, EUR J NEUROSCI, V7, P1424, DOI 10.1111/j.1460-9568.1995.tb01136.x; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x	43	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28959	28967		10.1074/jbc.M110.114835	http://dx.doi.org/10.1074/jbc.M110.114835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20605779	Green Published, hybrid			2022-12-27	WOS:000281594000061
J	de Groot, T; Verkaart, S; Xi, Q; Bindels, RJM; Hoenderop, JGJ				de Groot, Theun; Verkaart, Sjoerd; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.			The Identification of Histidine 712 as a Critical Residue for Constitutive TRPV5 Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL CA2+ CHANNEL; ANKYRIN REPEAT; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PERMEATION; ABSORPTION; PROTEINS	The epithelial Ca2+ channel TRPV5 constitutes the apical entry gate for Ca2+ transport in renal epithelial cells. Ablation of the trpv5 gene in mice leads to a reduced Ca2+ reabsorption. TRPV5 is tightly regulated by various calciotropic hormones, associated proteins, and other factors, which mainly affect channel activity via the C terminus. To further identify the role of the C terminus in TRPV5 regulation, we expressed channels harboring C-terminal deletions and studied channel activity by measuring intracellular Ca2+ concentration ([Ca2+](i)) using fura-2 analysis. Removal of amino acid His(712) elevated the [Ca2+](v) indicating enlarged TRPV5 activity. In addition, substitution of the positively charged His(712) for a negative (H712D) or neutral (H712N) amino acid also stimulated TRPV5 activity. This critical role of His712 was confirmed by patch clamp analysis, which demonstrates increased Na+ and Ca2+ currents for TRPV5-H712D. Cell surface biotinylation studies revealed enhanced plasma membrane expression of TRPV5-H712D as compared with wild-type (WT) TRPV5. This elevated plasma membrane presence also was observed with the Ca2+-impermeable TRPV5-H712D and TRPV5-WT pore mutants, demonstrating that the elevation is not due to the increased [Ca2+](i). Finally, using an internalization assay, we demonstrated a delayed cell surface retrieval for TRPV5-H712D, likely causing the increase in plasma membrane expression. Together, these results demonstrate that His(712) plays an essential role in plasma membrane regulation of TRPV5 via a constitutive endocytotic mechanism.	[de Groot, Theun; Verkaart, Sjoerd; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Groot, Theun/A-2596-2015; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Dutch Kidney Foundation [C03.6017, C06.2170]; Netherlands Organization for Scientific Research [NWO-ALW 814.02.001, NWO-CW 700.55.302, ZonMw 9120.6110]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Kidney Foundation (C03.6017 and C06.2170) and the Netherlands Organization for Scientific Research (NWO-ALW 814.02.001, NWO-CW 700.55.302, and ZonMw 9120.6110).	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; de Groot T, 2008, KIDNEY INT, V74, P1241, DOI 10.1038/ki.2008.320; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Suzuki Y, 2008, ANNU REV PHYSIOL, V70, P257, DOI 10.1146/annurev.physiol.69.031905.161003; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Yeh BI, 2006, J MEMBRANE BIOL, V212, P191, DOI 10.1007/s00232-006-0023-4	30	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28481	28487		10.1074/jbc.M110.117143	http://dx.doi.org/10.1074/jbc.M110.117143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628046	Green Published, hybrid			2022-12-27	WOS:000281594000011
J	Hu, YL; Pan, XM; Xiang, LX; Shao, JZ				Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong			Characterization of C1q in Teleosts INSIGHT INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION OF C1q FAMILY AND CLASSICAL PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARP CYPRINUS-CARPIO; JAPANESE MEDAKA FISH; COMPLEMENT-SYSTEM; MOLECULAR-CLONING; MODULAR ORGANIZATION; SEQUENCE ALIGNMENT; SUBCOMPONENT C1Q; LINKAGE ANALYSIS; INNATE IMMUNITY; C-CHAINS	C1qs are key components of the classical complement pathway. They have been well documented in human and mammals, but little is known about their molecular and functional characteristics in fish. In the present study, full-length cDNAs of c1qA, c1qB, and c1qC from zebrafish (Danio rerio) were cloned, revealing the conservation of their chromosomal synteny and organization between zebrafish and other species. For functional analysis, the globular heads of C1qA (ghA), C1qB (ghB), and C1qC (ghC) were expressed in Escherichia coli as soluble proteins. Hemolytic inhibitory assays showed that hemolytic activity in carp serum can be inhibited significantly by anti-C1qA, -C1qB, and -C1qC of zebrafish, respectively, indicating that C1qA, C1qB, and C1qC are involved in the classical pathway and are conserved functionally from fish to human. Zebrafish C1qs also could specifically bind to heat-aggregated zebrafish IgM, human IgG, and IgM. The involvement of globular head modules in the C1q-dependent classical pathway demonstrates the structural and functional conservation of these molecules in the classical pathway and their IgM or IgG binding sites during evolution. Phylogenetic analysis revealed that c1qA, c1qB, and c1qC may be formed by duplications of a single copy of c1qB and that the C1q family is, evolutionarily, closely related to the Emu family. This study improves current understanding of the evolutionary history of the C1q family and C1q-mediated immunity.	[Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Minist Agr, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Yu-Lan; Pan, Xin-Min; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Minist Agr, Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou 310058, Zhejiang, Peoples R China; [Shao, Jian-Zhong] Zhejiang Univ, Minist Agr, Key Lab Anim Epidem Etiol & Immunol Prevent, Hangzhou 310058, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Minist Agr, Hangzhou 310058, Zhejiang, Peoples R China.	shaojz@zju.edu.cn	胡, 瑜兰/I-8646-2014		National Basic Research Program of China (973) [2006CB101805]; Hi-Tech Research and Development Program of China (863) [2008AA09Z409]; National Natural Science Foundation of China [30871936, 30571423]; Science and Technology Foundation of Zhejiang Province [2006C12038, 2006C23045, 2006C12005, 2007C12011]	National Basic Research Program of China (973)(National Basic Research Program of China); Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Zhejiang Province	This work was supported by grants from the National Basic Research Program of China (973) (2006CB101805), the Hi-Tech Research and Development Program of China (863) (2008AA09Z409), the National Natural Science Foundation of China (30871936 and 30571423), and the Science and Technology Foundation of Zhejiang Province (2006C12038, 2006C23045, 2006C12005, and 2007C12011).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bag MR, 2009, FISH SHELLFISH IMMUN, V26, P275, DOI 10.1016/j.fsi.2008.11.009; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cross PS, 1999, DEV COMP IMMUNOL, V23, P429, DOI 10.1016/S0145-305X(99)00022-1; Dodds AW, 2007, IMMUNOBIOLOGY, V212, P233, DOI 10.1016/j.imbio.2006.11.009; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kishore U, 2003, J IMMUNOL, V171, P812, DOI 10.4049/jimmunol.171.2.812; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuroda N, 1996, IMMUNOGENETICS, V44, P459, DOI 10.1007/BF02602808; Kuroda N, 2000, IMMUNOGENETICS, V51, P117, DOI 10.1007/s002510050020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimeister C, 2002, DEV BIOL, V249, P204, DOI 10.1006/dbio.2002.0764; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Matsushita M, 2004, P NATL ACAD SCI USA, V101, P10127, DOI 10.1073/pnas.0402180101; Nakao M, 1998, J IMMUNOL, V161, P4811; Nakao M, 2001, IMMUNOGENETICS, V52, P255; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; Nonaka M, 2000, CURR TOP MICROBIOL, V248, P37; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SASAKI T, 1982, J IMMUNOL METHODS, V48, P121, DOI 10.1016/0022-1759(82)90216-2; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHULMAN MJ, 1987, EUR J IMMUNOL, V17, P549, DOI 10.1002/eji.1830170418; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Smith SL, 1998, IMMUNOL REV, V166, P67, DOI 10.1111/j.1600-065X.1998.tb01253.x; Sunyer JO, 1998, J IMMUNOL, V161, P4106; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015	39	36	42	8	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28777	28786		10.1074/jbc.M110.131318	http://dx.doi.org/10.1074/jbc.M110.131318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20615881	hybrid, Green Published			2022-12-27	WOS:000281594000043
J	Terui, Y; Tabei, Y; Akiyama, M; Higashi, K; Tomitori, H; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Terui, Yusuke; Tabei, Yuzuru; Akiyama, Mariko; Higashi, Kyohei; Tomitori, Hideyuki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Ribosome Modulation Factor, an Important Protein for Cell Viability Encoded by the Polyamine Modulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL-CHANGE; REQUIRING MUTANTS; RNA; ENHANCEMENT; GROWTH; STIMULATION; TRANSLATION; DECREASE; INVOLVEMENT	We searched for proteins whose synthesis is enhanced by polyamines at the stationary phase of cell growth using an Escherichia coli polyamine-requiring mutant in which cell viability is greatly decreased by polyamine deficiency. The synthesis of ribosome modulation factor (RMF) was strongly enhanced by polyamines at the level of translation at the stationary phase of cell growth. In rmf mRNA, a Shine-Dalgarno (SD) sequence is located 11 nucleotides upstream of the initiation codon AUG. When the SD sequence was moved to the more common position 8 nucleotides upstream of the initiation codon, the degree of polyamine stimulation was reduced, although the level of RMF synthesis was markedly increased. Polyamine stimulation of RMF synthesis was found to be caused by a selective structural change of the bulged-out region of the initiation site of rmf mRNA. The decrease in cell viability caused by polyamine deficiency was prevented by the addition of a modified rmf gene whose synthesis is not influenced by polyamines. The results indicate that polyamines enhance cell viability of E. coli at least in part by enhancing RMF synthesis.	[Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan	Chiba University; Chiba University; Hosei University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp		Higashi, Kyohei/0000-0002-2622-4825; Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology of Japan; Promotion and Mutual Aid Corporation for Private Schools of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported by a grant-in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Apirakaramwong A, 1998, BIOCHEM BIOPH RES CO, V251, P482, DOI 10.1006/bbrc.1998.9494; Apirakaramwong A, 1999, BIOCHEM BIOPH RES CO, V264, P643, DOI 10.1006/bbrc.1999.1556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V62, P313, DOI 10.1016/S0006-291X(75)80140-9; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; HENGGEARONIS R, 1993, J BACTERIOL, V175, P259, DOI 10.1128/JB.175.1.259-265.1993; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1981, EUR J BIOCHEM, V114, P127; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1983, BIOCHIM BIOPHYS ACTA, V755, P326, DOI 10.1016/0304-4165(83)90234-9; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; Izutsu K, 2001, GENES CELLS, V6, P665, DOI 10.1046/j.1365-2443.2001.00457.x; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; KUSAMAEGUCHI K, 1991, BIOCHEM BIOPH RES CO, V177, P745, DOI 10.1016/0006-291X(91)91851-3; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; PEGG AE, 1982, BIOCHEM J, V202, P519, DOI 10.1042/bj2020519; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raj VS, 2002, BIOCHEM BIOPH RES CO, V299, P252, DOI 10.1016/S0006-291X(02)02627-X; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; WADA A, 1995, BIOCHEM BIOPH RES CO, V214, P410, DOI 10.1006/bbrc.1995.2302; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, p2.4.1, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; YAMAGISHI M, 1993, EMBO J, V12, P625, DOI 10.1002/j.1460-2075.1993.tb05695.x; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200; Yoshida M, 2001, J BIOL CHEM, V276, P16289, DOI 10.1074/jbc.M011059200; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	24	24	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28698	28707		10.1074/jbc.M110.111195	http://dx.doi.org/10.1074/jbc.M110.111195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628056	hybrid, Green Published			2022-12-27	WOS:000281594000035
J	Bruce, SJ; Butterfield, NC; Metzis, V; Town, L; McGlinn, E; Wicking, C				Bruce, Stephen J.; Butterfield, Natalie C.; Metzis, Vicki; Town, Liam; McGlinn, Edwina; Wicking, Carol			Inactivation of Patched1 in the Mouse Limb Has Novel Inhibitory Effects on the Chondrogenic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; VERTEBRATE LIMB; CARTILAGE FORMATION; CHONDROCYTE DIFFERENTIATION; INDIAN-HEDGEHOG; CELL-DIFFERENTIATION; ENDOCHONDRAL BONE; DIGIT NUMBER; IN-VITRO; EXPRESSION	The bones of the vertebrate limb form by the process of endochondral ossification, whereby limb mesenchyme condenses to form an intermediate cartilage scaffold that is then replaced by bone. Although Indian hedgehog (IHH) is known to control hypertophic differentiation of chondrocytes during this process, the role of hedgehog signaling in the earlier stages of chondrogenesis is less clear. We have conditionally inactivated the hedgehog receptor Ptc1 in undifferentiated limb mesenchyme of the mouse limb using Prx1-Cre, thus inducing constitutively active ligand-independent hedgehog signaling. In addition to major patterning defects, we observed a marked disruption to the cartilage elements in the limbs of Prx1-Cre:Ptc1c/c embryos. Using an in vitro micromass culture system we show that this defect lies downstream of mesenchymal cell condensation and likely upstream of chondrocyte differentiation. Despite early increases in levels of chondrogenic genes, soon after mesenchymal condensation the stromal layer of Prx1-Cre:Ptc1c/c-derived micromass cultures is characterized by a loss of cell integrity, which is associated with increased cell death and a striking decrease in Alcian blue staining cartilage nodules. Furthermore, inhibition of the hedgehog pathway activation using cyclopamine was sufficient to essentially overcome this chondrogenic defect in both micromass and ex vivo explant assays of Prx1-Cre: Ptc1c/c limbs. These data demonstrate for the first time the inhibitory effect of cell autonomously activated hedgehog signaling on chondrogenesis, and stress the importance of PTC1 in maintaining strict control of signaling levels during this phase of skeletal development.	[Bruce, Stephen J.; Butterfield, Natalie C.; Metzis, Vicki; Town, Liam; Wicking, Carol] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [McGlinn, Edwina] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Queensland; Harvard University; Harvard Medical School		c.wicking@imb.uq.edu.au	McGlinn, Edwina/AAE-1945-2021; Metzis, Vicki/AAU-5081-2020; Butterfield, Natalie/AAV-5483-2020; Wicking, Carol/J-1814-2014	Metzis, Vicki/0000-0002-0399-1722; Butterfield, Natalie/0000-0002-5209-7508; McGlinn, Edwina/0000-0002-1829-986X; Wicking, Carol/0000-0002-7225-3803	National Health and Medical Research Council (NHMRC) of Australia [569713]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Project Grant 569713.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bobick BE, 2007, J CELL PHYSIOL, V211, P233, DOI 10.1002/jcp.20923; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Incardona JP, 1998, DEVELOPMENT, V125, P3553; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Karp SJ, 2000, DEVELOPMENT, V127, P543; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; LEE YS, 1998, CELLS MAT, V8, P19; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Montero JA, 2007, DEV BIOL, V303, P325, DOI 10.1016/j.ydbio.2006.11.019; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nagy A., 2003, MANIPULATING MOUSE E; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stott NS, 1997, J CELL SCI, V110, P2691; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Tavella S, 2004, J BONE MINER RES, V19, P1678, DOI 10.1359/JBMR.040706; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yu K, 2008, DEVELOPMENT, V135, P483, DOI 10.1242/dev.013268	58	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27967	27981		10.1074/jbc.M109.091785	http://dx.doi.org/10.1074/jbc.M109.091785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576618	Green Published, hybrid			2022-12-27	WOS:000281404100051
J	Sakurai, T; Misaka, T; Ishiguro, M; Masuda, K; Sugawara, T; Ito, K; Kobayashi, T; Matsuo, S; Ishimaru, Y; Asakura, T; Abe, K				Sakurai, Takanobu; Misaka, Takumi; Ishiguro, Masaji; Masuda, Katsuyoshi; Sugawara, Taishi; Ito, Keisuke; Kobayashi, Takuya; Matsuo, Shinji; Ishimaru, Yoshiro; Asakura, Tomiko; Abe, Keiko			Characterization of the beta-D-Glucopyranoside Binding Site of the Human Bitter Taste Receptor hTAS2R16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MODIFYING SWEET PROTEIN; CRYSTAL-STRUCTURE; CURCULIGO-LATIFOLIA; SQUID RHODOPSIN; UMAMI TASTE; NEOCULIN; SACCHARIN; SUBUNITS; VARIETY	G-protein-coupled receptors mediate the senses of taste, smell, and vision in mammals. Humans recognize thousands of compounds as bitter, and this response is mediated by the hTAS2R family, which is one of the G-protein-coupled receptors composed of only 25 receptors. However, structural information on these receptors is limited. To address the molecular basis of bitter tastant discrimination by the hTAS2Rs, we performed ligand docking simulation and functional analysis using a series of point mutants of hTAS2R16 to identify its binding sites. The docking simulation predicted two candidate binding structures for a salicin-hTAS2R16 complex, and at least seven amino acid residues in transmembrane 3 (TM3), TM5, and TM6 were shown to be involved in ligand recognition. We also identified the probable salicin-hTAS2R16 binding mode using a mutated receptor experiment. This study characterizes the molecular interaction between hTAS2R16 and beta-D-glucopyranoside and will also facilitate rational design of bitter blockers.	[Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Matsuo, Shinji] Nissin Foods Holdings Co Ltd, Gen Res Inst Food Sci & Technol, Shiga 5250058, Japan; [Ishiguro, Masaji; Masuda, Katsuyoshi] Niigata Univ Pharm & Appl Life Sci, Niigata 9568503, Japan; [Kobayashi, Takuya] Kyoto Univ, Fac Med, Dept Med Chem, Kyoto 6068501, Japan	University of Tokyo; Niigata University; Kyoto University	Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp	Ito, Keisuke/J-5926-2013; Ishimaru, Yoshiro/AAI-3049-2020	Ito, Keisuke/0000-0002-8719-9635; Misaka, Takumi/0000-0002-9547-5767	Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19880008, 20780089, 18688005, 20688015, 21658046, 19300248, 20380183]	Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of Bio-oriented Technology Research Advancement Institution. This work was also supported by Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 19880008 and Grants 20780089 (to Y. I.), 18688005, 20688015, and 21658046 (to T. M.), 19300248 (to T. A.), and 20380183 (to K. A.).	Ammon C., 2002, Archives of Physiology and Biochemistry, V110, P137, DOI 10.1076/apab.110.1.137.908; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Ishiguro M, 2004, CHEMBIOCHEM, V5, P298, DOI 10.1002/cbic.200300668; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakajima K, 2006, NEUROREPORT, V17, P1241, DOI 10.1097/01.wnr.0000230513.01339.3b; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NOGUCHI M, 1975, J FOOD SCI, V40, P367, DOI 10.1111/j.1365-2621.1975.tb02203.x; Okubo S, 2008, J PLANT PHYSIOL, V165, P1964, DOI 10.1016/j.jplph.2008.04.019; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ruiz-Avila L, 2000, CHEM SENSES, V25, P361, DOI 10.1093/chemse/25.4.361; Sainz E, 2007, BIOCHEM J, V403, P537, DOI 10.1042/BJ20061744; Sakurai T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/jf8040148; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; Ueda T, 2003, J NEUROSCI, V23, P7376; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	39	69	70	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28373	28378		10.1074/jbc.M110.144444	http://dx.doi.org/10.1074/jbc.M110.144444			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20605788	hybrid, Green Published			2022-12-27	WOS:000281404100079
J	Pu, MM; Orr, A; Redfield, AG; Roberts, MF				Pu, Mingming; Orr, Andrew; Redfield, Alfred G.; Roberts, Mary F.			Defining Specific Lipid Binding Sites for a Peripheral Membrane Protein in Situ Using Subtesla Field-cycling NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; ACTIVATION; DYNAMICS; SPECTROSCOPY; INHIBITION; RELAXATION; SUBSTRATE	Despite the profound physiological consequences associated with peripheral membrane protein localization, only a rudimentary understanding of the interactions of proteins with membrane surfaces exists because these questions are inaccessible by commonly used structural techniques. Here, we combine high resolution field-cycling P-31 NMR relaxation methods with spin-labeled proteins to delineate specific interactions of a bacterial phospholipase C with phospholipid vesicles. Unexpectedly, discrete binding sites for both a substrate analogue and a different phospholipid (phosphatidylcholine) known to activate the enzyme are observed. The lifetimes for the occupation of these sites (when the protein is anchored transiently to the membrane) are > 1-2 mu s (but < 1 ms), which represents the first estimate of an off-rate for a lipid dissociating from a specific site on the protein and returning to the bilayer. Furthermore, analyses of the spin-label induced NMR relaxation corroborates the presence of a discrete tyrosine-rich phosphatidylcholine binding site whose location is consistent with that suggested by modeling studies. The methodology illustrated here may	Boston Coll, Dept Chem, Chestnut Hill, MA 02465 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Merkert Chem Ctr, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Pu, Mingming/F-6760-2012		National Institutes of Health [GM60418, GM077974]; National Science Foundation [MCB-0517381]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077974, R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60418 (to M. F. R.) and GM077974 (to A. G. R.). This work was also supported by National Science Foundation Grant MCB-0517381 (to M. F. R.).	Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Hondal RJ, 1998, BIOCHEMISTRY-US, V37, P4568, DOI 10.1021/bi972646i; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Pu MM, 2009, J BIOL CHEM, V284, P16099, DOI 10.1074/jbc.M809600200; Redfield AG, 2003, MAGN RESON CHEM, V41, P753, DOI 10.1002/mrc.1264; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Sivanandam VN, 2009, J AM CHEM SOC, V131, P3420, DOI 10.1021/ja808431h; Victor K, 2005, BIOPHYS J, V88, P443, DOI 10.1529/biophysj.104.046459; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	17	32	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26916	26922		10.1074/jbc.M110.123083	http://dx.doi.org/10.1074/jbc.M110.123083			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576615	Green Published, hybrid			2022-12-27	WOS:000281172700023
J	Wegmann, S; Jung, YJ; Chinnathambi, S; Mandelkow, EM; Mandelkow, E; Muller, DJ				Wegmann, Susanne; Jung, Yu Jin; Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard; Muller, Daniel J.			Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ATOMIC-FORCE MICROSCOPY; PRION-LIKE PROPAGATION; ALZHEIMERS-DISEASE; BETA-STRUCTURE; AMYLOID FIBRILS; CORTICOBASAL DEGENERATION; ELECTRON-MICROSCOPY; SINGLE-MOLECULE; SOLID-SURFACES	Fibrous aggregates of Tau protein are characteristic features of Alzheimer disease. We applied high resolution atomic force and EM microscopy to study fibrils assembled from different human Tau isoforms and domains. All fibrils reveal structural polymorphism; the "thin twisted" and "thin smooth" fibrils resemble flat ribbons (cross-section similar to 10 x 15 nm) with diverse twist periodicities. "Thick fibrils" show periodicities of similar to 5-70 nm and thicknesses of similar to 9-18 nm such as routinely reported for "paired helical filaments" but structurally resemble heavily twisted ribbons. Therefore, thin and thick fibrils assembled from different human Tau isoforms challenge current structural models of paired helical filaments. Furthermore, all Tau fibrils reveal axial subperiodicities of similar to 17-19 nm and, upon exposure to mechanical stress or hydrophobic surfaces, disassemble into uniform fragments that remain connected by thin thread-like structures (similar to 2 nm). This hydrophobically induced disassembly is inhibited at enhanced electrolyte concentrations, indicating that the fragments resemble structural building blocks and the fibril integrity depends largely on hydrophobic and electrostatic interactions. Because full-length Tau and repeat domain constructs assemble into fibrils of similar thickness, the "fuzzy coat" of Tau protein termini surrounding the fibril axis is nearly invisible for atomic force microscopy and EM, presumably because of its high flexibility.	[Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Wegmann, Susanne; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Jung, Yu Jin] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard] CAESAR, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mandelkow, E (corresponding author), DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de; daniel.mueller@bsse.ethz.ch	Chinnathambi, Subashchandrabose/T-8471-2019; Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665; Chinnathambi, Subashchandrabose/0000-0002-5468-2129	Deutsche Forschungsgemeinschaft; Max-Planck Society; VW Foundation [1/82544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); VW Foundation(Volkswagen)	This work was supported by the Deutsche Forschungsgemeinschaft (to D. M.), Max-Planck Society (to D. J. M. and E. M. M.), and VW Foundation Grant 1/82544 (to E. M. M.).	ALLEN MJ, 1992, ULTRAMICROSCOPY, V42, P1095, DOI 10.1016/0304-3991(92)90408-C; Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Bright JN, 2001, PROG BIOPHYS MOL BIO, V76, P131, DOI 10.1016/S0079-6107(01)00012-8; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buee L, 1999, BRAIN PATHOL, V9, P681; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; CROWTHER RA, 1990, BIOCHIM BIOPHYS ACTA, V1096, P1, DOI 10.1016/0925-4439(90)90004-9; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1; Fandrich M, 2009, PRION, V3, P89; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Flory, 1969, STAT MECH CHAIN MOL, P432; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; KATO S, 1990, ACTA NEUROPATHOL, V81, P125, DOI 10.1007/BF00334500; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Krammer C, 2009, PRION, V3, P206, DOI 10.4161/pri.3.4.10013; Krebs MRH, 2009, BIOCHEM SOC T, V37, P682, DOI 10.1042/BST0370682; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; LECKBAND D, 2001, Q REV BIOPHYS, V105, P267; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Moreno-Herrero F, 2006, NUCLEIC ACIDS RES, V34, P3057, DOI 10.1093/nar/gkl397; Moreno-Herrero F, 2001, J ALZHEIMERS DIS, V3, P443, DOI 10.3233/JAD-2001-3502; Moya S, 2005, ANGEW CHEM INT EDIT, V44, P4578, DOI 10.1002/anie.200500228; Muller DJ, 2006, CURR OPIN STRUC BIOL, V16, P489, DOI 10.1016/j.sbi.2006.06.001; Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Perez M, 1996, J NEUROCHEM, V67, P1183; POLLANEN MS, 1994, AM J PATHOL, V144, P869; Pollanen MS, 1997, J NEUROPATH EXP NEUR, V56, P79, DOI 10.1097/00005072-199701000-00008; Rivetti C, 2001, ULTRAMICROSCOPY, V87, P55, DOI 10.1016/S0304-3991(00)00064-4; Ruben GC, 2005, MICROSC RES TECHNIQ, V67, P175, DOI 10.1002/jemt.20197; Sagis LMC, 2004, LANGMUIR, V20, P924, DOI 10.1021/la035390s; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Schaap IAT, 2007, J STRUCT BIOL, V158, P282, DOI 10.1016/j.jsb.2006.11.010; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Su TX, 2009, ACTA BIOMATER, V5, P1855, DOI 10.1016/j.actbio.2009.01.038; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	83	85	90	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27302	27313		10.1074/jbc.M110.145318	http://dx.doi.org/10.1074/jbc.M110.145318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566652	Green Published, hybrid			2022-12-27	WOS:000281172700060
J	Baudry, A; Bitard, J; Mouillet-Richard, S; Locker, M; Poliard, A; Launay, JM; Kellermann, O				Baudry, Anne; Bitard, Juliette; Mouillet-Richard, Sophie; Locker, Morgane; Poliard, Anne; Launay, Jean-Marie; Kellermann, Odile			Serotonergic 5-HT2B Receptor Controls Tissue-nonspecific Alkaline Phosphatase Activity in Osteoblasts via Eicosanoids and Phosphatidylinositol-specific Phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; INFANTILE HYPOPHOSPHATASIA; INHIBITION; CELL; 5-HYDROXYTRYPTAMINE; DIFFERENTIATION; MINERALIZATION; ACTIVATION; EXPRESSION; PROTEIN	In previous studies, we observed that mice knocked out for the serotonin-2B receptor (5-HT2BR) show defects in bone homeostasis. The present work focuses on the downstream targets relaying the anabolic function of this receptor in osteoblasts. A functional link between the 5-HT2BR and the activity of the tissue-nonspecific alkaline phosphatase (TNAP) is established using the C1 osteoprogenitor cell line. During C1 osteogenic differentiation, both 5-HT2BR and TNAP mRNA translations are delayed with respect to extracellular matrix deposition. Once the receptor is expressed, it constitutively controls TNAP activity at a post-translational level along the overall period of mineral deposition. Indeed, pharmacological inhibition of the 5-HT2BR intrinsic activity or shRNA-mediated 5-HT2BR knockdown prevents TNAP activation, but not its mRNA translation. In contrast, agonist stimulation of the receptor further increases TNAP activity during the initial mineralization phase. Building upon our previous observations that the 5-HT2BR couples with the phospholipase A2 pathway and prostaglandin production at the beginning of mineral deposition, we show that the 5-HT2BR controls leukotriene synthesis via phospholipase A2 at the terminal stages of C1 differentiation. These two 5-HT2BR-dependent eicosanoid productions delineate distinct time windows of TNAP regulation during the osteogenic program. Finally, prostaglandins or leukotrienes are shown to relay the post-translational activation of TNAP via stimulation of the phosphatidylinositol-specific phospholipase C. In agreement with the above findings, primary calvarial osteoblasts from 5-HT2BR-null mice exhibit defects in TNAP activity.	[Baudry, Anne; Bitard, Juliette; Mouillet-Richard, Sophie; Locker, Morgane; Poliard, Anne; Kellermann, Odile] Univ Paris 05, INSERM U747, F-75006 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM U942, Serv Biochim, AP HP, F-75009 Paris, France; [Launay, Jean-Marie] F Hoffmann La Roche & Co Ltd, Pharma Res Dept, CH-4070 Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Roche Holding	Kellermann, O (corresponding author), Univ Paris 05, INSERM U747, 45 Rue St Peres, F-75006 Paris, France.	odile.kellermann@parisdescartes.fr	Mouillet, Sophie/E-4960-2017; Baudry, Anne/O-2624-2017	Mouillet, Sophie/0000-0002-8950-1949; Baudry, Anne/0000-0002-7729-1753; BITARD, Juliette/0000-0001-6626-3522	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from Centre National de la Recherche Scientifique and the Institut National de la Sante et de la Recherche Medicale.	BAXTER G, 1995, TRENDS PHARMACOL SCI, V16, P105, DOI 10.1016/S0165-6147(00)88991-9; Baxter GS, 1996, BEHAV BRAIN RES, V73, P149; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2; Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053; HENTHORN PS, 1992, CLIN CHEM, V38, P2501; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Jonnakuty C, 2008, J CELL PHYSIOL, V217, P301, DOI 10.1002/jcp.21533; Kleven MS, 1997, J PHARMACOL EXP THER, V282, P747; Kozak W, 2004, FRONT BIOSCI-LANDMRK, V9, P3339, DOI 10.2741/1486; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Locker M, 2006, CELL SIGNAL, V18, P628, DOI 10.1016/j.cellsig.2005.06.006; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Masferrer JL, 1999, ANN NY ACAD SCI, V889, P84, DOI 10.1111/j.1749-6632.1999.tb08726.x; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Minamizaki T, 2009, BONE, V44, P1177, DOI 10.1016/j.bone.2009.02.010; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nakano Y, 2004, BONE, V35, P1077, DOI 10.1016/j.bone.2004.07.009; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; POLIARD A, 1995, J CELL BIOL, V130, P1461, DOI 10.1083/jcb.130.6.1461; Poliard A, 1999, EXP CELL RES, V253, P385, DOI 10.1006/excr.1999.4704; Spyridakis S, 2010, AM J RESP CELL MOL, V42, P357, DOI 10.1165/rcmb.2009-0078OC; Tesch W, 2003, J BONE MINER RES, V18, P117, DOI 10.1359/jbmr.2003.18.1.117; VANBELLE H, 1976, CLIN CHEM, V22, P972; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Warden SJ, 2010, BONE, V46, P4, DOI 10.1016/j.bone.2009.06.029; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	38	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26066	26073		10.1074/jbc.M109.073791	http://dx.doi.org/10.1074/jbc.M109.073791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573958	Green Published, hybrid			2022-12-27	WOS:000280921000022
J	Riera, L; Lasorsa, E; Ambrogio, C; Surrenti, N; Voena, C; Chiarle, R				Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Surrenti, Nadia; Voena, Claudia; Chiarle, Roberto			Involvement of Grb2 Adaptor Protein in Nucleophosmin-Anaplastic Lymphoma Kinase (NPM-ALK)-mediated Signaling and Anaplastic Large Cell Lymphoma Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; NPM-ALK; BINDING PROTEIN-2; FUSION PROTEIN; SH3 DOMAIN; TRANSFORMATION; PHOSPHORYLATION; DOWNSTREAM; PROLIFERATION; INTERFERENCE	Most anaplastic large cell lymphomas (ALCL) express oncogenic fusion proteins derived from chromosomal translocations or inversions of the anaplastic lymphoma kinase (ALK) gene. Frequently ALCL carry the t(2;5) translocation, which fuses the ALK gene to the nucleophosmin (NPM1) gene. The transforming activity mediated by NPM-ALK fusion induces different pathways that control proliferation and survival of lymphoma cells. Grb2 is an adaptor protein thought to play an important role in ALK-mediated transformation, but its interaction with NPM-ALK, as well as its function in regulating ALCL signaling pathways and cell growth, has never been elucidated. Here we show that active NPM-ALK, but not a kinase-dead mutant, bound and induced Grb2 phosphorylation in tyrosine 160. An intact SH3 domain at the C terminus of Grb2 was required for Tyr(160) phosphorylation. Furthermore, Grb2 did not bind to a single region but rather to different regions of NPM-ALK, mainly Tyr(152-156), Tyr(567), and a proline-rich region, Pro(415-417). Finally, shRNA knockdown experiments showed that Grb2 regulates primarily the NPM-ALK-mediated phosphorylation of SHP2 and plays a key role in ALCL cell growth.	[Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Voena, Claudia; Chiarle, Roberto] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Riera, Ludovica; Lasorsa, Elena; Ambrogio, Chiara; Surrenti, Nadia; Voena, Claudia; Chiarle, Roberto] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy	University of Turin; University of Turin	Chiarle, R (corresponding author), Univ Turin, Dept Biomed Sci & Human Oncol, Via Santena 7, I-10126 Turin, Italy.	roberto.chiarle@unito.it	VOENA, Claudia/ADJ-6244-2022	Ambrogio, Chiara/0000-0003-4122-701X; Voena, Claudia/0000-0002-1324-1431; RIERA, LUDOVICA/0000-0002-7695-6565; CHIARLE, Roberto/0000-0003-1564-8531	Associazione Italiana per la Ricerca sul Cancro (AIRC); Compagnia di San Paolo, Torino (Progetto Oncologia) [ERC-2009-StG]; Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo, Torino (Progetto Oncologia)(Compagnia di San Paolo); Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica)(Regione Piemonte)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Compagnia di San Paolo, Torino (Progetto Oncologia), FP7 ERC-2009-StG (Proposal 242965-"LUNELY") (to R. C.) and the Regione Piemonte (Ricerca Sanitaria Finalizzata and Ricerca Scientifica).	Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Crockett DK, 2004, ONCOGENE, V23, P2617, DOI 10.1038/sj.onc.1207398; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GISHIZKY ML, 1995, P NATL ACAD SCI USA, V92, P10889, DOI 10.1073/pnas.92.24.10889; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ho JMY, 2002, BLOOD, V100, P1438; Jones DA, 1997, ARCH BIOCHEM BIOPHYS, V337, P143, DOI 10.1006/abbi.1996.9789; Kuefer MU, 1997, BLOOD, V90, P2901, DOI 10.1182/blood.V90.8.2901; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; Minoo P, 2003, CELL SIGNAL, V15, P319, DOI 10.1016/S0898-6568(02)00122-5; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Polgar D, 2005, MUTAT RES-FUND MOL M, V570, P9, DOI 10.1016/j.mrfmmm.2004.09.011; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Taulli R, 2005, CANCER GENE THER, V12, P456, DOI 10.1038/sj.cgt.7700815; Trinei M, 2000, CANCER RES, V60, P793; Vihinen M, 1996, CRIT REV IMMUNOL, V16, P251, DOI 10.1615/CritRevImmunol.v16.i3.20; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Wasik MA, 2009, SEMIN ONCOL, V36, pS27, DOI 10.1053/j.seminoncol.2009.02.007; Wellmann A, 1997, FASEB J, V11, P965, DOI 10.1096/fasebj.11.12.9337149; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396	44	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26441	26450		10.1074/jbc.M110.116327	http://dx.doi.org/10.1074/jbc.M110.116327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554525	Green Published, hybrid			2022-12-27	WOS:000280921000062
J	Schelter, F; Gerg, M; Halbgewachs, B; Schaten, S; Gorlach, A; Schrotzlmair, F; Kruger, A				Schelter, Florian; Gerg, Michael; Halbgewachs, Birgit; Schaten, Susanne; Goerlach, Agnes; Schroetzlmair, Florian; Krueger, Achim			Identification of a Survival-independent Metastasis-enhancing Role of Hypoxia-inducible Factor-1 alpha with a Hypoxia-tolerant Tumor Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR 1-ALPHA; TRANSCRIPTIONAL ACTIVATION; BREAST-CANCER; MET RECEPTOR; IN-VIVO; HIF-1-ALPHA; INVASION; EXPRESSION; INHIBITOR	During tumor progression, malignant cells must repeatedly survive microenvironmental stress. Hypoxia-inducible factor-1 (HIF-1) signaling has emerged as one major pathway allowing cellular adaptation to stress. Recent findings led to the hypothesis that HIF-1 alpha may enhance the metastatic potential of tumor cells by a survival-independent mechanism. So far it has not been shown that HIF-1 alpha also directly regulates invasive processes during metastasis in addition to conferring a survival advantage to metastasizing tumor cells. In a hypoxia-tolerant tumor cell line (L-CI.5s), which did not rely on HIF-1 signaling for viability in vitro and in vivo, knockdown of Hif-1 alpha reduced invasiveness of the tumor cells in vitro as well as extravasation and secondary infiltration in vivo. Liver metastases associated induction of proinvasive receptor tyrosine kinase Met phosphorylation as well as gelatinolytic activity were Hif-1 alpha-dependent. Indeed, promoter activity of the matrix metalloproteinase-9 (mmp-9) was shown to be Hif-1 alpha-dependent. This study uncovers a new survival-independent biological function of HIF-1 alpha contributing to the efficacy of metastases formation.	[Schelter, Florian; Gerg, Michael; Halbgewachs, Birgit; Schaten, Susanne; Schroetzlmair, Florian; Krueger, Achim] Tech Univ Munich, Inst Expt Onkol & Therapieforsch, Klinikum Rechts Isar, D-81675 Munich, Germany; [Goerlach, Agnes] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany	Technical University of Munich; German Heart Centre Munich; Technical University of Munich	Kruger, A (corresponding author), Tech Univ Munich, Inst Expt Onkol & Therapieforsch, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany.	achim.krueger@lrz.tu-muenchen.de	Gorlach, Agnes/B-3494-2013		European Union [HEALTH-2007-201279/Microenvimet, HEALTH-F2-2009-222741/Metoxia]; Deutsche Forschungsgemeinschaft [KR2047/1-1]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the European Union Research Framework Programme 7, Project HEALTH-2007-201279/Microenvimet (to A.K.) and Project HEALTH-F2-2009-222741/Metoxia (to A.G.), and Deutsche Forschungsgemeinschaft grant KR2047/1-1 (to A.K.).	Akakura Nobuaki, 2001, Hokkaido Journal of Medical Science, V76, P375; Arlt M, 2002, CANCER RES, V62, P5543; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen CG, 2009, ANTICANCER RES, V29, P1367; Dikmen ZG, 2008, J CELL BIOCHEM, V104, P985, DOI 10.1002/jcb.21681; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Esteve PO, 2002, BIOCHEM BIOPH RES CO, V296, P864, DOI 10.1016/S0006-291X(02)02008-9; Fujiwara S, 2007, INT J ONCOL, V30, P793; Furlan D, 2007, SURG ONCOL, V16, pS25, DOI 10.1016/j.suronc.2007.10.014; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerg M, 2008, MOL CANCER RES, V6, P341, DOI 10.1158/1541-7786.MCR-07-2032; Gorden DL, 2007, INT J CANCER, V121, P495, DOI 10.1002/ijc.22594; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Krueger A, 2009, BIOL CHEM, V390, P91, DOI 10.1515/BC.2009.015; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; KRUGER A, 1994, INT J CANCER, V58, P275, DOI 10.1002/ijc.2910580222; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LERNER WA, 1983, INT J CANCER, V31, P463, DOI 10.1002/ijc.2910310411; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Nguyen MVC, 2007, J NEUROSCI RES, V85, P1119, DOI 10.1002/jnr.21202; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Victor N, 2006, CLIN EXP METASTAS, V23, P87, DOI 10.1007/s10585-006-9024-z; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zhong H, 1999, CANCER RES, V59, P5830	45	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26182	26189		10.1074/jbc.M110.140608	http://dx.doi.org/10.1074/jbc.M110.140608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566631	hybrid, Green Published			2022-12-27	WOS:000280921000035
J	Staples, CJ; Owens, DM; Maier, JV; Cato, ACB; Keyse, SM				Staples, Christopher J.; Owens, David M.; Maier, Jana V.; Cato, Andrew C. B.; Keyse, Stephen M.			Cross-talk between the p38 alpha and JNK MAPK Pathways Mediated by MAP Kinase Phosphatase-1 Determines Cellular Sensitivity to UV Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; INNATE IMMUNE-RESPONSES; C-FOS; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL REGULATION; CISPLATIN RESISTANCE; FEEDBACK-REGULATION; INDUCED APOPTOSIS; GENOTOXIC STRESS; GENE-EXPRESSION	MAPK phosphatase-1 (DUSP1/MKP-1) is a mitogen and stress-inducible dual specificity protein phosphatase, which can inactivate all three major classes of MAPK in mammalian cells. DUSP1/MKP-1 is implicated in cellular protection against a variety of genotoxic insults including hydrogen peroxide, ionizing radiation, and cisplatin, but its role in the interplay between different MAPK pathways in determining cell death and survival is not fully understood. We have used pharmacological and genetic tools to demonstrate that DUSP1/MKP-1 is an essential non-redundant regulator of UV-induced cell death in mouse embryo fibroblasts (MEFs). The induction of DUSP1/MKP-1 mRNA and protein in response to UV radiation is mediated by activation of the p38 alpha but not the JNK1 or JNK2 MAPK pathways. Furthermore, we identify MSK1 and -2 and their downstream effectors cAMP-response element-binding protein/ATF1 as mediators of UV-induced p38 alpha-dependent DUSP1/MKP-1 transcription. Dusp1/Mkp-1 null MEFs display increased signaling through both the p38 alpha and JNK MAPK pathways and are acutely sensitive to UV-induced apoptosis. This lethality is rescued by the reintroduction of wild-type DUSP1/MKP-1 and by a mutant of DUSP1/MKP-1, which is unable to bind to either p38 alpha or ERK1/2, but retains full activity toward JNK. Importantly, whereas small interfering RNA-mediated knockdown of DUSP1/MKP-1 sensitizes wild-type MEFs to UV radiation, DUSP1/MKP-1 knockdown in MEFS lacking JNK1 and -2 does not result in increased cell death. Our results demonstrate that cross-talk between the p38 alpha and JNK pathways mediated by induction of DUSP1/MKP-1 regulates the cellular response to UV radiation.	[Staples, Christopher J.; Owens, David M.; Keyse, Stephen M.] Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Staples, Christopher J.; Owens, David M.; Keyse, Stephen M.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Maier, Jana V.; Cato, Andrew C. B.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany	University of Dundee; University of Dundee; Helmholtz Association; Karlsruhe Institute of Technology	Keyse, SM (corresponding author), Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp, Level 5, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk	Cato, Andrew C. B./H-2071-2013; Keyse, Stephen M./B-9575-2009	Cato, Andrew C. B./0000-0001-8508-3834; Keyse, Stephen M./0000-0002-5150-8221; Staples, Christopher/0000-0002-0482-9954	Cancer Research UK; MRC; Cancer Research UK [12053] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported a grant from Cancer Research UK (to S. M. K.) and a MRC Ph.D studentship (to C. J. S.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dorfman K, 1996, ONCOGENE, V13, P925; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Iordanov MS, 1998, J BIOL CHEM, V273, P15794, DOI 10.1074/jbc.273.25.15794; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kinney CM, 2009, AM J PHYSIOL-CELL PH, V296, pC242, DOI 10.1152/ajpcell.00492.2008; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rojo F, 2009, CLIN CANCER RES, V15, P3530, DOI 10.1158/1078-0432.CCR-08-2070; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vicent S, 2004, CLIN CANCER RES, V10, P3639, DOI 10.1158/1078-0432.CCR-03-0771; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Yang HJ, 2004, CANCER BIOL THER, V3, P1277, DOI 10.4161/cbt.3.12.1370; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou JY, 2006, CANCER RES, V66, P4888, DOI 10.1158/0008-5472.CAN-05-4229; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	62	57	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25928	25940		10.1074/jbc.M110.117911	http://dx.doi.org/10.1074/jbc.M110.117911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547488	Green Published, hybrid			2022-12-27	WOS:000280921000007
J	Jutooru, I; Chadalapaka, G; Lei, P; Safe, S				Jutooru, Indira; Chadalapaka, Gayathri; Lei, Ping; Safe, Stephen			Inhibition of NF kappa B and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-II TRIAL; TRANSCRIPTION FACTORS; ONCOGENIC MICRORNA-27A; FACTOR RECEPTOR; EXPRESSION; ANGIOGENESIS; PROLIFERATION; APOPTOSIS; SP1; ADENOCARCINOMA	Curcumin activates diverse anticancer activities that lead to inhibition of cancer cell and tumor growth, induction of apoptosis, and antiangiogenic responses. In this study, we observed that curcumin inhibits Panc28 and L3.6pL pancreatic cancer cell and tumor growth in nude mice bearing L3.6pL cells as xenografts. In addition, curcumin decreased expression of p50 and p65 proteins and NF kappa B-dependent transactivation and also decreased Sp1, Sp3, and Sp4 transcription factors that are over-expressed in pancreatic cancer cells. Because both Sp transcription factors and NF kappa B regulate several common genes such as cyclin D1, survivin, and vascular endothelial growth factor that contribute to the cancer phenotype, we also investigated interactions between Sp and NF kappa B transcription factors. Results of Sp1, Sp3, and Sp4 knockdown by RNA interference demonstrate that both p50 and p65 are Sp-regulated genes and that inhibition of constitutive or tumor necrosis factor-induced NF kappa B by curcumin is dependent on down-regulation of Sp1, Sp3, and Sp4 proteins by this compound. Curcumin also decreased mitochondrial membrane potential and induced reactive oxygen species in pancreatic cancer cells, and this pathway is required for down-regulation of Sp proteins in these cells, demonstrating that the mitochondriotoxic effects of curcumin are important for its anticancer activities.	[Jutooru, Indira; Chadalapaka, Gayathri; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Lei, Ping] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, 4466 TAMU,Vet Res Bldg,410, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu			National Institutes of Health [R01CA108718, R01CA136571]; Texas A&M AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571, R01CA108718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA108718 and R01CA136571 and a grant from Texas A&M AgriLife Research.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Arbiser JL, 1998, MOL MED, V4, P376, DOI 10.1007/BF03401744; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bhaumik S, 1999, FEBS LETT, V456, P311, DOI 10.1016/S0014-5793(99)00969-2; Bramhall SR, 2001, J CLIN ONCOL, V19, P3447, DOI 10.1200/JCO.2001.19.15.3447; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Evans DB, 1997, CANC PRINCIPLES PRAC, V1, P1126; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haller DG, 2003, INT J RADIAT ONCOL, V56, P16, DOI 10.1016/S0360-3016(03)00448-6; Higgins KJ, 2006, BIOCHEM BIOPH RES CO, V345, P292, DOI 10.1016/j.bbrc.2006.04.111; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hotz HG, 2001, J GASTROINTEST SURG, V5, P131, DOI 10.1016/S1091-255X(01)80024-X; Hruban RH, 2001, J GASTROINTEST SURG, V5, P583, DOI 10.1016/S1091-255X(01)80099-8; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; JUTOORU I, 2010, MOL PHARM IN PRESS; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Khan S, 2007, J MOL ENDOCRINOL, V39, P289, DOI 10.1677/JME-07-0043; Klein AP, 2001, CANCER J, V7, P266; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Li DH, 2001, CANCER J, V7, P259; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; McKenna S, 2003, ONCOLOGIST, V8, P149, DOI 10.1634/theoncologist.8-2-149; McNally SJ, 2007, INT J MOL MED, V19, P165; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Moore MJ, 2003, J CLIN ONCOL, V21, P3296, DOI 10.1200/JCO.2003.02.098; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shi Q, 2001, CANCER RES, V61, P4143; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Xiong HQ, 2004, J CLIN ONCOL, V22, P2610, DOI 10.1200/JCO.2004.12.040; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997	48	156	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25332	25344		10.1074/jbc.M109.095240	http://dx.doi.org/10.1074/jbc.M109.095240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538607	Green Published, hybrid			2022-12-27	WOS:000280682400026
J	Liang, GY; Taranova, O; Xia, K; Zhang, Y				Liang, Gaoyang; Taranova, Olena; Xia, Kai; Zhang, Yi			Butyrate Promotes Induced Pluripotent Stem Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE COMPOUNDS; FIBROBLASTS; INDUCTION; MOUSE; EXPRESSION; PATHWAY; STATE; OCT4	Recent studies have demonstrated that embryonic stem cell-like induced pluripotent stem (iPS) cells can be generated by enforced expression of defined transcription factors. The fact that cell fate change is accompanied by changes in epigenetic modifications prompted us to investigate whether chemicals known to modulate epigenetic regulators are capable of enhancing the efficiency of iPS cell generation. Here, we report that butyrate, a natural small fatty acid and histone deacetylase inhibitor, significantly increases the efficiency of mouse iPS cell generation using the transcription factors Oct4, Sox2, Klf4, and c-Myc. We show that butyrate not only changes the reprogramming dynamics, but also increases the ratio of iPS cell colonies to total colonies by reducing the frequency of partially reprogrammed cells and transformed cells. Detailed analysis reveals that the effect of butyrate on reprogramming appears to be mediated by c-Myc and occurs during an early stage of reprogramming. Genome-wide gene expression analysis reveals up-regulation of ES cell-enriched genes when mouse embryonic fibroblasts are treated with butyrate during reprogramming. Thus, our study identifies butyrate as a chemical factor capable of promoting iPS cell generation.	[Liang, Gaoyang; Taranova, Olena; Xia, Kai; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, 450 West Dr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	liang, gaoyang/A-8059-2010; Liang, Gaoyang/L-2087-2013; Xia, Kai/B-7214-2014	Liang, Gaoyang/0000-0002-2157-974X; Xia, Kai/0000-0003-1326-0891; Zhang, Yi/0000-0002-2789-0811	National Institutes of Health through the NIDDK	National Institutes of Health through the NIDDK	This work was supported, in whole or in part, by a National Institutes of Health Beta Cell Biology Consortium project through the NIDDK.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NEWMARK HL, 1994, CANCER LETT, V78, P1, DOI 10.1016/0304-3835(94)90023-X; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	22	109	115	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25516	25521		10.1074/jbc.M110.142059	http://dx.doi.org/10.1074/jbc.M110.142059			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554530	Green Published, hybrid			2022-12-27	WOS:000280682400045
J	Furuya, F; Shimura, H; Yamashita, S; Endo, T; Kobayashi, T				Furuya, Fumihiko; Shimura, Hiroki; Yamashita, Sayaka; Endo, Toyoshi; Kobayashi, Tetsuro			Liganded Thyroid Hormone Receptor-alpha Enhances Proliferation of Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; CYCLE PROGRESSION; CANCER CELLS; MICE; REGENERATION; ACTIVATION; INDUCTION; APOPTOSIS; ISLETS; THYROGLOBULIN	Failure of the functional pancreatic beta-cell mass to expand in response to increased metabolic demand is a hallmark of type 2 diabetes. Lineage tracing studies indicate that replication of existing beta-cells is important for beta-cell proliferation in adult animals. In rat pancreatic beta-cell lines (RIN5F), treatment with 100 nM thyroid hormone (triiodothyronine, T-3) enhances cell proliferation. This result suggests that T-3 is required for beta-cell proliferation or replication. To identify the role of thyroid hormone receptor alpha (TR alpha) in the processes of beta-cell growth and cell cycle regulation, we constructed a recombinant adenovirus vector, AdTR alpha. Infection with AdTR alpha to RIN5F cells increased the expression of cyclin D1 mRNA and protein. Overexpression of the cyclin D1 protein in AdTR alpha-infected cells led to activation of the cyclin D1/cyclin- dependent kinase/retinoblastoma protein/E2F pathway, along with cell cycle progression and cell proliferation following treatment with 100 nM T-3. Conversely, lowering cellular cyclin D1 by small interfering RNA knockdown in AdTR alpha-infected cells led to down-regulation of the cyclin D1/CDK/Rb/E2F pathway and inhibited cell proliferation. Furthermore, in immunodeficient mice with streptozotocin-induced diabetes, intrapancreatic injection of AdTR alpha led to the restoration of islet function and to an increase in the beta-cell mass. These results support the hypothesis that liganded TR alpha plays a critical role in beta-cell replication and in expansion of the beta-cell mass during postnatal development. Thus, liganded TR alpha may be a target for therapeutic strategies that can induce the expansion and regeneration of beta-cells.	[Furuya, Fumihiko; Shimura, Hiroki; Yamashita, Sayaka; Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Dept Internal Med 3, Interdisciplinary Grad Sch Med & Engn, Chuo, Yamanashi 4093898, Japan	University of Yamanashi	Kobayashi, T (corresponding author), 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	tetsurou@yamanashi.ac.jp						Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; CHIN WW, 1994, THYROID, V4, P389, DOI 10.1089/thy.1994.4.389; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Fazio EN, 2007, BIOCHEM BIOPH RES CO, V353, P823, DOI 10.1016/j.bbrc.2006.12.110; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hassani Z, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm152; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Ledda-Columbano GM, 2005, J ENDOCRINOL, V185, P393, DOI 10.1677/joe.1.06110; LENZEN S, 1978, ENDOCRINOLOGY, V103, P1546, DOI 10.1210/endo-103-5-1546; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; O'Shea PJ, 2005, MOL ENDOCRINOL, V19, P3045, DOI 10.1210/me.2005-0224; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P79, DOI 10.1210/jc.76.1.79; Rood PPM, 2006, PHARM RES-DORDR, V23, P227, DOI 10.1007/s11095-005-9095-6; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; Shimura H, 2001, CANCER RES, V61, P3640; Sugden MC, 2008, BIOCHEM SOC T, V36, P891, DOI 10.1042/BST0360891; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; Verga Falzacappa C, 2009, J CELL BIOCHEM, V106, P835, DOI 10.1002/jcb.22045; Ximenes HM, 2007, LIFE SCI, V80, P2045, DOI 10.1016/j.lfs.2007.03.001; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Yu QS, 2008, MOL CELL BIOCHEM, V315, P17, DOI 10.1007/s11010-008-9783-8	39	45	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24477	24486		10.1074/jbc.M109.100222	http://dx.doi.org/10.1074/jbc.M109.100222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529852	hybrid, Green Published			2022-12-27	WOS:000280542100020
J	Gamblin, SJ; Skehel, JJ				Gamblin, Steven J.; Skehel, John J.			Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RECEPTOR-BINDING PROPERTIES; CELL-SURFACE RECEPTOR; A H1N1 VIRUSES; SIALIC-ACID; CLEAVAGE SITE; STALK-LENGTH; SPECIFICITY; RESISTANCE; COMPLEX; GLYCOSYLATION	Considerable progress has been made toward understanding the structural basis of the interaction of the two major surface glycoproteins of influenza A virus with their common ligand/substrate: carbohydrate chains terminating in sialic acid. The specificity of virus attachment to target cells is mediated by hemagglutinin, which acquires characteristic changes in its receptor-binding site to switch its host from avian species to humans. Anti-influenza drugs mimic the natural sialic acid substrate of the virus neuraminidase enzyme but utilize the much tighter binding of the drugs for efficacy. Resistance to one of the two main antiviral drugs is differentially acquired by the two distinct subsets of neuraminidase as a consequence of structural differences in the enzyme active site between the two phylogenetic groups.	[Gamblin, Steven J.; Skehel, John J.] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk; skeheljj@nimr.mrc.ac.uk			MRC [MC_U117584222] Funding Source: UKRI; Medical Research Council [MC_U117584222] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; [Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; BAUM LG, 1990, ACTA HISTOCHEM, P35; BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; COLEMAN MT, 1968, LANCET, V2, P1384; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; COLMAN PM, 1989, INFLUENZA VIRUSES; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gambaryan AS, 1999, VIROLOGY, V258, P232, DOI 10.1006/viro.1999.9732; Gambaryan AS, 2004, VIROLOGY, V326, P310, DOI 10.1016/j.virol.2004.06.002; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Gottschalk, 1959, VIRUSES, V3, P51; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; KLENK E, 1955, H-S Z PHYSIOL CHEM, V301, P235, DOI 10.1515/bchm2.1955.301.1-2.235; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; MONTO AS, 1973, LANCET, V1, P623, DOI 10.1016/S0140-6736(73)92196-X; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SETO JT, 1966, VIROLOGY, V30, P731, DOI 10.1016/0042-6822(66)90178-4; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Takemoto DK, 1996, VIROLOGY, V217, P452, DOI 10.1006/viro.1996.0139; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VARGHESE JN, 1995, PROTEIN SCI, V4, P1081, DOI 10.1002/pro.5560040606; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; WEBSTER RG, 1967, J IMMUNOL, V99, P49; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WRIGHT PF, 2006, FIELDS VIROLOGY, P1691; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	98	384	417	2	121	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28403	28409		10.1074/jbc.R110.129809	http://dx.doi.org/10.1074/jbc.R110.129809			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20538598	Green Published, hybrid			2022-12-27	WOS:000281594000002
J	Li, C; Tan, TW; Zhang, HY; Feng, W				Li, Cong; Tan, Tianwei; Zhang, Haiyang; Feng, Wei			Analysis of the Conformational Stability and Activity of Candida antarctica Lipase B in Organic Solvents INSIGHT FROM MOLECULAR DYNAMICS AND QUANTUM MECHANICS/SIMULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNDAMENTAL PHYSICAL CONSTANTS; CODATA RECOMMENDED VALUES; SUBSTRATE-SPECIFICITY; SECONDARY ALCOHOLS; ENZYME; ENANTIOSELECTIVITY; MEDIA; WATER	The conformational stability and activity of Candida antarctica lipase B (CALB) in the polar and nonpolar organic solvents were investigated by molecular dynamics and quantum mechanics/molecular mechanics simulations. The conformation change of CALB in the polar and nonpolar solvents was examined in two aspects: the overall conformation change of CALB and the conformation change of the active site. The simulation results show that the overall conformation of CALB is stable in the organic solvents. In the nonpolar solvents, the conformation of the active site keeps stable, whereas in the polar solvents, the solvent molecules reach into the active site and interact intensively with the active site. This interaction destroys the hydrogen bonding between Ser(105) and His(224). In the solvents, the activation energy of CALB and that of the active site region were further simulated by quantum mechanics/molecular mechanics simulation. The results indicate that the conformation change in the region of active sites is the main factor that influences the activity of CALB.	[Li, Cong; Tan, Tianwei; Zhang, Haiyang; Feng, Wei] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Tan, TW (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.	twtan@mail.buct.edu.cn; fengwei@mail.buct.edu.cn	Zhang, Haiyang/A-8413-2011; li, cong/X-4978-2019	Zhang, Haiyang/0000-0002-2410-7078	National Science Foundation of China [20636010]; National Basic Research Program of China [2007CB714304]; 863 Program [2009AA033001]; Program for New Century Excellent Talents in University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Science Foundation of China Grant 20636010, National Basic Research Program of China Grant 2007CB714304, 863 Program Grant 2009AA033001, and the Program for New Century Excellent Talents in University.	[Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carlqvist P, 2003, J MOL MODEL, V9, P164, DOI 10.1007/s00894-003-0128-y; Cherukuvada SL, 2005, PLOS COMPUT BIOL, V1, P182, DOI 10.1371/journal.pcbi.0010028; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Kirk O, 2002, ORG PROCESS RES DEV, V6, P446, DOI 10.1021/op0200165; LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112; Lee J, 2000, J BIOMOL STRUCT DYN, V18, P297, DOI 10.1080/07391102.2000.10506667; Magnusson AO, 2005, CHEMBIOCHEM, V6, P1051, DOI 10.1002/cbic.200400410; Mohr PJ, 2000, REV MOD PHYS, V72, P351, DOI 10.1103/RevModPhys.72.351; Mohr PJ, 1999, J PHYS CHEM REF DATA, V28, P1713, DOI 10.1063/1.556049; NORIN M, 1994, BIOPHYS J, V67, P548, DOI 10.1016/S0006-3495(94)80515-6; OTTOSSON J, 2001, ENTHALPY ENTROPY ENZ, pP12; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Rotticci D, 2001, CHEMBIOCHEM, V2, P766, DOI 10.1002/1439-7633(20011001)2:10<766::AID-CBIC766>3.0.CO;2-K; RUSSELL AJ, 1989, BIOCHEM SOC T, V17, P1145, DOI 10.1042/bst0171145; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Speight J.G., 2004, LANGES HDB CHEM, V16th; STAHL M, 1991, J AM CHEM SOC, V113, P9366; STORER JW, 1995, J COMPUT AID MOL DES, V9, P87, DOI 10.1007/BF00117280; TAWAKI S, 1992, J AM CHEM SOC, V114, P1882, DOI 10.1021/ja00031a054; Tejo BA, 2004, J MOL MODEL, V10, P358, DOI 10.1007/s00894-004-0203-z; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Uppenberg J, 1995, BIOCHEMISTRY-US, V34, P16838, DOI 10.1021/bi00051a035; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WESCOTT CR, 1994, BBA-PROTEIN STRUCT M, V1206, P1, DOI 10.1016/0167-4838(94)90065-5; Wescott CR, 1997, BIOTECHNOL BIOENG, V56, P340, DOI 10.1002/(SICI)1097-0290(19971105)56:3<340::AID-BIT12>3.0.CO;2-K; WESCOTT CR, 1993, J AM CHEM SOC, V115, P1629, DOI 10.1021/ja00058a002; ZAKS A, 1986, J AM CHEM SOC, V108, P2767, DOI 10.1021/ja00270a053; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192	32	118	119	3	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28434	28441		10.1074/jbc.M110.136200	http://dx.doi.org/10.1074/jbc.M110.136200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20601697	Green Published, hybrid			2022-12-27	WOS:000281594000006
J	Marcoux, J; Man, P; Petit-Haertlein, I; Vives, C; Forest, E; Fieschi, F				Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck			p47(phox) Molecular Activation for Assembly of the Neutrophil NADPH Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-3 DOMAINS; PHOSPHORYLATION-INDUCED ACTIVATION; TANDEM SH3 DOMAINS; PX DOMAINS; INTRAMOLECULAR INTERACTION; RESTING STATE; NOX-FAMILY; BINDING; P40(PHOX); P67(PHOX)	The p47(phox) cytosolic factor from neutrophilic NADPH oxidase has always been resistant to crystallogenesis trials due to its modular organization leading to relative flexibility. Hydrogen/deuterium exchange coupled to mass spectrometry was used to obtain structural information on the conformational mechanism that underlies p47(phox) activation. We confirmed a relative opening of the protein with exposure of the SH3 Src loops that are known to bind p22(phox) upon activation. A new surface was shown to be unmasked after activation, representing a potential autoinhibitory surface that may block the interaction of the PX domain with the membrane in the resting state. Within this surface, we identified 2 residues involved in the interaction with the PX domain. The double mutant R162A/D166A showed a higher affinity for specific phospholipids but none for the C-terminal part of p22(phox), reflecting an intermediate conformation between the autoinhibited and activated forms.	[Fieschi, Franck] IBS, Direct Sci Vivant, CEA, Lab Prot Membranaires, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Forest, Eric] IBS, Direct Sci Vivant, CEA, Lab Spectrometrie Masse Prote, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck] CNRS, UMR 5075, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck] Univ Grenoble 1, F-38041 Grenoble, France; [Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Vvi, CZ-14220 Prague 4, Czech Republic; Charles Univ Prague, Fac Sci, Dept Biochem, CZ-12840 Prague 2, Czech Republic	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Fieschi, F (corresponding author), IBS, Direct Sci Vivant, CEA, Lab Prot Membranaires, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	franck.fieschi@ibs.fr	Man, Petr/H-2451-2014; Marcoux, Julien/I-3908-2012; Forest, Eric/E-9042-2012; Fieschi, Franck/W-2748-2019	Man, Petr/0000-0002-1485-2197; FIESCHI, Franck/0000-0003-1194-8107; Marcoux, Julien/0000-0001-7321-7436	CEA; Association pour la Recherche sur le Cancer	CEA(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the CEA and the Association pour la Recherche sur le Cancer.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Marcoux J, 2009, FEBS LETT, V583, P835, DOI 10.1016/j.febslet.2009.01.046; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nobuhisa I, 2006, BIOCHEM J, V396, P183, DOI 10.1042/BJ20051899; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TANG J, 1963, NATURE, V199, P1094, DOI 10.1038/1991094a0; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Taylor RA, 2007, BIOCHEMISTRY-US, V46, P14291, DOI 10.1021/bi701626p; Wilson L, 1997, INFLAMM RES, V46, P265, DOI 10.1007/s000110050185; Yuzawa S, 2004, J BIOL CHEM, V279, P29752, DOI 10.1074/jbc.M401457200; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	36	32	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28980	28990		10.1074/jbc.M110.139824	http://dx.doi.org/10.1074/jbc.M110.139824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592030	Green Published, hybrid			2022-12-27	WOS:000281594000063
J	Volpicelli-Daley, LA; Lucast, L; Gong, LW; Liu, LJ; Sasaki, J; Sasaki, T; Abrams, CS; Kanaho, Y; De Camilli, P				Volpicelli-Daley, Laura A.; Lucast, Louise; Gong, Liang-Wei; Liu, Lijuan; Sasaki, Junko; Sasaki, Takehiko; Abrams, Charles S.; Kanaho, Yasunori; De Camilli, Pietro			Phosphatidylinositol-4-Phosphate 5-Kinases and Phosphatidylinositol 4,5-Bisphosphate Synthesis in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-METABOLIZING ENZYMES; LIPID KINASE FAMILY; 4-PHOSPHATE 5-KINASE; INOSITOL POLYPHOSPHATE-5-PHOSPHATASE; PTDINS(4,5)P-2 SYNTHESIS; PSYCHIATRIC-DISORDERS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CANDIDATE GENE; HUMAN-DISEASE	The predominant pathway for phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P-2) synthesis is thought to be phosphorylation of phosphatidylinositol 4-phosphate at the 5 position of the inositol ring by type I phosphatidylinositol phosphate kinases (PIPK): PIPKI alpha, PIPKI beta, and PIPKI gamma. PIPKI gamma has been shown to play a role in PI(4,5)P-2 synthesis in brain, and the absence of PIPKI gamma is incompatible with postnatal life. Conversely, mice lacking PIPKI alpha or PIPKI beta (isoforms are referred to according to the nomenclature of human PIPKIs) live to adulthood, although functional effects in specific cell types are observed. To determine the contribution of PIPKI alpha and PIPKI beta to PI(4,5)P-2 synthesis in brain, we investigated the impact of disrupting multiple PIPKI genes. Our results show that a single allele of PIPKI gamma, in the absence of both PIPKI alpha and PIPKI beta, can support life to adulthood. In addition, PIPKI alpha alone, but not PIPKI beta alone, can support prenatal development, indicating an essential and partially overlapping function of PIPKI alpha and PIPKI gamma during embryogenesis. This is consistent with early embryonic expression of PIPKI alpha and PIPKI gamma but not of PIPKI beta. PIPKI beta expression in brain correlates with neuronal differentiation. The absence of PIPKI beta does not impact embryonic development in the PIPKI gamma knock-out (KO) background but worsens the early postnatal phenotype of the PIPKI gamma KO (death occurs within minutes rather than hours). Analysis of PIP2 in brain reveals that only the absence of PIPKI gamma significantly impacts its levels. Collectively, our results provide new evidence for the dominant importance of PIPKI gamma in mammals and imply that PIPKI alpha and PIPKI beta function in the generation of specific PI(4,5)P-2 pools that, at least in brain, do not have a major impact on overall PI(4,5)P-2 levels.	[De Camilli, Pietro] Howard Hughes Med Inst, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, Chevy Chase, MD USA; [De Camilli, Pietro] Howard Hughes Med Inst, Dept Neurobiol, Program Cellular Neurosci Neurodegenerat & Repair, Chevy Chase, MD USA; [De Camilli, Pietro] Yale Univ, Kavli Inst Neurosci, Sch Med, New Haven, CT 06510 USA; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; [Abrams, Charles S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Dept Med Biol, Grad Sch Med, Akita 010, Japan	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Yale University; University of Tsukuba; University of Tsukuba; University of Pennsylvania; Akita University	De Camilli, P (corresponding author), 295 Congress Ave,BCMM 236, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu		Sasaki, Takehiko/0000-0003-1837-3748	National Institutes of Health [NS36251, DK45735, DA018343]; Yale Center for Genomics and Proteomics; National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Genomics and Proteomics; National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS36251, DK45735, and DA018343 (to P. D. C.). This work was also supported by the Yale Center for Genomics and Proteomics and by a National Alliance for Research on Schizophrenia and Depression distinguished Neuroscience Award (to P. D. C.).	Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Davis JN, 1997, MOL CELL BIOL, V17, P7398, DOI 10.1128/MCB.17.12.7398; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; HOKIN MR, 1953, J BIOL CHEM, V203, P967; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Min Sang H, 2009, Biochem J, V423, pe5, DOI 10.1042/BJ20091274; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Parker G J, 1998, Methods Mol Biol, V105, P127; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Saito T, 2003, AM J MED GENET B, V116B, P77, DOI 10.1002/ajmg.b.10042; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Schurman SJ, 2009, NAT REV NEPHROL, V5, P529, DOI 10.1038/nrneph.2009.124; Soares JC, 2001, NEUROSCI LETT, V299, P150, DOI 10.1016/S0304-3940(00)01775-4; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stopkova P, 2003, AM J MED GENET B, V123B, P50, DOI 10.1002/ajmg.b.20012; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vasudevan L, 2009, J CELL SCI, V122, P2567, DOI 10.1242/jcs.048124; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	63	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28708	28714		10.1074/jbc.M110.132191	http://dx.doi.org/10.1074/jbc.M110.132191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20622009	Green Published, hybrid			2022-12-27	WOS:000281594000036
J	Yang, LK; Manithody, C; Qureshi, SH; Rezaie, AR				Yang, Likui; Manithody, Chandrashekhara; Qureshi, Shabir H.; Rezaie, Alireza R.			Role of the Residues of the 39-Loop in Determining the Substrate and Inhibitor Specificity of Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR IXA; HEPARIN-BINDING EXOSITE; ACTIVATED PROTEIN-C; FACTOR-XA; BLOOD-COAGULATION; BASIC RESIDUES; MOLECULAR-BASIS; PLASMINOGEN-ACTIVATOR; AUTOLYSIS LOOP; ALPHA-THROMBIN	The activation of antithrombin (AT) by heparin facilitates the exosite-dependent interaction of the serpin with factors IXa (FIXa) and Xa (FXa), thereby improving the rate of reactions by 300- to 500-fold. Relative to FXa, AT inhibits FIXa with similar to 40-fold slower rate constant. Structural data suggest that differences in the residues of the 39-loop (residues 31-41) may partly be responsible for the differential reactivity of the two proteases with AT. This loop is highly acidic in FXa, containing three Glu residues at positions 36, 37, and 39. By contrast, the loop is shorter by one residue in FIXa (residue 37 is missing), and it contains a Lys and an Asp at positions 36 and 39, respectively. To determine whether differences in the residues of this loop contribute to the slower reactivity of FIXa with AT, we prepared an FIXa/FXa chimera in which the 39-loop of the protease was replaced with the corresponding loop of FXa. The chimeric mutant cleaved a FIXa- specific chromogenic substrate with normal catalytic efficiency, however, the mutant exhibited similar to 5-fold enhanced reactivity with AT specifically in the absence of the cofactor, heparin. Further studies revealed that the FIXa mutant activates factor X with similar to 4-fold decreased k(cat) and similar to 2-fold decreased K-m, although the mutant interacted normally with factor VIIIa. Based on these results we conclude that residues of the 39-loop regulate the cofactor-independent interaction of FIXa with its physiological inhibitor AT and substrate factor X.	[Yang, Likui; Manithody, Chandrashekhara; Qureshi, Shabir H.; Rezaie, Alireza R.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Qureshi, Shabir H/B-3610-2014		NHLBI, National Institutes of Health [HL68571, HL62565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068571, R01HL062565] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68571 and HL62565 (to A. R. R.) from NHLBI.	Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1982, J BIOL CHEM, V257, P3875; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jenkins PV, 2004, J THROMB HAEMOST, V2, P452, DOI 10.1111/j.1538-7933.2004.00625.x; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MARCUM JA, 1984, BIOCHEMISTRY-US, V23, P1730, DOI 10.1021/bi00303a023; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; Neuenschwander PF, 2006, J BIOL CHEM, V281, P23066, DOI 10.1074/jbc.M603743200; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Rezaie AR, 1998, BIOCHEMISTRY-US, V37, P13138, DOI 10.1021/bi9808518; Rezaie AR, 1996, J BIOL CHEM, V271, P23807, DOI 10.1074/jbc.271.39.23807; Rezaie AR, 2002, J BIOL CHEM, V277, P1235, DOI 10.1074/jbc.M108544200; Rezaie AR, 2001, BBA-GEN SUBJECTS, V1528, P167, DOI 10.1016/S0304-4165(01)00189-1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; THOMPSON AR, 1986, BLOOD, V67, P565; Wiebe EM, 2003, J BIOL CHEM, V278, P35767, DOI 10.1074/jbc.M304803200; Yang LK, 2006, PROTEIN EXPRES PURIF, V50, P196, DOI 10.1016/j.pep.2006.05.012; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	46	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28488	28495		10.1074/jbc.M110.143321	http://dx.doi.org/10.1074/jbc.M110.143321			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20628058	Green Published, hybrid			2022-12-27	WOS:000281594000012
J	Yuan, XQ; Yin, P; Hao, Q; Yan, CY; Wang, JW; Yan, NE				Yuan, Xiaoqiu; Yin, Ping; Hao, Qi; Yan, Chuangye; Wang, Jiawei; Yan, Nieng			Single Amino Acid Alteration between Valine and Isoleucine Determines the Distinct Pyrabactin Selectivity by PYL1 and PYL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; START	Abscisic acid (ABA) is one of the most important phytohormones in plant. PYL proteins were identified to be ABA receptors in Arabidopsis thaliana. Despite the remarkably high degree of sequence similarity, PYL1 and PYL2 exhibit distinct responses toward pyrabactin, an ABA agonist. PYL1 inhibits protein phosphatase type 2C upon binding of pyrabactin. In contrast, PYL2 appears relatively insensitive to this compound. The crystal structure of pyrabactin-bound PYL1 revealed that most of the PYL1 residues involved in pyrabactin binding are conserved, hence failing to explain the selectivity of pyrabactin for PYL1 over PYL2. To understand the molecular basis of pyrabactin selectivity, we determined the crystal structure of PYL2 in complex with pyrabactin at 1.64 angstrom resolution. Structural comparison and biochemical analyses demonstrated that one single amino acid alteration between a corresponding valine and isoleucine determines the distinct pyrabactin selectivity by PYL1 and PYL2. These characterizations provide an important clue to dissecting the redundancy of PYL proteins.	[Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Med, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Med, Rm C329,Med Sci Bldg, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918802]; Tsinghua University; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; Li Foundation	This work was supported by Ministry of Science and Technology Grant 2009CB918802, Tsinghua University 985 Phase II funds, Yuyuan Foundation, and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Hao Q, 2010, J BIOL CHEM, V285, P28946, DOI 10.1074/jbc.M110.149005; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	19	41	48	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28953	28958		10.1074/jbc.M110.160192	http://dx.doi.org/10.1074/jbc.M110.160192			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630864	Green Published, hybrid			2022-12-27	WOS:000281594000060
J	Chen, YJ; Chen, YH; Chow, LP; Tsai, YH; Chen, PH; Huang, CYF; Chen, WT; Hwang, LH				Chen, Yin-Ju; Chen, Yu-Hsuan; Chow, Lu-Ping; Tsai, Ya-Hui; Chen, Pei-Hong; Huang, Chi-Ying F.; Chen, Wei-Tzu; Hwang, Lih-Hwa			Heat Shock Protein 72 Is Associated with the Hepatitis C Virus Replicase Complex and Enhances Viral RNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; NS5A PROTEIN; CELL-CULTURE; ANTIVIRAL ACTIVITY; HSP70 CHAPERONES; INTERFERON; EXPRESSION; KINASE; IDENTIFICATION; MUTATIONS	The NS5A protein of the hepatitis C virus (HCV) is an integral component of the viral replicase. It also modulates cellular signaling and perturbs host interferon responses. The multifunctional characteristics of NS5A are mostly attributed to its ability to interact with various cellular proteins. This study aimed to identify the novel cellular factors that interact with NS5A and decipher the significance of this interaction in viral replication. The NS5A-interacting proteins were purified by the tandem affinity purification (TAP) procedure from cells expressing NS5A and identified by mass spectrometry. The chaperone protein Hsp72 was identified herein. In vivo protein-protein interaction was verified by co-immunoprecipitation and an in situ proximity ligation assay. In addition to NS5A, Hsp72 was also associated with other members of the replicase complex, NS3 and NS5B, suggesting that it might be directly involved in the HCV replication complex. Hsp72 plays a positive regulatory role in HCV RNA replication by increasing levels of the replicase complex, which was attributed either to the increased stability of the viral proteins in the replicase complex or to the enhanced translational activity of the internal ribosome entry site of HCV. The fact that the host chaperone protein Hsp72 is involved in HCV RNA replication may represent a therapeutic target for controlling virus production.	[Hwang, Lih-Hwa] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Chen, Wei-Tzu] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Hwang, LH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	lhhwang@ym.edu.tw	Huang, Chi-Ying/AAG-7672-2022; Huang, Chi-Ying/AFL-7729-2022	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; CHOW, LU-PING/0000-0002-4420-211X; TSAI, YA-HUI/0000-0002-7913-6415	National Science Council of the Republic of China [NSC 97-2320-B-010-031-MY3]; Ministry of Education, Aim for the Top University Plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by Grant NSC 97-2320-B-010-031-MY3 from the National Science Council of the Republic of China and in part by a grant from Ministry of Education, Aim for the Top University Plan.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2003, ANTIVIR RES, V60, P91, DOI 10.1016/j.antiviral.2003.08.016; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass Volker, 2006, Int J Med Sci, V3, P29; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; Choi Yook-Wah, 2004, Biochemical and Biophysical Research Communications, V318, P514, DOI 10.1016/j.bbrc.2004.04.052; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Elazar M, 2003, J VIROL, V77, P6055, DOI 10.1128/JVI.77.10.6055-6061.2003; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Georgopoulou U, 2006, BIOCHIMIE, V88, P651, DOI 10.1016/j.biochi.2005.12.003; Ghosh AK, 2003, VIROLOGY, V306, P51, DOI 10.1016/S0042-6822(02)00029-6; Gong GZ, 2007, WORLD J GASTROENTERO, V13, P4080, DOI 10.3748/wjg.v13.i30.4080; Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232; He YP, 2003, J GEN VIROL, V84, P535, DOI 10.1099/vir.0.18658-0; Inubushi S, 2008, J GEN VIROL, V89, P1231, DOI 10.1099/vir.0.83510-0; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song J, 1999, J GEN VIROL, V80, P879, DOI 10.1099/0022-1317-80-4-879; Taguchi T, 2004, J GEN VIROL, V85, P959, DOI 10.1099/vir.0.19513-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Thomson BJ, 2005, CLIN MICROBIOL INFEC, V11, P86, DOI 10.1111/j.1469-0691.2004.01061.x; Tsai YH, 2008, J HEPATOL, V49, P899, DOI 10.1016/j.jhep.2008.06.030; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhang ZB, 2008, J VIROL, V82, P5761, DOI 10.1128/JVI.00064-08	53	49	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28183	28190		10.1074/jbc.M110.118323	http://dx.doi.org/10.1074/jbc.M110.118323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20601427	Green Published, hybrid			2022-12-27	WOS:000281404100061
J	Eriksen, J; Bjorn-Yoshimoto, WE; Jorgensen, TN; Newman, AH; Gether, U				Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Newman, Amy Hauck; Gether, Ulrik			Postendocytic Sorting of Constitutively Internalized Dopamine Transporter in Cell Lines and Dopaminergic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MONOAMINE TRANSPORTERS; STRIATAL SYNAPTOSOMES; MEMBRANE TRAFFICKING; RECYCLING PATHWAY; UBIQUITINATION; ENDOCYTOSIS; IDENTIFICATION; GLUTAMATE; MECHANISM	The dopamine transporter (DAT) mediates reuptake of released dopamine and is the target for psychostimulants, such as cocaine and amphetamine. DAT undergoes marked constitutive endocytosis, but little is known about the fate and sorting of the endocytosed transporter. To study DAT sorting in cells lines, we fused the one-transmembrane segment protein Tac to DAT, thereby generating a transporter (TacDAT) with an extracellular antibody epitope suited for trafficking studies. TacDAT was functional and endocytosed constitutively in HEK293 cells. According to an ELISA-based assay, TacDAT intracellular accumulation was increased by the lysosomal protease inhibitor leupeptin and by monensin, an inhibitor of lysosomal degradation and recycling. Monensin also reduced TacDAT surface expression consistent with partial recycling. In both HEK293 cells and in the dopaminergic cell line 1Rb3An27, constitutively internalized TacDAT displayed primary co-localization with the late endosomal marker Rab7, less co-localization with the "short loop" recycling marker Rab4, and little co-localization with the marker of "long loop" recycling endosomes, Rab11. Removal by mutation of N-terminal ubiquitination sites did not affect this sorting pattern. The sorting pattern was distinct from a bona fide recycling membrane protein, the beta 2-adrenergic receptor, that co-localized primarily with Rab11 and Rab4. Constitutively internalized wild type DAT probed with the fluorescently tagged cocaine analogue JHC 1-64, exhibited the same co-localization pattern as TacDAT in 1Rb3An27 cells and in cultured midbrain dopaminergic neurons. We conclude that DAT is constitutively internalized and sorted in a ubiquitination-independent manner to late endosomes/lysosomes and in part to a Rab4 positive short loop recycling pathway.	[Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Gether, Ulrik] Panum Inst, Dept Neurosci & Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen N, Denmark; [Eriksen, Jacob; Bjorn-Yoshimoto, Walden Emil; Jorgensen, Trine Nygaard; Gether, Ulrik] Panum Inst, Dept Neurosci & Pharmacol, Ctr Pharmacogen, DK-2200 Copenhagen N, Denmark; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Gether, U (corresponding author), Panum Inst, Dept Neurosci & Pharmacol, Mol Neuropharmacol Grp, 18-6 Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Bjørn-Yoshimoto, Walden/ABH-3709-2020	Eriksen, Jacob/0000-0003-0726-9769; Bjorn-Yoshimoto, Walden Emil/0000-0003-1019-9239; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; National Institute on Drug Abuse; Lundbeck Foundation; Danish Medical Research Councils; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Councils(Danish Medical Research Council); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.) and by the National Institute on Drug Abuse Intramural Research Program (to A. H. N.). This work was also supported by the Lundbeck Foundation (to U. G.), the Danish Medical Research Councils (to U. G.), and "Fabrikant Vilhelm Pedersen og Hustrus Mindelegat" (to U. G.).	Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Chmelar RS, 2006, J BIOL CHEM, V281, P35381, DOI 10.1074/jbc.M605954200; Colgan L, 2007, TRAFFIC, V8, P512, DOI 10.1111/j.1600-0854.2007.00555.x; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; DIPORZIO U, 1980, NATURE, V288, P370, DOI 10.1038/288370a0; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Moron JA, 2003, J NEUROSCI, V23, P8480; Mortensen OV, 2008, MOL BIOL CELL, V19, P2818, DOI 10.1091/mbc.E07-09-0980; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zhu SJ, 1997, J PHARMACOL EXP THER, V282, P1358	61	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27289	27301		10.1074/jbc.M110.131003	http://dx.doi.org/10.1074/jbc.M110.131003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20551317	hybrid, Green Published			2022-12-27	WOS:000281172700059
J	Prasad, S; Yadav, VR; Sundaram, C; Reuter, S; Hema, PS; Nair, MS; Chaturvedi, MM; Aggarwal, BB				Prasad, Sahdeo; Yadav, Vivek R.; Sundaram, Chitra; Reuter, Simone; Hema, Padmanabhan S.; Nair, Mangalam S.; Chaturvedi, Madan M.; Aggarwal, Bharat B.			RETRACTED: Crotepoxide Chemosensitizes Tumor Cells through Inhibition of Expression of Proliferation, Invasion, and Angiogenic Proteins Linked to Proinflammatory Pathway (Retracted article. See vol. 291, pg. 16921, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NF-KAPPA-B; ALPHA KINASE ACTIVATION; NECROSIS-FACTOR; CYCLOHEXANE DIEPOXIDE; TRANSCRIPTION FACTOR; KAEMPFERIA-ROTUNDA; GENE-PRODUCTS; CROTON MACROSTACHYS; PROSTATE-CANCER; TYROSINE KINASE	Crotepoxide (a substituted cyclohexane diepoxide), isolated from Kaempferia pulchra (peacock ginger), although linked to antitumor and anti-inflammatory activities, the mechanism by which it exhibits these activities, is not yet understood. Because nuclear factor kappa B (NF-kappa B) plays a critical role in these signaling pathways, we investigated the effects of crotepoxide on NF-kappa B-mediated cellular responses in human cancer cells. We found that crotepoxide potentiated tumor necrosis factor (TNF), and chemotherapeutic agents induced apoptosis and inhibited the expression of NF-kappa B-regulated gene products involved in anti-apoptosis (Bcl-2, Bcl-xL, IAP1,(2) MCl-1, survivin, and TRAF1), apoptosis (Bax, Bid), inflammation (COX-2), proliferation (cyclin D1 and c-myc), invasion (ICAM-1 and MMP-9), and angiogenesis (VEGF). We also found that crotepoxide inhibited both inducible and constitutive NF-kappa B activation. Crotepoxide inhibition of NF-kappa B was not inducer-specific; it inhibited NF-kappa B activation induced by TNF, phorbol 12-myristate 13-acetate, lipopolysaccharide, and cigarette smoke. Crotepoxide suppression of NF-kappa B was not cell type-specific because NF-kappa B activation was inhibited in myeloid, leukemia, and epithelial cells. Furthermore, we found that crotepoxide inhibited TAK1 activation, which led to suppression of I kappa B alpha kinase, abrogation of I kappa B alpha phosphorylation and degradation, nuclear translocation of p65, and suppression of NF-kappa B-dependent reporter gene expression. Overall, our results indicate that crotepoxide sensitizes tumor cells to cytokines and chemotherapeutic agents through inhibition of NF-kappa B and NF-kappa B-regulated gene products, and this may provide the molecular basis for crotepoxide ability to suppress inflammation and carcinogenesis.	[Prasad, Sahdeo; Yadav, Vivek R.; Sundaram, Chitra; Reuter, Simone; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Hema, Padmanabhan S.; Nair, Mangalam S.] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013; MSN, Nair/F-9473-2013		National Institutes of Health [CA-124787-01A2, CA-16 672]; Clayton Foundation for Research; Center for Targeted Therapy of the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P01CA124787, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-124787-01A2 (a program project grant) and CA-16 672 (a core grant). This work was also supported by grants from the Clayton Foundation for Research (to B. B. A.) and the Center for Targeted Therapy of the MD Anderson Cancer Center.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; CHATURVEDI MM, 1994, J BIOL CHEM, V269, P14575; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DEMUTH MR, 1976, J AM CHEM SOC, V98, P634, DOI 10.1021/ja00418a065; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Han G. Q., 1989, Acta Pharmaceutica Sinica, V24, P438; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Joseph CC, 2007, NAT PROD RES, V21, P1009, DOI 10.1080/14786410701194310; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KUPCHAN SM, 1968, J AM CHEM SOC, V90, P2982, DOI 10.1021/ja01013a056; KUPCHAN SM, 1969, J ORG CHEM, V34, P3898, DOI 10.1021/jo01264a033; Lin LC, 2006, J NAT PROD, V69, P842, DOI 10.1021/np0505521; Lotulung Puspa D N, 2008, Pak J Biol Sci, V11, P2447, DOI 10.3923/pjbs.2008.2447.2450; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; Mulholland D, 2000, BIOCHEM SYST ECOL, V28, P595, DOI 10.1016/S0305-1978(99)00099-X; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; NELSEN B, 1988, MOL CELL BIOL, V8, P3526, DOI 10.1128/MCB.8.8.3526; PAI BR, 1970, INDIAN J CHEM, V8, P468; PANCHAROEN O, 1989, PHYTOCHEMISTRY, V28, P1143, DOI 10.1016/0031-9422(89)80198-0; Pancharoen O, 1996, PHYTOCHEMISTRY, V43, P305, DOI 10.1016/0031-9422(96)00218-X; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Partha P, 2007, BANGL J PLANT TAXON, V14, P129; Politi C, 2008, NEUROPATH APPL NEURO, V34, P357, DOI 10.1111/j.1365-2990.2007.00901.x; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Shishodia Shishir, 2004, Cancer Treat Res, V119, P139; Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stevenson PC, 2007, PHYTOCHEMISTRY, V68, P1579, DOI 10.1016/j.phytochem.2007.03.015; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Takada Y, 2003, J BIOL CHEM, V278, P23390, DOI 10.1074/jbc.M213237200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; TANEJA SC, 1991, PHYTOCHEMISTRY, V30, P871, DOI 10.1016/0031-9422(91)85269-6; THEVENIN C, 1990, New Biologist, V2, P793; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328; Zerbini LF, 2003, CANCER RES, V63, P2206	55	16	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26987	26997		10.1074/jbc.M110.121061	http://dx.doi.org/10.1074/jbc.M110.121061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576605	Green Published, hybrid			2022-12-27	WOS:000281172700030
J	Monzon, ME; Fregien, N; Schmid, N; Falcon, NS; Campos, M; Casalino-Matsuda, SM; Forteza, RM				Monzon, Maria E.; Fregien, Nevis; Schmid, Nathalie; Falcon, Nieves S.; Campos, Michael; Casalino-Matsuda, S. Marina; Forteza, Rosanna Malbran			Reactive Oxygen Species and Hyaluronidase 2 Regulate Airway Epithelial Hyaluronan Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; FACTOR RECEPTOR ACTIVATION; PHOSPHOLIPASE-D; PROTEIN-KINASE; IN-VITRO; EXPRESSION; CELLS; INFLAMMATION; DEGRADATION; SYNTHESIZE	Hyaluronidase 2 (Hyal2) is a hyaluronan (HA)-degrading enzyme found intracellularly or/and anchored to the plasma membrane through glycosylphosphatidylinositol (GPI). Normal human bronchial epithelial cells (NHBE) grown at the air-liquid interphase (ALI), treated with PI-specific phospholipase C (PIPLC), exhibited increased Hyal activity in secretions and decreased protein and activity on the apical membrane, confirming that GPI-anchored Hyal2 is expressed in NHBE cells and it remains active in its soluble form. We have reported that HA degradation was mediated by reactive oxygen species (ROS) in human airways. Here we show that ROS increase Hyal2 expression and activity in NHBE cells and that the p38MAPK signaling pathway is involved in this effect. Hyal2 induction was confirmed by using small interfering RNA (siRNA) expressing lentivirus. These in vitro findings correlated in vivo with smokers, where increased Hyal2 immunoreactivity in the epithelium was associated with augmented levels of HA and the appearance of low molecular mass HA species in bronchial secretions. In summary, this work provides evidence that ROS induce Hyal2, suggesting that Hyal2 is likely responsible for the sustained HA fragmentation in the airway lumen observed in inflammatory conditions associated with oxidative stress.	[Casalino-Matsuda, S. Marina; Forteza, Rosanna Malbran] Univ Miami, Miller Sch Med, Div Pulm Crit Care Sleep Med, Miami, FL 33136 USA; [Fregien, Nevis] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA	University of Miami; University of Miami	Monzon, ME (corresponding author), Univ Miami, Div Pulm & Crit Care, Miller Sch Med, 1600 NW 10th Ave, Miami, FL 33136 USA.	mmonzonmedina@med.miami.edu; RForteza@med.miami.edu	Matsuda, Marina/AAH-2959-2019; Campos, Michael/X-2025-2019	Matsuda, Marina/0000-0002-7566-4560; Campos, Michael/0000-0001-5485-9062	National Institutes of Health [HL-073156]; Flight Attendant Medical Research Institute (FAMRI); James and Esther King Foundation [JEK12292]; AHA; JEK [12324]; American Lung Association of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); James and Esther King Foundation; AHA(American Heart Association); JEK; American Lung Association of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-073156. This work was also supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (FAMRI) (to M. E. M.), a Bridge Award from the James and Esther King Foundation (JEK12292), and a Clinical Innovator Award from FAMRI (to R.M.F.); a Scientist Development Grant from AHA and JEK (12324) (to S. M. C.-M.), a Career Development Award from the American Lung Association of Florida, and a Clinical Innovator Award from FAMRI (to N.S.F.).	Al-Assaf S, 2006, FREE RADICAL BIO MED, V40, P2018, DOI 10.1016/j.freeradbiomed.2006.01.033; BASBAUM CB, 1988, HORM METAB RES, V20, P661, DOI 10.1055/s-2007-1010912; Bassa BV, 1999, AM J PHYSIOL-RENAL, V277, pF328, DOI 10.1152/ajprenal.1999.277.3.F328; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Blundell C.D., 2004, CHEM BIOL HYALURONAN; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; BREWIS IA, 1994, BIOCHEM J, V303, P633, DOI 10.1042/bj3030633; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P342; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; DAY AJ, 2001, GLYCOFORUM; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; FORTEZA RM, 2002, GLYCOFORUM; Frati E, 1997, FREE RADICAL BIO MED, V22, P1139, DOI 10.1016/S0891-5849(96)00525-4; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; JEFFERY PK, 1992, RESPIRATION, V59, P13; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; MAGUIRE GA, 1995, ANN CLIN BIOCHEM, V32, P74, DOI 10.1177/000456329503200107; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Miller AD, 2008, SEMIN CANCER BIOL, V18, P296, DOI 10.1016/j.semcancer.2008.03.010; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; O'Brien KD, 1999, CIRCULATION, V99, P2876, DOI 10.1161/01.CIR.99.22.2876; Pardue Erin L, 2008, Organogenesis, V4, P203; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Salustri A, 1999, HUM REPROD UPDATE, V5, P293, DOI 10.1093/humupd/5.4.293; Sinn PL, 2005, HUM GENE THER, V16, P479, DOI 10.1089/hum.2005.16.479; Skold CM, 1996, RESP MED, V90, P523, DOI 10.1016/S0954-6111(96)90144-4; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	65	80	80	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26126	26134		10.1074/jbc.M110.135194	http://dx.doi.org/10.1074/jbc.M110.135194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554532	hybrid, Green Published			2022-12-27	WOS:000280921000030
J	Satow, R; Shitashige, M; Jigami, T; Honda, K; Ono, M; Hirohashi, S; Yamada, T				Satow, Reiko; Shitashige, Miki; Jigami, Takafumi; Honda, Kazufumi; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi			Traf2-and Nck-interacting Kinase Is Essential for Canonical Wnt Signaling in Xenopus Axis Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; COLORECTAL-CANCER; TARGET GENES; EMBRYOS; EXPRESSION; PATHWAY; COMPLEX; DORSAL; CELLS; TNIK	Wnt signaling pathways play important roles in various stages of developmental events and several aspects of adult homeostasis. Aberrant activation of Wnt signaling has also been associated with several types of cancer. We have recently identified Traf2- and Nck-interacting kinase (TNIK) as a novel activator of Wnt signaling through a comprehensive proteomic approach in human colorectal cancer cell lines. TNIK is an activating kinase for T-cell factor-4 (TCF4) and essential for the beta-catenin-TCF4 transactivation and colorectal cancer growth. Here, we report the essential role of TNIK in Wnt signaling during Xenopus development. We found that Xenopus TNIK (XTNIK) was expressed maternally and that the functional knockdown of XTNIK by catalytically inactive XTNIK (K54R) or antisense morpholino oligonucleotides resulted in significant malformations with a complete loss of head and axis structures. XTNIK enhanced beta-catenin-induced axis duplication and the expression of beta-catenin-TCF target genes, whereas knockdown of XTNIK inhibited it. XTNIK was recruited to the promoter region of beta-catenin-TCF target genes in a beta-catenin-dependent manner. These results demonstrate that XTNIK is an essential factor for the transcriptional activity of the beta-catenin-TCF complex and dorsal axis determination in Xenopus embryos.	[Satow, Reiko; Shitashige, Miki; Jigami, Takafumi; Honda, Kazufumi; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi] Natl Canc Ctr, Div Chemotherapy, Chuo Ku, Tokyo 1040045, Japan	National Cancer Center - Japan	Satow, R (corresponding author), Natl Canc Ctr, Div Chemotherapy, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	resato@ncc.go.jp		Satow, Reiko/0000-0002-6339-4268	National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor, and Welfare of Japan	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the "Program for Promotion of Fundamental Studies in Health Sciences" conducted by the National Institute of Biomedical Innovation of Japan and the "Third-Term Comprehensive Control Research for Cancer" and "Research on Biological Markers for New Drug Development" conducted by the Ministry of Health, Labor, and Welfare of Japan.	Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Fan MJ, 1998, P NATL ACAD SCI USA, V95, P5626, DOI 10.1073/pnas.95.10.5626; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Haramoto Y, 2004, DEV BIOL, V265, P155, DOI 10.1016/j.ydbio.2003.09.015; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Houston DW, 2002, DEVELOPMENT, V129, P4015; Huang L, 2007, GASTROENTEROLOGY, V133, P1569, DOI 10.1053/j.gastro.2007.08.011; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Shitashige M, 2008, GASTROENTEROLOGY, V134, P1961, DOI 10.1053/j.gastro.2008.03.010; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434	27	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26289	26294		10.1074/jbc.M109.090597	http://dx.doi.org/10.1074/jbc.M109.090597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566648	Green Published, hybrid			2022-12-27	WOS:000280921000046
J	Sun, XX; Wang, YG; Xirodimas, DP; Dai, MS				Sun, Xiao-Xin; Wang, Yue-Gang; Xirodimas, Dimitris P.; Dai, Mu-Shui			Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5-and L11-dependent p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; CELL-CYCLE ARREST; ONCOPROTEIN MDM2; NUCLEOLAR DISRUPTION; C-MYC; L11; INHIBITION; PATHWAY; UBIQUITINATION; CANCER	Ribosomal proteins play an important role in p53 activation in response to nucleolar stress. Multiple ribosomal proteins, including L5, L11, L23, and S7, have been shown to bind to and inhibit MDM2, leading to p53 activation. However, it is not clear whether ribosomal protein regulation of MDM2 is specific to some, but not all ribosomal proteins. Here we show that L29 and L30, two ribosomal proteins from the 60 S ribosomal subunit, do not bind to MDM2 and do not inhibit MDM2-mediated p53 suppression, indicating that the ribosomal protein regulation of the MDM2-p53 feedback loop is specific. Interestingly, direct perturbation of the 60 S ribosomal biogenesis by knocking down either L29 or L30 drastically induced the level and activity of p53, leading to p53-depedent cell cycle arrest. This p53 activation was drastically inhibited by knockdown of L11 or L5. Consistently, knockdown of L29 or L30 enhanced the interaction of MDM2 with L11 and L5 and markedly inhibited MDM2-mediated p53 ubiquitination, suggesting that direct perturbation of 60 S ribosomal biogenesis activates p53 via L11- and L5-mediated MDM2 suppression. Mechanistically, knockdown of L30 or L29 significantly increased the NEDDylation and nuclear retention of L11. Knocking down endogenous NEDD8 suppressed p53 activation induced by knockdown of L30. These results demonstrate that NEDDylation of L11 plays a critical role in mediating p53 activation in response to perturbation of ribosomal biogenesis.	[Dai, Mu-Shui] Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Xirodimas, Dimitris P.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	Oregon Health & Science University; Oregon Health & Science University; University of Dundee	Dai, MS (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Mol & Med Genet, Portland, OR 97239 USA.	daim@ohsu.edu		Xirodimas, Dimitris/0000-0001-9275-1140	NCI [R00 CA127134]; Medical Research Foundation of Oregon; Oregon Health & Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA127134] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Foundation of Oregon; Oregon Health & Science University; OHSU Knight Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 CA127134 from the NCI. This work was also supported by a grant from Medical Research Foundation of Oregon and a startup fund from Oregon Health & Science University (to M.-S. D.).; A recipient of a Cancer Research Development Award from the OHSU Knight Cancer Institute.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DEOCALUNA R, 1995, NATURE, V0378; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mekhail K, 2005, J CELL BIOL, V170, P733, DOI 10.1083/jcb.200506030; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	46	61	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25812	25821		10.1074/jbc.M109.098442	http://dx.doi.org/10.1074/jbc.M109.098442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554519	Green Published, hybrid			2022-12-27	WOS:000280682400073
J	Ahmed, IS; Rohe, HJ; Twist, KE; Craven, RJ				Ahmed, Ikhlas S.; Rohe, Hannah J.; Twist, Katherine E.; Craven, Rolf J.			Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILES; HEME-1 DOMAIN PROTEIN; BREAST-CANCER CELLS; LUNG-CANCER; TYROSINE KINASE; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; ANTIAPOPTOTIC ACTION; ESTROGEN-RECEPTOR	Tumorigenesis requires the concerted action of multiple pathways, including pathways that stimulate proliferation and metabolism. Epidermal growth factor receptor (EGFR) is a transmembrane receptor-tyrosine kinase that is associated with cancer progression, and the EGFR inhibitors erlotinib/tarceva and tyrphostin/AG-1478 are potent anti-cancer therapeutics. Pgrmc1 (progesterone receptor membrane component 1) is a cytochrome b(5)-related protein that is up-regulated in tumors and promotes cancer growth. Pgrmc1 and its homologues have been implicated in cell signaling, and we show here that Pgrmc1 increases susceptibility to AG-1478 and erlotinib, increases plasma membrane EGFR levels, and co-precipitates with EGFR. Pgrmc1 co-localizes with EGFR in cytoplasmic vesicles and co-fractionates with EGFR in high density microsomes. The findings have therapeutic potential because a Pgrmc1 small molecule ligand, which inhibits growth in a variety of cancer cell types, de-stabilized EGFR in multiple tumor cell lines. EGFR is one of the most potent receptor-tyrosine kinases driving tumorigenesis, and our data support a role for Pgrmc1 in promoting several cancer phenotypes at least in part by binding EGFR and stabilizing plasma membrane pools of the receptor.	[Ahmed, Ikhlas S.; Rohe, Hannah J.; Twist, Katherine E.; Craven, Rolf J.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA.	rolf.craven@uky.edu			American Cancer Society [85-001-19-IRG]; Kentucky Lung Cancer Research Program	American Cancer Society(American Cancer Society); Kentucky Lung Cancer Research Program	This work was supported in part by American Cancer Society Grant 85-001-19-IRG and by the Kentucky Lung Cancer Research Program.	Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Bareschino MA, 2007, ANN ONCOL, V18, P35, DOI 10.1093/annonc/mdm222; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Craven RJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2191; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Difilippantonio S, 2003, EUR J CANCER, V39, P1936, DOI 10.1016/S0959-8049(03)00419-2; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Furukawa M, 2007, DNA CELL BIOL, V26, P178, DOI 10.1089/dna.2006.0573; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; GOLDENBERG A, 1989, J NATL CANCER I, V81, P1616, DOI 10.1093/jnci/81.21.1616; Hand RA, 2003, J CELL BIOCHEM, V90, P534, DOI 10.1002/jcb.10648; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Irby RB, 2005, CANCER RES, V65, P1814, DOI 10.1158/0008-5472.CAN-04-3609; Jaramillo ML, 2008, CANCER BIOL THER, V7, P557, DOI 10.4161/cbt.7.4.5533; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Nagy P, 2003, EXP CELL RES, V285, P39, DOI 10.1016/S0014-4827(02)00050-2; Neubauer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2155; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2005, BIOL REPROD, V73, P261, DOI 10.1095/biolreprod.105.041061; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Peluso JJ, 2009, ENDOCRINOLOGY, V150, P4846, DOI 10.1210/en.2009-0730; Ritter CA, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50027; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Runko E, 2004, J NEUROSCI, V24, P9015, DOI 10.1523/JNEUROSCI.2385-04.2004; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Thompson AM, 2007, BIOCHEMISTRY-US, V46, P14629, DOI 10.1021/bi7013739; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Wang T, 2007, CANCER SCI, V98, P506, DOI 10.1111/j.1349-7006.2007.00428.x; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Zhang Min, 2005, Genet Vaccines Ther, V3, P5, DOI 10.1186/1479-0556-3-5	54	100	102	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24775	24782		10.1074/jbc.M110.134585	http://dx.doi.org/10.1074/jbc.M110.134585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20538600	Green Published, hybrid			2022-12-27	WOS:000280542100050
J	Jones, MB; Nasirikenari, M; Feng, L; Migliore, MT; Choi, KS; Kazim, L; Lau, JTY				Jones, Mark B.; Nasirikenari, Mehrab; Feng, Li; Migliore, Marina T.; Choi, Kyoung-Soo; Kazim, Latif; Lau, Joseph T. Y.			Role for Hepatic and Circulatory ST6Gal-1 Sialyltransferase in Regulating Myelopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; SERUM SIALYLTRANSFERASE; BETA-SECRETASE; P1 PROMOTER; RAT-LIVER; IN-VIVO; INFLAMMATION; SIALYLATION; EXPRESSION; MICE	Recent findings have established a role for the ST6Gal-1 sialyltransferase in modulating inflammatory cell production during Th1 and Th2 responses. ST6Gal-1 synthesizes the Sia(alpha 2,6) to Gal(beta 1,4) GlcNAc linkage on glycoproteins on cell surfaces and in systemic circulation. Engagement of P1, one of six promoter/regulatory regions driving murine ST6Gal-1 gene expression, generates the ST6Gal-1 for myelopoietic regulation. P1 utilization, however, is restricted to the liver and silent in hematopoietic cells. We considered the possibility that myelopoiesis is responsive to the sialylation of liver-derived circulatory glycoproteins, such that reduced alpha 2,6-sialylation results in elevated myelopoiesis. However, 2-dimensional differential in gel electrophoresis (2D-DIGE) analysis disclosed only minimal alterations in the sialylation of sera glycoproteins of ST6Gal-1deficient mice when compared with wild-type controls, either at baseline or during an acute phase response when the demand for sialylation is greatest. Furthermore, sera from ST6Gal-1-deficient animals did not enhance myelopoietic activity in ex vivo colony formation assays. Whereas there was only minimal consequence to the alpha 2,6-sialylation of circulatory glycoproteins, ablation of the P1 promoter did result in strikingly depressed levels of ST6Gal-1 released into systemic circulation. Therefore, we considered the alternative possibility that myelopoiesis may be regulated not by the hepatic sialyl glycoproteins, but by the ST6Gal-1 that was released directly into circulation. Supporting this, ex vivo colony formation was notably attenuated upon introduction of physiologic levels of ST6Gal-1 into the culture medium. Our data support the idea that circulatory ST6Gal-1, mostly of hepatic origin, limits myelopoiesis by a mechanism independent of hepatic sialylation of serum glycoproteins.	[Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, MRC330, Buffalo, NY 14263 USA; [Migliore, Marina T.; Choi, Kyoung-Soo; Kazim, Latif] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, MRC330, Elm & Carlton St, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Institutes of Health [AI056082, AI078429]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078429, R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health the P1-mediated pool of ST6Gal-1 in the regulation of myeloGrant AI056082 (to J.T.Y.L.) and National Institutes of Health Grant AI078429 (to J.T.Y.L.).	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; CHANDRASEKARAN EV, 1995, BIOCHEMISTRY-US, V34, P2925, DOI 10.1021/bi00009a024; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; EVANS IM, 1980, CANCER RES, V40, P3103; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Gracheva EV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1315; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; IP C, 1978, CANCER RES, V38, P723; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2004, GLYCOCONJUGATE J, V21, P25, DOI 10.1023/B:GLYC.0000043743.21735.ff; Kitazume S, 2003, GLYCOCONJUGATE J, V20, P59, DOI 10.1023/B:GLYC.0000016743.25495.45; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; LAMMERS G, 1986, COMP BIOCHEM PHYS B, V84, P181, DOI 10.1016/0305-0491(86)90203-8; Maguire TM, 1998, BBA-GEN SUBJECTS, V1379, P23, DOI 10.1016/S0304-4165(97)00077-9; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Thorne-Tjomsland G, 2000, TRANSPLANTATION, V69, P806; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WOLOSKI BMRNJ, 1985, BIOCHEM BIOPH RES CO, V130, P30, DOI 10.1016/0006-291X(85)90377-8; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068	36	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					25009	25017		10.1074/jbc.M110.104406	http://dx.doi.org/10.1074/jbc.M110.104406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529847	hybrid, Green Published			2022-12-27	WOS:000280542100073
J	Zhao, M; Li, XD; Chen, ZJ				Zhao, Meng; Li, Xiao-Dong; Chen, Zhijian			CC2D1A, a DM14 and C2 Domain Protein, Activates NF-kappa B through the Canonical Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; GROWTH-FACTOR; UBIQUITIN; GENE; CYLD; IKK; IDENTIFICATION; TRAFFICKING; DROSOPHILA; KINASE	CC2D1A is an evolutionarily conserved protein that contains four DM14 domains at the N terminus and a C2 domain at the C terminus. Loss-of-function mutations in CC2D1A have been linked to mental retardation in human, but the biochemical function of this protein is largely unknown. Here, we show that CC2D1A is a potent activator of NF-kappa B. The activation of NF-kappa B by CC2D1A requires its C2 domain. CC2D1A activates NF-kappa B in a manner that depends on the ubiquitin-conjugating enzyme Ubc13, TNF receptor-associated factor TRAF2, the protein kinase TAK1, and the I kappa B kinase (IKK) complex. In addition, the deubiquitination enzyme Cylindromatosis (CYLD) negatively regulates the activity of CC2D1A. These results suggest that CC2D1A activates NF-kappa B through the canonical IKK pathway.	[Zhao, Meng; Li, Xiao-Dong; Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	National Institutes of Health [RO1AI060919]; Welch Foundation [I-1389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI060919. This work was also supported by Welch Foundation Grant I-1389.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ou XM, 2003, J NEUROSCI, V23, P7415; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wilkinson KD, 2004, CELL, V119, P741, DOI 10.1016/S0092-8674(04)01154-7; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	27	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24372	24380		10.1074/jbc.M109.100057	http://dx.doi.org/10.1074/jbc.M109.100057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20529849	Green Published, hybrid			2022-12-27	WOS:000280542100008
J	Poillot, C; Dridi, K; Bichraoui, H; Pecher, J; Alphonse, S; Douzi, B; Ronjat, M; Darbon, H; De Waard, M				Poillot, Cathy; Dridi, Kaouthar; Bichraoui, Hicham; Pecher, Julien; Alphonse, Sebastien; Douzi, Badreddine; Ronjat, Michel; Darbon, Herve; De Waard, Michel			D-Maurocalcine, a Pharmacologically Inert Efficient Cell-penetrating Peptide Analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO-ACID; SKELETAL RYANODINE RECEPTOR; TORSION ANGLE DYNAMICS; SCORPION TOXIN; EXCITATORY PEPTIDE; PROTEIN STRUCTURES; IN-VITRO; NMR; MECHANISM; DELIVERY	Maurocalcine has been the first demonstrated animal toxin acting as a cell-penetrating peptide. Although it possesses competitive advantages, its use as a cell-penetrating peptide (CPP) requires that analogues be developed that lack its characteristic pharmacological activity on ryanodine-sensitive calcium channels without affecting its cell-penetrating and vector efficiencies. Here, we present the synthesis, three-dimensional (HNMR)-H-1 structure, and activity of D-maurocalcine. We demonstrate that it possesses all of the desired features for an excellent CPP: preserved structure, lack of pharmacological action, conserved vector properties, and absence of cell toxicity. This is the first report of a folded/oxidized animal toxin in its D-diastereomer conformation for use as a CPP. The protease resistance of this new peptide analogue, combined with its efficient cell penetration at concentrations devoid of cell toxicity, suggests that D-maurocalcine should be an excellent vector for in vivo applications.	[Ronjat, Michel; De Waard, Michel] INSERM, U836, Grenoble Inst Neurosci, F-38042 Grenoble 9, France; [Dridi, Kaouthar; Alphonse, Sebastien; Douzi, Badreddine; Darbon, Herve] Architecture & Funct Macromol Biol CNRS, UMR 6098, F-13288 Marseille 9, France; [Pecher, Julien; De Waard, Michel] Smartox Biotechnol, Floralis, Biopolis, F-38700 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	De Waard, M (corresponding author), INSERM, U836, Grenoble Inst Neurosci, BP170, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	douzi, Badreddine/Z-5707-2019; De Waard, Michel/G-7406-2014; Douzi, Badreddine/ABA-4540-2021	De Waard, Michel/0000-0002-2782-9615; Douzi, Badreddine/0000-0003-3140-4713; Ronjat, Michel/0000-0002-9728-6425; Alphonse, Sebastien/0000-0002-2054-2005	Technology pour la Sante; Agence Nationale de la Recherche; Association Francaise contre les Myopathies	Technology pour la Sante; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique) and from Agence Nationale de la Recherche PNANO (Programs SYNERGIE and NanoFret).; Supported by a grant of the Association Francaise contre les Myopathies.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang FJ, 2009, TOXICON, V54, P153, DOI 10.1016/j.toxicon.2009.03.033; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KIM DH, 1983, J BIOL CHEM, V258, P9662; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lukacs B, 2008, BIOPHYS J, V95, P3497, DOI 10.1529/biophysj.107.120840; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Ram N, 2008, J BIOL CHEM, V283, P27048, DOI 10.1074/jbc.M804727200; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Rhee M, 2006, J BIOL CHEM, V281, P1233, DOI 10.1074/jbc.M509813200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34168	34180		10.1074/jbc.M110.104919	http://dx.doi.org/10.1074/jbc.M110.104919			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20610396	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-27	WOS:000283354000062
J	Aachmann, FL; Sal, LS; Kim, HY; Marino, SM; Gladyshev, VN; Dikiy, A				Aachmann, Finn L.; Sal, Lena S.; Kim, Hwa-Young; Marino, Stefano M.; Gladyshev, Vadim N.; Dikiy, Alexander			Insights into Function, Catalytic Mechanism, and Fold Evolution of Selenoprotein Methionine Sulfoxide Reductase B1 through Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-SULFOXIDE; NEISSERIA-MENINGITIDIS; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; PROTEIN; CYSTEINE; ZINC; SELENOCYSTEINE; THIOREDOXIN	Methionine sulfoxide reductases protect cells by repairing oxidatively damaged methionine residues in proteins. Here, we report the first three-dimensional structure of the mammalian selenoprotein methionine sulfoxide reductase B1 (MsrB1), determined by high resolution NMR spectroscopy. Heteronuclear multidimensional spectra yielded NMR spectral assignments for the reduced form of MsrB1 in which catalytic selenocysteine (Sec) was replaced with cysteine (Cys). MsrB1 consists of a central structured core of two beta-sheets and a highly flexible, disordered N-terminal region. Analysis of pH dependence of NMR signals of catalytically relevant residues, comparison with the data for bacterial MsrBs, and NMR-based structural analysis of methionine sulfoxide (substrate) and methionine sulfone (inhibitor) binding to MsrB1 at the atomic level reveal a mechanism involving catalytic Sec(95) and resolving Cys(4) residues in catalysis. The MsrB1 structure differs from the structures of Cys-containing MsrBs in the use of distal selenenylsulfide, residues needed for catalysis, and the mode in which the active form of the enzyme is regenerated. In addition, this is the first structure of a eukaryotic zinc-containing MsrB, which highlights the structural role of this metal ion bound to four conserved Cys. We integrated this information into a structural model of evolution of MsrB superfamily.	[Aachmann, Finn L.; Sal, Lena S.; Dikiy, Alexander] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Marino, Stefano M.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Marino, Stefano M.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Norwegian University of Science & Technology (NTNU); Yeungnam University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dikiy, A (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.	alex.dikiy@biotech.ntnu.no	Gladyshev, Vadim N/A-9894-2013; Aachmann, Finn/G-4136-2015; Gladyshev, Vadim N/J-6187-2013	Aachmann, Finn/0000-0003-1613-4663; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518]; Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology; National Research Foundation of Korea [2010-0001240]; EUNMR [RII3-026145]; Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (KMB) [182695/I40]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); EUNMR; Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (KMB); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V. N. G.). This work was also supported by the Faculty of Natural Sciences and Technology at the Norwegian University of Science and Technology (A. D.) and National Research Foundation of Korea Grant 2010-0001240 (to H.-Y. K.). Access to the 800-MHz NMR spectrometer at the NMR center at the University of Florence was within the EUNMR project Contract RII3-026145.; Supported by the Norwegian Research Council Kompetenseprogjekt Med Brukermedvizkning (182695/I40) (KMB) project.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; CHEIGHTON TE, 1996, PROTEIN STRUCTURE MO; COLONNACESARI F, 1986, J BIOL CHEM, V261, P5273; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeLano WL, 2002, PYMOL USERS MANUAL; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Kauffmann B, 2005, BBA-PROTEINS PROTEOM, V1703, P249, DOI 10.1016/j.bbapap.2004.09.008; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller RLJ., 2004, OPTIMIZING PROCESS N; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lee TH, 2008, ARCH BIOCHEM BIOPHYS, V478, P175, DOI 10.1016/j.abb.2008.07.028; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; Neiers F, 2004, J BIOL CHEM, V279, P42462, DOI 10.1074/jbc.M407464200; Neiers F, 2007, J BIOL CHEM, V282, P32397, DOI 10.1074/jbc.M704730200; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Sal LS, 2007, BIOMOL NMR ASSIGM, V1, P131, DOI 10.1007/s12104-007-9039-7; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664	36	21	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33315	33323		10.1074/jbc.M110.132308	http://dx.doi.org/10.1074/jbc.M110.132308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20605785	hybrid, Green Published			2022-12-27	WOS:000283048200067
J	Hall, D; Poussin, C; Velagapudi, VR; Empsen, C; Joffraud, M; Beckmann, JS; Geerts, AE; Ravussin, Y; Ibberson, M; Oresic, M; Thorens, B				Hall, Diana; Poussin, Carine; Velagapudi, Vidya R.; Empsen, Christophe; Joffraud, Magali; Beckmann, Jacques S.; Geerts, Albert E.; Ravussin, Yann; Ibberson, Mark; Oresic, Matej; Thorens, Bernard			Peroxisomal and Microsomal Lipid Pathways Associated with Resistance to Hepatic Steatosis and Reduced Pro-inflammatory State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL LEAST-SQUARES; HIGH-FAT DIET; INSULIN-RESISTANCE; OBESITY; EXPRESSION; C57BL/6J; LIVER; GENE; BIOINFORMATICS; SENSITIVITY	Accumulation of fat in the liver increases the risk to develop fibrosis and cirrhosis and is associated with development of the metabolic syndrome. Here, to identify genes or gene pathways that may underlie the genetic susceptibility to fat accumulation in liver, we studied A/J and C57Bl/6 mice that are resistant and sensitive to diet-induced hepatosteatosis and obesity, respectively. We performed comparative transcriptomic and lipidomic analysis of the livers of both strains of mice fed a high fat diet for 2, 10, and 30 days. We found that resistance to steatosis in A/J mice was associated with the following: (i) a coordinated up-regulation of 10 genes controlling peroxisome biogenesis and beta-oxidation; (ii) an increased expression of the elongase Elovl5 and desaturases Fads1 and Fads2. In agreement with these observations, peroxisomal beta-oxidation was increased in livers of A/J mice, and lipidomic analysis showed increased concentrations of long chain fatty acid-containing triglycerides, arachidonic acid-containing lysophosphatidylcholine, and 2-arachidonylglycerol, a cannabinoid receptor agonist. We found that the anti-inflammatory CB2 receptor was the main hepatic cannabinoid receptor, which was highly expressed in Kupffer cells. We further found that A/J mice had a lower proinflammatory state as determined by lower plasma levels and IL-1 beta and granulocyte-CSF and reduced hepatic expression of their mRNAs, which were found only in Kupffer cells. This suggests that increased 2-arachidonylglycerol production may limit Kupffer cell activity. Collectively, our data suggest that genetic variations in the expression of peroxisomal beta-oxidation genes and of genes controlling the production of an anti-inflammatory lipid may underlie the differential susceptibility to diet-induced hepatic steatosis and pro-inflammatory state.	[Hall, Diana; Poussin, Carine; Joffraud, Magali; Ravussin, Yann; Ibberson, Mark; Thorens, Bernard] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland; [Hall, Diana; Poussin, Carine; Joffraud, Magali; Ravussin, Yann; Ibberson, Mark; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Velagapudi, Vidya R.; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo 02044, Finland; [Empsen, Christophe; Geerts, Albert E.] Vrije Univ Brussel, B-1090 Brussels, Belgium; [Beckmann, Jacques S.] CHU Vaudois, Serv & Dept Med Genet, CH-1011 Lausanne, Switzerland; [Beckmann, Jacques S.] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Ibberson, Mark] Vital IT, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne; VTT Technical Research Center Finland; Vrije Universiteit Brussel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Bernard.Thorens@unil.ch	Velagapudi, Vidya/L-7278-2015; Oresic, Matej/AAV-3978-2020; Beckmann, Jacques S/A-9772-2008; Ravussin, Yann/ABE-8061-2021; Ravussin, Yann/AAE-1440-2020; Oresic, Matej/K-7673-2016	Velagapudi, Vidya/0000-0002-8261-7164; Beckmann, Jacques S/0000-0002-9741-1900; Ravussin, Yann/0000-0002-6699-3944; Oresic, Matej/0000-0002-2856-9165; Ibberson, Mark/0000-0003-3152-5670	Swiss National Science Foundation [3100A0-113525]; Swiss SystemsX.ch Initiative [LipidX-2008/011]; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch Initiative; European Union(European Commission)	This work was supported in part by Swiss National Science Foundation Grant 3100A0-113525 and the Swiss SystemsX.ch Initiative LipidX-2008/011 (to B. T.) and by the European Union Sixth Framework Programme on Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome Grant EU-FP6 HEPADIP (to B. T. and A. E. G.).	Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CHU RY, 1995, J BIOL CHEM, V270, P4908, DOI 10.1074/jbc.270.9.4908; CRANE DI, 1986, BIOCHIM BIOPHYS ACTA, V876, P256, DOI 10.1016/0005-2760(86)90282-1; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dennis C, 2003, NATURE, V421, P686, DOI 10.1038/421686a; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Hashimoto T, 2000, CELL BIOCHEM BIOPHYS, V32, P63, DOI 10.1385/CBB:32:1-3:63; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jeong S, 2004, METABOLISM, V53, P1284, DOI 10.1016/j.metabol.2004.05.003; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Raborn ES, 2010, J PHARMACOL EXP THER, V333, P319, DOI 10.1124/jpet.109.163055; Rajesh M, 2007, J LEUKOCYTE BIOL, V82, P1382, DOI 10.1189/jlb.0307180; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; SURWIT RS, 1991, DIABETES, V40, P82, DOI 10.2337/diabetes.40.1.82; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; Watson PM, 2000, AM J PHYSIOL-ENDOC M, V279, pE356, DOI 10.1152/ajpendo.2000.279.2.E356; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wise B. M., 2006, CHEMOMETRICS TUTORIA; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12	47	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31011	31023		10.1074/jbc.M110.127159	http://dx.doi.org/10.1074/jbc.M110.127159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20610391	Green Published, hybrid			2022-12-27	WOS:000282135500066
J	Ong, YC; Reese, ML; Boothroyd, JC				Ong, Yi-Ching; Reese, Michael L.; Boothroyd, John C.			Toxoplasma Rhoptry Protein 16 (ROP16) Subverts Host Function by Direct Tyrosine Phosphorylation of STAT6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; GAMMA-INTERFERON; TARGET GENES; GONDII; CELLS; PATHWAYS; REVEALS; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	The obligate intracellular parasite, Toxoplasma gondii, modulates host immunity in a variety of highly specific ways. Previous work revealed a polymorphic, injected parasite factor, ROP16, to be a key virulence determinant and regulator of host cell transcription. These properties were shown to be partially mediated by dysregulation of the host transcription factors STAT3 and STAT6, but the molecular mechanisms underlying this phenotype were unclear. Here, we use a Type I Toxoplasma strain deficient in ROP16 to show that ROP16 induces not only sustained activation but also an extremely rapid (within 1 min) initial activation of STAT6. Using recombinant wild-type and kinase-deficient ROP16, we demonstrate in vitro that ROP16 has intrinsic tyrosine kinase activity and is capable of directly phosphorylating the key tyrosine residue for STAT6 activation, Tyr(641). Furthermore, ROP16 co-immunoprecipitates with STAT6 from infected cells. Taken together, these data strongly suggest that STAT6 is a direct substrate for ROP16 in vivo.	[Ong, Yi-Ching; Reese, Michael L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Fairchild Bldg D305,300 Pasteur Dr, Stanford, CA 94305 USA.	jboothr@stanford.edu		Reese, Michael/0000-0001-9401-9594; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [AI21423, AI73756]; National Science Foundation; Smith Stanford Graduate Fellowship; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI021423, R01AI073756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Smith Stanford Graduate Fellowship; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI21423 and AI73756 (to J. C. B.). This work was also supported by a National Science Foundation Graduate Research Fellowship and Smith Stanford Graduate Fellowship (to Y.-C.O.) and an American Cancer Society fellowship (to M. L. R.).	Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Bradley PJ, 2002, MOL BIOCHEM PARASIT, V125, P189, DOI 10.1016/S0166-6851(02)00162-7; Carme B, 2009, EMERG INFECT DIS, V15, P656, DOI 10.3201/eid1504.081306; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Daines MO, 2003, J BIOL CHEM, V278, P30971, DOI 10.1074/jbc.M301094200; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; ENDO T, 1990, J PROTOZOOL, V37, P133, DOI 10.1111/j.1550-7408.1990.tb05883.x; Gaddi PJ, 2007, IMMUNOL CELL BIOL, V85, P155, DOI 10.1038/sj.icb.7100038; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayakawa F, 2006, ANN NY ACAD SCI, V1086, P213, DOI 10.1196/annals.1377.002; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hsiao WLW, 1996, CARCINOGENESIS, V17, P2771, DOI 10.1093/carcin/17.12.2771; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Lodoen MB, 2010, CELL MICROBIOL, V12, P55, DOI 10.1111/j.1462-5822.2009.01378.x; McKee AS, 2004, J IMMUNOL, V173, P2632, DOI 10.4049/jimmunol.173.4.2632; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Montag DT, 2006, CLIN IMMUNOL, V121, P215, DOI 10.1016/j.clim.2006.06.013; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Schnyder B, 2002, BIOCHEM BIOPH RES CO, V292, P841, DOI 10.1006/bbrc.2002.6754; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tomkinson A, 1999, AM J RESP CRIT CARE, V160, P1283, DOI 10.1164/ajrccm.160.4.9809065; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016; Zimmermann N, 2004, J IMMUNOL, V172, P1815, DOI 10.4049/jimmunol.172.3.1815	50	154	178	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28731	28740		10.1074/jbc.M110.112359	http://dx.doi.org/10.1074/jbc.M110.112359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20624917	hybrid, Green Published			2022-12-27	WOS:000281594000039
J	Cao, HN; Pauff, JM; Hille, R				Cao, Hongnan; Pauff, James M.; Hille, Russ			Substrate Orientation and Catalytic Specificity in the Action of Xanthine Oxidase THE SEQUENTIAL HYDROXYLATION OF HYPOXANTHINE TO URIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; MOLYBDENUM; MECHANISM; DEHYDROGENASE; REFINEMENT; RESIDUES; ENZYME; SITE	Xanthine oxidase is a molybdenum-containing enzyme catalyzing the hydroxylation of a sp(2)-hybridized carbon in a broad range of aromatic heterocycles and aldehydes. Crystal structures of the bovine enzyme in complex with the physiological substrate hypoxanthine at 1.8A resolution and the chemotherapeutic agent 6-mercaptopurine at 2.6A resolution have been determined, showing in each case two alternate orientations of substrate in the two active sites of the crystallographic asymmetric unit. One orientation is such that it is expected to yield hydroxylation at C-2 of substrate, yielding xanthine. The other suggests hydroxylation at C-8 to give 6,8-dihydroxypurine, a putative product not previously thought to be generated by the enzyme. Kinetic experiments demonstrate that > 98% of hypoxanthine is hydroxylated at C-2 rather than C-8, indicating that the second crystallographically observed orientation is significantly less catalytically effective than the former. Theoretical calculations suggest that enzyme selectivity for the C-2 over C-8 of hypoxanthine is largely due to differences in the intrinsic reactivity of the two sites. For the orientation of hypoxanthine with C-2 proximal to the molybdenum center, the disposition of substrate in the active site is such that Arg(880) and Glu(802), previous shown to be catalytically important for the conversion of xanthine to uric acid, play similar roles in hydroxylation at C-2 as at C-8. Contrary to the literature, we find that 6,8-dihydroxypurine is effectively converted to uric acid by xanthine oxidase.	[Cao, Hongnan; Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pauff, James M.] Ohio State Univ, Med Scientist Program, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Cao, Hongnan/M-2047-2014	Cao, Hongnan/0000-0002-9808-3240; Cao, Hongnan/0000-0003-2496-1298	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Eli Lilly Company	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Eli Lilly Company(Eli Lilly)	This work was supported in part by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357 and by Eli Lilly & Company.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cultrone A, 2005, MOL MICROBIOL, V57, P276, DOI 10.1111/j.1365-2958.2005.04686.x; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; EDMONDSON D, 1972, J BIOL CHEM, V247, P1597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ilich P, 1997, INORG CHIM ACTA, V263, P87, DOI 10.1016/S0020-1693(97)05654-5; JEZEWSKA MM, 1973, EUR J BIOCHEM, V36, P385, DOI 10.1111/j.1432-1033.1973.tb02923.x; Kim JH, 1996, J BIOL CHEM, V271, P6771, DOI 10.1074/jbc.271.12.6771; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Montero-Moran GM, 2007, BIOCHEMISTRY-US, V46, P5293, DOI 10.1021/bi700065h; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murshudov GN, 1996, P CCP4 STUDY WEEKEND, P93; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Pauff JM, 2009, J BIOL CHEM, V284, P8751, DOI 10.1074/jbc.M804517200; Pope SD, 2009, J BACTERIOL, V191, P1006, DOI 10.1128/JB.01281-08; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stewart J. J. P, 2008, MOPAC2009; Stockert AL, 2002, J AM CHEM SOC, V124, P14554, DOI 10.1021/ja027388d; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	35	73	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28044	28053		10.1074/jbc.M110.128561	http://dx.doi.org/10.1074/jbc.M110.128561			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20615869	Green Published, hybrid			2022-12-27	WOS:000288742300003
J	Basu, B; Sarkar, C; Chakroborty, D; Ganguly, S; Shome, S; Dasgupta, PS; Basu, S				Basu, Biswarup; Sarkar, Chandrani; Chakroborty, Debanjan; Ganguly, Subhalakshmi; Shome, Saurav; Dasgupta, Partha Sarathi; Basu, Sujit			D-1 and D-2 Dopamine Receptor-mediated Inhibition of Activated Normal T Cell Proliferation Is Lost in Jurkat T Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; MESSENGER-RNA EXPRESSION; ENDOGENOUS CATECHOLAMINES; STRUCTURAL POLYMORPHISM; TYROSINE-HYDROXYLASE; D2 RECEPTOR; GENE; SCHIZOPHRENIA; CANCER; NEUROTRANSMITTER	Dopamine is a catecholamine neurotransmitter, which plays an important role in the regulation of T cell functions. In activated T cells from normal volunteers, stimulation of D-1 and D-2 dopamine receptors inhibit cell proliferation and cytokine secretion. However, there is no report yet regarding the regulatory role of D-1 and D-2 dopamine receptors in abnormally proliferating T cells. The present study investigates the expression and effect of activation of these dopamine receptors in Jurkat cells, a leukemic T cell line showing uncontrolled proliferation. Like normal human T cells, in Jurkat cells, D-1 and D-2 dopamine receptors are also expressed; however, unlike activated normal T cells, stimulation of these dopamine receptors in Jurkat cells fails to inhibit their T cell receptor-induced proliferation. This alteration is due to failure of D-1 dopamine receptor-mediated activation of cyclic AMP signaling and a missense mutation at the third cytoplasmic loop of D-2 dopamine receptors affecting inhibition of phosphorylation of ZAP-70, an important downstream protein transducing signal from the T cell receptor. These results help to understand the biology of abnormal proliferation of T cells in pathophysiological conditions where dopamine plays an important role.	[Sarkar, Chandrani; Chakroborty, Debanjan; Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Basu, Biswarup; Ganguly, Subhalakshmi; Shome, Saurav; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata 700026, India	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Basu, S (corresponding author), Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	sujit.basu@osumc.edu	Basu, Biswarup/ABD-3331-2020	Basu, Biswarup/0000-0002-5417-2735	National Institutes of Health [CA118265, CA124763]; Council of Scientific and Industrial Research Government of India [9/30(43)/2005-EMR-1, 9/30(54)/2009-EMR-1]; Department of Defense [W81XWH-07-1-0051]; NATIONAL CANCER INSTITUTE [R01CA124763, R21CA118265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA118265 (to S. B.) and CA124763 (to S. B.). This work was also supported by Council of Scientific and Industrial Research Government of India Fellowships 9/30(43)/2005-EMR-1 (to B. B.) and 9/30(54)/2009-EMR-1 (to S. S.) and Department of Defense Grant W81XWH-07-1-0051 (to S. B.).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ARINAMI T, 1994, LANCET, V343, P703, DOI 10.1016/S0140-6736(94)91581-4; Barbanti P, 1996, NEUROSCI LETT, V207, P73, DOI 10.1016/0304-3940(96)12491-5; Barbanti P, 2000, MECH AGEING DEV, V120, P65, DOI 10.1016/S0047-6374(00)00183-4; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 1997, ELECTROPHORESIS, V18, P1760, DOI 10.1002/elps.1150181009; Campa D, 2007, LUNG CANCER, V56, P17, DOI 10.1016/j.lungcan.2006.11.007; Carr L, 2003, J NEUROIMMUNOL, V137, P87, DOI 10.1016/S0165-5728(03)00047-X; Cianfarani F, 2010, J INVEST DERMATOL, V130, P93, DOI 10.1038/jid.2009.180; Cioca DP, 2000, JPN HEART J, V41, P385; CLARK BJ, 1985, DOPAMINERGIC SYSTEM, P27; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; DiMaio S, 2003, J PSYCHIATR NEUROSCI, V28, P27; Ekholm D, 1999, BIOCHEM PHARMACOL, V58, P935, DOI 10.1016/S0006-2952(99)00188-4; EPSTEIN PM, 1977, CANCER RES, V37, P4016; Ferrari M, 2004, BIOCHEM PHARMACOL, V67, P865, DOI 10.1016/j.bcp.2003.10.004; Ferrari M, 2008, J PSYCHIATR RES, V43, P24, DOI 10.1016/j.jpsychires.2008.01.014; FLEMSTROM G, 1993, GASTROENTEROLOGY, V104, P825, DOI 10.1016/0016-5085(93)91019-E; Gemignani F, 2005, CANCER EPIDEM BIOMAR, V14, P1633, DOI 10.1158/1055-9965.EPI-05-0057; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Giorelli M, 2005, J INTERF CYTOK RES, V25, P395, DOI 10.1089/jir.2005.25.395; GRANDY DK, 1990, AM J HUM GENET, V47, P828; GRANDY DK, 1989, AM J HUM GENET, V45, P778; HASKEL Y, 1994, DIGEST DIS SCI, V39, P2364, DOI 10.1007/BF02087652; HIGUCHI S, 1994, BIOCHEM BIOPH RES CO, V204, P1199, DOI 10.1006/bbrc.1994.2590; Ilani T, 2001, P NATL ACAD SCI USA, V98, P625, DOI 10.1073/pnas.021535398; ITOKAWA M, 1993, BIOCHEM BIOPH RES CO, V196, P1369, DOI 10.1006/bbrc.1993.2404; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaiser R, 2002, MOL PSYCHIATR, V7, P695, DOI 10.1038/sj.mp.4001054; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; Lemmer K, 2002, LIFE SCI, V71, P667, DOI 10.1016/S0024-3205(02)01703-4; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RIEDERER P, 1985, ROLE BRAIN DOPAMINE, P1; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; Sarkar C, 2006, J IMMUNOL, V177, P7525, DOI 10.4049/jimmunol.177.11.7525; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Seybold J, 1998, J BIOL CHEM, V273, P20575, DOI 10.1074/jbc.273.32.20575; Stockinger B, 2004, IMMUNOLOGY, V111, P241, DOI 10.1111/j.1365-2567.2004.01831.x; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; WEISS A, 1984, J IMMUNOL, V133, P123	48	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27026	27032		10.1074/jbc.M110.144022	http://dx.doi.org/10.1074/jbc.M110.144022			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592018	Green Published, hybrid			2022-12-27	WOS:000281172700034
J	Pelissier, MC; Lesley, SA; Kuhn, P; Bourne, Y				Pelissier, Marie-Cecile; Lesley, Scott A.; Kuhn, Peter; Bourne, Yves			Structural Insights into the Catalytic Mechanism of Bacterial Guanosine-diphospho-D-mannose Pyrophosphorylase and Its Regulation by Divalent Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGINATE BIOSYNTHETIC-PATHWAY; GDP-MANNOSE; PHOSPHOMANNOSE ISOMERASE; BIFUNCTIONAL ENZYME; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; IDENTIFICATION; PURIFICATION; URIDYLTRANSFERASE	GMP catalyzes the formation of GDP-Man, a fundamental precursor for protein glycosylation and bacterial cell wall and capsular polysaccharide biosynthesis. Crystal structures of GMP from the thermophilic bacterium Thermotoga maritima in the apo form, in complex with the substrates mannose-1-phosphate or GTP and bound with the end product GDP-Man in the presence of the essential divalent cation Mg2+, were solved in the 2.1-2.8 angstrom resolution range. The T. maritima GMP molecule is organized in two separate domains: a N-terminal Rossman fold-like domain and a C-terminal left-handed beta-helix domain. Two molecules associate into a dimer through a tail-to-tail arrangement of the C-terminal domains. Comparative analysis of the structures along with characterization of enzymatic parameters reveals the bases of substrate specificity of this class of sugar nucleotidyltransferases. In particular, substrate and product binding are associated with significant changes in the conformation of loop regions lining the active center and in the relative orientation of the two domains. Involvement of both the N- and C-terminal domains, coupled to the catalytic role of a bivalent metal ion, highlights the catalytic features of bacterial GMPs compared with other members of the pyrophosphorylase superfamily.	[Pelissier, Marie-Cecile; Bourne, Yves] Univ Aix Marseille, UMR6098, AFMB, CNRS, F-13288 Marseille 09, France; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Kuhn, Peter] Scripps Res Inst, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Novartis; Scripps Research Institute	Bourne, Y (corresponding author), Univ Aix Marseille, UMR6098, AFMB, CNRS, Case 932,163 Ave Luminy, F-13288 Marseille 09, France.	yves.bourne@afmb.univ-mrs.fr	Bourne, Yves/AAC-4635-2022	Bourne, Yves/0000-0003-3850-0548	CNRS; Fondation de la Recherche Medicale; National Institutes of Health [U54GM074961]; French Ministry of Research; Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from the CNRS and the Fondation de la Recherche Medicale (to Y.B.) and Grant U54GM074961 from the National Institutes of Health (to P.K.).; Recipient of a fellowship from the French Ministry of Research and an Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee. Present address: EMBL, c/o DESY, Bldg. 25A, Not-kestrasse 85, 22603 Hamburg, Germany.	Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; DeLano W.L, PYMOL MOL GRAPHICS S; Diez MDA, 2010, ARCH MICROBIOL, V192, P103, DOI 10.1007/s00203-009-0534-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fey S, 1997, CARBOHYD RES, V305, P475, DOI 10.1016/S0008-6215(97)10095-7; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HJ, 2008, FEBS LETT, V582, P3479, DOI 10.1016/j.febslet.2008.09.013; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LINDQUIST L, 1993, EUR J BIOCHEM, V211, P763, DOI 10.1111/j.1432-1033.1993.tb17607.x; MAY TB, 1994, J BIOL CHEM, V269, P4872; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Mizanur RM, 2009, ORG BIOMOL CHEM, V7, P2135, DOI 10.1039/b822794b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ning B, 1999, ARCH BIOCHEM BIOPHYS, V362, P339, DOI 10.1006/abbi.1998.1053; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PAULE MR, 1971, J BIOL CHEM, V246, P4602; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; PREISS J, 1964, J BIOL CHEM, V239, P3119; SHINABARGER D, 1991, J BIOL CHEM, V266, P2080; Sousa SA, 2008, APPL MICROBIOL BIOT, V80, P1015, DOI 10.1007/s00253-008-1612-1; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017; Wu BY, 2002, FEBS LETT, V519, P87, DOI 10.1016/S0014-5793(02)02717-5; Yang J, 2004, BIOORGAN MED CHEM, V12, P1577, DOI 10.1016/j.bmc.2003.12.046; Yang YH, 2005, J MOL CATAL B-ENZYM, V37, P1, DOI 10.1016/j.molcatb.2005.08.002; Zuccotti S, 2001, J MOL BIOL, V313, P831, DOI 10.1006/jmbi.2001.5073	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27468	27476		10.1074/jbc.M109.095182	http://dx.doi.org/10.1074/jbc.M109.095182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573954	hybrid, Green Published			2022-12-27	WOS:000281172700076
J	Apostolatos, H; Apostolatos, A; Vickers, T; Watson, JE; Song, SJ; Vale, F; Cooper, DR; Sanchez-Ramos, J; Patel, NA				Apostolatos, Hercules; Apostolatos, Andre; Vickers, Timothy; Watson, James E.; Song, Shijie; Vale, Fernando; Cooper, Denise R.; Sanchez-Ramos, Juan; Patel, Niketa A.			Vitamin A Metabolite, All-trans-retinoic Acid, Mediates Alternative Splicing of Protein Kinase C delta VIII (PKC delta VIII) Isoform via Splicing Factor SC35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVATION; INDUCED APOPTOSIS; BETA-II; EXON; EXPRESSION; CELLS; IDENTIFICATION; SIGNALS; VARIANT; ELEMENT	Vitamin A metabolite, all-trans-retinoic acid (RA), induces cell growth, differentiation, and apoptosis and has an emerging role in gene regulation and alternative splicing events. Protein kinase C delta (PKC delta), a serine/threonine kinase, has a role in cell proliferation, differentiation, and apoptosis. We reported an alternatively spliced variant of human PKC delta, PKC delta VIII that functions as a pro-survival protein (1). RA regulates the splicing and expression of PKC delta VIII via utilization of a downstream 5' splice site of exon 10 on PKC delta pre-mRNA. Here, we further elucidate the molecular mechanisms involved in RA regulation of alternative splicing of PKC delta VIII mRNA. Overexpression and knockdown of the splicing factor SC35 (i.e. SRp30b) indicated that it is involved in PKC delta VIII alternative splicing. To identify the cis-elements involved in 5' splice site selection we cloned a minigene, which included PKC delta exon 10 and its flanking introns in the pSPL3 splicing vector. Alternative 5' splice site utilization in the minigene was promoted by RA. Further, co-transfection of SC35 with PKC delta minigene promoted selection of 5 delta splice site II. Mutation of the SC35 binding site in the PKC delta minigene abolished RA-mediated utilization of 5' splice splice II. RNA binding assays demonstrated that the enhancer element downstream of PKC delta exon 10 is a SC35 cis-element. We conclude that SC35 is pivotal in RA-mediated PKC delta pre-mRNA alternative splicing. This study demonstrates how a nutrient, vitamin A, via its metabolite RA, regulates alternative splicing and thereby gene expression of the pro-survival protein PKC delta VIII.	[Patel, Niketa A.] James A Haley Vet Hosp, Res Serv VAR 151, Tampa, FL 33612 USA; [Apostolatos, Hercules; Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Vale, Fernando] Univ S Florida, Dept Neurosurg, Tampa, FL 33612 USA; [Vickers, Timothy] ISIS Pharmaceut, Carlsbad, CA 92008 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Isis Pharmaceuticals Inc	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Cooper, Denise R./A-4740-2012; Patel, Niketa/A-1392-2012; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857; Apostolatos, Andre/0000-0002-4527-7084; Patel, Niketa A./0000-0003-4811-8596	NIDDK; National Institutes of Health [54393]; Veteran's Administration MREP; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration MREP; Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant 54393 (to D. R. C.) and a Veteran's Administration MREP Grant (to N. A. P.).	Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chand HS, 2006, INT J CANCER, V118, P1713, DOI 10.1002/ijc.21550; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Ise R, 2005, FEBS LETT, V579, P1732, DOI 10.1016/j.febslet.2005.02.033; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kawaguchi T, 2006, FEBS LETT, V580, P2458, DOI 10.1016/j.febslet.2006.03.084; Kawahigashi H, 1998, BBA-GENE STRUCT EXPR, V1397, P305, DOI 10.1016/S0167-4781(98)00021-9; Khoo B, 2003, TRENDS BIOTECHNOL, V21, P328, DOI 10.1016/S0167-7799(03)00168-9; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Ladd AN, 2002, GENOME BIOL, V3; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; McCracken MA, 2003, MOL CANCER THER, V2, P273; Meshorer E, 2005, MOL PSYCHIATR, V10, P985, DOI 10.1038/sj.mp.4001735; Misiuta IE, 2003, DEV BRAIN RES, V145, P107, DOI 10.1016/S0165-3806(03)00221-9; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Patel NA, 2003, J BIOL CHEM, V278, P1149, DOI 10.1074/jbc.M206797200; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; SITAILO L, 2004, J INVEST DERMATOL, V123, P1; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Ueyama T, 2000, BIOCHEM BIOPH RES CO, V269, P557, DOI 10.1006/bbrc.2000.2331; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Walton HS, 2007, J NEUROSCI METH, V160, P294, DOI 10.1016/j.jneumeth.2006.09.022; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Yang ZQ, 2007, NUCLEIC ACIDS RES, V35, P1919, DOI 10.1093/nar/gkl1092; Zrachia A, 2002, J BIOL CHEM, V277, P23693, DOI 10.1074/jbc.M111658200	46	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25987	25995		10.1074/jbc.M110.100735	http://dx.doi.org/10.1074/jbc.M110.100735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20547768	hybrid, Green Published			2022-12-27	WOS:000280921000013
J	Dailey, TA; Boynton, TO; Albetel, AN; Gerdes, S; Johnson, MK; Dailey, HA				Dailey, Tamara A.; Boynton, Tye O.; Albetel, Angela-Nadia; Gerdes, Svetlana; Johnson, Michael K.; Dailey, Harry A.			Discovery and Characterization of HemQ AN ESSENTIAL HEME BIOSYNTHETIC PATHWAY COMPONENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRINOGEN OXIDASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORITE DISMUTASE; PURIFICATION; EXPRESSION; IDENTIFICATION; FERROCHELATASE; ENZYME; GENOMICS	Here we identify a previously undescribed protein, HemQ, that is required for heme synthesis in Gram-positive bacteria. We have characterized HemQ from Bacillus subtilis and a number of Actinobacteria. HemQ is a multimeric heme-binding protein. Spectroscopic studies indicate that this heme is high spin ferric iron and is ligated by a conserved histidine with the sixth coordination site available for binding a small molecule. The presence of HemQ along with the terminal two pathway enzymes, protoporphyrinogen oxidase (HemY) and ferrochelatase, is required to synthesize heme in vivo and in vitro. Although the exact role played by HemQ remains to be characterized, to be fully functional in vitro it requires the presence of a bound heme. HemQ possesses minimal peroxidase activity, but as a catalase it has a turnover of over 10(4) min(-1). We propose that this activity may be required to eliminate hydrogen peroxide that is generated by each turnover of HemY. Given the essential nature of heme synthesis and the restricted distribution of HemQ, this protein is a potential antimicrobial target for pathogens such as Mycobacterium tuberculosis.	[Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Paul D Coverdell Ctr, Athens, GA 30602 USA; [Dailey, Tamara A.; Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Boynton, Tye O.; Dailey, Harry A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gerdes, Svetlana] Fellowship Interpretat Genomes, Bar Ridge, IL 60527 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dailey, HA (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Paul D Coverdell Ctr, Athens, GA 30602 USA.	hdailey@uga.edu			National Institutes of Health [DK032303, GM62524]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032303, R56DK032303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK032303 (to H. A. D.) and GM62524 (to M. K. J.).	Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; BEERS RF, 1952, J BIOL CHEM, V195, P133; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Che DS, 2006, NUCLEIC ACIDS RES, V34, P2418, DOI 10.1093/nar/gkl294; CHEESMAN MR, 1991, ADV INORG CHEM RAD, V36, P201; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Corrigall AV, 1998, ARCH BIOCHEM BIOPHYS, V358, P251, DOI 10.1006/abbi.1998.0834; Dailey H. A., 2003, PORPHYRIN HDB, V12, P93; Dailey HA, 1997, J BIOL INORG CHEM, V2, P411, DOI 10.1007/s007750050151; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; Dailey HA, 1996, J BIOL CHEM, V271, P8714, DOI 10.1074/jbc.271.15.8714; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Dailey TA, 1996, PROTEIN SCI, V5, P98; Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002; Dailey TA, 1995, ARCH BIOCHEM BIOPHYS, V324, P379, DOI 10.1006/abbi.1995.0051; de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Finnegan MG, 1996, BBA-BIOENERGETICS, V1274, P9, DOI 10.1016/0005-2728(95)00155-7; Hagedoorn PL, 2002, EUR J BIOCHEM, V269, P4905, DOI 10.1046/j.1432-1033.2002.03208.x; HANSSON M, 1994, EUR J BIOCHEM, V220, P201, DOI 10.1111/j.1432-1033.1994.tb18615.x; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Loewen P, 1996, GENE, V179, P39, DOI 10.1016/S0378-1119(96)00321-6; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MIYAMOTO K, 1991, J MOL BIOL, V219, P393, DOI 10.1016/0022-2836(91)90180-E; Najahi-Missaoui W, 2005, BLOOD, V106, P1098, DOI 10.1182/blood-2004-12-4661; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; O'Brian MR, 2002, ADV MICROB PHYSIOL, V46, P257, DOI 10.1016/S0065-2911(02)46006-7; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Qin XH, 2010, J STRUCT BIOL, V170, P76, DOI 10.1016/j.jsb.2009.11.012; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; Schlafli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0; SHEMIN D, 1946, J BIOL CHEM, V166, P621; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Spiro T, 2008, ACS CHEM BIOL, V3, P673, DOI 10.1021/cb800269h; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	52	54	56	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25978	25986		10.1074/jbc.M110.142604	http://dx.doi.org/10.1074/jbc.M110.142604			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20543190	Green Published, hybrid			2022-12-27	WOS:000280921000012
J	Kelly, SM; Leung, SW; Apponi, LH; Bramley, AM; Tran, EJ; Chekanova, JA; Wente, SR; Corbett, AH				Kelly, Seth M.; Leung, Sara W.; Apponi, Luciano H.; Bramley, Anna M.; Tran, Elizabeth J.; Chekanova, Julia A.; Wente, Susan R.; Corbett, Anita H.			Recognition of Polyadenosine RNA by the Zinc Finger Domain of Nuclear Poly(A) RNA-binding Protein 2 (Nab2) Is Required for Correct mRNA 3 '-End Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL LENGTH CONTROL; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC FIBRILS; GENE-EXPRESSION; EXPORT; YEAST; BIOGENESIS; COMPLEX; DEFECTS; MEX67P	Proteins bound to the poly(A) tail of mRNA transcripts, called poly(A)-binding proteins (Pabs), play critical roles in regulating RNA stability, translation, and nuclear export. Like many mRNA-binding proteins that modulate post-transcriptional processing events, assigning specific functions to Pabs is challenging because these processing events are tightly coupled to one another. To investigate the role that a novel class of zinc finger-containing Pabs plays in these coupled processes, we defined the mode of polyadenosine RNA recognition for the conserved Saccharomyces cerevisiae Nab2 protein and assessed in vivo consequences caused by disruption of RNA binding. The polyadenosine RNA recognition domain of Nab2 consists of three tandem Cys-Cys-Cys-His (CCCH) zinc fingers. Cells expressing mutant Nab2 proteins with decreased binding to polyadenosine RNA show growth defects as well as defects in poly(A) tail length but do not accumulate poly(A) RNA in the nucleus. We also demonstrate genetic interactions between mutant nab2 alleles and mutant alleles of the mRNA 3'-end processing machinery. Together, these data provide strong evidence that Nab2 binding to RNA is critical for proper control of poly(A) tail length.	[Kelly, Seth M.; Leung, Sara W.; Bramley, Anna M.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Apponi, Luciano H.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Tran, Elizabeth J.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Chekanova, Julia A.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Emory University; Emory University; Vanderbilt University; University of Missouri System; University of Missouri Kansas City	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021; Apponi, Luciano H/A-4081-2013; Tran, Elizabeth/G-7818-2018	Corbett, Anita/0000-0002-0461-6895; Chekanova, Julia/0000-0002-2214-8896; Tran, Elizabeth/0000-0002-9541-004X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, R01GM065442, R37GM051219] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058728, R01 GM065442, R37 GM051219] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Buratowski S, 2005, NATURE, V435, P1174, DOI 10.1038/4351174b; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Dheur S, 2005, J BIOL CHEM, V280, P24532, DOI 10.1074/jbc.M504720200; Farny NG, 2008, GENE DEV, V22, P66, DOI 10.1101/gad.1616008; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; PATEL D, 1992, MOL CELL BIOL, V12, P3297, DOI 10.1128/MCB.12.7.3297; Sambrook J., 2002, MOL CLONING LAB MANU; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; SIKORSKI RS, 1989, GENETICS, V122, P19; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; WACH A, 1994, YEAST, V10, P1808; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a	44	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26022	26032		10.1074/jbc.M110.141127	http://dx.doi.org/10.1074/jbc.M110.141127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554526	Green Published, hybrid			2022-12-27	WOS:000280921000017
J	Reed, T; Lushington, GH; Xia, Y; Hirakawa, H; Travis, DM; Mure, M; Scott, EE; Limburg, J				Reed, Timothy; Lushington, Gerald H.; Xia, Yan; Hirakawa, Hidehiko; Travis, DeAnna M.; Mure, Minae; Scott, Emily E.; Limburg, Julian			Crystal Structure of Histamine Dehydrogenase from Nocardioides simplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON TRANSFERRING FLAVOPROTEIN; TRIMETHYLAMINE DEHYDROGENASE; MOLECULAR-CLONING; WILD-TYPE; 3-DIMENSIONAL STRUCTURE; PROTEIN CRYSTALS; AMMONIUM LIGANDS; BINDING PROTEINS; RECEPTOR; FLAVIN	Histamine dehydrogenase (HADH) isolated from Nocardioides simplex catalyzes the oxidative deamination of histamine to imidazole acetaldehyde. HADH is highly specific for histamine, and we are interested in understanding the recognition mode of histamine in its active site. We describe the first crystal structure of a recombinant form of HADH (HADH) to 2.7-angstrom resolution. HADH is a homodimer, where each 76-kDa subunit contains an iron-sulfur cluster ([4Fe-4S](2+)) and a 6-S-cysteinyl flavin mononucleotide (6-S-Cys-FMN) as redox cofactors. The overall structure of HADH is very similar to that of trimethylamine dehydrogenase (TMADH) from Methylotrophus methylophilus (bacterium W3A1). However, some distinct differences between the structure of HADH and TMADH have been found. Tyr(60), Trp(264), and Trp(355) provide the framework for the "aromatic bowl" that serves as a trimethylamine-binding site in TMADH is comprised of Gln(65), Trp(267), and Asp(358), respectively, in HADH. The surface Tyr(442) that is essential in transferring electrons to electron-transfer flavoprotein (ETF) in TMADH is not conserved in HADH. We use this structure to propose the binding mode for histamine in the active site of HADH through molecular modeling and to compare the interactions to those observed for other histamine-binding proteins whose structures are known.	[Limburg, Julian] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lushington, Gerald H.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Xia, Yan] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas		mmure@ku.edu; eescott@ku.edu	Lushington, Gerald/AAH-3205-2020; Lushington, Gerald/P-8421-2019; Hirakawa, Hidehiko/A-3089-2013	Lushington, Gerald/0000-0001-5821-4253; Hirakawa, Hidehiko/0000-0003-0623-8573	National Institutes of Health [5P20 RR17708, MCB-0747377, RR-017708 RPH]; National Science Foundation [MCB-0747377]; University of Kansas Center for Research; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Kansas Center for Research; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20 RR17708 (to J. L., COBRE Center in Protein Structure and Function) and GM079446 (to J. L. and M. M.), National Science Foundation MCB-0747377 (to M. M.), and the University of Kansas Center for Research (to J. L. and M. M.).; We thank Scott Schreiber for assistance in protein purification. We thank reviewers for their constructive and valuable critiques to improve our manuscript. We also thank Masao Ikeda-Saito and Kunio Miki for critical reading and helpful discussion in revising the manuscript. Crystals were grown and initially screened using the facilities of the Protein Structure Laboratory core facility at The University of Kansas (supported by National Institutes of Health Grant RR-017708 RPH). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.	Bao LL, 2002, ANAL CHEM, V74, P1144, DOI 10.1021/ac0106086; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BELLAMY HD, 1989, J BIOL CHEM, V264, P11887; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Burgess SG, 2008, BIOCHEMISTRY-US, V47, P5168, DOI 10.1021/bi800127d; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; DeLano W.L, PYMOL MOL GRAPHICS S; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fournel A, 1998, J CHEM PHYS, V109, P10905, DOI 10.1063/1.477786; Fujieda N, 2004, BIOCHEMISTRY-US, V43, P10800, DOI 10.1021/bi049061q; FUKUI H, 1994, BIOCHEM BIOPH RES CO, V201, P894, DOI 10.1006/bbrc.1994.1786; GANTZ I, 1991, P NATL ACAD SCI USA, V88, P429, DOI 10.1073/pnas.88.2.429; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Iwaki S, 2002, ANAL BIOCHEM, V304, P236, DOI 10.1006/abio.2002.5598; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; Jones M, 2002, J BIOL CHEM, V277, P8457, DOI 10.1074/jbc.M111105200; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; LIM LW, 1988, J BIOL CHEM, V263, P3075; LIM LW, 1986, J BIOL CHEM, V261, P5140; Limburg J, 2005, ARCH BIOCHEM BIOPHYS, V436, P8, DOI 10.1016/j.abb.2004.11.024; Loechel C, 2003, ANALYST, V128, P166, DOI 10.1039/b211895e; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mewies M, 1997, BIOCHEMISTRY-US, V36, P7162, DOI 10.1021/bi970621d; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2000, BIOCHEM BIOPH RES CO, V279, P615, DOI 10.1006/bbrc.2000.4008; PACE CP, 1991, ARCH BIOCHEM BIOPHYS, V287, P97, DOI 10.1016/0003-9861(91)90393-W; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; RAINE ARC, 1995, PROTEIN SCI, V4, P2625, DOI 10.1002/pro.5560041222; Rarey M, 1996, J COMPUT AID MOL DES, V10, P41, DOI 10.1007/BF00124464; Reed TM, 2008, ACTA CRYSTALLOGR F, V64, P785, DOI 10.1107/S1744309108023336; Roberts P, 1999, BIOCHEMISTRY-US, V38, P14927, DOI 10.1021/bi9914098; ROHLFS RJ, 1995, J BIOL CHEM, V270, P22196, DOI 10.1074/jbc.270.38.22196; Scrutton NS, 1996, BIOCHEM J, V319, P1; Shin N, 2002, MOL PHARMACOL, V62, P38, DOI 10.1124/mol.62.1.38; Siddiqui JA, 2000, FEMS MICROBIOL LETT, V189, P183, DOI 10.1016/S0378-1097(00)00277-9; STEENKAMP DJ, 1982, BIOCHEM J, V207, P241, DOI 10.1042/bj2070241; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Trickey P, 2000, BIOCHEMISTRY-US, V39, P7678, DOI 10.1021/bi9927181; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zheng YJ, 1996, J AM CHEM SOC, V118, P9402, DOI 10.1021/ja9608151	63	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25782	25791		10.1074/jbc.M109.084301	http://dx.doi.org/10.1074/jbc.M109.084301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20538584	Green Published, hybrid			2022-12-27	WOS:000280682400070
J	Lu, XL; Shi, Y; Lu, QL; Ma, Y; Luo, J; Wang, QS; Ji, JG; Jiang, Q; Zhang, CM				Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Wang, Qingsong; Ji, Jianguo; Jiang, Qing; Zhang, Chuanmao			Requirement for Lamin B Receptor and Its Regulation by Importin beta and Phosphorylation in Nuclear Envelope Assembly during Mitotic Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LBR; RAN GTPASE; BINDING-PROTEIN; CHROMODOMAIN PROTEINS; LOCALIZATION SIGNAL; INTEGRAL PROTEIN; IN-VIVO; CHROMATIN; MUTATIONS; MITOSIS	Lamin B receptor (LBR), a chromatin and lamin B-binding protein in the inner nuclear membrane, has been proposed to target the membrane precursor vesicles to chromatin mediated by importin beta during the nuclear envelope (NE) assembly. However, the mechanisms for the binding of LBR with importin beta and the membrane targeting by LBR in NE assembly remain largely unknown. In this report, we show that the amino acids (aa) 69-90 of LBR sequences are required to bind with importin beta at aa 45-462, and the binding is essential for the NE membrane precursor vesicle targeting to the chromatin during the NE assembly at the end of mitosis. We also show that this binding is cell cycle-regulated and dependent on the phosphorylation of LBR Ser-71 by p34(cdc2) kinase. RNAi knockdown of LBR causes the NE assembly failure and abnormal chromatin decondensation of the daughter cell nuclei, leading to the daughter cell death at early G(1) phase by apoptosis. Perturbation of the interaction of LBR with importin beta by deleting the LBR N-terminal spanning region or aa 69-73 also induces the NE assembly failure, the abnormal chromatin decondensation, and the daughter cell death. The first transmembrane domain of LBR promotes the NE production and expansion, because overexpressing this domain is sufficient to induce membrane overproduction of the NE. Thus, these results demonstrate that LBR targets the membrane precursor vesicles to chromatin by interacting with importin beta in a LBR phosphorylation-dependent manner during the NE assembly at the end of mitosis and that the first transmembrane domain of LBR promotes the LBR-bearing membrane production and the NE expansion in interphase.	[Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Beijing 100871, Peoples R China; [Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, State Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn	Lu, Quanlong/M-4436-2015	Lu, Quanlong/0000-0002-4261-5121	National Natural Science Foundation of China [30721064, 31030044, 31971188, 30900726, 90913021, 90919023]; State Key Basic Research and Development Plan [2010CB833705, 2007CB914502, 2006CB910101, 2010CB912203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan	This work was supported by the National Natural Science Foundation of China (Grants 30721064, 31030044, 31971188, 30900726, 90913021, and 90919023) and by the State Key Basic Research and Development Plan (Grants 2010CB833705, 2007CB914502, 2006CB910101, and 2010CB912203).	APPELBAUM J, 1990, J BIOL CHEM, V265, P4181; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Best S, 2003, BRIT J HAEMATOL, V123, P542, DOI 10.1046/j.1365-2141.2003.04621.x; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; Delmar VA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-14; DREGER M, 2004, S SOC EXP BIOL, V9; Duband-Goulet I, 1998, J CELL SCI, V111, P1441; Duband-Goulet I, 2000, BIOCHEMISTRY-US, V39, P6483, DOI 10.1021/bi992908b; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Foisner Roland, 2003, ScientificWorldJournal, V3, P1; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Gaines P, 2008, EXP HEMATOL, V36, P965, DOI 10.1016/j.exphem.2008.04.006; Gajewski A, 1999, J CELL SCI, V112, P2583; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GOLDBERG M, 2004, S SOC EXP BIOL, V115; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Haraguchi T, 2000, J CELL SCI, V113, P779; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; HARTL P, 1994, J CELL BIOL, V124, P235, DOI 10.1083/jcb.124.3.235; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8; Hughes M, 1998, J CELL SCI, V111, P3017; Irons SL, 2003, J EXP BOT, V54, P943, DOI 10.1093/jxb/erg102; Ito H, 2007, EXP CELL RES, V313, P1897, DOI 10.1016/j.yexcr.2007.03.015; Kabuta T, 2008, BIOCHEM BIOPH RES CO, V377, P741, DOI 10.1016/j.bbrc.2008.09.106; Kawahire S, 1997, J BIOCHEM-TOKYO, V121, P881, DOI 10.1093/oxfordjournals.jbchem.a021669; Kushibiki S, 2001, J DAIRY RES, V68, P579, DOI 10.1017/S0022029901005040; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; MEIER J, 1994, EMBO J, V13, P1888, DOI 10.1002/j.1460-2075.1994.tb06458.x; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Nikolakaki E, 1997, J BIOL CHEM, V272, P6208, DOI 10.1074/jbc.272.10.6208; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Sambrook J., 2001, MOL CLONING LAB MANU; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shultz LD, 2003, HUM MOL GENET, V12, P61, DOI 10.1093/hmg/ddg003; SIMOS G, 1992, EMBO J, V11, P4027, DOI 10.1002/j.1460-2075.1992.tb05496.x; SMITH S, 1993, J CELL BIOL, V120, P631, DOI 10.1083/jcb.120.3.631; SMITH S, 1994, P NATL ACAD SCI USA, V91, P10124, DOI 10.1073/pnas.91.21.10124; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Takano M, 2004, J BIOL CHEM, V279, P13265, DOI 10.1074/jbc.M308854200; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Takizawa CG, 1999, P NATL ACAD SCI USA, V96, P7938, DOI 10.1073/pnas.96.14.7938; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WORMAN HJ, 1990, J CELL BIOL, V111, P1535, DOI 10.1083/jcb.111.4.1535; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1996, J CELL SCI, V109, P2275; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zwerger M, 2008, EXP HEMATOL, V36, P977, DOI 10.1016/j.exphem.2008.03.003	76	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33281	33293		10.1074/jbc.M110.102368	http://dx.doi.org/10.1074/jbc.M110.102368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20576617	Green Published, hybrid			2022-12-27	WOS:000283048200064
J	Saiepour, L; Fuchs, C; Patrizi, A; Sassoe-Pognetto, M; Harvey, RJ; Harvey, K				Saiepour, Leila; Fuchs, Celine; Patrizi, Annarita; Sassoe-Pognetto, Marco; Harvey, Robert J.; Harvey, Kirsten			Complex Role of Collybistin and Gephyrin in GABA(A) Receptor Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABAERGIC SYNAPSES; INHIBITORY SYNAPSES; ALPHA-5 SUBUNIT; BINDING; BRAIN; MOTIF; IDENTIFICATION; MAINTENANCE; DISRUPTION; ARHGEF9	Gephyrin and collybistin are key components of GABA(A) receptor (GABA(A)R) clustering. Nonetheless, resolving the molecular interactions between the plethora of GABA(A)R subunits and these clustering proteins is a significant challenge. We report a direct interaction of GABA(A)R alpha 2 and alpha 3 subunit intracellular M3-M4 domain (but not alpha 1, alpha 4, alpha 5, alpha 6, beta 1-3, or gamma 1-3) with gephyrin. Curiously, GABA(A)R alpha 2, but not alpha 3, binds to both gephyrin and collybistin using overlapping sites. The reciprocal binding sites on gephyrin for collybistin and GABA(A)R alpha 2 also overlap at the start of the gephyrin E domain. This suggests that although GABA(A)R alpha 3 interacts with gephyrin, GABA(A)R alpha 2, collybistin, and gephyrin form a trimeric complex. In support of this proposal, tri-hybrid interactions between GABA(A)R alpha 2 and collybistin or GABA(A)R alpha 2 and gephyrin are strengthened in the presence of gephyrin or collybistin, respectively. Collybistin and gephyrin also compete for binding to GABA(A)R alpha 2 in co-immuno-precipitation experiments and co-localize in transfected cells in both intracellular and submembrane aggregates. Interestingly, GABA(A)R alpha 2 is capable of "activating" collybistin isoforms harboring the regulatory SH3 domain, enabling targeting of gephyrin to the submembrane aggregates. The GABA(A)R alpha 2-collybistin interaction was disrupted by a pathogenic mutation in the collybistin SH3 domain (p.G55A) that causes X-linked intellectual disability and seizures by disrupting GABA(A)R and gephyrin clustering. Because immunohistochemistry in retina revealed a preferential co-localization of collybistin with alpha 2 subunit containing GABA(A)Rs, but not GlyRs or other GABA(A)R subtypes, we propose that the collybistin-gephyrin complex has an intimate role in the clustering of GABA(A)Rs containing the alpha 2 subunit.	[Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Patrizi, Annarita; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Natl Inst Neurosci Italy, I-10126 Turin, Italy	University of London; University College London; University of London School of Pharmacy; University of Turin	Harvey, K (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	kirsten.harvey@pharmacy.ac.uk	Harvey, Robert/D-3994-2016; Sassoe-Pognetto, Marco/AAE-3536-2022	Harvey, Robert/0000-0001-5956-6664; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Medical Research Council [G0501258]; Compagnia di San Paolo; Regione Piemonte Ricerca Sanitaria Finalizzata; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0501258, G0800498] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte Ricerca Sanitaria Finalizzata(Regione Piemonte); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Award G0501258 (to K. H.) and by a Compagnia di San Paolo and Regione Piemonte Ricerca Sanitaria Finalizzata 2008 grant (to M. S.-P.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jedlicka P, 2009, MOL CELL NEUROSCI, V41, P94, DOI 10.1016/j.mcn.2009.02.005; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Marco EJ, 2008, J MED GENET, V45, P100, DOI 10.1136/jmg.2007.052324; Meier J, 2004, J PHYSIOL-LONDON, V559, P355, DOI 10.1113/jphysiol.2004.066233; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mohler H, 2009, BIOCHEM SOC T, V37, P1328, DOI 10.1042/BST0371328; Nymann-Andersen J, 2002, J NEUROCHEM, V83, P1164, DOI 10.1046/j.1471-4159.2002.01222.x; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WISDEN W, 1992, J NEUROSCI, V12, P1040; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	49	101	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29623	29631		10.1074/jbc.M110.121368	http://dx.doi.org/10.1074/jbc.M110.121368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20622020	hybrid, Green Published			2022-12-27	WOS:000281740100063
J	To, C; Shilton, BH; Di Guglielmo, GM				To, Ciric; Shilton, Brian H.; Di Guglielmo, Gianni M.			Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; CDDO INDUCES APOPTOSIS; NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; 2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OIC ACID CDDO; INDUCED INFLAMMATORY RESPONSE; TUMOR-NECROSIS-FACTOR; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; DOWN-REGULATION; GROWTH ARREST	Synthetic triterpenoids are anti-tumor agents that affect numerous cellular functions including apoptosis and growth inhibition. Here, we used mass spectrometric and protein array approaches and uncovered that triterpenoids associate with proteins of the actin cytoskeleton, including actin-related protein 3 (Arp3). Arp3, a subunit of the Arp2/3 complex, is involved in branched actin polymerization and the formation of lamellipodia. 2-cyano-3,12-dioxooleana-1,9-dien- 28-oic acid (CDDO)-Im and CDDO-Me were observed to 1) inhibit the localization of Arp3 and actin at the leading edge of cells, 2) abrogate cell polarity, and 3) inhibit Arp2/3-dependent branched actin polymerization. We confirmed our drug effects with siRNA targeting of Arp3 and observed a decrease in Rat2 cell migration. Taken together, our data suggest that synthetic triterpenoids target Arp3 and branched actin polymerization to inhibit cell migration.	[To, Ciric; Di Guglielmo, Gianni M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Di Guglielmo, GM (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Med Sci Bldg, London, ON N6A 5C1, Canada.	john.diguglielmo@schulich.uwo.ca	To, Ciric/AAE-7406-2019; Shilton, Brian H/A-6667-2011		National Cancer Institute of Canada [17189]; Canadian Institutes of Health [MOP-93625]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by National Cancer Institute of Canada Grant 17189 and Canadian Institutes of Health Research Grant MOP-93625.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Bore L, 2002, ACTA CRYSTALLOGR C, V58, po199, DOI 10.1107/S010827010102176X; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P119, DOI 10.1124/mol.105.011437; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; Deeb D, 2007, ANTICANCER RES, V27, P3035; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao XH, 2008, IMMUNOPHARM IMMUNOT, V30, P581, DOI 10.1080/08923970802135559; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Han SS, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-22; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 1999, BIOORG MED CHEM LETT, V9, P3429, DOI 10.1016/S0960-894X(99)00623-X; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Ikeda T, 2003, CANCER RES, V63, P5551; Inoue S, 2004, LEUKEMIA, V18, P948, DOI 10.1038/sj.leu.2403328; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Kim KB, 2002, MOL CANCER THER, V1, P177; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2005, LEUKEMIA, V19, P1350, DOI 10.1038/sj.leu.2403828; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Kress CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000559; Lapillonne H, 2003, CANCER RES, V63, P5926; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pedersen IM, 2002, BLOOD, V100, P2965, DOI 10.1182/blood-2002-04-1174; Ray DM, 2006, EXP HEMATOL, V34, P1202, DOI 10.1016/j.exphem.2006.04.026; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; Stadheim TA, 2002, J BIOL CHEM, V277, P16448, DOI 10.1074/jbc.M108974200; Suh NJ, 1999, CANCER RES, V59, P336; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	56	35	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27944	27957		10.1074/jbc.M110.103036	http://dx.doi.org/10.1074/jbc.M110.103036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566646	hybrid, Green Published			2022-12-27	WOS:000281404100049
J	Lepesheva, GI; Hargrove, TY; Anderson, S; Kleshchenko, Y; Furtak, V; Wawrzak, Z; Villalta, F; Waterman, MR				Lepesheva, Galina I.; Hargrove, Tatiana Y.; Anderson, Spencer; Kleshchenko, Yuliya; Furtak, Vyacheslav; Wawrzak, Zdzislaw; Villalta, Fernando; Waterman, Michael R.			Structural Insights into Inhibition of Sterol 14 alpha-Demethylase in the Human Pathogen Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAGAS-DISEASE; CRYSTAL-STRUCTURES; POSACONAZOLE; KETOCONAZOLE; CYP51; KINETOPLASTIDA; EPIMASTIGOTES; BIOSYNTHESIS; EPIDEMIOLOGY; CHEMOTHERAPY	Trypanosoma cruzi causes Chagas disease (American trypanosomiasis), which threatens the lives of millions of people and remains incurable in its chronic stage. The antifungal drug posaconazole that blocks sterol biosynthesis in the parasite is the only compound entering clinical trials for the chronic form of this infection. Crystal structures of the drug target enzyme, Trypanosoma cruzi sterol 14 alpha-demethylase (CYP51), complexed with posaconazole, another antifungal agent fluconazole and an experimental inhibitor, (R)-4'-chloro-N-(1-(2,4-dichlorophenyl)-2-(1H-imid-azol-1-yl)ethyl)biphenyl-4-carboxamide (VNF), allow prediction of important chemical features that enhance the drug potencies. Combined with comparative analysis of inhibitor binding parameters, influence on the catalytic activity of the trypanosomal enzyme and its human counterpart, and their cellular effects at different stages of the Trypanosoma cruzi life cycle, the structural data provide a molecular background to CYP51 inhibition and azole resistance and enlighten the path for directed design of new, more potent and selective drugs to develop an efficient treatment for Chagas disease.	[Lepesheva, Galina I.; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Anderson, Spencer; Wawrzak, Zdzislaw] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Dept Biochem Mol Biol & Cell Biol, Argonne, IL 60439 USA; [Kleshchenko, Yuliya; Furtak, Vyacheslav; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; Northwestern University; Meharry Medical College	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu		Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [GM 067871, AI 080580]; American Heart Association [0535121N];  [DE-AC02-06CH11357];  [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grants GM 067871 (to M. R. W. and G. I. L.) and AI 080580 (to F. V.). This work was also supported by American Heart Association Grant 0535121N (to G. I. L.), and use of the Advanced Photon Source and Life Sciences Collaborative Access Team Sector 21 was supported by Grants DE-AC02-06CH11357 and 085P1000817.	Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; Buckner FS, 1998, ANTIMICROB AGENTS CH, V42, P3245, DOI 10.1128/AAC.42.12.3245; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; DOCAMPO R, 1981, MOL BIOCHEM PARASIT, V3, P169, DOI 10.1016/0166-6851(81)90047-5; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueiredo RCBQ, 2004, PARASITOLOGY, V129, P431, DOI 10.1017/S0031182004005797; GHOMARI MJ, 1997, J PHYS ORG CHEM, V10, P669; Guevara P, 2005, J MED ENTOMOL, V42, P48, DOI 10.1603/0022-2585(2005)042[0048:EOFGIT]2.0.CO;2; Gonzalez-Granado LI, 2009, LANCET, V373, P2025, DOI 10.1016/S0140-6736(09)61110-7; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Moreira DRM, 2009, CURR DRUG TARGETS, V10, P212; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Nagappan V, 2007, CLIN INFECT DIS, V45, P1610, DOI 10.1086/523576; NEVA FA, 2007, CECIL MED EXPERT CON, pCH368; OTNINOWSKI Z, 1995, HKL MANUAL; Paulino M, 2005, MINI-REV MED CHEM, V5, P499, DOI 10.2174/1389557053765565; Pena-Diaz J, 2004, MOL BIOL CELL, V15, P1356, DOI 10.1091/mbc.E03-10-0720; Soares MBP, 2009, MEM I OSWALDO CRUZ, V104, P325, DOI 10.1590/S0074-02762009000900043; Petrikkos G, 2007, INT J ANTIMICROB AG, V30, P108, DOI 10.1016/j.ijantimicag.2007.03.009; POULOS TL, 2005, CYTOCHROME P450 STRU; Quinones W, 2004, EXP PARASITOL, V106, P135, DOI 10.1016/j.exppara.2004.03.006; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Schiller DS, 2007, CLIN THER, V29, P1862, DOI 10.1016/j.clinthera.2007.09.015; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; VILLALTA F, 1982, J PROTOZOOL, V29, P570, DOI 10.1111/j.1550-7408.1982.tb01338.x; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	46	115	117	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25582	25590		10.1074/jbc.M110.133215	http://dx.doi.org/10.1074/jbc.M110.133215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20530488	Green Published, hybrid			2022-12-27	WOS:000280682400052
J	Guo, YJ; Golebiewska, U; D'Amico, S; Scarlata, S				Guo, Yuanjian; Golebiewska, Urszula; D'Amico, Stephen; Scarlata, Suzanne			The Small G Protein Rac1 Activates Phospholipase C delta 1 through Phospholipase C beta 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTP-BINDING PROTEIN; C-BETA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE INTERACTIONS; COUPLED-RECEPTOR; ASSOCIATION; STIMULATION; DELTA; PURIFICATION	Rac1, which is associated with cytoskeletal pathways, can activate phospholipase C beta 2 (PLC beta 2) to increase intracellular Ca2+ levels. This increased Ca2+ can in turn activate the very robust PLC delta 1 to synergize Ca2+ signals. Wehave previously found that PLC beta 2 will bind to and inhibit PLC delta 1 in solution by an unknown mechanism and that PLC beta 2 center dot PLC delta 1 complexes can be disrupted by G beta gamma subunits. However, because the major populations of PLC beta 2 and PLC delta 1 are cytosolic, their regulation by G beta gamma subunits is not clear. Here, we have found that the pleckstrin homology (PH) domains of PLC beta 2 and PLC beta 3 are the regions that result in PLC delta 1 binding and inhibition. In cells, PLC beta 2 center dot PLC delta 1 form complexes as seen by Forster resonance energy transfer and co-immunoprecipitation, and microinjection of PH beta 2 dissociates the complex. Using PH beta 2 as a tool to assess the contribution of PLC delta inhibition of PLC delta 1 to Ca2+ release, we found that, although PH beta 2 only results in a 25% inhibition of PLC delta 1 in solution, in cells the presence of PH beta 2 appears to eliminates Ca2+ release suggesting a large threshold effect. Wefound that the small plasma membrane population of PLC beta 2 center dot PLC delta 1 is disrupted by activation of heterotrimeric G proteins, and that the major cytosolic population of the complexes are disrupted by Rac1 activation. Thus, the activity of PLC delta 1 is controlled by the amount of bound PLC beta 2 that changes with displacement of the enzyme by heterotrimeric or smallGproteins. Through PLC beta 2, PLC delta 1 activation is linked to surface receptors as well as signals that mediate cytoskeletal pathways.	SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] Queensboro Community Coll, Dept Biol Sci & Geol, Bayside, NY 11364 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook		Suzanne.Scarlata@stonybrook.edu			National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053132.	Allen WE, 1997, J CELL SCI, V110, P707; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Ghosh Mousumi, 2003, V237, P55; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hardoy MC, 2006, J CLIN PSYCHOPHARM, V26, P379, DOI 10.1097/01.jcp.0000229483.52955.ec; Hodson EAM, 1998, BBA-MOL CELL RES, V1403, P97, DOI 10.1016/S0167-4889(98)00028-7; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Lee SB, 1996, BLOOD, V88, P1684; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Scarlata S, 2002, METHOD ENZYMOL, V345, P306; Schmidt M, 2000, J BIOL CHEM, V275, P32603, DOI 10.1074/jbc.M004784200; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Wang TL, 1999, BIOCHEMISTRY-US, V38, P1517, DOI 10.1021/bi982008f	39	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 6	2010	285	32					24999	25008		10.1074/jbc.M110.132654	http://dx.doi.org/10.1074/jbc.M110.132654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	633YB	20530480	Green Published, hybrid			2022-12-27	WOS:000280542100072
